data_2gqm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gqm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.424 0 CA-C-O 118.25 -1.305 . . . . 3.4300000000000002 110.518 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.63 147.87 36.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.191 1.928 . . . . 3.6899999999999999 110.164 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -143.88 154.19 43.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.602 0.761 . . . . 4.75 111.062 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 m -122.87 15.74 10.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.595 1.702 . . . . 3.2999999999999998 115.595 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.37 147.89 50.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.152 2.181 . . . . 3.29 112.419 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.31 151.09 24.97 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.713 1.605 . . . . 3.6299999999999999 109.971 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 146' ' ' THR . 0.6 OUTLIER -95.64 161.83 13.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.656 1.217 . . . . 3.8799999999999999 111.971 175.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -45.49 -28.24 0.88 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.257 2.623 . . . . 1.8200000000000001 115.248 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 144' ' ' THR . 10.3 m -72.02 -20.1 61.75 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.451 1.9 . . . . 3.75 113.456 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.33 11.78 56.87 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.073 1.32 . . . . 2.29 114.559 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.5 -162.73 0.98 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.929 1.291 . . . . 4.3200000000000003 110.45 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -144.07 103.74 4.05 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.496 1.044 . . . . 5.0700000000000003 113.06 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 175.68 5.49 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.682 1.364 . . . . 5.6500000000000004 114.682 173.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.4 p -137.19 -179.28 5.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.446 2.298 . . . . 3.25 111.092 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.44 -26.94 62.03 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.703 -1.248 . . . . 3.5899999999999999 112.916 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -94.68 -19.45 20.41 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.051 1.871 . . . . 8.0099999999999998 116.051 -167.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -71.21 -28.79 64.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.26 1.391 . . . . 3.0299999999999998 112.102 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -96.04 40.83 1.11 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.276 1.03 . . . . 5.6299999999999999 112.535 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.64 169.15 13.34 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.254 -0.903 . . . . 6.3399999999999999 112.409 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 75.93 -10.05 15.66 Favored Glycine 0 CA--C 1.54 1.635 0 O-C-N 120.517 -1.365 . . . . 2.52 116.319 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -116.02 156.23 26.69 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.671 2.388 . . . . 3.25 110.094 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -70.88 100.31 1.92 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.569 1.077 . . . . 1.8100000000000001 111.176 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.9 mt -83.85 134.57 34.7 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.138 0.971 . . . . 3.5600000000000001 109.907 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.69 112.59 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.42 -1.696 . . . . 3.8199999999999998 106.42 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.1 pt -114.77 122.21 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.079 0.552 . . . . 3.8300000000000001 109.547 -165.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -111.79 143.74 42.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.791 1.236 . . . . 3.8199999999999998 112.024 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.02 104.5 12.76 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.414 1.486 . . . . 3.1800000000000002 108.681 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -120.5 -176.18 15.6 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.39 1.471 . . . . 1.3600000000000001 114.852 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -157.5 115.75 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.739 2.015 . . . . 5.0099999999999998 106.406 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.6 m -76.28 71.89 3.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.215 1.406 . . . . 4.5599999999999996 110.178 -166.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 173.79 -48.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.17 2.588 . . . . 7.6299999999999999 110.338 -158.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 52.1 -161.86 0.01 OUTLIER Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.664 2.385 . . . . 3.9399999999999999 115.321 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -71.66 -74.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 124.7 3.6 . . . . 5.7599999999999998 110.619 120.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -163.68 30.17 0.08 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.482 1.037 . . . . 4.2199999999999998 113.735 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.8 -17.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 115.311 1.597 . . . . 4.3499999999999996 115.311 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 29.7 m -49.7 -48.3 77.11 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 116.354 -1.784 . . . . 1.72 112.888 155.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.14 -39.89 9.73 Favored 'Trans proline' 0 C--N 1.354 0.825 0 CA-C-N 122.751 2.018 . . . . 2.0099999999999998 112.206 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.67 -48.49 81.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.381 1.072 . . . . 3.52 111.076 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 4.9 tp10 -75.44 -22.38 57.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.012 0.925 . . . . 3.7400000000000002 112.871 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.25 -37.65 78.07 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 116.762 -1.589 . . . . 3.73 110.897 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -52.53 65.24 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.236 1.835 . . . . 5.2400000000000002 109.41 170.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 38.8 mtmt -63.35 -39.35 94.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.409 0.522 . . . . 4.1699999999999999 112.409 -174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.6 ttm -57.41 -49.0 77.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.493 1.517 . . . . 3.7000000000000002 111.518 167.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.25 -41.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.568 1.147 . . . . 2.98 113.105 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.429 ' HG3' ' HE2' ' A' ' 283' ' ' LYS . 35.6 mm-40 -70.88 -50.67 32.57 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.02 1.282 . . . . 3.9300000000000002 109.159 173.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -17.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.879 1.437 . . . . 3.25 114.879 -169.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.81 -45.72 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 119.441 1.019 . . . . 3.3399999999999999 110.931 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.21 -25.67 18.55 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.259 0.466 . . . . 6.0499999999999998 112.259 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.507 ' CD ' ' HZ2' ' A' ' 283' ' ' LYS . 54.7 mt-10 -65.07 -29.36 70.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.781 1.232 . . . . 2.9100000000000001 113.055 166.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -45.22 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 118.508 -0.758 . . . . 3.1600000000000001 112.767 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.407 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 0.9 OUTLIER -61.97 -30.92 71.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.145 1.339 . . . . 4.8399999999999999 110.924 174.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.3 t -60.78 -24.47 65.81 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.298 1.839 . . . . 3.04 113.184 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.44 -26.58 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.113 -1.617 . . . . 6.0899999999999999 110.403 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.7 m 76.85 -36.72 0.26 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.31 2.244 . . . . 5.0999999999999996 112.966 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.4 m -73.48 -22.96 60.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.396 1.478 . . . . 6.2300000000000004 113.1 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.3 156.46 81.45 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 121.18 -0.95 . . . . 4.5199999999999996 110.808 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.447 ' HG2' ' H ' ' A' ' 195' ' ' ASP . 55.6 Cg_endo -66.66 -62.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.713 2.275 . . . . 3.2799999999999998 109.338 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . 0.447 ' H ' ' HG2' ' A' ' 194' ' ' PRO . 5.6 p-10 -171.21 157.08 4.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.613 3.565 . . . . 4.6399999999999997 107.909 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.94 125.68 48.68 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.975 -0.75 . . . . 3.8199999999999998 108.975 156.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.8 m -112.55 111.51 51.96 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.105 1.362 . . . . 2.5699999999999998 110.062 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.71 134.08 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.734 2.956 . . . . 1.24 111.717 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.65 116.32 25.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.425 1.09 . . . . 3.1400000000000001 109.778 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.24 112.93 24.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 4.0999999999999996 109.679 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.7 mm -99.7 123.58 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.494 -1.298 . . . . 3.2799999999999998 107.494 166.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 9.8 t -90.64 153.79 20.05 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.565 -0.709 . . . . 2.7200000000000002 109.861 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.9 pt -115.95 -2.23 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.015 1.117 . . . . 3.1699999999999999 114.015 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -119.54 74.71 17.33 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 120.144 1.338 . . . . 3.48 110.287 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.5 160.38 50.01 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.507 2.805 . . . . 3.3100000000000001 110.722 -169.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 77.53 -51.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.237 2.615 . . . . 7.4900000000000002 109.392 -172.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -63.62 -52.3 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.507 1.123 . . . . 6.9100000000000001 109.43 172.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.4 83.21 5.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.369 1.08 . . . . 5.1900000000000004 109.178 159.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -64.94 132.61 49.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.289 -0.869 . . . . 3.6400000000000001 109.136 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -43.93 -50.22 8.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.623 1.169 . . . . 3.96 112.895 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -27.02 61.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.353 1.242 . . . . 3.6200000000000001 114.353 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.18 87.96 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.052 -1.03 . . . . 3.3199999999999998 110.651 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.78 -36.0 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.929 0.892 . . . . 3.0 110.35 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.48 -17.83 15.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.572 1.149 . . . . 2.0899999999999999 113.757 166.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -88.89 -47.9 7.84 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.991 -1.068 . . . . 5.4100000000000001 112.792 167.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -58.19 -38.47 76.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.116 0.966 . . . . 4.75 112.576 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.4 t -54.28 -60.44 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.963 1.705 . . . . 2.1400000000000001 110.68 165.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -66.16 -40.8 90.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.517 1.527 . . . . 4.9199999999999999 114.698 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.92 -28.9 58.19 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.03 1.122 . . . . 3.4500000000000002 114.03 -172.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -77.96 -53.01 7.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.461 0.573 . . . . 5.46 112.024 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.1 t -169.42 136.84 1.49 Allowed Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.422 1.089 . . . . 3.3700000000000001 110.916 168.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.91 -4.64 11.71 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.247 2.631 . . . . 1.8 113.996 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . 0.407 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 17.1 tttt -71.29 -14.25 62.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.964 1.256 . . . . 3.3599999999999999 113.521 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.81 140.75 55.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.361 1.064 . . . . 4.1900000000000004 112.58 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.3 t -118.36 130.88 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.998 1.319 . . . . 2.7999999999999998 108.578 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -124.54 121.56 4.42 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.683 0.659 . . . . 1.1200000000000001 114.051 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.77 159.46 15.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.921 1.288 . . . . 4.3099999999999996 113.215 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -152.86 150.47 29.35 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.517 1.927 . . . . 3.48 108.899 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -172.09 165.24 37.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.952 -2.059 . . . . 1.8 107.952 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -70.55 172.63 8.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.877 0.839 . . . . 4.0099999999999998 111.959 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.439 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 30.4 ptt180 -43.01 -38.81 2.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.412 1.485 . . . . 8.9600000000000009 113.691 173.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -64.68 -37.94 89.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.095 1.358 . . . . 3.0899999999999999 111.669 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.77 -44.65 22.81 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.653 1.181 . . . . 2.9300000000000002 113.281 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.8 m -65.97 -27.11 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.074 0.397 . . . . 3.9399999999999999 111.739 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.77 -45.68 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.269 -0.872 . . . . 3.1000000000000001 112.054 165.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -50.0 -58.39 5.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.862 1.21 . . . . 3.7400000000000002 110.981 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.72 -25.69 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.181 0.9 . . . . 3.0099999999999998 112.023 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.77 -40.35 72.69 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.983 -0.448 . . . . 2.1299999999999999 110.292 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -71.2 -38.32 72.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.23 1.012 . . . . 5.7999999999999998 112.237 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -44.48 85.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.354 1.462 . . . . 2.7000000000000002 113.82 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -100.89 5.82 43.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.462 1.105 . . . . 3.1099999999999999 113.523 170.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 64.2 37.89 8.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.787 2.035 . . . . 6.0499999999999998 113.732 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.32 151.18 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.694 0.798 . . . . 3.3999999999999999 111.749 -173.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 140.36 36.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.811 0.845 . . . . 5.7000000000000002 112.318 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.45 165.67 26.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.5 2.32 . . . . 5.0300000000000002 109.875 168.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.69 106.29 1.06 Allowed Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 121.249 -0.907 . . . . 3.2200000000000002 110.781 175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -94.98 134.29 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.411 2.741 . . . . 2.8399999999999999 112.632 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.415 0 C-N-CA 125.309 1.433 . . . . 2.8599999999999999 111.144 174.213 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 108.747 -0.835 . . . . 5.8499999999999996 108.747 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp -49.86 152.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 126.621 1.968 . . . . 4.2300000000000004 113.849 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.48 130.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.221 1.408 . . . . 4.21 108.145 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.69 141.15 31.68 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.654 1.582 . . . . 3.7400000000000002 110.709 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -126.82 155.67 42.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.707 0.765 . . . . 3.21 111.549 165.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.7 m -62.78 113.44 3.04 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 4.3200000000000003 109.6 168.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.31 44.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.316 1.046 . . . . 4.9199999999999999 112.849 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.7 mt -132.95 135.5 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.123 0.969 . . . . 3.25 110.653 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.3 ptp -104.01 142.96 33.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.112 1.365 . . . . 3.3700000000000001 110.911 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -99.88 141.71 32.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.346 1.058 . . . . 3.4199999999999999 112.019 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -101.8 119.34 38.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.884 1.274 . . . . 3.8500000000000001 109.243 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 63.4 mt -100.16 138.16 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.915 1.686 . . . . 3.3399999999999999 107.887 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 171.45 42.05 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.54 1.067 . . . . 2.1000000000000001 111.515 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -82.7 66.1 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.249 2.633 . . . . 2.77 109.367 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -177.52 -69.17 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.553 2.341 . . . . 4.9400000000000004 108.988 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 160.55 -21.61 0.24 Allowed Glycine 0 CA--C 1.538 1.527 0 N-CA-C 117.02 1.568 . . . . 2.9100000000000001 117.02 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.76 152.89 44.73 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.965 1.382 . . . . 6.6600000000000001 112.429 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -99.45 129.51 45.64 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.38 -1.45 . . . . 5.6500000000000004 112.271 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.95 -18.07 10.23 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.74 1.385 . . . . 4.1699999999999999 114.74 -167.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -162.98 171.46 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.633 1.173 . . . . 2.6699999999999999 110.987 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -148.51 149.02 30.9 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.144 1.377 . . . . 3.7000000000000002 111.527 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.403 ' CD1' HG12 ' A' ' 286' ' ' ILE . 1.4 m-85 -130.0 105.0 7.68 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.105 1.362 . . . . 3.6600000000000001 109.737 -173.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -86.01 153.27 26.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.225 -1.95 . . . . 2.7000000000000002 108.225 153.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -17.05 2.99 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 117.279 2.326 . . . . 5.8899999999999997 117.279 -164.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -63.2 -27.47 69.38 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.943 1.09 . . . . 6.25 113.943 169.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -92.87 96.0 9.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.025 1.73 . . . . 5.1399999999999997 109.744 165.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.15 176.87 8.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.737 1.615 . . . . 5.5199999999999996 112.753 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.507 ' HZ2' ' CD ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -57.28 -27.3 62.0 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.022 1.86 . . . . 3.3799999999999999 116.022 -169.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.7 -36.2 53.83 Favored Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.527 -0.733 . . . . 1.71 112.07 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.77 -31.8 46.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.082 1.753 . . . . 3.5699999999999998 111.216 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . 0.403 HG12 ' CD1' ' A' ' 277' ' ' PHE . 79.0 mt -64.85 -45.44 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 2.2599999999999998 110.077 166.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.55 87.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.175 0.898 . . . . 2.3100000000000001 111.095 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.91 97.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.087 0.858 . . . . 2.8300000000000001 113.092 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 94.2 p -74.55 -38.42 62.73 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.99 -1.069 . . . . 2.79 113.414 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.01 -35.64 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.662 1.573 . . . . 2.1200000000000001 111.707 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.01 -18.77 63.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.531 -1.356 . . . . 2.2799999999999998 113.479 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.1 m -74.83 -55.1 6.17 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.407 -0.808 . . . . 2.96 109.737 167.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -64.55 -22.58 67.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.876 1.67 . . . . 3.3999999999999999 113.555 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -42.09 46.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.814 1.646 . . . . 6.0700000000000003 112.157 165.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -64.21 -55.36 31.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 116.419 -1.753 . . . . 6.3600000000000003 113.249 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.47 -38.34 1.97 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.284 1.989 . . . . 3.0499999999999998 112.686 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 17.66 7.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.752 1.019 . . . . 4.3899999999999997 113.752 -173.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 7.8899999999999997 113.198 -164.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.425 0 CA-C-O 118.593 -1.115 . . . . 3.8599999999999999 114.388 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.75 149.71 54.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.99 3.127 . . . . 3.4100000000000001 112.134 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -154.88 172.69 17.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.24 1.016 . . . . 4.2800000000000002 112.128 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.8 m -143.42 119.9 11.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.91 -1.515 . . . . 3.5 106.91 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 12.6 tp -157.35 140.21 15.1 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.561 0.619 . . . . 3.6600000000000001 111.432 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.1 m -74.43 146.67 42.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.626 0.727 . . . . 2.6000000000000001 109.44 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.7 m -99.35 139.81 34.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.509 1.124 . . . . 3.4199999999999999 110.77 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.47 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -51.67 -36.54 46.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.896 2.078 . . . . 3.04 113.117 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -108.09 -1.11 20.7 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.046 1.738 . . . . 4.3600000000000003 111.968 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.15 -125.56 1.62 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 119.151 0.887 . . . . 4.5499999999999998 111.789 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.0 -160.94 1.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.146 1.378 . . . . 5.3899999999999997 110.715 -157.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.28 97.11 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.34 1.056 . . . . 7.04 111.653 -168.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.26 149.61 33.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.697 1.599 . . . . 4.3300000000000001 110.911 172.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 58.5 p -140.12 141.42 36.11 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.439 2.296 . . . . 3.1400000000000001 107.498 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -28.04 -69.36 0.05 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.978 1.711 . . . . 3.75 115.369 -171.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -65.86 0.04 2.01 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 116.913 2.19 . . . . 8.1799999999999997 116.913 -174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.39 -54.91 29.38 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 119.848 1.204 . . . . 3.1400000000000001 110.161 162.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -91.21 -28.0 18.11 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.703 1.001 . . . . 4.54 113.703 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 59.37 4.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.596 1.159 . . . . 7.0700000000000003 112.609 -168.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -108.94 0.07 31.79 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.086 1.803 . . . . 3.1499999999999999 113.138 162.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -153.46 175.12 13.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.859 2.064 . . . . 3.9199999999999999 108.993 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -66.42 118.33 9.91 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.12 0.968 . . . . 2.0499999999999998 112.748 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 mp -107.85 147.34 31.05 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.598 0.759 . . . . 4.3799999999999999 112.206 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.0 mp -111.94 118.02 34.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.308 1.843 . . . . 3.5299999999999998 107.527 166.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.2 mt -118.79 124.47 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.672 0.789 . . . . 2.5 110.102 -173.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -127.88 139.98 52.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.874 1.27 . . . . 3.4399999999999999 113.23 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.7 120.32 42.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.903 1.281 . . . . 3.5899999999999999 110.636 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -145.6 -175.51 18.75 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 116.108 1.203 . . . . 1.3999999999999999 116.108 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -139.65 133.77 31.09 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 123.63 1.681 . . . . 4.6900000000000004 113.718 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 23.41 0.07 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.743 2.017 . . . . 3.4500000000000002 114.036 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -165.66 32.83 0.05 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.125 2.17 . . . . 7.8099999999999996 110.403 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 82.2 m -54.27 159.1 3.31 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.15 -1.594 . . . . 2.1699999999999999 111.941 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.21 68.93 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.164 2.576 . . . . 3.52 108.455 159.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 68.07 -17.49 0.17 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.996 3.318 . . . . 5.4500000000000002 115.626 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.0 t -43.87 -65.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.646 1.978 . . . . 4.1900000000000004 113.146 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 28.1 m -58.41 -50.37 88.4 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 116.579 -1.676 . . . . 1.6399999999999999 114.285 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.72 -34.23 51.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.955 2.091 . . . . 2.3700000000000001 114.159 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.82 -36.59 64.98 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.394 0.997 . . . . 4.1900000000000004 111.885 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.87 -35.28 72.31 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.44 -1.412 . . . . 3.7200000000000002 112.563 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.67 -27.33 67.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 117.23 -1.367 . . . . 4.1600000000000001 112.51 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -62.78 1.3 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.997 1.271 . . . . 3.3500000000000001 109.053 167.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -58.23 -21.09 46.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.694 -1.254 . . . . 5.6900000000000004 113.215 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.0 mmm -79.79 -41.46 26.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.047 1.499 . . . . 6.3499999999999996 115.047 165.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.94 -31.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 122.477 2.399 . . . . 3.02 110.5 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -37.31 -41.6 0.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.484 1.914 . . . . 4.1699999999999999 112.854 162.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.2 -22.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 2.7999999999999998 111.775 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.61 -39.27 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.932 0.787 . . . . 2.8399999999999999 109.55 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.25 -44.15 95.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.27 1.028 . . . . 4.0800000000000001 111.011 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.575 ' CD ' ' HZ3' ' A' ' 283' ' ' LYS . 37.2 mt-10 -71.42 -7.82 49.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.83 1.652 . . . . 3.3799999999999999 114.867 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.2 mt -119.85 -48.35 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 118.088 -0.958 . . . . 3.0600000000000001 113.427 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.64 -27.35 67.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.925 1.239 . . . . 3.77 111.711 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.9 t -70.65 -11.3 60.86 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.845 -1.159 . . . . 3.8700000000000001 113.743 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 34.3 mm -90.61 86.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 120.441 -1.412 . . . . 4.6200000000000001 108.71 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 81.0 p -63.98 60.54 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.387 2.675 . . . . 5.3899999999999997 115.41 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 10.5 t -173.18 -24.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 129.907 3.283 . . . . 5.0800000000000001 110.871 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.17 156.02 8.13 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.774 -1.204 . . . . 4.0199999999999996 109.934 151.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.44 -66.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.378 -1.816 . . . . 3.3599999999999999 107.378 162.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.15 173.2 2.64 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.269 3.027 . . . . 3.6200000000000001 109.791 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 tp -119.2 110.17 16.72 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.858 0.863 . . . . 3.23 111.1 161.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.8 m -92.78 120.05 67.48 Favored Pre-proline 0 N--CA 1.482 1.128 0 O-C-N 120.939 -1.1 . . . . 2.0499999999999998 111.467 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -93.63 131.12 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.538 2.825 . . . . 1.1699999999999999 112.571 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.97 119.49 30.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.854 2.062 . . . . 3.4100000000000001 110.472 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -99.8 136.16 40.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.01 1.724 . . . . 4.29 110.8 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.06 126.26 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.576 1.55 . . . . 2.6499999999999999 109.204 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 92.0 p -84.01 141.79 30.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.214 0.531 . . . . 2.8300000000000001 110.23 165.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.9 pt -108.53 19.96 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.029 -1.044 . . . . 2.5099999999999998 112.841 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -118.05 77.06 12.08 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.816 2.046 . . . . 3.3300000000000001 110.897 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.38 83.06 2.33 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.285 3.323 . . . . 3.2799999999999998 109.713 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.45 -124.18 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.601 1.961 . . . . 4.7199999999999998 106.283 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.99 11.25 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 117.965 2.58 . . . . 8.1999999999999993 117.965 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -89.74 150.89 22.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.782 -1.824 . . . . 3.3999999999999999 111.049 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.1 p -142.71 144.9 32.88 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.486 1.136 . . . . 3.98 112.252 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -42.97 -55.47 3.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.088 2.155 . . . . 4.7599999999999998 111.952 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -70.57 -34.0 71.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.159 0.983 . . . . 4.21 113.221 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.99 68.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.311 1.414 . . . . 2.6800000000000002 111.224 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.3 mm -58.62 -39.19 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 119.407 -0.33 . . . . 2.3900000000000001 111.612 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.9 -29.46 60.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.978 1.311 . . . . 2.8500000000000001 113.805 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -90.26 -38.69 13.25 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.778 0.831 . . . . 5.8099999999999996 112.983 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.17 -38.74 80.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.271 1.428 . . . . 4.0999999999999996 111.787 174.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.9 t -54.55 -34.19 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.477 1.511 . . . . 1.99 113.541 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.32 -35.68 78.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.151 -0.928 . . . . 6.4100000000000001 111.939 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.2 -36.43 81.72 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 124.396 1.06 . . . . 4.0099999999999998 111.223 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.9 -44.03 61.74 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.934 0.788 . . . . 5.0099999999999998 113.033 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.5 m 150.42 143.1 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 130.056 3.342 . . . . 2.6899999999999999 111.042 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.26 -0.97 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.495 2.797 . . . . 1.8899999999999999 115.908 -167.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.86 -14.7 60.7 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 120.631 1.56 . . . . 3.73 112.546 168.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.98 127.67 33.49 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.628 -1.295 . . . . 3.8500000000000001 111.917 -170.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.9 124.35 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.448 -1.686 . . . . 3.2400000000000002 106.448 171.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.47 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -103.8 127.01 8.98 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 108.672 -1.771 . . . . 1.1100000000000001 108.672 170.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.28 150.53 32.32 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.968 0.507 . . . . 3.96 110.253 167.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.3 t -167.07 176.08 7.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.397 2.279 . . . . 3.73 108.971 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.63 34.22 Favored Glycine 0 N--CA 1.468 0.83 0 O-C-N 120.771 -1.206 . . . . 1.76 115.2 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -73.81 161.88 29.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.332 1.053 . . . . 3.0299999999999998 111.164 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -43.88 67.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.745 0.818 . . . . 8.3499999999999996 111.246 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.58 1.552 . . . . 3.8700000000000001 112.969 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.12 -46.68 49.84 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.54 -0.725 . . . . 3.2200000000000002 111.675 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.19 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 119.155 -0.45 . . . . 2.6099999999999999 111.372 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.61 -39.61 80.79 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.321 0.964 . . . . 3.8999999999999999 112.127 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -62.72 -49.13 76.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.016 1.28 . . . . 4.1900000000000004 110.909 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.77 -48.22 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.794 0.838 . . . . 4.0899999999999999 111.909 -171.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.52 -50.53 51.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.868 0.867 . . . . 2.1499999999999999 110.396 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -72.62 -27.34 62.09 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 117.461 -1.257 . . . . 4.2699999999999996 113.556 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.51 65.32 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.864 1.211 . . . . 2.1699999999999999 111.037 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -84.3 12.1 7.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.454 1.102 . . . . 3.3199999999999998 113.569 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 65.71 -41.72 0.34 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.781 2.832 . . . . 7.1100000000000003 115.021 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.3 t 18.85 103.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 131.622 3.969 . . . . 3.6499999999999999 115.907 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -71.47 142.47 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.917 0.887 . . . . 4.8099999999999996 113.201 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -169.73 155.29 5.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.737 2.015 . . . . 4.6200000000000001 110.273 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -148.45 106.58 3.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.424 0.69 . . . . 3.4100000000000001 109.795 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.61 138.45 15.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.337 2.025 . . . . 3.1000000000000001 110.243 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.268 0 CA-C-O 119.646 -0.53 . . . . 2.4399999999999999 112.418 -176.157 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 18.6 t80 . . . . . 0 CA--C 1.544 0.718 0 CA-C-O 121.167 0.508 . . . . 4.5800000000000001 111.324 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 tp -71.31 156.81 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.974 0.909 . . . . 3.6600000000000001 111.208 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.3 m -151.16 166.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.481 1.912 . . . . 4.3899999999999997 109.894 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.97 158.99 26.52 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.859 2.864 . . . . 3.7599999999999998 111.01 169.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 161.2 9.34 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.066 1.746 . . . . 2.9199999999999999 113.943 -166.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 29.0 p -60.89 -42.31 97.75 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.194 1.553 . . . . 4.9000000000000004 115.194 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.29 0.3 OUTLIER 54.55 41.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.261 1.424 . . . . 4.6299999999999999 112.815 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.53 140.77 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 120.459 -1.401 . . . . 3.5600000000000001 110.67 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 58.7 tpp -99.88 115.89 30.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.348 1.859 . . . . 3.8100000000000001 109.172 165.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -95.03 148.59 22.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.102 -1.624 . . . . 4.1799999999999997 112.373 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -99.42 126.06 45.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.553 1.141 . . . . 3.1800000000000002 109.619 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.2 mm -107.94 126.96 64.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 108.221 -1.029 . . . . 3.8900000000000001 108.221 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.72 160.53 53.02 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 117.969 -1.462 . . . . 2.0600000000000001 110.163 162.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.78 -11.8 19.22 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.134 3.223 . . . . 3.6400000000000001 113.911 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.5 -41.82 88.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.727 2.811 . . . . 4.1299999999999999 110.573 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.95 31.43 2.69 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.065 1.317 . . . . 3.1499999999999999 115.723 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -142.84 164.04 31.18 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.684 1.242 . . . . 4.75 112.177 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -67.44 125.75 27.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 6.4000000000000004 112.505 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.4 tt -118.52 -24.23 6.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.383 1.473 . . . . 4.2999999999999998 112.405 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -165.53 171.92 12.65 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.49 2.316 . . . . 2.7999999999999998 109.234 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -159.24 158.76 33.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.497 1.119 . . . . 5.0999999999999996 113.673 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.85 -179.85 7.31 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.594 1.958 . . . . 3.54 112.055 -165.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.3 -145.34 16.91 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.05 1.786 . . . . 4.3799999999999999 109.91 -171.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -54.5 3.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 118.942 2.942 . . . . 3.8399999999999999 118.942 -161.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -135.96 -45.35 0.65 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.288 -1.508 . . . . 5.2599999999999998 112.132 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -79.19 86.31 4.99 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.935 -1.103 . . . . 5.3300000000000001 110.458 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.07 155.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.003 2.521 . . . . 6.6399999999999997 114.901 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.575 ' HZ3' ' CD ' ' A' ' 186' ' ' GLU . 1.1 tmmt? -41.7 -70.22 0.11 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.016 2.127 . . . . 3.77 116.143 -172.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.31 -24.95 75.54 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 122.564 1.091 . . . . 2.1299999999999999 111.284 -170.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -70.14 -23.91 63.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.377 1.871 . . . . 5.29 111.317 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.24 -51.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.258 -0.901 . . . . 2.46 110.752 162.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.1 71.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.38 0.991 . . . . 2.04 111.939 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.77 73.79 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.25 1.204 . . . . 2.8399999999999999 114.25 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.6 p -75.04 -37.63 61.66 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.842 -1.161 . . . . 2.3100000000000001 112.644 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mm -56.61 -47.65 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 119.943 1.247 . . . . 3.46 110.842 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.17 -18.16 60.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.063 1.134 . . . . 2.5600000000000001 114.063 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.5 m -84.05 -40.94 17.74 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.447 1.099 . . . . 3.0600000000000001 110.984 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -69.94 -29.29 66.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.181 0.993 . . . . 3.0800000000000001 113.516 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.66 19.25 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.536 -1.353 . . . . 7.2199999999999998 114.197 164.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -74.43 -58.98 1.71 Allowed Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.471 -1.728 . . . . 6.5599999999999996 111.303 152.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.85 -48.8 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.842 2.362 . . . . 2.71 112.518 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -68.75 121.89 17.44 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.033 0.833 . . . . 4.6500000000000004 110.677 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 123.451 0.7 . . . . 9.3800000000000008 112.13 -178.904 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.2 0 CA-C-O 118.327 -1.263 . . . . 5.1600000000000001 113.169 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.54 142.43 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.315 2.01 . . . . 3.3900000000000001 112.772 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -108.34 175.19 5.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.361 -1.29 . . . . 4.0499999999999998 111.567 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -141.35 22.07 2.21 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.709 1.744 . . . . 3.9300000000000002 115.709 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.32 165.4 23.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.748 1.219 . . . . 3.9300000000000002 110.825 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.1 m -117.3 151.65 36.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.861 2.064 . . . . 3.6000000000000001 109.171 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.3 p -86.28 158.99 19.56 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.642 1.211 . . . . 2.7000000000000002 113.206 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -59.77 -21.59 60.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.91 1.684 . . . . 2.0099999999999998 113.225 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.8 m -72.08 -39.49 68.95 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.65 1.18 . . . . 3.6299999999999999 110.166 172.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 120.07 -8.36 11.51 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.53 1.538 . . . . 1.9399999999999999 114.47 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -83.11 147.64 27.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.149 0.974 . . . . 4.1399999999999997 109.879 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -87.72 125.41 34.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.229 -0.656 . . . . 4.9900000000000002 109.229 163.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.27 134.94 36.7 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.974 1.31 . . . . 4.4800000000000004 109.62 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.9 p -109.83 166.29 11.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.682 1.593 . . . . 3.4500000000000002 112.352 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.96 2.65 0.49 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.829 2.452 . . . . 4.1900000000000004 114.817 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -7.51 12.58 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.244 1.202 . . . . 8.1500000000000004 114.244 165.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.59 -44.55 64.26 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.713 1.142 . . . . 3.4500000000000002 110.063 161.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -78.02 10.59 2.77 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.834 1.42 . . . . 5.0300000000000002 114.834 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.82 108.39 1.17 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 5.9699999999999998 110.101 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.09 -8.69 6.33 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.507 1.051 . . . . 4.1200000000000001 114.629 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -129.07 158.97 37.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.944 1.372 . . . . 5.6900000000000004 110.48 165.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . 0.417 ' CE3' ' HD3' ' A' ' 269' ' ' PRO . 94.7 m95 -67.8 118.97 11.76 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.451 0.7 . . . . 3.8100000000000001 112.555 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.78 109.14 21.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.782 1.633 . . . . 4.1200000000000001 109.582 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.61 98.25 7.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.118 -0.697 . . . . 4.1699999999999999 109.118 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -95.35 126.97 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.903 1.281 . . . . 3.0499999999999998 108.998 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -140.55 150.1 43.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.787 1.235 . . . . 3.75 113.658 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -123.09 112.74 18.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.941 1.296 . . . . 3.5600000000000001 111.053 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.18 142.62 13.68 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.151 1.358 . . . . 1.4099999999999999 112.023 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -92.11 129.1 38.14 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.131 0.965 . . . . 5.4199999999999999 112.27 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.1 m -75.72 66.77 2.08 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.643 1.577 . . . . 3.8599999999999999 111.285 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -174.91 -28.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.801 2.841 . . . . 8.1899999999999995 112.441 -171.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 m -67.03 160.54 69.71 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 117.452 2.39 . . . . 2.3799999999999999 117.452 -163.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.96 -168.09 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.882 3.722 . . . . 3.25 110.724 159.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.72 -7.04 3.02 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.521 2.415 . . . . 4.1500000000000004 117.521 -151.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 74.0 t -65.0 -60.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.895 1.278 . . . . 3.3199999999999998 108.761 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 23.8 m -49.53 -60.41 4.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.733 -1.127 . . . . 1.74 113.028 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.39 -30.57 19.15 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-O 116.105 -1.706 . . . . 1.5 113.715 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.15 -45.97 65.69 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.996 2.18 . . . . 3.21 110.492 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.455 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 58.5 mm-40 -61.44 -33.22 73.35 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.25 0.932 . . . . 3.0499999999999998 112.068 174.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -48.6 64.67 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.659 -0.651 . . . . 3.3399999999999999 111.939 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -41.29 94.13 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.828 -1.17 . . . . 3.75 111.07 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.455 ' HZ2' ' CD ' ' A' ' 176' ' ' GLU . 40.9 mttt -46.96 -52.14 15.36 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 119.943 -1.723 . . . . 3.3900000000000001 112.209 167.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.4 ptp -70.77 -8.34 51.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.492 1.664 . . . . 3.2999999999999998 115.492 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mm -75.78 -60.04 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.414 1.461 . . . . 2.77 108.686 161.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.72 -38.74 56.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.256 0.836 . . . . 3.02 113.256 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.1 t -60.02 -19.02 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 117.823 -1.084 . . . . 3.1200000000000001 112.756 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.68 -53.93 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.699 1.59 . . . . 3.5600000000000001 110.558 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.62 -27.58 67.02 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.643 1.177 . . . . 4.0300000000000002 111.883 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.4 ' CD ' ' HZ2' ' A' ' 283' ' ' LYS . 58.7 mt-10 -71.48 -19.63 62.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.928 1.291 . . . . 3.7599999999999998 113.427 169.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.64 -56.99 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.279 1.431 . . . . 3.1099999999999999 113.845 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.86 -30.7 71.35 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.783 0.801 . . . . 5.5 109.261 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.9 m -60.31 -12.26 8.65 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.88 2.472 . . . . 4.0499999999999998 115.163 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.5 mm -79.01 -39.45 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.871 -1.143 . . . . 4.9900000000000002 112.139 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.3 m -176.82 2.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.632 1.573 . . . . 8.6600000000000001 114.349 -158.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.2 m 77.2 41.59 0.15 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.059 2.544 . . . . 6.4400000000000004 111.065 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.2 150.46 0.27 Allowed Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 128.987 2.915 . . . . 4.4699999999999998 113.949 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.32 -43.25 58.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.485 2.79 . . . . 3.2599999999999998 113.569 -170.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.3 t70 161.34 154.45 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 131.532 3.933 . . . . 3.5800000000000001 107.648 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.58 111.71 17.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.495 0.718 . . . . 4.5700000000000003 109.913 168.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.8 m -105.45 112.25 64.81 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.535 1.134 . . . . 3.1099999999999999 108.596 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.33 137.67 23.7 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.112 1.875 . . . . 1.48 109.002 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.277 1.5 pt? -136.18 118.44 15.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.644 1.212 . . . . 4.3399999999999999 110.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.05 125.91 54.9 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.657 1.583 . . . . 3.1699999999999999 110.201 -157.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.55 120.44 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.405 -0.961 . . . . 2.5899999999999999 108.405 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.2 t -72.38 -15.24 61.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.795 1.405 . . . . 3.25 114.795 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . 0.287 43.8 pt 51.7 9.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 128.539 2.735 . . . . 3.0299999999999998 117.912 170.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -111.16 56.54 0.38 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.221 1.408 . . . . 3.5 114.502 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.04 69.99 7.26 Favored 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.406 4.071 . . . . 3.7400000000000002 112.685 -167.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -171.2 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.5 2.32 . . . . 4.04 109.673 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -17.69 10.1 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.23 1.412 . . . . 9.0399999999999991 112.82 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.4 153.31 2.2 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.696 1.598 . . . . 4.6200000000000001 112.912 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.4 m -144.59 125.33 14.2 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.299 -0.876 . . . . 3.0600000000000001 109.854 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -48.33 -47.72 36.75 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.467 1.907 . . . . 3.7599999999999998 112.793 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -68.77 -33.21 73.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.231 1.197 . . . . 3.8100000000000001 114.231 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.91 84.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.483 1.492 . . . . 2.54 110.941 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.66 -34.46 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.276 0.63 . . . . 2.4300000000000002 111.857 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.35 -19.31 64.52 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.066 -1.021 . . . . 2.3300000000000001 113.697 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -84.98 -42.64 14.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.957 1.253 . . . . 4.0499999999999998 112.992 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -57.04 -35.26 69.09 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.153 1.381 . . . . 3.73 112.133 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.53 -37.03 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.238 1.415 . . . . 2.4100000000000001 113.078 169.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -70.96 -51.27 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.799 -1.188 . . . . 6.3200000000000003 112.204 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.49 -18.42 62.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.619 1.567 . . . . 4.0800000000000001 113.769 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -80.55 -79.4 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.734 0.697 . . . . 4.1699999999999999 109.676 154.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 178.23 139.69 0.25 Allowed Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.307 1.843 . . . . 2.5099999999999998 110.304 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.45 5.9 1.77 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.15 3.233 . . . . 2.5499999999999998 114.942 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -18.27 63.5 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.841 -1.162 . . . . 4.6699999999999999 112.763 161.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.6 tp -78.78 138.13 38.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.18 1.792 . . . . 3.0299999999999998 111.224 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 26.2 t -101.88 130.35 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.042 0.937 . . . . 2.8599999999999999 108.881 158.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.58 132.91 11.11 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.798 -0.921 . . . . 0.82999999999999996 110.798 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.5 144.97 50.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.131 0.972 . . . . 3.1400000000000001 112.926 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.6 t -149.1 176.44 10.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.204 2.202 . . . . 3.6499999999999999 111.194 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 165.37 -168.15 39.25 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 127.141 2.305 . . . . 2.04 109.374 -170.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.3 174.59 10.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.053 1.426 . . . . 3.8100000000000001 111.373 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -47.86 -38.37 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.59 0.756 . . . . 9.5800000000000001 112.168 170.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -36.11 47.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.809 0.732 . . . . 5.7000000000000002 112.572 -169.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -70.37 -33.57 71.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.242 -1.537 . . . . 3.79 111.847 170.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.96 -31.68 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.726 0.81 . . . . 3.1000000000000001 110.816 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.72 -32.3 41.19 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.941 0.791 . . . . 3.1800000000000002 112.664 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.42 -53.17 60.83 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.113 -0.992 . . . . 4.1500000000000004 109.736 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.2 p -62.2 -27.71 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 119.426 -0.321 . . . . 3.5899999999999999 111.812 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.61 -46.18 66.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.248 0.931 . . . . 3.04 111.518 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -58.83 -53.83 53.99 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.576 1.55 . . . . 4.2599999999999998 111.066 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.39 65.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.973 1.309 . . . . 2.9199999999999999 114.362 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -117.4 3.82 12.51 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.575 1.324 . . . . 3.7000000000000002 114.575 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 57.6 31.19 19.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.085 1.354 . . . . 5.9699999999999998 113.421 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.38 161.99 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.58 1.152 . . . . 4.0999999999999996 110.325 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -146.22 154.9 42.26 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.592 0.96 . . . . 6.4699999999999998 113.592 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.62 110.81 6.96 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.991 1.716 . . . . 7.0899999999999999 110.669 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -104.73 124.16 37.79 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 120.66 -1.275 . . . . 3.71 113.158 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.39 130.27 14.86 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.302 2.001 . . . . 3.71 113.274 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 C-N-CA 124.191 0.9 . . . . 2.6800000000000002 110.912 173.659 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 3.1 t80 . . . . . 0 CA--C 1.549 0.917 0 CA-C-O 121.565 0.698 . . . . 5.3099999999999996 111.938 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 tt -124.07 168.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.842 1.657 . . . . 5.2400000000000002 111.223 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.24 135.75 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 4.9299999999999997 105.214 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 169.33 1.67 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.205 1.002 . . . . 4.29 112.113 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -153.87 126.8 8.3 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.524 -0.735 . . . . 3.04 111.518 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.3 p -59.37 118.74 6.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.676 0.79 . . . . 3.9500000000000002 110.265 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 11.1 tp -78.41 59.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.177 1.391 . . . . 4.96 113.657 -168.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.0 mm -109.2 138.01 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.78 1.232 . . . . 3.54 111.806 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.3 ttt -121.33 134.75 55.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.02 1.728 . . . . 3.2200000000000002 108.992 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.48 141.77 44.61 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.762 0.825 . . . . 3.8399999999999999 111.927 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.92 116.87 31.01 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.164 0.986 . . . . 2.7599999999999998 109.983 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.0 136.93 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.683 1.193 . . . . 2.8599999999999999 107.835 166.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.52 168.9 48.53 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 123.792 0.711 . . . . 2.25 114.59 -168.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.417 ' HD3' ' CE3' ' A' ' 159' ' ' TRP . 42.0 Cg_endo -77.3 56.09 5.35 Favored 'Trans proline' 0 CA--C 1.539 0.749 1 C-N-CA 125.964 4.443 . . . . 4.0199999999999996 109.38 173.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -162.1 -55.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.753 -0.658 . . . . 4.8099999999999996 111.252 -143.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 154.19 -54.33 0.44 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.093 -1.393 . . . . 3.7400000000000002 112.611 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -130.06 -174.23 3.26 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.806 1.303 . . . . 5.8700000000000001 114.326 -162.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -80.37 142.97 33.9 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.995 -1.066 . . . . 5.9900000000000002 113.525 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.67 -25.91 0.89 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.453 1.279 . . . . 3.7200000000000002 114.453 -157.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -162.78 165.91 24.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.672 2.389 . . . . 2.54 109.247 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -155.81 150.54 26.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.53 1.308 . . . . 4.9199999999999999 114.53 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -126.89 119.49 26.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.307 1.443 . . . . 3.6899999999999999 109.339 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -111.12 72.77 0.21 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 108.993 -1.643 . . . . 4.0300000000000002 108.993 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 41.37 -134.68 0.28 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.215 1.406 . . . . 3.6600000000000001 111.308 -155.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.2 t30 70.6 -65.8 0.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.593 2.357 . . . . 5.4199999999999999 114.615 167.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -66.01 120.36 13.01 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.546 1.138 . . . . 6.0499999999999998 110.376 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -77.97 138.46 38.86 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.611 -1.305 . . . . 10.81 110.238 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.4 ' HZ2' ' CD ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -32.7 -47.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.486 3.143 . . . . 3.8999999999999999 119.486 -158.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -15.81 57.82 Favored Glycine 0 N--CA 1.476 1.363 0 CA-C-N 119.748 1.158 . . . . 2.1299999999999999 112.698 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.15 -24.09 65.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.482 0.919 . . . . 3.25 113.482 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.15 -41.61 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.59 1.086 . . . . 2.8700000000000001 109.005 172.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.8 99.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.94 -0.553 . . . . 2.3999999999999999 111.478 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.11 98.27 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.842 1.053 . . . . 2.4900000000000002 113.842 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.1 p -70.03 -47.29 62.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.2 1.364 . . . . 2.0800000000000001 111.763 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.02 -34.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 120.065 1.302 . . . . 2.6299999999999999 112.448 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.9 76.02 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.93 -1.106 . . . . 2.2599999999999998 112.999 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 38.9 m -70.22 -45.45 66.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.267 1.027 . . . . 2.79 109.394 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -65.59 -28.46 69.15 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 3.4100000000000001 113.06 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -19.83 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.94 -1.1 . . . . 5.6500000000000004 112.546 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -46.23 95.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.759 -1.591 . . . . 6.4400000000000004 112.401 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.8 -45.56 0.1 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.168 2.578 . . . . 2.8100000000000001 113.989 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.18 170.51 14.81 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.937 1.244 . . . . 4.1200000000000001 114.093 -174.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 . . . . . 0 N--CA 1.477 0.893 0 O-C-N 120.497 -1.377 . . . . 8.7899999999999991 112.265 -178.433 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.217 0 CA-C-O 118.983 -0.898 . . . . 3.1000000000000001 113.855 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.52 144.85 62.43 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.168 2.579 . . . . 4.0800000000000001 110.618 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -95.71 177.69 5.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.397 1.479 . . . . 3.9199999999999999 112.524 -169.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.9 m -129.64 22.62 5.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.865 1.431 . . . . 2.8599999999999999 114.865 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.41 157.9 15.8 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.32 1.048 . . . . 3.5800000000000001 112.839 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 149' ' ' ARG . 58.3 m -101.03 148.21 25.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.892 1.677 . . . . 2.3900000000000001 110.606 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.3 p -81.36 166.69 20.22 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.735 1.614 . . . . 2.9199999999999999 113.49 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -61.3 -23.05 65.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.948 2.099 . . . . 2.04 113.152 169.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.7 m -73.93 -61.5 1.83 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.312 1.045 . . . . 3.9199999999999999 108.183 167.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 141.53 -1.22 1.81 Allowed Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.914 1.245 . . . . 2.3399999999999999 115.936 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.12 145.59 29.14 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.584 1.192 . . . . 4.1600000000000001 109.781 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 0.9 OUTLIER -96.7 74.28 2.72 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.106 2.563 . . . . 6.54 112.533 -178.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -81.03 89.79 5.96 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.287 -0.883 . . . . 7.2599999999999998 112.734 -166.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.6 p -68.57 127.59 33.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.345 1.058 . . . . 3.96 110.278 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -1.28 12.05 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 117.806 2.521 . . . . 6.1900000000000004 117.806 -155.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -77.58 4.48 11.2 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 120.944 -1.098 . . . . 7.5300000000000002 112.954 164.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 156' ' ' LEU . 21.1 t70 -73.28 -71.89 0.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.633 2.773 . . . . 3.7400000000000002 114.375 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -69.57 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.397 1.879 . . . . 5.6699999999999999 114.441 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 154' ' ' ASP . 2.0 tm? -60.0 -32.68 71.09 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.795 2.038 . . . . 4.4199999999999999 114.442 -157.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.08 2.02 87.67 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.482 0.953 . . . . 3.5 115.482 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -96.55 -138.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.92 1.688 . . . . 3.79 109.189 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -140.89 140.82 34.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.851 1.26 . . . . 2.0600000000000001 109.967 164.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.89 151.61 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.922 1.082 . . . . 3.8100000000000001 113.922 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.22 119.22 34.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.863 1.665 . . . . 3.25 108.148 163.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.1 mt -109.88 110.22 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.61 -0.885 . . . . 2.4700000000000002 108.61 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -113.35 153.98 27.63 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.272 1.829 . . . . 4.3300000000000001 113.431 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -127.34 97.88 5.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.081 1.352 . . . . 3.6699999999999999 112.859 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.54 -176.91 14.65 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 128.205 2.812 . . . . 1.8999999999999999 112.35 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -113.32 141.11 47.41 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.818 1.647 . . . . 4.8300000000000001 112.165 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -65.49 113.42 4.14 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.823 -1.173 . . . . 3.77 110.939 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.432 ' HE2' ' CD ' ' A' ' 219' ' ' GLU . 73.7 m80 63.75 35.0 11.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.075 1.75 . . . . 11.550000000000001 112.348 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 49.9 t -59.1 157.2 22.87 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.225 1.41 . . . . 2.9900000000000002 111.594 163.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.66 177.34 1.33 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.621 2.881 . . . . 3.6699999999999999 112.031 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.38 -3.27 0.9 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.12 2.637 . . . . 5.2599999999999998 118.12 -148.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.45 -59.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.049 1.739 . . . . 3.8599999999999999 110.353 171.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.8 m -53.76 -58.73 11.93 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 118.055 -0.974 . . . . 2.1600000000000001 112.606 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.85 -29.9 41.14 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.575 1.517 . . . . 2.1099999999999999 113.805 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -60.62 -53.1 61.49 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 121.09 1.768 . . . . 3.9900000000000002 111.211 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.46 0.704 . . . . 3.3900000000000001 112.023 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.22 -28.87 61.45 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.354 -1.467 . . . . 4.1299999999999999 112.357 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -56.93 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.264 1.025 . . . . 4.0899999999999999 108.612 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -45.34 72.47 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.438 -0.789 . . . . 6.6900000000000004 111.676 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 47.1 ttp -57.93 -45.0 87.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.854 2.061 . . . . 4.4100000000000001 112.408 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.78 -45.16 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.608 1.094 . . . . 2.5600000000000001 110.652 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -69.11 -27.37 65.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.229 1.377 . . . . 5.0199999999999996 110.654 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.41 -47.83 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 120.622 1.556 . . . . 3.0 110.591 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.8 -42.54 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.515 1.052 . . . . 4.6200000000000001 113.269 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -76.29 -25.94 55.37 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.443 1.02 . . . . 5.7999999999999998 113.337 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -63.98 -31.12 72.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.382 1.473 . . . . 2.98 113.474 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.46 -41.76 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.649 1.18 . . . . 3.1600000000000001 112.167 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.0 -27.92 61.99 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.132 0.967 . . . . 4.4699999999999998 112.218 167.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.8 m -70.57 -9.76 57.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.381 1.072 . . . . 4.7400000000000002 113.06 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 14.8 mm -85.75 58.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.437 -1.414 . . . . 4.1699999999999999 109.097 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.1 m -58.77 85.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.781 1.632 . . . . 6.1399999999999997 112.293 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m 171.0 -32.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.962 3.705 . . . . 4.8300000000000001 108.386 -167.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.2 mt -73.25 162.01 76.47 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.193 -0.432 . . . . 5.2800000000000002 111.231 143.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -81.74 -154.15 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.77 3.646 . . . . 3.7400000000000002 108.569 154.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.83 158.35 25.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.217 1.562 . . . . 3.8999999999999999 115.217 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.09 94.1 4.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.077 1.351 . . . . 3.02 109.35 161.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.9 m -76.68 121.72 85.32 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 120.643 -1.286 . . . . 1.9399999999999999 110.206 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.29 126.66 2.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.442 2.761 . . . . 1.04 111.544 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 tt -125.04 112.51 16.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.784 1.234 . . . . 3.6099999999999999 110.505 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -100.66 124.24 45.99 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.526 1.131 . . . . 3.1200000000000001 110.698 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.92 120.4 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.482 -0.933 . . . . 2.52 108.482 170.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.3 t -82.15 106.46 14.06 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.504 -0.924 . . . . 2.3700000000000001 108.504 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.71 12.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.955 1.302 . . . . 3.5299999999999998 113.032 -176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -113.69 27.77 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.295 2.638 . . . . 3.6200000000000001 114.532 -171.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.41 -13.68 41.03 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.733 2.955 . . . . 2.4100000000000001 116.218 -154.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.67 1.8 43.8 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.963 1.098 . . . . 4.5599999999999996 113.963 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.289 2.2 ppt_? -137.28 0.82 2.36 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.137 1.532 . . . . 6.8799999999999999 115.137 158.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.27 -173.05 0.05 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.117 1.767 . . . . 3.5299999999999998 110.413 152.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -178.83 132.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.387 3.075 . . . . 3.1000000000000001 105.533 -172.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmpt? -56.98 -30.78 64.42 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.278 0.844 . . . . 4.3700000000000001 113.278 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -35.13 52.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.456 1.503 . . . . 3.3300000000000001 114.025 169.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.05 78.1 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.352 -1.467 . . . . 2.6200000000000001 111.897 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -70.37 -32.66 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.43 0.559 . . . . 3.8599999999999999 112.085 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.78 -35.21 80.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.934 1.243 . . . . 2.6800000000000002 112.368 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.09 -40.13 75.16 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.513 -0.742 . . . . 5.0999999999999996 111.832 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.84 -42.08 97.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.992 0.917 . . . . 4.2999999999999998 111.983 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.0 t -54.67 -50.76 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.771 0.714 . . . . 2.2799999999999998 111.368 168.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.13 -23.4 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.962 1.305 . . . . 5.7699999999999996 114.035 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.432 ' CD ' ' HE2' ' A' ' 168' ' ' HIS . 20.3 mt-10 -70.91 -22.62 62.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.461 1.504 . . . . 4.8799999999999999 113.211 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -108.54 -52.72 2.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.225 1.01 . . . . 3.6699999999999999 112.766 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 t 178.99 143.13 0.31 Allowed Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.82 1.648 . . . . 2.7200000000000002 109.97 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.63 -9.62 23.36 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.683 2.255 . . . . 2.2000000000000002 113.158 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.55 -18.1 62.92 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.226 0.921 . . . . 3.7400000000000002 113.203 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.35 127.29 32.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.231 -0.918 . . . . 3.2000000000000002 110.59 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.54 121.89 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.294 -1.002 . . . . 3.3799999999999999 108.294 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.56 139.45 14.72 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.917 -0.873 . . . . 1.1000000000000001 110.917 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mp -132.97 147.28 52.28 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.599 1.2 . . . . 3.1099999999999999 112.298 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 13.5 t -150.37 -174.06 4.64 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.085 1.754 . . . . 3.8599999999999999 109.926 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 149.01 -64.5 0.4 Allowed Glycine 0 N--CA 1.474 1.202 0 N-CA-C 115.626 1.01 . . . . 2.73 115.626 170.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.1 t -160.07 145.78 15.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.322 1.061 . . . . 4.4400000000000004 112.702 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -48.72 -42.5 35.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.275 2.23 . . . . 6.8899999999999997 112.511 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.89 -27.19 67.3 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.011 1.732 . . . . 4.4199999999999999 114.456 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -35.79 25.82 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.495 . . . . 4.46 112.052 172.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.29 -41.49 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.024 0.53 . . . . 3.3799999999999999 110.639 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.2 -40.36 95.83 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.184 -0.912 . . . . 3.29 111.307 170.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -58.17 -51.12 71.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.346 1.43 . . . . 2.8799999999999999 111.684 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -25.4 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.251 0.932 . . . . 4.1900000000000004 112.604 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.44 -53.03 18.06 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.161 -0.962 . . . . 3.2000000000000002 111.724 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -64.0 -31.9 73.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.163 2.185 . . . . 4.6200000000000001 111.762 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.29 62.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.73 1.612 . . . . 2.9500000000000002 115.042 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.45 3.04 7.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.178 0.807 . . . . 3.71 113.178 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 74.06 34.63 0.84 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.359 2.264 . . . . 5.9400000000000004 112.355 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 147.84 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.235 1.814 . . . . 4.1399999999999997 110.886 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.54 140.21 48.94 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.047 1.339 . . . . 4.5300000000000002 112.844 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.55 162.59 41.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.195 1.798 . . . . 8.3900000000000006 110.71 161.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.5 m -127.69 88.44 53.45 Favored Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 123.733 0.813 . . . . 3.3399999999999999 110.655 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 144.76 22.85 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.844 2.363 . . . . 5.1900000000000004 110.068 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.492 0 CA-C-O 118.615 -1.103 . . . . 4.3200000000000003 112.84 -177.409 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 22.3 p90 . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 121.413 0.625 . . . . 5.6399999999999997 111.919 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.5 tp -72.36 136.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.056 -1.028 . . . . 4.0800000000000001 109.825 167.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.52 144.73 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.573 1.549 . . . . 6.75 110.863 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.19 150.75 39.79 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.625 1.202 . . . . 3.6200000000000001 113.03 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 162.6 8.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.615 1.566 . . . . 3.5600000000000001 112.911 -153.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -38.39 57.93 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.071 -1.442 . . . . 4.04 114.447 -171.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.0 mt 66.03 29.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 123.258 1.504 . . . . 5.4500000000000002 110.302 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.6 mm -126.06 149.47 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 127.191 2.196 . . . . 5.2199999999999998 108.954 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.43 146.17 51.94 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.328 1.451 . . . . 3.3799999999999999 114.122 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -97.94 137.39 36.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.16 1.784 . . . . 4.0499999999999998 110.746 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.37 107.73 19.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.385 1.474 . . . . 3.48 108.465 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.73 125.21 47.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.165 0.986 . . . . 2.7000000000000002 108.677 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.5 173.25 42.01 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.986 -0.896 . . . . 1.6699999999999999 111.905 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.12 78.32 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.287 3.325 . . . . 2.6499999999999999 110.803 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.13 -47.43 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 131.335 3.854 . . . . 5.3799999999999999 109.871 -173.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.61 -9.92 21.71 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.467 -1.741 . . . . 3.9500000000000002 116.236 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -82.87 153.27 25.21 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 119.888 1.844 . . . . 4.9699999999999998 110.901 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -80.18 120.8 24.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.414 -0.804 . . . . 4.54 111.099 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.5 pp -104.29 -3.31 24.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.468 1.107 . . . . 4.2800000000000002 113.758 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -157.18 164.29 37.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.899 2.08 . . . . 2.1800000000000002 108.707 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.68 135.25 6.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.241 1.416 . . . . 4.3799999999999999 111.755 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.03 -160.5 0.91 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.214 1.806 . . . . 4.2699999999999996 109.355 -168.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.96 -132.47 3.57 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 109.826 -1.31 . . . . 3.77 109.826 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -53.05 152.1 4.37 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.827 0.822 . . . . 4.3799999999999999 112.711 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 75.7 -18.48 0.45 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.317 1.847 . . . . 6.8899999999999997 112.501 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 146.99 26.24 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.588 -1.32 . . . . 7.6100000000000003 109.911 158.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -107.42 154.73 20.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.309 -0.869 . . . . 6.7999999999999998 110.983 -167.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -47.55 -55.52 9.04 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 3.0099999999999998 112.795 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.67 -19.08 76.28 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 115.238 0.855 . . . . 1.6399999999999999 115.238 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -78.37 -41.82 32.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.171 1.389 . . . . 4.25 111.193 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.69 -42.77 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.475 -0.565 . . . . 2.3399999999999999 109.475 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.91 81.65 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.686 -0.634 . . . . 2.3500000000000001 112.145 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.06 -37.52 86.04 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.767 1.025 . . . . 2.1699999999999999 113.767 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.8 p -67.33 -49.01 65.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.523 1.056 . . . . 2.48 111.074 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.98 -37.82 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.235 -0.915 . . . . 2.6000000000000001 111.693 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.82 67.05 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.735 -1.228 . . . . 2.1299999999999999 113.747 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.7 m -78.27 -50.02 12.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.471 1.108 . . . . 2.54 110.203 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -62.86 -31.31 72.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.811 1.244 . . . . 3.0099999999999998 112.985 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 62.1 ttp -56.36 -18.73 11.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.929 1.692 . . . . 4.96 113.25 168.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.22 -56.55 3.21 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.631 -1.652 . . . . 5.8499999999999996 112.981 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.12 -39.82 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.866 2.377 . . . . 2.6800000000000002 112.996 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -93.15 121.5 34.57 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 122.137 0.97 . . . . 4.2300000000000004 111.116 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 127.567 2.347 . . . . 10.74 112.556 167.804 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 118.859 -0.967 . . . . 3.6400000000000001 111.527 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.78 177.73 8.46 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.812 3.008 . . . . 3.3199999999999998 109.924 165.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -156.26 166.39 33.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.164 0.983 . . . . 3.9500000000000002 113.298 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.2 m -156.97 72.69 0.73 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.537 -1.352 . . . . 4.3499999999999996 112.364 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.38 166.98 10.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.631 1.172 . . . . 4.8899999999999997 111.88 -167.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.3 m -99.57 143.34 29.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.471 1.108 . . . . 2.5299999999999998 109.154 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.27 162.28 14.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.889 0.852 . . . . 4.0700000000000003 111.652 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -41.0 -28.76 0.09 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.742 2.417 . . . . 2.0800000000000001 116.264 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 m -77.08 -22.3 53.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.842 2.457 . . . . 3.9100000000000001 114.088 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.25 70.64 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.954 1.264 . . . . 1.96 113.612 -167.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 161.05 30.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.111 1.764 . . . . 3.8999999999999999 110.71 168.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -124.16 141.26 52.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.641 1.177 . . . . 5.5300000000000002 112.222 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -133.88 145.94 50.1 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.325 -0.86 . . . . 3.8500000000000001 111.993 -173.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.1 p -128.28 167.02 17.49 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.117 1.767 . . . . 4.1500000000000004 110.089 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.455 ' CG ' ' HZ2' ' A' ' 153' ' ' LYS . 10.0 p-10 -61.36 -10.07 6.55 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.197 0.814 . . . . 4.7599999999999998 113.197 167.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.455 ' HZ2' ' CG ' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -81.4 -37.09 28.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.5 0.926 . . . . 6.6299999999999999 113.5 170.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.51 -32.68 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.768 1.227 . . . . 3.23 111.47 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -93.98 -0.11 55.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.362 1.615 . . . . 4.3099999999999996 115.362 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.34 174.76 9.12 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 119.59 1.086 . . . . 4.29 112.039 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.21 3.34 60.94 Favored Glycine 0 N--CA 1.478 1.47 0 N-CA-C 116.259 1.264 . . . . 2.7200000000000002 116.259 165.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -130.77 164.34 25.34 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.96 2.104 . . . . 3.0099999999999998 109.144 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -70.19 132.97 46.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.726 1.148 . . . . 3.1600000000000001 109.105 157.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.46 144.62 38.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.801 0.81 . . . . 4.2800000000000002 112.496 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.7 mt -114.95 120.52 40.19 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.383 1.873 . . . . 3.27 106.169 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.9 pt -115.98 112.59 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.184 -1.043 . . . . 4.3600000000000003 108.184 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -100.47 127.95 46.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.712 1.605 . . . . 4.4699999999999998 112.263 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -100.87 82.6 2.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.313 1.445 . . . . 3.3799999999999999 109.721 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -95.16 164.4 24.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 113.665 -1.607 . . . . 1.6100000000000001 111.279 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.01 -170.45 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.022 -1.103 . . . . 5.3200000000000003 108.022 157.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.3 m -146.3 95.04 2.55 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.324 1.849 . . . . 3.8399999999999999 107.141 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -169.05 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.451 1.649 . . . . 8.3399999999999999 115.451 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 37.6 m -79.78 -179.88 1.58 Allowed Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.298 1.439 . . . . 3.23 111.446 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.9 -129.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.242 2.628 . . . . 5.2599999999999998 108.585 157.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 50.57 0.13 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.377 2.671 . . . . 5.5999999999999996 114.367 -173.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.9 -60.17 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.214 1.805 . . . . 5.3499999999999996 109.873 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 63.8 m -46.96 -44.92 49.8 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-O 117.375 -1.297 . . . . 3.6299999999999999 114.476 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.57 -9.11 6.94 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.432 2.755 . . . . 1.8899999999999999 114.865 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.69 -67.2 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.375 1.443 . . . . 4.04 111.213 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.45 -21.18 65.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.359 0.981 . . . . 3.1099999999999999 113.04 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -47.08 81.62 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.199 0.6 . . . . 3.4399999999999999 110.468 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -40.31 95.32 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.688 -1.258 . . . . 3.5 111.481 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -55.24 24.1 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.074 -1.016 . . . . 4.0899999999999999 110.947 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.37 -16.13 62.94 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.446 0.906 . . . . 4.2800000000000002 113.446 -176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.9 mm -69.36 -56.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.835 1.198 . . . . 2.3100000000000001 109.985 162.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.463 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 80.8 mt-30 -60.51 -22.58 63.73 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.284 1.402 . . . . 3.1699999999999999 113.185 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.82 -28.02 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.113 -0.992 . . . . 2.8399999999999999 111.264 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.92 -34.61 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.309 0.959 . . . . 3.3799999999999999 110.419 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.43 -45.29 84.83 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.042 1.337 . . . . 4.7599999999999998 112.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.14 -20.39 61.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.535 1.134 . . . . 2.8799999999999999 113.478 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.55 -57.58 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.324 1.05 . . . . 2.6000000000000001 111.543 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.07 -23.69 65.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.584 1.154 . . . . 3.0499999999999998 112.161 -174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 73.4 m -68.11 -19.12 64.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.32 1.048 . . . . 3.3199999999999998 113.713 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.16 -25.22 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.999 0.92 . . . . 4.54 111.176 171.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.0 m 72.63 -33.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 129.801 3.24 . . . . 6.1299999999999999 114.272 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.8 p -99.56 19.25 16.09 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 4.29 111.863 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.09 165.41 43.17 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.477 1.111 . . . . 3.7000000000000002 108.314 159.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 51.62 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.154 2.569 . . . . 4.0899999999999999 110.947 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.61 -173.84 0.16 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.775 2.83 . . . . 4.5599999999999996 113.784 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 45.5 tp -140.55 117.39 11.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.153 -1.054 . . . . 2.6499999999999999 108.153 150.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.0 m -106.56 96.03 13.19 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.288 1.035 . . . . 2.2999999999999998 108.651 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.12 144.12 33.23 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.205 1.937 . . . . 1.5 110.535 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.25 147.11 43.35 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.542 0.687 . . . . 4.0899999999999999 110.806 171.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -112.92 121.09 43.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.895 1.278 . . . . 3.3599999999999999 108.234 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.35 118.03 40.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.738 -1.578 . . . . 2.3599999999999999 106.738 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.57 137.99 38.9 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.567 0.698 . . . . 2.3199999999999998 110.679 162.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.1 pt -114.6 24.48 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.835 1.254 . . . . 3.02 111.092 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -97.69 0.7 0.09 OUTLIER Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 129.337 3.055 . . . . 5.1699999999999999 118.586 -161.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.48 120.55 7.77 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 123.405 2.252 . . . . 2.5299999999999998 111.727 -165.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 149.23 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 130.425 3.49 . . . . 4.4400000000000004 110.402 -171.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -35.46 3.56 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.014 1.116 . . . . 5.8700000000000001 114.014 173.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.4 163.72 12.41 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.35 1.611 . . . . 4.8899999999999997 115.35 -166.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -138.95 153.36 48.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.512 -1.222 . . . . 3.1400000000000001 112.536 -164.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -45.61 -43.95 12.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.87 1.268 . . . . 5.3300000000000001 112.34 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.61 -44.24 62.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.612 1.565 . . . . 4.0599999999999996 112.853 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.84 97.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.34 1.427 . . . . 2.1000000000000001 111.229 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.69 -33.99 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.537 -0.727 . . . . 2.9399999999999999 110.543 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.83 78.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.554 1.07 . . . . 2.0800000000000001 112.638 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -62.43 -53.47 54.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.835 1.198 . . . . 3.8300000000000001 109.983 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -55.83 -46.61 78.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 5.8399999999999999 112.448 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.5 t -62.24 -45.72 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.555 -1.341 . . . . 2.1699999999999999 111.397 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.03 -39.18 91.44 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 118.315 -0.85 . . . . 6.2699999999999996 113.086 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -78.19 -37.28 45.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.059 1.3 . . . . 4.0199999999999996 112.436 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -68.4 -59.68 3.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.536 -0.745 . . . . 4.1900000000000004 112.484 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 174.85 157.28 0.35 Allowed Pre-proline 0 N--CA 1.484 1.257 0 N-CA-C 115.173 1.546 . . . . 2.3599999999999999 115.173 170.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.19 -8.93 18.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.762 2.975 . . . . 2.48 114.552 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -86.16 -0.03 54.73 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 119.95 1.25 . . . . 3.7799999999999998 112.78 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 29.9 tp -94.41 151.04 19.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.995 1.318 . . . . 3.04 109.912 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 87.7 t -133.43 132.43 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.98 1.712 . . . . 2.8999999999999999 108.313 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.6 105.36 1.42 Allowed Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.082 0.848 . . . . 1.1200000000000001 112.068 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.91 147.4 25.59 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.7 1.2 . . . . 2.98 112.453 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 65.4 p -140.49 149.73 42.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.488 1.915 . . . . 3.98 111.164 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -131.44 -170.72 12.7 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.151 1.358 . . . . 1.6599999999999999 110.856 160.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.9 t -84.33 174.59 10.01 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.622 0.711 . . . . 2.71 109.146 152.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -52.26 -24.45 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.026 1.33 . . . . 7.29 113.603 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -74.86 -52.33 11.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.87 2.468 . . . . 2.8300000000000001 110.784 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.07 -25.84 64.64 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.272 -1.517 . . . . 3.9700000000000002 111.96 171.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 33.3 t -62.98 -38.95 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 117.22 -1.371 . . . . 2.8199999999999998 110.991 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.8 -52.53 65.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.451 1.478 . . . . 3.9399999999999999 109.042 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -49.98 -57.28 7.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.606 1.094 . . . . 2.96 112.02 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.48 -29.19 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.315 1.416 . . . . 3.9300000000000002 113.002 -170.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.38 -42.33 79.28 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.831 -0.543 . . . . 2.23 110.732 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -72.02 -33.93 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.854 2.062 . . . . 5.3099999999999996 112.573 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -54.87 -30.72 58.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.039 1.336 . . . . 2.6299999999999999 114.487 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -118.22 3.72 11.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.616 1.166 . . . . 4.6299999999999999 113.099 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.75 39.92 16.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.204 2.202 . . . . 7.5800000000000001 112.91 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.17 155.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.867 0.867 . . . . 3.4199999999999999 112.131 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -104.58 148.98 25.91 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.591 1.556 . . . . 3.8100000000000001 114.084 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -170.37 150.12 3.48 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.837 2.855 . . . . 4.6699999999999999 109.497 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.2 m -157.78 144.45 13.11 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 124.979 1.312 . . . . 3.7400000000000002 111.623 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.06 154.04 37.31 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.508 2.139 . . . . 3.3700000000000001 111.414 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.728 0 C-N-CA 123.886 0.755 . . . . 3.1600000000000001 114.259 171.622 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 111.887 0.328 . . . . 6.1600000000000001 111.887 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.54 160.61 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 121.245 -0.909 . . . . 3.8999999999999999 110.255 162.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 41.1 t -153.74 128.03 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.566 1.947 . . . . 3.9100000000000001 106.568 172.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.19 146.41 49.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.556 1.542 . . . . 3.3199999999999998 112.196 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -148.77 129.51 14.16 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.135 0.974 . . . . 3.1000000000000001 111.237 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.6 m -54.45 -31.15 54.91 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.93 1.085 . . . . 4.0700000000000003 113.93 -171.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 69.74 -20.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.42 1.888 . . . . 5.0 114.402 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 84.4 mt -54.94 138.78 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.082 0.953 . . . . 3.27 110.504 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.7 mtm -99.78 141.2 32.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.324 -1.307 . . . . 3.5600000000000001 110.46 162.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -99.21 140.32 33.55 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.241 0.616 . . . . 4.7400000000000002 110.006 168.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 21.6 tp -99.1 117.04 32.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.919 0.888 . . . . 3.1499999999999999 108.918 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.48 141.99 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.795 -1.187 . . . . 3.48 107.795 169.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.41 168.28 34.78 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.23 0.919 . . . . 1.9099999999999999 115.156 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.66 61.25 7.44 Favored 'Trans proline' 0 C--N 1.351 0.695 1 C-N-CA 126.063 4.509 . . . . 3.0299999999999998 110.722 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.54 -67.45 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.091 1.356 . . . . 4.1299999999999999 108.232 -149.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.61 -23.22 2.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.07 -1.406 . . . . 2.5600000000000001 115.046 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.59 172.25 11.07 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.335 1.567 . . . . 4.7199999999999998 113.219 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -88.56 137.64 32.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.755 2.022 . . . . 6.6699999999999999 111.429 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.22 -30.15 4.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.055 1.872 . . . . 3.4399999999999999 116.055 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -164.68 155.98 15.22 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.686 1.585 . . . . 2.52 112.995 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 146.09 31.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.728 0.811 . . . . 7.0199999999999996 112.825 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.37 159.92 40.05 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.344 1.058 . . . . 4.0999999999999996 111.771 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.48 -174.37 29.04 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.347 1.451 . . . . 3.25 110.213 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -73.83 38.57 0.1 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.29 2.236 . . . . 4.0899999999999999 114.637 -167.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -121.48 -43.25 2.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.542 1.537 . . . . 6.4000000000000004 109.91 167.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -87.32 118.59 26.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.449 1.5 . . . . 5.0700000000000003 108.945 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -73.42 177.92 4.93 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.264 -0.897 . . . . 6.9699999999999998 108.709 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.463 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 12.7 tmtt? -54.45 -47.33 73.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.301 1.223 . . . . 2.5299999999999998 114.301 -170.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -32.8 85.39 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-N 118.414 0.552 . . . . 1.6899999999999999 112.757 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.08 -22.84 62.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.357 1.063 . . . . 3.4700000000000002 113.078 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.04 -49.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.111 -0.993 . . . . 2.52 109.923 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.79 88.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.544 -0.723 . . . . 2.3700000000000001 112.657 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.49 66.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.361 1.245 . . . . 2.5899999999999999 114.361 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.3 p -74.72 -44.82 48.01 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.296 -0.878 . . . . 2.4399999999999999 111.544 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.01 -40.34 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 120.142 1.337 . . . . 2.27 110.93 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.97 -5.36 9.22 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 114.663 1.357 . . . . 2.3700000000000001 114.663 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.1 m -96.41 -47.93 5.78 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.288 1.435 . . . . 2.75 110.087 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -65.21 -24.94 67.49 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.619 1.168 . . . . 3.6699999999999999 113.301 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -55.78 -35.71 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.549 2.34 . . . . 5.8399999999999999 113.9 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -59.4 -43.23 95.91 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 116.838 -1.553 . . . . 7.3600000000000003 111.913 -172.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.61 -61.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.133 1.889 . . . . 2.3799999999999999 110.519 161.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.24 74.24 3.97 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 122.795 1.283 . . . . 4.1600000000000001 113.722 -169.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 127.375 2.27 . . . . 10.26 110.831 173.704 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 109.531 -1.428 . . . . 3.8900000000000001 109.531 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.93 144.31 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.613 2.208 . . . . 2.7999999999999998 112.968 -151.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -86.33 175.09 8.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.288 1.518 . . . . 3.4199999999999999 114.092 -166.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -148.19 106.37 3.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.983 1.313 . . . . 3.46 108.607 165.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mp -148.57 165.17 32.05 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.682 1.593 . . . . 3.3300000000000001 110.137 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.2 m -107.95 134.07 51.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.763 1.225 . . . . 2.29 111.904 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -73.61 160.27 31.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.494 1.118 . . . . 3.0099999999999998 112.216 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -60.6 -20.01 59.4 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 121.508 -0.745 . . . . 2.3500000000000001 112.486 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.2 m -78.43 -60.02 2.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.35 1.86 . . . . 3.9100000000000001 109.822 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.85 -14.9 0.69 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 116.11 1.204 . . . . 2.3399999999999999 116.11 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.2 133.67 44.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.829 1.815 . . . . 3.9199999999999999 109.973 171.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -82.31 129.5 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.119 -1.067 . . . . 6.5499999999999998 108.119 157.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -140.37 175.99 9.14 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.818 1.247 . . . . 4.7699999999999996 112.806 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.6 p -140.77 172.45 12.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 128.583 2.753 . . . . 3.6600000000000001 109.383 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.83 -25.03 62.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.128 0.788 . . . . 3.9100000000000001 113.128 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -75.07 -11.59 60.13 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 119.938 -1.726 . . . . 8.3599999999999994 113.979 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.73 -28.87 21.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.866 1.666 . . . . 4.1900000000000004 111.636 164.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -108.58 -2.47 18.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.535 1.68 . . . . 4.9400000000000004 115.535 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.9 mt -77.56 -176.64 4.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.9 1.227 . . . . 5.29 109.777 165.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.7 10.86 Favored Glycine 0 N--CA 1.48 1.573 0 O-C-N 120.889 -1.132 . . . . 2.7400000000000002 114.991 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -126.18 168.88 13.44 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.048 2.939 . . . . 3.79 108.252 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . 0.461 ' CD1' ' HD3' ' A' ' 269' ' ' PRO . 53.9 m95 -81.77 140.39 34.27 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.445 1.02 . . . . 2.73 109.807 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.6 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.203 -0.936 . . . . 4.0700000000000003 112.438 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.17 100.63 10.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.935 -1.135 . . . . 4.5499999999999998 107.935 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.2 mt -96.26 127.75 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.743 -0.836 . . . . 2.6299999999999999 108.743 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -139.95 143.82 36.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.122 0.969 . . . . 3.7200000000000002 111.94 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.81 127.21 53.51 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.674 1.19 . . . . 3.3900000000000001 112.34 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -147.47 163.96 28.74 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.506 1.05 . . . . 1.3400000000000001 112.654 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.95 -179.04 6.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 117.745 0.772 . . . . 4.3099999999999996 111.313 168.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 174.89 5.67 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.963 -1.125 . . . . 3.75 107.963 152.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 73.92 -24.76 0.2 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.516 1.526 . . . . 8.0399999999999991 113.921 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 83.6 m -52.42 159.69 1.54 Allowed Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 120.648 1.567 . . . . 2.8799999999999999 113.293 161.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.54 -173.44 1.8 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.386 3.39 . . . . 4.4699999999999998 111.474 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.44 -2.46 1.05 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.248 2.219 . . . . 6.3399999999999999 115.904 -157.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.29 -60.41 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.362 1.465 . . . . 5.5800000000000001 110.163 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 15.6 m -52.43 -44.02 93.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.372 -1.299 . . . . 3.0800000000000001 114.212 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.63 -39.59 0.51 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.435 2.09 . . . . 2.4100000000000001 113.774 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.41 -32.62 68.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 122.171 2.26 . . . . 4.6699999999999999 112.086 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -60.11 -44.98 94.46 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.506 -1.371 . . . . 4.0700000000000003 111.484 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.77 -39.46 91.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.02 0.928 . . . . 4.0700000000000003 111.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -72.81 -25.98 61.34 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.417 -1.427 . . . . 6.7699999999999996 114.06 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -56.03 -56.96 14.44 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.431 -1.418 . . . . 3.4900000000000002 109.812 165.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 10.0 ptp -64.7 -30.9 71.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.013 -0.994 . . . . 4.5999999999999996 113.093 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.2 mt -75.16 -48.34 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 121.773 2.079 . . . . 4.3099999999999996 109.821 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -68.07 -16.63 64.1 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.252 1.387 . . . . 6.54 111.776 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.84 -30.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.95 1.25 . . . . 2.7799999999999998 112.584 163.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.82 -46.03 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 121.061 1.755 . . . . 3.3700000000000001 110.257 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.23 -37.35 77.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.332 1.053 . . . . 4.6299999999999999 113.153 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -57.53 -46.1 84.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 3.5600000000000001 111.721 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.8 mt -71.87 -33.3 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.711 1.204 . . . . 2.8199999999999998 114.232 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.44 -29.47 61.69 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.429 1.892 . . . . 3.2000000000000002 112.359 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.5 t -68.52 -14.67 63.16 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.471 -1.393 . . . . 4.1600000000000001 113.562 170.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.43 45.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 127.069 2.147 . . . . 4.1699999999999999 108.666 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.06 4.3 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.617 2.767 . . . . 7.3300000000000001 116.252 -159.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 78.0 p -78.21 -24.33 47.1 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.94 -1.1 . . . . 5.6200000000000001 112.382 166.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.33 142.63 67.74 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 118.72 0.691 . . . . 4.7300000000000004 111.046 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.415 ' HD2' ' CD1' ' A' ' 159' ' ' TRP . 1.7 Cg_endo -81.77 46.63 2.28 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.604 4.203 . . . . 5.0700000000000003 112.233 -174.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 72.88 101.21 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.633 1.682 . . . . 5.6299999999999999 112.725 145.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 84.76 4.99 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.387 1.475 . . . . 3.1400000000000001 111.012 -160.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.8 m -79.95 122.31 83.09 Favored Pre-proline 0 N--CA 1.478 0.94 0 O-C-N 120.84 -1.163 . . . . 2.0 112.094 -173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.04 124.43 1.79 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.381 2.721 . . . . 1.3 111.97 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 tp -126.58 93.96 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.085 1.354 . . . . 3.5299999999999998 110.327 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.77 115.39 14.3 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.94 -0.763 . . . . 3.3199999999999998 108.94 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.94 112.51 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.793 1.237 . . . . 2.7000000000000002 108.584 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -83.88 135.03 34.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.649 -1.16 . . . . 2.3599999999999999 109.55 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.7 34.95 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.582 1.153 . . . . 2.4399999999999999 112.657 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -121.55 44.49 0.79 Allowed Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 127.158 2.183 . . . . 3.71 111.97 -173.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -77.71 35.15 0.5 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.231 3.287 . . . . 2.1600000000000001 113.811 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -91.34 -16.59 27.23 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.204 -0.426 . . . . 5.4299999999999997 110.406 150.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.49 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.494 2.405 . . . . 9.0199999999999996 117.494 -171.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -79.73 52.48 1.45 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.317 1.847 . . . . 4.0300000000000002 114.619 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.1 m -55.5 129.79 40.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.388 1.075 . . . . 3.2799999999999998 110.785 -167.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -41.62 -48.51 4.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.363 1.465 . . . . 3.79 113.922 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -26.07 43.98 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.993 1.109 . . . . 4.0700000000000003 113.993 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.11 86.44 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 2.8500000000000001 110.83 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.84 -30.76 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.351 1.06 . . . . 3.0899999999999999 112.613 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.31 74.38 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.408 1.458 . . . . 2.3700000000000001 113.09 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 -44.73 58.02 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.699 0.799 . . . . 4.0099999999999998 111.201 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -55.9 -39.98 72.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.476 1.51 . . . . 5.0800000000000001 111.517 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.15 -20.72 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.053 1.741 . . . . 2.4100000000000001 113.583 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -111.69 -21.55 11.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.46 1.652 . . . . 9.5500000000000007 115.46 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.73 -19.13 58.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.377 0.989 . . . . 4.0499999999999998 113.044 168.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -74.14 -87.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.707 1.603 . . . . 4.8300000000000001 110.147 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.2 t -148.61 132.1 8.33 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.646 -1.283 . . . . 3.6000000000000001 110.121 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.07 -19.44 45.37 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.382 2.055 . . . . 3.7000000000000002 114.663 -156.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -84.61 2.69 40.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.713 1.375 . . . . 4.25 114.713 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.2 tp -72.55 147.3 46.07 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.624 1.102 . . . . 3.0 113.083 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 2.3 p -118.31 130.97 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.668 1.587 . . . . 3.7799999999999998 108.66 160.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.45 160.82 19.75 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 123.919 0.771 . . . . 1.27 111.909 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -153.36 114.04 4.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.497 -1.297 . . . . 4.7800000000000002 107.497 -166.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.0 m -112.88 152.65 29.04 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.24 2.216 . . . . 3.0600000000000001 107.877 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -144.51 146.29 16.6 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 121.819 -0.551 . . . . 3.04 112.71 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -63.51 154.3 32.84 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.057 0.928 . . . . 3.3900000000000001 109.693 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.453 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -47.23 -33.25 5.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.929 1.292 . . . . 8.7799999999999994 113.38 -170.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.44 -50.57 58.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.874 1.215 . . . . 5.2699999999999996 112.411 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.62 -44.7 90.04 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.961 -1.087 . . . . 3.4300000000000002 111.967 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 15.6 m -70.95 -22.32 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 113.844 1.053 . . . . 3.9399999999999999 113.844 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.68 -53.09 37.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.847 1.203 . . . . 3.5499999999999998 108.808 164.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -55.82 -57.82 10.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.361 -0.828 . . . . 3.6600000000000001 112.378 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.97 -35.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 119.356 0.98 . . . . 2.98 113.323 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.42 67.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.063 0.945 . . . . 3.0899999999999999 111.477 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -70.21 -26.49 63.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.626 1.57 . . . . 3.7799999999999998 112.433 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.8 -62.89 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.695 1.198 . . . . 2.8199999999999998 113.367 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -67.5 -33.78 75.79 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.038 -1.039 . . . . 4.6699999999999999 112.735 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.259 2.2 ptp180 109.16 117.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 1 C-N-CA 132.411 4.284 . . . . 10.4 109.777 179.365 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.83 153.61 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.027 2.131 . . . . 5.2699999999999996 110.473 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -119.53 135.98 54.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.73 0.412 . . . . 5.2999999999999998 110.163 148.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -165.91 166.18 17.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.167 1.787 . . . . 4.9699999999999998 111.323 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 48.9 p -113.16 165.8 12.46 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.46 1.504 . . . . 5.0 112.743 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.27 143.63 17.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.595 2.197 . . . . 5.5700000000000003 111.046 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.747 0 CA-C-O 118.026 -1.43 . . . . 3.8100000000000001 112.14 177.222 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 43.3 p90 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 116.504 2.038 . . . . 4.4900000000000002 116.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt -138.84 163.93 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.711 2.004 . . . . 5.2400000000000002 108.52 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.56 148.42 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.627 1.571 . . . . 4.29 109.108 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -86.28 135.19 33.64 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.312 -0.996 . . . . 4.0300000000000002 108.312 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.62 139.85 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.59 1.156 . . . . 3.3500000000000001 111.274 -169.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -68.42 -14.94 63.35 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.977 2.214 . . . . 4.6500000000000004 116.977 -165.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 28.3 mt 50.8 56.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 120.169 1.349 . . . . 5.3899999999999997 110.36 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.0 mt -112.31 147.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.128 1.371 . . . . 3.3799999999999999 109.986 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.0 ttp -114.49 144.8 42.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.622 1.969 . . . . 5.0999999999999996 109.856 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -107.14 136.26 47.29 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.242 -0.912 . . . . 3.5699999999999998 110.874 163.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 39.2 tp -94.95 106.97 19.0 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.967 0.907 . . . . 3.1099999999999999 108.85 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.3 mp -86.84 135.58 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.501 -1.666 . . . . 2.98 106.501 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.49 165.29 24.77 Favored Glycine 0 CA--C 1.539 1.593 0 N-CA-C 111.587 -0.605 . . . . 1.8100000000000001 111.587 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.461 ' HD3' ' CD1' ' A' ' 159' ' ' TRP . 21.0 Cg_endo -67.5 9.92 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 125.181 3.921 . . . . 2.9199999999999999 114.16 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -141.93 -1.03 1.27 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.904 2.482 . . . . 5.04 111.492 -167.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 163.34 156.56 8.71 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.105 0.859 . . . . 3.9100000000000001 114.483 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -74.71 -22.05 59.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.08 1.352 . . . . 6.1900000000000004 114.638 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.87 108.17 9.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.133 -0.979 . . . . 4.9900000000000002 111.32 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 -36.76 4.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.572 1.149 . . . . 4.1500000000000004 111.152 170.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -157.45 178.63 10.08 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.98 2.112 . . . . 2.2999999999999998 110.479 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -155.26 138.3 15.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.311 1.444 . . . . 4.6299999999999999 113.354 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.8 -151.35 0.39 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.166 1.387 . . . . 4.1699999999999999 110.968 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.85 -127.05 7.92 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.849 2.166 . . . . 3.8799999999999999 108.492 -171.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -53.44 156.25 2.55 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.078 1.351 . . . . 3.46 113.11 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.6 -40.84 0.39 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.772 2.429 . . . . 5.0999999999999996 112.459 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -63.41 108.84 1.43 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.982 1.313 . . . . 5.5 112.709 -174.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.61 141.66 57.64 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.331 -0.856 . . . . 8.4600000000000009 108.845 177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -48.59 -53.57 17.9 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.205 -1.559 . . . . 3.3500000000000001 114.449 -165.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.3 -14.41 71.56 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 115.707 1.043 . . . . 1.79 115.707 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.3 -38.87 82.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.033 1.417 . . . . 3.6499999999999999 110.439 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.7 -48.54 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.65 0.78 . . . . 2.29 109.259 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.73 77.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 119.121 -0.466 . . . . 2.0699999999999998 111.858 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.79 90.39 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.712 1.004 . . . . 2.6299999999999999 113.712 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 86.8 p -60.01 -48.59 81.07 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.581 -0.699 . . . . 2.1899999999999999 111.795 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.13 -31.69 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.658 -1.276 . . . . 2.3700000000000001 111.368 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.0 64.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.957 0.903 . . . . 2.29 113.093 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.6 m -70.71 -46.09 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.539 -0.726 . . . . 2.8999999999999999 109.597 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -69.72 -27.89 65.35 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.844 1.053 . . . . 2.9700000000000002 113.844 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.7 ttt -59.98 -40.17 88.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.413 1.485 . . . . 5.21 112.167 166.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.07 36.78 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 117.36 -1.305 . . . . 6.25 113.348 -173.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.53 -57.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.408 2.739 . . . . 3.1000000000000001 112.379 158.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.67 28.61 8.51 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.439 1.644 . . . . 5.0199999999999996 115.439 -154.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 126.667 1.987 . . . . 8.8800000000000008 114.612 165.117 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.617 0 CA-C-O 118.548 -1.14 . . . . 3.1000000000000001 112.307 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.65 174.77 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.127 3.218 . . . . 3.8900000000000001 112.171 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.76 173.38 15.36 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.973 1.709 . . . . 4.1600000000000001 109.843 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.71 32.21 4.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.618 0.97 . . . . 4.4400000000000004 113.618 172.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.3 mt -51.72 149.3 4.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 3.8199999999999998 112.563 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -108.38 142.35 38.85 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.396 1.078 . . . . 2.1400000000000001 109.731 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.3 t -91.32 165.09 13.61 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.295 1.038 . . . . 3.4500000000000002 113.245 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -61.2 -25.37 67.0 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 3.04 114.124 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -83.12 0.93 42.89 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.249 1.82 . . . . 3.7000000000000002 114.178 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.94 -6.37 73.04 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.227 1.394 . . . . 2.02 115.555 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -73.63 132.95 43.32 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.347 1.073 . . . . 4.0800000000000001 111.293 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -82.52 105.3 13.46 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.092 -1.005 . . . . 5.1299999999999999 108.494 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -179.1 4.3 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.976 1.31 . . . . 3.9500000000000002 113.614 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 62.3 p -146.54 166.16 27.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.035 2.534 . . . . 3.1099999999999999 109.005 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.31 -38.17 76.55 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.449 0.568 . . . . 4.0800000000000001 112.343 173.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -81.78 4.25 22.8 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.89 1.441 . . . . 7.8300000000000001 114.89 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.81 -41.33 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.622 0.769 . . . . 3.46 109.828 160.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -84.5 -29.19 26.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.756 1.391 . . . . 4.5099999999999998 114.756 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.89 101.96 0.43 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.781 1.232 . . . . 4.9800000000000004 110.23 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 144.2 -20.97 2.09 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.643 1.116 . . . . 3.0 113.48 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.67 170.45 7.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.876 -0.787 . . . . 3.7000000000000002 108.876 152.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -82.42 127.4 33.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.478 0.581 . . . . 2.5899999999999999 109.856 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.48 145.94 44.88 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.636 0.653 . . . . 4.2999999999999998 112.506 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.1 mt -107.19 121.61 44.87 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.09 1.356 . . . . 3.4399999999999999 108.01 158.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.5 118.66 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.267 0.627 . . . . 3.1800000000000002 109.626 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -122.9 149.88 43.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.305 1.442 . . . . 3.7799999999999998 114.015 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -99.19 120.54 39.69 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 3.6000000000000001 112.524 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.96 155.71 15.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.515 1.055 . . . . 1.9299999999999999 113.791 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -114.08 -43.75 3.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.362 1.065 . . . . 4.1799999999999997 111.865 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.5 m 67.71 -18.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 126.453 1.901 . . . . 5.2000000000000002 114.835 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -71.93 -18.86 61.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.319 1.048 . . . . 8.2899999999999991 111.326 160.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.54 164.38 58.33 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.768 1.227 . . . . 2.48 111.741 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -78.82 -146.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.433 2.755 . . . . 4.3399999999999999 109.387 164.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.53 57.72 0.13 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.872 3.269 . . . . 5.5899999999999999 113.348 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.5 t -115.24 -84.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 126.849 2.06 . . . . 4.71 108.073 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -47.59 98.34 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 117.062 -1.447 . . . . 2.9100000000000001 113.761 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.46 -23.57 43.67 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.029 1.82 . . . . 1.78 114.219 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.78 -56.55 14.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.82 0.848 . . . . 4.1900000000000004 109.961 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.436 ' CD ' ' HZ1' ' A' ' 281' ' ' LYS . 4.9 tp10 -60.75 -39.89 90.4 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 2.9500000000000002 112.129 175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.1 tt -55.58 -39.58 70.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.82 1.248 . . . . 3.7000000000000002 112.036 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . 0.263 0.3 OUTLIER -75.77 -34.02 60.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.144 0.884 . . . . 3.21 112.305 175.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -55.65 -46.12 77.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.283 -1.511 . . . . 5.71 111.643 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.4 ptp -67.89 -28.53 67.59 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.728 0.64 . . . . 3.5099999999999998 112.728 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.23 -38.09 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.295 -0.878 . . . . 3.0 111.018 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.457 ' OE1' ' HE3' ' A' ' 283' ' ' LYS . 73.9 mt-30 -62.57 -40.43 96.85 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.297 -0.859 . . . . 3.1499999999999999 111.931 171.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . 0.259 4.4 m -72.31 -28.93 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.218 1.372 . . . . 4.2199999999999998 113.243 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.2 t -63.07 -52.83 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.793 1.179 . . . . 2.9500000000000002 111.717 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -74.92 -19.97 59.9 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.155 0.798 . . . . 5.1799999999999997 113.155 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -64.93 -55.59 18.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.596 0.758 . . . . 3.2799999999999998 111.241 164.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.25 -37.37 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.111 1.365 . . . . 3.2599999999999998 112.902 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.51 -35.56 65.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.49 1.516 . . . . 3.21 112.205 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.9 t -72.34 -18.2 61.78 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.931 1.085 . . . . 4.3499999999999996 113.931 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 11.8 mt -94.36 75.38 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.357 1.463 . . . . 4.0999999999999996 107.795 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -3.55 0.06 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 128.111 2.565 . . . . 5.4199999999999999 116.623 -162.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.1 t -71.59 -22.44 61.73 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.378 1.871 . . . . 6.6699999999999999 113.071 167.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.4 151.74 59.75 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.434 1.016 . . . . 4.8899999999999997 111.195 166.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 -40.11 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.074 2.516 . . . . 3.23 110.779 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -172.74 -179.89 2.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.235 2.614 . . . . 4.4800000000000004 109.331 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.0 tp -149.27 73.26 1.19 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.799 1.24 . . . . 2.96 109.948 160.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -63.03 119.96 56.82 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 121.077 -1.015 . . . . 2.1899999999999999 110.717 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.93 128.37 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.29 1.993 . . . . 1.3400000000000001 110.459 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.6 tp -115.81 115.36 26.15 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.663 1.585 . . . . 3.7400000000000002 110.735 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -87.24 126.52 34.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.174 0.99 . . . . 3.5499999999999998 109.884 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.79 119.53 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.429 -0.952 . . . . 2.3999999999999999 108.429 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.8 t -79.1 139.49 38.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.956 -0.565 . . . . 2.3100000000000001 111.632 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -124.19 21.76 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.916 1.286 . . . . 2.71 113.119 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -111.52 61.66 0.5 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.803 1.241 . . . . 3.5600000000000001 113.647 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.17 73.17 5.6 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.18 2.587 . . . . 2.4100000000000001 110.255 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -153.32 -37.15 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.101 1.36 . . . . 5.4199999999999999 112.555 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.09 7.36 0.91 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.081 1.141 . . . . 5.8700000000000001 114.081 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 177.73 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.987 -0.445 . . . . 3.46 110.828 157.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 32.8 m -155.95 136.9 13.57 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.025 -1.047 . . . . 2.6200000000000001 108.181 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.43 ' HZ2' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -51.76 -44.86 63.5 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.013 0.925 . . . . 4.8399999999999999 112.216 177.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . 0.43 ' CD ' ' HZ2' ' A' ' 210' ' ' LYS . 17.7 mp0 -60.35 -40.24 90.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.083 1.753 . . . . 3.5699999999999998 112.776 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.98 69.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.227 -0.921 . . . . 2.52 112.346 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.61 -43.24 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.919 0.888 . . . . 3.0699999999999998 110.654 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.56 66.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.219 1.008 . . . . 2.1899999999999999 112.484 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.446 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 0.7 OUTLIER -71.21 -46.79 60.43 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.19 0.996 . . . . 4.21 112.331 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.79 -37.11 86.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.467 1.507 . . . . 5.5300000000000002 111.422 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -50.64 -44.9 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.877 2.071 . . . . 2.0499999999999998 112.987 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 7.7 mtmp? -55.23 -45.53 75.97 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.662 0.664 . . . . 4.79 112.386 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -20.46 60.12 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 124.363 1.04 . . . . 5.1600000000000001 112.211 -163.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -86.16 -48.24 8.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.012 0.925 . . . . 3.4900000000000002 111.993 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 87.8 p -174.04 127.89 0.46 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.753 -1.118 . . . . 3.3399999999999999 110.902 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.15 76.59 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.661 2.907 . . . . 3.1699999999999999 109.244 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 178.18 -28.27 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.996 2.919 . . . . 3.2799999999999998 111.005 -163.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.93 143.96 55.43 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.917 1.687 . . . . 3.6299999999999999 110.722 164.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.72 133.97 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.378 1.471 . . . . 3.73 109.797 170.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.51 115.66 3.58 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 123.841 0.734 . . . . 1.0700000000000001 112.181 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.87 148.67 27.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.365 1.066 . . . . 3.5800000000000001 111.455 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 71.9 p -136.59 161.61 35.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.986 1.314 . . . . 3.0099999999999998 110.635 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.6 23.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 124.659 1.123 . . . . 2.8799999999999999 110.372 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.6 t -60.57 166.53 3.13 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.507 1.123 . . . . 3.5099999999999998 111.293 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -38.36 7.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.306 1.042 . . . . 7.5499999999999998 112.528 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 23.5 mp0 -67.15 -42.03 85.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.408 2.283 . . . . 3.75 111.751 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -71.16 -34.37 70.91 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.036 -1.04 . . . . 4.0899999999999999 111.667 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.71 -38.89 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 118.363 -0.827 . . . . 3.27 109.669 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -70.66 -41.85 71.55 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.859 -1.067 . . . . 3.4300000000000002 111.748 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -54.51 -50.04 68.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.293 1.861 . . . . 2.6600000000000001 110.752 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.44 -55.13 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.715 0.806 . . . . 3.4700000000000002 111.821 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.86 62.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.959 0.904 . . . . 2.6499999999999999 113.439 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -87.86 -30.26 20.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.675 1.59 . . . . 5.0599999999999996 112.305 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.24 13.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.109 1.322 . . . . 2.4100000000000001 111.206 168.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -76.96 -14.42 59.85 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.603 0.964 . . . . 4.96 113.603 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 76.77 62.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.112 2.165 . . . . 6.1100000000000003 112.881 159.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.86 145.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.341 1.457 . . . . 4.9199999999999999 111.979 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.74 135.88 40.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.02 0.914 . . . . 4.1299999999999999 113.033 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -145.64 136.36 24.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.881 2.872 . . . . 6.46 108.077 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.3 t -121.25 105.08 39.99 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.097 0.959 . . . . 3.4100000000000001 109.921 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.72 101.32 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.505 2.137 . . . . 3.5899999999999999 108.845 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 CA-C-O 119.617 -0.546 . . . . 2.46 113.052 -177.509 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 28.4 p90 . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 122.331 1.063 . . . . 4.8899999999999997 112.169 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.75 162.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.193 1.397 . . . . 3.4399999999999999 109.019 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 t -128.18 137.68 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.791 2.037 . . . . 4.2699999999999996 108.374 -169.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.96 119.2 21.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 107.049 -1.463 . . . . 4.5099999999999998 107.049 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.17 131.6 54.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.747 -0.834 . . . . 2.6099999999999999 108.747 168.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 56.7 m -53.24 -47.82 68.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.718 0.807 . . . . 4.3799999999999999 112.566 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.5 mt 82.6 98.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.169 2.588 . . . . 4.6600000000000001 108.339 -172.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.42 146.26 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.4 1.48 . . . . 4.2000000000000002 107.146 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.1 ttm -119.47 128.54 54.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.794 1.638 . . . . 3.3100000000000001 108.516 159.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -98.08 139.62 33.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.74 -0.6 . . . . 5.0499999999999998 111.109 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.78 113.98 26.32 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.671 -1.233 . . . . 3.4500000000000002 107.671 169.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 tp -106.28 125.84 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.922 -1.14 . . . . 5.5999999999999996 107.922 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.49 165.21 48.01 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.604 -0.599 . . . . 1.6899999999999999 111.604 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.34 48.64 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.507 3.471 . . . . 2.8500000000000001 110.49 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -165.96 -50.51 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.077 1.751 . . . . 4.4699999999999998 110.209 -156.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 151.49 -178.29 28.91 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 115.772 1.069 . . . . 3.21 115.772 166.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 50.33 -132.15 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.987 2.115 . . . . 4.7199999999999998 114.225 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.36 131.49 54.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.147 0.979 . . . . 5.4699999999999998 109.333 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.0 -29.18 23.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.056 0.943 . . . . 3.8100000000000001 110.591 169.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -162.4 158.81 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.105 2.162 . . . . 2.21 109.428 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -134.59 99.28 4.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.021 1.391 . . . . 4.8399999999999999 111.04 -170.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -95.53 110.96 22.96 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.177 -0.952 . . . . 3.98 110.1 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -75.34 -165.13 15.13 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.12 -1.192 . . . . 4.0499999999999998 110.12 163.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -74.62 -26.19 59.73 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.749 -1.442 . . . . 4.75 112.309 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -46.96 -41.78 16.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 128.231 2.612 . . . . 7.25 117.479 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.436 ' HZ1' ' CD ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -61.77 151.57 33.76 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.051 1.741 . . . . 9.5399999999999991 113.548 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.711 -1.243 . . . . 6.9800000000000004 109.331 159.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.457 ' HE3' ' OE1' ' A' ' 182' ' ' GLN . 13.5 tmtt? -65.37 -44.72 86.73 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.709 -1.244 . . . . 2.8399999999999999 113.672 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.55 -30.43 76.53 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 123.278 0.466 . . . . 1.9299999999999999 112.398 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -63.66 -24.55 67.83 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.007 1.323 . . . . 2.8399999999999999 113.489 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 13.8 mt -79.89 -30.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.901 1.228 . . . . 2.2200000000000002 111.341 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.9 72.5 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.951 -1.093 . . . . 2.0800000000000001 110.552 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.44 83.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.02 1.118 . . . . 2.3799999999999999 114.02 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 70.9 p -63.57 -49.28 74.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.131 0.878 . . . . 2.1000000000000001 111.137 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.91 -36.62 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.016 -1.052 . . . . 2.25 111.508 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.21 -6.18 4.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.721 1.209 . . . . 2.2999999999999998 114.203 168.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 40.0 m -101.88 -44.38 5.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.843 1.657 . . . . 2.1400000000000001 110.472 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -63.38 -28.23 69.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.636 1.174 . . . . 3.71 113.166 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -48.82 -40.84 30.8 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 125.988 1.715 . . . . 6.2699999999999996 111.506 165.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -60.91 -40.44 74.52 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.414 -1.755 . . . . 6.8799999999999999 112.829 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.6 -58.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.947 2.431 . . . . 2.04 113.525 163.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -83.78 8.86 13.4 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.81 1.781 . . . . 4.0199999999999996 115.81 -165.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.806 0 C-N-CA 126.734 2.014 . . . . 9.2300000000000004 114.314 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-O 117.841 -1.533 . . . . 3.0899999999999999 110.357 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.91 142.78 35.58 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.682 2.255 . . . . 3.3300000000000001 111.435 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -93.87 168.13 11.18 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.595 -1.184 . . . . 3.6699999999999999 111.663 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.6 m -140.6 78.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.109 1.364 . . . . 3.1299999999999999 110.012 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.56 147.5 40.64 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.38 0.672 . . . . 2.8199999999999998 111.234 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -75.91 131.84 39.9 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.291 2.236 . . . . 2.4100000000000001 110.183 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.9 p -92.61 160.97 14.77 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.033 1.333 . . . . 2.8300000000000001 112.162 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -64.91 -6.62 8.77 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.332 1.453 . . . . 1.8100000000000001 114.638 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.2 m -66.75 -60.62 2.52 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.625 1.17 . . . . 3.7000000000000002 109.093 162.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 160.13 0.48 0.07 OUTLIER Glycine 0 CA--C 1.534 1.255 0 N-CA-C 116.446 1.338 . . . . 2.5499999999999998 116.446 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.34 165.48 33.93 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.751 1.775 . . . . 4.8799999999999999 113.567 -170.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.72 120.78 25.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.819 2.448 . . . . 5.1799999999999997 113.79 -167.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -99.63 171.58 7.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.228 1.411 . . . . 5.96 111.324 165.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.6 p -130.16 157.3 42.81 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.27 1.428 . . . . 2.8900000000000001 110.176 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.6 -41.96 43.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.269 1.428 . . . . 3.54 111.455 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.56 -26.4 63.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.648 1.579 . . . . 9.0700000000000003 113.765 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -80.06 -33.09 39.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.169 1.349 . . . . 3.0099999999999998 112.193 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.72 -23.17 58.55 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.79 0.663 . . . . 4.29 112.79 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.63 131.69 51.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.852 1.261 . . . . 4.2999999999999998 111.048 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 108.72 -25.42 19.25 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.522 1.534 . . . . 2.79 112.726 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -88.23 -152.47 0.22 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.575 1.55 . . . . 3.9500000000000002 108.726 165.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.8 157.56 44.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.307 1.043 . . . . 2.5299999999999998 110.659 163.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.14 152.96 28.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.915 0.864 . . . . 3.3500000000000001 113.011 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.8 pp -106.52 155.15 19.9 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.825 1.25 . . . . 4.8600000000000003 107.853 165.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.75 123.23 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.439 -0.949 . . . . 2.7599999999999998 108.439 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -123.05 154.3 38.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.719 1.208 . . . . 4.3099999999999996 111.677 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -108.84 116.7 32.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.845 0.858 . . . . 3.3500000000000001 109.601 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.74 162.43 33.26 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.923 1.249 . . . . 2.48 113.585 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.08 -44.97 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 115.947 -1.978 . . . . 5.25 114.759 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t 136.95 177.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 131.426 3.89 . . . . 6.1299999999999999 110.118 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 77.46 -15.27 0.76 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 127.841 2.456 . . . . 8.4000000000000004 112.958 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.3 p -51.36 155.59 2.41 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 125.321 1.448 . . . . 3.5499999999999998 112.179 155.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 172' ' ' VAL . 87.3 Cg_endo -78.88 74.44 5.52 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.642 2.894 . . . . 4.4199999999999999 109.75 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 69.25 -7.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.665 2.386 . . . . 4.1500000000000004 114.628 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 170' ' ' PRO . 95.6 t -46.57 -55.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.854 2.462 . . . . 3.77 113.485 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.99 -67.49 0.52 Allowed Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 118.051 -0.976 . . . . 1.78 111.367 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.72 -40.63 21.63 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.944 1.763 . . . . 1.54 113.938 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -58.22 -43.33 87.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.869 1.213 . . . . 3.6699999999999999 111.686 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -84.6 -34.46 23.14 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.232 -0.918 . . . . 3.1800000000000002 112.931 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.6 -35.62 80.13 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.293 1.406 . . . . 4.54 112.082 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -47.73 -51.01 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.449 1.1 . . . . 3.3500000000000001 111.226 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -60.88 -38.32 85.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.053 -1.029 . . . . 3.4700000000000002 111.789 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -70.13 -41.47 73.87 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.386 -0.821 . . . . 5.0800000000000001 112.702 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.47 -53.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.722 1.146 . . . . 2.7999999999999998 109.048 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -55.65 -13.79 1.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.285 1.434 . . . . 4.0700000000000003 114.573 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 t -97.99 -46.77 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.088 2.155 . . . . 2.9199999999999999 112.942 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 21.3 m -62.25 -25.53 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.426 1.466 . . . . 4.54 112.311 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -70.88 -22.16 62.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.318 0.647 . . . . 4.1299999999999999 112.68 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' CD ' ' HZ1' ' A' ' 283' ' ' LYS . 16.4 mt-10 -79.71 -19.66 48.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.066 1.347 . . . . 2.5699999999999998 111.789 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 43.3 mm -81.36 -58.97 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 2.7999999999999998 109.746 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -32.86 74.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.15 1.78 . . . . 3.4500000000000002 113.544 -170.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 t -69.49 -20.18 63.73 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.898 1.279 . . . . 3.2400000000000002 112.87 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.2 mm -91.84 89.24 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.589 -1.319 . . . . 5.0599999999999996 108.352 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.5 p -60.74 69.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.353 2.261 . . . . 6.4000000000000004 113.76 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 175.73 -29.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.527 2.731 . . . . 5.04 111.777 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.15 159.07 68.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.605 0.762 . . . . 4.4100000000000001 110.824 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.25 160.16 17.64 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.299 2.666 . . . . 3.29 109.486 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.0 134.76 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.167 0.508 . . . . 3.8900000000000001 111.652 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -95.87 95.71 8.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.027 -1.471 . . . . 3.96 107.027 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 m -68.56 124.59 90.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 108.549 -0.908 . . . . 1.8100000000000001 108.549 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.07 118.15 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.486 2.124 . . . . 1.1100000000000001 110.476 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.79 121.08 43.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.273 1.429 . . . . 3.27 110.487 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.12 112.38 19.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.571 1.148 . . . . 4.71 110.216 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.67 110.11 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.045 1.338 . . . . 2.5899999999999999 110.505 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 m -90.0 96.03 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.132 -0.98 . . . . 3.3900000000000001 111.581 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.03 -2.77 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 116.359 1.985 . . . . 3.1899999999999999 116.359 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -117.9 60.84 3.63 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 119.929 1.241 . . . . 4.1299999999999999 110.572 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.1 149.25 40.95 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.178 2.585 . . . . 2.21 109.506 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 114.13 -43.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 129.682 3.193 . . . . 5.2000000000000002 108.974 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -35.77 36.67 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.1 -0.375 . . . . 7.2199999999999998 111.895 160.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.18 151.06 20.82 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.685 1.194 . . . . 4.5899999999999999 110.964 167.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.4 p -132.42 154.76 49.52 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 124.819 1.248 . . . . 4.1900000000000004 109.28 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -48.42 -43.24 34.06 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.561 1.144 . . . . 4.0800000000000001 112.032 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -81.0 -26.07 36.76 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.082 1.141 . . . . 3.27 114.082 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.86 68.84 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.249 0.932 . . . . 2.3500000000000001 110.266 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.5 mm -65.41 -36.08 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 117.706 -1.14 . . . . 2.8500000000000001 110.816 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.2 66.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.784 1.629 . . . . 2.27 113.148 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -73.2 -49.53 27.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.378 0.671 . . . . 4.0700000000000003 112.339 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.33 -41.04 65.33 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.94 -1.1 . . . . 4.1699999999999999 112.088 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.5 t -62.96 -50.92 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.262 1.825 . . . . 2.8599999999999999 112.294 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 17.8 ttpp -59.34 -40.44 86.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.087 0.955 . . . . 4.71 111.248 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 0.4 OUTLIER -70.14 -33.22 71.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.481 1.512 . . . . 4.6600000000000001 112.25 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.88 -13.21 61.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.049 1.129 . . . . 4.71 114.049 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.6 p 139.92 149.57 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 130.744 3.618 . . . . 3.0600000000000001 111.816 168.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.26 5.65 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.36 2.706 . . . . 2.04 113.865 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.63 -24.74 23.85 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.769 1.168 . . . . 2.46 112.784 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.4 146.31 32.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.399 -1.438 . . . . 3.1800000000000002 112.765 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.5 127.09 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.17 0.588 . . . . 3.2799999999999998 111.862 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.68 129.94 10.06 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.81000000000000005 110.813 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.2 113.62 26.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.264 -1.384 . . . . 2.77 107.264 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.4 m -141.15 68.84 1.34 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.633 1.573 . . . . 3.6099999999999999 108.633 -164.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -91.15 -174.06 43.67 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.741 1.163 . . . . 2.02 112.405 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -75.79 163.32 27.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.918 1.287 . . . . 2.5899999999999999 112.418 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.451 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 36.9 ttm180 -43.02 -31.58 0.55 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.255 2.622 . . . . 6.71 114.433 173.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -77.14 -38.02 52.76 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.957 1.303 . . . . 4.2599999999999998 113.311 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.33 -45.99 85.45 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.102 -0.999 . . . . 3.9700000000000002 109.145 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 19.5 m -70.16 -18.51 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.247 1.203 . . . . 4.1299999999999999 114.247 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.14 -40.86 71.11 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.055 -1.028 . . . . 3.5699999999999998 112.178 168.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -61.96 -50.86 70.44 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.883 -0.511 . . . . 3.6699999999999999 111.565 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.38 -24.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 120.359 -0.536 . . . . 2.7400000000000002 112.195 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.39 67.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.441 1.096 . . . . 3.48 112.025 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -36.7 63.82 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.47 0.915 . . . . 3.9700000000000002 113.47 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.55 -26.51 65.45 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.972 1.471 . . . . 2.2400000000000002 114.972 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.96 10.27 1.75 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.244 1.572 . . . . 4.0700000000000003 115.244 -168.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 74.39 -58.68 0.58 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.252 2.621 . . . . 6.7199999999999998 110.765 -165.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 55.8 t 63.58 -64.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 128.143 2.577 . . . . 4.46 111.185 -165.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 30.7 t80 58.38 62.11 2.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.572 1.549 . . . . 6.0099999999999998 113.251 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -68.13 148.53 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.319 -0.863 . . . . 4.71 111.234 165.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 m -107.25 98.38 22.48 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 121.464 -0.772 . . . . 4.2599999999999998 109.862 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -80.57 113.24 2.82 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.039 1.826 . . . . 2.9700000000000002 112.172 -171.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.503 0 N-CA-C 111.345 -0.702 . . . . 2.3999999999999999 111.345 167.771 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.7 t80 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 107.786 -1.191 . . . . 4.1200000000000001 107.786 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.303 0.2 OUTLIER -81.5 58.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.569 -1.332 . . . . 3.9199999999999999 113.074 -158.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.76 130.5 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.281 1.432 . . . . 3.9900000000000002 110.693 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.71 155.67 16.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.837 2.055 . . . . 3.6099999999999999 112.482 169.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -131.98 81.56 1.97 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.086 0.954 . . . . 2.6899999999999999 112.796 164.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -73.32 95.74 2.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.252 1.421 . . . . 5.6799999999999997 111.826 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 158.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 116.062 1.875 . . . . 7.3899999999999997 116.062 -174.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.4 tt -95.78 156.24 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 128.107 2.563 . . . . 4.8200000000000003 109.761 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 35.8 ttm -96.99 145.82 25.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.785 1.234 . . . . 3.4900000000000002 110.39 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -113.68 144.65 42.57 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.707 1.203 . . . . 5.2699999999999996 112.275 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 13.6 tp -110.05 128.02 55.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.647 1.179 . . . . 2.9199999999999999 108.689 165.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.89 143.04 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.557 -1.275 . . . . 2.8300000000000001 107.557 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -108.56 176.31 20.05 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.142 0.877 . . . . 1.8300000000000001 112.481 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 66.93 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.917 3.745 . . . . 2.5800000000000001 109.053 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -160.22 -56.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.502 1.521 . . . . 4.2699999999999996 110.487 -161.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 153.79 -134.4 4.34 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.504 0.573 . . . . 2.6400000000000001 113.529 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.03 -39.76 69.49 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.849 1.426 . . . . 4.5599999999999996 114.849 -150.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.4 p90 179.91 150.07 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.757 2.423 . . . . 6.2800000000000002 109.225 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.91 -21.87 13.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.074 1.35 . . . . 4.5099999999999998 111.505 164.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -152.46 163.16 40.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 2.6000000000000001 112.234 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -158.12 131.86 7.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.727 2.011 . . . . 7.21 110.609 172.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.87 154.94 30.61 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.14 -0.975 . . . . 4.3200000000000003 112.286 -171.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.66 163.17 40.21 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 122.114 0.841 . . . . 3.73 112.762 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -68.23 114.11 6.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.827 -1.546 . . . . 5.7300000000000004 106.827 150.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 155.76 -14.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 129.619 3.168 . . . . 5.6299999999999999 113.341 -165.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -90.41 130.94 36.43 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.966 -1.084 . . . . 5.3099999999999996 113.118 -171.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -72.61 122.72 21.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.771 1.228 . . . . 7.7999999999999998 108.338 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.508 ' HZ1' ' CD ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -37.61 -55.24 1.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.531 2.049 . . . . 3.3399999999999999 116.531 -155.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -60.58 -17.16 47.61 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.427 1.013 . . . . 1.55 114.918 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.18 -30.0 70.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.479 1.14 . . . . 3.48 112.644 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.5 mt -82.76 -41.8 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.982 0.913 . . . . 2.3399999999999999 108.947 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.1 -41.32 64.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.39 0.541 . . . . 2.1000000000000001 112.093 168.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.49 -43.45 94.1 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.145 1.165 . . . . 2.4500000000000002 114.145 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.8 p -68.53 -41.84 79.3 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.29 1.405 . . . . 2.9700000000000002 111.582 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 38.2 mt -56.39 -52.39 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.374 0.988 . . . . 2.3399999999999999 110.829 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.81 65.15 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.235 0.828 . . . . 2.5499999999999998 113.235 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 88.7 m -70.84 -48.23 55.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.98 1.312 . . . . 2.98 110.75 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -67.16 -29.38 69.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.425 1.011 . . . . 3.1600000000000001 113.434 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -19.8 63.06 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.465 1.506 . . . . 7.7199999999999998 114.135 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -71.79 -45.45 12.25 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.499 -1.715 . . . . 6.8200000000000003 114.157 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.45 -58.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.373 2.715 . . . . 2.2000000000000002 111.722 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -85.86 119.94 26.72 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.364 -0.835 . . . . 3.9900000000000002 110.916 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 N--CA 1.472 0.648 0 C-N-CA 127.625 2.37 . . . . 12.039999999999999 112.904 163.484 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 N-CA-C 112.929 -0.069 . . . . 3.0899999999999999 112.929 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.05 159.45 53.87 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.774 2.983 . . . . 2.8399999999999999 111.762 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -138.98 172.04 13.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.875 1.27 . . . . 3.3999999999999999 110.779 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 p -141.12 18.94 2.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.506 1.669 . . . . 3.2400000000000002 115.506 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.83 154.89 41.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.933 1.349 . . . . 2.9500000000000002 114.396 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.9 m -91.68 147.2 23.17 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.628 1.171 . . . . 2.27 109.149 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.8 p -78.89 156.11 28.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.087 1.355 . . . . 2.5800000000000001 112.549 -173.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -50.68 -25.7 4.59 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 113.906 -1.497 . . . . 2.2400000000000002 113.427 162.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.0 m -72.97 -64.78 0.9 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.207 1.803 . . . . 4.2400000000000002 109.513 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.01 55.0 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.488 1.518 . . . . 2.7799999999999998 112.645 -169.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.22 144.84 9.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.803 2.041 . . . . 3.7000000000000002 108.335 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -89.85 126.11 35.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.706 1.139 . . . . 5.8899999999999997 112.047 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -112.68 162.94 15.14 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.473 -1.392 . . . . 4.0 112.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.6 p -136.04 -179.21 5.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.648 1.979 . . . . 3.5899999999999999 109.784 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -68.54 -22.21 64.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.218 1.007 . . . . 4.3799999999999999 112.668 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -32.2 66.95 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.865 1.061 . . . . 5.9199999999999999 113.865 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.14 -37.95 84.69 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.926 1.29 . . . . 3.46 111.435 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -107.84 20.99 18.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.557 1.543 . . . . 4.9900000000000002 114.284 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -80.46 167.58 19.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.379 -0.826 . . . . 4.0499999999999998 110.59 167.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.89 14.21 75.74 Favored Glycine 0 N--CA 1.478 1.499 0 O-C-N 120.663 -1.273 . . . . 2.7999999999999998 114.348 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -162.17 151.52 15.84 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.675 2.79 . . . . 3.1400000000000001 106.743 -172.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -71.76 129.57 38.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.932 1.242 . . . . 1.95 111.647 -173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.57 133.52 53.78 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.525 1.13 . . . . 3.5699999999999998 110.911 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.24 126.42 53.58 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.86 1.264 . . . . 3.7599999999999998 108.415 165.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.9 mt -120.35 119.39 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.479 -0.934 . . . . 2.5499999999999998 108.479 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -113.29 141.36 47.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 4.6399999999999997 111.559 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -108.32 126.76 53.21 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.981 0.912 . . . . 3.4399999999999999 111.802 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.444 ' HA3' ' SG ' ' A' ' 173' ' ' CYS . . . -169.95 -179.77 41.79 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.319 1.438 . . . . 1.3300000000000001 113.605 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.76 137.91 26.8 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.014 1.407 . . . . 5.2300000000000004 112.333 -177.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.8 t -74.97 70.6 2.01 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.761 1.267 . . . . 4.3399999999999999 112.249 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.4 -31.25 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.107 0.963 . . . . 8.9100000000000001 111.138 -149.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 14.1 m -47.9 143.13 6.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.732 1.213 . . . . 2.1099999999999999 112.316 161.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.88 -59.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.971 2.448 . . . . 3.96 109.999 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.15 137.99 21.23 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.426 -0.953 . . . . 5.3700000000000001 108.426 136.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.4 t -162.21 -55.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.553 3.141 . . . . 4.0800000000000001 107.283 169.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.444 ' SG ' ' HA3' ' A' ' 165' ' ' GLY . 1.7 m -57.3 -65.31 1.83 Allowed Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.775 1.63 . . . . 1.6299999999999999 113.237 173.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.64 -44.97 44.48 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.957 2.438 . . . . 2.79 114.73 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 22.8 tp10 -47.98 -46.11 32.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.067 1.747 . . . . 3.75 112.067 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.451 ' CD ' ' HZ2' ' A' ' 281' ' ' LYS . 1.2 mm-40 -77.5 -40.3 43.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.791 1.178 . . . . 3.1699999999999999 112.829 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.7 76.6 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.063 -1.023 . . . . 3.8900000000000001 111.997 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.07 -59.6 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.618 1.967 . . . . 3.3799999999999999 110.223 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 175' ' ' GLU . 9.1 mptt -62.84 -37.61 87.48 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.541 -1.349 . . . . 5.9699999999999998 111.346 -173.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.66 -27.28 64.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.493 1.117 . . . . 4.4699999999999998 113.642 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.8 mm -69.05 -55.58 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 120.005 1.275 . . . . 2.7999999999999998 109.972 171.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -68.29 -17.99 64.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.771 1.623 . . . . 4.8499999999999996 111.724 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.53 -44.59 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.553 1.07 . . . . 2.5099999999999998 111.007 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.31 -27.19 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 121.081 1.764 . . . . 3.7400000000000002 112.88 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.74 -48.3 55.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.952 1.701 . . . . 4.4199999999999999 113.278 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.73 -32.89 72.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.329 -0.857 . . . . 3.4700000000000002 112.341 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.83 -50.39 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.931 0.892 . . . . 2.8999999999999999 111.424 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.38 -22.71 57.29 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.672 1.124 . . . . 5.5899999999999999 112.747 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.3 m -65.08 -11.45 39.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.287 -0.883 . . . . 3.2400000000000002 113.268 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.95 -20.23 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 4.75 111.179 164.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.295 70.3 p 128.77 -11.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 1 C-N-CA 132.475 4.31 . . . . 7.0599999999999996 115.337 152.585 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 t -178.77 71.4 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.065 1.346 . . . . 4.3200000000000003 112.042 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.97 158.71 52.78 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 121.181 -0.949 . . . . 4.5199999999999996 111.628 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.86 -9.85 18.2 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.789 2.326 . . . . 3.4100000000000001 111.912 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS 0.269 17.5 t0 100.81 152.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 130.398 3.479 . . . . 4.21 114.058 162.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 134.12 55.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.175 1.79 . . . . 3.1600000000000001 112.074 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.7 m -110.42 121.36 41.59 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.946 1.298 . . . . 1.95 109.796 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -89.3 126.43 1.6 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.941 3.094 . . . . 1.0700000000000001 110.74 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.3 106.29 12.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.519 1.928 . . . . 3.48 110.783 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 115.24 26.17 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.51 -0.744 . . . . 4.0499999999999998 109.681 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -89.61 112.21 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.198 0.999 . . . . 2.7999999999999998 109.502 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 6.2 t -71.25 122.23 19.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.755 -0.657 . . . . 2.2400000000000002 109.908 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.0 pt -106.79 48.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.806 1.642 . . . . 2.9300000000000002 109.662 162.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -104.54 31.41 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.258 1.823 . . . . 4.2699999999999996 113.39 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.63 -17.89 56.94 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 124.331 3.354 . . . . 3.1200000000000001 114.234 -162.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -62.81 -23.95 67.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.944 1.298 . . . . 5.5499999999999998 113.331 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.0 8.91 0.66 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 116.209 1.929 . . . . 7.5300000000000002 116.209 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -42.11 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.881 3.272 . . . . 4.6399999999999997 115.462 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.3 m -88.83 125.51 34.94 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 120.801 -1.187 . . . . 2.8900000000000001 108.761 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -41.09 65.71 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.835 0.854 . . . . 5.0800000000000001 113.176 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -73.76 -43.03 60.21 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-O 117.306 -1.33 . . . . 5.75 112.699 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.25 60.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.4 1.909 . . . . 2.52 112.621 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.08 -32.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 118.465 -0.779 . . . . 3.5299999999999998 112.4 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.64 88.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.473 1.488 . . . . 2.29 111.352 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.93 -54.64 44.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.747 1.619 . . . . 4.1900000000000004 108.698 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -47.88 -48.44 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.307 0.958 . . . . 4.6200000000000001 112.9 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.9 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.072 0.851 . . . . 2.3599999999999999 111.847 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -19.79 63.26 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.293 1.22 . . . . 6.04 114.293 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -69.69 -24.66 63.62 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.347 0.976 . . . . 3.6800000000000002 112.171 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -89.46 -72.8 0.54 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 4.21 112.571 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 85.8 p -173.51 153.26 2.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 120.711 -1.243 . . . . 2.6099999999999999 112.869 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.62 -1.68 11.41 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.167 2.578 . . . . 2.3500000000000001 114.518 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 195' ' ' ASP . 73.5 tttt -95.2 2.4 54.95 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.096 1.316 . . . . 2.9199999999999999 112.573 170.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.0 tp -89.73 139.74 30.27 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.715 -1.241 . . . . 2.8500000000000001 110.424 173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.29 136.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.512 1.125 . . . . 4.2300000000000004 108.814 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.73 150.79 18.24 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 124.187 0.898 . . . . 1.24 110.996 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.0 155.98 35.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.987 1.315 . . . . 3.6000000000000001 110.491 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.6 p -129.1 169.71 14.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.615 2.366 . . . . 3.25 109.484 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.96 148.47 14.23 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 115.879 1.112 . . . . 2.1400000000000001 115.879 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -62.47 143.29 57.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.662 -0.769 . . . . 2.8500000000000001 109.395 162.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.31 -21.85 66.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.194 1.183 . . . . 8.3300000000000001 114.194 -161.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.4 mp0 -65.24 -45.36 84.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.645 1.578 . . . . 2.6699999999999999 111.133 170.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -81.81 -33.9 30.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.905 1.282 . . . . 3.4100000000000001 111.71 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.05 -36.77 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 118.605 -0.712 . . . . 2.6699999999999999 111.179 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.38 -45.95 88.7 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.667 -1.158 . . . . 2.9100000000000001 109.765 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -50.36 -54.21 23.39 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.291 1.405 . . . . 2.6699999999999999 112.337 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.21 -38.88 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.931 1.241 . . . . 3.0800000000000001 113.321 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.19 -34.28 77.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.649 0.779 . . . . 2.8300000000000001 112.296 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -88.98 -32.63 17.54 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.791 2.437 . . . . 3.98 113.198 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.19 70.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.566 1.075 . . . . 2.48 110.537 165.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -85.16 9.7 14.25 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.406 1.082 . . . . 3.77 112.946 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 35.81 46.81 0.35 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.58 2.752 . . . . 5.3799999999999999 115.053 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.95 136.38 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 109.386 -0.598 . . . . 3.8900000000000001 109.386 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.22 129.64 37.82 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.174 -0.328 . . . . 4.8099999999999996 111.352 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.27 108.53 0.73 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.36 1.864 . . . . 5.1399999999999997 109.764 -160.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 149.7 37.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.062 1.134 . . . . 4.0700000000000003 114.062 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.23 148.77 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.474 2.782 . . . . 5.4100000000000001 110.812 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 C-N-CA 124.852 1.215 . . . . 4.0499999999999998 114.265 -178.437 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 47.1 p90 . . . . . 0 C--O 1.237 0.415 0 N-CA-C 109.144 -0.687 . . . . 6.9100000000000001 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 20.7 tt -72.75 76.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.552 -1.343 . . . . 3.8999999999999999 110.45 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.7 t -44.94 130.86 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 127.104 2.162 . . . . 3.5699999999999998 112.726 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -70.26 137.41 50.77 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.732 1.213 . . . . 4.2400000000000002 111.707 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.12 137.63 19.83 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.865 -1.061 . . . . 2.2999999999999998 109.703 163.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t -64.23 -24.01 67.51 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.145 1.165 . . . . 4.54 114.145 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.269 0.7 OUTLIER 67.12 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 128.789 2.836 . . . . 5.0599999999999996 112.966 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.27 145.29 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.129 -1.607 . . . . 4.3600000000000003 112.766 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 140.81 32.9 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 127.318 2.247 . . . . 3.9100000000000001 109.638 164.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.65 145.08 41.86 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.732 0.813 . . . . 4.6299999999999999 112.501 154.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.6 tp -100.51 130.69 46.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.012 1.725 . . . . 2.7400000000000002 110.019 168.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.62 133.63 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.672 -1.973 . . . . 3.27 105.672 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 -177.48 19.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.168 -0.373 . . . . 1.8700000000000001 112.168 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.41 42.77 1.36 Allowed 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.742 2.961 . . . . 2.9700000000000002 110.818 172.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -177.76 -67.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.837 2.455 . . . . 5.2000000000000002 111.009 -163.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -135.67 142.0 13.26 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 114.704 0.642 . . . . 3.8900000000000001 114.704 -158.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -86.75 161.21 18.52 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.395 1.478 . . . . 7.2300000000000004 114.467 -173.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 63.0 53.2 2.4 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.372 1.869 . . . . 5.2999999999999998 111.974 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 55.5 tp -92.11 -33.46 14.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.564 1.146 . . . . 3.7000000000000002 112.645 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -162.31 163.34 28.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.045 1.738 . . . . 2.29 109.734 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.66 142.73 11.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.164 0.985 . . . . 4.8899999999999997 113.604 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -140.2 136.23 33.21 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.125 -0.985 . . . . 4.4500000000000002 112.22 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.54 -171.27 45.04 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.913 -0.875 . . . . 3.1600000000000001 110.913 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.59 139.44 58.77 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.505 -1.294 . . . . 3.8700000000000001 107.505 147.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 14.3 t30 149.29 -59.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 129.292 3.037 . . . . 5.6799999999999997 108.233 -171.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.451 ' HZ2' ' CD ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -72.85 158.36 35.68 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.56 0.578 . . . . 8.7699999999999996 112.56 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -100.44 177.54 5.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.824 1.25 . . . . 6.4299999999999997 110.541 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -53.25 -48.77 67.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.736 1.214 . . . . 2.5499999999999998 113.803 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.74 86.08 Favored Glycine 0 N--CA 1.469 0.857 0 CA-C-N 118.416 0.553 . . . . 1.6100000000000001 112.272 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.92 -28.8 64.77 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.692 1.197 . . . . 3.04 112.785 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.5 mt -69.31 -33.21 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.611 -0.681 . . . . 2.79 110.717 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -79.5 -49.47 12.22 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.063 0.847 . . . . 2.0899999999999999 112.108 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.21 -32.26 73.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.778 1.231 . . . . 2.1299999999999999 113.938 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.7 p -58.68 -61.62 2.47 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.095 0.958 . . . . 1.8700000000000001 111.221 167.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.0 mt -52.78 -45.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.898 1.279 . . . . 2.3900000000000001 111.357 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.16 -5.77 24.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.257 1.423 . . . . 2.6699999999999999 114.209 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.3 m -89.11 -54.89 3.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.102 0.961 . . . . 2.2599999999999998 108.732 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.54 -27.55 26.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.654 1.582 . . . . 3.2999999999999998 114.321 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -51.03 -22.5 2.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.884 2.473 . . . . 5.0 114.779 170.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -98.8 -36.69 0.24 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.811 2.044 . . . . 7.2199999999999998 116.387 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.36 -32.91 2.74 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.151 2.567 . . . . 2.5699999999999998 111.729 166.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 -171.88 2.15 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.49 0.586 . . . . 4.1900000000000004 110.008 149.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? . . . . . 0 N--CA 1.478 0.942 0 C-N-CA 125.64 1.576 . . . . 9.0099999999999998 110.576 175.192 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.406 0 CA-C-O 118.648 -1.085 . . . . 3.3500000000000001 112.661 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -69.47 160.14 50.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.027 2.484 . . . . 3.2599999999999998 110.772 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -128.85 -155.08 0.68 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.399 1.48 . . . . 3.8300000000000001 110.57 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -160.17 147.21 16.11 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.801 -1.187 . . . . 3.8300000000000001 109.659 148.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 tp -156.82 167.27 30.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.049 0.94 . . . . 3.98 110.054 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -109.63 140.51 43.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.732 0.813 . . . . 3.5 110.41 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.1 p -72.08 164.86 25.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.446 1.098 . . . . 2.8300000000000001 111.396 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -57.58 -12.49 2.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.96 2.504 . . . . 2.29 114.15 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 t -119.83 16.79 12.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.233 2.213 . . . . 3.8599999999999999 112.537 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.79 -17.32 36.56 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 116.762 1.465 . . . . 2.3100000000000001 116.762 164.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.28 140.98 55.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.464 1.632 . . . . 4.0599999999999996 109.808 168.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.406 ' O ' ' HE2' ' A' ' 150' ' ' LYS . 0.7 OUTLIER -64.26 135.29 56.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.45 1.5 . . . . 10.01 108.694 167.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 149' ' ' ARG . 2.9 tppt? -142.2 119.09 11.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.025 -1.672 . . . . 4.3300000000000001 112.705 170.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 94.4 m -132.37 143.26 49.72 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 127.582 2.353 . . . . 4.1699999999999999 107.336 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.77 -29.3 70.04 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.193 0.997 . . . . 5.6399999999999997 113.373 -174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 5.21 50.51 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.199 1.555 . . . . 8.4900000000000002 115.199 174.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -41.47 6.57 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.738 0.699 . . . . 3.2400000000000002 112.165 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.9 40.46 1.0 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.265 0.839 . . . . 7.0999999999999996 113.265 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 tp -83.88 169.8 14.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.049 1.34 . . . . 4.2199999999999998 112.898 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.82 -12.93 51.05 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.368 -1.457 . . . . 2.7599999999999998 114.798 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 175.62 5.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.111 2.964 . . . . 3.96 109.916 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -88.97 80.31 7.1 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.023 1.283 . . . . 2.4500000000000002 113.017 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.3 mt -67.29 140.67 57.33 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.849 0.86 . . . . 3.8799999999999999 112.753 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 28.1 tp -139.16 108.74 6.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.113 1.765 . . . . 3.4700000000000002 108.518 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.21 131.88 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.305 1.042 . . . . 2.5899999999999999 108.515 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -128.16 155.42 44.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.681 1.192 . . . . 3.8500000000000001 109.284 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -121.28 115.82 23.7 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.106 0.963 . . . . 3.3900000000000001 109.063 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.22 176.12 21.52 Favored Glycine 0 N--CA 1.467 0.708 0 CA-C-O 122.452 1.029 . . . . 1.5 115.139 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -93.95 138.0 32.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.105 0.962 . . . . 4.5 109.9 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -70.54 14.05 0.15 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.338 -0.851 . . . . 4.54 111.872 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -141.81 -73.19 0.32 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.419 -1.425 . . . . 10.109999999999999 108.914 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.8 t 70.11 174.71 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.793 2.037 . . . . 2.9900000000000002 111.817 -174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.63 -73.17 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.659 2.906 . . . . 3.8500000000000001 109.623 143.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.68 16.65 0.08 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.462 1.505 . . . . 4.7300000000000004 113.08 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.404 HG13 HE22 ' A' ' 279' ' ' GLN . 92.1 t -84.95 -49.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 119.894 -1.754 . . . . 3.7400000000000002 110.715 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 64.4 m -50.77 -44.54 85.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 116.356 -1.783 . . . . 1.8500000000000001 114.387 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.01 -34.82 57.48 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 122.57 1.953 . . . . 1.3600000000000001 113.048 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.88 -38.27 76.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.568 1.531 . . . . 3.2000000000000002 111.868 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.27 -34.67 73.07 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.314 -1.491 . . . . 3.3700000000000001 112.665 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.5 tp -68.88 -42.95 76.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.363 1.065 . . . . 4.29 111.067 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.51 -45.34 66.18 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.255 1.422 . . . . 3.3500000000000001 111.543 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -53.78 -59.61 4.39 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.631 -1.293 . . . . 3.8599999999999999 111.863 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 5.7 ptp -64.84 -34.53 78.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.361 -0.837 . . . . 3.0299999999999998 113.194 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -60.86 -52.91 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 118.108 -0.948 . . . . 2.8599999999999999 110.734 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -68.11 -25.63 65.4 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.753 1.615 . . . . 3.77 110.692 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.51 -41.13 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.05 -0.976 . . . . 2.6299999999999999 112.634 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.91 -31.87 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.827 1.194 . . . . 3.6600000000000001 112.217 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.15 -42.85 99.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.265 1.426 . . . . 4.2199999999999998 111.951 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.15 -54.87 23.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.557 1.543 . . . . 3.04 112.214 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.41 -35.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.556 0.947 . . . . 3.4199999999999999 113.556 -163.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.03 -37.32 74.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.166 0.986 . . . . 3.5299999999999998 111.099 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -68.18 -15.46 63.59 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.114 -0.991 . . . . 3.3300000000000001 112.946 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.15 -0.05 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 119.838 -1.789 . . . . 3.6099999999999999 111.651 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.0 m 77.28 -24.08 0.23 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.045 1.498 . . . . 4.6900000000000004 115.045 144.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 61.8 m -102.65 -0.04 32.47 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.174 1.352 . . . . 5.3499999999999996 112.133 164.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.27 124.86 91.38 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.206 -1.405 . . . . 4.5099999999999998 107.206 157.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 -26.43 23.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.414 1.409 . . . . 3.8999999999999999 109.934 160.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.43 175.5 3.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.956 1.702 . . . . 4.0 112.499 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 16.9 tp -137.44 117.64 13.54 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.368 -2.086 . . . . 2.5499999999999998 105.368 143.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.2 m -103.06 106.55 51.43 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 119.778 1.172 . . . . 2.0 110.746 -172.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.14 117.08 4.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.642 2.228 . . . . 1.0900000000000001 111.292 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 12.1 tp -99.86 94.71 6.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.675 2.39 . . . . 3.02 108.58 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -84.04 104.22 13.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.835 -0.802 . . . . 3.7200000000000002 108.835 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 44.0 mm -79.48 110.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.575 -0.898 . . . . 2.7599999999999998 108.575 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 75.7 m -82.16 114.17 20.5 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.132 -0.98 . . . . 3.3199999999999998 111.001 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.19 2.05 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.095 1.517 . . . . 2.6099999999999999 115.095 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.01 69.63 1.18 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.756 1.223 . . . . 2.9700000000000002 110.722 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -79.02 38.14 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.508 3.472 . . . . 2.4700000000000002 111.501 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 208' ' ' ASP . 75.3 mt-10 -136.4 144.63 44.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.475 2.31 . . . . 3.7999999999999998 105.566 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.95 -37.13 0.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.696 1.599 . . . . 5.8799999999999999 112.829 -172.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 206' ' ' GLU . 15.9 t0 -68.82 161.91 27.53 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.841 1.656 . . . . 4.5599999999999996 111.595 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.73 152.41 51.74 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.469 1.128 . . . . 4.5099999999999998 109.568 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -67.27 -21.27 65.72 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.257 0.836 . . . . 6.7000000000000002 113.257 -167.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -19.89 15.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.879 2.472 . . . . 3.9100000000000001 113.298 171.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.81 95.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.184 1.811 . . . . 2.48 110.893 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.69 -35.06 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.694 0.627 . . . . 4.3899999999999997 112.694 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.39 -21.51 62.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.165 1.172 . . . . 2.1899999999999999 114.165 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -79.21 -44.7 21.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.136 0.974 . . . . 4.7699999999999996 111.102 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -43.9 72.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.542 1.137 . . . . 5.1500000000000004 111.435 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.4 t -54.6 -44.1 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.731 1.212 . . . . 2.7799999999999998 112.548 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.25 -35.16 73.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.988 -1.006 . . . . 7.7999999999999998 112.972 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.22 -47.83 72.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.555 1.142 . . . . 3.3900000000000001 111.933 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -83.74 -36.67 23.47 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.628 1.344 . . . . 3.77 114.628 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.0 m 154.05 137.31 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 129.451 3.101 . . . . 2.5 112.277 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.19 -8.08 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.037 2.492 . . . . 2.2000000000000002 114.706 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -78.64 -11.88 59.99 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.584 1.083 . . . . 3.0899999999999999 112.939 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.65 114.09 23.07 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.387 1.475 . . . . 3.6800000000000002 107.765 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 18.6 m -96.93 131.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.998 -0.438 . . . . 3.4399999999999999 110.467 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.54 105.7 2.91 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.733 1.158 . . . . 1.0900000000000001 111.838 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.34 127.25 37.75 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.768 1.227 . . . . 3.77 110.064 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.2 p -151.15 140.8 21.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.094 1.758 . . . . 3.9300000000000002 111.374 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.96 -139.64 2.87 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.159 0.885 . . . . 2.0699999999999998 111.576 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.55 159.06 31.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.159 1.784 . . . . 4.0499999999999998 110.499 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -65.17 -36.31 83.8 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.103 -0.373 . . . . 7.2699999999999996 110.331 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -49.9 -55.51 14.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.584 2.354 . . . . 2.9900000000000002 111.473 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -71.44 -26.98 62.96 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.858 -1.151 . . . . 4.2999999999999998 113.531 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.55 -38.01 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.358 1.463 . . . . 3.04 110.61 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.39 -32.84 58.79 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.767 1.227 . . . . 5.2199999999999998 109.884 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -60.16 -57.68 11.78 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.121 -0.942 . . . . 2.6000000000000001 110.326 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.59 -33.51 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.608 1.095 . . . . 3.23 112.322 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.11 -54.3 36.06 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.741 -0.599 . . . . 2.6000000000000001 110.64 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -70.07 -33.75 72.3 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 117.846 -1.073 . . . . 4.8399999999999999 112.502 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.06 93.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.557 1.143 . . . . 2.48 113.017 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.83 2.75 55.86 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.69 1.196 . . . . 4.04 114.045 173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 77.32 24.17 0.84 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.249 2.62 . . . . 5.21 114.799 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.0 140.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.88 1.272 . . . . 3.4700000000000002 110.747 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -110.07 138.28 46.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.23 1.012 . . . . 4.6600000000000001 112.554 164.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.56 175.38 10.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.479 1.912 . . . . 4.8200000000000003 110.456 162.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -163.26 150.65 10.93 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.4 1.08 . . . . 4.5099999999999998 112.2 165.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.24 165.08 26.16 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.667 2.911 . . . . 3.4399999999999999 110.755 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.623 0 C-N-CA 124.185 0.898 . . . . 2.4300000000000002 113.963 178.884 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.695 0.76 . . . . 4.7000000000000002 109.52 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.4 tp -67.14 175.52 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 O-C-N 121.667 -0.646 . . . . 4.2800000000000002 111.495 165.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -167.45 75.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 119.316 -2.115 . . . . 5.2300000000000004 108.972 -157.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -111.81 142.63 43.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.055 0.931 . . . . 5.5300000000000002 111.305 -153.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -145.81 125.05 12.95 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.178 1.177 . . . . 2.3700000000000001 114.178 -158.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 53.0 m -84.77 -48.82 9.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.017 0.927 . . . . 4.8399999999999999 109.666 168.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.323 0.2 OUTLIER 43.36 -150.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.828 1.651 . . . . 7.5800000000000001 113.622 -174.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 8.8 tt -179.58 161.86 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 129.089 2.956 . . . . 5.46 107.412 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 57.5 mtp -119.52 139.44 52.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.961 1.304 . . . . 2.7599999999999998 109.957 158.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -120.63 136.72 54.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.94 0.896 . . . . 4.6399999999999997 110.989 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.0 tt -102.22 118.99 38.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.603 1.561 . . . . 3.21 107.968 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.4 135.21 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.129 0.972 . . . . 2.77 109.326 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.16 147.9 50.42 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.108 -1.197 . . . . 2.1400000000000001 110.108 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 62.1 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.013 3.142 . . . . 3.3599999999999999 109.066 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -174.28 -66.67 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 5.0999999999999996 110.977 -150.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -156.11 -68.77 0.01 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 117.289 1.676 . . . . 3.54 117.289 -157.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.43 -178.42 7.32 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.723 1.609 . . . . 6.2300000000000004 109.667 -168.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -70.52 145.73 50.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.143 1.164 . . . . 4.7800000000000002 114.143 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -132.1 1.99 3.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.372 1.469 . . . . 3.77 113.073 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -160.36 144.21 13.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.104 1.761 . . . . 2.8199999999999998 108.128 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -154.2 147.13 24.46 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.712 1.205 . . . . 4.8899999999999997 110.664 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.27 147.28 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.083 1.353 . . . . 4.4699999999999998 107.806 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -81.87 -152.21 9.77 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 109.485 -1.446 . . . . 4.5700000000000003 109.485 167.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.404 HE22 HG13 ' A' ' 172' ' ' VAL . 3.0 mt-30 -79.91 67.02 5.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.675 -1.231 . . . . 5.3799999999999999 107.675 151.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.6 153.63 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.22 2.208 . . . . 5.54 112.657 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 89.19 123.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.411 2.284 . . . . 5.5899999999999999 107.569 -139.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.1 mtt85 -81.15 -177.4 6.44 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.769 -1.197 . . . . 7.0700000000000003 107.769 158.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -40.26 93.73 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.539 -1.35 . . . . 2.7400000000000002 113.757 -171.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.58 -38.39 94.62 Favored Glycine 0 N--CA 1.473 1.103 0 O-C-N 121.467 -0.77 . . . . 2.0099999999999998 112.022 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.19 -16.34 63.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.859 1.263 . . . . 3.1899999999999999 113.471 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.42 -46.96 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.957 -1.089 . . . . 2.3100000000000001 110.841 169.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.69 79.02 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.291 -0.881 . . . . 2.21 112.015 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.68 -31.83 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.866 1.061 . . . . 2.48 113.866 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.9 p -75.5 -41.92 54.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.62 1.1 . . . . 2.75 111.372 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.39 -43.63 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.143 0.883 . . . . 2.5699999999999998 111.458 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.02 68.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.928 0.891 . . . . 2.1000000000000001 113.249 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.2 m -76.6 -52.19 10.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.274 1.029 . . . . 2.5800000000000001 109.978 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -61.2 -34.13 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 3.04 112.378 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.6 ttt -55.66 -33.67 64.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.221 1.008 . . . . 5.4000000000000004 111.754 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -58.72 -54.35 57.17 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 116.145 -1.883 . . . . 5.1299999999999999 112.605 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.68 -51.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.8 3.0 . . . . 2.1800000000000002 113.136 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -74.24 14.35 0.45 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.046 1.128 . . . . 4.3799999999999999 114.046 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 5.5 ttp-105 . . . . . 0 CA--C 1.516 -0.35 0 C-N-CA 125.923 1.689 . . . . 9.1799999999999997 112.689 -163.047 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.398 0 CA-C-O 117.332 -1.816 . . . . 2.9300000000000002 110.74 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.99 168.26 15.58 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.663 2.909 . . . . 2.8199999999999998 112.733 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -135.62 150.7 49.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 3.8700000000000001 111.174 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -141.08 75.4 1.5 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.605 -1.309 . . . . 3.1899999999999999 111.63 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.93 153.38 32.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 4.5099999999999998 112.41 -166.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.2 m -79.72 128.22 33.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.822 1.249 . . . . 2.4399999999999999 108.475 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.8 t -80.35 146.51 31.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.979 0.912 . . . . 3.4700000000000002 110.843 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -56.02 -19.89 14.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.644 2.378 . . . . 1.8500000000000001 114.598 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.3 t -72.12 -38.98 69.17 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 118.232 -0.89 . . . . 3.7200000000000002 112.153 170.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 116.41 70.12 0.44 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.724 1.631 . . . . 2.5099999999999998 113.084 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.91 159.53 15.92 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.176 2.19 . . . . 4.0599999999999996 107.635 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -109.55 123.69 49.84 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 121.193 1.815 . . . . 6.1100000000000003 111.4 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -114.55 159.4 20.44 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.833 1.049 . . . . 5.2800000000000002 113.833 175.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 m -139.7 158.15 44.59 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.181 2.592 . . . . 3.8500000000000001 106.863 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.98 -39.31 81.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.175 0.99 . . . . 4.3499999999999996 113.541 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.21 -13.06 58.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.826 1.417 . . . . 8.0199999999999996 114.826 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -77.21 -47.11 21.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.214 0.915 . . . . 4.3700000000000001 110.168 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.25 -33.99 55.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.932 1.293 . . . . 4.9900000000000002 111.469 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 73.38 149.7 0.1 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.593 2.757 . . . . 7.0899999999999999 108.983 -168.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -71.67 -4.88 59.26 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.353 -1.467 . . . . 6.04 115.433 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -27.02 61.68 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 1 C-N-CA 132.84 4.456 . . . . 3.5800000000000001 119.659 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 80.5 m95 66.18 35.36 6.12 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.174 1.79 . . . . 3.6400000000000001 112.008 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 mp -71.24 132.64 45.25 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.531 -0.731 . . . . 4.3099999999999996 110.092 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.45 111.89 24.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.762 1.625 . . . . 3.5600000000000001 107.028 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.38 124.91 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.683 -0.858 . . . . 3.25 108.683 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -127.25 130.05 48.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.096 2.158 . . . . 3.8799999999999999 112.142 -166.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.65 93.76 5.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.232 0.613 . . . . 3.7999999999999998 111.831 -172.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.86 -174.86 14.01 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.018 1.77 . . . . 1.8899999999999999 114.972 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.54 179.37 6.6 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.468 1.507 . . . . 6.3300000000000001 111.906 -167.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.9 m -58.78 -32.47 69.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 115.758 -2.068 . . . . 4.0700000000000003 116.254 -168.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.6 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.459 2.392 . . . . 11.82 117.459 -172.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.2 m -58.14 120.21 41.35 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-N 121.781 2.082 . . . . 4.1799999999999997 114.396 -154.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.68 71.11 7.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.146 2.564 . . . . 7.1900000000000004 114.117 -160.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -153.41 -117.39 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.314 2.246 . . . . 6.8399999999999999 106.851 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 p -54.29 -31.23 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.143 1.777 . . . . 5.0800000000000001 114.792 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.72 17.36 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 117.494 -1.241 . . . . 2.21 110.289 -173.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.48 -27.11 5.43 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.121 2.547 . . . . 1.3899999999999999 113.813 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -70.92 -49.79 41.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.625 1.102 . . . . 3.1699999999999999 111.659 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . 0.274 6.4 mt-10 -72.85 -14.28 61.46 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 119.67 -1.893 . . . . 2.9700000000000002 112.627 174.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.47 -32.12 70.83 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.728 -1.233 . . . . 3.75 112.577 163.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -49.06 78.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.511 1.05 . . . . 4.9000000000000004 108.85 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -58.46 -48.09 81.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.103 -0.951 . . . . 4.2000000000000002 110.607 -175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.3 ptp -63.78 -43.53 96.1 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.724 1.602 . . . . 3.4500000000000002 113.642 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.41 -53.34 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.438 -0.578 . . . . 2.8900000000000001 109.438 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.472 ' HB3' ' HZ3' ' A' ' 283' ' ' LYS . 2.2 mp0 -70.56 -24.1 62.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 117.162 -1.399 . . . . 5.3099999999999996 110.932 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.35 -50.79 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 121.911 2.141 . . . . 2.5099999999999998 111.59 165.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.02 -31.06 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 120.685 1.584 . . . . 3.75 113.017 -173.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -83.09 -29.4 28.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.913 1.079 . . . . 4.7300000000000004 113.913 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -73.17 -23.09 60.39 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.627 -1.296 . . . . 5.8600000000000003 112.729 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.55 -50.8 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.474 1.909 . . . . 3.2799999999999998 111.862 164.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.36 -38.29 73.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.821 1.648 . . . . 4.0999999999999996 112.605 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.1 t -61.24 -22.02 64.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.583 1.553 . . . . 4.4000000000000004 112.381 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 mm -79.31 11.92 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 O-C-N 120.432 -1.418 . . . . 5.2300000000000004 111.261 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.7 m 89.63 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.107 2.563 . . . . 5.9000000000000004 113.445 151.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.295 1.1 t -161.09 37.94 0.15 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.625 1.203 . . . . 4.8399999999999999 114.109 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.06 168.8 13.71 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.433 -0.792 . . . . 5.7300000000000004 111.637 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 120.03 6.92 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.697 1.598 . . . . 5.5800000000000001 108.959 167.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.93 119.57 13.47 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.804 1.288 . . . . 3.9900000000000002 110.633 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.2 tp -85.0 97.17 9.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.611 1.565 . . . . 3.3199999999999998 108.341 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.6 m -77.06 115.14 46.09 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 117.824 -1.084 . . . . 2.5299999999999998 110.317 -169.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.78 121.15 2.44 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.067 2.511 . . . . 1.1000000000000001 112.163 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.8 tp -118.75 103.92 10.11 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.59 1.556 . . . . 3.4100000000000001 110.863 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -86.81 125.48 33.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.877 0.871 . . . . 3.7999999999999998 111.011 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.69 107.17 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.437 1.095 . . . . 2.8599999999999999 109.869 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.23 96.64 3.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.198 0.523 . . . . 2.6699999999999999 110.543 175.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.3 pt -87.0 28.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.228 -0.92 . . . . 4.1500000000000004 113.405 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -128.68 46.35 2.15 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.828 1.651 . . . . 4.9299999999999997 114.477 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.12 88.72 0.57 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.827 3.685 . . . . 2.98 109.753 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 231' ' ' ARG . 2.9 mt-10 162.27 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.188 1.795 . . . . 5.1500000000000004 113.559 -159.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.91 9.14 4.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.739 1.216 . . . . 5.8099999999999996 113.532 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -99.5 -137.65 0.31 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.558 2.343 . . . . 5.1200000000000001 111.528 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m 155.31 137.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 1 C-N-CA 133.653 4.781 . . . . 3.5899999999999999 104.739 169.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -41.51 -53.77 3.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.237 1.015 . . . . 3.8100000000000001 112.242 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -70.11 -25.91 63.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.499 1.52 . . . . 3.7400000000000002 114.386 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.94 -43.04 56.37 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.467 -1.395 . . . . 2.8700000000000001 111.898 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 mm -64.66 -39.96 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 118.217 -0.897 . . . . 2.9300000000000002 110.147 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.47 61.33 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.678 1.126 . . . . 2.6800000000000002 113.188 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -69.82 -44.18 70.5 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.492 1.042 . . . . 4.3700000000000001 111.465 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.1 -34.24 77.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.548 0.613 . . . . 3.79 112.434 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.87 -41.9 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.456 1.503 . . . . 3.0600000000000001 111.557 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -46.16 89.77 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.099 -1.001 . . . . 5.9900000000000002 110.732 174.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -43.12 -53.15 5.12 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.32 1.848 . . . . 4.1399999999999997 112.034 -163.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -71.07 -73.03 0.19 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.899 1.28 . . . . 3.8199999999999998 113.554 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.7 m -176.41 150.17 0.98 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.235 1.414 . . . . 3.0699999999999998 112.292 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.87 5.41 3.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.49 3.46 . . . . 2.1200000000000001 114.983 -165.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.47 -17.09 62.38 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.932 -1.105 . . . . 3.7999999999999998 112.57 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.97 135.16 35.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.475 1.51 . . . . 3.0800000000000001 112.539 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.73 136.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.301 1.441 . . . . 2.9199999999999999 108.823 168.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.55 133.76 11.82 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.16 0.886 . . . . 1.47 112.408 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.8 mp -109.62 142.32 40.9 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.914 1.685 . . . . 3.4500000000000002 111.005 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.0 p -149.64 167.11 27.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.891 2.876 . . . . 4.7000000000000002 109.696 -166.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 172.58 -155.87 24.03 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.289 0.947 . . . . 1.9199999999999999 111.226 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.1 t -96.68 172.85 7.64 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.931 1.348 . . . . 3.1600000000000001 110.597 163.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.448 HH21 ' CD ' ' A' ' 206' ' ' GLU . 40.9 ttm-85 -49.36 -30.07 7.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.871 2.069 . . . . 7.0 113.274 177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.42 -53.2 25.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.353 1.461 . . . . 3.7799999999999998 111.789 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.18 -41.87 84.83 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.065 -1.022 . . . . 3.5499999999999998 111.466 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.5 t -67.67 -29.96 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.994 0.917 . . . . 3.21 112.456 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.43 -49.79 74.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.733 -1.127 . . . . 3.2599999999999998 108.883 173.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -56.63 -55.65 31.31 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.457 1.026 . . . . 4.71 111.862 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.85 -35.43 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.525 0.565 . . . . 4.4500000000000002 112.525 -172.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.11 -44.76 68.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.927 0.491 . . . . 2.0899999999999999 111.086 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -73.29 -36.08 66.24 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.302 1.841 . . . . 3.9100000000000001 112.508 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.64 -54.09 47.4 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.591 1.156 . . . . 3.3399999999999999 112.372 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -85.09 2.43 43.46 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.327 0.651 . . . . 3.8700000000000001 112.451 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 58.47 39.94 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.712 2.405 . . . . 6.4199999999999999 113.091 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.2 m -69.89 -25.98 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.429 1.27 . . . . 3.4900000000000002 114.429 -161.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 81.1 t80 66.67 141.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.67 1.988 . . . . 4.4199999999999999 115.097 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.62 159.78 27.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.469 2.308 . . . . 4.3399999999999999 109.401 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.6 t -164.09 134.32 3.21 Favored Pre-proline 0 N--CA 1.477 0.92 0 O-C-N 120.977 -1.077 . . . . 3.7999999999999998 112.331 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.67 141.28 21.85 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.414 2.743 . . . . 3.3900000000000001 112.282 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.445 0 C-N-CA 124.079 0.847 . . . . 2.5699999999999998 114.75 -177.06 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 CA--C 1.546 0.807 0 CA-C-O 121.858 0.837 . . . . 4.3499999999999996 112.325 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp -57.47 164.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.615 1.166 . . . . 3.6600000000000001 112.009 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.7 t -149.83 136.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 105.786 -1.931 . . . . 3.7000000000000002 105.786 172.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -66.16 134.36 52.59 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.398 1.079 . . . . 3.4700000000000002 110.509 172.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -154.34 114.49 3.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.985 0.914 . . . . 2.8900000000000001 111.371 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.8 p -67.64 -22.98 65.29 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.321 1.448 . . . . 4.1699999999999999 114.274 -170.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 tp 76.48 -5.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 127.912 2.485 . . . . 6.3300000000000001 114.025 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.8 mt -49.5 133.54 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.154 1.782 . . . . 4.2699999999999996 111.602 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 11.6 ptm -141.44 143.78 34.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 113.564 -1.653 . . . . 3.1600000000000001 111.131 -163.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -127.64 145.2 50.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.907 0.883 . . . . 4.2699999999999996 111.801 -162.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.88 125.66 38.63 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.513 1.125 . . . . 2.7599999999999998 109.127 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -100.48 135.6 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.969 1.308 . . . . 3.2400000000000002 108.149 170.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.38 -177.24 45.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.725 1.155 . . . . 2.29 111.454 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.77 54.48 4.5 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.967 3.111 . . . . 3.0099999999999998 114.271 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -166.8 -54.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.648 1.979 . . . . 6.4699999999999998 111.193 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 147.5 -20.81 1.51 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.658 0.623 . . . . 3.02 114.658 -160.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.39 144.56 57.08 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.175 0.99 . . . . 7.0199999999999996 111.778 165.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -74.67 155.95 37.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.23 1.012 . . . . 5.3899999999999997 112.491 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -36.94 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.606 0.762 . . . . 4.04 112.842 174.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -165.52 172.44 12.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.759 1.224 . . . . 2.0800000000000001 111.133 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.26 164.54 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.331 1.452 . . . . 4.0300000000000002 112.945 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.03 -179.21 7.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.737 1.615 . . . . 3.8500000000000001 111.322 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 119.36 146.33 7.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.326 1.441 . . . . 2.8100000000000001 113.702 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 40.75 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 1 C-N-CA 132.526 4.33 . . . . 4.7000000000000002 118.135 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.43 -46.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.702 -1.249 . . . . 5.7599999999999998 112.755 -173.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.27 90.03 0.9 Allowed 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.346 -0.846 . . . . 5.3899999999999997 110.582 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -67.29 161.26 25.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.405 1.882 . . . . 5.8600000000000003 112.641 -165.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.472 ' HZ3' ' HB3' ' A' ' 182' ' ' GLN . 0.9 OUTLIER -42.07 -59.04 1.88 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.691 1.996 . . . . 4.8799999999999999 115.388 -168.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.92 -34.05 76.21 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.292 -0.88 . . . . 1.6499999999999999 113.159 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.97 -31.56 72.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.124 1.37 . . . . 3.6499999999999999 111.934 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.6 mt -58.16 -56.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.227 -0.921 . . . . 2.0499999999999998 109.519 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.88 -40.42 76.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.366 0.506 . . . . 2.0899999999999999 112.366 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.85 87.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.862 0.865 . . . . 2.1800000000000002 113.227 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.6 p -63.7 -43.44 96.6 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.298 -0.876 . . . . 1.8899999999999999 111.983 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 49.3 mt -64.71 -37.0 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.036 -1.04 . . . . 2.6200000000000001 111.436 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.7 -22.84 65.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.304 1.041 . . . . 2.2799999999999998 113.429 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 39.7 m -71.12 -48.35 52.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.163 -0.68 . . . . 2.3700000000000001 109.163 169.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -67.38 -26.07 66.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.113 1.365 . . . . 3.3399999999999999 113.503 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -25.3 63.21 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.888 -1.132 . . . . 6.5 111.8 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -57.19 -40.71 86.78 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 117.364 -1.303 . . . . 5.5199999999999996 112.608 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.22 -60.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.852 2.368 . . . . 3.2999999999999998 111.448 160.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.45 31.11 6.02 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.565 1.321 . . . . 6.0999999999999996 114.565 -156.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 O-C-N 121.05 -1.032 . . . . 7.8499999999999996 112.259 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 119.43 -0.65 . . . . 3.0499999999999998 113.898 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.51 -170.79 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.292 3.328 . . . . 2.73 110.049 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -146.46 177.81 8.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.686 1.195 . . . . 3.2799999999999998 111.081 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -144.38 34.07 1.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.549 1.315 . . . . 3.3500000000000001 114.549 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mp -64.83 156.29 31.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.649 1.214 . . . . 3.1800000000000002 112.636 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -92.72 142.74 27.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.173 1.389 . . . . 2.6099999999999999 109.05 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -83.62 166.21 18.35 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.861 1.265 . . . . 2.8500000000000001 111.757 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -3.84 2.32 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.197 1.799 . . . . 2.2599999999999998 114.958 173.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.6 m -79.03 -36.86 40.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.837 1.655 . . . . 4.0599999999999996 111.729 164.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.08 11.89 30.92 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.704 1.621 . . . . 1.95 113.679 -164.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 141.07 43.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.122 1.369 . . . . 3.3999999999999999 110.406 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.33 112.74 24.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.26 1.424 . . . . 5.9699999999999998 111.46 -164.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.87 158.52 16.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.139 1.375 . . . . 3.7200000000000002 112.663 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.2 p -115.54 -179.82 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.311 2.245 . . . . 2.9399999999999999 108.739 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -38.19 88.74 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.844 -0.535 . . . . 3.6000000000000001 111.841 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -77.88 -6.58 54.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.107 1.521 . . . . 7.2199999999999998 115.107 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.28 -29.89 70.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.05 0.94 . . . . 2.8599999999999999 111.724 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -100.14 -11.88 20.1 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.095 1.517 . . . . 4.29 115.095 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.34 108.2 1.54 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.579 1.151 . . . . 4.46 111.563 -170.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.13 2.67 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.811 1.196 . . . . 2.8999999999999999 112.888 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.21 163.85 17.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.193 0.997 . . . . 3.5699999999999998 109.268 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -78.49 138.53 38.48 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.523 -0.736 . . . . 2.29 109.494 161.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.23 144.02 36.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.161 0.982 . . . . 4.4100000000000001 113.523 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.16 117.88 24.04 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.592 1.157 . . . . 3.6499999999999999 108.729 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.9 mt -101.93 127.13 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.059 0.943 . . . . 2.8599999999999999 109.125 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.64 142.14 39.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.73 0.776 . . . . 4.5 111.168 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -99.72 126.9 45.85 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.321 1.049 . . . . 3.5899999999999999 108.97 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.39 169.34 26.43 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 124.292 0.995 . . . . 1.3200000000000001 114.721 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -120.07 171.24 8.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.317 1.847 . . . . 5.5300000000000002 108.018 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 71.2 m -53.82 -12.22 0.51 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.666 2.469 . . . . 3.8700000000000001 117.666 -166.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -177.22 -27.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 122.427 2.376 . . . . 11.41 116.776 167.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 61.6 m 60.85 174.62 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 117.548 2.425 . . . . 2.8599999999999999 117.548 167.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.21 164.41 30.45 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.236 1.957 . . . . 3.5600000000000001 109.865 154.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.09 46.63 0.32 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.086 2.554 . . . . 4.3700000000000001 113.932 -165.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 94.8 t -111.86 -53.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 127.584 2.354 . . . . 3.6400000000000001 109.07 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 34.6 t -64.16 -60.84 7.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.187 0.995 . . . . 2.8599999999999999 112.922 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.69 -24.95 47.13 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.25 1.967 . . . . 1.71 112.635 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -71.2 -55.21 8.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.441 1.096 . . . . 2.8100000000000001 111.254 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.413 ' CD ' ' HZ1' ' A' ' 281' ' ' LYS . 67.2 mt-10 -65.26 -25.84 67.83 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.279 -0.888 . . . . 3.8500000000000001 112.194 172.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -65.17 -34.42 78.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.018 -0.991 . . . . 4.25 110.695 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.89 -43.04 59.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.44 1.473 . . . . 3.54 111.788 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -50.22 -39.3 44.09 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.452 -1.405 . . . . 4.6200000000000001 112.162 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.79 -50.41 43.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.914 1.286 . . . . 4.3399999999999999 112.426 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.77 -37.16 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 120.789 1.631 . . . . 2.8100000000000001 112.025 -174.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.514 ' C ' ' HE3' ' A' ' 283' ' ' LYS . 54.3 mt-30 -56.09 -27.57 54.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.84 1.2 . . . . 3.48 111.522 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 36.0 t -68.75 -20.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 120.586 -1.321 . . . . 3.2400000000000002 111.771 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.9 t -67.28 -38.82 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.856 0.753 . . . . 3.1499999999999999 109.479 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -49.99 74.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.486 1.114 . . . . 5.0300000000000002 110.963 171.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.27 -25.54 63.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.5 1.12 . . . . 3.1600000000000001 113.781 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.15 -45.33 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.986 1.715 . . . . 3.4900000000000002 112.703 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.36 -32.37 66.7 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.476 1.035 . . . . 3.6899999999999999 111.1 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -20.23 63.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.565 1.546 . . . . 3.6299999999999999 112.901 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.08 -16.94 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 120.897 -1.127 . . . . 3.9300000000000002 111.701 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.5 t 56.47 -7.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.694 3.197 . . . . 5.5099999999999998 118.633 165.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 67.4 p -109.18 9.25 26.08 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 120.802 1.637 . . . . 4.21 114.411 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.92 160.92 29.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.226 1.81 . . . . 4.2599999999999998 112.847 -168.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -82.8 51.56 3.74 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.282 3.321 . . . . 3.52 110.729 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.1 t0 57.94 -175.84 0.08 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.332 2.253 . . . . 4.4800000000000004 115.405 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.94 118.06 28.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.969 1.308 . . . . 2.9700000000000002 108.63 155.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.5 m -98.88 99.92 8.76 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.437 1.495 . . . . 1.97 109.983 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.09 133.02 17.46 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.96 2.44 . . . . 1.1699999999999999 111.649 170.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.38 89.21 3.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.103 2.161 . . . . 3.46 108.161 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -83.7 130.86 34.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.716 0.806 . . . . 2.9900000000000002 109.575 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.7 mt -108.55 122.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.892 0.877 . . . . 2.96 109.855 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.4 m -67.34 119.61 12.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.587 0.755 . . . . 2.9700000000000002 110.839 166.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.29 -3.55 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 120.955 -1.091 . . . . 3.6200000000000001 113.721 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -111.81 57.34 0.46 Allowed Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 127.381 2.272 . . . . 4.2400000000000002 113.554 -170.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.94 75.9 2.62 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.866 3.711 . . . . 2.75 109.966 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -173.42 -35.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.846 2.458 . . . . 3.6099999999999999 111.473 -169.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.34 32.52 2.83 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.028 0.931 . . . . 6.5999999999999996 112.388 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -119.99 173.29 7.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.912 2.485 . . . . 4.0099999999999998 109.673 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.3 m -169.2 139.98 2.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.275 2.63 . . . . 3.9399999999999999 107.143 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -36.61 66.82 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.434 0.901 . . . . 4.2400000000000002 113.434 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -79.59 -28.0 41.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.893 2.077 . . . . 3.8500000000000001 112.67 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.45 42.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.797 0.726 . . . . 2.8700000000000001 110.084 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.1 tp -62.01 -31.6 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.72 0.408 . . . . 3.3900000000000001 111.989 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.62 95.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.184 -0.948 . . . . 1.9099999999999999 111.826 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -69.21 -29.22 67.13 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.196 0.813 . . . . 4.9900000000000002 113.196 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -68.1 -48.36 65.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.544 1.138 . . . . 5.0599999999999996 110.778 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.1 t -52.2 -45.74 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.166 -0.959 . . . . 2.3199999999999998 111.519 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -18.67 46.25 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.39 1.476 . . . . 5.8799999999999999 113.188 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.91 -48.03 80.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.959 1.708 . . . . 4.7699999999999996 110.927 171.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -87.82 -53.2 4.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.347 0.869 . . . . 4.2000000000000002 113.347 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.7 p -177.33 159.61 1.39 Allowed Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.634 -1.291 . . . . 3.7200000000000002 112.91 -159.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -86.24 -16.0 4.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.716 2.944 . . . . 2.4900000000000002 113.807 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -85.61 -4.44 59.16 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.788 1.176 . . . . 3.2400000000000002 113.52 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.89 136.79 36.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.942 0.897 . . . . 3.54 111.171 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 t -110.99 131.36 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.574 -1.269 . . . . 3.0800000000000001 107.574 163.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.73 114.65 4.59 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 109.497 -1.441 . . . . 1.01 109.497 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.4 144.35 33.21 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.665 0.786 . . . . 2.96 110.756 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -157.79 -179.7 8.39 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.641 1.576 . . . . 3.0699999999999998 110.785 -172.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 167.42 -116.69 0.69 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.255 -1.138 . . . . 1.8400000000000001 110.255 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.5 p -128.0 168.0 15.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.613 1.165 . . . . 3.04 112.211 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -39.36 46.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.67 0.788 . . . . 6.4400000000000004 111.248 -177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 2.2 mp0 -59.76 -54.23 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.293 2.237 . . . . 3.52 113.131 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -69.46 -31.68 70.13 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.879 -1.138 . . . . 4.9800000000000004 111.831 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.43 -29.61 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 117.944 -1.027 . . . . 2.5899999999999999 111.625 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.29 -42.53 88.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.031 1.287 . . . . 3.1800000000000002 110.227 162.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -56.49 -50.5 71.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 117.987 -1.006 . . . . 2.8500000000000001 112.622 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.4 m -71.2 -26.86 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 120.583 1.538 . . . . 3.6400000000000001 114.576 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.615 1.098 . . . . 2.4199999999999999 112.628 175.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -105.09 -21.76 13.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.772 3.229 . . . . 7.54 113.467 -167.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.72 -28.99 64.06 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.472 1.033 . . . . 2.6299999999999999 112.268 162.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.08 -127.06 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.402 1.081 . . . . 3.6499999999999999 109.404 164.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -164.78 74.71 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.572 1.149 . . . . 6.2300000000000004 110.145 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.5 m -83.63 173.92 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 111.765 0.283 . . . . 4.46 111.765 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.8 154.19 40.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.126 1.371 . . . . 7.4500000000000002 110.737 166.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -154.94 125.43 6.89 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.524 1.53 . . . . 5.5999999999999996 111.176 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.6 t -106.74 110.54 63.76 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 120.795 -1.19 . . . . 4.3799999999999999 109.257 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.99 144.52 38.3 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.524 2.149 . . . . 3.4900000000000002 111.367 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.365 0 C-N-CA 124.892 1.234 . . . . 3.1000000000000001 115.092 -175.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 109.431 -0.581 . . . . 4.21 109.431 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.0 tp -83.95 154.07 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.384 -0.823 . . . . 3.8500000000000001 111.639 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.7 134.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 129.449 3.099 . . . . 3.75 105.635 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.83 168.0 14.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.162 0.982 . . . . 3.71 110.397 165.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -150.46 36.26 0.65 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.079 0.943 . . . . 3.6499999999999999 110.907 168.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . 0.266 13.7 p 65.51 -134.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.54 2.336 . . . . 4.1200000000000001 110.999 -171.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 176.19 -17.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 129.029 2.932 . . . . 5.9500000000000002 110.795 -163.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.4 mt -69.92 134.03 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.57 1.148 . . . . 3.3399999999999999 109.546 170.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.8 ttm -119.6 137.49 53.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.3 1.84 . . . . 3.8500000000000001 108.206 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.97 127.59 51.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.677 0.791 . . . . 4.7199999999999998 112.18 -159.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.83 130.74 48.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.595 1.158 . . . . 2.8300000000000001 112.075 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.9 151.3 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.296 1.838 . . . . 2.9500000000000002 106.297 166.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -142.55 -135.07 3.02 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 121.268 -0.895 . . . . 2.75 113.0 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.11 1.61 7.02 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.654 2.903 . . . . 2.5099999999999998 113.545 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.87 -47.0 55.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.23 2.212 . . . . 5.6100000000000003 113.723 172.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.88 13.09 54.45 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 117.628 -1.651 . . . . 3.0099999999999998 116.746 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.57 -70.7 0.35 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.065 1.432 . . . . 4.1600000000000001 111.883 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -166.69 146.96 5.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.164 0.985 . . . . 6.0499999999999998 111.915 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 -33.01 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.424 1.639 . . . . 3.7599999999999998 115.424 -170.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -168.52 167.94 11.33 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.11 1.323 . . . . 2.5600000000000001 112.76 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.45 152.55 32.11 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.694 1.738 . . . . 4.4800000000000004 115.694 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -120.33 163.71 17.42 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.888 1.275 . . . . 3.7400000000000002 110.481 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -167.08 102.56 0.19 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.326 -0.859 . . . . 4.0800000000000001 111.765 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 64.15 164.06 0.13 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.24 1.416 . . . . 4.7199999999999998 110.965 -162.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 37.8 t30 77.1 -57.2 0.52 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.309 1.843 . . . . 6.5199999999999996 112.467 165.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.413 ' HZ1' ' CD ' ' A' ' 176' ' ' GLU . 1.6 mptm? 49.71 19.97 0.47 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.085 2.154 . . . . 10.66 116.226 162.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.39 142.38 56.98 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 119.139 -2.226 . . . . 6.4199999999999999 110.612 -163.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.514 ' HE3' ' C ' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -46.03 -52.18 12.36 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.192 0.997 . . . . 3.5099999999999998 113.593 -170.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.37 -23.28 71.71 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.506 -1.164 . . . . 1.5700000000000001 114.647 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -74.07 -49.14 25.38 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.494 1.647 . . . . 3.3599999999999999 110.378 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.66 -47.73 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.324 0.649 . . . . 2.2599999999999998 109.389 174.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.96 75.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.207 -0.901 . . . . 2.27 112.516 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.43 91.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.925 1.239 . . . . 2.0499999999999998 112.752 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 91.5 p -60.02 -57.35 13.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.932 0.333 . . . . 2.1600000000000001 111.562 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.34 -35.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.754 -1.216 . . . . 2.2400000000000002 110.993 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.37 73.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.825 1.25 . . . . 2.4500000000000002 113.921 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 14.4 t -76.25 -33.27 59.18 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.182 1.356 . . . . 3.9900000000000002 111.452 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -70.87 -24.59 62.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.976 0.91 . . . . 2.8100000000000001 113.26 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.5 mtt -54.1 -40.95 67.73 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.432 -1.418 . . . . 6.5700000000000003 111.467 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -59.01 -45.09 99.59 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 115.714 -2.089 . . . . 5.2000000000000002 114.557 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.85 -7.55 11.32 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.606 2.87 . . . . 2.4100000000000001 114.429 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -119.85 -154.65 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 120.027 1.285 . . . . 4.0499999999999998 113.4 -171.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 . . . . . 0 CA--C 1.538 0.488 0 O-C-N 120.027 -1.671 . . . . 12.07 111.354 -174.052 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.356 0 CA-C-O 118.216 -1.325 . . . . 5.6100000000000003 112.1 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.57 148.02 90.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.837 2.358 . . . . 4.46 112.136 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -151.23 171.76 16.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 4.3899999999999997 111.988 -174.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 p -139.04 42.28 2.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.954 1.835 . . . . 3.8799999999999999 115.954 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.49 152.64 21.34 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 119.902 -1.749 . . . . 4.7699999999999996 112.699 -170.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.9 m -92.14 139.65 30.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.682 1.193 . . . . 3.1899999999999999 110.155 -173.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.2 p -84.38 159.79 20.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.037 0.935 . . . . 3.5800000000000001 112.587 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -9.36 2.07 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.479 1.512 . . . . 2.27 115.0 169.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 99.7 m -71.68 -53.68 12.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.463 1.105 . . . . 4.6799999999999997 109.858 164.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.63 -10.84 8.0 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.358 1.933 . . . . 3.0499999999999998 113.619 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 148.73 27.96 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 124.83 1.252 . . . . 5.1399999999999997 111.112 171.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 97.59 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.695 1.198 . . . . 6.9900000000000002 111.663 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -95.66 161.94 13.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.178 1.177 . . . . 5.54 114.178 -171.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -112.43 169.5 8.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.2 1.8 . . . . 3.4500000000000002 110.773 164.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -41.87 -42.68 2.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.914 2.486 . . . . 4.0999999999999996 113.213 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -82.04 -22.68 36.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.168 1.173 . . . . 8.1400000000000006 114.168 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.24 -14.39 60.92 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.928 0.871 . . . . 3.8599999999999999 111.936 165.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -102.88 9.96 38.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.968 2.507 . . . . 4.3099999999999996 114.782 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.35 156.38 26.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.614 1.552 . . . . 3.98 115.003 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.59 43.05 Favored Glycine 0 N--CA 1.478 1.463 0 C-N-CA 124.818 1.199 . . . . 2.8599999999999999 115.656 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -140.39 162.68 34.74 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.917 2.487 . . . . 3.7400000000000002 109.695 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.8 131.6 43.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.259 0.552 . . . . 2.4399999999999999 111.943 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.8 mt -108.09 125.39 51.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.035 1.334 . . . . 4.0199999999999996 109.781 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.57 103.99 9.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.624 1.169 . . . . 4.4500000000000002 108.094 -173.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.3 mt -117.67 124.97 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.934 0.893 . . . . 2.73 109.934 -155.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -142.37 155.12 45.12 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.007 1.323 . . . . 3.6000000000000001 112.159 -165.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.87 122.63 39.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.752 1.221 . . . . 4.1699999999999999 111.114 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.69 -154.66 8.25 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.538 1.066 . . . . 1.3300000000000001 112.653 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -168.02 169.32 11.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.721 1.608 . . . . 4.9100000000000001 111.42 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.27 13.5 t -77.97 30.9 0.17 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 119.602 -1.936 . . . . 4.8700000000000001 112.75 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -97.43 -29.79 13.29 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.777 1.631 . . . . 8.4499999999999993 113.775 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 60.4 m -104.72 153.11 39.5 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 116.221 1.934 . . . . 2.8799999999999999 116.221 -165.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.21 -22.27 2.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.886 3.058 . . . . 5.0199999999999996 113.534 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -140.65 -58.19 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.948 1.092 . . . . 4.79 113.948 -171.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.7 p -60.36 -32.41 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.675 1.59 . . . . 4.2800000000000002 114.687 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.8 m -74.89 -66.11 0.47 Allowed Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.167 0.894 . . . . 1.6000000000000001 112.129 161.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 -28.5 68.92 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.713 1.608 . . . . 1.3400000000000001 115.154 -166.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -71.32 -30.47 66.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.762 1.619 . . . . 3.04 112.49 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.67 -40.48 72.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.808 0.731 . . . . 3.1200000000000001 110.448 168.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.45 -37.66 74.38 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.873 1.215 . . . . 4.3399999999999999 113.05 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.03 -58.82 5.89 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.315 1.446 . . . . 4.21 110.205 165.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -56.68 -40.98 76.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.081 1.352 . . . . 4.04 112.972 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 48.3 mtp -60.62 -40.75 93.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.929 1.692 . . . . 3.8100000000000001 112.529 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.6 tp -87.41 -37.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.693 1.588 . . . . 3.46 112.678 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -53.2 -43.28 67.08 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 124.762 1.225 . . . . 3.48 110.704 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.86 -13.56 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 113.801 1.037 . . . . 3.4700000000000002 113.801 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.2 -23.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.998 -1.064 . . . . 2.9399999999999999 111.603 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -50.37 67.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.746 0.818 . . . . 4.6799999999999997 112.187 -170.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.54 -19.1 65.24 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.673 1.589 . . . . 3.8399999999999999 114.115 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -56.49 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 120.914 -1.116 . . . . 3.6699999999999999 109.347 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.78 -36.99 82.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.605 1.162 . . . . 4.0 112.159 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -71.87 -7.61 49.49 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.773 1.027 . . . . 3.8999999999999999 113.773 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.5 mm -103.34 -29.72 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.128 0.876 . . . . 5.7400000000000002 111.095 168.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.0 m 72.73 -25.88 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 127.56 2.344 . . . . 7.0999999999999996 114.211 157.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 56.0 m -74.81 -2.67 27.67 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.794 3.237 . . . . 4.5700000000000003 112.673 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 mp -99.26 157.66 33.64 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.594 1.558 . . . . 4.1500000000000004 110.075 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.46 143.68 48.14 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.28 1.987 . . . . 3.6200000000000001 108.183 155.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.26 159.31 3.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 116.078 1.881 . . . . 3.5 116.078 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.19 95.52 7.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.246 -1.39 . . . . 3.8999999999999999 107.246 157.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.4 m -86.95 112.04 44.63 Favored Pre-proline 0 N--CA 1.475 0.786 0 N-CA-C 108.126 -1.065 . . . . 2.3300000000000001 108.126 168.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -86.82 136.86 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.789 2.326 . . . . 1.25 109.86 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.15 123.11 16.6 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.484 1.135 . . . . 4.5099999999999998 112.442 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -109.45 133.15 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.535 1.534 . . . . 3.3100000000000001 110.554 -160.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 36.3 mm -99.55 122.01 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.154 0.981 . . . . 3.0699999999999998 110.516 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 95.6 p -74.07 124.61 26.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.102 0.561 . . . . 4.3399999999999999 110.097 165.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.5 pt -94.05 -18.05 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.322 1.601 . . . . 3.3300000000000001 115.322 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -119.48 59.38 5.17 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 120.419 1.463 . . . . 3.6200000000000001 114.367 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.54 99.57 0.21 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.43 2.087 . . . . 2.6800000000000002 107.393 165.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 165.65 -45.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.986 2.515 . . . . 4.46 108.523 -147.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 -18.19 0.6 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.927 1.455 . . . . 6.6699999999999999 114.927 151.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.66 136.77 54.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.847 1.203 . . . . 4.2999999999999998 109.394 155.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.2 t -154.0 155.73 36.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 3.8399999999999999 112.384 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -58.1 -47.04 84.47 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.484 1.914 . . . . 3.6099999999999999 113.983 -163.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -71.66 -38.69 70.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.328 1.422 . . . . 3.54 112.77 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.7 93.99 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.221 -0.924 . . . . 2.4399999999999999 111.14 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 mm -61.3 -39.77 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.057 0.943 . . . . 2.8900000000000001 111.736 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.45 86.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.629 1.104 . . . . 2.5899999999999999 112.309 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -62.55 -52.71 62.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.922 0.783 . . . . 3.6400000000000001 111.811 168.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -55.58 -32.17 62.81 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.726 1.21 . . . . 4.2199999999999998 113.519 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.35 -58.16 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.02 2.128 . . . . 2.1899999999999999 112.576 166.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -52.91 -48.14 67.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.953 0.901 . . . . 4.7000000000000002 112.181 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.63 -20.46 58.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.231 0.957 . . . . 5.0199999999999996 112.627 -162.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -79.86 -56.14 4.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.79 0.723 . . . . 4.0999999999999996 110.875 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.8 m 169.14 132.25 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 127.297 2.239 . . . . 2.7599999999999998 112.208 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.19 7.34 1.44 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.394 3.396 . . . . 3.6299999999999999 116.094 -168.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -67.94 -35.33 78.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.205 1.366 . . . . 2.98 110.768 159.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.08 118.51 7.43 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.258 -1.386 . . . . 3.0899999999999999 107.258 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.85 131.38 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.098 -1.075 . . . . 3.1499999999999999 108.098 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -93.51 127.78 9.18 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.117 -1.593 . . . . 1.0900000000000001 109.117 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.48 144.92 50.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.837 0.827 . . . . 3.0699999999999998 111.291 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 26.1 p -140.36 176.15 9.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.706 2.002 . . . . 3.1899999999999999 109.255 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -175.69 -154.55 11.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.183 -1.967 . . . . 2.3399999999999999 108.183 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.5 p -81.94 171.99 13.8 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.331 0.586 . . . . 4.0499999999999998 110.615 167.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -63.07 -23.99 67.7 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.756 -0.59 . . . . 7.3300000000000001 112.085 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 16.2 mp0 -80.8 -31.12 35.81 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.536 1.934 . . . . 3.8799999999999999 111.913 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.15 -41.51 73.74 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.916 -1.115 . . . . 4.96 109.691 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.99 -38.69 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.268 -0.895 . . . . 3.2400000000000002 111.92 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.09 -39.32 79.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.423 -0.799 . . . . 3.71 111.143 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -52.33 -58.87 5.32 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.737 -1.125 . . . . 3.7000000000000002 110.377 173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.26 -31.61 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.79 1.177 . . . . 4.1799999999999997 113.17 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.97 -50.75 38.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.54 1.064 . . . . 3.1200000000000001 111.37 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -36.95 74.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.003 1.721 . . . . 8.8000000000000007 112.402 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.21 65.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.689 1.132 . . . . 3.0600000000000001 110.724 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -76.17 -7.85 55.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.555 0.742 . . . . 3.8900000000000001 112.827 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 26.3 ttp-105 71.06 38.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.567 2.347 . . . . 8.9199999999999999 112.431 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.69 138.92 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.365 1.466 . . . . 5.5599999999999996 108.659 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -105.85 136.86 44.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.222 0.534 . . . . 5.4699999999999998 111.177 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -89.85 144.2 26.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.897 0.479 . . . . 4.0199999999999996 109.912 164.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 t -119.69 94.2 48.26 Favored Pre-proline 0 N--CA 1.477 0.906 0 O-C-N 120.895 -1.128 . . . . 3.8999999999999999 112.704 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.78 138.76 9.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.362 2.708 . . . . 3.1899999999999999 113.149 -171.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.636 0 C-N-CA 123.78 0.705 . . . . 2.6800000000000002 112.503 163.947 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . 0.262 6.9 p90 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 122.338 1.066 . . . . 5.0499999999999998 112.397 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.4 tp -105.39 148.73 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.054 1.342 . . . . 3.75 111.338 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.9 132.61 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.452 -2.055 . . . . 4.0700000000000003 105.452 161.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.42 139.17 43.81 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.561 0.618 . . . . 4.1100000000000003 111.298 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -131.41 93.9 3.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.936 0.894 . . . . 2.79 110.876 161.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.7 t -48.2 122.53 5.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.525 0.73 . . . . 5.2999999999999998 110.266 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 10.5 pt -88.07 101.1 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.816 0.817 . . . . 5.5199999999999996 112.372 -165.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.1 mt -132.57 127.04 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.973 1.309 . . . . 3.8999999999999999 108.05 162.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.8 ptm -94.0 130.48 40.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.268 0.627 . . . . 3.79 109.734 162.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -97.92 135.14 40.08 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.215 -0.928 . . . . 3.98 111.233 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 108.96 19.68 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.269 -1.012 . . . . 2.8500000000000001 108.269 168.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.7 mm -93.73 135.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.627 -1.249 . . . . 3.7200000000000002 107.627 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.08 176.61 29.86 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 122.872 0.272 . . . . 2.1299999999999999 112.535 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.4 39.96 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 125.256 3.97 . . . . 2.6400000000000001 112.153 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -161.11 -36.45 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.3 2.24 . . . . 4.8899999999999997 113.53 -158.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.86 0.0 21.34 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 117.169 -1.906 . . . . 3.1600000000000001 116.307 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -99.4 157.94 16.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.898 1.849 . . . . 5.3799999999999999 111.195 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -74.28 108.21 6.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.111 1.365 . . . . 5.21 110.386 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.33 -28.59 16.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.575 0.75 . . . . 3.7200000000000002 112.275 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -170.79 -179.71 2.93 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.756 1.622 . . . . 2.6600000000000001 111.842 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -158.87 157.71 32.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.648 1.979 . . . . 5.2199999999999998 112.321 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -147.7 -179.46 6.9 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.517 1.927 . . . . 4.0599999999999996 111.394 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.75 -100.87 0.23 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.816 1.198 . . . . 4.1600000000000001 112.362 174.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -67.38 -30.28 70.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.937 -1.331 . . . . 4.71 113.461 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.95 137.39 50.32 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.758 0.823 . . . . 5.2199999999999998 109.508 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.54 86.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.641 0.777 . . . . 5.0499999999999998 110.641 -143.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -89.02 -164.38 1.13 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.83 1.652 . . . . 10.82 109.227 156.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -29.61 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.636 2.374 . . . . 3.1499999999999999 116.446 -168.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.71 -20.95 72.99 Favored Glycine 0 N--CA 1.476 1.327 0 CA-C-N 118.945 0.793 . . . . 2.0 112.74 -168.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -18.73 30.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.386 0.674 . . . . 5.0599999999999996 112.168 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.92 -49.69 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.105 -0.997 . . . . 2.5 109.379 156.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.47 70.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.144 0.883 . . . . 2.2200000000000002 113.169 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.22 60.06 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.279 1.215 . . . . 2.1499999999999999 114.279 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 64.3 p -69.56 -52.55 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.618 -0.676 . . . . 2.4100000000000001 111.689 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.5 mm -58.48 -42.51 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.256 -0.903 . . . . 3.1600000000000001 109.708 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.08 -11.97 23.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.087 1.755 . . . . 2.3700000000000001 114.248 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.9 m -97.39 -54.95 2.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.084 1.354 . . . . 3.0499999999999998 109.566 170.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -64.09 -25.58 68.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.362 1.465 . . . . 3.02 113.986 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 mmm -65.53 -20.51 66.37 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.525 1.13 . . . . 5.9199999999999999 113.987 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -62.45 -48.58 86.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 116.12 -1.895 . . . . 5.6299999999999999 112.257 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.35 -43.71 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.61 2.207 . . . . 2.0699999999999998 112.05 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.14 53.2 2.74 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.105 1.15 . . . . 3.5499999999999998 114.105 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 . . . . . 0 N--CA 1.479 0.982 0 C-N-CA 130.258 3.423 . . . . 12.0 111.477 165.449 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 CA-C-O 118.066 -1.408 . . . . 3.54 111.314 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.5 157.59 28.85 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.976 2.451 . . . . 3.5299999999999998 112.403 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -131.13 168.85 16.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.327 1.851 . . . . 4.0700000000000003 111.538 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.4 p -125.49 22.12 7.72 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.772 2.138 . . . . 4.5099999999999998 116.772 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.92 162.34 29.17 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.837 1.051 . . . . 3.1299999999999999 113.837 -163.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 142.6 30.69 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.536 1.534 . . . . 2.9700000000000002 109.8 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 m -98.53 140.26 33.04 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.089 1.756 . . . . 3.9700000000000002 110.243 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -47.53 -20.86 0.27 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.405 2.682 . . . . 2.23 116.445 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.4 t -90.08 -7.39 53.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.802 1.241 . . . . 4.1200000000000001 113.798 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.21 38.43 4.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.433 1.015 . . . . 3.46 113.265 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.49 -172.99 3.56 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.226 1.41 . . . . 5.2400000000000002 110.016 172.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -152.9 136.82 16.26 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.459 1.027 . . . . 7.8300000000000001 109.709 -156.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.526 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 8.8 mptt -132.16 167.28 20.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.747 1.758 . . . . 4.9500000000000002 115.747 -168.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 88.2 m -164.91 156.17 14.86 Favored 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 132.732 4.413 . . . . 3.8700000000000001 105.232 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.51 -42.27 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.808 1.185 . . . . 3.6899999999999999 113.049 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -3.93 9.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.156 1.539 . . . . 9.3000000000000007 115.156 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -87.36 -20.08 27.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.742 1.217 . . . . 3.1099999999999999 112.767 166.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.526 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 7.8 m-85 -109.0 -20.45 13.03 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.039 1.496 . . . . 4.7800000000000002 115.039 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 137.14 31.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.204 1.402 . . . . 4.1100000000000003 112.304 -171.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.85 58.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.81 1.195 . . . . 2.5 112.778 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -107.34 165.4 11.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.697 1.999 . . . . 3.4399999999999999 108.296 161.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -89.61 137.48 32.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.136 -0.69 . . . . 2.3999999999999999 109.136 170.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.5 pp -137.47 154.3 49.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.513 0.673 . . . . 3.7799999999999998 112.471 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.5 mt -121.45 114.79 21.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.147 1.779 . . . . 3.5 109.141 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.75 120.94 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.341 0.973 . . . . 3.1000000000000001 108.959 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.13 134.34 54.75 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.261 1.025 . . . . 3.3799999999999999 111.478 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.38 118.19 36.34 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.632 0.773 . . . . 4.6600000000000001 110.164 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.67 -178.41 15.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.294 1.426 . . . . 1.6200000000000001 114.806 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -144.61 124.06 13.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.594 0.757 . . . . 5.0599999999999996 111.206 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 1.5 p -81.08 28.77 0.35 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.318 -1.489 . . . . 4.0099999999999998 114.679 -174.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -146.16 39.38 1.1 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 127.076 2.151 . . . . 8.5299999999999994 109.322 162.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.97 147.42 94.22 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 116.133 1.901 . . . . 2.8500000000000001 116.133 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -76.68 63.89 7.42 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.819 3.013 . . . . 5.1299999999999999 110.2 157.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 66.37 -18.2 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 130.022 3.329 . . . . 4.5 116.66 163.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.51 -30.16 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.244 -0.91 . . . . 4.4199999999999999 112.782 -170.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 17.5 m -58.58 -64.41 2.9 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 116.745 -1.598 . . . . 1.6200000000000001 112.03 166.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -63.27 -26.32 71.88 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.756 1.663 . . . . 1.6100000000000001 113.88 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.55 -59.69 3.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.924 1.238 . . . . 3.04 111.308 171.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.66 -29.68 69.04 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.576 0.751 . . . . 3.48 111.936 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.94 -28.18 67.25 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.376 -1.452 . . . . 4.3399999999999999 112.423 170.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -69.93 -49.66 49.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.354 0.979 . . . . 3.8999999999999999 109.378 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -39.47 71.04 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.788 -1.195 . . . . 5.0899999999999999 112.004 176.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.3 ttm -55.78 -48.73 74.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.298 1.839 . . . . 3.8599999999999999 111.714 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 12.6 mm -66.06 -37.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 120.362 1.437 . . . . 2.4399999999999999 110.464 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -62.33 -31.97 72.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.049 -1.453 . . . . 3.8300000000000001 113.321 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.3 p -86.39 -34.77 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.788 1.176 . . . . 3.4199999999999999 114.151 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.4 t -57.14 -44.45 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.896 1.226 . . . . 3.6000000000000001 111.32 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.67 -31.38 66.73 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.124 0.97 . . . . 4.5199999999999996 112.67 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -64.23 -49.69 70.94 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.992 -1.067 . . . . 2.9300000000000002 112.195 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.4 mm -64.86 -38.7 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.093 0.957 . . . . 3.5099999999999998 113.397 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.12 -42.57 90.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.422 1.089 . . . . 2.8900000000000001 110.315 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.1 t -70.46 -11.52 60.98 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.999 1.111 . . . . 3.6899999999999999 113.999 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.21 -23.51 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.82 1.191 . . . . 3.8500000000000001 110.84 169.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 67.07 -20.47 0.11 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.025 2.53 . . . . 4.9100000000000001 115.714 167.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 48.2 p -67.42 -39.14 85.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.523 -1.361 . . . . 6.6900000000000004 110.885 165.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.96 158.48 75.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.207 1.403 . . . . 5.3099999999999996 111.444 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.57 -32.56 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.156 2.57 . . . . 3.3399999999999999 113.812 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 t70 160.04 153.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.584 3.554 . . . . 3.6600000000000001 108.748 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 36.0 tp -123.11 90.21 3.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.439 1.496 . . . . 2.9500000000000002 107.958 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.2 m -75.03 125.64 89.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 O-C-N 121.069 -1.02 . . . . 2.0299999999999998 110.265 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.46 133.37 4.54 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.093 2.528 . . . . 0.95999999999999996 111.183 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.29 97.73 5.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.238 1.415 . . . . 4.2599999999999998 109.12 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -84.03 129.99 34.89 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.267 1.027 . . . . 3.6699999999999999 109.847 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.03 129.82 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.498 1.119 . . . . 3.1099999999999999 109.03 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.6 t -92.69 117.62 30.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.152 0.581 . . . . 3.1200000000000001 111.53 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -90.01 40.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.145 -0.972 . . . . 3.1299999999999999 112.321 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -121.39 55.22 5.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.522 1.129 . . . . 3.2999999999999998 112.624 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.95 66.94 8.7 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 125.064 3.843 . . . . 2.73 111.956 -166.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -151.97 -63.08 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.064 1.746 . . . . 6.7199999999999998 109.282 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.04 27.1 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 7.2599999999999998 113.334 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -80.95 156.36 26.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.889 0.852 . . . . 4.9299999999999997 112.348 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 m -170.02 129.72 0.95 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.137 2.575 . . . . 3.8100000000000001 106.639 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -52.57 -43.34 65.2 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.995 0.918 . . . . 5.1399999999999997 112.347 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -64.28 -32.99 74.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.419 1.888 . . . . 3.7400000000000002 114.228 172.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.51 72.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.954 1.252 . . . . 2.3100000000000001 111.341 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.29 -40.2 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.882 -0.511 . . . . 2.6000000000000001 110.357 169.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.07 68.46 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.333 -0.841 . . . . 2.8900000000000001 113.096 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.8 -51.6 64.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.369 0.986 . . . . 6.1799999999999997 111.65 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -57.15 -41.84 79.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.545 0.688 . . . . 5.3600000000000003 111.539 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.3 t -65.35 -15.9 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.883 0.873 . . . . 2.2000000000000002 112.521 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.66 -39.23 12.59 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 119.716 -1.865 . . . . 6.6299999999999999 113.349 166.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.56 -53.66 48.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.193 1.397 . . . . 4.9000000000000004 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -76.26 -52.34 10.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.996 0.739 . . . . 3.73 112.996 -171.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.8 t -179.44 145.23 0.42 Allowed Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.152 1.381 . . . . 2.9100000000000001 110.514 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.83 -16.12 37.13 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.793 2.329 . . . . 2.6600000000000001 114.27 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -72.22 -20.86 61.49 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.443 1.474 . . . . 2.6600000000000001 112.974 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.6 tp -68.86 149.04 49.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.26 1.424 . . . . 3.1099999999999999 113.346 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.81 141.12 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.151 0.981 . . . . 3.3399999999999999 110.82 166.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.45 114.28 3.6 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.678 -1.369 . . . . 1.28 109.678 175.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.22 145.14 36.35 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.446 0.698 . . . . 3.6800000000000002 109.871 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.9 m -154.46 163.71 39.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.391 1.076 . . . . 3.4300000000000002 109.155 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -150.05 170.76 30.08 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 124.022 0.82 . . . . 1.8799999999999999 111.345 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -61.4 162.44 7.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 3.2200000000000002 110.342 164.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -48.28 -31.76 6.39 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.694 1.198 . . . . 9.0099999999999998 113.741 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -67.98 -43.33 79.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.023 1.729 . . . . 3.48 111.873 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.07 -34.0 68.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.407 1.083 . . . . 3.3100000000000001 111.19 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.23 -39.51 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 118.485 -0.769 . . . . 3.0800000000000001 110.504 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.31 -43.06 92.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 117.539 -1.22 . . . . 3.3199999999999998 110.219 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -52.59 -59.04 4.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.87 1.214 . . . . 3.5499999999999998 111.306 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.7 -34.28 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.145 0.884 . . . . 4.6399999999999997 112.675 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.71 86.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.681 -0.637 . . . . 3.02 111.817 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -76.74 -41.7 44.0 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.824 2.45 . . . . 4.75 112.081 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.04 50.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.055 1.342 . . . . 3.3300000000000001 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.48 -2.32 57.92 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.165 0.802 . . . . 5.8499999999999996 113.165 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 62.77 42.58 7.89 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.274 1.83 . . . . 7.6100000000000003 112.011 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.3 m -73.79 148.97 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.828 1.251 . . . . 4.4299999999999997 112.079 -165.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -76.23 132.33 39.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.812 0.845 . . . . 4.0099999999999998 112.568 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -171.73 161.6 6.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.124 2.17 . . . . 4.4199999999999999 111.721 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 33.4 t -150.53 108.7 3.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.941 1.296 . . . . 3.5800000000000001 110.799 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.3 128.54 2.63 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.791 2.327 . . . . 3.23 112.446 -172.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.685 0 C-N-CA 124.24 0.924 . . . . 2.96 112.303 171.777 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.776 0.798 . . . . 7.0999999999999996 109.733 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.1 tp -135.13 139.4 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.152 -0.968 . . . . 3.98 108.619 167.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.58 110.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 105.28 -2.118 . . . . 3.8700000000000001 105.28 155.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.82 138.41 57.32 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.001 -1.111 . . . . 3.27 108.001 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -156.42 152.15 27.15 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.71 -1.244 . . . . 2.9399999999999999 113.743 -166.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 263' ' ' ILE . 58.5 p 3.71 -57.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 131.485 3.914 . . . . 5.5800000000000001 119.541 169.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 62.52 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 128.9 2.88 . . . . 5.25 112.868 -160.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.439 ' H ' ' C ' ' A' ' 261' ' ' THR . 36.4 pt -84.5 146.59 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 114.826 1.417 . . . . 4.3300000000000001 114.826 -175.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ttm -111.62 135.4 52.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.028 2.531 . . . . 3.21 108.871 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 135.37 47.23 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.157 -0.964 . . . . 4.5099999999999998 113.386 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.84 118.82 25.57 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.026 0.93 . . . . 3.2799999999999998 109.312 164.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.32 131.48 47.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.137 -1.801 . . . . 3.02 106.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -79.01 178.43 53.6 Favored Glycine 0 CA--C 1.536 1.404 0 N-CA-C 113.835 0.294 . . . . 2.0800000000000001 113.835 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -74.69 58.08 4.56 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.413 3.409 . . . . 2.6699999999999999 108.712 163.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.81 -63.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.938 1.695 . . . . 4.4699999999999998 109.511 -149.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.17 -22.55 9.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.469 1.509 . . . . 3.3900000000000001 114.995 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -83.15 169.44 15.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.867 1.334 . . . . 4.0 112.207 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -83.17 134.32 34.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.149 0.98 . . . . 6.25 111.249 169.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.69 -24.66 9.5 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.011 1.115 . . . . 4.6600000000000001 114.011 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -160.3 166.75 28.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.047 1.339 . . . . 3.1800000000000002 111.187 161.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -131.01 140.46 50.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.709 1.204 . . . . 5.1200000000000001 112.764 172.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.1 -172.51 2.23 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.288 2.235 . . . . 3.9700000000000002 108.532 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.55 73.11 0.5 Allowed Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.581 1.086 . . . . 3.29 110.758 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 88.63 151.03 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.104 2.962 . . . . 4.1200000000000001 112.809 176.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.4 t30 69.16 -43.64 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.909 2.884 . . . . 5.6699999999999999 115.624 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.32 113.44 4.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.23 0.923 . . . . 5.8200000000000003 110.106 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 150.84 38.23 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.902 -0.499 . . . . 6.7699999999999996 110.411 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -57.94 -36.46 72.55 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 119.66 -1.9 . . . . 3.0 115.178 -168.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.36 80.23 Favored Glycine 0 N--CA 1.483 1.778 0 O-C-N 120.661 -1.274 . . . . 2.27 116.038 170.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.58 -36.43 29.04 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.149 1.78 . . . . 4.7199999999999998 110.308 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.86 -41.88 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.681 0.792 . . . . 2.4100000000000001 108.908 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.84 96.18 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.301 0.852 . . . . 2.9100000000000001 113.301 170.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.25 84.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.437 1.017 . . . . 3.1099999999999999 113.224 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 p -68.7 -44.85 73.06 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 1.97 111.696 172.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.82 -35.12 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 119.992 1.269 . . . . 2.7200000000000002 112.373 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.25 65.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.459 -1.401 . . . . 3.0800000000000001 113.043 170.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.2 m -81.88 -44.51 16.75 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.796 0.838 . . . . 3.4199999999999999 109.805 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -62.28 -25.08 67.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.551 1.14 . . . . 3.6899999999999999 112.994 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 ttt -58.67 -34.74 71.58 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.114 0.966 . . . . 5.79 112.127 167.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -53.4 -49.01 90.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 116.62 -1.657 . . . . 4.8700000000000001 113.945 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.62 -56.78 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.38 2.054 . . . . 4.0599999999999996 111.702 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -88.17 29.81 0.92 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.982 1.475 . . . . 5.5499999999999998 114.982 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.609 0 O-C-N 120.771 -1.205 . . . . 9.1099999999999994 109.205 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.483 0 CA-C-O 118.944 -0.92 . . . . 3.23 114.355 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -93.28 171.35 2.07 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.346 3.364 . . . . 4.21 112.102 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.99 166.82 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.839 1.256 . . . . 4.8799999999999999 111.349 162.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 m -140.58 29.68 1.93 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.098 1.518 . . . . 3.4300000000000002 115.098 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -54.65 148.46 12.55 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.355 1.243 . . . . 3.5699999999999998 114.355 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.1 m -72.31 139.31 47.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.369 1.468 . . . . 2.3399999999999999 108.929 168.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.1 m -108.33 154.71 21.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.757 1.623 . . . . 3.79 109.126 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -60.25 -17.78 44.26 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.12 1.155 . . . . 2.3300000000000001 114.12 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -65.04 -23.18 67.12 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.286 2.234 . . . . 5.1699999999999999 113.749 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.21 -6.05 53.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.794 1.664 . . . . 2.1099999999999999 114.134 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.25 174.25 9.22 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 4.8300000000000001 111.972 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.19 130.56 48.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.003 0.521 . . . . 7.5199999999999996 109.685 160.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -102.0 172.66 6.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.6 0.76 . . . . 4.0300000000000002 110.678 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.72 154.48 13.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.734 2.014 . . . . 4.25 107.655 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -45.9 -26.25 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.45 2.3 . . . . 4.1600000000000001 114.401 164.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -98.94 -1.06 40.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.171 1.545 . . . . 7.0599999999999996 115.171 173.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.74 -59.97 2.1 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.549 -0.908 . . . . 3.4100000000000001 108.549 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -62.04 -30.95 71.32 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.389 0.885 . . . . 5.1100000000000003 113.389 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.78 -108.64 0.45 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.326 1.85 . . . . 5.7999999999999998 110.566 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -135.78 105.67 0.54 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.489 -2.644 . . . . 4.9500000000000002 106.489 165.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -107.01 -26.01 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.504 -1.236 . . . . 3.6400000000000001 114.319 166.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 49.1 m95 117.77 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 1 C-N-CA 132.185 4.194 . . . . 2.8599999999999999 109.02 -161.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.23 135.73 43.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.442 1.097 . . . . 3.9900000000000002 109.836 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 10.1 mt -118.73 104.8 10.93 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.832 1.653 . . . . 3.5600000000000001 106.908 168.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.9 pt -99.61 135.79 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.308 0.243 . . . . 4.75 111.283 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -140.37 143.8 35.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.428 1.091 . . . . 4.9299999999999997 112.324 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -123.75 117.34 24.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.433 1.493 . . . . 4.2199999999999998 109.37 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.55 -177.74 15.16 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.612 1.101 . . . . 1.6799999999999999 114.333 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 135.5 46.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.363 1.465 . . . . 4.9800000000000004 109.972 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 m -79.39 59.09 2.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.2 1.4 . . . . 3.4300000000000002 110.189 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -152.59 -104.7 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.88 2.472 . . . . 8.8900000000000006 107.597 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.6 152.8 0.14 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 130.147 3.379 . . . . 3.0099999999999998 116.887 173.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -92.03 -17.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.497 2.798 . . . . 3.75 113.366 159.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 168.79 -37.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.385 1.448 . . . . 4.6600000000000001 113.245 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -25.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 115.581 1.697 . . . . 4.2800000000000002 115.581 -160.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 m -66.89 -62.25 4.02 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.59 1.086 . . . . 1.8600000000000001 111.47 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.2 -25.43 57.73 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.508 1.472 . . . . 1.28 113.781 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.63 -23.68 67.34 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.272 1.212 . . . . 3.04 114.272 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -101.32 -18.79 15.91 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.977 1.262 . . . . 3.8300000000000001 113.867 162.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.53 -43.54 98.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.661 1.573 . . . . 3.6800000000000002 111.195 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.07 -55.29 18.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 3.4100000000000001 112.128 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -62.55 -45.44 92.95 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.347 -1.471 . . . . 3.6899999999999999 111.335 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ttm -56.24 -41.23 75.41 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.586 1.955 . . . . 3.1499999999999999 112.138 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.6 mm -59.98 -54.38 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.483 -0.932 . . . . 2.9700000000000002 108.483 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.445 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 63.0 mt-30 -63.51 -27.45 69.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 117.877 -1.058 . . . . 3.0800000000000001 112.592 -174.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.6 -37.21 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 120.932 1.697 . . . . 3.02 111.872 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -20.14 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.733 0.813 . . . . 3.9900000000000002 112.766 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -46.05 82.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.794 1.237 . . . . 4.8499999999999996 111.314 170.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -66.95 -39.48 87.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.82 0.282 . . . . 2.98 111.558 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.4 mm -65.85 -46.21 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.661 -0.649 . . . . 2.9399999999999999 112.448 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -65.9 -35.78 81.57 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.233 0.469 . . . . 3.7400000000000002 110.713 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.7 m -73.57 -23.12 59.91 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.325 1.231 . . . . 3.6499999999999999 114.325 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 11.0 mm -81.83 -28.29 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.261 1.424 . . . . 3.6899999999999999 110.467 167.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.4 m 67.17 -12.4 0.24 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.905 2.482 . . . . 5.7999999999999998 114.242 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 58.0 m -84.43 -30.31 25.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.549 1.94 . . . . 4.3899999999999997 112.128 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.46 159.73 48.44 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.67 1.188 . . . . 5.1500000000000004 109.788 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -61.76 -46.04 15.14 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.392 1.394 . . . . 3.7200000000000002 109.31 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -168.09 -178.55 3.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.126 2.57 . . . . 3.96 109.537 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 51.8 tp -125.67 123.57 39.23 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.563 -1.643 . . . . 3.0600000000000001 106.563 150.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.8 m -106.27 98.89 20.97 Favored Pre-proline 0 N--CA 1.465 0.298 0 C-N-CA 124.67 1.188 . . . . 2.0299999999999998 108.952 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.09 137.19 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.444 . . . . 1.0600000000000001 109.737 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.91 111.18 9.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 123.061 1.41 . . . . 4.8200000000000003 112.899 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.69 134.73 34.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.215 1.806 . . . . 4.2199999999999998 109.676 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.3 mt -120.36 131.78 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.154 1.782 . . . . 2.6400000000000001 106.984 168.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.37 126.22 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.741 0.701 . . . . 3.46 110.367 170.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.1 pt -98.96 16.77 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.531 1.133 . . . . 3.0899999999999999 113.176 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.91 44.82 0.2 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 127.395 2.278 . . . . 3.5800000000000001 114.25 168.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 207' ' ' ARG . 66.1 Cg_endo -73.59 -8.64 21.87 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.414 2.742 . . . . 2.1699999999999999 115.163 -169.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.23 0.4 0.27 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.321 1.848 . . . . 5.29 114.223 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 205' ' ' PRO . 0.0 OUTLIER -172.77 30.55 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.321 2.648 . . . . 5.71 111.412 -165.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.77 -174.75 3.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.146 1.379 . . . . 3.9900000000000002 111.057 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.5 t -162.36 151.08 14.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.673 1.225 . . . . 4.4199999999999999 112.891 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.53 -34.92 59.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.746 1.618 . . . . 3.48 112.825 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.57 71.31 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.797 1.239 . . . . 3.6200000000000001 114.05 174.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.34 74.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.923 1.238 . . . . 2.8999999999999999 110.862 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.4 mm -60.39 -43.56 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.131 0.972 . . . . 2.8300000000000001 111.616 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.53 89.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.341 0.656 . . . . 2.25 111.74 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.419 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 6.3 t30 -65.32 -43.84 89.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.526 -0.734 . . . . 4.0099999999999998 112.188 173.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -56.51 -41.39 76.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.736 0.815 . . . . 4.1200000000000001 111.404 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.3 -46.09 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.271 1.428 . . . . 2.1200000000000001 111.996 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 8.3 mtmp? -52.51 -55.13 24.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.673 1.124 . . . . 4.9000000000000004 112.73 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -33.62 59.91 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.822 0.675 . . . . 4.6500000000000004 112.822 -160.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -73.95 -36.42 64.62 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.507 0.594 . . . . 4.1200000000000001 111.613 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 m 153.38 136.15 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 129.886 3.274 . . . . 3.5 110.829 161.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -68.28 1.95 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.63 2.887 . . . . 3.0600000000000001 114.47 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -66.69 -16.44 64.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 121.154 -0.966 . . . . 3.3700000000000001 112.145 162.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.5 tp -80.75 145.36 31.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.654 1.581 . . . . 2.7400000000000002 111.805 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.9 t -102.02 137.6 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.589 1.156 . . . . 2.8900000000000001 109.572 167.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.86 132.42 9.86 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.442 1.02 . . . . 1.1399999999999999 111.731 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.88 151.6 48.18 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.737 1.215 . . . . 3.2000000000000002 112.211 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -166.16 -158.29 0.33 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.854 2.462 . . . . 3.5600000000000001 109.135 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 152.75 -115.34 0.68 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 108.834 -1.706 . . . . 1.8600000000000001 108.834 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.2 p -113.42 166.49 11.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.838 0.828 . . . . 3.25 111.656 166.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.62 -33.65 47.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.158 1.783 . . . . 7.8099999999999996 113.084 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -67.62 -43.55 80.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.068 0.947 . . . . 2.9300000000000002 112.112 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -70.31 -40.37 74.25 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.356 0.98 . . . . 5.5099999999999998 111.577 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.6 t -55.27 -38.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.863 0.865 . . . . 3.0299999999999998 111.988 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.5 -45.82 64.9 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 117.385 -1.293 . . . . 4.0300000000000002 110.301 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -52.04 -53.96 35.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.026 1.739 . . . . 3.2599999999999998 111.342 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.09 -32.31 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 113.226 0.824 . . . . 3.5299999999999998 113.226 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.65 -47.93 61.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.907 -1.12 . . . . 2.8700000000000001 111.306 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -70.87 -34.06 71.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.611 2.764 . . . . 4.8700000000000001 112.147 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.13 9.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.332 1.453 . . . . 3.1099999999999999 111.195 169.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.32 8.68 8.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.043 0.757 . . . . 4.7000000000000002 113.043 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 42.44 43.92 3.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.258 2.223 . . . . 5.6399999999999997 113.251 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 263' ' ' ILE . 7.9 p -69.72 -30.2 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 118.444 -0.789 . . . . 4.8200000000000003 112.711 -172.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.7 t80 67.32 156.49 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.368 1.867 . . . . 3.9300000000000002 113.9 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -176.88 164.44 2.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.476 2.711 . . . . 4.4400000000000004 109.558 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.5 t -154.77 99.16 2.42 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 121.546 -0.721 . . . . 4.0199999999999996 111.017 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -95.63 154.33 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.141 3.228 . . . . 3.7799999999999998 112.252 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.895 0 CA-C-N 116.304 -0.407 . . . . 3.1699999999999999 112.969 166.077 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 13.6 p90 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 113.464 0.912 . . . . 6.3099999999999996 113.464 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 33.8 mm 70.49 157.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.855 2.062 . . . . 4.9699999999999998 111.367 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.25 140.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.243 1.417 . . . . 5.9100000000000001 108.894 170.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -63.18 108.83 1.35 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.428 1.491 . . . . 4.6799999999999997 109.951 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -75.97 10.48 1.86 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.495 1.918 . . . . 6.9699999999999998 115.558 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.0 m -74.69 95.7 2.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.826 1.25 . . . . 6.4699999999999998 109.807 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.93 156.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.9 1.28 . . . . 5.9900000000000002 111.053 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.431 ' H ' HG22 ' A' ' 243' ' ' VAL . 70.8 mt -133.97 134.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.282 1.433 . . . . 3.3100000000000001 109.342 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 89.5 mtp -89.89 145.5 25.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.926 0.891 . . . . 3.0800000000000001 111.045 171.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -126.21 153.4 44.73 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.332 1.053 . . . . 3.79 112.354 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 10.6 tp -103.62 131.63 50.59 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.044 1.738 . . . . 3.1200000000000001 109.996 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 130.71 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 107.524 -1.287 . . . . 2.8599999999999999 107.524 162.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.4 179.84 53.15 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.682 1.134 . . . . 2.29 114.425 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -91.89 75.46 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.251 3.301 . . . . 3.9700000000000002 110.367 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.7 t70 177.19 -77.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.647 -1.615 . . . . 4.7800000000000002 108.822 -135.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.79 -16.63 2.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 117.359 -1.801 . . . . 3.23 115.156 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.83 168.57 9.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.532 1.666 . . . . 4.8300000000000001 114.397 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.46 150.97 29.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.056 2.142 . . . . 7.5099999999999998 113.534 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.0 mt -136.64 -38.73 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.424 1.638 . . . . 3.5800000000000001 115.424 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -166.36 167.45 15.85 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.616 1.098 . . . . 2.6499999999999999 113.306 -168.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.29 158.82 43.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.923 1.289 . . . . 5.3700000000000001 113.911 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.05 177.21 9.33 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.202 1.401 . . . . 3.71 114.207 -170.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.9 -177.1 22.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.179 2.8 . . . . 3.3999999999999999 109.736 -169.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -55.34 1.14 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 119.785 3.254 . . . . 4.8099999999999996 119.785 -166.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -111.63 -6.45 14.37 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.402 1.63 . . . . 6.0199999999999996 115.402 165.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -116.79 89.27 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.459 1.104 . . . . 5.04 109.965 157.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.7 mtt85 -82.88 -167.85 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.134 1.774 . . . . 6.7000000000000002 110.062 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.445 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.6 tmtt? -40.21 -57.71 1.65 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.148 1.779 . . . . 3.1899999999999999 115.149 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.51 -38.37 51.99 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 123.437 0.542 . . . . 1.9199999999999999 112.031 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.11 -33.05 75.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.894 0.877 . . . . 4.4500000000000002 112.289 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 30.2 mt -68.4 -56.15 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.505 0.722 . . . . 2.48 110.049 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.06 78.7 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.096 0.776 . . . . 2.6499999999999999 113.096 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -71.37 -33.86 69.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.631 1.173 . . . . 3.7000000000000002 113.732 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.9 p -68.78 -45.27 71.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.662 -1.161 . . . . 2.71 111.288 168.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.6 mt -56.31 -42.28 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.41 1.459 . . . . 2.3300000000000001 111.492 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.56 -28.5 69.68 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.141 -0.974 . . . . 2.73 113.342 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.5 m -73.1 -43.6 61.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.318 1.047 . . . . 3.2799999999999998 110.132 172.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -64.68 -25.91 68.15 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.722 1.209 . . . . 3.8900000000000001 112.353 172.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.1 ttp -69.93 -16.81 63.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.638 1.575 . . . . 5.5099999999999998 112.676 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -51.77 77.56 Favored Pre-proline 0 CA--C 1.553 1.086 0 O-C-N 120.195 -1.566 . . . . 7.7199999999999998 110.438 174.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.0 -51.61 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.074 1.849 . . . . 2.46 111.038 166.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.92 44.2 0.98 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.596 1.332 . . . . 4.3700000000000001 114.596 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 . . . . . 0 N--CA 1.467 0.419 0 O-C-N 121.341 -0.85 . . . . 10.01 109.279 163.658 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 117.656 -1.636 . . . . 4.1699999999999999 110.091 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.34 165.0 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.256 2.637 . . . . 3.79 112.691 -170.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -91.45 159.91 15.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.77 1.228 . . . . 4.3300000000000001 109.007 166.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 m -142.31 57.23 1.46 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 120.159 1.345 . . . . 2.6099999999999999 114.145 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.81 166.24 12.29 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 119.69 -1.882 . . . . 4.5999999999999996 113.814 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 m -89.75 152.76 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.493 1.917 . . . . 3.3100000000000001 108.762 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.5 p -95.87 161.25 14.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.395 1.093 . . . . 3.7400000000000002 112.524 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -52.72 -33.7 49.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.612 2.365 . . . . 2.6600000000000001 113.461 170.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.5 p -76.0 -47.61 24.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.098 1.359 . . . . 5.25 111.5 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.07 39.25 0.46 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.407 1.003 . . . . 3.0 114.672 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 -179.66 3.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.712 1.605 . . . . 3.46 109.059 170.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.53 97.28 3.53 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.128 1.331 . . . . 5.9100000000000001 110.697 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.06 159.69 15.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.761 1.224 . . . . 3.6800000000000002 112.411 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 153' ' ' LYS . 67.7 m -139.16 149.74 44.8 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.33 1.852 . . . . 4.5800000000000001 107.167 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -25.13 61.2 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.105 0.955 . . . . 3.8900000000000001 112.702 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.422 ' H ' HG23 ' A' ' 151' ' ' THR . 1.5 mmmp? -68.26 -18.34 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.552 1.686 . . . . 6.3700000000000001 115.552 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.4 -48.11 36.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.852 1.261 . . . . 3.23 109.341 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -89.47 13.34 14.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.643 1.177 . . . . 4.7199999999999998 113.187 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.78 118.46 6.67 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.344 -1.472 . . . . 5.8799999999999999 109.683 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 104.89 -8.66 46.37 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 123.656 0.646 . . . . 3.5499999999999998 114.38 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.486 ' HG3' ' H ' ' A' ' 159' ' ' TRP . 1.8 tp60 -80.77 -154.65 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.223 1.409 . . . . 4.71 111.412 -170.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . 0.486 ' H ' ' HG3' ' A' ' 158' ' ' GLN . 73.0 m95 -126.16 119.45 27.55 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.289 -1.507 . . . . 2.8599999999999999 107.215 154.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.25 45.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.012 0.91 . . . . 4.4100000000000001 111.701 -173.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 mt -131.37 135.56 47.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.219 1.807 . . . . 4.25 108.964 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.65 132.66 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.667 0.787 . . . . 3.3100000000000001 110.007 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -139.88 148.91 42.74 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.265 1.426 . . . . 3.8799999999999999 112.217 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -114.92 118.76 34.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.398 1.479 . . . . 4.5800000000000001 108.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -124.48 160.53 19.07 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 116.858 1.503 . . . . 2.0 116.858 -166.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -100.53 22.62 11.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.532 2.333 . . . . 6.3099999999999996 110.366 165.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 34.3 m 70.51 -66.59 0.28 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.02 2.528 . . . . 5.1399999999999997 110.972 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -108.5 -29.04 8.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 117.696 -1.145 . . . . 11.31 113.147 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.22 -172.03 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.699 1.199 . . . . 2.48 113.284 -176.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.06 61.18 1.34 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.57 2.18 . . . . 3.8999999999999999 110.161 139.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 65.25 -4.23 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 129.817 3.247 . . . . 4.4400000000000004 115.808 166.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.11 -33.43 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 117.878 -1.058 . . . . 3.8799999999999999 113.847 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.5 m -48.24 -60.68 4.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 120.452 1.478 . . . . 1.51 112.454 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 -24.35 42.42 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.427 2.085 . . . . 1.47 114.414 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.3 -43.96 96.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.971 1.26 . . . . 3.0800000000000001 111.398 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.54 -35.17 75.19 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.128 -0.983 . . . . 3.4399999999999999 111.571 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 -56.36 20.1 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.828 1.251 . . . . 4.0099999999999998 111.651 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.02 -43.97 94.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.057 0.844 . . . . 3.79 110.267 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -54.07 -39.46 66.3 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.035 -1.666 . . . . 4.8399999999999999 113.016 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ptp -68.74 -34.82 76.27 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.988 1.722 . . . . 3.3799999999999999 113.771 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.2 mm -66.02 -42.78 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 120.34 1.427 . . . . 2.8500000000000001 111.436 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -63.3 -37.97 89.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.606 1.562 . . . . 4.0599999999999996 110.847 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.53 -45.47 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.674 -0.642 . . . . 3.6200000000000001 111.989 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.59 -40.09 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.253 1.021 . . . . 3.0699999999999998 113.04 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -58.06 7.48 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.048 1.339 . . . . 6.2199999999999998 111.91 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.05 -40.12 92.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.417 0.525 . . . . 4.6699999999999999 112.417 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 56.3 mt -59.9 -48.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.339 1.856 . . . . 4.3899999999999997 112.651 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.07 -48.38 81.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.946 1.298 . . . . 3.46 109.371 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.8 t -68.92 -6.07 25.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.952 2.101 . . . . 4.7300000000000004 114.409 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 32.8 mm -56.62 -48.61 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 119.626 1.103 . . . . 5.79 110.291 171.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 32.9 p -171.55 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.464 2.394 . . . . 7.3700000000000001 117.464 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.253 5.7 t 102.36 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.065 1.746 . . . . 5.7199999999999998 107.438 -121.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.3 mp -93.39 161.86 29.57 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.456 -0.778 . . . . 4.5999999999999996 110.495 136.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -86.16 35.84 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.199 3.932 . . . . 3.73 111.308 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 t0 70.0 174.72 0.29 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.143 2.577 . . . . 4.2199999999999998 114.022 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.09 134.97 44.99 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.088 1.755 . . . . 4.0899999999999999 108.1 166.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.8 m -107.43 100.71 35.39 Favored Pre-proline 0 N--CA 1.47 0.575 0 C-N-CA 123.619 0.767 . . . . 2.3100000000000001 110.2 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.7 127.34 4.26 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.001 2.468 . . . . 1.79 111.099 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.02 108.52 19.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.749 2.02 . . . . 3.8199999999999998 109.174 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -99.55 113.68 26.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.159 -0.682 . . . . 4.6200000000000001 109.159 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.18 119.46 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.198 -0.667 . . . . 3.5499999999999998 109.198 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.7 m -80.45 133.53 35.87 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.431 -0.793 . . . . 3.6699999999999999 111.513 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.4 pt -82.23 -1.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 114.093 1.146 . . . . 3.5899999999999999 114.093 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.65 48.89 0.23 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 127.425 2.29 . . . . 3.2400000000000002 114.026 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.63 -6.79 19.28 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.636 2.224 . . . . 4.2300000000000004 113.458 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -81.8 -2.76 51.99 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.303 0.956 . . . . 4.3200000000000003 112.845 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.79 -27.48 1.29 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.62 1.341 . . . . 7.5099999999999998 114.62 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -109.15 141.21 41.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.216 1.371 . . . . 6.79 111.915 172.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 82.7 p -95.64 159.71 14.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.551 1.167 . . . . 4.4100000000000001 112.805 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -54.77 -36.71 65.16 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.193 1.397 . . . . 4.46 112.335 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -71.93 -33.51 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.112 1.365 . . . . 3.0699999999999998 112.877 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.27 91.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.586 1.084 . . . . 2.79 112.248 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . 0.269 4.3 tp -70.57 -23.54 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 121.123 -0.986 . . . . 4.04 113.142 173.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.85 -42.61 94.75 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.563 -1.336 . . . . 2.7200000000000002 111.924 167.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -58.57 -41.01 84.7 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.436 -0.79 . . . . 6.2199999999999998 112.082 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -62.63 -45.62 92.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.676 1.191 . . . . 4.4500000000000002 112.136 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.6 t -52.21 -44.31 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.036 -1.04 . . . . 2.8900000000000001 111.55 169.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -13.1 62.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.361 1.245 . . . . 6.4299999999999997 114.361 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -79.1 -47.05 16.82 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.419 1.463 . . . . 4.3600000000000003 110.666 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -95.19 -50.23 5.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.581 0.956 . . . . 4.6500000000000004 113.581 -172.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 170.52 141.06 0.09 OUTLIER Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 124.715 1.206 . . . . 2.8799999999999999 113.293 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.57 -5.64 17.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.794 2.996 . . . . 2.0600000000000001 114.217 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -71.83 -16.91 62.17 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.948 1.249 . . . . 2.8199999999999998 112.959 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.06 132.35 44.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.335 0.97 . . . . 2.9900000000000002 109.892 174.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.9 119.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.943 -1.502 . . . . 3.0 106.943 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.96 134.83 12.7 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 107.949 -2.061 . . . . 1.3300000000000001 107.949 163.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.02 151.18 39.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.991 0.916 . . . . 3.9700000000000002 110.399 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.6 m -152.76 -179.9 8.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.166 2.186 . . . . 3.2400000000000002 107.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 171.85 -132.34 2.4 Favored Glycine 0 N--CA 1.468 0.792 0 O-C-N 120.175 -1.578 . . . . 3.23 110.619 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.5 p -96.88 155.34 16.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.291 -1.003 . . . . 3.8900000000000001 108.291 155.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.31 -26.82 65.33 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 117.912 -1.042 . . . . 7.4699999999999998 111.818 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -66.38 -34.35 77.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.424 1.465 . . . . 3.4900000000000002 111.802 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.25 -37.78 75.01 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.026 -1.047 . . . . 3.3199999999999998 111.439 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.89 -33.73 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 122.128 -0.357 . . . . 3.3199999999999998 111.191 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.16 -35.39 71.62 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.35 1.06 . . . . 3.3700000000000001 111.0 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -57.7 -54.18 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.086 0.857 . . . . 3.04 110.76 174.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.11 -33.97 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.098 0.777 . . . . 2.8300000000000001 113.098 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.47 -48.31 75.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.153 0.981 . . . . 2.6099999999999999 111.792 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -32.81 69.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.353 2.261 . . . . 5.3600000000000003 112.869 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.47 -67.01 0.48 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.525 1.057 . . . . 2.8300000000000001 110.138 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -72.36 4.14 4.03 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.389 1.255 . . . . 3.5699999999999998 114.389 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 58.96 44.72 16.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.29 1.836 . . . . 5.9800000000000004 113.799 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.41 144.81 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.57 -0.706 . . . . 4.3200000000000003 111.401 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.09 136.93 33.82 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.789 -0.57 . . . . 4.0899999999999999 110.701 165.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -162.05 161.68 28.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.021 1.729 . . . . 4.1100000000000003 111.322 176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.4 m -164.26 115.1 0.95 Allowed Pre-proline 0 N--CA 1.478 0.952 0 O-C-N 121.055 -1.028 . . . . 3.54 112.644 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -88.63 140.18 4.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.426 2.751 . . . . 3.1800000000000002 113.771 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.524 0 N-CA-C 110.239 -1.144 . . . . 2.8799999999999999 110.239 163.754 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 113.616 0.969 . . . . 4.7300000000000004 113.616 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.4 132.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 119.296 -2.128 . . . . 3.8799999999999999 111.838 170.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.78 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.156 1.383 . . . . 3.8900000000000001 108.524 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.22 148.23 35.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 3.3100000000000001 112.03 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -150.86 154.32 37.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.57 1.548 . . . . 2.4399999999999999 110.896 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 t -59.62 153.56 19.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.495 0.718 . . . . 4.1100000000000003 111.46 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.83 58.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 122.635 1.207 . . . . 4.7400000000000002 108.17 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.1 mt -133.79 132.58 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.384 1.473 . . . . 3.5499999999999998 108.698 -172.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 40.5 mtp -102.88 135.18 45.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.708 2.003 . . . . 3.8700000000000001 111.737 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -102.54 135.19 44.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.022 1.329 . . . . 5.29 111.152 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.09 124.55 41.14 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.307 0.958 . . . . 5.1100000000000003 109.54 171.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.92 131.39 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.076 -1.453 . . . . 3.6499999999999999 107.076 158.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -138.45 -133.95 3.14 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.734 -1.037 . . . . 3.23 112.293 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -77.33 79.75 3.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.813 2.342 . . . . 3.8399999999999999 109.922 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -171.84 -64.39 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.984 2.914 . . . . 5.9000000000000004 108.346 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.27 7.23 35.39 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.958 -1.468 . . . . 4.6799999999999997 116.585 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -138.26 -47.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.267 1.534 . . . . 5.54 113.443 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -168.19 156.87 8.97 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 4.79 112.53 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -151.54 -42.64 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.887 1.069 . . . . 4.3899999999999997 113.887 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -170.88 172.76 5.46 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.479 1.912 . . . . 3.4399999999999999 110.415 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -145.96 157.46 43.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.201 -0.937 . . . . 3.8900000000000001 112.636 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.88 -167.63 2.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.04 1.736 . . . . 4.4199999999999999 110.477 -170.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.92 -115.41 1.25 Allowed Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.017 1.294 . . . . 3.1899999999999999 110.866 164.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.91 -7.59 1.79 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.805 1.409 . . . . 4.0599999999999996 114.805 175.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -145.64 157.94 43.91 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.075 0.852 . . . . 5.3300000000000001 111.045 163.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 72.47 131.29 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.959 2.104 . . . . 6.4800000000000004 108.894 -143.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.67 175.63 5.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.881 2.072 . . . . 8.4199999999999999 111.607 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -29.35 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 126.593 1.957 . . . . 3.3300000000000001 113.886 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.83 -19.72 69.81 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-O 119.418 -0.657 . . . . 2.2999999999999998 113.839 -175.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -63.88 -37.07 86.05 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.099 1.449 . . . . 3.3199999999999998 111.175 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.43 -50.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.806 0.842 . . . . 3.21 110.986 175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.82 88.81 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.042 -0.411 . . . . 3.0800000000000001 111.601 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.29 80.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.538 . . . . 2.9100000000000001 113.453 173.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.5 p -60.57 -43.27 97.51 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.832 1.196 . . . . 2.3399999999999999 111.501 167.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.48 -33.77 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.445 -1.409 . . . . 3.3399999999999999 111.997 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.51 -25.03 65.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.92 1.288 . . . . 2.8100000000000001 113.272 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.8 m -75.16 -46.61 33.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.262 1.025 . . . . 3.0600000000000001 109.896 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -59.2 -26.44 64.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.372 1.469 . . . . 3.5499999999999998 112.832 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -59.93 -25.29 65.03 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.739 -1.226 . . . . 5.54 113.154 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -61.54 -51.75 74.77 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 117.213 -1.375 . . . . 5.2400000000000002 111.824 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.71 -55.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.586 2.191 . . . . 3.8300000000000001 111.463 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -81.53 77.35 8.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.011 1.324 . . . . 4.9199999999999999 111.295 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 125.22 1.408 . . . . 9.8300000000000001 112.824 -177.695 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.259 0 CA-C-O 117.734 -1.592 . . . . 4.5800000000000001 110.152 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.65 159.97 41.8 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.728 2.285 . . . . 3.7999999999999998 111.176 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -136.85 165.95 24.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.377 1.071 . . . . 3.7400000000000002 111.909 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 p -146.04 112.33 5.81 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.771 -1.206 . . . . 3.23 112.154 157.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.08 146.91 27.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.99 0.9 . . . . 3.1600000000000001 111.585 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.2 m -83.43 130.38 35.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.174 1.39 . . . . 2.6899999999999999 107.572 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -84.08 168.31 16.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.483 -1.386 . . . . 3.2200000000000002 112.2 -171.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -60.13 -30.28 69.19 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.818 1.247 . . . . 1.96 112.837 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 t -91.99 13.52 18.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.633 1.573 . . . . 3.6400000000000001 113.129 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.98 88.01 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 119.124 0.875 . . . . 1.98 115.075 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -91.79 -168.63 2.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.04 1.736 . . . . 3.4399999999999999 109.964 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -157.71 114.39 2.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 121.947 2.158 . . . . 5.7300000000000004 113.401 -169.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -109.06 167.94 9.73 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.584 1.698 . . . . 3.6400000000000001 115.584 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 39.9 p -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.462 2.705 . . . . 2.8199999999999998 110.133 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.31 -56.95 2.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.557 1.543 . . . . 4.3099999999999996 113.159 172.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -0.7 3.89 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.918 1.821 . . . . 7.8499999999999996 115.918 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -81.44 -40.06 23.92 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.424 1.466 . . . . 2.9500000000000002 110.134 165.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.1 -32.05 17.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.597 1.332 . . . . 4.5 114.597 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.92 109.6 1.51 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.376 0.989 . . . . 5.0499999999999998 110.108 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.67 1.99 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 124.461 1.029 . . . . 2.6200000000000001 113.322 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -94.96 172.28 8.25 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.079 -1.082 . . . . 3.8500000000000001 108.079 154.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -85.0 138.94 32.14 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.548 -0.538 . . . . 2.6200000000000001 109.548 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.04 155.39 45.4 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.466 1.127 . . . . 3.7799999999999998 113.499 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.58 127.58 52.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.579 1.552 . . . . 3.2999999999999998 108.114 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.4 mt -112.74 118.08 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.97 -0.752 . . . . 2.96 108.97 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -125.49 142.68 51.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.056 1.742 . . . . 3.6600000000000001 111.161 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.85 111.98 24.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.255 1.422 . . . . 3.71 111.059 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.56 -176.07 15.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.937 1.732 . . . . 1.4099999999999999 113.332 -173.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -154.56 14.13 0.43 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.578 2.066 . . . . 5.3700000000000001 116.578 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m 72.81 -25.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.66 1.584 . . . . 3.3300000000000001 113.987 166.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -77.06 -25.68 52.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.781 1.173 . . . . 8.6099999999999994 112.037 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.51 123.52 74.26 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.337 1.455 . . . . 2.9500000000000002 111.547 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -90.74 -0.43 5.1 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.167 2.578 . . . . 4.6600000000000001 113.155 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -125.39 -89.25 0.57 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.138 1.375 . . . . 6.3200000000000003 109.504 -162.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.55 -31.18 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 117.222 -1.37 . . . . 5.1399999999999997 114.181 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.6 m -59.82 -50.77 85.06 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 121.766 2.076 . . . . 1.71 111.844 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.52 -43.58 26.73 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.782 1.655 . . . . 1.4199999999999999 113.23 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.4 -30.52 53.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.818 1.19 . . . . 3.2000000000000002 113.162 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.28 -36.05 74.14 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.762 -1.211 . . . . 3.0600000000000001 111.737 166.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.7 mt -61.3 -49.25 77.78 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.978 1.263 . . . . 3.8399999999999999 111.409 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.44 -46.28 76.76 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.346 1.058 . . . . 4.04 111.953 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -53.67 -57.37 11.06 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.222 -0.924 . . . . 4.3899999999999997 111.245 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.1 ptp -66.99 -19.36 65.7 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.036 1.124 . . . . 3.3900000000000001 114.036 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.566 1.53 . . . . 2.6899999999999999 110.389 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.472 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 72.9 mt-30 -62.76 -27.01 68.99 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.437 1.017 . . . . 3.1699999999999999 111.908 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 t -61.65 -32.0 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.464 1.106 . . . . 2.96 113.131 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -31.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.864 1.211 . . . . 4.0800000000000001 111.582 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 187' ' ' ILE . 0.0 OUTLIER -59.81 -50.75 72.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.973 1.309 . . . . 5.1900000000000004 110.08 167.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -65.76 1.97 1.16 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.256 2.622 . . . . 2.8199999999999998 115.55 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 185' ' ' ASP . 58.2 mt -123.22 -57.56 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 130.087 3.355 . . . . 3.5699999999999998 110.587 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.76 -37.64 73.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.757 2.023 . . . . 3.8999999999999999 112.44 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t -61.42 -27.87 68.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.751 1.22 . . . . 4.0099999999999998 110.819 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.5 mm -77.46 7.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 O-C-N 120.464 -1.398 . . . . 4.8099999999999996 111.195 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 67.8 m 82.54 -33.28 0.09 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.204 2.202 . . . . 5.71 113.693 147.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.2 m -153.73 45.96 0.62 Allowed 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.863 -1.148 . . . . 5.4100000000000001 111.301 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.38 -175.51 0.6 Allowed Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.064 0.945 . . . . 5.0300000000000002 111.437 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -83.45 136.97 7.83 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.512 2.142 . . . . 5.0599999999999996 109.517 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.86 133.1 37.02 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.516 0.562 . . . . 3.9100000000000001 112.516 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 14.1 tp -105.19 116.67 32.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.347 1.859 . . . . 2.7000000000000002 111.173 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.0 m -103.09 99.1 13.22 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.81 1.244 . . . . 1.96 110.096 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -72.44 138.09 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.304 2.002 . . . . 1.4199999999999999 112.661 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -117.95 110.93 18.31 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.797 2.039 . . . . 3.9100000000000001 109.308 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -97.09 115.72 28.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.022 0.929 . . . . 3.52 109.069 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 90.3 mt -97.02 120.79 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.207 1.003 . . . . 2.6899999999999999 109.845 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.2 m -69.19 132.19 46.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.611 0.364 . . . . 2.71 111.303 168.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.04 -5.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 114.536 1.31 . . . . 2.4900000000000002 114.536 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -113.76 47.45 0.39 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 125.08 1.352 . . . . 3.7400000000000002 113.265 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.03 73.98 3.6 Favored 'Trans proline' 0 C--N 1.363 1.337 1 C-N-CA 125.854 4.37 . . . . 2.1699999999999999 112.714 -165.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -169.75 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.878 2.871 . . . . 4.2300000000000004 107.298 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -7.86 12.73 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.168 1.173 . . . . 9.0399999999999991 114.168 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.08 107.21 15.05 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 121.002 1.728 . . . . 4.21 111.207 160.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.6 t -82.32 154.68 25.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.596 1.158 . . . . 4.0899999999999999 113.086 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.68 -39.32 80.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.713 1.375 . . . . 7.25 114.713 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -80.08 -19.67 46.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.775 1.17 . . . . 5.8399999999999999 113.632 173.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.76 68.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.21 1.823 . . . . 2.6899999999999999 110.261 170.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 3.0 mm -54.39 -51.91 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.256 0.622 . . . . 3.3300000000000001 111.351 165.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.98 -29.12 70.02 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.257 -1.354 . . . . 2.4500000000000002 113.832 -175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -70.42 -48.95 53.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.439 1.927 . . . . 4.2999999999999998 110.556 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.36 -41.44 65.83 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.682 0.793 . . . . 4.9299999999999997 111.571 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.95 -53.29 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 125.511 1.524 . . . . 2.5099999999999998 113.598 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -57.07 -40.86 77.68 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.382 1.073 . . . . 6.8899999999999997 112.883 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.97 -53.12 51.32 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.925 2.09 . . . . 3.6099999999999999 111.228 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.65 -36.81 85.46 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.503 1.298 . . . . 4.4800000000000004 114.503 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.1 m 148.38 148.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 128.681 2.792 . . . . 2.9900000000000002 113.581 167.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.15 9.66 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.201 3.268 . . . . 3.04 116.525 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -91.22 -9.24 45.99 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 120.989 1.722 . . . . 3.3300000000000001 113.17 161.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 66.8 tp -84.08 147.12 27.55 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.667 1.187 . . . . 2.9700000000000002 109.842 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 t -130.56 138.64 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.474 1.11 . . . . 2.8799999999999999 108.503 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.82 122.18 7.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.234 -1.546 . . . . 1.0900000000000001 109.234 169.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.34 140.11 39.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.283 1.033 . . . . 3.23 108.945 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.0 p -151.72 -172.6 4.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.621 1.969 . . . . 3.9700000000000002 109.399 -165.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.14 -155.84 10.16 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 123.121 0.391 . . . . 2.2400000000000002 113.088 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.3 t -73.81 -177.08 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.546 -1.279 . . . . 2.6699999999999999 107.546 136.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -44.91 -39.43 5.43 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.288 1.035 . . . . 8.0199999999999996 111.817 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -70.41 -37.65 74.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.555 1.07 . . . . 2.8700000000000001 113.601 -165.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.8 -30.56 68.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.805 1.639 . . . . 3.5299999999999998 111.511 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.43 -38.94 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.862 0.865 . . . . 2.54 111.136 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.72 -50.07 75.27 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.736 -1.209 . . . . 3.8900000000000001 107.736 171.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -54.93 -61.58 2.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.612 -1.185 . . . . 3.5800000000000001 112.959 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.62 -34.33 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.598 1.545 . . . . 3.0699999999999998 113.232 -166.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.22 96.18 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.279 -0.888 . . . . 2.2400000000000002 110.535 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -73.47 -32.85 64.55 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.884 1.673 . . . . 4.7300000000000004 112.846 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.43 97.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.794 1.179 . . . . 2.6299999999999999 112.007 171.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -84.03 1.97 41.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.698 0.799 . . . . 3.54 112.946 171.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.54 22.05 9.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.001 2.121 . . . . 7.5899999999999999 113.991 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.0 m -86.99 164.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.647 0.779 . . . . 4.0499999999999998 110.181 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -155.38 168.99 25.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.776 1.23 . . . . 5.2800000000000002 111.989 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -161.98 128.58 3.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.336 0.655 . . . . 5.1600000000000001 110.869 -163.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.8 m -110.27 110.38 58.28 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-O 118.598 -0.715 . . . . 3.27 111.835 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.1 146.31 20.02 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.828 2.352 . . . . 3.3199999999999998 111.839 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.69 0 CA-C-O 119.504 -0.609 . . . . 2.7200000000000002 113.11 176.618 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 24.0 t80 . . . . . 0 CA--C 1.55 0.956 0 CA-C-O 122.885 1.326 . . . . 4.3099999999999996 114.444 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.14 153.31 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.559 1.543 . . . . 5.2599999999999998 110.303 159.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.85 150.54 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.055 1.742 . . . . 3.8900000000000001 106.919 163.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.13 155.66 34.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.114 -0.698 . . . . 3.71 109.114 164.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -140.47 87.7 2.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.53 0.681 . . . . 2.5099999999999998 110.865 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.5 t -74.51 76.57 1.95 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 124.037 1.875 . . . . 6.5300000000000002 109.379 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.1 pp -132.25 172.65 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.167 1.787 . . . . 7.7400000000000002 109.532 -172.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 11.3 tt -141.42 164.59 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.198 -0.939 . . . . 3.5699999999999998 109.121 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 22.6 ttm -99.13 141.28 32.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.571 1.078 . . . . 3.6499999999999999 110.229 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -109.66 148.73 30.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.352 1.061 . . . . 3.6299999999999999 112.792 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 127.0 46.32 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.649 1.58 . . . . 3.9399999999999999 108.208 163.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 156.48 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.149 1.379 . . . . 2.98 108.334 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -155.5 -134.45 1.86 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.505 1.05 . . . . 2.5 111.977 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -85.86 36.4 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.852 3.701 . . . . 3.3199999999999998 112.412 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -120.61 -38.52 2.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.739 2.015 . . . . 6.79 114.889 -164.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.29 2.46 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.086 -1.206 . . . . 4.3700000000000001 110.086 -158.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.32 -2.95 3.08 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.717 1.377 . . . . 5.7599999999999998 114.717 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -138.88 76.79 1.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.632 1.173 . . . . 4.7300000000000004 112.001 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -34.87 17.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.161 0.984 . . . . 4.1399999999999997 111.824 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -168.96 174.77 6.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.828 2.851 . . . . 2.3199999999999998 108.441 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -153.86 150.02 27.96 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.64 -1.287 . . . . 3.71 111.715 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.95 114.03 21.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.352 1.061 . . . . 3.5699999999999998 108.885 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.98 42.2 3.05 Favored Glycine 0 N--CA 1.464 0.542 0 CA-C-O 118.324 -1.265 . . . . 4.0700000000000003 111.467 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . 0.266 3.5 pt20 44.17 45.16 6.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.011 1.724 . . . . 4.54 112.186 -170.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -139.63 -37.41 0.49 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.755 1.761 . . . . 5.79 115.755 -164.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -63.84 135.32 56.5 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.356 -1.465 . . . . 5.0 109.098 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -76.71 171.22 15.05 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 121.395 1.907 . . . . 9.0999999999999996 109.193 163.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -48.33 -43.97 33.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.935 0.894 . . . . 2.8500000000000001 113.167 -177.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -57.18 -36.34 74.62 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.942 1.258 . . . . 1.8200000000000001 114.951 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -86.83 -18.08 31.83 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.421 1.61 . . . . 4.0499999999999998 112.774 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 69.1 mt -69.22 -55.75 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.052 -1.092 . . . . 2.3399999999999999 108.052 170.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.35 95.59 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.087 0.773 . . . . 2.6800000000000002 113.087 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.39 90.63 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.83 1.195 . . . . 2.98 112.47 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.4 p -61.59 -43.83 98.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.567 1.076 . . . . 2.1699999999999999 112.142 170.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.86 -47.11 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.637 1.108 . . . . 2.1800000000000002 110.723 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.54 -30.72 70.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.309 0.959 . . . . 2.3900000000000001 113.061 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.2 m -68.37 -50.27 54.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.433 1.093 . . . . 2.8799999999999999 109.89 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -70.27 -34.04 72.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.761 1.225 . . . . 2.9700000000000002 113.449 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -60.66 -33.82 73.38 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.288 1.835 . . . . 4.8899999999999997 112.84 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -59.6 -52.44 74.03 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 116.785 -1.579 . . . . 5.1299999999999999 112.985 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.91 -44.5 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.274 2.649 . . . . 3.3300000000000001 111.589 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.16 62.65 7.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.625 1.17 . . . . 4.1799999999999997 111.038 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 . . . . . 0 N--CA 1.471 0.611 0 C-N-CA 125.618 1.567 . . . . 9.1300000000000008 114.591 -166.213 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.144 0 CA-C-O 119.042 -0.866 . . . . 3.54 113.088 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.4 148.92 30.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.029 2.486 . . . . 3.6400000000000001 111.854 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -130.68 125.16 33.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.6 1.16 . . . . 4.1200000000000001 111.302 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -109.81 46.57 1.0 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.448 -1.407 . . . . 2.8599999999999999 111.983 -162.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -85.35 155.25 21.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.573 1.549 . . . . 4.1299999999999999 111.792 -160.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.3 m -79.83 133.78 36.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.302 1.041 . . . . 2.8900000000000001 109.868 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.2 p -81.94 160.65 23.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 123.061 1.41 . . . . 2.8399999999999999 112.655 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -2.73 1.57 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.773 2.029 . . . . 2.3799999999999999 114.905 168.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 t -100.37 -41.31 7.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.953 0.901 . . . . 3.8799999999999999 110.961 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.28 -0.77 7.05 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 125.154 1.359 . . . . 2.02 115.546 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.09 157.81 35.38 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.102 0.951 . . . . 3.7799999999999998 108.544 163.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.434 HH12 ' CD ' ' A' ' 233' ' ' GLU . 87.5 mtt-85 -92.13 134.24 35.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.749 -1.219 . . . . 8.5500000000000007 110.857 174.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -138.47 136.02 35.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.706 1.002 . . . . 3.6400000000000001 113.706 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 149.1 51.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 128.57 2.748 . . . . 4.4500000000000002 109.469 -164.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -32.42 -43.59 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.582 2.353 . . . . 4.0199999999999996 114.389 158.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.02 -25.73 68.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.23 1.412 . . . . 8.6300000000000008 113.227 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -89.4 -28.22 19.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.406 1.082 . . . . 3.0099999999999998 111.521 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -80.58 -16.85 53.13 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.808 1.04 . . . . 3.9700000000000002 113.808 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 111.31 1.39 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.865 1.266 . . . . 4.6699999999999999 111.945 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.35 -24.13 4.48 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.092 1.329 . . . . 3.0299999999999998 112.796 -171.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.15 -162.11 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 117.825 0.813 . . . . 4.4400000000000004 109.11 149.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -105.66 153.3 22.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.618 1.167 . . . . 2.0800000000000001 110.115 168.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 pp -135.37 134.95 40.3 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.402 -0.811 . . . . 3.5499999999999998 110.918 173.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.59 132.07 54.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.296 1.838 . . . . 4.1299999999999999 107.499 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.13 129.3 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.398 1.079 . . . . 3.2400000000000002 110.441 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -106.74 145.82 31.59 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.755 2.022 . . . . 3.8100000000000001 111.523 163.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -112.3 118.28 34.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.557 1.143 . . . . 3.5499999999999998 112.793 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.89 164.15 27.9 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 117.059 1.584 . . . . 1.5600000000000001 117.059 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -26.97 11.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.129 1.772 . . . . 5.0800000000000001 112.929 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 89.1 m 118.66 109.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.202 3.801 . . . . 3.8599999999999999 109.997 163.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . 0.346 1.5 t-160 41.12 52.01 3.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.725 2.01 . . . . 11.75 114.241 -161.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.76 149.63 41.3 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 126.219 1.808 . . . . 4.2599999999999998 109.993 159.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.03 -17.85 21.85 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.795 2.33 . . . . 5.0 114.361 -156.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -42.15 42.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.248 1.019 . . . . 11.16 112.528 -162.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 p 174.6 3.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 127.139 2.176 . . . . 5.6699999999999999 114.623 -163.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . 0.251 46.9 t -57.93 -66.79 1.13 Allowed Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 115.423 1.638 . . . . 2.9500000000000002 115.423 -147.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.34 -17.63 39.36 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.212 2.608 . . . . 2.1200000000000001 113.246 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -69.35 -31.42 69.85 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 117.881 -1.057 . . . . 6.7400000000000002 112.844 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -87.86 -20.12 26.47 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 121.164 1.802 . . . . 3.1699999999999999 113.323 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -47.42 85.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.41 -1.431 . . . . 3.5899999999999999 109.681 164.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.99 -51.27 64.43 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.49 1.516 . . . . 4.5800000000000001 111.256 171.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -67.75 -21.53 65.27 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.673 -1.267 . . . . 4.1299999999999999 113.666 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.9 ttp -67.47 -32.26 72.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.1 0.864 . . . . 3.7000000000000002 112.362 164.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.58 -53.28 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 119.914 -1.742 . . . . 4.3099999999999996 108.973 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.45 21.79 0.1 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.711 1.375 . . . . 3.3300000000000001 114.711 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.46 -40.77 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 120.569 1.531 . . . . 4.4500000000000002 111.912 147.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.9 t -57.66 -49.41 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.254 0.933 . . . . 2.9500000000000002 110.428 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -59.83 -32.23 70.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.152 1.781 . . . . 3.6200000000000001 113.168 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -81.45 -35.12 30.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 2.5499999999999998 113.012 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.9 mt -62.92 -49.54 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.279 0.632 . . . . 3.7799999999999998 109.601 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -62.92 -35.14 79.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.658 2.383 . . . . 3.54 111.585 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -66.54 -13.47 61.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.411 1.263 . . . . 3.8100000000000001 114.411 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 87.6 mt -100.33 96.68 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.541 -1.349 . . . . 4.0700000000000003 108.309 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.4 m -65.11 69.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.31 2.244 . . . . 5.9800000000000004 112.529 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 176.2 -28.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.372 1.869 . . . . 4.8600000000000003 112.78 -165.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.11 148.19 47.06 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 119.789 1.177 . . . . 4.7000000000000002 112.139 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.24 142.87 15.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.398 2.732 . . . . 3.2000000000000002 109.318 168.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -69.45 162.3 27.7 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.579 1.696 . . . . 3.8199999999999998 115.579 -163.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 35.3 tp -119.51 96.07 5.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.128 2.171 . . . . 3.6699999999999999 108.917 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.6 m -72.84 123.47 89.61 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-O 118.193 -0.908 . . . . 3.0600000000000001 109.609 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.15 118.6 2.67 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.503 2.802 . . . . 1.1799999999999999 111.118 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.9 mt -108.91 126.03 52.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.231 1.412 . . . . 4.9900000000000002 110.482 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -104.04 130.56 51.73 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.468 1.107 . . . . 3.1699999999999999 109.227 168.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.47 124.8 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.752 0.787 . . . . 2.8599999999999999 111.444 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.6 m -66.07 129.95 41.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.924 0.89 . . . . 2.9700000000000002 111.899 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.29 -17.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 114.831 1.419 . . . . 3.5299999999999998 114.831 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -117.06 44.63 0.46 Allowed Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 125.23 1.412 . . . . 4.5800000000000001 112.406 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.31 83.22 1.51 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.776 2.984 . . . . 2.6099999999999999 113.778 -166.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -155.68 28.53 0.38 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.794 2.038 . . . . 5.1699999999999999 110.501 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -156.54 -35.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.055 1.132 . . . . 5.4500000000000002 114.055 -166.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -98.69 83.91 3.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.602 1.961 . . . . 3.5099999999999998 111.088 -167.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 m -49.77 138.24 14.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.678 1.191 . . . . 3.3399999999999999 109.588 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -43.04 -41.46 3.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.202 1.401 . . . . 4.0099999999999998 113.283 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.34 -37.66 74.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.804 2.842 . . . . 6.5199999999999996 113.365 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.12 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.16 0.984 . . . . 2.3700000000000001 111.218 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.0 -46.44 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 118.968 -0.539 . . . . 2.4300000000000002 110.49 167.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.67 69.38 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.559 1.072 . . . . 2.6099999999999999 112.579 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.416 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 4.4 t30 -63.75 -51.54 64.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.389 0.995 . . . . 5.5700000000000003 112.184 172.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -60.82 -41.46 95.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.586 1.555 . . . . 4.5499999999999998 112.117 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.5 t -61.26 -46.63 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.318 1.047 . . . . 2.2599999999999998 111.368 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 5.9 ttpp -58.48 -35.23 71.86 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.957 0.903 . . . . 5.9100000000000001 112.827 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -64.11 -19.67 65.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.343 1.057 . . . . 4.5899999999999999 113.075 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -91.84 -64.19 1.15 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.381 1.072 . . . . 3.8500000000000001 112.959 171.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t 174.02 145.2 0.2 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 126.271 1.828 . . . . 3.02 109.692 -168.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.55 -5.38 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.382 2.721 . . . . 2.0800000000000001 113.92 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -77.74 -8.72 58.37 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.638 1.108 . . . . 2.7000000000000002 113.635 169.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.46 143.87 33.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.508 1.049 . . . . 5.0300000000000002 112.191 173.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.97 133.75 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.337 1.455 . . . . 2.96 108.999 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -112.71 128.51 8.49 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.995 -0.842 . . . . 1.0800000000000001 110.995 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.7 mp -123.83 144.92 49.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.211 1.004 . . . . 3.1000000000000001 110.88 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.3 t -161.02 -161.0 0.78 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.289 2.236 . . . . 3.21 108.201 -170.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 159.54 -114.64 0.62 Allowed Glycine 0 N--CA 1.465 0.628 0 C-N-CA 124.779 1.181 . . . . 2.71 110.898 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.3 p -137.28 174.16 10.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.263 1.425 . . . . 5.0999999999999996 109.852 165.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -23.56 63.63 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.596 0.962 . . . . 8.7699999999999996 113.596 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -68.24 -41.08 81.71 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.455 1.502 . . . . 3.4199999999999999 111.287 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.434 ' CD ' HH12 ' A' ' 149' ' ' ARG . 45.1 mt-10 -69.03 -37.82 78.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.117 0.871 . . . . 4.6600000000000001 110.897 170.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -27.61 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 117.774 -1.108 . . . . 3.9900000000000002 113.36 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.06 -41.62 92.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.839 1.199 . . . . 5.0300000000000002 110.308 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -60.29 -54.47 45.37 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 3.8799999999999999 111.75 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.18 -40.91 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.127 0.876 . . . . 2.73 111.771 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.9 73.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.97 0.508 . . . . 3.25 111.318 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.64 -34.55 69.87 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.061 1.744 . . . . 6.8700000000000001 112.963 -177.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.08 -58.5 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.457 1.103 . . . . 3.02 111.792 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.77 0.67 22.8 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.475 0.917 . . . . 3.54 113.475 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.0 ttt85 45.06 38.94 3.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.752 2.821 . . . . 8.4100000000000001 113.696 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.8 m -78.81 133.64 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.529 0.732 . . . . 4.3799999999999999 110.278 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.79 148.57 25.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.733 0.813 . . . . 6.1299999999999999 111.235 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -172.05 163.03 5.99 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.645 1.978 . . . . 4.5300000000000002 110.675 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.4 t -160.6 135.58 5.59 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-O 117.902 -1.047 . . . . 4.9299999999999997 111.204 172.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.02 156.38 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.162 1.908 . . . . 3.9199999999999999 110.665 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.588 0 C-N-CA 124.384 0.992 . . . . 2.3999999999999999 113.609 177.859 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.0 p90 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 122.178 0.99 . . . . 5.1500000000000004 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 82.1 mt -57.85 145.03 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.067 -1.021 . . . . 4.4900000000000002 109.483 158.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.94 158.78 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 4.2199999999999998 110.481 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -101.39 141.06 34.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.911 1.684 . . . . 4.3200000000000003 110.115 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.45 149.61 17.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.104 1.52 . . . . 2.6400000000000001 115.104 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -51.97 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.752 2.021 . . . . 4.7699999999999996 111.859 172.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.55 52.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.276 1.431 . . . . 6.7800000000000002 112.24 168.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mt -136.06 128.18 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.254 1.422 . . . . 3.5800000000000001 107.914 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 60.5 mtp -99.07 159.55 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.114 1.766 . . . . 3.1899999999999999 110.252 174.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -135.75 146.28 47.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.908 1.077 . . . . 3.8900000000000001 113.908 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.3 tp -104.59 130.06 52.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.977 1.311 . . . . 3.5099999999999998 110.059 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.3 mt -111.13 142.21 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 106.997 -1.482 . . . . 5.25 106.997 150.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -114.08 -171.75 17.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.627 0.632 . . . . 2.25 113.817 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.53 70.86 6.69 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.305 3.337 . . . . 2.6099999999999999 108.623 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -167.72 -62.21 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.001 1.72 . . . . 4.2000000000000002 110.025 -169.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.02 -112.19 0.83 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.603 -0.726 . . . . 2.6000000000000001 113.633 -162.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.54 123.11 28.89 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.512 0.931 . . . . 4.1900000000000004 113.512 -149.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.5 t80 35.43 63.42 0.53 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.646 1.978 . . . . 4.9500000000000002 114.393 156.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.0 tp -86.64 -4.02 59.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.423 0.897 . . . . 4.3300000000000001 113.423 -166.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.85 150.11 4.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.911 2.085 . . . . 2.6600000000000001 110.167 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -126.48 123.85 38.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.452 1.12 . . . . 4.7199999999999998 111.078 161.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.63 86.81 3.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.134 1.374 . . . . 4.9800000000000004 107.546 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.59 161.77 48.37 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.829 -1.309 . . . . 4.0800000000000001 109.829 164.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -50.2 -16.03 0.28 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.554 1.687 . . . . 3.8700000000000001 115.554 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -19.78 61.5 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 120.5 -1.375 . . . . 5.8099999999999996 114.346 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -93.49 123.1 36.57 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.437 -1.415 . . . . 6.1699999999999999 109.075 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -169.91 1.92 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.2 1.0 . . . . 6.3300000000000001 108.789 167.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -30.85 -60.24 0.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.836 1.654 . . . . 4.0300000000000002 113.527 170.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.04 84.07 Favored Glycine 0 N--CA 1.472 1.066 0 O-C-N 121.307 -0.871 . . . . 2.77 112.798 -166.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -76.38 -31.87 58.25 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.598 1.559 . . . . 3.1299999999999999 111.562 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.32 -56.94 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.138 -0.689 . . . . 2.3199999999999998 109.138 165.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.48 -43.35 88.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.624 0.972 . . . . 2.4700000000000002 113.624 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.11 77.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.331 0.652 . . . . 2.98 112.469 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 16.4 p -66.84 -48.03 70.16 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.052 1.13 . . . . 1.95 114.052 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.13 -33.07 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.075 1.761 . . . . 2.5899999999999999 112.168 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.0 71.84 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.906 0.776 . . . . 2.5499999999999998 112.834 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 84.1 m -68.27 -41.84 80.46 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.634 0.652 . . . . 2.9100000000000001 110.513 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -65.84 -27.1 67.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.544 1.137 . . . . 3.0899999999999999 113.753 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.3 mmt -70.59 -10.78 60.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.577 0.955 . . . . 7.2000000000000002 113.577 170.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.64 -50.41 1.27 Allowed Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 116.69 -1.624 . . . . 6.7000000000000002 114.582 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.93 -37.12 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.41 2.073 . . . . 1.96 111.935 173.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.13 148.02 26.27 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.272 1.034 . . . . 3.79 112.256 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 126.563 1.945 . . . . 12.77 116.107 161.413 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.238 0 N-CA-C 110.028 -1.229 . . . . 4.3300000000000001 110.028 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.89 129.16 6.13 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.558 2.172 . . . . 4.5899999999999999 111.366 -170.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.46 162.65 33.95 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.579 1.952 . . . . 4.4900000000000002 110.554 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.3 p -144.96 57.38 1.27 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.029 -1.045 . . . . 3.6499999999999999 111.249 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.74 160.4 14.5 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.714 1.206 . . . . 3.3799999999999999 113.935 -166.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -87.23 135.54 33.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.244 1.418 . . . . 2.4199999999999999 111.205 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.7 p -97.03 162.95 13.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 122.82 1.295 . . . . 3.6600000000000001 112.89 176.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -63.31 -20.43 65.47 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.265 1.426 . . . . 1.9099999999999999 114.546 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.0 t -88.36 -4.79 58.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.815 1.246 . . . . 4.5899999999999999 113.24 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.96 2.4 62.61 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 119.547 1.067 . . . . 2.25 115.525 171.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.33 154.9 17.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.789 1.235 . . . . 4.7000000000000002 109.637 170.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.22 112.54 24.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.259 1.824 . . . . 6.0800000000000001 109.593 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -78.79 165.78 23.18 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.301 -1.499 . . . . 4.9800000000000004 112.249 177.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.4 m -154.67 144.74 21.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.708 1.203 . . . . 4.46 108.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -48.73 -41.49 32.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.566 1.147 . . . . 4.2599999999999998 112.484 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.92 -2.45 27.06 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.516 1.673 . . . . 9.1500000000000004 115.516 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.402 ' CG ' ' HZ3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -89.44 -34.58 16.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 120.353 1.433 . . . . 4.3600000000000003 112.335 168.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -94.23 -29.9 14.86 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.382 1.253 . . . . 4.5899999999999999 114.382 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.79 124.72 23.72 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.656 1.571 . . . . 6.8399999999999999 109.198 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.87 -18.4 26.6 Favored Glycine 0 N--CA 1.477 1.397 0 C-N-CA 124.211 0.91 . . . . 4.1900000000000004 112.349 -160.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.17 167.84 9.63 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.018 2.527 . . . . 6.1699999999999999 108.08 167.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -82.09 99.99 9.52 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.575 -1.328 . . . . 2.23 110.45 163.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -96.37 140.38 31.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.409 0.623 . . . . 4.7999999999999998 110.096 167.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 tt -125.02 113.55 17.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.112 -1.81 . . . . 3.6000000000000001 106.112 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.17 136.97 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 4.5700000000000003 111.068 -170.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -123.19 129.61 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.861 1.665 . . . . 4.29 110.688 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -99.93 102.62 14.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.576 1.15 . . . . 4.21 112.795 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.91 163.63 13.77 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.895 1.236 . . . . 1.5600000000000001 114.756 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -124.34 116.66 22.96 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.966 0.906 . . . . 4.5099999999999998 110.723 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.1 m -58.89 129.31 41.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.709 -1.589 . . . . 4.3200000000000003 106.709 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 90.03 -1.16 0.28 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.124 2.17 . . . . 8.1899999999999995 113.791 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 158.17 85.8 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 119.925 1.239 . . . . 3.8199999999999998 110.103 157.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.51 -177.26 3.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.149 3.233 . . . . 3.3500000000000001 112.153 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.16 1.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.404 1.882 . . . . 5.21 115.876 -171.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.24 -38.17 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.987 1.715 . . . . 4.6200000000000001 110.727 172.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -60.49 9.87 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.603 1.161 . . . . 1.8300000000000001 111.603 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.57 -23.75 49.45 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.897 1.731 . . . . 1.46 113.943 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -51.62 -52.02 51.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.801 1.637 . . . . 3.6200000000000001 113.422 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -80.35 -25.78 39.03 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.874 -1.141 . . . . 4.2999999999999998 112.955 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.21 -44.9 71.14 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.212 1.005 . . . . 4.0199999999999996 110.936 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -48.1 -54.37 13.43 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.729 1.612 . . . . 5.21 110.912 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -66.64 -28.09 68.2 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.535 -1.353 . . . . 5.3700000000000001 113.009 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 46.9 ttp -65.85 -39.47 90.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 117.524 -1.227 . . . . 4.5499999999999998 111.429 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.33 -45.9 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 120.948 1.704 . . . . 2.7400000000000002 110.722 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.5 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.124 -0.941 . . . . 4.9299999999999997 112.387 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.88 -29.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.945 1.702 . . . . 3.0600000000000001 110.731 168.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.77 -46.49 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.721 0.808 . . . . 2.9399999999999999 109.532 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.66 -43.82 80.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.115 2.566 . . . . 4.1100000000000003 113.14 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.21 -42.26 96.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.221 1.809 . . . . 3.23 112.041 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.3 mt -68.62 -40.7 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.158 0.983 . . . . 3.0899999999999999 112.121 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -61.42 -31.44 71.37 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.828 1.251 . . . . 3.7799999999999998 111.226 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.6 m -72.12 -21.64 61.44 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.49 -0.756 . . . . 3.9199999999999999 112.874 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.52 63.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.349 -1.469 . . . . 4.2999999999999998 108.131 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 75.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.659 1.984 . . . . 6.5199999999999996 113.021 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.6 m 174.43 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.856 3.663 . . . . 4.5800000000000001 111.239 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.28 154.18 54.13 Favored Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 121.613 2.006 . . . . 4.0700000000000003 111.434 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.52 -55.13 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.719 2.279 . . . . 3.4399999999999999 110.242 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -178.73 170.94 1.53 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 129.991 3.316 . . . . 3.9500000000000002 108.099 168.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.3 tt -118.96 115.28 24.03 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.067 -1.827 . . . . 4.0499999999999998 106.067 150.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.3 m -95.65 108.16 38.21 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 118.041 -0.98 . . . . 2.54 109.226 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.38 122.75 2.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.212 2.608 . . . . 1.3200000000000001 111.171 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.0 tp -118.5 100.14 7.27 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.303 1.041 . . . . 3.3599999999999999 110.469 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -84.65 120.92 26.94 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.651 -0.5 . . . . 3.29 109.651 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.9 mt -102.28 103.84 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.413 1.485 . . . . 3.8399999999999999 107.161 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.8 t -97.59 132.85 42.87 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.648 -0.658 . . . . 3.2999999999999998 111.125 170.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.2 pt -102.89 13.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.1 1.76 . . . . 2.6800000000000002 114.665 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.23 32.39 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 116.098 1.888 . . . . 3.7200000000000002 116.098 -173.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -7.83 21.9 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 123.417 2.256 . . . . 2.6000000000000001 114.247 -171.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -85.68 41.39 0.9 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.264 1.025 . . . . 4.46 110.8 167.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 16.1 ttm105 -178.94 -58.25 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 131.128 3.771 . . . . 5.4299999999999997 109.107 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.75 171.31 15.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.946 1.299 . . . . 4.3099999999999996 111.455 -175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.1 t -149.3 153.13 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.148 -0.97 . . . . 3.6699999999999999 112.305 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -41.87 50.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.818 1.647 . . . . 3.9399999999999999 111.951 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -67.94 -36.44 80.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.547 1.539 . . . . 3.8100000000000001 112.535 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.63 -44.5 64.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.52 1.055 . . . . 2.0099999999999998 111.081 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.58 -43.06 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.353 1.061 . . . . 2.6899999999999999 111.717 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.34 80.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.232 1.013 . . . . 2.0099999999999998 113.115 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -70.96 -42.68 69.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.496 0.718 . . . . 5.0300000000000002 111.742 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -62.65 -41.03 98.84 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.913 0.885 . . . . 4.0499999999999998 111.596 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.38 -51.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.449 1.9 . . . . 2.3700000000000001 112.327 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -56.77 -34.42 67.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.283 1.033 . . . . 5.6600000000000001 113.372 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 221' ' ' SER . 40.9 mm-40 -67.96 -48.01 67.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.945 0.339 . . . . 5.0499999999999998 110.547 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -72.86 21.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 3.9900000000000002 114.389 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 219' ' ' GLU . 52.3 p 106.43 147.42 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.656 1 C-N-CA 131.792 4.037 . . . . 3.1899999999999999 112.504 178.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.16 -1.82 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.078 2.519 . . . . 1.8400000000000001 113.329 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -90.29 -7.85 52.39 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.287 0.949 . . . . 3.5099999999999998 112.793 171.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 136.36 46.72 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.523 -1.361 . . . . 3.8700000000000001 111.565 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.21 121.48 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.543 0.737 . . . . 3.1800000000000002 109.263 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.55 125.05 8.16 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.542 -1.423 . . . . 1.0600000000000001 109.542 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.62 130.15 41.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.977 1.711 . . . . 5.2400000000000002 108.817 -173.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -163.71 -163.05 0.76 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.511 1.924 . . . . 4.6600000000000001 109.849 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.51 -149.01 6.88 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.448 1.023 . . . . 1.6399999999999999 112.015 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -74.08 166.16 23.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.842 0.821 . . . . 3.3900000000000001 110.488 159.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -47.8 -38.19 15.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.602 1.161 . . . . 6.9400000000000004 113.069 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -70.85 -29.46 65.6 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.153 1.381 . . . . 3.48 111.743 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.03 -36.21 61.9 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 3.5099999999999998 111.72 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.52 -35.78 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 118.836 -0.602 . . . . 2.98 111.189 170.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.55 -48.07 70.82 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.682 -1.628 . . . . 2.5699999999999998 110.095 165.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -46.94 -57.78 4.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 121.555 1.979 . . . . 2.8900000000000001 111.438 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.67 -39.33 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.304 0.956 . . . . 3.2400000000000002 112.77 -173.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -35.5 72.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.965 0.802 . . . . 2.4300000000000002 112.585 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -74.28 -40.01 62.59 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.886 2.074 . . . . 3.6899999999999999 111.575 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.49 81.49 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 2.2200000000000002 112.648 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.35 -6.74 59.23 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.478 0.711 . . . . 4.2199999999999998 112.897 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.73 39.17 29.92 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.827 2.051 . . . . 7.1500000000000004 112.708 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.2 -39.75 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.079 -1.013 . . . . 3.9700000000000002 111.918 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 29.4 t80 64.47 130.6 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.198 1.799 . . . . 5.7400000000000002 112.77 -165.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -116.2 152.57 33.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.002 0.921 . . . . 4.3200000000000003 110.653 164.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.0 t -106.92 107.0 59.75 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.479 -0.772 . . . . 3.21 110.457 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.86 131.35 16.89 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.364 2.043 . . . . 3.1499999999999999 109.993 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.515 0 C-N-CA 124.489 1.042 . . . . 2.2999999999999998 114.819 -175.437 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 37.6 p90 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.816 0.341 . . . . 4.4199999999999999 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.5 mm -121.08 148.93 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.575 1.55 . . . . 5.0499999999999998 108.741 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.45 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 106.402 -1.703 . . . . 4.1699999999999999 106.402 162.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -104.1 163.85 12.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.188 1.795 . . . . 3.5800000000000001 111.569 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 158.82 33.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.534 1.133 . . . . 2.9100000000000001 113.022 -158.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 49.3 p -59.19 -16.5 20.84 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.836 1.421 . . . . 3.9500000000000002 114.836 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.407 HG12 ' H ' ' A' ' 263' ' ' ILE 0.347 10.6 tt 43.54 -143.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.819 1.248 . . . . 4.8799999999999999 109.404 -147.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 262' ' ' ILE . 73.8 mt 76.18 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.285 1.834 . . . . 4.4699999999999998 110.992 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -118.78 149.66 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.625 -1.17 . . . . 4.2800000000000002 110.443 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.41 144.38 45.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.966 0.906 . . . . 5.1200000000000001 112.749 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.1 tp -97.41 128.4 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.709 1.203 . . . . 3.0499999999999998 108.52 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.31 142.24 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.207 -1.775 . . . . 3.6600000000000001 106.207 161.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -132.64 -168.06 11.91 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.207 0.843 . . . . 2.5600000000000001 115.207 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.63 58.84 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.652 1 C-N-CA 125.442 4.095 . . . . 4.8799999999999999 110.801 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -154.39 -55.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.109 1.364 . . . . 7.1200000000000001 108.292 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.07 138.36 4.47 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.09 1.328 . . . . 5.4400000000000004 113.316 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 64.64 -168.61 0.21 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.388 1.475 . . . . 5.5599999999999996 112.697 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -74.13 99.44 3.37 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.79 -1.194 . . . . 6.5800000000000001 112.259 -173.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -24.55 27.9 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.758 1.623 . . . . 5.0499999999999998 112.231 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -165.46 175.14 9.3 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.05 1.74 . . . . 2.3300000000000001 110.326 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -153.29 166.49 32.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.817 1.647 . . . . 5.54 112.869 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -143.01 150.9 40.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.527 1.531 . . . . 3.8500000000000001 110.196 -173.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.28 166.8 15.42 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.711 -1.049 . . . . 3.8599999999999999 111.989 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -24.66 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 134.236 5.014 . . . . 4.2000000000000002 119.885 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.94 -41.18 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.829 2.452 . . . . 6.1399999999999997 110.21 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -76.56 113.05 13.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.335 0.97 . . . . 4.9500000000000002 109.844 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.8 ttm105 -66.65 167.09 11.67 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.861 -1.15 . . . . 6.1200000000000001 109.101 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -50.56 -44.84 56.73 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.25 -1.531 . . . . 2.9900000000000002 113.279 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -58.15 -39.68 92.61 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.553 -0.582 . . . . 2.0 112.302 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.53 -28.55 46.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.007 1.114 . . . . 4.4900000000000002 114.007 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.5 mt -58.46 -49.24 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.708 1.14 . . . . 3.27 109.002 168.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.02 91.9 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.391 0.886 . . . . 2.0299999999999998 113.391 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.85 -32.03 69.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.588 0.755 . . . . 2.0499999999999998 112.881 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -52.71 64.29 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.709 0.633 . . . . 2.21 112.709 168.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.35 -38.94 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.399 -1.438 . . . . 2.0600000000000001 111.255 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.09 -8.77 25.6 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.079 1.352 . . . . 2.3100000000000001 114.194 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 92.9 m -92.19 -48.92 6.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.053 1.341 . . . . 2.1899999999999999 110.318 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -69.13 -23.34 63.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.681 0.993 . . . . 2.7400000000000002 113.681 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 27.3 ttt -55.93 -26.42 47.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.163 1.785 . . . . 5.1699999999999999 113.866 164.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -69.59 -46.8 26.14 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.247 -1.835 . . . . 7.5800000000000001 112.464 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -59.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.22 1.946 . . . . 1.9099999999999999 110.927 167.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -96.07 125.42 40.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.7 1.0 . . . . 4.4400000000000004 113.7 -166.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.777 1.631 . . . . 9.7200000000000006 111.964 -173.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.241 0 CA-C-O 118.199 -1.334 . . . . 3.3399999999999999 110.267 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.72 138.25 6.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.399 2.099 . . . . 3.4500000000000002 112.467 -163.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -162.22 165.72 26.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.447 1.899 . . . . 4.2699999999999996 110.846 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.7 p -137.01 92.75 2.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.351 -0.843 . . . . 4.0800000000000001 110.543 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mt -104.24 139.95 38.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.153 1.381 . . . . 3.6400000000000001 111.632 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 84.8 m -67.97 135.45 52.38 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.997 0.904 . . . . 3.52 110.503 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 157.96 18.16 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.859 -1.151 . . . . 3.48 110.459 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 2.9 0.89 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.413 1.085 . . . . 2.73 113.502 165.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 m -89.96 -45.14 9.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.138 1.375 . . . . 3.7000000000000002 110.8 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.31 38.47 1.11 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.987 1.279 . . . . 2.3399999999999999 113.473 -168.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.87 174.82 10.05 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.905 2.082 . . . . 4.8799999999999999 107.588 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -125.86 106.63 9.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 121.258 1.844 . . . . 7.7999999999999998 112.551 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -99.34 153.91 18.6 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.204 1.187 . . . . 4.5300000000000002 114.204 -171.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.0 p -123.03 148.2 45.82 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.345 2.658 . . . . 3.3399999999999999 108.626 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -46.65 -51.75 15.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.507 1.123 . . . . 3.54 113.622 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -71.95 6.17 2.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.653 2.094 . . . . 7.8399999999999999 116.653 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.11 -55.09 8.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.407 1.003 . . . . 3.7799999999999998 110.76 162.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.5 -31.44 26.47 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.832 1.049 . . . . 3.98 113.832 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.04 118.73 5.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.328 1.051 . . . . 5.04 111.079 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 123.62 -27.38 5.74 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 124.114 0.864 . . . . 2.6499999999999999 111.299 -167.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -84.21 166.87 17.19 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.352 -0.981 . . . . 3.8599999999999999 108.352 143.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -78.54 110.17 13.39 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.728 -0.607 . . . . 2.3300000000000001 112.451 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.4 mt -91.45 140.62 29.58 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.156 0.979 . . . . 3.7799999999999998 112.916 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -137.43 121.66 18.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.679 1.992 . . . . 3.73 107.408 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.0 mt -126.09 131.87 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.53 0.732 . . . . 2.6699999999999999 110.718 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -147.53 153.54 39.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.379 1.472 . . . . 3.8599999999999999 113.068 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.44 123.06 42.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.518 1.527 . . . . 3.9700000000000002 110.514 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.82 -176.95 36.23 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.21 0.844 . . . . 1.4099999999999999 115.21 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -156.47 139.21 15.14 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.123 0.962 . . . . 5.2400000000000002 112.946 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 t -82.2 74.5 9.17 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.424 1.011 . . . . 5.4000000000000004 110.36 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 169.79 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 129.568 3.147 . . . . 8.2899999999999991 110.538 -163.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.7 t -51.11 151.85 4.44 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.911 1.284 . . . . 2.4199999999999999 113.844 159.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.38 64.18 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.314 3.343 . . . . 4.1900000000000004 111.009 165.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.3 t0 69.59 -14.59 0.33 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.763 3.225 . . . . 4.9000000000000004 114.821 162.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.37 -34.36 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 120.584 -1.323 . . . . 4.3700000000000001 111.395 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.7 m -59.28 -54.34 57.18 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.317 -1.325 . . . . 2.3199999999999998 114.415 167.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -67.36 -26.71 41.04 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.011 1.807 . . . . 1.97 114.154 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -66.38 -42.98 87.15 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.909 1.686 . . . . 3.5299999999999998 110.814 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.73 -36.92 80.07 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.378 -0.826 . . . . 4.0700000000000003 111.474 168.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.56 -40.8 76.58 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.264 1.026 . . . . 3.46 112.694 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -57.76 11.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.148 1.379 . . . . 3.21 108.433 170.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -54.2 -37.51 64.63 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 120.174 -1.579 . . . . 4.5099999999999998 113.74 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.9 ptp -68.73 -41.82 78.47 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 117.058 -1.448 . . . . 3.3300000000000001 112.408 169.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.38 -44.66 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 121.212 1.824 . . . . 2.75 109.807 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -62.95 -29.71 71.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.214 -1.374 . . . . 3.8799999999999999 113.558 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 p -86.95 -32.41 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.688 1.131 . . . . 3.48 113.394 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.03 -46.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 120.707 1.594 . . . . 3.27 110.78 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -31.54 68.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.571 1.148 . . . . 4.6500000000000004 113.41 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -78.2 -13.63 59.78 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.174 -0.954 . . . . 2.98 113.328 174.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.6 mm -85.35 -55.29 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.635 1.574 . . . . 2.8500000000000001 109.921 167.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -50.69 -39.3 50.88 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.406 1.482 . . . . 3.9199999999999999 113.092 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -60.3 -29.41 68.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.316 1.046 . . . . 3.77 112.483 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.88 56.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 120.607 -1.308 . . . . 4.0800000000000001 107.612 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -36.58 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 130.001 3.32 . . . . 4.9500000000000002 118.775 -168.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -27.66 63.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.816 1.189 . . . . 5.3300000000000001 111.536 172.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.84 163.01 69.72 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.127 1.771 . . . . 4.2400000000000002 112.527 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -99.15 -172.35 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.924 3.083 . . . . 3.8399999999999999 113.67 -166.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.48 62.73 4.68 Favored 'General case' 0 CA--C 1.549 0.942 1 C-N-CA 132.304 4.241 . . . . 5.54 116.667 -156.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.2 tp -59.76 96.94 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.67 -1.268 . . . . 2.79 112.809 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.3 m -96.35 117.86 65.84 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 125.567 1.547 . . . . 2.0800000000000001 110.084 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -87.44 124.91 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.968 2.446 . . . . 0.98999999999999999 111.926 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.79 102.55 9.2 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.989 2.116 . . . . 3.29 109.598 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -99.83 133.98 43.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.154 1.381 . . . . 3.9100000000000001 111.618 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.82 126.19 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.556 0.742 . . . . 2.6400000000000001 108.998 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 62.2 p -90.59 111.7 23.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.08 1.352 . . . . 2.8799999999999999 110.733 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.3 pt -106.38 10.81 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 115.034 1.494 . . . . 2.77 115.034 -162.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.444 ' CG ' ' HE ' ' A' ' 207' ' ' ARG . 46.2 t0 -115.63 52.41 0.83 Allowed Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.595 1.158 . . . . 3.2999999999999998 111.405 169.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.2 132.37 25.81 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.635 2.223 . . . . 2.5800000000000001 109.188 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 128.19 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 130.334 3.454 . . . . 5.3499999999999996 107.384 -163.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.444 ' HE ' ' CG ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -123.01 -38.24 2.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.51 -0.757 . . . . 6.1399999999999997 112.617 166.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.61 101.54 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.411 1.005 . . . . 4.5599999999999996 108.672 160.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 48.0 m -115.82 149.37 38.68 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.372 1.469 . . . . 3.04 109.368 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -54.9 1.33 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.674 1.19 . . . . 4.1900000000000004 112.148 170.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -69.03 -37.41 78.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.854 1.262 . . . . 3.1899999999999999 112.94 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.71 -39.86 76.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.479 0.712 . . . . 2.4500000000000002 111.793 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.07 -34.62 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.539 0.736 . . . . 2.6400000000000001 110.556 175.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.0 75.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 118.693 -0.67 . . . . 2.0899999999999999 111.889 170.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.6 -47.44 60.14 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.343 0.974 . . . . 5.3600000000000003 112.281 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -53.42 -40.98 65.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.675 1.19 . . . . 5.25 111.485 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.4 t -64.64 -50.68 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.762 1.225 . . . . 2.3700000000000001 112.017 170.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -57.28 -27.56 62.22 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.735 1.214 . . . . 6.1399999999999997 113.754 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.36 -56.75 4.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.078 1.751 . . . . 3.7000000000000002 111.656 174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -79.3 -38.44 35.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.328 1.233 . . . . 4.6900000000000004 114.328 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 m 167.71 129.72 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 127.13 2.172 . . . . 2.4900000000000002 112.806 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.77 -0.26 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.375 2.717 . . . . 2.0 113.516 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.68 -26.37 68.62 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.277 0.944 . . . . 5.1200000000000001 113.418 162.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.18 133.42 35.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.164 0.893 . . . . 3.1800000000000002 112.788 -165.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.82 122.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.876 1.27 . . . . 2.7999999999999998 107.768 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.11 132.35 10.9 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.181 -1.168 . . . . 0.87 110.181 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.14 143.62 48.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 3.4900000000000002 109.607 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.3 m -143.08 176.27 9.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 128.813 2.845 . . . . 3.23 106.676 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 168.11 -179.85 41.04 Favored Glycine 0 N--CA 1.472 1.056 0 O-C-N 120.436 -1.415 . . . . 1.9099999999999999 114.364 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.0 t -75.42 163.47 27.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.264 0.625 . . . . 2.8799999999999999 111.053 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.401 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -49.55 -21.42 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.419 2.288 . . . . 8.4000000000000004 115.684 176.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -66.9 -51.46 55.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.137 1.375 . . . . 2.96 111.175 166.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -68.55 -43.86 75.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.242 1.017 . . . . 4.4699999999999998 111.354 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.1 m -74.55 -19.94 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 114.186 1.18 . . . . 4.0099999999999998 114.186 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.83 -57.54 4.52 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.807 1.185 . . . . 2.8399999999999999 108.602 161.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.15 -55.41 10.42 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.223 1.409 . . . . 3.6000000000000001 112.29 -173.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.37 -40.78 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 118.923 0.783 . . . . 3.2000000000000002 112.94 -171.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.17 75.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.611 0.764 . . . . 2.3500000000000001 110.436 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -70.6 -34.23 71.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 4.3300000000000001 112.678 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.16 -58.0 5.14 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.384 1.474 . . . . 3.0099999999999998 112.579 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -1.87 13.99 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.631 0.974 . . . . 3.4500000000000002 113.631 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.02 32.17 6.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.29 2.236 . . . . 6.75 113.013 165.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.56 155.66 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.664 1.185 . . . . 4.2699999999999996 110.149 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -74.14 137.87 43.49 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.276 0.56 . . . . 5.6299999999999999 112.041 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -164.83 141.7 6.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.58 2.752 . . . . 6.1699999999999999 109.481 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 129.83 2.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 117.936 -1.031 . . . . 6.0999999999999996 112.586 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -69.19 141.66 48.18 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.407 2.738 . . . . 5.0999999999999996 110.689 171.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.427 0 C-N-CA 124.068 0.842 . . . . 4.3200000000000003 114.471 -172.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.2 t80 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 109.323 -0.621 . . . . 4.3099999999999996 109.323 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.91 146.14 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 122.032 0.92 . . . . 5.2199999999999998 110.464 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.32 128.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.132 2.173 . . . . 4.6900000000000004 105.556 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -105.19 152.05 23.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.637 0.732 . . . . 3.8900000000000001 111.713 -170.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -165.18 152.46 10.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.548 1.166 . . . . 3.02 114.024 -169.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 99.2 m -59.21 120.42 9.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.182 -1.372 . . . . 4.46 108.698 164.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.29 135.73 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.023 -1.473 . . . . 4.4500000000000002 107.023 146.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.2 mt 135.65 127.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.108 1 C-N-CA 131.964 4.106 . . . . 4.0199999999999996 109.454 176.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -100.6 150.79 22.34 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.682 1.993 . . . . 3.6099999999999999 110.756 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -118.22 132.13 56.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.014 1.326 . . . . 4.8399999999999999 112.196 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 8.8 tt -90.69 125.88 35.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.181 0.991 . . . . 3.2000000000000002 111.091 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 143.82 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 127.629 2.372 . . . . 2.5099999999999998 108.684 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.32 149.11 49.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.541 -1.144 . . . . 2.5299999999999998 111.209 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.77 63.8 6.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.122 3.215 . . . . 2.8799999999999999 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 153.72 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 131.36 3.864 . . . . 8.25 113.91 173.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 168.92 149.9 6.43 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 120.455 1.48 . . . . 3.3199999999999998 116.023 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . 0.283 60.7 mt-10 41.33 -145.32 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.549 2.74 . . . . 4.1799999999999997 113.87 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -148.54 155.49 41.2 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.044 1.293 . . . . 5.1500000000000004 113.869 -163.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.84 -37.53 4.82 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.261 1.424 . . . . 3.5800000000000001 111.912 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -145.32 170.85 15.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.43 1.092 . . . . 4.1900000000000004 112.735 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -158.86 133.32 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.808 1.243 . . . . 4.7199999999999998 111.519 160.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -178.1 -122.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.179 2.192 . . . . 4.9400000000000004 111.118 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 95.79 -94.48 1.69 Allowed Glycine 0 N--CA 1.469 0.862 0 N-CA-C 109.479 -1.448 . . . . 4.5899999999999999 109.479 -168.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.08 139.39 41.62 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 117.646 0.723 . . . . 3.4700000000000002 111.104 168.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 80.82 -1.6 1.83 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.895 2.478 . . . . 6.5899999999999999 113.311 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 121.21 36.1 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.032 1.733 . . . . 7.1200000000000001 110.134 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -72.04 141.84 49.28 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.774 -1.204 . . . . 8.0600000000000005 108.31 166.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -41.07 31.54 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.117 1.895 . . . . 2.7000000000000002 116.117 -160.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.25 -18.77 71.64 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 119.787 1.176 . . . . 1.4299999999999999 114.833 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.75 -33.89 76.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.899 -0.766 . . . . 2.9500000000000002 110.777 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.6 -46.84 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.952 0.901 . . . . 2.6200000000000001 109.101 172.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.97 72.39 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.685 1.129 . . . . 2.1600000000000001 112.409 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.27 70.57 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.821 1.045 . . . . 2.52 113.821 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 5.7 p -87.43 -41.6 13.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.653 0.612 . . . . 2.7200000000000002 112.653 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mt -52.03 -38.8 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.418 1.087 . . . . 2.2200000000000002 111.01 169.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -51.73 -31.5 26.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.911 1.078 . . . . 3.0600000000000001 113.911 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 19.6 p -75.26 -32.72 61.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.073 0.949 . . . . 3.75 112.036 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -72.42 -32.01 65.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.19 0.996 . . . . 3.4900000000000002 112.372 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.19 -32.77 70.86 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.522 1.129 . . . . 7.5800000000000001 112.299 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -49.94 -51.32 62.28 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 116.307 -1.806 . . . . 6.2699999999999996 113.365 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.81 -44.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.218 2.612 . . . . 2.5899999999999999 113.367 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -92.4 123.1 35.47 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.888 1.222 . . . . 4.1699999999999999 114.146 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 127.258 2.223 . . . . 14.470000000000001 112.962 155.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 CA-C-O 118.963 -0.909 . . . . 4.21 113.585 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.78 156.61 39.58 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.206 2.604 . . . . 3.6499999999999999 113.804 -168.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -138.91 169.14 18.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.54 2.336 . . . . 4.04 109.199 174.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.9 m -138.53 69.47 1.38 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.727 -1.233 . . . . 3.7000000000000002 112.482 -176.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.22 172.65 7.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.441 1.097 . . . . 3.8599999999999999 112.333 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.0 m -103.42 158.52 16.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.501 1.52 . . . . 2.3999999999999999 109.525 173.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.3 m -107.94 159.79 16.27 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.939 1.296 . . . . 3.8799999999999999 111.612 -172.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -55.23 -9.74 0.47 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 115.793 1.775 . . . . 2.23 115.793 176.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 t -113.53 7.35 17.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.951 2.1 . . . . 4.21 113.622 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.49 -10.41 69.06 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.575 1.56 . . . . 2.02 115.842 173.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.99 148.71 25.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.772 1.229 . . . . 3.48 111.984 -177.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.63 115.14 28.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.56 1.544 . . . . 7.1600000000000001 111.249 -173.14 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 161.66 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.462 1.505 . . . . 4.79 112.742 -168.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.5 m -154.18 148.5 26.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.001 0.92 . . . . 3.7599999999999998 111.176 -152.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -36.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.041 2.136 . . . . 3.1600000000000001 112.569 165.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.82 3.19 2.72 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.712 1.375 . . . . 8.0299999999999994 114.712 -177.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.04 -24.43 11.59 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.335 1.854 . . . . 3.29 112.822 173.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -84.64 -15.93 43.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.865 1.061 . . . . 4.3399999999999999 113.865 165.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.03 154.43 9.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.207 1.403 . . . . 4.7000000000000002 112.929 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.19 -20.11 21.79 Favored Glycine 0 N--CA 1.478 1.495 0 C-N-CA 126.622 2.058 . . . . 2.8599999999999999 113.679 -174.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.01 173.68 6.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.277 1.831 . . . . 3.6299999999999999 108.412 165.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -67.76 110.87 3.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.226 -0.657 . . . . 2.0299999999999998 109.226 170.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.4 tp -99.16 120.66 39.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.185 0.993 . . . . 3.4300000000000002 109.207 -172.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -104.69 116.21 31.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.158 1.383 . . . . 4.7999999999999998 107.884 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.54 102.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.27 -1.011 . . . . 3.46 108.27 -178.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -100.21 148.91 24.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.024 1.73 . . . . 3.5499999999999998 111.429 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.16 117.26 29.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.094 . . . . 3.3900000000000001 110.743 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.97 153.64 23.4 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 115.777 1.071 . . . . 1.5 115.777 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.34 60.82 5.89 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.344 -1.092 . . . . 4.9100000000000001 112.561 -170.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.7 m 64.1 -20.55 0.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 128.174 2.59 . . . . 4.5700000000000003 115.551 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 176.83 -50.23 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 128.688 2.795 . . . . 11.48 110.101 -166.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.1 OUTLIER 61.0 177.8 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.881 1.272 . . . . 2.6499999999999999 112.7 -164.533 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 39.7 Cg_endo -88.92 -132.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.88 3.053 . . . . 3.77 107.341 159.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -80.56 61.98 4.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.717 1.207 . . . . 5.0599999999999996 112.403 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.75 -83.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.594 1.557 . . . . 4.7400000000000002 110.365 175.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.4 m -49.87 -48.31 78.17 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.739 1.755 . . . . 2.2599999999999998 115.739 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.77 -25.47 23.91 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.563 2.176 . . . . 1.52 113.732 -169.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.68 -52.93 63.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.973 1.709 . . . . 4.04 110.806 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.57 -26.05 61.57 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.848 -1.158 . . . . 2.8399999999999999 111.963 171.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -45.6 78.53 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.465 -1.397 . . . . 3.4399999999999999 111.849 -177.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.93 -41.01 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.227 1.376 . . . . 4.8799999999999999 111.033 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -60.68 -47.85 84.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.594 1.558 . . . . 4.2699999999999996 110.706 174.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.85 -57.13 13.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.351 1.46 . . . . 3.5800000000000001 111.428 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.26 -47.66 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.085 1.311 . . . . 3.5600000000000001 111.786 -172.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -63.13 -28.6 70.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.921 0.782 . . . . 3.1800000000000002 110.889 -173.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.34 -27.5 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 116.846 -1.55 . . . . 2.6600000000000001 113.304 -178.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.534 HG21 ' H ' ' A' ' 196' ' ' LEU . 3.4 p -67.43 -32.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 121.276 1.853 . . . . 4.0899999999999999 111.365 171.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -87.78 -15.25 37.45 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.794 0.838 . . . . 5.4900000000000002 112.95 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.6 -13.17 59.98 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.676 -1.265 . . . . 3.4700000000000002 113.004 164.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.59 -58.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.679 1.591 . . . . 3.0800000000000001 111.675 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -63.44 -38.64 91.92 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.31 1.414 . . . . 3.75 112.671 -176.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 7.9 t -67.79 -11.23 58.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.582 2.753 . . . . 3.6800000000000002 113.835 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.99 -25.86 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.391 -1.443 . . . . 4.7699999999999996 113.157 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t 174.29 -42.14 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.466 2.306 . . . . 5.9000000000000004 112.126 167.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.9 m 173.83 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 130.557 3.543 . . . . 6.3300000000000001 105.052 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.7 mp -103.05 173.65 3.34 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.291 0.636 . . . . 5.5700000000000003 111.345 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.44 154.46 21.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.567 2.178 . . . . 3.98 110.801 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.39 142.64 32.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.068 0.937 . . . . 3.6600000000000001 111.83 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.534 ' H ' HG21 ' A' ' 184' ' ' VAL . 48.3 tp -104.79 63.89 0.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.479 2.312 . . . . 2.77 108.188 175.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.1 m -57.66 115.46 10.99 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.142 -0.932 . . . . 2.6400000000000001 110.39 -166.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -86.92 116.06 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.729 2.286 . . . . 1.02 112.134 -173.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.43 117.44 34.1 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.693 1.597 . . . . 3.3900000000000001 109.518 178.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -97.99 114.27 26.36 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.269 1.028 . . . . 3.3599999999999999 110.124 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -83.21 122.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.256 -1.016 . . . . 2.9199999999999999 108.256 165.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.53 128.98 34.94 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.854 -0.738 . . . . 2.21 111.243 166.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 pt -104.66 28.81 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 125.285 1.434 . . . . 2.8999999999999999 113.261 178.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -122.8 47.44 1.57 Allowed Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 127.907 2.483 . . . . 3.4100000000000001 112.942 -176.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.67 82.6 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.19 1 C-N-CA 126.206 4.604 . . . . 2.7599999999999998 111.817 -172.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 175.38 -33.33 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.293 1.437 . . . . 3.98 114.406 -160.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -151.25 11.13 0.61 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.392 1.256 . . . . 6.2800000000000002 114.392 170.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -70.11 54.49 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 130.888 3.675 . . . . 5.04 112.284 172.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 98.7 m -60.3 137.89 58.05 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.297 1.839 . . . . 2.5899999999999999 110.464 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -43.35 -55.16 4.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.242 1.417 . . . . 4.75 112.984 -178.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -66.04 -33.53 76.01 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.119 1.768 . . . . 3.1299999999999999 114.096 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.52 -36.14 73.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.961 1.255 . . . . 2.23 111.596 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.82 -36.6 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.186 0.995 . . . . 2.7200000000000002 110.848 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.9 70.71 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.092 0.86 . . . . 2.1899999999999999 112.061 168.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -66.24 -47.29 74.26 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.334 -0.853 . . . . 5.4699999999999998 111.837 171.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -65.87 -32.56 74.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.933 0.716 . . . . 4.9900000000000002 112.933 178.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.54 -49.0 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.13 0.972 . . . . 2.3399999999999999 111.34 166.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.571 1.148 . . . . 5.3700000000000001 113.515 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -62.43 -33.35 74.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.43 1.092 . . . . 4.8499999999999996 112.164 177.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -98.73 -63.25 1.14 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.484 0.92 . . . . 3.9199999999999999 113.484 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.4 m 170.89 145.72 0.12 Allowed Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 126.717 2.007 . . . . 2.8300000000000001 112.197 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.94 4.71 2.99 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.545 3.497 . . . . 2.2400000000000002 114.556 -175.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -71.36 -23.72 61.96 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 119.687 1.13 . . . . 2.9100000000000001 111.494 163.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.1 tt -87.35 145.13 26.45 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.463 1.505 . . . . 3.2599999999999998 111.096 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.6 m -130.18 139.77 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.666 1.186 . . . . 3.6699999999999999 110.951 175.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.94 130.94 9.62 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.544 1.069 . . . . 0.90000000000000002 111.708 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.82 143.84 51.11 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.159 0.984 . . . . 3.4700000000000002 113.243 -173.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.8 p -147.37 169.39 19.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.078 2.151 . . . . 3.0699999999999998 112.16 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -179.02 -178.94 48.59 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.332 1.92 . . . . 1.8999999999999999 110.45 -176.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -63.96 163.02 12.85 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.532 1.166 . . . . 3.29 111.636 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.7 mtt-85 -47.58 -35.22 8.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.055 1.342 . . . . 6.7999999999999998 112.738 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 18.3 mp0 -72.05 -37.1 69.75 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.582 1.953 . . . . 2.9100000000000001 112.147 178.172 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -70.39 -42.66 71.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.711 -1.243 . . . . 3.48 111.345 176.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.4 t -63.36 -36.9 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.414 0.686 . . . . 2.5899999999999999 110.98 173.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.03 -44.51 84.45 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.757 -0.639 . . . . 3.0800000000000001 110.457 174.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -55.82 -50.94 69.16 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.232 0.924 . . . . 2.8199999999999998 111.787 176.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.26 -36.07 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.703 0.683 . . . . 3.25 112.216 -175.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.99 92.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.827 0.739 . . . . 2.2400000000000002 111.624 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.9 ttm105 -67.36 -38.78 85.35 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.927 1.291 . . . . 4.0999999999999996 112.255 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.57 70.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.371 0.987 . . . . 2.6800000000000002 112.076 178.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -88.63 12.58 14.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.199 1.4 . . . . 3.6400000000000001 113.893 176.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 46.19 37.86 4.39 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.008 2.123 . . . . 7.5199999999999996 115.28 -176.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.62 145.08 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.715 2.006 . . . . 4.54 112.577 -173.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -80.63 139.2 36.35 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.562 1.319 . . . . 4.2300000000000004 114.562 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -155.03 158.95 39.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.451 1.5 . . . . 4.5499999999999998 111.878 154.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 41.2 m -126.7 125.53 24.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.329 1.852 . . . . 4.4000000000000004 107.883 167.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.77 147.67 45.08 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.04 2.494 . . . . 4.1500000000000004 111.062 -178.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 N-CA-C 114.599 0.599 . . . . 2.9700000000000002 114.599 -167.91 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 33.4 t80 . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 121.154 0.502 . . . . 5.2800000000000002 112.047 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.86 108.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 120.414 -1.429 . . . . 5.2800000000000002 111.765 170.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.5 143.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.53 1.532 . . . . 3.9100000000000001 108.17 164.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.5 160.09 23.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.131 0.972 . . . . 3.4500000000000002 110.672 173.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.55 154.39 0.38 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.494 -1.379 . . . . 3.5800000000000001 112.959 -134.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -68.59 -30.72 69.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 117.285 2.328 . . . . 5.46 117.285 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.7 pt 39.4 34.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 126.556 1.942 . . . . 4.7800000000000002 116.045 -172.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 19.1 mt -113.9 144.26 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 3.2799999999999998 110.113 -177.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.7 143.04 31.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.481 0.712 . . . . 5.6500000000000004 111.289 156.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -97.87 132.79 43.15 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.723 0.809 . . . . 4.5700000000000003 111.096 162.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -93.14 93.63 8.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.759 1.224 . . . . 2.71 109.829 178.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.17 127.44 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.875 1.27 . . . . 2.4500000000000002 108.672 175.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.51 161.97 54.24 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 110.851 -0.899 . . . . 1.72 110.851 172.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -65.23 -8.83 19.77 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.376 2.051 . . . . 3.0299999999999998 113.794 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -107.23 29.74 6.85 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.097 1.759 . . . . 5.6100000000000003 112.093 170.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.16 -42.04 3.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.663 1.601 . . . . 2.5800000000000001 116.399 161.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -78.74 151.76 31.88 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.351 1.576 . . . . 5.6699999999999999 111.369 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -89.53 144.05 26.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.033 -1.042 . . . . 4.3600000000000003 113.738 -177.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -23.94 14.83 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.867 1.267 . . . . 3.6400000000000001 112.881 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -168.25 170.01 10.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.887 1.275 . . . . 2.3900000000000001 111.016 -167.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -153.56 140.1 18.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.847 0.859 . . . . 5.0199999999999996 112.432 175.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . 0.556 ' CE1' ' HE2' ' A' ' 281' ' ' LYS . 13.2 m-85 -137.06 130.3 31.11 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.653 -0.654 . . . . 4.4800000000000004 111.91 -169.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.12 91.83 0.08 OUTLIER Glycine 0 N--CA 1.471 0.985 0 N-CA-C 115.221 0.848 . . . . 4.1699999999999999 115.221 174.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 137.32 127.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 1 C-N-CA 132.823 4.449 . . . . 4.3099999999999996 107.073 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -40.51 98.91 0.01 OUTLIER 'General case' 0 C--O 1.237 0.409 0 O-C-N 124.763 1.289 . . . . 9.7699999999999996 113.752 -140.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.556 ' HE2' ' CE1' ' A' ' 277' ' ' PHE . 45.7 tttp -78.95 -18.22 54.15 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.442 -0.786 . . . . 5.0199999999999996 111.488 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.39 120.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.13 2.572 . . . . 6.7199999999999998 108.583 -177.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -26.05 -77.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.673 2.389 . . . . 3.7400000000000002 114.815 -176.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.53 -13.14 49.51 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 115.439 0.936 . . . . 2.2999999999999998 115.439 -175.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.74 -30.76 40.94 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.218 2.009 . . . . 3.4900000000000002 112.532 172.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 21.8 mt -60.03 -40.65 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.136 -0.977 . . . . 2.6400000000000001 108.859 165.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.12 -51.42 64.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.24 -0.41 . . . . 2.3399999999999999 111.88 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.87 78.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.226 1.195 . . . . 2.75 114.226 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.5 p -67.33 -50.11 61.38 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 2.6299999999999999 111.761 172.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.63 -38.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.742 1.156 . . . . 2.1600000000000001 112.491 174.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.4 -16.18 33.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.743 1.217 . . . . 2.1600000000000001 114.254 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.7 m -81.27 -47.86 12.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 2.1499999999999999 110.281 167.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -67.32 -27.64 67.32 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.24 1.016 . . . . 3.5899999999999999 113.641 -178.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 76.4 mtm -71.61 -23.41 61.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.378 -1.451 . . . . 5.7999999999999998 113.498 174.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.16 -35.25 11.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 116.29 -1.814 . . . . 4.6500000000000004 114.048 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.89 -41.39 1.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.912 2.076 . . . . 1.98 112.577 162.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.76 -157.19 0.11 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.837 1.791 . . . . 4.5 115.837 -169.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 N--CA 1.476 0.829 0 O-C-N 119.992 -1.693 . . . . 11.140000000000001 110.939 174.304 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.516 0 CA-C-O 119.919 -0.378 . . . . 3.4199999999999999 113.329 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.28 151.49 26.47 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.44 2.76 . . . . 3.6899999999999999 112.525 -167.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -81.52 155.79 25.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.881 0.872 . . . . 4.0899999999999999 110.143 166.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.5 t -142.41 101.52 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.686 -1.259 . . . . 3.3100000000000001 108.916 167.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.89 162.49 32.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.191 1.396 . . . . 3.3999999999999999 110.733 -170.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.9 m -84.27 133.53 34.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.465 0.706 . . . . 2.8900000000000001 109.58 172.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.2 t -98.2 162.76 13.03 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.593 1.557 . . . . 3.48 109.974 177.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -65.37 -9.42 24.74 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.192 1.553 . . . . 2.5699999999999998 115.192 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.7 p -73.44 -21.94 60.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.159 1.384 . . . . 3.7999999999999998 113.292 166.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.85 -9.54 63.95 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.626 1.584 . . . . 1.8 113.401 -170.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -65.91 148.64 51.48 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.677 1.238 . . . . 4.79 110.508 170.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.66 109.08 20.9 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.684 0.793 . . . . 7.1799999999999997 109.152 171.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.06 167.81 10.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.463 1.905 . . . . 4.54 113.742 -161.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -148.73 165.42 31.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.466 1.507 . . . . 3.7999999999999998 110.44 -178.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -47.28 -45.05 23.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.901 2.08 . . . . 3.8100000000000001 113.09 175.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -80.49 -4.49 54.06 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.165 1.172 . . . . 6.4100000000000001 114.165 -176.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.37 -47.47 7.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.768 1.627 . . . . 3.96 109.16 163.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -75.46 11.13 1.35 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.823 1.786 . . . . 4.3099999999999996 115.823 -176.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tp -78.67 -170.51 2.14 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.716 1.606 . . . . 4.7699999999999996 113.238 -172.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.3 -36.04 1.54 Allowed Glycine 0 N--CA 1.479 1.505 0 C-N-CA 125.681 1.61 . . . . 4.0199999999999996 114.463 176.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -76.86 -179.53 5.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.791 1.236 . . . . 4.2999999999999998 111.448 162.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -91.35 149.54 21.69 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.673 0.749 . . . . 2.2200000000000002 109.734 156.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.4 tp -136.89 140.28 42.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.519 0.728 . . . . 4.3399999999999999 111.111 -173.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.41 138.63 51.69 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.674 1.19 . . . . 3.8100000000000001 108.042 164.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.7 mt -123.65 131.89 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.473 1.109 . . . . 3.6600000000000001 108.525 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -134.37 138.85 45.2 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.002 1.321 . . . . 3.7400000000000002 111.834 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -102.54 117.97 35.84 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.498 1.119 . . . . 3.8900000000000001 111.22 175.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.77 -178.36 15.97 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.098 0.856 . . . . 1.21 114.289 173.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -136.12 119.58 16.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.136 0.975 . . . . 4.8300000000000001 110.847 -168.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 m -71.36 20.5 0.05 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.167 1.787 . . . . 3.1600000000000001 113.407 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -124.48 -16.33 6.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.203 1.801 . . . . 8.2200000000000006 111.351 168.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 38.4 t -63.53 136.91 96.92 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 119.531 1.059 . . . . 3.2599999999999998 112.349 -171.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.25 99.69 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.332 2.688 . . . . 3.3700000000000001 109.621 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 74.88 -35.8 0.3 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.141 2.576 . . . . 4.1299999999999999 114.777 155.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 72.4 t -54.55 -56.73 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.472 1.509 . . . . 3.27 110.836 176.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 33.4 m -53.85 -57.59 17.0 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.65 -1.166 . . . . 1.8200000000000001 113.316 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.74 -39.48 4.6 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.768 1.645 . . . . 1.8400000000000001 114.223 -175.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -41.02 70.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.235 1.38 . . . . 3.5299999999999998 111.888 -178.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -30.38 69.42 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.433 1.015 . . . . 2.98 111.28 176.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.8 tp -69.87 -35.31 74.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 3.7400000000000002 112.323 173.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -42.98 90.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.987 0.812 . . . . 3.7000000000000002 110.314 170.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -54.33 -35.62 62.89 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 119.995 -1.69 . . . . 3.75 112.012 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.3 ttp -70.17 -28.02 64.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.914 1.079 . . . . 3.73 113.914 171.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.95 -52.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.803 1.638 . . . . 2.6200000000000001 109.781 167.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -56.1 -27.0 52.01 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.201 1.001 . . . . 3.8399999999999999 112.022 -176.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 t -64.56 -29.99 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 117.402 -1.285 . . . . 2.7799999999999998 111.729 176.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.91 -44.55 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.679 2.036 . . . . 3.4300000000000002 111.892 -175.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.89 -43.73 98.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.761 1.624 . . . . 3.4900000000000002 111.631 174.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.18 -38.98 84.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.507 1.523 . . . . 3.9500000000000002 111.811 170.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 -49.38 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.801 1.64 . . . . 3.25 112.906 -177.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.68 -28.13 68.85 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.528 1.513 . . . . 5.6100000000000003 109.762 176.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.0 t -67.84 -13.47 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.793 1.405 . . . . 5.75 114.793 172.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.32 -26.55 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.608 1.549 . . . . 6.8799999999999999 111.04 169.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.305 60.9 p 119.65 50.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 1 C-N-CA 133.119 4.567 . . . . 8.4199999999999999 111.119 -175.469 . . . . . . . . 3 2 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.423 0.6 OUTLIER 79.16 67.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.658 1.983 . . . . 5.6299999999999999 114.67 146.52 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.04 166.82 0.37 Allowed Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 126.651 1.98 . . . . 5.4500000000000002 111.52 160.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.37 -55.43 0.37 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.183 1.815 . . . . 3.71 109.296 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -169.65 158.22 7.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.288 3.035 . . . . 4.6500000000000004 107.22 160.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.3 tp -112.77 106.91 15.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.945 1.298 . . . . 3.0 110.889 166.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -78.7 130.51 70.54 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.675 -0.678 . . . . 2.5899999999999999 110.411 170.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.52 114.91 1.02 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.451 2.768 . . . . 1.23 109.908 159.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.84 111.28 23.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.375 1.47 . . . . 4.2400000000000002 108.641 174.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -91.97 124.83 36.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 3.02 110.043 174.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.25 119.97 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.788 0.835 . . . . 2.4399999999999999 108.81 167.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -83.24 130.39 35.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.186 -0.461 . . . . 2.46 109.989 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -104.62 16.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.559 0.948 . . . . 2.71 113.559 171.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.11 14.57 0.04 OUTLIER Pre-proline 0 CA--C 1.573 1.841 0 C-N-CA 127.926 2.49 . . . . 3.3500000000000001 117.17 177.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -80.41 53.56 4.82 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 123.863 2.415 . . . . 3.3599999999999999 113.171 -177.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -83.91 -41.33 17.51 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.143 -0.688 . . . . 4.5800000000000001 109.143 141.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.76 0.53 4.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.088 1.355 . . . . 7.7400000000000002 114.181 -171.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -93.2 156.75 16.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.886 1.274 . . . . 4.3399999999999999 110.91 174.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -137.5 147.92 45.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 3.2000000000000002 111.02 -176.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.2 -34.31 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.157 -0.929 . . . . 3.6699999999999999 111.774 173.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -66.21 -44.1 84.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.593 1.957 . . . . 3.1699999999999999 112.522 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.05 78.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.469 1.032 . . . . 2.1400000000000001 111.193 174.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.94 -41.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.694 0.798 . . . . 2.8100000000000001 111.415 174.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.46 -15.81 30.35 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.933 1.086 . . . . 2.1499999999999999 113.933 176.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.59 -47.11 7.28 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.403 1.456 . . . . 4.9500000000000002 113.149 165.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.09 -37.73 47.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.93 1.692 . . . . 4.1500000000000004 111.565 175.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.0 t -43.56 -56.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.305 2.242 . . . . 2.71 112.792 167.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.14 -31.55 67.86 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.785 0.661 . . . . 4.7699999999999996 112.785 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -63.36 -23.86 67.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.35 1.06 . . . . 4.0300000000000002 111.643 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.95 -45.36 10.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.63 0.974 . . . . 4.4100000000000001 113.63 168.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.2 p -174.33 167.59 2.2 Favored Pre-proline 0 N--CA 1.476 0.851 0 O-C-N 120.497 -1.377 . . . . 3.5099999999999998 113.764 -168.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.59 2.54 8.27 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.485 2.79 . . . . 4.2300000000000004 113.959 165.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.43 -26.24 6.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.953 1.464 . . . . 2.7999999999999998 114.953 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.69 148.48 48.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.193 0.997 . . . . 3.2999999999999998 111.217 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.43 132.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.24 1.016 . . . . 3.5 109.738 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.0 110.4 2.76 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.085 0.85 . . . . 1.3200000000000001 111.606 -170.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp -108.99 144.88 36.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.5 1.12 . . . . 3.8300000000000001 111.949 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.01 178.51 10.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.761 1.624 . . . . 3.4399999999999999 108.892 -175.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.95 -140.64 3.39 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 108.498 -1.841 . . . . 1.8799999999999999 108.498 166.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 65.7 p -80.36 176.43 9.78 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.446 1.498 . . . . 3.6299999999999999 111.988 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.485 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -62.02 -21.68 65.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 118.346 -0.835 . . . . 9.1899999999999995 112.78 165.788 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.485 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 22.2 mp0 -71.19 -39.44 71.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.105 1.362 . . . . 2.9199999999999999 111.431 171.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -64.12 -42.95 96.64 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.051 -1.031 . . . . 3.8999999999999999 111.616 173.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.5 t -59.47 -43.66 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.818 0.699 . . . . 2.7400000000000002 110.769 173.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.25 -49.78 70.57 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.024 -0.988 . . . . 3.6600000000000001 108.725 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -47.12 -56.91 5.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.41 -0.805 . . . . 3.9100000000000001 111.242 174.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.9 m -76.87 -27.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.877 1.065 . . . . 3.6699999999999999 113.877 -168.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.83 -40.17 55.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.525 0.602 . . . . 2.1499999999999999 111.549 172.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -75.01 -33.71 61.84 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.62 1.968 . . . . 4.2300000000000004 111.801 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -49.58 -72.51 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.561 1.073 . . . . 2.3500000000000001 110.956 167.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -85.21 9.24 15.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.063 1.505 . . . . 4.5999999999999996 115.063 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.92 18.8 11.18 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.47 1.508 . . . . 9.0299999999999994 113.715 171.11 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 m -67.89 -15.09 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 117.435 2.383 . . . . 3.9900000000000002 117.435 -145.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.4 t80 60.83 131.54 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.086 2.555 . . . . 4.4000000000000004 116.898 -174.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -160.54 165.68 30.41 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.873 2.469 . . . . 4.1399999999999997 109.391 170.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.3 t -154.49 134.51 8.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 121.291 -0.88 . . . . 3.71 110.813 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.44 144.51 10.31 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.913 2.409 . . . . 3.1000000000000001 112.977 -173.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 N-CA-C 110.76 -0.936 . . . . 2.7400000000000002 110.76 163.821 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.94 0 CA-C-O 121.791 0.805 . . . . 4.6100000000000003 111.416 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.2 tp -56.68 161.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 119.364 -2.085 . . . . 3.4199999999999999 110.263 159.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.73 146.73 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.181 -0.95 . . . . 5.5199999999999996 109.869 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.62 143.78 28.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.924 1.29 . . . . 3.9900000000000002 109.15 161.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.9 145.01 8.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.167 1.387 . . . . 3.48 111.129 -172.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.7 p -62.19 -22.35 65.84 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.963 1.097 . . . . 4.2199999999999998 113.963 171.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.334 0.1 OUTLIER 49.12 62.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.769 1.747 . . . . 4.96 110.715 -174.473 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.1 mm -118.92 152.44 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.283 2.233 . . . . 3.4900000000000002 110.94 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.0 mtp -132.93 155.67 48.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.418 2.687 . . . . 3.3799999999999999 109.376 -175.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -117.29 143.74 45.6 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.746 1.017 . . . . 4.5 113.746 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.76 127.5 42.79 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.906 1.682 . . . . 3.96 107.322 168.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.6 130.87 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.497 0.719 . . . . 3.9300000000000002 109.073 171.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.13 173.16 37.4 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.921 0.772 . . . . 2.2200000000000002 112.285 177.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.05 68.16 6.63 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.185 3.257 . . . . 3.27 111.085 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -167.83 -56.69 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.325 1.85 . . . . 5.4699999999999998 109.729 -164.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 144.12 165.05 10.75 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.191 1.236 . . . . 3.8300000000000001 116.191 170.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 70.65 -86.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.054 1.741 . . . . 8.4100000000000001 111.976 165.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.72 157.01 9.9 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.779 1.632 . . . . 6.8799999999999999 112.281 -173.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -39.38 0.6 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.395 1.478 . . . . 4.9900000000000002 111.579 -175.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.33 176.01 13.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.756 2.023 . . . . 3.6800000000000002 108.538 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -135.39 150.05 49.8 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.211 1.004 . . . . 4.4100000000000001 112.437 178.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -133.18 -170.02 2.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.591 1.557 . . . . 4.3099999999999996 110.477 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.91 -157.75 14.73 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.521 1.057 . . . . 3.3799999999999999 110.888 -171.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -71.91 90.71 1.14 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.546 0.943 . . . . 4.9400000000000004 113.546 -164.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.1 p30 165.71 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 130.267 3.427 . . . . 8.7599999999999998 112.984 164.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.94 108.91 7.04 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.368 -0.832 . . . . 7.0800000000000001 108.934 170.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.71 135.5 37.17 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.19 0.996 . . . . 9.5800000000000001 109.672 -172.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -21.24 -66.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.121 2.267 . . . . 3.9700000000000002 117.121 -163.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.33 -20.41 65.32 Favored Glycine 0 N--CA 1.48 1.607 0 CA-C-N 119.944 1.247 . . . . 2.2799999999999998 114.733 -173.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.94 -22.5 66.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.633 1.173 . . . . 4.4299999999999997 111.642 172.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.41 -48.69 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.822 -1.173 . . . . 2.6899999999999999 109.729 175.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.25 92.26 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.179 0.807 . . . . 2.6499999999999999 113.179 173.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.93 74.19 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.984 0.735 . . . . 2.7000000000000002 112.984 178.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 14.1 p -72.33 -44.07 63.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.72 -1.238 . . . . 2.04 111.677 170.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.9 -34.52 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.742 1.155 . . . . 2.8300000000000001 111.985 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.38 47.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.613 1.338 . . . . 3.0 114.613 171.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.9 m -80.6 -48.45 12.66 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.115 0.87 . . . . 3.9300000000000002 110.413 170.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -64.85 -28.29 69.45 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.849 1.26 . . . . 3.5899999999999999 112.55 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.0 ttp -58.86 -20.0 46.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.225 2.61 . . . . 5.6299999999999999 113.457 170.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -72.23 -50.41 8.75 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.824 -1.56 . . . . 6.9000000000000004 111.936 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.27 -54.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 123.26 2.64 . . . . 3.4199999999999999 112.966 169.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.65 126.27 33.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.554 0.742 . . . . 4.8300000000000001 110.618 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 115.211 1.56 . . . . 7.8899999999999997 115.211 -166.2 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.46 0 CA-C-O 118.428 -1.207 . . . . 3.6200000000000001 114.365 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.01 150.79 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.707 2.271 . . . . 3.0099999999999998 110.289 168.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -156.01 165.25 37.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.752 0.821 . . . . 3.7200000000000002 112.122 -167.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.8 m -121.41 137.99 54.47 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.722 -0.611 . . . . 2.6000000000000001 109.999 147.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 mt -142.8 153.5 43.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.3 1.04 . . . . 4.2199999999999998 109.575 168.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.3 m -93.25 150.75 20.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.886 0.874 . . . . 2.2599999999999998 108.76 174.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.9 p -96.34 163.03 13.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 2.46 112.17 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -61.74 -16.8 52.48 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.075 1.139 . . . . 2.2599999999999998 114.075 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -87.23 -43.7 12.0 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 117.566 -1.207 . . . . 3.5600000000000001 111.368 168.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.9 5.98 1.57 Allowed Glycine 0 N--CA 1.474 1.185 0 N-CA-C 119.145 2.418 . . . . 1.77 119.145 158.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.4 158.0 19.11 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 121.419 2.609 . . . . 3.9900000000000002 111.944 172.145 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -111.54 120.49 42.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.207 1.403 . . . . 6.7000000000000002 110.963 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.63 167.49 22.43 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.539 1.311 . . . . 6.3399999999999999 114.539 -168.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.4 p -120.85 173.92 6.93 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.744 2.818 . . . . 2.98 111.742 -171.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.05 -31.63 72.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.276 0.63 . . . . 3.8599999999999999 112.629 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -19.3 65.13 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.96 -1.088 . . . . 9.1999999999999993 112.388 174.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -85.89 -43.78 12.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.868 0.867 . . . . 3.6600000000000001 111.138 172.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -67.41 -25.88 66.15 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.596 1.332 . . . . 4.4199999999999999 114.596 175.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 49.15 42.52 21.51 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.442 2.297 . . . . 6.2699999999999996 112.486 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.3 -74.44 0.06 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.169 2.319 . . . . 5.71 113.286 -173.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 63.12 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.352 2.261 . . . . 4.1200000000000001 111.803 -175.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -167.82 92.28 0.36 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.605 2.762 . . . . 2.8100000000000001 109.172 173.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.05 131.06 53.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.764 1.226 . . . . 4.3200000000000003 113.569 -174.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.49 124.77 49.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.113 1.365 . . . . 3.48 108.525 166.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 29.3 mt -126.84 114.35 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.238 1.015 . . . . 2.73 109.822 -164.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -122.43 139.91 53.32 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.701 1.0 . . . . 3.8700000000000001 113.701 -174.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -96.36 109.31 21.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.727 0.811 . . . . 3.9300000000000002 109.549 172.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.48 146.67 18.13 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.058 1.314 . . . . 1.23 113.471 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.429 ' CD1' ' HB ' ' A' ' 258' ' ' VAL . 1.2 m-85 -81.54 61.12 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.13 0.972 . . . . 5.7999999999999998 111.317 -174.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.3 p 45.84 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.071 2.148 . . . . 5.0599999999999996 110.894 -170.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -103.62 116.72 32.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.29 0.95 . . . . 10.6 108.957 155.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.8 t -44.29 -174.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 130.954 3.702 . . . . 2.6000000000000001 115.089 169.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -47.31 -70.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.77 1.646 . . . . 4.0499999999999998 109.776 138.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -167.66 21.77 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.84 1.793 . . . . 5.0899999999999999 115.84 166.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 -34.71 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.318 -1.489 . . . . 3.4300000000000002 111.766 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 90.1 m -44.2 -55.53 9.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.649 -1.643 . . . . 1.8100000000000001 112.823 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.7 -29.35 60.01 Favored 'Trans proline' 0 C--N 1.354 0.817 0 CA-C-N 122.308 1.86 . . . . 1.3500000000000001 114.092 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -75.58 -38.93 58.77 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.374 0.988 . . . . 3.6099999999999999 112.216 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.51 -37.27 65.73 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.564 -1.335 . . . . 3.3199999999999998 111.979 171.138 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.0 tt -55.85 -43.91 77.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.396 1.078 . . . . 4.8600000000000003 111.492 169.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.22 -35.04 74.55 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.628 1.103 . . . . 3.1600000000000001 112.466 -177.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -62.79 -45.18 93.84 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.587 -1.321 . . . . 4.0099999999999998 111.238 173.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.7 ptp -68.81 -21.44 64.32 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 117.596 -1.192 . . . . 3.0800000000000001 114.199 173.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.1 -57.23 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 120.586 1.539 . . . . 3.0800000000000001 109.322 166.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -59.45 -19.81 50.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.325 1.45 . . . . 4.5300000000000002 113.169 -177.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.78 -29.6 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.562 1.074 . . . . 2.6400000000000001 113.758 170.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.04 -36.56 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 121.361 1.891 . . . . 3.7400000000000002 110.706 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -50.56 36.56 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.57 1.948 . . . . 6.7400000000000002 112.248 166.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -67.05 -36.58 82.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.603 0.761 . . . . 4.0499999999999998 112.073 178.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mm -69.42 -45.98 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.995 1.318 . . . . 3.5299999999999998 111.238 -177.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -66.04 -33.61 76.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 4.9900000000000002 110.475 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.2 t -70.36 -8.15 48.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.657 1.183 . . . . 5.4000000000000004 113.848 171.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.5 mm -79.19 -38.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.978 1.263 . . . . 4.79 110.287 165.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 57.87 -23.38 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 129.386 3.074 . . . . 4.9500000000000002 116.082 -176.175 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 p -75.92 -20.79 57.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.249 -1.532 . . . . 6.0899999999999999 112.942 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.83 173.64 1.98 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.367 1.467 . . . . 4.7699999999999996 113.316 169.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.74 -40.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.831 2.354 . . . . 3.75 111.914 169.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 30.0 t70 165.08 165.07 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.86 2.864 . . . . 4.0199999999999996 108.908 -159.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.75 122.54 36.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.312 -0.995 . . . . 3.29 108.312 153.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 m -101.05 114.96 65.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 109.374 -0.602 . . . . 2.3500000000000001 109.374 173.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.95 142.99 15.99 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.27 1.98 . . . . 1.24 109.918 166.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.4 146.07 43.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 122.912 1.339 . . . . 3.6400000000000001 112.433 170.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -114.44 130.82 56.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.913 -1.494 . . . . 3.8799999999999999 109.623 -170.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 68.5 mt -107.13 117.97 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.743 1.217 . . . . 2.48 109.668 174.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.8 p -73.13 136.09 44.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.134 0.574 . . . . 4.0 110.699 167.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.7 pt -121.15 31.85 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.472 1.509 . . . . 2.3199999999999998 111.634 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.41 ' HB3' ' CD1' ' A' ' 166' ' ' PHE . 16.3 p-10 -161.74 65.59 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.908 1.283 . . . . 4.1600000000000001 111.261 -158.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.35 -19.76 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.653 2.236 . . . . 2.8300000000000001 113.427 -171.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.31 41.86 0.19 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.118 1.367 . . . . 4.4400000000000004 111.966 168.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.0 -14.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 130.04 3.336 . . . . 6.5300000000000002 114.257 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.83 159.93 8.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.563 1.074 . . . . 4.7000000000000002 112.515 161.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.7 m -154.18 127.0 8.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 106.722 -1.584 . . . . 2.7599999999999998 106.722 155.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -52.01 -43.86 63.87 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.535 1.134 . . . . 3.8599999999999999 112.283 -177.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -70.23 -30.23 67.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.662 1.185 . . . . 3.5099999999999998 114.194 172.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.33 -39.47 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.195 1.361 . . . . 2.4300000000000002 111.715 176.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.19 -24.6 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.873 -1.142 . . . . 3.1400000000000001 110.891 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.18 67.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 119.91 -1.744 . . . . 2.25 112.938 166.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -77.26 -35.67 55.11 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.397 1.079 . . . . 4.5999999999999996 111.847 168.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.71 -36.09 81.84 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.549 -0.719 . . . . 7.25 111.563 176.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.6 t -54.5 -24.47 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 120.984 -1.073 . . . . 3.1899999999999999 112.349 169.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -87.38 -22.31 25.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.544 -1.348 . . . . 6.4500000000000002 114.134 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.82 -45.06 68.71 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.248 0.931 . . . . 4.8200000000000003 110.307 165.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -105.1 -26.5 12.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.138 1.903 . . . . 4.8099999999999996 116.138 -159.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 46.4 p 143.38 147.49 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 128.722 2.809 . . . . 3.0 113.413 169.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 66.43 5.42 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.023 3.148 . . . . 2.7799999999999998 109.684 166.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.06 -31.66 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.047 2.139 . . . . 4.5099999999999998 110.854 -171.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.47 145.92 48.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.412 0.551 . . . . 3.1499999999999999 111.165 158.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.77 133.02 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.868 1.667 . . . . 2.8399999999999999 106.891 162.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.71 128.71 9.66 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.346 -1.102 . . . . 0.82999999999999996 110.346 176.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.57 130.47 49.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.278 1.031 . . . . 3.1899999999999999 111.538 -176.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -144.03 -178.95 6.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.613 1.565 . . . . 3.1099999999999999 111.675 -167.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 176.74 -167.82 39.45 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.4 1.0 . . . . 1.53 113.766 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -84.0 157.29 21.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.772 1.229 . . . . 2.5600000000000001 110.414 174.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -61.27 -20.57 63.01 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.068 1.507 . . . . 8.7699999999999996 115.068 -169.534 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -70.33 -40.65 74.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.672 1.589 . . . . 2.98 111.175 172.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.39 -32.6 62.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.664 1.185 . . . . 3.4100000000000001 111.745 173.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.67 -38.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 118.206 -0.902 . . . . 2.6800000000000002 110.989 166.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.03 -44.5 92.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.133 1.333 . . . . 3.0800000000000001 110.362 171.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -49.67 -57.28 7.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.667 1.121 . . . . 3.0 110.934 172.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 32.6 m -74.11 -37.66 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.917 1.235 . . . . 4.2699999999999996 113.261 -171.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.73 74.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.648 0.379 . . . . 2.4700000000000002 111.65 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -95.68 -23.22 17.1 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.353 1.461 . . . . 4.6100000000000003 113.555 -175.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.02 75.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.351 1.432 . . . . 2.8300000000000001 110.768 164.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -82.55 -11.94 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.632 1.173 . . . . 4.4299999999999997 114.098 174.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 71.64 37.19 1.13 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.279 1.832 . . . . 9.0600000000000005 112.451 165.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 m -94.13 141.0 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.266 1.426 . . . . 3.5699999999999998 112.328 -175.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -76.47 154.17 34.93 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.298 0.851 . . . . 6.04 113.298 171.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.01 149.53 16.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.923 1.689 . . . . 4.6600000000000001 109.729 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.3 t -155.54 145.01 15.28 Favored Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 121.454 -0.779 . . . . 5.2699999999999996 110.987 171.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.36 165.12 28.03 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.387 2.058 . . . . 5.0099999999999998 109.628 151.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.684 0 C-N-CA 124.356 0.979 . . . . 3.5800000000000001 114.426 174.754 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 113.655 0.983 . . . . 7.8799999999999999 113.655 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 11.8 mm -61.52 153.11 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.547 -0.72 . . . . 4.4400000000000004 109.261 159.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 166' ' ' PHE . 30.7 m -154.88 141.67 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 128.018 2.527 . . . . 5.8499999999999996 104.855 171.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -157.81 157.44 33.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.369 0.986 . . . . 4.8600000000000003 113.299 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -160.44 -179.11 7.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.916 1.686 . . . . 3.1699999999999999 113.686 -163.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.3 p -74.35 -15.11 60.95 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 116.899 2.185 . . . . 4.25 116.899 -176.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 56.86 11.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.15 1.78 . . . . 5.1600000000000001 115.292 177.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 1.6 pp -95.65 148.13 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 119.997 -1.689 . . . . 5.4000000000000004 114.384 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.5 ttp -122.51 121.76 37.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.806 2.442 . . . . 3.1800000000000002 109.408 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -85.16 146.33 27.17 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.549 -0.719 . . . . 3.6899999999999999 111.362 176.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.4 tp -109.1 127.51 54.22 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.918 1.287 . . . . 3.1699999999999999 109.92 168.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.19 124.75 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.912 2.085 . . . . 2.73 106.131 171.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.95 -162.66 36.9 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 109.618 -1.393 . . . . 2.02 109.618 164.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -85.02 54.48 3.94 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 120.392 2.096 . . . . 2.6499999999999999 109.799 178.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.06 -34.77 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.486 1.515 . . . . 5.6399999999999997 114.157 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.66 29.69 59.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.695 -1.058 . . . . 4.3099999999999996 113.623 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -147.52 -39.02 0.19 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.034 1.417 . . . . 4.6900000000000004 113.853 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.32 0.0 OUTLIER 102.74 152.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 132.368 4.267 . . . . 4.79 111.407 -171.944 . . . . . . . . 4 3 . 1 . 023 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 56.9 tp -129.48 -35.24 1.75 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.346 1.239 . . . . 3.98 114.346 -155.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -166.05 172.36 11.48 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.505 1.522 . . . . 2.8399999999999999 111.026 -174.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -156.21 145.96 21.06 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.62 -1.3 . . . . 4.4000000000000004 113.908 174.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -136.84 173.72 11.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.292 1.837 . . . . 4.0099999999999998 111.447 -163.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.41 -169.06 36.13 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 125.807 1.67 . . . . 2.6800000000000002 111.803 175.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -36.52 124.41 0.82 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.061 1.745 . . . . 4.25 113.071 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.9 t30 98.49 -34.94 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 130.315 3.446 . . . . 5.3099999999999996 112.681 -174.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.71 109.87 0.89 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.31 1.414 . . . . 5.0499999999999998 110.611 178.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.5 145.56 41.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.15 -0.969 . . . . 7.5599999999999996 109.453 -171.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -56.17 -50.54 70.89 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.407 -1.433 . . . . 3.3900000000000001 113.549 -168.645 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.28 -13.18 70.19 Favored Glycine 0 N--CA 1.479 1.565 0 O-C-N 121.463 -0.773 . . . . 1.8899999999999999 114.926 175.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -86.72 -19.4 29.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.826 1.25 . . . . 5.3200000000000003 111.046 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.23 -51.32 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 120.586 -1.322 . . . . 2.5 109.595 157.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -37.51 75.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 118.261 -0.876 . . . . 2.98 112.954 176.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.687 1.131 . . . . 3.3199999999999998 112.831 173.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -48.89 79.87 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.422 -0.799 . . . . 2.3399999999999999 112.157 169.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.64 -30.44 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.079 0.854 . . . . 2.5299999999999998 111.504 179.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.34 -7.22 22.99 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.585 -1.322 . . . . 3.6699999999999999 114.053 173.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 31.2 m -80.47 -57.04 3.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.026 0.931 . . . . 4.4800000000000004 108.834 160.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -62.31 -26.8 68.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.312 1.845 . . . . 3.5899999999999999 114.487 -174.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 31.7 mtt -55.86 -30.13 60.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.597 1.159 . . . . 6.0800000000000001 111.619 170.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -59.71 -47.11 98.27 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.406 -1.759 . . . . 5.8200000000000003 111.38 -176.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.26 -58.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.872 2.381 . . . . 4.0199999999999996 113.403 163.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.83 17.89 17.05 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 116.669 2.1 . . . . 4.5199999999999996 116.669 -157.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 . . . . . 0 N--CA 1.478 0.926 0 O-C-N 120.956 -1.09 . . . . 7.8200000000000003 111.415 159.739 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.673 0 CA-C-O 118.118 -1.379 . . . . 3.3399999999999999 111.973 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.67 142.06 62.58 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.078 2.518 . . . . 2.8900000000000001 112.706 -167.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -116.45 168.44 10.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.201 1.8 . . . . 4.0899999999999999 111.264 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 p -148.5 85.48 1.51 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.84 1.256 . . . . 3.1400000000000001 111.28 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.64 143.84 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.208 1.003 . . . . 2.8199999999999998 110.791 175.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 p -75.38 150.28 38.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 4.5199999999999996 111.863 171.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 p -96.0 120.68 36.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.621 1.969 . . . . 2.79 108.273 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.5 m170 51.15 24.79 2.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.195 1.554 . . . . 4.1799999999999997 115.195 177.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.379 0.6 OUTLIER 31.36 39.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.509 2.724 . . . . 11.140000000000001 115.491 -155.695 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -110.82 -28.71 3.83 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.833 2.158 . . . . 2.8300000000000001 113.051 -178.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -155.3 179.81 8.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.808 1.304 . . . . 4.0300000000000002 112.28 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -118.6 111.23 18.31 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.446 1.098 . . . . 7.9500000000000002 111.033 -159.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -119.71 168.9 10.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.462 1.601 . . . . 3.8900000000000001 115.171 167.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.7 m -158.79 158.05 32.81 Favored 'General case' 0 C--N 1.326 -0.422 1 C-N-CA 132.099 4.16 . . . . 3.4399999999999999 103.962 -169.358 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -41.74 -52.34 3.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.624 1.17 . . . . 3.3500000000000001 112.86 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -82.75 -8.56 59.58 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.338 1.607 . . . . 7.5300000000000002 115.338 178.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -75.93 -18.76 59.23 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.399 1.454 . . . . 4.0800000000000001 111.631 165.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -97.69 -40.44 8.58 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.103 1.361 . . . . 4.9500000000000002 114.124 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.98 154.28 19.32 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.39 0.995 . . . . 4.9900000000000002 113.533 -170.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.47 10.25 22.05 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.878 1.704 . . . . 2.8300000000000001 112.708 -158.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.54 160.89 18.17 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.218 2.607 . . . . 3.1200000000000001 107.758 -176.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -83.33 121.91 27.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.624 -0.673 . . . . 2.3300000000000001 110.823 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.61 135.29 39.64 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.242 1.02 . . . . 3.54 111.304 -176.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -115.16 126.15 54.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.487 1.515 . . . . 3.2000000000000002 107.897 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.7 mt -129.4 118.49 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.413 0.685 . . . . 2.5 109.941 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -120.68 145.09 47.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.349 1.459 . . . . 4.0199999999999996 112.934 -175.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -114.67 97.61 6.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.232 1.413 . . . . 3.2200000000000002 110.87 -177.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.61 -160.52 10.69 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.592 1.567 . . . . 1.51 115.423 -169.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -156.03 159.41 39.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.434 1.494 . . . . 5.7199999999999998 110.746 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 p -69.49 127.04 31.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.014 -1.679 . . . . 4.04 110.287 172.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 73.2 -43.78 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.429 2.292 . . . . 9.4199999999999999 111.821 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.4 t 86.59 177.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 127.277 2.231 . . . . 2.8500000000000001 111.419 -166.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -40.7 -69.69 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.458 2.772 . . . . 4.7400000000000002 111.493 130.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . 0.26 1.1 m-20 171.24 58.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 128.417 2.687 . . . . 4.9299999999999997 111.366 170.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.81 -27.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.869 1.268 . . . . 4.8600000000000003 114.02 174.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.36 -37.19 19.53 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 115.852 -2.023 . . . . 2.4300000000000002 113.854 162.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.52 -80.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.336 2.024 . . . . 2.3199999999999998 111.051 166.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.19 -29.01 69.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.676 0.991 . . . . 4.4100000000000001 113.676 -165.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.63 -41.68 59.96 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.255 -1.528 . . . . 3.6600000000000001 112.691 177.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.4 -36.76 74.25 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.299 -1.334 . . . . 4.1699999999999999 110.521 172.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -57.14 -43.99 82.98 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.733 1.606 . . . . 6.0800000000000001 111.806 173.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -60.84 -55.27 35.02 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.712 -1.243 . . . . 3.8199999999999998 112.219 168.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.67 -24.66 62.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.078 1.14 . . . . 4.6299999999999999 114.078 -170.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -56.7 -37.88 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.258 1.39 . . . . 3.0099999999999998 111.279 169.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.98 -28.68 66.83 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.379 -0.819 . . . . 3.04 110.609 176.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.8 -34.68 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.454 1.024 . . . . 2.9700000000000002 111.355 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.82 -37.73 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.598 1.09 . . . . 3.3599999999999999 111.439 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -32.51 58.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.364 0.983 . . . . 4.6100000000000003 113.298 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -60.21 -26.26 66.24 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.596 1.558 . . . . 3.54 112.946 170.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -90.16 -55.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.104 1.762 . . . . 3.3500000000000001 112.387 175.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.15 -30.45 71.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.819 2.048 . . . . 3.1600000000000001 113.133 -175.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.1 t -66.07 -12.8 57.87 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.786 -1.196 . . . . 3.7000000000000002 112.894 169.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.0 mm -121.56 44.41 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.15 1.78 . . . . 5.46 108.186 -178.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.24 0.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.5 3.52 . . . . 7.0999999999999996 118.419 -158.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.3 p -69.08 -18.99 64.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.88 1.272 . . . . 4.8099999999999996 113.047 157.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.41 163.15 43.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 127.28 2.232 . . . . 5.3700000000000001 109.908 169.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.41 162.21 11.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.514 2.143 . . . . 6.0499999999999998 114.178 -148.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.55 94.5 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.71 1.604 . . . . 6.1600000000000001 111.606 -172.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.3 mp -93.86 116.6 29.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.111 0.964 . . . . 3.25 112.722 -175.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.6 m -107.59 111.82 62.58 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.261 1.024 . . . . 2.0800000000000001 110.89 171.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -88.05 122.9 1.62 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.954 3.102 . . . . 1.1699999999999999 112.254 177.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.64 122.83 47.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.742 2.417 . . . . 4.0499999999999998 110.529 -178.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -102.06 121.08 41.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.943 0.897 . . . . 3.46 111.182 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.45 119.99 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.602 1.161 . . . . 2.8900000000000001 108.331 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.1 p -78.65 131.35 36.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.285 -0.884 . . . . 3.0499999999999998 110.581 164.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.43 -21.73 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 115.547 1.684 . . . . 3.73 115.547 -176.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -125.74 75.23 70.59 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 124.525 1.13 . . . . 4.9800000000000004 109.194 -177.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.45 98.51 0.4 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.683 3.588 . . . . 2.21 109.31 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -162.31 -24.04 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.102 1.149 . . . . 4.5300000000000002 114.102 -166.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.45 9.16 0.54 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.176 1.176 . . . . 5.9699999999999998 114.176 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -111.8 75.33 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 129.645 3.178 . . . . 3.8100000000000001 108.798 -173.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.29 155.96 30.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.04 1.4 . . . . 3.6600000000000001 114.363 -163.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.84 -50.42 7.91 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.409 2.283 . . . . 4.5099999999999998 114.784 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.93 -35.0 20.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.808 1.643 . . . . 4.7199999999999998 112.321 174.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.24 71.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.367 0.985 . . . . 2.9399999999999999 113.501 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 18.9 mm -64.53 -42.64 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.842 1.201 . . . . 2.5600000000000001 111.675 170.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.3 -22.54 66.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.734 0.814 . . . . 2.5699999999999998 112.897 176.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -83.41 -44.73 14.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.699 1.6 . . . . 4.9699999999999998 112.027 168.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -53.26 -35.83 60.46 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.648 1.579 . . . . 3.98 111.922 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -52.47 -43.91 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.415 1.486 . . . . 2.6299999999999999 113.617 167.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -67.03 -47.44 71.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 117.807 -1.092 . . . . 7.2599999999999998 111.982 -176.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -43.19 63.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.507 1.523 . . . . 4.1900000000000004 111.917 177.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -70.28 -62.71 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.858 0.463 . . . . 4.54 111.53 175.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.8 m 169.73 145.57 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.534 2.734 . . . . 2.6000000000000001 110.833 177.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.59 -6.52 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.585 2.857 . . . . 1.8600000000000001 114.709 -177.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.41 -10.4 59.43 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.709 1.141 . . . . 4.4900000000000002 113.581 170.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.85 137.93 34.23 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.624 1.17 . . . . 3.1200000000000001 111.557 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -113.36 129.92 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.255 1.022 . . . . 2.5699999999999998 109.561 -174.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.09 129.37 9.87 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.841 -0.904 . . . . 1.0900000000000001 110.841 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.82 156.9 18.67 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.868 -0.79 . . . . 3.71 108.868 168.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.3 m -150.39 126.91 10.82 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.223 -1.399 . . . . 3.8700000000000001 107.223 171.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.58 -145.04 4.05 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.094 1.807 . . . . 1.99 111.189 -174.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -121.75 174.72 6.67 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.301 1.051 . . . . 2.7999999999999998 110.91 165.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.26 -18.09 14.72 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.627 1.171 . . . . 9.3599999999999994 113.327 -174.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.48 -41.99 19.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.194 2.198 . . . . 3.4399999999999999 112.153 -173.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.83 -31.75 66.85 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.286 -1.509 . . . . 3.71 110.702 166.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.8 -35.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.364 -0.827 . . . . 2.6400000000000001 110.916 172.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -58.78 -57.01 14.93 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 117.632 -1.175 . . . . 2.7400000000000002 109.778 163.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -49.87 -56.33 10.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.219 1.372 . . . . 3.1899999999999999 112.514 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.55 -29.51 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.288 0.495 . . . . 2.8399999999999999 111.771 -171.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.32 -50.8 20.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.647 0.779 . . . . 2.5099999999999998 111.525 171.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -56.15 -49.12 74.85 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.148 2.579 . . . . 3.52 111.398 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.78 77.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.551 0.74 . . . . 2.6400000000000001 112.947 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -94.64 14.43 21.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.233 1.413 . . . . 3.79 113.363 176.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 61.6 12.26 4.4 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.134 2.174 . . . . 6.1399999999999997 115.111 176.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.99 140.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.393 1.477 . . . . 3.6800000000000002 111.254 -177.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -109.52 173.43 6.33 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.542 1.537 . . . . 5.5899999999999999 112.481 174.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -121.59 148.55 44.38 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.008 0.923 . . . . 4.5800000000000001 111.534 176.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -128.95 63.14 65.61 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.159 0.984 . . . . 5.0099999999999998 111.654 176.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 138.98 42.83 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.598 2.198 . . . . 3.4300000000000002 110.332 176.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.411 0 CA-C-O 119.676 -0.513 . . . . 3.5 113.342 -176.017 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.731 1.382 . . . . 4.8399999999999999 114.731 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.08 128.71 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.778 -1.201 . . . . 4.3700000000000001 109.919 157.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.1 153.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.304 1.442 . . . . 5.1299999999999999 107.902 170.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.57 174.85 11.05 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 122.752 1.263 . . . . 5.75 112.273 -174.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 167.54 11.13 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.889 -1.132 . . . . 3.04 112.737 -143.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.1 t -68.09 -20.25 64.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.318 1.97 . . . . 4.96 116.318 -171.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.5 mt 47.9 55.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.914 1.686 . . . . 5.4000000000000004 111.593 -177.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.6 mt -137.79 139.77 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.518 1.527 . . . . 3.3100000000000001 110.348 -178.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.66 120.46 39.72 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.51 2.724 . . . . 4.25 109.326 161.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -88.31 135.11 33.61 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.136 0.574 . . . . 3.5699999999999998 111.266 165.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.4 tt -103.41 120.67 41.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.699 2.0 . . . . 3.21 109.441 174.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.92 143.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 127.271 2.229 . . . . 2.8799999999999999 108.167 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.34 178.23 18.49 Favored Glycine 0 CA--C 1.545 1.914 0 C-N-CA 123.931 0.777 . . . . 2.23 113.95 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 -42.97 2.15 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.6 2.866 . . . . 4.0599999999999996 112.904 -174.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -142.87 84.53 1.84 Allowed 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 107.092 -1.447 . . . . 7.71 107.092 161.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.17 -150.85 6.78 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.232 1.872 . . . . 3.4399999999999999 110.315 -176.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -122.78 -162.57 1.03 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.008 0.923 . . . . 4.2599999999999998 111.217 -179.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -52.58 134.94 35.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.076 0.941 . . . . 5.4400000000000004 110.43 173.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.37 -33.02 1.13 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.428 1.491 . . . . 4.2300000000000004 110.328 -169.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -155.28 172.83 17.54 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.828 2.051 . . . . 2.4100000000000001 110.481 175.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -162.21 148.01 13.04 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.616 -1.303 . . . . 4.7800000000000002 114.257 176.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -132.47 128.24 36.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.887 1.275 . . . . 3.54 110.706 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -101.88 -176.62 28.11 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.79 0.709 . . . . 2.7400000000000002 112.282 165.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -52.3 154.29 2.49 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.418 0.687 . . . . 4.2599999999999998 110.588 167.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.3 t30 81.83 -17.86 0.52 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.737 2.415 . . . . 6.1100000000000003 112.196 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -69.54 107.94 3.6 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.238 -1.539 . . . . 6.8200000000000003 110.532 161.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -66.14 144.54 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.502 1.144 . . . . 8.7799999999999994 109.785 176.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -32.49 65.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.051 . . . . 3.2799999999999998 113.839 -167.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.18 86.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.01 -0.883 . . . . 1.6200000000000001 113.489 -178.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.36 -18.03 61.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.359 1.579 . . . . 3.21 112.944 174.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.8 mt -70.01 -47.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.457 -0.777 . . . . 2.02 109.201 172.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.78 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.08 0.552 . . . . 2.21 112.065 170.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.89 81.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.567 0.951 . . . . 2.3300000000000001 113.567 173.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 52.2 p -65.5 -47.18 76.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.996 0.817 . . . . 2.04 111.669 172.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.62 -39.63 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 120.74 -1.225 . . . . 2.7799999999999998 110.638 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.07 72.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.907 0.883 . . . . 2.4199999999999999 113.159 171.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.1 m -71.59 -48.08 50.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.219 1.008 . . . . 2.8700000000000001 110.333 174.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -70.74 -20.27 62.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.206 1.003 . . . . 2.7799999999999998 113.075 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.1 mmm -66.49 -33.67 76.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.193 1.397 . . . . 4.5099999999999998 113.255 162.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -52.63 -40.2 74.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 116.358 -1.782 . . . . 5.9299999999999997 113.13 -176.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.26 -60.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.196 2.597 . . . . 2.3900000000000001 111.544 162.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -86.28 47.25 1.44 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.823 1.416 . . . . 4.1399999999999997 114.823 -165.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.787 0 O-C-N 120.832 -1.167 . . . . 10.859999999999999 111.658 176.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.286 0 CA-C-O 118.237 -1.313 . . . . 3.4300000000000002 112.486 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.58 154.18 30.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.206 2.604 . . . . 3.9199999999999999 111.939 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -160.82 154.31 22.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.579 1.151 . . . . 4.2199999999999998 111.651 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 t -138.17 95.58 3.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.951 -1.093 . . . . 3.4199999999999999 112.874 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.63 162.9 14.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.115 1.366 . . . . 3.7000000000000002 112.153 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.4 m -98.14 142.6 29.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.53 1.132 . . . . 2.23 110.779 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.9 m -98.29 164.7 12.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.184 1.793 . . . . 3.0699999999999998 112.049 -171.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -61.17 -5.37 1.49 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 117.649 2.463 . . . . 3.6099999999999999 117.649 -170.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -35.02 6.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 121.023 1.738 . . . . 5.3399999999999999 111.29 165.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.47 11.61 0.45 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.719 2.104 . . . . 2.4300000000000002 115.185 -177.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -84.04 129.28 34.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.057 2.143 . . . . 5.4800000000000004 110.051 -176.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -69.2 130.2 41.98 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.52 -1.363 . . . . 5.3099999999999996 110.012 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 158.72 24.61 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.441 . . . . 3.71 109.834 168.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.6 p -152.02 162.94 40.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.573 1.549 . . . . 3.1600000000000001 110.233 -167.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -46.63 -49.68 18.72 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.792 1.237 . . . . 5.0800000000000001 112.034 166.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -79.48 4.23 16.26 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.536 1.31 . . . . 8.2300000000000004 114.536 -172.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.08 -30.34 16.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.966 1.706 . . . . 3.6000000000000001 111.452 169.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -103.38 -16.24 15.68 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.988 1.477 . . . . 5.6900000000000004 114.988 -177.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 tt -75.08 88.88 2.43 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.386 1.088 . . . . 5.7800000000000002 110.304 -171.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 164.78 -30.55 0.23 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.783 1.658 . . . . 3.21 111.923 -167.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -103.76 -179.6 4.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 4.4199999999999999 111.453 159.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -85.06 140.72 30.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.023 0.529 . . . . 4.2199999999999998 110.366 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 pp -134.28 153.39 51.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.139 0.976 . . . . 5.0099999999999998 111.09 175.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.61 138.45 54.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.754 1.222 . . . . 4.8499999999999996 109.072 171.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.3 mt -111.59 130.16 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.103 -0.703 . . . . 3.7200000000000002 109.103 177.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -120.61 142.25 49.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.932 1.293 . . . . 4.1900000000000004 110.508 164.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.69 123.49 50.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.064 1.345 . . . . 3.6200000000000001 110.107 171.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -160.38 146.77 13.03 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.459 -0.634 . . . . 2.1600000000000001 113.541 175.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.87 18.35 14.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.381 1.623 . . . . 5.6500000000000004 115.381 -171.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.2 m 66.99 -15.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.603 1.961 . . . . 3.73 114.048 173.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -111.2 16.38 21.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.898 2.079 . . . . 9.3000000000000007 112.684 -167.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.58 171.49 6.97 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.937 1.695 . . . . 2.6899999999999999 114.538 176.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.14 -176.92 1.46 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.117 2.544 . . . . 3.5299999999999998 110.479 150.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.36 64.56 2.13 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 5.9000000000000004 113.139 -172.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 80.5 t -130.97 -45.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.964 2.105 . . . . 4.5800000000000001 109.728 174.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.4 t -62.71 -52.04 67.6 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.855 1.262 . . . . 2.5299999999999998 112.591 172.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.5 -34.71 25.24 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.981 1.788 . . . . 1.54 113.077 172.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.542 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 13.4 tm-20 -64.89 -40.41 95.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.99 1.268 . . . . 2.6899999999999999 112.384 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.43 ' CD ' ' HZ2' ' A' ' 281' ' ' LYS . 2.0 tp10 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.424 -1.423 . . . . 2.5299999999999998 111.594 171.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 37.4 mt -62.72 -37.4 86.4 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.215 0.916 . . . . 3.9300000000000002 112.859 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.68 4.67 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.18 0.9 . . . . 3.3900000000000001 110.336 174.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.542 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 30.0 mtmm -57.53 -28.72 63.75 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.773 -1.204 . . . . 3.6899999999999999 112.713 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.34 -49.11 72.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.016 0.826 . . . . 4.0099999999999998 111.664 168.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.35 -36.19 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 119.636 1.107 . . . . 3.23 110.627 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.28 -23.31 35.68 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.326 0.862 . . . . 4.3700000000000001 113.326 171.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.83 -38.52 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.69 1.132 . . . . 3.1400000000000001 110.718 173.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.35 -40.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.328 1.051 . . . . 2.9399999999999999 110.921 -179.173 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.81 -53.94 34.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.458 1.503 . . . . 5.3099999999999996 110.971 169.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -69.74 -34.27 73.61 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 112.494 0.553 . . . . 4.0199999999999996 112.494 -174.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.34 -40.35 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.056 1.342 . . . . 3.0 112.952 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.68 -34.83 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.294 0.497 . . . . 3.2999999999999998 111.79 168.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.2 t -64.89 -36.01 82.99 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.711 -1.243 . . . . 3.5699999999999998 112.658 172.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.42 -3.06 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.332 1.853 . . . . 4.8300000000000001 112.216 167.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.329 73.1 p 124.43 -9.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 1 C-N-CA 132.796 4.438 . . . . 6.0499999999999998 114.945 152.696 . . . . . . . . 3 2 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.7 t 143.01 -18.53 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 129.824 3.25 . . . . 7.7699999999999996 113.675 178.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.3 -146.4 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.655 -1.641 . . . . 5.5999999999999996 109.561 -172.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.75 -42.11 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 124.079 2.493 . . . . 3.77 109.467 146.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.5 t70 161.8 157.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 1 C-N-CA 132.216 4.206 . . . . 4.1399999999999997 107.973 174.324 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.28 90.07 3.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.904 0.882 . . . . 3.4500000000000002 108.786 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 35.9 m -66.02 117.54 43.5 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 108.28 -1.007 . . . . 2.96 108.28 178.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -91.01 127.34 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.175 1.917 . . . . 1.78 110.085 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.0 tp -121.23 108.42 13.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.555 1.142 . . . . 3.73 109.983 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -90.06 123.38 33.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.378 1.071 . . . . 3.6800000000000002 109.594 169.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.2 mt -111.36 125.25 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.404 -0.961 . . . . 2.2599999999999998 108.404 171.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.6 t -96.03 144.29 26.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.794 -0.566 . . . . 2.75 110.6 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.0 pt -108.5 3.99 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.877 1.066 . . . . 2.9399999999999999 113.877 -174.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.24 77.35 1.55 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.661 1.184 . . . . 3.0 112.435 -169.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.77 -9.33 18.27 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.006 1.804 . . . . 3.5600000000000001 111.834 166.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -70.33 -4.87 24.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.998 2.119 . . . . 4.5499999999999998 114.153 174.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -9.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.813 2.523 . . . . 5.6200000000000001 117.813 178.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.99 97.23 10.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.611 2.005 . . . . 4.4400000000000004 110.039 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 m -74.28 128.94 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.978 -0.749 . . . . 2.7200000000000002 108.978 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -54.15 8.64 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.425 1.49 . . . . 3.8999999999999999 111.597 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -68.25 -23.42 64.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.269 1.428 . . . . 3.6800000000000002 113.741 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.16 -44.64 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.439 -1.413 . . . . 3.0099999999999998 111.247 172.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.07 -37.48 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.818 0.847 . . . . 3.8100000000000001 110.397 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.76 -33.76 36.52 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.822 1.045 . . . . 2.1200000000000001 113.822 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -80.38 -49.49 11.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.752 -0.592 . . . . 5.6600000000000001 111.926 175.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -49.49 -37.57 26.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.674 1.19 . . . . 4.0999999999999996 113.385 171.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.37 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.675 1.59 . . . . 3.02 112.134 173.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -56.02 -48.3 76.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.977 0.911 . . . . 5.7300000000000004 112.474 -178.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -19.42 62.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.367 1.467 . . . . 7.4800000000000004 112.604 -174.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -53.94 7.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.406 0.682 . . . . 4.5 111.017 164.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.6 t -167.96 139.29 2.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.253 1.021 . . . . 3.8700000000000001 111.503 167.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.69 0.81 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.036 2.491 . . . . 2.4300000000000002 114.078 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -86.6 -16.3 37.15 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 120.051 1.296 . . . . 3.73 113.064 165.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.62 143.88 34.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.25 1.42 . . . . 3.25 110.948 -177.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.46 145.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.404 0.681 . . . . 3.4500000000000002 110.269 164.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.02 124.84 6.29 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 124.054 0.835 . . . . 0.87 111.383 173.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 11.1 mp -117.39 145.95 43.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.817 1.247 . . . . 3.3100000000000001 111.438 -179.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.3 p -149.92 174.94 12.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.211 2.604 . . . . 3.2200000000000002 109.964 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.35 -152.11 8.09 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.497 -1.441 . . . . 1.8300000000000001 109.497 158.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.8 p -64.3 165.33 9.7 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.62 1.568 . . . . 3.9100000000000001 112.571 162.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.87 -36.37 62.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.315 -0.857 . . . . 7.9699999999999998 110.698 169.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.09 -45.91 69.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.877 2.071 . . . . 3.3399999999999999 112.667 176.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.98 -47.82 84.24 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.178 -0.951 . . . . 4.71 110.803 173.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -17.03 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.152 1.168 . . . . 3.5899999999999999 114.152 -178.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.55 -43.83 97.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.337 0.971 . . . . 3.1200000000000001 109.78 168.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.92 -53.18 61.26 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.061 -0.495 . . . . 4.0999999999999996 111.096 -176.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.36 -23.75 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 112.752 0.649 . . . . 2.8799999999999999 112.752 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.04 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.561 0.745 . . . . 2.7799999999999998 112.83 171.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -70.4 -41.54 72.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.559 2.343 . . . . 4.8300000000000001 111.528 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.58 -46.2 63.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.983 1.713 . . . . 3.1099999999999999 112.795 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.42 -126.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.881 0.764 . . . . 3.3399999999999999 110.389 171.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.17 61.65 0.7 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.593 -1.317 . . . . 6.8899999999999997 111.783 -172.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.36 156.87 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.075 0.95 . . . . 5.0300000000000002 109.228 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -152.8 169.71 22.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.113 2.565 . . . . 5.2699999999999996 109.165 -173.493 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -165.77 153.9 11.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.993 1.317 . . . . 5.9199999999999999 111.148 -177.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.4 t -149.56 138.31 12.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.912 1.685 . . . . 5.96 108.254 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.28 151.07 15.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.155 2.57 . . . . 5.7800000000000002 111.947 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.305 0 CA-C-O 118.717 -1.046 . . . . 4.6399999999999997 110.716 172.465 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 122.13 0.967 . . . . 6.25 110.679 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.5 tt -73.22 175.34 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.714 1.205 . . . . 3.9300000000000002 110.996 167.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.7 t -151.64 158.77 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 127.554 2.341 . . . . 4.6100000000000003 106.208 172.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -85.55 150.6 24.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.398 1.479 . . . . 5.25 112.37 169.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -148.1 150.29 33.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.828 1.047 . . . . 2.4100000000000001 113.828 153.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.24 164.05 1.01 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.058 1.343 . . . . 4.8499999999999996 110.486 171.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.2 tp -143.19 155.11 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.997 1.319 . . . . 5.0499999999999998 109.175 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.7 mt 108.48 141.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 130.987 3.715 . . . . 4.1399999999999997 107.901 -162.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 mtt -101.15 136.21 41.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.501 1.12 . . . . 4.6500000000000004 108.822 167.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -111.53 126.28 54.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.651 0.78 . . . . 5.3300000000000001 110.75 -172.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 14.0 tp -99.9 123.72 44.45 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.872 1.269 . . . . 3.4700000000000002 110.562 -175.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.85 131.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.571 -1.27 . . . . 3.8399999999999999 107.571 174.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.59 169.28 25.81 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.562 0.601 . . . . 3.4100000000000001 112.737 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.97 71.21 5.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.077 3.184 . . . . 4.0599999999999996 108.236 167.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -156.51 -59.86 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.764 1.626 . . . . 6.1399999999999997 108.536 -162.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.78 -38.86 0.2 Allowed Glycine 0 C--N 1.345 1.045 0 N-CA-C 115.51 0.964 . . . . 4.7699999999999996 115.51 170.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -157.01 -151.4 0.32 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.333 1.235 . . . . 6.1699999999999999 114.333 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -70.26 109.87 4.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.094 1.358 . . . . 5.8700000000000001 111.278 -173.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 tt -99.45 -21.37 16.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.308 1.043 . . . . 4.7400000000000002 111.642 179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.24 160.08 38.28 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.726 2.01 . . . . 2.6800000000000002 109.618 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -165.39 123.01 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.507 1.523 . . . . 4.1100000000000003 111.754 177.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -139.31 136.14 34.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.548 1.539 . . . . 4.6699999999999999 111.687 -165.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.41 145.99 13.44 Favored Glycine 0 N--CA 1.471 1.033 0 O-C-N 120.661 -1.274 . . . . 3.02 116.033 -174.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 64.24 -105.31 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.358 1.863 . . . . 3.9199999999999999 110.642 171.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.91 87.49 0.25 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.147 1.379 . . . . 6.21 112.161 -176.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.43 ' HZ2' ' CD ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER 178.99 130.56 0.08 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 128.737 2.815 . . . . 9.4800000000000004 111.067 178.695 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -90.61 158.92 16.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.555 1.942 . . . . 7.2599999999999998 110.201 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -40.04 80.04 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.373 1.62 . . . . 2.9700000000000002 115.373 -164.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.91 -24.19 71.4 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 118.129 0.422 . . . . 1.6899999999999999 113.185 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.17 -39.94 93.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.04 0.92 . . . . 3.6099999999999999 111.384 175.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 46.9 mt -70.55 -42.15 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.74 0.816 . . . . 2.4100000000000001 110.541 177.14 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.84 90.93 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.831 -0.543 . . . . 2.3100000000000001 111.2 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.06 87.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.05 1.34 . . . . 2.2400000000000002 113.716 173.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.0 p -64.98 -45.43 85.69 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.483 1.492 . . . . 2.9399999999999999 110.889 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.8 -40.8 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 120.898 -1.127 . . . . 2.98 111.686 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.32 -25.05 67.44 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.645 -1.284 . . . . 2.73 113.188 171.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.9 m -73.48 -43.05 61.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.003 . . . . 2.4700000000000002 110.598 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -70.55 -25.64 63.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.66 0.784 . . . . 2.9900000000000002 112.83 174.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.3 ttp -69.02 -22.58 64.05 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.749 -1.219 . . . . 4.9900000000000002 113.221 165.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -55.78 -42.73 97.6 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 116.632 -1.652 . . . . 5.0700000000000003 112.838 177.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.43 -51.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.342 2.695 . . . . 2.5299999999999998 111.968 163.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -83.97 68.25 9.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.38 1.086 . . . . 4.0099999999999998 112.37 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 126.251 1.82 . . . . 9.0199999999999996 113.91 -169.169 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.369 0 CA-C-O 117.869 -1.517 . . . . 4.5599999999999996 111.512 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -78.98 167.92 21.39 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.442 2.761 . . . . 3.5099999999999998 114.645 -168.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -158.01 163.04 38.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.954 2.102 . . . . 3.4700000000000002 110.974 -169.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.7 t -126.65 116.95 21.79 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.989 -1.07 . . . . 3.5499999999999998 110.401 161.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 mp -135.96 160.24 39.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.098 0.952 . . . . 3.4900000000000002 112.363 -178.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m -82.88 136.56 34.56 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.177 1.791 . . . . 2.6000000000000001 109.764 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.9 t -97.38 158.7 15.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.954 1.302 . . . . 4.1500000000000004 111.894 -178.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -14.98 57.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.475 1.657 . . . . 2.4100000000000001 115.475 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.4 -11.51 59.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.635 1.574 . . . . 3.8900000000000001 112.404 171.325 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.89 -26.17 16.53 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.873 1.701 . . . . 2.7200000000000002 114.538 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.82 -142.61 0.1 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.005 1.322 . . . . 6.3899999999999997 111.216 176.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.2 ttm105 -140.76 157.97 44.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 122.807 1.289 . . . . 7.4100000000000001 113.287 -159.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -140.06 149.13 42.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.691 1.596 . . . . 4.8600000000000003 112.471 169.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.7 p -118.3 162.38 18.37 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.03 1.332 . . . . 2.7999999999999998 109.741 158.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.93 -42.79 63.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.961 1.705 . . . . 3.6400000000000001 112.595 176.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -47.43 -30.29 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.946 1.699 . . . . 9.3900000000000006 113.908 171.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.45 -5.15 43.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.046 1.338 . . . . 3.0699999999999998 112.85 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.71 -25.14 14.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.625 1.17 . . . . 4.1200000000000001 112.619 163.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.37 142.11 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.114 1.765 . . . . 4.8399999999999999 112.596 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.85 35.13 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.055 0.782 . . . . 2.7000000000000002 115.055 173.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -139.19 -166.88 2.12 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.705 1.602 . . . . 3.4100000000000001 108.943 172.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -90.69 70.02 6.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.083 0.945 . . . . 2.5899999999999999 109.003 171.283 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.55 151.78 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.278 -0.638 . . . . 3.5899999999999999 109.278 175.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.8 tp -148.23 122.69 9.72 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.789 -0.569 . . . . 3.8599999999999999 109.577 -173.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -109.59 115.02 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 122.787 0.435 . . . . 2.6200000000000001 111.732 -169.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.89 146.05 41.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.844 1.658 . . . . 4.0999999999999996 112.62 173.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -111.65 118.54 35.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.687 1.195 . . . . 3.6899999999999999 110.068 174.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.36 153.93 23.78 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.327 0.965 . . . . 1.3 114.888 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -81.06 -29.33 35.03 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.977 1.311 . . . . 5.4699999999999998 112.819 176.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.3 m 96.78 123.7 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.899 2.879 . . . . 3.6000000000000001 107.352 -173.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 72.11 -46.25 0.64 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.152 2.181 . . . . 9.9100000000000001 113.357 -178.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m 58.7 -172.28 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.214 1.405 . . . . 2.6899999999999999 113.018 -173.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.17 -43.2 9.12 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.039 1.826 . . . . 3.4199999999999999 110.368 144.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -154.5 -53.68 0.1 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.419 1.888 . . . . 6.5899999999999999 115.353 -159.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.64 -35.82 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 114.978 1.473 . . . . 4.9800000000000004 114.978 -159.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -46.29 -64.78 0.83 Allowed Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 120.245 1.384 . . . . 1.8999999999999999 111.386 167.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.5 -32.21 32.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.678 2.252 . . . . 1.74 113.053 -177.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -59.81 -49.78 76.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.472 1.033 . . . . 4.0800000000000001 111.429 175.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.36 -30.63 53.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.451 0.908 . . . . 3.98 113.451 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.6 -41.05 76.34 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.259 -0.901 . . . . 3.3399999999999999 111.075 168.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.95 -47.48 86.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.892 0.769 . . . . 3.8199999999999998 111.572 176.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -53.22 54.87 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.379 -1.451 . . . . 4.6900000000000004 110.74 170.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.7 ttp -59.36 -40.7 87.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.189 1.396 . . . . 3.46 112.714 -175.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.5 mm -71.64 -53.85 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 2.8500000000000001 110.174 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.518 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 67.4 mt-30 -62.86 -34.54 77.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.818 0.735 . . . . 3.71 110.269 -172.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 t -52.01 -31.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.525 -1.226 . . . . 2.3500000000000001 112.853 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.49 -34.8 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.941 1.7 . . . . 3.9500000000000002 111.352 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -37.54 82.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.699 0.681 . . . . 5.8600000000000003 112.307 -177.024 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -84.85 -33.53 22.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.949 1.299 . . . . 3.9399999999999999 112.143 -178.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.76 -40.19 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.503 1.121 . . . . 2.3799999999999999 111.384 172.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -73.49 -48.2 35.22 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 117.969 0.35 . . . . 4.8099999999999996 111.233 171.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 55.5 m -70.01 -20.86 63.25 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.437 1.643 . . . . 3.6699999999999999 115.437 -171.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.1 mm -74.23 -53.4 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.684 1.129 . . . . 5.21 112.301 -178.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.4 p -150.6 13.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.943 1.297 . . . . 8.4900000000000002 113.413 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 6.1 t 52.67 66.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.379 2.272 . . . . 7.1900000000000004 110.819 -173.589 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -53.7 158.2 3.33 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.834 1.654 . . . . 4.0899999999999999 111.589 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -77.12 38.45 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.211 3.274 . . . . 3.1400000000000001 112.467 178.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . 0.479 ' CG ' ' HZ2' ' A' ' 223' ' ' LYS 0.265 5.0 t0 76.13 138.45 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 131.555 3.942 . . . . 4.6600000000000001 117.412 167.613 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.04 110.12 21.59 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.021 2.129 . . . . 5.0700000000000003 107.691 170.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -110.94 96.4 29.18 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 124.671 1.189 . . . . 2.5800000000000001 109.693 -175.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.3 125.62 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.317 2.678 . . . . 1.0600000000000001 113.626 -173.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.0 tp -104.55 118.65 37.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.114 1.765 . . . . 3.4399999999999999 109.339 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -104.76 132.02 51.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.749 1.22 . . . . 3.9300000000000002 109.495 176.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.1 mm -114.42 133.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.522 1.529 . . . . 2.7599999999999998 110.427 177.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.4 m -67.19 -172.95 0.23 Allowed 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 115.158 1.54 . . . . 3.3599999999999999 115.158 170.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.3 pt -144.99 -34.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.439 -1.413 . . . . 3.8500000000000001 114.747 175.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -130.92 71.82 82.2 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.73 1.612 . . . . 4.5 111.288 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.95 -1.44 2.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 124.982 3.788 . . . . 3.02 115.657 -172.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.26 -6.51 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.495 1.043 . . . . 4.3600000000000003 113.343 160.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -132.63 -60.83 0.87 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.39 1.476 . . . . 6.4699999999999998 114.145 -173.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.54 74.7 9.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.836 1.303 . . . . 4.04 110.906 -172.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.4 t -65.01 154.7 36.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.185 1.469 . . . . 3.4199999999999999 112.11 -170.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -56.16 -32.74 64.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.331 1.852 . . . . 7.2199999999999998 113.626 -171.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 20.0 mp0 -77.2 -39.36 49.02 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.809 2.844 . . . . 4.5499999999999998 110.803 178.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.98 77.57 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.863 0.865 . . . . 2.48 111.235 172.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.55 -42.95 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 2.5699999999999998 110.631 168.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.17 96.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.719 -0.658 . . . . 1.9299999999999999 112.118 175.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -61.72 -50.39 72.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.78 1.173 . . . . 4.2699999999999996 111.617 171.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.08 -42.52 72.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.413 1.485 . . . . 4.54 111.807 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.18 -46.32 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.325 1.05 . . . . 2.1000000000000001 112.234 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.482 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -63.82 -25.43 68.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.449 0.907 . . . . 5.6200000000000001 113.449 -176.651 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.482 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 7.0 mm-40 -83.98 -40.31 18.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.138 0.881 . . . . 5.1799999999999997 112.411 175.394 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -76.22 -45.51 32.64 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.969 1.099 . . . . 4.3600000000000003 113.969 -176.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 153.14 146.52 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 128.99 2.916 . . . . 2.79 112.985 173.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.69 8.19 2.04 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.42 3.413 . . . . 2.5600000000000001 115.702 -175.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . 0.479 ' HZ2' ' CG ' ' A' ' 195' ' ' ASP . 89.4 mttt -76.4 -18.0 59.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.057 1.299 . . . . 3.0 112.509 163.297 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.72 139.05 39.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.428 1.091 . . . . 3.9300000000000002 111.237 171.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.66 138.58 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.426 1.09 . . . . 3.1800000000000002 108.954 161.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.66 125.41 8.57 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.889 1.233 . . . . 1.1299999999999999 111.464 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.9 mp -108.19 129.88 55.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.672 1.189 . . . . 3.5699999999999998 110.249 176.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t 174.29 122.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.421 2.288 . . . . 3.3300000000000001 110.037 -167.396 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.46 -62.19 0.12 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 124.368 0.985 . . . . 2.9300000000000002 112.221 176.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.0 p -145.16 171.1 15.01 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.281 1.832 . . . . 3.1400000000000001 109.192 -176.167 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -31.59 69.4 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.78 -0.575 . . . . 8.1799999999999997 111.245 178.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 21.7 mp0 -70.71 -51.77 25.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 2.79 112.632 -176.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . 0.32 0.0 OUTLIER -80.03 -29.09 39.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.09 1.313 . . . . 3.9300000000000002 113.659 -174.833 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.37 -53.01 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.0 0.92 . . . . 3.1699999999999999 111.324 157.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.37 -23.07 61.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.947 -1.096 . . . . 3.6899999999999999 113.525 -175.335 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -57.74 6.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.213 0.915 . . . . 3.2999999999999998 110.118 163.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.68 -21.08 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 118.445 0.566 . . . . 3.1600000000000001 111.929 -171.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.261 1.024 . . . . 2.4100000000000001 110.367 167.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -44.34 65.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.187 1.395 . . . . 5.9199999999999999 111.946 173.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -53.03 -43.77 66.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.868 1.213 . . . . 2.23 112.473 175.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -96.71 11.22 36.28 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.921 1.082 . . . . 3.4300000000000002 113.921 178.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 41.73 45.8 3.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.846 2.458 . . . . 7.1600000000000001 114.955 -177.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 13.3 m -67.89 159.48 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.587 1.155 . . . . 4.0199999999999996 112.516 -170.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -101.67 102.39 13.06 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.225 0.536 . . . . 4.9299999999999997 110.946 163.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -102.69 143.37 32.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.271 -0.64 . . . . 4.0099999999999998 109.271 154.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.6 m -70.13 137.52 87.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 121.569 -0.707 . . . . 4.5199999999999996 112.307 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.59 119.32 5.87 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 107.396 -1.809 . . . . 6.0999999999999996 107.396 154.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.549 0 N-CA-C 114.015 0.366 . . . . 3.6200000000000001 114.015 -171.064 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 25.0 p90 . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 116.659 2.096 . . . . 5.7699999999999996 116.659 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 47.0 pt -56.71 148.53 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.255 0.55 . . . . 5.3600000000000003 111.715 166.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.6 m -124.22 147.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.684 1.594 . . . . 4.0599999999999996 107.368 166.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.59 165.56 18.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.154 1.382 . . . . 5.25 108.883 172.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -150.41 143.0 24.53 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.031 1.122 . . . . 2.73 114.031 175.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.3 t -151.6 149.99 29.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.108 0.963 . . . . 5.4000000000000004 109.562 167.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.2 174.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.614 1.966 . . . . 7.6299999999999999 110.799 -159.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.99 140.63 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.47 -1.678 . . . . 4.9500000000000002 106.47 152.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.4 ttt -94.92 127.99 41.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.017 1.327 . . . . 3.1400000000000001 108.863 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -111.06 134.9 52.29 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 5.4000000000000004 114.293 -165.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.53 107.07 17.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.048 1.339 . . . . 4.1799999999999997 109.242 171.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.01 110.5 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 105.267 -2.123 . . . . 2.71 105.267 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.93 -168.57 44.02 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 113.601 0.2 . . . . 1.99 113.601 -168.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.31 71.18 5.29 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.763 2.975 . . . . 3.5099999999999998 109.275 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -155.13 -60.11 0.11 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.456 1.502 . . . . 4.6799999999999997 110.145 -159.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.04 -31.03 4.41 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.116 -1.38 . . . . 3.4700000000000002 114.716 -178.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -113.12 -61.43 1.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.759 1.279 . . . . 5.0999999999999996 112.42 -175.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -170.16 145.3 2.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.337 -0.852 . . . . 8.4499999999999993 112.625 -162.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.81 -44.55 1.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.211 1.004 . . . . 4.3200000000000003 113.574 176.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -159.33 158.93 33.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 2.8700000000000001 111.547 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -119.54 125.1 48.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.826 1.25 . . . . 5.5599999999999996 110.919 172.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 104.22 14.01 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.197 -1.038 . . . . 4.1200000000000001 108.197 178.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -74.47 157.01 50.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.016 -1.234 . . . . 3.79 110.016 162.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.3 57.44 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.683 1.593 . . . . 4.6299999999999999 111.537 175.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -156.63 -31.96 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.152 1.781 . . . . 6.0800000000000001 113.186 -171.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.76 131.91 46.96 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.244 -0.91 . . . . 5.3200000000000003 109.43 170.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -82.85 155.68 24.01 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.423 1.889 . . . . 8.8699999999999992 109.794 172.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.518 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 9.3 tmtt? -38.91 -54.03 1.68 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.403 1.881 . . . . 2.7000000000000002 114.687 -172.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.27 -36.8 93.67 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.142 -0.81 . . . . 1.54 113.63 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.3 -27.3 64.28 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.677 1.738 . . . . 3.3199999999999998 112.763 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 95.0 mt -69.02 -48.81 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.196 0.998 . . . . 2.23 110.094 176.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.3 -45.2 85.33 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.303 0.483 . . . . 2.1299999999999999 112.303 174.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.93 67.65 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 2.77 114.403 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 p -67.37 -47.99 68.75 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.017 -1.052 . . . . 2.3900000000000001 111.327 168.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.93 -36.64 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.727 -1.233 . . . . 2.6600000000000001 112.182 173.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.78 67.6 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.364 -1.46 . . . . 2.46 113.175 172.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.4 m -75.62 -51.76 12.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.888 0.875 . . . . 3.5099999999999998 109.319 172.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -61.33 -26.42 67.79 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.536 1.535 . . . . 3.2999999999999998 113.985 176.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.1 ttp -66.59 -15.01 63.13 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.724 -1.235 . . . . 5.71 112.99 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -59.9 -51.95 77.05 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 116.962 -1.494 . . . . 6.1600000000000001 111.513 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.55 -58.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.867 2.378 . . . . 2.4500000000000002 112.368 166.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -79.98 66.42 5.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.215 1.406 . . . . 4.4100000000000001 111.724 -176.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 124.94 1.296 . . . . 9.4600000000000009 113.753 -177.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.554 0 CA-C-O 119.104 -0.831 . . . . 3.98 114.518 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -82.11 -178.74 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.703 3.602 . . . . 3.3399999999999999 112.413 -175.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -170.85 168.52 7.17 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.47 2.708 . . . . 3.9500000000000002 108.762 -176.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -134.34 32.09 3.42 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.734 -1.229 . . . . 3.9199999999999999 112.744 167.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.71 146.3 21.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 123.446 1.593 . . . . 2.96 111.304 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 m -108.39 140.39 41.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.788 -1.551 . . . . 2.4700000000000002 109.19 -168.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.4 m -90.74 148.21 22.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.412 1.885 . . . . 4.4900000000000002 110.459 -167.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -55.69 -13.08 1.47 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 117.347 2.351 . . . . 2.8599999999999999 117.347 -170.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.4 t -86.11 -27.39 24.69 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 4.6299999999999999 113.605 170.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.97 26.91 1.63 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.789 1.662 . . . . 2.5600000000000001 116.172 -177.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.13 139.94 51.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.393 2.096 . . . . 3.6499999999999999 111.203 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -96.04 123.69 39.74 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.188 2.195 . . . . 7.3499999999999996 110.739 -170.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 164.24 14.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.385 0.674 . . . . 4.4500000000000002 111.292 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -128.02 -179.51 5.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.586 1.154 . . . . 3.73 108.184 167.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -38.8 -65.8 0.33 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.141 1.777 . . . . 4.9900000000000002 113.217 163.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 13.28 0.36 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.191 1.922 . . . . 9.9399999999999995 116.191 -172.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -90.68 -26.91 19.34 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.573 -1.33 . . . . 3.8300000000000001 112.26 158.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -113.36 -9.15 13.4 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.093 1.757 . . . . 3.8500000000000001 114.345 -178.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tt -111.5 120.95 43.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.354 2.261 . . . . 4.7999999999999998 109.539 -175.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.33 -39.81 1.75 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.101 2.286 . . . . 2.54 109.708 -170.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -78.62 -156.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.762 0.825 . . . . 3.5899999999999999 109.988 138.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.04 155.79 27.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.834 1.253 . . . . 2.8100000000000001 112.165 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.66 149.7 34.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.508 1.299 . . . . 3.3900000000000001 114.508 170.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.42 137.8 38.35 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.163 1.785 . . . . 3.5600000000000001 107.859 164.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.2 mt -123.11 139.0 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.465 1.106 . . . . 2.6699999999999999 108.271 177.265 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -151.99 149.2 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.427 1.491 . . . . 3.6800000000000002 111.372 177.603 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -104.02 118.42 36.62 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.923 0.889 . . . . 3.5800000000000001 109.92 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -168.96 156.59 28.03 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.693 1.616 . . . . 2.3199999999999998 114.312 -171.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.29 171.33 12.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.551 -0.97 . . . . 5.3899999999999997 113.572 -155.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m -96.27 18.42 13.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.353 0.871 . . . . 3.9399999999999999 113.353 -172.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -106.2 -3.51 21.27 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.069 -1.019 . . . . 9.3699999999999992 113.266 170.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.34 160.47 81.27 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 127.526 2.33 . . . . 2.6499999999999999 115.4 -171.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.27 -160.17 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.235 3.29 . . . . 4.4900000000000002 110.764 156.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.68 -10.17 7.93 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.45 2.3 . . . . 4.8099999999999996 115.459 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -78.45 -32.28 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 118.495 -0.764 . . . . 4.5800000000000001 112.412 -170.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.69 -61.03 6.34 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 117.147 -1.406 . . . . 1.5700000000000001 112.31 166.198 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.1 -36.75 56.66 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.583 2.188 . . . . 2.1600000000000001 114.315 -175.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -54.91 -60.08 3.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.953 1.301 . . . . 4.79 110.95 171.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.82 -35.88 75.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.324 0.65 . . . . 3.1499999999999999 112.174 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.49 -33.41 64.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.878 1.671 . . . . 3.79 112.416 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -61.34 2.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.158 1.345 . . . . 5.5199999999999996 108.35 170.717 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -38.59 67.36 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.786 -0.571 . . . . 7.8799999999999999 110.829 -175.261 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 11.4 ttm -64.88 -45.69 84.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.717 1.207 . . . . 3.3399999999999999 113.065 177.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.7 pt -76.96 -28.79 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 120.34 1.427 . . . . 4.9900000000000002 110.854 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.45 ' C ' ' HE3' ' A' ' 283' ' ' LYS . 0.6 OUTLIER -80.4 -34.44 36.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.175 0.443 . . . . 4.3099999999999996 110.604 -175.444 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.4 -40.71 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.696 0.799 . . . . 2.6400000000000001 112.517 176.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 22.4 m -64.29 -39.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.276 0.944 . . . . 4.04 111.94 -175.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.04 -41.24 91.12 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.841 -1.162 . . . . 5.0 112.463 173.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.01 -19.54 64.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.497 1.519 . . . . 2.9500000000000002 113.482 179.52 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.39 -58.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.977 1.711 . . . . 3.0299999999999998 112.08 173.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.34 -28.4 69.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.845 0.831 . . . . 4.4500000000000002 112.358 -170.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.7 m -71.07 -16.95 62.61 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.232 -0.918 . . . . 4.9900000000000002 113.346 176.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.2 mm -80.63 64.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.335 -1.358 . . . . 5.1100000000000003 107.335 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.9 t -47.02 -12.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 129.751 3.22 . . . . 6.3700000000000001 118.181 -157.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.0 m -73.98 -22.95 59.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.825 1.65 . . . . 4.5599999999999996 111.874 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.7 mt -74.83 162.23 74.38 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.364 1.866 . . . . 4.8499999999999996 113.583 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.63 154.59 27.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.596 2.864 . . . . 3.0699999999999998 110.375 168.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.35 133.22 38.8 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.483 1.913 . . . . 5.0 113.649 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.5 107.86 19.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.247 1.819 . . . . 3.27 111.383 -175.101 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.2 m -72.86 131.91 83.54 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.449 -1.407 . . . . 2.4100000000000001 111.194 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -91.56 94.7 0.21 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.166 3.244 . . . . 1.71 111.342 165.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.24 101.26 11.53 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.742 0.782 . . . . 3.2599999999999998 112.492 -173.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -93.03 126.03 37.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.212 1.405 . . . . 4.0599999999999996 110.632 -177.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.21 119.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.226 1.01 . . . . 2.98 110.145 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.5 m -98.87 162.49 13.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.573 1.149 . . . . 3.6800000000000002 112.677 175.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.2 pt -147.83 -13.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.91 2.189 . . . . 2.4399999999999999 116.91 -148.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -94.38 93.38 0.93 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 120.618 1.554 . . . . 3.7799999999999998 107.495 170.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.37 -22.32 52.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.762 1.641 . . . . 3.0 112.499 -177.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -63.22 -14.85 53.98 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.109 1.364 . . . . 4.0099999999999998 114.611 170.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -161.64 -10.91 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 118.7 2.852 . . . . 6.04 118.7 -170.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -75.36 65.44 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.352 2.342 . . . . 4.8099999999999996 111.862 170.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.0 m -65.07 136.92 57.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.57 1.948 . . . . 3.21 111.076 -176.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -38.22 -64.59 0.4 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.197 1.799 . . . . 4.2699999999999996 113.411 175.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -65.96 -25.08 66.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.245 1.418 . . . . 3.3300000000000001 113.73 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.59 -47.03 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.434 1.015 . . . . 2.6200000000000001 110.814 175.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 38.5 mm -57.23 -45.22 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.22 1.008 . . . . 2.96 110.405 170.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.81 -46.55 67.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.834 0.853 . . . . 2.9700000000000002 112.467 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -68.78 -46.18 69.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.33 0.514 . . . . 3.75 111.876 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -54.64 -49.28 70.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.81 1.244 . . . . 4.2599999999999998 111.353 176.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.5 t -55.27 -49.32 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.555 1.942 . . . . 3.21 111.33 172.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.435 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 0.3 OUTLIER -64.07 -30.43 71.5 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.081 -1.438 . . . . 6.5199999999999996 114.254 -177.224 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 3.5 mm-40 -68.74 -29.95 68.47 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.278 1.399 . . . . 4.04 112.083 175.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -81.8 -54.07 5.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.907 0.483 . . . . 4.1600000000000001 111.509 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.9 p -169.85 148.96 3.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 121.591 -0.693 . . . . 3.48 111.445 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.53 -7.41 20.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.359 2.706 . . . . 3.1499999999999999 113.278 173.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -85.01 -21.34 29.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.277 1.031 . . . . 3.6600000000000001 112.997 176.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.42 143.91 48.34 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.661 1.185 . . . . 3.1400000000000001 111.378 -178.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.62 134.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.882 0.873 . . . . 4.1399999999999997 111.216 172.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.66 124.79 6.66 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.28 1.419 . . . . 1.3500000000000001 111.763 -178.276 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -108.76 139.65 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.348 1.459 . . . . 3.4399999999999999 110.901 -178.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 t -139.54 164.38 30.04 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.81 1.644 . . . . 3.1699999999999999 110.678 176.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.31 171.95 39.97 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.67 1.605 . . . . 1.8799999999999999 112.166 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -64.84 160.26 20.76 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.736 0.814 . . . . 3.0099999999999998 110.529 168.648 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -50.07 -35.74 26.49 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.864 0.866 . . . . 6.2000000000000002 113.167 -174.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 18.1 mp0 -67.22 -38.5 85.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.003 1.721 . . . . 2.8799999999999999 110.108 -178.318 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.09 -40.84 52.16 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.599 1.16 . . . . 4.3300000000000001 113.022 172.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.48 -42.62 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.869 -0.419 . . . . 2.6499999999999999 109.869 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -75.35 -29.45 59.93 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.129 -0.938 . . . . 3.0499999999999998 112.653 175.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -60.21 -59.69 5.01 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.625 2.011 . . . . 2.6699999999999999 110.261 167.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.22 -30.6 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 118.466 0.576 . . . . 3.0299999999999998 111.986 -171.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.45 -52.34 14.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.996 0.816 . . . . 2.3500000000000001 112.216 173.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -76.54 -32.55 58.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.592 1.157 . . . . 4.4800000000000004 112.936 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.72 78.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.539 1.136 . . . . 2.4700000000000002 111.242 173.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -73.2 -1.89 19.52 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.24 -0.912 . . . . 3.1600000000000001 113.03 168.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 45.61 39.68 5.18 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.372 2.669 . . . . 8.0999999999999996 114.471 -176.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 p -71.37 137.6 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.195 -0.668 . . . . 4.0999999999999996 109.195 174.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -75.46 130.65 39.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.87 0.367 . . . . 5.5700000000000003 110.88 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -148.84 144.39 26.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.185 1.394 . . . . 5.2300000000000004 109.956 172.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.0 m -149.48 106.35 3.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 O-C-N 121.493 -0.755 . . . . 5.0499999999999998 112.133 -171.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.35 142.35 10.6 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.447 2.765 . . . . 3.3500000000000001 113.055 -177.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.514 0 CA-C-O 118.088 -1.396 . . . . 3.1099999999999999 110.322 166.567 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.4 p90 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.866 0.841 . . . . 4.6900000000000004 111.935 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.4 tt -157.45 164.85 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.106 1.762 . . . . 4.4500000000000002 108.059 157.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.39 140.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.278 -1.378 . . . . 4.9800000000000004 107.278 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.7 147.71 47.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.261 0.553 . . . . 4.5599999999999996 110.996 167.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -143.26 136.25 27.84 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.618 0.767 . . . . 2.9399999999999999 110.13 158.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -66.2 131.37 46.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.811 -1.181 . . . . 4.3899999999999997 110.339 174.298 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.253 0.0 OUTLIER -82.52 64.48 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 123.172 1.463 . . . . 5.9400000000000004 112.653 -171.091 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.63 127.09 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.04 1.336 . . . . 3.2200000000000002 111.402 -176.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.7 mmm -88.09 137.66 32.13 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.552 1.541 . . . . 3.3999999999999999 109.411 158.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -114.14 131.56 56.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 3.8500000000000001 109.524 168.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.05 121.45 41.4 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.901 0.88 . . . . 3.4100000000000001 108.685 173.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.08 117.89 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.052 -1.462 . . . . 2.4700000000000002 107.052 172.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.51 -137.12 5.76 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 109.357 -1.497 . . . . 2.0800000000000001 109.357 167.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -81.19 3.67 7.62 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.391 2.06 . . . . 3.5899999999999999 112.381 170.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -31.37 53.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.954 1.302 . . . . 4.8600000000000003 112.744 -176.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.98 1.85 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.07 1.319 . . . . 2.9399999999999999 113.345 -170.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -77.86 19.26 0.41 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.983 1.713 . . . . 4.6699999999999999 115.04 -166.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 92.1 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 129.972 3.309 . . . . 5.3399999999999999 110.676 173.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.32 -33.29 10.78 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.727 1.211 . . . . 3.6899999999999999 111.144 176.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -168.97 167.12 10.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.139 2.175 . . . . 2.7200000000000002 108.325 -168.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -161.47 146.04 13.28 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.444 1.098 . . . . 5.8399999999999999 112.288 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -129.91 115.22 16.88 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.914 0.886 . . . . 3.9300000000000002 109.862 -175.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.32 110.75 4.09 Favored Glycine 0 N--CA 1.465 0.616 0 N-CA-C 109.652 -1.379 . . . . 3.6099999999999999 109.652 173.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 76.44 166.32 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.483 1.913 . . . . 4.1699999999999999 110.949 -167.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -42.03 -48.46 4.63 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.094 2.557 . . . . 10.58 113.408 -169.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 59.0 tttp 67.95 -23.29 0.12 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.566 1.946 . . . . 6.0300000000000002 113.89 -172.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 102.3 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.319 3.448 . . . . 6.6299999999999999 107.259 -174.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.45 ' HE3' ' C ' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -34.78 -60.07 0.46 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.285 2.234 . . . . 3.4399999999999999 113.25 179.012 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.8 -19.38 69.41 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.256 -1.302 . . . . 1.76 115.755 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.84 -26.11 49.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.739 2.27 . . . . 3.9100000000000001 112.981 177.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.85 -40.47 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.735 -0.839 . . . . 3.9199999999999999 108.735 169.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.31 77.54 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.484 0.584 . . . . 2.3799999999999999 111.461 169.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.41 -39.21 85.52 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.196 1.184 . . . . 2.5 114.196 176.032 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.9 p -70.0 -46.95 64.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.108 0.867 . . . . 2.7599999999999998 111.571 175.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.8 mt -54.82 -44.18 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.954 . . . . 2.5600000000000001 110.77 171.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.408 -1.433 . . . . 2.7400000000000002 113.701 178.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 57.4 m -76.95 -47.88 19.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.079 0.952 . . . . 2.98 109.93 170.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -62.73 -31.78 72.77 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.338 1.055 . . . . 3.7000000000000002 112.288 175.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.56 24.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.633 1.573 . . . . 7.0 112.749 168.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.47 -57.16 0.31 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 116.337 -1.792 . . . . 6.5 111.801 152.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.17 -49.48 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.251 2.634 . . . . 2.7400000000000002 113.133 176.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.33 70.42 10.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.863 0.756 . . . . 4.3099999999999996 111.712 -176.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 . . . . . 0 CA--C 1.549 0.933 0 C-N-CA 124.879 1.272 . . . . 11.970000000000001 109.318 -174.83 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 N-CA-C 110.494 -1.042 . . . . 4.9199999999999999 110.494 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.55 161.78 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.905 2.403 . . . . 3.9700000000000002 113.279 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -156.08 179.43 9.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.85 2.46 . . . . 4.25 108.366 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.2 m -140.31 117.27 11.09 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.957 -1.714 . . . . 3.8599999999999999 111.528 157.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.72 161.65 28.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.694 1.997 . . . . 3.4399999999999999 108.39 176.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.4 t -87.31 146.62 25.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.467 0.651 . . . . 4.1799999999999997 110.93 173.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.9 p -92.85 159.28 15.44 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 123.152 1.454 . . . . 3.46 112.409 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -56.82 -26.86 59.05 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.127 -0.983 . . . . 2.4300000000000002 112.474 163.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.0 p -71.72 -20.29 61.93 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.367 1.247 . . . . 4.5999999999999996 114.367 169.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.77 11.16 54.24 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 120.287 1.403 . . . . 1.96 115.163 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -88.76 -175.37 4.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.673 1.589 . . . . 4.0599999999999996 110.136 170.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -131.56 121.72 24.9 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.887 1.275 . . . . 6.5700000000000003 108.969 168.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -132.72 156.39 47.11 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.903 1.075 . . . . 4.9299999999999997 113.903 -162.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -108.0 164.16 12.52 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.37 1.868 . . . . 3.3900000000000001 109.63 171.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -39.61 -55.77 1.8 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.63 2.372 . . . . 4.1799999999999997 112.42 159.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.465 ' HZ1' ' CD ' ' A' ' 272' ' ' GLU . 11.4 mptt -74.34 -15.66 60.94 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.537 1.31 . . . . 8.8000000000000007 114.537 -174.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.74 -42.64 77.29 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.824 1.193 . . . . 3.04 110.988 166.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.68 11.19 3.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.385 1.254 . . . . 4.1600000000000001 114.385 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.36 -169.49 0.82 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.662 1.185 . . . . 5.2000000000000002 111.763 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 76.41 8.35 85.67 Favored Glycine 0 N--CA 1.482 1.702 0 O-C-N 120.517 -1.364 . . . . 3.96 114.56 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.55 154.96 27.51 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.361 2.664 . . . . 3.5699999999999998 107.593 -171.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -68.07 125.09 25.25 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.314 0.507 . . . . 2.7799999999999998 110.071 170.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.7 mt -105.86 125.72 51.33 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.963 0.887 . . . . 4.29 111.652 177.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.04 92.22 3.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.865 1.666 . . . . 3.9399999999999999 106.748 176.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.85 121.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.787 1.235 . . . . 3.6899999999999999 110.199 -167.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -128.98 153.6 47.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.542 1.312 . . . . 4.9800000000000004 114.542 -175.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.85 102.13 9.7 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.109 1.763 . . . . 3.98 112.31 175.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.02 171.31 17.72 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.396 1.474 . . . . 2.3399999999999999 113.329 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -111.42 -12.99 13.95 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.765 0.654 . . . . 4.8200000000000003 112.765 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.0 m 58.04 47.53 14.62 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.137 1.446 . . . . 4.6799999999999997 108.891 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -150.4 -56.65 0.17 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 114.638 -1.164 . . . . 8.6600000000000001 110.738 -161.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.3 m -70.4 141.03 87.87 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.156 0.982 . . . . 2.98 111.219 -170.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.22 -17.54 21.58 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.907 1.738 . . . . 5.04 111.243 166.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.51 -76.57 0.54 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.779 1.632 . . . . 5.2999999999999998 112.673 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.29 -54.44 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.486 1.114 . . . . 3.5600000000000001 111.945 -162.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.5 m -47.25 -60.7 3.64 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.325 -1.321 . . . . 1.6799999999999999 112.596 176.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.24 -34.55 27.3 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.657 1.571 . . . . 1.48 113.127 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.458 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 11.8 tm-20 -67.08 -33.43 75.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 121.092 1.769 . . . . 3.75 112.097 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -31.2 37.67 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.299 -1.501 . . . . 3.6299999999999999 113.521 170.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -43.74 98.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.967 1.307 . . . . 3.6800000000000002 111.171 174.204 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.24 -46.34 76.03 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 3.4700000000000002 111.055 172.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.458 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 36.5 mtmm -66.51 -33.69 76.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.186 0.81 . . . . 4.7000000000000002 113.186 174.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 69.7 mtp -61.18 -42.6 98.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.017 1.281 . . . . 4.5199999999999996 111.915 169.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.9 mm -75.41 -61.97 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.971 -0.751 . . . . 2.6899999999999999 108.971 -172.06 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.26 -12.41 28.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.748 1.219 . . . . 3.1000000000000001 114.225 -165.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.13 -39.67 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.648 1.179 . . . . 2.7400000000000002 111.044 171.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.11 -53.86 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.021 1.282 . . . . 3.2799999999999998 110.205 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.8 -20.03 61.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.256 1.422 . . . . 4.4900000000000002 112.064 -171.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -79.32 -38.13 35.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.796 1.239 . . . . 2.6499999999999999 111.909 167.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.82 -49.54 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.782 1.401 . . . . 3.4700000000000002 114.782 -168.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -33.52 75.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.571 1.532 . . . . 4.4900000000000002 109.74 179.35 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -19.83 42.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.527 1.931 . . . . 3.6499999999999999 114.714 173.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.46 -14.34 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.321 -1.487 . . . . 4.4400000000000004 112.494 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m 157.64 -33.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 130.422 3.489 . . . . 6.6100000000000003 112.832 164.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 7.1 t 157.34 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.16 3.384 . . . . 6.6399999999999997 110.785 166.589 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.07 147.09 1.88 Allowed Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 114.302 -1.317 . . . . 4.8300000000000001 111.493 169.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.28 -44.25 19.77 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.372 2.715 . . . . 3.5699999999999998 112.459 -159.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.12 153.67 0.23 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.895 2.878 . . . . 4.5 108.669 161.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.16 128.11 29.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.044 0.537 . . . . 3.8900000000000001 109.704 171.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.4 m -124.84 119.1 25.65 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.704 1.202 . . . . 2.4199999999999999 108.562 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.73 133.63 10.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.001 2.467 . . . . 1.1899999999999999 110.127 172.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.84 97.25 4.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.832 1.253 . . . . 3.5600000000000001 109.336 -169.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -94.27 133.04 38.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.97 1.308 . . . . 3.5600000000000001 110.661 -173.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 54.0 mt -122.62 129.43 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.586 1.155 . . . . 2.6899999999999999 109.41 176.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -83.03 137.35 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.656 -0.653 . . . . 3.0499999999999998 112.409 171.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 pt -81.74 3.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.891 1.071 . . . . 3.9700000000000002 113.891 172.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.78 80.14 12.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 115.937 1.829 . . . . 5.1200000000000001 115.937 -172.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -80.14 63.21 8.72 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.295 3.33 . . . . 2.5699999999999998 112.12 174.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -108.74 -50.26 3.04 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.565 -1.198 . . . . 3.8799999999999999 108.343 139.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.39 -6.32 28.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.793 1.775 . . . . 5.79 115.793 -170.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -76.46 28.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.715 1.598 . . . . 5.4199999999999999 114.75 -177.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.2 m -61.29 134.74 57.29 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.486 -0.759 . . . . 4.1699999999999999 109.746 -141.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -39.37 9.14 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.828 1.418 . . . . 4.6699999999999999 114.828 -161.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -85.74 -28.31 24.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.655 0.983 . . . . 4.0599999999999996 113.655 178.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.81 91.78 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 2.75 111.44 166.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.6 -41.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.485 0.714 . . . . 3.6899999999999999 112.274 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.64 -38.79 75.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.297 0.953 . . . . 2.54 111.677 170.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -68.69 -38.29 80.19 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.062 0.764 . . . . 4.7800000000000002 113.062 173.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.61 -37.9 87.92 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.023 0.829 . . . . 4.1799999999999997 111.217 174.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.6 t -56.61 -47.94 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.951 -1.093 . . . . 2.23 111.721 170.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -79.84 19.9 0.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.493 1.294 . . . . 5.4400000000000004 114.493 174.698 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -92.48 -59.88 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.572 -1.33 . . . . 3.8999999999999999 109.557 160.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -80.79 -53.17 6.73 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.449 1.277 . . . . 4.7199999999999998 114.449 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.3 t -177.35 132.02 0.35 Allowed Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.135 1.374 . . . . 3.0899999999999999 109.031 -174.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.37 -5.72 16.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.184 2.589 . . . . 2.2000000000000002 113.081 -176.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -76.55 -8.56 57.46 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.333 0.969 . . . . 4.7699999999999996 113.401 171.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.48 131.04 44.11 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.32 0.964 . . . . 2.6499999999999999 110.09 169.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.3 t -99.97 129.2 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.757 -1.201 . . . . 3.2200000000000002 107.757 171.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.48 134.48 11.9 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.951 -0.86 . . . . 1.3500000000000001 110.951 172.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.2 161.0 22.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.911 0.884 . . . . 3.1699999999999999 112.129 171.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 9.7 t -162.72 -168.96 1.93 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 129.449 3.1 . . . . 3.4900000000000002 108.165 -176.063 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 173.58 -147.43 9.48 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 120.305 1.411 . . . . 1.9099999999999999 110.418 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.9 p -90.37 164.91 14.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.494 -0.928 . . . . 3.1200000000000001 108.494 157.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -30.17 69.57 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.523 -0.751 . . . . 9.2200000000000006 112.523 -173.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -56.09 -35.61 67.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.861 1.664 . . . . 3.4500000000000002 113.114 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.38 -35.77 54.14 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.792 -1.193 . . . . 3.6600000000000001 112.534 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.04 -35.1 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.009 0.524 . . . . 3.1400000000000001 110.657 171.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -30.45 67.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.226 1.01 . . . . 3.6899999999999999 111.318 174.144 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -60.41 3.91 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.405 1.082 . . . . 3.1000000000000001 110.798 162.428 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.9 p -71.51 -16.28 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.942 1.247 . . . . 3.71 112.806 -168.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.78 -39.62 69.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.974 0.91 . . . . 2.52 110.255 173.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.05 -49.58 76.79 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.384 -0.817 . . . . 4.21 110.478 163.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.9 -16.51 42.91 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 116.501 2.037 . . . . 2.9500000000000002 116.501 -170.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -129.75 15.56 5.87 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.118 . . . . 3.8700000000000001 113.671 173.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 56.61 43.32 25.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.136 1.374 . . . . 6.2599999999999998 112.678 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.51 126.72 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.623 1.569 . . . . 3.96 108.511 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -94.14 149.78 20.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.127 1.371 . . . . 6.0099999999999998 111.577 175.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -165.23 127.88 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.635 1.974 . . . . 5.9500000000000002 110.056 -174.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.1 t -136.42 79.2 42.69 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.826 1.65 . . . . 4.0999999999999996 111.8 -171.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.47 138.0 21.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.66 2.907 . . . . 3.27 113.877 -170.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.76 0 C-N-CA 125.521 1.534 . . . . 3.8199999999999998 112.829 163.784 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 121.489 0.662 . . . . 4.9500000000000002 112.088 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 28.1 mm -77.04 78.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.791 -0.818 . . . . 5.5599999999999996 108.791 169.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.37 146.64 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.414 -1.699 . . . . 4.9299999999999997 106.414 151.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.66 -174.68 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.326 1.06 . . . . 4.6200000000000001 111.315 162.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -146.87 151.31 36.85 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.08 -1.013 . . . . 2.9900000000000002 111.453 138.339 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.1 m -60.09 128.47 36.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.055 1.342 . . . . 4.0 109.309 165.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 15.4 pt -104.07 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.56 1.544 . . . . 6.29 111.579 -177.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.3 mm -128.72 141.12 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.491 1.117 . . . . 3.8300000000000001 109.954 177.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 7.9 ttp -124.35 128.31 48.9 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.621 1.968 . . . . 3.6400000000000001 109.167 173.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.72 141.39 32.58 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.318 1.047 . . . . 4.0700000000000003 112.053 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -104.19 110.86 23.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.632 1.173 . . . . 3.75 110.215 174.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.0 138.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.477 1.511 . . . . 3.3700000000000001 109.38 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.92 160.53 37.19 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.351 -0.694 . . . . 2.3399999999999999 114.089 -178.014 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.53 64.52 4.64 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.593 3.529 . . . . 3.8599999999999999 109.192 167.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.02 -60.69 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.807 1.643 . . . . 4.79 108.254 -154.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 171.59 -70.25 0.12 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 123.798 0.714 . . . . 3.3399999999999999 112.464 -178.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.465 ' CD ' ' HZ1' ' A' ' 153' ' ' LYS . 49.3 mm-40 -118.11 -175.75 2.92 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.594 0.711 . . . . 5.9800000000000004 112.812 -161.195 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -85.05 145.74 27.53 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.329 0.863 . . . . 4.6500000000000004 113.329 -176.043 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 pp -141.93 0.86 1.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.398 1.629 . . . . 4.1600000000000001 115.398 -178.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -157.46 171.54 20.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.742 1.617 . . . . 3.1699999999999999 110.005 171.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -155.67 156.84 35.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.347 1.459 . . . . 4.5300000000000002 113.362 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -147.9 177.6 9.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.796 1.638 . . . . 3.9100000000000001 113.18 -168.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.09 -164.89 37.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 128.188 2.804 . . . . 3.1499999999999999 108.93 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -56.51 -28.16 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.133 0.967 . . . . 3.7799999999999998 113.225 179.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.29 -8.91 58.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 114.336 1.236 . . . . 5.2699999999999996 114.336 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -135.44 98.32 3.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 5.25 108.419 171.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.32 -172.31 4.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.357 0.663 . . . . 6.8200000000000003 112.518 -164.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -50.12 74.89 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.166 -1.584 . . . . 2.98 114.862 -159.08 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.89 -28.68 70.24 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.624 0.647 . . . . 1.96 111.809 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.68 -26.86 60.12 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.282 1.033 . . . . 4.2800000000000002 112.808 177.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.38 -51.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.861 0.865 . . . . 1.95 109.724 167.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.13 93.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.14 0.576 . . . . 2.6099999999999999 111.603 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.91 95.49 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.534 1.134 . . . . 3.25 113.882 177.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 25.1 p -71.73 -39.0 70.4 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.766 1.166 . . . . 2.27 111.982 174.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.11 -40.0 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.335 1.425 . . . . 2.4399999999999999 111.772 176.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.36 -22.0 66.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.26 1.024 . . . . 3.46 113.216 171.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 95.0 m -78.64 -40.27 34.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.928 0.891 . . . . 4.2000000000000002 110.673 170.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.53 -21.79 64.55 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.74 1.216 . . . . 3.3399999999999999 112.974 174.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -63.88 -33.26 75.3 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.848 -1.157 . . . . 5.9100000000000001 112.522 166.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -60.75 -36.22 33.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 116.409 -1.757 . . . . 6.1600000000000001 114.814 -172.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -86.41 -8.65 7.31 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.508 2.805 . . . . 3.5800000000000001 114.452 167.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -94.99 -171.08 2.34 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.54 1.536 . . . . 5.6100000000000003 112.471 179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 . . . . . 0 N--CA 1.471 0.591 0 O-C-N 120.716 -1.24 . . . . 9.3300000000000001 111.184 159.589 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.881 0 CA-C-O 118.24 -1.311 . . . . 4.0800000000000001 111.458 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.95 135.9 66.08 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.606 2.871 . . . . 3.9199999999999999 112.084 -169.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -140.91 176.92 8.41 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.571 -1.65 . . . . 3.8399999999999999 112.516 -168.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.8 t -127.73 132.86 49.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.634 1.974 . . . . 4.5700000000000003 106.168 159.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 tp -164.56 143.18 6.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.977 0.911 . . . . 3.3900000000000001 110.319 -176.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.0 m -93.81 140.29 29.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.746 0.703 . . . . 2.2000000000000002 109.617 -174.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.0 m -101.5 139.32 37.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.829 1.652 . . . . 3.9100000000000001 110.634 -178.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -16.35 1.37 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.597 2.759 . . . . 2.6400000000000001 116.842 -169.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 t -76.65 -35.79 57.76 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.468 1.031 . . . . 4.1600000000000001 112.127 172.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.32 68.42 0.44 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.403 1.477 . . . . 2.8199999999999998 112.257 -166.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.67 148.21 6.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.164 1.785 . . . . 4.8799999999999999 108.747 171.292 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -108.36 115.85 30.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.717 1.207 . . . . 4.9100000000000001 111.662 -175.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -104.5 163.27 12.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.836 1.254 . . . . 4.9000000000000004 112.574 -173.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -119.84 160.73 22.09 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.613 1.965 . . . . 3.8799999999999999 108.054 162.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -49.3 -37.37 23.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.0 1.72 . . . . 4.6399999999999997 111.552 169.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -71.23 -31.48 67.62 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.876 1.065 . . . . 8.4600000000000009 113.876 -177.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.29 -3.77 33.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.101 0.864 . . . . 5.1600000000000001 113.33 175.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -33.01 59.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.383 0.883 . . . . 5.5199999999999996 113.383 160.124 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.12 178.78 0.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.966 1.306 . . . . 6.2999999999999998 113.856 -173.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 8.98 75.44 Favored Glycine 0 N--CA 1.474 1.206 0 O-C-N 121.172 -0.955 . . . . 3.1699999999999999 113.228 -166.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -156.14 165.45 36.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.088 1.755 . . . . 3.8300000000000001 109.428 -177.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -69.51 112.25 5.9 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.965 -0.459 . . . . 2.27 112.206 177.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -98.52 122.65 41.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.613 1.165 . . . . 3.73 110.981 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -118.13 109.16 16.07 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.505 -1.665 . . . . 4.0300000000000002 106.505 176.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.3 pt -111.81 126.82 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.093 0.405 . . . . 4.9299999999999997 112.093 -170.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.31 149.17 51.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 3.9399999999999999 112.208 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -122.77 121.27 35.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.428 1.091 . . . . 4.0999999999999996 109.927 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.38 -178.37 16.95 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 1.6799999999999999 116.123 -169.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.5 151.34 50.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.683 1.193 . . . . 4.9900000000000002 111.686 175.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.9 p -53.63 -30.9 45.09 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.19 1.396 . . . . 4.0999999999999996 113.831 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -143.17 94.42 2.62 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 108.952 -0.758 . . . . 9.1300000000000008 108.952 150.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.414 ' C ' ' H ' ' A' ' 171' ' ' ASP . 9.2 t -38.31 166.77 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 128.377 2.671 . . . . 2.7200000000000002 115.613 160.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -65.54 43.71 0.16 Allowed 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.537 2.825 . . . . 4.4100000000000001 111.815 146.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 169' ' ' CYS 0.28 29.8 m-20 58.03 11.87 1.62 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.154 2.982 . . . . 4.96 116.75 173.913 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.6 -35.99 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.975 0.91 . . . . 3.2799999999999998 110.708 169.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 38.5 m -53.07 -56.24 25.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.635 -1.65 . . . . 2.1200000000000001 114.272 175.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.0 -43.47 11.69 Favored 'Trans proline' 0 C--N 1.351 0.7 0 CA-C-N 122.472 1.918 . . . . 1.76 112.149 177.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -51.52 -46.27 63.21 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.826 1.65 . . . . 3.3199999999999998 112.573 174.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.89 -45.26 24.65 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.121 -0.987 . . . . 2.8900000000000001 112.316 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -62.49 -29.05 70.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.955 -1.091 . . . . 3.3700000000000001 112.313 -177.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -60.42 -52.19 66.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.769 0.828 . . . . 4.0 111.84 168.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -58.08 -50.8 72.2 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 120.17 -1.581 . . . . 3.5899999999999999 110.801 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -57.22 -53.75 54.57 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.705 -0.664 . . . . 3.73 110.99 175.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.7 tp -68.08 -38.35 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.479 1.49 . . . . 3.27 111.197 -170.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.482 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 62.1 mt-30 -65.85 -24.08 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 118.1 -0.952 . . . . 2.9100000000000001 112.168 179.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.18 -19.21 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 120.669 1.577 . . . . 3.6400000000000001 113.732 173.067 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.25 -40.0 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.11 1.323 . . . . 3.0099999999999998 109.394 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -55.4 -48.69 73.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.551 1.541 . . . . 3.9500000000000002 112.401 172.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -70.3 -36.46 74.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.994 0.918 . . . . 3.4399999999999999 112.83 -177.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -77.76 -27.72 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.083 -1.011 . . . . 2.79 112.823 177.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.79 -48.74 79.27 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.244 1.018 . . . . 3.3500000000000001 109.133 165.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.6 t -64.49 -26.73 68.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.405 0.891 . . . . 4.0499999999999998 113.405 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.0 -30.87 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.604 1.161 . . . . 4.3700000000000001 111.786 172.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.4 m 73.47 -36.32 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.788 2.035 . . . . 5.1900000000000004 113.553 167.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 80.1 p -78.94 24.3 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.644 1.978 . . . . 6.5800000000000001 113.11 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.2 mt -134.21 156.28 79.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.345 1.858 . . . . 5.2400000000000002 110.456 174.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.83 -75.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.131 2.554 . . . . 3.3700000000000001 109.625 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.61 167.28 30.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.842 2.057 . . . . 3.4700000000000002 108.06 162.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.17 114.7 26.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.275 1.43 . . . . 2.8399999999999999 108.705 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.5 m -108.38 94.58 13.84 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 123.312 0.645 . . . . 2.8300000000000001 110.887 -168.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.98 131.06 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.813 2.342 . . . . 1.9099999999999999 110.885 170.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.01 139.19 49.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.533 1.159 . . . . 4.9500000000000002 111.621 168.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -109.94 123.65 50.01 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.51 1.924 . . . . 4.0 109.272 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.9 mt -108.79 115.02 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.887 0.875 . . . . 2.8399999999999999 109.554 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.404 ' HG ' ' HB3' ' A' ' 204' ' ' ASP . 8.0 t -83.71 104.69 14.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 2.8100000000000001 108.649 176.504 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.5 pt -79.27 35.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 122.013 0.911 . . . . 2.5600000000000001 111.823 -178.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.404 ' HB3' ' HG ' ' A' ' 202' ' ' SER . 33.3 t0 -126.93 46.94 2.2 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 127.291 2.236 . . . . 3.8999999999999999 111.301 -160.056 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -13.26 36.89 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.456 2.77 . . . . 2.8999999999999999 114.302 -163.104 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -76.88 9.93 2.58 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.906 1.283 . . . . 3.9900000000000002 113.33 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -163.44 25.08 0.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.866 1.432 . . . . 5.2400000000000002 114.866 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -71.21 152.79 43.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.112 0.958 . . . . 5.7000000000000002 111.814 172.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 4.4 m -154.81 122.47 5.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.079 1.752 . . . . 3.4700000000000002 106.499 164.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -46.56 -48.08 19.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.796 1.238 . . . . 4.6200000000000001 113.105 -170.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.43 -30.47 61.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.547 1.139 . . . . 5.1200000000000001 113.525 177.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.14 73.66 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.066 -1.021 . . . . 2.8599999999999999 110.755 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.15 -42.94 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 3.8100000000000001 110.444 173.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.7 77.21 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.333 0.653 . . . . 2.3500000000000001 112.586 176.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -65.66 -45.97 80.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.452 0.701 . . . . 5.2599999999999998 112.56 176.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -49.98 -45.22 51.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.027 0.931 . . . . 3.75 111.387 170.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.4 t -72.56 -39.7 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.74 1.015 . . . . 2.9700000000000002 113.74 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -57.68 -50.5 72.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.214 -0.898 . . . . 4.79 113.291 -176.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -69.6 -17.25 63.52 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.318 1.229 . . . . 6.6100000000000003 114.318 -165.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.82 -32.62 72.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.195 0.907 . . . . 3.73 112.639 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 t 138.2 129.25 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 131.032 3.733 . . . . 3.8300000000000001 109.711 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.32 8.13 1.25 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.549 2.833 . . . . 2.6099999999999999 116.018 -166.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -73.19 -16.06 61.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.036 1.289 . . . . 3.1200000000000001 112.73 161.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.04 137.56 43.48 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.449 -0.782 . . . . 2.8999999999999999 109.223 166.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.57 148.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.377 0.671 . . . . 3.6600000000000001 112.156 171.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.69 138.68 15.1 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 124.501 1.048 . . . . 1.04 112.865 -177.101 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.83 148.32 40.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 114.758 1.392 . . . . 2.96 114.758 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.2 p -155.12 170.61 21.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.576 2.35 . . . . 3.3599999999999999 110.19 -179.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.39 -173.63 37.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.612 1.101 . . . . 1.9399999999999999 111.447 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.8 t -65.27 162.99 16.24 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.161 0.48 . . . . 3.7799999999999998 110.553 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -56.64 -31.84 64.75 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.34 -0.85 . . . . 7.3499999999999996 112.233 -176.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 18.9 mp0 -72.14 -35.75 69.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.799 2.04 . . . . 3.6800000000000002 111.045 178.499 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.66 -39.72 76.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.747 -0.595 . . . . 3.1499999999999999 111.881 169.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.21 -36.47 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.965 0.906 . . . . 2.9199999999999999 111.951 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.15 -46.24 43.65 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.473 1.033 . . . . 4.2400000000000002 110.113 173.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -46.08 -50.68 14.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.622 0.769 . . . . 3.8799999999999999 110.8 173.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.44 -43.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.123 0.969 . . . . 3.79 111.803 -174.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.55 87.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.806 0.842 . . . . 2.8599999999999999 111.906 173.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -32.09 35.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.236 1.814 . . . . 7.8799999999999999 113.013 -177.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.56 -60.86 2.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.835 1.254 . . . . 2.7400000000000002 112.235 176.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -74.68 -6.13 47.01 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.578 0.955 . . . . 3.54 113.578 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 66.66 54.89 0.81 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.63 1.972 . . . . 5.6699999999999999 113.319 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.07 152.27 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.759 2.024 . . . . 4.3799999999999999 110.54 177.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -103.67 145.93 29.33 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.009 1.114 . . . . 5.0599999999999996 114.009 -176.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -129.87 142.63 50.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.536 1.934 . . . . 4.4299999999999997 111.354 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 42.4 t -128.92 106.14 18.28 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 124.059 0.944 . . . . 5.1399999999999997 111.136 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.74 153.28 8.75 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.478 2.785 . . . . 3.6099999999999999 111.138 170.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.591 0 N-CA-C 114.75 0.66 . . . . 3.6699999999999999 114.75 176.305 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.547 0.837 0 CA-C-O 122.195 0.998 . . . . 6.8600000000000003 111.676 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.61 150.17 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.883 -1.136 . . . . 4.3200000000000003 110.917 155.011 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.3 m -156.44 152.63 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.024 1.73 . . . . 6.2800000000000002 107.605 -178.24 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -150.86 145.18 25.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.964 1.364 . . . . 5.9400000000000004 112.077 -179.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -133.13 95.99 3.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.413 1.085 . . . . 2.6699999999999999 109.92 170.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 t -72.54 58.26 0.42 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.852 1.661 . . . . 6.6799999999999997 110.461 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.4 pp -113.09 158.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 122.472 1.13 . . . . 6.54 113.827 -167.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.7 pt -107.55 163.63 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.328 1.451 . . . . 4.7599999999999998 109.014 161.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 76.5 mtp -97.51 159.01 15.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.739 0.816 . . . . 3.7000000000000002 109.869 161.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.32 142.02 45.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.414 0.686 . . . . 3.77 111.116 165.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.2 tp -92.12 118.07 30.46 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 106.535 -1.654 . . . . 3.25 106.535 158.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.18 136.02 31.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.617 -1.623 . . . . 4.0099999999999998 106.617 164.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.48 172.07 45.82 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 2.2999999999999998 111.968 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.17 -13.44 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.191 2.594 . . . . 3.4900000000000002 113.094 177.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -113.57 -0.14 14.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 129.713 3.205 . . . . 4.4199999999999999 112.178 -176.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 108.34 -148.67 16.78 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.917 1.722 . . . . 4.2800000000000002 113.072 -176.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.81 158.64 0.13 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.428 2.691 . . . . 5.9699999999999998 116.543 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.86 85.78 6.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.813 1.245 . . . . 5.0 108.854 172.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.3 tt -86.31 -36.06 19.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.005 0.922 . . . . 4.1699999999999999 111.834 -163.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -159.24 159.88 34.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.895 1.678 . . . . 2.6099999999999999 109.413 175.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -136.46 147.34 47.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 122.676 1.227 . . . . 5.2599999999999998 113.3 172.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.67 156.34 44.4 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.843 1.257 . . . . 3.5899999999999999 111.101 -162.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.21 170.82 42.63 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.874 1.702 . . . . 2.8399999999999999 110.036 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.473 ' H ' ' NE2' ' A' ' 279' ' ' GLN . 1.9 mp0 -55.88 -25.35 42.19 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.913 2.19 . . . . 4.5 116.913 -149.625 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.85 -21.35 25.06 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.512 1.301 . . . . 6.8099999999999996 114.512 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -57.93 107.07 0.42 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.769 1.628 . . . . 4.7400000000000002 108.593 178.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -74.93 143.8 43.55 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.395 -1.441 . . . . 7.1299999999999999 109.813 -157.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.482 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.1 tmtt? -42.79 -53.0 4.8 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 121.095 1.77 . . . . 2.6699999999999999 113.438 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -18.38 74.92 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.361 0.904 . . . . 1.6399999999999999 115.361 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -31.78 17.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.877 1.271 . . . . 4.6200000000000001 111.395 174.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.2 mt -56.36 -43.5 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.103 -0.998 . . . . 2.54 109.901 161.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.46 -53.17 58.75 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.54 0.57 . . . . 2.1800000000000002 112.54 170.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.05 72.1 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.562 1.319 . . . . 2.4199999999999999 114.562 -177.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.9 p -68.92 -48.83 62.33 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.446 -0.783 . . . . 2.6899999999999999 111.07 170.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.24 -34.05 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.28 1.4 . . . . 2.3999999999999999 111.709 176.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.35 -21.18 62.92 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.118 0.967 . . . . 2.0699999999999998 113.494 172.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 100.0 m -76.98 -45.65 26.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.722 0.809 . . . . 2.7200000000000002 109.537 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -62.83 -21.11 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.855 1.262 . . . . 2.9199999999999999 113.402 174.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -66.5 -23.49 66.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.086 1.355 . . . . 5.0999999999999996 113.287 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -59.8 -45.48 98.36 Favored Pre-proline 0 N--CA 1.477 0.891 0 O-C-N 119.971 -1.706 . . . . 6.0 113.277 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.6 -57.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.554 2.169 . . . . 2.2599999999999998 111.491 164.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -83.63 23.47 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.029 1.862 . . . . 4.9100000000000001 116.029 -167.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 ptt85 . . . . . 0 N--CA 1.471 0.618 0 C-N-CA 125.606 1.563 . . . . 9.5700000000000003 111.752 174.686 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 N-CA-C 108.149 -1.98 . . . . 4.29 108.149 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.33 134.94 25.73 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.667 2.245 . . . . 4.5300000000000002 111.772 -161.531 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -75.51 -179.97 4.92 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.497 1.519 . . . . 3.46 113.194 -172.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.2 m -157.83 62.1 0.47 Allowed 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.246 -1.534 . . . . 3.8700000000000001 112.695 177.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -98.8 160.74 14.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.556 1.142 . . . . 3.3100000000000001 110.511 -177.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -103.42 139.86 38.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.635 1.574 . . . . 2.6299999999999999 111.656 -164.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -94.59 158.93 15.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.877 1.799 . . . . 2.4500000000000002 115.706 -167.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.439 ' O ' ' HE3' ' A' ' 210' ' ' LYS . 0.3 OUTLIER -57.39 -21.7 37.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.481 1.912 . . . . 2.2599999999999998 113.327 164.349 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -71.76 -68.85 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.194 1.398 . . . . 3.8700000000000001 109.086 160.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.28 -12.44 1.6 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 124.769 1.176 . . . . 1.98 115.114 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.3 153.94 41.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.812 1.306 . . . . 4.2000000000000002 110.626 166.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -85.26 135.14 34.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.449 -0.574 . . . . 5.8600000000000003 109.449 153.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -120.27 153.86 35.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.833 0.853 . . . . 3.6899999999999999 110.198 178.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 153' ' ' LYS . 12.1 p -141.14 156.46 45.95 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.701 1.2 . . . . 3.6299999999999999 110.705 -166.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.09 13.61 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.189 0.996 . . . . 3.9300000000000002 113.444 168.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 151' ' ' THR . 86.5 mttt -103.67 -32.11 9.55 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.225 -1.547 . . . . 8.2799999999999994 112.684 167.52 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -96.81 -22.59 16.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.646 1.178 . . . . 3.4700000000000002 112.731 177.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -77.83 -15.31 59.16 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.573 0.953 . . . . 4.2300000000000004 113.573 162.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.37 133.65 56.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.618 1.167 . . . . 4.1799999999999997 110.551 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.32 6.68 88.51 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.273 -0.892 . . . . 2.5099999999999998 114.199 -176.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 159' ' ' TRP . 1.2 tp-100 -84.98 -155.73 0.22 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.088 1.444 . . . . 3.48 110.449 163.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . 0.409 ' H ' ' HG3' ' A' ' 158' ' ' GLN . 97.8 m95 -136.12 111.56 9.2 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.003 -1.481 . . . . 2.1200000000000001 107.003 153.065 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.22 148.3 41.33 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.483 1.135 . . . . 3.5600000000000001 113.163 -173.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.43 114.86 27.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.69 1.596 . . . . 3.8700000000000001 106.977 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.47 111.31 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.035 -1.839 . . . . 4.3899999999999997 106.035 -177.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -108.91 139.99 43.0 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.163 0.982 . . . . 3.54 113.278 -173.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -111.68 92.94 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.579 2.352 . . . . 3.4199999999999999 110.877 175.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -130.69 154.47 20.72 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.426 1.965 . . . . 1.6000000000000001 109.681 166.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -97.18 157.0 16.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.688 0.744 . . . . 7.2699999999999996 111.093 -175.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 53.1 p -70.66 -3.71 19.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.388 -1.445 . . . . 4.1100000000000003 113.336 172.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -67.74 -47.2 69.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.215 1.806 . . . . 8.6300000000000008 114.316 -178.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.9 m -102.92 119.62 54.98 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.448 1.022 . . . . 2.6400000000000001 113.504 -150.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -90.85 44.34 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.353 2.702 . . . . 6.5499999999999998 111.16 174.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.88 -104.45 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.138 -1.43 . . . . 6.0499999999999998 107.138 -157.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.11 -66.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.221 1.808 . . . . 4.2300000000000004 114.2 171.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 87.6 m -51.49 -48.74 85.7 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.868 1.433 . . . . 1.7 114.868 -174.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.25 -31.63 14.06 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.399 2.066 . . . . 1.4099999999999999 113.571 175.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -64.37 -36.04 82.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.399 1.454 . . . . 3.3900000000000001 110.734 171.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -33.71 76.46 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.546 -1.346 . . . . 3.1800000000000002 112.809 174.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.15 -36.96 75.11 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.336 -0.84 . . . . 4.0300000000000002 112.11 171.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -60.24 3.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.937 1.295 . . . . 4.5899999999999999 111.423 -178.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -20.01 66.15 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 119.623 -1.923 . . . . 3.9500000000000002 113.713 175.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 29.8 ttm -70.89 -45.02 65.08 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.636 1.107 . . . . 3.04 111.217 172.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -57.33 -47.57 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.311 -0.868 . . . . 3.2599999999999998 110.076 174.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -54.58 -20.76 8.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.201 1.186 . . . . 4.8600000000000003 114.201 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.73 -25.79 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.336 1.235 . . . . 3.6200000000000001 114.336 177.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -54.46 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.62 1.1 . . . . 3.5 108.84 165.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -57.13 -37.87 72.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.475 1.11 . . . . 4.6900000000000004 113.034 177.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.29 -40.73 50.88 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.345 -0.847 . . . . 2.9300000000000002 112.814 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mt -66.86 -34.8 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.876 0.762 . . . . 2.6299999999999999 110.833 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.405 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 1.2 m-20 -67.81 -44.89 76.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.541 1.136 . . . . 3.6600000000000001 111.588 167.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -64.67 -27.59 69.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.393 -1.442 . . . . 3.29 112.862 177.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.86 -19.69 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.218 1.407 . . . . 3.9100000000000001 112.022 172.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.3 m 73.96 -35.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 127.225 2.21 . . . . 5.7400000000000002 114.212 162.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -97.63 4.14 50.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.802 1.641 . . . . 5.3700000000000001 112.96 178.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.73 152.07 37.94 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.255 -1.017 . . . . 4.25 108.255 158.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -94.95 -23.18 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.742 2.295 . . . . 3.79 114.474 -162.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.7 t70 170.65 150.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.333 2.653 . . . . 3.6600000000000001 110.334 -173.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 11.0 tp -132.28 100.39 5.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.182 1.793 . . . . 2.9300000000000002 108.376 156.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 m -81.71 121.71 79.77 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-O 118.118 -0.944 . . . . 2.4500000000000002 110.906 -178.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.24 117.96 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.128 3.218 . . . . 1.6399999999999999 110.409 168.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.32 119.12 34.69 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 3.7000000000000002 109.224 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -102.76 112.66 25.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.983 0.913 . . . . 4.0199999999999996 110.66 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 9.5 mm -82.55 122.51 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 107.254 -1.387 . . . . 2.6899999999999999 107.254 165.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.9 p -71.66 -29.46 64.64 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.499 1.666 . . . . 4.0 115.499 -175.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . 0.329 14.1 pt 53.2 -6.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 119.825 3.269 . . . . 4.4699999999999998 119.825 168.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -119.87 62.27 7.75 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.485 1.914 . . . . 3.5600000000000001 112.196 161.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -59.3 140.49 94.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 107.95 -1.596 . . . . 2.3999999999999999 107.95 161.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 231' ' ' ARG . 32.7 mt-10 108.8 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.394 3.878 . . . . 4.8799999999999999 112.357 -174.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -107.61 4.74 26.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.161 0.892 . . . . 6.2599999999999998 112.303 163.163 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.41 -179.44 7.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.39 1.476 . . . . 5.5800000000000001 112.246 -175.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.6 m -167.27 129.67 1.68 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 128.129 2.572 . . . . 3.0299999999999998 105.791 162.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 145' ' ' HIS . 1.2 tmtp? -54.08 -43.47 70.36 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.472 0.709 . . . . 3.8599999999999999 112.478 -175.461 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -67.81 -31.52 71.43 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.741 1.617 . . . . 3.1000000000000001 113.256 173.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.02 73.79 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.566 -1.334 . . . . 2.29 111.768 175.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.94 -38.15 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.537 0.735 . . . . 3.7000000000000002 111.036 170.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.9 69.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.838 0.745 . . . . 2.2599999999999998 112.822 174.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.01 -49.33 52.47 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.357 -0.84 . . . . 5.4900000000000002 111.584 170.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.16 -30.94 71.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.708 0.633 . . . . 4.0700000000000003 112.708 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.58 -60.21 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.005 1.322 . . . . 2.5099999999999998 110.92 162.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -62.18 -30.74 71.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.388 0.884 . . . . 6.3700000000000001 113.388 -174.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.22 -34.94 72.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.23 1.412 . . . . 4.6299999999999999 111.964 -177.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -108.67 -21.41 12.71 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.689 1.366 . . . . 4.5999999999999996 114.689 -174.183 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.4 p 159.17 151.38 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.888 2.475 . . . . 3.0600000000000001 112.015 167.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.54 -3.29 10.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.861 2.374 . . . . 2.3199999999999998 114.413 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . 0.405 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 19.1 ttmt -87.07 -8.62 56.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.008 1.276 . . . . 2.9700000000000002 113.395 171.788 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.64 123.19 18.2 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.029 -1.669 . . . . 4.25 109.567 171.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.36 116.17 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.293 -1.002 . . . . 3.8700000000000001 108.293 165.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.57 141.51 15.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.458 1.028 . . . . 1.1200000000000001 111.271 -177.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.44 151.29 37.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.961 1.097 . . . . 3.9700000000000002 113.961 -175.229 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 25.5 p -133.53 170.78 15.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.588 3.155 . . . . 4.1500000000000004 108.908 -176.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.81 161.06 15.04 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.902 1.715 . . . . 2.0299999999999998 109.455 -173.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.4 p -69.03 169.11 12.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.048 1.424 . . . . 3.0099999999999998 112.266 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 206' ' ' GLU . 99.6 mtt180 -40.7 -43.4 1.95 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.973 1.709 . . . . 6.4400000000000004 112.732 170.256 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -67.53 -38.38 84.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.505 1.122 . . . . 3.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.51 -47.63 59.53 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.119 -0.988 . . . . 3.4700000000000002 111.453 174.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.1 m -65.6 -24.77 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.851 0.686 . . . . 4.0899999999999999 112.851 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.11 -33.43 29.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.194 0.906 . . . . 3.0299999999999998 112.34 169.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -59.61 -51.48 69.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.42 1.464 . . . . 2.7599999999999998 110.655 171.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.52 -20.64 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.31 0.485 . . . . 3.0 112.31 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.4 -54.37 14.77 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.947 0.794 . . . . 2.98 110.789 167.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.75 -45.09 82.22 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.258 1.423 . . . . 3.5699999999999998 111.844 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.41 -56.45 14.96 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.335 1.054 . . . . 3.04 112.404 -175.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.53 10.72 26.73 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.122 -0.986 . . . . 4.8399999999999999 113.576 176.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 61.24 33.45 19.13 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.343 1.457 . . . . 6.1299999999999999 113.655 177.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.32 147.96 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.535 2.334 . . . . 4.1299999999999999 110.447 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -119.83 153.16 36.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.421 1.105 . . . . 6.8399999999999999 113.413 168.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -124.45 146.33 48.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 6.4800000000000004 109.317 171.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 26.2 m -123.51 72.29 49.56 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.721 1.208 . . . . 4.1900000000000004 110.329 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.66 125.03 10.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.603 2.202 . . . . 3.4399999999999999 111.574 -171.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.414 0 CA-C-O 118.454 -1.192 . . . . 2.52 111.377 178.551 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.887 0.851 . . . . 5.3700000000000001 109.771 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.97 167.14 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.817 1.247 . . . . 3.7400000000000002 112.744 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 58.6 t -149.62 129.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 105.392 -2.077 . . . . 3.8900000000000001 105.392 156.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.16 158.34 19.17 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.267 0.94 . . . . 3.6299999999999999 110.451 167.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.06 132.98 7.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.499 1.296 . . . . 3.0699999999999998 114.499 -153.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.72 -12.8 37.71 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.713 2.116 . . . . 4.5199999999999996 116.713 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.31 5.8 tt 43.48 55.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 126.211 1.804 . . . . 4.0999999999999996 115.441 169.26 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.3 mm -103.46 146.41 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.694 1.198 . . . . 3.96 111.005 174.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 77.3 mtp -108.3 117.11 33.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.789 1.636 . . . . 3.1600000000000001 109.987 158.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.76 135.68 39.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.975 0.91 . . . . 3.5899999999999999 112.694 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 56.6 tp -93.61 118.23 31.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.283 1.033 . . . . 3.2799999999999998 110.998 178.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.4 148.88 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.43 1.092 . . . . 3.27 108.333 169.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -175.32 -142.17 4.02 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.481 -1.177 . . . . 3.6099999999999999 112.43 -172.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -88.56 70.43 2.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.399 2.733 . . . . 3.02 110.069 -171.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -169.96 -67.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.113 1.365 . . . . 4.6600000000000001 108.678 -163.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.82 -4.54 69.39 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 116.543 -2.254 . . . . 2.96 116.658 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.44 -47.84 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.497 2.148 . . . . 6.0499999999999998 111.742 176.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 162.24 121.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.436 2.694 . . . . 5.5499999999999998 111.051 171.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.83 -46.9 6.69 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.207 0.817 . . . . 5.1500000000000004 113.207 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.74 164.18 9.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.526 1.93 . . . . 2.5699999999999998 109.237 -170.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -158.39 135.02 9.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.838 1.255 . . . . 4.6399999999999997 112.993 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -114.57 118.49 33.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.608 1.163 . . . . 3.6200000000000001 108.711 -176.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.12 112.5 3.47 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 118.936 -0.924 . . . . 3.9900000000000002 111.386 -174.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 52.62 60.72 3.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.47 1.129 . . . . 3.6299999999999999 108.723 -155.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.7 p30 42.68 -147.58 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.401 2.28 . . . . 7.9000000000000004 114.244 -172.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -147.31 -4.93 0.51 Allowed 'General case' 0 CA--C 1.549 0.91 0 O-C-N 120.297 -1.502 . . . . 5.29 114.018 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 72.61 136.39 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.03 2.932 . . . . 8.8100000000000005 109.243 -163.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -47.53 63.81 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.375 1.621 . . . . 3.8399999999999999 115.375 -155.345 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.82 -17.14 73.0 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 123.925 0.774 . . . . 1.8600000000000001 114.518 -175.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.71 -29.02 61.05 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.327 1.063 . . . . 5.4400000000000004 111.582 174.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.09 -40.72 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.585 -0.697 . . . . 2.54 109.477 174.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.99 88.09 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.951 -0.468 . . . . 2.5099999999999998 111.599 171.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.06 79.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.185 0.809 . . . . 2.79 113.185 176.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 60.5 p -59.74 -60.2 4.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.514 0.726 . . . . 2.5699999999999998 111.721 174.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.4 mm -58.92 -35.52 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 119.305 0.957 . . . . 4.0300000000000002 111.95 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.28 73.69 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.483 -0.761 . . . . 2.7000000000000002 112.932 175.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.8 m -76.09 -36.51 58.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.999 1.32 . . . . 3.0499999999999998 110.806 173.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.038 0.835 . . . . 3.8700000000000001 112.025 173.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 32.5 mmt -65.55 -10.2 33.04 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.667 -1.27 . . . . 6.3099999999999996 114.043 168.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -57.07 2.88 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.39 -1.766 . . . . 8.3800000000000008 112.081 172.381 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.55 -51.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.043 2.495 . . . . 2.52 112.738 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -72.08 169.66 15.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.839 0.856 . . . . 4.71 110.948 176.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 36.6 mmt-85 . . . . . 0 N--CA 1.474 0.728 0 O-C-N 120.604 -1.31 . . . . 9.8000000000000007 112.521 -167.622 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 118.462 -0.78 . . . . 19.129999999999999 110.106 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -81.53 46.9 1.0 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.425 1.09 . . . . 17.75 113.257 -173.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -161.54 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.837 2.055 . . . . 13.279999999999999 110.595 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.51 -176.78 27.28 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.138 -0.976 . . . . 10.56 113.322 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.5 mttp 107.83 -32.64 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 130.549 3.54 . . . . 11.630000000000001 116.806 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -82.28 179.7 5.3 Favored 'Trans proline' 0 C--N 1.355 0.898 0 CA-C-N 122.992 2.104 . . . . 9.5 111.077 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -52.65 129.28 28.92 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.953 1.701 . . . . 12.039999999999999 111.433 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -118.7 -167.1 1.32 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.85 1.66 . . . . 8.5500000000000007 113.629 -173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.31 137.51 3.09 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.496 1.522 . . . . 4.2199999999999998 111.189 -172.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.4 114.09 5.24 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.25 -1.305 . . . . 3.4300000000000002 110.518 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.63 147.87 36.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.191 1.928 . . . . 3.6899999999999999 110.164 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -143.88 154.19 43.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.602 0.761 . . . . 4.75 111.062 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 m -122.87 15.74 10.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.595 1.702 . . . . 3.2999999999999998 115.595 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.37 147.89 50.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.152 2.181 . . . . 3.29 112.419 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.31 151.09 24.97 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.713 1.605 . . . . 3.6299999999999999 109.971 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 146' ' ' THR . 0.6 OUTLIER -95.64 161.83 13.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.656 1.217 . . . . 3.8799999999999999 111.971 175.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -45.49 -28.24 0.88 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.257 2.623 . . . . 1.8200000000000001 115.248 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 144' ' ' THR . 10.3 m -72.02 -20.1 61.75 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.451 1.9 . . . . 3.75 113.456 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.33 11.78 56.87 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.073 1.32 . . . . 2.29 114.559 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.5 -162.73 0.98 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.929 1.291 . . . . 4.3200000000000003 110.45 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -144.07 103.74 4.05 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.496 1.044 . . . . 5.0700000000000003 113.06 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 175.68 5.49 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.682 1.364 . . . . 5.6500000000000004 114.682 173.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.4 p -137.19 -179.28 5.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.446 2.298 . . . . 3.25 111.092 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.44 -26.94 62.03 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.703 -1.248 . . . . 3.5899999999999999 112.916 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -94.68 -19.45 20.41 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.051 1.871 . . . . 8.0099999999999998 116.051 -167.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -71.21 -28.79 64.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.26 1.391 . . . . 3.0299999999999998 112.102 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -96.04 40.83 1.11 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.276 1.03 . . . . 5.6299999999999999 112.535 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.64 169.15 13.34 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.254 -0.903 . . . . 6.3399999999999999 112.409 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 75.93 -10.05 15.66 Favored Glycine 0 CA--C 1.54 1.635 0 O-C-N 120.517 -1.365 . . . . 2.52 116.319 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -116.02 156.23 26.69 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.671 2.388 . . . . 3.25 110.094 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -70.88 100.31 1.92 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.569 1.077 . . . . 1.8100000000000001 111.176 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.9 mt -83.85 134.57 34.7 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.138 0.971 . . . . 3.5600000000000001 109.907 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.69 112.59 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.42 -1.696 . . . . 3.8199999999999998 106.42 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.1 pt -114.77 122.21 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.079 0.552 . . . . 3.8300000000000001 109.547 -165.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -111.79 143.74 42.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.791 1.236 . . . . 3.8199999999999998 112.024 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.02 104.5 12.76 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.414 1.486 . . . . 3.1800000000000002 108.681 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -120.5 -176.18 15.6 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.39 1.471 . . . . 1.3600000000000001 114.852 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -157.5 115.75 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.739 2.015 . . . . 5.0099999999999998 106.406 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.6 m -76.28 71.89 3.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.215 1.406 . . . . 4.5599999999999996 110.178 -166.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 173.79 -48.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.17 2.588 . . . . 7.6299999999999999 110.338 -158.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 52.1 -161.86 0.01 OUTLIER Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.664 2.385 . . . . 3.9399999999999999 115.321 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -71.66 -74.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 124.7 3.6 . . . . 5.7599999999999998 110.619 120.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -163.68 30.17 0.08 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.482 1.037 . . . . 4.2199999999999998 113.735 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.8 -17.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 115.311 1.597 . . . . 4.3499999999999996 115.311 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 29.7 m -49.7 -48.3 77.11 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 116.354 -1.784 . . . . 1.72 112.888 155.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.14 -39.89 9.73 Favored 'Trans proline' 0 C--N 1.354 0.825 0 CA-C-N 122.751 2.018 . . . . 2.0099999999999998 112.206 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.67 -48.49 81.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.381 1.072 . . . . 3.52 111.076 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 4.9 tp10 -75.44 -22.38 57.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.012 0.925 . . . . 3.7400000000000002 112.871 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.25 -37.65 78.07 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 116.762 -1.589 . . . . 3.73 110.897 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -52.53 65.24 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.236 1.835 . . . . 5.2400000000000002 109.41 170.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 38.8 mtmt -63.35 -39.35 94.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.409 0.522 . . . . 4.1699999999999999 112.409 -174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.6 ttm -57.41 -49.0 77.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.493 1.517 . . . . 3.7000000000000002 111.518 167.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.25 -41.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.568 1.147 . . . . 2.98 113.105 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.429 ' HG3' ' HE2' ' A' ' 283' ' ' LYS . 35.6 mm-40 -70.88 -50.67 32.57 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.02 1.282 . . . . 3.9300000000000002 109.159 173.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -17.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.879 1.437 . . . . 3.25 114.879 -169.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.81 -45.72 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 119.441 1.019 . . . . 3.3399999999999999 110.931 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.21 -25.67 18.55 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.259 0.466 . . . . 6.0499999999999998 112.259 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.507 ' CD ' ' HZ2' ' A' ' 283' ' ' LYS . 54.7 mt-10 -65.07 -29.36 70.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.781 1.232 . . . . 2.9100000000000001 113.055 166.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -45.22 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 118.508 -0.758 . . . . 3.1600000000000001 112.767 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.407 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 0.9 OUTLIER -61.97 -30.92 71.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.145 1.339 . . . . 4.8399999999999999 110.924 174.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.3 t -60.78 -24.47 65.81 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.298 1.839 . . . . 3.04 113.184 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.44 -26.58 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.113 -1.617 . . . . 6.0899999999999999 110.403 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.7 m 76.85 -36.72 0.26 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.31 2.244 . . . . 5.0999999999999996 112.966 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.4 m -73.48 -22.96 60.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.396 1.478 . . . . 6.2300000000000004 113.1 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.3 156.46 81.45 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 121.18 -0.95 . . . . 4.5199999999999996 110.808 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.447 ' HG2' ' H ' ' A' ' 195' ' ' ASP . 55.6 Cg_endo -66.66 -62.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.713 2.275 . . . . 3.2799999999999998 109.338 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . 0.447 ' H ' ' HG2' ' A' ' 194' ' ' PRO . 5.6 p-10 -171.21 157.08 4.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.613 3.565 . . . . 4.6399999999999997 107.909 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.94 125.68 48.68 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.975 -0.75 . . . . 3.8199999999999998 108.975 156.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.8 m -112.55 111.51 51.96 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.105 1.362 . . . . 2.5699999999999998 110.062 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.71 134.08 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.734 2.956 . . . . 1.24 111.717 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.65 116.32 25.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.425 1.09 . . . . 3.1400000000000001 109.778 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.24 112.93 24.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 4.0999999999999996 109.679 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.7 mm -99.7 123.58 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.494 -1.298 . . . . 3.2799999999999998 107.494 166.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 9.8 t -90.64 153.79 20.05 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.565 -0.709 . . . . 2.7200000000000002 109.861 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.9 pt -115.95 -2.23 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.015 1.117 . . . . 3.1699999999999999 114.015 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -119.54 74.71 17.33 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 120.144 1.338 . . . . 3.48 110.287 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.5 160.38 50.01 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.507 2.805 . . . . 3.3100000000000001 110.722 -169.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 77.53 -51.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.237 2.615 . . . . 7.4900000000000002 109.392 -172.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -63.62 -52.3 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.507 1.123 . . . . 6.9100000000000001 109.43 172.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.4 83.21 5.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.369 1.08 . . . . 5.1900000000000004 109.178 159.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -64.94 132.61 49.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.289 -0.869 . . . . 3.6400000000000001 109.136 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -43.93 -50.22 8.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.623 1.169 . . . . 3.96 112.895 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -27.02 61.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.353 1.242 . . . . 3.6200000000000001 114.353 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.18 87.96 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.052 -1.03 . . . . 3.3199999999999998 110.651 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.78 -36.0 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.929 0.892 . . . . 3.0 110.35 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.48 -17.83 15.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.572 1.149 . . . . 2.0899999999999999 113.757 166.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -88.89 -47.9 7.84 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.991 -1.068 . . . . 5.4100000000000001 112.792 167.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -58.19 -38.47 76.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.116 0.966 . . . . 4.75 112.576 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.4 t -54.28 -60.44 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.963 1.705 . . . . 2.1400000000000001 110.68 165.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -66.16 -40.8 90.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.517 1.527 . . . . 4.9199999999999999 114.698 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.92 -28.9 58.19 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.03 1.122 . . . . 3.4500000000000002 114.03 -172.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -77.96 -53.01 7.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.461 0.573 . . . . 5.46 112.024 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.1 t -169.42 136.84 1.49 Allowed Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.422 1.089 . . . . 3.3700000000000001 110.916 168.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.91 -4.64 11.71 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.247 2.631 . . . . 1.8 113.996 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . 0.407 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 17.1 tttt -71.29 -14.25 62.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.964 1.256 . . . . 3.3599999999999999 113.521 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.81 140.75 55.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.361 1.064 . . . . 4.1900000000000004 112.58 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.3 t -118.36 130.88 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.998 1.319 . . . . 2.7999999999999998 108.578 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -124.54 121.56 4.42 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.683 0.659 . . . . 1.1200000000000001 114.051 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.77 159.46 15.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.921 1.288 . . . . 4.3099999999999996 113.215 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -152.86 150.47 29.35 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.517 1.927 . . . . 3.48 108.899 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -172.09 165.24 37.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.952 -2.059 . . . . 1.8 107.952 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -70.55 172.63 8.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.877 0.839 . . . . 4.0099999999999998 111.959 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.439 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 30.4 ptt180 -43.01 -38.81 2.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.412 1.485 . . . . 8.9600000000000009 113.691 173.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -64.68 -37.94 89.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.095 1.358 . . . . 3.0899999999999999 111.669 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.77 -44.65 22.81 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.653 1.181 . . . . 2.9300000000000002 113.281 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.8 m -65.97 -27.11 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.074 0.397 . . . . 3.9399999999999999 111.739 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.77 -45.68 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.269 -0.872 . . . . 3.1000000000000001 112.054 165.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -50.0 -58.39 5.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.862 1.21 . . . . 3.7400000000000002 110.981 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.72 -25.69 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.181 0.9 . . . . 3.0099999999999998 112.023 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.77 -40.35 72.69 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.983 -0.448 . . . . 2.1299999999999999 110.292 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -71.2 -38.32 72.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.23 1.012 . . . . 5.7999999999999998 112.237 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -44.48 85.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.354 1.462 . . . . 2.7000000000000002 113.82 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -100.89 5.82 43.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.462 1.105 . . . . 3.1099999999999999 113.523 170.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 64.2 37.89 8.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.787 2.035 . . . . 6.0499999999999998 113.732 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.32 151.18 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.694 0.798 . . . . 3.3999999999999999 111.749 -173.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 140.36 36.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.811 0.845 . . . . 5.7000000000000002 112.318 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.45 165.67 26.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.5 2.32 . . . . 5.0300000000000002 109.875 168.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.69 106.29 1.06 Allowed Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 121.249 -0.907 . . . . 3.2200000000000002 110.781 175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -94.98 134.29 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.411 2.741 . . . . 2.8399999999999999 112.632 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.44 115.84 4.71 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.309 1.433 . . . . 2.8599999999999999 111.144 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.24 161.52 32.07 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.266 2.644 . . . . 6.2800000000000002 111.631 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 143.16 51.44 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.014 1.116 . . . . 8.4499999999999993 114.014 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -115.9 -72.21 0.7 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 117.99 -1.005 . . . . 7.9199999999999999 111.482 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -67.89 -58.15 5.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.972 1.26 . . . . 7.7999999999999998 110.159 166.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . 0.251 24.5 p30 166.71 -36.23 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 128.926 2.89 . . . . 6.79 115.032 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -91.42 50.6 1.76 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.868 1.318 . . . . 8.3399999999999999 111.928 -173.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -161.77 146.01 12.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.483 1.513 . . . . 6.0 110.059 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -166.75 49.7 0.07 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.854 2.462 . . . . 5.8499999999999996 108.747 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp -49.86 152.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 126.621 1.968 . . . . 4.2300000000000004 113.849 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.48 130.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.221 1.408 . . . . 4.21 108.145 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.69 141.15 31.68 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.654 1.582 . . . . 3.7400000000000002 110.709 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -126.82 155.67 42.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.707 0.765 . . . . 3.21 111.549 165.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.7 m -62.78 113.44 3.04 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 4.3200000000000003 109.6 168.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.31 44.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.316 1.046 . . . . 4.9199999999999999 112.849 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.7 mt -132.95 135.5 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.123 0.969 . . . . 3.25 110.653 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.3 ptp -104.01 142.96 33.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.112 1.365 . . . . 3.3700000000000001 110.911 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -99.88 141.71 32.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.346 1.058 . . . . 3.4199999999999999 112.019 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -101.8 119.34 38.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.884 1.274 . . . . 3.8500000000000001 109.243 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 63.4 mt -100.16 138.16 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.915 1.686 . . . . 3.3399999999999999 107.887 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 171.45 42.05 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.54 1.067 . . . . 2.1000000000000001 111.515 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -82.7 66.1 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.249 2.633 . . . . 2.77 109.367 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -177.52 -69.17 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.553 2.341 . . . . 4.9400000000000004 108.988 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 160.55 -21.61 0.24 Allowed Glycine 0 CA--C 1.538 1.527 0 N-CA-C 117.02 1.568 . . . . 2.9100000000000001 117.02 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.76 152.89 44.73 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.965 1.382 . . . . 6.6600000000000001 112.429 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -99.45 129.51 45.64 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.38 -1.45 . . . . 5.6500000000000004 112.271 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.95 -18.07 10.23 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.74 1.385 . . . . 4.1699999999999999 114.74 -167.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -162.98 171.46 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.633 1.173 . . . . 2.6699999999999999 110.987 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -148.51 149.02 30.9 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.144 1.377 . . . . 3.7000000000000002 111.527 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.403 ' CD1' HG12 ' A' ' 286' ' ' ILE . 1.4 m-85 -130.0 105.0 7.68 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.105 1.362 . . . . 3.6600000000000001 109.737 -173.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -86.01 153.27 26.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.225 -1.95 . . . . 2.7000000000000002 108.225 153.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -17.05 2.99 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 117.279 2.326 . . . . 5.8899999999999997 117.279 -164.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -63.2 -27.47 69.38 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.943 1.09 . . . . 6.25 113.943 169.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -92.87 96.0 9.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.025 1.73 . . . . 5.1399999999999997 109.744 165.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.15 176.87 8.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.737 1.615 . . . . 5.5199999999999996 112.753 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.507 ' HZ2' ' CD ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -57.28 -27.3 62.0 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.022 1.86 . . . . 3.3799999999999999 116.022 -169.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.7 -36.2 53.83 Favored Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.527 -0.733 . . . . 1.71 112.07 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.77 -31.8 46.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.082 1.753 . . . . 3.5699999999999998 111.216 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . 0.403 HG12 ' CD1' ' A' ' 277' ' ' PHE . 79.0 mt -64.85 -45.44 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 2.2599999999999998 110.077 166.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.55 87.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.175 0.898 . . . . 2.3100000000000001 111.095 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.91 97.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.087 0.858 . . . . 2.8300000000000001 113.092 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 94.2 p -74.55 -38.42 62.73 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.99 -1.069 . . . . 2.79 113.414 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.01 -35.64 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.662 1.573 . . . . 2.1200000000000001 111.707 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.01 -18.77 63.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.531 -1.356 . . . . 2.2799999999999998 113.479 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.1 m -74.83 -55.1 6.17 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.407 -0.808 . . . . 2.96 109.737 167.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -64.55 -22.58 67.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.876 1.67 . . . . 3.3999999999999999 113.555 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -42.09 46.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.814 1.646 . . . . 6.0700000000000003 112.157 165.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -64.21 -55.36 31.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 116.419 -1.753 . . . . 6.3600000000000003 113.249 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.47 -38.34 1.97 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.284 1.989 . . . . 3.0499999999999998 112.686 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 17.66 7.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.752 1.019 . . . . 4.3899999999999997 113.752 -173.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.95 134.06 55.32 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 7.8899999999999997 113.198 -164.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -109.76 -179.0 3.68 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.959 1.304 . . . . 12.17 111.967 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 81.0 mttt 58.21 -134.02 1.08 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 117.309 -1.329 . . . . 7.9199999999999999 110.226 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 C--O 1.248 1.016 0 C-N-CA 125.812 1.645 . . . . 7.6299999999999999 113.929 -172.303 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 116.785 -1.579 . . . . 17.690000000000001 108.232 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -64.1 -51.42 64.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.74 1.609 . . . . 14.779999999999999 108.904 152.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.7 m -59.68 135.37 57.66 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.387 1.475 . . . . 13.369999999999999 110.495 165.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -159.88 -178.92 34.3 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 127.135 2.302 . . . . 10.130000000000001 110.76 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.99 147.38 10.29 Favored Pre-proline 0 N--CA 1.476 0.829 0 CA-C-O 117.819 -1.086 . . . . 10.59 111.932 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.35 160.09 50.71 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.522 2.148 . . . . 8.1699999999999999 110.682 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 mt -158.94 161.3 36.72 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.769 2.027 . . . . 10.59 107.986 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mp -134.18 -162.62 1.27 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.405 1.082 . . . . 6.6299999999999999 110.243 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.72 163.17 19.92 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.747 1.165 . . . . 4.5700000000000003 112.05 -159.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.14 81.66 0.3 Allowed Glycine 0 CA--C 1.537 1.425 0 CA-C-O 118.593 -1.115 . . . . 3.8599999999999999 114.388 -172.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.75 149.71 54.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.99 3.127 . . . . 3.4100000000000001 112.134 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -154.88 172.69 17.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.24 1.016 . . . . 4.2800000000000002 112.128 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.8 m -143.42 119.9 11.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.91 -1.515 . . . . 3.5 106.91 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 12.6 tp -157.35 140.21 15.1 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.561 0.619 . . . . 3.6600000000000001 111.432 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.1 m -74.43 146.67 42.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.626 0.727 . . . . 2.6000000000000001 109.44 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.7 m -99.35 139.81 34.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.509 1.124 . . . . 3.4199999999999999 110.77 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.47 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -51.67 -36.54 46.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.896 2.078 . . . . 3.04 113.117 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -108.09 -1.11 20.7 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.046 1.738 . . . . 4.3600000000000003 111.968 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.15 -125.56 1.62 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 119.151 0.887 . . . . 4.5499999999999998 111.789 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.0 -160.94 1.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.146 1.378 . . . . 5.3899999999999997 110.715 -157.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.28 97.11 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.34 1.056 . . . . 7.04 111.653 -168.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.26 149.61 33.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.697 1.599 . . . . 4.3300000000000001 110.911 172.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 58.5 p -140.12 141.42 36.11 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.439 2.296 . . . . 3.1400000000000001 107.498 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -28.04 -69.36 0.05 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.978 1.711 . . . . 3.75 115.369 -171.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -65.86 0.04 2.01 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 116.913 2.19 . . . . 8.1799999999999997 116.913 -174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.39 -54.91 29.38 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 119.848 1.204 . . . . 3.1400000000000001 110.161 162.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -91.21 -28.0 18.11 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.703 1.001 . . . . 4.54 113.703 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 59.37 4.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.596 1.159 . . . . 7.0700000000000003 112.609 -168.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -108.94 0.07 31.79 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.086 1.803 . . . . 3.1499999999999999 113.138 162.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -153.46 175.12 13.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.859 2.064 . . . . 3.9199999999999999 108.993 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -66.42 118.33 9.91 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.12 0.968 . . . . 2.0499999999999998 112.748 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 mp -107.85 147.34 31.05 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.598 0.759 . . . . 4.3799999999999999 112.206 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.0 mp -111.94 118.02 34.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.308 1.843 . . . . 3.5299999999999998 107.527 166.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.2 mt -118.79 124.47 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.672 0.789 . . . . 2.5 110.102 -173.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -127.88 139.98 52.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.874 1.27 . . . . 3.4399999999999999 113.23 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.7 120.32 42.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.903 1.281 . . . . 3.5899999999999999 110.636 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -145.6 -175.51 18.75 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 116.108 1.203 . . . . 1.3999999999999999 116.108 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -139.65 133.77 31.09 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 123.63 1.681 . . . . 4.6900000000000004 113.718 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 23.41 0.07 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.743 2.017 . . . . 3.4500000000000002 114.036 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -165.66 32.83 0.05 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.125 2.17 . . . . 7.8099999999999996 110.403 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 82.2 m -54.27 159.1 3.31 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.15 -1.594 . . . . 2.1699999999999999 111.941 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.21 68.93 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.164 2.576 . . . . 3.52 108.455 159.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 68.07 -17.49 0.17 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.996 3.318 . . . . 5.4500000000000002 115.626 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.0 t -43.87 -65.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.646 1.978 . . . . 4.1900000000000004 113.146 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 28.1 m -58.41 -50.37 88.4 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 116.579 -1.676 . . . . 1.6399999999999999 114.285 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.72 -34.23 51.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.955 2.091 . . . . 2.3700000000000001 114.159 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.82 -36.59 64.98 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.394 0.997 . . . . 4.1900000000000004 111.885 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.87 -35.28 72.31 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.44 -1.412 . . . . 3.7200000000000002 112.563 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.67 -27.33 67.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 117.23 -1.367 . . . . 4.1600000000000001 112.51 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -62.78 1.3 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.997 1.271 . . . . 3.3500000000000001 109.053 167.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -58.23 -21.09 46.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.694 -1.254 . . . . 5.6900000000000004 113.215 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.0 mmm -79.79 -41.46 26.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.047 1.499 . . . . 6.3499999999999996 115.047 165.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.94 -31.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 122.477 2.399 . . . . 3.02 110.5 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -37.31 -41.6 0.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.484 1.914 . . . . 4.1699999999999999 112.854 162.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.2 -22.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 2.7999999999999998 111.775 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.61 -39.27 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.932 0.787 . . . . 2.8399999999999999 109.55 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.25 -44.15 95.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.27 1.028 . . . . 4.0800000000000001 111.011 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.575 ' CD ' ' HZ3' ' A' ' 283' ' ' LYS . 37.2 mt-10 -71.42 -7.82 49.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.83 1.652 . . . . 3.3799999999999999 114.867 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.2 mt -119.85 -48.35 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 118.088 -0.958 . . . . 3.0600000000000001 113.427 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.64 -27.35 67.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.925 1.239 . . . . 3.77 111.711 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.9 t -70.65 -11.3 60.86 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.845 -1.159 . . . . 3.8700000000000001 113.743 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 34.3 mm -90.61 86.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 120.441 -1.412 . . . . 4.6200000000000001 108.71 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 81.0 p -63.98 60.54 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.387 2.675 . . . . 5.3899999999999997 115.41 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 10.5 t -173.18 -24.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 129.907 3.283 . . . . 5.0800000000000001 110.871 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.17 156.02 8.13 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.774 -1.204 . . . . 4.0199999999999996 109.934 151.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.44 -66.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.378 -1.816 . . . . 3.3599999999999999 107.378 162.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.15 173.2 2.64 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.269 3.027 . . . . 3.6200000000000001 109.791 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 tp -119.2 110.17 16.72 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.858 0.863 . . . . 3.23 111.1 161.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.8 m -92.78 120.05 67.48 Favored Pre-proline 0 N--CA 1.482 1.128 0 O-C-N 120.939 -1.1 . . . . 2.0499999999999998 111.467 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -93.63 131.12 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.538 2.825 . . . . 1.1699999999999999 112.571 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.97 119.49 30.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.854 2.062 . . . . 3.4100000000000001 110.472 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -99.8 136.16 40.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.01 1.724 . . . . 4.29 110.8 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.06 126.26 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.576 1.55 . . . . 2.6499999999999999 109.204 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 92.0 p -84.01 141.79 30.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.214 0.531 . . . . 2.8300000000000001 110.23 165.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.9 pt -108.53 19.96 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.029 -1.044 . . . . 2.5099999999999998 112.841 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -118.05 77.06 12.08 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.816 2.046 . . . . 3.3300000000000001 110.897 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.38 83.06 2.33 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.285 3.323 . . . . 3.2799999999999998 109.713 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.45 -124.18 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.601 1.961 . . . . 4.7199999999999998 106.283 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.99 11.25 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 117.965 2.58 . . . . 8.1999999999999993 117.965 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -89.74 150.89 22.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.782 -1.824 . . . . 3.3999999999999999 111.049 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.1 p -142.71 144.9 32.88 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.486 1.136 . . . . 3.98 112.252 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -42.97 -55.47 3.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.088 2.155 . . . . 4.7599999999999998 111.952 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -70.57 -34.0 71.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.159 0.983 . . . . 4.21 113.221 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.99 68.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.311 1.414 . . . . 2.6800000000000002 111.224 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.3 mm -58.62 -39.19 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 119.407 -0.33 . . . . 2.3900000000000001 111.612 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.9 -29.46 60.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.978 1.311 . . . . 2.8500000000000001 113.805 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -90.26 -38.69 13.25 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.778 0.831 . . . . 5.8099999999999996 112.983 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.17 -38.74 80.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.271 1.428 . . . . 4.0999999999999996 111.787 174.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.9 t -54.55 -34.19 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.477 1.511 . . . . 1.99 113.541 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.32 -35.68 78.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.151 -0.928 . . . . 6.4100000000000001 111.939 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.2 -36.43 81.72 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 124.396 1.06 . . . . 4.0099999999999998 111.223 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.9 -44.03 61.74 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.934 0.788 . . . . 5.0099999999999998 113.033 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.5 m 150.42 143.1 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 130.056 3.342 . . . . 2.6899999999999999 111.042 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.26 -0.97 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.495 2.797 . . . . 1.8899999999999999 115.908 -167.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.86 -14.7 60.7 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 120.631 1.56 . . . . 3.73 112.546 168.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.98 127.67 33.49 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.628 -1.295 . . . . 3.8500000000000001 111.917 -170.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.9 124.35 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.448 -1.686 . . . . 3.2400000000000002 106.448 171.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.47 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -103.8 127.01 8.98 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 108.672 -1.771 . . . . 1.1100000000000001 108.672 170.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.28 150.53 32.32 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.968 0.507 . . . . 3.96 110.253 167.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.3 t -167.07 176.08 7.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.397 2.279 . . . . 3.73 108.971 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.63 34.22 Favored Glycine 0 N--CA 1.468 0.83 0 O-C-N 120.771 -1.206 . . . . 1.76 115.2 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -73.81 161.88 29.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.332 1.053 . . . . 3.0299999999999998 111.164 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -43.88 67.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.745 0.818 . . . . 8.3499999999999996 111.246 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.58 1.552 . . . . 3.8700000000000001 112.969 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.12 -46.68 49.84 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.54 -0.725 . . . . 3.2200000000000002 111.675 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.19 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 119.155 -0.45 . . . . 2.6099999999999999 111.372 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.61 -39.61 80.79 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.321 0.964 . . . . 3.8999999999999999 112.127 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -62.72 -49.13 76.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.016 1.28 . . . . 4.1900000000000004 110.909 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.77 -48.22 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.794 0.838 . . . . 4.0899999999999999 111.909 -171.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.52 -50.53 51.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.868 0.867 . . . . 2.1499999999999999 110.396 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -72.62 -27.34 62.09 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 117.461 -1.257 . . . . 4.2699999999999996 113.556 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.51 65.32 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.864 1.211 . . . . 2.1699999999999999 111.037 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -84.3 12.1 7.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.454 1.102 . . . . 3.3199999999999998 113.569 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 65.71 -41.72 0.34 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.781 2.832 . . . . 7.1100000000000003 115.021 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.3 t 18.85 103.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 131.622 3.969 . . . . 3.6499999999999999 115.907 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -71.47 142.47 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.917 0.887 . . . . 4.8099999999999996 113.201 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -169.73 155.29 5.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.737 2.015 . . . . 4.6200000000000001 110.273 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -148.45 106.58 3.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.424 0.69 . . . . 3.4100000000000001 109.795 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.61 138.45 15.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.337 2.025 . . . . 3.1000000000000001 110.243 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.99 139.96 23.38 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.646 -0.53 . . . . 2.4399999999999999 112.418 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.16 16.94 1.28 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.925 3.083 . . . . 3.77 112.851 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 115.86 156.43 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 1 C-N-CA 132.762 4.425 . . . . 5.3200000000000003 109.312 -159.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -95.0 -132.32 0.17 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.481 1.912 . . . . 8.9800000000000004 109.926 171.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.31 -17.64 64.68 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.206 1.402 . . . . 8.3699999999999992 114.055 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -164.41 -71.34 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.496 1.519 . . . . 6.0899999999999999 110.063 175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -120.64 -19.04 7.58 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.056 1.132 . . . . 5.6200000000000001 114.056 -167.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.2 139.66 54.56 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 119.555 -1.966 . . . . 4.8600000000000003 112.079 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -85.91 82.78 8.01 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.125 -0.984 . . . . 4.5800000000000001 111.324 170.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 tp -71.31 156.81 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.974 0.909 . . . . 3.6600000000000001 111.208 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.3 m -151.16 166.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.481 1.912 . . . . 4.3899999999999997 109.894 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.97 158.99 26.52 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.859 2.864 . . . . 3.7599999999999998 111.01 169.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 161.2 9.34 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.066 1.746 . . . . 2.9199999999999999 113.943 -166.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 29.0 p -60.89 -42.31 97.75 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.194 1.553 . . . . 4.9000000000000004 115.194 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.29 0.3 OUTLIER 54.55 41.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.261 1.424 . . . . 4.6299999999999999 112.815 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.53 140.77 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 120.459 -1.401 . . . . 3.5600000000000001 110.67 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 58.7 tpp -99.88 115.89 30.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.348 1.859 . . . . 3.8100000000000001 109.172 165.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -95.03 148.59 22.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.102 -1.624 . . . . 4.1799999999999997 112.373 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -99.42 126.06 45.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.553 1.141 . . . . 3.1800000000000002 109.619 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.2 mm -107.94 126.96 64.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 108.221 -1.029 . . . . 3.8900000000000001 108.221 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.72 160.53 53.02 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 117.969 -1.462 . . . . 2.0600000000000001 110.163 162.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.78 -11.8 19.22 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.134 3.223 . . . . 3.6400000000000001 113.911 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.5 -41.82 88.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.727 2.811 . . . . 4.1299999999999999 110.573 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.95 31.43 2.69 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.065 1.317 . . . . 3.1499999999999999 115.723 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -142.84 164.04 31.18 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.684 1.242 . . . . 4.75 112.177 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -67.44 125.75 27.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 6.4000000000000004 112.505 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.4 tt -118.52 -24.23 6.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.383 1.473 . . . . 4.2999999999999998 112.405 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -165.53 171.92 12.65 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.49 2.316 . . . . 2.7999999999999998 109.234 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -159.24 158.76 33.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.497 1.119 . . . . 5.0999999999999996 113.673 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.85 -179.85 7.31 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.594 1.958 . . . . 3.54 112.055 -165.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.3 -145.34 16.91 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.05 1.786 . . . . 4.3799999999999999 109.91 -171.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -54.5 3.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 118.942 2.942 . . . . 3.8399999999999999 118.942 -161.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -135.96 -45.35 0.65 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.288 -1.508 . . . . 5.2599999999999998 112.132 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -79.19 86.31 4.99 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.935 -1.103 . . . . 5.3300000000000001 110.458 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.07 155.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.003 2.521 . . . . 6.6399999999999997 114.901 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.575 ' HZ3' ' CD ' ' A' ' 186' ' ' GLU . 1.1 tmmt? -41.7 -70.22 0.11 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.016 2.127 . . . . 3.77 116.143 -172.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.31 -24.95 75.54 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 122.564 1.091 . . . . 2.1299999999999999 111.284 -170.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -70.14 -23.91 63.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.377 1.871 . . . . 5.29 111.317 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.24 -51.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.258 -0.901 . . . . 2.46 110.752 162.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.1 71.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.38 0.991 . . . . 2.04 111.939 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.77 73.79 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.25 1.204 . . . . 2.8399999999999999 114.25 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.6 p -75.04 -37.63 61.66 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.842 -1.161 . . . . 2.3100000000000001 112.644 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mm -56.61 -47.65 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 119.943 1.247 . . . . 3.46 110.842 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.17 -18.16 60.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.063 1.134 . . . . 2.5600000000000001 114.063 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.5 m -84.05 -40.94 17.74 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.447 1.099 . . . . 3.0600000000000001 110.984 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -69.94 -29.29 66.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.181 0.993 . . . . 3.0800000000000001 113.516 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.66 19.25 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.536 -1.353 . . . . 7.2199999999999998 114.197 164.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -74.43 -58.98 1.71 Allowed Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.471 -1.728 . . . . 6.5599999999999996 111.303 152.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.85 -48.8 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.842 2.362 . . . . 2.71 112.518 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -68.75 121.89 17.44 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.033 0.833 . . . . 4.6500000000000004 110.677 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -63.15 149.17 45.96 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.451 0.7 . . . . 9.3800000000000008 112.13 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -90.27 -172.06 3.32 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.379 1.072 . . . . 10.779999999999999 110.9 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -79.54 74.35 6.19 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.555 -1.341 . . . . 8.0199999999999996 107.529 149.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.482 1.168 1 C-N-CA 132.021 4.128 . . . . 7.2400000000000002 111.214 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 118.209 -0.9 . . . . 20.780000000000001 110.371 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -156.0 156.99 35.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.356 1.062 . . . . 17.100000000000001 110.857 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.1 t 175.5 65.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 129.114 2.966 . . . . 15.949999999999999 108.146 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.13 142.52 19.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.06 0.838 . . . . 12.08 112.005 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.85 143.88 8.65 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.431 1.492 . . . . 15.630000000000001 110.937 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -83.79 -174.11 1.81 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.665 2.91 . . . . 8.0700000000000003 110.25 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.3 tp -85.29 153.0 22.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.237 -0.653 . . . . 10.289999999999999 109.237 155.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.0 tp -145.23 157.04 44.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.945 1.298 . . . . 8.4700000000000006 109.087 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -146.13 -173.17 17.13 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 125.729 1.633 . . . . 3.6600000000000001 111.97 174.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.33 -84.07 0.35 Allowed Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.327 -1.263 . . . . 5.1600000000000001 113.169 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.54 142.43 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.315 2.01 . . . . 3.3900000000000001 112.772 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -108.34 175.19 5.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.361 -1.29 . . . . 4.0499999999999998 111.567 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -141.35 22.07 2.21 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.709 1.744 . . . . 3.9300000000000002 115.709 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.32 165.4 23.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.748 1.219 . . . . 3.9300000000000002 110.825 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.1 m -117.3 151.65 36.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.861 2.064 . . . . 3.6000000000000001 109.171 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.3 p -86.28 158.99 19.56 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.642 1.211 . . . . 2.7000000000000002 113.206 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -59.77 -21.59 60.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.91 1.684 . . . . 2.0099999999999998 113.225 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.8 m -72.08 -39.49 68.95 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.65 1.18 . . . . 3.6299999999999999 110.166 172.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 120.07 -8.36 11.51 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.53 1.538 . . . . 1.9399999999999999 114.47 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -83.11 147.64 27.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.149 0.974 . . . . 4.1399999999999997 109.879 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -87.72 125.41 34.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.229 -0.656 . . . . 4.9900000000000002 109.229 163.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.27 134.94 36.7 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.974 1.31 . . . . 4.4800000000000004 109.62 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.9 p -109.83 166.29 11.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.682 1.593 . . . . 3.4500000000000002 112.352 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.96 2.65 0.49 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.829 2.452 . . . . 4.1900000000000004 114.817 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -7.51 12.58 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.244 1.202 . . . . 8.1500000000000004 114.244 165.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.59 -44.55 64.26 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.713 1.142 . . . . 3.4500000000000002 110.063 161.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -78.02 10.59 2.77 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.834 1.42 . . . . 5.0300000000000002 114.834 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.82 108.39 1.17 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 5.9699999999999998 110.101 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.09 -8.69 6.33 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.507 1.051 . . . . 4.1200000000000001 114.629 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -129.07 158.97 37.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.944 1.372 . . . . 5.6900000000000004 110.48 165.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . 0.417 ' CE3' ' HD3' ' A' ' 269' ' ' PRO . 94.7 m95 -67.8 118.97 11.76 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.451 0.7 . . . . 3.8100000000000001 112.555 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.78 109.14 21.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.782 1.633 . . . . 4.1200000000000001 109.582 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.61 98.25 7.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.118 -0.697 . . . . 4.1699999999999999 109.118 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -95.35 126.97 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.903 1.281 . . . . 3.0499999999999998 108.998 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -140.55 150.1 43.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.787 1.235 . . . . 3.75 113.658 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -123.09 112.74 18.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.941 1.296 . . . . 3.5600000000000001 111.053 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.18 142.62 13.68 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.151 1.358 . . . . 1.4099999999999999 112.023 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -92.11 129.1 38.14 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.131 0.965 . . . . 5.4199999999999999 112.27 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.1 m -75.72 66.77 2.08 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.643 1.577 . . . . 3.8599999999999999 111.285 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -174.91 -28.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.801 2.841 . . . . 8.1899999999999995 112.441 -171.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 m -67.03 160.54 69.71 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 117.452 2.39 . . . . 2.3799999999999999 117.452 -163.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.96 -168.09 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.882 3.722 . . . . 3.25 110.724 159.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.72 -7.04 3.02 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.521 2.415 . . . . 4.1500000000000004 117.521 -151.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 74.0 t -65.0 -60.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.895 1.278 . . . . 3.3199999999999998 108.761 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 23.8 m -49.53 -60.41 4.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.733 -1.127 . . . . 1.74 113.028 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.39 -30.57 19.15 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-O 116.105 -1.706 . . . . 1.5 113.715 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.15 -45.97 65.69 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.996 2.18 . . . . 3.21 110.492 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.455 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 58.5 mm-40 -61.44 -33.22 73.35 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.25 0.932 . . . . 3.0499999999999998 112.068 174.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -48.6 64.67 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.659 -0.651 . . . . 3.3399999999999999 111.939 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -41.29 94.13 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.828 -1.17 . . . . 3.75 111.07 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.455 ' HZ2' ' CD ' ' A' ' 176' ' ' GLU . 40.9 mttt -46.96 -52.14 15.36 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 119.943 -1.723 . . . . 3.3900000000000001 112.209 167.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.4 ptp -70.77 -8.34 51.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.492 1.664 . . . . 3.2999999999999998 115.492 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mm -75.78 -60.04 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.414 1.461 . . . . 2.77 108.686 161.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.72 -38.74 56.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.256 0.836 . . . . 3.02 113.256 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.1 t -60.02 -19.02 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 117.823 -1.084 . . . . 3.1200000000000001 112.756 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.68 -53.93 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.699 1.59 . . . . 3.5600000000000001 110.558 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.62 -27.58 67.02 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.643 1.177 . . . . 4.0300000000000002 111.883 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.4 ' CD ' ' HZ2' ' A' ' 283' ' ' LYS . 58.7 mt-10 -71.48 -19.63 62.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.928 1.291 . . . . 3.7599999999999998 113.427 169.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.64 -56.99 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.279 1.431 . . . . 3.1099999999999999 113.845 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.86 -30.7 71.35 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.783 0.801 . . . . 5.5 109.261 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.9 m -60.31 -12.26 8.65 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.88 2.472 . . . . 4.0499999999999998 115.163 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.5 mm -79.01 -39.45 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.871 -1.143 . . . . 4.9900000000000002 112.139 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.3 m -176.82 2.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.632 1.573 . . . . 8.6600000000000001 114.349 -158.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.2 m 77.2 41.59 0.15 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.059 2.544 . . . . 6.4400000000000004 111.065 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.2 150.46 0.27 Allowed Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 128.987 2.915 . . . . 4.4699999999999998 113.949 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.32 -43.25 58.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.485 2.79 . . . . 3.2599999999999998 113.569 -170.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.3 t70 161.34 154.45 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 131.532 3.933 . . . . 3.5800000000000001 107.648 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.58 111.71 17.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.495 0.718 . . . . 4.5700000000000003 109.913 168.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.8 m -105.45 112.25 64.81 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.535 1.134 . . . . 3.1099999999999999 108.596 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.33 137.67 23.7 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.112 1.875 . . . . 1.48 109.002 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.277 1.5 pt? -136.18 118.44 15.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.644 1.212 . . . . 4.3399999999999999 110.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.05 125.91 54.9 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.657 1.583 . . . . 3.1699999999999999 110.201 -157.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.55 120.44 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.405 -0.961 . . . . 2.5899999999999999 108.405 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.2 t -72.38 -15.24 61.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.795 1.405 . . . . 3.25 114.795 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . 0.287 43.8 pt 51.7 9.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 128.539 2.735 . . . . 3.0299999999999998 117.912 170.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -111.16 56.54 0.38 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.221 1.408 . . . . 3.5 114.502 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.04 69.99 7.26 Favored 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.406 4.071 . . . . 3.7400000000000002 112.685 -167.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -171.2 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.5 2.32 . . . . 4.04 109.673 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -17.69 10.1 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.23 1.412 . . . . 9.0399999999999991 112.82 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.4 153.31 2.2 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.696 1.598 . . . . 4.6200000000000001 112.912 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.4 m -144.59 125.33 14.2 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.299 -0.876 . . . . 3.0600000000000001 109.854 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -48.33 -47.72 36.75 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.467 1.907 . . . . 3.7599999999999998 112.793 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -68.77 -33.21 73.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.231 1.197 . . . . 3.8100000000000001 114.231 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.91 84.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.483 1.492 . . . . 2.54 110.941 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.66 -34.46 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.276 0.63 . . . . 2.4300000000000002 111.857 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.35 -19.31 64.52 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.066 -1.021 . . . . 2.3300000000000001 113.697 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -84.98 -42.64 14.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.957 1.253 . . . . 4.0499999999999998 112.992 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -57.04 -35.26 69.09 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.153 1.381 . . . . 3.73 112.133 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.53 -37.03 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.238 1.415 . . . . 2.4100000000000001 113.078 169.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -70.96 -51.27 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.799 -1.188 . . . . 6.3200000000000003 112.204 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.49 -18.42 62.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.619 1.567 . . . . 4.0800000000000001 113.769 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -80.55 -79.4 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.734 0.697 . . . . 4.1699999999999999 109.676 154.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 178.23 139.69 0.25 Allowed Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.307 1.843 . . . . 2.5099999999999998 110.304 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.45 5.9 1.77 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.15 3.233 . . . . 2.5499999999999998 114.942 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -18.27 63.5 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.841 -1.162 . . . . 4.6699999999999999 112.763 161.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.6 tp -78.78 138.13 38.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.18 1.792 . . . . 3.0299999999999998 111.224 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 26.2 t -101.88 130.35 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.042 0.937 . . . . 2.8599999999999999 108.881 158.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.58 132.91 11.11 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.798 -0.921 . . . . 0.82999999999999996 110.798 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.5 144.97 50.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.131 0.972 . . . . 3.1400000000000001 112.926 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.6 t -149.1 176.44 10.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.204 2.202 . . . . 3.6499999999999999 111.194 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 165.37 -168.15 39.25 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 127.141 2.305 . . . . 2.04 109.374 -170.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.3 174.59 10.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.053 1.426 . . . . 3.8100000000000001 111.373 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -47.86 -38.37 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.59 0.756 . . . . 9.5800000000000001 112.168 170.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -36.11 47.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.809 0.732 . . . . 5.7000000000000002 112.572 -169.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -70.37 -33.57 71.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.242 -1.537 . . . . 3.79 111.847 170.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.96 -31.68 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.726 0.81 . . . . 3.1000000000000001 110.816 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.72 -32.3 41.19 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.941 0.791 . . . . 3.1800000000000002 112.664 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.42 -53.17 60.83 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.113 -0.992 . . . . 4.1500000000000004 109.736 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.2 p -62.2 -27.71 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 119.426 -0.321 . . . . 3.5899999999999999 111.812 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.61 -46.18 66.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.248 0.931 . . . . 3.04 111.518 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -58.83 -53.83 53.99 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.576 1.55 . . . . 4.2599999999999998 111.066 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.39 65.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.973 1.309 . . . . 2.9199999999999999 114.362 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -117.4 3.82 12.51 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.575 1.324 . . . . 3.7000000000000002 114.575 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 57.6 31.19 19.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.085 1.354 . . . . 5.9699999999999998 113.421 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.38 161.99 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.58 1.152 . . . . 4.0999999999999996 110.325 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -146.22 154.9 42.26 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.592 0.96 . . . . 6.4699999999999998 113.592 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.62 110.81 6.96 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.991 1.716 . . . . 7.0899999999999999 110.669 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -104.73 124.16 37.79 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 120.66 -1.275 . . . . 3.71 113.158 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.39 130.27 14.86 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.302 2.001 . . . . 3.71 113.274 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.6 133.29 12.91 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.191 0.9 . . . . 2.6800000000000002 110.912 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.66 61.93 8.38 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.669 2.913 . . . . 4.5 109.244 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp 100.03 177.18 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 131.355 3.862 . . . . 6.7599999999999998 112.58 -166.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -143.32 20.85 1.9 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 128.018 2.527 . . . . 11.01 110.289 165.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 253' ' ' ASP . 5.2 tm-20 173.73 -140.42 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.185 1 C-N-CA 132.071 4.149 . . . . 8.1199999999999992 104.486 -163.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.413 ' H ' ' CD ' ' A' ' 252' ' ' GLU . 22.9 t0 -129.95 -2.84 4.62 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 122.082 2.219 . . . . 7.7300000000000004 113.79 151.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -92.76 -41.47 10.11 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.272 -1.518 . . . . 6.8600000000000003 112.515 155.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -88.87 170.26 10.87 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.084 1.354 . . . . 5.2699999999999996 114.091 -171.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -159.63 128.32 5.09 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.646 1.978 . . . . 5.3099999999999996 111.938 -161.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 tt -124.07 168.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.842 1.657 . . . . 5.2400000000000002 111.223 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.24 135.75 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 4.9299999999999997 105.214 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 169.33 1.67 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.205 1.002 . . . . 4.29 112.113 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -153.87 126.8 8.3 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.524 -0.735 . . . . 3.04 111.518 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.3 p -59.37 118.74 6.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.676 0.79 . . . . 3.9500000000000002 110.265 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 11.1 tp -78.41 59.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.177 1.391 . . . . 4.96 113.657 -168.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.0 mm -109.2 138.01 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.78 1.232 . . . . 3.54 111.806 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.3 ttt -121.33 134.75 55.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.02 1.728 . . . . 3.2200000000000002 108.992 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.48 141.77 44.61 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.762 0.825 . . . . 3.8399999999999999 111.927 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.92 116.87 31.01 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.164 0.986 . . . . 2.7599999999999998 109.983 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.0 136.93 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.683 1.193 . . . . 2.8599999999999999 107.835 166.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.52 168.9 48.53 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 123.792 0.711 . . . . 2.25 114.59 -168.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.417 ' HD3' ' CE3' ' A' ' 159' ' ' TRP . 42.0 Cg_endo -77.3 56.09 5.35 Favored 'Trans proline' 0 CA--C 1.539 0.749 1 C-N-CA 125.964 4.443 . . . . 4.0199999999999996 109.38 173.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -162.1 -55.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.753 -0.658 . . . . 4.8099999999999996 111.252 -143.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 154.19 -54.33 0.44 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.093 -1.393 . . . . 3.7400000000000002 112.611 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -130.06 -174.23 3.26 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.806 1.303 . . . . 5.8700000000000001 114.326 -162.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -80.37 142.97 33.9 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.995 -1.066 . . . . 5.9900000000000002 113.525 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.67 -25.91 0.89 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.453 1.279 . . . . 3.7200000000000002 114.453 -157.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -162.78 165.91 24.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.672 2.389 . . . . 2.54 109.247 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -155.81 150.54 26.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.53 1.308 . . . . 4.9199999999999999 114.53 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -126.89 119.49 26.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.307 1.443 . . . . 3.6899999999999999 109.339 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -111.12 72.77 0.21 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 108.993 -1.643 . . . . 4.0300000000000002 108.993 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 41.37 -134.68 0.28 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.215 1.406 . . . . 3.6600000000000001 111.308 -155.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.2 t30 70.6 -65.8 0.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.593 2.357 . . . . 5.4199999999999999 114.615 167.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -66.01 120.36 13.01 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.546 1.138 . . . . 6.0499999999999998 110.376 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -77.97 138.46 38.86 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.611 -1.305 . . . . 10.81 110.238 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.4 ' HZ2' ' CD ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -32.7 -47.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.486 3.143 . . . . 3.8999999999999999 119.486 -158.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -15.81 57.82 Favored Glycine 0 N--CA 1.476 1.363 0 CA-C-N 119.748 1.158 . . . . 2.1299999999999999 112.698 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.15 -24.09 65.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.482 0.919 . . . . 3.25 113.482 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.15 -41.61 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.59 1.086 . . . . 2.8700000000000001 109.005 172.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.8 99.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.94 -0.553 . . . . 2.3999999999999999 111.478 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.11 98.27 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.842 1.053 . . . . 2.4900000000000002 113.842 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.1 p -70.03 -47.29 62.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.2 1.364 . . . . 2.0800000000000001 111.763 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.02 -34.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 120.065 1.302 . . . . 2.6299999999999999 112.448 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.9 76.02 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.93 -1.106 . . . . 2.2599999999999998 112.999 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 38.9 m -70.22 -45.45 66.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.267 1.027 . . . . 2.79 109.394 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -65.59 -28.46 69.15 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 3.4100000000000001 113.06 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -19.83 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.94 -1.1 . . . . 5.6500000000000004 112.546 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -46.23 95.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.759 -1.591 . . . . 6.4400000000000004 112.401 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.8 -45.56 0.1 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.168 2.578 . . . . 2.8100000000000001 113.989 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.18 170.51 14.81 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.937 1.244 . . . . 4.1200000000000001 114.093 -174.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -128.22 -179.91 5.26 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.497 -1.377 . . . . 8.7899999999999991 112.265 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -121.05 -178.35 3.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.755 1.222 . . . . 8.1199999999999992 113.99 -158.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -28.77 70.21 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.948 0.721 . . . . 9.6899999999999995 112.948 158.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--O 1.251 1.178 0 C-N-CA 130.448 3.499 . . . . 10.130000000000001 107.669 176.267 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 117.775 -1.107 . . . . 18.18 109.85 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -165.01 163.71 20.66 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.234 1.414 . . . . 14.92 110.268 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 t -174.9 172.93 2.81 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.121 2.569 . . . . 12.869999999999999 108.9 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 123.78 153.56 8.71 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.899 1.714 . . . . 10.24 112.231 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -159.94 116.46 1.51 Allowed Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 121.523 -0.986 . . . . 11.85 112.195 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.47 167.26 15.39 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.383 2.722 . . . . 7.9800000000000004 111.062 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 pp -166.77 164.93 16.56 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.285 2.634 . . . . 9.0199999999999996 109.229 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.8 mt -146.09 179.03 7.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.099 1.36 . . . . 6.04 110.657 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.01 156.95 6.7 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.343 1.449 . . . . 2.7599999999999998 113.088 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -146.3 78.89 0.24 Allowed Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.329 -1.101 . . . . 3.1000000000000001 113.855 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.52 144.85 62.43 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.168 2.579 . . . . 4.0800000000000001 110.618 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -95.71 177.69 5.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.397 1.479 . . . . 3.9199999999999999 112.524 -169.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.9 m -129.64 22.62 5.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.865 1.431 . . . . 2.8599999999999999 114.865 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.41 157.9 15.8 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.32 1.048 . . . . 3.5800000000000001 112.839 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 149' ' ' ARG . 58.3 m -101.03 148.21 25.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.892 1.677 . . . . 2.3900000000000001 110.606 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.3 p -81.36 166.69 20.22 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.735 1.614 . . . . 2.9199999999999999 113.49 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -61.3 -23.05 65.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.948 2.099 . . . . 2.04 113.152 169.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.7 m -73.93 -61.5 1.83 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.312 1.045 . . . . 3.9199999999999999 108.183 167.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 141.53 -1.22 1.81 Allowed Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.914 1.245 . . . . 2.3399999999999999 115.936 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.12 145.59 29.14 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.584 1.192 . . . . 4.1600000000000001 109.781 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 0.9 OUTLIER -96.7 74.28 2.72 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.106 2.563 . . . . 6.54 112.533 -178.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -81.03 89.79 5.96 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.287 -0.883 . . . . 7.2599999999999998 112.734 -166.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.6 p -68.57 127.59 33.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.345 1.058 . . . . 3.96 110.278 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -1.28 12.05 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 117.806 2.521 . . . . 6.1900000000000004 117.806 -155.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -77.58 4.48 11.2 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 120.944 -1.098 . . . . 7.5300000000000002 112.954 164.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 156' ' ' LEU . 21.1 t70 -73.28 -71.89 0.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.633 2.773 . . . . 3.7400000000000002 114.375 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -69.57 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.397 1.879 . . . . 5.6699999999999999 114.441 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 154' ' ' ASP . 2.0 tm? -60.0 -32.68 71.09 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.795 2.038 . . . . 4.4199999999999999 114.442 -157.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.08 2.02 87.67 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.482 0.953 . . . . 3.5 115.482 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -96.55 -138.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.92 1.688 . . . . 3.79 109.189 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -140.89 140.82 34.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.851 1.26 . . . . 2.0600000000000001 109.967 164.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.89 151.61 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.922 1.082 . . . . 3.8100000000000001 113.922 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.22 119.22 34.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.863 1.665 . . . . 3.25 108.148 163.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.1 mt -109.88 110.22 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.61 -0.885 . . . . 2.4700000000000002 108.61 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -113.35 153.98 27.63 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.272 1.829 . . . . 4.3300000000000001 113.431 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -127.34 97.88 5.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.081 1.352 . . . . 3.6699999999999999 112.859 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.54 -176.91 14.65 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 128.205 2.812 . . . . 1.8999999999999999 112.35 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -113.32 141.11 47.41 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.818 1.647 . . . . 4.8300000000000001 112.165 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -65.49 113.42 4.14 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.823 -1.173 . . . . 3.77 110.939 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.432 ' HE2' ' CD ' ' A' ' 219' ' ' GLU . 73.7 m80 63.75 35.0 11.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.075 1.75 . . . . 11.550000000000001 112.348 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 49.9 t -59.1 157.2 22.87 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.225 1.41 . . . . 2.9900000000000002 111.594 163.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.66 177.34 1.33 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.621 2.881 . . . . 3.6699999999999999 112.031 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.38 -3.27 0.9 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.12 2.637 . . . . 5.2599999999999998 118.12 -148.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.45 -59.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.049 1.739 . . . . 3.8599999999999999 110.353 171.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.8 m -53.76 -58.73 11.93 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 118.055 -0.974 . . . . 2.1600000000000001 112.606 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.85 -29.9 41.14 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.575 1.517 . . . . 2.1099999999999999 113.805 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -60.62 -53.1 61.49 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 121.09 1.768 . . . . 3.9900000000000002 111.211 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.46 0.704 . . . . 3.3900000000000001 112.023 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.22 -28.87 61.45 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.354 -1.467 . . . . 4.1299999999999999 112.357 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -56.93 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.264 1.025 . . . . 4.0899999999999999 108.612 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -45.34 72.47 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.438 -0.789 . . . . 6.6900000000000004 111.676 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 47.1 ttp -57.93 -45.0 87.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.854 2.061 . . . . 4.4100000000000001 112.408 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.78 -45.16 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.608 1.094 . . . . 2.5600000000000001 110.652 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -69.11 -27.37 65.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.229 1.377 . . . . 5.0199999999999996 110.654 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.41 -47.83 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 120.622 1.556 . . . . 3.0 110.591 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.8 -42.54 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.515 1.052 . . . . 4.6200000000000001 113.269 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -76.29 -25.94 55.37 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.443 1.02 . . . . 5.7999999999999998 113.337 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -63.98 -31.12 72.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.382 1.473 . . . . 2.98 113.474 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.46 -41.76 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.649 1.18 . . . . 3.1600000000000001 112.167 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.0 -27.92 61.99 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.132 0.967 . . . . 4.4699999999999998 112.218 167.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.8 m -70.57 -9.76 57.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.381 1.072 . . . . 4.7400000000000002 113.06 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 14.8 mm -85.75 58.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.437 -1.414 . . . . 4.1699999999999999 109.097 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.1 m -58.77 85.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.781 1.632 . . . . 6.1399999999999997 112.293 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m 171.0 -32.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.962 3.705 . . . . 4.8300000000000001 108.386 -167.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.2 mt -73.25 162.01 76.47 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.193 -0.432 . . . . 5.2800000000000002 111.231 143.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -81.74 -154.15 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.77 3.646 . . . . 3.7400000000000002 108.569 154.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.83 158.35 25.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.217 1.562 . . . . 3.8999999999999999 115.217 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.09 94.1 4.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.077 1.351 . . . . 3.02 109.35 161.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.9 m -76.68 121.72 85.32 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 120.643 -1.286 . . . . 1.9399999999999999 110.206 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.29 126.66 2.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.442 2.761 . . . . 1.04 111.544 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 tt -125.04 112.51 16.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.784 1.234 . . . . 3.6099999999999999 110.505 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -100.66 124.24 45.99 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.526 1.131 . . . . 3.1200000000000001 110.698 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.92 120.4 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.482 -0.933 . . . . 2.52 108.482 170.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.3 t -82.15 106.46 14.06 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.504 -0.924 . . . . 2.3700000000000001 108.504 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.71 12.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.955 1.302 . . . . 3.5299999999999998 113.032 -176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -113.69 27.77 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.295 2.638 . . . . 3.6200000000000001 114.532 -171.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.41 -13.68 41.03 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.733 2.955 . . . . 2.4100000000000001 116.218 -154.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.67 1.8 43.8 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.963 1.098 . . . . 4.5599999999999996 113.963 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.289 2.2 ppt_? -137.28 0.82 2.36 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.137 1.532 . . . . 6.8799999999999999 115.137 158.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.27 -173.05 0.05 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.117 1.767 . . . . 3.5299999999999998 110.413 152.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -178.83 132.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.387 3.075 . . . . 3.1000000000000001 105.533 -172.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmpt? -56.98 -30.78 64.42 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.278 0.844 . . . . 4.3700000000000001 113.278 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -35.13 52.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.456 1.503 . . . . 3.3300000000000001 114.025 169.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.05 78.1 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.352 -1.467 . . . . 2.6200000000000001 111.897 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -70.37 -32.66 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.43 0.559 . . . . 3.8599999999999999 112.085 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.78 -35.21 80.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.934 1.243 . . . . 2.6800000000000002 112.368 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.09 -40.13 75.16 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.513 -0.742 . . . . 5.0999999999999996 111.832 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.84 -42.08 97.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.992 0.917 . . . . 4.2999999999999998 111.983 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.0 t -54.67 -50.76 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.771 0.714 . . . . 2.2799999999999998 111.368 168.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.13 -23.4 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.962 1.305 . . . . 5.7699999999999996 114.035 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.432 ' CD ' ' HE2' ' A' ' 168' ' ' HIS . 20.3 mt-10 -70.91 -22.62 62.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.461 1.504 . . . . 4.8799999999999999 113.211 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -108.54 -52.72 2.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.225 1.01 . . . . 3.6699999999999999 112.766 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 t 178.99 143.13 0.31 Allowed Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.82 1.648 . . . . 2.7200000000000002 109.97 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.63 -9.62 23.36 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.683 2.255 . . . . 2.2000000000000002 113.158 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.55 -18.1 62.92 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.226 0.921 . . . . 3.7400000000000002 113.203 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.35 127.29 32.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.231 -0.918 . . . . 3.2000000000000002 110.59 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.54 121.89 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.294 -1.002 . . . . 3.3799999999999999 108.294 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.56 139.45 14.72 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.917 -0.873 . . . . 1.1000000000000001 110.917 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mp -132.97 147.28 52.28 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.599 1.2 . . . . 3.1099999999999999 112.298 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 13.5 t -150.37 -174.06 4.64 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.085 1.754 . . . . 3.8599999999999999 109.926 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 149.01 -64.5 0.4 Allowed Glycine 0 N--CA 1.474 1.202 0 N-CA-C 115.626 1.01 . . . . 2.73 115.626 170.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.1 t -160.07 145.78 15.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.322 1.061 . . . . 4.4400000000000004 112.702 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -48.72 -42.5 35.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.275 2.23 . . . . 6.8899999999999997 112.511 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.89 -27.19 67.3 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.011 1.732 . . . . 4.4199999999999999 114.456 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -35.79 25.82 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.495 . . . . 4.46 112.052 172.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.29 -41.49 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.024 0.53 . . . . 3.3799999999999999 110.639 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.2 -40.36 95.83 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.184 -0.912 . . . . 3.29 111.307 170.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -58.17 -51.12 71.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.346 1.43 . . . . 2.8799999999999999 111.684 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -25.4 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.251 0.932 . . . . 4.1900000000000004 112.604 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.44 -53.03 18.06 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.161 -0.962 . . . . 3.2000000000000002 111.724 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -64.0 -31.9 73.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.163 2.185 . . . . 4.6200000000000001 111.762 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.29 62.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.73 1.612 . . . . 2.9500000000000002 115.042 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.45 3.04 7.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.178 0.807 . . . . 3.71 113.178 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 74.06 34.63 0.84 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.359 2.264 . . . . 5.9400000000000004 112.355 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 147.84 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.235 1.814 . . . . 4.1399999999999997 110.886 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.54 140.21 48.94 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.047 1.339 . . . . 4.5300000000000002 112.844 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.55 162.59 41.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.195 1.798 . . . . 8.3900000000000006 110.71 161.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.5 m -127.69 88.44 53.45 Favored Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 123.733 0.813 . . . . 3.3399999999999999 110.655 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 144.76 22.85 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.844 2.363 . . . . 5.1900000000000004 110.068 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -95.53 138.36 13.91 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 118.615 -1.103 . . . . 4.3200000000000003 112.84 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.33 73.76 5.38 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.117 3.211 . . . . 7.7000000000000002 109.289 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 250' ' ' LYS . 2.9 mmpt? -148.87 172.6 14.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.908 2.483 . . . . 8.4299999999999997 114.788 -164.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -171.39 155.82 4.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.993 2.117 . . . . 11.960000000000001 109.107 -147.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.99 138.82 48.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.623 0.769 . . . . 15.779999999999999 112.306 -168.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.2 t0 99.59 -5.43 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 130.589 3.556 . . . . 7.7199999999999998 111.652 -172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -126.4 -40.16 1.98 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.566 1.146 . . . . 9.5199999999999996 110.854 159.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 30.6 t0 67.73 -173.24 0.19 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.218 2.207 . . . . 4.4000000000000004 111.317 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -152.61 140.84 20.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.709 -1.244 . . . . 5.6399999999999997 111.919 164.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.5 tp -72.36 136.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.056 -1.028 . . . . 4.0800000000000001 109.825 167.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.52 144.73 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.573 1.549 . . . . 6.75 110.863 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.19 150.75 39.79 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.625 1.202 . . . . 3.6200000000000001 113.03 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 162.6 8.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.615 1.566 . . . . 3.5600000000000001 112.911 -153.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -38.39 57.93 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.071 -1.442 . . . . 4.04 114.447 -171.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.0 mt 66.03 29.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 123.258 1.504 . . . . 5.4500000000000002 110.302 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.6 mm -126.06 149.47 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 127.191 2.196 . . . . 5.2199999999999998 108.954 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.43 146.17 51.94 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.328 1.451 . . . . 3.3799999999999999 114.122 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -97.94 137.39 36.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.16 1.784 . . . . 4.0499999999999998 110.746 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.37 107.73 19.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.385 1.474 . . . . 3.48 108.465 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.73 125.21 47.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.165 0.986 . . . . 2.7000000000000002 108.677 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.5 173.25 42.01 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.986 -0.896 . . . . 1.6699999999999999 111.905 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.12 78.32 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.287 3.325 . . . . 2.6499999999999999 110.803 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.13 -47.43 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 131.335 3.854 . . . . 5.3799999999999999 109.871 -173.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.61 -9.92 21.71 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.467 -1.741 . . . . 3.9500000000000002 116.236 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -82.87 153.27 25.21 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 119.888 1.844 . . . . 4.9699999999999998 110.901 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -80.18 120.8 24.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.414 -0.804 . . . . 4.54 111.099 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.5 pp -104.29 -3.31 24.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.468 1.107 . . . . 4.2800000000000002 113.758 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -157.18 164.29 37.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.899 2.08 . . . . 2.1800000000000002 108.707 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.68 135.25 6.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.241 1.416 . . . . 4.3799999999999999 111.755 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.03 -160.5 0.91 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.214 1.806 . . . . 4.2699999999999996 109.355 -168.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.96 -132.47 3.57 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 109.826 -1.31 . . . . 3.77 109.826 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -53.05 152.1 4.37 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.827 0.822 . . . . 4.3799999999999999 112.711 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 75.7 -18.48 0.45 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.317 1.847 . . . . 6.8899999999999997 112.501 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 146.99 26.24 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.588 -1.32 . . . . 7.6100000000000003 109.911 158.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -107.42 154.73 20.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.309 -0.869 . . . . 6.7999999999999998 110.983 -167.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -47.55 -55.52 9.04 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 3.0099999999999998 112.795 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.67 -19.08 76.28 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 115.238 0.855 . . . . 1.6399999999999999 115.238 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -78.37 -41.82 32.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.171 1.389 . . . . 4.25 111.193 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.69 -42.77 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.475 -0.565 . . . . 2.3399999999999999 109.475 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.91 81.65 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.686 -0.634 . . . . 2.3500000000000001 112.145 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.06 -37.52 86.04 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.767 1.025 . . . . 2.1699999999999999 113.767 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.8 p -67.33 -49.01 65.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.523 1.056 . . . . 2.48 111.074 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.98 -37.82 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.235 -0.915 . . . . 2.6000000000000001 111.693 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.82 67.05 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.735 -1.228 . . . . 2.1299999999999999 113.747 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.7 m -78.27 -50.02 12.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.471 1.108 . . . . 2.54 110.203 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -62.86 -31.31 72.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.811 1.244 . . . . 3.0099999999999998 112.985 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 62.1 ttp -56.36 -18.73 11.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.929 1.692 . . . . 4.96 113.25 168.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.22 -56.55 3.21 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.631 -1.652 . . . . 5.8499999999999996 112.981 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.12 -39.82 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.866 2.377 . . . . 2.6800000000000002 112.996 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -93.15 121.5 34.57 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 122.137 0.97 . . . . 4.2300000000000004 111.116 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? 83.13 -100.82 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.567 2.347 . . . . 10.74 112.556 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.489 ' HZ1' ' C ' ' A' ' 301' ' ' SER . 1.5 ttmt 1.36 -117.63 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 129.231 3.012 . . . . 11.15 117.523 -166.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -149.56 13.65 0.84 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 126.858 2.063 . . . . 9.4600000000000009 112.718 -174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.489 ' C ' ' HZ1' ' A' ' 299' ' ' LYS . 51.0 m . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 128.033 2.533 . . . . 11.09 108.171 -135.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 118.135 -0.936 . . . . 16.18 108.764 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 177.08 152.89 0.21 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.796 1.639 . . . . 16.09 109.275 -158.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.73 176.38 4.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.865 2.066 . . . . 11.699999999999999 109.088 -165.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.68 -5.6 68.9 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 116.537 1.375 . . . . 9.3100000000000005 116.537 162.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -54.49 115.75 9.28 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 119.826 1.813 . . . . 10.029999999999999 111.618 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -81.43 170.96 14.1 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.38 2.72 . . . . 7.8499999999999996 111.732 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -156.72 -66.74 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.226 1.41 . . . . 8.5299999999999994 110.529 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.3 mp 71.15 -80.81 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.745 2.418 . . . . 6.0800000000000001 110.329 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -111.42 -149.28 11.4 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.839 1.685 . . . . 3.46 112.665 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -142.69 154.46 25.25 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.19 1.376 . . . . 3.6400000000000001 111.527 165.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.78 177.73 8.46 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.812 3.008 . . . . 3.3199999999999998 109.924 165.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -156.26 166.39 33.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.164 0.983 . . . . 3.9500000000000002 113.298 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.2 m -156.97 72.69 0.73 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.537 -1.352 . . . . 4.3499999999999996 112.364 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.38 166.98 10.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.631 1.172 . . . . 4.8899999999999997 111.88 -167.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.3 m -99.57 143.34 29.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.471 1.108 . . . . 2.5299999999999998 109.154 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.27 162.28 14.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.889 0.852 . . . . 4.0700000000000003 111.652 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -41.0 -28.76 0.09 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.742 2.417 . . . . 2.0800000000000001 116.264 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.4 m -77.08 -22.3 53.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.842 2.457 . . . . 3.9100000000000001 114.088 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.25 70.64 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.954 1.264 . . . . 1.96 113.612 -167.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 161.05 30.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.111 1.764 . . . . 3.8999999999999999 110.71 168.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -124.16 141.26 52.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.641 1.177 . . . . 5.5300000000000002 112.222 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -133.88 145.94 50.1 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.325 -0.86 . . . . 3.8500000000000001 111.993 -173.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.1 p -128.28 167.02 17.49 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.117 1.767 . . . . 4.1500000000000004 110.089 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.455 ' CG ' ' HZ2' ' A' ' 153' ' ' LYS . 10.0 p-10 -61.36 -10.07 6.55 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.197 0.814 . . . . 4.7599999999999998 113.197 167.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' HZ2' ' CG ' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -81.4 -37.09 28.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.5 0.926 . . . . 6.6299999999999999 113.5 170.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.51 -32.68 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.768 1.227 . . . . 3.23 111.47 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -93.98 -0.11 55.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.362 1.615 . . . . 4.3099999999999996 115.362 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.34 174.76 9.12 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 119.59 1.086 . . . . 4.29 112.039 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.21 3.34 60.94 Favored Glycine 0 N--CA 1.478 1.47 0 N-CA-C 116.259 1.264 . . . . 2.7200000000000002 116.259 165.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -130.77 164.34 25.34 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.96 2.104 . . . . 3.0099999999999998 109.144 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -70.19 132.97 46.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.726 1.148 . . . . 3.1600000000000001 109.105 157.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.46 144.62 38.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.801 0.81 . . . . 4.2800000000000002 112.496 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.7 mt -114.95 120.52 40.19 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.383 1.873 . . . . 3.27 106.169 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.9 pt -115.98 112.59 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.184 -1.043 . . . . 4.3600000000000003 108.184 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -100.47 127.95 46.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.712 1.605 . . . . 4.4699999999999998 112.263 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -100.87 82.6 2.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.313 1.445 . . . . 3.3799999999999999 109.721 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -95.16 164.4 24.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 113.665 -1.607 . . . . 1.6100000000000001 111.279 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.01 -170.45 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.022 -1.103 . . . . 5.3200000000000003 108.022 157.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.3 m -146.3 95.04 2.55 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.324 1.849 . . . . 3.8399999999999999 107.141 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -169.05 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.451 1.649 . . . . 8.3399999999999999 115.451 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 37.6 m -79.78 -179.88 1.58 Allowed Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.298 1.439 . . . . 3.23 111.446 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.9 -129.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.242 2.628 . . . . 5.2599999999999998 108.585 157.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 50.57 0.13 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.377 2.671 . . . . 5.5999999999999996 114.367 -173.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.9 -60.17 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.214 1.805 . . . . 5.3499999999999996 109.873 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 63.8 m -46.96 -44.92 49.8 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-O 117.375 -1.297 . . . . 3.6299999999999999 114.476 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.57 -9.11 6.94 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.432 2.755 . . . . 1.8899999999999999 114.865 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.69 -67.2 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.375 1.443 . . . . 4.04 111.213 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.45 -21.18 65.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.359 0.981 . . . . 3.1099999999999999 113.04 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -47.08 81.62 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.199 0.6 . . . . 3.4399999999999999 110.468 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -40.31 95.32 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.688 -1.258 . . . . 3.5 111.481 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -55.24 24.1 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.074 -1.016 . . . . 4.0899999999999999 110.947 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.37 -16.13 62.94 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.446 0.906 . . . . 4.2800000000000002 113.446 -176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.9 mm -69.36 -56.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.835 1.198 . . . . 2.3100000000000001 109.985 162.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.463 ' CB ' ' HE3' ' A' ' 283' ' ' LYS . 80.8 mt-30 -60.51 -22.58 63.73 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.284 1.402 . . . . 3.1699999999999999 113.185 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.82 -28.02 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.113 -0.992 . . . . 2.8399999999999999 111.264 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.92 -34.61 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.309 0.959 . . . . 3.3799999999999999 110.419 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.43 -45.29 84.83 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.042 1.337 . . . . 4.7599999999999998 112.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.14 -20.39 61.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.535 1.134 . . . . 2.8799999999999999 113.478 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.55 -57.58 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.324 1.05 . . . . 2.6000000000000001 111.543 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.07 -23.69 65.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.584 1.154 . . . . 3.0499999999999998 112.161 -174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 73.4 m -68.11 -19.12 64.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.32 1.048 . . . . 3.3199999999999998 113.713 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.16 -25.22 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.999 0.92 . . . . 4.54 111.176 171.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.0 m 72.63 -33.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 129.801 3.24 . . . . 6.1299999999999999 114.272 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.8 p -99.56 19.25 16.09 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 4.29 111.863 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.09 165.41 43.17 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.477 1.111 . . . . 3.7000000000000002 108.314 159.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 51.62 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.154 2.569 . . . . 4.0899999999999999 110.947 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.61 -173.84 0.16 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.775 2.83 . . . . 4.5599999999999996 113.784 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 45.5 tp -140.55 117.39 11.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.153 -1.054 . . . . 2.6499999999999999 108.153 150.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.0 m -106.56 96.03 13.19 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.288 1.035 . . . . 2.2999999999999998 108.651 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.12 144.12 33.23 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.205 1.937 . . . . 1.5 110.535 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.25 147.11 43.35 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.542 0.687 . . . . 4.0899999999999999 110.806 171.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -112.92 121.09 43.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.895 1.278 . . . . 3.3599999999999999 108.234 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.35 118.03 40.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.738 -1.578 . . . . 2.3599999999999999 106.738 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.57 137.99 38.9 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.567 0.698 . . . . 2.3199999999999998 110.679 162.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.1 pt -114.6 24.48 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.835 1.254 . . . . 3.02 111.092 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -97.69 0.7 0.09 OUTLIER Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 129.337 3.055 . . . . 5.1699999999999999 118.586 -161.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.48 120.55 7.77 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 123.405 2.252 . . . . 2.5299999999999998 111.727 -165.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 149.23 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 130.425 3.49 . . . . 4.4400000000000004 110.402 -171.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -35.46 3.56 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.014 1.116 . . . . 5.8700000000000001 114.014 173.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.4 163.72 12.41 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.35 1.611 . . . . 4.8899999999999997 115.35 -166.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -138.95 153.36 48.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.512 -1.222 . . . . 3.1400000000000001 112.536 -164.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -45.61 -43.95 12.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.87 1.268 . . . . 5.3300000000000001 112.34 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.61 -44.24 62.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.612 1.565 . . . . 4.0599999999999996 112.853 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.84 97.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.34 1.427 . . . . 2.1000000000000001 111.229 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.69 -33.99 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.537 -0.727 . . . . 2.9399999999999999 110.543 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.83 78.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.554 1.07 . . . . 2.0800000000000001 112.638 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -62.43 -53.47 54.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.835 1.198 . . . . 3.8300000000000001 109.983 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -55.83 -46.61 78.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 5.8399999999999999 112.448 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.5 t -62.24 -45.72 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.555 -1.341 . . . . 2.1699999999999999 111.397 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.03 -39.18 91.44 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 118.315 -0.85 . . . . 6.2699999999999996 113.086 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -78.19 -37.28 45.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.059 1.3 . . . . 4.0199999999999996 112.436 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -68.4 -59.68 3.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.536 -0.745 . . . . 4.1900000000000004 112.484 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 174.85 157.28 0.35 Allowed Pre-proline 0 N--CA 1.484 1.257 0 N-CA-C 115.173 1.546 . . . . 2.3599999999999999 115.173 170.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.19 -8.93 18.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.762 2.975 . . . . 2.48 114.552 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -86.16 -0.03 54.73 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 119.95 1.25 . . . . 3.7799999999999998 112.78 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 29.9 tp -94.41 151.04 19.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.995 1.318 . . . . 3.04 109.912 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 87.7 t -133.43 132.43 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.98 1.712 . . . . 2.8999999999999999 108.313 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.6 105.36 1.42 Allowed Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.082 0.848 . . . . 1.1200000000000001 112.068 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.91 147.4 25.59 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.7 1.2 . . . . 2.98 112.453 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 65.4 p -140.49 149.73 42.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.488 1.915 . . . . 3.98 111.164 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -131.44 -170.72 12.7 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.151 1.358 . . . . 1.6599999999999999 110.856 160.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.9 t -84.33 174.59 10.01 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.622 0.711 . . . . 2.71 109.146 152.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -52.26 -24.45 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.026 1.33 . . . . 7.29 113.603 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -74.86 -52.33 11.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.87 2.468 . . . . 2.8300000000000001 110.784 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.07 -25.84 64.64 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.272 -1.517 . . . . 3.9700000000000002 111.96 171.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 33.3 t -62.98 -38.95 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 117.22 -1.371 . . . . 2.8199999999999998 110.991 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.8 -52.53 65.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.451 1.478 . . . . 3.9399999999999999 109.042 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -49.98 -57.28 7.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.606 1.094 . . . . 2.96 112.02 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.48 -29.19 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.315 1.416 . . . . 3.9300000000000002 113.002 -170.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.38 -42.33 79.28 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.831 -0.543 . . . . 2.23 110.732 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -72.02 -33.93 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.854 2.062 . . . . 5.3099999999999996 112.573 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -54.87 -30.72 58.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.039 1.336 . . . . 2.6299999999999999 114.487 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -118.22 3.72 11.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.616 1.166 . . . . 4.6299999999999999 113.099 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.75 39.92 16.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.204 2.202 . . . . 7.5800000000000001 112.91 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.17 155.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.867 0.867 . . . . 3.4199999999999999 112.131 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -104.58 148.98 25.91 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.591 1.556 . . . . 3.8100000000000001 114.084 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -170.37 150.12 3.48 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.837 2.855 . . . . 4.6699999999999999 109.497 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.2 m -157.78 144.45 13.11 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 124.979 1.312 . . . . 3.7400000000000002 111.623 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.06 154.04 37.31 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.508 2.139 . . . . 3.3700000000000001 111.414 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -69.92 176.02 33.85 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 123.886 0.755 . . . . 3.1600000000000001 114.259 171.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.64 -27.93 10.32 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.431 2.754 . . . . 5.5 112.63 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt 62.7 54.69 2.29 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.378 1.871 . . . . 4.8600000000000003 114.882 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . 0.256 0.8 OUTLIER -141.51 -155.21 0.57 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 113.366 0.876 . . . . 7.4699999999999998 113.366 172.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.258 17.3 mt-10 49.26 -82.39 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.862 2.065 . . . . 9.3800000000000008 111.772 -148.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -93.2 -47.93 6.7 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.273 1.029 . . . . 8.1799999999999997 112.029 168.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -178.65 -1.52 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 127.031 2.132 . . . . 5.9699999999999998 113.248 -168.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -29.11 98.93 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 116.948 2.203 . . . . 6.46 116.948 -147.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -93.21 41.1 1.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.746 -1.116 . . . . 6.1600000000000001 111.887 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.54 160.61 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 121.245 -0.909 . . . . 3.8999999999999999 110.255 162.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 41.1 t -153.74 128.03 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.566 1.947 . . . . 3.9100000000000001 106.568 172.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.19 146.41 49.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.556 1.542 . . . . 3.3199999999999998 112.196 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -148.77 129.51 14.16 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.135 0.974 . . . . 3.1000000000000001 111.237 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.6 m -54.45 -31.15 54.91 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.93 1.085 . . . . 4.0700000000000003 113.93 -171.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 69.74 -20.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.42 1.888 . . . . 5.0 114.402 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 84.4 mt -54.94 138.78 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.082 0.953 . . . . 3.27 110.504 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.7 mtm -99.78 141.2 32.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.324 -1.307 . . . . 3.5600000000000001 110.46 162.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -99.21 140.32 33.55 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.241 0.616 . . . . 4.7400000000000002 110.006 168.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 21.6 tp -99.1 117.04 32.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.919 0.888 . . . . 3.1499999999999999 108.918 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.48 141.99 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.795 -1.187 . . . . 3.48 107.795 169.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.41 168.28 34.78 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.23 0.919 . . . . 1.9099999999999999 115.156 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.66 61.25 7.44 Favored 'Trans proline' 0 C--N 1.351 0.695 1 C-N-CA 126.063 4.509 . . . . 3.0299999999999998 110.722 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.54 -67.45 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.091 1.356 . . . . 4.1299999999999999 108.232 -149.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.61 -23.22 2.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.07 -1.406 . . . . 2.5600000000000001 115.046 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.59 172.25 11.07 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.335 1.567 . . . . 4.7199999999999998 113.219 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -88.56 137.64 32.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.755 2.022 . . . . 6.6699999999999999 111.429 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.22 -30.15 4.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.055 1.872 . . . . 3.4399999999999999 116.055 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -164.68 155.98 15.22 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.686 1.585 . . . . 2.52 112.995 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 146.09 31.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.728 0.811 . . . . 7.0199999999999996 112.825 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.37 159.92 40.05 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.344 1.058 . . . . 4.0999999999999996 111.771 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.48 -174.37 29.04 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.347 1.451 . . . . 3.25 110.213 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -73.83 38.57 0.1 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.29 2.236 . . . . 4.0899999999999999 114.637 -167.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -121.48 -43.25 2.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.542 1.537 . . . . 6.4000000000000004 109.91 167.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -87.32 118.59 26.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.449 1.5 . . . . 5.0700000000000003 108.945 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -73.42 177.92 4.93 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.264 -0.897 . . . . 6.9699999999999998 108.709 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.463 ' HE3' ' CB ' ' A' ' 182' ' ' GLN . 12.7 tmtt? -54.45 -47.33 73.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.301 1.223 . . . . 2.5299999999999998 114.301 -170.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -32.8 85.39 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-N 118.414 0.552 . . . . 1.6899999999999999 112.757 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.08 -22.84 62.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.357 1.063 . . . . 3.4700000000000002 113.078 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.04 -49.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.111 -0.993 . . . . 2.52 109.923 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.79 88.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.544 -0.723 . . . . 2.3700000000000001 112.657 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.49 66.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.361 1.245 . . . . 2.5899999999999999 114.361 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.3 p -74.72 -44.82 48.01 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.296 -0.878 . . . . 2.4399999999999999 111.544 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.01 -40.34 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 120.142 1.337 . . . . 2.27 110.93 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.97 -5.36 9.22 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 114.663 1.357 . . . . 2.3700000000000001 114.663 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.1 m -96.41 -47.93 5.78 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.288 1.435 . . . . 2.75 110.087 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -65.21 -24.94 67.49 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.619 1.168 . . . . 3.6699999999999999 113.301 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -55.78 -35.71 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.549 2.34 . . . . 5.8399999999999999 113.9 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -59.4 -43.23 95.91 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 116.838 -1.553 . . . . 7.3600000000000003 111.913 -172.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.61 -61.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.133 1.889 . . . . 2.3799999999999999 110.519 161.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.24 74.24 3.97 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 122.795 1.283 . . . . 4.1600000000000001 113.722 -169.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -97.29 150.13 21.3 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.375 2.27 . . . . 10.26 110.831 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -76.64 -13.01 60.09 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.589 1.7 . . . . 9.1699999999999999 115.589 -173.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -132.91 -45.51 0.86 Allowed 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.545 1.683 . . . . 9.8499999999999996 115.545 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.251 1.158 0 C-N-CA 130.026 3.33 . . . . 8.2400000000000002 108.944 -152.642 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 117.711 -1.138 . . . . 20.93 109.873 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -165.25 151.86 10.27 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.289 1.435 . . . . 16.829999999999998 110.35 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t 155.25 -168.0 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 1 C-N-CA 132.033 4.133 . . . . 13.789999999999999 107.82 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.06 -2.09 77.08 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 116.457 1.343 . . . . 10.91 116.457 162.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.98 115.77 8.0 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-N 119.534 1.667 . . . . 10.66 112.04 -175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.73 -175.99 2.99 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.202 2.601 . . . . 10.77 111.667 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.45 164.68 32.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.607 1.963 . . . . 8.5299999999999994 109.214 171.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.7 tp -166.25 153.46 9.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.065 2.146 . . . . 7.9199999999999999 108.264 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.45 175.36 22.32 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.881 1.229 . . . . 3.23 114.498 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.72 61.73 0.65 Allowed Glycine 0 CA--C 1.531 1.053 0 N-CA-C 109.531 -1.428 . . . . 3.8900000000000001 109.531 162.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.93 144.31 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.613 2.208 . . . . 2.7999999999999998 112.968 -151.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -86.33 175.09 8.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.288 1.518 . . . . 3.4199999999999999 114.092 -166.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -148.19 106.37 3.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.983 1.313 . . . . 3.46 108.607 165.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mp -148.57 165.17 32.05 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.682 1.593 . . . . 3.3300000000000001 110.137 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.2 m -107.95 134.07 51.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.763 1.225 . . . . 2.29 111.904 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -73.61 160.27 31.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.494 1.118 . . . . 3.0099999999999998 112.216 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -60.6 -20.01 59.4 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 121.508 -0.745 . . . . 2.3500000000000001 112.486 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.2 m -78.43 -60.02 2.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.35 1.86 . . . . 3.9100000000000001 109.822 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.85 -14.9 0.69 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 116.11 1.204 . . . . 2.3399999999999999 116.11 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.2 133.67 44.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.829 1.815 . . . . 3.9199999999999999 109.973 171.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -82.31 129.5 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.119 -1.067 . . . . 6.5499999999999998 108.119 157.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -140.37 175.99 9.14 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.818 1.247 . . . . 4.7699999999999996 112.806 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.6 p -140.77 172.45 12.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 128.583 2.753 . . . . 3.6600000000000001 109.383 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.83 -25.03 62.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.128 0.788 . . . . 3.9100000000000001 113.128 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -75.07 -11.59 60.13 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 119.938 -1.726 . . . . 8.3599999999999994 113.979 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.73 -28.87 21.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.866 1.666 . . . . 4.1900000000000004 111.636 164.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -108.58 -2.47 18.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.535 1.68 . . . . 4.9400000000000004 115.535 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.9 mt -77.56 -176.64 4.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.9 1.227 . . . . 5.29 109.777 165.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.7 10.86 Favored Glycine 0 N--CA 1.48 1.573 0 O-C-N 120.889 -1.132 . . . . 2.7400000000000002 114.991 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -126.18 168.88 13.44 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.048 2.939 . . . . 3.79 108.252 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . 0.461 ' CD1' ' HD3' ' A' ' 269' ' ' PRO . 53.9 m95 -81.77 140.39 34.27 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.445 1.02 . . . . 2.73 109.807 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.6 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.203 -0.936 . . . . 4.0700000000000003 112.438 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.17 100.63 10.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.935 -1.135 . . . . 4.5499999999999998 107.935 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.2 mt -96.26 127.75 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.743 -0.836 . . . . 2.6299999999999999 108.743 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -139.95 143.82 36.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.122 0.969 . . . . 3.7200000000000002 111.94 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.81 127.21 53.51 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.674 1.19 . . . . 3.3900000000000001 112.34 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -147.47 163.96 28.74 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.506 1.05 . . . . 1.3400000000000001 112.654 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.95 -179.04 6.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 117.745 0.772 . . . . 4.3099999999999996 111.313 168.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 174.89 5.67 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.963 -1.125 . . . . 3.75 107.963 152.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 73.92 -24.76 0.2 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.516 1.526 . . . . 8.0399999999999991 113.921 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 83.6 m -52.42 159.69 1.54 Allowed Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 120.648 1.567 . . . . 2.8799999999999999 113.293 161.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.54 -173.44 1.8 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.386 3.39 . . . . 4.4699999999999998 111.474 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.44 -2.46 1.05 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.248 2.219 . . . . 6.3399999999999999 115.904 -157.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.29 -60.41 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.362 1.465 . . . . 5.5800000000000001 110.163 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 15.6 m -52.43 -44.02 93.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.372 -1.299 . . . . 3.0800000000000001 114.212 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.63 -39.59 0.51 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.435 2.09 . . . . 2.4100000000000001 113.774 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.41 -32.62 68.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 122.171 2.26 . . . . 4.6699999999999999 112.086 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -60.11 -44.98 94.46 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.506 -1.371 . . . . 4.0700000000000003 111.484 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.77 -39.46 91.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.02 0.928 . . . . 4.0700000000000003 111.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -72.81 -25.98 61.34 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.417 -1.427 . . . . 6.7699999999999996 114.06 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -56.03 -56.96 14.44 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.431 -1.418 . . . . 3.4900000000000002 109.812 165.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 10.0 ptp -64.7 -30.9 71.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.013 -0.994 . . . . 4.5999999999999996 113.093 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.2 mt -75.16 -48.34 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 121.773 2.079 . . . . 4.3099999999999996 109.821 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -68.07 -16.63 64.1 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.252 1.387 . . . . 6.54 111.776 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.84 -30.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.95 1.25 . . . . 2.7799999999999998 112.584 163.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.82 -46.03 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 121.061 1.755 . . . . 3.3700000000000001 110.257 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.23 -37.35 77.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.332 1.053 . . . . 4.6299999999999999 113.153 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -57.53 -46.1 84.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 3.5600000000000001 111.721 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.8 mt -71.87 -33.3 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.711 1.204 . . . . 2.8199999999999998 114.232 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.44 -29.47 61.69 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.429 1.892 . . . . 3.2000000000000002 112.359 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.5 t -68.52 -14.67 63.16 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.471 -1.393 . . . . 4.1600000000000001 113.562 170.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.43 45.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 127.069 2.147 . . . . 4.1699999999999999 108.666 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.06 4.3 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.617 2.767 . . . . 7.3300000000000001 116.252 -159.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 78.0 p -78.21 -24.33 47.1 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.94 -1.1 . . . . 5.6200000000000001 112.382 166.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.33 142.63 67.74 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 118.72 0.691 . . . . 4.7300000000000004 111.046 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.415 ' HD2' ' CD1' ' A' ' 159' ' ' TRP . 1.7 Cg_endo -81.77 46.63 2.28 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.604 4.203 . . . . 5.0700000000000003 112.233 -174.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . 0.416 ' CG ' ' HZ3' ' A' ' 300' ' ' LYS . 20.4 m-20 72.88 101.21 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.633 1.682 . . . . 5.6299999999999999 112.725 145.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 84.76 4.99 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.387 1.475 . . . . 3.1400000000000001 111.012 -160.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.8 m -79.95 122.31 83.09 Favored Pre-proline 0 N--CA 1.478 0.94 0 O-C-N 120.84 -1.163 . . . . 2.0 112.094 -173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.04 124.43 1.79 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.381 2.721 . . . . 1.3 111.97 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 tp -126.58 93.96 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.085 1.354 . . . . 3.5299999999999998 110.327 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.77 115.39 14.3 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.94 -0.763 . . . . 3.3199999999999998 108.94 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.94 112.51 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.793 1.237 . . . . 2.7000000000000002 108.584 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -83.88 135.03 34.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.649 -1.16 . . . . 2.3599999999999999 109.55 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.7 34.95 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.582 1.153 . . . . 2.4399999999999999 112.657 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -121.55 44.49 0.79 Allowed Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 127.158 2.183 . . . . 3.71 111.97 -173.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -77.71 35.15 0.5 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.231 3.287 . . . . 2.1600000000000001 113.811 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -91.34 -16.59 27.23 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.204 -0.426 . . . . 5.4299999999999997 110.406 150.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.49 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.494 2.405 . . . . 9.0199999999999996 117.494 -171.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -79.73 52.48 1.45 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.317 1.847 . . . . 4.0300000000000002 114.619 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.1 m -55.5 129.79 40.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.388 1.075 . . . . 3.2799999999999998 110.785 -167.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -41.62 -48.51 4.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.363 1.465 . . . . 3.79 113.922 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -26.07 43.98 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.993 1.109 . . . . 4.0700000000000003 113.993 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.11 86.44 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 2.8500000000000001 110.83 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.84 -30.76 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.351 1.06 . . . . 3.0899999999999999 112.613 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.31 74.38 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.408 1.458 . . . . 2.3700000000000001 113.09 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 -44.73 58.02 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.699 0.799 . . . . 4.0099999999999998 111.201 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -55.9 -39.98 72.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.476 1.51 . . . . 5.0800000000000001 111.517 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.15 -20.72 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.053 1.741 . . . . 2.4100000000000001 113.583 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -111.69 -21.55 11.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.46 1.652 . . . . 9.5500000000000007 115.46 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.73 -19.13 58.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.377 0.989 . . . . 4.0499999999999998 113.044 168.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -74.14 -87.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.707 1.603 . . . . 4.8300000000000001 110.147 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.2 t -148.61 132.1 8.33 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.646 -1.283 . . . . 3.6000000000000001 110.121 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.07 -19.44 45.37 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.382 2.055 . . . . 3.7000000000000002 114.663 -156.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -84.61 2.69 40.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.713 1.375 . . . . 4.25 114.713 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.2 tp -72.55 147.3 46.07 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.624 1.102 . . . . 3.0 113.083 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 2.3 p -118.31 130.97 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.668 1.587 . . . . 3.7799999999999998 108.66 160.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.45 160.82 19.75 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 123.919 0.771 . . . . 1.27 111.909 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -153.36 114.04 4.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.497 -1.297 . . . . 4.7800000000000002 107.497 -166.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.0 m -112.88 152.65 29.04 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.24 2.216 . . . . 3.0600000000000001 107.877 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -144.51 146.29 16.6 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 121.819 -0.551 . . . . 3.04 112.71 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -63.51 154.3 32.84 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.057 0.928 . . . . 3.3900000000000001 109.693 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.453 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -47.23 -33.25 5.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.929 1.292 . . . . 8.7799999999999994 113.38 -170.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.44 -50.57 58.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.874 1.215 . . . . 5.2699999999999996 112.411 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.62 -44.7 90.04 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.961 -1.087 . . . . 3.4300000000000002 111.967 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 15.6 m -70.95 -22.32 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 113.844 1.053 . . . . 3.9399999999999999 113.844 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.68 -53.09 37.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.847 1.203 . . . . 3.5499999999999998 108.808 164.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -55.82 -57.82 10.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.361 -0.828 . . . . 3.6600000000000001 112.378 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.97 -35.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 119.356 0.98 . . . . 2.98 113.323 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.42 67.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.063 0.945 . . . . 3.0899999999999999 111.477 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -70.21 -26.49 63.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.626 1.57 . . . . 3.7799999999999998 112.433 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.8 -62.89 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.695 1.198 . . . . 2.8199999999999998 113.367 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -67.5 -33.78 75.79 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.038 -1.039 . . . . 4.6699999999999999 112.735 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.259 2.2 ptp180 109.16 117.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 1 C-N-CA 132.411 4.284 . . . . 10.4 109.777 179.365 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.83 153.61 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.027 2.131 . . . . 5.2699999999999996 110.473 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -119.53 135.98 54.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.73 0.412 . . . . 5.2999999999999998 110.163 148.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -165.91 166.18 17.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.167 1.787 . . . . 4.9699999999999998 111.323 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 48.9 p -113.16 165.8 12.46 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.46 1.504 . . . . 5.0 112.743 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.27 143.63 17.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.595 2.197 . . . . 5.5700000000000003 111.046 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -72.25 136.07 23.28 Favored Glycine 0 CA--C 1.542 1.747 0 CA-C-O 118.026 -1.43 . . . . 3.8100000000000001 112.14 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.59 -23.82 9.45 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.159 2.573 . . . . 6.5700000000000003 116.283 -167.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt 59.95 30.5 20.01 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 120.736 1.607 . . . . 6.6600000000000001 113.985 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -140.0 153.48 46.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.227 1.811 . . . . 6.8600000000000003 110.454 -169.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 110.98 -52.49 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 131.305 3.842 . . . . 7.8600000000000003 110.05 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -140.73 -49.82 0.44 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.573 1.549 . . . . 6.9000000000000004 109.196 162.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -176.85 -29.37 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.98 3.312 . . . . 6.4900000000000002 108.988 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -60.42 152.82 24.56 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.34 2.256 . . . . 7.1799999999999997 113.66 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -163.41 -179.31 6.44 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.504 2.038 . . . . 4.4900000000000002 116.504 -166.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt -138.84 163.93 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.711 2.004 . . . . 5.2400000000000002 108.52 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.56 148.42 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.627 1.571 . . . . 4.29 109.108 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -86.28 135.19 33.64 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.312 -0.996 . . . . 4.0300000000000002 108.312 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.62 139.85 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.59 1.156 . . . . 3.3500000000000001 111.274 -169.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -68.42 -14.94 63.35 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.977 2.214 . . . . 4.6500000000000004 116.977 -165.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 28.3 mt 50.8 56.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 120.169 1.349 . . . . 5.3899999999999997 110.36 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.0 mt -112.31 147.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.128 1.371 . . . . 3.3799999999999999 109.986 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.0 ttp -114.49 144.8 42.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.622 1.969 . . . . 5.0999999999999996 109.856 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -107.14 136.26 47.29 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.242 -0.912 . . . . 3.5699999999999998 110.874 163.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 39.2 tp -94.95 106.97 19.0 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.967 0.907 . . . . 3.1099999999999999 108.85 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.3 mp -86.84 135.58 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.501 -1.666 . . . . 2.98 106.501 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.49 165.29 24.77 Favored Glycine 0 CA--C 1.539 1.593 0 N-CA-C 111.587 -0.605 . . . . 1.8100000000000001 111.587 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.461 ' HD3' ' CD1' ' A' ' 159' ' ' TRP . 21.0 Cg_endo -67.5 9.92 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 125.181 3.921 . . . . 2.9199999999999999 114.16 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -141.93 -1.03 1.27 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.904 2.482 . . . . 5.04 111.492 -167.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 163.34 156.56 8.71 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.105 0.859 . . . . 3.9100000000000001 114.483 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -74.71 -22.05 59.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.08 1.352 . . . . 6.1900000000000004 114.638 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.87 108.17 9.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.133 -0.979 . . . . 4.9900000000000002 111.32 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 -36.76 4.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.572 1.149 . . . . 4.1500000000000004 111.152 170.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -157.45 178.63 10.08 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.98 2.112 . . . . 2.2999999999999998 110.479 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -155.26 138.3 15.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.311 1.444 . . . . 4.6299999999999999 113.354 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.8 -151.35 0.39 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.166 1.387 . . . . 4.1699999999999999 110.968 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.85 -127.05 7.92 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.849 2.166 . . . . 3.8799999999999999 108.492 -171.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -53.44 156.25 2.55 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.078 1.351 . . . . 3.46 113.11 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.6 -40.84 0.39 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.772 2.429 . . . . 5.0999999999999996 112.459 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -63.41 108.84 1.43 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.982 1.313 . . . . 5.5 112.709 -174.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.61 141.66 57.64 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.331 -0.856 . . . . 8.4600000000000009 108.845 177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -48.59 -53.57 17.9 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.205 -1.559 . . . . 3.3500000000000001 114.449 -165.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.3 -14.41 71.56 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 115.707 1.043 . . . . 1.79 115.707 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.3 -38.87 82.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.033 1.417 . . . . 3.6499999999999999 110.439 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.7 -48.54 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.65 0.78 . . . . 2.29 109.259 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.73 77.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 119.121 -0.466 . . . . 2.0699999999999998 111.858 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.79 90.39 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.712 1.004 . . . . 2.6299999999999999 113.712 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 86.8 p -60.01 -48.59 81.07 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.581 -0.699 . . . . 2.1899999999999999 111.795 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.13 -31.69 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.658 -1.276 . . . . 2.3700000000000001 111.368 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.0 64.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.957 0.903 . . . . 2.29 113.093 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.6 m -70.71 -46.09 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.539 -0.726 . . . . 2.8999999999999999 109.597 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -69.72 -27.89 65.35 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.844 1.053 . . . . 2.9700000000000002 113.844 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.7 ttt -59.98 -40.17 88.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.413 1.485 . . . . 5.21 112.167 166.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.07 36.78 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 117.36 -1.305 . . . . 6.25 113.348 -173.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.53 -57.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.408 2.739 . . . . 3.1000000000000001 112.379 158.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 299' ' ' LYS . 0.6 OUTLIER -110.67 28.61 8.51 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.439 1.644 . . . . 5.0199999999999996 115.439 -154.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -33.48 -53.67 0.41 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.667 1.987 . . . . 8.8800000000000008 114.612 165.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 297' ' ' TYR . 62.7 mttt 53.36 177.63 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.716 1.206 . . . . 13.32 111.334 -158.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.416 ' HZ3' ' CG ' ' A' ' 195' ' ' ASP . 21.6 mttt 54.97 -62.14 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.953 2.101 . . . . 8.4499999999999993 114.815 -166.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 C-N-CA 129.216 3.006 . . . . 7.0300000000000002 112.213 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 118.218 -0.896 . . . . 14.34 109.91 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -72.61 144.48 47.83 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.631 0.65 . . . . 14.02 111.461 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 t 161.5 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 131.305 3.842 . . . . 11.74 108.127 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.06 1.45 6.89 Favored Glycine 0 N--CA 1.476 1.322 0 N-CA-C 117.852 1.901 . . . . 9.8100000000000005 117.852 163.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -97.42 106.94 35.88 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 119.626 1.713 . . . . 9.9900000000000002 112.548 -162.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -81.03 148.32 17.03 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.637 2.891 . . . . 9.25 112.688 170.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 38.9 tp -112.6 -18.7 12.31 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.443 1.275 . . . . 9.0500000000000007 114.443 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.07 33.39 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 118.211 2.671 . . . . 9.3900000000000006 118.211 -154.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 125.51 126.95 3.05 Favored Glycine 0 N--CA 1.471 1.013 0 O-C-N 120.647 -1.283 . . . . 3.6099999999999999 114.158 166.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.71 148.34 31.94 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.734 1.159 . . . . 3.1000000000000001 112.307 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.65 174.77 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.127 3.218 . . . . 3.8900000000000001 112.171 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.76 173.38 15.36 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.973 1.709 . . . . 4.1600000000000001 109.843 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.71 32.21 4.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.618 0.97 . . . . 4.4400000000000004 113.618 172.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.3 mt -51.72 149.3 4.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 3.8199999999999998 112.563 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -108.38 142.35 38.85 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.396 1.078 . . . . 2.1400000000000001 109.731 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.3 t -91.32 165.09 13.61 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.295 1.038 . . . . 3.4500000000000002 113.245 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -61.2 -25.37 67.0 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 3.04 114.124 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -83.12 0.93 42.89 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.249 1.82 . . . . 3.7000000000000002 114.178 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.94 -6.37 73.04 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.227 1.394 . . . . 2.02 115.555 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -73.63 132.95 43.32 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.347 1.073 . . . . 4.0800000000000001 111.293 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -82.52 105.3 13.46 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.092 -1.005 . . . . 5.1299999999999999 108.494 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -179.1 4.3 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.976 1.31 . . . . 3.9500000000000002 113.614 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 62.3 p -146.54 166.16 27.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.035 2.534 . . . . 3.1099999999999999 109.005 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.31 -38.17 76.55 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.449 0.568 . . . . 4.0800000000000001 112.343 173.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -81.78 4.25 22.8 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.89 1.441 . . . . 7.8300000000000001 114.89 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.81 -41.33 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.622 0.769 . . . . 3.46 109.828 160.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -84.5 -29.19 26.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.756 1.391 . . . . 4.5099999999999998 114.756 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.89 101.96 0.43 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.781 1.232 . . . . 4.9800000000000004 110.23 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 144.2 -20.97 2.09 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.643 1.116 . . . . 3.0 113.48 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.67 170.45 7.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.876 -0.787 . . . . 3.7000000000000002 108.876 152.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -82.42 127.4 33.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.478 0.581 . . . . 2.5899999999999999 109.856 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.48 145.94 44.88 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.636 0.653 . . . . 4.2999999999999998 112.506 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.1 mt -107.19 121.61 44.87 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.09 1.356 . . . . 3.4399999999999999 108.01 158.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.5 118.66 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.267 0.627 . . . . 3.1800000000000002 109.626 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -122.9 149.88 43.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.305 1.442 . . . . 3.7799999999999998 114.015 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -99.19 120.54 39.69 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 3.6000000000000001 112.524 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.96 155.71 15.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.515 1.055 . . . . 1.9299999999999999 113.791 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -114.08 -43.75 3.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.362 1.065 . . . . 4.1799999999999997 111.865 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.5 m 67.71 -18.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 126.453 1.901 . . . . 5.2000000000000002 114.835 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.425 ' HE2' ' CG ' ' A' ' 255' ' ' ASP . 14.0 t-80 -71.93 -18.86 61.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.319 1.048 . . . . 8.2899999999999991 111.326 160.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.54 164.38 58.33 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.768 1.227 . . . . 2.48 111.741 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -78.82 -146.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.433 2.755 . . . . 4.3399999999999999 109.387 164.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.53 57.72 0.13 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.872 3.269 . . . . 5.5899999999999999 113.348 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.5 t -115.24 -84.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 126.849 2.06 . . . . 4.71 108.073 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -47.59 98.34 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 117.062 -1.447 . . . . 2.9100000000000001 113.761 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.46 -23.57 43.67 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.029 1.82 . . . . 1.78 114.219 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.78 -56.55 14.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.82 0.848 . . . . 4.1900000000000004 109.961 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.436 ' CD ' ' HZ1' ' A' ' 281' ' ' LYS . 4.9 tp10 -60.75 -39.89 90.4 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 2.9500000000000002 112.129 175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.1 tt -55.58 -39.58 70.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.82 1.248 . . . . 3.7000000000000002 112.036 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . 0.263 0.3 OUTLIER -75.77 -34.02 60.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.144 0.884 . . . . 3.21 112.305 175.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -55.65 -46.12 77.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.283 -1.511 . . . . 5.71 111.643 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.4 ptp -67.89 -28.53 67.59 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.728 0.64 . . . . 3.5099999999999998 112.728 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.23 -38.09 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.295 -0.878 . . . . 3.0 111.018 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.457 ' OE1' ' HE3' ' A' ' 283' ' ' LYS . 73.9 mt-30 -62.57 -40.43 96.85 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.297 -0.859 . . . . 3.1499999999999999 111.931 171.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . 0.259 4.4 m -72.31 -28.93 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.218 1.372 . . . . 4.2199999999999998 113.243 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.2 t -63.07 -52.83 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.793 1.179 . . . . 2.9500000000000002 111.717 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -74.92 -19.97 59.9 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.155 0.798 . . . . 5.1799999999999997 113.155 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -64.93 -55.59 18.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.596 0.758 . . . . 3.2799999999999998 111.241 164.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.25 -37.37 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.111 1.365 . . . . 3.2599999999999998 112.902 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.51 -35.56 65.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.49 1.516 . . . . 3.21 112.205 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.9 t -72.34 -18.2 61.78 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.931 1.085 . . . . 4.3499999999999996 113.931 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 11.8 mt -94.36 75.38 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.357 1.463 . . . . 4.0999999999999996 107.795 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -3.55 0.06 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 128.111 2.565 . . . . 5.4199999999999999 116.623 -162.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 301' ' ' SER . 15.1 t -71.59 -22.44 61.73 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.378 1.871 . . . . 6.6699999999999999 113.071 167.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.4 151.74 59.75 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.434 1.016 . . . . 4.8899999999999997 111.195 166.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 -40.11 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.074 2.516 . . . . 3.23 110.779 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -172.74 -179.89 2.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.235 2.614 . . . . 4.4800000000000004 109.331 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.0 tp -149.27 73.26 1.19 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.799 1.24 . . . . 2.96 109.948 160.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -63.03 119.96 56.82 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 121.077 -1.015 . . . . 2.1899999999999999 110.717 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.93 128.37 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.29 1.993 . . . . 1.3400000000000001 110.459 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.6 tp -115.81 115.36 26.15 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.663 1.585 . . . . 3.7400000000000002 110.735 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -87.24 126.52 34.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.174 0.99 . . . . 3.5499999999999998 109.884 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.79 119.53 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.429 -0.952 . . . . 2.3999999999999999 108.429 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.8 t -79.1 139.49 38.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.956 -0.565 . . . . 2.3100000000000001 111.632 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -124.19 21.76 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.916 1.286 . . . . 2.71 113.119 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -111.52 61.66 0.5 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.803 1.241 . . . . 3.5600000000000001 113.647 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.17 73.17 5.6 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.18 2.587 . . . . 2.4100000000000001 110.255 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -153.32 -37.15 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.101 1.36 . . . . 5.4199999999999999 112.555 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.09 7.36 0.91 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.081 1.141 . . . . 5.8700000000000001 114.081 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 177.73 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.987 -0.445 . . . . 3.46 110.828 157.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 32.8 m -155.95 136.9 13.57 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.025 -1.047 . . . . 2.6200000000000001 108.181 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.43 ' HZ2' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -51.76 -44.86 63.5 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.013 0.925 . . . . 4.8399999999999999 112.216 177.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.43 ' CD ' ' HZ2' ' A' ' 210' ' ' LYS . 17.7 mp0 -60.35 -40.24 90.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.083 1.753 . . . . 3.5699999999999998 112.776 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.98 69.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.227 -0.921 . . . . 2.52 112.346 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.61 -43.24 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.919 0.888 . . . . 3.0699999999999998 110.654 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.56 66.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.219 1.008 . . . . 2.1899999999999999 112.484 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.446 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 0.7 OUTLIER -71.21 -46.79 60.43 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.19 0.996 . . . . 4.21 112.331 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.79 -37.11 86.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.467 1.507 . . . . 5.5300000000000002 111.422 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -50.64 -44.9 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.877 2.071 . . . . 2.0499999999999998 112.987 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 7.7 mtmp? -55.23 -45.53 75.97 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.662 0.664 . . . . 4.79 112.386 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -20.46 60.12 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 124.363 1.04 . . . . 5.1600000000000001 112.211 -163.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -86.16 -48.24 8.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.012 0.925 . . . . 3.4900000000000002 111.993 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 87.8 p -174.04 127.89 0.46 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.753 -1.118 . . . . 3.3399999999999999 110.902 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.15 76.59 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.661 2.907 . . . . 3.1699999999999999 109.244 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 178.18 -28.27 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.996 2.919 . . . . 3.2799999999999998 111.005 -163.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.93 143.96 55.43 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.917 1.687 . . . . 3.6299999999999999 110.722 164.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.72 133.97 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.378 1.471 . . . . 3.73 109.797 170.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.51 115.66 3.58 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 123.841 0.734 . . . . 1.0700000000000001 112.181 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.87 148.67 27.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.365 1.066 . . . . 3.5800000000000001 111.455 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 71.9 p -136.59 161.61 35.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.986 1.314 . . . . 3.0099999999999998 110.635 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.6 23.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 124.659 1.123 . . . . 2.8799999999999999 110.372 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.6 t -60.57 166.53 3.13 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.507 1.123 . . . . 3.5099999999999998 111.293 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -38.36 7.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.306 1.042 . . . . 7.5499999999999998 112.528 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 23.5 mp0 -67.15 -42.03 85.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.408 2.283 . . . . 3.75 111.751 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -71.16 -34.37 70.91 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.036 -1.04 . . . . 4.0899999999999999 111.667 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.71 -38.89 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 118.363 -0.827 . . . . 3.27 109.669 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -70.66 -41.85 71.55 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.859 -1.067 . . . . 3.4300000000000002 111.748 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -54.51 -50.04 68.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.293 1.861 . . . . 2.6600000000000001 110.752 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.44 -55.13 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.715 0.806 . . . . 3.4700000000000002 111.821 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.86 62.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.959 0.904 . . . . 2.6499999999999999 113.439 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -87.86 -30.26 20.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.675 1.59 . . . . 5.0599999999999996 112.305 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.24 13.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.109 1.322 . . . . 2.4100000000000001 111.206 168.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -76.96 -14.42 59.85 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.603 0.964 . . . . 4.96 113.603 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 76.77 62.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.112 2.165 . . . . 6.1100000000000003 112.881 159.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.86 145.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.341 1.457 . . . . 4.9199999999999999 111.979 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.74 135.88 40.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.02 0.914 . . . . 4.1299999999999999 113.033 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -145.64 136.36 24.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.881 2.872 . . . . 6.46 108.077 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.3 t -121.25 105.08 39.99 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.097 0.959 . . . . 3.4100000000000001 109.921 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.72 101.32 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.505 2.137 . . . . 3.5899999999999999 108.845 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -66.67 148.36 50.51 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 119.617 -0.546 . . . . 2.46 113.052 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -67.96 146.7 72.24 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.039 2.492 . . . . 3.9300000000000002 109.631 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -78.72 140.9 38.25 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.765 0.654 . . . . 6.2800000000000002 112.765 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -150.84 165.76 32.61 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.506 1.523 . . . . 5.96 111.733 -159.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 60.98 -45.4 0.12 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 130.948 3.699 . . . . 7.7000000000000002 114.612 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -163.98 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.002 2.121 . . . . 7.4400000000000004 110.108 168.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -167.65 36.23 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.701 1.2 . . . . 7.5800000000000001 113.634 -174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.425 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 33.1 t0 -135.4 172.83 12.45 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 119.329 -2.107 . . . . 5.3099999999999996 113.187 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -164.21 168.17 19.19 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.275 1.43 . . . . 4.8899999999999997 112.169 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.75 162.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.193 1.397 . . . . 3.4399999999999999 109.019 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 t -128.18 137.68 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.791 2.037 . . . . 4.2699999999999996 108.374 -169.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.96 119.2 21.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 107.049 -1.463 . . . . 4.5099999999999998 107.049 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.17 131.6 54.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.747 -0.834 . . . . 2.6099999999999999 108.747 168.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 56.7 m -53.24 -47.82 68.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.718 0.807 . . . . 4.3799999999999999 112.566 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.5 mt 82.6 98.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.169 2.588 . . . . 4.6600000000000001 108.339 -172.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.42 146.26 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.4 1.48 . . . . 4.2000000000000002 107.146 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.1 ttm -119.47 128.54 54.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.794 1.638 . . . . 3.3100000000000001 108.516 159.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -98.08 139.62 33.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.74 -0.6 . . . . 5.0499999999999998 111.109 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.78 113.98 26.32 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.671 -1.233 . . . . 3.4500000000000002 107.671 169.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 tp -106.28 125.84 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.922 -1.14 . . . . 5.5999999999999996 107.922 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.49 165.21 48.01 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.604 -0.599 . . . . 1.6899999999999999 111.604 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.34 48.64 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.507 3.471 . . . . 2.8500000000000001 110.49 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -165.96 -50.51 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.077 1.751 . . . . 4.4699999999999998 110.209 -156.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 151.49 -178.29 28.91 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 115.772 1.069 . . . . 3.21 115.772 166.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 50.33 -132.15 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.987 2.115 . . . . 4.7199999999999998 114.225 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.36 131.49 54.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.147 0.979 . . . . 5.4699999999999998 109.333 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.0 -29.18 23.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.056 0.943 . . . . 3.8100000000000001 110.591 169.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -162.4 158.81 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.105 2.162 . . . . 2.21 109.428 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -134.59 99.28 4.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.021 1.391 . . . . 4.8399999999999999 111.04 -170.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -95.53 110.96 22.96 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.177 -0.952 . . . . 3.98 110.1 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -75.34 -165.13 15.13 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.12 -1.192 . . . . 4.0499999999999998 110.12 163.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -74.62 -26.19 59.73 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.749 -1.442 . . . . 4.75 112.309 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -46.96 -41.78 16.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 128.231 2.612 . . . . 7.25 117.479 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.436 ' HZ1' ' CD ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -61.77 151.57 33.76 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.051 1.741 . . . . 9.5399999999999991 113.548 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.711 -1.243 . . . . 6.9800000000000004 109.331 159.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.457 ' HE3' ' OE1' ' A' ' 182' ' ' GLN . 13.5 tmtt? -65.37 -44.72 86.73 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.709 -1.244 . . . . 2.8399999999999999 113.672 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.55 -30.43 76.53 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 123.278 0.466 . . . . 1.9299999999999999 112.398 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -63.66 -24.55 67.83 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.007 1.323 . . . . 2.8399999999999999 113.489 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 13.8 mt -79.89 -30.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.901 1.228 . . . . 2.2200000000000002 111.341 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.9 72.5 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.951 -1.093 . . . . 2.0800000000000001 110.552 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.44 83.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.02 1.118 . . . . 2.3799999999999999 114.02 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 70.9 p -63.57 -49.28 74.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.131 0.878 . . . . 2.1000000000000001 111.137 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.91 -36.62 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.016 -1.052 . . . . 2.25 111.508 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.21 -6.18 4.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.721 1.209 . . . . 2.2999999999999998 114.203 168.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 40.0 m -101.88 -44.38 5.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.843 1.657 . . . . 2.1400000000000001 110.472 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -63.38 -28.23 69.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.636 1.174 . . . . 3.71 113.166 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -48.82 -40.84 30.8 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 125.988 1.715 . . . . 6.2699999999999996 111.506 165.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -60.91 -40.44 74.52 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.414 -1.755 . . . . 6.8799999999999999 112.829 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.6 -58.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.947 2.431 . . . . 2.04 113.525 163.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -83.78 8.86 13.4 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.81 1.781 . . . . 4.0199999999999996 115.81 -165.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.28 153.67 2.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.734 2.014 . . . . 9.2300000000000004 114.314 175.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -66.25 -42.36 88.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.302 -1.332 . . . . 7.8899999999999997 113.72 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -155.73 -94.38 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.981 2.512 . . . . 10.25 110.001 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.406 ' C ' ' HG1' ' A' ' 192' ' ' THR . 22.7 m . . . . . 0 C--O 1.237 0.444 0 CA-C-O 116.775 -1.583 . . . . 8.3800000000000008 109.424 134.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 118.12 -0.943 . . . . 15.470000000000001 109.913 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -76.76 77.85 3.38 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.902 0.774 . . . . 13.119999999999999 109.107 174.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -160.45 146.98 15.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.806 0.842 . . . . 11.42 110.065 -158.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.01 -81.77 1.72 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.108 0.861 . . . . 10.98 112.911 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -76.9 146.65 76.18 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 113.211 0.819 . . . . 12.06 113.211 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -69.95 160.48 49.49 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.376 2.051 . . . . 11.140000000000001 108.906 151.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tt -41.45 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.101 1.76 . . . . 8.4199999999999999 113.79 -164.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.6 tp 60.43 156.42 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 128.127 2.571 . . . . 7.7599999999999998 113.604 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.03 21.26 63.49 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 120.764 -1.21 . . . . 3.7000000000000002 113.673 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.79 127.75 10.62 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.841 -1.533 . . . . 3.0899999999999999 110.357 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.91 142.78 35.58 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.682 2.255 . . . . 3.3300000000000001 111.435 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -93.87 168.13 11.18 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.595 -1.184 . . . . 3.6699999999999999 111.663 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.6 m -140.6 78.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.109 1.364 . . . . 3.1299999999999999 110.012 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.56 147.5 40.64 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.38 0.672 . . . . 2.8199999999999998 111.234 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -75.91 131.84 39.9 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.291 2.236 . . . . 2.4100000000000001 110.183 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.9 p -92.61 160.97 14.77 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.033 1.333 . . . . 2.8300000000000001 112.162 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -64.91 -6.62 8.77 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.332 1.453 . . . . 1.8100000000000001 114.638 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.2 m -66.75 -60.62 2.52 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.625 1.17 . . . . 3.7000000000000002 109.093 162.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 160.13 0.48 0.07 OUTLIER Glycine 0 CA--C 1.534 1.255 0 N-CA-C 116.446 1.338 . . . . 2.5499999999999998 116.446 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.34 165.48 33.93 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.751 1.775 . . . . 4.8799999999999999 113.567 -170.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.72 120.78 25.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.819 2.448 . . . . 5.1799999999999997 113.79 -167.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -99.63 171.58 7.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.228 1.411 . . . . 5.96 111.324 165.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.6 p -130.16 157.3 42.81 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.27 1.428 . . . . 2.8900000000000001 110.176 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.6 -41.96 43.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.269 1.428 . . . . 3.54 111.455 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.56 -26.4 63.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.648 1.579 . . . . 9.0700000000000003 113.765 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -80.06 -33.09 39.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.169 1.349 . . . . 3.0099999999999998 112.193 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.72 -23.17 58.55 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.79 0.663 . . . . 4.29 112.79 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.63 131.69 51.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.852 1.261 . . . . 4.2999999999999998 111.048 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 108.72 -25.42 19.25 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.522 1.534 . . . . 2.79 112.726 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -88.23 -152.47 0.22 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.575 1.55 . . . . 3.9500000000000002 108.726 165.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.8 157.56 44.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.307 1.043 . . . . 2.5299999999999998 110.659 163.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.14 152.96 28.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.915 0.864 . . . . 3.3500000000000001 113.011 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.8 pp -106.52 155.15 19.9 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.825 1.25 . . . . 4.8600000000000003 107.853 165.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.75 123.23 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.439 -0.949 . . . . 2.7599999999999998 108.439 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -123.05 154.3 38.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.719 1.208 . . . . 4.3099999999999996 111.677 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -108.84 116.7 32.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.845 0.858 . . . . 3.3500000000000001 109.601 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.74 162.43 33.26 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.923 1.249 . . . . 2.48 113.585 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.08 -44.97 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 115.947 -1.978 . . . . 5.25 114.759 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t 136.95 177.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 131.426 3.89 . . . . 6.1299999999999999 110.118 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 77.46 -15.27 0.76 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 127.841 2.456 . . . . 8.4000000000000004 112.958 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.3 p -51.36 155.59 2.41 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 125.321 1.448 . . . . 3.5499999999999998 112.179 155.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 172' ' ' VAL . 87.3 Cg_endo -78.88 74.44 5.52 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.642 2.894 . . . . 4.4199999999999999 109.75 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 69.25 -7.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.665 2.386 . . . . 4.1500000000000004 114.628 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 170' ' ' PRO . 95.6 t -46.57 -55.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.854 2.462 . . . . 3.77 113.485 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.99 -67.49 0.52 Allowed Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 118.051 -0.976 . . . . 1.78 111.367 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.72 -40.63 21.63 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.944 1.763 . . . . 1.54 113.938 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -58.22 -43.33 87.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.869 1.213 . . . . 3.6699999999999999 111.686 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -84.6 -34.46 23.14 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.232 -0.918 . . . . 3.1800000000000002 112.931 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.6 -35.62 80.13 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.293 1.406 . . . . 4.54 112.082 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -47.73 -51.01 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.449 1.1 . . . . 3.3500000000000001 111.226 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -60.88 -38.32 85.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.053 -1.029 . . . . 3.4700000000000002 111.789 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -70.13 -41.47 73.87 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.386 -0.821 . . . . 5.0800000000000001 112.702 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.47 -53.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.722 1.146 . . . . 2.7999999999999998 109.048 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -55.65 -13.79 1.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.285 1.434 . . . . 4.0700000000000003 114.573 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 t -97.99 -46.77 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.088 2.155 . . . . 2.9199999999999999 112.942 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 21.3 m -62.25 -25.53 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.426 1.466 . . . . 4.54 112.311 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -70.88 -22.16 62.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.318 0.647 . . . . 4.1299999999999999 112.68 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' CD ' ' HZ1' ' A' ' 283' ' ' LYS . 16.4 mt-10 -79.71 -19.66 48.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.066 1.347 . . . . 2.5699999999999998 111.789 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 43.3 mm -81.36 -58.97 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 2.7999999999999998 109.746 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -32.86 74.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.15 1.78 . . . . 3.4500000000000002 113.544 -170.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 t -69.49 -20.18 63.73 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.898 1.279 . . . . 3.2400000000000002 112.87 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.2 mm -91.84 89.24 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.589 -1.319 . . . . 5.0599999999999996 108.352 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.5 p -60.74 69.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.353 2.261 . . . . 6.4000000000000004 113.76 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 175.73 -29.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.527 2.731 . . . . 5.04 111.777 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.15 159.07 68.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.605 0.762 . . . . 4.4100000000000001 110.824 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.25 160.16 17.64 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.299 2.666 . . . . 3.29 109.486 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.0 134.76 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.167 0.508 . . . . 3.8900000000000001 111.652 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -95.87 95.71 8.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.027 -1.471 . . . . 3.96 107.027 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 m -68.56 124.59 90.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 108.549 -0.908 . . . . 1.8100000000000001 108.549 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.07 118.15 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.486 2.124 . . . . 1.1100000000000001 110.476 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.79 121.08 43.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.273 1.429 . . . . 3.27 110.487 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.12 112.38 19.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.571 1.148 . . . . 4.71 110.216 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.67 110.11 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.045 1.338 . . . . 2.5899999999999999 110.505 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 m -90.0 96.03 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.132 -0.98 . . . . 3.3900000000000001 111.581 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.03 -2.77 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 116.359 1.985 . . . . 3.1899999999999999 116.359 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -117.9 60.84 3.63 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 119.929 1.241 . . . . 4.1299999999999999 110.572 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.1 149.25 40.95 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.178 2.585 . . . . 2.21 109.506 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 114.13 -43.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 129.682 3.193 . . . . 5.2000000000000002 108.974 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -35.77 36.67 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.1 -0.375 . . . . 7.2199999999999998 111.895 160.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.18 151.06 20.82 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.685 1.194 . . . . 4.5899999999999999 110.964 167.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.4 p -132.42 154.76 49.52 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 124.819 1.248 . . . . 4.1900000000000004 109.28 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -48.42 -43.24 34.06 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.561 1.144 . . . . 4.0800000000000001 112.032 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -81.0 -26.07 36.76 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.082 1.141 . . . . 3.27 114.082 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.86 68.84 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.249 0.932 . . . . 2.3500000000000001 110.266 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.5 mm -65.41 -36.08 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 117.706 -1.14 . . . . 2.8500000000000001 110.816 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.2 66.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.784 1.629 . . . . 2.27 113.148 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -73.2 -49.53 27.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.378 0.671 . . . . 4.0700000000000003 112.339 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.33 -41.04 65.33 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.94 -1.1 . . . . 4.1699999999999999 112.088 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.5 t -62.96 -50.92 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.262 1.825 . . . . 2.8599999999999999 112.294 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 17.8 ttpp -59.34 -40.44 86.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.087 0.955 . . . . 4.71 111.248 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 0.4 OUTLIER -70.14 -33.22 71.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.481 1.512 . . . . 4.6600000000000001 112.25 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.88 -13.21 61.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.049 1.129 . . . . 4.71 114.049 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.6 p 139.92 149.57 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 130.744 3.618 . . . . 3.0600000000000001 111.816 168.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.26 5.65 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.36 2.706 . . . . 2.04 113.865 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.63 -24.74 23.85 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.769 1.168 . . . . 2.46 112.784 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.4 146.31 32.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.399 -1.438 . . . . 3.1800000000000002 112.765 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.5 127.09 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.17 0.588 . . . . 3.2799999999999998 111.862 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.68 129.94 10.06 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.81000000000000005 110.813 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.2 113.62 26.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.264 -1.384 . . . . 2.77 107.264 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.4 m -141.15 68.84 1.34 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.633 1.573 . . . . 3.6099999999999999 108.633 -164.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -91.15 -174.06 43.67 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.741 1.163 . . . . 2.02 112.405 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -75.79 163.32 27.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.918 1.287 . . . . 2.5899999999999999 112.418 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.451 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 36.9 ttm180 -43.02 -31.58 0.55 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.255 2.622 . . . . 6.71 114.433 173.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -77.14 -38.02 52.76 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.957 1.303 . . . . 4.2599999999999998 113.311 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.33 -45.99 85.45 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.102 -0.999 . . . . 3.9700000000000002 109.145 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 19.5 m -70.16 -18.51 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.247 1.203 . . . . 4.1299999999999999 114.247 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.14 -40.86 71.11 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.055 -1.028 . . . . 3.5699999999999998 112.178 168.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -61.96 -50.86 70.44 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.883 -0.511 . . . . 3.6699999999999999 111.565 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.38 -24.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 120.359 -0.536 . . . . 2.7400000000000002 112.195 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.39 67.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.441 1.096 . . . . 3.48 112.025 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -36.7 63.82 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.47 0.915 . . . . 3.9700000000000002 113.47 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.55 -26.51 65.45 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.972 1.471 . . . . 2.2400000000000002 114.972 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.96 10.27 1.75 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.244 1.572 . . . . 4.0700000000000003 115.244 -168.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 74.39 -58.68 0.58 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.252 2.621 . . . . 6.7199999999999998 110.765 -165.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 55.8 t 63.58 -64.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 128.143 2.577 . . . . 4.46 111.185 -165.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 30.7 t80 58.38 62.11 2.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.572 1.549 . . . . 6.0099999999999998 113.251 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -68.13 148.53 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.319 -0.863 . . . . 4.71 111.234 165.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 m -107.25 98.38 22.48 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 121.464 -0.772 . . . . 4.2599999999999998 109.862 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -80.57 113.24 2.82 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.039 1.826 . . . . 2.9700000000000002 112.172 -171.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.98 148.9 40.34 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 111.345 -0.702 . . . . 2.3999999999999999 111.345 167.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.86 173.52 13.37 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.495 2.797 . . . . 3.8100000000000001 111.589 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.544 ' HZ2' ' CD ' ' A' ' 254' ' ' GLU . 2.5 mmpt? -66.22 122.88 18.46 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 118.538 -0.744 . . . . 5.6399999999999997 109.913 161.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.73 167.19 30.78 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.208 1.559 . . . . 5.7599999999999998 115.208 -165.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.261 14.1 tt0 48.96 -68.55 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 131.588 3.955 . . . . 7.1600000000000001 115.81 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -153.97 57.21 0.73 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.898 1.679 . . . . 6.9400000000000004 111.189 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.544 ' CD ' ' HZ2' ' A' ' 250' ' ' LYS . 6.0 mm-40 85.54 14.75 0.16 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.211 2.604 . . . . 5.7800000000000002 113.118 169.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -70.05 174.21 5.66 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.693 -1.254 . . . . 3.8999999999999999 111.135 165.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -162.3 76.16 0.46 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.098 2.559 . . . . 4.1200000000000001 107.786 -168.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.303 0.2 OUTLIER -81.5 58.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.569 -1.332 . . . . 3.9199999999999999 113.074 -158.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.76 130.5 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.281 1.432 . . . . 3.9900000000000002 110.693 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.71 155.67 16.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.837 2.055 . . . . 3.6099999999999999 112.482 169.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -131.98 81.56 1.97 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.086 0.954 . . . . 2.6899999999999999 112.796 164.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -73.32 95.74 2.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.252 1.421 . . . . 5.6799999999999997 111.826 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 158.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 116.062 1.875 . . . . 7.3899999999999997 116.062 -174.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.4 tt -95.78 156.24 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 128.107 2.563 . . . . 4.8200000000000003 109.761 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 35.8 ttm -96.99 145.82 25.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.785 1.234 . . . . 3.4900000000000002 110.39 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -113.68 144.65 42.57 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.707 1.203 . . . . 5.2699999999999996 112.275 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 13.6 tp -110.05 128.02 55.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.647 1.179 . . . . 2.9199999999999999 108.689 165.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.89 143.04 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.557 -1.275 . . . . 2.8300000000000001 107.557 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -108.56 176.31 20.05 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.142 0.877 . . . . 1.8300000000000001 112.481 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 66.93 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.917 3.745 . . . . 2.5800000000000001 109.053 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -160.22 -56.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.502 1.521 . . . . 4.2699999999999996 110.487 -161.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 153.79 -134.4 4.34 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.504 0.573 . . . . 2.6400000000000001 113.529 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.03 -39.76 69.49 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.849 1.426 . . . . 4.5599999999999996 114.849 -150.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.4 p90 179.91 150.07 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.757 2.423 . . . . 6.2800000000000002 109.225 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.91 -21.87 13.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.074 1.35 . . . . 4.5099999999999998 111.505 164.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -152.46 163.16 40.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 2.6000000000000001 112.234 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -158.12 131.86 7.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.727 2.011 . . . . 7.21 110.609 172.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.87 154.94 30.61 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.14 -0.975 . . . . 4.3200000000000003 112.286 -171.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.66 163.17 40.21 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 122.114 0.841 . . . . 3.73 112.762 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -68.23 114.11 6.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.827 -1.546 . . . . 5.7300000000000004 106.827 150.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 155.76 -14.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 129.619 3.168 . . . . 5.6299999999999999 113.341 -165.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -90.41 130.94 36.43 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.966 -1.084 . . . . 5.3099999999999996 113.118 -171.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -72.61 122.72 21.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.771 1.228 . . . . 7.7999999999999998 108.338 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.508 ' HZ1' ' CD ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -37.61 -55.24 1.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.531 2.049 . . . . 3.3399999999999999 116.531 -155.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -60.58 -17.16 47.61 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.427 1.013 . . . . 1.55 114.918 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.18 -30.0 70.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.479 1.14 . . . . 3.48 112.644 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.5 mt -82.76 -41.8 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.982 0.913 . . . . 2.3399999999999999 108.947 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.1 -41.32 64.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.39 0.541 . . . . 2.1000000000000001 112.093 168.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.49 -43.45 94.1 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.145 1.165 . . . . 2.4500000000000002 114.145 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.8 p -68.53 -41.84 79.3 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.29 1.405 . . . . 2.9700000000000002 111.582 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 38.2 mt -56.39 -52.39 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.374 0.988 . . . . 2.3399999999999999 110.829 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.81 65.15 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.235 0.828 . . . . 2.5499999999999998 113.235 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 88.7 m -70.84 -48.23 55.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.98 1.312 . . . . 2.98 110.75 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -67.16 -29.38 69.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.425 1.011 . . . . 3.1600000000000001 113.434 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -19.8 63.06 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.465 1.506 . . . . 7.7199999999999998 114.135 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -71.79 -45.45 12.25 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.499 -1.715 . . . . 6.8200000000000003 114.157 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.45 -58.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.373 2.715 . . . . 2.2000000000000002 111.722 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -85.86 119.94 26.72 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.364 -0.835 . . . . 3.9900000000000002 110.916 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? 89.02 -87.05 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.625 2.37 . . . . 12.039999999999999 112.904 163.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -155.38 120.66 4.91 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.093 1.357 . . . . 7.6399999999999997 113.113 -166.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 151.17 37.83 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.74 2.126 . . . . 11.68 116.74 -173.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.482 1.156 0 C-N-CA 125.1 1.36 . . . . 12.25 109.053 147.379 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 117.76 -1.114 . . . . 17.109999999999999 109.901 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -163.15 167.06 22.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.1 1.36 . . . . 13.92 110.044 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -171.84 166.01 6.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.1 2.56 . . . . 12.48 108.716 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.26 -172.1 34.51 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.738 1.161 . . . . 9.9499999999999993 113.18 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -126.91 121.82 23.11 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.403 1.081 . . . . 9.6400000000000006 110.817 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.86 139.11 42.55 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.423 2.082 . . . . 7.5899999999999999 109.595 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 tt -173.93 153.25 2.1 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.884 2.474 . . . . 7.3399999999999999 107.806 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.6 mt -127.08 146.79 50.24 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.449 1.5 . . . . 7.4400000000000004 108.258 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.7 -131.81 26.47 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.315 -0.714 . . . . 3.9300000000000002 111.315 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 134.09 165.4 10.96 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.135 1.826 . . . . 3.0899999999999999 112.929 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.05 159.45 53.87 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.774 2.983 . . . . 2.8399999999999999 111.762 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -138.98 172.04 13.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.875 1.27 . . . . 3.3999999999999999 110.779 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 p -141.12 18.94 2.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.506 1.669 . . . . 3.2400000000000002 115.506 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.83 154.89 41.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.933 1.349 . . . . 2.9500000000000002 114.396 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.9 m -91.68 147.2 23.17 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.628 1.171 . . . . 2.27 109.149 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.8 p -78.89 156.11 28.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.087 1.355 . . . . 2.5800000000000001 112.549 -173.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -50.68 -25.7 4.59 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 113.906 -1.497 . . . . 2.2400000000000002 113.427 162.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.0 m -72.97 -64.78 0.9 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.207 1.803 . . . . 4.2400000000000002 109.513 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.01 55.0 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.488 1.518 . . . . 2.7799999999999998 112.645 -169.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.22 144.84 9.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.803 2.041 . . . . 3.7000000000000002 108.335 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -89.85 126.11 35.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.706 1.139 . . . . 5.8899999999999997 112.047 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -112.68 162.94 15.14 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.473 -1.392 . . . . 4.0 112.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.6 p -136.04 -179.21 5.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.648 1.979 . . . . 3.5899999999999999 109.784 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -68.54 -22.21 64.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.218 1.007 . . . . 4.3799999999999999 112.668 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -32.2 66.95 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.865 1.061 . . . . 5.9199999999999999 113.865 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.14 -37.95 84.69 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.926 1.29 . . . . 3.46 111.435 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -107.84 20.99 18.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.557 1.543 . . . . 4.9900000000000002 114.284 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -80.46 167.58 19.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.379 -0.826 . . . . 4.0499999999999998 110.59 167.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.89 14.21 75.74 Favored Glycine 0 N--CA 1.478 1.499 0 O-C-N 120.663 -1.273 . . . . 2.7999999999999998 114.348 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -162.17 151.52 15.84 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.675 2.79 . . . . 3.1400000000000001 106.743 -172.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -71.76 129.57 38.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.932 1.242 . . . . 1.95 111.647 -173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.57 133.52 53.78 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.525 1.13 . . . . 3.5699999999999998 110.911 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.24 126.42 53.58 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.86 1.264 . . . . 3.7599999999999998 108.415 165.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.9 mt -120.35 119.39 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.479 -0.934 . . . . 2.5499999999999998 108.479 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -113.29 141.36 47.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 4.6399999999999997 111.559 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -108.32 126.76 53.21 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.981 0.912 . . . . 3.4399999999999999 111.802 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.444 ' HA3' ' SG ' ' A' ' 173' ' ' CYS . . . -169.95 -179.77 41.79 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.319 1.438 . . . . 1.3300000000000001 113.605 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.76 137.91 26.8 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.014 1.407 . . . . 5.2300000000000004 112.333 -177.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.8 t -74.97 70.6 2.01 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.761 1.267 . . . . 4.3399999999999999 112.249 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.4 -31.25 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.107 0.963 . . . . 8.9100000000000001 111.138 -149.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 14.1 m -47.9 143.13 6.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.732 1.213 . . . . 2.1099999999999999 112.316 161.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.88 -59.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.971 2.448 . . . . 3.96 109.999 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.15 137.99 21.23 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.426 -0.953 . . . . 5.3700000000000001 108.426 136.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.4 t -162.21 -55.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.553 3.141 . . . . 4.0800000000000001 107.283 169.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.444 ' SG ' ' HA3' ' A' ' 165' ' ' GLY . 1.7 m -57.3 -65.31 1.83 Allowed Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.775 1.63 . . . . 1.6299999999999999 113.237 173.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.64 -44.97 44.48 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.957 2.438 . . . . 2.79 114.73 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 22.8 tp10 -47.98 -46.11 32.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.067 1.747 . . . . 3.75 112.067 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.451 ' CD ' ' HZ2' ' A' ' 281' ' ' LYS . 1.2 mm-40 -77.5 -40.3 43.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.791 1.178 . . . . 3.1699999999999999 112.829 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.7 76.6 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.063 -1.023 . . . . 3.8900000000000001 111.997 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.07 -59.6 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.618 1.967 . . . . 3.3799999999999999 110.223 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 175' ' ' GLU . 9.1 mptt -62.84 -37.61 87.48 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.541 -1.349 . . . . 5.9699999999999998 111.346 -173.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.66 -27.28 64.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.493 1.117 . . . . 4.4699999999999998 113.642 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.8 mm -69.05 -55.58 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 120.005 1.275 . . . . 2.7999999999999998 109.972 171.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -68.29 -17.99 64.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.771 1.623 . . . . 4.8499999999999996 111.724 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.53 -44.59 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.553 1.07 . . . . 2.5099999999999998 111.007 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.31 -27.19 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 121.081 1.764 . . . . 3.7400000000000002 112.88 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.74 -48.3 55.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.952 1.701 . . . . 4.4199999999999999 113.278 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.73 -32.89 72.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.329 -0.857 . . . . 3.4700000000000002 112.341 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.83 -50.39 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.931 0.892 . . . . 2.8999999999999999 111.424 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.38 -22.71 57.29 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.672 1.124 . . . . 5.5899999999999999 112.747 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.3 m -65.08 -11.45 39.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.287 -0.883 . . . . 3.2400000000000002 113.268 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.95 -20.23 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 4.75 111.179 164.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.295 70.3 p 128.77 -11.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 1 C-N-CA 132.475 4.31 . . . . 7.0599999999999996 115.337 152.585 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 t -178.77 71.4 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.065 1.346 . . . . 4.3200000000000003 112.042 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.97 158.71 52.78 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 121.181 -0.949 . . . . 4.5199999999999996 111.628 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.86 -9.85 18.2 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.789 2.326 . . . . 3.4100000000000001 111.912 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS 0.269 17.5 t0 100.81 152.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 130.398 3.479 . . . . 4.21 114.058 162.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 134.12 55.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.175 1.79 . . . . 3.1600000000000001 112.074 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.7 m -110.42 121.36 41.59 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.946 1.298 . . . . 1.95 109.796 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -89.3 126.43 1.6 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.941 3.094 . . . . 1.0700000000000001 110.74 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.3 106.29 12.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.519 1.928 . . . . 3.48 110.783 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 115.24 26.17 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.51 -0.744 . . . . 4.0499999999999998 109.681 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -89.61 112.21 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.198 0.999 . . . . 2.7999999999999998 109.502 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 6.2 t -71.25 122.23 19.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.755 -0.657 . . . . 2.2400000000000002 109.908 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.0 pt -106.79 48.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.806 1.642 . . . . 2.9300000000000002 109.662 162.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -104.54 31.41 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.258 1.823 . . . . 4.2699999999999996 113.39 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.63 -17.89 56.94 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 124.331 3.354 . . . . 3.1200000000000001 114.234 -162.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -62.81 -23.95 67.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.944 1.298 . . . . 5.5499999999999998 113.331 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.0 8.91 0.66 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 116.209 1.929 . . . . 7.5300000000000002 116.209 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -42.11 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.881 3.272 . . . . 4.6399999999999997 115.462 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.3 m -88.83 125.51 34.94 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 120.801 -1.187 . . . . 2.8900000000000001 108.761 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -41.09 65.71 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.835 0.854 . . . . 5.0800000000000001 113.176 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -73.76 -43.03 60.21 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-O 117.306 -1.33 . . . . 5.75 112.699 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.25 60.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.4 1.909 . . . . 2.52 112.621 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.08 -32.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 118.465 -0.779 . . . . 3.5299999999999998 112.4 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.64 88.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.473 1.488 . . . . 2.29 111.352 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.93 -54.64 44.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.747 1.619 . . . . 4.1900000000000004 108.698 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -47.88 -48.44 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.307 0.958 . . . . 4.6200000000000001 112.9 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.9 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.072 0.851 . . . . 2.3599999999999999 111.847 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -19.79 63.26 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.293 1.22 . . . . 6.04 114.293 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -69.69 -24.66 63.62 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.347 0.976 . . . . 3.6800000000000002 112.171 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -89.46 -72.8 0.54 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 4.21 112.571 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 85.8 p -173.51 153.26 2.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 120.711 -1.243 . . . . 2.6099999999999999 112.869 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.62 -1.68 11.41 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.167 2.578 . . . . 2.3500000000000001 114.518 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 195' ' ' ASP . 73.5 tttt -95.2 2.4 54.95 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.096 1.316 . . . . 2.9199999999999999 112.573 170.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.0 tp -89.73 139.74 30.27 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.715 -1.241 . . . . 2.8500000000000001 110.424 173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.29 136.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.512 1.125 . . . . 4.2300000000000004 108.814 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.73 150.79 18.24 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 124.187 0.898 . . . . 1.24 110.996 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.0 155.98 35.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.987 1.315 . . . . 3.6000000000000001 110.491 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.6 p -129.1 169.71 14.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.615 2.366 . . . . 3.25 109.484 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.96 148.47 14.23 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 115.879 1.112 . . . . 2.1400000000000001 115.879 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -62.47 143.29 57.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.662 -0.769 . . . . 2.8500000000000001 109.395 162.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.31 -21.85 66.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.194 1.183 . . . . 8.3300000000000001 114.194 -161.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.4 mp0 -65.24 -45.36 84.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.645 1.578 . . . . 2.6699999999999999 111.133 170.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -81.81 -33.9 30.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.905 1.282 . . . . 3.4100000000000001 111.71 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.05 -36.77 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 118.605 -0.712 . . . . 2.6699999999999999 111.179 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.38 -45.95 88.7 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.667 -1.158 . . . . 2.9100000000000001 109.765 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -50.36 -54.21 23.39 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.291 1.405 . . . . 2.6699999999999999 112.337 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.21 -38.88 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.931 1.241 . . . . 3.0800000000000001 113.321 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.19 -34.28 77.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.649 0.779 . . . . 2.8300000000000001 112.296 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -88.98 -32.63 17.54 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.791 2.437 . . . . 3.98 113.198 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.19 70.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.566 1.075 . . . . 2.48 110.537 165.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -85.16 9.7 14.25 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.406 1.082 . . . . 3.77 112.946 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 35.81 46.81 0.35 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.58 2.752 . . . . 5.3799999999999999 115.053 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.95 136.38 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 109.386 -0.598 . . . . 3.8900000000000001 109.386 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.22 129.64 37.82 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.174 -0.328 . . . . 4.8099999999999996 111.352 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.27 108.53 0.73 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.36 1.864 . . . . 5.1399999999999997 109.764 -160.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 149.7 37.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.062 1.134 . . . . 4.0700000000000003 114.062 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.23 148.77 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.474 2.782 . . . . 5.4100000000000001 110.812 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -110.75 165.08 12.15 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.852 1.215 . . . . 4.0499999999999998 114.265 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -79.4 -176.03 3.05 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 125.015 3.81 . . . . 4.4400000000000004 111.829 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.429 ' HZ3' ' C ' ' A' ' 253' ' ' ASP . 21.0 mmmt -114.72 130.91 56.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.081 1.752 . . . . 5.7699999999999996 111.046 164.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.6 p30 173.19 -39.66 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.196 2.198 . . . . 6.7199999999999998 109.79 -165.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.14 156.33 37.47 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.671 0.748 . . . . 8.3300000000000001 110.612 136.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.429 ' C ' ' HZ3' ' A' ' 250' ' ' LYS . 17.0 t70 -86.58 -37.67 17.9 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.572 0.749 . . . . 7.8899999999999997 111.209 -161.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.303 2.1 tp10 -169.14 45.5 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.603 2.361 . . . . 8.6400000000000006 112.665 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -121.99 163.0 20.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.362 1.465 . . . . 4.9000000000000004 108.593 149.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -149.49 149.17 30.34 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.144 -0.687 . . . . 6.9100000000000001 109.144 131.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 20.7 tt -72.75 76.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.552 -1.343 . . . . 3.8999999999999999 110.45 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.7 t -44.94 130.86 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 127.104 2.162 . . . . 3.5699999999999998 112.726 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -70.26 137.41 50.77 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.732 1.213 . . . . 4.2400000000000002 111.707 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.12 137.63 19.83 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.865 -1.061 . . . . 2.2999999999999998 109.703 163.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t -64.23 -24.01 67.51 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.145 1.165 . . . . 4.54 114.145 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.269 0.7 OUTLIER 67.12 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 128.789 2.836 . . . . 5.0599999999999996 112.966 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.27 145.29 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.129 -1.607 . . . . 4.3600000000000003 112.766 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 140.81 32.9 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 127.318 2.247 . . . . 3.9100000000000001 109.638 164.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.65 145.08 41.86 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.732 0.813 . . . . 4.6299999999999999 112.501 154.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.6 tp -100.51 130.69 46.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.012 1.725 . . . . 2.7400000000000002 110.019 168.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.62 133.63 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.672 -1.973 . . . . 3.27 105.672 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 -177.48 19.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.168 -0.373 . . . . 1.8700000000000001 112.168 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.41 42.77 1.36 Allowed 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.742 2.961 . . . . 2.9700000000000002 110.818 172.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -177.76 -67.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.837 2.455 . . . . 5.2000000000000002 111.009 -163.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -135.67 142.0 13.26 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 114.704 0.642 . . . . 3.8900000000000001 114.704 -158.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -86.75 161.21 18.52 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.395 1.478 . . . . 7.2300000000000004 114.467 -173.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 63.0 53.2 2.4 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.372 1.869 . . . . 5.2999999999999998 111.974 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 55.5 tp -92.11 -33.46 14.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.564 1.146 . . . . 3.7000000000000002 112.645 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -162.31 163.34 28.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.045 1.738 . . . . 2.29 109.734 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.66 142.73 11.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.164 0.985 . . . . 4.8899999999999997 113.604 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -140.2 136.23 33.21 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.125 -0.985 . . . . 4.4500000000000002 112.22 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.54 -171.27 45.04 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.913 -0.875 . . . . 3.1600000000000001 110.913 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.59 139.44 58.77 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.505 -1.294 . . . . 3.8700000000000001 107.505 147.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 14.3 t30 149.29 -59.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 129.292 3.037 . . . . 5.6799999999999997 108.233 -171.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.451 ' HZ2' ' CD ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -72.85 158.36 35.68 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.56 0.578 . . . . 8.7699999999999996 112.56 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -100.44 177.54 5.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.824 1.25 . . . . 6.4299999999999997 110.541 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -53.25 -48.77 67.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.736 1.214 . . . . 2.5499999999999998 113.803 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.74 86.08 Favored Glycine 0 N--CA 1.469 0.857 0 CA-C-N 118.416 0.553 . . . . 1.6100000000000001 112.272 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.92 -28.8 64.77 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.692 1.197 . . . . 3.04 112.785 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.5 mt -69.31 -33.21 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.611 -0.681 . . . . 2.79 110.717 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -79.5 -49.47 12.22 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.063 0.847 . . . . 2.0899999999999999 112.108 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.21 -32.26 73.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.778 1.231 . . . . 2.1299999999999999 113.938 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.7 p -58.68 -61.62 2.47 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.095 0.958 . . . . 1.8700000000000001 111.221 167.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.0 mt -52.78 -45.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.898 1.279 . . . . 2.3900000000000001 111.357 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.16 -5.77 24.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.257 1.423 . . . . 2.6699999999999999 114.209 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.3 m -89.11 -54.89 3.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.102 0.961 . . . . 2.2599999999999998 108.732 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.54 -27.55 26.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.654 1.582 . . . . 3.2999999999999998 114.321 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -51.03 -22.5 2.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.884 2.473 . . . . 5.0 114.779 170.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -98.8 -36.69 0.24 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.811 2.044 . . . . 7.2199999999999998 116.387 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.36 -32.91 2.74 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.151 2.567 . . . . 2.5699999999999998 111.729 166.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 -171.88 2.15 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.49 0.586 . . . . 4.1900000000000004 110.008 149.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -167.23 175.35 7.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.64 1.576 . . . . 9.0099999999999998 110.576 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -60.27 131.27 50.26 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.378 -1.452 . . . . 8.4900000000000002 112.709 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -66.02 -33.73 76.48 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.891 0.876 . . . . 10.26 112.302 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 C--O 1.245 0.829 1 C-N-CA 133.082 4.553 . . . . 11.300000000000001 106.422 -158.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 117.451 -1.261 . . . . 15.35 108.821 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -73.96 80.17 1.67 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 120.609 1.549 . . . . 15.279999999999999 108.593 163.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.3 p -159.65 122.96 3.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.87 1.668 . . . . 12.789999999999999 109.221 -162.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.25 164.01 39.61 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.051 0.834 . . . . 10.44 113.649 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -172.64 148.58 1.82 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.259 1.424 . . . . 11.699999999999999 111.011 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.07 126.1 17.24 Favored 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 107.484 -1.775 . . . . 8.1400000000000006 107.484 155.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.75 39.66 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.506 1.122 . . . . 8.3900000000000006 111.295 -166.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.44 54.62 2.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.982 1.313 . . . . 6.9100000000000001 109.612 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.44 -165.9 48.86 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 111.181 -0.768 . . . . 4.0899999999999999 111.181 -154.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -150.06 130.51 3.3 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 118.648 -1.085 . . . . 3.3500000000000001 112.661 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -69.47 160.14 50.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.027 2.484 . . . . 3.2599999999999998 110.772 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -128.85 -155.08 0.68 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.399 1.48 . . . . 3.8300000000000001 110.57 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -160.17 147.21 16.11 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.801 -1.187 . . . . 3.8300000000000001 109.659 148.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 tp -156.82 167.27 30.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.049 0.94 . . . . 3.98 110.054 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -109.63 140.51 43.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.732 0.813 . . . . 3.5 110.41 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.1 p -72.08 164.86 25.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.446 1.098 . . . . 2.8300000000000001 111.396 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -57.58 -12.49 2.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.96 2.504 . . . . 2.29 114.15 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 t -119.83 16.79 12.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.233 2.213 . . . . 3.8599999999999999 112.537 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.79 -17.32 36.56 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 116.762 1.465 . . . . 2.3100000000000001 116.762 164.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.28 140.98 55.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.464 1.632 . . . . 4.0599999999999996 109.808 168.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.406 ' O ' ' HE2' ' A' ' 150' ' ' LYS . 0.7 OUTLIER -64.26 135.29 56.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.45 1.5 . . . . 10.01 108.694 167.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 149' ' ' ARG . 2.9 tppt? -142.2 119.09 11.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.025 -1.672 . . . . 4.3300000000000001 112.705 170.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 94.4 m -132.37 143.26 49.72 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 127.582 2.353 . . . . 4.1699999999999999 107.336 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.77 -29.3 70.04 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.193 0.997 . . . . 5.6399999999999997 113.373 -174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 5.21 50.51 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.199 1.555 . . . . 8.4900000000000002 115.199 174.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -41.47 6.57 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.738 0.699 . . . . 3.2400000000000002 112.165 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.9 40.46 1.0 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.265 0.839 . . . . 7.0999999999999996 113.265 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 tp -83.88 169.8 14.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.049 1.34 . . . . 4.2199999999999998 112.898 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.82 -12.93 51.05 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.368 -1.457 . . . . 2.7599999999999998 114.798 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 175.62 5.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.111 2.964 . . . . 3.96 109.916 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -88.97 80.31 7.1 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.023 1.283 . . . . 2.4500000000000002 113.017 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.3 mt -67.29 140.67 57.33 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.849 0.86 . . . . 3.8799999999999999 112.753 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 28.1 tp -139.16 108.74 6.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.113 1.765 . . . . 3.4700000000000002 108.518 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.21 131.88 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.305 1.042 . . . . 2.5899999999999999 108.515 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -128.16 155.42 44.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.681 1.192 . . . . 3.8500000000000001 109.284 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -121.28 115.82 23.7 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.106 0.963 . . . . 3.3900000000000001 109.063 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.22 176.12 21.52 Favored Glycine 0 N--CA 1.467 0.708 0 CA-C-O 122.452 1.029 . . . . 1.5 115.139 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -93.95 138.0 32.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.105 0.962 . . . . 4.5 109.9 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -70.54 14.05 0.15 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.338 -0.851 . . . . 4.54 111.872 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -141.81 -73.19 0.32 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.419 -1.425 . . . . 10.109999999999999 108.914 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.8 t 70.11 174.71 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.793 2.037 . . . . 2.9900000000000002 111.817 -174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.63 -73.17 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.659 2.906 . . . . 3.8500000000000001 109.623 143.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.68 16.65 0.08 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.462 1.505 . . . . 4.7300000000000004 113.08 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.404 HG13 HE22 ' A' ' 279' ' ' GLN . 92.1 t -84.95 -49.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 119.894 -1.754 . . . . 3.7400000000000002 110.715 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 64.4 m -50.77 -44.54 85.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 116.356 -1.783 . . . . 1.8500000000000001 114.387 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.01 -34.82 57.48 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 122.57 1.953 . . . . 1.3600000000000001 113.048 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.88 -38.27 76.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.568 1.531 . . . . 3.2000000000000002 111.868 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.27 -34.67 73.07 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.314 -1.491 . . . . 3.3700000000000001 112.665 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.5 tp -68.88 -42.95 76.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.363 1.065 . . . . 4.29 111.067 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.51 -45.34 66.18 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.255 1.422 . . . . 3.3500000000000001 111.543 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -53.78 -59.61 4.39 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.631 -1.293 . . . . 3.8599999999999999 111.863 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 5.7 ptp -64.84 -34.53 78.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.361 -0.837 . . . . 3.0299999999999998 113.194 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -60.86 -52.91 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 118.108 -0.948 . . . . 2.8599999999999999 110.734 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -68.11 -25.63 65.4 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.753 1.615 . . . . 3.77 110.692 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.51 -41.13 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.05 -0.976 . . . . 2.6299999999999999 112.634 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.91 -31.87 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.827 1.194 . . . . 3.6600000000000001 112.217 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.15 -42.85 99.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.265 1.426 . . . . 4.2199999999999998 111.951 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.15 -54.87 23.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.557 1.543 . . . . 3.04 112.214 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.41 -35.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.556 0.947 . . . . 3.4199999999999999 113.556 -163.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.03 -37.32 74.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.166 0.986 . . . . 3.5299999999999998 111.099 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -68.18 -15.46 63.59 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.114 -0.991 . . . . 3.3300000000000001 112.946 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.15 -0.05 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 119.838 -1.789 . . . . 3.6099999999999999 111.651 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.0 m 77.28 -24.08 0.23 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.045 1.498 . . . . 4.6900000000000004 115.045 144.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 61.8 m -102.65 -0.04 32.47 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.174 1.352 . . . . 5.3499999999999996 112.133 164.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.27 124.86 91.38 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.206 -1.405 . . . . 4.5099999999999998 107.206 157.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 -26.43 23.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.414 1.409 . . . . 3.8999999999999999 109.934 160.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.43 175.5 3.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.956 1.702 . . . . 4.0 112.499 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 16.9 tp -137.44 117.64 13.54 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.368 -2.086 . . . . 2.5499999999999998 105.368 143.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.2 m -103.06 106.55 51.43 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 119.778 1.172 . . . . 2.0 110.746 -172.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.14 117.08 4.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.642 2.228 . . . . 1.0900000000000001 111.292 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 12.1 tp -99.86 94.71 6.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.675 2.39 . . . . 3.02 108.58 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -84.04 104.22 13.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.835 -0.802 . . . . 3.7200000000000002 108.835 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 44.0 mm -79.48 110.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.575 -0.898 . . . . 2.7599999999999998 108.575 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 75.7 m -82.16 114.17 20.5 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.132 -0.98 . . . . 3.3199999999999998 111.001 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.19 2.05 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.095 1.517 . . . . 2.6099999999999999 115.095 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.01 69.63 1.18 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.756 1.223 . . . . 2.9700000000000002 110.722 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -79.02 38.14 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.508 3.472 . . . . 2.4700000000000002 111.501 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 208' ' ' ASP . 75.3 mt-10 -136.4 144.63 44.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.475 2.31 . . . . 3.7999999999999998 105.566 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.95 -37.13 0.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.696 1.599 . . . . 5.8799999999999999 112.829 -172.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 206' ' ' GLU . 15.9 t0 -68.82 161.91 27.53 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.841 1.656 . . . . 4.5599999999999996 111.595 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.73 152.41 51.74 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.469 1.128 . . . . 4.5099999999999998 109.568 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -67.27 -21.27 65.72 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.257 0.836 . . . . 6.7000000000000002 113.257 -167.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -19.89 15.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.879 2.472 . . . . 3.9100000000000001 113.298 171.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.81 95.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.184 1.811 . . . . 2.48 110.893 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.69 -35.06 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.694 0.627 . . . . 4.3899999999999997 112.694 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.39 -21.51 62.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.165 1.172 . . . . 2.1899999999999999 114.165 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -79.21 -44.7 21.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.136 0.974 . . . . 4.7699999999999996 111.102 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -43.9 72.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.542 1.137 . . . . 5.1500000000000004 111.435 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.4 t -54.6 -44.1 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.731 1.212 . . . . 2.7799999999999998 112.548 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.25 -35.16 73.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.988 -1.006 . . . . 7.7999999999999998 112.972 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.22 -47.83 72.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.555 1.142 . . . . 3.3900000000000001 111.933 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -83.74 -36.67 23.47 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.628 1.344 . . . . 3.77 114.628 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.0 m 154.05 137.31 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 129.451 3.101 . . . . 2.5 112.277 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.19 -8.08 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.037 2.492 . . . . 2.2000000000000002 114.706 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -78.64 -11.88 59.99 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.584 1.083 . . . . 3.0899999999999999 112.939 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.65 114.09 23.07 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.387 1.475 . . . . 3.6800000000000002 107.765 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 18.6 m -96.93 131.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.998 -0.438 . . . . 3.4399999999999999 110.467 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.54 105.7 2.91 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.733 1.158 . . . . 1.0900000000000001 111.838 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.34 127.25 37.75 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.768 1.227 . . . . 3.77 110.064 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.2 p -151.15 140.8 21.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.094 1.758 . . . . 3.9300000000000002 111.374 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.96 -139.64 2.87 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.159 0.885 . . . . 2.0699999999999998 111.576 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.55 159.06 31.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.159 1.784 . . . . 4.0499999999999998 110.499 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -65.17 -36.31 83.8 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.103 -0.373 . . . . 7.2699999999999996 110.331 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -49.9 -55.51 14.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.584 2.354 . . . . 2.9900000000000002 111.473 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -71.44 -26.98 62.96 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.858 -1.151 . . . . 4.2999999999999998 113.531 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.55 -38.01 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.358 1.463 . . . . 3.04 110.61 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.39 -32.84 58.79 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.767 1.227 . . . . 5.2199999999999998 109.884 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -60.16 -57.68 11.78 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.121 -0.942 . . . . 2.6000000000000001 110.326 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.59 -33.51 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.608 1.095 . . . . 3.23 112.322 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.11 -54.3 36.06 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.741 -0.599 . . . . 2.6000000000000001 110.64 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -70.07 -33.75 72.3 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 117.846 -1.073 . . . . 4.8399999999999999 112.502 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.06 93.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.557 1.143 . . . . 2.48 113.017 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.83 2.75 55.86 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.69 1.196 . . . . 4.04 114.045 173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 77.32 24.17 0.84 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.249 2.62 . . . . 5.21 114.799 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.0 140.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.88 1.272 . . . . 3.4700000000000002 110.747 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -110.07 138.28 46.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.23 1.012 . . . . 4.6600000000000001 112.554 164.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.56 175.38 10.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.479 1.912 . . . . 4.8200000000000003 110.456 162.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -163.26 150.65 10.93 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.4 1.08 . . . . 4.5099999999999998 112.2 165.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.24 165.08 26.16 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.667 2.911 . . . . 3.4399999999999999 110.755 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.19 153.43 52.92 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.185 0.898 . . . . 2.4300000000000002 113.963 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -85.74 2.17 7.73 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.196 3.264 . . . . 5.0300000000000002 115.209 -173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.517 ' HZ3' ' CD ' ' A' ' 254' ' ' GLU . 0.9 OUTLIER 67.33 46.02 1.52 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 120.591 1.541 . . . . 6.2300000000000004 113.127 -176.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -77.38 160.6 28.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.022 1.729 . . . . 8.4900000000000002 112.083 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 61.05 -58.74 0.09 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 129.391 3.076 . . . . 8.5800000000000001 113.518 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 175.41 -32.5 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 130.381 3.472 . . . . 8.8399999999999999 111.248 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.517 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 9.2 tp10 -137.91 45.91 2.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.685 1.194 . . . . 6.46 112.794 -172.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -75.38 138.36 41.67 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.751 0.786 . . . . 7.3499999999999996 112.049 157.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -149.32 71.73 1.13 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.854 -1.066 . . . . 4.7000000000000002 109.52 148.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.4 tp -67.14 175.52 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 O-C-N 121.667 -0.646 . . . . 4.2800000000000002 111.495 165.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -167.45 75.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 119.316 -2.115 . . . . 5.2300000000000004 108.972 -157.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -111.81 142.63 43.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.055 0.931 . . . . 5.5300000000000002 111.305 -153.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -145.81 125.05 12.95 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.178 1.177 . . . . 2.3700000000000001 114.178 -158.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 53.0 m -84.77 -48.82 9.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.017 0.927 . . . . 4.8399999999999999 109.666 168.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.323 0.2 OUTLIER 43.36 -150.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.828 1.651 . . . . 7.5800000000000001 113.622 -174.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 8.8 tt -179.58 161.86 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 129.089 2.956 . . . . 5.46 107.412 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 57.5 mtp -119.52 139.44 52.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.961 1.304 . . . . 2.7599999999999998 109.957 158.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -120.63 136.72 54.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.94 0.896 . . . . 4.6399999999999997 110.989 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.0 tt -102.22 118.99 38.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.603 1.561 . . . . 3.21 107.968 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.4 135.21 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.129 0.972 . . . . 2.77 109.326 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.16 147.9 50.42 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.108 -1.197 . . . . 2.1400000000000001 110.108 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 62.1 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.013 3.142 . . . . 3.3599999999999999 109.066 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -174.28 -66.67 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 5.0999999999999996 110.977 -150.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -156.11 -68.77 0.01 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 117.289 1.676 . . . . 3.54 117.289 -157.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.43 -178.42 7.32 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.723 1.609 . . . . 6.2300000000000004 109.667 -168.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -70.52 145.73 50.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.143 1.164 . . . . 4.7800000000000002 114.143 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -132.1 1.99 3.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.372 1.469 . . . . 3.77 113.073 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -160.36 144.21 13.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.104 1.761 . . . . 2.8199999999999998 108.128 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -154.2 147.13 24.46 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.712 1.205 . . . . 4.8899999999999997 110.664 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.27 147.28 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.083 1.353 . . . . 4.4699999999999998 107.806 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -81.87 -152.21 9.77 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 109.485 -1.446 . . . . 4.5700000000000003 109.485 167.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.404 HE22 HG13 ' A' ' 172' ' ' VAL . 3.0 mt-30 -79.91 67.02 5.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.675 -1.231 . . . . 5.3799999999999999 107.675 151.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.6 153.63 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.22 2.208 . . . . 5.54 112.657 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 89.19 123.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.411 2.284 . . . . 5.5899999999999999 107.569 -139.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.1 mtt85 -81.15 -177.4 6.44 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.769 -1.197 . . . . 7.0700000000000003 107.769 158.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -40.26 93.73 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.539 -1.35 . . . . 2.7400000000000002 113.757 -171.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.58 -38.39 94.62 Favored Glycine 0 N--CA 1.473 1.103 0 O-C-N 121.467 -0.77 . . . . 2.0099999999999998 112.022 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.19 -16.34 63.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.859 1.263 . . . . 3.1899999999999999 113.471 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.42 -46.96 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.957 -1.089 . . . . 2.3100000000000001 110.841 169.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.69 79.02 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.291 -0.881 . . . . 2.21 112.015 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.68 -31.83 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.866 1.061 . . . . 2.48 113.866 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.9 p -75.5 -41.92 54.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.62 1.1 . . . . 2.75 111.372 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.39 -43.63 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.143 0.883 . . . . 2.5699999999999998 111.458 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.02 68.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.928 0.891 . . . . 2.1000000000000001 113.249 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.2 m -76.6 -52.19 10.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.274 1.029 . . . . 2.5800000000000001 109.978 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -61.2 -34.13 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 3.04 112.378 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.6 ttt -55.66 -33.67 64.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.221 1.008 . . . . 5.4000000000000004 111.754 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -58.72 -54.35 57.17 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 116.145 -1.883 . . . . 5.1299999999999999 112.605 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.68 -51.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.8 3.0 . . . . 2.1800000000000002 113.136 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -74.24 14.35 0.45 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.046 1.128 . . . . 4.3799999999999999 114.046 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 5.5 ttp-105 -57.44 110.3 0.84 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.923 1.689 . . . . 9.1799999999999997 112.689 -163.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -71.19 -7.71 48.61 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.484 2.031 . . . . 10.970000000000001 116.484 -157.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.72 -15.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 117.602 2.445 . . . . 8.6300000000000008 117.602 171.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.483 1.198 0 C-N-CA 125.281 1.432 . . . . 7.0899999999999999 111.798 -174.483 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 118.0 -1.0 . . . . 20.899999999999999 109.999 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -78.05 -167.37 1.0 Allowed 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.475 0.58 . . . . 16.210000000000001 109.701 156.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.1 t -141.75 -178.88 5.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.238 1.415 . . . . 12.720000000000001 110.982 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.07 175.41 50.04 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.878 1.227 . . . . 11.359999999999999 113.806 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -76.33 148.39 80.57 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 121.535 -0.979 . . . . 10.130000000000001 110.806 170.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 106.24 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.033 1.822 . . . . 8.1400000000000006 109.492 170.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 73.92 -32.53 0.24 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.677 2.391 . . . . 11.529999999999999 114.116 171.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.56 80.04 1.97 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.809 1.244 . . . . 7.8099999999999996 110.871 -176.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.26 123.89 4.18 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.366 1.936 . . . . 4.0599999999999996 112.367 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -133.4 117.52 1.92 Allowed Glycine 0 CA--C 1.536 1.398 0 CA-C-O 117.332 -1.816 . . . . 2.9300000000000002 110.74 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.99 168.26 15.58 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.663 2.909 . . . . 2.8199999999999998 112.733 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -135.62 150.7 49.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 3.8700000000000001 111.174 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -141.08 75.4 1.5 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.605 -1.309 . . . . 3.1899999999999999 111.63 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.93 153.38 32.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 4.5099999999999998 112.41 -166.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.2 m -79.72 128.22 33.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.822 1.249 . . . . 2.4399999999999999 108.475 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.8 t -80.35 146.51 31.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.979 0.912 . . . . 3.4700000000000002 110.843 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -56.02 -19.89 14.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.644 2.378 . . . . 1.8500000000000001 114.598 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.3 t -72.12 -38.98 69.17 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 118.232 -0.89 . . . . 3.7200000000000002 112.153 170.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 116.41 70.12 0.44 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.724 1.631 . . . . 2.5099999999999998 113.084 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.91 159.53 15.92 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.176 2.19 . . . . 4.0599999999999996 107.635 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -109.55 123.69 49.84 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 121.193 1.815 . . . . 6.1100000000000003 111.4 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -114.55 159.4 20.44 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.833 1.049 . . . . 5.2800000000000002 113.833 175.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 m -139.7 158.15 44.59 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.181 2.592 . . . . 3.8500000000000001 106.863 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.98 -39.31 81.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.175 0.99 . . . . 4.3499999999999996 113.541 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.21 -13.06 58.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.826 1.417 . . . . 8.0199999999999996 114.826 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -77.21 -47.11 21.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.214 0.915 . . . . 4.3700000000000001 110.168 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.25 -33.99 55.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.932 1.293 . . . . 4.9900000000000002 111.469 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 73.38 149.7 0.1 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.593 2.757 . . . . 7.0899999999999999 108.983 -168.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -71.67 -4.88 59.26 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.353 -1.467 . . . . 6.04 115.433 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -27.02 61.68 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 1 C-N-CA 132.84 4.456 . . . . 3.5800000000000001 119.659 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 80.5 m95 66.18 35.36 6.12 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.174 1.79 . . . . 3.6400000000000001 112.008 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 mp -71.24 132.64 45.25 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.531 -0.731 . . . . 4.3099999999999996 110.092 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.45 111.89 24.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.762 1.625 . . . . 3.5600000000000001 107.028 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.38 124.91 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.683 -0.858 . . . . 3.25 108.683 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -127.25 130.05 48.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.096 2.158 . . . . 3.8799999999999999 112.142 -166.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.65 93.76 5.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.232 0.613 . . . . 3.7999999999999998 111.831 -172.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.86 -174.86 14.01 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.018 1.77 . . . . 1.8899999999999999 114.972 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.54 179.37 6.6 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.468 1.507 . . . . 6.3300000000000001 111.906 -167.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.9 m -58.78 -32.47 69.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 115.758 -2.068 . . . . 4.0700000000000003 116.254 -168.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.6 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.459 2.392 . . . . 11.82 117.459 -172.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.2 m -58.14 120.21 41.35 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-N 121.781 2.082 . . . . 4.1799999999999997 114.396 -154.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.68 71.11 7.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.146 2.564 . . . . 7.1900000000000004 114.117 -160.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -153.41 -117.39 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.314 2.246 . . . . 6.8399999999999999 106.851 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 p -54.29 -31.23 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.143 1.777 . . . . 5.0800000000000001 114.792 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.72 17.36 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 117.494 -1.241 . . . . 2.21 110.289 -173.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.48 -27.11 5.43 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.121 2.547 . . . . 1.3899999999999999 113.813 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -70.92 -49.79 41.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.625 1.102 . . . . 3.1699999999999999 111.659 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . 0.274 6.4 mt-10 -72.85 -14.28 61.46 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 119.67 -1.893 . . . . 2.9700000000000002 112.627 174.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.47 -32.12 70.83 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.728 -1.233 . . . . 3.75 112.577 163.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -49.06 78.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.511 1.05 . . . . 4.9000000000000004 108.85 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -58.46 -48.09 81.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.103 -0.951 . . . . 4.2000000000000002 110.607 -175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.3 ptp -63.78 -43.53 96.1 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.724 1.602 . . . . 3.4500000000000002 113.642 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.41 -53.34 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.438 -0.578 . . . . 2.8900000000000001 109.438 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.472 ' HB3' ' HZ3' ' A' ' 283' ' ' LYS . 2.2 mp0 -70.56 -24.1 62.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 117.162 -1.399 . . . . 5.3099999999999996 110.932 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.35 -50.79 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 121.911 2.141 . . . . 2.5099999999999998 111.59 165.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.02 -31.06 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 120.685 1.584 . . . . 3.75 113.017 -173.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -83.09 -29.4 28.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.913 1.079 . . . . 4.7300000000000004 113.913 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -73.17 -23.09 60.39 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.627 -1.296 . . . . 5.8600000000000003 112.729 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.55 -50.8 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.474 1.909 . . . . 3.2799999999999998 111.862 164.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.36 -38.29 73.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.821 1.648 . . . . 4.0999999999999996 112.605 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.1 t -61.24 -22.02 64.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.583 1.553 . . . . 4.4000000000000004 112.381 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 mm -79.31 11.92 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 O-C-N 120.432 -1.418 . . . . 5.2300000000000004 111.261 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.7 m 89.63 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.107 2.563 . . . . 5.9000000000000004 113.445 151.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.295 1.1 t -161.09 37.94 0.15 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.625 1.203 . . . . 4.8399999999999999 114.109 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.06 168.8 13.71 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.433 -0.792 . . . . 5.7300000000000004 111.637 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 120.03 6.92 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.697 1.598 . . . . 5.5800000000000001 108.959 167.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.93 119.57 13.47 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.804 1.288 . . . . 3.9900000000000002 110.633 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.2 tp -85.0 97.17 9.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.611 1.565 . . . . 3.3199999999999998 108.341 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.6 m -77.06 115.14 46.09 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 117.824 -1.084 . . . . 2.5299999999999998 110.317 -169.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.78 121.15 2.44 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.067 2.511 . . . . 1.1000000000000001 112.163 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.8 tp -118.75 103.92 10.11 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.59 1.556 . . . . 3.4100000000000001 110.863 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -86.81 125.48 33.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.877 0.871 . . . . 3.7999999999999998 111.011 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.69 107.17 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.437 1.095 . . . . 2.8599999999999999 109.869 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.23 96.64 3.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.198 0.523 . . . . 2.6699999999999999 110.543 175.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.3 pt -87.0 28.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.228 -0.92 . . . . 4.1500000000000004 113.405 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -128.68 46.35 2.15 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.828 1.651 . . . . 4.9299999999999997 114.477 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.12 88.72 0.57 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.827 3.685 . . . . 2.98 109.753 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 231' ' ' ARG . 2.9 mt-10 162.27 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.188 1.795 . . . . 5.1500000000000004 113.559 -159.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.91 9.14 4.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.739 1.216 . . . . 5.8099999999999996 113.532 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -99.5 -137.65 0.31 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.558 2.343 . . . . 5.1200000000000001 111.528 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m 155.31 137.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 1 C-N-CA 133.653 4.781 . . . . 3.5899999999999999 104.739 169.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -41.51 -53.77 3.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.237 1.015 . . . . 3.8100000000000001 112.242 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -70.11 -25.91 63.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.499 1.52 . . . . 3.7400000000000002 114.386 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.94 -43.04 56.37 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.467 -1.395 . . . . 2.8700000000000001 111.898 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 mm -64.66 -39.96 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 118.217 -0.897 . . . . 2.9300000000000002 110.147 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.47 61.33 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.678 1.126 . . . . 2.6800000000000002 113.188 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -69.82 -44.18 70.5 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.492 1.042 . . . . 4.3700000000000001 111.465 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.1 -34.24 77.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.548 0.613 . . . . 3.79 112.434 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.87 -41.9 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.456 1.503 . . . . 3.0600000000000001 111.557 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -46.16 89.77 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.099 -1.001 . . . . 5.9900000000000002 110.732 174.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -43.12 -53.15 5.12 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.32 1.848 . . . . 4.1399999999999997 112.034 -163.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -71.07 -73.03 0.19 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.899 1.28 . . . . 3.8199999999999998 113.554 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.7 m -176.41 150.17 0.98 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.235 1.414 . . . . 3.0699999999999998 112.292 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.87 5.41 3.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.49 3.46 . . . . 2.1200000000000001 114.983 -165.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.47 -17.09 62.38 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.932 -1.105 . . . . 3.7999999999999998 112.57 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.97 135.16 35.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.475 1.51 . . . . 3.0800000000000001 112.539 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.73 136.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.301 1.441 . . . . 2.9199999999999999 108.823 168.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.55 133.76 11.82 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.16 0.886 . . . . 1.47 112.408 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.8 mp -109.62 142.32 40.9 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.914 1.685 . . . . 3.4500000000000002 111.005 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.0 p -149.64 167.11 27.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.891 2.876 . . . . 4.7000000000000002 109.696 -166.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 172.58 -155.87 24.03 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.289 0.947 . . . . 1.9199999999999999 111.226 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.1 t -96.68 172.85 7.64 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.931 1.348 . . . . 3.1600000000000001 110.597 163.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.448 HH21 ' CD ' ' A' ' 206' ' ' GLU . 40.9 ttm-85 -49.36 -30.07 7.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.871 2.069 . . . . 7.0 113.274 177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.42 -53.2 25.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.353 1.461 . . . . 3.7799999999999998 111.789 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.18 -41.87 84.83 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.065 -1.022 . . . . 3.5499999999999998 111.466 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.5 t -67.67 -29.96 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.994 0.917 . . . . 3.21 112.456 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.43 -49.79 74.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.733 -1.127 . . . . 3.2599999999999998 108.883 173.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -56.63 -55.65 31.31 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.457 1.026 . . . . 4.71 111.862 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.85 -35.43 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.525 0.565 . . . . 4.4500000000000002 112.525 -172.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.11 -44.76 68.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.927 0.491 . . . . 2.0899999999999999 111.086 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -73.29 -36.08 66.24 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.302 1.841 . . . . 3.9100000000000001 112.508 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.64 -54.09 47.4 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.591 1.156 . . . . 3.3399999999999999 112.372 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -85.09 2.43 43.46 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.327 0.651 . . . . 3.8700000000000001 112.451 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 58.47 39.94 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.712 2.405 . . . . 6.4199999999999999 113.091 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.2 m -69.89 -25.98 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.429 1.27 . . . . 3.4900000000000002 114.429 -161.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 81.1 t80 66.67 141.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.67 1.988 . . . . 4.4199999999999999 115.097 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.62 159.78 27.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.469 2.308 . . . . 4.3399999999999999 109.401 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.6 t -164.09 134.32 3.21 Favored Pre-proline 0 N--CA 1.477 0.92 0 O-C-N 120.977 -1.077 . . . . 3.7999999999999998 112.331 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.67 141.28 21.85 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.414 2.743 . . . . 3.3900000000000001 112.282 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.95 164.85 51.88 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.079 0.847 . . . . 2.5699999999999998 114.75 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -82.58 -164.12 0.25 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.741 3.628 . . . . 5.1500000000000004 110.873 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -87.54 133.22 33.82 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.154 -0.684 . . . . 6.3200000000000003 109.154 151.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -147.93 152.87 38.27 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.88 0.872 . . . . 8.5299999999999994 109.622 171.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 55.83 -52.62 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 129.104 2.961 . . . . 9.5899999999999999 113.819 -157.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -163.33 -51.96 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.018 2.127 . . . . 6.7800000000000002 110.047 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -162.32 67.26 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.764 1.626 . . . . 5.5199999999999996 111.014 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -67.28 162.62 22.32 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.894 -1.129 . . . . 4.5099999999999998 111.701 148.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -146.76 62.54 1.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.202 -0.936 . . . . 4.3499999999999996 112.325 161.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp -57.47 164.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.615 1.166 . . . . 3.6600000000000001 112.009 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.7 t -149.83 136.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 105.786 -1.931 . . . . 3.7000000000000002 105.786 172.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -66.16 134.36 52.59 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.398 1.079 . . . . 3.4700000000000002 110.509 172.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -154.34 114.49 3.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.985 0.914 . . . . 2.8900000000000001 111.371 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.8 p -67.64 -22.98 65.29 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.321 1.448 . . . . 4.1699999999999999 114.274 -170.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 tp 76.48 -5.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 127.912 2.485 . . . . 6.3300000000000001 114.025 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.8 mt -49.5 133.54 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.154 1.782 . . . . 4.2699999999999996 111.602 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 11.6 ptm -141.44 143.78 34.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 113.564 -1.653 . . . . 3.1600000000000001 111.131 -163.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -127.64 145.2 50.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.907 0.883 . . . . 4.2699999999999996 111.801 -162.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.88 125.66 38.63 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.513 1.125 . . . . 2.7599999999999998 109.127 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -100.48 135.6 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.969 1.308 . . . . 3.2400000000000002 108.149 170.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.38 -177.24 45.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.725 1.155 . . . . 2.29 111.454 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.77 54.48 4.5 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.967 3.111 . . . . 3.0099999999999998 114.271 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -166.8 -54.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.648 1.979 . . . . 6.4699999999999998 111.193 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 147.5 -20.81 1.51 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.658 0.623 . . . . 3.02 114.658 -160.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.39 144.56 57.08 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.175 0.99 . . . . 7.0199999999999996 111.778 165.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -74.67 155.95 37.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.23 1.012 . . . . 5.3899999999999997 112.491 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -36.94 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.606 0.762 . . . . 4.04 112.842 174.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -165.52 172.44 12.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.759 1.224 . . . . 2.0800000000000001 111.133 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.26 164.54 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.331 1.452 . . . . 4.0300000000000002 112.945 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.03 -179.21 7.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.737 1.615 . . . . 3.8500000000000001 111.322 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 119.36 146.33 7.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.326 1.441 . . . . 2.8100000000000001 113.702 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 40.75 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 1 C-N-CA 132.526 4.33 . . . . 4.7000000000000002 118.135 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.43 -46.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.702 -1.249 . . . . 5.7599999999999998 112.755 -173.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.27 90.03 0.9 Allowed 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.346 -0.846 . . . . 5.3899999999999997 110.582 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -67.29 161.26 25.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.405 1.882 . . . . 5.8600000000000003 112.641 -165.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.472 ' HZ3' ' HB3' ' A' ' 182' ' ' GLN . 0.9 OUTLIER -42.07 -59.04 1.88 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.691 1.996 . . . . 4.8799999999999999 115.388 -168.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.92 -34.05 76.21 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.292 -0.88 . . . . 1.6499999999999999 113.159 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.97 -31.56 72.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.124 1.37 . . . . 3.6499999999999999 111.934 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.6 mt -58.16 -56.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.227 -0.921 . . . . 2.0499999999999998 109.519 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.88 -40.42 76.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.366 0.506 . . . . 2.0899999999999999 112.366 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.85 87.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.862 0.865 . . . . 2.1800000000000002 113.227 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.6 p -63.7 -43.44 96.6 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.298 -0.876 . . . . 1.8899999999999999 111.983 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 49.3 mt -64.71 -37.0 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.036 -1.04 . . . . 2.6200000000000001 111.436 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.7 -22.84 65.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.304 1.041 . . . . 2.2799999999999998 113.429 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 39.7 m -71.12 -48.35 52.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.163 -0.68 . . . . 2.3700000000000001 109.163 169.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -67.38 -26.07 66.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.113 1.365 . . . . 3.3399999999999999 113.503 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -25.3 63.21 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.888 -1.132 . . . . 6.5 111.8 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -57.19 -40.71 86.78 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 117.364 -1.303 . . . . 5.5199999999999996 112.608 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.22 -60.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.852 2.368 . . . . 3.2999999999999998 111.448 160.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.45 31.11 6.02 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.565 1.321 . . . . 6.0999999999999996 114.565 -156.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.4 136.07 4.32 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.05 -1.032 . . . . 7.8499999999999996 112.259 172.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.504 ' HZ3' ' C ' ' A' ' 301' ' ' SER . 0.0 OUTLIER 70.81 -168.13 0.15 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.075 1.75 . . . . 8.3699999999999992 111.489 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -159.48 24.14 0.19 Allowed 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.384 -1.447 . . . . 12.19 112.701 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.504 ' C ' ' HZ3' ' A' ' 299' ' ' LYS . 43.1 m . . . . . 0 N--CA 1.477 0.878 1 C-N-CA 133.207 4.603 . . . . 12.300000000000001 106.246 -159.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 118.111 -0.947 . . . . 17.649999999999999 108.782 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -159.97 171.41 19.42 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.336 1.454 . . . . 14.970000000000001 109.741 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -167.48 163.15 14.82 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.955 1.702 . . . . 11.67 110.161 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.81 -165.32 12.12 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.909 1.242 . . . . 9.8200000000000003 113.782 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -148.41 151.68 37.09 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.103 1.361 . . . . 10.99 111.364 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.73 174.36 12.81 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.992 2.462 . . . . 8.4499999999999993 110.397 163.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -109.75 173.86 6.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.312 1.445 . . . . 7.4800000000000004 111.301 167.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.19 136.03 39.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.262 1.025 . . . . 6.7699999999999996 108.61 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.35 -136.59 50.88 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.743 0.687 . . . . 3.5800000000000001 112.535 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 173.68 164.98 29.73 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.095 0.855 . . . . 3.0499999999999998 113.898 170.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.51 -170.79 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.292 3.328 . . . . 2.73 110.049 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -146.46 177.81 8.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.686 1.195 . . . . 3.2799999999999998 111.081 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -144.38 34.07 1.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.549 1.315 . . . . 3.3500000000000001 114.549 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mp -64.83 156.29 31.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.649 1.214 . . . . 3.1800000000000002 112.636 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -92.72 142.74 27.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.173 1.389 . . . . 2.6099999999999999 109.05 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -83.62 166.21 18.35 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.861 1.265 . . . . 2.8500000000000001 111.757 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -3.84 2.32 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.197 1.799 . . . . 2.2599999999999998 114.958 173.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.6 m -79.03 -36.86 40.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.837 1.655 . . . . 4.0599999999999996 111.729 164.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.08 11.89 30.92 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.704 1.621 . . . . 1.95 113.679 -164.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 141.07 43.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.122 1.369 . . . . 3.3999999999999999 110.406 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.33 112.74 24.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.26 1.424 . . . . 5.9699999999999998 111.46 -164.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.87 158.52 16.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.139 1.375 . . . . 3.7200000000000002 112.663 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.2 p -115.54 -179.82 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.311 2.245 . . . . 2.9399999999999999 108.739 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -38.19 88.74 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.844 -0.535 . . . . 3.6000000000000001 111.841 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -77.88 -6.58 54.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.107 1.521 . . . . 7.2199999999999998 115.107 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.28 -29.89 70.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.05 0.94 . . . . 2.8599999999999999 111.724 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -100.14 -11.88 20.1 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.095 1.517 . . . . 4.29 115.095 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.34 108.2 1.54 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.579 1.151 . . . . 4.46 111.563 -170.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.13 2.67 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.811 1.196 . . . . 2.8999999999999999 112.888 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.21 163.85 17.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.193 0.997 . . . . 3.5699999999999998 109.268 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -78.49 138.53 38.48 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.523 -0.736 . . . . 2.29 109.494 161.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.23 144.02 36.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.161 0.982 . . . . 4.4100000000000001 113.523 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.16 117.88 24.04 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.592 1.157 . . . . 3.6499999999999999 108.729 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.9 mt -101.93 127.13 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.059 0.943 . . . . 2.8599999999999999 109.125 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.64 142.14 39.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.73 0.776 . . . . 4.5 111.168 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -99.72 126.9 45.85 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.321 1.049 . . . . 3.5899999999999999 108.97 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.39 169.34 26.43 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 124.292 0.995 . . . . 1.3200000000000001 114.721 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -120.07 171.24 8.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.317 1.847 . . . . 5.5300000000000002 108.018 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 71.2 m -53.82 -12.22 0.51 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.666 2.469 . . . . 3.8700000000000001 117.666 -166.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -177.22 -27.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 122.427 2.376 . . . . 11.41 116.776 167.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 61.6 m 60.85 174.62 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 117.548 2.425 . . . . 2.8599999999999999 117.548 167.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.21 164.41 30.45 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.236 1.957 . . . . 3.5600000000000001 109.865 154.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.09 46.63 0.32 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.086 2.554 . . . . 4.3700000000000001 113.932 -165.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 94.8 t -111.86 -53.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 127.584 2.354 . . . . 3.6400000000000001 109.07 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 34.6 t -64.16 -60.84 7.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.187 0.995 . . . . 2.8599999999999999 112.922 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.69 -24.95 47.13 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.25 1.967 . . . . 1.71 112.635 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -71.2 -55.21 8.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.441 1.096 . . . . 2.8100000000000001 111.254 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.413 ' CD ' ' HZ1' ' A' ' 281' ' ' LYS . 67.2 mt-10 -65.26 -25.84 67.83 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.279 -0.888 . . . . 3.8500000000000001 112.194 172.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -65.17 -34.42 78.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.018 -0.991 . . . . 4.25 110.695 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.89 -43.04 59.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.44 1.473 . . . . 3.54 111.788 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -50.22 -39.3 44.09 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.452 -1.405 . . . . 4.6200000000000001 112.162 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.79 -50.41 43.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.914 1.286 . . . . 4.3399999999999999 112.426 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.77 -37.16 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 120.789 1.631 . . . . 2.8100000000000001 112.025 -174.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.514 ' C ' ' HE3' ' A' ' 283' ' ' LYS . 54.3 mt-30 -56.09 -27.57 54.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.84 1.2 . . . . 3.48 111.522 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 36.0 t -68.75 -20.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 120.586 -1.321 . . . . 3.2400000000000002 111.771 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.9 t -67.28 -38.82 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.856 0.753 . . . . 3.1499999999999999 109.479 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -49.99 74.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.486 1.114 . . . . 5.0300000000000002 110.963 171.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.27 -25.54 63.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.5 1.12 . . . . 3.1600000000000001 113.781 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.15 -45.33 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.986 1.715 . . . . 3.4900000000000002 112.703 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.36 -32.37 66.7 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.476 1.035 . . . . 3.6899999999999999 111.1 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -20.23 63.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.565 1.546 . . . . 3.6299999999999999 112.901 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.08 -16.94 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 120.897 -1.127 . . . . 3.9300000000000002 111.701 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.5 t 56.47 -7.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.694 3.197 . . . . 5.5099999999999998 118.633 165.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 67.4 p -109.18 9.25 26.08 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 120.802 1.637 . . . . 4.21 114.411 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.92 160.92 29.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.226 1.81 . . . . 4.2599999999999998 112.847 -168.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -82.8 51.56 3.74 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.282 3.321 . . . . 3.52 110.729 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.1 t0 57.94 -175.84 0.08 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.332 2.253 . . . . 4.4800000000000004 115.405 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.94 118.06 28.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.969 1.308 . . . . 2.9700000000000002 108.63 155.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.5 m -98.88 99.92 8.76 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.437 1.495 . . . . 1.97 109.983 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.09 133.02 17.46 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.96 2.44 . . . . 1.1699999999999999 111.649 170.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.38 89.21 3.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.103 2.161 . . . . 3.46 108.161 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -83.7 130.86 34.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.716 0.806 . . . . 2.9900000000000002 109.575 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.7 mt -108.55 122.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.892 0.877 . . . . 2.96 109.855 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.4 m -67.34 119.61 12.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.587 0.755 . . . . 2.9700000000000002 110.839 166.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.29 -3.55 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 120.955 -1.091 . . . . 3.6200000000000001 113.721 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -111.81 57.34 0.46 Allowed Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 127.381 2.272 . . . . 4.2400000000000002 113.554 -170.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.94 75.9 2.62 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.866 3.711 . . . . 2.75 109.966 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -173.42 -35.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.846 2.458 . . . . 3.6099999999999999 111.473 -169.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.34 32.52 2.83 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.028 0.931 . . . . 6.5999999999999996 112.388 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -119.99 173.29 7.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.912 2.485 . . . . 4.0099999999999998 109.673 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.3 m -169.2 139.98 2.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.275 2.63 . . . . 3.9399999999999999 107.143 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -36.61 66.82 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.434 0.901 . . . . 4.2400000000000002 113.434 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -79.59 -28.0 41.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.893 2.077 . . . . 3.8500000000000001 112.67 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.45 42.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.797 0.726 . . . . 2.8700000000000001 110.084 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.1 tp -62.01 -31.6 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.72 0.408 . . . . 3.3900000000000001 111.989 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.62 95.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.184 -0.948 . . . . 1.9099999999999999 111.826 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -69.21 -29.22 67.13 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.196 0.813 . . . . 4.9900000000000002 113.196 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -68.1 -48.36 65.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.544 1.138 . . . . 5.0599999999999996 110.778 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.1 t -52.2 -45.74 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.166 -0.959 . . . . 2.3199999999999998 111.519 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -18.67 46.25 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.39 1.476 . . . . 5.8799999999999999 113.188 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.91 -48.03 80.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.959 1.708 . . . . 4.7699999999999996 110.927 171.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -87.82 -53.2 4.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.347 0.869 . . . . 4.2000000000000002 113.347 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.7 p -177.33 159.61 1.39 Allowed Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.634 -1.291 . . . . 3.7200000000000002 112.91 -159.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -86.24 -16.0 4.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.716 2.944 . . . . 2.4900000000000002 113.807 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -85.61 -4.44 59.16 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.788 1.176 . . . . 3.2400000000000002 113.52 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.89 136.79 36.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.942 0.897 . . . . 3.54 111.171 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 t -110.99 131.36 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.574 -1.269 . . . . 3.0800000000000001 107.574 163.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.73 114.65 4.59 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 109.497 -1.441 . . . . 1.01 109.497 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.4 144.35 33.21 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.665 0.786 . . . . 2.96 110.756 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -157.79 -179.7 8.39 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.641 1.576 . . . . 3.0699999999999998 110.785 -172.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 167.42 -116.69 0.69 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.255 -1.138 . . . . 1.8400000000000001 110.255 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.5 p -128.0 168.0 15.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.613 1.165 . . . . 3.04 112.211 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -39.36 46.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.67 0.788 . . . . 6.4400000000000004 111.248 -177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 2.2 mp0 -59.76 -54.23 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.293 2.237 . . . . 3.52 113.131 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -69.46 -31.68 70.13 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.879 -1.138 . . . . 4.9800000000000004 111.831 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.43 -29.61 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 117.944 -1.027 . . . . 2.5899999999999999 111.625 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.29 -42.53 88.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.031 1.287 . . . . 3.1800000000000002 110.227 162.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -56.49 -50.5 71.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 117.987 -1.006 . . . . 2.8500000000000001 112.622 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.4 m -71.2 -26.86 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 120.583 1.538 . . . . 3.6400000000000001 114.576 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.615 1.098 . . . . 2.4199999999999999 112.628 175.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -105.09 -21.76 13.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.772 3.229 . . . . 7.54 113.467 -167.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.72 -28.99 64.06 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.472 1.033 . . . . 2.6299999999999999 112.268 162.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.08 -127.06 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.402 1.081 . . . . 3.6499999999999999 109.404 164.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -164.78 74.71 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.572 1.149 . . . . 6.2300000000000004 110.145 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.5 m -83.63 173.92 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 111.765 0.283 . . . . 4.46 111.765 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -147.8 154.19 40.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.126 1.371 . . . . 7.4500000000000002 110.737 166.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -154.94 125.43 6.89 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.524 1.53 . . . . 5.5999999999999996 111.176 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.6 t -106.74 110.54 63.76 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 120.795 -1.19 . . . . 4.3799999999999999 109.257 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.99 144.52 38.3 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.524 2.149 . . . . 3.4900000000000002 111.367 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -87.73 -173.65 48.01 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.892 1.234 . . . . 3.1000000000000001 115.092 -175.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.58 53.97 4.97 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 125.048 3.832 . . . . 6.1799999999999997 112.579 -172.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 250' ' ' LYS 0.26 0.0 OUTLIER -63.1 123.5 18.76 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.85 -1.156 . . . . 5.9000000000000004 110.989 177.369 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 103.22 -8.88 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.318 1 C-N-CA 131.755 4.022 . . . . 10.06 113.309 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -81.88 -48.65 11.27 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.985 1.266 . . . . 10.279999999999999 112.591 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -156.65 49.33 0.47 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.561 0.949 . . . . 8.7200000000000006 113.561 -170.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 76.99 -1.05 2.88 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 127.776 2.431 . . . . 8.3800000000000008 112.802 171.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.67 151.06 21.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.34 1.456 . . . . 4.9699999999999998 114.496 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.96 71.55 0.68 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 113.964 -1.471 . . . . 4.21 109.431 145.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.0 tp -83.95 154.07 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.384 -0.823 . . . . 3.8500000000000001 111.639 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.7 134.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 129.449 3.099 . . . . 3.75 105.635 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.83 168.0 14.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.162 0.982 . . . . 3.71 110.397 165.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -150.46 36.26 0.65 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.079 0.943 . . . . 3.6499999999999999 110.907 168.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . 0.266 13.7 p 65.51 -134.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.54 2.336 . . . . 4.1200000000000001 110.999 -171.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 176.19 -17.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 129.029 2.932 . . . . 5.9500000000000002 110.795 -163.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.4 mt -69.92 134.03 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.57 1.148 . . . . 3.3399999999999999 109.546 170.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.8 ttm -119.6 137.49 53.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.3 1.84 . . . . 3.8500000000000001 108.206 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.97 127.59 51.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.677 0.791 . . . . 4.7199999999999998 112.18 -159.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.83 130.74 48.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.595 1.158 . . . . 2.8300000000000001 112.075 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.9 151.3 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.296 1.838 . . . . 2.9500000000000002 106.297 166.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -142.55 -135.07 3.02 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 121.268 -0.895 . . . . 2.75 113.0 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.11 1.61 7.02 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.654 2.903 . . . . 2.5099999999999998 113.545 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.87 -47.0 55.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.23 2.212 . . . . 5.6100000000000003 113.723 172.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.88 13.09 54.45 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 117.628 -1.651 . . . . 3.0099999999999998 116.746 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.57 -70.7 0.35 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.065 1.432 . . . . 4.1600000000000001 111.883 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -166.69 146.96 5.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.164 0.985 . . . . 6.0499999999999998 111.915 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 -33.01 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.424 1.639 . . . . 3.7599999999999998 115.424 -170.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -168.52 167.94 11.33 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.11 1.323 . . . . 2.5600000000000001 112.76 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.45 152.55 32.11 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.694 1.738 . . . . 4.4800000000000004 115.694 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -120.33 163.71 17.42 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.888 1.275 . . . . 3.7400000000000002 110.481 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -167.08 102.56 0.19 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.326 -0.859 . . . . 4.0800000000000001 111.765 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 64.15 164.06 0.13 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.24 1.416 . . . . 4.7199999999999998 110.965 -162.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 37.8 t30 77.1 -57.2 0.52 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.309 1.843 . . . . 6.5199999999999996 112.467 165.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.413 ' HZ1' ' CD ' ' A' ' 176' ' ' GLU . 1.6 mptm? 49.71 19.97 0.47 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.085 2.154 . . . . 10.66 116.226 162.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.39 142.38 56.98 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 119.139 -2.226 . . . . 6.4199999999999999 110.612 -163.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.514 ' HE3' ' C ' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -46.03 -52.18 12.36 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.192 0.997 . . . . 3.5099999999999998 113.593 -170.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.37 -23.28 71.71 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.506 -1.164 . . . . 1.5700000000000001 114.647 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -74.07 -49.14 25.38 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.494 1.647 . . . . 3.3599999999999999 110.378 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.66 -47.73 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.324 0.649 . . . . 2.2599999999999998 109.389 174.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.96 75.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.207 -0.901 . . . . 2.27 112.516 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.43 91.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.925 1.239 . . . . 2.0499999999999998 112.752 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 91.5 p -60.02 -57.35 13.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.932 0.333 . . . . 2.1600000000000001 111.562 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.34 -35.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.754 -1.216 . . . . 2.2400000000000002 110.993 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.37 73.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.825 1.25 . . . . 2.4500000000000002 113.921 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 14.4 t -76.25 -33.27 59.18 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.182 1.356 . . . . 3.9900000000000002 111.452 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -70.87 -24.59 62.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.976 0.91 . . . . 2.8100000000000001 113.26 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.5 mtt -54.1 -40.95 67.73 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.432 -1.418 . . . . 6.5700000000000003 111.467 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -59.01 -45.09 99.59 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 115.714 -2.089 . . . . 5.2000000000000002 114.557 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.85 -7.55 11.32 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.606 2.87 . . . . 2.4100000000000001 114.429 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -119.85 -154.65 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 120.027 1.285 . . . . 4.0499999999999998 113.4 -171.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -69.59 121.59 17.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.027 -1.671 . . . . 12.07 111.354 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -164.3 0.51 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.821 1.786 . . . . 10.24 115.821 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 79.4 mttt 34.91 45.57 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 127.379 2.271 . . . . 10.970000000000001 116.4 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.255 1.373 0 C-N-CA 129.598 3.159 . . . . 8.6099999999999994 107.686 -170.532 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 118.044 -0.979 . . . . 19.469999999999999 109.83 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -63.95 157.58 24.57 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.879 0.763 . . . . 17.890000000000001 110.758 164.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 t -175.82 167.33 3.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.595 2.758 . . . . 13.99 108.666 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 93.36 159.75 34.88 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.763 1.173 . . . . 12.01 113.264 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -173.84 155.03 2.4 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.558 1.543 . . . . 14.210000000000001 111.903 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.25 150.9 29.47 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.771 2.314 . . . . 12.18 112.167 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.6 tt -171.45 134.84 0.88 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 129.733 3.213 . . . . 10.300000000000001 106.588 162.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 tp -164.57 -178.69 5.51 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.013 0.925 . . . . 6.2000000000000002 111.118 -168.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.08 155.26 19.18 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.179 1.371 . . . . 4.8399999999999999 110.098 154.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.1 -84.28 0.36 Allowed Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.216 -1.325 . . . . 5.6100000000000003 112.1 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.57 148.02 90.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.837 2.358 . . . . 4.46 112.136 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -151.23 171.76 16.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 4.3899999999999997 111.988 -174.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 p -139.04 42.28 2.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.954 1.835 . . . . 3.8799999999999999 115.954 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.49 152.64 21.34 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 119.902 -1.749 . . . . 4.7699999999999996 112.699 -170.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.9 m -92.14 139.65 30.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.682 1.193 . . . . 3.1899999999999999 110.155 -173.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.2 p -84.38 159.79 20.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.037 0.935 . . . . 3.5800000000000001 112.587 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -9.36 2.07 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.479 1.512 . . . . 2.27 115.0 169.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 99.7 m -71.68 -53.68 12.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.463 1.105 . . . . 4.6799999999999997 109.858 164.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.63 -10.84 8.0 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.358 1.933 . . . . 3.0499999999999998 113.619 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 148.73 27.96 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 124.83 1.252 . . . . 5.1399999999999997 111.112 171.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 97.59 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.695 1.198 . . . . 6.9900000000000002 111.663 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -95.66 161.94 13.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.178 1.177 . . . . 5.54 114.178 -171.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -112.43 169.5 8.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.2 1.8 . . . . 3.4500000000000002 110.773 164.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -41.87 -42.68 2.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.914 2.486 . . . . 4.0999999999999996 113.213 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -82.04 -22.68 36.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.168 1.173 . . . . 8.1400000000000006 114.168 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.24 -14.39 60.92 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.928 0.871 . . . . 3.8599999999999999 111.936 165.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -102.88 9.96 38.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.968 2.507 . . . . 4.3099999999999996 114.782 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.35 156.38 26.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.614 1.552 . . . . 3.98 115.003 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.59 43.05 Favored Glycine 0 N--CA 1.478 1.463 0 C-N-CA 124.818 1.199 . . . . 2.8599999999999999 115.656 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -140.39 162.68 34.74 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.917 2.487 . . . . 3.7400000000000002 109.695 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.8 131.6 43.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.259 0.552 . . . . 2.4399999999999999 111.943 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.8 mt -108.09 125.39 51.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.035 1.334 . . . . 4.0199999999999996 109.781 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.57 103.99 9.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.624 1.169 . . . . 4.4500000000000002 108.094 -173.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.3 mt -117.67 124.97 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.934 0.893 . . . . 2.73 109.934 -155.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -142.37 155.12 45.12 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.007 1.323 . . . . 3.6000000000000001 112.159 -165.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.87 122.63 39.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.752 1.221 . . . . 4.1699999999999999 111.114 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.69 -154.66 8.25 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.538 1.066 . . . . 1.3300000000000001 112.653 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -168.02 169.32 11.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.721 1.608 . . . . 4.9100000000000001 111.42 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.27 13.5 t -77.97 30.9 0.17 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 119.602 -1.936 . . . . 4.8700000000000001 112.75 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -97.43 -29.79 13.29 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.777 1.631 . . . . 8.4499999999999993 113.775 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 60.4 m -104.72 153.11 39.5 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 116.221 1.934 . . . . 2.8799999999999999 116.221 -165.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.21 -22.27 2.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.886 3.058 . . . . 5.0199999999999996 113.534 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -140.65 -58.19 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.948 1.092 . . . . 4.79 113.948 -171.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.7 p -60.36 -32.41 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.675 1.59 . . . . 4.2800000000000002 114.687 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.8 m -74.89 -66.11 0.47 Allowed Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.167 0.894 . . . . 1.6000000000000001 112.129 161.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 -28.5 68.92 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.713 1.608 . . . . 1.3400000000000001 115.154 -166.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -71.32 -30.47 66.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.762 1.619 . . . . 3.04 112.49 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.67 -40.48 72.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.808 0.731 . . . . 3.1200000000000001 110.448 168.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.45 -37.66 74.38 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.873 1.215 . . . . 4.3399999999999999 113.05 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.03 -58.82 5.89 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.315 1.446 . . . . 4.21 110.205 165.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -56.68 -40.98 76.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.081 1.352 . . . . 4.04 112.972 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 48.3 mtp -60.62 -40.75 93.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.929 1.692 . . . . 3.8100000000000001 112.529 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.6 tp -87.41 -37.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.693 1.588 . . . . 3.46 112.678 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -53.2 -43.28 67.08 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 124.762 1.225 . . . . 3.48 110.704 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.86 -13.56 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 113.801 1.037 . . . . 3.4700000000000002 113.801 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.2 -23.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.998 -1.064 . . . . 2.9399999999999999 111.603 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -50.37 67.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.746 0.818 . . . . 4.6799999999999997 112.187 -170.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.54 -19.1 65.24 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.673 1.589 . . . . 3.8399999999999999 114.115 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -56.49 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 120.914 -1.116 . . . . 3.6699999999999999 109.347 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.78 -36.99 82.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.605 1.162 . . . . 4.0 112.159 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -71.87 -7.61 49.49 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.773 1.027 . . . . 3.8999999999999999 113.773 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.5 mm -103.34 -29.72 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.128 0.876 . . . . 5.7400000000000002 111.095 168.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.0 m 72.73 -25.88 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 127.56 2.344 . . . . 7.0999999999999996 114.211 157.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 56.0 m -74.81 -2.67 27.67 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.794 3.237 . . . . 4.5700000000000003 112.673 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 mp -99.26 157.66 33.64 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.594 1.558 . . . . 4.1500000000000004 110.075 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.46 143.68 48.14 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.28 1.987 . . . . 3.6200000000000001 108.183 155.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.26 159.31 3.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 116.078 1.881 . . . . 3.5 116.078 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.19 95.52 7.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.246 -1.39 . . . . 3.8999999999999999 107.246 157.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.4 m -86.95 112.04 44.63 Favored Pre-proline 0 N--CA 1.475 0.786 0 N-CA-C 108.126 -1.065 . . . . 2.3300000000000001 108.126 168.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -86.82 136.86 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.789 2.326 . . . . 1.25 109.86 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.15 123.11 16.6 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.484 1.135 . . . . 4.5099999999999998 112.442 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -109.45 133.15 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.535 1.534 . . . . 3.3100000000000001 110.554 -160.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 36.3 mm -99.55 122.01 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.154 0.981 . . . . 3.0699999999999998 110.516 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 95.6 p -74.07 124.61 26.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.102 0.561 . . . . 4.3399999999999999 110.097 165.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.5 pt -94.05 -18.05 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.322 1.601 . . . . 3.3300000000000001 115.322 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -119.48 59.38 5.17 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 120.419 1.463 . . . . 3.6200000000000001 114.367 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.54 99.57 0.21 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.43 2.087 . . . . 2.6800000000000002 107.393 165.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 165.65 -45.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.986 2.515 . . . . 4.46 108.523 -147.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 -18.19 0.6 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.927 1.455 . . . . 6.6699999999999999 114.927 151.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.66 136.77 54.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.847 1.203 . . . . 4.2999999999999998 109.394 155.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.2 t -154.0 155.73 36.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 3.8399999999999999 112.384 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -58.1 -47.04 84.47 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.484 1.914 . . . . 3.6099999999999999 113.983 -163.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -71.66 -38.69 70.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.328 1.422 . . . . 3.54 112.77 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.7 93.99 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.221 -0.924 . . . . 2.4399999999999999 111.14 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 mm -61.3 -39.77 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.057 0.943 . . . . 2.8900000000000001 111.736 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.45 86.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.629 1.104 . . . . 2.5899999999999999 112.309 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -62.55 -52.71 62.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.922 0.783 . . . . 3.6400000000000001 111.811 168.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -55.58 -32.17 62.81 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.726 1.21 . . . . 4.2199999999999998 113.519 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.35 -58.16 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.02 2.128 . . . . 2.1899999999999999 112.576 166.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -52.91 -48.14 67.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.953 0.901 . . . . 4.7000000000000002 112.181 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.63 -20.46 58.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.231 0.957 . . . . 5.0199999999999996 112.627 -162.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -79.86 -56.14 4.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.79 0.723 . . . . 4.0999999999999996 110.875 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.8 m 169.14 132.25 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 127.297 2.239 . . . . 2.7599999999999998 112.208 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.19 7.34 1.44 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.394 3.396 . . . . 3.6299999999999999 116.094 -168.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -67.94 -35.33 78.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.205 1.366 . . . . 2.98 110.768 159.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.08 118.51 7.43 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.258 -1.386 . . . . 3.0899999999999999 107.258 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.85 131.38 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.098 -1.075 . . . . 3.1499999999999999 108.098 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -93.51 127.78 9.18 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.117 -1.593 . . . . 1.0900000000000001 109.117 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.48 144.92 50.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.837 0.827 . . . . 3.0699999999999998 111.291 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 26.1 p -140.36 176.15 9.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.706 2.002 . . . . 3.1899999999999999 109.255 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -175.69 -154.55 11.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.183 -1.967 . . . . 2.3399999999999999 108.183 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.5 p -81.94 171.99 13.8 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.331 0.586 . . . . 4.0499999999999998 110.615 167.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -63.07 -23.99 67.7 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.756 -0.59 . . . . 7.3300000000000001 112.085 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 16.2 mp0 -80.8 -31.12 35.81 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.536 1.934 . . . . 3.8799999999999999 111.913 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.15 -41.51 73.74 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.916 -1.115 . . . . 4.96 109.691 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.99 -38.69 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.268 -0.895 . . . . 3.2400000000000002 111.92 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.09 -39.32 79.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.423 -0.799 . . . . 3.71 111.143 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -52.33 -58.87 5.32 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.737 -1.125 . . . . 3.7000000000000002 110.377 173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.26 -31.61 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.79 1.177 . . . . 4.1799999999999997 113.17 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.97 -50.75 38.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.54 1.064 . . . . 3.1200000000000001 111.37 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -36.95 74.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.003 1.721 . . . . 8.8000000000000007 112.402 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.21 65.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.689 1.132 . . . . 3.0600000000000001 110.724 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -76.17 -7.85 55.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.555 0.742 . . . . 3.8900000000000001 112.827 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 26.3 ttp-105 71.06 38.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.567 2.347 . . . . 8.9199999999999999 112.431 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.69 138.92 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.365 1.466 . . . . 5.5599999999999996 108.659 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -105.85 136.86 44.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.222 0.534 . . . . 5.4699999999999998 111.177 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -89.85 144.2 26.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.897 0.479 . . . . 4.0199999999999996 109.912 164.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 t -119.69 94.2 48.26 Favored Pre-proline 0 N--CA 1.477 0.906 0 O-C-N 120.895 -1.128 . . . . 3.8999999999999999 112.704 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.78 138.76 9.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.362 2.708 . . . . 3.1899999999999999 113.149 -171.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.49 -177.64 51.25 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 123.78 0.705 . . . . 2.6800000000000002 112.503 163.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -82.59 151.08 14.94 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.393 2.729 . . . . 3.8799999999999999 110.615 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.1 128.55 19.27 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.961 1.304 . . . . 5.7599999999999998 112.034 159.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -129.82 162.66 28.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.455 0.702 . . . . 6.46 112.194 174.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 39.34 -109.41 0.08 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.763 2.025 . . . . 8.1999999999999993 111.989 -158.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -106.37 -38.81 6.1 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.883 0.765 . . . . 8.9900000000000002 112.069 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -170.17 75.05 0.08 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 127.151 2.18 . . . . 7.8300000000000001 109.655 167.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -94.07 162.58 13.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.647 -1.16 . . . . 3.77 109.729 132.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . 0.262 6.9 p90 173.25 160.02 0.13 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.515 2.326 . . . . 5.0499999999999998 112.397 140.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.4 tp -105.39 148.73 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.054 1.342 . . . . 3.75 111.338 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.9 132.61 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.452 -2.055 . . . . 4.0700000000000003 105.452 161.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.42 139.17 43.81 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.561 0.618 . . . . 4.1100000000000003 111.298 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -131.41 93.9 3.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.936 0.894 . . . . 2.79 110.876 161.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.7 t -48.2 122.53 5.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.525 0.73 . . . . 5.2999999999999998 110.266 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 10.5 pt -88.07 101.1 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.816 0.817 . . . . 5.5199999999999996 112.372 -165.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.1 mt -132.57 127.04 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.973 1.309 . . . . 3.8999999999999999 108.05 162.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.8 ptm -94.0 130.48 40.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.268 0.627 . . . . 3.79 109.734 162.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -97.92 135.14 40.08 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.215 -0.928 . . . . 3.98 111.233 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 108.96 19.68 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.269 -1.012 . . . . 2.8500000000000001 108.269 168.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.7 mm -93.73 135.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.627 -1.249 . . . . 3.7200000000000002 107.627 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.08 176.61 29.86 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 122.872 0.272 . . . . 2.1299999999999999 112.535 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.4 39.96 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 125.256 3.97 . . . . 2.6400000000000001 112.153 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -161.11 -36.45 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.3 2.24 . . . . 4.8899999999999997 113.53 -158.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.86 0.0 21.34 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 117.169 -1.906 . . . . 3.1600000000000001 116.307 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -99.4 157.94 16.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.898 1.849 . . . . 5.3799999999999999 111.195 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -74.28 108.21 6.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.111 1.365 . . . . 5.21 110.386 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.33 -28.59 16.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.575 0.75 . . . . 3.7200000000000002 112.275 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -170.79 -179.71 2.93 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.756 1.622 . . . . 2.6600000000000001 111.842 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -158.87 157.71 32.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.648 1.979 . . . . 5.2199999999999998 112.321 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -147.7 -179.46 6.9 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.517 1.927 . . . . 4.0599999999999996 111.394 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.75 -100.87 0.23 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.816 1.198 . . . . 4.1600000000000001 112.362 174.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -67.38 -30.28 70.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.937 -1.331 . . . . 4.71 113.461 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.95 137.39 50.32 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.758 0.823 . . . . 5.2199999999999998 109.508 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.54 86.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.641 0.777 . . . . 5.0499999999999998 110.641 -143.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -89.02 -164.38 1.13 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.83 1.652 . . . . 10.82 109.227 156.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -29.61 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.636 2.374 . . . . 3.1499999999999999 116.446 -168.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.71 -20.95 72.99 Favored Glycine 0 N--CA 1.476 1.327 0 CA-C-N 118.945 0.793 . . . . 2.0 112.74 -168.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -18.73 30.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.386 0.674 . . . . 5.0599999999999996 112.168 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.92 -49.69 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.105 -0.997 . . . . 2.5 109.379 156.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.47 70.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.144 0.883 . . . . 2.2200000000000002 113.169 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.22 60.06 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.279 1.215 . . . . 2.1499999999999999 114.279 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 64.3 p -69.56 -52.55 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.618 -0.676 . . . . 2.4100000000000001 111.689 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.5 mm -58.48 -42.51 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.256 -0.903 . . . . 3.1600000000000001 109.708 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.08 -11.97 23.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.087 1.755 . . . . 2.3700000000000001 114.248 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.9 m -97.39 -54.95 2.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.084 1.354 . . . . 3.0499999999999998 109.566 170.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -64.09 -25.58 68.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.362 1.465 . . . . 3.02 113.986 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 mmm -65.53 -20.51 66.37 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.525 1.13 . . . . 5.9199999999999999 113.987 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -62.45 -48.58 86.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 116.12 -1.895 . . . . 5.6299999999999999 112.257 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.35 -43.71 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.61 2.207 . . . . 2.0699999999999998 112.05 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.14 53.2 2.74 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.105 1.15 . . . . 3.5499999999999998 114.105 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 114.53 -98.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 130.258 3.423 . . . . 12.0 111.477 165.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -151.88 165.07 35.67 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.215 1.191 . . . . 11.23 114.215 -159.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.7 -49.94 0.59 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.593 1.157 . . . . 14.33 109.69 168.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.247 0.948 0 C-N-CA 128.445 2.698 . . . . 9.8000000000000007 107.951 150.407 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 118.376 -0.821 . . . . 25.649999999999999 110.287 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -68.45 168.91 11.78 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.875 0.761 . . . . 19.690000000000001 110.936 159.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 t -138.08 168.11 20.41 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.032 1.733 . . . . 18.370000000000001 108.256 154.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.51 -156.72 34.62 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.027 1.299 . . . . 14.390000000000001 113.949 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . 0.279 1.5 mptm? 118.88 -59.21 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.379 1 C-N-CA 132.901 4.48 . . . . 13.91 110.894 176.365 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.89 165.75 31.92 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.713 1.609 . . . . 9.7200000000000006 109.437 153.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 pp -175.86 163.39 2.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.831 2.852 . . . . 8.2799999999999994 108.638 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.9 mt -124.71 -113.63 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.236 1.414 . . . . 7.54 110.394 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.44 18.11 28.4 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.288 1.423 . . . . 4.8899999999999997 114.907 -173.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.24 111.79 4.47 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.066 -1.408 . . . . 3.54 111.314 -170.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.5 157.59 28.85 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.976 2.451 . . . . 3.5299999999999998 112.403 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -131.13 168.85 16.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.327 1.851 . . . . 4.0700000000000003 111.538 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.4 p -125.49 22.12 7.72 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.772 2.138 . . . . 4.5099999999999998 116.772 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.92 162.34 29.17 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.837 1.051 . . . . 3.1299999999999999 113.837 -163.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 142.6 30.69 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.536 1.534 . . . . 2.9700000000000002 109.8 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 m -98.53 140.26 33.04 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.089 1.756 . . . . 3.9700000000000002 110.243 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -47.53 -20.86 0.27 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.405 2.682 . . . . 2.23 116.445 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.4 t -90.08 -7.39 53.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.802 1.241 . . . . 4.1200000000000001 113.798 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.21 38.43 4.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.433 1.015 . . . . 3.46 113.265 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.49 -172.99 3.56 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.226 1.41 . . . . 5.2400000000000002 110.016 172.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -152.9 136.82 16.26 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.459 1.027 . . . . 7.8300000000000001 109.709 -156.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.526 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 8.8 mptt -132.16 167.28 20.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.747 1.758 . . . . 4.9500000000000002 115.747 -168.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 88.2 m -164.91 156.17 14.86 Favored 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 132.732 4.413 . . . . 3.8700000000000001 105.232 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.51 -42.27 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.808 1.185 . . . . 3.6899999999999999 113.049 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -3.93 9.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.156 1.539 . . . . 9.3000000000000007 115.156 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -87.36 -20.08 27.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.742 1.217 . . . . 3.1099999999999999 112.767 166.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.526 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 7.8 m-85 -109.0 -20.45 13.03 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.039 1.496 . . . . 4.7800000000000002 115.039 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 137.14 31.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.204 1.402 . . . . 4.1100000000000003 112.304 -171.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.85 58.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.81 1.195 . . . . 2.5 112.778 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -107.34 165.4 11.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.697 1.999 . . . . 3.4399999999999999 108.296 161.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -89.61 137.48 32.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.136 -0.69 . . . . 2.3999999999999999 109.136 170.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.5 pp -137.47 154.3 49.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.513 0.673 . . . . 3.7799999999999998 112.471 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.5 mt -121.45 114.79 21.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.147 1.779 . . . . 3.5 109.141 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.75 120.94 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.341 0.973 . . . . 3.1000000000000001 108.959 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.13 134.34 54.75 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.261 1.025 . . . . 3.3799999999999999 111.478 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.38 118.19 36.34 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.632 0.773 . . . . 4.6600000000000001 110.164 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.67 -178.41 15.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.294 1.426 . . . . 1.6200000000000001 114.806 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -144.61 124.06 13.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.594 0.757 . . . . 5.0599999999999996 111.206 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 1.5 p -81.08 28.77 0.35 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.318 -1.489 . . . . 4.0099999999999998 114.679 -174.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -146.16 39.38 1.1 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 127.076 2.151 . . . . 8.5299999999999994 109.322 162.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.97 147.42 94.22 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 116.133 1.901 . . . . 2.8500000000000001 116.133 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -76.68 63.89 7.42 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.819 3.013 . . . . 5.1299999999999999 110.2 157.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 66.37 -18.2 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 130.022 3.329 . . . . 4.5 116.66 163.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.51 -30.16 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.244 -0.91 . . . . 4.4199999999999999 112.782 -170.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 17.5 m -58.58 -64.41 2.9 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 116.745 -1.598 . . . . 1.6200000000000001 112.03 166.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -63.27 -26.32 71.88 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.756 1.663 . . . . 1.6100000000000001 113.88 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.55 -59.69 3.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.924 1.238 . . . . 3.04 111.308 171.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.66 -29.68 69.04 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.576 0.751 . . . . 3.48 111.936 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.94 -28.18 67.25 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.376 -1.452 . . . . 4.3399999999999999 112.423 170.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -69.93 -49.66 49.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.354 0.979 . . . . 3.8999999999999999 109.378 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -39.47 71.04 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.788 -1.195 . . . . 5.0899999999999999 112.004 176.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.3 ttm -55.78 -48.73 74.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.298 1.839 . . . . 3.8599999999999999 111.714 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 12.6 mm -66.06 -37.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 120.362 1.437 . . . . 2.4399999999999999 110.464 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -62.33 -31.97 72.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.049 -1.453 . . . . 3.8300000000000001 113.321 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.3 p -86.39 -34.77 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.788 1.176 . . . . 3.4199999999999999 114.151 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.4 t -57.14 -44.45 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.896 1.226 . . . . 3.6000000000000001 111.32 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.67 -31.38 66.73 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.124 0.97 . . . . 4.5199999999999996 112.67 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -64.23 -49.69 70.94 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.992 -1.067 . . . . 2.9300000000000002 112.195 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.4 mm -64.86 -38.7 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.093 0.957 . . . . 3.5099999999999998 113.397 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.12 -42.57 90.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.422 1.089 . . . . 2.8900000000000001 110.315 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.1 t -70.46 -11.52 60.98 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.999 1.111 . . . . 3.6899999999999999 113.999 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.21 -23.51 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.82 1.191 . . . . 3.8500000000000001 110.84 169.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 67.07 -20.47 0.11 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.025 2.53 . . . . 4.9100000000000001 115.714 167.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 48.2 p -67.42 -39.14 85.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.523 -1.361 . . . . 6.6900000000000004 110.885 165.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.96 158.48 75.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.207 1.403 . . . . 5.3099999999999996 111.444 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.57 -32.56 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.156 2.57 . . . . 3.3399999999999999 113.812 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 t70 160.04 153.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.584 3.554 . . . . 3.6600000000000001 108.748 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 36.0 tp -123.11 90.21 3.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.439 1.496 . . . . 2.9500000000000002 107.958 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.2 m -75.03 125.64 89.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 O-C-N 121.069 -1.02 . . . . 2.0299999999999998 110.265 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.46 133.37 4.54 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.093 2.528 . . . . 0.95999999999999996 111.183 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.29 97.73 5.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.238 1.415 . . . . 4.2599999999999998 109.12 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -84.03 129.99 34.89 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.267 1.027 . . . . 3.6699999999999999 109.847 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.03 129.82 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.498 1.119 . . . . 3.1099999999999999 109.03 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.6 t -92.69 117.62 30.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.152 0.581 . . . . 3.1200000000000001 111.53 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -90.01 40.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.145 -0.972 . . . . 3.1299999999999999 112.321 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -121.39 55.22 5.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.522 1.129 . . . . 3.2999999999999998 112.624 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.95 66.94 8.7 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 125.064 3.843 . . . . 2.73 111.956 -166.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -151.97 -63.08 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.064 1.746 . . . . 6.7199999999999998 109.282 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.04 27.1 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 7.2599999999999998 113.334 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -80.95 156.36 26.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.889 0.852 . . . . 4.9299999999999997 112.348 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 m -170.02 129.72 0.95 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.137 2.575 . . . . 3.8100000000000001 106.639 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -52.57 -43.34 65.2 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.995 0.918 . . . . 5.1399999999999997 112.347 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -64.28 -32.99 74.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.419 1.888 . . . . 3.7400000000000002 114.228 172.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.51 72.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.954 1.252 . . . . 2.3100000000000001 111.341 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.29 -40.2 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.882 -0.511 . . . . 2.6000000000000001 110.357 169.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.07 68.46 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.333 -0.841 . . . . 2.8900000000000001 113.096 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.8 -51.6 64.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.369 0.986 . . . . 6.1799999999999997 111.65 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -57.15 -41.84 79.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.545 0.688 . . . . 5.3600000000000003 111.539 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.3 t -65.35 -15.9 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.883 0.873 . . . . 2.2000000000000002 112.521 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.66 -39.23 12.59 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 119.716 -1.865 . . . . 6.6299999999999999 113.349 166.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.56 -53.66 48.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.193 1.397 . . . . 4.9000000000000004 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -76.26 -52.34 10.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.996 0.739 . . . . 3.73 112.996 -171.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.8 t -179.44 145.23 0.42 Allowed Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.152 1.381 . . . . 2.9100000000000001 110.514 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.83 -16.12 37.13 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.793 2.329 . . . . 2.6600000000000001 114.27 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -72.22 -20.86 61.49 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.443 1.474 . . . . 2.6600000000000001 112.974 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.6 tp -68.86 149.04 49.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.26 1.424 . . . . 3.1099999999999999 113.346 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.81 141.12 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.151 0.981 . . . . 3.3399999999999999 110.82 166.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.45 114.28 3.6 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.678 -1.369 . . . . 1.28 109.678 175.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.22 145.14 36.35 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.446 0.698 . . . . 3.6800000000000002 109.871 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.9 m -154.46 163.71 39.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.391 1.076 . . . . 3.4300000000000002 109.155 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -150.05 170.76 30.08 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 124.022 0.82 . . . . 1.8799999999999999 111.345 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -61.4 162.44 7.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 3.2200000000000002 110.342 164.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -48.28 -31.76 6.39 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.694 1.198 . . . . 9.0099999999999998 113.741 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -67.98 -43.33 79.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.023 1.729 . . . . 3.48 111.873 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.07 -34.0 68.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.407 1.083 . . . . 3.3100000000000001 111.19 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.23 -39.51 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 118.485 -0.769 . . . . 3.0800000000000001 110.504 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.31 -43.06 92.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 117.539 -1.22 . . . . 3.3199999999999998 110.219 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -52.59 -59.04 4.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.87 1.214 . . . . 3.5499999999999998 111.306 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.7 -34.28 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.145 0.884 . . . . 4.6399999999999997 112.675 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.71 86.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.681 -0.637 . . . . 3.02 111.817 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -76.74 -41.7 44.0 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.824 2.45 . . . . 4.75 112.081 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.04 50.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.055 1.342 . . . . 3.3300000000000001 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.48 -2.32 57.92 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.165 0.802 . . . . 5.8499999999999996 113.165 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 62.77 42.58 7.89 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.274 1.83 . . . . 7.6100000000000003 112.011 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.3 m -73.79 148.97 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.828 1.251 . . . . 4.4299999999999997 112.079 -165.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -76.23 132.33 39.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.812 0.845 . . . . 4.0099999999999998 112.568 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -171.73 161.6 6.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.124 2.17 . . . . 4.4199999999999999 111.721 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 33.4 t -150.53 108.7 3.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.941 1.296 . . . . 3.5800000000000001 110.799 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.3 128.54 2.63 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.791 2.327 . . . . 3.23 112.446 -172.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -90.38 146.3 18.52 Favored Glycine 0 CA--C 1.541 1.685 0 C-N-CA 124.24 0.924 . . . . 2.96 112.303 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.89 173.64 13.67 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.469 2.78 . . . . 5.5099999999999998 110.077 170.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.576 ' HE2' ' CD1' ' A' ' 256' ' ' TYR . 9.7 mmtp -67.13 127.84 34.11 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.933 -0.479 . . . . 7.7999999999999998 111.144 169.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -77.64 -29.91 51.93 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.758 0.823 . . . . 6.3600000000000003 112.373 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.47 -77.12 0.34 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.794 1.638 . . . . 8.3100000000000005 109.777 159.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -121.16 -56.53 1.91 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.373 1.069 . . . . 8.2100000000000009 113.513 -173.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.85 49.19 1.14 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.475 1.11 . . . . 9.1500000000000004 110.613 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -138.87 152.44 47.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.599 -0.728 . . . . 4.9800000000000004 109.162 156.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.576 ' CD1' ' HE2' ' A' ' 250' ' ' LYS . 0.2 OUTLIER 164.44 163.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 129.499 3.12 . . . . 7.0999999999999996 109.733 -163.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.1 tp -135.13 139.4 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.152 -0.968 . . . . 3.98 108.619 167.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.58 110.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 105.28 -2.118 . . . . 3.8700000000000001 105.28 155.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.82 138.41 57.32 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.001 -1.111 . . . . 3.27 108.001 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -156.42 152.15 27.15 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.71 -1.244 . . . . 2.9399999999999999 113.743 -166.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 263' ' ' ILE . 58.5 p 3.71 -57.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 131.485 3.914 . . . . 5.5800000000000001 119.541 169.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 62.52 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 128.9 2.88 . . . . 5.25 112.868 -160.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.439 ' H ' ' C ' ' A' ' 261' ' ' THR . 36.4 pt -84.5 146.59 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 114.826 1.417 . . . . 4.3300000000000001 114.826 -175.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ttm -111.62 135.4 52.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.028 2.531 . . . . 3.21 108.871 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 135.37 47.23 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.157 -0.964 . . . . 4.5099999999999998 113.386 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.84 118.82 25.57 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.026 0.93 . . . . 3.2799999999999998 109.312 164.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.32 131.48 47.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.137 -1.801 . . . . 3.02 106.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -79.01 178.43 53.6 Favored Glycine 0 CA--C 1.536 1.404 0 N-CA-C 113.835 0.294 . . . . 2.0800000000000001 113.835 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -74.69 58.08 4.56 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.413 3.409 . . . . 2.6699999999999999 108.712 163.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.81 -63.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.938 1.695 . . . . 4.4699999999999998 109.511 -149.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.17 -22.55 9.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.469 1.509 . . . . 3.3900000000000001 114.995 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -83.15 169.44 15.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.867 1.334 . . . . 4.0 112.207 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -83.17 134.32 34.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.149 0.98 . . . . 6.25 111.249 169.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.69 -24.66 9.5 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.011 1.115 . . . . 4.6600000000000001 114.011 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -160.3 166.75 28.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.047 1.339 . . . . 3.1800000000000002 111.187 161.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -131.01 140.46 50.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.709 1.204 . . . . 5.1200000000000001 112.764 172.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.1 -172.51 2.23 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.288 2.235 . . . . 3.9700000000000002 108.532 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.55 73.11 0.5 Allowed Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.581 1.086 . . . . 3.29 110.758 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 88.63 151.03 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.104 2.962 . . . . 4.1200000000000001 112.809 176.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.4 t30 69.16 -43.64 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.909 2.884 . . . . 5.6699999999999999 115.624 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.32 113.44 4.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.23 0.923 . . . . 5.8200000000000003 110.106 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 150.84 38.23 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.902 -0.499 . . . . 6.7699999999999996 110.411 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -57.94 -36.46 72.55 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 119.66 -1.9 . . . . 3.0 115.178 -168.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.36 80.23 Favored Glycine 0 N--CA 1.483 1.778 0 O-C-N 120.661 -1.274 . . . . 2.27 116.038 170.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.58 -36.43 29.04 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.149 1.78 . . . . 4.7199999999999998 110.308 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.86 -41.88 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.681 0.792 . . . . 2.4100000000000001 108.908 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.84 96.18 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.301 0.852 . . . . 2.9100000000000001 113.301 170.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.25 84.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.437 1.017 . . . . 3.1099999999999999 113.224 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 p -68.7 -44.85 73.06 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 1.97 111.696 172.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.82 -35.12 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 119.992 1.269 . . . . 2.7200000000000002 112.373 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.25 65.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.459 -1.401 . . . . 3.0800000000000001 113.043 170.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.2 m -81.88 -44.51 16.75 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.796 0.838 . . . . 3.4199999999999999 109.805 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -62.28 -25.08 67.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.551 1.14 . . . . 3.6899999999999999 112.994 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 ttt -58.67 -34.74 71.58 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.114 0.966 . . . . 5.79 112.127 167.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -53.4 -49.01 90.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 116.62 -1.657 . . . . 4.8700000000000001 113.945 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.62 -56.78 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.38 2.054 . . . . 4.0599999999999996 111.702 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -88.17 29.81 0.92 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.982 1.475 . . . . 5.5499999999999998 114.982 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 117.78 7.2 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.771 -1.205 . . . . 9.1099999999999994 109.205 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -100.94 -31.89 10.91 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.078 1.51 . . . . 11.630000000000001 115.078 -146.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.41 27.3 0.29 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.345 1.458 . . . . 7.54 111.354 -175.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 C--O 1.243 0.761 0 C-N-CA 130.756 3.623 . . . . 6.9699999999999998 105.058 -138.865 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 118.081 -0.961 . . . . 22.449999999999999 110.054 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -156.07 168.77 26.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.747 1.219 . . . . 17.940000000000001 109.988 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -144.49 -170.52 3.4 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.624 1.57 . . . . 17.030000000000001 110.429 -169.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.08 170.11 42.65 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.205 0.907 . . . . 13.59 114.237 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -167.92 141.57 2.77 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.01 1.724 . . . . 11.789999999999999 110.217 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.56 149.25 61.52 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.083 1.855 . . . . 8.5700000000000003 109.177 163.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.3 mt -147.88 167.22 25.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.891 1.676 . . . . 8.0299999999999994 110.037 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.94 150.05 31.3 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.563 1.945 . . . . 6.6799999999999997 108.858 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.05 -138.68 37.27 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.14 -1.184 . . . . 3.9199999999999999 110.14 -165.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.67 161.91 32.63 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-O 118.944 -0.92 . . . . 3.23 114.355 167.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -93.28 171.35 2.07 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.346 3.364 . . . . 4.21 112.102 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.99 166.82 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.839 1.256 . . . . 4.8799999999999999 111.349 162.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 m -140.58 29.68 1.93 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.098 1.518 . . . . 3.4300000000000002 115.098 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -54.65 148.46 12.55 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.355 1.243 . . . . 3.5699999999999998 114.355 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.1 m -72.31 139.31 47.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.369 1.468 . . . . 2.3399999999999999 108.929 168.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.1 m -108.33 154.71 21.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.757 1.623 . . . . 3.79 109.126 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -60.25 -17.78 44.26 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.12 1.155 . . . . 2.3300000000000001 114.12 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -65.04 -23.18 67.12 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.286 2.234 . . . . 5.1699999999999999 113.749 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.21 -6.05 53.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.794 1.664 . . . . 2.1099999999999999 114.134 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.25 174.25 9.22 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 4.8300000000000001 111.972 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.19 130.56 48.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.003 0.521 . . . . 7.5199999999999996 109.685 160.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -102.0 172.66 6.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.6 0.76 . . . . 4.0300000000000002 110.678 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.72 154.48 13.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.734 2.014 . . . . 4.25 107.655 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -45.9 -26.25 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.45 2.3 . . . . 4.1600000000000001 114.401 164.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -98.94 -1.06 40.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.171 1.545 . . . . 7.0599999999999996 115.171 173.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.74 -59.97 2.1 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.549 -0.908 . . . . 3.4100000000000001 108.549 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -62.04 -30.95 71.32 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.389 0.885 . . . . 5.1100000000000003 113.389 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.78 -108.64 0.45 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.326 1.85 . . . . 5.7999999999999998 110.566 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -135.78 105.67 0.54 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.489 -2.644 . . . . 4.9500000000000002 106.489 165.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -107.01 -26.01 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.504 -1.236 . . . . 3.6400000000000001 114.319 166.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 49.1 m95 117.77 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 1 C-N-CA 132.185 4.194 . . . . 2.8599999999999999 109.02 -161.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.23 135.73 43.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.442 1.097 . . . . 3.9900000000000002 109.836 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 10.1 mt -118.73 104.8 10.93 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.832 1.653 . . . . 3.5600000000000001 106.908 168.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.9 pt -99.61 135.79 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.308 0.243 . . . . 4.75 111.283 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -140.37 143.8 35.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.428 1.091 . . . . 4.9299999999999997 112.324 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -123.75 117.34 24.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.433 1.493 . . . . 4.2199999999999998 109.37 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.55 -177.74 15.16 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.612 1.101 . . . . 1.6799999999999999 114.333 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 135.5 46.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.363 1.465 . . . . 4.9800000000000004 109.972 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 m -79.39 59.09 2.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.2 1.4 . . . . 3.4300000000000002 110.189 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -152.59 -104.7 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.88 2.472 . . . . 8.8900000000000006 107.597 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.6 152.8 0.14 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 130.147 3.379 . . . . 3.0099999999999998 116.887 173.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -92.03 -17.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.497 2.798 . . . . 3.75 113.366 159.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 168.79 -37.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.385 1.448 . . . . 4.6600000000000001 113.245 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -25.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 115.581 1.697 . . . . 4.2800000000000002 115.581 -160.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 m -66.89 -62.25 4.02 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.59 1.086 . . . . 1.8600000000000001 111.47 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.2 -25.43 57.73 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.508 1.472 . . . . 1.28 113.781 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.63 -23.68 67.34 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.272 1.212 . . . . 3.04 114.272 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -101.32 -18.79 15.91 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.977 1.262 . . . . 3.8300000000000001 113.867 162.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.53 -43.54 98.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.661 1.573 . . . . 3.6800000000000002 111.195 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.07 -55.29 18.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 3.4100000000000001 112.128 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -62.55 -45.44 92.95 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.347 -1.471 . . . . 3.6899999999999999 111.335 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ttm -56.24 -41.23 75.41 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.586 1.955 . . . . 3.1499999999999999 112.138 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.6 mm -59.98 -54.38 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.483 -0.932 . . . . 2.9700000000000002 108.483 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.445 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 63.0 mt-30 -63.51 -27.45 69.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 117.877 -1.058 . . . . 3.0800000000000001 112.592 -174.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.6 -37.21 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 120.932 1.697 . . . . 3.02 111.872 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -20.14 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.733 0.813 . . . . 3.9900000000000002 112.766 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -46.05 82.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.794 1.237 . . . . 4.8499999999999996 111.314 170.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -66.95 -39.48 87.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.82 0.282 . . . . 2.98 111.558 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.4 mm -65.85 -46.21 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.661 -0.649 . . . . 2.9399999999999999 112.448 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -65.9 -35.78 81.57 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.233 0.469 . . . . 3.7400000000000002 110.713 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.7 m -73.57 -23.12 59.91 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.325 1.231 . . . . 3.6499999999999999 114.325 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 11.0 mm -81.83 -28.29 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.261 1.424 . . . . 3.6899999999999999 110.467 167.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.4 m 67.17 -12.4 0.24 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.905 2.482 . . . . 5.7999999999999998 114.242 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 58.0 m -84.43 -30.31 25.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.549 1.94 . . . . 4.3899999999999997 112.128 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.46 159.73 48.44 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.67 1.188 . . . . 5.1500000000000004 109.788 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -61.76 -46.04 15.14 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.392 1.394 . . . . 3.7200000000000002 109.31 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -168.09 -178.55 3.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.126 2.57 . . . . 3.96 109.537 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 51.8 tp -125.67 123.57 39.23 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.563 -1.643 . . . . 3.0600000000000001 106.563 150.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.8 m -106.27 98.89 20.97 Favored Pre-proline 0 N--CA 1.465 0.298 0 C-N-CA 124.67 1.188 . . . . 2.0299999999999998 108.952 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.09 137.19 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.444 . . . . 1.0600000000000001 109.737 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.91 111.18 9.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 123.061 1.41 . . . . 4.8200000000000003 112.899 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.69 134.73 34.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.215 1.806 . . . . 4.2199999999999998 109.676 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.3 mt -120.36 131.78 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.154 1.782 . . . . 2.6400000000000001 106.984 168.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.37 126.22 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.741 0.701 . . . . 3.46 110.367 170.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.1 pt -98.96 16.77 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.531 1.133 . . . . 3.0899999999999999 113.176 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.91 44.82 0.2 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 127.395 2.278 . . . . 3.5800000000000001 114.25 168.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 207' ' ' ARG . 66.1 Cg_endo -73.59 -8.64 21.87 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.414 2.742 . . . . 2.1699999999999999 115.163 -169.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.23 0.4 0.27 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.321 1.848 . . . . 5.29 114.223 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.421 ' HE ' ' CD ' ' A' ' 254' ' ' GLU . 0.0 OUTLIER -172.77 30.55 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.321 2.648 . . . . 5.71 111.412 -165.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.77 -174.75 3.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.146 1.379 . . . . 3.9900000000000002 111.057 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.5 t -162.36 151.08 14.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.673 1.225 . . . . 4.4199999999999999 112.891 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.53 -34.92 59.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.746 1.618 . . . . 3.48 112.825 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.57 71.31 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.797 1.239 . . . . 3.6200000000000001 114.05 174.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.34 74.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.923 1.238 . . . . 2.8999999999999999 110.862 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.4 mm -60.39 -43.56 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.131 0.972 . . . . 2.8300000000000001 111.616 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.53 89.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.341 0.656 . . . . 2.25 111.74 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.419 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 6.3 t30 -65.32 -43.84 89.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.526 -0.734 . . . . 4.0099999999999998 112.188 173.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -56.51 -41.39 76.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.736 0.815 . . . . 4.1200000000000001 111.404 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.3 -46.09 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.271 1.428 . . . . 2.1200000000000001 111.996 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 8.3 mtmp? -52.51 -55.13 24.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.673 1.124 . . . . 4.9000000000000004 112.73 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -33.62 59.91 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.822 0.675 . . . . 4.6500000000000004 112.822 -160.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -73.95 -36.42 64.62 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.507 0.594 . . . . 4.1200000000000001 111.613 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 m 153.38 136.15 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 129.886 3.274 . . . . 3.5 110.829 161.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -68.28 1.95 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.63 2.887 . . . . 3.0600000000000001 114.47 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -66.69 -16.44 64.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 121.154 -0.966 . . . . 3.3700000000000001 112.145 162.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.5 tp -80.75 145.36 31.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.654 1.581 . . . . 2.7400000000000002 111.805 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.9 t -102.02 137.6 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.589 1.156 . . . . 2.8900000000000001 109.572 167.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.86 132.42 9.86 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.442 1.02 . . . . 1.1399999999999999 111.731 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.88 151.6 48.18 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.737 1.215 . . . . 3.2000000000000002 112.211 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -166.16 -158.29 0.33 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.854 2.462 . . . . 3.5600000000000001 109.135 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 152.75 -115.34 0.68 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 108.834 -1.706 . . . . 1.8600000000000001 108.834 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.2 p -113.42 166.49 11.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.838 0.828 . . . . 3.25 111.656 166.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.62 -33.65 47.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.158 1.783 . . . . 7.8099999999999996 113.084 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -67.62 -43.55 80.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.068 0.947 . . . . 2.9300000000000002 112.112 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -70.31 -40.37 74.25 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.356 0.98 . . . . 5.5099999999999998 111.577 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.6 t -55.27 -38.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.863 0.865 . . . . 3.0299999999999998 111.988 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.5 -45.82 64.9 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 117.385 -1.293 . . . . 4.0300000000000002 110.301 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -52.04 -53.96 35.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.026 1.739 . . . . 3.2599999999999998 111.342 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.09 -32.31 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 113.226 0.824 . . . . 3.5299999999999998 113.226 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.65 -47.93 61.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.907 -1.12 . . . . 2.8700000000000001 111.306 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -70.87 -34.06 71.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.611 2.764 . . . . 4.8700000000000001 112.147 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.13 9.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.332 1.453 . . . . 3.1099999999999999 111.195 169.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.32 8.68 8.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.043 0.757 . . . . 4.7000000000000002 113.043 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 42.44 43.92 3.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.258 2.223 . . . . 5.6399999999999997 113.251 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 263' ' ' ILE . 7.9 p -69.72 -30.2 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 118.444 -0.789 . . . . 4.8200000000000003 112.711 -172.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.7 t80 67.32 156.49 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.368 1.867 . . . . 3.9300000000000002 113.9 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -176.88 164.44 2.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.476 2.711 . . . . 4.4400000000000004 109.558 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.5 t -154.77 99.16 2.42 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 121.546 -0.721 . . . . 4.0199999999999996 111.017 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -95.63 154.33 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.141 3.228 . . . . 3.7799999999999998 112.252 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.95 169.17 52.87 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 116.304 -0.407 . . . . 3.1699999999999999 112.969 166.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -81.11 136.89 10.48 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.856 3.037 . . . . 6.0099999999999998 110.057 168.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 138.46 58.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.503 1.297 . . . . 6.2699999999999996 114.503 -172.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -130.41 178.05 6.89 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.833 1.653 . . . . 8.0199999999999996 111.836 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.264 17.5 tt0 40.0 -108.69 0.08 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.553 3.141 . . . . 8.4499999999999993 112.572 -170.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -81.32 -60.84 2.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.217 1.407 . . . . 9.5199999999999996 109.888 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.421 ' CD ' ' HE ' ' A' ' 207' ' ' ARG . 0.5 OUTLIER -172.28 36.5 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.197 1.399 . . . . 8.9499999999999993 112.633 -176.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -103.83 155.19 18.81 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.962 0.887 . . . . 4.25 111.903 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -179.92 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.308 2.643 . . . . 6.3099999999999996 113.464 -168.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 33.8 mm 70.49 157.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.855 2.062 . . . . 4.9699999999999998 111.367 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.25 140.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.243 1.417 . . . . 5.9100000000000001 108.894 170.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -63.18 108.83 1.35 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.428 1.491 . . . . 4.6799999999999997 109.951 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -75.97 10.48 1.86 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.495 1.918 . . . . 6.9699999999999998 115.558 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.0 m -74.69 95.7 2.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.826 1.25 . . . . 6.4699999999999998 109.807 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.93 156.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.9 1.28 . . . . 5.9900000000000002 111.053 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.431 ' H ' HG22 ' A' ' 243' ' ' VAL . 70.8 mt -133.97 134.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.282 1.433 . . . . 3.3100000000000001 109.342 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 89.5 mtp -89.89 145.5 25.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.926 0.891 . . . . 3.0800000000000001 111.045 171.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -126.21 153.4 44.73 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.332 1.053 . . . . 3.79 112.354 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 10.6 tp -103.62 131.63 50.59 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.044 1.738 . . . . 3.1200000000000001 109.996 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 130.71 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 107.524 -1.287 . . . . 2.8599999999999999 107.524 162.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.4 179.84 53.15 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.682 1.134 . . . . 2.29 114.425 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -91.89 75.46 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.251 3.301 . . . . 3.9700000000000002 110.367 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.7 t70 177.19 -77.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.647 -1.615 . . . . 4.7800000000000002 108.822 -135.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.79 -16.63 2.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 117.359 -1.801 . . . . 3.23 115.156 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.83 168.57 9.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.532 1.666 . . . . 4.8300000000000001 114.397 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.46 150.97 29.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.056 2.142 . . . . 7.5099999999999998 113.534 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.0 mt -136.64 -38.73 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.424 1.638 . . . . 3.5800000000000001 115.424 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -166.36 167.45 15.85 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.616 1.098 . . . . 2.6499999999999999 113.306 -168.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.29 158.82 43.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.923 1.289 . . . . 5.3700000000000001 113.911 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.05 177.21 9.33 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.202 1.401 . . . . 3.71 114.207 -170.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.9 -177.1 22.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.179 2.8 . . . . 3.3999999999999999 109.736 -169.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -55.34 1.14 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 119.785 3.254 . . . . 4.8099999999999996 119.785 -166.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -111.63 -6.45 14.37 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.402 1.63 . . . . 6.0199999999999996 115.402 165.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -116.79 89.27 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.459 1.104 . . . . 5.04 109.965 157.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.7 mtt85 -82.88 -167.85 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.134 1.774 . . . . 6.7000000000000002 110.062 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.445 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.6 tmtt? -40.21 -57.71 1.65 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.148 1.779 . . . . 3.1899999999999999 115.149 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.51 -38.37 51.99 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 123.437 0.542 . . . . 1.9199999999999999 112.031 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.11 -33.05 75.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.894 0.877 . . . . 4.4500000000000002 112.289 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 30.2 mt -68.4 -56.15 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.505 0.722 . . . . 2.48 110.049 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.06 78.7 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.096 0.776 . . . . 2.6499999999999999 113.096 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -71.37 -33.86 69.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.631 1.173 . . . . 3.7000000000000002 113.732 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.9 p -68.78 -45.27 71.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.662 -1.161 . . . . 2.71 111.288 168.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.6 mt -56.31 -42.28 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.41 1.459 . . . . 2.3300000000000001 111.492 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.56 -28.5 69.68 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.141 -0.974 . . . . 2.73 113.342 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.5 m -73.1 -43.6 61.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.318 1.047 . . . . 3.2799999999999998 110.132 172.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -64.68 -25.91 68.15 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.722 1.209 . . . . 3.8900000000000001 112.353 172.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.1 ttp -69.93 -16.81 63.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.638 1.575 . . . . 5.5099999999999998 112.676 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -51.77 77.56 Favored Pre-proline 0 CA--C 1.553 1.086 0 O-C-N 120.195 -1.566 . . . . 7.7199999999999998 110.438 174.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.0 -51.61 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.074 1.849 . . . . 2.46 111.038 166.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.92 44.2 0.98 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.596 1.332 . . . . 4.3700000000000001 114.596 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -64.88 148.77 50.77 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.341 -0.85 . . . . 10.01 109.279 163.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -146.36 172.58 13.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.504 1.122 . . . . 10.65 109.933 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 83.3 mttt 75.89 -10.19 1.31 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 128.337 2.655 . . . . 8.3599999999999994 113.048 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 29.4 m . . . . . 0 C--O 1.252 1.197 1 C-N-CA 133.763 4.825 . . . . 7.9299999999999997 107.255 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 117.919 -1.039 . . . . 29.640000000000001 108.759 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -161.85 -178.67 6.64 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.103 1.761 . . . . 24.93 109.524 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.1 t -165.61 173.38 10.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.444 2.298 . . . . 22.07 108.454 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.57 -163.49 31.22 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.38 0.99 . . . . 17.579999999999998 113.686 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -151.5 161.67 28.95 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.818 1.647 . . . . 14.300000000000001 110.838 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.75 -177.53 3.19 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.14 2.56 . . . . 11.02 110.166 162.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 tt -149.88 123.19 8.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.735 1.214 . . . . 9.1600000000000001 107.938 167.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.5 tp -161.77 -17.22 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.747 1.619 . . . . 8.2799999999999994 114.023 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.18 126.58 41.87 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.65 1.02 . . . . 3.7599999999999998 115.65 -165.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.92 125.03 5.4 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.918 1.723 . . . . 4.1699999999999999 110.091 171.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.34 165.0 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.256 2.637 . . . . 3.79 112.691 -170.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -91.45 159.91 15.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.77 1.228 . . . . 4.3300000000000001 109.007 166.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 m -142.31 57.23 1.46 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 120.159 1.345 . . . . 2.6099999999999999 114.145 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.81 166.24 12.29 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 119.69 -1.882 . . . . 4.5999999999999996 113.814 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 m -89.75 152.76 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.493 1.917 . . . . 3.3100000000000001 108.762 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.5 p -95.87 161.25 14.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.395 1.093 . . . . 3.7400000000000002 112.524 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -52.72 -33.7 49.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.612 2.365 . . . . 2.6600000000000001 113.461 170.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.5 p -76.0 -47.61 24.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.098 1.359 . . . . 5.25 111.5 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.07 39.25 0.46 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.407 1.003 . . . . 3.0 114.672 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 -179.66 3.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.712 1.605 . . . . 3.46 109.059 170.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.53 97.28 3.53 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.128 1.331 . . . . 5.9100000000000001 110.697 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.06 159.69 15.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.761 1.224 . . . . 3.6800000000000002 112.411 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 153' ' ' LYS . 67.7 m -139.16 149.74 44.8 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.33 1.852 . . . . 4.5800000000000001 107.167 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -25.13 61.2 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.105 0.955 . . . . 3.8900000000000001 112.702 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.422 ' H ' HG23 ' A' ' 151' ' ' THR . 1.5 mmmp? -68.26 -18.34 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.552 1.686 . . . . 6.3700000000000001 115.552 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.4 -48.11 36.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.852 1.261 . . . . 3.23 109.341 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -89.47 13.34 14.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.643 1.177 . . . . 4.7199999999999998 113.187 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.78 118.46 6.67 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.344 -1.472 . . . . 5.8799999999999999 109.683 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 104.89 -8.66 46.37 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 123.656 0.646 . . . . 3.5499999999999998 114.38 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.486 ' HG3' ' H ' ' A' ' 159' ' ' TRP . 1.8 tp60 -80.77 -154.65 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.223 1.409 . . . . 4.71 111.412 -170.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . 0.486 ' H ' ' HG3' ' A' ' 158' ' ' GLN . 73.0 m95 -126.16 119.45 27.55 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.289 -1.507 . . . . 2.8599999999999999 107.215 154.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.25 45.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.012 0.91 . . . . 4.4100000000000001 111.701 -173.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 mt -131.37 135.56 47.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.219 1.807 . . . . 4.25 108.964 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.65 132.66 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.667 0.787 . . . . 3.3100000000000001 110.007 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -139.88 148.91 42.74 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.265 1.426 . . . . 3.8799999999999999 112.217 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -114.92 118.76 34.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.398 1.479 . . . . 4.5800000000000001 108.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -124.48 160.53 19.07 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 116.858 1.503 . . . . 2.0 116.858 -166.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -100.53 22.62 11.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.532 2.333 . . . . 6.3099999999999996 110.366 165.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 34.3 m 70.51 -66.59 0.28 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.02 2.528 . . . . 5.1399999999999997 110.972 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -108.5 -29.04 8.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 117.696 -1.145 . . . . 11.31 113.147 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.22 -172.03 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.699 1.199 . . . . 2.48 113.284 -176.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.06 61.18 1.34 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.57 2.18 . . . . 3.8999999999999999 110.161 139.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 65.25 -4.23 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 129.817 3.247 . . . . 4.4400000000000004 115.808 166.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.11 -33.43 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 117.878 -1.058 . . . . 3.8799999999999999 113.847 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.5 m -48.24 -60.68 4.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 120.452 1.478 . . . . 1.51 112.454 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 -24.35 42.42 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.427 2.085 . . . . 1.47 114.414 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.3 -43.96 96.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.971 1.26 . . . . 3.0800000000000001 111.398 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.54 -35.17 75.19 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.128 -0.983 . . . . 3.4399999999999999 111.571 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 -56.36 20.1 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.828 1.251 . . . . 4.0099999999999998 111.651 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.02 -43.97 94.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.057 0.844 . . . . 3.79 110.267 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -54.07 -39.46 66.3 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.035 -1.666 . . . . 4.8399999999999999 113.016 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ptp -68.74 -34.82 76.27 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.988 1.722 . . . . 3.3799999999999999 113.771 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.2 mm -66.02 -42.78 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 120.34 1.427 . . . . 2.8500000000000001 111.436 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -63.3 -37.97 89.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.606 1.562 . . . . 4.0599999999999996 110.847 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.53 -45.47 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.674 -0.642 . . . . 3.6200000000000001 111.989 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.59 -40.09 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.253 1.021 . . . . 3.0699999999999998 113.04 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -58.06 7.48 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.048 1.339 . . . . 6.2199999999999998 111.91 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.05 -40.12 92.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.417 0.525 . . . . 4.6699999999999999 112.417 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 56.3 mt -59.9 -48.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.339 1.856 . . . . 4.3899999999999997 112.651 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.07 -48.38 81.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.946 1.298 . . . . 3.46 109.371 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.8 t -68.92 -6.07 25.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.952 2.101 . . . . 4.7300000000000004 114.409 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 32.8 mm -56.62 -48.61 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 119.626 1.103 . . . . 5.79 110.291 171.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 32.9 p -171.55 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.464 2.394 . . . . 7.3700000000000001 117.464 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.253 5.7 t 102.36 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.065 1.746 . . . . 5.7199999999999998 107.438 -121.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.3 mp -93.39 161.86 29.57 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.456 -0.778 . . . . 4.5999999999999996 110.495 136.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -86.16 35.84 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.199 3.932 . . . . 3.73 111.308 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 t0 70.0 174.72 0.29 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.143 2.577 . . . . 4.2199999999999998 114.022 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.09 134.97 44.99 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.088 1.755 . . . . 4.0899999999999999 108.1 166.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.8 m -107.43 100.71 35.39 Favored Pre-proline 0 N--CA 1.47 0.575 0 C-N-CA 123.619 0.767 . . . . 2.3100000000000001 110.2 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.7 127.34 4.26 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.001 2.468 . . . . 1.79 111.099 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.02 108.52 19.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.749 2.02 . . . . 3.8199999999999998 109.174 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -99.55 113.68 26.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.159 -0.682 . . . . 4.6200000000000001 109.159 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.18 119.46 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.198 -0.667 . . . . 3.5499999999999998 109.198 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.7 m -80.45 133.53 35.87 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.431 -0.793 . . . . 3.6699999999999999 111.513 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.4 pt -82.23 -1.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 114.093 1.146 . . . . 3.5899999999999999 114.093 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.65 48.89 0.23 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 127.425 2.29 . . . . 3.2400000000000002 114.026 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.63 -6.79 19.28 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.636 2.224 . . . . 4.2300000000000004 113.458 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -81.8 -2.76 51.99 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.303 0.956 . . . . 4.3200000000000003 112.845 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.79 -27.48 1.29 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.62 1.341 . . . . 7.5099999999999998 114.62 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -109.15 141.21 41.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.216 1.371 . . . . 6.79 111.915 172.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 82.7 p -95.64 159.71 14.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.551 1.167 . . . . 4.4100000000000001 112.805 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -54.77 -36.71 65.16 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.193 1.397 . . . . 4.46 112.335 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -71.93 -33.51 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.112 1.365 . . . . 3.0699999999999998 112.877 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.27 91.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.586 1.084 . . . . 2.79 112.248 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . 0.269 4.3 tp -70.57 -23.54 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 121.123 -0.986 . . . . 4.04 113.142 173.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.85 -42.61 94.75 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.563 -1.336 . . . . 2.7200000000000002 111.924 167.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -58.57 -41.01 84.7 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.436 -0.79 . . . . 6.2199999999999998 112.082 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -62.63 -45.62 92.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.676 1.191 . . . . 4.4500000000000002 112.136 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.6 t -52.21 -44.31 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.036 -1.04 . . . . 2.8900000000000001 111.55 169.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -13.1 62.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.361 1.245 . . . . 6.4299999999999997 114.361 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -79.1 -47.05 16.82 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.419 1.463 . . . . 4.3600000000000003 110.666 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -95.19 -50.23 5.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.581 0.956 . . . . 4.6500000000000004 113.581 -172.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 170.52 141.06 0.09 OUTLIER Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 124.715 1.206 . . . . 2.8799999999999999 113.293 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.57 -5.64 17.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.794 2.996 . . . . 2.0600000000000001 114.217 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -71.83 -16.91 62.17 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.948 1.249 . . . . 2.8199999999999998 112.959 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.06 132.35 44.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.335 0.97 . . . . 2.9900000000000002 109.892 174.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.9 119.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.943 -1.502 . . . . 3.0 106.943 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.96 134.83 12.7 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 107.949 -2.061 . . . . 1.3300000000000001 107.949 163.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.02 151.18 39.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.991 0.916 . . . . 3.9700000000000002 110.399 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.6 m -152.76 -179.9 8.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.166 2.186 . . . . 3.2400000000000002 107.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 171.85 -132.34 2.4 Favored Glycine 0 N--CA 1.468 0.792 0 O-C-N 120.175 -1.578 . . . . 3.23 110.619 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.5 p -96.88 155.34 16.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.291 -1.003 . . . . 3.8900000000000001 108.291 155.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.31 -26.82 65.33 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 117.912 -1.042 . . . . 7.4699999999999998 111.818 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -66.38 -34.35 77.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.424 1.465 . . . . 3.4900000000000002 111.802 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.25 -37.78 75.01 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.026 -1.047 . . . . 3.3199999999999998 111.439 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.89 -33.73 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 122.128 -0.357 . . . . 3.3199999999999998 111.191 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.16 -35.39 71.62 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.35 1.06 . . . . 3.3700000000000001 111.0 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -57.7 -54.18 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.086 0.857 . . . . 3.04 110.76 174.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.11 -33.97 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.098 0.777 . . . . 2.8300000000000001 113.098 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.47 -48.31 75.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.153 0.981 . . . . 2.6099999999999999 111.792 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -32.81 69.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.353 2.261 . . . . 5.3600000000000003 112.869 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.47 -67.01 0.48 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.525 1.057 . . . . 2.8300000000000001 110.138 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -72.36 4.14 4.03 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.389 1.255 . . . . 3.5699999999999998 114.389 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 58.96 44.72 16.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.29 1.836 . . . . 5.9800000000000004 113.799 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.41 144.81 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.57 -0.706 . . . . 4.3200000000000003 111.401 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.09 136.93 33.82 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.789 -0.57 . . . . 4.0899999999999999 110.701 165.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -162.05 161.68 28.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.021 1.729 . . . . 4.1100000000000003 111.322 176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.4 m -164.26 115.1 0.95 Allowed Pre-proline 0 N--CA 1.478 0.952 0 O-C-N 121.055 -1.028 . . . . 3.54 112.644 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -88.63 140.18 4.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.426 2.751 . . . . 3.1800000000000002 113.771 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.59 119.45 6.12 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 110.239 -1.144 . . . . 2.8799999999999999 110.239 163.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.63 -21.02 15.12 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.05 2.5 . . . . 5.1500000000000004 116.544 -167.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.444 ' HZ1' ' CD ' ' A' ' 254' ' ' GLU . 0.1 OUTLIER 151.58 60.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 130.06 3.344 . . . . 5.9100000000000001 110.653 -175.14 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.09 148.68 21.94 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.46 1.904 . . . . 6.4000000000000004 111.731 -166.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.13 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 130.347 3.459 . . . . 7.9299999999999997 117.777 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 30.6 t70 179.07 -49.32 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 129.929 3.292 . . . . 5.8700000000000001 110.124 160.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.444 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 7.2 tp10 -168.88 130.92 1.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.535 1.934 . . . . 5.4699999999999998 110.098 -175.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -179.43 -64.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.843 2.057 . . . . 4.3200000000000003 110.762 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.1 t80 69.45 42.25 1.18 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.115 1.766 . . . . 4.7300000000000004 113.616 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.4 132.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 119.296 -2.128 . . . . 3.8799999999999999 111.838 170.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.78 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.156 1.383 . . . . 3.8900000000000001 108.524 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.22 148.23 35.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 3.3100000000000001 112.03 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -150.86 154.32 37.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.57 1.548 . . . . 2.4399999999999999 110.896 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 t -59.62 153.56 19.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.495 0.718 . . . . 4.1100000000000003 111.46 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.83 58.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 122.635 1.207 . . . . 4.7400000000000002 108.17 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.1 mt -133.79 132.58 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.384 1.473 . . . . 3.5499999999999998 108.698 -172.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 40.5 mtp -102.88 135.18 45.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.708 2.003 . . . . 3.8700000000000001 111.737 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -102.54 135.19 44.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.022 1.329 . . . . 5.29 111.152 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.09 124.55 41.14 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.307 0.958 . . . . 5.1100000000000003 109.54 171.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.92 131.39 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.076 -1.453 . . . . 3.6499999999999999 107.076 158.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -138.45 -133.95 3.14 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.734 -1.037 . . . . 3.23 112.293 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -77.33 79.75 3.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.813 2.342 . . . . 3.8399999999999999 109.922 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -171.84 -64.39 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.984 2.914 . . . . 5.9000000000000004 108.346 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.27 7.23 35.39 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.958 -1.468 . . . . 4.6799999999999997 116.585 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -138.26 -47.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.267 1.534 . . . . 5.54 113.443 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -168.19 156.87 8.97 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 4.79 112.53 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -151.54 -42.64 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.887 1.069 . . . . 4.3899999999999997 113.887 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -170.88 172.76 5.46 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.479 1.912 . . . . 3.4399999999999999 110.415 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -145.96 157.46 43.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.201 -0.937 . . . . 3.8900000000000001 112.636 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.88 -167.63 2.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.04 1.736 . . . . 4.4199999999999999 110.477 -170.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.92 -115.41 1.25 Allowed Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.017 1.294 . . . . 3.1899999999999999 110.866 164.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.91 -7.59 1.79 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.805 1.409 . . . . 4.0599999999999996 114.805 175.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -145.64 157.94 43.91 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.075 0.852 . . . . 5.3300000000000001 111.045 163.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 72.47 131.29 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.959 2.104 . . . . 6.4800000000000004 108.894 -143.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.67 175.63 5.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.881 2.072 . . . . 8.4199999999999999 111.607 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -29.35 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 126.593 1.957 . . . . 3.3300000000000001 113.886 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.83 -19.72 69.81 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-O 119.418 -0.657 . . . . 2.2999999999999998 113.839 -175.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -63.88 -37.07 86.05 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.099 1.449 . . . . 3.3199999999999998 111.175 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.43 -50.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.806 0.842 . . . . 3.21 110.986 175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.82 88.81 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.042 -0.411 . . . . 3.0800000000000001 111.601 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.29 80.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.538 . . . . 2.9100000000000001 113.453 173.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.5 p -60.57 -43.27 97.51 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.832 1.196 . . . . 2.3399999999999999 111.501 167.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.48 -33.77 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.445 -1.409 . . . . 3.3399999999999999 111.997 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.51 -25.03 65.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.92 1.288 . . . . 2.8100000000000001 113.272 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.8 m -75.16 -46.61 33.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.262 1.025 . . . . 3.0600000000000001 109.896 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -59.2 -26.44 64.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.372 1.469 . . . . 3.5499999999999998 112.832 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -59.93 -25.29 65.03 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.739 -1.226 . . . . 5.54 113.154 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -61.54 -51.75 74.77 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 117.213 -1.375 . . . . 5.2400000000000002 111.824 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.71 -55.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.586 2.191 . . . . 3.8300000000000001 111.463 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -81.53 77.35 8.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.011 1.324 . . . . 4.9199999999999999 111.295 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -53.14 152.14 4.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.22 1.408 . . . . 9.8300000000000001 112.824 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.53 154.27 8.9 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.695 -0.628 . . . . 7.0700000000000003 112.629 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -88.91 -84.63 0.21 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.055 -1.461 . . . . 13.199999999999999 107.055 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.795 -1.574 . . . . 11.279999999999999 110.956 139.316 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 106.695 -1.594 . . . . 17.059999999999999 106.695 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -60.51 163.39 5.36 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 119.045 0.838 . . . . 14.65 109.693 142.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -165.99 154.93 11.46 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.703 1.601 . . . . 11.6 109.866 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.96 173.06 42.79 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.752 0.692 . . . . 10.470000000000001 111.656 165.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -150.94 116.01 3.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.039 1.336 . . . . 9.6500000000000004 109.769 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.6 152.12 82.69 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.089 1.859 . . . . 8.5999999999999996 109.278 167.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 tt -68.39 -82.57 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.864 0.866 . . . . 10.67 111.619 -166.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.0 mt -147.76 -153.53 0.5 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 129.018 2.927 . . . . 8.1500000000000004 107.447 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.76 178.76 37.94 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.86 1.219 . . . . 4.5199999999999996 113.876 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -156.6 134.17 3.93 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.734 -1.592 . . . . 4.5800000000000001 110.152 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.65 159.97 41.8 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.728 2.285 . . . . 3.7999999999999998 111.176 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -136.85 165.95 24.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.377 1.071 . . . . 3.7400000000000002 111.909 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 p -146.04 112.33 5.81 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.771 -1.206 . . . . 3.23 112.154 157.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.08 146.91 27.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.99 0.9 . . . . 3.1600000000000001 111.585 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.2 m -83.43 130.38 35.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.174 1.39 . . . . 2.6899999999999999 107.572 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -84.08 168.31 16.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.483 -1.386 . . . . 3.2200000000000002 112.2 -171.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -60.13 -30.28 69.19 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.818 1.247 . . . . 1.96 112.837 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 t -91.99 13.52 18.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.633 1.573 . . . . 3.6400000000000001 113.129 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.98 88.01 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 119.124 0.875 . . . . 1.98 115.075 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -91.79 -168.63 2.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.04 1.736 . . . . 3.4399999999999999 109.964 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -157.71 114.39 2.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 121.947 2.158 . . . . 5.7300000000000004 113.401 -169.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -109.06 167.94 9.73 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.584 1.698 . . . . 3.6400000000000001 115.584 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 39.9 p -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.462 2.705 . . . . 2.8199999999999998 110.133 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.31 -56.95 2.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.557 1.543 . . . . 4.3099999999999996 113.159 172.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -0.7 3.89 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.918 1.821 . . . . 7.8499999999999996 115.918 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -81.44 -40.06 23.92 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.424 1.466 . . . . 2.9500000000000002 110.134 165.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.1 -32.05 17.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.597 1.332 . . . . 4.5 114.597 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.92 109.6 1.51 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.376 0.989 . . . . 5.0499999999999998 110.108 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.67 1.99 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 124.461 1.029 . . . . 2.6200000000000001 113.322 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -94.96 172.28 8.25 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.079 -1.082 . . . . 3.8500000000000001 108.079 154.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -85.0 138.94 32.14 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.548 -0.538 . . . . 2.6200000000000001 109.548 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.04 155.39 45.4 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.466 1.127 . . . . 3.7799999999999998 113.499 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.58 127.58 52.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.579 1.552 . . . . 3.2999999999999998 108.114 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.4 mt -112.74 118.08 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.97 -0.752 . . . . 2.96 108.97 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -125.49 142.68 51.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.056 1.742 . . . . 3.6600000000000001 111.161 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.85 111.98 24.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.255 1.422 . . . . 3.71 111.059 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.56 -176.07 15.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.937 1.732 . . . . 1.4099999999999999 113.332 -173.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -154.56 14.13 0.43 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.578 2.066 . . . . 5.3700000000000001 116.578 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m 72.81 -25.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.66 1.584 . . . . 3.3300000000000001 113.987 166.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -77.06 -25.68 52.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.781 1.173 . . . . 8.6099999999999994 112.037 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.51 123.52 74.26 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.337 1.455 . . . . 2.9500000000000002 111.547 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -90.74 -0.43 5.1 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.167 2.578 . . . . 4.6600000000000001 113.155 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -125.39 -89.25 0.57 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.138 1.375 . . . . 6.3200000000000003 109.504 -162.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.55 -31.18 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 117.222 -1.37 . . . . 5.1399999999999997 114.181 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.6 m -59.82 -50.77 85.06 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 121.766 2.076 . . . . 1.71 111.844 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.52 -43.58 26.73 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.782 1.655 . . . . 1.4199999999999999 113.23 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.4 -30.52 53.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.818 1.19 . . . . 3.2000000000000002 113.162 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.28 -36.05 74.14 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.762 -1.211 . . . . 3.0600000000000001 111.737 166.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.7 mt -61.3 -49.25 77.78 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.978 1.263 . . . . 3.8399999999999999 111.409 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.44 -46.28 76.76 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.346 1.058 . . . . 4.04 111.953 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -53.67 -57.37 11.06 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.222 -0.924 . . . . 4.3899999999999997 111.245 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.1 ptp -66.99 -19.36 65.7 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.036 1.124 . . . . 3.3900000000000001 114.036 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.566 1.53 . . . . 2.6899999999999999 110.389 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.472 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 72.9 mt-30 -62.76 -27.01 68.99 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.437 1.017 . . . . 3.1699999999999999 111.908 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 t -61.65 -32.0 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.464 1.106 . . . . 2.96 113.131 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -31.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.864 1.211 . . . . 4.0800000000000001 111.582 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 187' ' ' ILE . 0.0 OUTLIER -59.81 -50.75 72.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.973 1.309 . . . . 5.1900000000000004 110.08 167.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -65.76 1.97 1.16 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.256 2.622 . . . . 2.8199999999999998 115.55 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 185' ' ' ASP . 58.2 mt -123.22 -57.56 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 130.087 3.355 . . . . 3.5699999999999998 110.587 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.76 -37.64 73.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.757 2.023 . . . . 3.8999999999999999 112.44 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t -61.42 -27.87 68.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.751 1.22 . . . . 4.0099999999999998 110.819 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.5 mm -77.46 7.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 O-C-N 120.464 -1.398 . . . . 4.8099999999999996 111.195 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 67.8 m 82.54 -33.28 0.09 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.204 2.202 . . . . 5.71 113.693 147.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.2 m -153.73 45.96 0.62 Allowed 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.863 -1.148 . . . . 5.4100000000000001 111.301 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.38 -175.51 0.6 Allowed Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.064 0.945 . . . . 5.0300000000000002 111.437 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -83.45 136.97 7.83 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.512 2.142 . . . . 5.0599999999999996 109.517 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.86 133.1 37.02 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.516 0.562 . . . . 3.9100000000000001 112.516 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 14.1 tp -105.19 116.67 32.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.347 1.859 . . . . 2.7000000000000002 111.173 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.0 m -103.09 99.1 13.22 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.81 1.244 . . . . 1.96 110.096 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -72.44 138.09 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.304 2.002 . . . . 1.4199999999999999 112.661 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -117.95 110.93 18.31 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.797 2.039 . . . . 3.9100000000000001 109.308 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -97.09 115.72 28.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.022 0.929 . . . . 3.52 109.069 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 90.3 mt -97.02 120.79 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.207 1.003 . . . . 2.6899999999999999 109.845 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.2 m -69.19 132.19 46.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.611 0.364 . . . . 2.71 111.303 168.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.04 -5.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 114.536 1.31 . . . . 2.4900000000000002 114.536 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -113.76 47.45 0.39 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 125.08 1.352 . . . . 3.7400000000000002 113.265 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.03 73.98 3.6 Favored 'Trans proline' 0 C--N 1.363 1.337 1 C-N-CA 125.854 4.37 . . . . 2.1699999999999999 112.714 -165.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -169.75 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.878 2.871 . . . . 4.2300000000000004 107.298 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -7.86 12.73 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.168 1.173 . . . . 9.0399999999999991 114.168 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.08 107.21 15.05 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 121.002 1.728 . . . . 4.21 111.207 160.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.6 t -82.32 154.68 25.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.596 1.158 . . . . 4.0899999999999999 113.086 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.68 -39.32 80.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.713 1.375 . . . . 7.25 114.713 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -80.08 -19.67 46.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.775 1.17 . . . . 5.8399999999999999 113.632 173.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.76 68.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.21 1.823 . . . . 2.6899999999999999 110.261 170.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 3.0 mm -54.39 -51.91 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.256 0.622 . . . . 3.3300000000000001 111.351 165.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.98 -29.12 70.02 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.257 -1.354 . . . . 2.4500000000000002 113.832 -175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -70.42 -48.95 53.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.439 1.927 . . . . 4.2999999999999998 110.556 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.36 -41.44 65.83 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.682 0.793 . . . . 4.9299999999999997 111.571 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.95 -53.29 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 125.511 1.524 . . . . 2.5099999999999998 113.598 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -57.07 -40.86 77.68 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.382 1.073 . . . . 6.8899999999999997 112.883 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.97 -53.12 51.32 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.925 2.09 . . . . 3.6099999999999999 111.228 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.65 -36.81 85.46 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.503 1.298 . . . . 4.4800000000000004 114.503 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.1 m 148.38 148.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 128.681 2.792 . . . . 2.9900000000000002 113.581 167.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.15 9.66 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.201 3.268 . . . . 3.04 116.525 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -91.22 -9.24 45.99 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 120.989 1.722 . . . . 3.3300000000000001 113.17 161.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 66.8 tp -84.08 147.12 27.55 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.667 1.187 . . . . 2.9700000000000002 109.842 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 t -130.56 138.64 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.474 1.11 . . . . 2.8799999999999999 108.503 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.82 122.18 7.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.234 -1.546 . . . . 1.0900000000000001 109.234 169.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.34 140.11 39.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.283 1.033 . . . . 3.23 108.945 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.0 p -151.72 -172.6 4.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.621 1.969 . . . . 3.9700000000000002 109.399 -165.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.14 -155.84 10.16 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 123.121 0.391 . . . . 2.2400000000000002 113.088 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.3 t -73.81 -177.08 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.546 -1.279 . . . . 2.6699999999999999 107.546 136.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -44.91 -39.43 5.43 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.288 1.035 . . . . 8.0199999999999996 111.817 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -70.41 -37.65 74.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.555 1.07 . . . . 2.8700000000000001 113.601 -165.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.8 -30.56 68.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.805 1.639 . . . . 3.5299999999999998 111.511 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.43 -38.94 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.862 0.865 . . . . 2.54 111.136 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.72 -50.07 75.27 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.736 -1.209 . . . . 3.8900000000000001 107.736 171.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -54.93 -61.58 2.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.612 -1.185 . . . . 3.5800000000000001 112.959 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.62 -34.33 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.598 1.545 . . . . 3.0699999999999998 113.232 -166.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.22 96.18 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.279 -0.888 . . . . 2.2400000000000002 110.535 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -73.47 -32.85 64.55 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.884 1.673 . . . . 4.7300000000000004 112.846 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.43 97.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.794 1.179 . . . . 2.6299999999999999 112.007 171.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -84.03 1.97 41.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.698 0.799 . . . . 3.54 112.946 171.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.54 22.05 9.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.001 2.121 . . . . 7.5899999999999999 113.991 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.0 m -86.99 164.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.647 0.779 . . . . 4.0499999999999998 110.181 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -155.38 168.99 25.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.776 1.23 . . . . 5.2800000000000002 111.989 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -161.98 128.58 3.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.336 0.655 . . . . 5.1600000000000001 110.869 -163.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.8 m -110.27 110.38 58.28 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-O 118.598 -0.715 . . . . 3.27 111.835 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.1 146.31 20.02 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.828 2.352 . . . . 3.3199999999999998 111.839 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.76 155.2 38.8 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-O 119.504 -0.609 . . . . 2.7200000000000002 113.11 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -81.5 35.86 0.6 Allowed 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.829 3.686 . . . . 4.0899999999999999 111.806 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 65.83 172.76 0.23 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.08 2.152 . . . . 5.9800000000000004 112.6 -156.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -153.5 160.98 42.67 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.08 2.152 . . . . 7.7000000000000002 107.846 173.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -72.37 -16.1 61.86 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.193 1.553 . . . . 8.3100000000000005 115.193 -158.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.95 2.17 44.08 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.553 1.141 . . . . 11.17 112.765 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 80.23 11.58 1.08 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.166 2.586 . . . . 6.8300000000000001 113.133 171.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.32 162.36 4.75 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.876 2.07 . . . . 4.6399999999999997 115.653 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -139.86 70.63 1.36 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.885 1.326 . . . . 4.3099999999999996 114.444 160.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.14 153.31 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.559 1.543 . . . . 5.2599999999999998 110.303 159.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.85 150.54 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.055 1.742 . . . . 3.8900000000000001 106.919 163.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.13 155.66 34.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.114 -0.698 . . . . 3.71 109.114 164.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -140.47 87.7 2.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.53 0.681 . . . . 2.5099999999999998 110.865 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.5 t -74.51 76.57 1.95 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 124.037 1.875 . . . . 6.5300000000000002 109.379 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.1 pp -132.25 172.65 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.167 1.787 . . . . 7.7400000000000002 109.532 -172.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 11.3 tt -141.42 164.59 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.198 -0.939 . . . . 3.5699999999999998 109.121 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 22.6 ttm -99.13 141.28 32.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.571 1.078 . . . . 3.6499999999999999 110.229 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -109.66 148.73 30.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.352 1.061 . . . . 3.6299999999999999 112.792 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 127.0 46.32 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.649 1.58 . . . . 3.9399999999999999 108.208 163.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 156.48 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.149 1.379 . . . . 2.98 108.334 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -155.5 -134.45 1.86 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.505 1.05 . . . . 2.5 111.977 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -85.86 36.4 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.852 3.701 . . . . 3.3199999999999998 112.412 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -120.61 -38.52 2.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.739 2.015 . . . . 6.79 114.889 -164.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.29 2.46 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.086 -1.206 . . . . 4.3700000000000001 110.086 -158.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.32 -2.95 3.08 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.717 1.377 . . . . 5.7599999999999998 114.717 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -138.88 76.79 1.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.632 1.173 . . . . 4.7300000000000004 112.001 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -34.87 17.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.161 0.984 . . . . 4.1399999999999997 111.824 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -168.96 174.77 6.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.828 2.851 . . . . 2.3199999999999998 108.441 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -153.86 150.02 27.96 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.64 -1.287 . . . . 3.71 111.715 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.95 114.03 21.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.352 1.061 . . . . 3.5699999999999998 108.885 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.98 42.2 3.05 Favored Glycine 0 N--CA 1.464 0.542 0 CA-C-O 118.324 -1.265 . . . . 4.0700000000000003 111.467 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . 0.266 3.5 pt20 44.17 45.16 6.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.011 1.724 . . . . 4.54 112.186 -170.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -139.63 -37.41 0.49 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.755 1.761 . . . . 5.79 115.755 -164.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -63.84 135.32 56.5 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.356 -1.465 . . . . 5.0 109.098 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -76.71 171.22 15.05 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 121.395 1.907 . . . . 9.0999999999999996 109.193 163.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -48.33 -43.97 33.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.935 0.894 . . . . 2.8500000000000001 113.167 -177.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -57.18 -36.34 74.62 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.942 1.258 . . . . 1.8200000000000001 114.951 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -86.83 -18.08 31.83 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.421 1.61 . . . . 4.0499999999999998 112.774 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 69.1 mt -69.22 -55.75 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.052 -1.092 . . . . 2.3399999999999999 108.052 170.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.35 95.59 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.087 0.773 . . . . 2.6800000000000002 113.087 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.39 90.63 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.83 1.195 . . . . 2.98 112.47 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.4 p -61.59 -43.83 98.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.567 1.076 . . . . 2.1699999999999999 112.142 170.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.86 -47.11 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.637 1.108 . . . . 2.1800000000000002 110.723 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.54 -30.72 70.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.309 0.959 . . . . 2.3900000000000001 113.061 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.2 m -68.37 -50.27 54.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.433 1.093 . . . . 2.8799999999999999 109.89 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -70.27 -34.04 72.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.761 1.225 . . . . 2.9700000000000002 113.449 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -60.66 -33.82 73.38 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.288 1.835 . . . . 4.8899999999999997 112.84 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -59.6 -52.44 74.03 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 116.785 -1.579 . . . . 5.1299999999999999 112.985 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.91 -44.5 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.274 2.649 . . . . 3.3300000000000001 111.589 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.16 62.65 7.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.625 1.17 . . . . 4.1799999999999997 111.038 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -43.0 132.27 4.03 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.618 1.567 . . . . 9.1300000000000008 114.591 -166.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -171.23 0.12 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.253 1.421 . . . . 7.7800000000000002 114.569 175.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 48.21 0.16 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 116.603 2.075 . . . . 8.9199999999999999 116.603 -173.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.489 1.493 1 C-N-CA 132.402 4.281 . . . . 7.6100000000000003 110.583 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 106.72 -1.585 . . . . 14.99 106.72 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -62.84 175.81 0.78 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.595 1.089 . . . . 17.949999999999999 110.162 138.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.9 m -108.12 158.58 17.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.901 1.68 . . . . 14.289999999999999 109.362 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.6 -118.83 1.32 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.082 -1.207 . . . . 12.890000000000001 110.082 167.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -55.12 129.33 67.24 Favored Pre-proline 0 CA--C 1.554 1.115 0 O-C-N 121.493 -1.004 . . . . 13.01 111.399 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.17 63.5 8.71 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.432 2.755 . . . . 13.1 108.876 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.1 tp -160.55 140.42 11.12 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.443 0.697 . . . . 11.19 111.177 -162.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.3 tt -170.4 -58.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.236 1.814 . . . . 7.1200000000000001 109.665 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.31 -146.4 18.99 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.932 -0.867 . . . . 3.29 110.932 -172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.96 166.63 21.08 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.195 0.902 . . . . 3.54 113.088 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.4 148.92 30.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.029 2.486 . . . . 3.6400000000000001 111.854 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -130.68 125.16 33.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.6 1.16 . . . . 4.1200000000000001 111.302 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -109.81 46.57 1.0 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.448 -1.407 . . . . 2.8599999999999999 111.983 -162.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -85.35 155.25 21.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.573 1.549 . . . . 4.1299999999999999 111.792 -160.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.3 m -79.83 133.78 36.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.302 1.041 . . . . 2.8900000000000001 109.868 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.2 p -81.94 160.65 23.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 123.061 1.41 . . . . 2.8399999999999999 112.655 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -2.73 1.57 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.773 2.029 . . . . 2.3799999999999999 114.905 168.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 t -100.37 -41.31 7.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.953 0.901 . . . . 3.8799999999999999 110.961 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.28 -0.77 7.05 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 125.154 1.359 . . . . 2.02 115.546 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.09 157.81 35.38 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.102 0.951 . . . . 3.7799999999999998 108.544 163.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.434 HH12 ' CD ' ' A' ' 233' ' ' GLU . 87.5 mtt-85 -92.13 134.24 35.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.749 -1.219 . . . . 8.5500000000000007 110.857 174.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -138.47 136.02 35.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.706 1.002 . . . . 3.6400000000000001 113.706 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 149.1 51.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 128.57 2.748 . . . . 4.4500000000000002 109.469 -164.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -32.42 -43.59 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.582 2.353 . . . . 4.0199999999999996 114.389 158.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.02 -25.73 68.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.23 1.412 . . . . 8.6300000000000008 113.227 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -89.4 -28.22 19.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.406 1.082 . . . . 3.0099999999999998 111.521 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -80.58 -16.85 53.13 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.808 1.04 . . . . 3.9700000000000002 113.808 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 111.31 1.39 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.865 1.266 . . . . 4.6699999999999999 111.945 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.35 -24.13 4.48 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.092 1.329 . . . . 3.0299999999999998 112.796 -171.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.15 -162.11 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 117.825 0.813 . . . . 4.4400000000000004 109.11 149.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -105.66 153.3 22.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.618 1.167 . . . . 2.0800000000000001 110.115 168.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 pp -135.37 134.95 40.3 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.402 -0.811 . . . . 3.5499999999999998 110.918 173.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.59 132.07 54.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.296 1.838 . . . . 4.1299999999999999 107.499 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.13 129.3 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.398 1.079 . . . . 3.2400000000000002 110.441 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -106.74 145.82 31.59 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.755 2.022 . . . . 3.8100000000000001 111.523 163.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -112.3 118.28 34.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.557 1.143 . . . . 3.5499999999999998 112.793 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.89 164.15 27.9 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 117.059 1.584 . . . . 1.5600000000000001 117.059 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -26.97 11.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.129 1.772 . . . . 5.0800000000000001 112.929 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 89.1 m 118.66 109.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.202 3.801 . . . . 3.8599999999999999 109.997 163.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . 0.346 1.5 t-160 41.12 52.01 3.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.725 2.01 . . . . 11.75 114.241 -161.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.76 149.63 41.3 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 126.219 1.808 . . . . 4.2599999999999998 109.993 159.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.03 -17.85 21.85 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.795 2.33 . . . . 5.0 114.361 -156.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -42.15 42.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.248 1.019 . . . . 11.16 112.528 -162.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 p 174.6 3.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 127.139 2.176 . . . . 5.6699999999999999 114.623 -163.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . 0.251 46.9 t -57.93 -66.79 1.13 Allowed Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 115.423 1.638 . . . . 2.9500000000000002 115.423 -147.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.34 -17.63 39.36 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.212 2.608 . . . . 2.1200000000000001 113.246 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -69.35 -31.42 69.85 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 117.881 -1.057 . . . . 6.7400000000000002 112.844 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -87.86 -20.12 26.47 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 121.164 1.802 . . . . 3.1699999999999999 113.323 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -47.42 85.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.41 -1.431 . . . . 3.5899999999999999 109.681 164.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.99 -51.27 64.43 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.49 1.516 . . . . 4.5800000000000001 111.256 171.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -67.75 -21.53 65.27 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.673 -1.267 . . . . 4.1299999999999999 113.666 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.9 ttp -67.47 -32.26 72.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.1 0.864 . . . . 3.7000000000000002 112.362 164.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.58 -53.28 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 119.914 -1.742 . . . . 4.3099999999999996 108.973 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.45 21.79 0.1 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.711 1.375 . . . . 3.3300000000000001 114.711 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.46 -40.77 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 120.569 1.531 . . . . 4.4500000000000002 111.912 147.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.9 t -57.66 -49.41 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.254 0.933 . . . . 2.9500000000000002 110.428 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -59.83 -32.23 70.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.152 1.781 . . . . 3.6200000000000001 113.168 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -81.45 -35.12 30.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 2.5499999999999998 113.012 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.9 mt -62.92 -49.54 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.279 0.632 . . . . 3.7799999999999998 109.601 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -62.92 -35.14 79.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.658 2.383 . . . . 3.54 111.585 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -66.54 -13.47 61.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.411 1.263 . . . . 3.8100000000000001 114.411 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 87.6 mt -100.33 96.68 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.541 -1.349 . . . . 4.0700000000000003 108.309 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.4 m -65.11 69.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.31 2.244 . . . . 5.9800000000000004 112.529 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 176.2 -28.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.372 1.869 . . . . 4.8600000000000003 112.78 -165.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.11 148.19 47.06 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 119.789 1.177 . . . . 4.7000000000000002 112.139 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.24 142.87 15.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.398 2.732 . . . . 3.2000000000000002 109.318 168.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -69.45 162.3 27.7 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.579 1.696 . . . . 3.8199999999999998 115.579 -163.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 35.3 tp -119.51 96.07 5.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.128 2.171 . . . . 3.6699999999999999 108.917 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.6 m -72.84 123.47 89.61 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-O 118.193 -0.908 . . . . 3.0600000000000001 109.609 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.15 118.6 2.67 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.503 2.802 . . . . 1.1799999999999999 111.118 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.9 mt -108.91 126.03 52.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.231 1.412 . . . . 4.9900000000000002 110.482 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -104.04 130.56 51.73 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.468 1.107 . . . . 3.1699999999999999 109.227 168.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.47 124.8 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.752 0.787 . . . . 2.8599999999999999 111.444 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.6 m -66.07 129.95 41.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.924 0.89 . . . . 2.9700000000000002 111.899 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.29 -17.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 114.831 1.419 . . . . 3.5299999999999998 114.831 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -117.06 44.63 0.46 Allowed Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 125.23 1.412 . . . . 4.5800000000000001 112.406 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.31 83.22 1.51 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.776 2.984 . . . . 2.6099999999999999 113.778 -166.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -155.68 28.53 0.38 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.794 2.038 . . . . 5.1699999999999999 110.501 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -156.54 -35.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.055 1.132 . . . . 5.4500000000000002 114.055 -166.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -98.69 83.91 3.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.602 1.961 . . . . 3.5099999999999998 111.088 -167.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 m -49.77 138.24 14.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.678 1.191 . . . . 3.3399999999999999 109.588 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -43.04 -41.46 3.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.202 1.401 . . . . 4.0099999999999998 113.283 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.34 -37.66 74.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.804 2.842 . . . . 6.5199999999999996 113.365 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.12 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.16 0.984 . . . . 2.3700000000000001 111.218 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.0 -46.44 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 118.968 -0.539 . . . . 2.4300000000000002 110.49 167.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.67 69.38 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.559 1.072 . . . . 2.6099999999999999 112.579 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.416 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 4.4 t30 -63.75 -51.54 64.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.389 0.995 . . . . 5.5700000000000003 112.184 172.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -60.82 -41.46 95.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.586 1.555 . . . . 4.5499999999999998 112.117 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.5 t -61.26 -46.63 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.318 1.047 . . . . 2.2599999999999998 111.368 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 5.9 ttpp -58.48 -35.23 71.86 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.957 0.903 . . . . 5.9100000000000001 112.827 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -64.11 -19.67 65.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.343 1.057 . . . . 4.5899999999999999 113.075 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -91.84 -64.19 1.15 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.381 1.072 . . . . 3.8500000000000001 112.959 171.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t 174.02 145.2 0.2 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 126.271 1.828 . . . . 3.02 109.692 -168.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.55 -5.38 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.382 2.721 . . . . 2.0800000000000001 113.92 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -77.74 -8.72 58.37 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.638 1.108 . . . . 2.7000000000000002 113.635 169.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.46 143.87 33.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.508 1.049 . . . . 5.0300000000000002 112.191 173.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.97 133.75 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.337 1.455 . . . . 2.96 108.999 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -112.71 128.51 8.49 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.995 -0.842 . . . . 1.0800000000000001 110.995 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.7 mp -123.83 144.92 49.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.211 1.004 . . . . 3.1000000000000001 110.88 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.3 t -161.02 -161.0 0.78 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.289 2.236 . . . . 3.21 108.201 -170.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 159.54 -114.64 0.62 Allowed Glycine 0 N--CA 1.465 0.628 0 C-N-CA 124.779 1.181 . . . . 2.71 110.898 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.3 p -137.28 174.16 10.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.263 1.425 . . . . 5.0999999999999996 109.852 165.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -23.56 63.63 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.596 0.962 . . . . 8.7699999999999996 113.596 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -68.24 -41.08 81.71 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.455 1.502 . . . . 3.4199999999999999 111.287 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.434 ' CD ' HH12 ' A' ' 149' ' ' ARG . 45.1 mt-10 -69.03 -37.82 78.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.117 0.871 . . . . 4.6600000000000001 110.897 170.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -27.61 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 117.774 -1.108 . . . . 3.9900000000000002 113.36 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.06 -41.62 92.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.839 1.199 . . . . 5.0300000000000002 110.308 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -60.29 -54.47 45.37 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 3.8799999999999999 111.75 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.18 -40.91 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.127 0.876 . . . . 2.73 111.771 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.9 73.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.97 0.508 . . . . 3.25 111.318 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.64 -34.55 69.87 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.061 1.744 . . . . 6.8700000000000001 112.963 -177.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.08 -58.5 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.457 1.103 . . . . 3.02 111.792 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.77 0.67 22.8 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.475 0.917 . . . . 3.54 113.475 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.0 ttt85 45.06 38.94 3.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.752 2.821 . . . . 8.4100000000000001 113.696 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.8 m -78.81 133.64 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.529 0.732 . . . . 4.3799999999999999 110.278 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.79 148.57 25.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.733 0.813 . . . . 6.1299999999999999 111.235 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -172.05 163.03 5.99 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.645 1.978 . . . . 4.5300000000000002 110.675 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.4 t -160.6 135.58 5.59 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-O 117.902 -1.047 . . . . 4.9299999999999997 111.204 172.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.02 156.38 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.162 1.908 . . . . 3.9199999999999999 110.665 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -89.2 165.12 32.59 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.384 0.992 . . . . 2.3999999999999999 113.609 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -77.17 -171.32 1.12 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.3 2.667 . . . . 3.75 109.783 168.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -82.09 131.95 35.24 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.922 -0.77 . . . . 5.1699999999999999 108.922 150.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -140.84 35.94 1.78 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.775 1.63 . . . . 7.2699999999999996 108.732 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 253' ' ' ASP . 3.0 tm-20 173.74 166.12 0.18 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.308 3.043 . . . . 7.0199999999999996 105.91 -151.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.488 ' H ' ' CD ' ' A' ' 252' ' ' GLU . 4.6 t70 -76.25 -27.11 56.6 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.768 1.227 . . . . 5.79 111.484 -176.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.26 3.66 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 117.172 2.286 . . . . 5.2400000000000002 117.172 163.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.63 147.28 22.86 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 122.572 2.442 . . . . 4.2599999999999998 112.579 169.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.55 92.66 2.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.178 0.99 . . . . 5.1500000000000004 110.826 149.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 82.1 mt -57.85 145.03 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.067 -1.021 . . . . 4.4900000000000002 109.483 158.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.94 158.78 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 4.2199999999999998 110.481 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -101.39 141.06 34.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.911 1.684 . . . . 4.3200000000000003 110.115 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.45 149.61 17.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.104 1.52 . . . . 2.6400000000000001 115.104 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -51.97 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.752 2.021 . . . . 4.7699999999999996 111.859 172.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.55 52.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.276 1.431 . . . . 6.7800000000000002 112.24 168.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mt -136.06 128.18 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.254 1.422 . . . . 3.5800000000000001 107.914 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 60.5 mtp -99.07 159.55 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.114 1.766 . . . . 3.1899999999999999 110.252 174.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -135.75 146.28 47.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.908 1.077 . . . . 3.8900000000000001 113.908 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.3 tp -104.59 130.06 52.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.977 1.311 . . . . 3.5099999999999998 110.059 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.3 mt -111.13 142.21 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 106.997 -1.482 . . . . 5.25 106.997 150.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -114.08 -171.75 17.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.627 0.632 . . . . 2.25 113.817 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.53 70.86 6.69 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.305 3.337 . . . . 2.6099999999999999 108.623 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -167.72 -62.21 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.001 1.72 . . . . 4.2000000000000002 110.025 -169.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.02 -112.19 0.83 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.603 -0.726 . . . . 2.6000000000000001 113.633 -162.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.54 123.11 28.89 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.512 0.931 . . . . 4.1900000000000004 113.512 -149.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.5 t80 35.43 63.42 0.53 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.646 1.978 . . . . 4.9500000000000002 114.393 156.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.0 tp -86.64 -4.02 59.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.423 0.897 . . . . 4.3300000000000001 113.423 -166.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.85 150.11 4.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.911 2.085 . . . . 2.6600000000000001 110.167 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -126.48 123.85 38.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.452 1.12 . . . . 4.7199999999999998 111.078 161.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.63 86.81 3.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.134 1.374 . . . . 4.9800000000000004 107.546 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.59 161.77 48.37 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.829 -1.309 . . . . 4.0800000000000001 109.829 164.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -50.2 -16.03 0.28 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.554 1.687 . . . . 3.8700000000000001 115.554 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -19.78 61.5 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 120.5 -1.375 . . . . 5.8099999999999996 114.346 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -93.49 123.1 36.57 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.437 -1.415 . . . . 6.1699999999999999 109.075 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -169.91 1.92 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.2 1.0 . . . . 6.3300000000000001 108.789 167.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -30.85 -60.24 0.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.836 1.654 . . . . 4.0300000000000002 113.527 170.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.04 84.07 Favored Glycine 0 N--CA 1.472 1.066 0 O-C-N 121.307 -0.871 . . . . 2.77 112.798 -166.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -76.38 -31.87 58.25 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.598 1.559 . . . . 3.1299999999999999 111.562 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.32 -56.94 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.138 -0.689 . . . . 2.3199999999999998 109.138 165.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.48 -43.35 88.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.624 0.972 . . . . 2.4700000000000002 113.624 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.11 77.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.331 0.652 . . . . 2.98 112.469 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 16.4 p -66.84 -48.03 70.16 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.052 1.13 . . . . 1.95 114.052 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.13 -33.07 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.075 1.761 . . . . 2.5899999999999999 112.168 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.0 71.84 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.906 0.776 . . . . 2.5499999999999998 112.834 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 84.1 m -68.27 -41.84 80.46 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.634 0.652 . . . . 2.9100000000000001 110.513 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -65.84 -27.1 67.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.544 1.137 . . . . 3.0899999999999999 113.753 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.3 mmt -70.59 -10.78 60.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.577 0.955 . . . . 7.2000000000000002 113.577 170.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.64 -50.41 1.27 Allowed Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 116.69 -1.624 . . . . 6.7000000000000002 114.582 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.93 -37.12 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.41 2.073 . . . . 1.96 111.935 173.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.13 148.02 26.27 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.272 1.034 . . . . 3.79 112.256 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 74.47 -34.88 0.28 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.563 1.945 . . . . 12.77 116.107 161.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -150.01 -72.84 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.891 2.132 . . . . 7.3600000000000003 115.565 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 39.4 pttt 151.21 -26.78 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.27 1 C-N-CA 132.757 4.423 . . . . 12.029999999999999 111.653 -163.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.487 1.415 0 C-N-CA 130.87 3.668 . . . . 11.19 106.569 -142.168 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 117.714 -1.136 . . . . 16.710000000000001 108.709 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -59.93 -45.01 93.98 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.944 1.247 . . . . 19.190000000000001 109.746 163.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.8 p -77.17 156.72 31.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.978 2.111 . . . . 14.26 111.563 164.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 118.81 124.77 3.35 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.881 1.705 . . . . 10.92 111.943 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm 166.4 143.46 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 130.151 3.381 . . . . 12.390000000000001 109.509 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.72 -178.37 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.669 2.912 . . . . 9.6600000000000001 110.83 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.8 mp 66.06 85.21 0.14 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.535 2.334 . . . . 11.48 111.415 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.88 -46.5 84.61 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.765 0.826 . . . . 7.1200000000000001 109.209 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.57 -14.05 4.59 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 127.186 2.327 . . . . 5.2400000000000002 114.704 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.24 73.04 1.08 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.028 -1.229 . . . . 4.3300000000000001 110.028 -158.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.89 129.16 6.13 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.558 2.172 . . . . 4.5899999999999999 111.366 -170.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.46 162.65 33.95 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.579 1.952 . . . . 4.4900000000000002 110.554 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.3 p -144.96 57.38 1.27 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.029 -1.045 . . . . 3.6499999999999999 111.249 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.74 160.4 14.5 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.714 1.206 . . . . 3.3799999999999999 113.935 -166.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -87.23 135.54 33.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.244 1.418 . . . . 2.4199999999999999 111.205 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.7 p -97.03 162.95 13.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 122.82 1.295 . . . . 3.6600000000000001 112.89 176.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -63.31 -20.43 65.47 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.265 1.426 . . . . 1.9099999999999999 114.546 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.0 t -88.36 -4.79 58.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.815 1.246 . . . . 4.5899999999999999 113.24 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.96 2.4 62.61 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 119.547 1.067 . . . . 2.25 115.525 171.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.33 154.9 17.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.789 1.235 . . . . 4.7000000000000002 109.637 170.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.22 112.54 24.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.259 1.824 . . . . 6.0800000000000001 109.593 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -78.79 165.78 23.18 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.301 -1.499 . . . . 4.9800000000000004 112.249 177.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.4 m -154.67 144.74 21.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.708 1.203 . . . . 4.46 108.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -48.73 -41.49 32.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.566 1.147 . . . . 4.2599999999999998 112.484 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.92 -2.45 27.06 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.516 1.673 . . . . 9.1500000000000004 115.516 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.402 ' CG ' ' HZ3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -89.44 -34.58 16.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 120.353 1.433 . . . . 4.3600000000000003 112.335 168.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -94.23 -29.9 14.86 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.382 1.253 . . . . 4.5899999999999999 114.382 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.79 124.72 23.72 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.656 1.571 . . . . 6.8399999999999999 109.198 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.87 -18.4 26.6 Favored Glycine 0 N--CA 1.477 1.397 0 C-N-CA 124.211 0.91 . . . . 4.1900000000000004 112.349 -160.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.17 167.84 9.63 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.018 2.527 . . . . 6.1699999999999999 108.08 167.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -82.09 99.99 9.52 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.575 -1.328 . . . . 2.23 110.45 163.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -96.37 140.38 31.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.409 0.623 . . . . 4.7999999999999998 110.096 167.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 tt -125.02 113.55 17.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.112 -1.81 . . . . 3.6000000000000001 106.112 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.17 136.97 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 4.5700000000000003 111.068 -170.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -123.19 129.61 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.861 1.665 . . . . 4.29 110.688 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -99.93 102.62 14.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.576 1.15 . . . . 4.21 112.795 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.91 163.63 13.77 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.895 1.236 . . . . 1.5600000000000001 114.756 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -124.34 116.66 22.96 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.966 0.906 . . . . 4.5099999999999998 110.723 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.1 m -58.89 129.31 41.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.709 -1.589 . . . . 4.3200000000000003 106.709 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 90.03 -1.16 0.28 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.124 2.17 . . . . 8.1899999999999995 113.791 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 158.17 85.8 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 119.925 1.239 . . . . 3.8199999999999998 110.103 157.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.51 -177.26 3.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.149 3.233 . . . . 3.3500000000000001 112.153 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.16 1.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.404 1.882 . . . . 5.21 115.876 -171.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.24 -38.17 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.987 1.715 . . . . 4.6200000000000001 110.727 172.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -60.49 9.87 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.603 1.161 . . . . 1.8300000000000001 111.603 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.57 -23.75 49.45 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.897 1.731 . . . . 1.46 113.943 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -51.62 -52.02 51.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.801 1.637 . . . . 3.6200000000000001 113.422 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -80.35 -25.78 39.03 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.874 -1.141 . . . . 4.2999999999999998 112.955 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.21 -44.9 71.14 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.212 1.005 . . . . 4.0199999999999996 110.936 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -48.1 -54.37 13.43 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.729 1.612 . . . . 5.21 110.912 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -66.64 -28.09 68.2 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.535 -1.353 . . . . 5.3700000000000001 113.009 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 46.9 ttp -65.85 -39.47 90.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 117.524 -1.227 . . . . 4.5499999999999998 111.429 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.33 -45.9 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 120.948 1.704 . . . . 2.7400000000000002 110.722 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.5 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.124 -0.941 . . . . 4.9299999999999997 112.387 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.88 -29.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.945 1.702 . . . . 3.0600000000000001 110.731 168.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.77 -46.49 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.721 0.808 . . . . 2.9399999999999999 109.532 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.66 -43.82 80.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.115 2.566 . . . . 4.1100000000000003 113.14 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.21 -42.26 96.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.221 1.809 . . . . 3.23 112.041 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.3 mt -68.62 -40.7 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.158 0.983 . . . . 3.0899999999999999 112.121 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -61.42 -31.44 71.37 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.828 1.251 . . . . 3.7799999999999998 111.226 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.6 m -72.12 -21.64 61.44 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.49 -0.756 . . . . 3.9199999999999999 112.874 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.52 63.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.349 -1.469 . . . . 4.2999999999999998 108.131 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 75.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.659 1.984 . . . . 6.5199999999999996 113.021 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.6 m 174.43 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.856 3.663 . . . . 4.5800000000000001 111.239 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.28 154.18 54.13 Favored Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 121.613 2.006 . . . . 4.0700000000000003 111.434 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.52 -55.13 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.719 2.279 . . . . 3.4399999999999999 110.242 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -178.73 170.94 1.53 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 129.991 3.316 . . . . 3.9500000000000002 108.099 168.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.3 tt -118.96 115.28 24.03 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.067 -1.827 . . . . 4.0499999999999998 106.067 150.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.3 m -95.65 108.16 38.21 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 118.041 -0.98 . . . . 2.54 109.226 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.38 122.75 2.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.212 2.608 . . . . 1.3200000000000001 111.171 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.0 tp -118.5 100.14 7.27 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.303 1.041 . . . . 3.3599999999999999 110.469 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -84.65 120.92 26.94 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.651 -0.5 . . . . 3.29 109.651 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.9 mt -102.28 103.84 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.413 1.485 . . . . 3.8399999999999999 107.161 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.8 t -97.59 132.85 42.87 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.648 -0.658 . . . . 3.2999999999999998 111.125 170.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.2 pt -102.89 13.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.1 1.76 . . . . 2.6800000000000002 114.665 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.23 32.39 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 116.098 1.888 . . . . 3.7200000000000002 116.098 -173.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -7.83 21.9 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 123.417 2.256 . . . . 2.6000000000000001 114.247 -171.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -85.68 41.39 0.9 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.264 1.025 . . . . 4.46 110.8 167.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 16.1 ttm105 -178.94 -58.25 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 131.128 3.771 . . . . 5.4299999999999997 109.107 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.75 171.31 15.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.946 1.299 . . . . 4.3099999999999996 111.455 -175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.1 t -149.3 153.13 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.148 -0.97 . . . . 3.6699999999999999 112.305 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -41.87 50.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.818 1.647 . . . . 3.9399999999999999 111.951 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -67.94 -36.44 80.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.547 1.539 . . . . 3.8100000000000001 112.535 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.63 -44.5 64.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.52 1.055 . . . . 2.0099999999999998 111.081 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.58 -43.06 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.353 1.061 . . . . 2.6899999999999999 111.717 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.34 80.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.232 1.013 . . . . 2.0099999999999998 113.115 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -70.96 -42.68 69.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.496 0.718 . . . . 5.0300000000000002 111.742 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -62.65 -41.03 98.84 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.913 0.885 . . . . 4.0499999999999998 111.596 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.38 -51.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.449 1.9 . . . . 2.3700000000000001 112.327 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -56.77 -34.42 67.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.283 1.033 . . . . 5.6600000000000001 113.372 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 221' ' ' SER . 40.9 mm-40 -67.96 -48.01 67.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.945 0.339 . . . . 5.0499999999999998 110.547 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -72.86 21.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 3.9900000000000002 114.389 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 219' ' ' GLU . 52.3 p 106.43 147.42 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.656 1 C-N-CA 131.792 4.037 . . . . 3.1899999999999999 112.504 178.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.16 -1.82 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.078 2.519 . . . . 1.8400000000000001 113.329 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -90.29 -7.85 52.39 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.287 0.949 . . . . 3.5099999999999998 112.793 171.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 136.36 46.72 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.523 -1.361 . . . . 3.8700000000000001 111.565 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.21 121.48 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.543 0.737 . . . . 3.1800000000000002 109.263 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.55 125.05 8.16 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.542 -1.423 . . . . 1.0600000000000001 109.542 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.62 130.15 41.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.977 1.711 . . . . 5.2400000000000002 108.817 -173.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -163.71 -163.05 0.76 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.511 1.924 . . . . 4.6600000000000001 109.849 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.51 -149.01 6.88 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.448 1.023 . . . . 1.6399999999999999 112.015 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -74.08 166.16 23.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.842 0.821 . . . . 3.3900000000000001 110.488 159.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -47.8 -38.19 15.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.602 1.161 . . . . 6.9400000000000004 113.069 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -70.85 -29.46 65.6 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.153 1.381 . . . . 3.48 111.743 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.03 -36.21 61.9 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 3.5099999999999998 111.72 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.52 -35.78 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 118.836 -0.602 . . . . 2.98 111.189 170.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.55 -48.07 70.82 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.682 -1.628 . . . . 2.5699999999999998 110.095 165.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -46.94 -57.78 4.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 121.555 1.979 . . . . 2.8900000000000001 111.438 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.67 -39.33 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.304 0.956 . . . . 3.2400000000000002 112.77 -173.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -35.5 72.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.965 0.802 . . . . 2.4300000000000002 112.585 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -74.28 -40.01 62.59 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.886 2.074 . . . . 3.6899999999999999 111.575 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.49 81.49 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 2.2200000000000002 112.648 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.35 -6.74 59.23 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.478 0.711 . . . . 4.2199999999999998 112.897 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.73 39.17 29.92 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.827 2.051 . . . . 7.1500000000000004 112.708 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.2 -39.75 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.079 -1.013 . . . . 3.9700000000000002 111.918 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 29.4 t80 64.47 130.6 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.198 1.799 . . . . 5.7400000000000002 112.77 -165.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -116.2 152.57 33.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.002 0.921 . . . . 4.3200000000000003 110.653 164.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.0 t -106.92 107.0 59.75 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.479 -0.772 . . . . 3.21 110.457 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.86 131.35 16.89 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.364 2.043 . . . . 3.1499999999999999 109.993 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -88.34 -174.71 47.52 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.489 1.042 . . . . 2.2999999999999998 114.819 -175.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.25 176.32 10.21 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.389 3.393 . . . . 4.6500000000000004 113.107 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -118.5 137.49 53.16 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.165 2.186 . . . . 4.9299999999999997 109.52 164.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.25 -79.53 0.46 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 118.382 -0.818 . . . . 5.6799999999999997 110.754 -163.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -67.78 -69.42 0.32 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.243 0.929 . . . . 7.0999999999999996 112.009 168.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.22 -72.6 0.06 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.841 0.682 . . . . 8.6699999999999999 112.841 -168.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -114.05 -32.38 6.05 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.468 -0.77 . . . . 8.1899999999999995 112.753 -161.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.36 169.82 17.64 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 113.771 1.026 . . . . 6.2300000000000004 113.771 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 37.6 p90 177.18 161.26 0.44 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.566 2.346 . . . . 4.4199999999999999 111.524 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.5 mm -121.08 148.93 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.575 1.55 . . . . 5.0499999999999998 108.741 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.45 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 106.402 -1.703 . . . . 4.1699999999999999 106.402 162.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -104.1 163.85 12.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.188 1.795 . . . . 3.5800000000000001 111.569 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 158.82 33.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.534 1.133 . . . . 2.9100000000000001 113.022 -158.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 49.3 p -59.19 -16.5 20.84 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.836 1.421 . . . . 3.9500000000000002 114.836 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.407 HG12 ' H ' ' A' ' 263' ' ' ILE 0.347 10.6 tt 43.54 -143.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.819 1.248 . . . . 4.8799999999999999 109.404 -147.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 262' ' ' ILE . 73.8 mt 76.18 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.285 1.834 . . . . 4.4699999999999998 110.992 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -118.78 149.66 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.625 -1.17 . . . . 4.2800000000000002 110.443 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.41 144.38 45.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.966 0.906 . . . . 5.1200000000000001 112.749 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.1 tp -97.41 128.4 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.709 1.203 . . . . 3.0499999999999998 108.52 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.31 142.24 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.207 -1.775 . . . . 3.6600000000000001 106.207 161.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -132.64 -168.06 11.91 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.207 0.843 . . . . 2.5600000000000001 115.207 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.63 58.84 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.652 1 C-N-CA 125.442 4.095 . . . . 4.8799999999999999 110.801 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -154.39 -55.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.109 1.364 . . . . 7.1200000000000001 108.292 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.07 138.36 4.47 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.09 1.328 . . . . 5.4400000000000004 113.316 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 64.64 -168.61 0.21 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.388 1.475 . . . . 5.5599999999999996 112.697 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -74.13 99.44 3.37 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.79 -1.194 . . . . 6.5800000000000001 112.259 -173.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -24.55 27.9 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.758 1.623 . . . . 5.0499999999999998 112.231 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -165.46 175.14 9.3 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.05 1.74 . . . . 2.3300000000000001 110.326 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -153.29 166.49 32.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.817 1.647 . . . . 5.54 112.869 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -143.01 150.9 40.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.527 1.531 . . . . 3.8500000000000001 110.196 -173.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.28 166.8 15.42 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.711 -1.049 . . . . 3.8599999999999999 111.989 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -24.66 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 134.236 5.014 . . . . 4.2000000000000002 119.885 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.94 -41.18 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.829 2.452 . . . . 6.1399999999999997 110.21 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -76.56 113.05 13.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.335 0.97 . . . . 4.9500000000000002 109.844 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.8 ttm105 -66.65 167.09 11.67 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.861 -1.15 . . . . 6.1200000000000001 109.101 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -50.56 -44.84 56.73 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.25 -1.531 . . . . 2.9900000000000002 113.279 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -58.15 -39.68 92.61 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.553 -0.582 . . . . 2.0 112.302 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.53 -28.55 46.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.007 1.114 . . . . 4.4900000000000002 114.007 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.5 mt -58.46 -49.24 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.708 1.14 . . . . 3.27 109.002 168.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.02 91.9 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.391 0.886 . . . . 2.0299999999999998 113.391 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.85 -32.03 69.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.588 0.755 . . . . 2.0499999999999998 112.881 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -52.71 64.29 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.709 0.633 . . . . 2.21 112.709 168.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.35 -38.94 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.399 -1.438 . . . . 2.0600000000000001 111.255 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.09 -8.77 25.6 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.079 1.352 . . . . 2.3100000000000001 114.194 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 92.9 m -92.19 -48.92 6.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.053 1.341 . . . . 2.1899999999999999 110.318 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -69.13 -23.34 63.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.681 0.993 . . . . 2.7400000000000002 113.681 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 27.3 ttt -55.93 -26.42 47.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.163 1.785 . . . . 5.1699999999999999 113.866 164.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -69.59 -46.8 26.14 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.247 -1.835 . . . . 7.5800000000000001 112.464 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -59.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.22 1.946 . . . . 1.9099999999999999 110.927 167.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -96.07 125.42 40.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.7 1.0 . . . . 4.4400000000000004 113.7 -166.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.58 -176.64 2.95 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.777 1.631 . . . . 9.7200000000000006 111.964 -173.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -120.86 145.11 47.97 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 128.383 2.673 . . . . 9.8000000000000007 106.906 165.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 34.4 mttt 92.55 -44.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 130.534 3.534 . . . . 8.9499999999999993 110.517 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.251 1.171 0 C-N-CA 129.804 3.242 . . . . 11.390000000000001 106.206 154.898 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 118.173 -0.917 . . . . 19.559999999999999 110.062 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.422 ' CZ ' ' HE2' ' A' ' 133' ' ' LYS . 44.5 t80 -156.85 151.77 26.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.472 1.109 . . . . 16.52 110.027 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t 175.78 -162.53 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.452 2.701 . . . . 14.44 108.836 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.33 49.69 9.11 Favored Glycine 0 N--CA 1.467 0.764 0 C-N-CA 125.128 1.347 . . . . 10.949999999999999 112.307 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HE2' ' CZ ' ' A' ' 130' ' ' PHE . 38.2 mmtm -135.88 73.59 59.57 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.204 1.402 . . . . 10.140000000000001 111.473 -176.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.04 167.47 26.65 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.487 2.791 . . . . 7.5700000000000003 110.74 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.5 mt -132.98 37.69 3.41 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.352 1.861 . . . . 8.3300000000000001 110.166 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 tt -65.12 81.11 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.629 1.972 . . . . 10.33 112.73 -172.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 92.03 96.38 1.35 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.498 1.999 . . . . 6.1299999999999999 110.041 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.62 111.61 4.08 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.199 -1.334 . . . . 3.3399999999999999 110.267 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.72 138.25 6.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.399 2.099 . . . . 3.4500000000000002 112.467 -163.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -162.22 165.72 26.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.447 1.899 . . . . 4.2699999999999996 110.846 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.7 p -137.01 92.75 2.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.351 -0.843 . . . . 4.0800000000000001 110.543 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mt -104.24 139.95 38.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.153 1.381 . . . . 3.6400000000000001 111.632 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 84.8 m -67.97 135.45 52.38 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.997 0.904 . . . . 3.52 110.503 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 157.96 18.16 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.859 -1.151 . . . . 3.48 110.459 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 2.9 0.89 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.413 1.085 . . . . 2.73 113.502 165.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 m -89.96 -45.14 9.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.138 1.375 . . . . 3.7000000000000002 110.8 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.31 38.47 1.11 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.987 1.279 . . . . 2.3399999999999999 113.473 -168.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.87 174.82 10.05 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.905 2.082 . . . . 4.8799999999999999 107.588 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -125.86 106.63 9.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 121.258 1.844 . . . . 7.7999999999999998 112.551 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -99.34 153.91 18.6 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.204 1.187 . . . . 4.5300000000000002 114.204 -171.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.0 p -123.03 148.2 45.82 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.345 2.658 . . . . 3.3399999999999999 108.626 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -46.65 -51.75 15.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.507 1.123 . . . . 3.54 113.622 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -71.95 6.17 2.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.653 2.094 . . . . 7.8399999999999999 116.653 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.11 -55.09 8.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.407 1.003 . . . . 3.7799999999999998 110.76 162.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.5 -31.44 26.47 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.832 1.049 . . . . 3.98 113.832 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.04 118.73 5.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.328 1.051 . . . . 5.04 111.079 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 123.62 -27.38 5.74 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 124.114 0.864 . . . . 2.6499999999999999 111.299 -167.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -84.21 166.87 17.19 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.352 -0.981 . . . . 3.8599999999999999 108.352 143.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -78.54 110.17 13.39 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.728 -0.607 . . . . 2.3300000000000001 112.451 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.4 mt -91.45 140.62 29.58 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.156 0.979 . . . . 3.7799999999999998 112.916 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -137.43 121.66 18.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.679 1.992 . . . . 3.73 107.408 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.0 mt -126.09 131.87 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.53 0.732 . . . . 2.6699999999999999 110.718 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -147.53 153.54 39.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.379 1.472 . . . . 3.8599999999999999 113.068 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.44 123.06 42.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.518 1.527 . . . . 3.9700000000000002 110.514 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.82 -176.95 36.23 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.21 0.844 . . . . 1.4099999999999999 115.21 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -156.47 139.21 15.14 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.123 0.962 . . . . 5.2400000000000002 112.946 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 t -82.2 74.5 9.17 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.424 1.011 . . . . 5.4000000000000004 110.36 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 169.79 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 129.568 3.147 . . . . 8.2899999999999991 110.538 -163.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.7 t -51.11 151.85 4.44 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.911 1.284 . . . . 2.4199999999999999 113.844 159.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.38 64.18 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.314 3.343 . . . . 4.1900000000000004 111.009 165.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.3 t0 69.59 -14.59 0.33 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.763 3.225 . . . . 4.9000000000000004 114.821 162.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.37 -34.36 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 120.584 -1.323 . . . . 4.3700000000000001 111.395 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.7 m -59.28 -54.34 57.18 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.317 -1.325 . . . . 2.3199999999999998 114.415 167.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -67.36 -26.71 41.04 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.011 1.807 . . . . 1.97 114.154 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -66.38 -42.98 87.15 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.909 1.686 . . . . 3.5299999999999998 110.814 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.73 -36.92 80.07 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.378 -0.826 . . . . 4.0700000000000003 111.474 168.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.56 -40.8 76.58 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.264 1.026 . . . . 3.46 112.694 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -57.76 11.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.148 1.379 . . . . 3.21 108.433 170.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -54.2 -37.51 64.63 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 120.174 -1.579 . . . . 4.5099999999999998 113.74 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.9 ptp -68.73 -41.82 78.47 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 117.058 -1.448 . . . . 3.3300000000000001 112.408 169.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.38 -44.66 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 121.212 1.824 . . . . 2.75 109.807 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -62.95 -29.71 71.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.214 -1.374 . . . . 3.8799999999999999 113.558 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 p -86.95 -32.41 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.688 1.131 . . . . 3.48 113.394 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.03 -46.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 120.707 1.594 . . . . 3.27 110.78 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -31.54 68.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.571 1.148 . . . . 4.6500000000000004 113.41 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -78.2 -13.63 59.78 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.174 -0.954 . . . . 2.98 113.328 174.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.6 mm -85.35 -55.29 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.635 1.574 . . . . 2.8500000000000001 109.921 167.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -50.69 -39.3 50.88 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.406 1.482 . . . . 3.9199999999999999 113.092 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -60.3 -29.41 68.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.316 1.046 . . . . 3.77 112.483 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.88 56.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 120.607 -1.308 . . . . 4.0800000000000001 107.612 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -36.58 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 130.001 3.32 . . . . 4.9500000000000002 118.775 -168.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -27.66 63.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.816 1.189 . . . . 5.3300000000000001 111.536 172.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.84 163.01 69.72 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.127 1.771 . . . . 4.2400000000000002 112.527 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -99.15 -172.35 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.924 3.083 . . . . 3.8399999999999999 113.67 -166.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.48 62.73 4.68 Favored 'General case' 0 CA--C 1.549 0.942 1 C-N-CA 132.304 4.241 . . . . 5.54 116.667 -156.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.2 tp -59.76 96.94 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.67 -1.268 . . . . 2.79 112.809 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.3 m -96.35 117.86 65.84 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 125.567 1.547 . . . . 2.0800000000000001 110.084 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -87.44 124.91 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.968 2.446 . . . . 0.98999999999999999 111.926 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.79 102.55 9.2 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.989 2.116 . . . . 3.29 109.598 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -99.83 133.98 43.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.154 1.381 . . . . 3.9100000000000001 111.618 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.82 126.19 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.556 0.742 . . . . 2.6400000000000001 108.998 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 62.2 p -90.59 111.7 23.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.08 1.352 . . . . 2.8799999999999999 110.733 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.3 pt -106.38 10.81 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 115.034 1.494 . . . . 2.77 115.034 -162.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.444 ' CG ' ' HE ' ' A' ' 207' ' ' ARG . 46.2 t0 -115.63 52.41 0.83 Allowed Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.595 1.158 . . . . 3.2999999999999998 111.405 169.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.2 132.37 25.81 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.635 2.223 . . . . 2.5800000000000001 109.188 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 128.19 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 130.334 3.454 . . . . 5.3499999999999996 107.384 -163.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.444 ' HE ' ' CG ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -123.01 -38.24 2.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.51 -0.757 . . . . 6.1399999999999997 112.617 166.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.61 101.54 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.411 1.005 . . . . 4.5599999999999996 108.672 160.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 48.0 m -115.82 149.37 38.68 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.372 1.469 . . . . 3.04 109.368 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -54.9 1.33 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.674 1.19 . . . . 4.1900000000000004 112.148 170.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -69.03 -37.41 78.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.854 1.262 . . . . 3.1899999999999999 112.94 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.71 -39.86 76.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.479 0.712 . . . . 2.4500000000000002 111.793 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.07 -34.62 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.539 0.736 . . . . 2.6400000000000001 110.556 175.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.0 75.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 118.693 -0.67 . . . . 2.0899999999999999 111.889 170.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.6 -47.44 60.14 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.343 0.974 . . . . 5.3600000000000003 112.281 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -53.42 -40.98 65.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.675 1.19 . . . . 5.25 111.485 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.4 t -64.64 -50.68 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.762 1.225 . . . . 2.3700000000000001 112.017 170.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -57.28 -27.56 62.22 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.735 1.214 . . . . 6.1399999999999997 113.754 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.36 -56.75 4.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.078 1.751 . . . . 3.7000000000000002 111.656 174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -79.3 -38.44 35.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.328 1.233 . . . . 4.6900000000000004 114.328 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 m 167.71 129.72 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 127.13 2.172 . . . . 2.4900000000000002 112.806 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.77 -0.26 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.375 2.717 . . . . 2.0 113.516 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.68 -26.37 68.62 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.277 0.944 . . . . 5.1200000000000001 113.418 162.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.18 133.42 35.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.164 0.893 . . . . 3.1800000000000002 112.788 -165.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.82 122.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.876 1.27 . . . . 2.7999999999999998 107.768 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.11 132.35 10.9 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.181 -1.168 . . . . 0.87 110.181 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.14 143.62 48.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 3.4900000000000002 109.607 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.3 m -143.08 176.27 9.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 128.813 2.845 . . . . 3.23 106.676 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 168.11 -179.85 41.04 Favored Glycine 0 N--CA 1.472 1.056 0 O-C-N 120.436 -1.415 . . . . 1.9099999999999999 114.364 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.0 t -75.42 163.47 27.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.264 0.625 . . . . 2.8799999999999999 111.053 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.401 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -49.55 -21.42 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.419 2.288 . . . . 8.4000000000000004 115.684 176.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -66.9 -51.46 55.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.137 1.375 . . . . 2.96 111.175 166.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -68.55 -43.86 75.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.242 1.017 . . . . 4.4699999999999998 111.354 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.1 m -74.55 -19.94 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 114.186 1.18 . . . . 4.0099999999999998 114.186 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.83 -57.54 4.52 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.807 1.185 . . . . 2.8399999999999999 108.602 161.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.15 -55.41 10.42 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.223 1.409 . . . . 3.6000000000000001 112.29 -173.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.37 -40.78 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 118.923 0.783 . . . . 3.2000000000000002 112.94 -171.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.17 75.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.611 0.764 . . . . 2.3500000000000001 110.436 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -70.6 -34.23 71.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 4.3300000000000001 112.678 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.16 -58.0 5.14 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.384 1.474 . . . . 3.0099999999999998 112.579 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -1.87 13.99 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.631 0.974 . . . . 3.4500000000000002 113.631 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.02 32.17 6.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.29 2.236 . . . . 6.75 113.013 165.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.56 155.66 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.664 1.185 . . . . 4.2699999999999996 110.149 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -74.14 137.87 43.49 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.276 0.56 . . . . 5.6299999999999999 112.041 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -164.83 141.7 6.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.58 2.752 . . . . 6.1699999999999999 109.481 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 129.83 2.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 117.936 -1.031 . . . . 6.0999999999999996 112.586 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -69.19 141.66 48.18 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.407 2.738 . . . . 5.0999999999999996 110.689 171.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -115.86 -170.25 15.88 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.068 0.842 . . . . 4.3200000000000003 114.471 -172.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -81.3 -174.14 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.19 3.26 . . . . 3.9700000000000002 112.105 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 255' ' ' ASP . 25.6 mmmt -60.7 148.32 39.09 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.879 -0.6 . . . . 4.8099999999999996 111.016 157.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -142.98 153.88 43.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.192 0.997 . . . . 8.0600000000000005 111.522 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 58.86 -59.22 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 128.451 2.7 . . . . 7.7000000000000002 112.519 -157.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -167.15 -52.63 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.987 2.915 . . . . 6.4699999999999998 109.108 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -133.84 5.95 3.67 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.107 1.521 . . . . 5.7400000000000002 115.107 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.434 ' O ' ' HE3' ' A' ' 250' ' ' LYS . 8.1 t70 -79.66 178.84 7.86 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 119.667 -1.896 . . . . 4.2400000000000002 110.339 164.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -132.32 106.18 7.76 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.036 -1.665 . . . . 4.3099999999999996 109.323 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.91 146.14 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 122.032 0.92 . . . . 5.2199999999999998 110.464 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.32 128.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.132 2.173 . . . . 4.6900000000000004 105.556 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -105.19 152.05 23.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.637 0.732 . . . . 3.8900000000000001 111.713 -170.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -165.18 152.46 10.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.548 1.166 . . . . 3.02 114.024 -169.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 99.2 m -59.21 120.42 9.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.182 -1.372 . . . . 4.46 108.698 164.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.29 135.73 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.023 -1.473 . . . . 4.4500000000000002 107.023 146.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.2 mt 135.65 127.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.108 1 C-N-CA 131.964 4.106 . . . . 4.0199999999999996 109.454 176.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -100.6 150.79 22.34 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.682 1.993 . . . . 3.6099999999999999 110.756 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -118.22 132.13 56.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.014 1.326 . . . . 4.8399999999999999 112.196 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 8.8 tt -90.69 125.88 35.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.181 0.991 . . . . 3.2000000000000002 111.091 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 143.82 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 127.629 2.372 . . . . 2.5099999999999998 108.684 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.32 149.11 49.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.541 -1.144 . . . . 2.5299999999999998 111.209 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.77 63.8 6.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.122 3.215 . . . . 2.8799999999999999 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 153.72 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 131.36 3.864 . . . . 8.25 113.91 173.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 168.92 149.9 6.43 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 120.455 1.48 . . . . 3.3199999999999998 116.023 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . 0.283 60.7 mt-10 41.33 -145.32 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.549 2.74 . . . . 4.1799999999999997 113.87 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -148.54 155.49 41.2 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.044 1.293 . . . . 5.1500000000000004 113.869 -163.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.84 -37.53 4.82 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.261 1.424 . . . . 3.5800000000000001 111.912 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -145.32 170.85 15.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.43 1.092 . . . . 4.1900000000000004 112.735 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -158.86 133.32 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.808 1.243 . . . . 4.7199999999999998 111.519 160.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -178.1 -122.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.179 2.192 . . . . 4.9400000000000004 111.118 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 95.79 -94.48 1.69 Allowed Glycine 0 N--CA 1.469 0.862 0 N-CA-C 109.479 -1.448 . . . . 4.5899999999999999 109.479 -168.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.08 139.39 41.62 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 117.646 0.723 . . . . 3.4700000000000002 111.104 168.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 80.82 -1.6 1.83 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.895 2.478 . . . . 6.5899999999999999 113.311 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 121.21 36.1 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.032 1.733 . . . . 7.1200000000000001 110.134 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -72.04 141.84 49.28 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.774 -1.204 . . . . 8.0600000000000005 108.31 166.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -41.07 31.54 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.117 1.895 . . . . 2.7000000000000002 116.117 -160.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.25 -18.77 71.64 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 119.787 1.176 . . . . 1.4299999999999999 114.833 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.75 -33.89 76.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.899 -0.766 . . . . 2.9500000000000002 110.777 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.6 -46.84 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.952 0.901 . . . . 2.6200000000000001 109.101 172.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.97 72.39 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.685 1.129 . . . . 2.1600000000000001 112.409 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.27 70.57 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.821 1.045 . . . . 2.52 113.821 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 5.7 p -87.43 -41.6 13.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.653 0.612 . . . . 2.7200000000000002 112.653 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mt -52.03 -38.8 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.418 1.087 . . . . 2.2200000000000002 111.01 169.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -51.73 -31.5 26.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.911 1.078 . . . . 3.0600000000000001 113.911 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 19.6 p -75.26 -32.72 61.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.073 0.949 . . . . 3.75 112.036 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -72.42 -32.01 65.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.19 0.996 . . . . 3.4900000000000002 112.372 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.19 -32.77 70.86 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.522 1.129 . . . . 7.5800000000000001 112.299 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -49.94 -51.32 62.28 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 116.307 -1.806 . . . . 6.2699999999999996 113.365 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.81 -44.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.218 2.612 . . . . 2.5899999999999999 113.367 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -92.4 123.1 35.47 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.888 1.222 . . . . 4.1699999999999999 114.146 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 78.81 -64.16 0.26 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 127.258 2.223 . . . . 14.470000000000001 112.962 155.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -137.32 111.37 8.35 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.872 0.869 . . . . 7.7699999999999996 110.61 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.424 ' HZ3' ' C ' ' A' ' 301' ' ' SER . 0.0 OUTLIER -58.72 -17.46 22.99 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 117.298 2.333 . . . . 10.6 117.298 -165.085 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.424 ' C ' ' HZ3' ' A' ' 300' ' ' LYS . 72.6 m . . . . . 0 N--CA 1.486 1.356 1 C-N-CA 133.606 4.762 . . . . 10.1 106.348 -149.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 117.702 -1.142 . . . . 17.859999999999999 110.255 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -49.48 -48.67 47.65 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.108 1.521 . . . . 14.02 115.108 -168.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.6 t -77.53 51.31 0.88 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.01 1.324 . . . . 12.140000000000001 112.811 178.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.12 164.09 42.02 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.471 1.034 . . . . 10.4 111.684 167.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt 179.44 152.25 0.54 Allowed Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.887 2.075 . . . . 9.5899999999999999 111.554 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.06 159.77 37.2 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.418 2.745 . . . . 8.3200000000000003 110.634 168.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.2 mp -121.05 134.67 55.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.884 1.273 . . . . 8.8499999999999996 108.766 172.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.05 -36.9 7.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.944 0.897 . . . . 6.6799999999999997 112.258 176.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 165.69 -158.93 32.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.89 1.71 . . . . 3.23 110.66 -169.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 134.3 -159.9 23.97 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.433 1.016 . . . . 4.21 113.585 174.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.78 156.61 39.58 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.206 2.604 . . . . 3.6499999999999999 113.804 -168.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -138.91 169.14 18.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.54 2.336 . . . . 4.04 109.199 174.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.9 m -138.53 69.47 1.38 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.727 -1.233 . . . . 3.7000000000000002 112.482 -176.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.22 172.65 7.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.441 1.097 . . . . 3.8599999999999999 112.333 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.0 m -103.42 158.52 16.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.501 1.52 . . . . 2.3999999999999999 109.525 173.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.3 m -107.94 159.79 16.27 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.939 1.296 . . . . 3.8799999999999999 111.612 -172.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -55.23 -9.74 0.47 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 115.793 1.775 . . . . 2.23 115.793 176.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 t -113.53 7.35 17.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.951 2.1 . . . . 4.21 113.622 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.49 -10.41 69.06 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.575 1.56 . . . . 2.02 115.842 173.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.99 148.71 25.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.772 1.229 . . . . 3.48 111.984 -177.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.63 115.14 28.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.56 1.544 . . . . 7.1600000000000001 111.249 -173.14 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 161.66 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.462 1.505 . . . . 4.79 112.742 -168.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.5 m -154.18 148.5 26.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.001 0.92 . . . . 3.7599999999999998 111.176 -152.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -36.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.041 2.136 . . . . 3.1600000000000001 112.569 165.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.82 3.19 2.72 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.712 1.375 . . . . 8.0299999999999994 114.712 -177.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.04 -24.43 11.59 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.335 1.854 . . . . 3.29 112.822 173.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -84.64 -15.93 43.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.865 1.061 . . . . 4.3399999999999999 113.865 165.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.03 154.43 9.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.207 1.403 . . . . 4.7000000000000002 112.929 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.19 -20.11 21.79 Favored Glycine 0 N--CA 1.478 1.495 0 C-N-CA 126.622 2.058 . . . . 2.8599999999999999 113.679 -174.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.01 173.68 6.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.277 1.831 . . . . 3.6299999999999999 108.412 165.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -67.76 110.87 3.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.226 -0.657 . . . . 2.0299999999999998 109.226 170.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.4 tp -99.16 120.66 39.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.185 0.993 . . . . 3.4300000000000002 109.207 -172.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -104.69 116.21 31.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.158 1.383 . . . . 4.7999999999999998 107.884 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.54 102.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.27 -1.011 . . . . 3.46 108.27 -178.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -100.21 148.91 24.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.024 1.73 . . . . 3.5499999999999998 111.429 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.16 117.26 29.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.094 . . . . 3.3900000000000001 110.743 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.97 153.64 23.4 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 115.777 1.071 . . . . 1.5 115.777 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.34 60.82 5.89 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.344 -1.092 . . . . 4.9100000000000001 112.561 -170.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.7 m 64.1 -20.55 0.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 128.174 2.59 . . . . 4.5700000000000003 115.551 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 176.83 -50.23 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 128.688 2.795 . . . . 11.48 110.101 -166.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.1 OUTLIER 61.0 177.8 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.881 1.272 . . . . 2.6499999999999999 112.7 -164.533 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 39.7 Cg_endo -88.92 -132.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.88 3.053 . . . . 3.77 107.341 159.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -80.56 61.98 4.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.717 1.207 . . . . 5.0599999999999996 112.403 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.75 -83.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.594 1.557 . . . . 4.7400000000000002 110.365 175.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.4 m -49.87 -48.31 78.17 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.739 1.755 . . . . 2.2599999999999998 115.739 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.77 -25.47 23.91 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.563 2.176 . . . . 1.52 113.732 -169.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.68 -52.93 63.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.973 1.709 . . . . 4.04 110.806 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.57 -26.05 61.57 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.848 -1.158 . . . . 2.8399999999999999 111.963 171.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -45.6 78.53 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.465 -1.397 . . . . 3.4399999999999999 111.849 -177.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.93 -41.01 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.227 1.376 . . . . 4.8799999999999999 111.033 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -60.68 -47.85 84.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.594 1.558 . . . . 4.2699999999999996 110.706 174.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.85 -57.13 13.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.351 1.46 . . . . 3.5800000000000001 111.428 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.26 -47.66 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.085 1.311 . . . . 3.5600000000000001 111.786 -172.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -63.13 -28.6 70.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.921 0.782 . . . . 3.1800000000000002 110.889 -173.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.34 -27.5 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 116.846 -1.55 . . . . 2.6600000000000001 113.304 -178.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.534 HG21 ' H ' ' A' ' 196' ' ' LEU . 3.4 p -67.43 -32.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 121.276 1.853 . . . . 4.0899999999999999 111.365 171.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -87.78 -15.25 37.45 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.794 0.838 . . . . 5.4900000000000002 112.95 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.6 -13.17 59.98 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.676 -1.265 . . . . 3.4700000000000002 113.004 164.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.59 -58.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.679 1.591 . . . . 3.0800000000000001 111.675 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -63.44 -38.64 91.92 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.31 1.414 . . . . 3.75 112.671 -176.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 7.9 t -67.79 -11.23 58.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.582 2.753 . . . . 3.6800000000000002 113.835 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.99 -25.86 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.391 -1.443 . . . . 4.7699999999999996 113.157 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t 174.29 -42.14 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.466 2.306 . . . . 5.9000000000000004 112.126 167.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.411 ' O ' ' HE3' ' A' ' 299' ' ' LYS . 26.9 m 173.83 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 130.557 3.543 . . . . 6.3300000000000001 105.052 -173.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.7 mp -103.05 173.65 3.34 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.291 0.636 . . . . 5.5700000000000003 111.345 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.44 154.46 21.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.567 2.178 . . . . 3.98 110.801 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.39 142.64 32.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.068 0.937 . . . . 3.6600000000000001 111.83 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.534 ' H ' HG21 ' A' ' 184' ' ' VAL . 48.3 tp -104.79 63.89 0.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.479 2.312 . . . . 2.77 108.188 175.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.1 m -57.66 115.46 10.99 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.142 -0.932 . . . . 2.6400000000000001 110.39 -166.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -86.92 116.06 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.729 2.286 . . . . 1.02 112.134 -173.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.43 117.44 34.1 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.693 1.597 . . . . 3.3900000000000001 109.518 178.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -97.99 114.27 26.36 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.269 1.028 . . . . 3.3599999999999999 110.124 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -83.21 122.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.256 -1.016 . . . . 2.9199999999999999 108.256 165.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.53 128.98 34.94 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.854 -0.738 . . . . 2.21 111.243 166.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 pt -104.66 28.81 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 125.285 1.434 . . . . 2.8999999999999999 113.261 178.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -122.8 47.44 1.57 Allowed Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 127.907 2.483 . . . . 3.4100000000000001 112.942 -176.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.67 82.6 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.19 1 C-N-CA 126.206 4.604 . . . . 2.7599999999999998 111.817 -172.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 175.38 -33.33 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.293 1.437 . . . . 3.98 114.406 -160.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -151.25 11.13 0.61 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.392 1.256 . . . . 6.2800000000000002 114.392 170.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -70.11 54.49 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 130.888 3.675 . . . . 5.04 112.284 172.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 98.7 m -60.3 137.89 58.05 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.297 1.839 . . . . 2.5899999999999999 110.464 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -43.35 -55.16 4.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.242 1.417 . . . . 4.75 112.984 -178.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -66.04 -33.53 76.01 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.119 1.768 . . . . 3.1299999999999999 114.096 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.52 -36.14 73.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.961 1.255 . . . . 2.23 111.596 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.82 -36.6 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.186 0.995 . . . . 2.7200000000000002 110.848 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.9 70.71 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.092 0.86 . . . . 2.1899999999999999 112.061 168.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -66.24 -47.29 74.26 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.334 -0.853 . . . . 5.4699999999999998 111.837 171.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -65.87 -32.56 74.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.933 0.716 . . . . 4.9900000000000002 112.933 178.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.54 -49.0 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.13 0.972 . . . . 2.3399999999999999 111.34 166.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.571 1.148 . . . . 5.3700000000000001 113.515 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -62.43 -33.35 74.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.43 1.092 . . . . 4.8499999999999996 112.164 177.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -98.73 -63.25 1.14 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.484 0.92 . . . . 3.9199999999999999 113.484 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.4 m 170.89 145.72 0.12 Allowed Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 126.717 2.007 . . . . 2.8300000000000001 112.197 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.94 4.71 2.99 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.545 3.497 . . . . 2.2400000000000002 114.556 -175.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -71.36 -23.72 61.96 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 119.687 1.13 . . . . 2.9100000000000001 111.494 163.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.1 tt -87.35 145.13 26.45 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.463 1.505 . . . . 3.2599999999999998 111.096 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.6 m -130.18 139.77 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.666 1.186 . . . . 3.6699999999999999 110.951 175.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.94 130.94 9.62 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.544 1.069 . . . . 0.90000000000000002 111.708 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.82 143.84 51.11 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.159 0.984 . . . . 3.4700000000000002 113.243 -173.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.8 p -147.37 169.39 19.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.078 2.151 . . . . 3.0699999999999998 112.16 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -179.02 -178.94 48.59 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.332 1.92 . . . . 1.8999999999999999 110.45 -176.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -63.96 163.02 12.85 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.532 1.166 . . . . 3.29 111.636 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.7 mtt-85 -47.58 -35.22 8.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.055 1.342 . . . . 6.7999999999999998 112.738 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 18.3 mp0 -72.05 -37.1 69.75 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.582 1.953 . . . . 2.9100000000000001 112.147 178.172 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -70.39 -42.66 71.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.711 -1.243 . . . . 3.48 111.345 176.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.4 t -63.36 -36.9 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.414 0.686 . . . . 2.5899999999999999 110.98 173.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.03 -44.51 84.45 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.757 -0.639 . . . . 3.0800000000000001 110.457 174.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -55.82 -50.94 69.16 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.232 0.924 . . . . 2.8199999999999998 111.787 176.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.26 -36.07 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.703 0.683 . . . . 3.25 112.216 -175.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.99 92.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.827 0.739 . . . . 2.2400000000000002 111.624 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.9 ttm105 -67.36 -38.78 85.35 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.927 1.291 . . . . 4.0999999999999996 112.255 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.57 70.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.371 0.987 . . . . 2.6800000000000002 112.076 178.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -88.63 12.58 14.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.199 1.4 . . . . 3.6400000000000001 113.893 176.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 46.19 37.86 4.39 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.008 2.123 . . . . 7.5199999999999996 115.28 -176.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.62 145.08 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.715 2.006 . . . . 4.54 112.577 -173.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -80.63 139.2 36.35 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.562 1.319 . . . . 4.2300000000000004 114.562 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -155.03 158.95 39.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.451 1.5 . . . . 4.5499999999999998 111.878 154.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 41.2 m -126.7 125.53 24.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.329 1.852 . . . . 4.4000000000000004 107.883 167.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.77 147.67 45.08 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.04 2.494 . . . . 4.1500000000000004 111.062 -178.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.73 151.63 39.68 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 114.599 0.599 . . . . 2.9700000000000002 114.599 -167.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -86.89 -149.61 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.762 3.641 . . . . 4.8899999999999997 109.479 173.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.475 ' HZ1' ' CD ' ' A' ' 254' ' ' GLU . 5.7 mmpt? -122.36 143.74 49.46 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.19 -0.944 . . . . 5.5199999999999996 108.628 154.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -88.4 -166.63 1.64 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 118.862 -0.59 . . . . 7.8300000000000001 111.317 166.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -82.37 -19.19 39.69 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.646 1.35 . . . . 9.5199999999999996 114.646 -172.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.35 -84.55 0.23 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.86 1.264 . . . . 7.2699999999999996 110.408 173.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.475 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 23.1 tp10 -166.54 18.23 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.532 2.333 . . . . 5.5199999999999996 111.247 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.64 149.48 48.88 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 119.684 -1.885 . . . . 4.8200000000000003 113.427 178.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -129.54 60.32 1.58 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.44 1.496 . . . . 5.2800000000000002 112.047 174.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.86 108.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 120.414 -1.429 . . . . 5.2800000000000002 111.765 170.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.5 143.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.53 1.532 . . . . 3.9100000000000001 108.17 164.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.5 160.09 23.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.131 0.972 . . . . 3.4500000000000002 110.672 173.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.55 154.39 0.38 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.494 -1.379 . . . . 3.5800000000000001 112.959 -134.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -68.59 -30.72 69.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 117.285 2.328 . . . . 5.46 117.285 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.7 pt 39.4 34.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 126.556 1.942 . . . . 4.7800000000000002 116.045 -172.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 19.1 mt -113.9 144.26 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 3.2799999999999998 110.113 -177.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.7 143.04 31.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.481 0.712 . . . . 5.6500000000000004 111.289 156.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -97.87 132.79 43.15 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.723 0.809 . . . . 4.5700000000000003 111.096 162.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -93.14 93.63 8.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.759 1.224 . . . . 2.71 109.829 178.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.17 127.44 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.875 1.27 . . . . 2.4500000000000002 108.672 175.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.51 161.97 54.24 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 110.851 -0.899 . . . . 1.72 110.851 172.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -65.23 -8.83 19.77 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.376 2.051 . . . . 3.0299999999999998 113.794 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -107.23 29.74 6.85 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.097 1.759 . . . . 5.6100000000000003 112.093 170.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.16 -42.04 3.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.663 1.601 . . . . 2.5800000000000001 116.399 161.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -78.74 151.76 31.88 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.351 1.576 . . . . 5.6699999999999999 111.369 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -89.53 144.05 26.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.033 -1.042 . . . . 4.3600000000000003 113.738 -177.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -23.94 14.83 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.867 1.267 . . . . 3.6400000000000001 112.881 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -168.25 170.01 10.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.887 1.275 . . . . 2.3900000000000001 111.016 -167.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -153.56 140.1 18.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.847 0.859 . . . . 5.0199999999999996 112.432 175.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . 0.556 ' CE1' ' HE2' ' A' ' 281' ' ' LYS . 13.2 m-85 -137.06 130.3 31.11 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.653 -0.654 . . . . 4.4800000000000004 111.91 -169.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.12 91.83 0.08 OUTLIER Glycine 0 N--CA 1.471 0.985 0 N-CA-C 115.221 0.848 . . . . 4.1699999999999999 115.221 174.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 137.32 127.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 1 C-N-CA 132.823 4.449 . . . . 4.3099999999999996 107.073 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -40.51 98.91 0.01 OUTLIER 'General case' 0 C--O 1.237 0.409 0 O-C-N 124.763 1.289 . . . . 9.7699999999999996 113.752 -140.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.556 ' HE2' ' CE1' ' A' ' 277' ' ' PHE . 45.7 tttp -78.95 -18.22 54.15 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.442 -0.786 . . . . 5.0199999999999996 111.488 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.39 120.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.13 2.572 . . . . 6.7199999999999998 108.583 -177.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -26.05 -77.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.673 2.389 . . . . 3.7400000000000002 114.815 -176.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.53 -13.14 49.51 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 115.439 0.936 . . . . 2.2999999999999998 115.439 -175.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.74 -30.76 40.94 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.218 2.009 . . . . 3.4900000000000002 112.532 172.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 21.8 mt -60.03 -40.65 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.136 -0.977 . . . . 2.6400000000000001 108.859 165.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.12 -51.42 64.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.24 -0.41 . . . . 2.3399999999999999 111.88 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.87 78.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.226 1.195 . . . . 2.75 114.226 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.5 p -67.33 -50.11 61.38 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 2.6299999999999999 111.761 172.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.63 -38.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.742 1.156 . . . . 2.1600000000000001 112.491 174.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.4 -16.18 33.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.743 1.217 . . . . 2.1600000000000001 114.254 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.7 m -81.27 -47.86 12.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 2.1499999999999999 110.281 167.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -67.32 -27.64 67.32 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.24 1.016 . . . . 3.5899999999999999 113.641 -178.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 76.4 mtm -71.61 -23.41 61.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.378 -1.451 . . . . 5.7999999999999998 113.498 174.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.16 -35.25 11.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 116.29 -1.814 . . . . 4.6500000000000004 114.048 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.89 -41.39 1.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.912 2.076 . . . . 1.98 112.577 162.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.76 -157.19 0.11 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.837 1.791 . . . . 4.5 115.837 -169.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -60.22 123.13 16.27 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 119.992 -1.693 . . . . 11.140000000000001 110.939 174.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 192' ' ' THR . 9.7 mmtt 63.45 115.15 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.524 2.33 . . . . 9.0800000000000001 114.519 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -45.78 16.87 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.066 -0.97 . . . . 12.52 111.164 175.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.256 1.418 0 C-N-CA 129.929 3.291 . . . . 10.74 105.803 -174.825 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 118.275 -0.869 . . . . 19.02 110.27 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -159.08 145.59 16.85 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.318 1.447 . . . . 16.489999999999998 109.597 178.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.0 m -137.81 48.89 1.99 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.879 0.871 . . . . 15.73 111.505 -165.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.37 31.84 0.56 Allowed Glycine 0 N--CA 1.478 1.468 0 C-N-CA 125.046 1.308 . . . . 11.48 115.609 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -134.13 65.23 68.63 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.087 1.355 . . . . 10.529999999999999 111.821 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.27 86.08 1.18 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.41 2.74 . . . . 10.380000000000001 111.081 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 74.93 -63.79 0.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 128.016 2.527 . . . . 11.949999999999999 112.705 172.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp 63.37 -174.78 0.16 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.295 2.638 . . . . 6.0300000000000002 113.169 178.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -175.21 -42.46 0.05 OUTLIER Glycine 0 N--CA 1.469 0.889 0 N-CA-C 115.879 1.112 . . . . 4.6299999999999999 115.879 166.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.49 -172.86 45.29 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 118.087 0.943 . . . . 3.4199999999999999 113.329 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.28 151.49 26.47 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.44 2.76 . . . . 3.6899999999999999 112.525 -167.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -81.52 155.79 25.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.881 0.872 . . . . 4.0899999999999999 110.143 166.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.5 t -142.41 101.52 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.686 -1.259 . . . . 3.3100000000000001 108.916 167.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.89 162.49 32.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.191 1.396 . . . . 3.3999999999999999 110.733 -170.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.9 m -84.27 133.53 34.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.465 0.706 . . . . 2.8900000000000001 109.58 172.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.2 t -98.2 162.76 13.03 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.593 1.557 . . . . 3.48 109.974 177.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -65.37 -9.42 24.74 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.192 1.553 . . . . 2.5699999999999998 115.192 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.7 p -73.44 -21.94 60.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.159 1.384 . . . . 3.7999999999999998 113.292 166.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.85 -9.54 63.95 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.626 1.584 . . . . 1.8 113.401 -170.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -65.91 148.64 51.48 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.677 1.238 . . . . 4.79 110.508 170.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.66 109.08 20.9 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.684 0.793 . . . . 7.1799999999999997 109.152 171.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.06 167.81 10.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.463 1.905 . . . . 4.54 113.742 -161.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -148.73 165.42 31.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.466 1.507 . . . . 3.7999999999999998 110.44 -178.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -47.28 -45.05 23.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.901 2.08 . . . . 3.8100000000000001 113.09 175.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -80.49 -4.49 54.06 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.165 1.172 . . . . 6.4100000000000001 114.165 -176.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.37 -47.47 7.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.768 1.627 . . . . 3.96 109.16 163.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -75.46 11.13 1.35 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.823 1.786 . . . . 4.3099999999999996 115.823 -176.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tp -78.67 -170.51 2.14 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.716 1.606 . . . . 4.7699999999999996 113.238 -172.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.3 -36.04 1.54 Allowed Glycine 0 N--CA 1.479 1.505 0 C-N-CA 125.681 1.61 . . . . 4.0199999999999996 114.463 176.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -76.86 -179.53 5.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.791 1.236 . . . . 4.2999999999999998 111.448 162.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -91.35 149.54 21.69 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.673 0.749 . . . . 2.2200000000000002 109.734 156.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.4 tp -136.89 140.28 42.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.519 0.728 . . . . 4.3399999999999999 111.111 -173.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.41 138.63 51.69 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.674 1.19 . . . . 3.8100000000000001 108.042 164.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.7 mt -123.65 131.89 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.473 1.109 . . . . 3.6600000000000001 108.525 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -134.37 138.85 45.2 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.002 1.321 . . . . 3.7400000000000002 111.834 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -102.54 117.97 35.84 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.498 1.119 . . . . 3.8900000000000001 111.22 175.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.77 -178.36 15.97 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.098 0.856 . . . . 1.21 114.289 173.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -136.12 119.58 16.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.136 0.975 . . . . 4.8300000000000001 110.847 -168.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 m -71.36 20.5 0.05 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.167 1.787 . . . . 3.1600000000000001 113.407 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -124.48 -16.33 6.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.203 1.801 . . . . 8.2200000000000006 111.351 168.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 38.4 t -63.53 136.91 96.92 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 119.531 1.059 . . . . 3.2599999999999998 112.349 -171.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.25 99.69 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.332 2.688 . . . . 3.3700000000000001 109.621 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 74.88 -35.8 0.3 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.141 2.576 . . . . 4.1299999999999999 114.777 155.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 72.4 t -54.55 -56.73 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.472 1.509 . . . . 3.27 110.836 176.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 33.4 m -53.85 -57.59 17.0 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.65 -1.166 . . . . 1.8200000000000001 113.316 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.74 -39.48 4.6 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.768 1.645 . . . . 1.8400000000000001 114.223 -175.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -41.02 70.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.235 1.38 . . . . 3.5299999999999998 111.888 -178.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -30.38 69.42 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.433 1.015 . . . . 2.98 111.28 176.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.8 tp -69.87 -35.31 74.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 3.7400000000000002 112.323 173.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -42.98 90.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.987 0.812 . . . . 3.7000000000000002 110.314 170.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -54.33 -35.62 62.89 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 119.995 -1.69 . . . . 3.75 112.012 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.3 ttp -70.17 -28.02 64.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.914 1.079 . . . . 3.73 113.914 171.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.95 -52.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.803 1.638 . . . . 2.6200000000000001 109.781 167.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -56.1 -27.0 52.01 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.201 1.001 . . . . 3.8399999999999999 112.022 -176.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 t -64.56 -29.99 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 117.402 -1.285 . . . . 2.7799999999999998 111.729 176.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.91 -44.55 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.679 2.036 . . . . 3.4300000000000002 111.892 -175.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.89 -43.73 98.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.761 1.624 . . . . 3.4900000000000002 111.631 174.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.18 -38.98 84.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.507 1.523 . . . . 3.9500000000000002 111.811 170.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 -49.38 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.801 1.64 . . . . 3.25 112.906 -177.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.68 -28.13 68.85 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.528 1.513 . . . . 5.6100000000000003 109.762 176.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.0 t -67.84 -13.47 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.793 1.405 . . . . 5.75 114.793 172.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.32 -26.55 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.608 1.549 . . . . 6.8799999999999999 111.04 169.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.305 60.9 p 119.65 50.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 1 C-N-CA 133.119 4.567 . . . . 8.4199999999999999 111.119 -175.469 . . . . . . . . 3 2 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.423 0.6 OUTLIER 79.16 67.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.658 1.983 . . . . 5.6299999999999999 114.67 146.52 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.04 166.82 0.37 Allowed Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 126.651 1.98 . . . . 5.4500000000000002 111.52 160.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.37 -55.43 0.37 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.183 1.815 . . . . 3.71 109.296 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -169.65 158.22 7.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.288 3.035 . . . . 4.6500000000000004 107.22 160.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.3 tp -112.77 106.91 15.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.945 1.298 . . . . 3.0 110.889 166.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -78.7 130.51 70.54 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.675 -0.678 . . . . 2.5899999999999999 110.411 170.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.52 114.91 1.02 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.451 2.768 . . . . 1.23 109.908 159.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.84 111.28 23.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.375 1.47 . . . . 4.2400000000000002 108.641 174.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -91.97 124.83 36.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 3.02 110.043 174.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.25 119.97 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.788 0.835 . . . . 2.4399999999999999 108.81 167.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -83.24 130.39 35.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.186 -0.461 . . . . 2.46 109.989 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -104.62 16.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.559 0.948 . . . . 2.71 113.559 171.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.11 14.57 0.04 OUTLIER Pre-proline 0 CA--C 1.573 1.841 0 C-N-CA 127.926 2.49 . . . . 3.3500000000000001 117.17 177.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -80.41 53.56 4.82 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 123.863 2.415 . . . . 3.3599999999999999 113.171 -177.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -83.91 -41.33 17.51 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.143 -0.688 . . . . 4.5800000000000001 109.143 141.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.76 0.53 4.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.088 1.355 . . . . 7.7400000000000002 114.181 -171.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -93.2 156.75 16.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.886 1.274 . . . . 4.3399999999999999 110.91 174.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -137.5 147.92 45.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 3.2000000000000002 111.02 -176.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.2 -34.31 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.157 -0.929 . . . . 3.6699999999999999 111.774 173.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -66.21 -44.1 84.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.593 1.957 . . . . 3.1699999999999999 112.522 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.05 78.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.469 1.032 . . . . 2.1400000000000001 111.193 174.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.94 -41.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.694 0.798 . . . . 2.8100000000000001 111.415 174.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.46 -15.81 30.35 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.933 1.086 . . . . 2.1499999999999999 113.933 176.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.59 -47.11 7.28 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.403 1.456 . . . . 4.9500000000000002 113.149 165.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.09 -37.73 47.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.93 1.692 . . . . 4.1500000000000004 111.565 175.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.0 t -43.56 -56.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.305 2.242 . . . . 2.71 112.792 167.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.14 -31.55 67.86 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.785 0.661 . . . . 4.7699999999999996 112.785 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -63.36 -23.86 67.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.35 1.06 . . . . 4.0300000000000002 111.643 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.95 -45.36 10.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.63 0.974 . . . . 4.4100000000000001 113.63 168.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.2 p -174.33 167.59 2.2 Favored Pre-proline 0 N--CA 1.476 0.851 0 O-C-N 120.497 -1.377 . . . . 3.5099999999999998 113.764 -168.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.59 2.54 8.27 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.485 2.79 . . . . 4.2300000000000004 113.959 165.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.43 -26.24 6.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.953 1.464 . . . . 2.7999999999999998 114.953 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.69 148.48 48.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.193 0.997 . . . . 3.2999999999999998 111.217 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.43 132.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.24 1.016 . . . . 3.5 109.738 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.0 110.4 2.76 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.085 0.85 . . . . 1.3200000000000001 111.606 -170.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp -108.99 144.88 36.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.5 1.12 . . . . 3.8300000000000001 111.949 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.01 178.51 10.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.761 1.624 . . . . 3.4399999999999999 108.892 -175.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.95 -140.64 3.39 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 108.498 -1.841 . . . . 1.8799999999999999 108.498 166.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 65.7 p -80.36 176.43 9.78 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.446 1.498 . . . . 3.6299999999999999 111.988 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.485 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -62.02 -21.68 65.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 118.346 -0.835 . . . . 9.1899999999999995 112.78 165.788 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.485 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 22.2 mp0 -71.19 -39.44 71.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.105 1.362 . . . . 2.9199999999999999 111.431 171.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -64.12 -42.95 96.64 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.051 -1.031 . . . . 3.8999999999999999 111.616 173.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.5 t -59.47 -43.66 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.818 0.699 . . . . 2.7400000000000002 110.769 173.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.25 -49.78 70.57 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.024 -0.988 . . . . 3.6600000000000001 108.725 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -47.12 -56.91 5.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.41 -0.805 . . . . 3.9100000000000001 111.242 174.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.9 m -76.87 -27.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.877 1.065 . . . . 3.6699999999999999 113.877 -168.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.83 -40.17 55.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.525 0.602 . . . . 2.1499999999999999 111.549 172.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -75.01 -33.71 61.84 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.62 1.968 . . . . 4.2300000000000004 111.801 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -49.58 -72.51 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.561 1.073 . . . . 2.3500000000000001 110.956 167.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -85.21 9.24 15.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.063 1.505 . . . . 4.5999999999999996 115.063 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.92 18.8 11.18 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.47 1.508 . . . . 9.0299999999999994 113.715 171.11 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 m -67.89 -15.09 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 117.435 2.383 . . . . 3.9900000000000002 117.435 -145.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.4 t80 60.83 131.54 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.086 2.555 . . . . 4.4000000000000004 116.898 -174.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -160.54 165.68 30.41 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.873 2.469 . . . . 4.1399999999999997 109.391 170.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.3 t -154.49 134.51 8.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 121.291 -0.88 . . . . 3.71 110.813 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.44 144.51 10.31 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.913 2.409 . . . . 3.1000000000000001 112.977 -173.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.3 130.64 38.2 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 110.76 -0.936 . . . . 2.7400000000000002 110.76 163.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.74 149.91 21.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.624 2.216 . . . . 3.6099999999999999 112.208 -166.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -75.27 38.96 0.14 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 127.615 2.366 . . . . 6.2199999999999998 113.149 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -135.29 -23.29 1.48 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.183 1.179 . . . . 7.9199999999999999 114.183 -142.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -88.68 -34.15 17.31 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.914 0.886 . . . . 8.4700000000000006 113.163 -176.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -173.28 -57.44 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.3 2.64 . . . . 5.5 107.86 165.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.3 134.23 0.52 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.931 2.092 . . . . 5.46 110.959 157.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 256' ' ' TYR . 26.1 t0 -166.36 173.5 9.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.997 1.719 . . . . 3.8999999999999999 112.152 176.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.457 ' H ' ' CG ' ' A' ' 255' ' ' ASP . 0.1 OUTLIER -151.56 49.88 0.82 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.748 1.619 . . . . 4.6100000000000003 111.416 170.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.2 tp -56.68 161.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 119.364 -2.085 . . . . 3.4199999999999999 110.263 159.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.73 146.73 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.181 -0.95 . . . . 5.5199999999999996 109.869 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.62 143.78 28.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.924 1.29 . . . . 3.9900000000000002 109.15 161.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.9 145.01 8.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.167 1.387 . . . . 3.48 111.129 -172.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.7 p -62.19 -22.35 65.84 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.963 1.097 . . . . 4.2199999999999998 113.963 171.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.334 0.1 OUTLIER 49.12 62.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.769 1.747 . . . . 4.96 110.715 -174.473 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.1 mm -118.92 152.44 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.283 2.233 . . . . 3.4900000000000002 110.94 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.0 mtp -132.93 155.67 48.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.418 2.687 . . . . 3.3799999999999999 109.376 -175.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -117.29 143.74 45.6 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.746 1.017 . . . . 4.5 113.746 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.76 127.5 42.79 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.906 1.682 . . . . 3.96 107.322 168.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.6 130.87 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.497 0.719 . . . . 3.9300000000000002 109.073 171.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.13 173.16 37.4 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.921 0.772 . . . . 2.2200000000000002 112.285 177.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.05 68.16 6.63 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.185 3.257 . . . . 3.27 111.085 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -167.83 -56.69 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.325 1.85 . . . . 5.4699999999999998 109.729 -164.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 144.12 165.05 10.75 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.191 1.236 . . . . 3.8300000000000001 116.191 170.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 70.65 -86.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.054 1.741 . . . . 8.4100000000000001 111.976 165.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.72 157.01 9.9 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.779 1.632 . . . . 6.8799999999999999 112.281 -173.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -39.38 0.6 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.395 1.478 . . . . 4.9900000000000002 111.579 -175.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.33 176.01 13.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.756 2.023 . . . . 3.6800000000000002 108.538 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -135.39 150.05 49.8 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.211 1.004 . . . . 4.4100000000000001 112.437 178.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -133.18 -170.02 2.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.591 1.557 . . . . 4.3099999999999996 110.477 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.91 -157.75 14.73 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.521 1.057 . . . . 3.3799999999999999 110.888 -171.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -71.91 90.71 1.14 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.546 0.943 . . . . 4.9400000000000004 113.546 -164.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.1 p30 165.71 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 130.267 3.427 . . . . 8.7599999999999998 112.984 164.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.94 108.91 7.04 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.368 -0.832 . . . . 7.0800000000000001 108.934 170.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.71 135.5 37.17 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.19 0.996 . . . . 9.5800000000000001 109.672 -172.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -21.24 -66.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.121 2.267 . . . . 3.9700000000000002 117.121 -163.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.33 -20.41 65.32 Favored Glycine 0 N--CA 1.48 1.607 0 CA-C-N 119.944 1.247 . . . . 2.2799999999999998 114.733 -173.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.94 -22.5 66.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.633 1.173 . . . . 4.4299999999999997 111.642 172.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.41 -48.69 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.822 -1.173 . . . . 2.6899999999999999 109.729 175.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.25 92.26 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.179 0.807 . . . . 2.6499999999999999 113.179 173.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.93 74.19 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.984 0.735 . . . . 2.7000000000000002 112.984 178.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 14.1 p -72.33 -44.07 63.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.72 -1.238 . . . . 2.04 111.677 170.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.9 -34.52 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.742 1.155 . . . . 2.8300000000000001 111.985 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.38 47.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.613 1.338 . . . . 3.0 114.613 171.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.9 m -80.6 -48.45 12.66 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.115 0.87 . . . . 3.9300000000000002 110.413 170.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -64.85 -28.29 69.45 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.849 1.26 . . . . 3.5899999999999999 112.55 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.0 ttp -58.86 -20.0 46.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.225 2.61 . . . . 5.6299999999999999 113.457 170.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -72.23 -50.41 8.75 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.824 -1.56 . . . . 6.9000000000000004 111.936 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.27 -54.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 123.26 2.64 . . . . 3.4199999999999999 112.966 169.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.65 126.27 33.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.554 0.742 . . . . 4.8300000000000001 110.618 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -80.27 174.79 11.25 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.211 1.56 . . . . 7.8899999999999997 115.211 -166.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -108.34 -79.59 0.58 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.713 1.205 . . . . 8.6600000000000001 112.211 -170.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -132.64 -32.47 1.29 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.067 2.147 . . . . 9.5099999999999998 109.56 177.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.247 0.97 0 C-N-CA 123.681 0.793 . . . . 8.0899999999999999 109.445 128.053 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 118.161 -0.924 . . . . 16.940000000000001 110.016 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -146.08 133.24 20.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.185 0.994 . . . . 16.800000000000001 108.729 172.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.1 p -158.53 119.41 3.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.278 1.431 . . . . 12.130000000000001 108.577 -170.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.72 -61.84 3.96 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.086 0.851 . . . . 11.390000000000001 113.761 177.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -154.76 167.46 13.94 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.826 1.251 . . . . 13.51 113.089 -170.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -81.18 -151.13 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 125.266 3.978 . . . . 9.8300000000000001 109.578 170.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.8 -22.03 63.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.179 1.548 . . . . 10.59 115.179 -173.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.8 tp 91.0 141.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 129.441 3.097 . . . . 7.5199999999999996 111.826 171.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.54 -170.36 37.25 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.616 1.103 . . . . 3.1099999999999999 113.256 169.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.6 89.94 0.65 Allowed Glycine 0 CA--C 1.537 1.46 0 CA-C-O 118.428 -1.207 . . . . 3.6200000000000001 114.365 -176.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.01 150.79 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.707 2.271 . . . . 3.0099999999999998 110.289 168.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -156.01 165.25 37.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.752 0.821 . . . . 3.7200000000000002 112.122 -167.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.8 m -121.41 137.99 54.47 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.722 -0.611 . . . . 2.6000000000000001 109.999 147.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 mt -142.8 153.5 43.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.3 1.04 . . . . 4.2199999999999998 109.575 168.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.3 m -93.25 150.75 20.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.886 0.874 . . . . 2.2599999999999998 108.76 174.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.9 p -96.34 163.03 13.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 2.46 112.17 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -61.74 -16.8 52.48 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.075 1.139 . . . . 2.2599999999999998 114.075 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -87.23 -43.7 12.0 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 117.566 -1.207 . . . . 3.5600000000000001 111.368 168.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.9 5.98 1.57 Allowed Glycine 0 N--CA 1.474 1.185 0 N-CA-C 119.145 2.418 . . . . 1.77 119.145 158.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.4 158.0 19.11 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 121.419 2.609 . . . . 3.9900000000000002 111.944 172.145 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -111.54 120.49 42.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.207 1.403 . . . . 6.7000000000000002 110.963 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.63 167.49 22.43 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.539 1.311 . . . . 6.3399999999999999 114.539 -168.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.4 p -120.85 173.92 6.93 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.744 2.818 . . . . 2.98 111.742 -171.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.05 -31.63 72.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.276 0.63 . . . . 3.8599999999999999 112.629 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -19.3 65.13 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.96 -1.088 . . . . 9.1999999999999993 112.388 174.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -85.89 -43.78 12.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.868 0.867 . . . . 3.6600000000000001 111.138 172.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -67.41 -25.88 66.15 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.596 1.332 . . . . 4.4199999999999999 114.596 175.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 49.15 42.52 21.51 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.442 2.297 . . . . 6.2699999999999996 112.486 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.3 -74.44 0.06 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.169 2.319 . . . . 5.71 113.286 -173.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 63.12 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.352 2.261 . . . . 4.1200000000000001 111.803 -175.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -167.82 92.28 0.36 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.605 2.762 . . . . 2.8100000000000001 109.172 173.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.05 131.06 53.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.764 1.226 . . . . 4.3200000000000003 113.569 -174.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.49 124.77 49.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.113 1.365 . . . . 3.48 108.525 166.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 29.3 mt -126.84 114.35 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.238 1.015 . . . . 2.73 109.822 -164.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -122.43 139.91 53.32 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.701 1.0 . . . . 3.8700000000000001 113.701 -174.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -96.36 109.31 21.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.727 0.811 . . . . 3.9300000000000002 109.549 172.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.48 146.67 18.13 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.058 1.314 . . . . 1.23 113.471 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.429 ' CD1' ' HB ' ' A' ' 258' ' ' VAL . 1.2 m-85 -81.54 61.12 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.13 0.972 . . . . 5.7999999999999998 111.317 -174.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.3 p 45.84 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.071 2.148 . . . . 5.0599999999999996 110.894 -170.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -103.62 116.72 32.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.29 0.95 . . . . 10.6 108.957 155.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.8 t -44.29 -174.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 130.954 3.702 . . . . 2.6000000000000001 115.089 169.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -47.31 -70.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.77 1.646 . . . . 4.0499999999999998 109.776 138.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -167.66 21.77 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.84 1.793 . . . . 5.0899999999999999 115.84 166.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 -34.71 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.318 -1.489 . . . . 3.4300000000000002 111.766 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 90.1 m -44.2 -55.53 9.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.649 -1.643 . . . . 1.8100000000000001 112.823 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.7 -29.35 60.01 Favored 'Trans proline' 0 C--N 1.354 0.817 0 CA-C-N 122.308 1.86 . . . . 1.3500000000000001 114.092 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -75.58 -38.93 58.77 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.374 0.988 . . . . 3.6099999999999999 112.216 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.51 -37.27 65.73 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.564 -1.335 . . . . 3.3199999999999998 111.979 171.138 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.0 tt -55.85 -43.91 77.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.396 1.078 . . . . 4.8600000000000003 111.492 169.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.22 -35.04 74.55 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.628 1.103 . . . . 3.1600000000000001 112.466 -177.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -62.79 -45.18 93.84 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.587 -1.321 . . . . 4.0099999999999998 111.238 173.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.7 ptp -68.81 -21.44 64.32 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 117.596 -1.192 . . . . 3.0800000000000001 114.199 173.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.1 -57.23 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 120.586 1.539 . . . . 3.0800000000000001 109.322 166.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -59.45 -19.81 50.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.325 1.45 . . . . 4.5300000000000002 113.169 -177.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.78 -29.6 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.562 1.074 . . . . 2.6400000000000001 113.758 170.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.04 -36.56 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 121.361 1.891 . . . . 3.7400000000000002 110.706 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -50.56 36.56 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.57 1.948 . . . . 6.7400000000000002 112.248 166.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -67.05 -36.58 82.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.603 0.761 . . . . 4.0499999999999998 112.073 178.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mm -69.42 -45.98 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.995 1.318 . . . . 3.5299999999999998 111.238 -177.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -66.04 -33.61 76.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 4.9900000000000002 110.475 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.2 t -70.36 -8.15 48.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.657 1.183 . . . . 5.4000000000000004 113.848 171.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.5 mm -79.19 -38.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.978 1.263 . . . . 4.79 110.287 165.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 57.87 -23.38 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 129.386 3.074 . . . . 4.9500000000000002 116.082 -176.175 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 p -75.92 -20.79 57.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.249 -1.532 . . . . 6.0899999999999999 112.942 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.83 173.64 1.98 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.367 1.467 . . . . 4.7699999999999996 113.316 169.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.74 -40.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.831 2.354 . . . . 3.75 111.914 169.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 30.0 t70 165.08 165.07 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.86 2.864 . . . . 4.0199999999999996 108.908 -159.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.75 122.54 36.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.312 -0.995 . . . . 3.29 108.312 153.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 m -101.05 114.96 65.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 109.374 -0.602 . . . . 2.3500000000000001 109.374 173.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.95 142.99 15.99 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.27 1.98 . . . . 1.24 109.918 166.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.4 146.07 43.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 122.912 1.339 . . . . 3.6400000000000001 112.433 170.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -114.44 130.82 56.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.913 -1.494 . . . . 3.8799999999999999 109.623 -170.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 68.5 mt -107.13 117.97 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.743 1.217 . . . . 2.48 109.668 174.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.8 p -73.13 136.09 44.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.134 0.574 . . . . 4.0 110.699 167.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.7 pt -121.15 31.85 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.472 1.509 . . . . 2.3199999999999998 111.634 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.41 ' HB3' ' CD1' ' A' ' 166' ' ' PHE . 16.3 p-10 -161.74 65.59 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.908 1.283 . . . . 4.1600000000000001 111.261 -158.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.35 -19.76 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.653 2.236 . . . . 2.8300000000000001 113.427 -171.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.31 41.86 0.19 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.118 1.367 . . . . 4.4400000000000004 111.966 168.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.0 -14.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 130.04 3.336 . . . . 6.5300000000000002 114.257 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.83 159.93 8.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.563 1.074 . . . . 4.7000000000000002 112.515 161.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.7 m -154.18 127.0 8.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 106.722 -1.584 . . . . 2.7599999999999998 106.722 155.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -52.01 -43.86 63.87 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.535 1.134 . . . . 3.8599999999999999 112.283 -177.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -70.23 -30.23 67.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.662 1.185 . . . . 3.5099999999999998 114.194 172.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.33 -39.47 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.195 1.361 . . . . 2.4300000000000002 111.715 176.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.19 -24.6 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.873 -1.142 . . . . 3.1400000000000001 110.891 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.18 67.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 119.91 -1.744 . . . . 2.25 112.938 166.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -77.26 -35.67 55.11 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.397 1.079 . . . . 4.5999999999999996 111.847 168.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.71 -36.09 81.84 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.549 -0.719 . . . . 7.25 111.563 176.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.6 t -54.5 -24.47 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 120.984 -1.073 . . . . 3.1899999999999999 112.349 169.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -87.38 -22.31 25.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.544 -1.348 . . . . 6.4500000000000002 114.134 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.82 -45.06 68.71 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.248 0.931 . . . . 4.8200000000000003 110.307 165.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -105.1 -26.5 12.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.138 1.903 . . . . 4.8099999999999996 116.138 -159.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 46.4 p 143.38 147.49 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 128.722 2.809 . . . . 3.0 113.413 169.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 66.43 5.42 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.023 3.148 . . . . 2.7799999999999998 109.684 166.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.06 -31.66 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.047 2.139 . . . . 4.5099999999999998 110.854 -171.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.47 145.92 48.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.412 0.551 . . . . 3.1499999999999999 111.165 158.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.77 133.02 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.868 1.667 . . . . 2.8399999999999999 106.891 162.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.71 128.71 9.66 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.346 -1.102 . . . . 0.82999999999999996 110.346 176.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.57 130.47 49.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.278 1.031 . . . . 3.1899999999999999 111.538 -176.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -144.03 -178.95 6.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.613 1.565 . . . . 3.1099999999999999 111.675 -167.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 176.74 -167.82 39.45 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.4 1.0 . . . . 1.53 113.766 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -84.0 157.29 21.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.772 1.229 . . . . 2.5600000000000001 110.414 174.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -61.27 -20.57 63.01 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.068 1.507 . . . . 8.7699999999999996 115.068 -169.534 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -70.33 -40.65 74.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.672 1.589 . . . . 2.98 111.175 172.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.39 -32.6 62.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.664 1.185 . . . . 3.4100000000000001 111.745 173.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.67 -38.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 118.206 -0.902 . . . . 2.6800000000000002 110.989 166.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.03 -44.5 92.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.133 1.333 . . . . 3.0800000000000001 110.362 171.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -49.67 -57.28 7.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.667 1.121 . . . . 3.0 110.934 172.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 32.6 m -74.11 -37.66 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.917 1.235 . . . . 4.2699999999999996 113.261 -171.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.73 74.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.648 0.379 . . . . 2.4700000000000002 111.65 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -95.68 -23.22 17.1 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.353 1.461 . . . . 4.6100000000000003 113.555 -175.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.02 75.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.351 1.432 . . . . 2.8300000000000001 110.768 164.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -82.55 -11.94 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.632 1.173 . . . . 4.4299999999999997 114.098 174.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 71.64 37.19 1.13 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.279 1.832 . . . . 9.0600000000000005 112.451 165.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 m -94.13 141.0 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.266 1.426 . . . . 3.5699999999999998 112.328 -175.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -76.47 154.17 34.93 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.298 0.851 . . . . 6.04 113.298 171.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.01 149.53 16.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.923 1.689 . . . . 4.6600000000000001 109.729 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.3 t -155.54 145.01 15.28 Favored Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 121.454 -0.779 . . . . 5.2699999999999996 110.987 171.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.36 165.12 28.03 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.387 2.058 . . . . 5.0099999999999998 109.628 151.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -86.01 -178.09 49.99 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 124.356 0.979 . . . . 3.5800000000000001 114.426 174.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.78 66.24 8.13 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.984 3.789 . . . . 5.54 113.804 -169.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.529 ' HZ1' ' CD ' ' A' ' 254' ' ' GLU . 0.2 OUTLIER -60.09 115.47 3.49 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.986 -1.071 . . . . 6.0599999999999996 109.976 166.276 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 15.8 t70 121.72 -15.57 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 1 C-N-CA 131.724 4.009 . . . . 9.4800000000000004 111.65 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -81.75 0.13 40.5 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.571 1.323 . . . . 10.609999999999999 114.571 176.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 16.0 t70 172.57 -87.91 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.265 3.026 . . . . 7.3099999999999996 107.167 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.529 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 14.6 tp10 -169.73 25.75 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.13 2.572 . . . . 6.4800000000000004 110.706 -176.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -48.69 151.27 1.2 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.91 1.684 . . . . 4.8200000000000003 115.16 -175.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.41 50.91 1.29 Allowed 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.046 -1.034 . . . . 7.8799999999999999 113.655 156.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 11.8 mm -61.52 153.11 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.547 -0.72 . . . . 4.4400000000000004 109.261 159.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 166' ' ' PHE . 30.7 m -154.88 141.67 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 128.018 2.527 . . . . 5.8499999999999996 104.855 171.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -157.81 157.44 33.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.369 0.986 . . . . 4.8600000000000003 113.299 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -160.44 -179.11 7.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.916 1.686 . . . . 3.1699999999999999 113.686 -163.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.3 p -74.35 -15.11 60.95 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 116.899 2.185 . . . . 4.25 116.899 -176.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 56.86 11.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.15 1.78 . . . . 5.1600000000000001 115.292 177.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 1.6 pp -95.65 148.13 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 119.997 -1.689 . . . . 5.4000000000000004 114.384 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.5 ttp -122.51 121.76 37.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.806 2.442 . . . . 3.1800000000000002 109.408 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -85.16 146.33 27.17 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.549 -0.719 . . . . 3.6899999999999999 111.362 176.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.4 tp -109.1 127.51 54.22 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.918 1.287 . . . . 3.1699999999999999 109.92 168.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.19 124.75 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.912 2.085 . . . . 2.73 106.131 171.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.95 -162.66 36.9 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 109.618 -1.393 . . . . 2.02 109.618 164.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -85.02 54.48 3.94 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 120.392 2.096 . . . . 2.6499999999999999 109.799 178.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.06 -34.77 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.486 1.515 . . . . 5.6399999999999997 114.157 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.66 29.69 59.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.695 -1.058 . . . . 4.3099999999999996 113.623 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -147.52 -39.02 0.19 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.034 1.417 . . . . 4.6900000000000004 113.853 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.32 0.0 OUTLIER 102.74 152.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 132.368 4.267 . . . . 4.79 111.407 -171.944 . . . . . . . . 4 3 . 1 . 023 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 56.9 tp -129.48 -35.24 1.75 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.346 1.239 . . . . 3.98 114.346 -155.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -166.05 172.36 11.48 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.505 1.522 . . . . 2.8399999999999999 111.026 -174.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -156.21 145.96 21.06 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.62 -1.3 . . . . 4.4000000000000004 113.908 174.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -136.84 173.72 11.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.292 1.837 . . . . 4.0099999999999998 111.447 -163.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.41 -169.06 36.13 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 125.807 1.67 . . . . 2.6800000000000002 111.803 175.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -36.52 124.41 0.82 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.061 1.745 . . . . 4.25 113.071 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.9 t30 98.49 -34.94 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 130.315 3.446 . . . . 5.3099999999999996 112.681 -174.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.71 109.87 0.89 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.31 1.414 . . . . 5.0499999999999998 110.611 178.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.5 145.56 41.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.15 -0.969 . . . . 7.5599999999999996 109.453 -171.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -56.17 -50.54 70.89 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.407 -1.433 . . . . 3.3900000000000001 113.549 -168.645 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.28 -13.18 70.19 Favored Glycine 0 N--CA 1.479 1.565 0 O-C-N 121.463 -0.773 . . . . 1.8899999999999999 114.926 175.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -86.72 -19.4 29.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.826 1.25 . . . . 5.3200000000000003 111.046 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.23 -51.32 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 120.586 -1.322 . . . . 2.5 109.595 157.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -37.51 75.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 118.261 -0.876 . . . . 2.98 112.954 176.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.687 1.131 . . . . 3.3199999999999998 112.831 173.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -48.89 79.87 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.422 -0.799 . . . . 2.3399999999999999 112.157 169.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.64 -30.44 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.079 0.854 . . . . 2.5299999999999998 111.504 179.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.34 -7.22 22.99 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.585 -1.322 . . . . 3.6699999999999999 114.053 173.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 31.2 m -80.47 -57.04 3.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.026 0.931 . . . . 4.4800000000000004 108.834 160.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -62.31 -26.8 68.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.312 1.845 . . . . 3.5899999999999999 114.487 -174.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 31.7 mtt -55.86 -30.13 60.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.597 1.159 . . . . 6.0800000000000001 111.619 170.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -59.71 -47.11 98.27 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.406 -1.759 . . . . 5.8200000000000003 111.38 -176.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.26 -58.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.872 2.381 . . . . 4.0199999999999996 113.403 163.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.83 17.89 17.05 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 116.669 2.1 . . . . 4.5199999999999996 116.669 -157.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 -53.77 164.99 0.48 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.956 -1.09 . . . . 7.8200000000000003 111.415 159.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -90.16 -13.52 35.46 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 119.933 -1.73 . . . . 11.23 115.356 -173.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -166.91 -110.24 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.538 1.935 . . . . 7.54 107.774 -163.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.06 -0.971 . . . . 7.0800000000000001 110.781 134.393 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 118.227 -0.892 . . . . 17.449999999999999 109.97 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -65.51 150.5 48.27 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.539 0.609 . . . . 15.77 109.686 154.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -145.23 131.39 19.42 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.958 1.703 . . . . 12.119999999999999 107.711 176.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -156.39 134.16 3.96 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 123.66 0.647 . . . . 10.73 112.362 176.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -169.62 72.51 0.68 Allowed Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.531 1.132 . . . . 10.1 113.463 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.89 178.73 6.07 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.567 2.845 . . . . 8.6899999999999995 111.366 175.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.7 tp -155.36 153.46 30.51 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.976 1.71 . . . . 8.0800000000000001 109.241 177.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 pp -162.82 -176.54 5.0 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.245 1.818 . . . . 8.0600000000000005 110.555 -171.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.83 -47.56 3.81 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 124.83 1.205 . . . . 4.0999999999999996 113.533 172.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.36 51.33 53.43 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-O 118.118 -1.379 . . . . 3.3399999999999999 111.973 -166.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.67 142.06 62.58 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.078 2.518 . . . . 2.8900000000000001 112.706 -167.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -116.45 168.44 10.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.201 1.8 . . . . 4.0899999999999999 111.264 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 p -148.5 85.48 1.51 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.84 1.256 . . . . 3.1400000000000001 111.28 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.64 143.84 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.208 1.003 . . . . 2.8199999999999998 110.791 175.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 p -75.38 150.28 38.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 4.5199999999999996 111.863 171.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 p -96.0 120.68 36.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.621 1.969 . . . . 2.79 108.273 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.5 m170 51.15 24.79 2.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.195 1.554 . . . . 4.1799999999999997 115.195 177.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.379 0.6 OUTLIER 31.36 39.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.509 2.724 . . . . 11.140000000000001 115.491 -155.695 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -110.82 -28.71 3.83 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.833 2.158 . . . . 2.8300000000000001 113.051 -178.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -155.3 179.81 8.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.808 1.304 . . . . 4.0300000000000002 112.28 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -118.6 111.23 18.31 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.446 1.098 . . . . 7.9500000000000002 111.033 -159.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -119.71 168.9 10.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.462 1.601 . . . . 3.8900000000000001 115.171 167.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.7 m -158.79 158.05 32.81 Favored 'General case' 0 C--N 1.326 -0.422 1 C-N-CA 132.099 4.16 . . . . 3.4399999999999999 103.962 -169.358 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -41.74 -52.34 3.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.624 1.17 . . . . 3.3500000000000001 112.86 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -82.75 -8.56 59.58 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.338 1.607 . . . . 7.5300000000000002 115.338 178.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -75.93 -18.76 59.23 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.399 1.454 . . . . 4.0800000000000001 111.631 165.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -97.69 -40.44 8.58 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.103 1.361 . . . . 4.9500000000000002 114.124 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.98 154.28 19.32 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.39 0.995 . . . . 4.9900000000000002 113.533 -170.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.47 10.25 22.05 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.878 1.704 . . . . 2.8300000000000001 112.708 -158.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.54 160.89 18.17 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.218 2.607 . . . . 3.1200000000000001 107.758 -176.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -83.33 121.91 27.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.624 -0.673 . . . . 2.3300000000000001 110.823 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.61 135.29 39.64 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.242 1.02 . . . . 3.54 111.304 -176.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -115.16 126.15 54.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.487 1.515 . . . . 3.2000000000000002 107.897 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.7 mt -129.4 118.49 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.413 0.685 . . . . 2.5 109.941 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -120.68 145.09 47.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.349 1.459 . . . . 4.0199999999999996 112.934 -175.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -114.67 97.61 6.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.232 1.413 . . . . 3.2200000000000002 110.87 -177.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.61 -160.52 10.69 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.592 1.567 . . . . 1.51 115.423 -169.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -156.03 159.41 39.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.434 1.494 . . . . 5.7199999999999998 110.746 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 p -69.49 127.04 31.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.014 -1.679 . . . . 4.04 110.287 172.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 73.2 -43.78 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.429 2.292 . . . . 9.4199999999999999 111.821 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.4 t 86.59 177.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 127.277 2.231 . . . . 2.8500000000000001 111.419 -166.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -40.7 -69.69 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.458 2.772 . . . . 4.7400000000000002 111.493 130.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . 0.26 1.1 m-20 171.24 58.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 128.417 2.687 . . . . 4.9299999999999997 111.366 170.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.81 -27.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.869 1.268 . . . . 4.8600000000000003 114.02 174.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.36 -37.19 19.53 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 115.852 -2.023 . . . . 2.4300000000000002 113.854 162.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.52 -80.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.336 2.024 . . . . 2.3199999999999998 111.051 166.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.19 -29.01 69.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.676 0.991 . . . . 4.4100000000000001 113.676 -165.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.63 -41.68 59.96 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.255 -1.528 . . . . 3.6600000000000001 112.691 177.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.4 -36.76 74.25 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.299 -1.334 . . . . 4.1699999999999999 110.521 172.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -57.14 -43.99 82.98 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.733 1.606 . . . . 6.0800000000000001 111.806 173.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -60.84 -55.27 35.02 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.712 -1.243 . . . . 3.8199999999999998 112.219 168.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.67 -24.66 62.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.078 1.14 . . . . 4.6299999999999999 114.078 -170.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -56.7 -37.88 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.258 1.39 . . . . 3.0099999999999998 111.279 169.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.98 -28.68 66.83 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.379 -0.819 . . . . 3.04 110.609 176.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.8 -34.68 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.454 1.024 . . . . 2.9700000000000002 111.355 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.82 -37.73 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.598 1.09 . . . . 3.3599999999999999 111.439 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -32.51 58.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.364 0.983 . . . . 4.6100000000000003 113.298 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -60.21 -26.26 66.24 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.596 1.558 . . . . 3.54 112.946 170.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -90.16 -55.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.104 1.762 . . . . 3.3500000000000001 112.387 175.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.15 -30.45 71.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.819 2.048 . . . . 3.1600000000000001 113.133 -175.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.1 t -66.07 -12.8 57.87 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.786 -1.196 . . . . 3.7000000000000002 112.894 169.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.0 mm -121.56 44.41 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.15 1.78 . . . . 5.46 108.186 -178.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.24 0.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.5 3.52 . . . . 7.0999999999999996 118.419 -158.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.3 p -69.08 -18.99 64.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.88 1.272 . . . . 4.8099999999999996 113.047 157.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.41 163.15 43.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 127.28 2.232 . . . . 5.3700000000000001 109.908 169.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.41 162.21 11.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.514 2.143 . . . . 6.0499999999999998 114.178 -148.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.55 94.5 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.71 1.604 . . . . 6.1600000000000001 111.606 -172.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.3 mp -93.86 116.6 29.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.111 0.964 . . . . 3.25 112.722 -175.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.6 m -107.59 111.82 62.58 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.261 1.024 . . . . 2.0800000000000001 110.89 171.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -88.05 122.9 1.62 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.954 3.102 . . . . 1.1699999999999999 112.254 177.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.64 122.83 47.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.742 2.417 . . . . 4.0499999999999998 110.529 -178.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -102.06 121.08 41.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.943 0.897 . . . . 3.46 111.182 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.45 119.99 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.602 1.161 . . . . 2.8900000000000001 108.331 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.1 p -78.65 131.35 36.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.285 -0.884 . . . . 3.0499999999999998 110.581 164.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.43 -21.73 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 115.547 1.684 . . . . 3.73 115.547 -176.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -125.74 75.23 70.59 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 124.525 1.13 . . . . 4.9800000000000004 109.194 -177.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.45 98.51 0.4 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.683 3.588 . . . . 2.21 109.31 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -162.31 -24.04 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.102 1.149 . . . . 4.5300000000000002 114.102 -166.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.45 9.16 0.54 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.176 1.176 . . . . 5.9699999999999998 114.176 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -111.8 75.33 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 129.645 3.178 . . . . 3.8100000000000001 108.798 -173.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.29 155.96 30.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.04 1.4 . . . . 3.6600000000000001 114.363 -163.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.84 -50.42 7.91 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.409 2.283 . . . . 4.5099999999999998 114.784 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.93 -35.0 20.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.808 1.643 . . . . 4.7199999999999998 112.321 174.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.24 71.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.367 0.985 . . . . 2.9399999999999999 113.501 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 18.9 mm -64.53 -42.64 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.842 1.201 . . . . 2.5600000000000001 111.675 170.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.3 -22.54 66.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.734 0.814 . . . . 2.5699999999999998 112.897 176.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -83.41 -44.73 14.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.699 1.6 . . . . 4.9699999999999998 112.027 168.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -53.26 -35.83 60.46 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.648 1.579 . . . . 3.98 111.922 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -52.47 -43.91 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.415 1.486 . . . . 2.6299999999999999 113.617 167.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -67.03 -47.44 71.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 117.807 -1.092 . . . . 7.2599999999999998 111.982 -176.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -43.19 63.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.507 1.523 . . . . 4.1900000000000004 111.917 177.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -70.28 -62.71 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.858 0.463 . . . . 4.54 111.53 175.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.8 m 169.73 145.57 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.534 2.734 . . . . 2.6000000000000001 110.833 177.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.59 -6.52 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.585 2.857 . . . . 1.8600000000000001 114.709 -177.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.41 -10.4 59.43 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.709 1.141 . . . . 4.4900000000000002 113.581 170.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.85 137.93 34.23 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.624 1.17 . . . . 3.1200000000000001 111.557 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -113.36 129.92 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.255 1.022 . . . . 2.5699999999999998 109.561 -174.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.09 129.37 9.87 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.841 -0.904 . . . . 1.0900000000000001 110.841 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.82 156.9 18.67 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.868 -0.79 . . . . 3.71 108.868 168.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.3 m -150.39 126.91 10.82 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.223 -1.399 . . . . 3.8700000000000001 107.223 171.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.58 -145.04 4.05 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.094 1.807 . . . . 1.99 111.189 -174.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -121.75 174.72 6.67 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.301 1.051 . . . . 2.7999999999999998 110.91 165.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.26 -18.09 14.72 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.627 1.171 . . . . 9.3599999999999994 113.327 -174.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.48 -41.99 19.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.194 2.198 . . . . 3.4399999999999999 112.153 -173.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.83 -31.75 66.85 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.286 -1.509 . . . . 3.71 110.702 166.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.8 -35.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.364 -0.827 . . . . 2.6400000000000001 110.916 172.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -58.78 -57.01 14.93 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 117.632 -1.175 . . . . 2.7400000000000002 109.778 163.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -49.87 -56.33 10.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.219 1.372 . . . . 3.1899999999999999 112.514 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.55 -29.51 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.288 0.495 . . . . 2.8399999999999999 111.771 -171.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.32 -50.8 20.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.647 0.779 . . . . 2.5099999999999998 111.525 171.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -56.15 -49.12 74.85 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.148 2.579 . . . . 3.52 111.398 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.78 77.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.551 0.74 . . . . 2.6400000000000001 112.947 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -94.64 14.43 21.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.233 1.413 . . . . 3.79 113.363 176.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 61.6 12.26 4.4 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.134 2.174 . . . . 6.1399999999999997 115.111 176.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.99 140.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.393 1.477 . . . . 3.6800000000000002 111.254 -177.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -109.52 173.43 6.33 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.542 1.537 . . . . 5.5899999999999999 112.481 174.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -121.59 148.55 44.38 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.008 0.923 . . . . 4.5800000000000001 111.534 176.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -128.95 63.14 65.61 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.159 0.984 . . . . 5.0099999999999998 111.654 176.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 138.98 42.83 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.598 2.198 . . . . 3.4300000000000002 110.332 176.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.64 152.57 37.46 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 119.676 -0.513 . . . . 3.5 113.342 -176.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -62.95 157.43 48.67 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.796 2.998 . . . . 5.2400000000000002 110.566 175.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 -0.29 45.34 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 122.677 1.227 . . . . 6.9000000000000004 111.6 175.125 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.22 43.07 1.08 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.228 2.211 . . . . 7.7199999999999998 112.277 -147.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -156.94 -40.8 0.07 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.208 1.803 . . . . 8.4399999999999995 110.71 -170.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -152.26 -53.83 0.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.667 1.187 . . . . 6.3300000000000001 109.646 165.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 172.92 -45.6 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 129.222 3.009 . . . . 5.7999999999999998 110.232 169.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 11.1 t70 1.85 113.09 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 129.108 2.963 . . . . 5.1399999999999997 118.215 -169.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.89 40.99 0.78 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 120.272 -1.517 . . . . 4.8399999999999999 114.731 -178.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.08 128.71 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.778 -1.201 . . . . 4.3700000000000001 109.919 157.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.1 153.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.304 1.442 . . . . 5.1299999999999999 107.902 170.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.57 174.85 11.05 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 122.752 1.263 . . . . 5.75 112.273 -174.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 167.54 11.13 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.889 -1.132 . . . . 3.04 112.737 -143.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.1 t -68.09 -20.25 64.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.318 1.97 . . . . 4.96 116.318 -171.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.5 mt 47.9 55.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.914 1.686 . . . . 5.4000000000000004 111.593 -177.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.6 mt -137.79 139.77 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.518 1.527 . . . . 3.3100000000000001 110.348 -178.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.66 120.46 39.72 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.51 2.724 . . . . 4.25 109.326 161.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -88.31 135.11 33.61 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.136 0.574 . . . . 3.5699999999999998 111.266 165.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.4 tt -103.41 120.67 41.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.699 2.0 . . . . 3.21 109.441 174.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.92 143.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 127.271 2.229 . . . . 2.8799999999999999 108.167 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.34 178.23 18.49 Favored Glycine 0 CA--C 1.545 1.914 0 C-N-CA 123.931 0.777 . . . . 2.23 113.95 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 -42.97 2.15 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.6 2.866 . . . . 4.0599999999999996 112.904 -174.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -142.87 84.53 1.84 Allowed 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 107.092 -1.447 . . . . 7.71 107.092 161.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.17 -150.85 6.78 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.232 1.872 . . . . 3.4399999999999999 110.315 -176.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -122.78 -162.57 1.03 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.008 0.923 . . . . 4.2599999999999998 111.217 -179.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -52.58 134.94 35.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.076 0.941 . . . . 5.4400000000000004 110.43 173.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.37 -33.02 1.13 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.428 1.491 . . . . 4.2300000000000004 110.328 -169.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -155.28 172.83 17.54 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.828 2.051 . . . . 2.4100000000000001 110.481 175.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -162.21 148.01 13.04 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.616 -1.303 . . . . 4.7800000000000002 114.257 176.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -132.47 128.24 36.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.887 1.275 . . . . 3.54 110.706 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -101.88 -176.62 28.11 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.79 0.709 . . . . 2.7400000000000002 112.282 165.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -52.3 154.29 2.49 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.418 0.687 . . . . 4.2599999999999998 110.588 167.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.3 t30 81.83 -17.86 0.52 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.737 2.415 . . . . 6.1100000000000003 112.196 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -69.54 107.94 3.6 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.238 -1.539 . . . . 6.8200000000000003 110.532 161.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -66.14 144.54 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.502 1.144 . . . . 8.7799999999999994 109.785 176.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -32.49 65.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.051 . . . . 3.2799999999999998 113.839 -167.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.18 86.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.01 -0.883 . . . . 1.6200000000000001 113.489 -178.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.36 -18.03 61.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.359 1.579 . . . . 3.21 112.944 174.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.8 mt -70.01 -47.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.457 -0.777 . . . . 2.02 109.201 172.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.78 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.08 0.552 . . . . 2.21 112.065 170.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.89 81.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.567 0.951 . . . . 2.3300000000000001 113.567 173.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 52.2 p -65.5 -47.18 76.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.996 0.817 . . . . 2.04 111.669 172.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.62 -39.63 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 120.74 -1.225 . . . . 2.7799999999999998 110.638 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.07 72.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.907 0.883 . . . . 2.4199999999999999 113.159 171.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.1 m -71.59 -48.08 50.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.219 1.008 . . . . 2.8700000000000001 110.333 174.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -70.74 -20.27 62.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.206 1.003 . . . . 2.7799999999999998 113.075 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.1 mmm -66.49 -33.67 76.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.193 1.397 . . . . 4.5099999999999998 113.255 162.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -52.63 -40.2 74.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 116.358 -1.782 . . . . 5.9299999999999997 113.13 -176.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.26 -60.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.196 2.597 . . . . 2.3900000000000001 111.544 162.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -86.28 47.25 1.44 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.823 1.416 . . . . 4.1399999999999997 114.823 -165.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.23 135.22 57.66 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.832 -1.167 . . . . 10.859999999999999 111.658 176.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -53.85 -21.18 7.05 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.966 1.839 . . . . 8.5899999999999999 115.966 176.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 35.53 1.19 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.917 0.887 . . . . 11.07 113.172 -175.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 127.626 2.37 . . . . 10.48 114.428 178.676 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 118.209 -0.9 . . . . 27.989999999999998 110.241 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -64.02 157.64 24.66 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.981 0.81 . . . . 24.199999999999999 111.037 167.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.2 t -170.17 46.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.393 1.477 . . . . 19.710000000000001 111.871 -170.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.09 149.23 43.97 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.712 -0.618 . . . . 17.550000000000001 112.326 173.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -148.03 156.37 43.76 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.426 1.89 . . . . 16.620000000000001 110.45 174.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.16 164.48 33.77 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.896 2.398 . . . . 13.17 110.52 167.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.6 tp -164.04 150.7 11.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.568 1.947 . . . . 10.470000000000001 109.11 -177.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . 0.269 0.8 OUTLIER 102.61 -142.3 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 131.018 3.727 . . . . 6.3300000000000001 107.896 -174.38 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.77 151.75 20.31 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.135 1.334 . . . . 3.2999999999999998 113.764 -173.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.33 98.92 1.42 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.237 -1.313 . . . . 3.4300000000000002 112.486 -177.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.58 154.18 30.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.206 2.604 . . . . 3.9199999999999999 111.939 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -160.82 154.31 22.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.579 1.151 . . . . 4.2199999999999998 111.651 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 t -138.17 95.58 3.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.951 -1.093 . . . . 3.4199999999999999 112.874 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.63 162.9 14.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.115 1.366 . . . . 3.7000000000000002 112.153 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.4 m -98.14 142.6 29.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.53 1.132 . . . . 2.23 110.779 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.9 m -98.29 164.7 12.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.184 1.793 . . . . 3.0699999999999998 112.049 -171.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -61.17 -5.37 1.49 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 117.649 2.463 . . . . 3.6099999999999999 117.649 -170.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -35.02 6.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 121.023 1.738 . . . . 5.3399999999999999 111.29 165.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.47 11.61 0.45 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.719 2.104 . . . . 2.4300000000000002 115.185 -177.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -84.04 129.28 34.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.057 2.143 . . . . 5.4800000000000004 110.051 -176.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -69.2 130.2 41.98 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.52 -1.363 . . . . 5.3099999999999996 110.012 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 158.72 24.61 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.441 . . . . 3.71 109.834 168.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.6 p -152.02 162.94 40.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.573 1.549 . . . . 3.1600000000000001 110.233 -167.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -46.63 -49.68 18.72 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.792 1.237 . . . . 5.0800000000000001 112.034 166.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -79.48 4.23 16.26 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.536 1.31 . . . . 8.2300000000000004 114.536 -172.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.08 -30.34 16.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.966 1.706 . . . . 3.6000000000000001 111.452 169.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -103.38 -16.24 15.68 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.988 1.477 . . . . 5.6900000000000004 114.988 -177.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 tt -75.08 88.88 2.43 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.386 1.088 . . . . 5.7800000000000002 110.304 -171.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 164.78 -30.55 0.23 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.783 1.658 . . . . 3.21 111.923 -167.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -103.76 -179.6 4.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 4.4199999999999999 111.453 159.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -85.06 140.72 30.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.023 0.529 . . . . 4.2199999999999998 110.366 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 pp -134.28 153.39 51.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.139 0.976 . . . . 5.0099999999999998 111.09 175.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.61 138.45 54.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.754 1.222 . . . . 4.8499999999999996 109.072 171.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.3 mt -111.59 130.16 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.103 -0.703 . . . . 3.7200000000000002 109.103 177.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -120.61 142.25 49.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.932 1.293 . . . . 4.1900000000000004 110.508 164.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.69 123.49 50.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.064 1.345 . . . . 3.6200000000000001 110.107 171.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -160.38 146.77 13.03 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.459 -0.634 . . . . 2.1600000000000001 113.541 175.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.87 18.35 14.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.381 1.623 . . . . 5.6500000000000004 115.381 -171.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.2 m 66.99 -15.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.603 1.961 . . . . 3.73 114.048 173.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -111.2 16.38 21.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.898 2.079 . . . . 9.3000000000000007 112.684 -167.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.58 171.49 6.97 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.937 1.695 . . . . 2.6899999999999999 114.538 176.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.14 -176.92 1.46 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.117 2.544 . . . . 3.5299999999999998 110.479 150.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.36 64.56 2.13 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 5.9000000000000004 113.139 -172.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 80.5 t -130.97 -45.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.964 2.105 . . . . 4.5800000000000001 109.728 174.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.4 t -62.71 -52.04 67.6 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.855 1.262 . . . . 2.5299999999999998 112.591 172.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.5 -34.71 25.24 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.981 1.788 . . . . 1.54 113.077 172.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.542 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 13.4 tm-20 -64.89 -40.41 95.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.99 1.268 . . . . 2.6899999999999999 112.384 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.43 ' CD ' ' HZ2' ' A' ' 281' ' ' LYS . 2.0 tp10 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.424 -1.423 . . . . 2.5299999999999998 111.594 171.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 37.4 mt -62.72 -37.4 86.4 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.215 0.916 . . . . 3.9300000000000002 112.859 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.68 4.67 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.18 0.9 . . . . 3.3900000000000001 110.336 174.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.542 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 30.0 mtmm -57.53 -28.72 63.75 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.773 -1.204 . . . . 3.6899999999999999 112.713 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.34 -49.11 72.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.016 0.826 . . . . 4.0099999999999998 111.664 168.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.35 -36.19 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 119.636 1.107 . . . . 3.23 110.627 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.28 -23.31 35.68 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.326 0.862 . . . . 4.3700000000000001 113.326 171.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.83 -38.52 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.69 1.132 . . . . 3.1400000000000001 110.718 173.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.35 -40.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.328 1.051 . . . . 2.9399999999999999 110.921 -179.173 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.81 -53.94 34.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.458 1.503 . . . . 5.3099999999999996 110.971 169.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -69.74 -34.27 73.61 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 112.494 0.553 . . . . 4.0199999999999996 112.494 -174.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.34 -40.35 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.056 1.342 . . . . 3.0 112.952 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.68 -34.83 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.294 0.497 . . . . 3.2999999999999998 111.79 168.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.2 t -64.89 -36.01 82.99 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.711 -1.243 . . . . 3.5699999999999998 112.658 172.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.42 -3.06 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.332 1.853 . . . . 4.8300000000000001 112.216 167.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.329 73.1 p 124.43 -9.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 1 C-N-CA 132.796 4.438 . . . . 6.0499999999999998 114.945 152.696 . . . . . . . . 3 2 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.7 t 143.01 -18.53 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 129.824 3.25 . . . . 7.7699999999999996 113.675 178.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.3 -146.4 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.655 -1.641 . . . . 5.5999999999999996 109.561 -172.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.75 -42.11 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 124.079 2.493 . . . . 3.77 109.467 146.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.5 t70 161.8 157.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 1 C-N-CA 132.216 4.206 . . . . 4.1399999999999997 107.973 174.324 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.28 90.07 3.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.904 0.882 . . . . 3.4500000000000002 108.786 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 35.9 m -66.02 117.54 43.5 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 108.28 -1.007 . . . . 2.96 108.28 178.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -91.01 127.34 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.175 1.917 . . . . 1.78 110.085 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.0 tp -121.23 108.42 13.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.555 1.142 . . . . 3.73 109.983 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -90.06 123.38 33.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.378 1.071 . . . . 3.6800000000000002 109.594 169.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.2 mt -111.36 125.25 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.404 -0.961 . . . . 2.2599999999999998 108.404 171.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.6 t -96.03 144.29 26.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.794 -0.566 . . . . 2.75 110.6 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.0 pt -108.5 3.99 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.877 1.066 . . . . 2.9399999999999999 113.877 -174.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.24 77.35 1.55 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.661 1.184 . . . . 3.0 112.435 -169.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.77 -9.33 18.27 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.006 1.804 . . . . 3.5600000000000001 111.834 166.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -70.33 -4.87 24.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.998 2.119 . . . . 4.5499999999999998 114.153 174.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -9.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.813 2.523 . . . . 5.6200000000000001 117.813 178.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.99 97.23 10.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.611 2.005 . . . . 4.4400000000000004 110.039 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 m -74.28 128.94 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.978 -0.749 . . . . 2.7200000000000002 108.978 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -54.15 8.64 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.425 1.49 . . . . 3.8999999999999999 111.597 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -68.25 -23.42 64.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.269 1.428 . . . . 3.6800000000000002 113.741 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.16 -44.64 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.439 -1.413 . . . . 3.0099999999999998 111.247 172.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.07 -37.48 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.818 0.847 . . . . 3.8100000000000001 110.397 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.76 -33.76 36.52 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.822 1.045 . . . . 2.1200000000000001 113.822 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -80.38 -49.49 11.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.752 -0.592 . . . . 5.6600000000000001 111.926 175.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -49.49 -37.57 26.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.674 1.19 . . . . 4.0999999999999996 113.385 171.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.37 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.675 1.59 . . . . 3.02 112.134 173.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -56.02 -48.3 76.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.977 0.911 . . . . 5.7300000000000004 112.474 -178.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -19.42 62.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.367 1.467 . . . . 7.4800000000000004 112.604 -174.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -53.94 7.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.406 0.682 . . . . 4.5 111.017 164.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.6 t -167.96 139.29 2.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.253 1.021 . . . . 3.8700000000000001 111.503 167.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.69 0.81 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.036 2.491 . . . . 2.4300000000000002 114.078 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -86.6 -16.3 37.15 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 120.051 1.296 . . . . 3.73 113.064 165.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.62 143.88 34.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.25 1.42 . . . . 3.25 110.948 -177.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.46 145.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.404 0.681 . . . . 3.4500000000000002 110.269 164.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.02 124.84 6.29 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 124.054 0.835 . . . . 0.87 111.383 173.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 11.1 mp -117.39 145.95 43.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.817 1.247 . . . . 3.3100000000000001 111.438 -179.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.3 p -149.92 174.94 12.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.211 2.604 . . . . 3.2200000000000002 109.964 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.35 -152.11 8.09 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.497 -1.441 . . . . 1.8300000000000001 109.497 158.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.8 p -64.3 165.33 9.7 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.62 1.568 . . . . 3.9100000000000001 112.571 162.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.87 -36.37 62.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.315 -0.857 . . . . 7.9699999999999998 110.698 169.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.09 -45.91 69.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.877 2.071 . . . . 3.3399999999999999 112.667 176.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.98 -47.82 84.24 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.178 -0.951 . . . . 4.71 110.803 173.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -17.03 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.152 1.168 . . . . 3.5899999999999999 114.152 -178.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.55 -43.83 97.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.337 0.971 . . . . 3.1200000000000001 109.78 168.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.92 -53.18 61.26 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.061 -0.495 . . . . 4.0999999999999996 111.096 -176.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.36 -23.75 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 112.752 0.649 . . . . 2.8799999999999999 112.752 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.04 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.561 0.745 . . . . 2.7799999999999998 112.83 171.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -70.4 -41.54 72.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.559 2.343 . . . . 4.8300000000000001 111.528 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.58 -46.2 63.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.983 1.713 . . . . 3.1099999999999999 112.795 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.42 -126.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.881 0.764 . . . . 3.3399999999999999 110.389 171.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.17 61.65 0.7 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.593 -1.317 . . . . 6.8899999999999997 111.783 -172.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.36 156.87 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.075 0.95 . . . . 5.0300000000000002 109.228 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -152.8 169.71 22.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.113 2.565 . . . . 5.2699999999999996 109.165 -173.493 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -165.77 153.9 11.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.993 1.317 . . . . 5.9199999999999999 111.148 -177.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.4 t -149.56 138.31 12.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.912 1.685 . . . . 5.96 108.254 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.28 151.07 15.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.155 2.57 . . . . 5.7800000000000002 111.947 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -72.37 123.38 9.2 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.717 -1.046 . . . . 4.6399999999999997 110.716 172.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.66 14.56 2.14 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.583 2.855 . . . . 4.7699999999999996 112.921 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.523 ' HZ2' ' CD ' ' A' ' 254' ' ' GLU . 8.1 mmtp 92.36 141.73 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 130.845 3.658 . . . . 8.1199999999999992 110.096 -154.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -153.56 155.53 36.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.536 1.134 . . . . 7.9199999999999999 109.205 164.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 62.92 -51.39 0.19 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.546 2.738 . . . . 10.09 113.425 -166.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -173.38 -49.02 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.2 2.2 . . . . 8.4900000000000002 110.861 169.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.523 ' CD ' ' HZ2' ' A' ' 250' ' ' LYS . 11.2 tp10 -143.18 124.44 14.6 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.176 1.39 . . . . 8.0500000000000007 110.291 -172.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -178.27 153.7 0.78 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.373 2.269 . . . . 4.3899999999999997 111.527 -166.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -145.36 76.08 1.46 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.13 0.967 . . . . 6.25 110.679 151.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.5 tt -73.22 175.34 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.714 1.205 . . . . 3.9300000000000002 110.996 167.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.7 t -151.64 158.77 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 127.554 2.341 . . . . 4.6100000000000003 106.208 172.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -85.55 150.6 24.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.398 1.479 . . . . 5.25 112.37 169.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -148.1 150.29 33.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.828 1.047 . . . . 2.4100000000000001 113.828 153.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.24 164.05 1.01 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.058 1.343 . . . . 4.8499999999999996 110.486 171.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.2 tp -143.19 155.11 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.997 1.319 . . . . 5.0499999999999998 109.175 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.7 mt 108.48 141.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 130.987 3.715 . . . . 4.1399999999999997 107.901 -162.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 mtt -101.15 136.21 41.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.501 1.12 . . . . 4.6500000000000004 108.822 167.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -111.53 126.28 54.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.651 0.78 . . . . 5.3300000000000001 110.75 -172.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 14.0 tp -99.9 123.72 44.45 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.872 1.269 . . . . 3.4700000000000002 110.562 -175.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.85 131.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.571 -1.27 . . . . 3.8399999999999999 107.571 174.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.59 169.28 25.81 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.562 0.601 . . . . 3.4100000000000001 112.737 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.97 71.21 5.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.077 3.184 . . . . 4.0599999999999996 108.236 167.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -156.51 -59.86 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.764 1.626 . . . . 6.1399999999999997 108.536 -162.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.78 -38.86 0.2 Allowed Glycine 0 C--N 1.345 1.045 0 N-CA-C 115.51 0.964 . . . . 4.7699999999999996 115.51 170.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -157.01 -151.4 0.32 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.333 1.235 . . . . 6.1699999999999999 114.333 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -70.26 109.87 4.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.094 1.358 . . . . 5.8700000000000001 111.278 -173.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 tt -99.45 -21.37 16.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.308 1.043 . . . . 4.7400000000000002 111.642 179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.24 160.08 38.28 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.726 2.01 . . . . 2.6800000000000002 109.618 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -165.39 123.01 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.507 1.523 . . . . 4.1100000000000003 111.754 177.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -139.31 136.14 34.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.548 1.539 . . . . 4.6699999999999999 111.687 -165.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.41 145.99 13.44 Favored Glycine 0 N--CA 1.471 1.033 0 O-C-N 120.661 -1.274 . . . . 3.02 116.033 -174.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 64.24 -105.31 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.358 1.863 . . . . 3.9199999999999999 110.642 171.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.91 87.49 0.25 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.147 1.379 . . . . 6.21 112.161 -176.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.43 ' HZ2' ' CD ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER 178.99 130.56 0.08 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 128.737 2.815 . . . . 9.4800000000000004 111.067 178.695 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -90.61 158.92 16.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.555 1.942 . . . . 7.2599999999999998 110.201 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -40.04 80.04 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.373 1.62 . . . . 2.9700000000000002 115.373 -164.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.91 -24.19 71.4 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 118.129 0.422 . . . . 1.6899999999999999 113.185 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.17 -39.94 93.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.04 0.92 . . . . 3.6099999999999999 111.384 175.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 46.9 mt -70.55 -42.15 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.74 0.816 . . . . 2.4100000000000001 110.541 177.14 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.84 90.93 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.831 -0.543 . . . . 2.3100000000000001 111.2 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.06 87.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.05 1.34 . . . . 2.2400000000000002 113.716 173.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.0 p -64.98 -45.43 85.69 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.483 1.492 . . . . 2.9399999999999999 110.889 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.8 -40.8 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 120.898 -1.127 . . . . 2.98 111.686 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.32 -25.05 67.44 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.645 -1.284 . . . . 2.73 113.188 171.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.9 m -73.48 -43.05 61.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.003 . . . . 2.4700000000000002 110.598 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -70.55 -25.64 63.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.66 0.784 . . . . 2.9900000000000002 112.83 174.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.456 ' SD ' ' HE2' ' A' ' 299' ' ' LYS . 1.3 ttp -69.02 -22.58 64.05 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.749 -1.219 . . . . 4.9900000000000002 113.221 165.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -55.78 -42.73 97.6 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 116.632 -1.652 . . . . 5.0700000000000003 112.838 177.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.43 -51.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.342 2.695 . . . . 2.5299999999999998 111.968 163.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -83.97 68.25 9.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.38 1.086 . . . . 4.0099999999999998 112.37 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -59.09 129.26 41.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.251 1.82 . . . . 9.0199999999999996 113.91 -169.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.456 ' HE2' ' SD ' ' A' ' 294' ' ' MET . 0.0 OUTLIER -9.01 -86.14 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.938 2.895 . . . . 8.7100000000000009 114.924 -173.119 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -135.82 25.58 3.35 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.925 2.49 . . . . 8.8499999999999996 108.302 171.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.253 1.275 1 C-N-CA 132.906 4.483 . . . . 8.3000000000000007 108.956 -153.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 118.248 -0.882 . . . . 17.350000000000001 110.035 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -67.32 160.76 26.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.135 0.574 . . . . 14.31 111.043 170.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 t -172.05 -177.34 1.86 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.657 1.983 . . . . 13.779999999999999 109.722 -176.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 133' ' ' LYS . . . 83.06 -168.14 46.54 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.811 1.196 . . . . 12.09 113.835 175.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -162.12 126.32 1.98 Allowed Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.541 1.136 . . . . 14.01 111.398 -178.242 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.62 65.8 8.62 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.34 2.693 . . . . 9.7400000000000002 109.495 172.231 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -165.27 39.44 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.977 1.311 . . . . 10.16 110.804 -170.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.0 tp -83.58 45.0 1.01 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.805 1.242 . . . . 8.2300000000000004 111.295 -177.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.78 -159.4 33.04 Favored Glycine 0 N--CA 1.464 0.549 0 C-N-CA 124.744 1.164 . . . . 4.7699999999999996 113.977 -177.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.62 -110.48 3.86 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 117.869 -1.517 . . . . 4.5599999999999996 111.512 -175.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -78.98 167.92 21.39 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.442 2.761 . . . . 3.5099999999999998 114.645 -168.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -158.01 163.04 38.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.954 2.102 . . . . 3.4700000000000002 110.974 -169.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.7 t -126.65 116.95 21.79 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.989 -1.07 . . . . 3.5499999999999998 110.401 161.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 mp -135.96 160.24 39.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.098 0.952 . . . . 3.4900000000000002 112.363 -178.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m -82.88 136.56 34.56 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.177 1.791 . . . . 2.6000000000000001 109.764 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.9 t -97.38 158.7 15.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.954 1.302 . . . . 4.1500000000000004 111.894 -178.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -14.98 57.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.475 1.657 . . . . 2.4100000000000001 115.475 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.4 -11.51 59.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.635 1.574 . . . . 3.8900000000000001 112.404 171.325 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.89 -26.17 16.53 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.873 1.701 . . . . 2.7200000000000002 114.538 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.82 -142.61 0.1 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.005 1.322 . . . . 6.3899999999999997 111.216 176.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.2 ttm105 -140.76 157.97 44.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 122.807 1.289 . . . . 7.4100000000000001 113.287 -159.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -140.06 149.13 42.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.691 1.596 . . . . 4.8600000000000003 112.471 169.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.7 p -118.3 162.38 18.37 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.03 1.332 . . . . 2.7999999999999998 109.741 158.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.93 -42.79 63.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.961 1.705 . . . . 3.6400000000000001 112.595 176.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -47.43 -30.29 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.946 1.699 . . . . 9.3900000000000006 113.908 171.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.45 -5.15 43.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.046 1.338 . . . . 3.0699999999999998 112.85 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.71 -25.14 14.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.625 1.17 . . . . 4.1200000000000001 112.619 163.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.37 142.11 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.114 1.765 . . . . 4.8399999999999999 112.596 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.85 35.13 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.055 0.782 . . . . 2.7000000000000002 115.055 173.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -139.19 -166.88 2.12 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.705 1.602 . . . . 3.4100000000000001 108.943 172.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -90.69 70.02 6.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.083 0.945 . . . . 2.5899999999999999 109.003 171.283 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.55 151.78 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.278 -0.638 . . . . 3.5899999999999999 109.278 175.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.8 tp -148.23 122.69 9.72 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.789 -0.569 . . . . 3.8599999999999999 109.577 -173.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -109.59 115.02 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 122.787 0.435 . . . . 2.6200000000000001 111.732 -169.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.89 146.05 41.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.844 1.658 . . . . 4.0999999999999996 112.62 173.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -111.65 118.54 35.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.687 1.195 . . . . 3.6899999999999999 110.068 174.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.36 153.93 23.78 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.327 0.965 . . . . 1.3 114.888 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -81.06 -29.33 35.03 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.977 1.311 . . . . 5.4699999999999998 112.819 176.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.3 m 96.78 123.7 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.899 2.879 . . . . 3.6000000000000001 107.352 -173.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 72.11 -46.25 0.64 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.152 2.181 . . . . 9.9100000000000001 113.357 -178.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m 58.7 -172.28 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.214 1.405 . . . . 2.6899999999999999 113.018 -173.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.17 -43.2 9.12 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.039 1.826 . . . . 3.4199999999999999 110.368 144.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -154.5 -53.68 0.1 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.419 1.888 . . . . 6.5899999999999999 115.353 -159.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.64 -35.82 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 114.978 1.473 . . . . 4.9800000000000004 114.978 -159.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -46.29 -64.78 0.83 Allowed Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 120.245 1.384 . . . . 1.8999999999999999 111.386 167.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.5 -32.21 32.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.678 2.252 . . . . 1.74 113.053 -177.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -59.81 -49.78 76.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.472 1.033 . . . . 4.0800000000000001 111.429 175.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.36 -30.63 53.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.451 0.908 . . . . 3.98 113.451 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.6 -41.05 76.34 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.259 -0.901 . . . . 3.3399999999999999 111.075 168.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.95 -47.48 86.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.892 0.769 . . . . 3.8199999999999998 111.572 176.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -53.22 54.87 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.379 -1.451 . . . . 4.6900000000000004 110.74 170.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.7 ttp -59.36 -40.7 87.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.189 1.396 . . . . 3.46 112.714 -175.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.5 mm -71.64 -53.85 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 2.8500000000000001 110.174 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.518 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 67.4 mt-30 -62.86 -34.54 77.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.818 0.735 . . . . 3.71 110.269 -172.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 t -52.01 -31.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.525 -1.226 . . . . 2.3500000000000001 112.853 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.49 -34.8 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.941 1.7 . . . . 3.9500000000000002 111.352 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -37.54 82.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.699 0.681 . . . . 5.8600000000000003 112.307 -177.024 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -84.85 -33.53 22.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.949 1.299 . . . . 3.9399999999999999 112.143 -178.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.76 -40.19 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.503 1.121 . . . . 2.3799999999999999 111.384 172.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -73.49 -48.2 35.22 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 117.969 0.35 . . . . 4.8099999999999996 111.233 171.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 55.5 m -70.01 -20.86 63.25 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.437 1.643 . . . . 3.6699999999999999 115.437 -171.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.1 mm -74.23 -53.4 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.684 1.129 . . . . 5.21 112.301 -178.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.4 p -150.6 13.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.943 1.297 . . . . 8.4900000000000002 113.413 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 6.1 t 52.67 66.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.379 2.272 . . . . 7.1900000000000004 110.819 -173.589 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -53.7 158.2 3.33 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.834 1.654 . . . . 4.0899999999999999 111.589 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -77.12 38.45 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.211 3.274 . . . . 3.1400000000000001 112.467 178.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . 0.479 ' CG ' ' HZ2' ' A' ' 223' ' ' LYS 0.265 5.0 t0 76.13 138.45 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 131.555 3.942 . . . . 4.6600000000000001 117.412 167.613 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.04 110.12 21.59 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.021 2.129 . . . . 5.0700000000000003 107.691 170.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -110.94 96.4 29.18 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 124.671 1.189 . . . . 2.5800000000000001 109.693 -175.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.3 125.62 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.317 2.678 . . . . 1.0600000000000001 113.626 -173.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.0 tp -104.55 118.65 37.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.114 1.765 . . . . 3.4399999999999999 109.339 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -104.76 132.02 51.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.749 1.22 . . . . 3.9300000000000002 109.495 176.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.1 mm -114.42 133.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.522 1.529 . . . . 2.7599999999999998 110.427 177.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.4 m -67.19 -172.95 0.23 Allowed 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 115.158 1.54 . . . . 3.3599999999999999 115.158 170.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.3 pt -144.99 -34.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.439 -1.413 . . . . 3.8500000000000001 114.747 175.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -130.92 71.82 82.2 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.73 1.612 . . . . 4.5 111.288 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.95 -1.44 2.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 124.982 3.788 . . . . 3.02 115.657 -172.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.26 -6.51 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.495 1.043 . . . . 4.3600000000000003 113.343 160.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -132.63 -60.83 0.87 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.39 1.476 . . . . 6.4699999999999998 114.145 -173.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.54 74.7 9.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.836 1.303 . . . . 4.04 110.906 -172.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.4 t -65.01 154.7 36.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.185 1.469 . . . . 3.4199999999999999 112.11 -170.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -56.16 -32.74 64.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.331 1.852 . . . . 7.2199999999999998 113.626 -171.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 20.0 mp0 -77.2 -39.36 49.02 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.809 2.844 . . . . 4.5499999999999998 110.803 178.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.98 77.57 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.863 0.865 . . . . 2.48 111.235 172.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.55 -42.95 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 2.5699999999999998 110.631 168.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.17 96.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.719 -0.658 . . . . 1.9299999999999999 112.118 175.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -61.72 -50.39 72.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.78 1.173 . . . . 4.2699999999999996 111.617 171.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.08 -42.52 72.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.413 1.485 . . . . 4.54 111.807 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.18 -46.32 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.325 1.05 . . . . 2.1000000000000001 112.234 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.482 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -63.82 -25.43 68.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.449 0.907 . . . . 5.6200000000000001 113.449 -176.651 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.482 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 7.0 mm-40 -83.98 -40.31 18.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.138 0.881 . . . . 5.1799999999999997 112.411 175.394 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -76.22 -45.51 32.64 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.969 1.099 . . . . 4.3600000000000003 113.969 -176.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 153.14 146.52 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 128.99 2.916 . . . . 2.79 112.985 173.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.69 8.19 2.04 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.42 3.413 . . . . 2.5600000000000001 115.702 -175.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . 0.479 ' HZ2' ' CG ' ' A' ' 195' ' ' ASP . 89.4 mttt -76.4 -18.0 59.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.057 1.299 . . . . 3.0 112.509 163.297 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.72 139.05 39.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.428 1.091 . . . . 3.9300000000000002 111.237 171.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.66 138.58 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.426 1.09 . . . . 3.1800000000000002 108.954 161.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.66 125.41 8.57 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.889 1.233 . . . . 1.1299999999999999 111.464 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.9 mp -108.19 129.88 55.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.672 1.189 . . . . 3.5699999999999998 110.249 176.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t 174.29 122.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.421 2.288 . . . . 3.3300000000000001 110.037 -167.396 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.46 -62.19 0.12 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 124.368 0.985 . . . . 2.9300000000000002 112.221 176.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.0 p -145.16 171.1 15.01 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.281 1.832 . . . . 3.1400000000000001 109.192 -176.167 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -31.59 69.4 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.78 -0.575 . . . . 8.1799999999999997 111.245 178.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 21.7 mp0 -70.71 -51.77 25.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 2.79 112.632 -176.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . 0.32 0.0 OUTLIER -80.03 -29.09 39.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.09 1.313 . . . . 3.9300000000000002 113.659 -174.833 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.37 -53.01 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.0 0.92 . . . . 3.1699999999999999 111.324 157.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.37 -23.07 61.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.947 -1.096 . . . . 3.6899999999999999 113.525 -175.335 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -57.74 6.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.213 0.915 . . . . 3.2999999999999998 110.118 163.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.68 -21.08 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 118.445 0.566 . . . . 3.1600000000000001 111.929 -171.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.261 1.024 . . . . 2.4100000000000001 110.367 167.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -44.34 65.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.187 1.395 . . . . 5.9199999999999999 111.946 173.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -53.03 -43.77 66.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.868 1.213 . . . . 2.23 112.473 175.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -96.71 11.22 36.28 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.921 1.082 . . . . 3.4300000000000002 113.921 178.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 41.73 45.8 3.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.846 2.458 . . . . 7.1600000000000001 114.955 -177.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 13.3 m -67.89 159.48 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.587 1.155 . . . . 4.0199999999999996 112.516 -170.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -101.67 102.39 13.06 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.225 0.536 . . . . 4.9299999999999997 110.946 163.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -102.69 143.37 32.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.271 -0.64 . . . . 4.0099999999999998 109.271 154.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.6 m -70.13 137.52 87.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 121.569 -0.707 . . . . 4.5199999999999996 112.307 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.59 119.32 5.87 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 107.396 -1.809 . . . . 6.0999999999999996 107.396 154.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.73 160.6 53.65 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 114.015 0.366 . . . . 3.6200000000000001 114.015 -171.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.51 -171.57 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.078 3.186 . . . . 4.8899999999999997 111.239 176.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.545 ' HZ3' ' CD ' ' A' ' 254' ' ' GLU . 0.0 OUTLIER -77.59 -18.52 56.77 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.759 -1.213 . . . . 8.6300000000000008 113.138 163.046 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.1 -158.92 0.32 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.839 2.056 . . . . 6.9299999999999997 113.239 178.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -64.62 -22.17 66.91 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.041 0.837 . . . . 7.4299999999999997 113.243 175.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -149.08 -49.31 0.15 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.83 1.419 . . . . 7.9800000000000004 114.83 173.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.545 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 7.3 tp10 -179.37 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.637 1.975 . . . . 9.6799999999999997 111.439 -165.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -75.86 56.09 0.93 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.999 1.719 . . . . 7.7000000000000002 114.15 -170.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -58.91 138.67 57.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 116.659 2.096 . . . . 5.7699999999999996 116.659 -160.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 47.0 pt -56.71 148.53 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.255 0.55 . . . . 5.3600000000000003 111.715 166.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.6 m -124.22 147.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.684 1.594 . . . . 4.0599999999999996 107.368 166.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.59 165.56 18.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.154 1.382 . . . . 5.25 108.883 172.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -150.41 143.0 24.53 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.031 1.122 . . . . 2.73 114.031 175.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.3 t -151.6 149.99 29.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.108 0.963 . . . . 5.4000000000000004 109.562 167.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.2 174.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.614 1.966 . . . . 7.6299999999999999 110.799 -159.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.99 140.63 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.47 -1.678 . . . . 4.9500000000000002 106.47 152.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.4 ttt -94.92 127.99 41.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.017 1.327 . . . . 3.1400000000000001 108.863 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -111.06 134.9 52.29 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 5.4000000000000004 114.293 -165.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.53 107.07 17.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.048 1.339 . . . . 4.1799999999999997 109.242 171.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.01 110.5 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 105.267 -2.123 . . . . 2.71 105.267 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.93 -168.57 44.02 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 113.601 0.2 . . . . 1.99 113.601 -168.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.31 71.18 5.29 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.763 2.975 . . . . 3.5099999999999998 109.275 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -155.13 -60.11 0.11 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.456 1.502 . . . . 4.6799999999999997 110.145 -159.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.04 -31.03 4.41 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.116 -1.38 . . . . 3.4700000000000002 114.716 -178.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -113.12 -61.43 1.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.759 1.279 . . . . 5.0999999999999996 112.42 -175.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -170.16 145.3 2.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.337 -0.852 . . . . 8.4499999999999993 112.625 -162.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.81 -44.55 1.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.211 1.004 . . . . 4.3200000000000003 113.574 176.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -159.33 158.93 33.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 2.8700000000000001 111.547 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -119.54 125.1 48.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.826 1.25 . . . . 5.5599999999999996 110.919 172.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 104.22 14.01 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.197 -1.038 . . . . 4.1200000000000001 108.197 178.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -74.47 157.01 50.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.016 -1.234 . . . . 3.79 110.016 162.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.3 57.44 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.683 1.593 . . . . 4.6299999999999999 111.537 175.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -156.63 -31.96 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.152 1.781 . . . . 6.0800000000000001 113.186 -171.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.76 131.91 46.96 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.244 -0.91 . . . . 5.3200000000000003 109.43 170.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -82.85 155.68 24.01 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.423 1.889 . . . . 8.8699999999999992 109.794 172.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.518 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 9.3 tmtt? -38.91 -54.03 1.68 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.403 1.881 . . . . 2.7000000000000002 114.687 -172.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.27 -36.8 93.67 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.142 -0.81 . . . . 1.54 113.63 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.3 -27.3 64.28 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.677 1.738 . . . . 3.3199999999999998 112.763 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 95.0 mt -69.02 -48.81 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.196 0.998 . . . . 2.23 110.094 176.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.3 -45.2 85.33 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.303 0.483 . . . . 2.1299999999999999 112.303 174.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.93 67.65 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 2.77 114.403 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 p -67.37 -47.99 68.75 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.017 -1.052 . . . . 2.3900000000000001 111.327 168.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.93 -36.64 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.727 -1.233 . . . . 2.6600000000000001 112.182 173.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.78 67.6 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.364 -1.46 . . . . 2.46 113.175 172.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.4 m -75.62 -51.76 12.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.888 0.875 . . . . 3.5099999999999998 109.319 172.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -61.33 -26.42 67.79 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.536 1.535 . . . . 3.2999999999999998 113.985 176.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.1 ttp -66.59 -15.01 63.13 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.724 -1.235 . . . . 5.71 112.99 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -59.9 -51.95 77.05 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 116.962 -1.494 . . . . 6.1600000000000001 111.513 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.55 -58.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.867 2.378 . . . . 2.4500000000000002 112.368 166.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -79.98 66.42 5.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.215 1.406 . . . . 4.4100000000000001 111.724 -176.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.08 158.17 1.16 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.94 1.296 . . . . 9.4600000000000009 113.753 -177.18 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -52.88 152.77 3.71 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.041 -1.037 . . . . 8.7100000000000009 112.201 168.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -56.11 -43.47 78.17 Favored 'General case' 0 CA--C 1.55 0.959 0 O-C-N 121.19 -0.944 . . . . 11.369999999999999 112.725 177.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.49 1.916 . . . . 9.25 111.136 172.232 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 118.462 -0.78 . . . . 20.600000000000001 109.077 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -69.3 171.19 8.92 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 118.838 0.745 . . . . 18.530000000000001 110.116 154.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.7 t -162.78 -173.03 3.32 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.333 1.453 . . . . 13.640000000000001 110.229 -174.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.03 -91.67 1.01 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.077 -1.209 . . . . 10.75 110.077 -177.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt 157.4 133.26 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 130.916 3.686 . . . . 11.68 111.474 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -87.87 171.46 5.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.528 2.819 . . . . 9.9100000000000001 110.835 168.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.18 177.63 4.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.561 1.544 . . . . 7.9000000000000004 109.044 159.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.02 143.2 51.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.668 1.187 . . . . 8.0299999999999994 110.539 177.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.84 -143.26 21.33 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.064 0.84 . . . . 4.1799999999999997 112.271 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.19 -156.25 15.78 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.554 1.073 . . . . 3.98 114.518 173.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -82.11 -178.74 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.703 3.602 . . . . 3.3399999999999999 112.413 -175.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -170.85 168.52 7.17 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.47 2.708 . . . . 3.9500000000000002 108.762 -176.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -134.34 32.09 3.42 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.734 -1.229 . . . . 3.9199999999999999 112.744 167.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.71 146.3 21.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 123.446 1.593 . . . . 2.96 111.304 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 m -108.39 140.39 41.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.788 -1.551 . . . . 2.4700000000000002 109.19 -168.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.4 m -90.74 148.21 22.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.412 1.885 . . . . 4.4900000000000002 110.459 -167.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -55.69 -13.08 1.47 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 117.347 2.351 . . . . 2.8599999999999999 117.347 -170.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.4 t -86.11 -27.39 24.69 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 4.6299999999999999 113.605 170.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.97 26.91 1.63 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.789 1.662 . . . . 2.5600000000000001 116.172 -177.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.13 139.94 51.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.393 2.096 . . . . 3.6499999999999999 111.203 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -96.04 123.69 39.74 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.188 2.195 . . . . 7.3499999999999996 110.739 -170.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 164.24 14.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.385 0.674 . . . . 4.4500000000000002 111.292 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -128.02 -179.51 5.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.586 1.154 . . . . 3.73 108.184 167.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -38.8 -65.8 0.33 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.141 1.777 . . . . 4.9900000000000002 113.217 163.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 13.28 0.36 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.191 1.922 . . . . 9.9399999999999995 116.191 -172.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -90.68 -26.91 19.34 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.573 -1.33 . . . . 3.8300000000000001 112.26 158.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -113.36 -9.15 13.4 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.093 1.757 . . . . 3.8500000000000001 114.345 -178.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tt -111.5 120.95 43.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.354 2.261 . . . . 4.7999999999999998 109.539 -175.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.33 -39.81 1.75 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.101 2.286 . . . . 2.54 109.708 -170.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -78.62 -156.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.762 0.825 . . . . 3.5899999999999999 109.988 138.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.04 155.79 27.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.834 1.253 . . . . 2.8100000000000001 112.165 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.66 149.7 34.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.508 1.299 . . . . 3.3900000000000001 114.508 170.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.42 137.8 38.35 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.163 1.785 . . . . 3.5600000000000001 107.859 164.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.2 mt -123.11 139.0 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.465 1.106 . . . . 2.6699999999999999 108.271 177.265 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -151.99 149.2 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.427 1.491 . . . . 3.6800000000000002 111.372 177.603 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -104.02 118.42 36.62 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.923 0.889 . . . . 3.5800000000000001 109.92 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -168.96 156.59 28.03 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.693 1.616 . . . . 2.3199999999999998 114.312 -171.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.29 171.33 12.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.551 -0.97 . . . . 5.3899999999999997 113.572 -155.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m -96.27 18.42 13.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.353 0.871 . . . . 3.9399999999999999 113.353 -172.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -106.2 -3.51 21.27 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.069 -1.019 . . . . 9.3699999999999992 113.266 170.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.34 160.47 81.27 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 127.526 2.33 . . . . 2.6499999999999999 115.4 -171.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.27 -160.17 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.235 3.29 . . . . 4.4900000000000002 110.764 156.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.68 -10.17 7.93 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.45 2.3 . . . . 4.8099999999999996 115.459 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -78.45 -32.28 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 118.495 -0.764 . . . . 4.5800000000000001 112.412 -170.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.69 -61.03 6.34 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 117.147 -1.406 . . . . 1.5700000000000001 112.31 166.198 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.1 -36.75 56.66 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.583 2.188 . . . . 2.1600000000000001 114.315 -175.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -54.91 -60.08 3.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.953 1.301 . . . . 4.79 110.95 171.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.82 -35.88 75.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.324 0.65 . . . . 3.1499999999999999 112.174 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.49 -33.41 64.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.878 1.671 . . . . 3.79 112.416 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -61.34 2.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.158 1.345 . . . . 5.5199999999999996 108.35 170.717 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -38.59 67.36 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.786 -0.571 . . . . 7.8799999999999999 110.829 -175.261 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 11.4 ttm -64.88 -45.69 84.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.717 1.207 . . . . 3.3399999999999999 113.065 177.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.7 pt -76.96 -28.79 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 120.34 1.427 . . . . 4.9900000000000002 110.854 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.45 ' C ' ' HE3' ' A' ' 283' ' ' LYS . 0.6 OUTLIER -80.4 -34.44 36.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.175 0.443 . . . . 4.3099999999999996 110.604 -175.444 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.4 -40.71 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.696 0.799 . . . . 2.6400000000000001 112.517 176.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 22.4 m -64.29 -39.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.276 0.944 . . . . 4.04 111.94 -175.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.04 -41.24 91.12 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.841 -1.162 . . . . 5.0 112.463 173.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.01 -19.54 64.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.497 1.519 . . . . 2.9500000000000002 113.482 179.52 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.39 -58.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.977 1.711 . . . . 3.0299999999999998 112.08 173.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.34 -28.4 69.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.845 0.831 . . . . 4.4500000000000002 112.358 -170.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.7 m -71.07 -16.95 62.61 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.232 -0.918 . . . . 4.9900000000000002 113.346 176.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.2 mm -80.63 64.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.335 -1.358 . . . . 5.1100000000000003 107.335 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.9 t -47.02 -12.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 129.751 3.22 . . . . 6.3700000000000001 118.181 -157.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.0 m -73.98 -22.95 59.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.825 1.65 . . . . 4.5599999999999996 111.874 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.7 mt -74.83 162.23 74.38 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.364 1.866 . . . . 4.8499999999999996 113.583 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.63 154.59 27.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.596 2.864 . . . . 3.0699999999999998 110.375 168.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.35 133.22 38.8 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.483 1.913 . . . . 5.0 113.649 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.5 107.86 19.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.247 1.819 . . . . 3.27 111.383 -175.101 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.2 m -72.86 131.91 83.54 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.449 -1.407 . . . . 2.4100000000000001 111.194 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -91.56 94.7 0.21 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.166 3.244 . . . . 1.71 111.342 165.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.24 101.26 11.53 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.742 0.782 . . . . 3.2599999999999998 112.492 -173.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -93.03 126.03 37.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.212 1.405 . . . . 4.0599999999999996 110.632 -177.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.21 119.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.226 1.01 . . . . 2.98 110.145 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.5 m -98.87 162.49 13.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.573 1.149 . . . . 3.6800000000000002 112.677 175.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.2 pt -147.83 -13.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.91 2.189 . . . . 2.4399999999999999 116.91 -148.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -94.38 93.38 0.93 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 120.618 1.554 . . . . 3.7799999999999998 107.495 170.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.37 -22.32 52.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.762 1.641 . . . . 3.0 112.499 -177.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -63.22 -14.85 53.98 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.109 1.364 . . . . 4.0099999999999998 114.611 170.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -161.64 -10.91 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 118.7 2.852 . . . . 6.04 118.7 -170.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -75.36 65.44 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.352 2.342 . . . . 4.8099999999999996 111.862 170.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.0 m -65.07 136.92 57.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.57 1.948 . . . . 3.21 111.076 -176.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -38.22 -64.59 0.4 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.197 1.799 . . . . 4.2699999999999996 113.411 175.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -65.96 -25.08 66.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.245 1.418 . . . . 3.3300000000000001 113.73 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.59 -47.03 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.434 1.015 . . . . 2.6200000000000001 110.814 175.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 38.5 mm -57.23 -45.22 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.22 1.008 . . . . 2.96 110.405 170.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.81 -46.55 67.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.834 0.853 . . . . 2.9700000000000002 112.467 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -68.78 -46.18 69.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.33 0.514 . . . . 3.75 111.876 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -54.64 -49.28 70.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.81 1.244 . . . . 4.2599999999999998 111.353 176.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.5 t -55.27 -49.32 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.555 1.942 . . . . 3.21 111.33 172.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.435 ' HZ3' ' CD ' ' A' ' 219' ' ' GLU . 0.3 OUTLIER -64.07 -30.43 71.5 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.081 -1.438 . . . . 6.5199999999999996 114.254 -177.224 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' A' ' 218' ' ' LYS . 3.5 mm-40 -68.74 -29.95 68.47 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.278 1.399 . . . . 4.04 112.083 175.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -81.8 -54.07 5.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.907 0.483 . . . . 4.1600000000000001 111.509 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.9 p -169.85 148.96 3.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 121.591 -0.693 . . . . 3.48 111.445 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.53 -7.41 20.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.359 2.706 . . . . 3.1499999999999999 113.278 173.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -85.01 -21.34 29.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.277 1.031 . . . . 3.6600000000000001 112.997 176.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.42 143.91 48.34 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.661 1.185 . . . . 3.1400000000000001 111.378 -178.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.62 134.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.882 0.873 . . . . 4.1399999999999997 111.216 172.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.66 124.79 6.66 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.28 1.419 . . . . 1.3500000000000001 111.763 -178.276 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -108.76 139.65 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.348 1.459 . . . . 3.4399999999999999 110.901 -178.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 t -139.54 164.38 30.04 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.81 1.644 . . . . 3.1699999999999999 110.678 176.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.31 171.95 39.97 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.67 1.605 . . . . 1.8799999999999999 112.166 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -64.84 160.26 20.76 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.736 0.814 . . . . 3.0099999999999998 110.529 168.648 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -50.07 -35.74 26.49 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.864 0.866 . . . . 6.2000000000000002 113.167 -174.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 18.1 mp0 -67.22 -38.5 85.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.003 1.721 . . . . 2.8799999999999999 110.108 -178.318 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.09 -40.84 52.16 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.599 1.16 . . . . 4.3300000000000001 113.022 172.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.48 -42.62 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.869 -0.419 . . . . 2.6499999999999999 109.869 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -75.35 -29.45 59.93 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.129 -0.938 . . . . 3.0499999999999998 112.653 175.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -60.21 -59.69 5.01 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.625 2.011 . . . . 2.6699999999999999 110.261 167.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.22 -30.6 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 118.466 0.576 . . . . 3.0299999999999998 111.986 -171.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.45 -52.34 14.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.996 0.816 . . . . 2.3500000000000001 112.216 173.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -76.54 -32.55 58.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.592 1.157 . . . . 4.4800000000000004 112.936 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.72 78.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.539 1.136 . . . . 2.4700000000000002 111.242 173.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -73.2 -1.89 19.52 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.24 -0.912 . . . . 3.1600000000000001 113.03 168.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 45.61 39.68 5.18 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.372 2.669 . . . . 8.0999999999999996 114.471 -176.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 p -71.37 137.6 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.195 -0.668 . . . . 4.0999999999999996 109.195 174.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -75.46 130.65 39.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.87 0.367 . . . . 5.5700000000000003 110.88 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -148.84 144.39 26.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.185 1.394 . . . . 5.2300000000000004 109.956 172.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.0 m -149.48 106.35 3.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 O-C-N 121.493 -0.755 . . . . 5.0499999999999998 112.133 -171.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.35 142.35 10.6 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.447 2.765 . . . . 3.3500000000000001 113.055 -177.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.23 122.66 6.22 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.088 -1.396 . . . . 3.1099999999999999 110.322 166.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.73 115.47 4.34 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.774 2.316 . . . . 6.8399999999999999 110.19 -176.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.502 ' HZ1' ' CD ' ' A' ' 254' ' ' GLU . 0.0 OUTLIER -160.05 -170.35 2.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.92 1.288 . . . . 7.1799999999999997 112.539 -167.042 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -142.13 -174.9 4.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.981 2.513 . . . . 10.08 109.371 -169.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -114.01 133.54 55.44 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.785 1.234 . . . . 16.239999999999998 109.067 177.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.6 t0 107.23 -1.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 131.389 3.876 . . . . 8.8200000000000003 111.041 -163.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.502 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 33.7 tt0 -135.05 -40.94 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.678 1.591 . . . . 9.0500000000000007 110.634 166.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 30.3 t0 72.1 -168.54 0.14 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.362 1.865 . . . . 5.4199999999999999 110.962 177.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -167.51 -162.57 0.46 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.408 -1.433 . . . . 4.6900000000000004 111.935 -161.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.4 tt -157.45 164.85 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.106 1.762 . . . . 4.4500000000000002 108.059 157.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.39 140.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.278 -1.378 . . . . 4.9800000000000004 107.278 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.7 147.71 47.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.261 0.553 . . . . 4.5599999999999996 110.996 167.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -143.26 136.25 27.84 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.618 0.767 . . . . 2.9399999999999999 110.13 158.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -66.2 131.37 46.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.811 -1.181 . . . . 4.3899999999999997 110.339 174.298 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.253 0.0 OUTLIER -82.52 64.48 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 123.172 1.463 . . . . 5.9400000000000004 112.653 -171.091 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.63 127.09 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.04 1.336 . . . . 3.2200000000000002 111.402 -176.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.7 mmm -88.09 137.66 32.13 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.552 1.541 . . . . 3.3999999999999999 109.411 158.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -114.14 131.56 56.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 3.8500000000000001 109.524 168.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.05 121.45 41.4 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.901 0.88 . . . . 3.4100000000000001 108.685 173.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.08 117.89 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.052 -1.462 . . . . 2.4700000000000002 107.052 172.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.51 -137.12 5.76 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 109.357 -1.497 . . . . 2.0800000000000001 109.357 167.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -81.19 3.67 7.62 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.391 2.06 . . . . 3.5899999999999999 112.381 170.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -31.37 53.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.954 1.302 . . . . 4.8600000000000003 112.744 -176.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.98 1.85 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.07 1.319 . . . . 2.9399999999999999 113.345 -170.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -77.86 19.26 0.41 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.983 1.713 . . . . 4.6699999999999999 115.04 -166.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 92.1 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 129.972 3.309 . . . . 5.3399999999999999 110.676 173.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.32 -33.29 10.78 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.727 1.211 . . . . 3.6899999999999999 111.144 176.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -168.97 167.12 10.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.139 2.175 . . . . 2.7200000000000002 108.325 -168.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -161.47 146.04 13.28 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.444 1.098 . . . . 5.8399999999999999 112.288 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -129.91 115.22 16.88 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.914 0.886 . . . . 3.9300000000000002 109.862 -175.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.32 110.75 4.09 Favored Glycine 0 N--CA 1.465 0.616 0 N-CA-C 109.652 -1.379 . . . . 3.6099999999999999 109.652 173.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 76.44 166.32 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.483 1.913 . . . . 4.1699999999999999 110.949 -167.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -42.03 -48.46 4.63 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.094 2.557 . . . . 10.58 113.408 -169.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 59.0 tttp 67.95 -23.29 0.12 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.566 1.946 . . . . 6.0300000000000002 113.89 -172.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 102.3 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.319 3.448 . . . . 6.6299999999999999 107.259 -174.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.45 ' HE3' ' C ' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -34.78 -60.07 0.46 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.285 2.234 . . . . 3.4399999999999999 113.25 179.012 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.8 -19.38 69.41 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.256 -1.302 . . . . 1.76 115.755 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.84 -26.11 49.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.739 2.27 . . . . 3.9100000000000001 112.981 177.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.85 -40.47 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.735 -0.839 . . . . 3.9199999999999999 108.735 169.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.31 77.54 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.484 0.584 . . . . 2.3799999999999999 111.461 169.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.41 -39.21 85.52 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.196 1.184 . . . . 2.5 114.196 176.032 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.9 p -70.0 -46.95 64.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.108 0.867 . . . . 2.7599999999999998 111.571 175.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.8 mt -54.82 -44.18 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.954 . . . . 2.5600000000000001 110.77 171.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.408 -1.433 . . . . 2.7400000000000002 113.701 178.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 57.4 m -76.95 -47.88 19.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.079 0.952 . . . . 2.98 109.93 170.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -62.73 -31.78 72.77 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.338 1.055 . . . . 3.7000000000000002 112.288 175.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.56 24.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.633 1.573 . . . . 7.0 112.749 168.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.47 -57.16 0.31 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 116.337 -1.792 . . . . 6.5 111.801 152.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.17 -49.48 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.251 2.634 . . . . 2.7400000000000002 113.133 176.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.33 70.42 10.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.863 0.756 . . . . 4.3099999999999996 111.712 -176.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 72.76 -168.16 0.12 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.879 1.272 . . . . 11.970000000000001 109.318 -174.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.486 ' HZ2' ' C ' ' A' ' 301' ' ' SER . 12.4 pttp -158.33 157.67 32.86 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.999 -1.063 . . . . 10.91 113.141 -169.227 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.547 ' HE3' ' H ' ' A' ' 300' ' ' LYS . 0.0 OUTLIER -66.29 -27.87 68.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.357 1.463 . . . . 12.65 113.278 -174.724 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.486 ' C ' ' HZ2' ' A' ' 299' ' ' LYS . 34.6 t . . . . . 0 C--O 1.253 1.285 0 C-N-CA 128.56 2.744 . . . . 9.1300000000000008 107.287 170.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 117.867 -1.063 . . . . 22.34 109.82 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -63.89 139.34 58.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.018 0.827 . . . . 18.399999999999999 110.024 163.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.3 t 144.77 -173.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.274 1 C-N-CA 132.108 4.163 . . . . 17.469999999999999 108.114 -176.22 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.83 -133.53 15.58 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.982 0.801 . . . . 15.31 112.521 172.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.22 154.86 2.69 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 127.392 2.277 . . . . 13.789999999999999 110.887 174.063 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.52 171.89 17.23 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.017 2.478 . . . . 10.9 110.627 166.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.9 mt -98.62 152.27 19.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.297 1.039 . . . . 12.779999999999999 109.961 167.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 75.6 mt -117.43 -166.87 1.23 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.577 1.551 . . . . 8.4600000000000009 110.966 -175.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -141.91 177.01 21.69 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 115.852 1.101 . . . . 3.9900000000000002 115.852 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.62 -91.62 0.94 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.833 1.682 . . . . 4.9199999999999999 110.494 -168.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.55 161.78 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.905 2.403 . . . . 3.9700000000000002 113.279 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -156.08 179.43 9.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.85 2.46 . . . . 4.25 108.366 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.2 m -140.31 117.27 11.09 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.957 -1.714 . . . . 3.8599999999999999 111.528 157.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.72 161.65 28.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.694 1.997 . . . . 3.4399999999999999 108.39 176.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.4 t -87.31 146.62 25.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.467 0.651 . . . . 4.1799999999999997 110.93 173.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.9 p -92.85 159.28 15.44 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 123.152 1.454 . . . . 3.46 112.409 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -56.82 -26.86 59.05 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.127 -0.983 . . . . 2.4300000000000002 112.474 163.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.0 p -71.72 -20.29 61.93 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.367 1.247 . . . . 4.5999999999999996 114.367 169.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.77 11.16 54.24 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 120.287 1.403 . . . . 1.96 115.163 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -88.76 -175.37 4.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.673 1.589 . . . . 4.0599999999999996 110.136 170.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -131.56 121.72 24.9 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.887 1.275 . . . . 6.5700000000000003 108.969 168.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -132.72 156.39 47.11 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.903 1.075 . . . . 4.9299999999999997 113.903 -162.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -108.0 164.16 12.52 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.37 1.868 . . . . 3.3900000000000001 109.63 171.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -39.61 -55.77 1.8 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.63 2.372 . . . . 4.1799999999999997 112.42 159.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.465 ' HZ1' ' CD ' ' A' ' 272' ' ' GLU . 11.4 mptt -74.34 -15.66 60.94 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.537 1.31 . . . . 8.8000000000000007 114.537 -174.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.74 -42.64 77.29 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.824 1.193 . . . . 3.04 110.988 166.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.68 11.19 3.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.385 1.254 . . . . 4.1600000000000001 114.385 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.36 -169.49 0.82 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.662 1.185 . . . . 5.2000000000000002 111.763 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 76.41 8.35 85.67 Favored Glycine 0 N--CA 1.482 1.702 0 O-C-N 120.517 -1.364 . . . . 3.96 114.56 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.55 154.96 27.51 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.361 2.664 . . . . 3.5699999999999998 107.593 -171.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -68.07 125.09 25.25 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.314 0.507 . . . . 2.7799999999999998 110.071 170.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.7 mt -105.86 125.72 51.33 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.963 0.887 . . . . 4.29 111.652 177.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.04 92.22 3.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.865 1.666 . . . . 3.9399999999999999 106.748 176.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.85 121.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.787 1.235 . . . . 3.6899999999999999 110.199 -167.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -128.98 153.6 47.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.542 1.312 . . . . 4.9800000000000004 114.542 -175.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.85 102.13 9.7 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.109 1.763 . . . . 3.98 112.31 175.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.02 171.31 17.72 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.396 1.474 . . . . 2.3399999999999999 113.329 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -111.42 -12.99 13.95 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.765 0.654 . . . . 4.8200000000000003 112.765 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.0 m 58.04 47.53 14.62 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.137 1.446 . . . . 4.6799999999999997 108.891 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -150.4 -56.65 0.17 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 114.638 -1.164 . . . . 8.6600000000000001 110.738 -161.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.3 m -70.4 141.03 87.87 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.156 0.982 . . . . 2.98 111.219 -170.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.22 -17.54 21.58 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.907 1.738 . . . . 5.04 111.243 166.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.51 -76.57 0.54 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.779 1.632 . . . . 5.2999999999999998 112.673 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.29 -54.44 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.486 1.114 . . . . 3.5600000000000001 111.945 -162.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.5 m -47.25 -60.7 3.64 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.325 -1.321 . . . . 1.6799999999999999 112.596 176.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.24 -34.55 27.3 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.657 1.571 . . . . 1.48 113.127 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.458 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 11.8 tm-20 -67.08 -33.43 75.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 121.092 1.769 . . . . 3.75 112.097 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -31.2 37.67 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.299 -1.501 . . . . 3.6299999999999999 113.521 170.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -43.74 98.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.967 1.307 . . . . 3.6800000000000002 111.171 174.204 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.24 -46.34 76.03 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 3.4700000000000002 111.055 172.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.458 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 36.5 mtmm -66.51 -33.69 76.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.186 0.81 . . . . 4.7000000000000002 113.186 174.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 69.7 mtp -61.18 -42.6 98.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.017 1.281 . . . . 4.5199999999999996 111.915 169.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.9 mm -75.41 -61.97 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.971 -0.751 . . . . 2.6899999999999999 108.971 -172.06 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.26 -12.41 28.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.748 1.219 . . . . 3.1000000000000001 114.225 -165.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.13 -39.67 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.648 1.179 . . . . 2.7400000000000002 111.044 171.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.11 -53.86 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.021 1.282 . . . . 3.2799999999999998 110.205 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.8 -20.03 61.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.256 1.422 . . . . 4.4900000000000002 112.064 -171.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -79.32 -38.13 35.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.796 1.239 . . . . 2.6499999999999999 111.909 167.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.82 -49.54 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.782 1.401 . . . . 3.4700000000000002 114.782 -168.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -33.52 75.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.571 1.532 . . . . 4.4900000000000002 109.74 179.35 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -19.83 42.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.527 1.931 . . . . 3.6499999999999999 114.714 173.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.46 -14.34 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.321 -1.487 . . . . 4.4400000000000004 112.494 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m 157.64 -33.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 130.422 3.489 . . . . 6.6100000000000003 112.832 164.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 7.1 t 157.34 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.16 3.384 . . . . 6.6399999999999997 110.785 166.589 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.409 ' O ' ' HE2' ' A' ' 300' ' ' LYS . 0.2 OUTLIER -46.07 147.09 1.88 Allowed Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 114.302 -1.317 . . . . 4.8300000000000001 111.493 169.679 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.28 -44.25 19.77 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.372 2.715 . . . . 3.5699999999999998 112.459 -159.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.12 153.67 0.23 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.895 2.878 . . . . 4.5 108.669 161.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.16 128.11 29.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.044 0.537 . . . . 3.8900000000000001 109.704 171.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.4 m -124.84 119.1 25.65 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.704 1.202 . . . . 2.4199999999999999 108.562 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.73 133.63 10.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.001 2.467 . . . . 1.1899999999999999 110.127 172.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.84 97.25 4.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.832 1.253 . . . . 3.5600000000000001 109.336 -169.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -94.27 133.04 38.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.97 1.308 . . . . 3.5600000000000001 110.661 -173.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 54.0 mt -122.62 129.43 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.586 1.155 . . . . 2.6899999999999999 109.41 176.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -83.03 137.35 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.656 -0.653 . . . . 3.0499999999999998 112.409 171.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 pt -81.74 3.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.891 1.071 . . . . 3.9700000000000002 113.891 172.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.78 80.14 12.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 115.937 1.829 . . . . 5.1200000000000001 115.937 -172.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -80.14 63.21 8.72 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.295 3.33 . . . . 2.5699999999999998 112.12 174.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -108.74 -50.26 3.04 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.565 -1.198 . . . . 3.8799999999999999 108.343 139.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.39 -6.32 28.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.793 1.775 . . . . 5.79 115.793 -170.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -76.46 28.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.715 1.598 . . . . 5.4199999999999999 114.75 -177.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.2 m -61.29 134.74 57.29 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.486 -0.759 . . . . 4.1699999999999999 109.746 -141.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -39.37 9.14 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.828 1.418 . . . . 4.6699999999999999 114.828 -161.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -85.74 -28.31 24.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.655 0.983 . . . . 4.0599999999999996 113.655 178.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.81 91.78 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 2.75 111.44 166.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.6 -41.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.485 0.714 . . . . 3.6899999999999999 112.274 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.64 -38.79 75.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.297 0.953 . . . . 2.54 111.677 170.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -68.69 -38.29 80.19 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.062 0.764 . . . . 4.7800000000000002 113.062 173.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.61 -37.9 87.92 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.023 0.829 . . . . 4.1799999999999997 111.217 174.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.6 t -56.61 -47.94 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.951 -1.093 . . . . 2.23 111.721 170.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -79.84 19.9 0.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.493 1.294 . . . . 5.4400000000000004 114.493 174.698 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -92.48 -59.88 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.572 -1.33 . . . . 3.8999999999999999 109.557 160.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -80.79 -53.17 6.73 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.449 1.277 . . . . 4.7199999999999998 114.449 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.3 t -177.35 132.02 0.35 Allowed Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.135 1.374 . . . . 3.0899999999999999 109.031 -174.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.37 -5.72 16.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.184 2.589 . . . . 2.2000000000000002 113.081 -176.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -76.55 -8.56 57.46 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.333 0.969 . . . . 4.7699999999999996 113.401 171.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.48 131.04 44.11 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.32 0.964 . . . . 2.6499999999999999 110.09 169.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.3 t -99.97 129.2 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.757 -1.201 . . . . 3.2200000000000002 107.757 171.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.48 134.48 11.9 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.951 -0.86 . . . . 1.3500000000000001 110.951 172.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.2 161.0 22.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.911 0.884 . . . . 3.1699999999999999 112.129 171.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 9.7 t -162.72 -168.96 1.93 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 129.449 3.1 . . . . 3.4900000000000002 108.165 -176.063 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 173.58 -147.43 9.48 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 120.305 1.411 . . . . 1.9099999999999999 110.418 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.9 p -90.37 164.91 14.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.494 -0.928 . . . . 3.1200000000000001 108.494 157.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -30.17 69.57 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.523 -0.751 . . . . 9.2200000000000006 112.523 -173.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -56.09 -35.61 67.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.861 1.664 . . . . 3.4500000000000002 113.114 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.38 -35.77 54.14 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.792 -1.193 . . . . 3.6600000000000001 112.534 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.04 -35.1 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.009 0.524 . . . . 3.1400000000000001 110.657 171.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -30.45 67.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.226 1.01 . . . . 3.6899999999999999 111.318 174.144 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -60.41 3.91 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.405 1.082 . . . . 3.1000000000000001 110.798 162.428 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.9 p -71.51 -16.28 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.942 1.247 . . . . 3.71 112.806 -168.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.78 -39.62 69.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.974 0.91 . . . . 2.52 110.255 173.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.05 -49.58 76.79 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.384 -0.817 . . . . 4.21 110.478 163.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.9 -16.51 42.91 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 116.501 2.037 . . . . 2.9500000000000002 116.501 -170.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -129.75 15.56 5.87 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.118 . . . . 3.8700000000000001 113.671 173.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 56.61 43.32 25.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.136 1.374 . . . . 6.2599999999999998 112.678 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.51 126.72 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.623 1.569 . . . . 3.96 108.511 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -94.14 149.78 20.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.127 1.371 . . . . 6.0099999999999998 111.577 175.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -165.23 127.88 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.635 1.974 . . . . 5.9500000000000002 110.056 -174.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.1 t -136.42 79.2 42.69 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.826 1.65 . . . . 4.0999999999999996 111.8 -171.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.47 138.0 21.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.66 2.907 . . . . 3.27 113.877 -170.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -91.02 -173.03 43.78 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 125.521 1.534 . . . . 3.8199999999999998 112.829 163.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -87.27 171.37 6.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.139 3.226 . . . . 4.54 112.702 -174.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -114.38 24.09 12.22 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 126.06 1.744 . . . . 8.7300000000000004 114.846 -166.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -72.51 -28.98 63.21 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 118.471 2.767 . . . . 8.5 118.471 -140.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.59 -26.53 14.37 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.115 1.325 . . . . 7.4199999999999999 114.217 -176.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -159.7 -45.72 0.05 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.42 1.488 . . . . 8.2200000000000006 109.923 172.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -179.69 -43.86 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.027 3.331 . . . . 9.2100000000000009 110.058 174.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -6.68 74.16 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.861 2.064 . . . . 4.3499999999999996 114.859 -152.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.37 94.86 0.98 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.923 -1.035 . . . . 4.9500000000000002 112.088 -155.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 28.1 mm -77.04 78.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.791 -0.818 . . . . 5.5599999999999996 108.791 169.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.37 146.64 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.414 -1.699 . . . . 4.9299999999999997 106.414 151.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.66 -174.68 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.326 1.06 . . . . 4.6200000000000001 111.315 162.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -146.87 151.31 36.85 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.08 -1.013 . . . . 2.9900000000000002 111.453 138.339 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.1 m -60.09 128.47 36.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.055 1.342 . . . . 4.0 109.309 165.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 15.4 pt -104.07 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.56 1.544 . . . . 6.29 111.579 -177.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.3 mm -128.72 141.12 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.491 1.117 . . . . 3.8300000000000001 109.954 177.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 7.9 ttp -124.35 128.31 48.9 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.621 1.968 . . . . 3.6400000000000001 109.167 173.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.72 141.39 32.58 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.318 1.047 . . . . 4.0700000000000003 112.053 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -104.19 110.86 23.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.632 1.173 . . . . 3.75 110.215 174.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.0 138.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.477 1.511 . . . . 3.3700000000000001 109.38 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.92 160.53 37.19 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.351 -0.694 . . . . 2.3399999999999999 114.089 -178.014 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.53 64.52 4.64 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.593 3.529 . . . . 3.8599999999999999 109.192 167.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.02 -60.69 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.807 1.643 . . . . 4.79 108.254 -154.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 171.59 -70.25 0.12 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 123.798 0.714 . . . . 3.3399999999999999 112.464 -178.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.465 ' CD ' ' HZ1' ' A' ' 153' ' ' LYS . 49.3 mm-40 -118.11 -175.75 2.92 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.594 0.711 . . . . 5.9800000000000004 112.812 -161.195 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -85.05 145.74 27.53 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.329 0.863 . . . . 4.6500000000000004 113.329 -176.043 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 pp -141.93 0.86 1.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.398 1.629 . . . . 4.1600000000000001 115.398 -178.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -157.46 171.54 20.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.742 1.617 . . . . 3.1699999999999999 110.005 171.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -155.67 156.84 35.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.347 1.459 . . . . 4.5300000000000002 113.362 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -147.9 177.6 9.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.796 1.638 . . . . 3.9100000000000001 113.18 -168.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.09 -164.89 37.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 128.188 2.804 . . . . 3.1499999999999999 108.93 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -56.51 -28.16 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.133 0.967 . . . . 3.7799999999999998 113.225 179.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.29 -8.91 58.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 114.336 1.236 . . . . 5.2699999999999996 114.336 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -135.44 98.32 3.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 5.25 108.419 171.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.32 -172.31 4.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.357 0.663 . . . . 6.8200000000000003 112.518 -164.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -50.12 74.89 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.166 -1.584 . . . . 2.98 114.862 -159.08 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.89 -28.68 70.24 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.624 0.647 . . . . 1.96 111.809 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.68 -26.86 60.12 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.282 1.033 . . . . 4.2800000000000002 112.808 177.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.38 -51.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.861 0.865 . . . . 1.95 109.724 167.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.13 93.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.14 0.576 . . . . 2.6099999999999999 111.603 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.91 95.49 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.534 1.134 . . . . 3.25 113.882 177.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 25.1 p -71.73 -39.0 70.4 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.766 1.166 . . . . 2.27 111.982 174.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.11 -40.0 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.335 1.425 . . . . 2.4399999999999999 111.772 176.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.36 -22.0 66.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.26 1.024 . . . . 3.46 113.216 171.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 95.0 m -78.64 -40.27 34.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.928 0.891 . . . . 4.2000000000000002 110.673 170.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.53 -21.79 64.55 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.74 1.216 . . . . 3.3399999999999999 112.974 174.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -63.88 -33.26 75.3 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.848 -1.157 . . . . 5.9100000000000001 112.522 166.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -60.75 -36.22 33.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 116.409 -1.757 . . . . 6.1600000000000001 114.814 -172.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -86.41 -8.65 7.31 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.508 2.805 . . . . 3.5800000000000001 114.452 167.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -94.99 -171.08 2.34 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.54 1.536 . . . . 5.6100000000000003 112.471 179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -108.05 168.55 9.21 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.716 -1.24 . . . . 9.3300000000000001 111.184 159.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.96 -152.62 0.48 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.942 1.297 . . . . 8.5099999999999998 110.232 179.03 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 193' ' ' LEU . 12.0 mtmt -64.95 99.29 0.34 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 107.022 -1.473 . . . . 10.73 107.022 147.192 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.1 t . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 128.522 2.729 . . . . 8.2100000000000009 113.715 -162.901 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 118.29 -0.862 . . . . 21.289999999999999 110.15 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -73.7 -175.21 1.98 Allowed 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.463 0.477 . . . . 21.010000000000002 110.254 156.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.6 t -151.47 166.34 31.39 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.824 1.65 . . . . 16.0 109.58 170.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.59 -161.75 27.02 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.903 1.24 . . . . 13.0 114.553 -171.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -151.13 132.01 7.42 Favored Pre-proline 0 CA--C 1.546 0.817 0 O-C-N 121.589 -0.948 . . . . 13.18 111.824 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -79.87 156.88 24.02 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.874 2.383 . . . . 7.7800000000000002 110.203 168.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.8 155.96 47.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.659 1.583 . . . . 11.949999999999999 108.324 168.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -86.89 164.26 16.69 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.352 1.061 . . . . 6.79 113.402 -179.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 158.25 -171.02 35.08 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.733 2.111 . . . . 3.3100000000000001 109.871 -174.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.78 63.72 0.61 Allowed Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.24 -1.311 . . . . 4.0800000000000001 111.458 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.95 135.9 66.08 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.606 2.871 . . . . 3.9199999999999999 112.084 -169.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -140.91 176.92 8.41 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.571 -1.65 . . . . 3.8399999999999999 112.516 -168.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.8 t -127.73 132.86 49.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.634 1.974 . . . . 4.5700000000000003 106.168 159.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 tp -164.56 143.18 6.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.977 0.911 . . . . 3.3900000000000001 110.319 -176.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.0 m -93.81 140.29 29.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.746 0.703 . . . . 2.2000000000000002 109.617 -174.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.0 m -101.5 139.32 37.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.829 1.652 . . . . 3.9100000000000001 110.634 -178.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -16.35 1.37 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.597 2.759 . . . . 2.6400000000000001 116.842 -169.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 t -76.65 -35.79 57.76 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.468 1.031 . . . . 4.1600000000000001 112.127 172.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.32 68.42 0.44 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.403 1.477 . . . . 2.8199999999999998 112.257 -166.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.67 148.21 6.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.164 1.785 . . . . 4.8799999999999999 108.747 171.292 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -108.36 115.85 30.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.717 1.207 . . . . 4.9100000000000001 111.662 -175.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -104.5 163.27 12.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.836 1.254 . . . . 4.9000000000000004 112.574 -173.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -119.84 160.73 22.09 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.613 1.965 . . . . 3.8799999999999999 108.054 162.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -49.3 -37.37 23.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.0 1.72 . . . . 4.6399999999999997 111.552 169.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -71.23 -31.48 67.62 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.876 1.065 . . . . 8.4600000000000009 113.876 -177.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.29 -3.77 33.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.101 0.864 . . . . 5.1600000000000001 113.33 175.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -33.01 59.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.383 0.883 . . . . 5.5199999999999996 113.383 160.124 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.12 178.78 0.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.966 1.306 . . . . 6.2999999999999998 113.856 -173.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 8.98 75.44 Favored Glycine 0 N--CA 1.474 1.206 0 O-C-N 121.172 -0.955 . . . . 3.1699999999999999 113.228 -166.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -156.14 165.45 36.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.088 1.755 . . . . 3.8300000000000001 109.428 -177.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -69.51 112.25 5.9 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.965 -0.459 . . . . 2.27 112.206 177.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -98.52 122.65 41.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.613 1.165 . . . . 3.73 110.981 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -118.13 109.16 16.07 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.505 -1.665 . . . . 4.0300000000000002 106.505 176.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.3 pt -111.81 126.82 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.093 0.405 . . . . 4.9299999999999997 112.093 -170.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.31 149.17 51.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 3.9399999999999999 112.208 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -122.77 121.27 35.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.428 1.091 . . . . 4.0999999999999996 109.927 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.38 -178.37 16.95 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 1.6799999999999999 116.123 -169.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.5 151.34 50.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.683 1.193 . . . . 4.9900000000000002 111.686 175.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.9 p -53.63 -30.9 45.09 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.19 1.396 . . . . 4.0999999999999996 113.831 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -143.17 94.42 2.62 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 108.952 -0.758 . . . . 9.1300000000000008 108.952 150.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.414 ' C ' ' H ' ' A' ' 171' ' ' ASP . 9.2 t -38.31 166.77 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 128.377 2.671 . . . . 2.7200000000000002 115.613 160.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -65.54 43.71 0.16 Allowed 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.537 2.825 . . . . 4.4100000000000001 111.815 146.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 169' ' ' CYS 0.28 29.8 m-20 58.03 11.87 1.62 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.154 2.982 . . . . 4.96 116.75 173.913 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.6 -35.99 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.975 0.91 . . . . 3.2799999999999998 110.708 169.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 38.5 m -53.07 -56.24 25.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.635 -1.65 . . . . 2.1200000000000001 114.272 175.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.0 -43.47 11.69 Favored 'Trans proline' 0 C--N 1.351 0.7 0 CA-C-N 122.472 1.918 . . . . 1.76 112.149 177.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -51.52 -46.27 63.21 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.826 1.65 . . . . 3.3199999999999998 112.573 174.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.89 -45.26 24.65 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.121 -0.987 . . . . 2.8900000000000001 112.316 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -62.49 -29.05 70.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.955 -1.091 . . . . 3.3700000000000001 112.313 -177.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -60.42 -52.19 66.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.769 0.828 . . . . 4.0 111.84 168.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -58.08 -50.8 72.2 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 120.17 -1.581 . . . . 3.5899999999999999 110.801 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -57.22 -53.75 54.57 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.705 -0.664 . . . . 3.73 110.99 175.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.7 tp -68.08 -38.35 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.479 1.49 . . . . 3.27 111.197 -170.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.482 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 62.1 mt-30 -65.85 -24.08 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 118.1 -0.952 . . . . 2.9100000000000001 112.168 179.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.18 -19.21 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 120.669 1.577 . . . . 3.6400000000000001 113.732 173.067 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.25 -40.0 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.11 1.323 . . . . 3.0099999999999998 109.394 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -55.4 -48.69 73.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.551 1.541 . . . . 3.9500000000000002 112.401 172.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -70.3 -36.46 74.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.994 0.918 . . . . 3.4399999999999999 112.83 -177.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -77.76 -27.72 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.083 -1.011 . . . . 2.79 112.823 177.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.79 -48.74 79.27 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.244 1.018 . . . . 3.3500000000000001 109.133 165.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.6 t -64.49 -26.73 68.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.405 0.891 . . . . 4.0499999999999998 113.405 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.0 -30.87 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.604 1.161 . . . . 4.3700000000000001 111.786 172.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.4 m 73.47 -36.32 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.788 2.035 . . . . 5.1900000000000004 113.553 167.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 80.1 p -78.94 24.3 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.644 1.978 . . . . 6.5800000000000001 113.11 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.2 mt -134.21 156.28 79.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.345 1.858 . . . . 5.2400000000000002 110.456 174.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.83 -75.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.131 2.554 . . . . 3.3700000000000001 109.625 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.61 167.28 30.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.842 2.057 . . . . 3.4700000000000002 108.06 162.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.17 114.7 26.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.275 1.43 . . . . 2.8399999999999999 108.705 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.5 m -108.38 94.58 13.84 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 123.312 0.645 . . . . 2.8300000000000001 110.887 -168.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.98 131.06 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.813 2.342 . . . . 1.9099999999999999 110.885 170.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.01 139.19 49.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.533 1.159 . . . . 4.9500000000000002 111.621 168.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -109.94 123.65 50.01 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.51 1.924 . . . . 4.0 109.272 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.9 mt -108.79 115.02 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.887 0.875 . . . . 2.8399999999999999 109.554 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.404 ' HG ' ' HB3' ' A' ' 204' ' ' ASP . 8.0 t -83.71 104.69 14.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 2.8100000000000001 108.649 176.504 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.5 pt -79.27 35.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 122.013 0.911 . . . . 2.5600000000000001 111.823 -178.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.404 ' HB3' ' HG ' ' A' ' 202' ' ' SER . 33.3 t0 -126.93 46.94 2.2 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 127.291 2.236 . . . . 3.8999999999999999 111.301 -160.056 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -13.26 36.89 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.456 2.77 . . . . 2.8999999999999999 114.302 -163.104 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -76.88 9.93 2.58 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.906 1.283 . . . . 3.9900000000000002 113.33 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -163.44 25.08 0.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.866 1.432 . . . . 5.2400000000000002 114.866 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -71.21 152.79 43.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.112 0.958 . . . . 5.7000000000000002 111.814 172.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 4.4 m -154.81 122.47 5.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.079 1.752 . . . . 3.4700000000000002 106.499 164.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -46.56 -48.08 19.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.796 1.238 . . . . 4.6200000000000001 113.105 -170.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.43 -30.47 61.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.547 1.139 . . . . 5.1200000000000001 113.525 177.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.14 73.66 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.066 -1.021 . . . . 2.8599999999999999 110.755 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.15 -42.94 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 3.8100000000000001 110.444 173.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.7 77.21 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.333 0.653 . . . . 2.3500000000000001 112.586 176.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -65.66 -45.97 80.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.452 0.701 . . . . 5.2599999999999998 112.56 176.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -49.98 -45.22 51.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.027 0.931 . . . . 3.75 111.387 170.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.4 t -72.56 -39.7 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.74 1.015 . . . . 2.9700000000000002 113.74 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -57.68 -50.5 72.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.214 -0.898 . . . . 4.79 113.291 -176.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -69.6 -17.25 63.52 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.318 1.229 . . . . 6.6100000000000003 114.318 -165.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.82 -32.62 72.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.195 0.907 . . . . 3.73 112.639 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 t 138.2 129.25 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 131.032 3.733 . . . . 3.8300000000000001 109.711 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.32 8.13 1.25 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.549 2.833 . . . . 2.6099999999999999 116.018 -166.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -73.19 -16.06 61.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.036 1.289 . . . . 3.1200000000000001 112.73 161.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.04 137.56 43.48 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.449 -0.782 . . . . 2.8999999999999999 109.223 166.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.57 148.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.377 0.671 . . . . 3.6600000000000001 112.156 171.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.69 138.68 15.1 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 124.501 1.048 . . . . 1.04 112.865 -177.101 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.83 148.32 40.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 114.758 1.392 . . . . 2.96 114.758 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.2 p -155.12 170.61 21.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.576 2.35 . . . . 3.3599999999999999 110.19 -179.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.39 -173.63 37.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.612 1.101 . . . . 1.9399999999999999 111.447 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.8 t -65.27 162.99 16.24 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.161 0.48 . . . . 3.7799999999999998 110.553 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -56.64 -31.84 64.75 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.34 -0.85 . . . . 7.3499999999999996 112.233 -176.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 18.9 mp0 -72.14 -35.75 69.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.799 2.04 . . . . 3.6800000000000002 111.045 178.499 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.66 -39.72 76.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.747 -0.595 . . . . 3.1499999999999999 111.881 169.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.21 -36.47 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.965 0.906 . . . . 2.9199999999999999 111.951 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.15 -46.24 43.65 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.473 1.033 . . . . 4.2400000000000002 110.113 173.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -46.08 -50.68 14.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.622 0.769 . . . . 3.8799999999999999 110.8 173.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.44 -43.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.123 0.969 . . . . 3.79 111.803 -174.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.55 87.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.806 0.842 . . . . 2.8599999999999999 111.906 173.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -32.09 35.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.236 1.814 . . . . 7.8799999999999999 113.013 -177.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.56 -60.86 2.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.835 1.254 . . . . 2.7400000000000002 112.235 176.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -74.68 -6.13 47.01 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.578 0.955 . . . . 3.54 113.578 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 66.66 54.89 0.81 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.63 1.972 . . . . 5.6699999999999999 113.319 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.07 152.27 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.759 2.024 . . . . 4.3799999999999999 110.54 177.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -103.67 145.93 29.33 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.009 1.114 . . . . 5.0599999999999996 114.009 -176.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -129.87 142.63 50.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.536 1.934 . . . . 4.4299999999999997 111.354 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 42.4 t -128.92 106.14 18.28 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 124.059 0.944 . . . . 5.1399999999999997 111.136 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.74 153.28 8.75 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.478 2.785 . . . . 3.6099999999999999 111.138 170.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.9 175.26 47.86 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 114.75 0.66 . . . . 3.6699999999999999 114.75 176.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -85.69 -168.42 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 124.695 3.596 . . . . 5.3600000000000003 110.908 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -105.06 120.55 41.76 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.841 -0.8 . . . . 5.0300000000000002 108.841 148.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -151.61 156.15 39.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.487 1.515 . . . . 7.46 109.227 175.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 63.11 -48.81 0.21 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.594 2.758 . . . . 8.5099999999999998 112.318 -160.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -173.9 -55.24 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.793 3.237 . . . . 6.4699999999999998 109.223 170.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -142.11 19.1 2.1 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.274 1.03 . . . . 5.9500000000000002 113.103 -159.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -46.56 139.95 4.72 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.413 -1.43 . . . . 4.8700000000000001 113.518 175.023 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -143.85 48.42 1.41 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.611 1.564 . . . . 6.8600000000000003 111.676 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.61 150.17 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.883 -1.136 . . . . 4.3200000000000003 110.917 155.011 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.3 m -156.44 152.63 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.024 1.73 . . . . 6.2800000000000002 107.605 -178.24 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -150.86 145.18 25.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.964 1.364 . . . . 5.9400000000000004 112.077 -179.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -133.13 95.99 3.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.413 1.085 . . . . 2.6699999999999999 109.92 170.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 t -72.54 58.26 0.42 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.852 1.661 . . . . 6.6799999999999997 110.461 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.4 pp -113.09 158.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 122.472 1.13 . . . . 6.54 113.827 -167.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.7 pt -107.55 163.63 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.328 1.451 . . . . 4.7599999999999998 109.014 161.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 76.5 mtp -97.51 159.01 15.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.739 0.816 . . . . 3.7000000000000002 109.869 161.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.32 142.02 45.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.414 0.686 . . . . 3.77 111.116 165.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.2 tp -92.12 118.07 30.46 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 106.535 -1.654 . . . . 3.25 106.535 158.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.18 136.02 31.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.617 -1.623 . . . . 4.0099999999999998 106.617 164.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.48 172.07 45.82 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 2.2999999999999998 111.968 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.17 -13.44 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.191 2.594 . . . . 3.4900000000000002 113.094 177.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -113.57 -0.14 14.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 129.713 3.205 . . . . 4.4199999999999999 112.178 -176.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 108.34 -148.67 16.78 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.917 1.722 . . . . 4.2800000000000002 113.072 -176.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.81 158.64 0.13 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.428 2.691 . . . . 5.9699999999999998 116.543 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.86 85.78 6.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.813 1.245 . . . . 5.0 108.854 172.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.3 tt -86.31 -36.06 19.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.005 0.922 . . . . 4.1699999999999999 111.834 -163.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -159.24 159.88 34.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.895 1.678 . . . . 2.6099999999999999 109.413 175.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -136.46 147.34 47.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 122.676 1.227 . . . . 5.2599999999999998 113.3 172.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.67 156.34 44.4 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.843 1.257 . . . . 3.5899999999999999 111.101 -162.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.21 170.82 42.63 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.874 1.702 . . . . 2.8399999999999999 110.036 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.473 ' H ' ' NE2' ' A' ' 279' ' ' GLN . 1.9 mp0 -55.88 -25.35 42.19 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.913 2.19 . . . . 4.5 116.913 -149.625 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.85 -21.35 25.06 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.512 1.301 . . . . 6.8099999999999996 114.512 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -57.93 107.07 0.42 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.769 1.628 . . . . 4.7400000000000002 108.593 178.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -74.93 143.8 43.55 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.395 -1.441 . . . . 7.1299999999999999 109.813 -157.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.482 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.1 tmtt? -42.79 -53.0 4.8 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 121.095 1.77 . . . . 2.6699999999999999 113.438 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -18.38 74.92 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.361 0.904 . . . . 1.6399999999999999 115.361 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -31.78 17.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.877 1.271 . . . . 4.6200000000000001 111.395 174.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.2 mt -56.36 -43.5 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.103 -0.998 . . . . 2.54 109.901 161.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.46 -53.17 58.75 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.54 0.57 . . . . 2.1800000000000002 112.54 170.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.05 72.1 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.562 1.319 . . . . 2.4199999999999999 114.562 -177.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.9 p -68.92 -48.83 62.33 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.446 -0.783 . . . . 2.6899999999999999 111.07 170.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.24 -34.05 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.28 1.4 . . . . 2.3999999999999999 111.709 176.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.35 -21.18 62.92 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.118 0.967 . . . . 2.0699999999999998 113.494 172.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 100.0 m -76.98 -45.65 26.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.722 0.809 . . . . 2.7200000000000002 109.537 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -62.83 -21.11 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.855 1.262 . . . . 2.9199999999999999 113.402 174.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -66.5 -23.49 66.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.086 1.355 . . . . 5.0999999999999996 113.287 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -59.8 -45.48 98.36 Favored Pre-proline 0 N--CA 1.477 0.891 0 O-C-N 119.971 -1.706 . . . . 6.0 113.277 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.6 -57.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.554 2.169 . . . . 2.2599999999999998 111.491 164.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -83.63 23.47 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.029 1.862 . . . . 4.9100000000000001 116.029 -167.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 ptt85 -57.3 125.68 23.87 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.606 1.563 . . . . 9.5700000000000003 111.752 174.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -75.75 142.53 42.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.087 1.355 . . . . 8.0999999999999996 109.238 166.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.498 ' HZ3' ' C ' ' A' ' 301' ' ' SER . 0.1 OUTLIER -62.9 130.22 43.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 117.38 -1.295 . . . . 10.25 108.518 158.565 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.498 ' C ' ' HZ3' ' A' ' 300' ' ' LYS . 14.9 m . . . . . 0 N--CA 1.479 0.997 0 CA-C-N 120.281 1.4 . . . . 8.0800000000000001 112.532 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 117.008 -1.472 . . . . 17.170000000000002 107.681 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -49.91 -44.52 50.26 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.544 1.52 . . . . 14.970000000000001 111.183 166.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 t -123.31 -173.19 2.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.571 1.149 . . . . 11.859999999999999 110.535 158.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.34 117.0 1.35 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.059 1.79 . . . . 10.470000000000001 111.031 -172.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -165.36 71.25 1.36 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 125.972 1.709 . . . . 12.390000000000001 111.648 -171.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -83.75 176.85 6.64 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.222 3.282 . . . . 9.9000000000000004 112.393 -171.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.17 -176.9 5.54 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.682 2.393 . . . . 8.1199999999999992 109.335 177.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.26 174.25 7.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.974 0.806 . . . . 9.1400000000000006 111.697 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.27 -151.62 21.61 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.383 0.992 . . . . 3.5800000000000001 111.852 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.9 97.33 1.79 Allowed Glycine 0 CA--C 1.532 1.11 0 N-CA-C 108.149 -1.98 . . . . 4.29 108.149 -161.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.33 134.94 25.73 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.667 2.245 . . . . 4.5300000000000002 111.772 -161.531 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -75.51 -179.97 4.92 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.497 1.519 . . . . 3.46 113.194 -172.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.2 m -157.83 62.1 0.47 Allowed 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.246 -1.534 . . . . 3.8700000000000001 112.695 177.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -98.8 160.74 14.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.556 1.142 . . . . 3.3100000000000001 110.511 -177.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -103.42 139.86 38.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.635 1.574 . . . . 2.6299999999999999 111.656 -164.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -94.59 158.93 15.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.877 1.799 . . . . 2.4500000000000002 115.706 -167.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.439 ' O ' ' HE3' ' A' ' 210' ' ' LYS . 0.3 OUTLIER -57.39 -21.7 37.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.481 1.912 . . . . 2.2599999999999998 113.327 164.349 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -71.76 -68.85 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.194 1.398 . . . . 3.8700000000000001 109.086 160.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.28 -12.44 1.6 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 124.769 1.176 . . . . 1.98 115.114 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.3 153.94 41.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.812 1.306 . . . . 4.2000000000000002 110.626 166.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -85.26 135.14 34.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.449 -0.574 . . . . 5.8600000000000003 109.449 153.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -120.27 153.86 35.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.833 0.853 . . . . 3.6899999999999999 110.198 178.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 153' ' ' LYS . 12.1 p -141.14 156.46 45.95 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.701 1.2 . . . . 3.6299999999999999 110.705 -166.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.09 13.61 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.189 0.996 . . . . 3.9300000000000002 113.444 168.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 151' ' ' THR . 86.5 mttt -103.67 -32.11 9.55 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.225 -1.547 . . . . 8.2799999999999994 112.684 167.52 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -96.81 -22.59 16.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.646 1.178 . . . . 3.4700000000000002 112.731 177.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -77.83 -15.31 59.16 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.573 0.953 . . . . 4.2300000000000004 113.573 162.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.37 133.65 56.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.618 1.167 . . . . 4.1799999999999997 110.551 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.32 6.68 88.51 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.273 -0.892 . . . . 2.5099999999999998 114.199 -176.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 159' ' ' TRP . 1.2 tp-100 -84.98 -155.73 0.22 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.088 1.444 . . . . 3.48 110.449 163.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . 0.409 ' H ' ' HG3' ' A' ' 158' ' ' GLN . 97.8 m95 -136.12 111.56 9.2 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.003 -1.481 . . . . 2.1200000000000001 107.003 153.065 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.22 148.3 41.33 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.483 1.135 . . . . 3.5600000000000001 113.163 -173.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.43 114.86 27.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.69 1.596 . . . . 3.8700000000000001 106.977 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.47 111.31 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.035 -1.839 . . . . 4.3899999999999997 106.035 -177.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -108.91 139.99 43.0 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.163 0.982 . . . . 3.54 113.278 -173.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -111.68 92.94 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.579 2.352 . . . . 3.4199999999999999 110.877 175.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -130.69 154.47 20.72 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.426 1.965 . . . . 1.6000000000000001 109.681 166.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -97.18 157.0 16.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.688 0.744 . . . . 7.2699999999999996 111.093 -175.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 53.1 p -70.66 -3.71 19.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.388 -1.445 . . . . 4.1100000000000003 113.336 172.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.402 ' HE2' ' CG ' ' A' ' 255' ' ' ASP . 43.7 t-80 -67.74 -47.2 69.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.215 1.806 . . . . 8.6300000000000008 114.316 -178.393 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.9 m -102.92 119.62 54.98 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.448 1.022 . . . . 2.6400000000000001 113.504 -150.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -90.85 44.34 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.353 2.702 . . . . 6.5499999999999998 111.16 174.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.88 -104.45 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.138 -1.43 . . . . 6.0499999999999998 107.138 -157.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.11 -66.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.221 1.808 . . . . 4.2300000000000004 114.2 171.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 87.6 m -51.49 -48.74 85.7 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.868 1.433 . . . . 1.7 114.868 -174.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.25 -31.63 14.06 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.399 2.066 . . . . 1.4099999999999999 113.571 175.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -64.37 -36.04 82.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.399 1.454 . . . . 3.3900000000000001 110.734 171.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -33.71 76.46 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.546 -1.346 . . . . 3.1800000000000002 112.809 174.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.15 -36.96 75.11 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.336 -0.84 . . . . 4.0300000000000002 112.11 171.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -60.24 3.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.937 1.295 . . . . 4.5899999999999999 111.423 -178.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -20.01 66.15 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 119.623 -1.923 . . . . 3.9500000000000002 113.713 175.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 29.8 ttm -70.89 -45.02 65.08 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.636 1.107 . . . . 3.04 111.217 172.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -57.33 -47.57 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.311 -0.868 . . . . 3.2599999999999998 110.076 174.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -54.58 -20.76 8.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.201 1.186 . . . . 4.8600000000000003 114.201 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.73 -25.79 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.336 1.235 . . . . 3.6200000000000001 114.336 177.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -54.46 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.62 1.1 . . . . 3.5 108.84 165.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -57.13 -37.87 72.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.475 1.11 . . . . 4.6900000000000004 113.034 177.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.29 -40.73 50.88 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.345 -0.847 . . . . 2.9300000000000002 112.814 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mt -66.86 -34.8 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.876 0.762 . . . . 2.6299999999999999 110.833 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.405 ' CG ' ' HZ1' ' A' ' 223' ' ' LYS . 1.2 m-20 -67.81 -44.89 76.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.541 1.136 . . . . 3.6600000000000001 111.588 167.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -64.67 -27.59 69.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.393 -1.442 . . . . 3.29 112.862 177.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.86 -19.69 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.218 1.407 . . . . 3.9100000000000001 112.022 172.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.3 m 73.96 -35.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 127.225 2.21 . . . . 5.7400000000000002 114.212 162.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -97.63 4.14 50.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.802 1.641 . . . . 5.3700000000000001 112.96 178.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.73 152.07 37.94 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.255 -1.017 . . . . 4.25 108.255 158.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -94.95 -23.18 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.742 2.295 . . . . 3.79 114.474 -162.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.7 t70 170.65 150.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.333 2.653 . . . . 3.6600000000000001 110.334 -173.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 11.0 tp -132.28 100.39 5.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.182 1.793 . . . . 2.9300000000000002 108.376 156.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 m -81.71 121.71 79.77 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-O 118.118 -0.944 . . . . 2.4500000000000002 110.906 -178.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.24 117.96 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.128 3.218 . . . . 1.6399999999999999 110.409 168.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.32 119.12 34.69 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 3.7000000000000002 109.224 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -102.76 112.66 25.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.983 0.913 . . . . 4.0199999999999996 110.66 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 9.5 mm -82.55 122.51 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 107.254 -1.387 . . . . 2.6899999999999999 107.254 165.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.9 p -71.66 -29.46 64.64 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.499 1.666 . . . . 4.0 115.499 -175.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . 0.329 14.1 pt 53.2 -6.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 119.825 3.269 . . . . 4.4699999999999998 119.825 168.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -119.87 62.27 7.75 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.485 1.914 . . . . 3.5600000000000001 112.196 161.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -59.3 140.49 94.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 107.95 -1.596 . . . . 2.3999999999999999 107.95 161.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 231' ' ' ARG . 32.7 mt-10 108.8 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.394 3.878 . . . . 4.8799999999999999 112.357 -174.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -107.61 4.74 26.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.161 0.892 . . . . 6.2599999999999998 112.303 163.163 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.41 -179.44 7.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.39 1.476 . . . . 5.5800000000000001 112.246 -175.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.6 m -167.27 129.67 1.68 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 128.129 2.572 . . . . 3.0299999999999998 105.791 162.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 145' ' ' HIS . 1.2 tmtp? -54.08 -43.47 70.36 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.472 0.709 . . . . 3.8599999999999999 112.478 -175.461 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -67.81 -31.52 71.43 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.741 1.617 . . . . 3.1000000000000001 113.256 173.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.02 73.79 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.566 -1.334 . . . . 2.29 111.768 175.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.94 -38.15 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.537 0.735 . . . . 3.7000000000000002 111.036 170.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.9 69.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.838 0.745 . . . . 2.2599999999999998 112.822 174.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.01 -49.33 52.47 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.357 -0.84 . . . . 5.4900000000000002 111.584 170.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.16 -30.94 71.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.708 0.633 . . . . 4.0700000000000003 112.708 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.58 -60.21 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.005 1.322 . . . . 2.5099999999999998 110.92 162.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -62.18 -30.74 71.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.388 0.884 . . . . 6.3700000000000001 113.388 -174.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.22 -34.94 72.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.23 1.412 . . . . 4.6299999999999999 111.964 -177.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -108.67 -21.41 12.71 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.689 1.366 . . . . 4.5999999999999996 114.689 -174.183 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.4 p 159.17 151.38 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.888 2.475 . . . . 3.0600000000000001 112.015 167.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.54 -3.29 10.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.861 2.374 . . . . 2.3199999999999998 114.413 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . 0.405 ' HZ1' ' CG ' ' A' ' 188' ' ' ASP . 19.1 ttmt -87.07 -8.62 56.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.008 1.276 . . . . 2.9700000000000002 113.395 171.788 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.64 123.19 18.2 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.029 -1.669 . . . . 4.25 109.567 171.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.36 116.17 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.293 -1.002 . . . . 3.8700000000000001 108.293 165.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.57 141.51 15.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.458 1.028 . . . . 1.1200000000000001 111.271 -177.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.44 151.29 37.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.961 1.097 . . . . 3.9700000000000002 113.961 -175.229 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 25.5 p -133.53 170.78 15.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.588 3.155 . . . . 4.1500000000000004 108.908 -176.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.81 161.06 15.04 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.902 1.715 . . . . 2.0299999999999998 109.455 -173.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.4 p -69.03 169.11 12.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.048 1.424 . . . . 3.0099999999999998 112.266 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 206' ' ' GLU . 99.6 mtt180 -40.7 -43.4 1.95 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.973 1.709 . . . . 6.4400000000000004 112.732 170.256 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -67.53 -38.38 84.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.505 1.122 . . . . 3.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.51 -47.63 59.53 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.119 -0.988 . . . . 3.4700000000000002 111.453 174.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.1 m -65.6 -24.77 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.851 0.686 . . . . 4.0899999999999999 112.851 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.11 -33.43 29.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.194 0.906 . . . . 3.0299999999999998 112.34 169.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -59.61 -51.48 69.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.42 1.464 . . . . 2.7599999999999998 110.655 171.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.52 -20.64 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.31 0.485 . . . . 3.0 112.31 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.4 -54.37 14.77 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.947 0.794 . . . . 2.98 110.789 167.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.75 -45.09 82.22 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.258 1.423 . . . . 3.5699999999999998 111.844 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.41 -56.45 14.96 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.335 1.054 . . . . 3.04 112.404 -175.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.53 10.72 26.73 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.122 -0.986 . . . . 4.8399999999999999 113.576 176.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 61.24 33.45 19.13 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.343 1.457 . . . . 6.1299999999999999 113.655 177.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.32 147.96 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.535 2.334 . . . . 4.1299999999999999 110.447 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -119.83 153.16 36.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.421 1.105 . . . . 6.8399999999999999 113.413 168.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -124.45 146.33 48.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 6.4800000000000004 109.317 171.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 26.2 m -123.51 72.29 49.56 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.721 1.208 . . . . 4.1900000000000004 110.329 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.66 125.03 10.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.603 2.202 . . . . 3.4399999999999999 111.574 -171.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.96 136.33 14.15 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.454 -1.192 . . . . 2.52 111.377 178.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -80.98 58.1 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.17 3.246 . . . . 5.1799999999999997 109.851 177.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt 72.24 164.22 0.28 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.967 2.507 . . . . 5.4299999999999997 113.997 -157.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -149.39 149.59 31.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.079 1.752 . . . . 8.6899999999999995 109.52 176.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 54.82 -63.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.468 2.307 . . . . 8.1699999999999999 112.485 -149.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 169.85 -38.88 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 131.293 3.837 . . . . 6.8499999999999996 108.792 -172.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.63 -28.51 12.46 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.658 1.725 . . . . 7.0899999999999999 115.658 -173.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.402 ' CG ' ' HE2' ' A' ' 168' ' ' HIS . 26.9 t0 -77.49 154.77 32.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.006 1.276 . . . . 4.1799999999999997 111.721 179.051 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.84 79.75 1.44 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.039 -1.038 . . . . 5.3700000000000001 109.771 166.568 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.97 167.14 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.817 1.247 . . . . 3.7400000000000002 112.744 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 58.6 t -149.62 129.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 105.392 -2.077 . . . . 3.8900000000000001 105.392 156.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.16 158.34 19.17 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.267 0.94 . . . . 3.6299999999999999 110.451 167.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.06 132.98 7.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.499 1.296 . . . . 3.0699999999999998 114.499 -153.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.72 -12.8 37.71 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.713 2.116 . . . . 4.5199999999999996 116.713 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.31 5.8 tt 43.48 55.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 126.211 1.804 . . . . 4.0999999999999996 115.441 169.26 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.3 mm -103.46 146.41 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.694 1.198 . . . . 3.96 111.005 174.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 77.3 mtp -108.3 117.11 33.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.789 1.636 . . . . 3.1600000000000001 109.987 158.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.76 135.68 39.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.975 0.91 . . . . 3.5899999999999999 112.694 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 56.6 tp -93.61 118.23 31.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.283 1.033 . . . . 3.2799999999999998 110.998 178.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.4 148.88 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.43 1.092 . . . . 3.27 108.333 169.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -175.32 -142.17 4.02 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.481 -1.177 . . . . 3.6099999999999999 112.43 -172.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -88.56 70.43 2.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.399 2.733 . . . . 3.02 110.069 -171.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -169.96 -67.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.113 1.365 . . . . 4.6600000000000001 108.678 -163.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.82 -4.54 69.39 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 116.543 -2.254 . . . . 2.96 116.658 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.44 -47.84 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.497 2.148 . . . . 6.0499999999999998 111.742 176.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 162.24 121.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.436 2.694 . . . . 5.5499999999999998 111.051 171.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.83 -46.9 6.69 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.207 0.817 . . . . 5.1500000000000004 113.207 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.74 164.18 9.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.526 1.93 . . . . 2.5699999999999998 109.237 -170.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -158.39 135.02 9.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.838 1.255 . . . . 4.6399999999999997 112.993 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -114.57 118.49 33.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.608 1.163 . . . . 3.6200000000000001 108.711 -176.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.12 112.5 3.47 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 118.936 -0.924 . . . . 3.9900000000000002 111.386 -174.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 52.62 60.72 3.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.47 1.129 . . . . 3.6299999999999999 108.723 -155.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.7 p30 42.68 -147.58 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.401 2.28 . . . . 7.9000000000000004 114.244 -172.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -147.31 -4.93 0.51 Allowed 'General case' 0 CA--C 1.549 0.91 0 O-C-N 120.297 -1.502 . . . . 5.29 114.018 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 72.61 136.39 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.03 2.932 . . . . 8.8100000000000005 109.243 -163.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -47.53 63.81 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.375 1.621 . . . . 3.8399999999999999 115.375 -155.345 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.82 -17.14 73.0 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 123.925 0.774 . . . . 1.8600000000000001 114.518 -175.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.71 -29.02 61.05 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.327 1.063 . . . . 5.4400000000000004 111.582 174.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.09 -40.72 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.585 -0.697 . . . . 2.54 109.477 174.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.99 88.09 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.951 -0.468 . . . . 2.5099999999999998 111.599 171.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.06 79.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.185 0.809 . . . . 2.79 113.185 176.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 60.5 p -59.74 -60.2 4.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.514 0.726 . . . . 2.5699999999999998 111.721 174.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.4 mm -58.92 -35.52 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 119.305 0.957 . . . . 4.0300000000000002 111.95 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.28 73.69 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.483 -0.761 . . . . 2.7000000000000002 112.932 175.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.8 m -76.09 -36.51 58.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.999 1.32 . . . . 3.0499999999999998 110.806 173.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.038 0.835 . . . . 3.8700000000000001 112.025 173.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 32.5 mmt -65.55 -10.2 33.04 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.667 -1.27 . . . . 6.3099999999999996 114.043 168.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -57.07 2.88 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.39 -1.766 . . . . 8.3800000000000008 112.081 172.381 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.55 -51.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.043 2.495 . . . . 2.52 112.738 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -72.08 169.66 15.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.839 0.856 . . . . 4.71 110.948 176.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 36.6 mmt-85 -113.91 144.33 43.23 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.604 -1.31 . . . . 9.8000000000000007 112.521 -167.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -68.8 146.23 53.07 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.267 1.827 . . . . 7.9500000000000002 111.562 176.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -128.83 54.36 1.79 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.529 1.059 . . . . 11.529999999999999 111.042 176.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 C--O 1.255 1.367 0 C-N-CA 129.966 3.306 . . . . 9.4800000000000004 107.768 -147.097 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.424 0 CA-C-O 118.25 -1.305 . . . . 2.67 110.518 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.63 147.87 36.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.191 1.928 . . . . 3.23 110.164 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.41 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 5.2 p90 -143.88 154.19 43.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.602 0.761 . . . . 3.55 111.062 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 m -122.87 15.74 10.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.595 1.702 . . . . 2.63 115.595 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.41 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 7.3 mp -69.37 147.89 50.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.152 2.181 . . . . 2.38 112.419 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.31 151.09 24.97 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.713 1.605 . . . . 2.25 109.971 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 146' ' ' THR . 0.6 OUTLIER -95.64 161.83 13.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.656 1.217 . . . . 2.87 111.971 175.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 6.3 p-80 -45.49 -28.24 0.88 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.257 2.623 . . . . 1.41 115.248 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.636 ' H ' HG23 ' A' ' 144' ' ' THR . 10.3 m -72.02 -20.1 61.75 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.451 1.9 . . . . 2.9 113.456 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.33 11.78 56.87 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.073 1.32 . . . . 2.29 114.559 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.5 -162.73 0.98 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.929 1.291 . . . . 4.32 110.45 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -144.07 103.74 4.05 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.496 1.044 . . . . 4.39 113.06 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 175.68 5.49 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.682 1.364 . . . . 4.76 114.682 173.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.4 p -137.19 -179.28 5.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.446 2.298 . . . . 2.3 111.092 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.44 -26.94 62.03 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.703 -1.248 . . . . 3.59 112.916 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -94.68 -19.45 20.41 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.051 1.871 . . . . 7.12 116.051 -167.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -71.21 -28.79 64.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.26 1.391 . . . . 3.03 112.102 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -96.04 40.83 1.11 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.276 1.03 . . . . 4.33 112.535 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.64 169.15 13.34 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.254 -0.903 . . . . 5.37 112.409 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 75.93 -10.05 15.66 Favored Glycine 0 CA--C 1.54 1.635 0 O-C-N 120.517 -1.365 . . . . 2.4 116.319 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -116.02 156.23 26.69 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.671 2.388 . . . . 3.25 110.094 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -70.88 100.31 1.92 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.569 1.077 . . . . 1.6 111.176 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.9 mt -83.85 134.57 34.7 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.138 0.971 . . . . 2.54 109.907 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.69 112.59 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.42 -1.696 . . . . 2.77 106.42 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.1 pt -114.77 122.21 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.079 0.552 . . . . 2.77 109.547 -165.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -111.79 143.74 42.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.791 1.236 . . . . 2.56 112.024 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.02 104.5 12.76 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.414 1.486 . . . . 2.0 108.681 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -120.5 -176.18 15.6 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.39 1.471 . . . . 1.36 114.852 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -157.5 115.75 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.739 2.015 . . . . 3.76 106.406 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.6 m -76.28 71.89 3.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.215 1.406 . . . . 3.49 110.178 -166.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 173.79 -48.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.17 2.588 . . . . 6.46 110.338 -158.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 52.1 -161.86 0.01 OUTLIER Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.664 2.385 . . . . 3.94 115.321 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -71.66 -74.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 124.7 3.6 . . . . 4.73 110.619 120.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -163.68 30.17 0.08 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.482 1.037 . . . . 4.22 113.735 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.8 -17.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 115.311 1.597 . . . . 3.18 115.311 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 29.7 m -49.7 -48.3 77.11 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 116.354 -1.784 . . . . 1.58 112.888 155.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.14 -39.89 9.73 Favored 'Trans proline' 0 C--N 1.354 0.825 0 CA-C-N 122.751 2.018 . . . . 1.66 112.206 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.67 -48.49 81.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.381 1.072 . . . . 3.52 111.076 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.447 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 4.9 tp10 -75.44 -22.38 57.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.012 0.925 . . . . 3.74 112.871 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.25 -37.65 78.07 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 116.762 -1.589 . . . . 2.73 110.897 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -52.53 65.24 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.236 1.835 . . . . 5.24 109.41 170.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 38.8 mtmt -63.35 -39.35 94.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.409 0.522 . . . . 3.17 112.409 -174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.6 ttm -57.41 -49.0 77.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.493 1.517 . . . . 3.41 111.518 167.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.25 -41.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.568 1.147 . . . . 2.03 113.105 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.486 ' HG3' ' HE2' ' A' ' 283' ' ' LYS . 35.6 mm-40 -70.88 -50.67 32.57 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.02 1.282 . . . . 3.93 109.159 173.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -17.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.879 1.437 . . . . 2.27 114.879 -169.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.81 -45.72 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 119.441 1.019 . . . . 2.3 110.931 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.21 -25.67 18.55 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.259 0.466 . . . . 6.05 112.259 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -65.07 -29.36 70.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.781 1.232 . . . . 2.83 113.055 166.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -45.22 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 118.508 -0.758 . . . . 2.19 112.767 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -30.92 71.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.145 1.339 . . . . 4.84 110.924 174.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.3 t -60.78 -24.47 65.81 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.298 1.839 . . . . 3.01 113.184 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.44 -26.58 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.113 -1.617 . . . . 5.05 110.403 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.7 m 76.85 -36.72 0.26 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.31 2.244 . . . . 4.22 112.966 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.4 m -73.48 -22.96 60.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.396 1.478 . . . . 5.34 113.1 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.3 156.46 81.45 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 121.18 -0.95 . . . . 3.7 110.808 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.66 -62.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.713 2.275 . . . . 3.28 109.338 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -171.21 157.08 4.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.613 3.565 . . . . 4.64 107.909 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.94 125.68 48.68 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.975 -0.75 . . . . 2.49 108.975 156.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.8 m -112.55 111.51 51.96 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.105 1.362 . . . . 1.41 110.062 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.71 134.08 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.734 2.956 . . . . 1.15 111.717 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.65 116.32 25.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.425 1.09 . . . . 2.21 109.778 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.24 112.93 24.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 2.67 109.679 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.7 mm -99.7 123.58 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.494 -1.298 . . . . 1.99 107.494 166.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 9.8 t -90.64 153.79 20.05 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.565 -0.709 . . . . 2.44 109.861 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.9 pt -115.95 -2.23 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.015 1.117 . . . . 2.02 114.015 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -119.54 74.71 17.33 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 120.144 1.338 . . . . 3.48 110.287 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.5 160.38 50.01 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.507 2.805 . . . . 3.31 110.722 -169.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 77.53 -51.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.237 2.615 . . . . 7.49 109.392 -172.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 207' ' ' ARG . 1.5 mpt_? -63.62 -52.3 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.507 1.123 . . . . 6.15 109.43 172.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.4 83.21 5.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.369 1.08 . . . . 5.19 109.178 159.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -64.94 132.61 49.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.289 -0.869 . . . . 3.2 109.136 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -43.93 -50.22 8.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.623 1.169 . . . . 3.24 112.895 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -27.02 61.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.353 1.242 . . . . 3.62 114.353 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.18 87.96 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.052 -1.03 . . . . 2.07 110.651 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.78 -36.0 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.929 0.892 . . . . 2.22 110.35 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -57.48 -17.83 15.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.572 1.149 . . . . 1.21 113.757 166.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -88.89 -47.9 7.84 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.991 -1.068 . . . . 4.49 112.792 167.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -58.19 -38.47 76.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.116 0.966 . . . . 3.7 112.576 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.4 t -54.28 -60.44 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.963 1.705 . . . . 1.29 110.68 165.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -66.16 -40.8 90.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.517 1.527 . . . . 4.18 114.698 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.92 -28.9 58.19 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.03 1.122 . . . . 3.45 114.03 -172.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -77.96 -53.01 7.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.461 0.573 . . . . 4.11 112.024 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.1 t -169.42 136.84 1.49 Allowed Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.422 1.089 . . . . 2.34 110.916 168.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.91 -4.64 11.71 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.247 2.631 . . . . 1.57 113.996 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -71.29 -14.25 62.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.964 1.256 . . . . 2.45 113.521 170.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.81 140.75 55.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.361 1.064 . . . . 3.09 112.58 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.3 t -118.36 130.88 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.998 1.319 . . . . 1.92 108.578 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -124.54 121.56 4.42 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.683 0.659 . . . . 1.12 114.051 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.77 159.46 15.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.921 1.288 . . . . 3.05 113.215 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -152.86 150.47 29.35 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.517 1.927 . . . . 2.44 108.899 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -172.09 165.24 37.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.952 -2.059 . . . . 1.8 107.952 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -70.55 172.63 8.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.877 0.839 . . . . 2.92 111.959 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.462 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 30.4 ptt180 -43.01 -38.81 2.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.412 1.485 . . . . 7.89 113.691 173.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -64.68 -37.94 89.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.095 1.358 . . . . 3.09 111.669 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.77 -44.65 22.81 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.653 1.181 . . . . 2.86 113.281 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.8 m -65.97 -27.11 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.074 0.397 . . . . 2.9 111.739 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.77 -45.68 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.269 -0.872 . . . . 3.1 112.054 165.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -50.0 -58.39 5.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.862 1.21 . . . . 3.28 110.981 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.72 -25.69 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.181 0.9 . . . . 2.25 112.023 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.77 -40.35 72.69 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.983 -0.448 . . . . 1.46 110.292 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -71.2 -38.32 72.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.23 1.012 . . . . 4.89 112.237 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -44.48 85.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.354 1.462 . . . . 2.13 113.82 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -100.89 5.82 43.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.462 1.105 . . . . 2.15 113.523 170.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 64.2 37.89 8.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.787 2.035 . . . . 5.25 113.732 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.32 151.18 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.694 0.798 . . . . 2.51 111.749 -173.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 140.36 36.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.811 0.845 . . . . 4.22 112.318 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.45 165.67 26.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.5 2.32 . . . . 4.61 109.875 168.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.69 106.29 1.06 Allowed Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 121.249 -0.907 . . . . 2.79 110.781 175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -94.98 134.29 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.411 2.741 . . . . 2.49 112.632 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.415 0 C-N-CA 125.309 1.433 . . . . 2.33 111.144 174.213 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 108.747 -0.835 . . . . 4.82 108.747 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp -49.86 152.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 126.621 1.968 . . . . 3.33 113.849 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.48 130.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.221 1.408 . . . . 3.32 108.145 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.69 141.15 31.68 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.654 1.582 . . . . 3.74 110.709 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -126.82 155.67 42.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.707 0.765 . . . . 2.38 111.549 165.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.7 m -62.78 113.44 3.04 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 3.66 109.6 168.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.31 44.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.316 1.046 . . . . 4.21 112.849 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.7 mt -132.95 135.5 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.123 0.969 . . . . 2.51 110.653 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.3 ptp -104.01 142.96 33.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.112 1.365 . . . . 2.59 110.911 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -99.88 141.71 32.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.346 1.058 . . . . 2.39 112.019 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -101.8 119.34 38.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.884 1.274 . . . . 2.57 109.243 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 63.4 mt -100.16 138.16 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.915 1.686 . . . . 2.22 107.887 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 171.45 42.05 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.54 1.067 . . . . 1.61 111.515 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -82.7 66.1 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.249 2.633 . . . . 2.6 109.367 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -177.52 -69.17 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.553 2.341 . . . . 4.94 108.988 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 160.55 -21.61 0.24 Allowed Glycine 0 CA--C 1.538 1.527 0 N-CA-C 117.02 1.568 . . . . 2.48 117.02 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.76 152.89 44.73 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.965 1.382 . . . . 6.66 112.429 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -99.45 129.51 45.64 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.38 -1.45 . . . . 4.36 112.271 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.95 -18.07 10.23 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.74 1.385 . . . . 3.04 114.74 -167.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -162.98 171.46 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.633 1.173 . . . . 2.67 110.987 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -148.51 149.02 30.9 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.144 1.377 . . . . 2.9 111.527 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' PHE . . . . . 0.435 ' CZ ' HG23 ' A' ' 286' ' ' ILE . 1.4 m-85 -130.0 105.0 7.68 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.105 1.362 . . . . 2.48 109.737 -173.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -86.01 153.27 26.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.225 -1.95 . . . . 2.33 108.225 153.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -17.05 2.99 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 117.279 2.326 . . . . 4.65 117.279 -164.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -63.2 -27.47 69.38 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.943 1.09 . . . . 5.04 113.943 169.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -92.87 96.0 9.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.025 1.73 . . . . 4.52 109.744 165.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.15 176.87 8.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.737 1.615 . . . . 4.99 112.753 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.486 ' HE2' ' HG3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -57.28 -27.3 62.0 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.022 1.86 . . . . 2.27 116.022 -169.329 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.7 -36.2 53.83 Favored Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.527 -0.733 . . . . 1.36 112.07 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.77 -31.8 46.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.082 1.753 . . . . 3.57 111.216 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ILE . . . . . 0.435 HG23 ' CZ ' ' A' ' 277' ' ' PHE . 79.0 mt -64.85 -45.44 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 1.34 110.077 166.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.55 87.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.175 0.898 . . . . 1.44 111.095 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.91 97.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.087 0.858 . . . . 1.87 113.092 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 94.2 p -74.55 -38.42 62.73 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.99 -1.069 . . . . 1.56 113.414 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.01 -35.64 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.662 1.573 . . . . 1.38 111.707 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.01 -18.77 63.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.531 -1.356 . . . . 1.69 113.479 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.1 m -74.83 -55.1 6.17 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.407 -0.808 . . . . 1.89 109.737 167.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -64.55 -22.58 67.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.876 1.67 . . . . 2.71 113.555 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -42.09 46.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.814 1.646 . . . . 5.26 112.157 165.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -64.21 -55.36 31.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 116.419 -1.753 . . . . 5.27 113.249 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.47 -38.34 1.97 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.284 1.989 . . . . 3.05 112.686 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 17.66 7.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.752 1.019 . . . . 3.22 113.752 -173.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 7.12 113.198 -164.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.425 0 CA-C-O 118.593 -1.115 . . . . 2.85 114.388 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.75 149.71 54.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.99 3.127 . . . . 3.0 112.134 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.508 ' HB2' HG22 ' A' ' 237' ' ' VAL . 37.9 p90 -154.88 172.69 17.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.24 1.016 . . . . 2.96 112.128 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.8 m -143.42 119.9 11.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.91 -1.515 . . . . 3.29 106.91 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.432 ' HB2' HG21 ' A' ' 237' ' ' VAL . 12.6 tp -157.35 140.21 15.1 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.561 0.619 . . . . 2.56 111.432 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.1 m -74.43 146.67 42.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.626 0.727 . . . . 1.79 109.44 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.7 m -99.35 139.81 34.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.509 1.124 . . . . 2.91 110.77 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.46 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -51.67 -36.54 46.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.896 2.078 . . . . 2.24 113.117 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -108.09 -1.11 20.7 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.046 1.738 . . . . 3.24 111.968 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.15 -125.56 1.62 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 119.151 0.887 . . . . 2.81 111.789 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.0 -160.94 1.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.146 1.378 . . . . 4.2 110.715 -157.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.28 97.11 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.34 1.056 . . . . 6.13 111.653 -168.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.26 149.61 33.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.697 1.599 . . . . 3.45 110.911 172.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 58.5 p -140.12 141.42 36.11 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.439 2.296 . . . . 2.37 107.498 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -28.04 -69.36 0.05 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.978 1.711 . . . . 3.75 115.369 -171.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -65.86 0.04 2.01 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 116.913 2.19 . . . . 7.48 116.913 -174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.39 -54.91 29.38 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 119.848 1.204 . . . . 3.14 110.161 162.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -91.21 -28.0 18.11 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.703 1.001 . . . . 3.31 113.703 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 59.37 4.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.596 1.159 . . . . 6.27 112.609 -168.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -108.94 0.07 31.79 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.086 1.803 . . . . 2.42 113.138 162.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -153.46 175.12 13.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.859 2.064 . . . . 3.92 108.993 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -66.42 118.33 9.91 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.12 0.968 . . . . 1.73 112.748 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 mp -107.85 147.34 31.05 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.598 0.759 . . . . 3.2 112.206 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.0 mp -111.94 118.02 34.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.308 1.843 . . . . 2.7 107.527 166.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.2 mt -118.79 124.47 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.672 0.789 . . . . 1.93 110.102 -173.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -127.88 139.98 52.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.874 1.27 . . . . 2.22 113.23 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.7 120.32 42.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.903 1.281 . . . . 2.39 110.636 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -145.6 -175.51 18.75 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 116.108 1.203 . . . . 1.4 116.108 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.43 ' CD2' HG22 ' A' ' 258' ' ' VAL . 21.6 t80 -139.65 133.77 31.09 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 123.63 1.681 . . . . 3.55 113.718 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 23.41 0.07 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.743 2.017 . . . . 3.0 114.036 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -165.66 32.83 0.05 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.125 2.17 . . . . 6.75 110.403 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 82.2 m -54.27 159.1 3.31 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.15 -1.594 . . . . 2.17 111.941 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.21 68.93 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.164 2.576 . . . . 3.1 108.455 159.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 68.07 -17.49 0.17 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.996 3.318 . . . . 5.45 115.626 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.0 t -43.87 -65.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.646 1.978 . . . . 3.23 113.146 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 28.1 m -58.41 -50.37 88.4 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 116.579 -1.676 . . . . 1.61 114.285 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.72 -34.23 51.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.955 2.091 . . . . 2.11 114.159 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.82 -36.59 64.98 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.394 0.997 . . . . 3.75 111.885 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.87 -35.28 72.31 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.44 -1.412 . . . . 3.72 112.563 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.67 -27.33 67.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 117.23 -1.367 . . . . 3.13 112.51 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -62.78 1.3 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.997 1.271 . . . . 3.35 109.053 167.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -58.23 -21.09 46.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.694 -1.254 . . . . 4.26 113.215 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.0 mmm -79.79 -41.46 26.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.047 1.499 . . . . 5.45 115.047 165.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.94 -31.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 122.477 2.399 . . . . 1.95 110.5 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -37.31 -41.6 0.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.484 1.914 . . . . 3.28 112.854 162.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.2 -22.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 1.95 111.775 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.61 -39.27 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.932 0.787 . . . . 1.83 109.55 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.25 -44.15 95.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.27 1.028 . . . . 4.08 111.011 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -71.42 -7.82 49.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.83 1.652 . . . . 3.3 114.867 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.2 mt -119.85 -48.35 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 118.088 -0.958 . . . . 1.9 113.427 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.64 -27.35 67.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.925 1.239 . . . . 3.77 111.711 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.9 t -70.65 -11.3 60.86 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.845 -1.159 . . . . 3.03 113.743 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 34.3 mm -90.61 86.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 120.441 -1.412 . . . . 3.55 108.71 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 81.0 p -63.98 60.54 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.387 2.675 . . . . 4.6 115.41 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 10.5 t -173.18 -24.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 129.907 3.283 . . . . 4.41 110.871 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.17 156.02 8.13 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.774 -1.204 . . . . 3.01 109.934 151.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.44 -66.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.378 -1.816 . . . . 3.36 107.378 162.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.15 173.2 2.64 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.269 3.027 . . . . 3.62 109.791 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 tp -119.2 110.17 16.72 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.858 0.863 . . . . 1.96 111.1 161.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.8 m -92.78 120.05 67.48 Favored Pre-proline 0 N--CA 1.482 1.128 0 O-C-N 120.939 -1.1 . . . . 1.29 111.467 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -93.63 131.12 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.538 2.825 . . . . 0.97 112.571 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.97 119.49 30.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.854 2.062 . . . . 2.52 110.472 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -99.8 136.16 40.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.01 1.724 . . . . 2.75 110.8 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.06 126.26 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.576 1.55 . . . . 1.47 109.204 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 92.0 p -84.01 141.79 30.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.214 0.531 . . . . 2.38 110.23 165.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.9 pt -108.53 19.96 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.029 -1.044 . . . . 1.9 112.841 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -118.05 77.06 12.08 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.816 2.046 . . . . 3.33 110.897 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.38 83.06 2.33 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.285 3.323 . . . . 3.28 109.713 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.45 -124.18 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.601 1.961 . . . . 4.72 106.283 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.99 11.25 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 117.965 2.58 . . . . 6.94 117.965 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -89.74 150.89 22.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.782 -1.824 . . . . 3.4 111.049 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.1 p -142.71 144.9 32.88 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.486 1.136 . . . . 2.84 112.252 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -42.97 -55.47 3.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.088 2.155 . . . . 3.87 111.952 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -70.57 -34.0 71.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.159 0.983 . . . . 4.21 113.221 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.99 68.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.311 1.414 . . . . 1.78 111.224 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.3 mm -58.62 -39.19 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 119.407 -0.33 . . . . 1.52 111.612 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.9 -29.46 60.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.978 1.311 . . . . 1.75 113.805 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -90.26 -38.69 13.25 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.778 0.831 . . . . 4.85 112.983 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.17 -38.74 80.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.271 1.428 . . . . 2.88 111.787 174.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.9 t -54.55 -34.19 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.477 1.511 . . . . 1.1 113.541 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.32 -35.68 78.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.151 -0.928 . . . . 5.43 111.939 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.2 -36.43 81.72 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 124.396 1.06 . . . . 4.01 111.223 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.9 -44.03 61.74 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.934 0.788 . . . . 3.6 113.033 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.5 m 150.42 143.1 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 130.056 3.342 . . . . 2.3 111.042 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.26 -0.97 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.495 2.797 . . . . 1.65 115.908 -167.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.86 -14.7 60.7 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 120.631 1.56 . . . . 2.94 112.546 168.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.98 127.67 33.49 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.628 -1.295 . . . . 2.59 111.917 -170.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.9 124.35 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.448 -1.686 . . . . 2.3 106.448 171.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.46 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -103.8 127.01 8.98 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 108.672 -1.771 . . . . 1.11 108.672 170.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.28 150.53 32.32 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.968 0.507 . . . . 2.84 110.253 167.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.3 t -167.07 176.08 7.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.397 2.279 . . . . 3.12 108.971 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.63 34.22 Favored Glycine 0 N--CA 1.468 0.83 0 O-C-N 120.771 -1.206 . . . . 1.76 115.2 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -73.81 161.88 29.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.332 1.053 . . . . 2.29 111.164 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -43.88 67.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.745 0.818 . . . . 7.02 111.246 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.58 1.552 . . . . 3.87 112.969 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.12 -46.68 49.84 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.54 -0.725 . . . . 3.22 111.675 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.19 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 119.155 -0.45 . . . . 1.68 111.372 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.61 -39.61 80.79 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.321 0.964 . . . . 3.9 112.127 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -62.72 -49.13 76.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.016 1.28 . . . . 3.33 110.909 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 140' ' ' PHE . 54.4 t -64.77 -48.22 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.794 0.838 . . . . 2.87 111.909 -171.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.52 -50.53 51.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.868 0.867 . . . . 1.41 110.396 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -72.62 -27.34 62.09 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 117.461 -1.257 . . . . 3.64 113.556 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.51 65.32 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.864 1.211 . . . . 1.74 111.037 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -84.3 12.1 7.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.454 1.102 . . . . 2.26 113.569 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 65.71 -41.72 0.34 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.781 2.832 . . . . 6.36 115.021 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.3 t 18.85 103.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 131.622 3.969 . . . . 2.6 115.907 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -71.47 142.47 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.917 0.887 . . . . 3.47 113.201 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -169.73 155.29 5.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.737 2.015 . . . . 3.99 110.273 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -148.45 106.58 3.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.424 0.69 . . . . 2.8 109.795 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.61 138.45 15.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.337 2.025 . . . . 2.71 110.243 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.268 0 CA-C-O 119.646 -0.53 . . . . 2.44 112.418 -176.157 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 18.6 t80 . . . . . 0 CA--C 1.544 0.718 0 CA-C-O 121.167 0.508 . . . . 3.58 111.324 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 tp -71.31 156.81 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.974 0.909 . . . . 2.73 111.208 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 166' ' ' PHE . 4.3 m -151.16 166.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.481 1.912 . . . . 3.37 109.894 172.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.97 158.99 26.52 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.859 2.864 . . . . 3.76 111.01 169.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 161.2 9.34 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.066 1.746 . . . . 2.21 113.943 -166.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 29.0 p -60.89 -42.31 97.75 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.194 1.553 . . . . 4.34 115.194 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.29 0.3 OUTLIER 54.55 41.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.261 1.424 . . . . 3.92 112.815 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.53 140.77 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 120.459 -1.401 . . . . 2.48 110.67 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 58.7 tpp -99.88 115.89 30.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.348 1.859 . . . . 2.86 109.172 165.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -95.03 148.59 22.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.102 -1.624 . . . . 3.17 112.373 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -99.42 126.06 45.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.553 1.141 . . . . 2.29 109.619 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.2 mm -107.94 126.96 64.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 108.221 -1.029 . . . . 2.36 108.221 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.72 160.53 53.02 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 117.969 -1.462 . . . . 2.06 110.163 162.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.78 -11.8 19.22 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.134 3.223 . . . . 3.64 113.911 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.5 -41.82 88.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.727 2.811 . . . . 4.13 110.573 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.95 31.43 2.69 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.065 1.317 . . . . 3.04 115.723 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -142.84 164.04 31.18 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.684 1.242 . . . . 4.75 112.177 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -67.44 125.75 27.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 5.26 112.505 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.4 tt -118.52 -24.23 6.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.383 1.473 . . . . 3.34 112.405 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -165.53 171.92 12.65 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.49 2.316 . . . . 2.8 109.234 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -159.24 158.76 33.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.497 1.119 . . . . 4.04 113.673 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.85 -179.85 7.31 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.594 1.958 . . . . 2.54 112.055 -165.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.3 -145.34 16.91 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.05 1.786 . . . . 3.72 109.91 -171.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -54.5 3.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 118.942 2.942 . . . . 3.84 118.942 -161.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -135.96 -45.35 0.65 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.288 -1.508 . . . . 4.49 112.132 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -79.19 86.31 4.99 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.935 -1.103 . . . . 4.53 110.458 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.07 155.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.003 2.521 . . . . 5.78 114.901 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -41.7 -70.22 0.11 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.016 2.127 . . . . 2.86 116.143 -172.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.31 -24.95 75.54 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 122.564 1.091 . . . . 1.86 111.284 -170.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -70.14 -23.91 63.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.377 1.871 . . . . 5.29 111.317 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.24 -51.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.258 -0.901 . . . . 1.74 110.752 162.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.1 71.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.38 0.991 . . . . 1.45 111.939 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.77 73.79 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.25 1.204 . . . . 1.86 114.25 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.6 p -75.04 -37.63 61.66 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.842 -1.161 . . . . 1.86 112.644 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mm -56.61 -47.65 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 119.943 1.247 . . . . 1.98 110.842 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.17 -18.16 60.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.063 1.134 . . . . 1.68 114.063 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.5 m -84.05 -40.94 17.74 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.447 1.099 . . . . 2.2 110.984 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -69.94 -29.29 66.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.181 0.993 . . . . 2.65 113.516 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.66 19.25 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.536 -1.353 . . . . 6.25 114.197 164.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -74.43 -58.98 1.71 Allowed Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.471 -1.728 . . . . 5.93 111.303 152.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.85 -48.8 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.842 2.362 . . . . 2.62 112.518 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -68.75 121.89 17.44 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.033 0.833 . . . . 3.45 110.677 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 123.451 0.7 . . . . 8.33 112.13 -178.904 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.2 0 CA-C-O 118.327 -1.263 . . . . 3.81 113.169 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.54 142.43 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.315 2.01 . . . . 3.11 112.772 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -108.34 175.19 5.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.361 -1.29 . . . . 2.9 111.567 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -141.35 22.07 2.21 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.709 1.744 . . . . 3.44 115.709 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.32 165.4 23.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.748 1.219 . . . . 2.82 110.825 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.1 m -117.3 151.65 36.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.861 2.064 . . . . 2.43 109.171 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.3 p -86.28 158.99 19.56 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.642 1.211 . . . . 1.93 113.206 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -59.77 -21.59 60.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.91 1.684 . . . . 1.39 113.225 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.8 m -72.08 -39.49 68.95 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.65 1.18 . . . . 3.04 110.166 172.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 120.07 -8.36 11.51 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.53 1.538 . . . . 1.94 114.47 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -83.11 147.64 27.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.149 0.974 . . . . 4.14 109.879 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -87.72 125.41 34.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.229 -0.656 . . . . 4.25 109.229 163.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.27 134.94 36.7 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.974 1.31 . . . . 3.77 109.62 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.9 p -109.83 166.29 11.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.682 1.593 . . . . 3.42 112.352 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.96 2.65 0.49 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.829 2.452 . . . . 3.34 114.817 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -7.51 12.58 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.244 1.202 . . . . 7.26 114.244 165.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.59 -44.55 64.26 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.713 1.142 . . . . 3.02 110.063 161.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -78.02 10.59 2.77 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.834 1.42 . . . . 3.99 114.834 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.82 108.39 1.17 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 5.24 110.101 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.09 -8.69 6.33 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.507 1.051 . . . . 3.8 114.629 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -129.07 158.97 37.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.944 1.372 . . . . 4.71 110.48 165.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.464 ' CE3' ' HD3' ' A' ' 269' ' ' PRO . 94.7 m95 -67.8 118.97 11.76 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.451 0.7 . . . . 3.19 112.555 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.78 109.14 21.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.782 1.633 . . . . 3.07 109.582 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.61 98.25 7.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.118 -0.697 . . . . 3.21 109.118 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -95.35 126.97 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.903 1.281 . . . . 1.98 108.998 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -140.55 150.1 43.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.787 1.235 . . . . 2.44 113.658 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -123.09 112.74 18.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.941 1.296 . . . . 2.37 111.053 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.18 142.62 13.68 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.151 1.358 . . . . 1.41 112.023 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -92.11 129.1 38.14 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.131 0.965 . . . . 4.14 112.27 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.1 m -75.72 66.77 2.08 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.643 1.577 . . . . 3.86 111.285 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -174.91 -28.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.801 2.841 . . . . 7.22 112.441 -171.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 m -67.03 160.54 69.71 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 117.452 2.39 . . . . 2.38 117.452 -163.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.96 -168.09 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.882 3.722 . . . . 3.01 110.724 159.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.72 -7.04 3.02 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.521 2.415 . . . . 4.15 117.521 -151.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 74.0 t -65.0 -60.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.895 1.278 . . . . 2.69 108.761 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 23.8 m -49.53 -60.41 4.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.733 -1.127 . . . . 1.74 113.028 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.39 -30.57 19.15 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-O 116.105 -1.706 . . . . 1.24 113.715 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.15 -45.97 65.69 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.996 2.18 . . . . 3.21 110.492 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -61.44 -33.22 73.35 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.25 0.932 . . . . 3.05 112.068 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -48.6 64.67 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.659 -0.651 . . . . 2.32 111.939 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -41.29 94.13 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.828 -1.17 . . . . 3.75 111.07 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -46.96 -52.14 15.36 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 119.943 -1.723 . . . . 2.84 112.209 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.4 ptp -70.77 -8.34 51.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.492 1.664 . . . . 2.5 115.492 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mm -75.78 -60.04 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.414 1.461 . . . . 1.92 108.686 161.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.72 -38.74 56.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.256 0.836 . . . . 3.02 113.256 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.1 t -60.02 -19.02 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 117.823 -1.084 . . . . 2.15 112.756 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.68 -53.93 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.699 1.59 . . . . 2.54 110.558 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.62 -27.58 67.02 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.643 1.177 . . . . 4.03 111.883 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -71.48 -19.63 62.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.928 1.291 . . . . 3.76 113.427 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.64 -56.99 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.279 1.431 . . . . 2.28 113.845 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.86 -30.7 71.35 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.783 0.801 . . . . 5.5 109.261 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.9 m -60.31 -12.26 8.65 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.88 2.472 . . . . 4.05 115.163 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.5 mm -79.01 -39.45 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.871 -1.143 . . . . 4.99 112.139 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.3 m -176.82 2.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.632 1.573 . . . . 7.88 114.349 -158.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.2 m 77.2 41.59 0.15 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.059 2.544 . . . . 5.37 111.065 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.2 150.46 0.27 Allowed Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 128.987 2.915 . . . . 3.34 113.949 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.32 -43.25 58.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.485 2.79 . . . . 3.26 113.569 -170.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.3 t70 161.34 154.45 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 131.532 3.933 . . . . 3.58 107.648 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.58 111.71 17.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.495 0.718 . . . . 3.12 109.913 168.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.8 m -105.45 112.25 64.81 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.535 1.134 . . . . 1.97 108.596 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.33 137.67 23.7 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.112 1.875 . . . . 1.25 109.002 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.277 1.5 pt? -136.18 118.44 15.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.644 1.212 . . . . 3.22 110.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.05 125.91 54.9 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.657 1.583 . . . . 2.0 110.201 -157.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.55 120.44 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.405 -0.961 . . . . 1.59 108.405 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.2 t -72.38 -15.24 61.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.795 1.405 . . . . 3.25 114.795 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . 0.287 43.8 pt 51.7 9.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 128.539 2.735 . . . . 2.12 117.912 170.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -111.16 56.54 0.38 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.221 1.408 . . . . 3.5 114.502 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.04 69.99 7.26 Favored 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.406 4.071 . . . . 3.74 112.685 -167.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -171.2 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.5 2.32 . . . . 4.04 109.673 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -17.69 10.1 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.23 1.412 . . . . 8.18 112.82 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.4 153.31 2.2 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.696 1.598 . . . . 4.62 112.912 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.4 m -144.59 125.33 14.2 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.299 -0.876 . . . . 2.47 109.854 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -48.33 -47.72 36.75 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.467 1.907 . . . . 3.06 112.793 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -68.77 -33.21 73.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.231 1.197 . . . . 3.81 114.231 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.91 84.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.483 1.492 . . . . 1.65 110.941 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.66 -34.46 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.276 0.63 . . . . 1.56 111.857 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.35 -19.31 64.52 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.066 -1.021 . . . . 1.75 113.697 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -84.98 -42.64 14.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.957 1.253 . . . . 3.17 112.992 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -57.04 -35.26 69.09 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.153 1.381 . . . . 2.57 112.133 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.53 -37.03 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.238 1.415 . . . . 1.33 113.078 169.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -70.96 -51.27 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.799 -1.188 . . . . 5.25 112.204 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.49 -18.42 62.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.619 1.567 . . . . 4.08 113.769 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -80.55 -79.4 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.734 0.697 . . . . 3.0 109.676 154.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 178.23 139.69 0.25 Allowed Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.307 1.843 . . . . 1.97 110.304 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.45 5.9 1.77 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.15 3.233 . . . . 2.16 114.942 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -18.27 63.5 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.841 -1.162 . . . . 3.48 112.763 161.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.6 tp -78.78 138.13 38.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.18 1.792 . . . . 2.11 111.224 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 26.2 t -101.88 130.35 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.042 0.937 . . . . 1.8 108.881 158.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.58 132.91 11.11 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.798 -0.921 . . . . 0.83 110.798 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.5 144.97 50.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.131 0.972 . . . . 2.29 112.926 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.6 t -149.1 176.44 10.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.204 2.202 . . . . 2.68 111.194 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 165.37 -168.15 39.25 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 127.141 2.305 . . . . 2.04 109.374 -170.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.3 174.59 10.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.053 1.426 . . . . 3.48 111.373 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -47.86 -38.37 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.59 0.756 . . . . 8.46 112.168 170.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -36.11 47.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.809 0.732 . . . . 5.7 112.572 -169.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -70.37 -33.57 71.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.242 -1.537 . . . . 3.79 111.847 170.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.96 -31.68 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.726 0.81 . . . . 2.03 110.816 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.72 -32.3 41.19 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.941 0.791 . . . . 3.18 112.664 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.42 -53.17 60.83 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.113 -0.992 . . . . 3.16 109.736 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.2 p -62.2 -27.71 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 119.426 -0.321 . . . . 2.64 111.812 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.61 -46.18 66.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.248 0.931 . . . . 2.13 111.518 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -58.83 -53.83 53.99 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.576 1.55 . . . . 3.73 111.066 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.39 65.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.973 1.309 . . . . 2.73 114.362 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -117.4 3.82 12.51 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.575 1.324 . . . . 2.69 114.575 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 57.6 31.19 19.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.085 1.354 . . . . 5.23 113.421 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.38 161.99 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.58 1.152 . . . . 3.23 110.325 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -146.22 154.9 42.26 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.592 0.96 . . . . 5.84 113.592 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.62 110.81 6.96 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.991 1.716 . . . . 6.88 110.669 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -104.73 124.16 37.79 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 120.66 -1.275 . . . . 3.12 113.158 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.39 130.27 14.86 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.302 2.001 . . . . 3.25 113.274 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 C-N-CA 124.191 0.9 . . . . 2.47 110.912 173.659 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 3.1 t80 . . . . . 0 CA--C 1.549 0.917 0 CA-C-O 121.565 0.698 . . . . 4.71 111.938 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 tt -124.07 168.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.842 1.657 . . . . 4.21 111.223 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.24 135.75 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 4.07 105.214 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 169.33 1.67 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.205 1.002 . . . . 4.29 112.113 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -153.87 126.8 8.3 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.524 -0.735 . . . . 2.12 111.518 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.3 p -59.37 118.74 6.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.676 0.79 . . . . 3.57 110.265 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 11.1 tp -78.41 59.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.177 1.391 . . . . 4.15 113.657 -168.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.0 mm -109.2 138.01 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.78 1.232 . . . . 2.45 111.806 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.3 ttt -121.33 134.75 55.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.02 1.728 . . . . 2.38 108.992 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.48 141.77 44.61 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.762 0.825 . . . . 2.77 111.927 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.92 116.87 31.01 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.164 0.986 . . . . 1.91 109.983 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.0 136.93 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.683 1.193 . . . . 1.88 107.835 166.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.52 168.9 48.53 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 123.792 0.711 . . . . 2.25 114.59 -168.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.464 ' HD3' ' CE3' ' A' ' 159' ' ' TRP . 42.0 Cg_endo -77.3 56.09 5.35 Favored 'Trans proline' 0 CA--C 1.539 0.749 1 C-N-CA 125.964 4.443 . . . . 4.02 109.38 173.458 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -162.1 -55.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.753 -0.658 . . . . 4.81 111.252 -143.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 154.19 -54.33 0.44 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.093 -1.393 . . . . 3.56 112.611 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -130.06 -174.23 3.26 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.806 1.303 . . . . 5.87 114.326 -162.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -80.37 142.97 33.9 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.995 -1.066 . . . . 4.9 113.525 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.67 -25.91 0.89 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.453 1.279 . . . . 2.91 114.453 -157.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -162.78 165.91 24.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.672 2.389 . . . . 2.54 109.247 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -155.81 150.54 26.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.53 1.308 . . . . 3.59 114.53 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -126.89 119.49 26.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.307 1.443 . . . . 2.46 109.339 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -111.12 72.77 0.21 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 108.993 -1.643 . . . . 4.03 108.993 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 41.37 -134.68 0.28 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.215 1.406 . . . . 3.66 111.308 -155.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.2 t30 70.6 -65.8 0.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.593 2.357 . . . . 4.65 114.615 167.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -66.01 120.36 13.01 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.546 1.138 . . . . 5.28 110.376 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -77.97 138.46 38.86 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.611 -1.305 . . . . 9.33 110.238 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.7 -47.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.486 3.143 . . . . 2.92 119.486 -158.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -15.81 57.82 Favored Glycine 0 N--CA 1.476 1.363 0 CA-C-N 119.748 1.158 . . . . 1.93 112.698 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.15 -24.09 65.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.482 0.919 . . . . 3.25 113.482 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.15 -41.61 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.59 1.086 . . . . 1.62 109.005 172.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.8 99.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.94 -0.553 . . . . 1.34 111.478 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.11 98.27 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.842 1.053 . . . . 1.55 113.842 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.1 p -70.03 -47.29 62.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.2 1.364 . . . . 1.43 111.763 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.02 -34.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 120.065 1.302 . . . . 1.49 112.448 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.9 76.02 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.93 -1.106 . . . . 1.73 112.999 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 38.9 m -70.22 -45.45 66.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.267 1.027 . . . . 1.98 109.394 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -65.59 -28.46 69.15 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 2.83 113.06 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -19.83 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.94 -1.1 . . . . 4.54 112.546 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -46.23 95.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.759 -1.591 . . . . 5.92 112.401 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.8 -45.56 0.1 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.168 2.578 . . . . 2.72 113.989 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.18 170.51 14.81 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.937 1.244 . . . . 3.52 114.093 -174.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 . . . . . 0 N--CA 1.477 0.893 0 O-C-N 120.497 -1.377 . . . . 7.67 112.265 -178.433 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.217 0 CA-C-O 118.983 -0.898 . . . . 2.55 113.855 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.52 144.85 62.43 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.168 2.579 . . . . 3.39 110.618 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -95.71 177.69 5.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.397 1.479 . . . . 2.91 112.524 -169.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.9 m -129.64 22.62 5.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.865 1.431 . . . . 2.28 114.865 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.41 157.9 15.8 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.32 1.048 . . . . 2.63 112.839 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' ARG . 58.3 m -101.03 148.21 25.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.892 1.677 . . . . 1.54 110.606 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.3 p -81.36 166.69 20.22 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.735 1.614 . . . . 2.33 113.49 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -61.3 -23.05 65.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.948 2.099 . . . . 2.04 113.152 169.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.7 m -73.93 -61.5 1.83 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.312 1.045 . . . . 3.2 108.183 167.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 141.53 -1.22 1.81 Allowed Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.914 1.245 . . . . 2.34 115.936 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.12 145.59 29.14 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.584 1.192 . . . . 4.16 109.781 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 0.9 OUTLIER -96.7 74.28 2.72 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.106 2.563 . . . . 5.52 112.533 -178.25 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -81.03 89.79 5.96 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.287 -0.883 . . . . 6.18 112.734 -166.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.6 p -68.57 127.59 33.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.345 1.058 . . . . 3.11 110.278 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -1.28 12.05 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 117.806 2.521 . . . . 6.19 117.806 -155.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -77.58 4.48 11.2 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 120.944 -1.098 . . . . 6.7 112.954 164.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -73.28 -71.89 0.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.633 2.773 . . . . 3.74 114.375 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -69.57 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.397 1.879 . . . . 4.46 114.441 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.0 -32.68 71.09 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.795 2.038 . . . . 3.39 114.442 -157.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.08 2.02 87.67 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.482 0.953 . . . . 2.35 115.482 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -96.55 -138.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.92 1.688 . . . . 3.3 109.189 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -140.89 140.82 34.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.851 1.26 . . . . 1.72 109.967 164.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.89 151.61 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.922 1.082 . . . . 2.86 113.922 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.22 119.22 34.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.863 1.665 . . . . 2.43 108.148 163.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.1 mt -109.88 110.22 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.61 -0.885 . . . . 1.69 108.61 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -113.35 153.98 27.63 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.272 1.829 . . . . 2.95 113.431 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -127.34 97.88 5.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.081 1.352 . . . . 2.51 112.859 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.54 -176.91 14.65 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 128.205 2.812 . . . . 1.83 112.35 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -113.32 141.11 47.41 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.818 1.647 . . . . 3.52 112.165 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -65.49 113.42 4.14 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.823 -1.173 . . . . 3.04 110.939 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 73.7 m80 63.75 35.0 11.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.075 1.75 . . . . 10.13 112.348 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 49.9 t -59.1 157.2 22.87 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.225 1.41 . . . . 2.99 111.594 163.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.66 177.34 1.33 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.621 2.881 . . . . 3.13 112.031 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.38 -3.27 0.9 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.12 2.637 . . . . 5.26 118.12 -148.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.45 -59.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.049 1.739 . . . . 3.01 110.353 171.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.8 m -53.76 -58.73 11.93 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 118.055 -0.974 . . . . 1.86 112.606 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.85 -29.9 41.14 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.575 1.517 . . . . 1.94 113.805 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -60.62 -53.1 61.49 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 121.09 1.768 . . . . 3.99 111.211 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.46 0.704 . . . . 3.39 112.023 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.22 -28.87 61.45 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.354 -1.467 . . . . 3.01 112.357 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -56.93 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.264 1.025 . . . . 4.09 108.612 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -45.34 72.47 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.438 -0.789 . . . . 5.77 111.676 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 47.1 ttp -57.93 -45.0 87.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.854 2.061 . . . . 3.58 112.408 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.78 -45.16 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.608 1.094 . . . . 1.74 110.652 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -69.11 -27.37 65.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.229 1.377 . . . . 5.02 110.654 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.41 -47.83 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 120.622 1.556 . . . . 1.74 110.591 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.8 -42.54 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.515 1.052 . . . . 3.73 113.269 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -76.29 -25.94 55.37 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.443 1.02 . . . . 5.8 113.337 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -63.98 -31.12 72.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.382 1.473 . . . . 2.98 113.474 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.46 -41.76 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.649 1.18 . . . . 2.09 112.167 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.0 -27.92 61.99 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.132 0.967 . . . . 4.47 112.218 167.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.8 m -70.57 -9.76 57.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.381 1.072 . . . . 3.96 113.06 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 14.8 mm -85.75 58.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.437 -1.414 . . . . 4.17 109.097 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.1 m -58.77 85.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.781 1.632 . . . . 5.49 112.293 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m 171.0 -32.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.962 3.705 . . . . 4.1 108.386 -167.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 294' ' ' MET . 46.2 mt -73.25 162.01 76.47 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.193 -0.432 . . . . 4.31 111.231 143.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -81.74 -154.15 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.77 3.646 . . . . 3.17 108.569 154.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.83 158.35 25.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.217 1.562 . . . . 3.9 115.217 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.09 94.1 4.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.077 1.351 . . . . 1.93 109.35 161.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.9 m -76.68 121.72 85.32 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 120.643 -1.286 . . . . 1.47 110.206 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.29 126.66 2.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.442 2.761 . . . . 0.9 111.544 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 tt -125.04 112.51 16.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.784 1.234 . . . . 2.54 110.505 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -100.66 124.24 45.99 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.526 1.131 . . . . 2.07 110.698 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.92 120.4 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.482 -0.933 . . . . 1.59 108.482 170.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.3 t -82.15 106.46 14.06 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.504 -0.924 . . . . 2.04 108.504 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.71 12.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.955 1.302 . . . . 2.43 113.032 -176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -113.69 27.77 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.295 2.638 . . . . 3.62 114.532 -171.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.41 -13.68 41.03 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.733 2.955 . . . . 2.41 116.218 -154.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.67 1.8 43.8 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.963 1.098 . . . . 4.56 113.963 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.289 2.2 ppt_? -137.28 0.82 2.36 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.137 1.532 . . . . 5.86 115.137 158.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.27 -173.05 0.05 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.117 1.767 . . . . 3.53 110.413 152.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -178.83 132.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.387 3.075 . . . . 2.71 105.533 -172.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmpt? -56.98 -30.78 64.42 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.278 0.844 . . . . 3.34 113.278 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -35.13 52.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.456 1.503 . . . . 3.33 114.025 169.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.05 78.1 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.352 -1.467 . . . . 1.96 111.897 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -70.37 -32.66 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.43 0.559 . . . . 2.46 112.085 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.78 -35.21 80.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.934 1.243 . . . . 1.73 112.368 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.09 -40.13 75.16 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.513 -0.742 . . . . 4.24 111.832 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.84 -42.08 97.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.992 0.917 . . . . 3.42 111.983 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.0 t -54.67 -50.76 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.771 0.714 . . . . 1.53 111.368 168.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.13 -23.4 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.962 1.305 . . . . 4.94 114.035 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -70.91 -22.62 62.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.461 1.504 . . . . 4.88 113.211 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -108.54 -52.72 2.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.225 1.01 . . . . 2.52 112.766 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 t 178.99 143.13 0.31 Allowed Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.82 1.648 . . . . 2.06 109.97 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.63 -9.62 23.36 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.683 2.255 . . . . 2.1 113.158 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.55 -18.1 62.92 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.226 0.921 . . . . 2.62 113.203 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.35 127.29 32.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.231 -0.918 . . . . 2.35 110.59 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.54 121.89 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.294 -1.002 . . . . 2.18 108.294 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.56 139.45 14.72 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.917 -0.873 . . . . 1.1 110.917 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mp -132.97 147.28 52.28 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.599 1.2 . . . . 2.09 112.298 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 13.5 t -150.37 -174.06 4.64 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.085 1.754 . . . . 3.48 109.926 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 149.01 -64.5 0.4 Allowed Glycine 0 N--CA 1.474 1.202 0 N-CA-C 115.626 1.01 . . . . 2.45 115.626 170.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.1 t -160.07 145.78 15.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.322 1.061 . . . . 3.52 112.702 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -48.72 -42.5 35.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.275 2.23 . . . . 5.93 112.511 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.89 -27.19 67.3 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.011 1.732 . . . . 4.26 114.456 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -35.79 25.82 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.495 . . . . 4.46 112.052 172.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.29 -41.49 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.024 0.53 . . . . 2.71 110.639 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.2 -40.36 95.83 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.184 -0.912 . . . . 3.29 111.307 170.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -58.17 -51.12 71.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.346 1.43 . . . . 2.88 111.684 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -25.4 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.251 0.932 . . . . 2.97 112.604 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.44 -53.03 18.06 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.161 -0.962 . . . . 2.12 111.724 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -64.0 -31.9 73.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.163 2.185 . . . . 3.87 111.762 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.29 62.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.73 1.612 . . . . 2.14 115.042 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.45 3.04 7.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.178 0.807 . . . . 2.59 113.178 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 74.06 34.63 0.84 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.359 2.264 . . . . 5.38 112.355 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 147.84 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.235 1.814 . . . . 3.14 110.886 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.54 140.21 48.94 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.047 1.339 . . . . 4.11 112.844 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.55 162.59 41.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.195 1.798 . . . . 7.34 110.71 161.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.5 m -127.69 88.44 53.45 Favored Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 123.733 0.813 . . . . 2.82 110.655 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 144.76 22.85 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.844 2.363 . . . . 4.51 110.068 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.492 0 CA-C-O 118.615 -1.103 . . . . 4.32 112.84 -177.409 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 22.3 p90 . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 121.413 0.625 . . . . 4.69 111.919 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.5 tp -72.36 136.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.056 -1.028 . . . . 3.13 109.825 167.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.52 144.73 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.573 1.549 . . . . 5.88 110.863 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.19 150.75 39.79 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.625 1.202 . . . . 3.62 113.03 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 162.6 8.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.615 1.566 . . . . 2.83 112.911 -153.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -38.39 57.93 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.071 -1.442 . . . . 3.82 114.447 -171.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.0 mt 66.03 29.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 123.258 1.504 . . . . 4.69 110.302 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.6 mm -126.06 149.47 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 127.191 2.196 . . . . 3.99 108.954 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.43 146.17 51.94 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.328 1.451 . . . . 2.6 114.122 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -97.94 137.39 36.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.16 1.784 . . . . 2.7 110.746 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.37 107.73 19.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.385 1.474 . . . . 2.5 108.465 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.73 125.21 47.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.165 0.986 . . . . 1.89 108.677 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.5 173.25 42.01 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.986 -0.896 . . . . 1.57 111.905 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.12 78.32 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.287 3.325 . . . . 2.65 110.803 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.13 -47.43 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 131.335 3.854 . . . . 5.38 109.871 -173.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.61 -9.92 21.71 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.467 -1.741 . . . . 3.51 116.236 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -82.87 153.27 25.21 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 119.888 1.844 . . . . 4.97 110.901 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -80.18 120.8 24.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.414 -0.804 . . . . 3.45 111.099 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.5 pp -104.29 -3.31 24.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.468 1.107 . . . . 2.99 113.758 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -157.18 164.29 37.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.899 2.08 . . . . 2.18 108.707 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.68 135.25 6.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.241 1.416 . . . . 3.64 111.755 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.03 -160.5 0.91 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.214 1.806 . . . . 2.75 109.355 -168.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.96 -132.47 3.57 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 109.826 -1.31 . . . . 3.29 109.826 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -53.05 152.1 4.37 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.827 0.822 . . . . 3.57 112.711 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 75.7 -18.48 0.45 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.317 1.847 . . . . 5.73 112.501 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 146.99 26.24 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.588 -1.32 . . . . 6.73 109.911 158.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -107.42 154.73 20.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.309 -0.869 . . . . 5.82 110.983 -167.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -47.55 -55.52 9.04 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 2.29 112.795 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.67 -19.08 76.28 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 115.238 0.855 . . . . 1.53 115.238 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -78.37 -41.82 32.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.171 1.389 . . . . 4.25 111.193 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.69 -42.77 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.475 -0.565 . . . . 1.39 109.475 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.91 81.65 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.686 -0.634 . . . . 1.34 112.145 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.06 -37.52 86.04 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.767 1.025 . . . . 1.47 113.767 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.8 p -67.33 -49.01 65.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.523 1.056 . . . . 1.3 111.074 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.98 -37.82 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.235 -0.915 . . . . 1.58 111.693 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.82 67.05 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.735 -1.228 . . . . 1.5 113.747 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.7 m -78.27 -50.02 12.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.471 1.108 . . . . 1.73 110.203 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -62.86 -31.31 72.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.811 1.244 . . . . 2.43 112.985 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' MET . . . . . 0.408 ' HG3' HD21 ' A' ' 193' ' ' LEU . 62.1 ttp -56.36 -18.73 11.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.929 1.692 . . . . 4.25 113.25 168.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.22 -56.55 3.21 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.631 -1.652 . . . . 5.1 112.981 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.12 -39.82 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.866 2.377 . . . . 2.68 112.996 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -93.15 121.5 34.57 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 122.137 0.97 . . . . 3.25 111.116 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 127.567 2.347 . . . . 9.76 112.556 167.804 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 118.859 -0.967 . . . . 2.89 111.527 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.78 177.73 8.46 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.812 3.008 . . . . 2.9 109.924 165.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -156.26 166.39 33.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.164 0.983 . . . . 2.63 113.298 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.2 m -156.97 72.69 0.73 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.537 -1.352 . . . . 3.88 112.364 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.38 166.98 10.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.631 1.172 . . . . 3.81 111.88 -167.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.3 m -99.57 143.34 29.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.471 1.108 . . . . 1.73 109.154 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 146' ' ' THR . 0.8 OUTLIER -110.27 162.28 14.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.889 0.852 . . . . 3.03 111.652 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -41.0 -28.76 0.09 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.742 2.417 . . . . 1.53 116.264 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.494 ' H ' HG23 ' A' ' 144' ' ' THR . 11.4 m -77.08 -22.3 53.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.842 2.457 . . . . 3.1 114.088 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.25 70.64 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.954 1.264 . . . . 1.96 113.612 -167.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 161.05 30.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.111 1.764 . . . . 3.9 110.71 168.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -124.16 141.26 52.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.641 1.177 . . . . 4.81 112.222 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -133.88 145.94 50.1 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.325 -0.86 . . . . 3.01 111.993 -173.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.1 p -128.28 167.02 17.49 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.117 1.767 . . . . 3.03 110.089 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -61.36 -10.07 6.55 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.197 0.814 . . . . 4.76 113.197 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -37.09 28.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.5 0.926 . . . . 5.75 113.5 170.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.51 -32.68 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.768 1.227 . . . . 3.08 111.47 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -93.98 -0.11 55.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.362 1.615 . . . . 3.12 115.362 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.34 174.76 9.12 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 119.59 1.086 . . . . 3.62 112.039 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.21 3.34 60.94 Favored Glycine 0 N--CA 1.478 1.47 0 N-CA-C 116.259 1.264 . . . . 2.48 116.259 165.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -130.77 164.34 25.34 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.96 2.104 . . . . 3.01 109.144 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -70.19 132.97 46.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.726 1.148 . . . . 2.76 109.105 157.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.46 144.62 38.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.801 0.81 . . . . 3.21 112.496 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.7 mt -114.95 120.52 40.19 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.383 1.873 . . . . 2.42 106.169 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.9 pt -115.98 112.59 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.184 -1.043 . . . . 3.25 108.184 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -100.47 127.95 46.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.712 1.605 . . . . 3.15 112.263 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -100.87 82.6 2.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.313 1.445 . . . . 2.17 109.721 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -95.16 164.4 24.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 113.665 -1.607 . . . . 1.61 111.279 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.01 -170.45 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.022 -1.103 . . . . 3.95 108.022 157.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.3 m -146.3 95.04 2.55 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.324 1.849 . . . . 3.46 107.141 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -169.05 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.451 1.649 . . . . 7.29 115.451 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 170' ' ' PRO . 37.6 m -79.78 -179.88 1.58 Allowed Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.298 1.439 . . . . 2.93 111.446 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 169' ' ' CYS . 57.2 Cg_endo -76.9 -129.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.242 2.628 . . . . 4.5 108.585 157.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 50.57 0.13 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.377 2.671 . . . . 5.6 114.367 -173.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.9 -60.17 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.214 1.805 . . . . 4.03 109.873 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 63.8 m -46.96 -44.92 49.8 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-O 117.375 -1.297 . . . . 3.63 114.476 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.57 -9.11 6.94 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.432 2.755 . . . . 1.66 114.865 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.69 -67.2 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.375 1.443 . . . . 4.04 111.213 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.45 -21.18 65.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.359 0.981 . . . . 3.1 113.04 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -47.08 81.62 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.199 0.6 . . . . 2.61 110.468 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -40.31 95.32 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.688 -1.258 . . . . 3.5 111.481 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -55.24 24.1 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.074 -1.016 . . . . 2.92 110.947 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.37 -16.13 62.94 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.446 0.906 . . . . 2.99 113.446 -176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.9 mm -69.36 -56.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.835 1.198 . . . . 1.56 109.985 162.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.516 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 80.8 mt-30 -60.51 -22.58 63.73 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.284 1.402 . . . . 3.17 113.185 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.82 -28.02 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.113 -0.992 . . . . 1.76 111.264 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.92 -34.61 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.309 0.959 . . . . 2.34 110.419 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.43 -45.29 84.83 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.042 1.337 . . . . 4.76 112.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.14 -20.39 61.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.535 1.134 . . . . 2.88 113.478 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.55 -57.58 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.324 1.05 . . . . 1.73 111.543 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.07 -23.69 65.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.584 1.154 . . . . 3.05 112.161 -174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 73.4 m -68.11 -19.12 64.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.32 1.048 . . . . 2.61 113.713 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.16 -25.22 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.999 0.92 . . . . 3.71 111.176 171.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.0 m 72.63 -33.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 129.801 3.24 . . . . 5.38 114.272 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.8 p -99.56 19.25 16.09 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 3.56 111.863 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.09 165.41 43.17 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.477 1.111 . . . . 2.89 108.314 159.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 51.62 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.154 2.569 . . . . 4.09 110.947 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.61 -173.84 0.16 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.775 2.83 . . . . 4.56 113.784 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 45.5 tp -140.55 117.39 11.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.153 -1.054 . . . . 1.78 108.153 150.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.0 m -106.56 96.03 13.19 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.288 1.035 . . . . 1.64 108.651 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.12 144.12 33.23 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.205 1.937 . . . . 1.2 110.535 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.25 147.11 43.35 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.542 0.687 . . . . 2.72 110.806 171.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -112.92 121.09 43.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.895 1.278 . . . . 2.25 108.234 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.35 118.03 40.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.738 -1.578 . . . . 1.51 106.738 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.57 137.99 38.9 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.567 0.698 . . . . 1.98 110.679 162.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.1 pt -114.6 24.48 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.835 1.254 . . . . 2.07 111.092 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -97.69 0.7 0.09 OUTLIER Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 129.337 3.055 . . . . 5.17 118.586 -161.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.48 120.55 7.77 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 123.405 2.252 . . . . 2.53 111.727 -165.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 149.23 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 130.425 3.49 . . . . 4.44 110.402 -171.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -35.46 3.56 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.014 1.116 . . . . 4.96 114.014 173.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.4 163.72 12.41 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.35 1.611 . . . . 4.89 115.35 -166.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -138.95 153.36 48.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.512 -1.222 . . . . 2.75 112.536 -164.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -45.61 -43.95 12.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.87 1.268 . . . . 4.52 112.34 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.61 -44.24 62.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.612 1.565 . . . . 3.69 112.853 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.84 97.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.34 1.427 . . . . 1.29 111.229 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.69 -33.99 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.537 -0.727 . . . . 1.88 110.543 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.83 78.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.554 1.07 . . . . 1.19 112.638 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -62.43 -53.47 54.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.835 1.198 . . . . 3.55 109.983 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -55.83 -46.61 78.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 5.11 112.448 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.5 t -62.24 -45.72 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.555 -1.341 . . . . 1.49 111.397 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.03 -39.18 91.44 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 118.315 -0.85 . . . . 5.43 113.086 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -78.19 -37.28 45.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.059 1.3 . . . . 4.02 112.436 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -68.4 -59.68 3.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.536 -0.745 . . . . 3.03 112.484 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 174.85 157.28 0.35 Allowed Pre-proline 0 N--CA 1.484 1.257 0 N-CA-C 115.173 1.546 . . . . 1.93 115.173 170.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.19 -8.93 18.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.762 2.975 . . . . 2.23 114.552 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -86.16 -0.03 54.73 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 119.95 1.25 . . . . 2.85 112.78 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 29.9 tp -94.41 151.04 19.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.995 1.318 . . . . 1.88 109.912 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 87.7 t -133.43 132.43 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.98 1.712 . . . . 1.83 108.313 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.6 105.36 1.42 Allowed Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.082 0.848 . . . . 1.12 112.068 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.91 147.4 25.59 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.7 1.2 . . . . 2.1 112.453 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 65.4 p -140.49 149.73 42.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.488 1.915 . . . . 2.92 111.164 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -131.44 -170.72 12.7 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.151 1.358 . . . . 1.6 110.856 160.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.9 t -84.33 174.59 10.01 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.622 0.711 . . . . 2.63 109.146 152.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -52.26 -24.45 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.026 1.33 . . . . 6.41 113.603 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -74.86 -52.33 11.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.87 2.468 . . . . 2.83 110.784 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.07 -25.84 64.64 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.272 -1.517 . . . . 3.97 111.96 171.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 33.3 t -62.98 -38.95 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 117.22 -1.371 . . . . 1.79 110.991 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.8 -52.53 65.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.451 1.478 . . . . 3.94 109.042 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -49.98 -57.28 7.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.606 1.094 . . . . 2.52 112.02 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.48 -29.19 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.315 1.416 . . . . 3.01 113.002 -170.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.38 -42.33 79.28 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.831 -0.543 . . . . 1.74 110.732 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -72.02 -33.93 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.854 2.062 . . . . 4.68 112.573 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -54.87 -30.72 58.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.039 1.336 . . . . 2.56 114.487 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -118.22 3.72 11.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.616 1.166 . . . . 3.06 113.099 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.75 39.92 16.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.204 2.202 . . . . 6.31 112.91 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.17 155.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.867 0.867 . . . . 2.61 112.131 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -104.58 148.98 25.91 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.591 1.556 . . . . 3.51 114.084 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -170.37 150.12 3.48 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.837 2.855 . . . . 3.57 109.497 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.2 m -157.78 144.45 13.11 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 124.979 1.312 . . . . 3.24 111.623 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.06 154.04 37.31 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.508 2.139 . . . . 2.85 111.414 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.728 0 C-N-CA 123.886 0.755 . . . . 3.16 114.259 171.622 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 111.887 0.328 . . . . 4.77 111.887 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.5 HD13 ' H ' ' A' ' 258' ' ' VAL . 0.5 OUTLIER -65.54 160.61 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 121.245 -0.909 . . . . 2.85 110.255 162.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.5 ' H ' HD13 ' A' ' 257' ' ' ILE . 41.1 t -153.74 128.03 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.566 1.947 . . . . 3.15 106.568 172.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.19 146.41 49.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.556 1.542 . . . . 3.28 112.196 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.77 129.51 14.16 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.135 0.974 . . . . 2.34 111.237 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.6 m -54.45 -31.15 54.91 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.93 1.085 . . . . 3.33 113.93 -171.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 69.74 -20.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.42 1.888 . . . . 4.16 114.402 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 84.4 mt -54.94 138.78 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.082 0.953 . . . . 2.34 110.504 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.7 mtm -99.78 141.2 32.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.324 -1.307 . . . . 2.57 110.46 162.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -99.21 140.32 33.55 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.241 0.616 . . . . 3.29 110.006 168.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 21.6 tp -99.1 117.04 32.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.919 0.888 . . . . 1.94 108.918 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.48 141.99 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.795 -1.187 . . . . 2.26 107.795 169.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.41 168.28 34.78 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.23 0.919 . . . . 1.59 115.156 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.66 61.25 7.44 Favored 'Trans proline' 0 C--N 1.351 0.695 1 C-N-CA 126.063 4.509 . . . . 3.03 110.722 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.54 -67.45 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.091 1.356 . . . . 4.13 108.232 -149.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.61 -23.22 2.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.07 -1.406 . . . . 2.38 115.046 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.59 172.25 11.07 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.335 1.567 . . . . 4.44 113.219 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -88.56 137.64 32.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.755 2.022 . . . . 5.4 111.429 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.22 -30.15 4.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.055 1.872 . . . . 2.39 116.055 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -164.68 155.98 15.22 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.686 1.585 . . . . 2.52 112.995 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 146.09 31.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.728 0.811 . . . . 6.15 112.825 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.37 159.92 40.05 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.344 1.058 . . . . 2.78 111.771 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.48 -174.37 29.04 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.347 1.451 . . . . 2.83 110.213 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -73.83 38.57 0.1 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.29 2.236 . . . . 3.59 114.637 -167.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -121.48 -43.25 2.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.542 1.537 . . . . 5.45 109.91 167.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -87.32 118.59 26.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.449 1.5 . . . . 4.36 108.945 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -73.42 177.92 4.93 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.264 -0.897 . . . . 6.06 108.709 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 12.7 tmtt? -54.45 -47.33 73.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.301 1.223 . . . . 1.81 114.301 -170.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -32.8 85.39 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-N 118.414 0.552 . . . . 1.52 112.757 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.08 -22.84 62.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.357 1.063 . . . . 3.47 113.078 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.04 -49.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.111 -0.993 . . . . 1.49 109.923 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.79 88.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.544 -0.723 . . . . 1.4 112.657 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.49 66.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.361 1.245 . . . . 1.55 114.361 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.3 p -74.72 -44.82 48.01 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.296 -0.878 . . . . 1.53 111.544 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.01 -40.34 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 120.142 1.337 . . . . 1.35 110.93 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.97 -5.36 9.22 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 114.663 1.357 . . . . 2.01 114.663 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.1 m -96.41 -47.93 5.78 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.288 1.435 . . . . 1.97 110.087 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -65.21 -24.94 67.49 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.619 1.168 . . . . 2.91 113.301 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -55.78 -35.71 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.549 2.34 . . . . 4.77 113.9 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -59.4 -43.23 95.91 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 116.838 -1.553 . . . . 6.61 111.913 -172.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.61 -61.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.133 1.889 . . . . 2.38 110.519 161.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.24 74.24 3.97 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 122.795 1.283 . . . . 3.75 113.722 -169.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 127.375 2.27 . . . . 9.2 110.831 173.704 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 109.531 -1.428 . . . . 3.42 109.531 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.93 144.31 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.613 2.208 . . . . 2.48 112.968 -151.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -86.33 175.09 8.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.288 1.518 . . . . 2.29 114.092 -166.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -148.19 106.37 3.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.983 1.313 . . . . 3.24 108.607 165.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mp -148.57 165.17 32.05 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.682 1.593 . . . . 2.43 110.137 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.2 m -107.95 134.07 51.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.763 1.225 . . . . 1.6 111.904 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -73.61 160.27 31.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.494 1.118 . . . . 2.09 112.216 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -60.6 -20.01 59.4 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 121.508 -0.745 . . . . 1.61 112.486 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.2 m -78.43 -60.02 2.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.35 1.86 . . . . 3.26 109.822 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.85 -14.9 0.69 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 116.11 1.204 . . . . 2.34 116.11 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.2 133.67 44.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.829 1.815 . . . . 3.92 109.973 171.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -82.31 129.5 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.119 -1.067 . . . . 5.68 108.119 157.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -140.37 175.99 9.14 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.818 1.247 . . . . 3.57 112.806 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.6 p -140.77 172.45 12.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 128.583 2.753 . . . . 2.68 109.383 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.83 -25.03 62.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.128 0.788 . . . . 3.91 113.128 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -75.07 -11.59 60.13 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 119.938 -1.726 . . . . 7.5 113.979 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.73 -28.87 21.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.866 1.666 . . . . 4.19 111.636 164.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -108.58 -2.47 18.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.535 1.68 . . . . 3.72 115.535 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.9 mt -77.56 -176.64 4.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.9 1.227 . . . . 4.3 109.777 165.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.7 10.86 Favored Glycine 0 N--CA 1.48 1.573 0 O-C-N 120.889 -1.132 . . . . 2.53 114.991 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -126.18 168.88 13.44 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.048 2.939 . . . . 3.79 108.252 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.521 ' CD1' ' HD3' ' A' ' 269' ' ' PRO . 53.9 m95 -81.77 140.39 34.27 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.445 1.02 . . . . 2.42 109.807 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.498 HD12 ' HB ' ' A' ' 197' ' ' THR . 0.8 OUTLIER -123.6 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.203 -0.936 . . . . 2.97 112.438 177.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.17 100.63 10.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.935 -1.135 . . . . 3.58 107.935 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.2 mt -96.26 127.75 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.743 -0.836 . . . . 1.82 108.743 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -139.95 143.82 36.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.122 0.969 . . . . 2.44 111.94 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.81 127.21 53.51 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.674 1.19 . . . . 2.25 112.34 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -147.47 163.96 28.74 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.506 1.05 . . . . 1.34 112.654 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.95 -179.04 6.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 117.745 0.772 . . . . 3.1 111.313 168.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 174.89 5.67 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.963 -1.125 . . . . 3.49 107.963 152.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 73.92 -24.76 0.2 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.516 1.526 . . . . 7.01 113.921 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 83.6 m -52.42 159.69 1.54 Allowed Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 120.648 1.567 . . . . 2.88 113.293 161.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.54 -173.44 1.8 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.386 3.39 . . . . 3.99 111.474 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.44 -2.46 1.05 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.248 2.219 . . . . 6.34 115.904 -157.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.29 -60.41 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.362 1.465 . . . . 4.32 110.163 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 15.6 m -52.43 -44.02 93.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.372 -1.299 . . . . 3.08 114.212 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.63 -39.59 0.51 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.435 2.09 . . . . 1.88 113.774 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.41 -32.62 68.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 122.171 2.26 . . . . 4.33 112.086 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -60.11 -44.98 94.46 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.506 -1.371 . . . . 3.54 111.484 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.77 -39.46 91.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.02 0.928 . . . . 3.2 111.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -72.81 -25.98 61.34 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.417 -1.427 . . . . 6.77 114.06 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -56.03 -56.96 14.44 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.431 -1.418 . . . . 2.81 109.812 165.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 10.0 ptp -64.7 -30.9 71.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.013 -0.994 . . . . 3.71 113.093 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.2 mt -75.16 -48.34 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 121.773 2.079 . . . . 3.11 109.821 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.52 ' HB3' ' HZ1' ' A' ' 283' ' ' LYS . 3.5 mp0 -68.07 -16.63 64.1 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.252 1.387 . . . . 6.54 111.776 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.421 HG21 ' HB ' ' A' ' 286' ' ' ILE . 24.9 t -69.84 -30.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.95 1.25 . . . . 1.86 112.584 163.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.82 -46.03 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 121.061 1.755 . . . . 2.39 110.257 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.23 -37.35 77.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.332 1.053 . . . . 4.63 113.153 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -57.53 -46.1 84.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 3.56 111.721 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.8 mt -71.87 -33.3 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.711 1.204 . . . . 1.84 114.232 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.44 -29.47 61.69 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.429 1.892 . . . . 3.2 112.359 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.5 t -68.52 -14.67 63.16 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.471 -1.393 . . . . 3.05 113.562 170.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.43 45.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 127.069 2.147 . . . . 4.17 108.666 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.06 4.3 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.617 2.767 . . . . 6.4 116.252 -159.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 78.0 p -78.21 -24.33 47.1 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.94 -1.1 . . . . 4.66 112.382 166.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 194' ' ' PRO . 11.6 mt -56.33 142.63 67.74 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 118.72 0.691 . . . . 3.98 111.046 169.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 159' ' ' TRP . 1.7 Cg_endo -81.77 46.63 2.28 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.604 4.203 . . . . 5.07 112.233 -174.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 72.88 101.21 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.633 1.682 . . . . 5.63 112.725 145.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 84.76 4.99 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.387 1.475 . . . . 2.35 111.012 -160.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 160' ' ' LEU . 56.8 m -79.95 122.31 83.09 Favored Pre-proline 0 N--CA 1.478 0.94 0 O-C-N 120.84 -1.163 . . . . 1.43 112.094 -173.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.04 124.43 1.79 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.381 2.721 . . . . 1.08 111.97 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 tp -126.58 93.96 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.085 1.354 . . . . 2.59 110.327 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.77 115.39 14.3 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.94 -0.763 . . . . 2.14 108.94 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.94 112.51 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.793 1.237 . . . . 1.59 108.584 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -83.88 135.03 34.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.649 -1.16 . . . . 1.98 109.55 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.7 34.95 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.582 1.153 . . . . 1.71 112.657 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -121.55 44.49 0.79 Allowed Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 127.158 2.183 . . . . 3.71 111.97 -173.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -77.71 35.15 0.5 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.231 3.287 . . . . 2.16 113.811 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -91.34 -16.59 27.23 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.204 -0.426 . . . . 5.43 110.406 150.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.49 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.494 2.405 . . . . 7.59 117.494 -171.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -79.73 52.48 1.45 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.317 1.847 . . . . 4.03 114.619 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.1 m -55.5 129.79 40.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.388 1.075 . . . . 2.49 110.785 -167.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -41.62 -48.51 4.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.363 1.465 . . . . 3.0 113.922 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -26.07 43.98 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.993 1.109 . . . . 4.07 113.993 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.11 86.44 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 1.86 110.83 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.84 -30.76 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.351 1.06 . . . . 2.12 112.613 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.31 74.38 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.408 1.458 . . . . 1.43 113.09 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 -44.73 58.02 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.699 0.799 . . . . 3.13 111.201 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -55.9 -39.98 72.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.476 1.51 . . . . 3.93 111.517 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.401 HG21 ' HA3' ' A' ' 226' ' ' GLY . 45.0 t -65.15 -20.72 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.053 1.741 . . . . 1.38 113.583 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -111.69 -21.55 11.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.46 1.652 . . . . 8.54 115.46 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.73 -19.13 58.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.377 0.989 . . . . 3.9 113.044 168.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -74.14 -87.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.707 1.603 . . . . 3.78 110.147 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.2 t -148.61 132.1 8.33 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.646 -1.283 . . . . 2.73 110.121 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.07 -19.44 45.37 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.382 2.055 . . . . 3.27 114.663 -156.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -84.61 2.69 40.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.713 1.375 . . . . 2.78 114.713 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.2 tp -72.55 147.3 46.07 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.624 1.102 . . . . 1.96 113.083 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 2.3 p -118.31 130.97 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.668 1.587 . . . . 2.45 108.66 160.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.401 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -99.45 160.82 19.75 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 123.919 0.771 . . . . 1.27 111.909 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -153.36 114.04 4.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.497 -1.297 . . . . 3.92 107.497 -166.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.0 m -112.88 152.65 29.04 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.24 2.216 . . . . 2.54 107.877 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -144.51 146.29 16.6 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 121.819 -0.551 . . . . 2.97 112.71 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -63.51 154.3 32.84 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.057 0.928 . . . . 2.49 109.693 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.476 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -47.23 -33.25 5.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.929 1.292 . . . . 7.57 113.38 -170.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.44 -50.57 58.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.874 1.215 . . . . 5.27 112.411 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.62 -44.7 90.04 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.961 -1.087 . . . . 3.43 111.967 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 15.6 m -70.95 -22.32 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 113.844 1.053 . . . . 2.63 113.844 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.68 -53.09 37.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.847 1.203 . . . . 3.55 108.808 164.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -55.82 -57.82 10.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.361 -0.828 . . . . 3.66 112.378 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.97 -35.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 119.356 0.98 . . . . 2.12 113.323 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.42 67.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.063 0.945 . . . . 2.1 111.477 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -70.21 -26.49 63.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.626 1.57 . . . . 3.41 112.433 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.8 -62.89 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.695 1.198 . . . . 2.6 113.367 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -67.5 -33.78 75.79 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.038 -1.039 . . . . 3.15 112.735 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.259 2.2 ptp180 109.16 117.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 1 C-N-CA 132.411 4.284 . . . . 9.01 109.777 179.365 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.83 153.61 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.027 2.131 . . . . 4.08 110.473 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -119.53 135.98 54.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.73 0.412 . . . . 4.63 110.163 148.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -165.91 166.18 17.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.167 1.787 . . . . 4.2 111.323 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 48.9 p -113.16 165.8 12.46 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.46 1.504 . . . . 4.68 112.743 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.27 143.63 17.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.595 2.197 . . . . 4.43 111.046 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.747 0 CA-C-O 118.026 -1.43 . . . . 2.96 112.14 177.222 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 43.3 p90 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 116.504 2.038 . . . . 3.6 116.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt -138.84 163.93 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.711 2.004 . . . . 4.37 108.52 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.56 148.42 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.627 1.571 . . . . 3.3 109.108 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -86.28 135.19 33.64 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.312 -0.996 . . . . 4.03 108.312 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.62 139.85 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.59 1.156 . . . . 2.7 111.274 -169.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -68.42 -14.94 63.35 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.977 2.214 . . . . 3.8 116.977 -165.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 28.3 mt 50.8 56.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 120.169 1.349 . . . . 4.7 110.36 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.0 mt -112.31 147.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.128 1.371 . . . . 2.53 109.986 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.0 ttp -114.49 144.8 42.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.622 1.969 . . . . 4.25 109.856 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -107.14 136.26 47.29 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.242 -0.912 . . . . 2.54 110.874 163.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 39.2 tp -94.95 106.97 19.0 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.967 0.907 . . . . 2.17 108.85 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.3 mp -86.84 135.58 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.501 -1.666 . . . . 2.16 106.501 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.49 165.29 24.77 Favored Glycine 0 CA--C 1.539 1.593 0 N-CA-C 111.587 -0.605 . . . . 1.81 111.587 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.521 ' HD3' ' CD1' ' A' ' 159' ' ' TRP . 21.0 Cg_endo -67.5 9.92 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 125.181 3.921 . . . . 2.92 114.16 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -141.93 -1.03 1.27 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.904 2.482 . . . . 5.04 111.492 -167.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 163.34 156.56 8.71 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.105 0.859 . . . . 3.55 114.483 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -74.71 -22.05 59.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.08 1.352 . . . . 5.8 114.638 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.87 108.17 9.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.133 -0.979 . . . . 3.95 111.32 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 -36.76 4.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.572 1.149 . . . . 3.18 111.152 170.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -157.45 178.63 10.08 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.98 2.112 . . . . 2.3 110.479 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -155.26 138.3 15.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.311 1.444 . . . . 3.61 113.354 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.8 -151.35 0.39 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.166 1.387 . . . . 2.75 110.968 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.85 -127.05 7.92 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.849 2.166 . . . . 3.5 108.492 -171.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -53.44 156.25 2.55 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.078 1.351 . . . . 2.87 113.11 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.6 -40.84 0.39 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.772 2.429 . . . . 4.33 112.459 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -63.41 108.84 1.43 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.982 1.313 . . . . 4.71 112.709 -174.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.61 141.66 57.64 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.331 -0.856 . . . . 7.34 108.845 177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.52 ' HZ1' ' HB3' ' A' ' 182' ' ' GLN . 13.1 tmtt? -48.59 -53.57 17.9 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.205 -1.559 . . . . 2.62 114.449 -165.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.3 -14.41 71.56 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 115.707 1.043 . . . . 1.64 115.707 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.3 -38.87 82.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.033 1.417 . . . . 3.65 110.439 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ILE . . . . . 0.421 ' HB ' HG21 ' A' ' 183' ' ' VAL . 37.6 mt -60.7 -48.54 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.65 0.78 . . . . 1.48 109.259 174.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.73 77.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 119.121 -0.466 . . . . 1.27 111.858 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.79 90.39 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.712 1.004 . . . . 1.62 113.712 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 86.8 p -60.01 -48.59 81.07 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.581 -0.699 . . . . 1.62 111.795 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.13 -31.69 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.658 -1.276 . . . . 1.37 111.368 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.0 64.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.957 0.903 . . . . 1.78 113.093 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.6 m -70.71 -46.09 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.539 -0.726 . . . . 2.26 109.597 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -69.72 -27.89 65.35 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.844 1.053 . . . . 2.56 113.844 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.7 ttt -59.98 -40.17 88.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.413 1.485 . . . . 4.24 112.167 166.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.07 36.78 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 117.36 -1.305 . . . . 5.3 113.348 -173.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.53 -57.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.408 2.739 . . . . 3.01 112.379 158.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.67 28.61 8.51 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.439 1.644 . . . . 4.1 115.439 -154.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 126.667 1.987 . . . . 8.14 114.612 165.117 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.617 0 CA-C-O 118.548 -1.14 . . . . 2.35 112.307 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.65 174.77 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.127 3.218 . . . . 3.35 112.171 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.76 173.38 15.36 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.973 1.709 . . . . 2.88 109.843 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.71 32.21 4.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.618 0.97 . . . . 3.68 113.618 172.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.3 mt -51.72 149.3 4.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 3.02 112.563 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -108.38 142.35 38.85 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.396 1.078 . . . . 1.37 109.731 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.3 t -91.32 165.09 13.61 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.295 1.038 . . . . 2.43 113.245 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -61.2 -25.37 67.0 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 2.24 114.124 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -83.12 0.93 42.89 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.249 1.82 . . . . 3.09 114.178 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.94 -6.37 73.04 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.227 1.394 . . . . 2.02 115.555 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -73.63 132.95 43.32 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.347 1.073 . . . . 4.08 111.293 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -82.52 105.3 13.46 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.092 -1.005 . . . . 4.44 108.494 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -179.1 4.3 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.976 1.31 . . . . 2.94 113.614 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 62.3 p -146.54 166.16 27.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.035 2.534 . . . . 2.37 109.005 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.31 -38.17 76.55 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.449 0.568 . . . . 4.08 112.343 173.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -81.78 4.25 22.8 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.89 1.441 . . . . 6.93 114.89 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.81 -41.33 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.622 0.769 . . . . 3.46 109.828 160.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -84.5 -29.19 26.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.756 1.391 . . . . 3.33 114.756 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.89 101.96 0.43 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.781 1.232 . . . . 4.09 110.23 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 144.2 -20.97 2.09 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.643 1.116 . . . . 2.79 113.48 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.67 170.45 7.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.876 -0.787 . . . . 3.52 108.876 152.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -82.42 127.4 33.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.478 0.581 . . . . 2.12 109.856 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.48 145.94 44.88 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.636 0.653 . . . . 3.36 112.506 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.1 mt -107.19 121.61 44.87 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.09 1.356 . . . . 2.53 108.01 158.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.5 118.66 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.267 0.627 . . . . 2.11 109.626 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -122.9 149.88 43.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.305 1.442 . . . . 2.45 114.015 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -99.19 120.54 39.69 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 2.5 112.524 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.96 155.71 15.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.515 1.055 . . . . 1.57 113.791 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -114.08 -43.75 3.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.362 1.065 . . . . 2.93 111.865 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.5 m 67.71 -18.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 126.453 1.901 . . . . 4.0 114.835 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -71.93 -18.86 61.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.319 1.048 . . . . 7.22 111.326 160.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.54 164.38 58.33 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.768 1.227 . . . . 2.48 111.741 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -78.82 -146.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.433 2.755 . . . . 3.73 109.387 164.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.53 57.72 0.13 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.872 3.269 . . . . 5.59 113.348 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.5 t -115.24 -84.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 126.849 2.06 . . . . 3.65 108.073 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -47.59 98.34 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 117.062 -1.447 . . . . 1.87 113.761 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.46 -23.57 43.67 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.029 1.82 . . . . 1.54 114.219 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.78 -56.55 14.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.82 0.848 . . . . 4.19 109.961 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -60.75 -39.89 90.4 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 2.83 112.129 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.452 HD22 ' CG ' ' A' ' 220' ' ' PHE . 5.1 tt -55.58 -39.58 70.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.82 1.248 . . . . 2.72 112.036 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . 0.263 0.3 OUTLIER -75.77 -34.02 60.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.144 0.884 . . . . 3.03 112.305 175.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -55.65 -46.12 77.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.283 -1.511 . . . . 4.78 111.643 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.4 ptp -67.89 -28.53 67.59 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.728 0.64 . . . . 2.67 112.728 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.23 -38.09 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.295 -0.878 . . . . 1.79 111.018 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.446 ' OE1' ' HE3' ' A' ' 283' ' ' LYS . 73.9 mt-30 -62.57 -40.43 96.85 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.297 -0.859 . . . . 3.15 111.931 171.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . 0.259 4.4 m -72.31 -28.93 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.218 1.372 . . . . 2.98 113.243 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.2 t -63.07 -52.83 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.793 1.179 . . . . 2.07 111.717 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -74.92 -19.97 59.9 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.155 0.798 . . . . 5.18 113.155 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -64.93 -55.59 18.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.596 0.758 . . . . 3.28 111.241 164.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.25 -37.37 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.111 1.365 . . . . 2.15 112.902 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.51 -35.56 65.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.49 1.516 . . . . 3.21 112.205 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.9 t -72.34 -18.2 61.78 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.931 1.085 . . . . 3.25 113.931 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.43 HG22 HG22 ' A' ' 192' ' ' THR . 11.8 mt -94.36 75.38 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.357 1.463 . . . . 3.68 107.795 -175.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -3.55 0.06 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 128.111 2.565 . . . . 4.66 116.623 -162.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.43 HG22 HG22 ' A' ' 190' ' ' ILE . 15.1 t -71.59 -22.44 61.73 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.378 1.871 . . . . 6.18 113.071 167.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.4 151.74 59.75 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.434 1.016 . . . . 3.98 111.195 166.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 -40.11 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.074 2.516 . . . . 3.23 110.779 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -172.74 -179.89 2.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.235 2.614 . . . . 4.48 109.331 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.0 tp -149.27 73.26 1.19 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.799 1.24 . . . . 1.92 109.948 160.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -63.03 119.96 56.82 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 121.077 -1.015 . . . . 1.33 110.717 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.93 128.37 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.29 1.993 . . . . 1.15 110.459 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.6 tp -115.81 115.36 26.15 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.663 1.585 . . . . 2.78 110.735 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -87.24 126.52 34.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.174 0.99 . . . . 2.45 109.884 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.79 119.53 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.429 -0.952 . . . . 1.27 108.429 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.8 t -79.1 139.49 38.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.956 -0.565 . . . . 2.0 111.632 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -124.19 21.76 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.916 1.286 . . . . 1.86 113.119 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -111.52 61.66 0.5 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.803 1.241 . . . . 3.56 113.647 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.17 73.17 5.6 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.18 2.587 . . . . 2.41 110.255 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -153.32 -37.15 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.101 1.36 . . . . 5.42 112.555 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.09 7.36 0.91 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.081 1.141 . . . . 4.98 114.081 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 177.73 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.987 -0.445 . . . . 3.46 110.828 157.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 32.8 m -155.95 136.9 13.57 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.025 -1.047 . . . . 2.42 108.181 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.448 ' HZ3' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -51.76 -44.86 63.5 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.013 0.925 . . . . 3.9 112.216 177.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLU . . . . . 0.448 ' CD ' ' HZ3' ' A' ' 210' ' ' LYS . 17.7 mp0 -60.35 -40.24 90.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.083 1.753 . . . . 3.57 112.776 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.98 69.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.227 -0.921 . . . . 1.6 112.346 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.61 -43.24 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.919 0.888 . . . . 2.01 110.654 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.56 66.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.219 1.008 . . . . 1.28 112.484 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 0.7 OUTLIER -71.21 -46.79 60.43 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.19 0.996 . . . . 3.48 112.331 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.79 -37.11 86.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.467 1.507 . . . . 4.17 111.422 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -50.64 -44.9 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.877 2.071 . . . . 1.2 112.987 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 7.7 mtmp? -55.23 -45.53 75.97 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.662 0.664 . . . . 4.18 112.386 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -20.46 60.12 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 124.363 1.04 . . . . 5.16 112.211 -163.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' PHE . . . . . 0.452 ' CG ' HD22 ' A' ' 177' ' ' LEU . 68.9 m-85 -86.16 -48.24 8.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.012 0.925 . . . . 2.39 111.993 168.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 87.8 p -174.04 127.89 0.46 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.753 -1.118 . . . . 2.62 110.902 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.15 76.59 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.661 2.907 . . . . 3.17 109.244 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 178.18 -28.27 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.996 2.919 . . . . 2.3 111.005 -163.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.451 ' CD1' HD21 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -67.93 143.96 55.43 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.917 1.687 . . . . 2.29 110.722 164.175 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.72 133.97 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.378 1.471 . . . . 2.39 109.797 170.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.51 115.66 3.58 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 123.841 0.734 . . . . 1.07 112.181 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.87 148.67 27.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.365 1.066 . . . . 2.51 111.455 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 71.9 p -136.59 161.61 35.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.986 1.314 . . . . 2.23 110.635 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.6 23.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 124.659 1.123 . . . . 2.88 110.372 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.6 t -60.57 166.53 3.13 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.507 1.123 . . . . 3.23 111.293 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -38.36 7.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.306 1.042 . . . . 6.62 112.528 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.5 mp0 -67.15 -42.03 85.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.408 2.283 . . . . 3.75 111.751 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -71.16 -34.37 70.91 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.036 -1.04 . . . . 4.09 111.667 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.71 -38.89 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 118.363 -0.827 . . . . 2.5 109.669 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -70.66 -41.85 71.55 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.859 -1.067 . . . . 3.43 111.748 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -54.51 -50.04 68.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.293 1.861 . . . . 2.5 110.752 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.44 -55.13 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.715 0.806 . . . . 2.26 111.821 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.86 62.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.959 0.904 . . . . 1.69 113.439 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -87.86 -30.26 20.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.675 1.59 . . . . 4.34 112.305 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.24 13.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.109 1.322 . . . . 1.68 111.206 168.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -76.96 -14.42 59.85 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.603 0.964 . . . . 3.41 113.603 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 76.77 62.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.112 2.165 . . . . 5.28 112.881 159.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.86 145.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.341 1.457 . . . . 3.68 111.979 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.74 135.88 40.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.02 0.914 . . . . 3.7 113.033 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -145.64 136.36 24.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.881 2.872 . . . . 5.68 108.077 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.3 t -121.25 105.08 39.99 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.097 0.959 . . . . 2.89 109.921 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.72 101.32 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.505 2.137 . . . . 3.13 108.845 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 CA-C-O 119.617 -0.546 . . . . 2.28 113.052 -177.509 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 28.4 p90 . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 122.331 1.063 . . . . 3.8 112.169 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.75 162.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.193 1.397 . . . . 2.62 109.019 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 t -128.18 137.68 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.791 2.037 . . . . 3.34 108.374 -169.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.96 119.2 21.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 107.049 -1.463 . . . . 4.51 107.049 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.17 131.6 54.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.747 -0.834 . . . . 2.02 108.747 168.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 56.7 m -53.24 -47.82 68.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.718 0.807 . . . . 3.6 112.566 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.5 mt 82.6 98.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.169 2.588 . . . . 3.8 108.339 -172.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.42 146.26 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.4 1.48 . . . . 3.17 107.146 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.1 ttm -119.47 128.54 54.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.794 1.638 . . . . 2.57 108.516 159.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -98.08 139.62 33.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.74 -0.6 . . . . 3.6 111.109 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.78 113.98 26.32 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.671 -1.233 . . . . 2.28 107.671 169.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 tp -106.28 125.84 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.922 -1.14 . . . . 4.15 107.922 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.49 165.21 48.01 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.604 -0.599 . . . . 1.66 111.604 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.34 48.64 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.507 3.471 . . . . 2.8 110.49 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -165.96 -50.51 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.077 1.751 . . . . 4.47 110.209 -156.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 151.49 -178.29 28.91 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 115.772 1.069 . . . . 3.21 115.772 166.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 50.33 -132.15 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.987 2.115 . . . . 4.72 114.225 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.36 131.49 54.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.147 0.979 . . . . 4.27 109.333 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.0 -29.18 23.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.056 0.943 . . . . 2.97 110.591 169.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -162.4 158.81 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.105 2.162 . . . . 2.21 109.428 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -134.59 99.28 4.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.021 1.391 . . . . 3.8 111.04 -170.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -95.53 110.96 22.96 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.177 -0.952 . . . . 2.62 110.1 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -75.34 -165.13 15.13 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.12 -1.192 . . . . 3.29 110.12 163.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -74.62 -26.19 59.73 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.749 -1.442 . . . . 3.54 112.309 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -46.96 -41.78 16.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 128.231 2.612 . . . . 6.34 117.479 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 151.57 33.76 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.051 1.741 . . . . 8.26 113.548 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.711 -1.243 . . . . 6.23 109.331 159.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.446 ' HE3' ' OE1' ' A' ' 182' ' ' GLN . 13.5 tmtt? -65.37 -44.72 86.73 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.709 -1.244 . . . . 1.91 113.672 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.55 -30.43 76.53 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 123.278 0.466 . . . . 1.72 112.398 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -63.66 -24.55 67.83 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.007 1.323 . . . . 2.84 113.489 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 13.8 mt -79.89 -30.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.901 1.228 . . . . 1.36 111.341 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.9 72.5 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.951 -1.093 . . . . 1.14 110.552 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.44 83.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.02 1.118 . . . . 1.43 114.02 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 70.9 p -63.57 -49.28 74.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.131 0.878 . . . . 1.32 111.137 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.91 -36.62 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.016 -1.052 . . . . 1.23 111.508 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.21 -6.18 4.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.721 1.209 . . . . 1.89 114.203 168.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 40.0 m -101.88 -44.38 5.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.843 1.657 . . . . 1.67 110.472 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -63.38 -28.23 69.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.636 1.174 . . . . 2.91 113.166 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -48.82 -40.84 30.8 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 125.988 1.715 . . . . 5.12 111.506 165.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -60.91 -40.44 74.52 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.414 -1.755 . . . . 6.1 112.829 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.6 -58.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.947 2.431 . . . . 1.87 113.525 163.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -83.78 8.86 13.4 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.81 1.781 . . . . 2.84 115.81 -165.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.806 0 C-N-CA 126.734 2.014 . . . . 8.28 114.314 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-O 117.841 -1.533 . . . . 2.31 110.357 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.91 142.78 35.58 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.682 2.255 . . . . 2.88 111.435 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -93.87 168.13 11.18 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.595 -1.184 . . . . 2.41 111.663 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.6 m -140.6 78.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.109 1.364 . . . . 2.45 110.012 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.56 147.5 40.64 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.38 0.672 . . . . 1.92 111.234 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -75.91 131.84 39.9 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.291 2.236 . . . . 1.42 110.183 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.9 p -92.61 160.97 14.77 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.033 1.333 . . . . 1.93 112.162 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -64.91 -6.62 8.77 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.332 1.453 . . . . 1.38 114.638 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.2 m -66.75 -60.62 2.52 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.625 1.17 . . . . 2.87 109.093 162.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 160.13 0.48 0.07 OUTLIER Glycine 0 CA--C 1.534 1.255 0 N-CA-C 116.446 1.338 . . . . 2.55 116.446 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.34 165.48 33.93 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.751 1.775 . . . . 4.67 113.567 -170.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.72 120.78 25.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.819 2.448 . . . . 4.53 113.79 -167.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -99.63 171.58 7.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.228 1.411 . . . . 5.1 111.324 165.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.6 p -130.16 157.3 42.81 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.27 1.428 . . . . 2.16 110.176 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.6 -41.96 43.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.269 1.428 . . . . 3.54 111.455 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.56 -26.4 63.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.648 1.579 . . . . 8.16 113.765 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -80.06 -33.09 39.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.169 1.349 . . . . 3.01 112.193 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.72 -23.17 58.55 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.79 0.663 . . . . 2.94 112.79 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.63 131.69 51.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.852 1.261 . . . . 3.53 111.048 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 108.72 -25.42 19.25 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.522 1.534 . . . . 2.56 112.726 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -88.23 -152.47 0.22 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.575 1.55 . . . . 3.73 108.726 165.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.8 157.56 44.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.307 1.043 . . . . 2.28 110.659 163.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.14 152.96 28.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.915 0.864 . . . . 2.37 113.011 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.8 pp -106.52 155.15 19.9 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.825 1.25 . . . . 3.81 107.853 165.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.75 123.23 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.439 -0.949 . . . . 1.76 108.439 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -123.05 154.3 38.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.719 1.208 . . . . 2.9 111.677 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -108.84 116.7 32.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.845 0.858 . . . . 2.12 109.601 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.74 162.43 33.26 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.923 1.249 . . . . 2.48 113.585 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.08 -44.97 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 115.947 -1.978 . . . . 4.09 114.759 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t 136.95 177.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 131.426 3.89 . . . . 5.22 110.118 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 77.46 -15.27 0.76 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 127.841 2.456 . . . . 7.2 112.958 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.3 p -51.36 155.59 2.41 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 125.321 1.448 . . . . 2.52 112.179 155.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.88 74.44 5.52 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.642 2.894 . . . . 4.0 109.75 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 69.25 -7.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.665 2.386 . . . . 4.15 114.628 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 95.6 t -46.57 -55.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.854 2.462 . . . . 2.9 113.485 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.99 -67.49 0.52 Allowed Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 118.051 -0.976 . . . . 1.78 111.367 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.72 -40.63 21.63 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.944 1.763 . . . . 1.51 113.938 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -58.22 -43.33 87.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.869 1.213 . . . . 3.15 111.686 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -84.6 -34.46 23.14 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.232 -0.918 . . . . 3.18 112.931 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.6 -35.62 80.13 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.293 1.406 . . . . 3.65 112.082 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -47.73 -51.01 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.449 1.1 . . . . 3.35 111.226 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -60.88 -38.32 85.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.053 -1.029 . . . . 2.89 111.789 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -70.13 -41.47 73.87 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.386 -0.821 . . . . 5.08 112.702 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.47 -53.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.722 1.146 . . . . 1.66 109.048 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -55.65 -13.79 1.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.285 1.434 . . . . 4.07 114.573 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 t -97.99 -46.77 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.088 2.155 . . . . 2.0 112.942 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 21.3 m -62.25 -25.53 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.426 1.466 . . . . 3.52 112.311 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -70.88 -22.16 62.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.318 0.647 . . . . 4.13 112.68 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -79.71 -19.66 48.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.066 1.347 . . . . 2.56 111.789 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 43.3 mm -81.36 -58.97 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 1.8 109.746 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -32.86 74.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.15 1.78 . . . . 3.45 113.544 -170.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 t -69.49 -20.18 63.73 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.898 1.279 . . . . 3.24 112.87 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.2 mm -91.84 89.24 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.589 -1.319 . . . . 4.05 108.352 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.5 p -60.74 69.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.353 2.261 . . . . 5.52 113.76 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 175.73 -29.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.527 2.731 . . . . 4.26 111.777 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.15 159.07 68.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.605 0.762 . . . . 3.36 110.824 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.25 160.16 17.64 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.299 2.666 . . . . 3.29 109.486 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.0 134.76 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.167 0.508 . . . . 3.89 111.652 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -95.87 95.71 8.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.027 -1.471 . . . . 2.66 107.027 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 m -68.56 124.59 90.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 108.549 -0.908 . . . . 1.46 108.549 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.07 118.15 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.486 2.124 . . . . 0.89 110.476 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.79 121.08 43.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.273 1.429 . . . . 2.27 110.487 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.12 112.38 19.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.571 1.148 . . . . 3.15 110.216 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.67 110.11 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.045 1.338 . . . . 1.46 110.505 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 m -90.0 96.03 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.132 -0.98 . . . . 2.55 111.581 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.03 -2.77 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 116.359 1.985 . . . . 2.21 116.359 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -117.9 60.84 3.63 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 119.929 1.241 . . . . 4.13 110.572 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.1 149.25 40.95 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.178 2.585 . . . . 2.19 109.506 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 114.13 -43.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 129.682 3.193 . . . . 5.2 108.974 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -35.77 36.67 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.1 -0.375 . . . . 6.2 111.895 160.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.18 151.06 20.82 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.685 1.194 . . . . 4.59 110.964 167.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.4 p -132.42 154.76 49.52 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 124.819 1.248 . . . . 3.03 109.28 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -48.42 -43.24 34.06 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.561 1.144 . . . . 3.14 112.032 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -81.0 -26.07 36.76 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.082 1.141 . . . . 3.27 114.082 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.86 68.84 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.249 0.932 . . . . 1.53 110.266 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.5 mm -65.41 -36.08 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 117.706 -1.14 . . . . 1.96 110.816 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.2 66.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.784 1.629 . . . . 1.35 113.148 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -73.2 -49.53 27.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.378 0.671 . . . . 3.28 112.339 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.33 -41.04 65.33 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.94 -1.1 . . . . 2.92 112.088 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.485 HG21 ' HA3' ' A' ' 226' ' ' GLY . 25.5 t -62.96 -50.92 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.262 1.825 . . . . 1.82 112.294 172.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -59.34 -40.44 86.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.087 0.955 . . . . 3.97 111.248 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -33.22 71.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.481 1.512 . . . . 4.66 112.25 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.88 -13.21 61.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.049 1.129 . . . . 3.46 114.049 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.6 p 139.92 149.57 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 130.744 3.618 . . . . 2.53 111.816 168.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.26 5.65 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.36 2.706 . . . . 1.75 113.865 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.63 -24.74 23.85 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.769 1.168 . . . . 1.89 112.784 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.4 146.31 32.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.399 -1.438 . . . . 2.04 112.765 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.5 127.09 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.17 0.588 . . . . 2.13 111.862 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -99.68 129.94 10.06 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.81 110.813 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.2 113.62 26.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.264 -1.384 . . . . 1.96 107.264 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.4 m -141.15 68.84 1.34 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.633 1.573 . . . . 3.28 108.633 -164.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -91.15 -174.06 43.67 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.741 1.163 . . . . 1.73 112.405 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -75.79 163.32 27.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.918 1.287 . . . . 2.5 112.418 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.5 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 36.9 ttm180 -43.02 -31.58 0.55 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.255 2.622 . . . . 5.73 114.433 173.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -77.14 -38.02 52.76 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.957 1.303 . . . . 4.26 113.311 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.33 -45.99 85.45 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.102 -0.999 . . . . 3.97 109.145 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.5 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 19.5 m -70.16 -18.51 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.247 1.203 . . . . 2.84 114.247 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.14 -40.86 71.11 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.055 -1.028 . . . . 3.57 112.178 168.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -61.96 -50.86 70.44 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.883 -0.511 . . . . 2.65 111.565 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 234' ' ' VAL . 3.1 p -66.38 -24.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 120.359 -0.536 . . . . 1.85 112.195 -176.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.39 67.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.441 1.096 . . . . 2.41 112.025 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -36.7 63.82 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.47 0.915 . . . . 3.48 113.47 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.55 -26.51 65.45 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.972 1.471 . . . . 1.67 114.972 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.96 10.27 1.75 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.244 1.572 . . . . 3.01 115.244 -168.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 74.39 -58.68 0.58 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.252 2.621 . . . . 5.42 110.765 -165.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 55.8 t 63.58 -64.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 128.143 2.577 . . . . 3.56 111.185 -165.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 30.7 t80 58.38 62.11 2.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.572 1.549 . . . . 5.35 113.251 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -68.13 148.53 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.319 -0.863 . . . . 3.71 111.234 165.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 m -107.25 98.38 22.48 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 121.464 -0.772 . . . . 3.64 109.862 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -80.57 113.24 2.82 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.039 1.826 . . . . 2.59 112.172 -171.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.503 0 N-CA-C 111.345 -0.702 . . . . 2.4 111.345 167.771 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.7 t80 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 107.786 -1.191 . . . . 3.41 107.786 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.303 0.2 OUTLIER -81.5 58.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.569 -1.332 . . . . 2.97 113.074 -158.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.76 130.5 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.281 1.432 . . . . 3.2 110.693 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.71 155.67 16.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.837 2.055 . . . . 3.61 112.482 169.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -131.98 81.56 1.97 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.086 0.954 . . . . 2.26 112.796 164.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -73.32 95.74 2.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.252 1.421 . . . . 4.59 111.826 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 158.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 116.062 1.875 . . . . 6.35 116.062 -174.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.4 tt -95.78 156.24 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 128.107 2.563 . . . . 3.91 109.761 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 35.8 ttm -96.99 145.82 25.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.785 1.234 . . . . 2.34 110.39 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -113.68 144.65 42.57 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.707 1.203 . . . . 3.8 112.275 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 13.6 tp -110.05 128.02 55.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.647 1.179 . . . . 2.09 108.689 165.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.89 143.04 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.557 -1.275 . . . . 1.77 107.557 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -108.56 176.31 20.05 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.142 0.877 . . . . 1.58 112.481 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 66.93 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.917 3.745 . . . . 2.58 109.053 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -160.22 -56.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.502 1.521 . . . . 4.27 110.487 -161.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 153.79 -134.4 4.34 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.504 0.573 . . . . 2.48 113.529 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.03 -39.76 69.49 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.849 1.426 . . . . 4.56 114.849 -150.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.4 p90 179.91 150.07 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.757 2.423 . . . . 5.05 109.225 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.91 -21.87 13.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.074 1.35 . . . . 3.59 111.505 164.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -152.46 163.16 40.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 2.6 112.234 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -158.12 131.86 7.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.727 2.011 . . . . 5.68 110.609 172.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.87 154.94 30.61 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.14 -0.975 . . . . 3.14 112.286 -171.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.66 163.17 40.21 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 122.114 0.841 . . . . 2.96 112.762 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -68.23 114.11 6.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.827 -1.546 . . . . 4.99 106.827 150.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 155.76 -14.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 129.619 3.168 . . . . 5.08 113.341 -165.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -90.41 130.94 36.43 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.966 -1.084 . . . . 4.69 113.118 -171.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -72.61 122.72 21.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.771 1.228 . . . . 6.91 108.338 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.61 -55.24 1.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.531 2.049 . . . . 2.33 116.531 -155.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -60.58 -17.16 47.61 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.427 1.013 . . . . 1.32 114.918 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.18 -30.0 70.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.479 1.14 . . . . 3.48 112.644 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.5 mt -82.76 -41.8 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.982 0.913 . . . . 1.23 108.947 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.1 -41.32 64.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.39 0.541 . . . . 1.19 112.093 168.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.49 -43.45 94.1 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.145 1.165 . . . . 1.56 114.145 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.8 p -68.53 -41.84 79.3 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.29 1.405 . . . . 1.73 111.582 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 38.2 mt -56.39 -52.39 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.374 0.988 . . . . 1.55 110.829 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.81 65.15 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.235 0.828 . . . . 1.98 113.235 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 88.7 m -70.84 -48.23 55.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.98 1.312 . . . . 1.96 110.75 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -67.16 -29.38 69.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.425 1.011 . . . . 2.57 113.434 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -19.8 63.06 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.465 1.506 . . . . 6.47 114.135 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -71.79 -45.45 12.25 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.499 -1.715 . . . . 6.08 114.157 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.45 -58.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.373 2.715 . . . . 2.12 111.722 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -85.86 119.94 26.72 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.364 -0.835 . . . . 2.98 110.916 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 N--CA 1.472 0.648 0 C-N-CA 127.625 2.37 . . . . 10.94 112.904 163.484 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 N-CA-C 112.929 -0.069 . . . . 2.26 112.929 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.05 159.45 53.87 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.774 2.983 . . . . 2.51 111.762 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -138.98 172.04 13.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.875 1.27 . . . . 2.36 110.779 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 p -141.12 18.94 2.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.506 1.669 . . . . 2.58 115.506 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.83 154.89 41.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.933 1.349 . . . . 1.92 114.396 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.9 m -91.68 147.2 23.17 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.628 1.171 . . . . 1.51 109.149 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.8 p -78.89 156.11 28.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.087 1.355 . . . . 2.55 112.549 -173.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -50.68 -25.7 4.59 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 113.906 -1.497 . . . . 2.08 113.427 162.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.0 m -72.97 -64.78 0.9 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.207 1.803 . . . . 3.24 109.513 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.01 55.0 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.488 1.518 . . . . 2.78 112.645 -169.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.22 144.84 9.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.803 2.041 . . . . 3.7 108.335 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -89.85 126.11 35.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.706 1.139 . . . . 4.93 112.047 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -112.68 162.94 15.14 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.473 -1.392 . . . . 3.1 112.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.6 p -136.04 -179.21 5.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.648 1.979 . . . . 2.59 109.784 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -68.54 -22.21 64.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.218 1.007 . . . . 4.38 112.668 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -32.2 66.95 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.865 1.061 . . . . 5.27 113.865 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.14 -37.95 84.69 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.926 1.29 . . . . 3.19 111.435 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -107.84 20.99 18.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.557 1.543 . . . . 3.66 114.284 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -80.46 167.58 19.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.379 -0.826 . . . . 3.23 110.59 167.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.89 14.21 75.74 Favored Glycine 0 N--CA 1.478 1.499 0 O-C-N 120.663 -1.273 . . . . 2.75 114.348 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -162.17 151.52 15.84 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.675 2.79 . . . . 2.81 106.743 -172.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -71.76 129.57 38.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.932 1.242 . . . . 1.67 111.647 -173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.57 133.52 53.78 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.525 1.13 . . . . 2.69 110.911 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.24 126.42 53.58 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.86 1.264 . . . . 2.7 108.415 165.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.9 mt -120.35 119.39 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.479 -0.934 . . . . 1.96 108.479 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -113.29 141.36 47.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 3.22 111.559 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -108.32 126.76 53.21 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.981 0.912 . . . . 2.21 111.802 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.486 ' HA3' ' SG ' ' A' ' 173' ' ' CYS . . . -169.95 -179.77 41.79 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.319 1.438 . . . . 1.33 113.605 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.76 137.91 26.8 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.014 1.407 . . . . 3.74 112.333 -177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.8 t -74.97 70.6 2.01 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.761 1.267 . . . . 3.43 112.249 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.4 -31.25 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.107 0.963 . . . . 7.6 111.138 -149.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 14.1 m -47.9 143.13 6.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.732 1.213 . . . . 2.06 112.316 161.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.88 -59.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.971 2.448 . . . . 3.96 109.999 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.15 137.99 21.23 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.426 -0.953 . . . . 5.37 108.426 136.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.4 t -162.21 -55.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.553 3.141 . . . . 3.14 107.283 169.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.486 ' SG ' ' HA3' ' A' ' 165' ' ' GLY . 1.7 m -57.3 -65.31 1.83 Allowed Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.775 1.63 . . . . 1.61 113.237 173.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 173' ' ' CYS . 51.3 Cg_exo -53.64 -44.97 44.48 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.957 2.438 . . . . 1.86 114.73 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -47.98 -46.11 32.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.067 1.747 . . . . 3.75 112.067 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 281' ' ' LYS . 1.2 mm-40 -77.5 -40.3 43.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.791 1.178 . . . . 2.64 112.829 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.7 76.6 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.063 -1.023 . . . . 2.86 111.997 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.07 -59.6 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.618 1.967 . . . . 3.38 110.223 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -62.84 -37.61 87.48 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.541 -1.349 . . . . 4.79 111.346 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.66 -27.28 64.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.493 1.117 . . . . 4.22 113.642 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.8 mm -69.05 -55.58 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 120.005 1.275 . . . . 2.14 109.972 171.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -68.29 -17.99 64.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.771 1.623 . . . . 4.85 111.724 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.53 -44.59 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.553 1.07 . . . . 1.57 111.007 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.31 -27.19 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 121.081 1.764 . . . . 2.46 112.88 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.74 -48.3 55.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.952 1.701 . . . . 4.42 113.278 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.73 -32.89 72.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.329 -0.857 . . . . 3.37 112.341 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.83 -50.39 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.931 0.892 . . . . 2.26 111.424 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.38 -22.71 57.29 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.672 1.124 . . . . 5.59 112.747 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.3 m -65.08 -11.45 39.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.287 -0.883 . . . . 3.24 113.268 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.95 -20.23 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 4.17 111.179 164.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.295 70.3 p 128.77 -11.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 1 C-N-CA 132.475 4.31 . . . . 6.32 115.337 152.585 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 t -178.77 71.4 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.065 1.346 . . . . 3.98 112.042 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.97 158.71 52.78 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 121.181 -0.949 . . . . 3.5 111.628 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.86 -9.85 18.2 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.789 2.326 . . . . 3.41 111.912 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . 0.269 17.5 t0 100.81 152.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 130.398 3.479 . . . . 4.21 114.058 162.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 134.12 55.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.175 1.79 . . . . 2.01 112.074 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.7 m -110.42 121.36 41.59 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.946 1.298 . . . . 1.28 109.796 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -89.3 126.43 1.6 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.941 3.094 . . . . 0.94 110.74 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.3 106.29 12.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.519 1.928 . . . . 2.53 110.783 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 115.24 26.17 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.51 -0.744 . . . . 2.88 109.681 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -89.61 112.21 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.198 0.999 . . . . 1.78 109.502 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 6.2 t -71.25 122.23 19.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.755 -0.657 . . . . 1.77 109.908 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.0 pt -106.79 48.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.806 1.642 . . . . 2.24 109.662 162.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -104.54 31.41 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.258 1.823 . . . . 4.27 113.39 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.63 -17.89 56.94 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 124.331 3.354 . . . . 2.62 114.234 -162.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -62.81 -23.95 67.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.944 1.298 . . . . 5.55 113.331 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.0 8.91 0.66 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 116.209 1.929 . . . . 6.76 116.209 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -42.11 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.881 3.272 . . . . 4.64 115.462 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.3 m -88.83 125.51 34.94 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 120.801 -1.187 . . . . 2.46 108.761 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -41.09 65.71 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.835 0.854 . . . . 4.2 113.176 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -73.76 -43.03 60.21 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-O 117.306 -1.33 . . . . 5.75 112.699 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.25 60.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.4 1.909 . . . . 1.69 112.621 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.08 -32.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 118.465 -0.779 . . . . 2.4 112.4 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.64 88.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.473 1.488 . . . . 1.36 111.352 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.93 -54.64 44.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.747 1.619 . . . . 3.8 108.698 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -47.88 -48.44 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.307 0.958 . . . . 3.27 112.9 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.9 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.072 0.851 . . . . 1.23 111.847 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -19.79 63.26 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.293 1.22 . . . . 5.23 114.293 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -69.69 -24.66 63.62 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.347 0.976 . . . . 3.68 112.171 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -89.46 -72.8 0.54 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 2.85 112.571 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 85.8 p -173.51 153.26 2.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 120.711 -1.243 . . . . 2.03 112.869 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.62 -1.68 11.41 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.167 2.578 . . . . 2.09 114.518 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -95.2 2.4 54.95 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.096 1.316 . . . . 2.19 112.573 170.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.0 tp -89.73 139.74 30.27 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.715 -1.241 . . . . 2.0 110.424 173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.29 136.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.512 1.125 . . . . 3.02 108.814 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.73 150.79 18.24 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 124.187 0.898 . . . . 1.24 110.996 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.0 155.98 35.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.987 1.315 . . . . 2.27 110.491 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.6 p -129.1 169.71 14.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.615 2.366 . . . . 2.46 109.484 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.96 148.47 14.23 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 115.879 1.112 . . . . 2.14 115.879 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -62.47 143.29 57.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.662 -0.769 . . . . 2.07 109.395 162.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.31 -21.85 66.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.194 1.183 . . . . 7.39 114.194 -161.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.4 mp0 -65.24 -45.36 84.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.645 1.578 . . . . 2.67 111.133 170.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -81.81 -33.9 30.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.905 1.282 . . . . 3.41 111.71 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.05 -36.77 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 118.605 -0.712 . . . . 1.91 111.179 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.38 -45.95 88.7 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.667 -1.158 . . . . 2.91 109.765 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -50.36 -54.21 23.39 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.291 1.405 . . . . 2.43 112.337 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.21 -38.88 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.931 1.241 . . . . 2.27 113.321 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.19 -34.28 77.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.649 0.779 . . . . 1.79 112.296 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -88.98 -32.63 17.54 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.791 2.437 . . . . 3.39 113.198 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.19 70.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.566 1.075 . . . . 1.79 110.537 165.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -85.16 9.7 14.25 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.406 1.082 . . . . 2.75 112.946 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 35.81 46.81 0.35 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.58 2.752 . . . . 4.82 115.053 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.95 136.38 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 109.386 -0.598 . . . . 3.08 109.386 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.22 129.64 37.82 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.174 -0.328 . . . . 4.03 111.352 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.27 108.53 0.73 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.36 1.864 . . . . 4.24 109.764 -160.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 149.7 37.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.062 1.134 . . . . 3.58 114.062 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.23 148.77 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.474 2.782 . . . . 4.73 110.812 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 C-N-CA 124.852 1.215 . . . . 4.05 114.265 -178.437 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 47.1 p90 . . . . . 0 C--O 1.237 0.415 0 N-CA-C 109.144 -0.687 . . . . 5.81 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 20.7 tt -72.75 76.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.552 -1.343 . . . . 3.35 110.45 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.7 t -44.94 130.86 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 127.104 2.162 . . . . 2.86 112.726 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -70.26 137.41 50.77 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.732 1.213 . . . . 4.24 111.707 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.12 137.63 19.83 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.865 -1.061 . . . . 1.71 109.703 163.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t -64.23 -24.01 67.51 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.145 1.165 . . . . 3.93 114.145 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.269 0.7 OUTLIER 67.12 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 128.789 2.836 . . . . 4.03 112.966 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.27 145.29 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.129 -1.607 . . . . 3.15 112.766 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 140.81 32.9 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 127.318 2.247 . . . . 2.95 109.638 164.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.65 145.08 41.86 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.732 0.813 . . . . 3.18 112.501 154.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.6 tp -100.51 130.69 46.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.012 1.725 . . . . 1.95 110.019 168.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.62 133.63 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.672 -1.973 . . . . 2.06 105.672 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 -177.48 19.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.168 -0.373 . . . . 1.87 112.168 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.41 42.77 1.36 Allowed 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.742 2.961 . . . . 2.97 110.818 172.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -177.76 -67.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.837 2.455 . . . . 5.2 111.009 -163.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -135.67 142.0 13.26 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 114.704 0.642 . . . . 3.89 114.704 -158.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -86.75 161.21 18.52 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.395 1.478 . . . . 7.23 114.467 -173.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 63.0 53.2 2.4 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.372 1.869 . . . . 4.2 111.974 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 55.5 tp -92.11 -33.46 14.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.564 1.146 . . . . 2.58 112.645 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -162.31 163.34 28.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.045 1.738 . . . . 2.29 109.734 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.66 142.73 11.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.164 0.985 . . . . 4.14 113.604 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -140.2 136.23 33.21 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.125 -0.985 . . . . 3.15 112.22 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.54 -171.27 45.04 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.913 -0.875 . . . . 2.6 110.913 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.59 139.44 58.77 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.505 -1.294 . . . . 3.5 107.505 147.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 14.3 t30 149.29 -59.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 129.292 3.037 . . . . 4.88 108.233 -171.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -72.85 158.36 35.68 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.56 0.578 . . . . 7.87 112.56 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -100.44 177.54 5.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.824 1.25 . . . . 5.64 110.541 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -53.25 -48.77 67.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.736 1.214 . . . . 1.78 113.803 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.74 86.08 Favored Glycine 0 N--CA 1.469 0.857 0 CA-C-N 118.416 0.553 . . . . 1.42 112.272 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.92 -28.8 64.77 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.692 1.197 . . . . 3.04 112.785 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.5 mt -69.31 -33.21 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.611 -0.681 . . . . 1.87 110.717 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -79.5 -49.47 12.22 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.063 0.847 . . . . 1.54 112.108 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.21 -32.26 73.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.778 1.231 . . . . 1.37 113.938 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.7 p -58.68 -61.62 2.47 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.095 0.958 . . . . 1.39 111.221 167.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.0 mt -52.78 -45.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.898 1.279 . . . . 1.37 111.357 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.16 -5.77 24.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.257 1.423 . . . . 1.64 114.209 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.3 m -89.11 -54.89 3.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.102 0.961 . . . . 1.66 108.732 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.54 -27.55 26.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.654 1.582 . . . . 2.61 114.321 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -51.03 -22.5 2.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.884 2.473 . . . . 4.21 114.779 170.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -98.8 -36.69 0.24 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.811 2.044 . . . . 6.39 116.387 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.36 -32.91 2.74 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.151 2.567 . . . . 2.57 111.729 166.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 -171.88 2.15 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.49 0.586 . . . . 3.27 110.008 149.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? . . . . . 0 N--CA 1.478 0.942 0 C-N-CA 125.64 1.576 . . . . 8.13 110.576 175.192 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.406 0 CA-C-O 118.648 -1.085 . . . . 2.55 112.661 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -69.47 160.14 50.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.027 2.484 . . . . 2.7 110.772 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -128.85 -155.08 0.68 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.399 1.48 . . . . 2.69 110.57 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -160.17 147.21 16.11 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.801 -1.187 . . . . 3.46 109.659 148.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 tp -156.82 167.27 30.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.049 0.94 . . . . 2.97 110.054 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -109.63 140.51 43.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.732 0.813 . . . . 2.43 110.41 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.1 p -72.08 164.86 25.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.446 1.098 . . . . 2.28 111.396 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -57.58 -12.49 2.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.96 2.504 . . . . 1.63 114.15 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 t -119.83 16.79 12.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.233 2.213 . . . . 3.26 112.537 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.79 -17.32 36.56 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 116.762 1.465 . . . . 2.31 116.762 164.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.28 140.98 55.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.464 1.632 . . . . 4.06 109.808 168.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.26 135.29 56.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.45 1.5 . . . . 8.81 108.694 167.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -142.2 119.09 11.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.025 -1.672 . . . . 3.25 112.705 170.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 94.4 m -132.37 143.26 49.72 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 127.582 2.353 . . . . 3.19 107.336 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.77 -29.3 70.04 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.193 0.997 . . . . 5.64 113.373 -174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 5.21 50.51 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.199 1.555 . . . . 7.81 115.199 174.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -41.47 6.57 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.738 0.699 . . . . 2.83 112.165 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.9 40.46 1.0 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.265 0.839 . . . . 6.38 113.265 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 tp -83.88 169.8 14.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.049 1.34 . . . . 3.33 112.898 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.82 -12.93 51.05 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.368 -1.457 . . . . 2.57 114.798 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 175.62 5.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.111 2.964 . . . . 3.81 109.916 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -88.97 80.31 7.1 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.023 1.283 . . . . 2.18 113.017 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.3 mt -67.29 140.67 57.33 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.849 0.86 . . . . 2.81 112.753 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 28.1 tp -139.16 108.74 6.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.113 1.765 . . . . 2.38 108.518 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.21 131.88 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.305 1.042 . . . . 1.89 108.515 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -128.16 155.42 44.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.681 1.192 . . . . 2.59 109.284 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -121.28 115.82 23.7 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.106 0.963 . . . . 2.22 109.063 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.22 176.12 21.52 Favored Glycine 0 N--CA 1.467 0.708 0 CA-C-O 122.452 1.029 . . . . 1.5 115.139 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -93.95 138.0 32.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.105 0.962 . . . . 3.25 109.9 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -70.54 14.05 0.15 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.338 -0.851 . . . . 3.91 111.872 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -141.81 -73.19 0.32 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.419 -1.425 . . . . 8.56 108.914 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 1.8 t 70.11 174.71 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.793 2.037 . . . . 2.82 111.817 -174.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.403 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 31.9 Cg_endo -67.63 -73.17 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.659 2.906 . . . . 3.85 109.623 143.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.68 16.65 0.08 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.462 1.505 . . . . 4.73 113.08 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.409 HG12 HE22 ' A' ' 279' ' ' GLN . 92.1 t -84.95 -49.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 119.894 -1.754 . . . . 2.86 110.715 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 64.4 m -50.77 -44.54 85.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 116.356 -1.783 . . . . 1.49 114.387 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.01 -34.82 57.48 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 122.57 1.953 . . . . 1.16 113.048 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.88 -38.27 76.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.568 1.531 . . . . 3.2 111.868 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.27 -34.67 73.07 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.314 -1.491 . . . . 3.15 112.665 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.5 tp -68.88 -42.95 76.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.363 1.065 . . . . 2.98 111.067 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.51 -45.34 66.18 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.255 1.422 . . . . 3.35 111.543 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -53.78 -59.61 4.39 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.631 -1.293 . . . . 3.15 111.863 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 5.7 ptp -64.84 -34.53 78.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.361 -0.837 . . . . 2.34 113.194 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -60.86 -52.91 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 118.108 -0.948 . . . . 1.8 110.734 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.416 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 43.1 mt-30 -68.11 -25.63 65.4 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.753 1.615 . . . . 3.77 110.692 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.51 -41.13 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.05 -0.976 . . . . 1.73 112.634 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.91 -31.87 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.827 1.194 . . . . 2.56 112.217 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.15 -42.85 99.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.265 1.426 . . . . 4.22 111.951 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.15 -54.87 23.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.557 1.543 . . . . 3.04 112.214 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.41 -35.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.556 0.947 . . . . 2.52 113.556 -163.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.03 -37.32 74.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.166 0.986 . . . . 3.53 111.099 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -68.18 -15.46 63.59 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.114 -0.991 . . . . 2.58 112.946 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.15 -0.05 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 119.838 -1.789 . . . . 2.94 111.651 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.0 m 77.28 -24.08 0.23 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.045 1.498 . . . . 4.08 115.045 144.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.474 HG21 ' HG2' ' A' ' 298' ' ' ARG . 61.8 m -102.65 -0.04 32.47 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.174 1.352 . . . . 4.27 112.133 164.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.27 124.86 91.38 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.206 -1.405 . . . . 3.4 107.206 157.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 -26.43 23.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.414 1.409 . . . . 3.82 109.934 160.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.43 175.5 3.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.956 1.702 . . . . 4.0 112.499 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 16.9 tp -137.44 117.64 13.54 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.368 -2.086 . . . . 1.7 105.368 143.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.2 m -103.06 106.55 51.43 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 119.778 1.172 . . . . 1.31 110.746 -172.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.14 117.08 4.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.642 2.228 . . . . 0.86 111.292 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 12.1 tp -99.86 94.71 6.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.675 2.39 . . . . 2.28 108.58 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -84.04 104.22 13.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.835 -0.802 . . . . 2.49 108.835 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 44.0 mm -79.48 110.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.575 -0.898 . . . . 1.88 108.575 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 75.7 m -82.16 114.17 20.5 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.132 -0.98 . . . . 3.04 111.001 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.19 2.05 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.095 1.517 . . . . 1.74 115.095 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.01 69.63 1.18 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.756 1.223 . . . . 2.97 110.722 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -79.02 38.14 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.508 3.472 . . . . 2.47 111.501 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -136.4 144.63 44.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.475 2.31 . . . . 3.8 105.566 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.95 -37.13 0.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.696 1.599 . . . . 5.06 112.829 -172.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -68.82 161.91 27.53 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.841 1.656 . . . . 4.56 111.595 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.73 152.41 51.74 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.469 1.128 . . . . 3.49 109.568 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -67.27 -21.27 65.72 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.257 0.836 . . . . 5.65 113.257 -167.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 0.5 OUTLIER -101.12 -19.89 15.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.879 2.472 . . . . 3.91 113.298 171.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.81 95.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.184 1.811 . . . . 1.58 110.893 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.69 -35.06 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.694 0.627 . . . . 3.26 112.694 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.39 -21.51 62.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.165 1.172 . . . . 1.96 114.165 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -79.21 -44.7 21.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.136 0.974 . . . . 3.94 111.102 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -43.9 72.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.542 1.137 . . . . 3.8 111.435 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.4 t -54.6 -44.1 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.731 1.212 . . . . 1.75 112.548 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.25 -35.16 73.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.988 -1.006 . . . . 6.93 112.972 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.22 -47.83 72.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.555 1.142 . . . . 3.39 111.933 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -83.74 -36.67 23.47 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.628 1.344 . . . . 2.7 114.628 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.0 m 154.05 137.31 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 129.451 3.101 . . . . 2.05 112.277 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.19 -8.08 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.037 2.492 . . . . 1.92 114.706 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -78.64 -11.88 59.99 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.584 1.083 . . . . 2.25 112.939 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.65 114.09 23.07 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.387 1.475 . . . . 2.6 107.765 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 18.6 m -96.93 131.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.998 -0.438 . . . . 2.44 110.467 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.54 105.7 2.91 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.733 1.158 . . . . 1.09 111.838 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.34 127.25 37.75 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.768 1.227 . . . . 2.66 110.064 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.2 p -151.15 140.8 21.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.094 1.758 . . . . 3.25 111.374 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.96 -139.64 2.87 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.159 0.885 . . . . 1.85 111.576 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.55 159.06 31.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.159 1.784 . . . . 3.62 110.499 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -65.17 -36.31 83.8 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.103 -0.373 . . . . 6.53 110.331 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -49.9 -55.51 14.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.584 2.354 . . . . 2.99 111.473 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -71.44 -26.98 62.96 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.858 -1.151 . . . . 4.3 113.531 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.55 -38.01 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.358 1.463 . . . . 2.32 110.61 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.39 -32.84 58.79 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.767 1.227 . . . . 5.22 109.884 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -60.16 -57.68 11.78 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.121 -0.942 . . . . 2.6 110.326 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.59 -33.51 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.608 1.095 . . . . 2.24 112.322 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.11 -54.3 36.06 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.741 -0.599 . . . . 1.62 110.64 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -70.07 -33.75 72.3 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 117.846 -1.073 . . . . 4.23 112.502 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.06 93.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.557 1.143 . . . . 1.65 113.017 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.83 2.75 55.86 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.69 1.196 . . . . 2.66 114.045 173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 77.32 24.17 0.84 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.249 2.62 . . . . 4.69 114.799 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.0 140.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.88 1.272 . . . . 2.58 110.747 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -110.07 138.28 46.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.23 1.012 . . . . 4.16 112.554 164.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.56 175.38 10.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.479 1.912 . . . . 3.67 110.456 162.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -163.26 150.65 10.93 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.4 1.08 . . . . 3.62 112.2 165.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.24 165.08 26.16 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.667 2.911 . . . . 2.97 110.755 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.623 0 C-N-CA 124.185 0.898 . . . . 2.43 113.963 178.884 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.695 0.76 . . . . 3.61 109.52 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.4 tp -67.14 175.52 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 O-C-N 121.667 -0.646 . . . . 3.08 111.495 165.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -167.45 75.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 119.316 -2.115 . . . . 4.35 108.972 -157.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -111.81 142.63 43.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.055 0.931 . . . . 5.53 111.305 -153.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -145.81 125.05 12.95 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.178 1.177 . . . . 1.88 114.178 -158.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 53.0 m -84.77 -48.82 9.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.017 0.927 . . . . 4.21 109.666 168.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.323 0.2 OUTLIER 43.36 -150.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.828 1.651 . . . . 6.34 113.622 -174.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 8.8 tt -179.58 161.86 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 129.089 2.956 . . . . 4.3 107.412 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 57.5 mtp -119.52 139.44 52.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.961 1.304 . . . . 2.0 109.957 158.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -120.63 136.72 54.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.94 0.896 . . . . 3.57 110.989 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.0 tt -102.22 118.99 38.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.603 1.561 . . . . 2.16 107.968 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.4 135.21 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.129 0.972 . . . . 1.94 109.326 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.16 147.9 50.42 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.108 -1.197 . . . . 1.68 110.108 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 62.1 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.013 3.142 . . . . 3.36 109.066 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -174.28 -66.67 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 5.1 110.977 -150.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -156.11 -68.77 0.01 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 117.289 1.676 . . . . 3.42 117.289 -157.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.43 -178.42 7.32 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.723 1.609 . . . . 6.23 109.667 -168.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -70.52 145.73 50.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.143 1.164 . . . . 3.47 114.143 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -132.1 1.99 3.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.372 1.469 . . . . 2.44 113.073 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -160.36 144.21 13.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.104 1.761 . . . . 2.82 108.128 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -154.2 147.13 24.46 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.712 1.205 . . . . 3.85 110.664 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.27 147.28 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.083 1.353 . . . . 3.06 107.806 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -81.87 -152.21 9.77 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 109.485 -1.446 . . . . 3.92 109.485 167.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.409 HE22 HG12 ' A' ' 172' ' ' VAL . 3.0 mt-30 -79.91 67.02 5.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.675 -1.231 . . . . 5.33 107.675 151.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.6 153.63 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.22 2.208 . . . . 5.27 112.657 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 89.19 123.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.411 2.284 . . . . 4.87 107.569 -139.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.1 mtt85 -81.15 -177.4 6.44 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.769 -1.197 . . . . 6.09 107.769 158.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -61.4 -40.26 93.73 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.539 -1.35 . . . . 1.85 113.757 -171.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.58 -38.39 94.62 Favored Glycine 0 N--CA 1.473 1.103 0 O-C-N 121.467 -0.77 . . . . 1.7 112.022 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.19 -16.34 63.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.859 1.263 . . . . 3.19 113.471 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.42 -46.96 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.957 -1.089 . . . . 1.37 110.841 169.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.69 79.02 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.291 -0.881 . . . . 1.2 112.015 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.68 -31.83 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.866 1.061 . . . . 1.46 113.866 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.9 p -75.5 -41.92 54.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.62 1.1 . . . . 1.51 111.372 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.39 -43.63 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.143 0.883 . . . . 1.82 111.458 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.02 68.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.928 0.891 . . . . 1.41 113.249 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.2 m -76.6 -52.19 10.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.274 1.029 . . . . 1.64 109.978 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -61.2 -34.13 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 2.07 112.378 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.6 ttt -55.66 -33.67 64.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.221 1.008 . . . . 4.53 111.754 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -58.72 -54.35 57.17 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 116.145 -1.883 . . . . 4.4 112.605 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.68 -51.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.8 3.0 . . . . 2.1 113.136 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -74.24 14.35 0.45 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.046 1.128 . . . . 3.15 114.046 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.474 ' HG2' HG21 ' A' ' 192' ' ' THR . 5.5 ttp-105 . . . . . 0 CA--C 1.516 -0.35 0 C-N-CA 125.923 1.689 . . . . 8.65 112.689 -163.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.398 0 CA-C-O 117.332 -1.816 . . . . 2.35 110.74 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.99 168.26 15.58 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.663 2.909 . . . . 2.41 112.733 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -135.62 150.7 49.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 2.91 111.174 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -141.08 75.4 1.5 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.605 -1.309 . . . . 2.24 111.63 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.93 153.38 32.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 3.46 112.41 -166.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.2 m -79.72 128.22 33.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.822 1.249 . . . . 1.46 108.475 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.8 t -80.35 146.51 31.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.979 0.912 . . . . 2.59 110.843 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -56.02 -19.89 14.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.644 2.378 . . . . 1.63 114.598 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.3 t -72.12 -38.98 69.17 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 118.232 -0.89 . . . . 3.09 112.153 170.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 116.41 70.12 0.44 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.724 1.631 . . . . 2.51 113.084 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.91 159.53 15.92 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.176 2.19 . . . . 4.06 107.635 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -109.55 123.69 49.84 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 121.193 1.815 . . . . 5.33 111.4 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -114.55 159.4 20.44 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.833 1.049 . . . . 4.29 113.833 175.33 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 m -139.7 158.15 44.59 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.181 2.592 . . . . 2.86 106.863 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.98 -39.31 81.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.175 0.99 . . . . 4.35 113.541 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.21 -13.06 58.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.826 1.417 . . . . 6.97 114.826 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -77.21 -47.11 21.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.214 0.915 . . . . 4.37 110.168 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.25 -33.99 55.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.932 1.293 . . . . 3.49 111.469 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 157' ' ' GLY . 0.6 OUTLIER 73.38 149.7 0.1 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.593 2.757 . . . . 6.18 108.983 -168.67 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 156' ' ' LEU . . . -71.67 -4.88 59.26 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.353 -1.467 . . . . 5.97 115.433 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -27.02 61.68 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 1 C-N-CA 132.84 4.456 . . . . 3.14 119.659 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 80.5 m95 66.18 35.36 6.12 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.174 1.79 . . . . 2.0 112.008 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 mp -71.24 132.64 45.25 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.531 -0.731 . . . . 3.42 110.092 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.45 111.89 24.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.762 1.625 . . . . 2.53 107.028 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.38 124.91 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.683 -0.858 . . . . 2.18 108.683 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -127.25 130.05 48.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.096 2.158 . . . . 2.7 112.142 -166.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.65 93.76 5.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.232 0.613 . . . . 2.56 111.831 -172.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.86 -174.86 14.01 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.018 1.77 . . . . 1.89 114.972 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.54 179.37 6.6 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.468 1.507 . . . . 4.9 111.906 -167.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.9 m -58.78 -32.47 69.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 115.758 -2.068 . . . . 4.01 116.254 -168.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.6 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.459 2.392 . . . . 10.28 117.459 -172.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.2 m -58.14 120.21 41.35 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-N 121.781 2.082 . . . . 4.18 114.396 -154.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.68 71.11 7.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.146 2.564 . . . . 5.75 114.117 -160.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -153.41 -117.39 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.314 2.246 . . . . 6.84 106.851 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 p -54.29 -31.23 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.143 1.777 . . . . 3.99 114.792 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.72 17.36 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 117.494 -1.241 . . . . 2.09 110.289 -173.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.48 -27.11 5.43 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.121 2.547 . . . . 1.25 113.813 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -70.92 -49.79 41.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.625 1.102 . . . . 3.17 111.659 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . 0.274 6.4 mt-10 -72.85 -14.28 61.46 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 119.67 -1.893 . . . . 2.97 112.627 174.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.47 -32.12 70.83 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.728 -1.233 . . . . 2.82 112.577 163.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -49.06 78.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.511 1.05 . . . . 4.9 108.85 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -58.46 -48.09 81.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.103 -0.951 . . . . 3.18 110.607 -175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.3 ptp -63.78 -43.53 96.1 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.724 1.602 . . . . 2.95 113.642 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.41 -53.34 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.438 -0.578 . . . . 1.98 109.438 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.425 ' HB3' ' HZ1' ' A' ' 283' ' ' LYS . 2.2 mp0 -70.56 -24.1 62.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 117.162 -1.399 . . . . 5.31 110.932 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.35 -50.79 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 121.911 2.141 . . . . 1.71 111.59 165.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.02 -31.06 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 120.685 1.584 . . . . 2.6 113.017 -173.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -83.09 -29.4 28.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.913 1.079 . . . . 4.73 113.913 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -73.17 -23.09 60.39 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.627 -1.296 . . . . 5.86 112.729 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.55 -50.8 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.474 1.909 . . . . 2.85 111.862 164.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.36 -38.29 73.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.821 1.648 . . . . 4.1 112.605 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.1 t -61.24 -22.02 64.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.583 1.553 . . . . 3.4 112.381 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 mm -79.31 11.92 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 O-C-N 120.432 -1.418 . . . . 4.49 111.261 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.7 m 89.63 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.107 2.563 . . . . 5.61 113.445 151.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.295 1.1 t -161.09 37.94 0.15 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.625 1.203 . . . . 3.98 114.109 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.06 168.8 13.71 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.433 -0.792 . . . . 4.91 111.637 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 120.03 6.92 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.697 1.598 . . . . 5.53 108.959 167.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.93 119.57 13.47 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.804 1.288 . . . . 3.99 110.633 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.2 tp -85.0 97.17 9.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.611 1.565 . . . . 2.33 108.341 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.6 m -77.06 115.14 46.09 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 117.824 -1.084 . . . . 2.21 110.317 -169.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.78 121.15 2.44 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.067 2.511 . . . . 0.93 112.163 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.8 tp -118.75 103.92 10.11 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.59 1.556 . . . . 2.52 110.863 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -86.81 125.48 33.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.877 0.871 . . . . 2.7 111.011 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.69 107.17 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.437 1.095 . . . . 1.81 109.869 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.23 96.64 3.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.198 0.523 . . . . 1.94 110.543 175.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.3 pt -87.0 28.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.228 -0.92 . . . . 2.85 113.405 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -128.68 46.35 2.15 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.828 1.651 . . . . 4.93 114.477 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.12 88.72 0.57 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.827 3.685 . . . . 2.98 109.753 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 231' ' ' ARG . 2.9 mt-10 162.27 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.188 1.795 . . . . 5.15 113.559 -159.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.91 9.14 4.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.739 1.216 . . . . 5.09 113.532 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -99.5 -137.65 0.31 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.558 2.343 . . . . 5.12 111.528 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m 155.31 137.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 1 C-N-CA 133.653 4.781 . . . . 2.44 104.739 169.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -41.51 -53.77 3.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.237 1.015 . . . . 2.91 112.242 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -70.11 -25.91 63.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.499 1.52 . . . . 3.74 114.386 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.94 -43.04 56.37 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.467 -1.395 . . . . 1.79 111.898 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 mm -64.66 -39.96 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 118.217 -0.897 . . . . 1.94 110.147 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.47 61.33 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.678 1.126 . . . . 1.59 113.188 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -69.82 -44.18 70.5 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.492 1.042 . . . . 3.5 111.465 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.1 -34.24 77.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.548 0.613 . . . . 2.64 112.434 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.87 -41.9 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.456 1.503 . . . . 1.93 111.557 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -46.16 89.77 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.099 -1.001 . . . . 5.37 110.732 174.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -43.12 -53.15 5.12 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.32 1.848 . . . . 4.14 112.034 -163.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -71.07 -73.03 0.19 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.899 1.28 . . . . 2.54 113.554 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.7 m -176.41 150.17 0.98 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.235 1.414 . . . . 2.56 112.292 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.87 5.41 3.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.49 3.46 . . . . 1.86 114.983 -165.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.47 -17.09 62.38 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.932 -1.105 . . . . 3.04 112.57 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.97 135.16 35.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.475 1.51 . . . . 1.89 112.539 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.73 136.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.301 1.441 . . . . 1.87 108.823 168.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.55 133.76 11.82 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.16 0.886 . . . . 1.47 112.408 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.8 mp -109.62 142.32 40.9 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.914 1.685 . . . . 2.36 111.005 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.0 p -149.64 167.11 27.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.891 2.876 . . . . 3.63 109.696 -166.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 172.58 -155.87 24.03 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.289 0.947 . . . . 1.86 111.226 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.1 t -96.68 172.85 7.64 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.931 1.348 . . . . 2.35 110.597 163.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 206' ' ' GLU . 40.9 ttm-85 -49.36 -30.07 7.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.871 2.069 . . . . 5.74 113.274 177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.42 -53.2 25.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.353 1.461 . . . . 3.78 111.789 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.18 -41.87 84.83 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.065 -1.022 . . . . 3.55 111.466 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.5 t -67.67 -29.96 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.994 0.917 . . . . 2.14 112.456 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.43 -49.79 74.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.733 -1.127 . . . . 3.26 108.883 173.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -56.63 -55.65 31.31 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.457 1.026 . . . . 3.71 111.862 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.85 -35.43 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.525 0.565 . . . . 3.19 112.525 -172.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.11 -44.76 68.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.927 0.491 . . . . 1.45 111.086 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -73.29 -36.08 66.24 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.302 1.841 . . . . 3.35 112.508 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.64 -54.09 47.4 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.591 1.156 . . . . 2.67 112.372 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -85.09 2.43 43.46 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.327 0.651 . . . . 2.68 112.451 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 58.47 39.94 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.712 2.405 . . . . 5.66 113.091 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.2 m -69.89 -25.98 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.429 1.27 . . . . 3.49 114.429 -161.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 81.1 t80 66.67 141.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.67 1.988 . . . . 3.85 115.097 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.62 159.78 27.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.469 2.308 . . . . 3.64 109.401 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.6 t -164.09 134.32 3.21 Favored Pre-proline 0 N--CA 1.477 0.92 0 O-C-N 120.977 -1.077 . . . . 3.33 112.331 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.67 141.28 21.85 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.414 2.743 . . . . 2.92 112.282 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.445 0 C-N-CA 124.079 0.847 . . . . 2.57 114.75 -177.06 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 CA--C 1.546 0.807 0 CA-C-O 121.858 0.837 . . . . 3.75 112.325 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp -57.47 164.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.615 1.166 . . . . 2.8 112.009 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.7 t -149.83 136.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 105.786 -1.931 . . . . 2.93 105.786 172.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -66.16 134.36 52.59 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.398 1.079 . . . . 3.47 110.509 172.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -154.34 114.49 3.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.985 0.914 . . . . 2.47 111.371 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.8 p -67.64 -22.98 65.29 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.321 1.448 . . . . 3.15 114.274 -170.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 tp 76.48 -5.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 127.912 2.485 . . . . 5.32 114.025 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.8 mt -49.5 133.54 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.154 1.782 . . . . 3.22 111.602 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 11.6 ptm -141.44 143.78 34.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 113.564 -1.653 . . . . 2.37 111.131 -163.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -127.64 145.2 50.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.907 0.883 . . . . 2.81 111.801 -162.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.88 125.66 38.63 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.513 1.125 . . . . 1.89 109.127 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -100.48 135.6 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.969 1.308 . . . . 2.0 108.149 170.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.38 -177.24 45.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.725 1.155 . . . . 1.89 111.454 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.77 54.48 4.5 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.967 3.111 . . . . 2.57 114.271 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -166.8 -54.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.648 1.979 . . . . 6.47 111.193 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 147.5 -20.81 1.51 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.658 0.623 . . . . 2.5 114.658 -160.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.39 144.56 57.08 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.175 0.99 . . . . 7.02 111.778 165.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -74.67 155.95 37.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.23 1.012 . . . . 4.3 112.491 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -36.94 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.606 0.762 . . . . 3.13 112.842 174.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -165.52 172.44 12.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.759 1.224 . . . . 2.08 111.133 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.26 164.54 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.331 1.452 . . . . 3.23 112.945 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.03 -179.21 7.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.737 1.615 . . . . 2.52 111.322 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 119.36 146.33 7.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.326 1.441 . . . . 2.7 113.702 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 40.75 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 1 C-N-CA 132.526 4.33 . . . . 4.2 118.135 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.43 -46.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.702 -1.249 . . . . 4.85 112.755 -173.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.27 90.03 0.9 Allowed 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.346 -0.846 . . . . 4.64 110.582 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -67.29 161.26 25.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.405 1.882 . . . . 5.2 112.641 -165.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HZ1' ' HB3' ' A' ' 182' ' ' GLN . 0.9 OUTLIER -42.07 -59.04 1.88 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.691 1.996 . . . . 3.47 115.388 -168.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.92 -34.05 76.21 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.292 -0.88 . . . . 1.48 113.159 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.97 -31.56 72.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.124 1.37 . . . . 3.65 111.934 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.6 mt -58.16 -56.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.227 -0.921 . . . . 1.16 109.519 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.88 -40.42 76.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.366 0.506 . . . . 1.22 112.366 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.85 87.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.862 0.865 . . . . 1.41 113.227 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.6 p -63.7 -43.44 96.6 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.298 -0.876 . . . . 1.22 111.983 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 49.3 mt -64.71 -37.0 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.036 -1.04 . . . . 1.67 111.436 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.7 -22.84 65.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.304 1.041 . . . . 1.74 113.429 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 39.7 m -71.12 -48.35 52.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.163 -0.68 . . . . 1.84 109.163 169.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -67.38 -26.07 66.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.113 1.365 . . . . 2.7 113.503 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -25.3 63.21 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.888 -1.132 . . . . 5.48 111.8 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -57.19 -40.71 86.78 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 117.364 -1.303 . . . . 4.83 112.608 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.22 -60.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.852 2.368 . . . . 3.3 111.448 160.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.45 31.11 6.02 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.565 1.321 . . . . 5.13 114.565 -156.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 O-C-N 121.05 -1.032 . . . . 7.33 112.259 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 119.43 -0.65 . . . . 2.33 113.898 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.51 -170.79 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.292 3.328 . . . . 2.37 110.049 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -146.46 177.81 8.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.686 1.195 . . . . 2.2 111.081 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -144.38 34.07 1.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.549 1.315 . . . . 2.62 114.549 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mp -64.83 156.29 31.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.649 1.214 . . . . 2.15 112.636 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -92.72 142.74 27.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.173 1.389 . . . . 1.61 109.05 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -83.62 166.21 18.35 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.861 1.265 . . . . 2.07 111.757 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -3.84 2.32 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.197 1.799 . . . . 1.63 114.958 173.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.6 m -79.03 -36.86 40.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.837 1.655 . . . . 3.21 111.729 164.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.08 11.89 30.92 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.704 1.621 . . . . 1.95 113.679 -164.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 141.07 43.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.122 1.369 . . . . 3.4 110.406 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.33 112.74 24.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.26 1.424 . . . . 5.34 111.46 -164.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.87 158.52 16.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.139 1.375 . . . . 3.08 112.663 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.2 p -115.54 -179.82 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.311 2.245 . . . . 2.53 108.739 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -38.19 88.74 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.844 -0.535 . . . . 3.6 111.841 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -77.88 -6.58 54.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.107 1.521 . . . . 6.46 115.107 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.28 -29.89 70.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.05 0.94 . . . . 2.86 111.724 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -100.14 -11.88 20.1 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.095 1.517 . . . . 3.07 115.095 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.34 108.2 1.54 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.579 1.151 . . . . 3.68 111.563 -170.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.13 2.67 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.811 1.196 . . . . 2.79 112.888 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.21 163.85 17.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.193 0.997 . . . . 3.57 109.268 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -78.49 138.53 38.48 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.523 -0.736 . . . . 2.0 109.494 161.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.23 144.02 36.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.161 0.982 . . . . 3.11 113.523 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.16 117.88 24.04 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.592 1.157 . . . . 2.67 108.729 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.9 mt -101.93 127.13 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.059 0.943 . . . . 1.74 109.125 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.64 142.14 39.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.73 0.776 . . . . 3.34 111.168 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -99.72 126.9 45.85 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.321 1.049 . . . . 2.22 108.97 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.39 169.34 26.43 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 124.292 0.995 . . . . 1.32 114.721 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -120.07 171.24 8.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.317 1.847 . . . . 4.22 108.018 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 71.2 m -53.82 -12.22 0.51 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.666 2.469 . . . . 3.49 117.666 -166.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -177.22 -27.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 122.427 2.376 . . . . 10.01 116.776 167.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 61.6 m 60.85 174.62 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 117.548 2.425 . . . . 2.86 117.548 167.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.21 164.41 30.45 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.236 1.957 . . . . 3.07 109.865 154.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.09 46.63 0.32 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.086 2.554 . . . . 4.37 113.932 -165.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 94.8 t -111.86 -53.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 127.584 2.354 . . . . 2.9 109.07 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 34.6 t -64.16 -60.84 7.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.187 0.995 . . . . 1.71 112.922 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.69 -24.95 47.13 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.25 1.967 . . . . 1.4 112.635 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -71.2 -55.21 8.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.441 1.096 . . . . 2.81 111.254 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -65.26 -25.84 67.83 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.279 -0.888 . . . . 3.21 112.194 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -65.17 -34.42 78.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.018 -0.991 . . . . 3.21 110.695 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.89 -43.04 59.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.44 1.473 . . . . 3.54 111.788 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -50.22 -39.3 44.09 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.452 -1.405 . . . . 3.58 112.162 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.79 -50.41 43.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.914 1.286 . . . . 3.12 112.426 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.77 -37.16 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 120.789 1.631 . . . . 1.87 112.025 -174.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.531 ' C ' ' HE3' ' A' ' 283' ' ' LYS . 54.3 mt-30 -56.09 -27.57 54.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.84 1.2 . . . . 3.48 111.522 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 36.0 t -68.75 -20.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 120.586 -1.321 . . . . 2.2 111.771 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.9 t -67.28 -38.82 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.856 0.753 . . . . 2.15 109.479 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -49.99 74.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.486 1.114 . . . . 5.03 110.963 171.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.27 -25.54 63.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.5 1.12 . . . . 3.03 113.781 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.15 -45.33 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.986 1.715 . . . . 2.26 112.703 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.36 -32.37 66.7 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.476 1.035 . . . . 3.69 111.1 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -20.23 63.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.565 1.546 . . . . 2.92 112.901 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.08 -16.94 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 120.897 -1.127 . . . . 3.41 111.701 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.5 t 56.47 -7.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.694 3.197 . . . . 5.14 118.633 165.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 67.4 p -109.18 9.25 26.08 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 120.802 1.637 . . . . 3.52 114.411 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.92 160.92 29.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.226 1.81 . . . . 3.23 112.847 -168.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -82.8 51.56 3.74 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.282 3.321 . . . . 3.52 110.729 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.1 t0 57.94 -175.84 0.08 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.332 2.253 . . . . 4.48 115.405 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.94 118.06 28.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.969 1.308 . . . . 1.97 108.63 155.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.5 m -98.88 99.92 8.76 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.437 1.495 . . . . 1.22 109.983 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.09 133.02 17.46 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.96 2.44 . . . . 0.9 111.649 170.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.38 89.21 3.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.103 2.161 . . . . 2.51 108.161 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -83.7 130.86 34.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.716 0.806 . . . . 1.91 109.575 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.7 mt -108.55 122.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.892 0.877 . . . . 1.71 109.855 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.4 m -67.34 119.61 12.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.587 0.755 . . . . 2.43 110.839 166.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.29 -3.55 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 120.955 -1.091 . . . . 2.58 113.721 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -111.81 57.34 0.46 Allowed Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 127.381 2.272 . . . . 4.24 113.554 -170.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.94 75.9 2.62 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.866 3.711 . . . . 2.75 109.966 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -173.42 -35.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.846 2.458 . . . . 3.61 111.473 -169.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.34 32.52 2.83 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.028 0.931 . . . . 5.76 112.388 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -119.99 173.29 7.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.912 2.485 . . . . 4.01 109.673 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.3 m -169.2 139.98 2.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.275 2.63 . . . . 2.89 107.143 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -36.61 66.82 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.434 0.901 . . . . 3.44 113.434 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -79.59 -28.0 41.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.893 2.077 . . . . 3.85 112.67 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.45 42.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.797 0.726 . . . . 2.03 110.084 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.1 tp -62.01 -31.6 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.72 0.408 . . . . 2.31 111.989 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.62 95.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.184 -0.948 . . . . 1.24 111.826 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -69.21 -29.22 67.13 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.196 0.813 . . . . 4.21 113.196 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -68.1 -48.36 65.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.544 1.138 . . . . 3.61 110.778 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.1 t -52.2 -45.74 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.166 -0.959 . . . . 1.31 111.519 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -59.88 -18.67 46.25 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.39 1.476 . . . . 5.22 113.188 176.742 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.91 -48.03 80.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.959 1.708 . . . . 4.77 110.927 171.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -87.82 -53.2 4.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.347 0.869 . . . . 2.84 113.347 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.7 p -177.33 159.61 1.39 Allowed Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.634 -1.291 . . . . 3.22 112.91 -159.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -86.24 -16.0 4.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.716 2.944 . . . . 2.08 113.807 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -85.61 -4.44 59.16 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.788 1.176 . . . . 2.35 113.52 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.89 136.79 36.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.942 0.897 . . . . 2.33 111.171 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 t -110.99 131.36 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.574 -1.269 . . . . 2.02 107.574 163.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.73 114.65 4.59 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 109.497 -1.441 . . . . 1.01 109.497 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.4 144.35 33.21 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.665 0.786 . . . . 2.13 110.756 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -157.79 -179.7 8.39 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.641 1.576 . . . . 2.6 110.785 -172.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 167.42 -116.69 0.69 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.255 -1.138 . . . . 1.84 110.255 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.5 p -128.0 168.0 15.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.613 1.165 . . . . 3.04 112.211 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -39.36 46.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.67 0.788 . . . . 5.79 111.248 -177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 2.2 mp0 -59.76 -54.23 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.293 2.237 . . . . 3.52 113.131 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -69.46 -31.68 70.13 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.879 -1.138 . . . . 4.98 111.831 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.43 -29.61 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 117.944 -1.027 . . . . 1.68 111.625 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.29 -42.53 88.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.031 1.287 . . . . 3.18 110.227 162.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -56.49 -50.5 71.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 117.987 -1.006 . . . . 2.85 112.622 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.4 m -71.2 -26.86 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 120.583 1.538 . . . . 2.48 114.576 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.451 ' HB1' HG22 ' A' ' 243' ' ' VAL . . . -65.57 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.615 1.098 . . . . 1.51 112.628 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -105.09 -21.76 13.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.772 3.229 . . . . 5.96 113.467 -167.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.72 -28.99 64.06 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.472 1.033 . . . . 1.97 112.268 162.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.08 -127.06 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.402 1.081 . . . . 2.66 109.404 164.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -164.78 74.71 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.572 1.149 . . . . 5.7 110.145 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.451 HG22 ' HB1' ' A' ' 238' ' ' ALA . 7.5 m -83.63 173.92 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 111.765 0.283 . . . . 3.45 111.765 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.423 ' CD2' HG22 ' A' ' 261' ' ' THR . 13.0 p90 -147.8 154.19 40.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.126 1.371 . . . . 6.75 110.737 166.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -154.94 125.43 6.89 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.524 1.53 . . . . 4.32 111.176 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.6 t -106.74 110.54 63.76 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 120.795 -1.19 . . . . 3.89 109.257 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.99 144.52 38.3 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.524 2.149 . . . . 3.21 111.367 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.365 0 C-N-CA 124.892 1.234 . . . . 3.02 115.092 -175.992 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 109.431 -0.581 . . . . 3.22 109.431 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.0 tp -83.95 154.07 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.384 -0.823 . . . . 2.93 111.639 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.7 134.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 129.449 3.099 . . . . 2.94 105.635 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.83 168.0 14.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.162 0.982 . . . . 3.22 110.397 165.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -150.46 36.26 0.65 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.079 0.943 . . . . 3.65 110.907 168.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.423 HG22 ' CD2' ' A' ' 244' ' ' TYR 0.266 13.7 p 65.51 -134.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.54 2.336 . . . . 3.55 110.999 -171.418 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 176.19 -17.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 129.029 2.932 . . . . 5.21 110.795 -163.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.4 mt -69.92 134.03 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.57 1.148 . . . . 2.79 109.546 170.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.8 ttm -119.6 137.49 53.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.3 1.84 . . . . 2.94 108.206 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.97 127.59 51.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.677 0.791 . . . . 3.52 112.18 -159.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.83 130.74 48.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.595 1.158 . . . . 1.95 112.075 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.9 151.3 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.296 1.838 . . . . 1.82 106.297 166.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -142.55 -135.07 3.02 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 121.268 -0.895 . . . . 1.99 113.0 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.11 1.61 7.02 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.654 2.903 . . . . 2.46 113.545 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.87 -47.0 55.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.23 2.212 . . . . 5.61 113.723 172.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.88 13.09 54.45 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 117.628 -1.651 . . . . 3.01 116.746 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.57 -70.7 0.35 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.065 1.432 . . . . 4.16 111.883 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -166.69 146.96 5.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.164 0.985 . . . . 4.64 111.915 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 -33.01 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.424 1.639 . . . . 2.72 115.424 -170.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -168.52 167.94 11.33 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.11 1.323 . . . . 2.56 112.76 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.45 152.55 32.11 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.694 1.738 . . . . 3.21 115.694 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -120.33 163.71 17.42 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.888 1.275 . . . . 2.64 110.481 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -167.08 102.56 0.19 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.326 -0.859 . . . . 4.08 111.765 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 64.15 164.06 0.13 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.24 1.416 . . . . 3.68 110.965 -162.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 37.8 t30 77.1 -57.2 0.52 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.309 1.843 . . . . 5.83 112.467 165.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? 49.71 19.97 0.47 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.085 2.154 . . . . 9.88 116.226 162.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.39 142.38 56.98 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 119.139 -2.226 . . . . 5.61 110.612 -163.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.531 ' HE3' ' C ' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -46.03 -52.18 12.36 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.192 0.997 . . . . 2.38 113.593 -170.097 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.37 -23.28 71.71 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.506 -1.164 . . . . 1.45 114.647 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -74.07 -49.14 25.38 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.494 1.647 . . . . 3.36 110.378 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.66 -47.73 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.324 0.649 . . . . 1.28 109.389 174.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.96 75.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.207 -0.901 . . . . 1.35 112.516 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.43 91.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.925 1.239 . . . . 1.3 112.752 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 91.5 p -60.02 -57.35 13.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.932 0.333 . . . . 1.36 111.562 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.34 -35.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.754 -1.216 . . . . 1.45 110.993 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.37 73.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.825 1.25 . . . . 1.85 113.921 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 14.4 t -76.25 -33.27 59.18 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.182 1.356 . . . . 2.88 111.452 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -70.87 -24.59 62.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.976 0.91 . . . . 2.18 113.26 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.5 mtt -54.1 -40.95 67.73 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.432 -1.418 . . . . 5.8 111.467 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -59.01 -45.09 99.59 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 115.714 -2.089 . . . . 4.43 114.557 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.85 -7.55 11.32 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.606 2.87 . . . . 2.26 114.429 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -119.85 -154.65 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 120.027 1.285 . . . . 3.43 113.4 -171.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 . . . . . 0 CA--C 1.538 0.488 0 O-C-N 120.027 -1.671 . . . . 11.07 111.354 -174.052 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.356 0 CA-C-O 118.216 -1.325 . . . . 4.17 112.1 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.57 148.02 90.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.837 2.358 . . . . 4.02 112.136 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -151.23 171.76 16.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 3.21 111.988 -174.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 p -139.04 42.28 2.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.954 1.835 . . . . 3.7 115.954 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.49 152.64 21.34 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 119.902 -1.749 . . . . 3.57 112.699 -170.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.9 m -92.14 139.65 30.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.682 1.193 . . . . 2.47 110.155 -173.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.2 p -84.38 159.79 20.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.037 0.935 . . . . 2.51 112.587 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -9.36 2.07 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.479 1.512 . . . . 1.82 115.0 169.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 99.7 m -71.68 -53.68 12.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.463 1.105 . . . . 3.72 109.858 164.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.63 -10.84 8.0 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.358 1.933 . . . . 3.05 113.619 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 148.73 27.96 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 124.83 1.252 . . . . 5.14 111.112 171.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 97.59 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.695 1.198 . . . . 6.15 111.663 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -95.66 161.94 13.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.178 1.177 . . . . 4.7 114.178 -171.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -112.43 169.5 8.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.2 1.8 . . . . 2.88 110.773 164.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -41.87 -42.68 2.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.914 2.486 . . . . 4.1 113.213 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -82.04 -22.68 36.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.168 1.173 . . . . 7.17 114.168 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.24 -14.39 60.92 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.928 0.871 . . . . 3.86 111.936 165.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -102.88 9.96 38.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.968 2.507 . . . . 3.16 114.782 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.35 156.38 26.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.614 1.552 . . . . 3.17 115.003 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.59 43.05 Favored Glycine 0 N--CA 1.478 1.463 0 C-N-CA 124.818 1.199 . . . . 2.66 115.656 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -140.39 162.68 34.74 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.917 2.487 . . . . 3.3 109.695 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.8 131.6 43.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.259 0.552 . . . . 2.14 111.943 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.8 mt -108.09 125.39 51.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.035 1.334 . . . . 2.75 109.781 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.443 HD11 ' HG ' ' A' ' 196' ' ' LEU . 4.8 mp -121.57 103.99 9.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.624 1.169 . . . . 3.41 108.094 -173.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.3 mt -117.67 124.97 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.934 0.893 . . . . 2.01 109.934 -155.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -142.37 155.12 45.12 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.007 1.323 . . . . 2.25 112.159 -165.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.87 122.63 39.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.752 1.221 . . . . 2.8 111.114 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.69 -154.66 8.25 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.538 1.066 . . . . 1.26 112.653 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -168.02 169.32 11.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.721 1.608 . . . . 3.51 111.42 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.27 13.5 t -77.97 30.9 0.17 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 119.602 -1.936 . . . . 4.13 112.75 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -97.43 -29.79 13.29 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.777 1.631 . . . . 7.23 113.775 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 60.4 m -104.72 153.11 39.5 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 116.221 1.934 . . . . 2.88 116.221 -165.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.21 -22.27 2.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.886 3.058 . . . . 4.49 113.534 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -140.65 -58.19 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.948 1.092 . . . . 4.79 113.948 -171.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.7 p -60.36 -32.41 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.675 1.59 . . . . 3.29 114.687 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.8 m -74.89 -66.11 0.47 Allowed Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.167 0.894 . . . . 1.51 112.129 161.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 -28.5 68.92 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.713 1.608 . . . . 1.16 115.154 -166.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -71.32 -30.47 66.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.762 1.619 . . . . 3.04 112.49 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.67 -40.48 72.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.808 0.731 . . . . 3.12 110.448 168.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.45 -37.66 74.38 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.873 1.215 . . . . 3.26 113.05 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.03 -58.82 5.89 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.315 1.446 . . . . 4.21 110.205 165.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -56.68 -40.98 76.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.081 1.352 . . . . 3.23 112.972 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 48.3 mtp -60.62 -40.75 93.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.929 1.692 . . . . 2.89 112.529 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.6 tp -87.41 -37.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.693 1.588 . . . . 2.62 112.678 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -53.2 -43.28 67.08 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 124.762 1.225 . . . . 3.48 110.704 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.86 -13.56 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 113.801 1.037 . . . . 2.07 113.801 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.2 -23.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.998 -1.064 . . . . 2.0 111.603 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -50.37 67.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.746 0.818 . . . . 4.68 112.187 -170.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.54 -19.1 65.24 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.673 1.589 . . . . 3.37 114.115 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -56.49 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 120.914 -1.116 . . . . 2.51 109.347 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.78 -36.99 82.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.605 1.162 . . . . 4.0 112.159 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -71.87 -7.61 49.49 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.773 1.027 . . . . 3.36 113.773 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.5 mm -103.34 -29.72 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.128 0.876 . . . . 4.7 111.095 168.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.0 m 72.73 -25.88 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 127.56 2.344 . . . . 6.15 114.211 157.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 56.0 m -74.81 -2.67 27.67 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.794 3.237 . . . . 3.93 112.673 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 mp -99.26 157.66 33.64 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.594 1.558 . . . . 3.32 110.075 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.46 143.68 48.14 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.28 1.987 . . . . 3.62 108.183 155.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.26 159.31 3.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 116.078 1.881 . . . . 3.5 116.078 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.443 ' HG ' HD11 ' A' ' 161' ' ' LEU . 7.1 mp -99.19 95.52 7.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.246 -1.39 . . . . 2.84 107.246 157.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.4 m -86.95 112.04 44.63 Favored Pre-proline 0 N--CA 1.475 0.786 0 N-CA-C 108.126 -1.065 . . . . 1.28 108.126 168.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -86.82 136.86 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.789 2.326 . . . . 0.89 109.86 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.15 123.11 16.6 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.484 1.135 . . . . 3.6 112.442 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -109.45 133.15 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.535 1.534 . . . . 2.21 110.554 -160.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 36.3 mm -99.55 122.01 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.154 0.981 . . . . 1.83 110.516 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 95.6 p -74.07 124.61 26.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.102 0.561 . . . . 3.53 110.097 165.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.5 pt -94.05 -18.05 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.322 1.601 . . . . 2.2 115.322 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -119.48 59.38 5.17 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 120.419 1.463 . . . . 2.67 114.367 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.54 99.57 0.21 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.43 2.087 . . . . 2.68 107.393 165.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 165.65 -45.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.986 2.515 . . . . 4.46 108.523 -147.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 -18.19 0.6 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.927 1.455 . . . . 5.56 114.927 151.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.66 136.77 54.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.847 1.203 . . . . 4.3 109.394 155.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.2 t -154.0 155.73 36.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 3.5 112.384 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -58.1 -47.04 84.47 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.484 1.914 . . . . 2.8 113.983 -163.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -71.66 -38.69 70.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.328 1.422 . . . . 3.54 112.77 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.7 93.99 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.221 -0.924 . . . . 1.46 111.14 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 mm -61.3 -39.77 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.057 0.943 . . . . 1.87 111.736 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.45 86.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.629 1.104 . . . . 1.44 112.309 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -62.55 -52.71 62.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.922 0.783 . . . . 3.2 111.811 168.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -55.58 -32.17 62.81 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.726 1.21 . . . . 2.95 113.519 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 224' ' ' LEU . 2.4 t -65.35 -58.16 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.02 2.128 . . . . 1.3 112.576 166.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -52.91 -48.14 67.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.953 0.901 . . . . 3.82 112.181 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.63 -20.46 58.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.231 0.957 . . . . 5.02 112.627 -162.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -79.86 -56.14 4.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.79 0.723 . . . . 2.84 110.875 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.8 m 169.14 132.25 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 127.297 2.239 . . . . 2.32 112.208 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.19 7.34 1.44 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.394 3.396 . . . . 3.11 116.094 -168.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -67.94 -35.33 78.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.205 1.366 . . . . 2.36 110.768 159.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 217' ' ' VAL . 7.0 tt -62.08 118.51 7.43 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.258 -1.386 . . . . 2.11 107.258 173.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.85 131.38 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.098 -1.075 . . . . 2.04 108.098 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -93.51 127.78 9.18 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.117 -1.593 . . . . 1.09 109.117 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.48 144.92 50.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.837 0.827 . . . . 2.27 111.291 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 26.1 p -140.36 176.15 9.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.706 2.002 . . . . 2.81 109.255 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -175.69 -154.55 11.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.183 -1.967 . . . . 2.23 108.183 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.5 p -81.94 171.99 13.8 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.331 0.586 . . . . 4.05 110.615 167.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -63.07 -23.99 67.7 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.756 -0.59 . . . . 6.76 112.085 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 16.2 mp0 -80.8 -31.12 35.81 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.536 1.934 . . . . 3.88 111.913 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.15 -41.51 73.74 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.916 -1.115 . . . . 4.96 109.691 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.99 -38.69 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.268 -0.895 . . . . 2.39 111.92 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.09 -39.32 79.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.423 -0.799 . . . . 3.71 111.143 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -52.33 -58.87 5.32 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.737 -1.125 . . . . 3.59 110.377 173.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.26 -31.61 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.79 1.177 . . . . 2.85 113.17 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.97 -50.75 38.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.54 1.064 . . . . 2.36 111.37 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -36.95 74.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.003 1.721 . . . . 7.97 112.402 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.21 65.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.689 1.132 . . . . 2.69 110.724 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -76.17 -7.85 55.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.555 0.742 . . . . 2.93 112.827 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 26.3 ttp-105 71.06 38.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.567 2.347 . . . . 7.69 112.431 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.69 138.92 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.365 1.466 . . . . 4.28 108.659 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -105.85 136.86 44.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.222 0.534 . . . . 4.66 111.177 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -89.85 144.2 26.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.897 0.479 . . . . 3.16 109.912 164.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 t -119.69 94.2 48.26 Favored Pre-proline 0 N--CA 1.477 0.906 0 O-C-N 120.895 -1.128 . . . . 3.31 112.704 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.78 138.76 9.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.362 2.708 . . . . 2.91 113.149 -171.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.636 0 C-N-CA 123.78 0.705 . . . . 2.47 112.503 163.947 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . 0.262 6.9 p90 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 122.338 1.066 . . . . 3.94 112.397 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.4 tp -105.39 148.73 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.054 1.342 . . . . 3.03 111.338 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.9 132.61 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.452 -2.055 . . . . 3.27 105.452 161.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.42 139.17 43.81 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.561 0.618 . . . . 4.11 111.298 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -131.41 93.9 3.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.936 0.894 . . . . 2.3 110.876 161.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.7 t -48.2 122.53 5.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.525 0.73 . . . . 4.94 110.266 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 10.5 pt -88.07 101.1 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.816 0.817 . . . . 4.78 112.372 -165.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.1 mt -132.57 127.04 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.973 1.309 . . . . 2.79 108.05 162.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.8 ptm -94.0 130.48 40.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.268 0.627 . . . . 2.78 109.734 162.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -97.92 135.14 40.08 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.215 -0.928 . . . . 3.26 111.233 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 108.96 19.68 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.269 -1.012 . . . . 2.09 108.269 168.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.7 mm -93.73 135.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.627 -1.249 . . . . 2.91 107.627 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.08 176.61 29.86 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 122.872 0.272 . . . . 1.92 112.535 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.4 39.96 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 125.256 3.97 . . . . 2.64 112.153 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -161.11 -36.45 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.3 2.24 . . . . 4.89 113.53 -158.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.86 0.0 21.34 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 117.169 -1.906 . . . . 3.1 116.307 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -99.4 157.94 16.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.898 1.849 . . . . 5.33 111.195 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -74.28 108.21 6.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.111 1.365 . . . . 3.9 110.386 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.33 -28.59 16.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.575 0.75 . . . . 2.68 112.275 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -170.79 -179.71 2.93 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.756 1.622 . . . . 2.66 111.842 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -158.87 157.71 32.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.648 1.979 . . . . 3.99 112.321 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -147.7 -179.46 6.9 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.517 1.927 . . . . 2.83 111.394 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.75 -100.87 0.23 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.816 1.198 . . . . 4.16 112.362 174.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -67.38 -30.28 70.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.937 -1.331 . . . . 4.66 113.461 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.95 137.39 50.32 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.758 0.823 . . . . 4.58 109.508 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.54 86.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.641 0.777 . . . . 4.33 110.641 -143.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -89.02 -164.38 1.13 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.83 1.652 . . . . 9.69 109.227 156.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -29.61 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.636 2.374 . . . . 2.24 116.446 -168.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.71 -20.95 72.99 Favored Glycine 0 N--CA 1.476 1.327 0 CA-C-N 118.945 0.793 . . . . 1.8 112.74 -168.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -18.73 30.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.386 0.674 . . . . 5.06 112.168 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.92 -49.69 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.105 -0.997 . . . . 1.45 109.379 156.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.47 70.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.144 0.883 . . . . 1.36 113.169 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.22 60.06 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.279 1.215 . . . . 1.36 114.279 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 64.3 p -69.56 -52.55 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.618 -0.676 . . . . 1.74 111.689 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.5 mm -58.48 -42.51 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.256 -0.903 . . . . 1.93 109.708 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.08 -11.97 23.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.087 1.755 . . . . 2.09 114.248 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.9 m -97.39 -54.95 2.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.084 1.354 . . . . 1.95 109.566 170.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -64.09 -25.58 68.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.362 1.465 . . . . 2.5 113.986 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 mmm -65.53 -20.51 66.37 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.525 1.13 . . . . 4.76 113.987 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -62.45 -48.58 86.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 116.12 -1.895 . . . . 4.8 112.257 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.35 -43.71 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.61 2.207 . . . . 1.93 112.05 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.14 53.2 2.74 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.105 1.15 . . . . 2.58 114.105 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 . . . . . 0 N--CA 1.479 0.982 0 C-N-CA 130.258 3.423 . . . . 10.73 111.477 165.449 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 CA-C-O 118.066 -1.408 . . . . 2.73 111.314 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.5 157.59 28.85 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.976 2.451 . . . . 3.16 112.403 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -131.13 168.85 16.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.327 1.851 . . . . 2.92 111.538 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.4 p -125.49 22.12 7.72 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.772 2.138 . . . . 3.6 116.772 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.92 162.34 29.17 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.837 1.051 . . . . 2.05 113.837 -163.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 142.6 30.69 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.536 1.534 . . . . 2.02 109.8 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 m -98.53 140.26 33.04 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.089 1.756 . . . . 2.88 110.243 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -47.53 -20.86 0.27 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.405 2.682 . . . . 1.78 116.445 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.4 t -90.08 -7.39 53.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.802 1.241 . . . . 3.73 113.798 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.21 38.43 4.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.433 1.015 . . . . 3.46 113.265 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.49 -172.99 3.56 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.226 1.41 . . . . 5.24 110.016 172.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -152.9 136.82 16.26 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.459 1.027 . . . . 6.78 109.709 -156.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.545 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 8.8 mptt -132.16 167.28 20.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.747 1.758 . . . . 4.24 115.747 -168.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 88.2 m -164.91 156.17 14.86 Favored 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 132.732 4.413 . . . . 3.09 105.232 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.51 -42.27 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.808 1.185 . . . . 3.69 113.049 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -3.93 9.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.156 1.539 . . . . 8.35 115.156 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -87.36 -20.08 27.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.742 1.217 . . . . 3.11 112.767 166.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.545 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 7.8 m-85 -109.0 -20.45 13.03 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.039 1.496 . . . . 3.4 115.039 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 137.14 31.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.204 1.402 . . . . 3.3 112.304 -171.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.85 58.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.81 1.195 . . . . 2.26 112.778 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -107.34 165.4 11.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.697 1.999 . . . . 3.28 108.296 161.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -89.61 137.48 32.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.136 -0.69 . . . . 2.19 109.136 170.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.5 pp -137.47 154.3 49.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.513 0.673 . . . . 2.73 112.471 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.5 mt -121.45 114.79 21.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.147 1.779 . . . . 2.28 109.141 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.75 120.94 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.341 0.973 . . . . 2.33 108.959 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.13 134.34 54.75 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.261 1.025 . . . . 2.22 111.478 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.38 118.19 36.34 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.632 0.773 . . . . 3.24 110.164 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.67 -178.41 15.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.294 1.426 . . . . 1.62 114.806 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -144.61 124.06 13.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.594 0.757 . . . . 3.8 111.206 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 1.5 p -81.08 28.77 0.35 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.318 -1.489 . . . . 3.31 114.679 -174.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -146.16 39.38 1.1 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 127.076 2.151 . . . . 7.46 109.322 162.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.97 147.42 94.22 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 116.133 1.901 . . . . 2.85 116.133 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -76.68 63.89 7.42 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.819 3.013 . . . . 4.66 110.2 157.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 66.37 -18.2 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 130.022 3.329 . . . . 4.5 116.66 163.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.51 -30.16 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.244 -0.91 . . . . 3.57 112.782 -170.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 17.5 m -58.58 -64.41 2.9 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 116.745 -1.598 . . . . 1.62 112.03 166.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -63.27 -26.32 71.88 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.756 1.663 . . . . 1.42 113.88 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.55 -59.69 3.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.924 1.238 . . . . 3.04 111.308 171.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.66 -29.68 69.04 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.576 0.751 . . . . 3.48 111.936 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.94 -28.18 67.25 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.376 -1.452 . . . . 3.28 112.423 170.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -69.93 -49.66 49.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.354 0.979 . . . . 3.9 109.378 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -55.69 -39.47 71.04 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.788 -1.195 . . . . 3.96 112.004 176.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.3 ttm -55.78 -48.73 74.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.298 1.839 . . . . 2.85 111.714 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 12.6 mm -66.06 -37.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 120.362 1.437 . . . . 1.52 110.464 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -62.33 -31.97 72.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.049 -1.453 . . . . 3.14 113.321 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.3 p -86.39 -34.77 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.788 1.176 . . . . 2.49 114.151 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.4 t -57.14 -44.45 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.896 1.226 . . . . 2.66 111.32 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.67 -31.38 66.73 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.124 0.97 . . . . 4.52 112.67 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -64.23 -49.69 70.94 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.992 -1.067 . . . . 2.93 112.195 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 187' ' ' ILE . 5.4 mm -64.86 -38.7 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.093 0.957 . . . . 2.53 113.397 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.12 -42.57 90.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.422 1.089 . . . . 2.89 110.315 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.1 t -70.46 -11.52 60.98 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.999 1.111 . . . . 2.81 113.999 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.21 -23.51 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.82 1.191 . . . . 3.18 110.84 169.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 67.07 -20.47 0.11 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.025 2.53 . . . . 4.09 115.714 167.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 48.2 p -67.42 -39.14 85.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.523 -1.361 . . . . 5.73 110.885 165.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.96 158.48 75.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.207 1.403 . . . . 4.49 111.444 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.57 -32.56 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.156 2.57 . . . . 3.23 113.812 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 t70 160.04 153.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.584 3.554 . . . . 3.66 108.748 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 36.0 tp -123.11 90.21 3.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.439 1.496 . . . . 2.06 107.958 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.2 m -75.03 125.64 89.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 O-C-N 121.069 -1.02 . . . . 1.59 110.265 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.46 133.37 4.54 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.093 2.528 . . . . 0.86 111.183 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.29 97.73 5.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.238 1.415 . . . . 3.11 109.12 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -84.03 129.99 34.89 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.267 1.027 . . . . 2.48 109.847 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.03 129.82 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.498 1.119 . . . . 1.77 109.03 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.6 t -92.69 117.62 30.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.152 0.581 . . . . 2.88 111.53 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -90.01 40.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.145 -0.972 . . . . 1.94 112.321 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -121.39 55.22 5.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.522 1.129 . . . . 3.3 112.624 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.95 66.94 8.7 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 125.064 3.843 . . . . 2.57 111.956 -166.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -151.97 -63.08 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.064 1.746 . . . . 6.72 109.282 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.04 27.1 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 6.46 113.334 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -80.95 156.36 26.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.889 0.852 . . . . 4.93 112.348 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 m -170.02 129.72 0.95 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.137 2.575 . . . . 2.9 106.639 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -52.57 -43.34 65.2 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.995 0.918 . . . . 4.25 112.347 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -64.28 -32.99 74.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.419 1.888 . . . . 3.74 114.228 172.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.51 72.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.954 1.252 . . . . 1.74 111.341 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.29 -40.2 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.882 -0.511 . . . . 1.73 110.357 169.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.07 68.46 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.333 -0.841 . . . . 1.98 113.096 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.8 -51.6 64.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.369 0.986 . . . . 5.17 111.65 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -57.15 -41.84 79.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.545 0.688 . . . . 4.94 111.539 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.3 t -65.35 -15.9 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.883 0.873 . . . . 1.34 112.521 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.66 -39.23 12.59 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 119.716 -1.865 . . . . 5.64 113.349 166.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.56 -53.66 48.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.193 1.397 . . . . 4.9 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -76.26 -52.34 10.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.996 0.739 . . . . 2.63 112.996 -171.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.8 t -179.44 145.23 0.42 Allowed Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.152 1.381 . . . . 1.99 110.514 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.83 -16.12 37.13 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.793 2.329 . . . . 2.28 114.27 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -72.22 -20.86 61.49 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.443 1.474 . . . . 1.99 112.974 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.6 tp -68.86 149.04 49.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.26 1.424 . . . . 1.98 113.346 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.81 141.12 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.151 0.981 . . . . 2.27 110.82 166.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.45 114.28 3.6 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.678 -1.369 . . . . 1.28 109.678 175.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.22 145.14 36.35 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.446 0.698 . . . . 2.5 109.871 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.9 m -154.46 163.71 39.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.391 1.076 . . . . 2.85 109.155 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -150.05 170.76 30.08 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 124.022 0.82 . . . . 1.88 111.345 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -61.4 162.44 7.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 3.22 110.342 164.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -48.28 -31.76 6.39 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.694 1.198 . . . . 7.99 113.741 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -67.98 -43.33 79.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.023 1.729 . . . . 3.48 111.873 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.07 -34.0 68.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.407 1.083 . . . . 3.25 111.19 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.23 -39.51 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 118.485 -0.769 . . . . 2.14 110.504 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.31 -43.06 92.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 117.539 -1.22 . . . . 3.32 110.219 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -52.59 -59.04 4.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.87 1.214 . . . . 3.55 111.306 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.7 -34.28 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.145 0.884 . . . . 3.5 112.675 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.71 86.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.681 -0.637 . . . . 2.34 111.817 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -76.74 -41.7 44.0 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.824 2.45 . . . . 4.49 112.081 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.04 50.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.055 1.342 . . . . 2.84 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.48 -2.32 57.92 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.165 0.802 . . . . 4.38 113.165 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 62.77 42.58 7.89 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.274 1.83 . . . . 6.87 112.011 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.3 m -73.79 148.97 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.828 1.251 . . . . 3.33 112.079 -165.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -76.23 132.33 39.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.812 0.845 . . . . 3.41 112.568 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -171.73 161.6 6.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.124 2.17 . . . . 3.61 111.721 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 33.4 t -150.53 108.7 3.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.941 1.296 . . . . 3.04 110.799 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.3 128.54 2.63 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.791 2.327 . . . . 2.81 112.446 -172.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.685 0 C-N-CA 124.24 0.924 . . . . 2.96 112.303 171.777 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.776 0.798 . . . . 6.41 109.733 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.1 tp -135.13 139.4 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.152 -0.968 . . . . 3.17 108.619 167.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.58 110.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 105.28 -2.118 . . . . 3.14 105.28 155.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.82 138.41 57.32 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.001 -1.111 . . . . 3.27 108.001 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -156.42 152.15 27.15 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.71 -1.244 . . . . 2.18 113.743 -166.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 58.5 p 3.71 -57.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 131.485 3.914 . . . . 4.88 119.541 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 62.52 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 128.9 2.88 . . . . 4.51 112.868 -160.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.4 pt -84.5 146.59 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 114.826 1.417 . . . . 3.32 114.826 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ttm -111.62 135.4 52.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.028 2.531 . . . . 2.23 108.871 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 135.37 47.23 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.157 -0.964 . . . . 3.03 113.386 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.84 118.82 25.57 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.026 0.93 . . . . 2.09 109.312 164.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.32 131.48 47.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.137 -1.801 . . . . 2.15 106.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -79.01 178.43 53.6 Favored Glycine 0 CA--C 1.536 1.404 0 N-CA-C 113.835 0.294 . . . . 1.91 113.835 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -74.69 58.08 4.56 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.413 3.409 . . . . 2.67 108.712 163.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.81 -63.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.938 1.695 . . . . 4.47 109.511 -149.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.17 -22.55 9.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.469 1.509 . . . . 3.39 114.995 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -83.15 169.44 15.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.867 1.334 . . . . 4.0 112.207 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -83.17 134.32 34.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.149 0.98 . . . . 5.1 111.249 169.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.69 -24.66 9.5 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.011 1.115 . . . . 3.62 114.011 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -160.3 166.75 28.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.047 1.339 . . . . 3.18 111.187 161.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -131.01 140.46 50.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.709 1.204 . . . . 3.76 112.764 172.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.1 -172.51 2.23 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.288 2.235 . . . . 2.77 108.532 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.55 73.11 0.5 Allowed Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.581 1.086 . . . . 3.29 110.758 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 88.63 151.03 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.104 2.962 . . . . 3.94 112.809 176.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.4 t30 69.16 -43.64 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.909 2.884 . . . . 4.83 115.624 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.32 113.44 4.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.23 0.923 . . . . 5.08 110.106 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 150.84 38.23 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.902 -0.499 . . . . 6.12 110.411 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -57.94 -36.46 72.55 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 119.66 -1.9 . . . . 1.99 115.178 -168.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.36 80.23 Favored Glycine 0 N--CA 1.483 1.778 0 O-C-N 120.661 -1.274 . . . . 2.11 116.038 170.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.58 -36.43 29.04 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.149 1.78 . . . . 4.72 110.308 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.86 -41.88 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.681 0.792 . . . . 1.65 108.908 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.84 96.18 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.301 0.852 . . . . 1.87 113.301 170.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.25 84.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.437 1.017 . . . . 2.1 113.224 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 p -68.7 -44.85 73.06 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 1.96 111.696 172.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.82 -35.12 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 119.992 1.269 . . . . 2.0 112.373 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.25 65.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.459 -1.401 . . . . 2.61 113.043 170.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.2 m -81.88 -44.51 16.75 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.796 0.838 . . . . 2.76 109.805 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -62.28 -25.08 67.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.551 1.14 . . . . 2.93 112.994 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 ttt -58.67 -34.74 71.58 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.114 0.966 . . . . 4.99 112.127 167.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -53.4 -49.01 90.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 116.62 -1.657 . . . . 4.21 113.945 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.62 -56.78 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.38 2.054 . . . . 3.69 111.702 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -88.17 29.81 0.92 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.982 1.475 . . . . 4.43 114.982 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.609 0 O-C-N 120.771 -1.205 . . . . 8.23 109.205 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.483 0 CA-C-O 118.944 -0.92 . . . . 2.6 114.355 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -93.28 171.35 2.07 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.346 3.364 . . . . 3.5 112.102 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.99 166.82 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.839 1.256 . . . . 3.45 111.349 162.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 m -140.58 29.68 1.93 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.098 1.518 . . . . 2.79 115.098 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -54.65 148.46 12.55 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.355 1.243 . . . . 2.42 114.355 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.1 m -72.31 139.31 47.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.369 1.468 . . . . 1.55 108.929 168.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.1 m -108.33 154.71 21.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.757 1.623 . . . . 3.56 109.126 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -60.25 -17.78 44.26 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.12 1.155 . . . . 2.24 114.12 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -65.04 -23.18 67.12 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.286 2.234 . . . . 4.5 113.749 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.21 -6.05 53.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.794 1.664 . . . . 2.06 114.134 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.25 174.25 9.22 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 4.22 111.972 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.19 130.56 48.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.003 0.521 . . . . 6.81 109.685 160.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -102.0 172.66 6.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.6 0.76 . . . . 3.35 110.678 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.72 154.48 13.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.734 2.014 . . . . 3.22 107.655 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -45.9 -26.25 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.45 2.3 . . . . 4.16 114.401 164.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -98.94 -1.06 40.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.171 1.545 . . . . 6.25 115.171 173.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.74 -59.97 2.1 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.549 -0.908 . . . . 3.41 108.549 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -62.04 -30.95 71.32 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.389 0.885 . . . . 3.87 113.389 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.78 -108.64 0.45 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.326 1.85 . . . . 4.98 110.566 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -135.78 105.67 0.54 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.489 -2.644 . . . . 3.62 106.489 165.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -107.01 -26.01 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.504 -1.236 . . . . 3.64 114.319 166.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.542 ' CD1' HD23 ' A' ' 193' ' ' LEU . 49.1 m95 117.77 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 1 C-N-CA 132.185 4.194 . . . . 2.2 109.02 -161.35 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.23 135.73 43.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.442 1.097 . . . . 2.95 109.836 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 10.1 mt -118.73 104.8 10.93 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.832 1.653 . . . . 2.68 106.908 168.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.9 pt -99.61 135.79 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.308 0.243 . . . . 3.61 111.283 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -140.37 143.8 35.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.428 1.091 . . . . 3.45 112.324 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -123.75 117.34 24.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.433 1.493 . . . . 2.8 109.37 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.55 -177.74 15.16 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.612 1.101 . . . . 1.68 114.333 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 135.5 46.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.363 1.465 . . . . 3.71 109.972 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 m -79.39 59.09 2.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.2 1.4 . . . . 3.43 110.189 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -152.59 -104.7 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.88 2.472 . . . . 7.56 107.597 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.5 OUTLIER 69.6 152.8 0.14 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 130.147 3.379 . . . . 3.01 116.887 173.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 60.6 Cg_endo -92.03 -17.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.497 2.798 . . . . 3.75 113.366 159.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 168.79 -37.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.385 1.448 . . . . 4.66 113.245 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -25.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 115.581 1.697 . . . . 3.32 115.581 -160.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 m -66.89 -62.25 4.02 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.59 1.086 . . . . 1.86 111.47 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.2 -25.43 57.73 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.508 1.472 . . . . 1.17 113.781 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.63 -23.68 67.34 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.272 1.212 . . . . 3.04 114.272 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -101.32 -18.79 15.91 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.977 1.262 . . . . 3.83 113.867 162.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.53 -43.54 98.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.661 1.573 . . . . 2.8 111.195 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.07 -55.29 18.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 3.41 112.128 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -62.55 -45.44 92.95 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.347 -1.471 . . . . 2.83 111.335 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ttm -56.24 -41.23 75.41 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.586 1.955 . . . . 2.38 112.138 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.6 mm -59.98 -54.38 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.483 -0.932 . . . . 1.99 108.483 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.476 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 63.0 mt-30 -63.51 -27.45 69.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 117.877 -1.058 . . . . 3.08 112.592 -174.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.6 -37.21 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 120.932 1.697 . . . . 2.01 111.872 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -20.14 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.733 0.813 . . . . 2.97 112.766 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -46.05 82.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.794 1.237 . . . . 4.85 111.314 170.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -66.95 -39.48 87.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.82 0.282 . . . . 2.98 111.558 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.445 HG23 HD22 ' A' ' 193' ' ' LEU . 8.4 mm -65.85 -46.21 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.661 -0.649 . . . . 2.13 112.448 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -65.9 -35.78 81.57 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.233 0.469 . . . . 3.74 110.713 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.7 m -73.57 -23.12 59.91 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.325 1.231 . . . . 2.92 114.325 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 11.0 mm -81.83 -28.29 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.261 1.424 . . . . 3.0 110.467 167.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.4 m 67.17 -12.4 0.24 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.905 2.482 . . . . 4.82 114.242 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 58.0 m -84.43 -30.31 25.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.549 1.94 . . . . 3.82 112.128 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.542 HD23 ' CD1' ' A' ' 159' ' ' TRP . 7.0 mp -63.46 159.73 48.44 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.67 1.188 . . . . 4.0 109.788 173.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -61.76 -46.04 15.14 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.392 1.394 . . . . 3.72 109.31 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -168.09 -178.55 3.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.126 2.57 . . . . 3.96 109.537 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 51.8 tp -125.67 123.57 39.23 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.563 -1.643 . . . . 2.05 106.563 150.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.8 m -106.27 98.89 20.97 Favored Pre-proline 0 N--CA 1.465 0.298 0 C-N-CA 124.67 1.188 . . . . 1.17 108.952 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.09 137.19 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.444 . . . . 0.95 109.737 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.91 111.18 9.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 123.061 1.41 . . . . 3.71 112.899 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.69 134.73 34.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.215 1.806 . . . . 2.72 109.676 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.3 mt -120.36 131.78 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.154 1.782 . . . . 1.57 106.984 168.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.37 126.22 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.741 0.701 . . . . 3.04 110.367 170.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.1 pt -98.96 16.77 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.531 1.133 . . . . 2.16 113.176 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.91 44.82 0.2 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 127.395 2.278 . . . . 3.58 114.25 168.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.59 -8.64 21.87 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.414 2.742 . . . . 2.09 115.163 -169.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.23 0.4 0.27 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.321 1.848 . . . . 5.29 114.223 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.77 30.55 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.321 2.648 . . . . 4.56 111.412 -165.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.77 -174.75 3.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.146 1.379 . . . . 3.99 111.057 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.5 t -162.36 151.08 14.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.673 1.225 . . . . 4.02 112.891 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.53 -34.92 59.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.746 1.618 . . . . 2.75 112.825 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.57 71.31 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.797 1.239 . . . . 3.62 114.05 174.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.34 74.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.923 1.238 . . . . 1.75 110.862 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.4 mm -60.39 -43.56 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.131 0.972 . . . . 1.95 111.616 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.53 89.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.341 0.656 . . . . 1.38 111.74 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.425 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 6.3 t30 -65.32 -43.84 89.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.526 -0.734 . . . . 3.16 112.188 173.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -56.51 -41.39 76.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.736 0.815 . . . . 2.98 111.404 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.3 -46.09 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.271 1.428 . . . . 1.15 111.996 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 8.3 mtmp? -52.51 -55.13 24.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.673 1.124 . . . . 4.14 112.73 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -33.62 59.91 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.822 0.675 . . . . 4.65 112.822 -160.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -73.95 -36.42 64.62 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.507 0.594 . . . . 2.95 111.613 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 m 153.38 136.15 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 129.886 3.274 . . . . 3.13 110.829 161.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -68.28 1.95 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.63 2.887 . . . . 2.55 114.47 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -66.69 -16.44 64.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 121.154 -0.966 . . . . 2.1 112.145 162.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.5 tp -80.75 145.36 31.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.654 1.581 . . . . 1.8 111.805 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.9 t -102.02 137.6 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.589 1.156 . . . . 1.87 109.572 167.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.86 132.42 9.86 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.442 1.02 . . . . 1.14 111.731 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.88 151.6 48.18 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.737 1.215 . . . . 2.44 112.211 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -166.16 -158.29 0.33 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.854 2.462 . . . . 2.95 109.135 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 152.75 -115.34 0.68 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 108.834 -1.706 . . . . 1.86 108.834 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.2 p -113.42 166.49 11.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.838 0.828 . . . . 3.25 111.656 166.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.62 -33.65 47.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.158 1.783 . . . . 6.91 113.084 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -67.62 -43.55 80.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.068 0.947 . . . . 2.93 112.112 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -70.31 -40.37 74.25 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.356 0.98 . . . . 5.51 111.577 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.6 t -55.27 -38.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.863 0.865 . . . . 2.07 111.988 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.5 -45.82 64.9 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 117.385 -1.293 . . . . 4.03 110.301 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -52.04 -53.96 35.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.026 1.739 . . . . 3.26 111.342 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.09 -32.31 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 113.226 0.824 . . . . 2.61 113.226 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.65 -47.93 61.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.907 -1.12 . . . . 2.36 111.306 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -70.87 -34.06 71.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.611 2.764 . . . . 4.19 112.147 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.13 9.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.332 1.453 . . . . 2.32 111.195 169.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.32 8.68 8.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.043 0.757 . . . . 3.24 113.043 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 42.44 43.92 3.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.258 2.223 . . . . 5.08 113.251 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 263' ' ' ILE . 7.9 p -69.72 -30.2 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 118.444 -0.789 . . . . 4.77 112.711 -172.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.7 t80 67.32 156.49 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.368 1.867 . . . . 3.38 113.9 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -176.88 164.44 2.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.476 2.711 . . . . 3.29 109.558 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.5 t -154.77 99.16 2.42 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 121.546 -0.721 . . . . 3.19 111.017 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -95.63 154.33 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.141 3.228 . . . . 3.1 112.252 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.895 0 CA-C-N 116.304 -0.407 . . . . 2.83 112.969 166.077 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 13.6 p90 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 113.464 0.912 . . . . 6.31 113.464 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 33.8 mm 70.49 157.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.855 2.062 . . . . 3.83 111.367 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.25 140.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.243 1.417 . . . . 4.66 108.894 170.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -63.18 108.83 1.35 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.428 1.491 . . . . 4.68 109.951 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -75.97 10.48 1.86 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.495 1.918 . . . . 5.49 115.558 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.0 m -74.69 95.7 2.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.826 1.25 . . . . 5.95 109.807 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.93 156.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.9 1.28 . . . . 4.93 111.053 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.436 ' H ' HG23 ' A' ' 243' ' ' VAL . 70.8 mt -133.97 134.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.282 1.433 . . . . 2.67 109.342 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 89.5 mtp -89.89 145.5 25.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.926 0.891 . . . . 2.29 111.045 171.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -126.21 153.4 44.73 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.332 1.053 . . . . 2.8 112.354 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 10.6 tp -103.62 131.63 50.59 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.044 1.738 . . . . 2.03 109.996 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 130.71 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 107.524 -1.287 . . . . 1.91 107.524 162.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.4 179.84 53.15 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.682 1.134 . . . . 2.27 114.425 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -91.89 75.46 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.251 3.301 . . . . 3.97 110.367 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.7 t70 177.19 -77.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.647 -1.615 . . . . 4.78 108.822 -135.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.79 -16.63 2.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 117.359 -1.801 . . . . 2.88 115.156 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.83 168.57 9.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.532 1.666 . . . . 4.83 114.397 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.46 150.97 29.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.056 2.142 . . . . 6.21 113.534 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.0 mt -136.64 -38.73 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.424 1.638 . . . . 2.64 115.424 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -166.36 167.45 15.85 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.616 1.098 . . . . 2.65 113.306 -168.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.29 158.82 43.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.923 1.289 . . . . 5.19 113.911 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.05 177.21 9.33 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.202 1.401 . . . . 2.38 114.207 -170.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.9 -177.1 22.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.179 2.8 . . . . 3.35 109.736 -169.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -55.34 1.14 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 119.785 3.254 . . . . 4.37 119.785 -166.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -111.63 -6.45 14.37 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.402 1.63 . . . . 5.29 115.402 165.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -116.79 89.27 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.459 1.104 . . . . 4.39 109.965 157.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.7 mtt85 -82.88 -167.85 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.134 1.774 . . . . 6.01 110.062 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.6 tmtt? -40.21 -57.71 1.65 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.148 1.779 . . . . 2.33 115.149 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.51 -38.37 51.99 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 123.437 0.542 . . . . 1.85 112.031 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.11 -33.05 75.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.894 0.877 . . . . 4.45 112.289 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 30.2 mt -68.4 -56.15 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.505 0.722 . . . . 1.64 110.049 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.06 78.7 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.096 0.776 . . . . 1.85 113.096 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -71.37 -33.86 69.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.631 1.173 . . . . 2.46 113.732 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.9 p -68.78 -45.27 71.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.662 -1.161 . . . . 1.87 111.288 168.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.6 mt -56.31 -42.28 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.41 1.459 . . . . 1.47 111.492 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.56 -28.5 69.68 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.141 -0.974 . . . . 1.95 113.342 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.5 m -73.1 -43.6 61.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.318 1.047 . . . . 2.71 110.132 172.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -64.68 -25.91 68.15 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.722 1.209 . . . . 3.16 112.353 172.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.1 ttp -69.93 -16.81 63.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.638 1.575 . . . . 4.51 112.676 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -51.77 77.56 Favored Pre-proline 0 CA--C 1.553 1.086 0 O-C-N 120.195 -1.566 . . . . 6.62 110.438 174.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.0 -51.61 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.074 1.849 . . . . 2.46 111.038 166.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.92 44.2 0.98 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.596 1.332 . . . . 3.27 114.596 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 . . . . . 0 N--CA 1.467 0.419 0 O-C-N 121.341 -0.85 . . . . 8.9 109.279 163.658 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 117.656 -1.636 . . . . 3.42 110.091 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.34 165.0 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.256 2.637 . . . . 3.35 112.691 -170.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -91.45 159.91 15.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.77 1.228 . . . . 3.17 109.007 166.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 m -142.31 57.23 1.46 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 120.159 1.345 . . . . 2.27 114.145 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.81 166.24 12.29 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 119.69 -1.882 . . . . 3.51 113.814 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 m -89.75 152.76 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.493 1.917 . . . . 2.37 108.762 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.5 p -95.87 161.25 14.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.395 1.093 . . . . 2.82 112.524 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -52.72 -33.7 49.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.612 2.365 . . . . 2.11 113.461 170.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.5 p -76.0 -47.61 24.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.098 1.359 . . . . 4.35 111.5 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.07 39.25 0.46 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.407 1.003 . . . . 3.0 114.672 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 -179.66 3.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.712 1.605 . . . . 3.46 109.059 170.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.53 97.28 3.53 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.128 1.331 . . . . 5.14 110.697 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.06 159.69 15.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.761 1.224 . . . . 3.14 112.411 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 153' ' ' LYS . 67.7 m -139.16 149.74 44.8 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.33 1.852 . . . . 3.91 107.167 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -25.13 61.2 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.105 0.955 . . . . 3.89 112.702 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.452 ' H ' HG22 ' A' ' 151' ' ' THR . 1.5 mmmp? -68.26 -18.34 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.552 1.686 . . . . 5.57 115.552 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.4 -48.11 36.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.852 1.261 . . . . 3.23 109.341 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -89.47 13.34 14.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.643 1.177 . . . . 3.42 113.187 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.78 118.46 6.67 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.344 -1.472 . . . . 5.17 109.683 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 104.89 -8.66 46.37 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 123.656 0.646 . . . . 3.31 114.38 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -80.77 -154.65 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.223 1.409 . . . . 3.44 111.412 -170.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -126.16 119.45 27.55 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.289 -1.507 . . . . 2.14 107.215 154.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.25 45.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.012 0.91 . . . . 3.38 111.701 -173.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 mt -131.37 135.56 47.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.219 1.807 . . . . 3.25 108.964 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.65 132.66 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.667 0.787 . . . . 2.47 110.007 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -139.88 148.91 42.74 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.265 1.426 . . . . 2.63 112.217 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -114.92 118.76 34.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.398 1.479 . . . . 3.2 108.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -124.48 160.53 19.07 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 116.858 1.503 . . . . 2.0 116.858 -166.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -100.53 22.62 11.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.532 2.333 . . . . 5.0 110.366 165.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 34.3 m 70.51 -66.59 0.28 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.02 2.528 . . . . 5.14 110.972 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -108.5 -29.04 8.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 117.696 -1.145 . . . . 9.83 113.147 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER 61.22 -172.03 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.699 1.199 . . . . 2.25 113.284 -176.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 89.3 Cg_endo -69.06 61.18 1.34 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.57 2.18 . . . . 3.61 110.161 139.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 65.25 -4.23 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 129.817 3.247 . . . . 4.44 115.808 166.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.11 -33.43 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 117.878 -1.058 . . . . 3.06 113.847 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.5 m -48.24 -60.68 4.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 120.452 1.478 . . . . 1.41 112.454 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 -24.35 42.42 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.427 2.085 . . . . 1.29 114.414 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.3 -43.96 96.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.971 1.26 . . . . 3.08 111.398 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.54 -35.17 75.19 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.128 -0.983 . . . . 3.44 111.571 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 -56.36 20.1 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.828 1.251 . . . . 3.04 111.651 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.02 -43.97 94.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.057 0.844 . . . . 3.79 110.267 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -54.07 -39.46 66.3 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.035 -1.666 . . . . 4.09 113.016 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ptp -68.74 -34.82 76.27 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.988 1.722 . . . . 2.76 113.771 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.2 mm -66.02 -42.78 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 120.34 1.427 . . . . 1.96 111.436 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.404 ' HB3' ' CD ' ' A' ' 283' ' ' LYS . 83.8 mm-40 -63.3 -37.97 89.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.606 1.562 . . . . 3.41 110.847 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.53 -45.47 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.674 -0.642 . . . . 2.69 111.989 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.59 -40.09 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.253 1.021 . . . . 2.2 113.04 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -58.06 7.48 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.048 1.339 . . . . 6.22 111.91 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.05 -40.12 92.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.417 0.525 . . . . 4.67 112.417 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 56.3 mt -59.9 -48.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.339 1.856 . . . . 3.41 112.651 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.07 -48.38 81.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.946 1.298 . . . . 3.46 109.371 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.8 t -68.92 -6.07 25.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.952 2.101 . . . . 3.92 114.409 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 191' ' ' THR . 32.8 mm -56.62 -48.61 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 119.626 1.103 . . . . 4.9 110.291 171.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 190' ' ' ILE . 32.9 p -171.55 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.464 2.394 . . . . 6.45 117.464 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.253 5.7 t 102.36 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.065 1.746 . . . . 5.23 107.438 -121.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.3 mp -93.39 161.86 29.57 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.456 -0.778 . . . . 3.62 110.495 136.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -86.16 35.84 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.199 3.932 . . . . 3.73 111.308 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 t0 70.0 174.72 0.29 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.143 2.577 . . . . 4.22 114.022 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.09 134.97 44.99 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.088 1.755 . . . . 3.04 108.1 166.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.8 m -107.43 100.71 35.39 Favored Pre-proline 0 N--CA 1.47 0.575 0 C-N-CA 123.619 0.767 . . . . 1.79 110.2 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.7 127.34 4.26 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.001 2.468 . . . . 1.57 111.099 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.02 108.52 19.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.749 2.02 . . . . 2.85 109.174 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -99.55 113.68 26.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.159 -0.682 . . . . 3.09 109.159 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.18 119.46 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.198 -0.667 . . . . 2.58 109.198 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.7 m -80.45 133.53 35.87 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.431 -0.793 . . . . 2.97 111.513 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.447 ' HA ' HG11 ' A' ' 234' ' ' VAL . 37.4 pt -82.23 -1.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 114.093 1.146 . . . . 2.66 114.093 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.65 48.89 0.23 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 127.425 2.29 . . . . 3.12 114.026 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.63 -6.79 19.28 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.636 2.224 . . . . 4.23 113.458 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -81.8 -2.76 51.99 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.303 0.956 . . . . 4.32 112.845 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.79 -27.48 1.29 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.62 1.341 . . . . 6.11 114.62 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -109.15 141.21 41.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.216 1.371 . . . . 6.79 111.915 172.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 82.7 p -95.64 159.71 14.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.551 1.167 . . . . 3.72 112.805 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -54.77 -36.71 65.16 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.193 1.397 . . . . 3.51 112.335 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -71.93 -33.51 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.112 1.365 . . . . 3.07 112.877 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.27 91.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.586 1.084 . . . . 1.78 112.248 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . 0.269 4.3 tp -70.57 -23.54 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 121.123 -0.986 . . . . 3.05 113.142 173.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.85 -42.61 94.75 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.563 -1.336 . . . . 1.86 111.924 167.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -58.57 -41.01 84.7 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.436 -0.79 . . . . 4.88 112.082 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -62.63 -45.62 92.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.676 1.191 . . . . 3.55 112.136 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.6 t -52.21 -44.31 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.036 -1.04 . . . . 1.97 111.55 169.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -13.1 62.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.361 1.245 . . . . 5.49 114.361 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -79.1 -47.05 16.82 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.419 1.463 . . . . 4.36 110.666 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -95.19 -50.23 5.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.581 0.956 . . . . 3.46 113.581 -172.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 170.52 141.06 0.09 OUTLIER Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 124.715 1.206 . . . . 2.48 113.293 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.57 -5.64 17.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.794 2.996 . . . . 1.81 114.217 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -71.83 -16.91 62.17 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.948 1.249 . . . . 2.15 112.959 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.06 132.35 44.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.335 0.97 . . . . 2.06 109.892 174.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.9 119.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.943 -1.502 . . . . 1.92 106.943 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.96 134.83 12.7 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 107.949 -2.061 . . . . 1.33 107.949 163.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.02 151.18 39.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.991 0.916 . . . . 2.57 110.399 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 229' ' ' GLY . 11.6 m -152.76 -179.9 8.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.166 2.186 . . . . 3.15 107.332 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.446 ' H ' HG22 ' A' ' 228' ' ' THR . . . 171.85 -132.34 2.4 Favored Glycine 0 N--CA 1.468 0.792 0 O-C-N 120.175 -1.578 . . . . 3.23 110.619 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.5 p -96.88 155.34 16.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.291 -1.003 . . . . 2.96 108.291 155.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.31 -26.82 65.33 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 117.912 -1.042 . . . . 6.48 111.818 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -66.38 -34.35 77.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.424 1.465 . . . . 3.49 111.802 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.25 -37.78 75.01 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.026 -1.047 . . . . 3.32 111.439 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.447 HG11 ' HA ' ' A' ' 203' ' ' ILE . 21.5 t -64.89 -33.73 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 122.128 -0.357 . . . . 2.51 111.191 173.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.16 -35.39 71.62 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.35 1.06 . . . . 3.37 111.0 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -57.7 -54.18 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.086 0.857 . . . . 2.74 110.76 174.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.11 -33.97 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.098 0.777 . . . . 1.89 113.098 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.47 -48.31 75.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.153 0.981 . . . . 1.87 111.792 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -32.81 69.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.353 2.261 . . . . 4.65 112.869 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.47 -67.01 0.48 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.525 1.057 . . . . 2.54 110.138 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -72.36 4.14 4.03 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.389 1.255 . . . . 2.54 114.389 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 58.96 44.72 16.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.29 1.836 . . . . 5.31 113.799 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.41 144.81 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.57 -0.706 . . . . 3.42 111.401 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.09 136.93 33.82 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.789 -0.57 . . . . 3.59 110.701 165.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -162.05 161.68 28.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.021 1.729 . . . . 3.38 111.322 176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.4 m -164.26 115.1 0.95 Allowed Pre-proline 0 N--CA 1.478 0.952 0 O-C-N 121.055 -1.028 . . . . 2.68 112.644 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -88.63 140.18 4.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.426 2.751 . . . . 2.81 113.771 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.524 0 N-CA-C 110.239 -1.144 . . . . 2.88 110.239 163.754 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 113.616 0.969 . . . . 3.6 113.616 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.4 132.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 119.296 -2.128 . . . . 2.72 111.838 170.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.78 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.156 1.383 . . . . 3.23 108.524 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.22 148.23 35.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 3.31 112.03 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -150.86 154.32 37.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.57 1.548 . . . . 2.04 110.896 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 t -59.62 153.56 19.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.495 0.718 . . . . 3.36 111.46 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.83 58.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 122.635 1.207 . . . . 3.97 108.17 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.1 mt -133.79 132.58 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.384 1.473 . . . . 2.62 108.698 -172.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 40.5 mtp -102.88 135.18 45.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.708 2.003 . . . . 2.86 111.737 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -102.54 135.19 44.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.022 1.329 . . . . 4.02 111.152 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.09 124.55 41.14 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.307 0.958 . . . . 3.74 109.54 171.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.92 131.39 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.076 -1.453 . . . . 2.69 107.076 158.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -138.45 -133.95 3.14 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.734 -1.037 . . . . 2.44 112.293 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -77.33 79.75 3.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.813 2.342 . . . . 3.84 109.922 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -171.84 -64.39 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.984 2.914 . . . . 5.9 108.346 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.27 7.23 35.39 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.958 -1.468 . . . . 4.68 116.585 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -138.26 -47.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.267 1.534 . . . . 5.54 113.443 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -168.19 156.87 8.97 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 3.61 112.53 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -151.54 -42.64 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.887 1.069 . . . . 3.28 113.887 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -170.88 172.76 5.46 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.479 1.912 . . . . 3.44 110.415 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -145.96 157.46 43.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.201 -0.937 . . . . 2.99 112.636 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' PHE . . . . . 0.437 ' CD2' HG23 ' A' ' 286' ' ' ILE . 0.1 OUTLIER -152.88 -167.63 2.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.04 1.736 . . . . 3.26 110.477 -170.428 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.92 -115.41 1.25 Allowed Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.017 1.294 . . . . 2.73 110.866 164.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.91 -7.59 1.79 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.805 1.409 . . . . 3.61 114.805 175.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -145.64 157.94 43.91 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.075 0.852 . . . . 5.21 111.045 163.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 72.47 131.29 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.959 2.104 . . . . 5.67 108.894 -143.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.67 175.63 5.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.881 2.072 . . . . 7.3 111.607 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.404 ' CD ' ' HB3' ' A' ' 182' ' ' GLN . 2.1 tmtt? -29.35 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 126.593 1.957 . . . . 2.38 113.886 -174.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.83 -19.72 69.81 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-O 119.418 -0.657 . . . . 2.16 113.839 -175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -63.88 -37.07 86.05 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.099 1.449 . . . . 3.32 111.175 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 277' ' ' PHE . 96.6 mt -68.43 -50.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.806 0.842 . . . . 2.18 110.986 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.82 88.81 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.042 -0.411 . . . . 2.33 111.601 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.29 80.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.538 . . . . 2.22 113.453 173.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.5 p -60.57 -43.27 97.51 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.832 1.196 . . . . 2.2 111.501 167.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.48 -33.77 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.445 -1.409 . . . . 2.33 111.997 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.51 -25.03 65.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.92 1.288 . . . . 2.51 113.272 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.8 m -75.16 -46.61 33.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.262 1.025 . . . . 2.46 109.896 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -59.2 -26.44 64.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.372 1.469 . . . . 3.1 112.832 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -59.93 -25.29 65.03 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.739 -1.226 . . . . 4.6 113.154 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -61.54 -51.75 74.77 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 117.213 -1.375 . . . . 4.77 111.824 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.71 -55.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.586 2.191 . . . . 3.55 111.463 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -81.53 77.35 8.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.011 1.324 . . . . 4.12 111.295 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 125.22 1.408 . . . . 9.11 112.824 -177.695 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.259 0 CA-C-O 117.734 -1.592 . . . . 3.97 110.152 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.65 159.97 41.8 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.728 2.285 . . . . 3.48 111.176 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -136.85 165.95 24.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.377 1.071 . . . . 2.71 111.909 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 p -146.04 112.33 5.81 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.771 -1.206 . . . . 2.38 112.154 157.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.08 146.91 27.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.99 0.9 . . . . 2.13 111.585 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.2 m -83.43 130.38 35.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.174 1.39 . . . . 1.74 107.572 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -84.08 168.31 16.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.483 -1.386 . . . . 2.1 112.2 -171.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -60.13 -30.28 69.19 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.818 1.247 . . . . 1.92 112.837 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 t -91.99 13.52 18.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.633 1.573 . . . . 3.05 113.129 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.98 88.01 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 119.124 0.875 . . . . 1.91 115.075 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -91.79 -168.63 2.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.04 1.736 . . . . 3.44 109.964 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -157.71 114.39 2.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 121.947 2.158 . . . . 5.05 113.401 -169.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -109.06 167.94 9.73 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.584 1.698 . . . . 2.96 115.584 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 39.9 p -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.462 2.705 . . . . 2.29 110.133 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.31 -56.95 2.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.557 1.543 . . . . 4.31 113.159 172.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -0.7 3.89 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.918 1.821 . . . . 7.14 115.918 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -81.44 -40.06 23.92 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.424 1.466 . . . . 2.95 110.134 165.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.1 -32.05 17.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.597 1.332 . . . . 3.26 114.597 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.92 109.6 1.51 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.376 0.989 . . . . 4.26 110.108 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.67 1.99 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 124.461 1.029 . . . . 2.45 113.322 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -94.96 172.28 8.25 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.079 -1.082 . . . . 3.06 108.079 154.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -85.0 138.94 32.14 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.548 -0.538 . . . . 2.14 109.548 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.04 155.39 45.4 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.466 1.127 . . . . 2.85 113.499 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.58 127.58 52.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.579 1.552 . . . . 2.39 108.114 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.4 mt -112.74 118.08 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.97 -0.752 . . . . 1.84 108.97 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -125.49 142.68 51.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.056 1.742 . . . . 2.43 111.161 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.85 111.98 24.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.255 1.422 . . . . 2.33 111.059 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.56 -176.07 15.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.937 1.732 . . . . 1.41 113.332 -173.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -154.56 14.13 0.43 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.578 2.066 . . . . 3.9 116.578 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m 72.81 -25.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.66 1.584 . . . . 3.01 113.987 166.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -77.06 -25.68 52.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.781 1.173 . . . . 7.31 112.037 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.51 123.52 74.26 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.337 1.455 . . . . 2.95 111.547 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -90.74 -0.43 5.1 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.167 2.578 . . . . 4.09 113.155 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -125.39 -89.25 0.57 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.138 1.375 . . . . 6.32 109.504 -162.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.55 -31.18 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 117.222 -1.37 . . . . 4.21 114.181 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.6 m -59.82 -50.77 85.06 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 121.766 2.076 . . . . 1.42 111.844 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.52 -43.58 26.73 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.782 1.655 . . . . 1.14 113.23 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.4 -30.52 53.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.818 1.19 . . . . 3.2 113.162 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.438 ' HA ' ' HE2' ' A' ' 179' ' ' LYS . 5.5 mm-40 -70.28 -36.05 74.14 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.762 -1.211 . . . . 3.06 111.737 166.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.7 mt -61.3 -49.25 77.78 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.978 1.263 . . . . 2.84 111.409 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.44 -46.28 76.76 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.346 1.058 . . . . 4.04 111.953 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 176' ' ' GLU . 14.6 mtmm -53.67 -57.37 11.06 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.222 -0.924 . . . . 3.1 111.245 172.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.1 ptp -66.99 -19.36 65.7 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.036 1.124 . . . . 2.52 114.036 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.566 1.53 . . . . 1.76 110.389 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.515 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 72.9 mt-30 -62.76 -27.01 68.99 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.437 1.017 . . . . 3.17 111.908 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 t -61.65 -32.0 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.464 1.106 . . . . 1.64 113.131 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -31.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.864 1.211 . . . . 3.03 111.582 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -50.75 72.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.973 1.309 . . . . 5.19 110.08 167.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -65.76 1.97 1.16 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.256 2.622 . . . . 2.7 115.55 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 58.2 mt -123.22 -57.56 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 130.087 3.355 . . . . 2.39 110.587 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.76 -37.64 73.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.757 2.023 . . . . 3.9 112.44 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t -61.42 -27.87 68.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.751 1.22 . . . . 3.12 110.819 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.5 mm -77.46 7.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 O-C-N 120.464 -1.398 . . . . 3.97 111.195 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 67.8 m 82.54 -33.28 0.09 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.204 2.202 . . . . 5.32 113.693 147.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.2 m -153.73 45.96 0.62 Allowed 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.863 -1.148 . . . . 4.71 111.301 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.38 -175.51 0.6 Allowed Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.064 0.945 . . . . 4.18 111.437 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -83.45 136.97 7.83 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.512 2.142 . . . . 4.46 109.517 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.86 133.1 37.02 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.516 0.562 . . . . 3.91 112.516 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 14.1 tp -105.19 116.67 32.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.347 1.859 . . . . 1.71 111.173 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.0 m -103.09 99.1 13.22 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.81 1.244 . . . . 1.25 110.096 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -72.44 138.09 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.304 2.002 . . . . 1.08 112.661 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -117.95 110.93 18.31 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.797 2.039 . . . . 2.79 109.308 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -97.09 115.72 28.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.022 0.929 . . . . 2.37 109.069 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 90.3 mt -97.02 120.79 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.207 1.003 . . . . 1.69 109.845 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.2 m -69.19 132.19 46.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.611 0.364 . . . . 1.98 111.303 168.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.04 -5.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 114.536 1.31 . . . . 1.57 114.536 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -113.76 47.45 0.39 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 125.08 1.352 . . . . 3.74 113.265 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.03 73.98 3.6 Favored 'Trans proline' 0 C--N 1.363 1.337 1 C-N-CA 125.854 4.37 . . . . 2.17 112.714 -165.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -169.75 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.878 2.871 . . . . 4.23 107.298 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -7.86 12.73 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.168 1.173 . . . . 7.95 114.168 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.08 107.21 15.05 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 121.002 1.728 . . . . 3.88 111.207 160.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.6 t -82.32 154.68 25.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.596 1.158 . . . . 2.91 113.086 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.68 -39.32 80.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.713 1.375 . . . . 5.98 114.713 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 214' ' ' ALA . 6.9 mm-40 -80.08 -19.67 46.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.775 1.17 . . . . 5.84 113.632 173.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.76 68.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.21 1.823 . . . . 1.72 110.261 170.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 3.0 mm -54.39 -51.91 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.256 0.622 . . . . 2.29 111.351 165.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.508 ' HB3' ' HA ' ' A' ' 211' ' ' GLU . . . -64.98 -29.12 70.02 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.257 -1.354 . . . . 1.34 113.832 -175.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -70.42 -48.95 53.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.439 1.927 . . . . 3.34 110.556 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.36 -41.44 65.83 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.682 0.793 . . . . 3.61 111.571 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.95 -53.29 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 125.511 1.524 . . . . 1.64 113.598 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -57.07 -40.86 77.68 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.382 1.073 . . . . 5.92 112.883 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.97 -53.12 51.32 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.925 2.09 . . . . 3.49 111.228 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.65 -36.81 85.46 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.503 1.298 . . . . 3.18 114.503 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.1 m 148.38 148.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 128.681 2.792 . . . . 2.33 113.581 167.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.15 9.66 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.201 3.268 . . . . 2.77 116.525 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -91.22 -9.24 45.99 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 120.989 1.722 . . . . 2.72 113.17 161.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 66.8 tp -84.08 147.12 27.55 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.667 1.187 . . . . 1.79 109.842 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 t -130.56 138.64 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.474 1.11 . . . . 1.93 108.503 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.82 122.18 7.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.234 -1.546 . . . . 1.09 109.234 169.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.34 140.11 39.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.283 1.033 . . . . 2.36 108.945 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.0 p -151.72 -172.6 4.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.621 1.969 . . . . 2.86 109.399 -165.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.14 -155.84 10.16 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 123.121 0.391 . . . . 2.24 113.088 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 232' ' ' GLU . 5.3 t -73.81 -177.08 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.546 -1.279 . . . . 2.57 107.546 136.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -44.91 -39.43 5.43 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.288 1.035 . . . . 6.64 111.817 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.444 ' H ' HG23 ' A' ' 230' ' ' THR . 4.2 mp0 -70.41 -37.65 74.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.555 1.07 . . . . 2.87 113.601 -165.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.8 -30.56 68.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.805 1.639 . . . . 3.53 111.511 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.43 -38.94 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.862 0.865 . . . . 1.67 111.136 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.72 -50.07 75.27 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.736 -1.209 . . . . 3.89 107.736 171.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -54.93 -61.58 2.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.612 -1.185 . . . . 2.6 112.959 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.62 -34.33 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.598 1.545 . . . . 1.99 113.232 -166.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.22 96.18 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.279 -0.888 . . . . 1.53 110.535 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -73.47 -32.85 64.55 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.884 1.673 . . . . 4.11 112.846 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.43 97.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.794 1.179 . . . . 1.99 112.007 171.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -84.03 1.97 41.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.698 0.799 . . . . 2.52 112.946 171.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.54 22.05 9.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.001 2.121 . . . . 6.69 113.991 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.0 m -86.99 164.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.647 0.779 . . . . 2.85 110.181 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -155.38 168.99 25.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.776 1.23 . . . . 4.95 111.989 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -161.98 128.58 3.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.336 0.655 . . . . 4.1 110.869 -163.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.8 m -110.27 110.38 58.28 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-O 118.598 -0.715 . . . . 2.71 111.835 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.1 146.31 20.02 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.828 2.352 . . . . 2.96 111.839 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.69 0 CA-C-O 119.504 -0.609 . . . . 2.64 113.11 176.618 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 24.0 t80 . . . . . 0 CA--C 1.55 0.956 0 CA-C-O 122.885 1.326 . . . . 3.53 114.444 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.14 153.31 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.559 1.543 . . . . 4.12 110.303 159.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.85 150.54 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.055 1.742 . . . . 2.96 106.919 163.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.13 155.66 34.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.114 -0.698 . . . . 3.71 109.114 164.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -140.47 87.7 2.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.53 0.681 . . . . 1.99 110.865 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.5 t -74.51 76.57 1.95 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 124.037 1.875 . . . . 5.54 109.379 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.1 pp -132.25 172.65 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.167 1.787 . . . . 6.89 109.532 -172.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 11.3 tt -141.42 164.59 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.198 -0.939 . . . . 2.77 109.121 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 22.6 ttm -99.13 141.28 32.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.571 1.078 . . . . 2.76 110.229 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -109.66 148.73 30.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.352 1.061 . . . . 2.57 112.792 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 127.0 46.32 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.649 1.58 . . . . 2.69 108.208 163.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 156.48 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.149 1.379 . . . . 2.11 108.334 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -155.5 -134.45 1.86 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.505 1.05 . . . . 1.85 111.977 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -85.86 36.4 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.852 3.701 . . . . 3.32 112.412 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -120.61 -38.52 2.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.739 2.015 . . . . 6.79 114.889 -164.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.29 2.46 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.086 -1.206 . . . . 3.27 110.086 -158.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.32 -2.95 3.08 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.717 1.377 . . . . 4.32 114.717 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -138.88 76.79 1.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.632 1.173 . . . . 3.7 112.001 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -34.87 17.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.161 0.984 . . . . 3.05 111.824 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -168.96 174.77 6.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.828 2.851 . . . . 2.32 108.441 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -153.86 150.02 27.96 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.64 -1.287 . . . . 2.8 111.715 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.95 114.03 21.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.352 1.061 . . . . 2.47 108.885 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.98 42.2 3.05 Favored Glycine 0 N--CA 1.464 0.542 0 CA-C-O 118.324 -1.265 . . . . 3.73 111.467 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . 0.266 3.5 pt20 44.17 45.16 6.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.011 1.724 . . . . 4.02 112.186 -170.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -139.63 -37.41 0.49 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.755 1.761 . . . . 5.25 115.755 -164.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -63.84 135.32 56.5 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.356 -1.465 . . . . 4.43 109.098 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -76.71 171.22 15.05 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 121.395 1.907 . . . . 8.0 109.193 163.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -48.33 -43.97 33.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.935 0.894 . . . . 2.02 113.167 -177.335 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -57.18 -36.34 74.62 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.942 1.258 . . . . 1.58 114.951 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -86.83 -18.08 31.83 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.421 1.61 . . . . 4.05 112.774 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 69.1 mt -69.22 -55.75 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.052 -1.092 . . . . 1.37 108.052 170.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.35 95.59 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.087 0.773 . . . . 1.69 113.087 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.39 90.63 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.83 1.195 . . . . 1.9 112.47 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.4 p -61.59 -43.83 98.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.567 1.076 . . . . 1.51 112.142 170.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.86 -47.11 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.637 1.108 . . . . 1.47 110.723 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.54 -30.72 70.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.309 0.959 . . . . 1.58 113.061 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.2 m -68.37 -50.27 54.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.433 1.093 . . . . 2.36 109.89 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -70.27 -34.04 72.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.761 1.225 . . . . 2.55 113.449 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -60.66 -33.82 73.38 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.288 1.835 . . . . 4.04 112.84 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -59.6 -52.44 74.03 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 116.785 -1.579 . . . . 4.43 112.985 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.91 -44.5 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.274 2.649 . . . . 2.98 111.589 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.16 62.65 7.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.625 1.17 . . . . 2.88 111.038 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 . . . . . 0 N--CA 1.471 0.611 0 C-N-CA 125.618 1.567 . . . . 8.15 114.591 -166.213 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.144 0 CA-C-O 119.042 -0.866 . . . . 2.77 113.088 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.4 148.92 30.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.029 2.486 . . . . 3.25 111.854 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -130.68 125.16 33.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.6 1.16 . . . . 2.9 111.302 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -109.81 46.57 1.0 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.448 -1.407 . . . . 2.69 111.983 -162.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -85.35 155.25 21.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.573 1.549 . . . . 2.95 111.792 -160.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.3 m -79.83 133.78 36.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.302 1.041 . . . . 1.86 109.868 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.2 p -81.94 160.65 23.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 123.061 1.41 . . . . 2.68 112.655 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -2.73 1.57 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.773 2.029 . . . . 1.74 114.905 168.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 t -100.37 -41.31 7.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.953 0.901 . . . . 3.73 110.961 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.28 -0.77 7.05 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 125.154 1.359 . . . . 1.95 115.546 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.09 157.81 35.38 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.102 0.951 . . . . 3.78 108.544 163.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.451 HH12 ' CD ' ' A' ' 233' ' ' GLU . 87.5 mtt-85 -92.13 134.24 35.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.749 -1.219 . . . . 7.35 110.857 174.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -138.47 136.02 35.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.706 1.002 . . . . 3.09 113.706 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 149.1 51.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 128.57 2.748 . . . . 3.31 109.469 -164.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -32.42 -43.59 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.582 2.353 . . . . 4.02 114.389 158.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.02 -25.73 68.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.23 1.412 . . . . 7.78 113.227 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -89.4 -28.22 19.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.406 1.082 . . . . 2.93 111.521 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -80.58 -16.85 53.13 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.808 1.04 . . . . 2.82 113.808 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 111.31 1.39 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.865 1.266 . . . . 3.67 111.945 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.35 -24.13 4.48 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.092 1.329 . . . . 2.72 112.796 -171.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.15 -162.11 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 117.825 0.813 . . . . 3.74 109.11 149.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -105.66 153.3 22.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.618 1.167 . . . . 1.84 110.115 168.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 pp -135.37 134.95 40.3 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.402 -0.811 . . . . 2.49 110.918 173.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.59 132.07 54.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.296 1.838 . . . . 3.01 107.499 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.13 129.3 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.398 1.079 . . . . 2.23 110.441 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -106.74 145.82 31.59 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.755 2.022 . . . . 2.55 111.523 163.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -112.3 118.28 34.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.557 1.143 . . . . 2.38 112.793 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.89 164.15 27.9 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 117.059 1.584 . . . . 1.56 117.059 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -26.97 11.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.129 1.772 . . . . 3.76 112.929 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 89.1 m 118.66 109.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.202 3.801 . . . . 3.07 109.997 163.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . 0.346 1.5 t-160 41.12 52.01 3.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.725 2.01 . . . . 10.34 114.241 -161.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.76 149.63 41.3 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 126.219 1.808 . . . . 4.16 109.993 159.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.03 -17.85 21.85 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.795 2.33 . . . . 4.8 114.361 -156.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -42.15 42.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.248 1.019 . . . . 11.16 112.528 -162.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 p 174.6 3.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 127.139 2.176 . . . . 4.79 114.623 -163.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . 0.251 46.9 t -57.93 -66.79 1.13 Allowed Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 115.423 1.638 . . . . 1.85 115.423 -147.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.34 -17.63 39.36 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.212 2.608 . . . . 1.76 113.246 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -69.35 -31.42 69.85 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 117.881 -1.057 . . . . 6.74 112.844 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -87.86 -20.12 26.47 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 121.164 1.802 . . . . 3.17 113.323 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -47.42 85.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.41 -1.431 . . . . 2.61 109.681 164.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.99 -51.27 64.43 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.49 1.516 . . . . 4.58 111.256 171.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -67.75 -21.53 65.27 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.673 -1.267 . . . . 3.44 113.666 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.9 ttp -67.47 -32.26 72.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.1 0.864 . . . . 2.99 112.362 164.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.58 -53.28 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 119.914 -1.742 . . . . 2.92 108.973 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.45 21.79 0.1 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.711 1.375 . . . . 3.32 114.711 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.46 -40.77 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 120.569 1.531 . . . . 3.42 111.912 147.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.9 t -57.66 -49.41 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.254 0.933 . . . . 2.02 110.428 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -59.83 -32.23 70.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.152 1.781 . . . . 3.62 113.168 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -81.45 -35.12 30.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 2.55 113.012 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.9 mt -62.92 -49.54 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.279 0.632 . . . . 2.77 109.601 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -62.92 -35.14 79.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.658 2.383 . . . . 3.54 111.585 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -66.54 -13.47 61.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.411 1.263 . . . . 2.94 114.411 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 87.6 mt -100.33 96.68 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.541 -1.349 . . . . 4.04 108.309 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.4 m -65.11 69.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.31 2.244 . . . . 5.3 112.529 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 176.2 -28.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.372 1.869 . . . . 4.13 112.78 -165.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.11 148.19 47.06 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 119.789 1.177 . . . . 3.59 112.139 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.24 142.87 15.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.398 2.732 . . . . 3.2 109.318 168.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -69.45 162.3 27.7 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.579 1.696 . . . . 3.82 115.579 -163.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 35.3 tp -119.51 96.07 5.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.128 2.171 . . . . 2.49 108.917 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.6 m -72.84 123.47 89.61 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-O 118.193 -0.908 . . . . 1.92 109.609 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.15 118.6 2.67 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.503 2.802 . . . . 1.11 111.118 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.9 mt -108.91 126.03 52.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.231 1.412 . . . . 3.86 110.482 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -104.04 130.56 51.73 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.468 1.107 . . . . 2.06 109.227 168.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.47 124.8 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.752 0.787 . . . . 1.64 111.444 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.6 m -66.07 129.95 41.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.924 0.89 . . . . 2.1 111.899 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.29 -17.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 114.831 1.419 . . . . 2.35 114.831 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -117.06 44.63 0.46 Allowed Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 125.23 1.412 . . . . 4.58 112.406 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.31 83.22 1.51 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.776 2.984 . . . . 2.58 113.778 -166.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -155.68 28.53 0.38 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.794 2.038 . . . . 5.17 110.501 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -156.54 -35.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.055 1.132 . . . . 4.51 114.055 -166.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -98.69 83.91 3.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.602 1.961 . . . . 3.51 111.088 -167.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 m -49.77 138.24 14.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.678 1.191 . . . . 2.39 109.588 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -43.04 -41.46 3.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.202 1.401 . . . . 3.26 113.283 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.34 -37.66 74.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.804 2.842 . . . . 6.52 113.365 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.12 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.16 0.984 . . . . 1.61 111.218 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.0 -46.44 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 118.968 -0.539 . . . . 1.54 110.49 167.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.67 69.38 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.559 1.072 . . . . 1.85 112.579 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.431 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 4.4 t30 -63.75 -51.54 64.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.389 0.995 . . . . 4.59 112.184 172.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -60.82 -41.46 95.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.586 1.555 . . . . 3.14 112.117 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.5 t -61.26 -46.63 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.318 1.047 . . . . 1.41 111.368 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 5.9 ttpp -58.48 -35.23 71.86 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.957 0.903 . . . . 5.26 112.827 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -64.11 -19.67 65.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.343 1.057 . . . . 4.59 113.075 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -91.84 -64.19 1.15 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.381 1.072 . . . . 2.59 112.959 171.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t 174.02 145.2 0.2 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 126.271 1.828 . . . . 2.27 109.692 -168.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.55 -5.38 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.382 2.721 . . . . 1.85 113.92 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -77.74 -8.72 58.37 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.638 1.108 . . . . 1.95 113.635 169.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.46 143.87 33.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.508 1.049 . . . . 3.91 112.191 173.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.97 133.75 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.337 1.455 . . . . 1.85 108.999 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -112.71 128.51 8.49 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.995 -0.842 . . . . 1.08 110.995 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.7 mp -123.83 144.92 49.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.211 1.004 . . . . 2.11 110.88 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.3 t -161.02 -161.0 0.78 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.289 2.236 . . . . 2.66 108.201 -170.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 159.54 -114.64 0.62 Allowed Glycine 0 N--CA 1.465 0.628 0 C-N-CA 124.779 1.181 . . . . 2.71 110.898 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.3 p -137.28 174.16 10.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.263 1.425 . . . . 3.65 109.852 165.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -23.56 63.63 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.596 0.962 . . . . 7.8 113.596 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -68.24 -41.08 81.71 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.455 1.502 . . . . 3.41 111.287 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.451 ' CD ' HH12 ' A' ' 149' ' ' ARG . 45.1 mt-10 -69.03 -37.82 78.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.117 0.871 . . . . 4.66 110.897 170.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -27.61 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 117.774 -1.108 . . . . 2.62 113.36 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.06 -41.62 92.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.839 1.199 . . . . 5.03 110.308 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -60.29 -54.47 45.37 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 3.5 111.75 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.18 -40.91 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.127 0.876 . . . . 2.05 111.771 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.9 73.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.97 0.508 . . . . 2.35 111.318 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.64 -34.55 69.87 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.061 1.744 . . . . 6.13 112.963 -177.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.08 -58.5 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.457 1.103 . . . . 2.47 111.792 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.77 0.67 22.8 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.475 0.917 . . . . 2.71 113.475 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.0 ttt85 45.06 38.94 3.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.752 2.821 . . . . 7.22 113.696 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.8 m -78.81 133.64 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.529 0.732 . . . . 3.34 110.278 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.79 148.57 25.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.733 0.813 . . . . 4.99 111.235 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -172.05 163.03 5.99 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.645 1.978 . . . . 3.6 110.675 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.4 t -160.6 135.58 5.59 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-O 117.902 -1.047 . . . . 4.39 111.204 172.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.02 156.38 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.162 1.908 . . . . 3.45 110.665 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.588 0 C-N-CA 124.384 0.992 . . . . 2.26 113.609 177.859 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.0 p90 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 122.178 0.99 . . . . 4.28 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 82.1 mt -57.85 145.03 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.067 -1.021 . . . . 3.39 109.483 158.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.94 158.78 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 3.18 110.481 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -101.39 141.06 34.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.911 1.684 . . . . 4.32 110.115 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.45 149.61 17.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.104 1.52 . . . . 2.18 115.104 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -51.97 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.752 2.021 . . . . 4.4 111.859 172.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.55 52.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.276 1.431 . . . . 5.75 112.24 168.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mt -136.06 128.18 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.254 1.422 . . . . 2.67 107.914 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 60.5 mtp -99.07 159.55 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.114 1.766 . . . . 2.35 110.252 174.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -135.75 146.28 47.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.908 1.077 . . . . 2.78 113.908 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.3 tp -104.59 130.06 52.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.977 1.311 . . . . 2.49 110.059 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.3 mt -111.13 142.21 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 106.997 -1.482 . . . . 4.0 106.997 150.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -114.08 -171.75 17.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.627 0.632 . . . . 1.99 113.817 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.53 70.86 6.69 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.305 3.337 . . . . 2.61 108.623 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -167.72 -62.21 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.001 1.72 . . . . 4.2 110.025 -169.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.02 -112.19 0.83 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.603 -0.726 . . . . 2.5 113.633 -162.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.54 123.11 28.89 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.512 0.931 . . . . 4.19 113.512 -149.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.5 t80 35.43 63.42 0.53 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.646 1.978 . . . . 3.6 114.393 156.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.0 tp -86.64 -4.02 59.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.423 0.897 . . . . 3.36 113.423 -166.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.85 150.11 4.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.911 2.085 . . . . 2.66 110.167 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -126.48 123.85 38.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.452 1.12 . . . . 3.49 111.078 161.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.63 86.81 3.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.134 1.374 . . . . 3.62 107.546 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.59 161.77 48.37 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.829 -1.309 . . . . 3.57 109.829 164.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -50.2 -16.03 0.28 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.554 1.687 . . . . 3.35 115.554 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -19.78 61.5 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 120.5 -1.375 . . . . 5.81 114.346 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -93.49 123.1 36.57 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.437 -1.415 . . . . 5.42 109.075 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -169.91 1.92 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.2 1.0 . . . . 5.88 108.789 167.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -30.85 -60.24 0.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.836 1.654 . . . . 3.02 113.527 170.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.04 84.07 Favored Glycine 0 N--CA 1.472 1.066 0 O-C-N 121.307 -0.871 . . . . 2.27 112.798 -166.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -76.38 -31.87 58.25 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.598 1.559 . . . . 3.0 111.562 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.32 -56.94 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.138 -0.689 . . . . 1.82 109.138 165.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.48 -43.35 88.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.624 0.972 . . . . 1.56 113.624 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.11 77.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.331 0.652 . . . . 1.89 112.469 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 16.4 p -66.84 -48.03 70.16 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.052 1.13 . . . . 1.69 114.052 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.13 -33.07 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.075 1.761 . . . . 1.71 112.168 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.0 71.84 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.906 0.776 . . . . 1.9 112.834 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 84.1 m -68.27 -41.84 80.46 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.634 0.652 . . . . 1.87 110.513 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -65.84 -27.1 67.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.544 1.137 . . . . 2.37 113.753 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.3 mmt -70.59 -10.78 60.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.577 0.955 . . . . 6.25 113.577 170.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.64 -50.41 1.27 Allowed Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 116.69 -1.624 . . . . 5.79 114.582 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.93 -37.12 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.41 2.073 . . . . 1.96 111.935 173.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.13 148.02 26.27 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.272 1.034 . . . . 2.84 112.256 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 126.563 1.945 . . . . 11.8 116.107 161.413 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.238 0 N-CA-C 110.028 -1.229 . . . . 3.41 110.028 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.89 129.16 6.13 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.558 2.172 . . . . 4.03 111.366 -170.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.46 162.65 33.95 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.579 1.952 . . . . 3.16 110.554 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.3 p -144.96 57.38 1.27 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.029 -1.045 . . . . 3.04 111.249 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.74 160.4 14.5 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.714 1.206 . . . . 2.6 113.935 -166.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -87.23 135.54 33.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.244 1.418 . . . . 1.73 111.205 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.7 p -97.03 162.95 13.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 122.82 1.295 . . . . 2.72 112.89 176.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -63.31 -20.43 65.47 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.265 1.426 . . . . 1.66 114.546 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.0 t -88.36 -4.79 58.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.815 1.246 . . . . 3.84 113.24 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.96 2.4 62.61 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 119.547 1.067 . . . . 2.25 115.525 171.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.33 154.9 17.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.789 1.235 . . . . 4.7 109.637 170.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.22 112.54 24.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.259 1.824 . . . . 4.96 109.593 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -78.79 165.78 23.18 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.301 -1.499 . . . . 4.01 112.249 177.451 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.4 m -154.67 144.74 21.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.708 1.203 . . . . 3.39 108.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -48.73 -41.49 32.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.566 1.147 . . . . 4.26 112.484 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.92 -2.45 27.06 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.516 1.673 . . . . 8.26 115.516 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -34.58 16.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 120.353 1.433 . . . . 4.36 112.335 168.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -94.23 -29.9 14.86 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.382 1.253 . . . . 3.59 114.382 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.79 124.72 23.72 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.656 1.571 . . . . 5.98 109.198 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.87 -18.4 26.6 Favored Glycine 0 N--CA 1.477 1.397 0 C-N-CA 124.211 0.91 . . . . 3.92 112.349 -160.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.17 167.84 9.63 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.018 2.527 . . . . 5.36 108.08 167.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -82.09 99.99 9.52 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.575 -1.328 . . . . 2.1 110.45 163.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 160' ' ' LEU . 1.6 pt? -96.37 140.38 31.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.409 0.623 . . . . 3.7 110.096 167.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 tt -125.02 113.55 17.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.112 -1.81 . . . . 2.72 106.112 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.17 136.97 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 3.6 111.068 -170.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -123.19 129.61 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.861 1.665 . . . . 2.97 110.688 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -99.93 102.62 14.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.576 1.15 . . . . 2.91 112.795 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.91 163.63 13.77 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.895 1.236 . . . . 1.56 114.756 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -124.34 116.66 22.96 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.966 0.906 . . . . 3.35 110.723 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.1 m -58.89 129.31 41.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.709 -1.589 . . . . 4.32 106.709 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 90.03 -1.16 0.28 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.124 2.17 . . . . 7.13 113.791 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 158.17 85.8 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 119.925 1.239 . . . . 2.33 110.103 157.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.51 -177.26 3.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.149 3.233 . . . . 2.87 112.153 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.16 1.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.404 1.882 . . . . 5.21 115.876 -171.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.24 -38.17 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.987 1.715 . . . . 3.72 110.727 172.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -60.49 9.87 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.603 1.161 . . . . 1.47 111.603 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.57 -23.75 49.45 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.897 1.731 . . . . 1.24 113.943 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -51.62 -52.02 51.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.801 1.637 . . . . 3.62 113.422 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -80.35 -25.78 39.03 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.874 -1.141 . . . . 3.05 112.955 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.21 -44.9 71.14 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.212 1.005 . . . . 2.62 110.936 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -48.1 -54.37 13.43 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.729 1.612 . . . . 5.21 110.912 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -66.64 -28.09 68.2 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.535 -1.353 . . . . 4.19 113.009 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 46.9 ttp -65.85 -39.47 90.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 117.524 -1.227 . . . . 3.47 111.429 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.33 -45.9 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 120.948 1.704 . . . . 1.75 110.722 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.5 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.124 -0.941 . . . . 4.93 112.387 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.88 -29.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.945 1.702 . . . . 1.93 110.731 168.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.77 -46.49 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.721 0.808 . . . . 2.0 109.532 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.66 -43.82 80.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.115 2.566 . . . . 4.11 113.14 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.21 -42.26 96.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.221 1.809 . . . . 2.89 112.041 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.3 mt -68.62 -40.7 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.158 0.983 . . . . 2.18 112.121 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -61.42 -31.44 71.37 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.828 1.251 . . . . 3.78 111.226 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.6 m -72.12 -21.64 61.44 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.49 -0.756 . . . . 3.14 112.874 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.52 63.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.349 -1.469 . . . . 4.3 108.131 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 75.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.659 1.984 . . . . 5.87 113.021 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.6 m 174.43 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.856 3.663 . . . . 4.12 111.239 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.28 154.18 54.13 Favored Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 121.613 2.006 . . . . 3.23 111.434 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.52 -55.13 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.719 2.279 . . . . 3.44 110.242 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -178.73 170.94 1.53 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 129.991 3.316 . . . . 3.95 108.099 168.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.3 tt -118.96 115.28 24.03 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.067 -1.827 . . . . 2.74 106.067 150.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.3 m -95.65 108.16 38.21 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 118.041 -0.98 . . . . 2.27 109.226 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.38 122.75 2.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.212 2.608 . . . . 1.05 111.171 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.0 tp -118.5 100.14 7.27 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.303 1.041 . . . . 2.34 110.469 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -84.65 120.92 26.94 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.651 -0.5 . . . . 2.21 109.651 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.9 mt -102.28 103.84 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.413 1.485 . . . . 2.72 107.161 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.8 t -97.59 132.85 42.87 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.648 -0.658 . . . . 2.98 111.125 170.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.2 pt -102.89 13.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.1 1.76 . . . . 1.78 114.665 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.23 32.39 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 116.098 1.888 . . . . 3.72 116.098 -173.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -7.83 21.9 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 123.417 2.256 . . . . 2.6 114.247 -171.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -85.68 41.39 0.9 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.264 1.025 . . . . 4.46 110.8 167.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 16.1 ttm105 -178.94 -58.25 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 131.128 3.771 . . . . 4.76 109.107 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.75 171.31 15.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.946 1.299 . . . . 4.31 111.455 -175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.1 t -149.3 153.13 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.148 -0.97 . . . . 3.2 112.305 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -41.87 50.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.818 1.647 . . . . 2.95 111.951 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -67.94 -36.44 80.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.547 1.539 . . . . 3.81 112.535 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.63 -44.5 64.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.52 1.055 . . . . 1.22 111.081 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.58 -43.06 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.353 1.061 . . . . 1.67 111.717 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.34 80.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.232 1.013 . . . . 1.27 113.115 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -70.96 -42.68 69.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.496 0.718 . . . . 4.14 111.742 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -62.65 -41.03 98.84 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.913 0.885 . . . . 2.82 111.596 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.38 -51.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.449 1.9 . . . . 1.31 112.327 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -56.77 -34.42 67.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.283 1.033 . . . . 4.86 113.372 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.96 -48.01 67.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.945 0.339 . . . . 5.05 110.547 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -72.86 21.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 3.02 114.389 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.3 p 106.43 147.42 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.656 1 C-N-CA 131.792 4.037 . . . . 2.68 112.504 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.16 -1.82 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.078 2.519 . . . . 1.6 113.329 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -90.29 -7.85 52.39 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.287 0.949 . . . . 2.48 112.793 171.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 136.36 46.72 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.523 -1.361 . . . . 2.75 111.565 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.21 121.48 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.543 0.737 . . . . 2.1 109.263 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.55 125.05 8.16 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.542 -1.423 . . . . 1.06 109.542 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.62 130.15 41.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.977 1.711 . . . . 4.3 108.817 -173.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -163.71 -163.05 0.76 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.511 1.924 . . . . 4.0 109.849 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.51 -149.01 6.88 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.448 1.023 . . . . 1.64 112.015 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -74.08 166.16 23.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.842 0.821 . . . . 2.54 110.488 159.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -47.8 -38.19 15.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.602 1.161 . . . . 5.96 113.069 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -70.85 -29.46 65.6 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.153 1.381 . . . . 3.48 111.743 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.03 -36.21 61.9 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 3.51 111.72 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.52 -35.78 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 118.836 -0.602 . . . . 2.24 111.189 170.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.55 -48.07 70.82 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.682 -1.628 . . . . 2.57 110.095 165.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -46.94 -57.78 4.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 121.555 1.979 . . . . 2.25 111.438 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.67 -39.33 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.304 0.956 . . . . 2.37 112.77 -173.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -35.5 72.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.965 0.802 . . . . 1.55 112.585 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -74.28 -40.01 62.59 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.886 2.074 . . . . 3.08 111.575 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.49 81.49 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 1.56 112.648 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.35 -6.74 59.23 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.478 0.711 . . . . 2.8 112.897 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.73 39.17 29.92 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.827 2.051 . . . . 6.07 112.708 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.2 -39.75 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.079 -1.013 . . . . 3.41 111.918 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 29.4 t80 64.47 130.6 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.198 1.799 . . . . 4.74 112.77 -165.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -116.2 152.57 33.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.002 0.921 . . . . 3.22 110.653 164.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.0 t -106.92 107.0 59.75 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.479 -0.772 . . . . 2.75 110.457 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.86 131.35 16.89 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.364 2.043 . . . . 2.74 109.993 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.515 0 C-N-CA 124.489 1.042 . . . . 2.3 114.819 -175.437 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 37.6 p90 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.816 0.341 . . . . 3.91 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.5 mm -121.08 148.93 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.575 1.55 . . . . 4.08 108.741 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.45 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 106.402 -1.703 . . . . 3.37 106.402 162.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -104.1 163.85 12.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.188 1.795 . . . . 3.58 111.569 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 158.82 33.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.534 1.133 . . . . 2.11 113.022 -158.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 49.3 p -59.19 -16.5 20.84 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.836 1.421 . . . . 3.24 114.836 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 263' ' ' ILE 0.347 10.6 tt 43.54 -143.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.819 1.248 . . . . 4.07 109.404 -147.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 262' ' ' ILE . 73.8 mt 76.18 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.285 1.834 . . . . 3.39 110.992 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -118.78 149.66 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.625 -1.17 . . . . 3.25 110.443 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.41 144.38 45.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.966 0.906 . . . . 4.02 112.749 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.1 tp -97.41 128.4 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.709 1.203 . . . . 1.99 108.52 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.31 142.24 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.207 -1.775 . . . . 2.49 106.207 161.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -132.64 -168.06 11.91 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.207 0.843 . . . . 2.56 115.207 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.63 58.84 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.652 1 C-N-CA 125.442 4.095 . . . . 4.88 110.801 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -154.39 -55.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.109 1.364 . . . . 7.12 108.292 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.07 138.36 4.47 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.09 1.328 . . . . 5.44 113.316 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 64.64 -168.61 0.21 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.388 1.475 . . . . 5.56 112.697 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -74.13 99.44 3.37 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.79 -1.194 . . . . 5.17 112.259 -173.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -24.55 27.9 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.758 1.623 . . . . 3.74 112.231 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -165.46 175.14 9.3 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.05 1.74 . . . . 2.33 110.326 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -153.29 166.49 32.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.817 1.647 . . . . 4.51 112.869 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -143.01 150.9 40.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.527 1.531 . . . . 2.58 110.196 -173.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.28 166.8 15.42 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.711 -1.049 . . . . 3.38 111.989 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -24.66 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 134.236 5.014 . . . . 3.95 119.885 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.94 -41.18 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.829 2.452 . . . . 5.36 110.21 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -76.56 113.05 13.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.335 0.97 . . . . 4.34 109.844 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.8 ttm105 -66.65 167.09 11.67 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.861 -1.15 . . . . 5.63 109.101 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -50.56 -44.84 56.73 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.25 -1.531 . . . . 2.28 113.279 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -58.15 -39.68 92.61 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.553 -0.582 . . . . 1.87 112.302 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.53 -28.55 46.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.007 1.114 . . . . 4.49 114.007 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.5 mt -58.46 -49.24 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.708 1.14 . . . . 2.3 109.002 168.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.02 91.9 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.391 0.886 . . . . 1.25 113.391 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.85 -32.03 69.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.588 0.755 . . . . 1.2 112.881 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -52.71 64.29 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.709 0.633 . . . . 1.57 112.709 168.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.35 -38.94 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.399 -1.438 . . . . 1.28 111.255 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.09 -8.77 25.6 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.079 1.352 . . . . 1.65 114.194 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 92.9 m -92.19 -48.92 6.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.053 1.341 . . . . 1.73 110.318 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -69.13 -23.34 63.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.681 0.993 . . . . 2.21 113.681 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 27.3 ttt -55.93 -26.42 47.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.163 1.785 . . . . 4.31 113.866 164.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -69.59 -46.8 26.14 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.247 -1.835 . . . . 6.72 112.464 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -59.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.22 1.946 . . . . 1.9 110.927 167.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -96.07 125.42 40.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.7 1.0 . . . . 3.78 113.7 -166.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.777 1.631 . . . . 8.54 111.964 -173.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.241 0 CA-C-O 118.199 -1.334 . . . . 3.22 110.267 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.72 138.25 6.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.399 2.099 . . . . 2.96 112.467 -163.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -162.22 165.72 26.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.447 1.899 . . . . 2.97 110.846 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.7 p -137.01 92.75 2.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.351 -0.843 . . . . 3.4 110.543 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mt -104.24 139.95 38.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.153 1.381 . . . . 2.42 111.632 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 84.8 m -67.97 135.45 52.38 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.997 0.904 . . . . 2.38 110.503 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 157.96 18.16 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.859 -1.151 . . . . 2.72 110.459 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 2.9 0.89 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.413 1.085 . . . . 1.89 113.502 165.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 m -89.96 -45.14 9.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.138 1.375 . . . . 2.85 110.8 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.31 38.47 1.11 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.987 1.279 . . . . 2.34 113.473 -168.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.87 174.82 10.05 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.905 2.082 . . . . 4.88 107.588 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -125.86 106.63 9.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 121.258 1.844 . . . . 7.1 112.551 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -99.34 153.91 18.6 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.204 1.187 . . . . 3.82 114.204 -171.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.0 p -123.03 148.2 45.82 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.345 2.658 . . . . 2.52 108.626 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -46.65 -51.75 15.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.507 1.123 . . . . 3.54 113.622 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -71.95 6.17 2.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.653 2.094 . . . . 7.21 116.653 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.11 -55.09 8.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.407 1.003 . . . . 3.78 110.76 162.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.5 -31.44 26.47 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.832 1.049 . . . . 3.02 113.832 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.04 118.73 5.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.328 1.051 . . . . 4.03 111.079 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 123.62 -27.38 5.74 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 124.114 0.864 . . . . 2.45 111.299 -167.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -84.21 166.87 17.19 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.352 -0.981 . . . . 3.77 108.352 143.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -78.54 110.17 13.39 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.728 -0.607 . . . . 2.1 112.451 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.4 mt -91.45 140.62 29.58 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.156 0.979 . . . . 2.8 112.916 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -137.43 121.66 18.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.679 1.992 . . . . 2.61 107.408 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.0 mt -126.09 131.87 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.53 0.732 . . . . 1.77 110.718 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -147.53 153.54 39.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.379 1.472 . . . . 2.67 113.068 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.44 123.06 42.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.518 1.527 . . . . 2.56 110.514 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.82 -176.95 36.23 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.21 0.844 . . . . 1.41 115.21 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -156.47 139.21 15.14 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.123 0.962 . . . . 3.82 112.946 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 t -82.2 74.5 9.17 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.424 1.011 . . . . 4.87 110.36 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 169.79 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 129.568 3.147 . . . . 7.05 110.538 -163.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.7 t -51.11 151.85 4.44 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.911 1.284 . . . . 2.21 113.844 159.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.38 64.18 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.314 3.343 . . . . 3.74 111.009 165.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.3 t0 69.59 -14.59 0.33 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.763 3.225 . . . . 4.9 114.821 162.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.37 -34.36 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 120.584 -1.323 . . . . 3.31 111.395 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.7 m -59.28 -54.34 57.18 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.317 -1.325 . . . . 2.32 114.415 167.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -67.36 -26.71 41.04 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.011 1.807 . . . . 1.72 114.154 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -66.38 -42.98 87.15 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.909 1.686 . . . . 3.53 110.814 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.73 -36.92 80.07 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.378 -0.826 . . . . 3.78 111.474 168.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 180' ' ' MET . 0.7 OUTLIER -69.56 -40.8 76.58 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.264 1.026 . . . . 2.64 112.694 178.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -57.76 11.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.148 1.379 . . . . 3.21 108.433 170.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -54.2 -37.51 64.63 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 120.174 -1.579 . . . . 3.91 113.74 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.434 ' HG2' ' HA ' ' A' ' 177' ' ' LEU . 23.9 ptp -68.73 -41.82 78.47 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 117.058 -1.448 . . . . 2.51 112.408 169.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.38 -44.66 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 121.212 1.824 . . . . 1.68 109.807 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -62.95 -29.71 71.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.214 -1.374 . . . . 3.01 113.558 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 p -86.95 -32.41 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.688 1.131 . . . . 2.62 113.394 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.03 -46.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 120.707 1.594 . . . . 2.33 110.78 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -31.54 68.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.571 1.148 . . . . 4.65 113.41 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -78.2 -13.63 59.78 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.174 -0.954 . . . . 2.66 113.328 174.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.6 mm -85.35 -55.29 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.635 1.574 . . . . 1.91 109.921 167.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -50.69 -39.3 50.88 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.406 1.482 . . . . 3.92 113.092 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -60.3 -29.41 68.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.316 1.046 . . . . 2.9 112.483 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.88 56.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 120.607 -1.308 . . . . 3.35 107.612 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -36.58 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 130.001 3.32 . . . . 4.42 118.775 -168.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -27.66 63.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.816 1.189 . . . . 4.53 111.536 172.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.84 163.01 69.72 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.127 1.771 . . . . 3.64 112.527 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -99.15 -172.35 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.924 3.083 . . . . 3.84 113.67 -166.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.48 62.73 4.68 Favored 'General case' 0 CA--C 1.549 0.942 1 C-N-CA 132.304 4.241 . . . . 5.54 116.667 -156.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.2 tp -59.76 96.94 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.67 -1.268 . . . . 1.86 112.809 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.3 m -96.35 117.86 65.84 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 125.567 1.547 . . . . 1.32 110.084 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -87.44 124.91 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.968 2.446 . . . . 0.88 111.926 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.79 102.55 9.2 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.989 2.116 . . . . 2.4 109.598 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -99.83 133.98 43.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.154 1.381 . . . . 2.46 111.618 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.82 126.19 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.556 0.742 . . . . 1.52 108.998 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 62.2 p -90.59 111.7 23.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.08 1.352 . . . . 2.52 110.733 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.3 pt -106.38 10.81 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 115.034 1.494 . . . . 1.89 115.034 -162.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -115.63 52.41 0.83 Allowed Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.595 1.158 . . . . 3.3 111.405 169.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.2 132.37 25.81 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.635 2.223 . . . . 2.58 109.188 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 128.19 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 130.334 3.454 . . . . 5.35 107.384 -163.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 -38.24 2.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.51 -0.757 . . . . 4.89 112.617 166.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.61 101.54 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.411 1.005 . . . . 4.56 108.672 160.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 48.0 m -115.82 149.37 38.68 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.372 1.469 . . . . 2.34 109.368 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -54.9 1.33 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.674 1.19 . . . . 3.42 112.148 170.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -69.03 -37.41 78.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.854 1.262 . . . . 3.19 112.94 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.71 -39.86 76.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.479 0.712 . . . . 1.48 111.793 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.07 -34.62 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.539 0.736 . . . . 1.72 110.556 175.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.0 75.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 118.693 -0.67 . . . . 1.44 111.889 170.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.6 -47.44 60.14 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.343 0.974 . . . . 4.38 112.281 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -53.42 -40.98 65.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.675 1.19 . . . . 3.8 111.485 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.4 t -64.64 -50.68 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.762 1.225 . . . . 1.38 112.017 170.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -57.28 -27.56 62.22 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.735 1.214 . . . . 5.21 113.754 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.36 -56.75 4.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.078 1.751 . . . . 3.7 111.656 174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -79.3 -38.44 35.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.328 1.233 . . . . 3.36 114.328 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 m 167.71 129.72 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 127.13 2.172 . . . . 2.02 112.806 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.77 -0.26 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.375 2.717 . . . . 1.72 113.516 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.68 -26.37 68.62 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.277 0.944 . . . . 4.33 113.418 162.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.18 133.42 35.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.164 0.893 . . . . 2.1 112.788 -165.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.82 122.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.876 1.27 . . . . 1.84 107.768 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.11 132.35 10.9 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.181 -1.168 . . . . 0.87 110.181 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.14 143.62 48.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 2.43 109.607 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.3 m -143.08 176.27 9.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 128.813 2.845 . . . . 2.84 106.676 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 168.11 -179.85 41.04 Favored Glycine 0 N--CA 1.472 1.056 0 O-C-N 120.436 -1.415 . . . . 1.91 114.364 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.0 t -75.42 163.47 27.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.264 0.625 . . . . 2.88 111.053 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.415 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -49.55 -21.42 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.419 2.288 . . . . 7.14 115.684 176.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -66.9 -51.46 55.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.137 1.375 . . . . 2.96 111.175 166.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -68.55 -43.86 75.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.242 1.017 . . . . 4.47 111.354 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.1 m -74.55 -19.94 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 114.186 1.18 . . . . 2.91 114.186 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.83 -57.54 4.52 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.807 1.185 . . . . 2.84 108.602 161.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.15 -55.41 10.42 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.223 1.409 . . . . 3.47 112.29 -173.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.37 -40.78 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 118.923 0.783 . . . . 2.12 112.94 -171.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.17 75.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.611 0.764 . . . . 1.64 110.436 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -70.6 -34.23 71.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 3.79 112.678 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.16 -58.0 5.14 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.384 1.474 . . . . 2.34 112.579 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -1.87 13.99 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.631 0.974 . . . . 2.56 113.631 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.02 32.17 6.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.29 2.236 . . . . 5.9 113.013 165.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.56 155.66 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.664 1.185 . . . . 3.43 110.149 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -74.14 137.87 43.49 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.276 0.56 . . . . 4.28 112.041 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -164.83 141.7 6.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.58 2.752 . . . . 5.32 109.481 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 129.83 2.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 117.936 -1.031 . . . . 4.97 112.586 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -69.19 141.66 48.18 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.407 2.738 . . . . 4.77 110.689 171.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.427 0 C-N-CA 124.068 0.842 . . . . 3.7 114.471 -172.94 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.2 t80 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 109.323 -0.621 . . . . 3.73 109.323 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.91 146.14 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 122.032 0.92 . . . . 4.42 110.464 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.32 128.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.132 2.173 . . . . 3.77 105.556 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -105.19 152.05 23.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.637 0.732 . . . . 3.75 111.713 -170.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -165.18 152.46 10.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.548 1.166 . . . . 2.65 114.024 -169.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 99.2 m -59.21 120.42 9.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.182 -1.372 . . . . 3.9 108.698 164.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.29 135.73 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.023 -1.473 . . . . 3.57 107.023 146.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.2 mt 135.65 127.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.108 1 C-N-CA 131.964 4.106 . . . . 2.9 109.454 176.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -100.6 150.79 22.34 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.682 1.993 . . . . 2.64 110.756 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -118.22 132.13 56.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.014 1.326 . . . . 3.4 112.196 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 8.8 tt -90.69 125.88 35.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.181 0.991 . . . . 2.21 111.091 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 143.82 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 127.629 2.372 . . . . 1.73 108.684 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.32 149.11 49.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.541 -1.144 . . . . 1.92 111.209 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.77 63.8 6.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.122 3.215 . . . . 2.88 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 153.72 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 131.36 3.864 . . . . 8.25 113.91 173.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 168.92 149.9 6.43 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 120.455 1.48 . . . . 3.32 116.023 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . 0.283 60.7 mt-10 41.33 -145.32 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.549 2.74 . . . . 4.18 113.87 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -148.54 155.49 41.2 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.044 1.293 . . . . 3.84 113.869 -163.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.84 -37.53 4.82 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.261 1.424 . . . . 2.64 111.912 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -145.32 170.85 15.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.43 1.092 . . . . 4.19 112.735 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -158.86 133.32 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.808 1.243 . . . . 3.85 111.519 160.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -178.1 -122.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.179 2.192 . . . . 3.78 111.118 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 95.79 -94.48 1.69 Allowed Glycine 0 N--CA 1.469 0.862 0 N-CA-C 109.479 -1.448 . . . . 3.61 109.479 -168.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.08 139.39 41.62 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 117.646 0.723 . . . . 3.4 111.104 168.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 80.82 -1.6 1.83 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.895 2.478 . . . . 5.32 113.311 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 121.21 36.1 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.032 1.733 . . . . 6.28 110.134 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -72.04 141.84 49.28 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.774 -1.204 . . . . 6.95 108.31 166.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -41.07 31.54 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.117 1.895 . . . . 1.73 116.117 -160.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.25 -18.77 71.64 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 119.787 1.176 . . . . 1.29 114.833 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.75 -33.89 76.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.899 -0.766 . . . . 2.95 110.777 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.6 -46.84 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.952 0.901 . . . . 1.66 109.101 172.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.97 72.39 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.685 1.129 . . . . 1.4 112.409 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.27 70.57 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.821 1.045 . . . . 1.6 113.821 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 5.7 p -87.43 -41.6 13.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.653 0.612 . . . . 1.95 112.653 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mt -52.03 -38.8 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.418 1.087 . . . . 1.47 111.01 169.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -51.73 -31.5 26.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.911 1.078 . . . . 2.2 113.911 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 19.6 p -75.26 -32.72 61.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.073 0.949 . . . . 3.75 112.036 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -72.42 -32.01 65.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.19 0.996 . . . . 2.82 112.372 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.19 -32.77 70.86 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.522 1.129 . . . . 6.6 112.299 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -49.94 -51.32 62.28 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 116.307 -1.806 . . . . 5.53 113.365 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.81 -44.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.218 2.612 . . . . 2.59 113.367 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -92.4 123.1 35.47 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.888 1.222 . . . . 3.08 114.146 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 127.258 2.223 . . . . 13.47 112.962 155.232 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 CA-C-O 118.963 -0.909 . . . . 3.06 113.585 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.78 156.61 39.58 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.206 2.604 . . . . 3.22 113.804 -168.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -138.91 169.14 18.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.54 2.336 . . . . 2.72 109.199 174.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.9 m -138.53 69.47 1.38 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.727 -1.233 . . . . 2.79 112.482 -176.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.22 172.65 7.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.441 1.097 . . . . 2.59 112.333 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.0 m -103.42 158.52 16.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.501 1.52 . . . . 1.68 109.525 173.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.3 m -107.94 159.79 16.27 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.939 1.296 . . . . 2.5 111.612 -172.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -55.23 -9.74 0.47 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 115.793 1.775 . . . . 1.72 115.793 176.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 t -113.53 7.35 17.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.951 2.1 . . . . 3.78 113.622 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.49 -10.41 69.06 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.575 1.56 . . . . 1.84 115.842 173.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.99 148.71 25.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.772 1.229 . . . . 3.48 111.984 -177.146 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.63 115.14 28.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.56 1.544 . . . . 6.08 111.249 -173.14 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 161.66 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.462 1.505 . . . . 4.11 112.742 -168.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.5 m -154.18 148.5 26.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.001 0.92 . . . . 3.02 111.176 -152.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -36.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.041 2.136 . . . . 3.16 112.569 165.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.421 ' HZ2' ' CG ' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -69.82 3.19 2.72 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.712 1.375 . . . . 7.11 114.712 -177.502 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' ' 153' ' ' LYS . 5.7 m-20 -108.04 -24.43 11.59 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.335 1.854 . . . . 3.29 112.822 173.034 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -84.64 -15.93 43.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.865 1.061 . . . . 3.32 113.865 165.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.03 154.43 9.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.207 1.403 . . . . 3.7 112.929 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.19 -20.11 21.79 Favored Glycine 0 N--CA 1.478 1.495 0 C-N-CA 126.622 2.058 . . . . 2.44 113.679 -174.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.01 173.68 6.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.277 1.831 . . . . 3.63 108.412 165.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -67.76 110.87 3.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.226 -0.657 . . . . 1.75 109.226 170.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.4 tp -99.16 120.66 39.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.185 0.993 . . . . 2.47 109.207 -172.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -104.69 116.21 31.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.158 1.383 . . . . 3.73 107.884 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.54 102.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.27 -1.011 . . . . 2.37 108.27 -178.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -100.21 148.91 24.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.024 1.73 . . . . 2.38 111.429 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.16 117.26 29.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.094 . . . . 2.33 110.743 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.97 153.64 23.4 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 115.777 1.071 . . . . 1.5 115.777 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.34 60.82 5.89 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.344 -1.092 . . . . 3.61 112.561 -170.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.7 m 64.1 -20.55 0.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 128.174 2.59 . . . . 4.57 115.551 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 176.83 -50.23 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 128.688 2.795 . . . . 9.98 110.101 -166.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.511 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.1 OUTLIER 61.0 177.8 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.881 1.272 . . . . 2.65 112.7 -164.533 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.511 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 39.7 Cg_endo -88.92 -132.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.88 3.053 . . . . 3.18 107.341 159.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -80.56 61.98 4.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.717 1.207 . . . . 5.06 112.403 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.75 -83.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.594 1.557 . . . . 3.61 110.365 175.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.4 m -49.87 -48.31 78.17 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.739 1.755 . . . . 2.04 115.739 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.77 -25.47 23.91 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.563 2.176 . . . . 1.35 113.732 -169.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.68 -52.93 63.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.973 1.709 . . . . 3.06 110.806 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.57 -26.05 61.57 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.848 -1.158 . . . . 2.81 111.963 171.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -45.6 78.53 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.465 -1.397 . . . . 2.37 111.849 -177.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.93 -41.01 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.227 1.376 . . . . 4.88 111.033 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 183' ' ' VAL . 43.0 mttp -60.68 -47.85 84.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.594 1.558 . . . . 3.47 110.706 174.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.85 -57.13 13.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.351 1.46 . . . . 2.74 111.428 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.26 -47.66 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.085 1.311 . . . . 2.47 111.786 -172.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -63.13 -28.6 70.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.921 0.782 . . . . 3.18 110.889 -173.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.613 HG21 ' HB ' ' A' ' 286' ' ' ILE . 55.1 t -63.34 -27.5 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 116.846 -1.55 . . . . 1.64 113.304 -178.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.744 HG23 ' H ' ' A' ' 196' ' ' LEU . 3.4 p -67.43 -32.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 121.276 1.853 . . . . 3.07 111.365 171.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -87.78 -15.25 37.45 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.794 0.838 . . . . 5.49 112.95 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.6 -13.17 59.98 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.676 -1.265 . . . . 3.37 113.004 164.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.59 -58.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.679 1.591 . . . . 2.0 111.675 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -63.44 -38.64 91.92 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.31 1.414 . . . . 3.28 112.671 -176.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 7.9 t -67.79 -11.23 58.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.582 2.753 . . . . 3.02 113.835 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.99 -25.86 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.391 -1.443 . . . . 4.77 113.157 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t 174.29 -42.14 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.466 2.306 . . . . 5.18 112.126 167.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.9 m 173.83 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 130.557 3.543 . . . . 5.88 105.052 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.7 mp -103.05 173.65 3.34 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.291 0.636 . . . . 4.82 111.345 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.44 154.46 21.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.567 2.178 . . . . 3.98 110.801 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.39 142.64 32.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.068 0.937 . . . . 3.66 111.83 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.744 ' H ' HG23 ' A' ' 184' ' ' VAL . 48.3 tp -104.79 63.89 0.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.479 2.312 . . . . 1.96 108.188 175.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.1 m -57.66 115.46 10.99 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.142 -0.932 . . . . 1.72 110.39 -166.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -86.92 116.06 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.729 2.286 . . . . 0.93 112.134 -173.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.43 117.44 34.1 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.693 1.597 . . . . 2.42 109.518 178.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -97.99 114.27 26.36 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.269 1.028 . . . . 2.31 110.124 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -83.21 122.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.256 -1.016 . . . . 1.94 108.256 165.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.53 128.98 34.94 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.854 -0.738 . . . . 1.8 111.243 166.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 pt -104.66 28.81 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 125.285 1.434 . . . . 2.13 113.261 178.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -122.8 47.44 1.57 Allowed Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 127.907 2.483 . . . . 3.41 112.942 -176.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.67 82.6 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.19 1 C-N-CA 126.206 4.604 . . . . 2.76 111.817 -172.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 175.38 -33.33 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.293 1.437 . . . . 3.98 114.406 -160.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -151.25 11.13 0.61 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.392 1.256 . . . . 5.19 114.392 170.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -70.11 54.49 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 130.888 3.675 . . . . 5.04 112.284 172.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 98.7 m -60.3 137.89 58.05 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.297 1.839 . . . . 2.06 110.464 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -43.35 -55.16 4.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.242 1.417 . . . . 4.03 112.984 -178.607 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -66.04 -33.53 76.01 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.119 1.768 . . . . 3.13 114.096 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.52 -36.14 73.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.961 1.255 . . . . 1.33 111.596 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.82 -36.6 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.186 0.995 . . . . 1.8 110.848 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.9 70.71 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.092 0.86 . . . . 1.28 112.061 168.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -66.24 -47.29 74.26 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.334 -0.853 . . . . 4.48 111.837 171.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -65.87 -32.56 74.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.933 0.716 . . . . 3.7 112.933 178.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.54 -49.0 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.13 0.972 . . . . 1.17 111.34 166.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.571 1.148 . . . . 4.57 113.515 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -62.43 -33.35 74.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.43 1.092 . . . . 4.85 112.164 177.072 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -98.73 -63.25 1.14 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.484 0.92 . . . . 2.71 113.484 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.4 m 170.89 145.72 0.12 Allowed Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 126.717 2.007 . . . . 2.42 112.197 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.94 4.71 2.99 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.545 3.497 . . . . 1.94 114.556 -175.018 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -71.36 -23.72 61.96 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 119.687 1.13 . . . . 2.15 111.494 163.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.1 tt -87.35 145.13 26.45 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.463 1.505 . . . . 2.12 111.096 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.6 m -130.18 139.77 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.666 1.186 . . . . 2.69 110.951 175.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.94 130.94 9.62 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.544 1.069 . . . . 0.9 111.708 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.82 143.84 51.11 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.159 0.984 . . . . 2.35 113.243 -173.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.8 p -147.37 169.39 19.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.078 2.151 . . . . 2.49 112.16 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -179.02 -178.94 48.59 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.332 1.92 . . . . 1.9 110.45 -176.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -63.96 163.02 12.85 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.532 1.166 . . . . 2.37 111.636 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.7 mtt-85 -47.58 -35.22 8.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.055 1.342 . . . . 5.87 112.738 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.3 mp0 -72.05 -37.1 69.75 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.582 1.953 . . . . 2.91 112.147 178.172 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -70.39 -42.66 71.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.711 -1.243 . . . . 3.48 111.345 176.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.4 t -63.36 -36.9 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.414 0.686 . . . . 1.77 110.98 173.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.03 -44.51 84.45 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.757 -0.639 . . . . 3.08 110.457 174.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -55.82 -50.94 69.16 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.232 0.924 . . . . 2.82 111.787 176.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.26 -36.07 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.703 0.683 . . . . 2.21 112.216 -175.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.99 92.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.827 0.739 . . . . 1.82 111.624 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.9 ttm105 -67.36 -38.78 85.35 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.927 1.291 . . . . 3.36 112.255 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.57 70.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.371 0.987 . . . . 2.01 112.076 178.053 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -88.63 12.58 14.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.199 1.4 . . . . 2.67 113.893 176.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 46.19 37.86 4.39 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.008 2.123 . . . . 6.71 115.28 -176.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.62 145.08 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.715 2.006 . . . . 3.36 112.577 -173.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -80.63 139.2 36.35 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.562 1.319 . . . . 3.4 114.562 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -155.03 158.95 39.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.451 1.5 . . . . 4.12 111.878 154.316 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 41.2 m -126.7 125.53 24.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.329 1.852 . . . . 3.76 107.883 167.025 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.77 147.67 45.08 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.04 2.494 . . . . 3.61 111.062 -178.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 N-CA-C 114.599 0.599 . . . . 2.84 114.599 -167.91 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 33.4 t80 . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 121.154 0.502 . . . . 4.52 112.047 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.86 108.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 120.414 -1.429 . . . . 4.58 111.765 170.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.5 143.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.53 1.532 . . . . 3.0 108.17 164.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.5 160.09 23.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.131 0.972 . . . . 3.45 110.672 173.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.55 154.39 0.38 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.494 -1.379 . . . . 2.72 112.959 -134.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -68.59 -30.72 69.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 117.285 2.328 . . . . 4.77 117.285 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.7 pt 39.4 34.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 126.556 1.942 . . . . 3.9 116.045 -172.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 19.1 mt -113.9 144.26 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 2.32 110.113 -177.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.7 143.04 31.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.481 0.712 . . . . 4.8 111.289 156.513 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -97.87 132.79 43.15 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.723 0.809 . . . . 3.19 111.096 162.329 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -93.14 93.63 8.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.759 1.224 . . . . 1.91 109.829 178.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.17 127.44 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.875 1.27 . . . . 1.69 108.672 175.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.51 161.97 54.24 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 110.851 -0.899 . . . . 1.43 110.851 172.045 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -65.23 -8.83 19.77 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.376 2.051 . . . . 3.03 113.794 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -107.23 29.74 6.85 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.097 1.759 . . . . 5.61 112.093 170.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.16 -42.04 3.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.663 1.601 . . . . 2.42 116.399 161.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -78.74 151.76 31.88 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.351 1.576 . . . . 5.67 111.369 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -89.53 144.05 26.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.033 -1.042 . . . . 3.32 113.738 -177.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -23.94 14.83 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.867 1.267 . . . . 2.74 112.881 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -168.25 170.01 10.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.887 1.275 . . . . 2.39 111.016 -167.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -153.56 140.1 18.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.847 0.859 . . . . 3.64 112.432 175.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 277' ' ' PHE . . . . . 0.545 ' CE1' ' HE2' ' A' ' 281' ' ' LYS . 13.2 m-85 -137.06 130.3 31.11 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.653 -0.654 . . . . 3.01 111.91 -169.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.12 91.83 0.08 OUTLIER Glycine 0 N--CA 1.471 0.985 0 N-CA-C 115.221 0.848 . . . . 4.17 115.221 174.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 137.32 127.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 1 C-N-CA 132.823 4.449 . . . . 3.39 107.073 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -40.51 98.91 0.01 OUTLIER 'General case' 0 C--O 1.237 0.409 0 O-C-N 124.763 1.289 . . . . 8.64 113.752 -140.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.545 ' HE2' ' CE1' ' A' ' 277' ' ' PHE . 45.7 tttp -78.95 -18.22 54.15 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.442 -0.786 . . . . 4.34 111.488 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.39 120.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.13 2.572 . . . . 5.71 108.583 -177.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -26.05 -77.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.673 2.389 . . . . 2.86 114.815 -176.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.53 -13.14 49.51 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 115.439 0.936 . . . . 1.91 115.439 -175.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.74 -30.76 40.94 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.218 2.009 . . . . 3.49 112.532 172.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 286' ' ' ILE . . . . . 0.613 ' HB ' HG21 ' A' ' 183' ' ' VAL . 21.8 mt -60.03 -40.65 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.136 -0.977 . . . . 1.58 108.859 165.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.12 -51.42 64.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.24 -0.41 . . . . 1.24 111.88 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.87 78.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.226 1.195 . . . . 1.66 114.226 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.5 p -67.33 -50.11 61.38 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 1.78 111.761 172.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.63 -38.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.742 1.156 . . . . 1.32 112.491 174.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.4 -16.18 33.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.743 1.217 . . . . 1.55 114.254 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.7 m -81.27 -47.86 12.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 1.72 110.281 167.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -67.32 -27.64 67.32 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.24 1.016 . . . . 2.81 113.641 -178.076 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 76.4 mtm -71.61 -23.41 61.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.378 -1.451 . . . . 4.91 113.498 174.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.16 -35.25 11.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 116.29 -1.814 . . . . 4.07 114.048 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.89 -41.39 1.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.912 2.076 . . . . 1.84 112.577 162.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.76 -157.19 0.11 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.837 1.791 . . . . 3.26 115.837 -169.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 N--CA 1.476 0.829 0 O-C-N 119.992 -1.693 . . . . 10.3 110.939 174.304 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.516 0 CA-C-O 119.919 -0.378 . . . . 2.43 113.329 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.28 151.49 26.47 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.44 2.76 . . . . 3.19 112.525 -167.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -81.52 155.79 25.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.881 0.872 . . . . 2.99 110.143 166.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.4 ' H ' ' NE2' ' A' ' 236' ' ' GLN . 21.5 t -142.41 101.52 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.686 -1.259 . . . . 2.85 108.916 167.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.89 162.49 32.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.191 1.396 . . . . 2.41 110.733 -170.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.9 m -84.27 133.53 34.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.465 0.706 . . . . 1.92 109.58 172.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.2 t -98.2 162.76 13.03 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.593 1.557 . . . . 2.8 109.974 177.323 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -65.37 -9.42 24.74 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.192 1.553 . . . . 2.02 115.192 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.7 p -73.44 -21.94 60.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.159 1.384 . . . . 3.12 113.292 166.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.85 -9.54 63.95 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.626 1.584 . . . . 1.75 113.401 -170.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -65.91 148.64 51.48 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.677 1.238 . . . . 4.79 110.508 170.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.66 109.08 20.9 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.684 0.793 . . . . 6.02 109.152 171.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.06 167.81 10.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.463 1.905 . . . . 3.61 113.742 -161.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -148.73 165.42 31.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.466 1.507 . . . . 2.75 110.44 -178.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -47.28 -45.05 23.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.901 2.08 . . . . 3.81 113.09 175.224 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -80.49 -4.49 54.06 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.165 1.172 . . . . 5.6 114.165 -176.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.37 -47.47 7.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.768 1.627 . . . . 3.96 109.16 163.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -75.46 11.13 1.35 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.823 1.786 . . . . 3.34 115.823 -176.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tp -78.67 -170.51 2.14 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.716 1.606 . . . . 4.4 113.238 -172.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.3 -36.04 1.54 Allowed Glycine 0 N--CA 1.479 1.505 0 C-N-CA 125.681 1.61 . . . . 3.53 114.463 176.099 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -76.86 -179.53 5.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.791 1.236 . . . . 4.01 111.448 162.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -91.35 149.54 21.69 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.673 0.749 . . . . 1.91 109.734 156.242 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.4 tp -136.89 140.28 42.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.519 0.728 . . . . 3.53 111.111 -173.213 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.41 138.63 51.69 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.674 1.19 . . . . 2.69 108.042 164.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.7 mt -123.65 131.89 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.473 1.109 . . . . 2.59 108.525 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -134.37 138.85 45.2 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.002 1.321 . . . . 2.42 111.834 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -102.54 117.97 35.84 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.498 1.119 . . . . 2.53 111.22 175.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.77 -178.36 15.97 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.098 0.856 . . . . 1.21 114.289 173.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -136.12 119.58 16.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.136 0.975 . . . . 3.58 110.847 -168.049 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 m -71.36 20.5 0.05 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.167 1.787 . . . . 2.69 113.407 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -124.48 -16.33 6.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.203 1.801 . . . . 7.11 111.351 168.141 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 38.4 t -63.53 136.91 96.92 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 119.531 1.059 . . . . 2.29 112.349 -171.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.25 99.69 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.332 2.688 . . . . 3.2 109.621 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 74.88 -35.8 0.3 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.141 2.576 . . . . 4.13 114.777 155.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 72.4 t -54.55 -56.73 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.472 1.509 . . . . 2.54 110.836 176.346 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 33.4 m -53.85 -57.59 17.0 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.65 -1.166 . . . . 1.82 113.316 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.74 -39.48 4.6 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.768 1.645 . . . . 1.61 114.223 -175.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -41.02 70.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.235 1.38 . . . . 3.06 111.888 -178.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -30.38 69.42 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.433 1.015 . . . . 2.98 111.28 176.372 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.8 tp -69.87 -35.31 74.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 2.84 112.323 173.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -42.98 90.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.987 0.812 . . . . 3.7 110.314 170.166 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -54.33 -35.62 62.89 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 119.995 -1.69 . . . . 2.99 112.012 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.3 ttp -70.17 -28.02 64.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.914 1.079 . . . . 2.88 113.914 171.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.95 -52.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.803 1.638 . . . . 1.57 109.781 167.468 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -56.1 -27.0 52.01 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.201 1.001 . . . . 3.84 112.022 -176.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 t -64.56 -29.99 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 117.402 -1.285 . . . . 1.83 111.729 176.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.91 -44.55 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.679 2.036 . . . . 2.38 111.892 -175.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.89 -43.73 98.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.761 1.624 . . . . 3.49 111.631 174.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.18 -38.98 84.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.507 1.523 . . . . 3.95 111.811 170.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 -49.38 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.801 1.64 . . . . 2.74 112.906 -177.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.68 -28.13 68.85 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.528 1.513 . . . . 5.61 109.762 176.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.0 t -67.84 -13.47 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.793 1.405 . . . . 5.14 114.793 172.126 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.32 -26.55 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.608 1.549 . . . . 5.99 111.04 169.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.305 60.9 p 119.65 50.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 1 C-N-CA 133.119 4.567 . . . . 7.97 111.119 -175.469 . . . . . . . . 3 2 . 1 . 022 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.423 0.6 OUTLIER 79.16 67.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.658 1.983 . . . . 4.81 114.67 146.52 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.04 166.82 0.37 Allowed Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 126.651 1.98 . . . . 4.35 111.52 160.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.37 -55.43 0.37 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.183 1.815 . . . . 3.71 109.296 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -169.65 158.22 7.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.288 3.035 . . . . 4.65 107.22 160.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.3 tp -112.77 106.91 15.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.945 1.298 . . . . 1.95 110.889 166.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -78.7 130.51 70.54 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.675 -0.678 . . . . 1.94 110.411 170.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.52 114.91 1.02 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.451 2.768 . . . . 1.1 109.908 159.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.84 111.28 23.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.375 1.47 . . . . 3.0 108.641 174.531 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -91.97 124.83 36.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 1.92 110.043 174.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.25 119.97 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.788 0.835 . . . . 1.36 108.81 167.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -83.24 130.39 35.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.186 -0.461 . . . . 2.11 109.989 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -104.62 16.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.559 0.948 . . . . 1.94 113.559 171.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.11 14.57 0.04 OUTLIER Pre-proline 0 CA--C 1.573 1.841 0 C-N-CA 127.926 2.49 . . . . 3.35 117.17 177.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -80.41 53.56 4.82 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 123.863 2.415 . . . . 2.7 113.171 -177.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -83.91 -41.33 17.51 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.143 -0.688 . . . . 4.58 109.143 141.129 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.76 0.53 4.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.088 1.355 . . . . 6.58 114.181 -171.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -93.2 156.75 16.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.886 1.274 . . . . 4.34 110.91 174.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -137.5 147.92 45.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 2.68 111.02 -176.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.2 -34.31 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.157 -0.929 . . . . 3.0 111.774 173.207 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -66.21 -44.1 84.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.593 1.957 . . . . 3.17 112.522 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.05 78.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.469 1.032 . . . . 1.28 111.193 174.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.94 -41.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.694 0.798 . . . . 1.74 111.415 174.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.46 -15.81 30.35 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.933 1.086 . . . . 1.71 113.933 176.079 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.59 -47.11 7.28 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.403 1.456 . . . . 4.03 113.149 165.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.09 -37.73 47.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.93 1.692 . . . . 2.91 111.565 175.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.0 t -43.56 -56.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.305 2.242 . . . . 1.63 112.792 167.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.14 -31.55 67.86 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.785 0.661 . . . . 4.16 112.785 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -63.36 -23.86 67.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.35 1.06 . . . . 4.03 111.643 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.95 -45.36 10.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.63 0.974 . . . . 3.14 113.63 168.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.2 p -174.33 167.59 2.2 Favored Pre-proline 0 N--CA 1.476 0.851 0 O-C-N 120.497 -1.377 . . . . 2.77 113.764 -168.103 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.59 2.54 8.27 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.485 2.79 . . . . 3.55 113.959 165.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.43 -26.24 6.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.953 1.464 . . . . 2.04 114.953 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.69 148.48 48.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.193 0.997 . . . . 2.21 111.217 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.43 132.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.24 1.016 . . . . 2.37 109.738 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.0 110.4 2.76 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.085 0.85 . . . . 1.32 111.606 -170.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp -108.99 144.88 36.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.5 1.12 . . . . 2.81 111.949 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.01 178.51 10.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.761 1.624 . . . . 2.86 108.892 -175.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.95 -140.64 3.39 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 108.498 -1.841 . . . . 1.88 108.498 166.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 65.7 p -80.36 176.43 9.78 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.446 1.498 . . . . 2.56 111.988 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.408 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -62.02 -21.68 65.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 118.346 -0.835 . . . . 8.18 112.78 165.788 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.408 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 22.2 mp0 -71.19 -39.44 71.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.105 1.362 . . . . 2.92 111.431 171.387 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -64.12 -42.95 96.64 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.051 -1.031 . . . . 3.75 111.616 173.033 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.5 t -59.47 -43.66 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.818 0.699 . . . . 1.81 110.769 173.239 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.25 -49.78 70.57 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.024 -0.988 . . . . 3.66 108.725 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' A' ' 141' ' ' SER . 5.0 tt0 -47.12 -56.91 5.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.41 -0.805 . . . . 3.48 111.242 174.015 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.9 m -76.87 -27.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.877 1.065 . . . . 2.65 113.877 -168.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.83 -40.17 55.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.525 0.602 . . . . 1.66 111.549 172.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -75.01 -33.71 61.84 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.62 1.968 . . . . 3.92 111.801 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -49.58 -72.51 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.561 1.073 . . . . 2.22 110.956 167.255 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -85.21 9.24 15.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.063 1.505 . . . . 3.39 115.063 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.92 18.8 11.18 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.47 1.508 . . . . 8.29 113.715 171.11 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 m -67.89 -15.09 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 117.435 2.383 . . . . 3.08 117.435 -145.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.4 t80 60.83 131.54 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.086 2.555 . . . . 3.47 116.898 -174.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -160.54 165.68 30.41 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.873 2.469 . . . . 3.24 109.391 170.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.3 t -154.49 134.51 8.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 121.291 -0.88 . . . . 3.15 110.813 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.44 144.51 10.31 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.913 2.409 . . . . 2.72 112.977 -173.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 N-CA-C 110.76 -0.936 . . . . 2.74 110.76 163.821 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.94 0 CA-C-O 121.791 0.805 . . . . 3.65 111.416 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.2 tp -56.68 161.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 119.364 -2.085 . . . . 2.76 110.263 159.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.73 146.73 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.181 -0.95 . . . . 4.49 109.869 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.62 143.78 28.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.924 1.29 . . . . 3.99 109.15 161.045 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.9 145.01 8.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.167 1.387 . . . . 2.79 111.129 -172.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.7 p -62.19 -22.35 65.84 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.963 1.097 . . . . 3.48 113.963 171.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 279' ' ' GLN 0.334 0.1 OUTLIER 49.12 62.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.769 1.747 . . . . 3.93 110.715 -174.473 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.1 mm -118.92 152.44 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.283 2.233 . . . . 2.64 110.94 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.0 mtp -132.93 155.67 48.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.418 2.687 . . . . 2.33 109.376 -175.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -117.29 143.74 45.6 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.746 1.017 . . . . 3.54 113.746 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.76 127.5 42.79 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.906 1.682 . . . . 2.93 107.322 168.22 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.6 130.87 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.497 0.719 . . . . 2.87 109.073 171.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.13 173.16 37.4 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.921 0.772 . . . . 2.15 112.285 177.39 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.05 68.16 6.63 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.185 3.257 . . . . 3.27 111.085 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -167.83 -56.69 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.325 1.85 . . . . 5.47 109.729 -164.347 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 144.12 165.05 10.75 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.191 1.236 . . . . 3.27 116.191 170.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 70.65 -86.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.054 1.741 . . . . 8.41 111.976 165.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.72 157.01 9.9 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.779 1.632 . . . . 5.65 112.281 -173.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -39.38 0.6 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.395 1.478 . . . . 3.96 111.579 -175.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.33 176.01 13.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.756 2.023 . . . . 3.68 108.538 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -135.39 150.05 49.8 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.211 1.004 . . . . 3.22 112.437 178.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -133.18 -170.02 2.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.591 1.557 . . . . 3.06 110.477 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.91 -157.75 14.73 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.521 1.057 . . . . 2.84 110.888 -171.321 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 262' ' ' ILE . 12.0 tp-100 -71.91 90.71 1.14 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.546 0.943 . . . . 4.94 113.546 -164.116 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.1 p30 165.71 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 130.267 3.427 . . . . 7.4 112.984 164.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.94 108.91 7.04 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.368 -0.832 . . . . 6.23 108.934 170.062 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.427 ' HD2' ' H ' ' A' ' 282' ' ' ARG . 0.5 OUTLIER -78.71 135.5 37.17 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.19 0.996 . . . . 8.86 109.672 -172.572 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -21.24 -66.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.121 2.267 . . . . 3.0 117.121 -163.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.33 -20.41 65.32 Favored Glycine 0 N--CA 1.48 1.607 0 CA-C-N 119.944 1.247 . . . . 2.24 114.733 -173.486 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.94 -22.5 66.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.633 1.173 . . . . 4.43 111.642 172.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.41 -48.69 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.822 -1.173 . . . . 1.9 109.729 175.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.25 92.26 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.179 0.807 . . . . 1.84 113.179 173.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.93 74.19 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.984 0.735 . . . . 1.89 112.984 178.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 14.1 p -72.33 -44.07 63.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.72 -1.238 . . . . 1.89 111.677 170.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.9 -34.52 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.742 1.155 . . . . 1.91 111.985 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.38 47.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.613 1.338 . . . . 2.38 114.613 171.264 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.9 m -80.6 -48.45 12.66 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.115 0.87 . . . . 3.21 110.413 170.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -64.85 -28.29 69.45 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.849 1.26 . . . . 3.06 112.55 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.0 ttp -58.86 -20.0 46.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.225 2.61 . . . . 4.75 113.457 170.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -72.23 -50.41 8.75 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.824 -1.56 . . . . 6.22 111.936 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.27 -54.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 123.26 2.64 . . . . 3.16 112.966 169.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.65 126.27 33.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.554 0.742 . . . . 3.77 110.618 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 115.211 1.56 . . . . 7.14 115.211 -166.2 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.46 0 CA-C-O 118.428 -1.207 . . . . 2.69 114.365 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.01 150.79 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.707 2.271 . . . . 2.56 110.289 168.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -156.01 165.25 37.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.752 0.821 . . . . 2.45 112.122 -167.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.8 m -121.41 137.99 54.47 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.722 -0.611 . . . . 2.38 109.999 147.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 mt -142.8 153.5 43.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.3 1.04 . . . . 3.04 109.575 168.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.3 m -93.25 150.75 20.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.886 0.874 . . . . 1.43 108.76 174.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.9 p -96.34 163.03 13.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 2.18 112.17 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -61.74 -16.8 52.48 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.075 1.139 . . . . 1.6 114.075 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -87.23 -43.7 12.0 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 117.566 -1.207 . . . . 3.2 111.368 168.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.9 5.98 1.57 Allowed Glycine 0 N--CA 1.474 1.185 0 N-CA-C 119.145 2.418 . . . . 1.77 119.145 158.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.4 158.0 19.11 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 121.419 2.609 . . . . 3.99 111.944 172.145 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -111.54 120.49 42.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.207 1.403 . . . . 5.77 110.963 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.407 ' HE3' HD21 ' A' ' 227' ' ' LEU . 0.0 OUTLIER -144.63 167.49 22.43 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.539 1.311 . . . . 5.3 114.539 -168.191 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.4 p -120.85 173.92 6.93 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.744 2.818 . . . . 2.24 111.742 -171.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.05 -31.63 72.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.276 0.63 . . . . 3.86 112.629 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -19.3 65.13 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.96 -1.088 . . . . 8.57 112.388 174.163 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -85.89 -43.78 12.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.868 0.867 . . . . 3.66 111.138 172.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -67.41 -25.88 66.15 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.596 1.332 . . . . 3.19 114.596 175.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 49.15 42.52 21.51 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.442 2.297 . . . . 5.3 112.486 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.3 -74.44 0.06 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.169 2.319 . . . . 5.67 113.286 -173.456 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 63.12 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.352 2.261 . . . . 3.59 111.803 -175.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -167.82 92.28 0.36 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.605 2.762 . . . . 1.8 109.172 173.459 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.05 131.06 53.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.764 1.226 . . . . 3.44 113.569 -174.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.49 124.77 49.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.113 1.365 . . . . 2.51 108.525 166.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.421 HD12 HD13 ' A' ' 267' ' ' ILE . 29.3 mt -126.84 114.35 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.238 1.015 . . . . 2.08 109.822 -164.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -122.43 139.91 53.32 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.701 1.0 . . . . 2.51 113.701 -174.14 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -96.36 109.31 21.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.727 0.811 . . . . 2.58 109.549 172.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.48 146.67 18.13 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.058 1.314 . . . . 1.23 113.471 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 204' ' ' ASP . 1.2 m-85 -81.54 61.12 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.13 0.972 . . . . 4.45 111.317 -174.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.3 p 45.84 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.071 2.148 . . . . 4.45 110.894 -170.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -103.62 116.72 32.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.29 0.95 . . . . 9.07 108.957 155.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.43 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 1.8 t -44.29 -174.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 130.954 3.702 . . . . 2.46 115.089 169.23 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 13.3 Cg_endo -47.31 -70.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.77 1.646 . . . . 3.67 109.776 138.37 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -167.66 21.77 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.84 1.793 . . . . 5.09 115.84 166.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 -34.71 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.318 -1.489 . . . . 2.61 111.766 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 90.1 m -44.2 -55.53 9.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.649 -1.643 . . . . 1.43 112.823 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.7 -29.35 60.01 Favored 'Trans proline' 0 C--N 1.354 0.817 0 CA-C-N 122.308 1.86 . . . . 1.18 114.092 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -75.58 -38.93 58.77 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.374 0.988 . . . . 3.61 112.216 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.51 -37.27 65.73 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.564 -1.335 . . . . 2.99 111.979 171.138 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.0 tt -55.85 -43.91 77.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.396 1.078 . . . . 3.88 111.492 169.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.22 -35.04 74.55 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.628 1.103 . . . . 3.16 112.466 -177.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -62.79 -45.18 93.84 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.587 -1.321 . . . . 3.27 111.238 173.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.7 ptp -68.81 -21.44 64.32 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 117.596 -1.192 . . . . 2.38 114.199 173.355 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.1 -57.23 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 120.586 1.539 . . . . 2.09 109.322 166.031 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -59.45 -19.81 50.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.325 1.45 . . . . 4.53 113.169 -177.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.78 -29.6 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.562 1.074 . . . . 1.7 113.758 170.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.04 -36.56 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 121.361 1.891 . . . . 2.59 110.706 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -50.56 36.56 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.57 1.948 . . . . 6.74 112.248 166.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -67.05 -36.58 82.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.603 0.761 . . . . 4.05 112.073 178.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mm -69.42 -45.98 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.995 1.318 . . . . 2.21 111.238 -177.379 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -66.04 -33.61 76.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 4.99 110.475 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.2 t -70.36 -8.15 48.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.657 1.183 . . . . 4.75 113.848 171.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.5 mm -79.19 -38.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.978 1.263 . . . . 3.84 110.287 165.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 57.87 -23.38 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 129.386 3.074 . . . . 4.16 116.082 -176.175 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 p -75.92 -20.79 57.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.249 -1.532 . . . . 5.17 112.942 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.83 173.64 1.98 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.367 1.467 . . . . 3.85 113.316 169.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.74 -40.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.831 2.354 . . . . 3.75 111.914 169.441 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 30.0 t70 165.08 165.07 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.86 2.864 . . . . 4.02 108.908 -159.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.75 122.54 36.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.312 -0.995 . . . . 2.1 108.312 153.701 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 m -101.05 114.96 65.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 109.374 -0.602 . . . . 1.87 109.374 173.404 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.95 142.99 15.99 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.27 1.98 . . . . 1.08 109.918 166.209 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.4 146.07 43.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 122.912 1.339 . . . . 2.52 112.433 170.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -114.44 130.82 56.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.913 -1.494 . . . . 2.45 109.623 -170.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 68.5 mt -107.13 117.97 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.743 1.217 . . . . 1.5 109.668 174.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.8 p -73.13 136.09 44.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.134 0.574 . . . . 3.19 110.699 167.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.7 pt -121.15 31.85 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.472 1.509 . . . . 1.59 111.634 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 166' ' ' PHE . 16.3 p-10 -161.74 65.59 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.908 1.283 . . . . 4.16 111.261 -158.158 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.35 -19.76 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.653 2.236 . . . . 2.83 113.427 -171.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.31 41.86 0.19 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.118 1.367 . . . . 4.44 111.966 168.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.0 -14.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 130.04 3.336 . . . . 5.51 114.257 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.83 159.93 8.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.563 1.074 . . . . 4.7 112.515 161.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.7 m -154.18 127.0 8.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 106.722 -1.584 . . . . 2.01 106.722 155.589 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -52.01 -43.86 63.87 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.535 1.134 . . . . 2.99 112.283 -177.148 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -70.23 -30.23 67.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.662 1.185 . . . . 3.51 114.194 172.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.33 -39.47 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.195 1.361 . . . . 1.46 111.715 176.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.19 -24.6 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.873 -1.142 . . . . 2.23 110.891 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.18 67.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 119.91 -1.744 . . . . 1.52 112.938 166.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -77.26 -35.67 55.11 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.397 1.079 . . . . 3.62 111.847 168.152 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.71 -36.09 81.84 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.549 -0.719 . . . . 6.37 111.563 176.296 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.6 t -54.5 -24.47 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 120.984 -1.073 . . . . 2.2 112.349 169.529 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -87.38 -22.31 25.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.544 -1.348 . . . . 5.62 114.134 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.82 -45.06 68.71 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.248 0.931 . . . . 4.82 110.307 165.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -105.1 -26.5 12.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.138 1.903 . . . . 3.49 116.138 -159.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 46.4 p 143.38 147.49 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 128.722 2.809 . . . . 2.49 113.413 169.453 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 66.43 5.42 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.023 3.148 . . . . 2.78 109.684 166.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.414 ' O ' ' HE2' ' A' ' 223' ' ' LYS . 0.1 OUTLIER -166.06 -31.66 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.047 2.139 . . . . 3.44 110.854 -171.431 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.47 145.92 48.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.412 0.551 . . . . 2.37 111.165 158.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.77 133.02 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.868 1.667 . . . . 1.83 106.891 162.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.71 128.71 9.66 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.346 -1.102 . . . . 0.83 110.346 176.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.407 HD21 ' HE3' ' A' ' 150' ' ' LYS . 5.4 mp -127.57 130.47 49.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.278 1.031 . . . . 2.31 111.538 -176.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -144.03 -178.95 6.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.613 1.565 . . . . 2.28 111.675 -167.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 176.74 -167.82 39.45 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.4 1.0 . . . . 1.53 113.766 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -84.0 157.29 21.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.772 1.229 . . . . 2.56 110.414 174.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -61.27 -20.57 63.01 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.068 1.507 . . . . 7.6 115.068 -169.534 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -70.33 -40.65 74.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.672 1.589 . . . . 2.98 111.175 172.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.39 -32.6 62.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.664 1.185 . . . . 3.41 111.745 173.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.67 -38.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 118.206 -0.902 . . . . 1.81 110.989 166.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.03 -44.5 92.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.133 1.333 . . . . 3.08 110.362 171.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -49.67 -57.28 7.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.667 1.121 . . . . 2.41 110.934 172.425 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 32.6 m -74.11 -37.66 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.917 1.235 . . . . 3.07 113.261 -171.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.73 74.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.648 0.379 . . . . 1.96 111.65 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -95.68 -23.22 17.1 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.353 1.461 . . . . 3.83 113.555 -175.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.02 75.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.351 1.432 . . . . 2.16 110.768 164.33 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -82.55 -11.94 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.632 1.173 . . . . 2.93 114.098 174.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 71.64 37.19 1.13 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.279 1.832 . . . . 8.15 112.451 165.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 m -94.13 141.0 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.266 1.426 . . . . 2.64 112.328 -175.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -76.47 154.17 34.93 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.298 0.851 . . . . 5.79 113.298 171.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.01 149.53 16.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.923 1.689 . . . . 3.92 109.729 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.3 t -155.54 145.01 15.28 Favored Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 121.454 -0.779 . . . . 4.39 110.987 171.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.36 165.12 28.03 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.387 2.058 . . . . 4.49 109.628 151.081 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.684 0 C-N-CA 124.356 0.979 . . . . 3.36 114.426 174.754 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 113.655 0.983 . . . . 6.62 113.655 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 11.8 mm -61.52 153.11 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.547 -0.72 . . . . 3.38 109.261 159.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 30.7 m -154.88 141.67 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 128.018 2.527 . . . . 4.82 104.855 171.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -157.81 157.44 33.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.369 0.986 . . . . 4.86 113.299 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -160.44 -179.11 7.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.916 1.686 . . . . 2.28 113.686 -163.125 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.3 p -74.35 -15.11 60.95 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 116.899 2.185 . . . . 3.67 116.899 -176.142 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 56.86 11.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.15 1.78 . . . . 4.13 115.292 177.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 1.6 pp -95.65 148.13 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 119.997 -1.689 . . . . 4.51 114.384 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.5 ttp -122.51 121.76 37.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.806 2.442 . . . . 2.32 109.408 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -85.16 146.33 27.17 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.549 -0.719 . . . . 2.69 111.362 176.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.4 tp -109.1 127.51 54.22 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.918 1.287 . . . . 2.02 109.92 168.47 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.421 HD13 HD12 ' A' ' 162' ' ' ILE . 1.9 mp -119.19 124.75 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.912 2.085 . . . . 1.72 106.131 171.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.95 -162.66 36.9 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 109.618 -1.393 . . . . 1.64 109.618 164.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -85.02 54.48 3.94 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 120.392 2.096 . . . . 2.5 109.799 178.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.06 -34.77 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.486 1.515 . . . . 5.64 114.157 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.66 29.69 59.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.695 -1.058 . . . . 4.31 113.623 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -147.52 -39.02 0.19 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.034 1.417 . . . . 4.69 113.853 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.32 0.0 OUTLIER 102.74 152.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 132.368 4.267 . . . . 3.48 111.407 -171.944 . . . . . . . . 4 3 . 1 . 023 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 56.9 tp -129.48 -35.24 1.75 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.346 1.239 . . . . 2.89 114.346 -155.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -166.05 172.36 11.48 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.505 1.522 . . . . 2.84 111.026 -174.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -156.21 145.96 21.06 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.62 -1.3 . . . . 3.45 113.908 174.05 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -136.84 173.72 11.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.292 1.837 . . . . 2.66 111.447 -163.166 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.41 -169.06 36.13 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 125.807 1.67 . . . . 2.34 111.803 175.328 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -36.52 124.41 0.82 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.061 1.745 . . . . 3.52 113.071 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.9 t30 98.49 -34.94 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 130.315 3.446 . . . . 4.55 112.681 -174.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.71 109.87 0.89 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.31 1.414 . . . . 4.41 110.611 178.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.5 145.56 41.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.15 -0.969 . . . . 6.91 109.453 -171.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -56.17 -50.54 70.89 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.407 -1.433 . . . . 2.31 113.549 -168.645 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.28 -13.18 70.19 Favored Glycine 0 N--CA 1.479 1.565 0 O-C-N 121.463 -0.773 . . . . 1.82 114.926 175.136 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -86.72 -19.4 29.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.826 1.25 . . . . 5.32 111.046 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.23 -51.32 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 120.586 -1.322 . . . . 1.82 109.595 157.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -37.51 75.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 118.261 -0.876 . . . . 2.12 112.954 176.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.687 1.131 . . . . 2.36 112.831 173.425 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -48.89 79.87 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.422 -0.799 . . . . 1.99 112.157 169.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.64 -30.44 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.079 0.854 . . . . 1.84 111.504 179.108 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.34 -7.22 22.99 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.585 -1.322 . . . . 2.73 114.053 173.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 31.2 m -80.47 -57.04 3.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.026 0.931 . . . . 3.58 108.834 160.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -62.31 -26.8 68.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.312 1.845 . . . . 2.69 114.487 -174.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 31.7 mtt -55.86 -30.13 60.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.597 1.159 . . . . 5.14 111.619 170.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -59.71 -47.11 98.27 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.406 -1.759 . . . . 5.06 111.38 -176.247 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.26 -58.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.872 2.381 . . . . 3.53 113.403 163.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.83 17.89 17.05 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 116.669 2.1 . . . . 3.52 116.669 -157.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 . . . . . 0 N--CA 1.478 0.926 0 O-C-N 120.956 -1.09 . . . . 7.17 111.415 159.739 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.673 0 CA-C-O 118.118 -1.379 . . . . 2.57 111.973 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.67 142.06 62.58 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.078 2.518 . . . . 2.59 112.706 -167.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -116.45 168.44 10.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.201 1.8 . . . . 2.77 111.264 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 p -148.5 85.48 1.51 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.84 1.256 . . . . 2.89 111.28 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.64 143.84 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.208 1.003 . . . . 2.04 110.791 175.474 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 p -75.38 150.28 38.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 3.46 111.863 171.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 p -96.0 120.68 36.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.621 1.969 . . . . 2.29 108.273 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.5 m170 51.15 24.79 2.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.195 1.554 . . . . 3.26 115.195 177.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.379 0.6 OUTLIER 31.36 39.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.509 2.724 . . . . 9.9 115.491 -155.695 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -110.82 -28.71 3.83 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.833 2.158 . . . . 2.83 113.051 -178.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -155.3 179.81 8.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.808 1.304 . . . . 4.03 112.28 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -118.6 111.23 18.31 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.446 1.098 . . . . 7.17 111.033 -159.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -119.71 168.9 10.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.462 1.601 . . . . 3.13 115.171 167.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.7 m -158.79 158.05 32.81 Favored 'General case' 0 C--N 1.326 -0.422 1 C-N-CA 132.099 4.16 . . . . 2.91 103.962 -169.358 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -41.74 -52.34 3.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.624 1.17 . . . . 3.35 112.86 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -82.75 -8.56 59.58 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.338 1.607 . . . . 6.45 115.338 178.19 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -75.93 -18.76 59.23 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.399 1.454 . . . . 4.08 111.631 165.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -97.69 -40.44 8.58 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.103 1.361 . . . . 3.73 114.124 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.98 154.28 19.32 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.39 0.995 . . . . 4.0 113.533 -170.441 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.47 10.25 22.05 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.878 1.704 . . . . 2.73 112.708 -158.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.54 160.89 18.17 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.218 2.607 . . . . 3.12 107.758 -176.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -83.33 121.91 27.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.624 -0.673 . . . . 2.12 110.823 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.61 135.29 39.64 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.242 1.02 . . . . 2.78 111.304 -176.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -115.16 126.15 54.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.487 1.515 . . . . 2.26 107.897 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.7 mt -129.4 118.49 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.413 0.685 . . . . 1.7 109.941 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -120.68 145.09 47.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.349 1.459 . . . . 2.74 112.934 -175.176 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -114.67 97.61 6.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.232 1.413 . . . . 2.08 110.87 -177.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.61 -160.52 10.69 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.592 1.567 . . . . 1.51 115.423 -169.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -156.03 159.41 39.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.434 1.494 . . . . 4.61 110.746 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 p -69.49 127.04 31.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.014 -1.679 . . . . 3.45 110.287 172.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 73.2 -43.78 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.429 2.292 . . . . 8.19 111.821 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.4 t 86.59 177.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 127.277 2.231 . . . . 2.54 111.419 -166.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -40.7 -69.69 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.458 2.772 . . . . 4.23 111.493 130.084 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . 0.26 1.1 m-20 171.24 58.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 128.417 2.687 . . . . 4.93 111.366 170.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.81 -27.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.869 1.268 . . . . 3.82 114.02 174.159 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.36 -37.19 19.53 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 115.852 -2.023 . . . . 2.43 113.854 162.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.52 -80.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.336 2.024 . . . . 1.91 111.051 166.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.19 -29.01 69.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.676 0.991 . . . . 4.41 113.676 -165.119 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.63 -41.68 59.96 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.255 -1.528 . . . . 3.66 112.691 177.007 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.4 -36.76 74.25 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.299 -1.334 . . . . 3.04 110.521 172.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -57.14 -43.99 82.98 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.733 1.606 . . . . 6.08 111.806 173.216 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -60.84 -55.27 35.02 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.712 -1.243 . . . . 3.16 112.219 168.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.67 -24.66 62.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.078 1.14 . . . . 4.41 114.078 -170.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -56.7 -37.88 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.258 1.39 . . . . 1.74 111.279 169.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.98 -28.68 66.83 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.379 -0.819 . . . . 3.04 110.609 176.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.8 -34.68 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.454 1.024 . . . . 2.03 111.355 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.82 -37.73 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.598 1.09 . . . . 2.37 111.439 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -32.51 58.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.364 0.983 . . . . 4.61 113.298 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -60.21 -26.26 66.24 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.596 1.558 . . . . 3.54 112.946 170.169 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -90.16 -55.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.104 1.762 . . . . 2.14 112.387 175.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.15 -30.45 71.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.819 2.048 . . . . 3.16 113.133 -175.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.1 t -66.07 -12.8 57.87 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.786 -1.196 . . . . 2.95 112.894 169.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.0 mm -121.56 44.41 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.15 1.78 . . . . 4.56 108.186 -178.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.24 0.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.5 3.52 . . . . 6.42 118.419 -158.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.3 p -69.08 -18.99 64.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.88 1.272 . . . . 4.32 113.047 157.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.41 163.15 43.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 127.28 2.232 . . . . 4.55 109.908 169.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.41 162.21 11.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.514 2.143 . . . . 5.29 114.178 -148.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.55 94.5 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.71 1.604 . . . . 6.16 111.606 -172.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.3 mp -93.86 116.6 29.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.111 0.964 . . . . 2.43 112.722 -175.478 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.6 m -107.59 111.82 62.58 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.261 1.024 . . . . 1.35 110.89 171.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -88.05 122.9 1.62 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.954 3.102 . . . . 1.01 112.254 177.125 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.64 122.83 47.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.742 2.417 . . . . 2.95 110.529 -178.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -102.06 121.08 41.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.943 0.897 . . . . 2.36 111.182 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.45 119.99 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.602 1.161 . . . . 1.63 108.331 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.1 p -78.65 131.35 36.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.285 -0.884 . . . . 2.02 110.581 164.242 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.43 -21.73 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 115.547 1.684 . . . . 2.71 115.547 -176.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -125.74 75.23 70.59 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 124.525 1.13 . . . . 4.98 109.194 -177.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.45 98.51 0.4 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.683 3.588 . . . . 2.0 109.31 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -162.31 -24.04 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.102 1.149 . . . . 4.53 114.102 -166.018 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.45 9.16 0.54 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.176 1.176 . . . . 4.92 114.176 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -111.8 75.33 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 129.645 3.178 . . . . 3.81 108.798 -173.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.29 155.96 30.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.04 1.4 . . . . 2.73 114.363 -163.231 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.84 -50.42 7.91 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.409 2.283 . . . . 3.29 114.784 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 211' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -85.93 -35.0 20.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.808 1.643 . . . . 4.72 112.321 174.822 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.24 71.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.367 0.985 . . . . 1.95 113.501 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 18.9 mm -64.53 -42.64 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.842 1.201 . . . . 1.63 111.675 170.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.3 -22.54 66.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.734 0.814 . . . . 1.87 112.897 176.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -83.41 -44.73 14.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.699 1.6 . . . . 4.03 112.027 168.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -53.26 -35.83 60.46 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.648 1.579 . . . . 2.77 111.922 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -52.47 -43.91 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.415 1.486 . . . . 1.46 113.617 167.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -67.03 -47.44 71.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 117.807 -1.092 . . . . 6.4 111.982 -176.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -43.19 63.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.507 1.523 . . . . 4.19 111.917 177.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -70.28 -62.71 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.858 0.463 . . . . 3.3 111.53 175.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.8 m 169.73 145.57 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.534 2.734 . . . . 2.17 110.833 177.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.59 -6.52 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.585 2.857 . . . . 1.62 114.709 -177.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.41 -10.4 59.43 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.709 1.141 . . . . 3.57 113.581 170.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.85 137.93 34.23 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.624 1.17 . . . . 2.05 111.557 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -113.36 129.92 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.255 1.022 . . . . 1.73 109.561 -174.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.09 129.37 9.87 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.841 -0.904 . . . . 1.09 110.841 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.82 156.9 18.67 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.868 -0.79 . . . . 2.53 108.868 168.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.3 m -150.39 126.91 10.82 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.223 -1.399 . . . . 3.3 107.223 171.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.58 -145.04 4.05 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.094 1.807 . . . . 1.99 111.189 -174.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -121.75 174.72 6.67 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.301 1.051 . . . . 2.54 110.91 165.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.26 -18.09 14.72 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.627 1.171 . . . . 8.2 113.327 -174.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.48 -41.99 19.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.194 2.198 . . . . 3.44 112.153 -173.627 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.83 -31.75 66.85 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.286 -1.509 . . . . 3.71 110.702 166.007 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.8 -35.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.364 -0.827 . . . . 1.74 110.916 172.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -58.78 -57.01 14.93 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 117.632 -1.175 . . . . 2.74 109.778 163.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -49.87 -56.33 10.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.219 1.372 . . . . 3.19 112.514 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.55 -29.51 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.288 0.495 . . . . 2.07 111.771 -171.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.32 -50.8 20.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.647 0.779 . . . . 1.65 111.525 171.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -56.15 -49.12 74.85 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.148 2.579 . . . . 3.09 111.398 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.78 77.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.551 0.74 . . . . 2.04 112.947 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -94.64 14.43 21.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.233 1.413 . . . . 2.77 113.363 176.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 61.6 12.26 4.4 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.134 2.174 . . . . 5.47 115.111 176.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.99 140.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.393 1.477 . . . . 2.84 111.254 -177.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -109.52 173.43 6.33 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.542 1.537 . . . . 4.7 112.481 174.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -121.59 148.55 44.38 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.008 0.923 . . . . 3.89 111.534 176.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -128.95 63.14 65.61 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.159 0.984 . . . . 4.79 111.654 176.484 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 138.98 42.83 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.598 2.198 . . . . 3.23 110.332 176.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.411 0 CA-C-O 119.676 -0.513 . . . . 3.25 113.342 -176.017 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.731 1.382 . . . . 3.74 114.731 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.08 128.71 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.778 -1.201 . . . . 3.35 109.919 157.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.1 153.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.304 1.442 . . . . 3.91 107.902 170.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.57 174.85 11.05 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 122.752 1.263 . . . . 5.75 112.273 -174.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 167.54 11.13 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.889 -1.132 . . . . 2.19 112.737 -143.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.1 t -68.09 -20.25 64.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.318 1.97 . . . . 4.03 116.318 -171.005 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.5 mt 47.9 55.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.914 1.686 . . . . 4.49 111.593 -177.236 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.6 mt -137.79 139.77 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.518 1.527 . . . . 2.58 110.348 -178.372 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.66 120.46 39.72 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.51 2.724 . . . . 3.27 109.326 161.306 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -88.31 135.11 33.61 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.136 0.574 . . . . 2.56 111.266 165.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.4 tt -103.41 120.67 41.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.699 2.0 . . . . 2.29 109.441 174.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.92 143.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 127.271 2.229 . . . . 2.08 108.167 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.34 178.23 18.49 Favored Glycine 0 CA--C 1.545 1.914 0 C-N-CA 123.931 0.777 . . . . 1.82 113.95 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 -42.97 2.15 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.6 2.866 . . . . 4.06 112.904 -174.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -142.87 84.53 1.84 Allowed 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 107.092 -1.447 . . . . 7.71 107.092 161.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.17 -150.85 6.78 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.232 1.872 . . . . 2.54 110.315 -176.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -122.78 -162.57 1.03 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.008 0.923 . . . . 4.18 111.217 -179.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -52.58 134.94 35.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.076 0.941 . . . . 4.18 110.43 173.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.37 -33.02 1.13 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.428 1.491 . . . . 2.95 110.328 -169.658 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -155.28 172.83 17.54 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.828 2.051 . . . . 2.41 110.481 175.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -162.21 148.01 13.04 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.616 -1.303 . . . . 3.7 114.257 176.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -132.47 128.24 36.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.887 1.275 . . . . 2.35 110.706 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -101.88 -176.62 28.11 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.79 0.709 . . . . 2.64 112.282 165.441 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -52.3 154.29 2.49 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.418 0.687 . . . . 4.26 110.588 167.2 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.3 t30 81.83 -17.86 0.52 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.737 2.415 . . . . 6.11 112.196 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -69.54 107.94 3.6 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.238 -1.539 . . . . 6.06 110.532 161.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -66.14 144.54 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.502 1.144 . . . . 7.45 109.785 176.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -32.49 65.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.051 . . . . 2.47 113.839 -167.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.18 86.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.01 -0.883 . . . . 1.44 113.489 -178.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.36 -18.03 61.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.359 1.579 . . . . 3.21 112.944 174.231 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.8 mt -70.01 -47.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.457 -0.777 . . . . 1.21 109.201 172.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.78 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.08 0.552 . . . . 1.23 112.065 170.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.89 81.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.567 0.951 . . . . 1.45 113.567 173.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 52.2 p -65.5 -47.18 76.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.996 0.817 . . . . 1.42 111.669 172.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.62 -39.63 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 120.74 -1.225 . . . . 1.91 110.638 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.07 72.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.907 0.883 . . . . 1.74 113.159 171.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.1 m -71.59 -48.08 50.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.219 1.008 . . . . 2.14 110.333 174.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -70.74 -20.27 62.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.206 1.003 . . . . 2.3 113.075 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.1 mmm -66.49 -33.67 76.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.193 1.397 . . . . 3.81 113.255 162.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -52.63 -40.2 74.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 116.358 -1.782 . . . . 5.41 113.13 -176.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.26 -60.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.196 2.597 . . . . 2.29 111.544 162.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -86.28 47.25 1.44 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.823 1.416 . . . . 3.09 114.823 -165.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.787 0 O-C-N 120.832 -1.167 . . . . 9.68 111.658 176.644 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.286 0 CA-C-O 118.237 -1.313 . . . . 2.51 112.486 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.58 154.18 30.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.206 2.604 . . . . 3.43 111.939 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -160.82 154.31 22.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.579 1.151 . . . . 3.01 111.651 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 t -138.17 95.58 3.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.951 -1.093 . . . . 2.53 112.874 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.63 162.9 14.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.115 1.366 . . . . 2.72 112.153 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.4 m -98.14 142.6 29.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.53 1.132 . . . . 1.52 110.779 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.9 m -98.29 164.7 12.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.184 1.793 . . . . 2.65 112.049 -171.253 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -61.17 -5.37 1.49 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 117.649 2.463 . . . . 2.63 117.649 -170.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -35.02 6.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 121.023 1.738 . . . . 4.19 111.29 165.007 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.47 11.61 0.45 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.719 2.104 . . . . 2.36 115.185 -177.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -84.04 129.28 34.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.057 2.143 . . . . 5.48 110.051 -176.112 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -69.2 130.2 41.98 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.52 -1.363 . . . . 4.66 110.012 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 158.72 24.61 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.441 . . . . 2.89 109.834 168.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.6 p -152.02 162.94 40.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.573 1.549 . . . . 2.34 110.233 -167.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -46.63 -49.68 18.72 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.792 1.237 . . . . 5.08 112.034 166.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -79.48 4.23 16.26 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.536 1.31 . . . . 7.44 114.536 -172.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.08 -30.34 16.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.966 1.706 . . . . 3.6 111.452 169.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -103.38 -16.24 15.68 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.988 1.477 . . . . 4.4 114.988 -177.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 tt -75.08 88.88 2.43 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.386 1.088 . . . . 5.14 110.304 -171.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 164.78 -30.55 0.23 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.783 1.658 . . . . 3.21 111.923 -167.289 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -103.76 -179.6 4.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 4.42 111.453 159.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -85.06 140.72 30.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.023 0.529 . . . . 3.91 110.366 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 pp -134.28 153.39 51.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.139 0.976 . . . . 4.06 111.09 175.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.61 138.45 54.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.754 1.222 . . . . 3.82 109.072 171.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.3 mt -111.59 130.16 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.103 -0.703 . . . . 2.7 109.103 177.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -120.61 142.25 49.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.932 1.293 . . . . 2.93 110.508 164.106 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.69 123.49 50.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.064 1.345 . . . . 2.5 110.107 171.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -160.38 146.77 13.03 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.459 -0.634 . . . . 2.16 113.541 175.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.87 18.35 14.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.381 1.623 . . . . 4.17 115.381 -171.314 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.2 m 66.99 -15.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.603 1.961 . . . . 3.56 114.048 173.158 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -111.2 16.38 21.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.898 2.079 . . . . 7.81 112.684 -167.158 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.58 171.49 6.97 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.937 1.695 . . . . 2.69 114.538 176.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.14 -176.92 1.46 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.117 2.544 . . . . 3.14 110.479 150.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.36 64.56 2.13 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 5.9 113.139 -172.144 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 80.5 t -130.97 -45.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.964 2.105 . . . . 3.71 109.728 174.306 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.4 t -62.71 -52.04 67.6 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.855 1.262 . . . . 1.79 112.591 172.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.5 -34.71 25.24 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.981 1.788 . . . . 1.36 113.077 172.071 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.538 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 13.4 tm-20 -64.89 -40.41 95.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.99 1.268 . . . . 2.69 112.384 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.424 -1.423 . . . . 2.37 111.594 171.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 37.4 mt -62.72 -37.4 86.4 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.215 0.916 . . . . 2.89 112.859 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.68 4.67 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.18 0.9 . . . . 3.39 110.336 174.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.538 ' HZ2' ' CD ' ' A' ' 175' ' ' GLU . 30.0 mtmm -57.53 -28.72 63.75 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.773 -1.204 . . . . 2.64 112.713 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.34 -49.11 72.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.016 0.826 . . . . 3.17 111.664 168.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.35 -36.19 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 119.636 1.107 . . . . 1.88 110.627 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.28 -23.31 35.68 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.326 0.862 . . . . 3.3 113.326 171.154 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.83 -38.52 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.69 1.132 . . . . 1.88 110.718 173.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.35 -40.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.328 1.051 . . . . 1.94 110.921 -179.173 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.81 -53.94 34.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.458 1.503 . . . . 5.31 110.971 169.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -69.74 -34.27 73.61 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 112.494 0.553 . . . . 4.02 112.494 -174.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.34 -40.35 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.056 1.342 . . . . 2.12 112.952 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.68 -34.83 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.294 0.497 . . . . 3.3 111.79 168.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.2 t -64.89 -36.01 82.99 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.711 -1.243 . . . . 3.23 112.658 172.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.42 -3.06 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.332 1.853 . . . . 3.79 112.216 167.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.329 73.1 p 124.43 -9.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 1 C-N-CA 132.796 4.438 . . . . 5.72 114.945 152.696 . . . . . . . . 3 2 . 1 . 025 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.7 t 143.01 -18.53 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 129.824 3.25 . . . . 7.08 113.675 178.51 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.3 -146.4 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.655 -1.641 . . . . 4.76 109.561 -172.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.75 -42.11 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 124.079 2.493 . . . . 3.62 109.467 146.119 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.5 t70 161.8 157.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 1 C-N-CA 132.216 4.206 . . . . 4.14 107.973 174.324 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.28 90.07 3.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.904 0.882 . . . . 2.57 108.786 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 35.9 m -66.02 117.54 43.5 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 108.28 -1.007 . . . . 2.61 108.28 178.075 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -91.01 127.34 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.175 1.917 . . . . 1.47 110.085 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.0 tp -121.23 108.42 13.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.555 1.142 . . . . 2.67 109.983 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -90.06 123.38 33.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.378 1.071 . . . . 2.49 109.594 169.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.2 mt -111.36 125.25 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.404 -0.961 . . . . 1.39 108.404 171.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.6 t -96.03 144.29 26.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.794 -0.566 . . . . 2.32 110.6 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.429 ' HA ' HG21 ' A' ' 234' ' ' VAL . 25.0 pt -108.5 3.99 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.877 1.066 . . . . 2.08 113.877 -174.085 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.24 77.35 1.55 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.661 1.184 . . . . 3.0 112.435 -169.476 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.77 -9.33 18.27 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.006 1.804 . . . . 3.56 111.834 166.784 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -70.33 -4.87 24.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.998 2.119 . . . . 3.46 114.153 174.046 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -9.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.813 2.523 . . . . 4.72 117.813 178.236 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.99 97.23 10.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.611 2.005 . . . . 4.44 110.039 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 m -74.28 128.94 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.978 -0.749 . . . . 2.53 108.978 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -54.15 8.64 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.425 1.49 . . . . 3.06 111.597 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -68.25 -23.42 64.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.269 1.428 . . . . 3.68 113.741 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.16 -44.64 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.439 -1.413 . . . . 2.07 111.247 172.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.07 -37.48 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.818 0.847 . . . . 2.76 110.397 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.76 -33.76 36.52 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.822 1.045 . . . . 2.05 113.822 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -80.38 -49.49 11.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.752 -0.592 . . . . 4.68 111.926 175.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -49.49 -37.57 26.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.674 1.19 . . . . 3.03 113.385 171.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.474 HG21 ' HA3' ' A' ' 226' ' ' GLY . 39.0 t -62.37 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.675 1.59 . . . . 1.82 112.134 173.277 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -56.02 -48.3 76.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.977 0.911 . . . . 4.88 112.474 -178.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -19.42 62.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.367 1.467 . . . . 7.48 112.604 -174.27 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -53.94 7.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.406 0.682 . . . . 3.17 111.017 164.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.6 t -167.96 139.29 2.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.253 1.021 . . . . 3.09 111.503 167.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.69 0.81 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.036 2.491 . . . . 2.29 114.078 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -86.6 -16.3 37.15 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 120.051 1.296 . . . . 3.03 113.064 165.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.62 143.88 34.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.25 1.42 . . . . 2.06 110.948 -177.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.46 145.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.404 0.681 . . . . 2.37 110.269 164.078 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.474 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -117.02 124.84 6.29 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 124.054 0.835 . . . . 0.85 111.383 173.034 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 11.1 mp -117.39 145.95 43.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.817 1.247 . . . . 2.14 111.438 -179.383 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.3 p -149.92 174.94 12.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.211 2.604 . . . . 2.31 109.964 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.35 -152.11 8.09 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.497 -1.441 . . . . 1.83 109.497 158.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.8 p -64.3 165.33 9.7 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.62 1.568 . . . . 2.64 112.571 162.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.87 -36.37 62.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.315 -0.857 . . . . 7.11 110.698 169.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.09 -45.91 69.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.877 2.071 . . . . 3.34 112.667 176.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.98 -47.82 84.24 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.178 -0.951 . . . . 4.71 110.803 173.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 203' ' ' ILE . 0.9 OUTLIER -75.46 -17.03 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.152 1.168 . . . . 2.33 114.152 -178.553 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.55 -43.83 97.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.337 0.971 . . . . 3.12 109.78 168.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.92 -53.18 61.26 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.061 -0.495 . . . . 3.04 111.096 -176.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.36 -23.75 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 112.752 0.649 . . . . 2.08 112.752 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.04 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.561 0.745 . . . . 2.01 112.83 171.615 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -70.4 -41.54 72.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.559 2.343 . . . . 4.28 111.528 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.58 -46.2 63.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.983 1.713 . . . . 2.06 112.795 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.42 -126.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.881 0.764 . . . . 3.16 110.389 171.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.17 61.65 0.7 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.593 -1.317 . . . . 6.06 111.783 -172.114 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.36 156.87 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.075 0.95 . . . . 4.26 109.228 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -152.8 169.71 22.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.113 2.565 . . . . 4.65 109.165 -173.493 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -165.77 153.9 11.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.993 1.317 . . . . 4.87 111.148 -177.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.4 t -149.56 138.31 12.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.912 1.685 . . . . 5.55 108.254 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.28 151.07 15.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.155 2.57 . . . . 5.27 111.947 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.305 0 CA-C-O 118.717 -1.046 . . . . 4.64 110.716 172.465 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 122.13 0.967 . . . . 5.03 110.679 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.5 tt -73.22 175.34 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.714 1.205 . . . . 3.44 110.996 167.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.7 t -151.64 158.77 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 127.554 2.341 . . . . 3.94 106.208 172.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -85.55 150.6 24.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.398 1.479 . . . . 5.25 112.37 169.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -148.1 150.29 33.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.828 1.047 . . . . 2.38 113.828 153.26 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.24 164.05 1.01 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.058 1.343 . . . . 3.87 110.486 171.292 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.2 tp -143.19 155.11 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.997 1.319 . . . . 4.15 109.175 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.7 mt 108.48 141.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 130.987 3.715 . . . . 3.04 107.901 -162.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 mtt -101.15 136.21 41.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.501 1.12 . . . . 3.81 108.822 167.017 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -111.53 126.28 54.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.651 0.78 . . . . 4.38 110.75 -172.377 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 14.0 tp -99.9 123.72 44.45 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.872 1.269 . . . . 2.33 110.562 -175.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.85 131.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.571 -1.27 . . . . 2.93 107.571 174.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.59 169.28 25.81 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.562 0.601 . . . . 3.41 112.737 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.97 71.21 5.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.077 3.184 . . . . 4.06 108.236 167.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -156.51 -59.86 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.764 1.626 . . . . 6.14 108.536 -162.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.78 -38.86 0.2 Allowed Glycine 0 C--N 1.345 1.045 0 N-CA-C 115.51 0.964 . . . . 4.12 115.51 170.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -157.01 -151.4 0.32 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.333 1.235 . . . . 6.17 114.333 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -70.26 109.87 4.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.094 1.358 . . . . 4.97 111.278 -173.189 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 tt -99.45 -21.37 16.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.308 1.043 . . . . 3.6 111.642 179.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.24 160.08 38.28 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.726 2.01 . . . . 2.68 109.618 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -165.39 123.01 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.507 1.523 . . . . 3.52 111.754 177.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -139.31 136.14 34.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.548 1.539 . . . . 3.21 111.687 -165.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.41 145.99 13.44 Favored Glycine 0 N--CA 1.471 1.033 0 O-C-N 120.661 -1.274 . . . . 3.02 116.033 -174.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 64.24 -105.31 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.358 1.863 . . . . 3.63 110.642 171.16 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.91 87.49 0.25 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.147 1.379 . . . . 6.21 112.161 -176.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.99 130.56 0.08 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 128.737 2.815 . . . . 8.71 111.067 178.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -90.61 158.92 16.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.555 1.942 . . . . 6.62 110.201 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -40.04 80.04 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.373 1.62 . . . . 2.27 115.373 -164.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.91 -24.19 71.4 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 118.129 0.422 . . . . 1.48 113.185 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.17 -39.94 93.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.04 0.92 . . . . 3.61 111.384 175.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 46.9 mt -70.55 -42.15 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.74 0.816 . . . . 1.36 110.541 177.14 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.84 90.93 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.831 -0.543 . . . . 1.47 111.2 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.06 87.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.05 1.34 . . . . 1.61 113.716 173.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.0 p -64.98 -45.43 85.69 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.483 1.492 . . . . 1.71 110.889 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.8 -40.8 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 120.898 -1.127 . . . . 2.06 111.686 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.32 -25.05 67.44 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.645 -1.284 . . . . 2.32 113.188 171.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.9 m -73.48 -43.05 61.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.003 . . . . 2.17 110.598 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -70.55 -25.64 63.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.66 0.784 . . . . 2.72 112.83 174.536 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.3 ttp -69.02 -22.58 64.05 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.749 -1.219 . . . . 4.33 113.221 165.499 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -55.78 -42.73 97.6 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 116.632 -1.652 . . . . 4.55 112.838 177.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.43 -51.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.342 2.695 . . . . 2.42 111.968 163.035 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -83.97 68.25 9.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.38 1.086 . . . . 3.06 112.37 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 126.251 1.82 . . . . 7.93 113.91 -169.169 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.369 0 CA-C-O 117.869 -1.517 . . . . 3.1 111.512 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -78.98 167.92 21.39 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.442 2.761 . . . . 3.11 114.645 -168.534 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -158.01 163.04 38.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.954 2.102 . . . . 2.37 110.974 -169.683 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.7 t -126.65 116.95 21.79 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.989 -1.07 . . . . 2.72 110.401 161.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.485 ' HB2' HD23 ' A' ' 227' ' ' LEU . 2.1 mp -135.96 160.24 39.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.098 0.952 . . . . 2.67 112.363 -178.565 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m -82.88 136.56 34.56 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.177 1.791 . . . . 1.84 109.764 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.9 t -97.38 158.7 15.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.954 1.302 . . . . 2.98 111.894 -178.402 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -14.98 57.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.475 1.657 . . . . 1.65 115.475 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.4 -11.51 59.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.635 1.574 . . . . 3.06 112.404 171.325 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.89 -26.17 16.53 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.873 1.701 . . . . 2.72 114.538 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.82 -142.61 0.1 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.005 1.322 . . . . 6.39 111.216 176.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.2 ttm105 -140.76 157.97 44.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 122.807 1.289 . . . . 6.13 113.287 -159.112 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -140.06 149.13 42.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.691 1.596 . . . . 4.06 112.471 169.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.7 p -118.3 162.38 18.37 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.03 1.332 . . . . 2.33 109.741 158.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.93 -42.79 63.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.961 1.705 . . . . 3.64 112.595 176.506 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -47.43 -30.29 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.946 1.699 . . . . 8.28 113.908 171.351 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.45 -5.15 43.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.046 1.338 . . . . 3.07 112.85 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.71 -25.14 14.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.625 1.17 . . . . 3.01 112.619 163.075 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.37 142.11 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.114 1.765 . . . . 3.89 112.596 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.85 35.13 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.055 0.782 . . . . 2.65 115.055 173.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -139.19 -166.88 2.12 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.705 1.602 . . . . 3.41 108.943 172.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -90.69 70.02 6.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.083 0.945 . . . . 2.44 109.003 171.283 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.55 151.78 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.278 -0.638 . . . . 2.67 109.278 175.911 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.8 tp -148.23 122.69 9.72 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.789 -0.569 . . . . 2.78 109.577 -173.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -109.59 115.02 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 122.787 0.435 . . . . 1.73 111.732 -169.457 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.89 146.05 41.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.844 1.658 . . . . 2.69 112.62 173.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -111.65 118.54 35.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.687 1.195 . . . . 2.32 110.068 174.656 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.36 153.93 23.78 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.327 0.965 . . . . 1.3 114.888 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -81.06 -29.33 35.03 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.977 1.311 . . . . 4.26 112.819 176.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.3 m 96.78 123.7 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.899 2.879 . . . . 3.12 107.352 -173.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 72.11 -46.25 0.64 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.152 2.181 . . . . 8.77 113.357 -178.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.709 ' HB3' ' H ' ' A' ' 171' ' ' ASP . 1.3 m 58.7 -172.28 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.214 1.405 . . . . 2.29 113.018 -173.123 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.17 -43.2 9.12 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.039 1.826 . . . . 2.96 110.368 144.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.709 ' H ' ' HB3' ' A' ' 169' ' ' CYS . 9.5 p30 -154.5 -53.68 0.1 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.419 1.888 . . . . 6.59 115.353 -159.287 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.64 -35.82 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 114.978 1.473 . . . . 3.85 114.978 -159.343 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -46.29 -64.78 0.83 Allowed Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 120.245 1.384 . . . . 1.9 111.386 167.349 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.5 -32.21 32.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.678 2.252 . . . . 1.49 113.053 -177.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -59.81 -49.78 76.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.472 1.033 . . . . 4.08 111.429 175.7 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.36 -30.63 53.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.451 0.908 . . . . 3.98 113.451 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.6 -41.05 76.34 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.259 -0.901 . . . . 2.43 111.075 168.263 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.95 -47.48 86.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.892 0.769 . . . . 3.82 111.572 176.66 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -53.22 54.87 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.379 -1.451 . . . . 3.59 110.74 170.914 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.7 ttp -59.36 -40.7 87.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.189 1.396 . . . . 2.55 112.714 -175.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.5 mm -71.64 -53.85 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 1.75 110.174 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.584 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 67.4 mt-30 -62.86 -34.54 77.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.818 0.735 . . . . 3.71 110.269 -172.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 t -52.01 -31.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.525 -1.226 . . . . 1.48 112.853 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.49 -34.8 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.941 1.7 . . . . 2.82 111.352 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -37.54 82.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.699 0.681 . . . . 5.86 112.307 -177.024 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -84.85 -33.53 22.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.949 1.299 . . . . 3.94 112.143 -178.449 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.76 -40.19 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.503 1.121 . . . . 1.68 111.384 172.217 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -73.49 -48.2 35.22 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 117.969 0.35 . . . . 4.81 111.233 171.083 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 55.5 m -70.01 -20.86 63.25 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.437 1.643 . . . . 3.67 115.437 -171.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.1 mm -74.23 -53.4 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.684 1.129 . . . . 4.9 112.301 -178.762 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.4 p -150.6 13.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.943 1.297 . . . . 7.6 113.413 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 6.1 t 52.67 66.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.379 2.272 . . . . 6.39 110.819 -173.589 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -53.7 158.2 3.33 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.834 1.654 . . . . 3.18 111.589 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -77.12 38.45 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.211 3.274 . . . . 2.84 112.467 178.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . 0.265 5.0 t0 76.13 138.45 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 131.555 3.942 . . . . 4.66 117.412 167.613 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.04 110.12 21.59 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.021 2.129 . . . . 3.74 107.691 170.585 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -110.94 96.4 29.18 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 124.671 1.189 . . . . 1.74 109.693 -175.746 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.3 125.62 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.317 2.678 . . . . 0.85 113.626 -173.154 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.0 tp -104.55 118.65 37.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.114 1.765 . . . . 2.29 109.339 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -104.76 132.02 51.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.749 1.22 . . . . 2.44 109.495 176.549 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.1 mm -114.42 133.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.522 1.529 . . . . 1.62 110.427 177.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.4 m -67.19 -172.95 0.23 Allowed 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 115.158 1.54 . . . . 2.68 115.158 170.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.3 pt -144.99 -34.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.439 -1.413 . . . . 2.61 114.747 175.55 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -130.92 71.82 82.2 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.73 1.612 . . . . 3.22 111.288 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.95 -1.44 2.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 124.982 3.788 . . . . 3.02 115.657 -172.189 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.26 -6.51 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.495 1.043 . . . . 4.36 113.343 160.732 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -132.63 -60.83 0.87 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.39 1.476 . . . . 5.58 114.145 -173.821 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.54 74.7 9.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.836 1.303 . . . . 4.04 110.906 -172.564 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.4 t -65.01 154.7 36.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.185 1.469 . . . . 2.53 112.11 -170.561 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -56.16 -32.74 64.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.331 1.852 . . . . 6.25 113.626 -171.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -77.2 -39.36 49.02 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.809 2.844 . . . . 4.55 110.803 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.98 77.57 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.863 0.865 . . . . 1.37 111.235 172.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.55 -42.95 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 1.61 110.631 168.52 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.17 96.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.719 -0.658 . . . . 1.14 112.118 175.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -61.72 -50.39 72.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.78 1.173 . . . . 3.66 111.617 171.098 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.08 -42.52 72.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.413 1.485 . . . . 3.19 111.807 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.18 -46.32 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.325 1.05 . . . . 1.39 112.234 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.424 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -63.82 -25.43 68.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.449 0.907 . . . . 4.79 113.449 -176.651 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.424 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 7.0 mm-40 -83.98 -40.31 18.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.138 0.881 . . . . 5.18 112.411 175.394 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -76.22 -45.51 32.64 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.969 1.099 . . . . 3.04 113.969 -176.402 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 153.14 146.52 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 128.99 2.916 . . . . 2.37 112.985 173.328 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.69 8.19 2.04 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.42 3.413 . . . . 2.23 115.702 -175.29 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -76.4 -18.0 59.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.057 1.299 . . . . 2.35 112.509 163.297 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.72 139.05 39.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.428 1.091 . . . . 2.46 111.237 171.819 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.66 138.58 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.426 1.09 . . . . 2.33 108.954 161.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.66 125.41 8.57 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.889 1.233 . . . . 1.12 111.464 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 142' ' ' LEU . 3.9 mp -108.19 129.88 55.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.672 1.189 . . . . 2.4 110.249 176.082 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t 174.29 122.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.421 2.288 . . . . 2.91 110.037 -167.396 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.46 -62.19 0.12 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 124.368 0.985 . . . . 2.93 112.221 176.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.0 p -145.16 171.1 15.01 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.281 1.832 . . . . 2.58 109.192 -176.167 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -31.59 69.4 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.78 -0.575 . . . . 7.21 111.245 178.503 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -70.71 -51.77 25.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 2.79 112.632 -176.457 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . 0.32 0.0 OUTLIER -80.03 -29.09 39.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.09 1.313 . . . . 3.93 113.659 -174.833 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.37 -53.01 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.0 0.92 . . . . 2.36 111.324 157.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.37 -23.07 61.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.947 -1.096 . . . . 3.69 113.525 -175.335 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -57.74 6.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.213 0.915 . . . . 2.79 110.118 163.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.68 -21.08 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 118.445 0.566 . . . . 2.23 111.929 -171.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.261 1.024 . . . . 1.54 110.367 167.234 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -44.34 65.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.187 1.395 . . . . 5.48 111.946 173.621 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -53.03 -43.77 66.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.868 1.213 . . . . 1.7 112.473 175.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -96.71 11.22 36.28 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.921 1.082 . . . . 2.41 113.921 178.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 41.73 45.8 3.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.846 2.458 . . . . 6.37 114.955 -177.152 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 13.3 m -67.89 159.48 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.587 1.155 . . . . 3.12 112.516 -170.275 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -101.67 102.39 13.06 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.225 0.536 . . . . 3.71 110.946 163.291 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -102.69 143.37 32.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.271 -0.64 . . . . 3.38 109.271 154.618 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.6 m -70.13 137.52 87.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 121.569 -0.707 . . . . 4.08 112.307 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.59 119.32 5.87 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 107.396 -1.809 . . . . 4.96 107.396 154.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.549 0 N-CA-C 114.015 0.366 . . . . 3.62 114.015 -171.064 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 25.0 p90 . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 116.659 2.096 . . . . 4.8 116.659 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 47.0 pt -56.71 148.53 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.255 0.55 . . . . 4.14 111.715 166.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.6 m -124.22 147.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.684 1.594 . . . . 3.12 107.368 166.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.59 165.56 18.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.154 1.382 . . . . 5.25 108.883 172.985 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -150.41 143.0 24.53 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.031 1.122 . . . . 2.27 114.031 175.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.3 t -151.6 149.99 29.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.108 0.963 . . . . 4.35 109.562 167.118 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.2 174.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.614 1.966 . . . . 6.64 110.799 -159.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.99 140.63 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.47 -1.678 . . . . 3.52 106.47 152.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.4 ttt -94.92 127.99 41.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.017 1.327 . . . . 2.19 108.863 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -111.06 134.9 52.29 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 3.9 114.293 -165.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.53 107.07 17.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.048 1.339 . . . . 3.05 109.242 171.32 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.01 110.5 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 105.267 -2.123 . . . . 1.99 105.267 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.93 -168.57 44.02 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 113.601 0.2 . . . . 1.86 113.601 -168.225 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.31 71.18 5.29 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.763 2.975 . . . . 3.51 109.275 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -155.13 -60.11 0.11 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.456 1.502 . . . . 4.68 110.145 -159.69 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.04 -31.03 4.41 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.116 -1.38 . . . . 3.18 114.716 -178.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -113.12 -61.43 1.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.759 1.279 . . . . 5.1 112.42 -175.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -170.16 145.3 2.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.337 -0.852 . . . . 6.95 112.625 -162.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.81 -44.55 1.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.211 1.004 . . . . 3.3 113.574 176.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -159.33 158.93 33.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 2.87 111.547 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -119.54 125.1 48.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.826 1.25 . . . . 4.29 110.919 172.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 104.22 14.01 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.197 -1.038 . . . . 2.95 108.197 178.136 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -74.47 157.01 50.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.016 -1.234 . . . . 3.15 110.016 162.129 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.3 57.44 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.683 1.593 . . . . 4.1 111.537 175.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -156.63 -31.96 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.152 1.781 . . . . 5.44 113.186 -171.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.76 131.91 46.96 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.244 -0.91 . . . . 4.69 109.43 170.454 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -82.85 155.68 24.01 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.423 1.889 . . . . 7.88 109.794 172.496 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.584 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 9.3 tmtt? -38.91 -54.03 1.68 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.403 1.881 . . . . 2.08 114.687 -172.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.27 -36.8 93.67 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.142 -0.81 . . . . 1.4 113.63 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.3 -27.3 64.28 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.677 1.738 . . . . 3.32 112.763 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 95.0 mt -69.02 -48.81 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.196 0.998 . . . . 1.4 110.094 176.502 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.3 -45.2 85.33 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.303 0.483 . . . . 1.23 112.303 174.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.93 67.65 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 1.85 114.403 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 p -67.37 -47.99 68.75 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.017 -1.052 . . . . 1.69 111.327 168.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.93 -36.64 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.727 -1.233 . . . . 1.67 112.182 173.43 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.78 67.6 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.364 -1.46 . . . . 1.96 113.175 172.257 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.4 m -75.62 -51.76 12.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.888 0.875 . . . . 2.25 109.319 172.259 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -61.33 -26.42 67.79 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.536 1.535 . . . . 2.8 113.985 176.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.1 ttp -66.59 -15.01 63.13 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.724 -1.235 . . . . 4.74 112.99 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -59.9 -51.95 77.05 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 116.962 -1.494 . . . . 5.06 111.513 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.55 -58.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.867 2.378 . . . . 2.34 112.368 166.411 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -79.98 66.42 5.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.215 1.406 . . . . 3.19 111.724 -176.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 124.94 1.296 . . . . 8.46 113.753 -177.18 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.554 0 CA-C-O 119.104 -0.831 . . . . 3.0 114.518 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -82.11 -178.74 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.703 3.602 . . . . 3.0 112.413 -175.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -170.85 168.52 7.17 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.47 2.708 . . . . 2.74 108.762 -176.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -134.34 32.09 3.42 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.734 -1.229 . . . . 3.58 112.744 167.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.71 146.3 21.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 123.446 1.593 . . . . 2.05 111.304 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 m -108.39 140.39 41.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.788 -1.551 . . . . 1.71 109.19 -168.226 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.4 m -90.74 148.21 22.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.412 1.885 . . . . 3.25 110.459 -167.451 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -55.69 -13.08 1.47 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 117.347 2.351 . . . . 2.51 117.347 -170.468 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.4 t -86.11 -27.39 24.69 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 4.2 113.605 170.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.97 26.91 1.63 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.789 1.662 . . . . 2.56 116.172 -177.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.13 139.94 51.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.393 2.096 . . . . 3.38 111.203 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -96.04 123.69 39.74 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.188 2.195 . . . . 6.27 110.739 -170.76 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 164.24 14.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.385 0.674 . . . . 3.25 111.292 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -128.02 -179.51 5.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.586 1.154 . . . . 2.62 108.184 167.516 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -38.8 -65.8 0.33 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.141 1.777 . . . . 4.99 113.217 163.622 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 13.28 0.36 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.191 1.922 . . . . 9.06 116.191 -172.437 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -90.68 -26.91 19.34 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.573 -1.33 . . . . 3.47 112.26 158.522 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -113.36 -9.15 13.4 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.093 1.757 . . . . 2.78 114.345 -178.488 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tt -111.5 120.95 43.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.354 2.261 . . . . 3.83 109.539 -175.048 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.33 -39.81 1.75 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.101 2.286 . . . . 2.54 109.708 -170.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -78.62 -156.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.762 0.825 . . . . 3.59 109.988 138.24 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.04 155.79 27.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.834 1.253 . . . . 2.32 112.165 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.66 149.7 34.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.508 1.299 . . . . 2.34 114.508 170.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.42 137.8 38.35 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.163 1.785 . . . . 2.51 107.859 164.622 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.2 mt -123.11 139.0 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.465 1.106 . . . . 1.72 108.271 177.265 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -151.99 149.2 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.427 1.491 . . . . 2.52 111.372 177.603 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -104.02 118.42 36.62 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.923 0.889 . . . . 2.23 109.92 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -168.96 156.59 28.03 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.693 1.616 . . . . 2.32 114.312 -171.177 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.29 171.33 12.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.551 -0.97 . . . . 3.98 113.572 -155.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m -96.27 18.42 13.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.353 0.871 . . . . 3.04 113.353 -172.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -106.2 -3.51 21.27 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.069 -1.019 . . . . 8.24 113.266 170.533 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.8 OUTLIER -74.34 160.47 81.27 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 127.526 2.33 . . . . 2.32 115.4 -171.819 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 40.3 Cg_endo -79.27 -160.17 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.235 3.29 . . . . 3.8 110.764 156.883 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.68 -10.17 7.93 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.45 2.3 . . . . 4.81 115.459 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -78.45 -32.28 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 118.495 -0.764 . . . . 3.68 112.412 -170.374 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.69 -61.03 6.34 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 117.147 -1.406 . . . . 1.57 112.31 166.198 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.1 -36.75 56.66 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.583 2.188 . . . . 1.88 114.315 -175.833 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -54.91 -60.08 3.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.953 1.301 . . . . 3.83 110.95 171.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.82 -35.88 75.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.324 0.65 . . . . 2.7 112.174 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.49 -33.41 64.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.878 1.671 . . . . 2.79 112.416 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -61.34 2.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.158 1.345 . . . . 5.52 108.35 170.717 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -38.59 67.36 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.786 -0.571 . . . . 6.7 110.829 -175.261 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 11.4 ttm -64.88 -45.69 84.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.717 1.207 . . . . 2.75 113.065 177.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.7 pt -76.96 -28.79 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 120.34 1.427 . . . . 3.65 110.854 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.523 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 0.6 OUTLIER -80.4 -34.44 36.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.175 0.443 . . . . 4.31 110.604 -175.444 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.4 -40.71 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.696 0.799 . . . . 1.87 112.517 176.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 22.4 m -64.29 -39.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.276 0.944 . . . . 3.16 111.94 -175.215 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.04 -41.24 91.12 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.841 -1.162 . . . . 5.0 112.463 173.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.01 -19.54 64.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.497 1.519 . . . . 2.95 113.482 179.52 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.39 -58.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.977 1.711 . . . . 2.13 112.08 173.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.34 -28.4 69.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.845 0.831 . . . . 4.45 112.358 -170.146 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.7 m -71.07 -16.95 62.61 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.232 -0.918 . . . . 4.65 113.346 176.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.2 mm -80.63 64.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.335 -1.358 . . . . 3.97 107.335 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.9 t -47.02 -12.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 129.751 3.22 . . . . 5.98 118.181 -157.476 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.0 m -73.98 -22.95 59.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.825 1.65 . . . . 4.04 111.874 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.7 mt -74.83 162.23 74.38 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.364 1.866 . . . . 3.72 113.583 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.63 154.59 27.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.596 2.864 . . . . 3.07 110.375 168.703 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.35 133.22 38.8 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.483 1.913 . . . . 5.0 113.649 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.5 107.86 19.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.247 1.819 . . . . 2.16 111.383 -175.101 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.2 m -72.86 131.91 83.54 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.449 -1.407 . . . . 1.78 111.194 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -91.56 94.7 0.21 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.166 3.244 . . . . 1.28 111.342 165.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.24 101.26 11.53 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.742 0.782 . . . . 2.32 112.492 -173.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -93.03 126.03 37.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.212 1.405 . . . . 2.89 110.632 -177.813 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.21 119.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.226 1.01 . . . . 2.12 110.145 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.5 m -98.87 162.49 13.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.573 1.149 . . . . 2.62 112.677 175.286 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.2 pt -147.83 -13.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.91 2.189 . . . . 1.64 116.91 -148.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -94.38 93.38 0.93 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 120.618 1.554 . . . . 3.78 107.495 170.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.37 -22.32 52.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.762 1.641 . . . . 2.53 112.499 -177.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -63.22 -14.85 53.98 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.109 1.364 . . . . 4.01 114.611 170.71 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -161.64 -10.91 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 118.7 2.852 . . . . 5.08 118.7 -170.455 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -75.36 65.44 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.352 2.342 . . . . 4.81 111.862 170.339 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.0 m -65.07 136.92 57.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.57 1.948 . . . . 2.67 111.076 -176.043 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -38.22 -64.59 0.4 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.197 1.799 . . . . 3.51 113.411 175.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -65.96 -25.08 66.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.245 1.418 . . . . 3.33 113.73 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.59 -47.03 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.434 1.015 . . . . 1.89 110.814 175.889 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 38.5 mm -57.23 -45.22 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.22 1.008 . . . . 1.95 110.405 170.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.81 -46.55 67.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.834 0.853 . . . . 2.3 112.467 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -68.78 -46.18 69.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.33 0.514 . . . . 3.11 111.876 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -54.64 -49.28 70.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.81 1.244 . . . . 3.1 111.353 176.552 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.5 t -55.27 -49.32 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.555 1.942 . . . . 2.51 111.33 172.516 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -30.43 71.5 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.081 -1.438 . . . . 5.93 114.254 -177.224 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -68.74 -29.95 68.47 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.278 1.399 . . . . 4.04 112.083 175.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -81.8 -54.07 5.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.907 0.483 . . . . 3.1 111.509 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.9 p -169.85 148.96 3.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 121.591 -0.693 . . . . 2.79 111.445 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.53 -7.41 20.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.359 2.706 . . . . 2.92 113.278 173.698 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -85.01 -21.34 29.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.277 1.031 . . . . 2.64 112.997 176.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.42 143.91 48.34 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.661 1.185 . . . . 2.43 111.378 -178.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.62 134.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.882 0.873 . . . . 2.99 111.216 172.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.66 124.79 6.66 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.28 1.419 . . . . 1.34 111.763 -178.276 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -108.76 139.65 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.348 1.459 . . . . 2.38 110.901 -178.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 t -139.54 164.38 30.04 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.81 1.644 . . . . 2.77 110.678 176.783 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.31 171.95 39.97 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.67 1.605 . . . . 1.88 112.166 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -64.84 160.26 20.76 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.736 0.814 . . . . 2.12 110.529 168.648 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -50.07 -35.74 26.49 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.864 0.866 . . . . 5.43 113.167 -174.49 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.1 mp0 -67.22 -38.5 85.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.003 1.721 . . . . 2.88 110.108 -178.318 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.09 -40.84 52.16 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.599 1.16 . . . . 4.33 113.022 172.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.48 -42.62 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.869 -0.419 . . . . 1.66 109.869 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -75.35 -29.45 59.93 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.129 -0.938 . . . . 3.05 112.653 175.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -60.21 -59.69 5.01 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.625 2.011 . . . . 2.38 110.261 167.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.22 -30.6 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 118.466 0.576 . . . . 2.06 111.986 -171.198 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.45 -52.34 14.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.996 0.816 . . . . 1.69 112.216 173.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -76.54 -32.55 58.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.592 1.157 . . . . 3.74 112.936 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.72 78.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.539 1.136 . . . . 1.7 111.242 173.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -73.2 -1.89 19.52 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.24 -0.912 . . . . 2.29 113.03 168.62 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 45.61 39.68 5.18 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.372 2.669 . . . . 7.27 114.471 -176.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 p -71.37 137.6 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.195 -0.668 . . . . 2.88 109.195 174.105 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -75.46 130.65 39.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.87 0.367 . . . . 4.07 110.88 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -148.84 144.39 26.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.185 1.394 . . . . 4.05 109.956 172.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.0 m -149.48 106.35 3.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 O-C-N 121.493 -0.755 . . . . 4.29 112.133 -171.412 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.35 142.35 10.6 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.447 2.765 . . . . 3.05 113.055 -177.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.514 0 CA-C-O 118.088 -1.396 . . . . 2.97 110.322 166.567 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.4 p90 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.866 0.841 . . . . 3.5 111.935 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.4 tt -157.45 164.85 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.106 1.762 . . . . 3.52 108.059 157.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.39 140.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.278 -1.378 . . . . 3.89 107.278 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.7 147.71 47.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.261 0.553 . . . . 4.56 110.996 167.207 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -143.26 136.25 27.84 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.618 0.767 . . . . 2.56 110.13 158.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -66.2 131.37 46.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.811 -1.181 . . . . 3.78 110.339 174.298 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.457 ' CD1' ' H ' ' A' ' 262' ' ' ILE 0.253 0.0 OUTLIER -82.52 64.48 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 123.172 1.463 . . . . 4.93 112.653 -171.091 . . . . . . . . 4 4 . 1 . 027 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.63 127.09 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.04 1.336 . . . . 2.17 111.402 -176.645 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.7 mmm -88.09 137.66 32.13 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.552 1.541 . . . . 2.42 109.411 158.698 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -114.14 131.56 56.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 2.73 109.524 168.51 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.05 121.45 41.4 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.901 0.88 . . . . 2.3 108.685 173.458 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.08 117.89 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.052 -1.462 . . . . 1.65 107.052 172.731 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.51 -137.12 5.76 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 109.357 -1.497 . . . . 1.67 109.357 167.066 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -81.19 3.67 7.62 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.391 2.06 . . . . 3.59 112.381 170.197 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -31.37 53.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.954 1.302 . . . . 4.86 112.744 -176.795 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.98 1.85 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.07 1.319 . . . . 2.94 113.345 -170.027 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -77.86 19.26 0.41 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.983 1.713 . . . . 4.67 115.04 -166.344 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 92.1 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 129.972 3.309 . . . . 4.11 110.676 173.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.32 -33.29 10.78 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.727 1.211 . . . . 2.85 111.144 176.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -168.97 167.12 10.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.139 2.175 . . . . 2.72 108.325 -168.803 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -161.47 146.04 13.28 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.444 1.098 . . . . 4.39 112.288 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -129.91 115.22 16.88 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.914 0.886 . . . . 2.74 109.862 -175.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.32 110.75 4.09 Favored Glycine 0 N--CA 1.465 0.616 0 N-CA-C 109.652 -1.379 . . . . 3.5 109.652 173.1 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.482 ' HG3' ' H ' ' A' ' 280' ' ' ASN . 16.2 tp60 76.44 166.32 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.483 1.913 . . . . 4.17 110.949 -167.722 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.482 ' H ' ' HG3' ' A' ' 279' ' ' GLN . 53.4 t-20 -42.03 -48.46 4.63 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.094 2.557 . . . . 9.21 113.408 -169.714 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 59.0 tttp 67.95 -23.29 0.12 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.566 1.946 . . . . 5.35 113.89 -172.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 102.3 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.319 3.448 . . . . 5.84 107.259 -174.026 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.523 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -34.78 -60.07 0.46 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.285 2.234 . . . . 2.45 113.25 179.012 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.8 -19.38 69.41 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.256 -1.302 . . . . 1.59 115.755 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.84 -26.11 49.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.739 2.27 . . . . 3.91 112.981 177.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.85 -40.47 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.735 -0.839 . . . . 2.46 108.735 169.847 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.31 77.54 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.484 0.584 . . . . 1.49 111.461 169.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.41 -39.21 85.52 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.196 1.184 . . . . 1.51 114.196 176.032 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.9 p -70.0 -46.95 64.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.108 0.867 . . . . 1.74 111.571 175.781 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.8 mt -54.82 -44.18 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.954 . . . . 1.53 110.77 171.407 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.408 -1.433 . . . . 1.68 113.701 178.406 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 57.4 m -76.95 -47.88 19.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.079 0.952 . . . . 2.06 109.93 170.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -62.73 -31.78 72.77 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.338 1.055 . . . . 2.75 112.288 175.47 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.56 24.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.633 1.573 . . . . 5.86 112.749 168.372 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.47 -57.16 0.31 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 116.337 -1.792 . . . . 5.79 111.801 152.209 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.17 -49.48 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.251 2.634 . . . . 2.55 113.133 176.469 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.33 70.42 10.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.863 0.756 . . . . 3.19 111.712 -176.158 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 . . . . . 0 CA--C 1.549 0.933 0 C-N-CA 124.879 1.272 . . . . 10.63 109.318 -174.83 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 N-CA-C 110.494 -1.042 . . . . 3.55 110.494 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.55 161.78 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.905 2.403 . . . . 3.6 113.279 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -156.08 179.43 9.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.85 2.46 . . . . 2.92 108.366 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.2 m -140.31 117.27 11.09 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.957 -1.714 . . . . 3.11 111.528 157.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.72 161.65 28.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.694 1.997 . . . . 2.62 108.39 176.325 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.4 t -87.31 146.62 25.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.467 0.651 . . . . 2.69 110.93 173.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.9 p -92.85 159.28 15.44 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 123.152 1.454 . . . . 2.37 112.409 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -56.82 -26.86 59.05 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.127 -0.983 . . . . 1.99 112.474 163.068 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.0 p -71.72 -20.29 61.93 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.367 1.247 . . . . 4.18 114.367 169.133 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.77 11.16 54.24 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 120.287 1.403 . . . . 1.96 115.163 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -88.76 -175.37 4.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.673 1.589 . . . . 4.06 110.136 170.492 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -131.56 121.72 24.9 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.887 1.275 . . . . 5.75 108.969 168.561 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -132.72 156.39 47.11 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.903 1.075 . . . . 3.9 113.903 -162.233 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -108.0 164.16 12.52 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.37 1.868 . . . . 3.14 109.63 171.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -39.61 -55.77 1.8 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.63 2.372 . . . . 4.18 112.42 159.803 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -74.34 -15.66 60.94 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.537 1.31 . . . . 8.02 114.537 -174.362 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.74 -42.64 77.29 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.824 1.193 . . . . 3.04 110.988 166.208 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.68 11.19 3.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.385 1.254 . . . . 2.98 114.385 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.36 -169.49 0.82 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.662 1.185 . . . . 4.19 111.763 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 76.41 8.35 85.67 Favored Glycine 0 N--CA 1.482 1.702 0 O-C-N 120.517 -1.364 . . . . 3.85 114.56 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.55 154.96 27.51 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.361 2.664 . . . . 3.57 107.593 -171.286 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -68.07 125.09 25.25 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.314 0.507 . . . . 2.48 110.071 170.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.7 mt -105.86 125.72 51.33 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.963 0.887 . . . . 3.09 111.652 177.107 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.04 92.22 3.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.865 1.666 . . . . 3.13 106.748 176.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.85 121.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.787 1.235 . . . . 2.63 110.199 -167.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -128.98 153.6 47.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.542 1.312 . . . . 3.55 114.542 -175.622 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.85 102.13 9.7 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.109 1.763 . . . . 2.84 112.31 175.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.02 171.31 17.72 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.396 1.474 . . . . 2.34 113.329 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -111.42 -12.99 13.95 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.765 0.654 . . . . 3.7 112.765 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.0 m 58.04 47.53 14.62 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.137 1.446 . . . . 4.19 108.891 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -150.4 -56.65 0.17 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 114.638 -1.164 . . . . 7.65 110.738 -161.275 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.3 m -70.4 141.03 87.87 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.156 0.982 . . . . 2.45 111.219 -170.21 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.22 -17.54 21.58 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.907 1.738 . . . . 4.17 111.243 166.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.51 -76.57 0.54 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.779 1.632 . . . . 5.3 112.673 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.29 -54.44 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.486 1.114 . . . . 2.76 111.945 -162.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.5 m -47.25 -60.7 3.64 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.325 -1.321 . . . . 1.68 112.596 176.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.24 -34.55 27.3 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.657 1.571 . . . . 1.27 113.127 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -67.08 -33.43 75.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 121.092 1.769 . . . . 3.75 112.097 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -31.2 37.67 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.299 -1.501 . . . . 3.49 113.521 170.949 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -43.74 98.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.967 1.307 . . . . 2.63 111.171 174.204 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.24 -46.34 76.03 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 3.47 111.055 172.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -66.51 -33.69 76.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.186 0.81 . . . . 3.69 113.186 174.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 69.7 mtp -61.18 -42.6 98.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.017 1.281 . . . . 3.54 111.915 169.328 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.9 mm -75.41 -61.97 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.971 -0.751 . . . . 1.87 108.971 -172.06 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.26 -12.41 28.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.748 1.219 . . . . 3.1 114.225 -165.068 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.13 -39.67 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.648 1.179 . . . . 1.62 111.044 171.064 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.11 -53.86 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.021 1.282 . . . . 2.38 110.205 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.8 -20.03 61.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.256 1.422 . . . . 4.49 112.064 -171.354 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -79.32 -38.13 35.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.796 1.239 . . . . 2.6 111.909 167.206 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.82 -49.54 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.782 1.401 . . . . 2.14 114.782 -168.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -33.52 75.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.571 1.532 . . . . 4.49 109.74 179.35 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -19.83 42.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.527 1.931 . . . . 3.01 114.714 173.714 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.46 -14.34 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.321 -1.487 . . . . 4.44 112.494 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m 157.64 -33.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 130.422 3.489 . . . . 6.18 112.832 164.43 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 7.1 t 157.34 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.16 3.384 . . . . 5.97 110.785 166.589 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.07 147.09 1.88 Allowed Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 114.302 -1.317 . . . . 3.78 111.493 169.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.28 -44.25 19.77 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.372 2.715 . . . . 3.57 112.459 -159.527 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.12 153.67 0.23 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.895 2.878 . . . . 4.5 108.669 161.722 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.16 128.11 29.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.044 0.537 . . . . 2.64 109.704 171.969 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.4 m -124.84 119.1 25.65 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.704 1.202 . . . . 1.63 108.562 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.73 133.63 10.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.001 2.467 . . . . 1.05 110.127 172.267 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.84 97.25 4.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.832 1.253 . . . . 2.48 109.336 -169.219 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -94.27 133.04 38.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.97 1.308 . . . . 2.51 110.661 -173.175 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 54.0 mt -122.62 129.43 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.586 1.155 . . . . 1.71 109.41 176.407 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -83.03 137.35 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.656 -0.653 . . . . 2.54 112.409 171.673 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 pt -81.74 3.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.891 1.071 . . . . 2.78 113.891 172.469 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.78 80.14 12.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 115.937 1.829 . . . . 5.12 115.937 -172.63 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -80.14 63.21 8.72 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.295 3.33 . . . . 2.57 112.12 174.463 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -108.74 -50.26 3.04 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.565 -1.198 . . . . 3.88 108.343 139.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.39 -6.32 28.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.793 1.775 . . . . 4.73 115.793 -170.736 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -76.46 28.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.715 1.598 . . . . 5.42 114.75 -177.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.2 m -61.29 134.74 57.29 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.486 -0.759 . . . . 3.67 109.746 -141.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -39.37 9.14 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.828 1.418 . . . . 3.7 114.828 -161.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -85.74 -28.31 24.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.655 0.983 . . . . 4.06 113.655 178.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.81 91.78 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 1.65 111.44 166.585 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.6 -41.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.485 0.714 . . . . 2.6 112.274 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.64 -38.79 75.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.297 0.953 . . . . 1.31 111.677 170.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -68.69 -38.29 80.19 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.062 0.764 . . . . 3.98 113.062 173.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.61 -37.9 87.92 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.023 0.829 . . . . 3.03 111.217 174.756 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.6 t -56.61 -47.94 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.951 -1.093 . . . . 1.3 111.721 170.583 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -79.84 19.9 0.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.493 1.294 . . . . 4.61 114.493 174.698 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -92.48 -59.88 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.572 -1.33 . . . . 3.9 109.557 160.171 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -80.79 -53.17 6.73 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.449 1.277 . . . . 3.4 114.449 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.3 t -177.35 132.02 0.35 Allowed Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.135 1.374 . . . . 2.26 109.031 -174.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.37 -5.72 16.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.184 2.589 . . . . 1.92 113.081 -176.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -76.55 -8.56 57.46 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.333 0.969 . . . . 3.67 113.401 171.195 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.48 131.04 44.11 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.32 0.964 . . . . 1.82 110.09 169.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.3 t -99.97 129.2 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.757 -1.201 . . . . 2.23 107.757 171.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.48 134.48 11.9 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.951 -0.86 . . . . 1.35 110.951 172.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.2 161.0 22.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.911 0.884 . . . . 2.28 112.129 171.27 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 9.7 t -162.72 -168.96 1.93 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 129.449 3.1 . . . . 2.77 108.165 -176.063 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 173.58 -147.43 9.48 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 120.305 1.411 . . . . 1.91 110.418 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.9 p -90.37 164.91 14.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.494 -0.928 . . . . 3.12 108.494 157.239 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -30.17 69.57 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.523 -0.751 . . . . 7.85 112.523 -173.719 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -56.09 -35.61 67.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.861 1.664 . . . . 3.45 113.114 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.38 -35.77 54.14 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.792 -1.193 . . . . 3.66 112.534 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.04 -35.1 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.009 0.524 . . . . 2.09 110.657 171.208 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -30.45 67.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.226 1.01 . . . . 3.69 111.318 174.144 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -60.41 3.91 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.405 1.082 . . . . 2.57 110.798 162.428 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' A' ' 240' ' ' ALA . 6.9 p -71.51 -16.28 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.942 1.247 . . . . 2.55 112.806 -168.474 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.78 -39.62 69.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.974 0.91 . . . . 1.76 110.255 173.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.05 -49.58 76.79 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.384 -0.817 . . . . 3.53 110.478 163.348 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 237' ' ' VAL . . . -60.9 -16.51 42.91 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 116.501 2.037 . . . . 2.95 116.501 -170.867 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -129.75 15.56 5.87 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.118 . . . . 2.87 113.671 173.269 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 56.61 43.32 25.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.136 1.374 . . . . 5.52 112.678 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.51 126.72 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.623 1.569 . . . . 2.89 108.511 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -94.14 149.78 20.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.127 1.371 . . . . 4.53 111.577 175.52 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -165.23 127.88 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.635 1.974 . . . . 5.02 110.056 -174.136 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.1 t -136.42 79.2 42.69 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.826 1.65 . . . . 3.72 111.8 -171.071 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.47 138.0 21.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.66 2.907 . . . . 3.21 113.877 -170.661 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.76 0 C-N-CA 125.521 1.534 . . . . 3.29 112.829 163.784 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 121.489 0.662 . . . . 3.99 112.088 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 28.1 mm -77.04 78.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.791 -0.818 . . . . 4.42 108.791 169.053 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.37 146.64 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.414 -1.699 . . . . 4.07 106.414 151.723 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.66 -174.68 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.326 1.06 . . . . 4.62 111.315 162.562 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -146.87 151.31 36.85 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.08 -1.013 . . . . 2.27 111.453 138.339 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.1 m -60.09 128.47 36.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.055 1.342 . . . . 3.38 109.309 165.077 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 15.4 pt -104.07 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.56 1.544 . . . . 5.15 111.579 -177.276 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.3 mm -128.72 141.12 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.491 1.117 . . . . 2.99 109.954 177.266 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 7.9 ttp -124.35 128.31 48.9 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.621 1.968 . . . . 2.72 109.167 173.527 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.72 141.39 32.58 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.318 1.047 . . . . 3.02 112.053 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -104.19 110.86 23.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.632 1.173 . . . . 2.61 110.215 174.266 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.0 138.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.477 1.511 . . . . 2.28 109.38 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.92 160.53 37.19 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.351 -0.694 . . . . 2.18 114.089 -178.014 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.53 64.52 4.64 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.593 3.529 . . . . 3.86 109.192 167.105 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.02 -60.69 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.807 1.643 . . . . 4.79 108.254 -154.735 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 171.59 -70.25 0.12 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 123.798 0.714 . . . . 3.34 112.464 -178.349 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -118.11 -175.75 2.92 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.594 0.711 . . . . 5.98 112.812 -161.195 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -85.05 145.74 27.53 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.329 0.863 . . . . 3.73 113.329 -176.043 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 pp -141.93 0.86 1.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.398 1.629 . . . . 3.32 115.398 -178.549 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -157.46 171.54 20.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.742 1.617 . . . . 3.17 110.005 171.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -155.67 156.84 35.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.347 1.459 . . . . 3.64 113.362 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -147.9 177.6 9.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.796 1.638 . . . . 2.64 113.18 -168.327 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.09 -164.89 37.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 128.188 2.804 . . . . 3.15 108.93 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -28.16 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.133 0.967 . . . . 3.58 113.225 179.164 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.29 -8.91 58.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 114.336 1.236 . . . . 4.69 114.336 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -135.44 98.32 3.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 4.54 108.419 171.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.32 -172.31 4.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.357 0.663 . . . . 5.94 112.518 -164.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -50.12 74.89 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.166 -1.584 . . . . 2.06 114.862 -159.08 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.89 -28.68 70.24 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.624 0.647 . . . . 1.76 111.809 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.68 -26.86 60.12 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.282 1.033 . . . . 4.28 112.808 177.007 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.38 -51.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.861 0.865 . . . . 1.27 109.724 167.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.13 93.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.14 0.576 . . . . 1.74 111.603 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.91 95.49 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.534 1.134 . . . . 2.3 113.882 177.714 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 25.1 p -71.73 -39.0 70.4 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.766 1.166 . . . . 1.92 111.982 174.235 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.11 -40.0 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.335 1.425 . . . . 1.81 111.772 176.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.36 -22.0 66.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.26 1.024 . . . . 2.73 113.216 171.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 95.0 m -78.64 -40.27 34.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.928 0.891 . . . . 3.19 110.673 170.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.53 -21.79 64.55 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.74 1.216 . . . . 2.8 112.974 174.431 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -63.88 -33.26 75.3 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.848 -1.157 . . . . 4.8 112.522 166.656 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -60.75 -36.22 33.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 116.409 -1.757 . . . . 5.53 114.814 -172.528 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -86.41 -8.65 7.31 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.508 2.805 . . . . 3.31 114.452 167.665 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -94.99 -171.08 2.34 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.54 1.536 . . . . 4.69 112.471 179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 . . . . . 0 N--CA 1.471 0.591 0 O-C-N 120.716 -1.24 . . . . 8.29 111.184 159.589 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.881 0 CA-C-O 118.24 -1.311 . . . . 3.2 111.458 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.95 135.9 66.08 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.606 2.871 . . . . 3.56 112.084 -169.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -140.91 176.92 8.41 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.571 -1.65 . . . . 2.9 112.516 -168.107 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.8 t -127.73 132.86 49.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.634 1.974 . . . . 3.68 106.168 159.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 tp -164.56 143.18 6.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.977 0.911 . . . . 2.36 110.319 -176.487 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.0 m -93.81 140.29 29.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.746 0.703 . . . . 1.55 109.617 -174.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.0 m -101.5 139.32 37.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.829 1.652 . . . . 3.59 110.634 -178.66 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -16.35 1.37 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.597 2.759 . . . . 2.0 116.842 -169.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 t -76.65 -35.79 57.76 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.468 1.031 . . . . 3.51 112.127 172.054 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.32 68.42 0.44 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.403 1.477 . . . . 2.82 112.257 -166.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.67 148.21 6.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.164 1.785 . . . . 4.88 108.747 171.292 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -108.36 115.85 30.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.717 1.207 . . . . 4.39 111.662 -175.482 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -104.5 163.27 12.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.836 1.254 . . . . 4.23 112.574 -173.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -119.84 160.73 22.09 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.613 1.965 . . . . 3.25 108.054 162.057 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -49.3 -37.37 23.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.0 1.72 . . . . 4.64 111.552 169.352 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -71.23 -31.48 67.62 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.876 1.065 . . . . 7.75 113.876 -177.555 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.29 -3.77 33.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.101 0.864 . . . . 4.84 113.33 175.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -33.01 59.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.383 0.883 . . . . 4.48 113.383 160.124 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.12 178.78 0.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.966 1.306 . . . . 5.5 113.856 -173.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 8.98 75.44 Favored Glycine 0 N--CA 1.474 1.206 0 O-C-N 121.172 -0.955 . . . . 2.93 113.228 -166.896 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -156.14 165.45 36.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.088 1.755 . . . . 3.39 109.428 -177.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -69.51 112.25 5.9 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.965 -0.459 . . . . 2.19 112.206 177.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -98.52 122.65 41.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.613 1.165 . . . . 2.77 110.981 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -118.13 109.16 16.07 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.505 -1.665 . . . . 3.0 106.505 176.419 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.3 pt -111.81 126.82 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.093 0.405 . . . . 3.89 112.093 -170.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.31 149.17 51.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 2.66 112.208 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -122.77 121.27 35.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.428 1.091 . . . . 2.82 109.927 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.38 -178.37 16.95 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 1.68 116.123 -169.155 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.5 151.34 50.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.683 1.193 . . . . 3.6 111.686 175.366 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.9 p -53.63 -30.9 45.09 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.19 1.396 . . . . 4.04 113.831 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -143.17 94.42 2.62 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 108.952 -0.758 . . . . 7.86 108.952 150.789 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.448 ' C ' ' H ' ' A' ' 171' ' ' ASP . 9.2 t -38.31 166.77 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 128.377 2.671 . . . . 2.36 115.613 160.715 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -65.54 43.71 0.16 Allowed 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.537 2.825 . . . . 3.59 111.815 146.351 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 169' ' ' CYS 0.28 29.8 m-20 58.03 11.87 1.62 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.154 2.982 . . . . 4.96 116.75 173.913 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.6 -35.99 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.975 0.91 . . . . 2.47 110.708 169.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 38.5 m -53.07 -56.24 25.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.635 -1.65 . . . . 1.78 114.272 175.548 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.0 -43.47 11.69 Favored 'Trans proline' 0 C--N 1.351 0.7 0 CA-C-N 122.472 1.918 . . . . 1.53 112.149 177.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -51.52 -46.27 63.21 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.826 1.65 . . . . 2.9 112.573 174.17 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.89 -45.26 24.65 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.121 -0.987 . . . . 2.49 112.316 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -62.49 -29.05 70.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.955 -1.091 . . . . 2.49 112.313 -177.388 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -60.42 -52.19 66.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.769 0.828 . . . . 4.0 111.84 168.03 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -58.08 -50.8 72.2 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 120.17 -1.581 . . . . 2.84 110.801 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -57.22 -53.75 54.57 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.705 -0.664 . . . . 3.73 110.99 175.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 181' ' ' ILE . 5.7 tp -68.08 -38.35 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.479 1.49 . . . . 2.53 111.197 -170.858 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.598 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 62.1 mt-30 -65.85 -24.08 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 118.1 -0.952 . . . . 2.91 112.168 179.03 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.18 -19.21 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 120.669 1.577 . . . . 2.66 113.732 173.067 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.25 -40.0 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.11 1.323 . . . . 2.13 109.394 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -55.4 -48.69 73.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.551 1.541 . . . . 3.95 112.401 172.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -70.3 -36.46 74.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.994 0.918 . . . . 3.44 112.83 -177.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -77.76 -27.72 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.083 -1.011 . . . . 2.04 112.823 177.456 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.79 -48.74 79.27 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.244 1.018 . . . . 3.35 109.133 165.678 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.6 t -64.49 -26.73 68.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.405 0.891 . . . . 2.97 113.405 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.0 -30.87 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.604 1.161 . . . . 3.36 111.786 172.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.4 m 73.47 -36.32 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.788 2.035 . . . . 4.32 113.553 167.365 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 80.1 p -78.94 24.3 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.644 1.978 . . . . 5.63 113.11 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.2 mt -134.21 156.28 79.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.345 1.858 . . . . 4.34 110.456 174.069 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.83 -75.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.131 2.554 . . . . 3.01 109.625 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.61 167.28 30.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.842 2.057 . . . . 3.47 108.06 162.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.17 114.7 26.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.275 1.43 . . . . 1.81 108.705 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.5 m -108.38 94.58 13.84 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 123.312 0.645 . . . . 2.02 110.887 -168.685 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.98 131.06 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.813 2.342 . . . . 1.61 110.885 170.143 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.01 139.19 49.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.533 1.159 . . . . 3.8 111.621 168.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -109.94 123.65 50.01 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.51 1.924 . . . . 2.53 109.272 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.9 mt -108.79 115.02 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.887 0.875 . . . . 1.75 109.554 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.0 t -83.71 104.69 14.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 2.58 108.649 176.504 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.5 pt -79.27 35.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 122.013 0.911 . . . . 1.88 111.823 -178.729 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -126.93 46.94 2.2 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 127.291 2.236 . . . . 3.9 111.301 -160.056 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -13.26 36.89 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.456 2.77 . . . . 2.46 114.302 -163.104 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -76.88 9.93 2.58 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.906 1.283 . . . . 3.99 113.33 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -163.44 25.08 0.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.866 1.432 . . . . 4.49 114.866 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -71.21 152.79 43.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.112 0.958 . . . . 5.7 111.814 172.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 4.4 m -154.81 122.47 5.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.079 1.752 . . . . 2.75 106.499 164.582 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -46.56 -48.08 19.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.796 1.238 . . . . 3.98 113.105 -170.801 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.43 -30.47 61.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.547 1.139 . . . . 5.12 113.525 177.631 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.14 73.66 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.066 -1.021 . . . . 1.83 110.755 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.15 -42.94 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 2.66 110.444 173.489 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.7 77.21 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.333 0.653 . . . . 1.7 112.586 176.072 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -65.66 -45.97 80.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.452 0.701 . . . . 4.38 112.56 176.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -49.98 -45.22 51.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.027 0.931 . . . . 2.78 111.387 170.404 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.4 t -72.56 -39.7 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.74 1.015 . . . . 2.16 113.74 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -57.68 -50.5 72.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.214 -0.898 . . . . 4.09 113.291 -176.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -69.6 -17.25 63.52 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.318 1.229 . . . . 6.61 114.318 -165.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.82 -32.62 72.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.195 0.907 . . . . 2.5 112.639 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 t 138.2 129.25 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 131.032 3.733 . . . . 2.83 109.711 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.32 8.13 1.25 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.549 2.833 . . . . 2.25 116.018 -166.082 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -73.19 -16.06 61.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.036 1.289 . . . . 2.36 112.73 161.158 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.04 137.56 43.48 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.449 -0.782 . . . . 1.79 109.223 166.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.57 148.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.377 0.671 . . . . 2.47 112.156 171.59 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.69 138.68 15.1 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 124.501 1.048 . . . . 1.04 112.865 -177.101 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.83 148.32 40.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 114.758 1.392 . . . . 2.07 114.758 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.2 p -155.12 170.61 21.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.576 2.35 . . . . 2.29 110.19 -179.206 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.39 -173.63 37.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.612 1.101 . . . . 1.94 111.447 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.8 t -65.27 162.99 16.24 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.161 0.48 . . . . 2.61 110.553 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -56.64 -31.84 64.75 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.34 -0.85 . . . . 6.54 112.233 -176.716 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.9 mp0 -72.14 -35.75 69.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.799 2.04 . . . . 3.68 111.045 178.499 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.66 -39.72 76.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.747 -0.595 . . . . 3.15 111.881 169.676 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.21 -36.47 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.965 0.906 . . . . 2.19 111.951 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.15 -46.24 43.65 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.473 1.033 . . . . 4.24 110.113 173.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -46.08 -50.68 14.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.622 0.769 . . . . 3.31 110.8 173.256 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.44 -43.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.123 0.969 . . . . 2.48 111.803 -174.208 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.55 87.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.806 0.842 . . . . 2.02 111.906 173.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -32.09 35.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.236 1.814 . . . . 6.21 113.013 -177.281 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.56 -60.86 2.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.835 1.254 . . . . 2.16 112.235 176.661 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -74.68 -6.13 47.01 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.578 0.955 . . . . 2.46 113.578 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 66.66 54.89 0.81 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.63 1.972 . . . . 5.1 113.319 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.07 152.27 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.759 2.024 . . . . 3.29 110.54 177.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -103.67 145.93 29.33 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.009 1.114 . . . . 4.91 114.009 -176.59 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -129.87 142.63 50.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.536 1.934 . . . . 3.81 111.354 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 42.4 t -128.92 106.14 18.28 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 124.059 0.944 . . . . 4.56 111.136 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.74 153.28 8.75 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.478 2.785 . . . . 3.45 111.138 170.386 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.591 0 N-CA-C 114.75 0.66 . . . . 3.36 114.75 176.305 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.547 0.837 0 CA-C-O 122.195 0.998 . . . . 5.54 111.676 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.61 150.17 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.883 -1.136 . . . . 3.26 110.917 155.011 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.3 m -156.44 152.63 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.024 1.73 . . . . 5.22 107.605 -178.24 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -150.86 145.18 25.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.964 1.364 . . . . 5.94 112.077 -179.359 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -133.13 95.99 3.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.413 1.085 . . . . 2.34 109.92 170.951 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 t -72.54 58.26 0.42 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.852 1.661 . . . . 5.76 110.461 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.4 pp -113.09 158.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 122.472 1.13 . . . . 5.53 113.827 -167.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.7 pt -107.55 163.63 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.328 1.451 . . . . 3.89 109.014 161.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 76.5 mtp -97.51 159.01 15.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.739 0.816 . . . . 2.66 109.869 161.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.32 142.02 45.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.414 0.686 . . . . 2.82 111.116 165.464 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.2 tp -92.12 118.07 30.46 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 106.535 -1.654 . . . . 2.04 106.535 158.481 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.18 136.02 31.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.617 -1.623 . . . . 2.79 106.617 164.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.48 172.07 45.82 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 2.21 111.968 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.17 -13.44 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.191 2.594 . . . . 3.49 113.094 177.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -113.57 -0.14 14.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 129.713 3.205 . . . . 4.42 112.178 -176.34 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 108.34 -148.67 16.78 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.917 1.722 . . . . 4.28 113.072 -176.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.81 158.64 0.13 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.428 2.691 . . . . 5.91 116.543 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.86 85.78 6.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.813 1.245 . . . . 3.92 108.854 172.388 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.3 tt -86.31 -36.06 19.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.005 0.922 . . . . 3.2 111.834 -163.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -159.24 159.88 34.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.895 1.678 . . . . 2.61 109.413 175.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -136.46 147.34 47.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 122.676 1.227 . . . . 3.94 113.3 172.888 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.67 156.34 44.4 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.843 1.257 . . . . 2.39 111.101 -162.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.21 170.82 42.63 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.874 1.702 . . . . 2.75 110.036 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.88 -25.35 42.19 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.913 2.19 . . . . 4.48 116.913 -149.625 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.85 -21.35 25.06 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.512 1.301 . . . . 5.97 114.512 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -57.93 107.07 0.42 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.769 1.628 . . . . 4.09 108.593 178.649 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -74.93 143.8 43.55 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.395 -1.441 . . . . 6.36 109.813 -157.174 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.1 tmtt? -42.79 -53.0 4.8 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 121.095 1.77 . . . . 2.0 113.438 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -18.38 74.92 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.361 0.904 . . . . 1.58 115.361 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -31.78 17.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.877 1.271 . . . . 4.62 111.395 174.43 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.2 mt -56.36 -43.5 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.103 -0.998 . . . . 1.47 109.901 161.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.46 -53.17 58.75 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.54 0.57 . . . . 1.26 112.54 170.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.05 72.1 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.562 1.319 . . . . 1.5 114.562 -177.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.9 p -68.92 -48.83 62.33 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.446 -0.783 . . . . 1.75 111.07 170.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.24 -34.05 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.28 1.4 . . . . 1.49 111.709 176.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.35 -21.18 62.92 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.118 0.967 . . . . 1.51 113.494 172.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 100.0 m -76.98 -45.65 26.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.722 0.809 . . . . 1.9 109.537 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -62.83 -21.11 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.855 1.262 . . . . 2.44 113.402 174.837 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -66.5 -23.49 66.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.086 1.355 . . . . 4.27 113.287 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -59.8 -45.48 98.36 Favored Pre-proline 0 N--CA 1.477 0.891 0 O-C-N 119.971 -1.706 . . . . 5.0 113.277 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.6 -57.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.554 2.169 . . . . 2.12 111.491 164.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -83.63 23.47 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.029 1.862 . . . . 3.65 116.029 -167.624 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 ptt85 . . . . . 0 N--CA 1.471 0.618 0 C-N-CA 125.606 1.563 . . . . 8.89 111.752 174.686 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 N-CA-C 108.149 -1.98 . . . . 3.48 108.149 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.33 134.94 25.73 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.667 2.245 . . . . 3.97 111.772 -161.531 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -75.51 -179.97 4.92 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.497 1.519 . . . . 2.34 113.194 -172.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.2 m -157.83 62.1 0.47 Allowed 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.246 -1.534 . . . . 3.25 112.695 177.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -98.8 160.74 14.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.556 1.142 . . . . 2.21 110.511 -177.581 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -103.42 139.86 38.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.635 1.574 . . . . 1.69 111.656 -164.635 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -94.59 158.93 15.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.877 1.799 . . . . 2.24 115.706 -167.677 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.461 ' O ' ' HE3' ' A' ' 210' ' ' LYS . 0.3 OUTLIER -57.39 -21.7 37.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.481 1.912 . . . . 1.93 113.327 164.349 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -71.76 -68.85 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.194 1.398 . . . . 3.18 109.086 160.198 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.28 -12.44 1.6 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 124.769 1.176 . . . . 1.85 115.114 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.3 153.94 41.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.812 1.306 . . . . 4.2 110.626 166.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -85.26 135.14 34.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.449 -0.574 . . . . 5.21 109.449 153.164 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -120.27 153.86 35.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.833 0.853 . . . . 3.18 110.198 178.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.1 p -141.14 156.46 45.95 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.701 1.2 . . . . 2.52 110.705 -166.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.09 13.61 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.189 0.996 . . . . 3.93 113.444 168.339 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -103.67 -32.11 9.55 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.225 -1.547 . . . . 7.56 112.684 167.52 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -96.81 -22.59 16.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.646 1.178 . . . . 3.28 112.731 177.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -77.83 -15.31 59.16 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.573 0.953 . . . . 3.05 113.573 162.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.37 133.65 56.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.618 1.167 . . . . 3.43 110.551 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.32 6.68 88.51 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.273 -0.892 . . . . 2.33 114.199 -176.144 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -84.98 -155.73 0.22 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.088 1.444 . . . . 3.3 110.449 163.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -136.12 111.56 9.2 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.003 -1.481 . . . . 1.9 107.003 153.065 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.22 148.3 41.33 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.483 1.135 . . . . 2.51 113.163 -173.243 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.43 114.86 27.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.69 1.596 . . . . 2.83 106.977 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.47 111.31 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.035 -1.839 . . . . 3.07 106.035 -177.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -108.91 139.99 43.0 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.163 0.982 . . . . 2.23 113.278 -173.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -111.68 92.94 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.579 2.352 . . . . 2.15 110.877 175.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -130.69 154.47 20.72 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.426 1.965 . . . . 1.6 109.681 166.822 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.53 ' CE2' HG11 ' A' ' 258' ' ' VAL . 22.3 m-85 -97.18 157.0 16.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.688 0.744 . . . . 5.83 111.093 -175.482 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 53.1 p -70.66 -3.71 19.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.388 -1.445 . . . . 3.61 113.336 172.208 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -67.74 -47.2 69.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.215 1.806 . . . . 7.57 114.316 -178.393 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.9 m -102.92 119.62 54.98 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.448 1.022 . . . . 2.64 113.504 -150.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -90.85 44.34 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.353 2.702 . . . . 5.42 111.16 174.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.88 -104.45 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.138 -1.43 . . . . 6.05 107.138 -157.32 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.11 -66.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.221 1.808 . . . . 3.43 114.2 171.473 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 87.6 m -51.49 -48.74 85.7 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.868 1.433 . . . . 1.7 114.868 -174.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.25 -31.63 14.06 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.399 2.066 . . . . 1.27 113.571 175.856 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -64.37 -36.04 82.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.399 1.454 . . . . 3.39 110.734 171.596 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -33.71 76.46 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.546 -1.346 . . . . 3.18 112.809 174.625 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.15 -36.96 75.11 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.336 -0.84 . . . . 2.71 112.11 171.793 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -60.24 3.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.937 1.295 . . . . 4.59 111.423 -178.621 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -20.01 66.15 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 119.623 -1.923 . . . . 3.05 113.713 175.803 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 29.8 ttm -70.89 -45.02 65.08 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.636 1.107 . . . . 2.3 111.217 172.316 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -57.33 -47.57 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.311 -0.868 . . . . 2.61 110.076 174.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -54.58 -20.76 8.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.201 1.186 . . . . 4.86 114.201 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.73 -25.79 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.336 1.235 . . . . 2.35 114.336 177.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -54.46 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.62 1.1 . . . . 2.46 108.84 165.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -57.13 -37.87 72.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.475 1.11 . . . . 4.69 113.034 177.667 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.29 -40.73 50.88 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.345 -0.847 . . . . 2.93 112.814 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mt -66.86 -34.8 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.876 0.762 . . . . 1.83 110.833 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.81 -44.89 76.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.541 1.136 . . . . 3.66 111.588 167.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -64.67 -27.59 69.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.393 -1.442 . . . . 3.21 112.862 177.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.86 -19.69 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.218 1.407 . . . . 3.72 112.022 172.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.3 m 73.96 -35.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 127.225 2.21 . . . . 5.38 114.212 162.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -97.63 4.14 50.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.802 1.641 . . . . 4.48 112.96 178.186 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.73 152.07 37.94 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.255 -1.017 . . . . 3.23 108.255 158.413 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -94.95 -23.18 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.742 2.295 . . . . 3.79 114.474 -162.658 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.7 t70 170.65 150.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.333 2.653 . . . . 3.66 110.334 -173.539 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 11.0 tp -132.28 100.39 5.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.182 1.793 . . . . 2.2 108.376 156.691 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 m -81.71 121.71 79.77 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-O 118.118 -0.944 . . . . 1.72 110.906 -178.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.24 117.96 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.128 3.218 . . . . 1.48 110.409 168.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.32 119.12 34.69 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 2.49 109.224 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -102.76 112.66 25.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.983 0.913 . . . . 2.5 110.66 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.481 HG22 HG23 ' A' ' 203' ' ' ILE . 9.5 mm -82.55 122.51 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 107.254 -1.387 . . . . 1.51 107.254 165.321 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.9 p -71.66 -29.46 64.64 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.499 1.666 . . . . 3.13 115.499 -175.429 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 201' ' ' ILE 0.329 14.1 pt 53.2 -6.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 119.825 3.269 . . . . 3.08 119.825 168.752 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -119.87 62.27 7.75 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.485 1.914 . . . . 3.56 112.196 161.398 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -59.3 140.49 94.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 107.95 -1.596 . . . . 2.4 107.95 161.137 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 108.8 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.394 3.878 . . . . 4.88 112.357 -174.742 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -107.61 4.74 26.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.161 0.892 . . . . 5.33 112.303 163.163 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.41 -179.44 7.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.39 1.476 . . . . 5.58 112.246 -175.584 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.6 m -167.27 129.67 1.68 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 128.129 2.572 . . . . 2.27 105.791 162.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 145' ' ' HIS . 1.2 tmtp? -54.08 -43.47 70.36 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.472 0.709 . . . . 3.13 112.478 -175.461 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -67.81 -31.52 71.43 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.741 1.617 . . . . 3.1 113.256 173.19 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.02 73.79 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.566 -1.334 . . . . 1.29 111.768 175.596 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.94 -38.15 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.537 0.735 . . . . 2.41 111.036 170.246 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.9 69.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.838 0.745 . . . . 1.56 112.822 174.692 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.01 -49.33 52.47 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.357 -0.84 . . . . 4.48 111.584 170.061 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.16 -30.94 71.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.708 0.633 . . . . 2.88 112.708 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.58 -60.21 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.005 1.322 . . . . 1.6 110.92 162.521 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -62.18 -30.74 71.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.388 0.884 . . . . 5.36 113.388 -174.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.22 -34.94 72.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.23 1.412 . . . . 4.63 111.964 -177.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -108.67 -21.41 12.71 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.689 1.366 . . . . 3.39 114.689 -174.183 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.4 p 159.17 151.38 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.888 2.475 . . . . 2.58 112.015 167.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.54 -3.29 10.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.861 2.374 . . . . 2.06 114.413 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -87.07 -8.62 56.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.008 1.276 . . . . 2.12 113.395 171.788 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.64 123.19 18.2 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.029 -1.669 . . . . 2.88 109.567 171.847 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.36 116.17 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.293 -1.002 . . . . 2.6 108.293 165.762 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.57 141.51 15.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.458 1.028 . . . . 1.12 111.271 -177.174 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.44 151.29 37.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.961 1.097 . . . . 2.77 113.961 -175.229 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 25.5 p -133.53 170.78 15.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.588 3.155 . . . . 3.07 108.908 -176.484 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.81 161.06 15.04 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.902 1.715 . . . . 2.03 109.455 -173.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.4 p -69.03 169.11 12.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.048 1.424 . . . . 3.01 112.266 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -40.7 -43.4 1.95 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.973 1.709 . . . . 5.57 112.732 170.256 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -67.53 -38.38 84.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.505 1.122 . . . . 3.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.51 -47.63 59.53 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.119 -0.988 . . . . 3.47 111.453 174.477 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.1 m -65.6 -24.77 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.851 0.686 . . . . 2.85 112.851 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.11 -33.43 29.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.194 0.906 . . . . 3.03 112.34 169.669 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -59.61 -51.48 69.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.42 1.464 . . . . 2.6 110.655 171.146 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.52 -20.64 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.31 0.485 . . . . 2.1 112.31 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.4 -54.37 14.77 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.947 0.794 . . . . 2.0 110.789 167.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.75 -45.09 82.22 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.258 1.423 . . . . 3.12 111.844 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.41 -56.45 14.96 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.335 1.054 . . . . 2.22 112.404 -175.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.53 10.72 26.73 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.122 -0.986 . . . . 3.31 113.576 176.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 61.24 33.45 19.13 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.343 1.457 . . . . 5.2 113.655 177.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.32 147.96 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.535 2.334 . . . . 2.99 110.447 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -119.83 153.16 36.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.421 1.105 . . . . 5.85 113.413 168.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -124.45 146.33 48.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 6.26 109.317 171.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 259' ' ' ASP . 26.2 m -123.51 72.29 49.56 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.721 1.208 . . . . 3.69 110.329 -179.269 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.66 125.03 10.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.603 2.202 . . . . 3.03 111.574 -171.381 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.414 0 CA-C-O 118.454 -1.192 . . . . 2.43 111.377 178.551 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.887 0.851 . . . . 4.32 109.771 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.97 167.14 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.817 1.247 . . . . 2.95 112.744 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 166' ' ' PHE . 58.6 t -149.62 129.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 105.392 -2.077 . . . . 3.2 105.392 156.672 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 246' ' ' SER . 0.8 OUTLIER -87.16 158.34 19.17 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.267 0.94 . . . . 3.63 110.451 167.809 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.06 132.98 7.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.499 1.296 . . . . 2.44 114.499 -153.884 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.72 -12.8 37.71 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.713 2.116 . . . . 3.65 116.713 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.31 5.8 tt 43.48 55.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 126.211 1.804 . . . . 3.37 115.441 169.26 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.3 mm -103.46 146.41 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.694 1.198 . . . . 2.92 111.005 174.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 77.3 mtp -108.3 117.11 33.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.789 1.636 . . . . 2.33 109.987 158.102 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.76 135.68 39.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.975 0.91 . . . . 2.59 112.694 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 56.6 tp -93.61 118.23 31.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.283 1.033 . . . . 2.17 110.998 178.582 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.4 148.88 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.43 1.092 . . . . 2.36 108.333 169.449 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -175.32 -142.17 4.02 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.481 -1.177 . . . . 2.79 112.43 -172.545 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -88.56 70.43 2.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.399 2.733 . . . . 3.02 110.069 -171.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -169.96 -67.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.113 1.365 . . . . 4.66 108.678 -163.247 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.82 -4.54 69.39 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 116.543 -2.254 . . . . 2.96 116.658 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.44 -47.84 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.497 2.148 . . . . 6.05 111.742 176.339 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 162.24 121.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.436 2.694 . . . . 4.31 111.051 171.556 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.83 -46.9 6.69 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.207 0.817 . . . . 4.27 113.207 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.74 164.18 9.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.526 1.93 . . . . 2.57 109.237 -170.246 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -158.39 135.02 9.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.838 1.255 . . . . 3.66 112.993 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -114.57 118.49 33.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.608 1.163 . . . . 2.35 108.711 -176.158 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.12 112.5 3.47 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 118.936 -0.924 . . . . 3.82 111.386 -174.697 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 52.62 60.72 3.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.47 1.129 . . . . 3.11 108.723 -155.162 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.7 p30 42.68 -147.58 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.401 2.28 . . . . 7.41 114.244 -172.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -147.31 -4.93 0.51 Allowed 'General case' 0 CA--C 1.549 0.91 0 O-C-N 120.297 -1.502 . . . . 4.56 114.018 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 72.61 136.39 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.03 2.932 . . . . 8.01 109.243 -163.498 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -47.53 63.81 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.375 1.621 . . . . 2.66 115.375 -155.345 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.82 -17.14 73.0 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 123.925 0.774 . . . . 1.62 114.518 -175.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.71 -29.02 61.05 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.327 1.063 . . . . 5.44 111.582 174.42 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.09 -40.72 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.585 -0.697 . . . . 1.52 109.477 174.144 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.99 88.09 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.951 -0.468 . . . . 1.49 111.599 171.666 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.06 79.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.185 0.809 . . . . 1.87 113.185 176.32 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 60.5 p -59.74 -60.2 4.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.514 0.726 . . . . 2.21 111.721 174.09 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.4 mm -58.92 -35.52 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 119.305 0.957 . . . . 2.81 111.95 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.28 73.69 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.483 -0.761 . . . . 1.8 112.932 175.166 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.8 m -76.09 -36.51 58.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.999 1.32 . . . . 2.01 110.806 173.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.038 0.835 . . . . 3.08 112.025 173.683 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 32.5 mmt -65.55 -10.2 33.04 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.667 -1.27 . . . . 5.4 114.043 168.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -57.07 2.88 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.39 -1.766 . . . . 7.47 112.081 172.381 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.55 -51.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.043 2.495 . . . . 2.4 112.738 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -72.08 169.66 15.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.839 0.856 . . . . 3.38 110.948 176.192 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 36.6 mmt-85 . . . . . 0 N--CA 1.474 0.728 0 O-C-N 120.604 -1.31 . . . . 8.75 112.521 -167.622 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 118.462 -0.78 . . . . 18.41 110.106 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -81.53 46.9 1.0 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.425 1.09 . . . . 16.77 113.257 -173.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -161.54 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.837 2.055 . . . . 12.51 110.595 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.51 -176.78 27.28 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.138 -0.976 . . . . 10.27 113.322 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.5 mttp 107.83 -32.64 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 130.549 3.54 . . . . 11.06 116.806 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -82.28 179.7 5.3 Favored 'Trans proline' 0 C--N 1.355 0.898 0 CA-C-N 122.992 2.104 . . . . 8.44 111.077 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -52.65 129.28 28.92 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.953 1.701 . . . . 11.24 111.433 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 136' ' ' LEU . 1.4 pt? -118.7 -167.1 1.32 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.85 1.66 . . . . 7.82 113.629 -173.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.31 137.51 3.09 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.496 1.522 . . . . 4.01 111.189 -172.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.4 114.09 5.24 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.25 -1.305 . . . . 2.67 110.518 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.63 147.87 36.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.191 1.928 . . . . 3.23 110.164 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.41 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 5.2 p90 -143.88 154.19 43.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.602 0.761 . . . . 3.55 111.062 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 m -122.87 15.74 10.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.595 1.702 . . . . 2.63 115.595 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.41 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 7.3 mp -69.37 147.89 50.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.152 2.181 . . . . 2.38 112.419 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.31 151.09 24.97 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.713 1.605 . . . . 2.25 109.971 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 146' ' ' THR . 0.6 OUTLIER -95.64 161.83 13.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.656 1.217 . . . . 2.87 111.971 175.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 6.3 p-80 -45.49 -28.24 0.88 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.257 2.623 . . . . 1.41 115.248 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.636 ' H ' HG23 ' A' ' 144' ' ' THR . 10.3 m -72.02 -20.1 61.75 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.451 1.9 . . . . 2.9 113.456 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.33 11.78 56.87 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.073 1.32 . . . . 2.29 114.559 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.5 -162.73 0.98 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.929 1.291 . . . . 4.32 110.45 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -144.07 103.74 4.05 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.496 1.044 . . . . 4.39 113.06 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 175.68 5.49 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.682 1.364 . . . . 4.76 114.682 173.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.4 p -137.19 -179.28 5.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.446 2.298 . . . . 2.3 111.092 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.44 -26.94 62.03 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.703 -1.248 . . . . 3.59 112.916 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -94.68 -19.45 20.41 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.051 1.871 . . . . 7.12 116.051 -167.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -71.21 -28.79 64.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.26 1.391 . . . . 3.03 112.102 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -96.04 40.83 1.11 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.276 1.03 . . . . 4.33 112.535 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.64 169.15 13.34 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.254 -0.903 . . . . 5.37 112.409 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 75.93 -10.05 15.66 Favored Glycine 0 CA--C 1.54 1.635 0 O-C-N 120.517 -1.365 . . . . 2.4 116.319 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -116.02 156.23 26.69 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.671 2.388 . . . . 3.25 110.094 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -70.88 100.31 1.92 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.569 1.077 . . . . 1.6 111.176 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.9 mt -83.85 134.57 34.7 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.138 0.971 . . . . 2.54 109.907 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.69 112.59 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.42 -1.696 . . . . 2.77 106.42 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.1 pt -114.77 122.21 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.079 0.552 . . . . 2.77 109.547 -165.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -111.79 143.74 42.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.791 1.236 . . . . 2.56 112.024 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.02 104.5 12.76 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.414 1.486 . . . . 2.0 108.681 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -120.5 -176.18 15.6 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.39 1.471 . . . . 1.36 114.852 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -157.5 115.75 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.739 2.015 . . . . 3.76 106.406 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.6 m -76.28 71.89 3.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.215 1.406 . . . . 3.49 110.178 -166.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 173.79 -48.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.17 2.588 . . . . 6.46 110.338 -158.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 52.1 -161.86 0.01 OUTLIER Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.664 2.385 . . . . 3.94 115.321 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -71.66 -74.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 124.7 3.6 . . . . 4.73 110.619 120.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -163.68 30.17 0.08 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.482 1.037 . . . . 4.22 113.735 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.8 -17.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 115.311 1.597 . . . . 3.18 115.311 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 29.7 m -49.7 -48.3 77.11 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 116.354 -1.784 . . . . 1.58 112.888 155.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.14 -39.89 9.73 Favored 'Trans proline' 0 C--N 1.354 0.825 0 CA-C-N 122.751 2.018 . . . . 1.66 112.206 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.67 -48.49 81.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.381 1.072 . . . . 3.52 111.076 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.447 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 4.9 tp10 -75.44 -22.38 57.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.012 0.925 . . . . 3.74 112.871 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.25 -37.65 78.07 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 116.762 -1.589 . . . . 2.73 110.897 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -52.53 65.24 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.236 1.835 . . . . 5.24 109.41 170.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 38.8 mtmt -63.35 -39.35 94.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.409 0.522 . . . . 3.17 112.409 -174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.6 ttm -57.41 -49.0 77.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.493 1.517 . . . . 3.41 111.518 167.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.25 -41.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.568 1.147 . . . . 2.03 113.105 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.486 ' HG3' ' HE2' ' A' ' 283' ' ' LYS . 35.6 mm-40 -70.88 -50.67 32.57 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.02 1.282 . . . . 3.93 109.159 173.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -17.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.879 1.437 . . . . 2.27 114.879 -169.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.81 -45.72 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 119.441 1.019 . . . . 2.3 110.931 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.21 -25.67 18.55 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.259 0.466 . . . . 6.05 112.259 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -65.07 -29.36 70.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.781 1.232 . . . . 2.83 113.055 166.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -45.22 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 118.508 -0.758 . . . . 2.19 112.767 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -30.92 71.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.145 1.339 . . . . 4.84 110.924 174.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.3 t -60.78 -24.47 65.81 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.298 1.839 . . . . 3.01 113.184 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.44 -26.58 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.113 -1.617 . . . . 5.05 110.403 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.7 m 76.85 -36.72 0.26 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.31 2.244 . . . . 4.22 112.966 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.4 m -73.48 -22.96 60.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.396 1.478 . . . . 5.34 113.1 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.3 156.46 81.45 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 121.18 -0.95 . . . . 3.7 110.808 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.66 -62.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.713 2.275 . . . . 3.28 109.338 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -171.21 157.08 4.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.613 3.565 . . . . 4.64 107.909 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.94 125.68 48.68 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.975 -0.75 . . . . 2.49 108.975 156.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.8 m -112.55 111.51 51.96 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.105 1.362 . . . . 1.41 110.062 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.71 134.08 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.734 2.956 . . . . 1.15 111.717 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.65 116.32 25.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.425 1.09 . . . . 2.21 109.778 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.24 112.93 24.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 2.67 109.679 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.7 mm -99.7 123.58 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.494 -1.298 . . . . 1.99 107.494 166.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 9.8 t -90.64 153.79 20.05 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.565 -0.709 . . . . 2.44 109.861 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.9 pt -115.95 -2.23 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.015 1.117 . . . . 2.02 114.015 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -119.54 74.71 17.33 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 120.144 1.338 . . . . 3.48 110.287 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.5 160.38 50.01 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.507 2.805 . . . . 3.31 110.722 -169.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 77.53 -51.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.237 2.615 . . . . 7.49 109.392 -172.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 207' ' ' ARG . 1.5 mpt_? -63.62 -52.3 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.507 1.123 . . . . 6.15 109.43 172.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.4 83.21 5.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.369 1.08 . . . . 5.19 109.178 159.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -64.94 132.61 49.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.289 -0.869 . . . . 3.2 109.136 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -43.93 -50.22 8.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.623 1.169 . . . . 3.24 112.895 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -27.02 61.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.353 1.242 . . . . 3.62 114.353 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.18 87.96 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.052 -1.03 . . . . 2.07 110.651 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.78 -36.0 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.929 0.892 . . . . 2.22 110.35 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -57.48 -17.83 15.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.572 1.149 . . . . 1.21 113.757 166.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -88.89 -47.9 7.84 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.991 -1.068 . . . . 4.49 112.792 167.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -58.19 -38.47 76.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.116 0.966 . . . . 3.7 112.576 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.4 t -54.28 -60.44 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.963 1.705 . . . . 1.29 110.68 165.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -66.16 -40.8 90.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.517 1.527 . . . . 4.18 114.698 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.92 -28.9 58.19 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.03 1.122 . . . . 3.45 114.03 -172.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -77.96 -53.01 7.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.461 0.573 . . . . 4.11 112.024 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.1 t -169.42 136.84 1.49 Allowed Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.422 1.089 . . . . 2.34 110.916 168.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.91 -4.64 11.71 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.247 2.631 . . . . 1.57 113.996 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -71.29 -14.25 62.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.964 1.256 . . . . 2.45 113.521 170.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.81 140.75 55.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.361 1.064 . . . . 3.09 112.58 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.3 t -118.36 130.88 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.998 1.319 . . . . 1.92 108.578 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -124.54 121.56 4.42 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.683 0.659 . . . . 1.12 114.051 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.77 159.46 15.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.921 1.288 . . . . 3.05 113.215 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -152.86 150.47 29.35 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.517 1.927 . . . . 2.44 108.899 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -172.09 165.24 37.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.952 -2.059 . . . . 1.8 107.952 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -70.55 172.63 8.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.877 0.839 . . . . 2.92 111.959 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.462 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 30.4 ptt180 -43.01 -38.81 2.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.412 1.485 . . . . 7.89 113.691 173.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -64.68 -37.94 89.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.095 1.358 . . . . 3.09 111.669 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.77 -44.65 22.81 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.653 1.181 . . . . 2.86 113.281 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.8 m -65.97 -27.11 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.074 0.397 . . . . 2.9 111.739 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.77 -45.68 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.269 -0.872 . . . . 3.1 112.054 165.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -50.0 -58.39 5.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.862 1.21 . . . . 3.28 110.981 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.72 -25.69 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.181 0.9 . . . . 2.25 112.023 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.77 -40.35 72.69 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.983 -0.448 . . . . 1.46 110.292 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -71.2 -38.32 72.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.23 1.012 . . . . 4.89 112.237 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -44.48 85.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.354 1.462 . . . . 2.13 113.82 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -100.89 5.82 43.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.462 1.105 . . . . 2.15 113.523 170.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 64.2 37.89 8.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.787 2.035 . . . . 5.25 113.732 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.32 151.18 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.694 0.798 . . . . 2.51 111.749 -173.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 140.36 36.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.811 0.845 . . . . 4.22 112.318 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.45 165.67 26.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.5 2.32 . . . . 4.61 109.875 168.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.69 106.29 1.06 Allowed Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 121.249 -0.907 . . . . 2.79 110.781 175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -94.98 134.29 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.411 2.741 . . . . 2.49 112.632 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.44 115.84 4.71 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.309 1.433 . . . . 2.33 111.144 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.24 161.52 32.07 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.266 2.644 . . . . 5.1 111.631 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 143.16 51.44 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.014 1.116 . . . . 7.65 114.014 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -115.9 -72.21 0.7 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 117.99 -1.005 . . . . 7.92 111.482 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -67.89 -58.15 5.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.972 1.26 . . . . 7.76 110.159 166.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . 0.251 24.5 p30 166.71 -36.23 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 128.926 2.89 . . . . 6.32 115.032 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -91.42 50.6 1.76 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.868 1.318 . . . . 8.34 111.928 -173.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -161.77 146.01 12.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.483 1.513 . . . . 6.0 110.059 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -166.75 49.7 0.07 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.854 2.462 . . . . 4.82 108.747 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp -49.86 152.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 126.621 1.968 . . . . 3.33 113.849 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.48 130.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.221 1.408 . . . . 3.32 108.145 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.69 141.15 31.68 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.654 1.582 . . . . 3.74 110.709 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -126.82 155.67 42.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.707 0.765 . . . . 2.38 111.549 165.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.7 m -62.78 113.44 3.04 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 3.66 109.6 168.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.31 44.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.316 1.046 . . . . 4.21 112.849 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.7 mt -132.95 135.5 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.123 0.969 . . . . 2.51 110.653 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.3 ptp -104.01 142.96 33.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.112 1.365 . . . . 2.59 110.911 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -99.88 141.71 32.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.346 1.058 . . . . 2.39 112.019 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -101.8 119.34 38.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.884 1.274 . . . . 2.57 109.243 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 63.4 mt -100.16 138.16 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.915 1.686 . . . . 2.22 107.887 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 171.45 42.05 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.54 1.067 . . . . 1.61 111.515 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -82.7 66.1 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.249 2.633 . . . . 2.6 109.367 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -177.52 -69.17 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.553 2.341 . . . . 4.94 108.988 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 160.55 -21.61 0.24 Allowed Glycine 0 CA--C 1.538 1.527 0 N-CA-C 117.02 1.568 . . . . 2.48 117.02 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.76 152.89 44.73 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.965 1.382 . . . . 6.66 112.429 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -99.45 129.51 45.64 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.38 -1.45 . . . . 4.36 112.271 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.95 -18.07 10.23 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.74 1.385 . . . . 3.04 114.74 -167.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -162.98 171.46 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.633 1.173 . . . . 2.67 110.987 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -148.51 149.02 30.9 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.144 1.377 . . . . 2.9 111.527 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PHE . . . . . 0.435 ' CZ ' HG23 ' A' ' 286' ' ' ILE . 1.4 m-85 -130.0 105.0 7.68 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.105 1.362 . . . . 2.48 109.737 -173.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -86.01 153.27 26.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.225 -1.95 . . . . 2.33 108.225 153.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -17.05 2.99 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 117.279 2.326 . . . . 4.65 117.279 -164.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -63.2 -27.47 69.38 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.943 1.09 . . . . 5.04 113.943 169.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -92.87 96.0 9.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.025 1.73 . . . . 4.52 109.744 165.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.15 176.87 8.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.737 1.615 . . . . 4.99 112.753 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.486 ' HE2' ' HG3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -57.28 -27.3 62.0 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.022 1.86 . . . . 2.27 116.022 -169.329 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.7 -36.2 53.83 Favored Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.527 -0.733 . . . . 1.36 112.07 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.77 -31.8 46.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.082 1.753 . . . . 3.57 111.216 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ILE . . . . . 0.435 HG23 ' CZ ' ' A' ' 277' ' ' PHE . 79.0 mt -64.85 -45.44 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 1.34 110.077 166.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.55 87.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.175 0.898 . . . . 1.44 111.095 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.91 97.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.087 0.858 . . . . 1.87 113.092 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 94.2 p -74.55 -38.42 62.73 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.99 -1.069 . . . . 1.56 113.414 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.01 -35.64 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.662 1.573 . . . . 1.38 111.707 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.01 -18.77 63.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.531 -1.356 . . . . 1.69 113.479 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.1 m -74.83 -55.1 6.17 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.407 -0.808 . . . . 1.89 109.737 167.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -64.55 -22.58 67.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.876 1.67 . . . . 2.71 113.555 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -42.09 46.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.814 1.646 . . . . 5.26 112.157 165.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -64.21 -55.36 31.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 116.419 -1.753 . . . . 5.27 113.249 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.47 -38.34 1.97 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.284 1.989 . . . . 3.05 112.686 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 17.66 7.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.752 1.019 . . . . 3.22 113.752 -173.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.95 134.06 55.32 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 7.12 113.198 -164.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -109.76 -179.0 3.68 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.959 1.304 . . . . 11.37 111.967 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 81.0 mttt 58.21 -134.02 1.08 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 117.309 -1.329 . . . . 7.29 110.226 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 C--O 1.248 1.016 0 C-N-CA 125.812 1.645 . . . . 7.12 113.929 -172.303 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 116.785 -1.579 . . . . 17.21 108.232 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -64.1 -51.42 64.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.74 1.609 . . . . 14.13 108.904 152.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.7 m -59.68 135.37 57.66 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.387 1.475 . . . . 13.11 110.495 165.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -159.88 -178.92 34.3 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 127.135 2.302 . . . . 10.01 110.76 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.99 147.38 10.29 Favored Pre-proline 0 N--CA 1.476 0.829 0 CA-C-O 117.819 -1.086 . . . . 10.01 111.932 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.35 160.09 50.71 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.522 2.148 . . . . 7.42 110.682 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 mt -158.94 161.3 36.72 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.769 2.027 . . . . 9.46 107.986 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mp -134.18 -162.62 1.27 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.405 1.082 . . . . 5.87 110.243 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.72 163.17 19.92 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.747 1.165 . . . . 3.82 112.05 -159.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.14 81.66 0.3 Allowed Glycine 0 CA--C 1.537 1.425 0 CA-C-O 118.593 -1.115 . . . . 2.85 114.388 -172.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.75 149.71 54.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.99 3.127 . . . . 3.0 112.134 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.508 ' HB2' HG22 ' A' ' 237' ' ' VAL . 37.9 p90 -154.88 172.69 17.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.24 1.016 . . . . 2.96 112.128 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.8 m -143.42 119.9 11.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.91 -1.515 . . . . 3.29 106.91 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.432 ' HB2' HG21 ' A' ' 237' ' ' VAL . 12.6 tp -157.35 140.21 15.1 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.561 0.619 . . . . 2.56 111.432 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.1 m -74.43 146.67 42.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.626 0.727 . . . . 1.79 109.44 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.7 m -99.35 139.81 34.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.509 1.124 . . . . 2.91 110.77 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.46 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -51.67 -36.54 46.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.896 2.078 . . . . 2.24 113.117 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -108.09 -1.11 20.7 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.046 1.738 . . . . 3.24 111.968 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.15 -125.56 1.62 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 119.151 0.887 . . . . 2.81 111.789 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.0 -160.94 1.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.146 1.378 . . . . 4.2 110.715 -157.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.28 97.11 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.34 1.056 . . . . 6.13 111.653 -168.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.26 149.61 33.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.697 1.599 . . . . 3.45 110.911 172.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 58.5 p -140.12 141.42 36.11 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.439 2.296 . . . . 2.37 107.498 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -28.04 -69.36 0.05 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.978 1.711 . . . . 3.75 115.369 -171.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -65.86 0.04 2.01 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 116.913 2.19 . . . . 7.48 116.913 -174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.39 -54.91 29.38 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 119.848 1.204 . . . . 3.14 110.161 162.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -91.21 -28.0 18.11 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.703 1.001 . . . . 3.31 113.703 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 59.37 4.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.596 1.159 . . . . 6.27 112.609 -168.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -108.94 0.07 31.79 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.086 1.803 . . . . 2.42 113.138 162.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -153.46 175.12 13.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.859 2.064 . . . . 3.92 108.993 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -66.42 118.33 9.91 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.12 0.968 . . . . 1.73 112.748 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 mp -107.85 147.34 31.05 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.598 0.759 . . . . 3.2 112.206 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.0 mp -111.94 118.02 34.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.308 1.843 . . . . 2.7 107.527 166.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.2 mt -118.79 124.47 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.672 0.789 . . . . 1.93 110.102 -173.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -127.88 139.98 52.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.874 1.27 . . . . 2.22 113.23 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.7 120.32 42.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.903 1.281 . . . . 2.39 110.636 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -145.6 -175.51 18.75 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 116.108 1.203 . . . . 1.4 116.108 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.43 ' CD2' HG22 ' A' ' 258' ' ' VAL . 21.6 t80 -139.65 133.77 31.09 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 123.63 1.681 . . . . 3.55 113.718 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 23.41 0.07 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.743 2.017 . . . . 3.0 114.036 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -165.66 32.83 0.05 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.125 2.17 . . . . 6.75 110.403 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 82.2 m -54.27 159.1 3.31 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.15 -1.594 . . . . 2.17 111.941 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.21 68.93 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.164 2.576 . . . . 3.1 108.455 159.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 68.07 -17.49 0.17 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.996 3.318 . . . . 5.45 115.626 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.0 t -43.87 -65.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.646 1.978 . . . . 3.23 113.146 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 28.1 m -58.41 -50.37 88.4 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 116.579 -1.676 . . . . 1.61 114.285 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.72 -34.23 51.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.955 2.091 . . . . 2.11 114.159 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.82 -36.59 64.98 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.394 0.997 . . . . 3.75 111.885 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.87 -35.28 72.31 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.44 -1.412 . . . . 3.72 112.563 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.67 -27.33 67.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 117.23 -1.367 . . . . 3.13 112.51 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -62.78 1.3 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.997 1.271 . . . . 3.35 109.053 167.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -58.23 -21.09 46.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.694 -1.254 . . . . 4.26 113.215 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.0 mmm -79.79 -41.46 26.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.047 1.499 . . . . 5.45 115.047 165.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.94 -31.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 122.477 2.399 . . . . 1.95 110.5 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -37.31 -41.6 0.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.484 1.914 . . . . 3.28 112.854 162.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.2 -22.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 1.95 111.775 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.61 -39.27 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.932 0.787 . . . . 1.83 109.55 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.25 -44.15 95.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.27 1.028 . . . . 4.08 111.011 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -71.42 -7.82 49.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.83 1.652 . . . . 3.3 114.867 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.2 mt -119.85 -48.35 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 118.088 -0.958 . . . . 1.9 113.427 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.64 -27.35 67.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.925 1.239 . . . . 3.77 111.711 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.9 t -70.65 -11.3 60.86 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.845 -1.159 . . . . 3.03 113.743 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 34.3 mm -90.61 86.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 120.441 -1.412 . . . . 3.55 108.71 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 81.0 p -63.98 60.54 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.387 2.675 . . . . 4.6 115.41 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 10.5 t -173.18 -24.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 129.907 3.283 . . . . 4.41 110.871 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.17 156.02 8.13 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.774 -1.204 . . . . 3.01 109.934 151.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.44 -66.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.378 -1.816 . . . . 3.36 107.378 162.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.15 173.2 2.64 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.269 3.027 . . . . 3.62 109.791 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 tp -119.2 110.17 16.72 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.858 0.863 . . . . 1.96 111.1 161.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.8 m -92.78 120.05 67.48 Favored Pre-proline 0 N--CA 1.482 1.128 0 O-C-N 120.939 -1.1 . . . . 1.29 111.467 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -93.63 131.12 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.538 2.825 . . . . 0.97 112.571 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.97 119.49 30.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.854 2.062 . . . . 2.52 110.472 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -99.8 136.16 40.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.01 1.724 . . . . 2.75 110.8 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.06 126.26 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.576 1.55 . . . . 1.47 109.204 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 92.0 p -84.01 141.79 30.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.214 0.531 . . . . 2.38 110.23 165.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.9 pt -108.53 19.96 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.029 -1.044 . . . . 1.9 112.841 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -118.05 77.06 12.08 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.816 2.046 . . . . 3.33 110.897 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.38 83.06 2.33 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.285 3.323 . . . . 3.28 109.713 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.45 -124.18 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.601 1.961 . . . . 4.72 106.283 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.99 11.25 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 117.965 2.58 . . . . 6.94 117.965 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -89.74 150.89 22.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.782 -1.824 . . . . 3.4 111.049 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.1 p -142.71 144.9 32.88 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.486 1.136 . . . . 2.84 112.252 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -42.97 -55.47 3.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.088 2.155 . . . . 3.87 111.952 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -70.57 -34.0 71.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.159 0.983 . . . . 4.21 113.221 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.99 68.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.311 1.414 . . . . 1.78 111.224 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.3 mm -58.62 -39.19 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 119.407 -0.33 . . . . 1.52 111.612 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.9 -29.46 60.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.978 1.311 . . . . 1.75 113.805 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -90.26 -38.69 13.25 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.778 0.831 . . . . 4.85 112.983 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.17 -38.74 80.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.271 1.428 . . . . 2.88 111.787 174.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.9 t -54.55 -34.19 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.477 1.511 . . . . 1.1 113.541 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.32 -35.68 78.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.151 -0.928 . . . . 5.43 111.939 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.2 -36.43 81.72 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 124.396 1.06 . . . . 4.01 111.223 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.9 -44.03 61.74 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.934 0.788 . . . . 3.6 113.033 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.5 m 150.42 143.1 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 130.056 3.342 . . . . 2.3 111.042 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.26 -0.97 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.495 2.797 . . . . 1.65 115.908 -167.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.86 -14.7 60.7 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 120.631 1.56 . . . . 2.94 112.546 168.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.98 127.67 33.49 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.628 -1.295 . . . . 2.59 111.917 -170.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.9 124.35 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.448 -1.686 . . . . 2.3 106.448 171.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.46 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -103.8 127.01 8.98 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 108.672 -1.771 . . . . 1.11 108.672 170.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.28 150.53 32.32 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.968 0.507 . . . . 2.84 110.253 167.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.3 t -167.07 176.08 7.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.397 2.279 . . . . 3.12 108.971 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.63 34.22 Favored Glycine 0 N--CA 1.468 0.83 0 O-C-N 120.771 -1.206 . . . . 1.76 115.2 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -73.81 161.88 29.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.332 1.053 . . . . 2.29 111.164 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -43.88 67.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.745 0.818 . . . . 7.02 111.246 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.58 1.552 . . . . 3.87 112.969 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.12 -46.68 49.84 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.54 -0.725 . . . . 3.22 111.675 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.19 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 119.155 -0.45 . . . . 1.68 111.372 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.61 -39.61 80.79 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.321 0.964 . . . . 3.9 112.127 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -62.72 -49.13 76.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.016 1.28 . . . . 3.33 110.909 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 140' ' ' PHE . 54.4 t -64.77 -48.22 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.794 0.838 . . . . 2.87 111.909 -171.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.52 -50.53 51.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.868 0.867 . . . . 1.41 110.396 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -72.62 -27.34 62.09 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 117.461 -1.257 . . . . 3.64 113.556 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.51 65.32 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.864 1.211 . . . . 1.74 111.037 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -84.3 12.1 7.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.454 1.102 . . . . 2.26 113.569 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 65.71 -41.72 0.34 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.781 2.832 . . . . 6.36 115.021 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.3 t 18.85 103.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 131.622 3.969 . . . . 2.6 115.907 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -71.47 142.47 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.917 0.887 . . . . 3.47 113.201 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -169.73 155.29 5.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.737 2.015 . . . . 3.99 110.273 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -148.45 106.58 3.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.424 0.69 . . . . 2.8 109.795 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.61 138.45 15.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.337 2.025 . . . . 2.71 110.243 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.99 139.96 23.38 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.646 -0.53 . . . . 2.44 112.418 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.16 16.94 1.28 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.925 3.083 . . . . 3.19 112.851 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 115.86 156.43 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 1 C-N-CA 132.762 4.425 . . . . 5.32 109.312 -159.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -95.0 -132.32 0.17 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.481 1.912 . . . . 8.98 109.926 171.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.31 -17.64 64.68 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.206 1.402 . . . . 8.37 114.055 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -164.41 -71.34 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.496 1.519 . . . . 6.09 110.063 175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -120.64 -19.04 7.58 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.056 1.132 . . . . 5.41 114.056 -167.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.2 139.66 54.56 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 119.555 -1.966 . . . . 4.86 112.079 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -85.91 82.78 8.01 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.125 -0.984 . . . . 3.58 111.324 170.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 tp -71.31 156.81 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.974 0.909 . . . . 2.73 111.208 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 166' ' ' PHE . 4.3 m -151.16 166.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.481 1.912 . . . . 3.37 109.894 172.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.97 158.99 26.52 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.859 2.864 . . . . 3.76 111.01 169.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 161.2 9.34 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.066 1.746 . . . . 2.21 113.943 -166.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 29.0 p -60.89 -42.31 97.75 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.194 1.553 . . . . 4.34 115.194 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.29 0.3 OUTLIER 54.55 41.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.261 1.424 . . . . 3.92 112.815 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.53 140.77 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 120.459 -1.401 . . . . 2.48 110.67 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 58.7 tpp -99.88 115.89 30.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.348 1.859 . . . . 2.86 109.172 165.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -95.03 148.59 22.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.102 -1.624 . . . . 3.17 112.373 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -99.42 126.06 45.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.553 1.141 . . . . 2.29 109.619 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.2 mm -107.94 126.96 64.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 108.221 -1.029 . . . . 2.36 108.221 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.72 160.53 53.02 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 117.969 -1.462 . . . . 2.06 110.163 162.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.78 -11.8 19.22 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.134 3.223 . . . . 3.64 113.911 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.5 -41.82 88.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.727 2.811 . . . . 4.13 110.573 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.95 31.43 2.69 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.065 1.317 . . . . 3.04 115.723 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -142.84 164.04 31.18 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.684 1.242 . . . . 4.75 112.177 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -67.44 125.75 27.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 5.26 112.505 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.4 tt -118.52 -24.23 6.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.383 1.473 . . . . 3.34 112.405 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -165.53 171.92 12.65 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.49 2.316 . . . . 2.8 109.234 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -159.24 158.76 33.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.497 1.119 . . . . 4.04 113.673 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.85 -179.85 7.31 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.594 1.958 . . . . 2.54 112.055 -165.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.3 -145.34 16.91 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.05 1.786 . . . . 3.72 109.91 -171.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -54.5 3.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 118.942 2.942 . . . . 3.84 118.942 -161.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -135.96 -45.35 0.65 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.288 -1.508 . . . . 4.49 112.132 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -79.19 86.31 4.99 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.935 -1.103 . . . . 4.53 110.458 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.07 155.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.003 2.521 . . . . 5.78 114.901 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -41.7 -70.22 0.11 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.016 2.127 . . . . 2.86 116.143 -172.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.31 -24.95 75.54 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 122.564 1.091 . . . . 1.86 111.284 -170.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -70.14 -23.91 63.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.377 1.871 . . . . 5.29 111.317 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.24 -51.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.258 -0.901 . . . . 1.74 110.752 162.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.1 71.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.38 0.991 . . . . 1.45 111.939 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.77 73.79 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.25 1.204 . . . . 1.86 114.25 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.6 p -75.04 -37.63 61.66 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.842 -1.161 . . . . 1.86 112.644 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mm -56.61 -47.65 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 119.943 1.247 . . . . 1.98 110.842 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.17 -18.16 60.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.063 1.134 . . . . 1.68 114.063 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.5 m -84.05 -40.94 17.74 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.447 1.099 . . . . 2.2 110.984 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -69.94 -29.29 66.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.181 0.993 . . . . 2.65 113.516 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.66 19.25 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.536 -1.353 . . . . 6.25 114.197 164.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -74.43 -58.98 1.71 Allowed Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.471 -1.728 . . . . 5.93 111.303 152.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.85 -48.8 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.842 2.362 . . . . 2.62 112.518 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -68.75 121.89 17.44 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.033 0.833 . . . . 3.45 110.677 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -63.15 149.17 45.96 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.451 0.7 . . . . 8.33 112.13 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -90.27 -172.06 3.32 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.379 1.072 . . . . 9.67 110.9 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -79.54 74.35 6.19 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.555 -1.341 . . . . 7.38 107.529 149.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.482 1.168 1 C-N-CA 132.021 4.128 . . . . 7.2 111.214 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 118.209 -0.9 . . . . 20.16 110.371 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -156.0 156.99 35.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.356 1.062 . . . . 16.49 110.857 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.1 t 175.5 65.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 129.114 2.966 . . . . 15.42 108.146 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.13 142.52 19.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.06 0.838 . . . . 11.99 112.005 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.85 143.88 8.65 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.431 1.492 . . . . 14.87 110.937 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -83.79 -174.11 1.81 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.665 2.91 . . . . 7.9 110.25 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.3 tp -85.29 153.0 22.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.237 -0.653 . . . . 9.44 109.237 155.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.0 tp -145.23 157.04 44.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.945 1.298 . . . . 7.45 109.087 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -146.13 -173.17 17.13 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 125.729 1.633 . . . . 3.03 111.97 174.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.33 -84.07 0.35 Allowed Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.327 -1.263 . . . . 3.81 113.169 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.54 142.43 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.315 2.01 . . . . 3.11 112.772 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -108.34 175.19 5.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.361 -1.29 . . . . 2.9 111.567 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -141.35 22.07 2.21 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.709 1.744 . . . . 3.44 115.709 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.32 165.4 23.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.748 1.219 . . . . 2.82 110.825 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.1 m -117.3 151.65 36.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.861 2.064 . . . . 2.43 109.171 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.3 p -86.28 158.99 19.56 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.642 1.211 . . . . 1.93 113.206 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -59.77 -21.59 60.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.91 1.684 . . . . 1.39 113.225 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.8 m -72.08 -39.49 68.95 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.65 1.18 . . . . 3.04 110.166 172.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 120.07 -8.36 11.51 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.53 1.538 . . . . 1.94 114.47 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -83.11 147.64 27.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.149 0.974 . . . . 4.14 109.879 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -87.72 125.41 34.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.229 -0.656 . . . . 4.25 109.229 163.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.27 134.94 36.7 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.974 1.31 . . . . 3.77 109.62 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.9 p -109.83 166.29 11.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.682 1.593 . . . . 3.42 112.352 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.96 2.65 0.49 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.829 2.452 . . . . 3.34 114.817 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -7.51 12.58 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.244 1.202 . . . . 7.26 114.244 165.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.59 -44.55 64.26 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.713 1.142 . . . . 3.02 110.063 161.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -78.02 10.59 2.77 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.834 1.42 . . . . 3.99 114.834 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.82 108.39 1.17 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 5.24 110.101 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.09 -8.69 6.33 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.507 1.051 . . . . 3.8 114.629 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -129.07 158.97 37.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.944 1.372 . . . . 4.71 110.48 165.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.464 ' CE3' ' HD3' ' A' ' 269' ' ' PRO . 94.7 m95 -67.8 118.97 11.76 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.451 0.7 . . . . 3.19 112.555 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.78 109.14 21.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.782 1.633 . . . . 3.07 109.582 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.61 98.25 7.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.118 -0.697 . . . . 3.21 109.118 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -95.35 126.97 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.903 1.281 . . . . 1.98 108.998 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -140.55 150.1 43.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.787 1.235 . . . . 2.44 113.658 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -123.09 112.74 18.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.941 1.296 . . . . 2.37 111.053 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.18 142.62 13.68 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.151 1.358 . . . . 1.41 112.023 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -92.11 129.1 38.14 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.131 0.965 . . . . 4.14 112.27 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.1 m -75.72 66.77 2.08 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.643 1.577 . . . . 3.86 111.285 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -174.91 -28.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.801 2.841 . . . . 7.22 112.441 -171.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 m -67.03 160.54 69.71 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 117.452 2.39 . . . . 2.38 117.452 -163.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.96 -168.09 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.882 3.722 . . . . 3.01 110.724 159.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.72 -7.04 3.02 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.521 2.415 . . . . 4.15 117.521 -151.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 74.0 t -65.0 -60.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.895 1.278 . . . . 2.69 108.761 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 23.8 m -49.53 -60.41 4.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.733 -1.127 . . . . 1.74 113.028 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.39 -30.57 19.15 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-O 116.105 -1.706 . . . . 1.24 113.715 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.15 -45.97 65.69 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.996 2.18 . . . . 3.21 110.492 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -61.44 -33.22 73.35 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.25 0.932 . . . . 3.05 112.068 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -48.6 64.67 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.659 -0.651 . . . . 2.32 111.939 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -41.29 94.13 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.828 -1.17 . . . . 3.75 111.07 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -46.96 -52.14 15.36 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 119.943 -1.723 . . . . 2.84 112.209 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.4 ptp -70.77 -8.34 51.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.492 1.664 . . . . 2.5 115.492 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mm -75.78 -60.04 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.414 1.461 . . . . 1.92 108.686 161.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.72 -38.74 56.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.256 0.836 . . . . 3.02 113.256 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.1 t -60.02 -19.02 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 117.823 -1.084 . . . . 2.15 112.756 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.68 -53.93 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.699 1.59 . . . . 2.54 110.558 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.62 -27.58 67.02 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.643 1.177 . . . . 4.03 111.883 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -71.48 -19.63 62.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.928 1.291 . . . . 3.76 113.427 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.64 -56.99 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.279 1.431 . . . . 2.28 113.845 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.86 -30.7 71.35 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.783 0.801 . . . . 5.5 109.261 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.9 m -60.31 -12.26 8.65 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.88 2.472 . . . . 4.05 115.163 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.5 mm -79.01 -39.45 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.871 -1.143 . . . . 4.99 112.139 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.3 m -176.82 2.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.632 1.573 . . . . 7.88 114.349 -158.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.2 m 77.2 41.59 0.15 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.059 2.544 . . . . 5.37 111.065 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.2 150.46 0.27 Allowed Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 128.987 2.915 . . . . 3.34 113.949 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.32 -43.25 58.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.485 2.79 . . . . 3.26 113.569 -170.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.3 t70 161.34 154.45 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 131.532 3.933 . . . . 3.58 107.648 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.58 111.71 17.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.495 0.718 . . . . 3.12 109.913 168.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.8 m -105.45 112.25 64.81 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.535 1.134 . . . . 1.97 108.596 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.33 137.67 23.7 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.112 1.875 . . . . 1.25 109.002 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.277 1.5 pt? -136.18 118.44 15.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.644 1.212 . . . . 3.22 110.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.05 125.91 54.9 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.657 1.583 . . . . 2.0 110.201 -157.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.55 120.44 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.405 -0.961 . . . . 1.59 108.405 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.2 t -72.38 -15.24 61.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.795 1.405 . . . . 3.25 114.795 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . 0.287 43.8 pt 51.7 9.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 128.539 2.735 . . . . 2.12 117.912 170.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -111.16 56.54 0.38 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.221 1.408 . . . . 3.5 114.502 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.04 69.99 7.26 Favored 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.406 4.071 . . . . 3.74 112.685 -167.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -171.2 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.5 2.32 . . . . 4.04 109.673 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -17.69 10.1 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.23 1.412 . . . . 8.18 112.82 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.4 153.31 2.2 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.696 1.598 . . . . 4.62 112.912 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.4 m -144.59 125.33 14.2 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.299 -0.876 . . . . 2.47 109.854 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -48.33 -47.72 36.75 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.467 1.907 . . . . 3.06 112.793 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -68.77 -33.21 73.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.231 1.197 . . . . 3.81 114.231 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.91 84.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.483 1.492 . . . . 1.65 110.941 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.66 -34.46 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.276 0.63 . . . . 1.56 111.857 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.35 -19.31 64.52 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.066 -1.021 . . . . 1.75 113.697 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -84.98 -42.64 14.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.957 1.253 . . . . 3.17 112.992 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -57.04 -35.26 69.09 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.153 1.381 . . . . 2.57 112.133 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.53 -37.03 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.238 1.415 . . . . 1.33 113.078 169.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -70.96 -51.27 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.799 -1.188 . . . . 5.25 112.204 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.49 -18.42 62.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.619 1.567 . . . . 4.08 113.769 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -80.55 -79.4 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.734 0.697 . . . . 3.0 109.676 154.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 178.23 139.69 0.25 Allowed Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.307 1.843 . . . . 1.97 110.304 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.45 5.9 1.77 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.15 3.233 . . . . 2.16 114.942 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -18.27 63.5 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.841 -1.162 . . . . 3.48 112.763 161.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.6 tp -78.78 138.13 38.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.18 1.792 . . . . 2.11 111.224 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 26.2 t -101.88 130.35 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.042 0.937 . . . . 1.8 108.881 158.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.58 132.91 11.11 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.798 -0.921 . . . . 0.83 110.798 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.5 144.97 50.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.131 0.972 . . . . 2.29 112.926 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.6 t -149.1 176.44 10.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.204 2.202 . . . . 2.68 111.194 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 165.37 -168.15 39.25 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 127.141 2.305 . . . . 2.04 109.374 -170.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.3 174.59 10.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.053 1.426 . . . . 3.48 111.373 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -47.86 -38.37 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.59 0.756 . . . . 8.46 112.168 170.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -36.11 47.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.809 0.732 . . . . 5.7 112.572 -169.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -70.37 -33.57 71.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.242 -1.537 . . . . 3.79 111.847 170.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.96 -31.68 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.726 0.81 . . . . 2.03 110.816 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.72 -32.3 41.19 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.941 0.791 . . . . 3.18 112.664 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.42 -53.17 60.83 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.113 -0.992 . . . . 3.16 109.736 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.2 p -62.2 -27.71 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 119.426 -0.321 . . . . 2.64 111.812 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.61 -46.18 66.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.248 0.931 . . . . 2.13 111.518 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -58.83 -53.83 53.99 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.576 1.55 . . . . 3.73 111.066 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.39 65.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.973 1.309 . . . . 2.73 114.362 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -117.4 3.82 12.51 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.575 1.324 . . . . 2.69 114.575 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 57.6 31.19 19.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.085 1.354 . . . . 5.23 113.421 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.38 161.99 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.58 1.152 . . . . 3.23 110.325 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -146.22 154.9 42.26 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.592 0.96 . . . . 5.84 113.592 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.62 110.81 6.96 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.991 1.716 . . . . 6.88 110.669 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -104.73 124.16 37.79 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 120.66 -1.275 . . . . 3.12 113.158 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.39 130.27 14.86 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.302 2.001 . . . . 3.25 113.274 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.6 133.29 12.91 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.191 0.9 . . . . 2.47 110.912 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.66 61.93 8.38 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.669 2.913 . . . . 4.04 109.244 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp 100.03 177.18 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 131.355 3.862 . . . . 6.7 112.58 -166.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -143.32 20.85 1.9 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 128.018 2.527 . . . . 11.01 110.289 165.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 173.73 -140.42 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.185 1 C-N-CA 132.071 4.149 . . . . 7.45 104.486 -163.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -129.95 -2.84 4.62 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 122.082 2.219 . . . . 7.73 113.79 151.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -92.76 -41.47 10.11 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.272 -1.518 . . . . 6.86 112.515 155.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -88.87 170.26 10.87 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.084 1.354 . . . . 5.27 114.091 -171.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -159.63 128.32 5.09 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.646 1.978 . . . . 4.71 111.938 -161.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 tt -124.07 168.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.842 1.657 . . . . 4.21 111.223 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.24 135.75 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 4.07 105.214 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 169.33 1.67 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.205 1.002 . . . . 4.29 112.113 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -153.87 126.8 8.3 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.524 -0.735 . . . . 2.12 111.518 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.3 p -59.37 118.74 6.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.676 0.79 . . . . 3.57 110.265 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 11.1 tp -78.41 59.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.177 1.391 . . . . 4.15 113.657 -168.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.0 mm -109.2 138.01 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.78 1.232 . . . . 2.45 111.806 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.3 ttt -121.33 134.75 55.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.02 1.728 . . . . 2.38 108.992 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.48 141.77 44.61 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.762 0.825 . . . . 2.77 111.927 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.92 116.87 31.01 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.164 0.986 . . . . 1.91 109.983 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.0 136.93 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.683 1.193 . . . . 1.88 107.835 166.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.52 168.9 48.53 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 123.792 0.711 . . . . 2.25 114.59 -168.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.464 ' HD3' ' CE3' ' A' ' 159' ' ' TRP . 42.0 Cg_endo -77.3 56.09 5.35 Favored 'Trans proline' 0 CA--C 1.539 0.749 1 C-N-CA 125.964 4.443 . . . . 4.02 109.38 173.458 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -162.1 -55.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.753 -0.658 . . . . 4.81 111.252 -143.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 154.19 -54.33 0.44 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.093 -1.393 . . . . 3.56 112.611 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -130.06 -174.23 3.26 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.806 1.303 . . . . 5.87 114.326 -162.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -80.37 142.97 33.9 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.995 -1.066 . . . . 4.9 113.525 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.67 -25.91 0.89 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.453 1.279 . . . . 2.91 114.453 -157.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -162.78 165.91 24.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.672 2.389 . . . . 2.54 109.247 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -155.81 150.54 26.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.53 1.308 . . . . 3.59 114.53 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -126.89 119.49 26.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.307 1.443 . . . . 2.46 109.339 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -111.12 72.77 0.21 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 108.993 -1.643 . . . . 4.03 108.993 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 41.37 -134.68 0.28 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.215 1.406 . . . . 3.66 111.308 -155.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.2 t30 70.6 -65.8 0.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.593 2.357 . . . . 4.65 114.615 167.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -66.01 120.36 13.01 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.546 1.138 . . . . 5.28 110.376 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -77.97 138.46 38.86 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.611 -1.305 . . . . 9.33 110.238 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.7 -47.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.486 3.143 . . . . 2.92 119.486 -158.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -15.81 57.82 Favored Glycine 0 N--CA 1.476 1.363 0 CA-C-N 119.748 1.158 . . . . 1.93 112.698 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.15 -24.09 65.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.482 0.919 . . . . 3.25 113.482 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.15 -41.61 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.59 1.086 . . . . 1.62 109.005 172.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.8 99.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.94 -0.553 . . . . 1.34 111.478 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.11 98.27 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.842 1.053 . . . . 1.55 113.842 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.1 p -70.03 -47.29 62.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.2 1.364 . . . . 1.43 111.763 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.02 -34.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 120.065 1.302 . . . . 1.49 112.448 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.9 76.02 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.93 -1.106 . . . . 1.73 112.999 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 38.9 m -70.22 -45.45 66.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.267 1.027 . . . . 1.98 109.394 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -65.59 -28.46 69.15 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 2.83 113.06 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -19.83 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.94 -1.1 . . . . 4.54 112.546 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -46.23 95.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.759 -1.591 . . . . 5.92 112.401 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.8 -45.56 0.1 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.168 2.578 . . . . 2.72 113.989 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.18 170.51 14.81 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.937 1.244 . . . . 3.52 114.093 -174.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -128.22 -179.91 5.26 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.497 -1.377 . . . . 7.67 112.265 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -121.05 -178.35 3.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.755 1.222 . . . . 7.57 113.99 -158.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -28.77 70.21 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.948 0.721 . . . . 8.98 112.948 158.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--O 1.251 1.178 0 C-N-CA 130.448 3.499 . . . . 9.99 107.669 176.267 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 117.775 -1.107 . . . . 17.81 109.85 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -165.01 163.71 20.66 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.234 1.414 . . . . 14.42 110.268 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 t -174.9 172.93 2.81 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.121 2.569 . . . . 11.84 108.9 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 123.78 153.56 8.71 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.899 1.714 . . . . 9.68 112.231 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -159.94 116.46 1.51 Allowed Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 121.523 -0.986 . . . . 11.19 112.195 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.47 167.26 15.39 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.383 2.722 . . . . 7.21 111.062 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 pp -166.77 164.93 16.56 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.285 2.634 . . . . 8.3 109.229 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.8 mt -146.09 179.03 7.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.099 1.36 . . . . 5.27 110.657 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.01 156.95 6.7 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.343 1.449 . . . . 2.59 113.088 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -146.3 78.89 0.24 Allowed Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.329 -1.101 . . . . 2.55 113.855 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.52 144.85 62.43 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.168 2.579 . . . . 3.39 110.618 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -95.71 177.69 5.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.397 1.479 . . . . 2.91 112.524 -169.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.9 m -129.64 22.62 5.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.865 1.431 . . . . 2.28 114.865 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.41 157.9 15.8 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.32 1.048 . . . . 2.63 112.839 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' ARG . 58.3 m -101.03 148.21 25.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.892 1.677 . . . . 1.54 110.606 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.3 p -81.36 166.69 20.22 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.735 1.614 . . . . 2.33 113.49 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -61.3 -23.05 65.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.948 2.099 . . . . 2.04 113.152 169.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.7 m -73.93 -61.5 1.83 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.312 1.045 . . . . 3.2 108.183 167.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 141.53 -1.22 1.81 Allowed Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.914 1.245 . . . . 2.34 115.936 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.12 145.59 29.14 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.584 1.192 . . . . 4.16 109.781 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 0.9 OUTLIER -96.7 74.28 2.72 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.106 2.563 . . . . 5.52 112.533 -178.25 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -81.03 89.79 5.96 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.287 -0.883 . . . . 6.18 112.734 -166.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.6 p -68.57 127.59 33.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.345 1.058 . . . . 3.11 110.278 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -1.28 12.05 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 117.806 2.521 . . . . 6.19 117.806 -155.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -77.58 4.48 11.2 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 120.944 -1.098 . . . . 6.7 112.954 164.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -73.28 -71.89 0.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.633 2.773 . . . . 3.74 114.375 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -69.57 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.397 1.879 . . . . 4.46 114.441 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.0 -32.68 71.09 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.795 2.038 . . . . 3.39 114.442 -157.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.08 2.02 87.67 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.482 0.953 . . . . 2.35 115.482 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -96.55 -138.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.92 1.688 . . . . 3.3 109.189 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -140.89 140.82 34.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.851 1.26 . . . . 1.72 109.967 164.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.89 151.61 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.922 1.082 . . . . 2.86 113.922 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.22 119.22 34.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.863 1.665 . . . . 2.43 108.148 163.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.1 mt -109.88 110.22 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.61 -0.885 . . . . 1.69 108.61 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -113.35 153.98 27.63 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.272 1.829 . . . . 2.95 113.431 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -127.34 97.88 5.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.081 1.352 . . . . 2.51 112.859 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.54 -176.91 14.65 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 128.205 2.812 . . . . 1.83 112.35 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -113.32 141.11 47.41 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.818 1.647 . . . . 3.52 112.165 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -65.49 113.42 4.14 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.823 -1.173 . . . . 3.04 110.939 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 73.7 m80 63.75 35.0 11.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.075 1.75 . . . . 10.13 112.348 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 49.9 t -59.1 157.2 22.87 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.225 1.41 . . . . 2.99 111.594 163.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.66 177.34 1.33 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.621 2.881 . . . . 3.13 112.031 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.38 -3.27 0.9 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.12 2.637 . . . . 5.26 118.12 -148.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.45 -59.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.049 1.739 . . . . 3.01 110.353 171.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.8 m -53.76 -58.73 11.93 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 118.055 -0.974 . . . . 1.86 112.606 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.85 -29.9 41.14 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.575 1.517 . . . . 1.94 113.805 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -60.62 -53.1 61.49 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 121.09 1.768 . . . . 3.99 111.211 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.46 0.704 . . . . 3.39 112.023 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.22 -28.87 61.45 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.354 -1.467 . . . . 3.01 112.357 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -56.93 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.264 1.025 . . . . 4.09 108.612 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -45.34 72.47 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.438 -0.789 . . . . 5.77 111.676 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 47.1 ttp -57.93 -45.0 87.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.854 2.061 . . . . 3.58 112.408 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.78 -45.16 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.608 1.094 . . . . 1.74 110.652 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -69.11 -27.37 65.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.229 1.377 . . . . 5.02 110.654 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.41 -47.83 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 120.622 1.556 . . . . 1.74 110.591 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.8 -42.54 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.515 1.052 . . . . 3.73 113.269 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -76.29 -25.94 55.37 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.443 1.02 . . . . 5.8 113.337 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -63.98 -31.12 72.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.382 1.473 . . . . 2.98 113.474 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.46 -41.76 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.649 1.18 . . . . 2.09 112.167 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.0 -27.92 61.99 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.132 0.967 . . . . 4.47 112.218 167.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.8 m -70.57 -9.76 57.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.381 1.072 . . . . 3.96 113.06 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 14.8 mm -85.75 58.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.437 -1.414 . . . . 4.17 109.097 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.1 m -58.77 85.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.781 1.632 . . . . 5.49 112.293 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m 171.0 -32.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.962 3.705 . . . . 4.1 108.386 -167.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 294' ' ' MET . 46.2 mt -73.25 162.01 76.47 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.193 -0.432 . . . . 4.31 111.231 143.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -81.74 -154.15 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.77 3.646 . . . . 3.17 108.569 154.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.83 158.35 25.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.217 1.562 . . . . 3.9 115.217 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.09 94.1 4.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.077 1.351 . . . . 1.93 109.35 161.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.9 m -76.68 121.72 85.32 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 120.643 -1.286 . . . . 1.47 110.206 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.29 126.66 2.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.442 2.761 . . . . 0.9 111.544 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 tt -125.04 112.51 16.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.784 1.234 . . . . 2.54 110.505 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -100.66 124.24 45.99 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.526 1.131 . . . . 2.07 110.698 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.92 120.4 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.482 -0.933 . . . . 1.59 108.482 170.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.3 t -82.15 106.46 14.06 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.504 -0.924 . . . . 2.04 108.504 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.71 12.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.955 1.302 . . . . 2.43 113.032 -176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -113.69 27.77 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.295 2.638 . . . . 3.62 114.532 -171.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.41 -13.68 41.03 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.733 2.955 . . . . 2.41 116.218 -154.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.67 1.8 43.8 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.963 1.098 . . . . 4.56 113.963 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.289 2.2 ppt_? -137.28 0.82 2.36 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.137 1.532 . . . . 5.86 115.137 158.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.27 -173.05 0.05 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.117 1.767 . . . . 3.53 110.413 152.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -178.83 132.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.387 3.075 . . . . 2.71 105.533 -172.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmpt? -56.98 -30.78 64.42 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.278 0.844 . . . . 3.34 113.278 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -35.13 52.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.456 1.503 . . . . 3.33 114.025 169.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.05 78.1 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.352 -1.467 . . . . 1.96 111.897 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -70.37 -32.66 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.43 0.559 . . . . 2.46 112.085 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.78 -35.21 80.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.934 1.243 . . . . 1.73 112.368 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.09 -40.13 75.16 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.513 -0.742 . . . . 4.24 111.832 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.84 -42.08 97.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.992 0.917 . . . . 3.42 111.983 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.0 t -54.67 -50.76 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.771 0.714 . . . . 1.53 111.368 168.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.13 -23.4 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.962 1.305 . . . . 4.94 114.035 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -70.91 -22.62 62.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.461 1.504 . . . . 4.88 113.211 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -108.54 -52.72 2.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.225 1.01 . . . . 2.52 112.766 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 t 178.99 143.13 0.31 Allowed Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.82 1.648 . . . . 2.06 109.97 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.63 -9.62 23.36 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.683 2.255 . . . . 2.1 113.158 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.55 -18.1 62.92 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.226 0.921 . . . . 2.62 113.203 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.35 127.29 32.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.231 -0.918 . . . . 2.35 110.59 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.54 121.89 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.294 -1.002 . . . . 2.18 108.294 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.56 139.45 14.72 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.917 -0.873 . . . . 1.1 110.917 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mp -132.97 147.28 52.28 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.599 1.2 . . . . 2.09 112.298 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 13.5 t -150.37 -174.06 4.64 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.085 1.754 . . . . 3.48 109.926 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 149.01 -64.5 0.4 Allowed Glycine 0 N--CA 1.474 1.202 0 N-CA-C 115.626 1.01 . . . . 2.45 115.626 170.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.1 t -160.07 145.78 15.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.322 1.061 . . . . 3.52 112.702 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -48.72 -42.5 35.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.275 2.23 . . . . 5.93 112.511 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.89 -27.19 67.3 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.011 1.732 . . . . 4.26 114.456 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -35.79 25.82 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.495 . . . . 4.46 112.052 172.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.29 -41.49 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.024 0.53 . . . . 2.71 110.639 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.2 -40.36 95.83 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.184 -0.912 . . . . 3.29 111.307 170.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -58.17 -51.12 71.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.346 1.43 . . . . 2.88 111.684 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -25.4 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.251 0.932 . . . . 2.97 112.604 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.44 -53.03 18.06 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.161 -0.962 . . . . 2.12 111.724 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -64.0 -31.9 73.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.163 2.185 . . . . 3.87 111.762 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.29 62.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.73 1.612 . . . . 2.14 115.042 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.45 3.04 7.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.178 0.807 . . . . 2.59 113.178 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 74.06 34.63 0.84 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.359 2.264 . . . . 5.38 112.355 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 147.84 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.235 1.814 . . . . 3.14 110.886 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.54 140.21 48.94 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.047 1.339 . . . . 4.11 112.844 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.55 162.59 41.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.195 1.798 . . . . 7.34 110.71 161.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.5 m -127.69 88.44 53.45 Favored Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 123.733 0.813 . . . . 2.82 110.655 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 144.76 22.85 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.844 2.363 . . . . 4.51 110.068 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -95.53 138.36 13.91 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 118.615 -1.103 . . . . 4.32 112.84 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.33 73.76 5.38 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.117 3.211 . . . . 7.02 109.289 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' A' ' 250' ' ' LYS . 2.9 mmpt? -148.87 172.6 14.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.908 2.483 . . . . 8.43 114.788 -164.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -171.39 155.82 4.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.993 2.117 . . . . 11.96 109.107 -147.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.99 138.82 48.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.623 0.769 . . . . 15.78 112.306 -168.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.2 t0 99.59 -5.43 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 130.589 3.556 . . . . 6.84 111.652 -172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -126.4 -40.16 1.98 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.566 1.146 . . . . 9.52 110.854 159.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 30.6 t0 67.73 -173.24 0.19 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.218 2.207 . . . . 4.4 111.317 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -152.61 140.84 20.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.709 -1.244 . . . . 4.69 111.919 164.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.5 tp -72.36 136.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.056 -1.028 . . . . 3.13 109.825 167.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.52 144.73 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.573 1.549 . . . . 5.88 110.863 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.19 150.75 39.79 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.625 1.202 . . . . 3.62 113.03 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 162.6 8.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.615 1.566 . . . . 2.83 112.911 -153.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -38.39 57.93 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.071 -1.442 . . . . 3.82 114.447 -171.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.0 mt 66.03 29.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 123.258 1.504 . . . . 4.69 110.302 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.6 mm -126.06 149.47 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 127.191 2.196 . . . . 3.99 108.954 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.43 146.17 51.94 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.328 1.451 . . . . 2.6 114.122 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -97.94 137.39 36.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.16 1.784 . . . . 2.7 110.746 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.37 107.73 19.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.385 1.474 . . . . 2.5 108.465 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.73 125.21 47.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.165 0.986 . . . . 1.89 108.677 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.5 173.25 42.01 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.986 -0.896 . . . . 1.57 111.905 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.12 78.32 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.287 3.325 . . . . 2.65 110.803 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.13 -47.43 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 131.335 3.854 . . . . 5.38 109.871 -173.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.61 -9.92 21.71 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.467 -1.741 . . . . 3.51 116.236 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -82.87 153.27 25.21 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 119.888 1.844 . . . . 4.97 110.901 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -80.18 120.8 24.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.414 -0.804 . . . . 3.45 111.099 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.5 pp -104.29 -3.31 24.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.468 1.107 . . . . 2.99 113.758 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -157.18 164.29 37.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.899 2.08 . . . . 2.18 108.707 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.68 135.25 6.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.241 1.416 . . . . 3.64 111.755 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.03 -160.5 0.91 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.214 1.806 . . . . 2.75 109.355 -168.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.96 -132.47 3.57 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 109.826 -1.31 . . . . 3.29 109.826 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -53.05 152.1 4.37 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.827 0.822 . . . . 3.57 112.711 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 75.7 -18.48 0.45 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.317 1.847 . . . . 5.73 112.501 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 146.99 26.24 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.588 -1.32 . . . . 6.73 109.911 158.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -107.42 154.73 20.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.309 -0.869 . . . . 5.82 110.983 -167.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -47.55 -55.52 9.04 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 2.29 112.795 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.67 -19.08 76.28 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 115.238 0.855 . . . . 1.53 115.238 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -78.37 -41.82 32.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.171 1.389 . . . . 4.25 111.193 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.69 -42.77 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.475 -0.565 . . . . 1.39 109.475 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.91 81.65 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.686 -0.634 . . . . 1.34 112.145 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.06 -37.52 86.04 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.767 1.025 . . . . 1.47 113.767 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.8 p -67.33 -49.01 65.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.523 1.056 . . . . 1.3 111.074 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.98 -37.82 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.235 -0.915 . . . . 1.58 111.693 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.82 67.05 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.735 -1.228 . . . . 1.5 113.747 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.7 m -78.27 -50.02 12.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.471 1.108 . . . . 1.73 110.203 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -62.86 -31.31 72.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.811 1.244 . . . . 2.43 112.985 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.408 ' HG3' HD21 ' A' ' 193' ' ' LEU . 62.1 ttp -56.36 -18.73 11.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.929 1.692 . . . . 4.25 113.25 168.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.22 -56.55 3.21 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.631 -1.652 . . . . 5.1 112.981 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.12 -39.82 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.866 2.377 . . . . 2.68 112.996 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -93.15 121.5 34.57 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 122.137 0.97 . . . . 3.25 111.116 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? 83.13 -100.82 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.567 2.347 . . . . 9.76 112.556 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.421 ' HZ2' ' C ' ' A' ' 301' ' ' SER . 1.5 ttmt 1.36 -117.63 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 129.231 3.012 . . . . 10.45 117.523 -166.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -149.56 13.65 0.84 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 126.858 2.063 . . . . 8.66 112.718 -174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.421 ' C ' ' HZ2' ' A' ' 299' ' ' LYS . 51.0 m . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 128.033 2.533 . . . . 10.69 108.171 -135.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 118.135 -0.936 . . . . 15.71 108.764 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 177.08 152.89 0.21 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.796 1.639 . . . . 15.04 109.275 -158.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.73 176.38 4.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.865 2.066 . . . . 11.08 109.088 -165.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.68 -5.6 68.9 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 116.537 1.375 . . . . 8.74 116.537 162.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -54.49 115.75 9.28 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 119.826 1.813 . . . . 9.47 111.618 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -81.43 170.96 14.1 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.38 2.72 . . . . 6.97 111.732 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -156.72 -66.74 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.226 1.41 . . . . 7.92 110.529 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.3 mp 71.15 -80.81 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.745 2.418 . . . . 5.33 110.329 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -111.42 -149.28 11.4 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.839 1.685 . . . . 3.46 112.665 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -142.69 154.46 25.25 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.19 1.376 . . . . 2.89 111.527 165.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.78 177.73 8.46 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.812 3.008 . . . . 2.9 109.924 165.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -156.26 166.39 33.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.164 0.983 . . . . 2.63 113.298 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.2 m -156.97 72.69 0.73 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.537 -1.352 . . . . 3.88 112.364 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.38 166.98 10.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.631 1.172 . . . . 3.81 111.88 -167.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.3 m -99.57 143.34 29.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.471 1.108 . . . . 1.73 109.154 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 146' ' ' THR . 0.8 OUTLIER -110.27 162.28 14.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.889 0.852 . . . . 3.03 111.652 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -41.0 -28.76 0.09 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.742 2.417 . . . . 1.53 116.264 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.494 ' H ' HG23 ' A' ' 144' ' ' THR . 11.4 m -77.08 -22.3 53.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.842 2.457 . . . . 3.1 114.088 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.25 70.64 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.954 1.264 . . . . 1.96 113.612 -167.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 161.05 30.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.111 1.764 . . . . 3.9 110.71 168.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -124.16 141.26 52.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.641 1.177 . . . . 4.81 112.222 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -133.88 145.94 50.1 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.325 -0.86 . . . . 3.01 111.993 -173.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.1 p -128.28 167.02 17.49 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.117 1.767 . . . . 3.03 110.089 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -61.36 -10.07 6.55 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.197 0.814 . . . . 4.76 113.197 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -37.09 28.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.5 0.926 . . . . 5.75 113.5 170.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.51 -32.68 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.768 1.227 . . . . 3.08 111.47 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -93.98 -0.11 55.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.362 1.615 . . . . 3.12 115.362 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.34 174.76 9.12 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 119.59 1.086 . . . . 3.62 112.039 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.21 3.34 60.94 Favored Glycine 0 N--CA 1.478 1.47 0 N-CA-C 116.259 1.264 . . . . 2.48 116.259 165.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -130.77 164.34 25.34 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.96 2.104 . . . . 3.01 109.144 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -70.19 132.97 46.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.726 1.148 . . . . 2.76 109.105 157.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.46 144.62 38.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.801 0.81 . . . . 3.21 112.496 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.7 mt -114.95 120.52 40.19 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.383 1.873 . . . . 2.42 106.169 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.9 pt -115.98 112.59 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.184 -1.043 . . . . 3.25 108.184 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -100.47 127.95 46.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.712 1.605 . . . . 3.15 112.263 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -100.87 82.6 2.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.313 1.445 . . . . 2.17 109.721 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -95.16 164.4 24.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 113.665 -1.607 . . . . 1.61 111.279 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.01 -170.45 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.022 -1.103 . . . . 3.95 108.022 157.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.3 m -146.3 95.04 2.55 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.324 1.849 . . . . 3.46 107.141 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -169.05 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.451 1.649 . . . . 7.29 115.451 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 170' ' ' PRO . 37.6 m -79.78 -179.88 1.58 Allowed Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.298 1.439 . . . . 2.93 111.446 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 169' ' ' CYS . 57.2 Cg_endo -76.9 -129.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.242 2.628 . . . . 4.5 108.585 157.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 50.57 0.13 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.377 2.671 . . . . 5.6 114.367 -173.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.9 -60.17 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.214 1.805 . . . . 4.03 109.873 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 63.8 m -46.96 -44.92 49.8 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-O 117.375 -1.297 . . . . 3.63 114.476 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.57 -9.11 6.94 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.432 2.755 . . . . 1.66 114.865 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.69 -67.2 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.375 1.443 . . . . 4.04 111.213 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.45 -21.18 65.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.359 0.981 . . . . 3.1 113.04 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -47.08 81.62 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.199 0.6 . . . . 2.61 110.468 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -40.31 95.32 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.688 -1.258 . . . . 3.5 111.481 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -55.24 24.1 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.074 -1.016 . . . . 2.92 110.947 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.37 -16.13 62.94 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.446 0.906 . . . . 2.99 113.446 -176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.9 mm -69.36 -56.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.835 1.198 . . . . 1.56 109.985 162.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.516 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 80.8 mt-30 -60.51 -22.58 63.73 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.284 1.402 . . . . 3.17 113.185 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.82 -28.02 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.113 -0.992 . . . . 1.76 111.264 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.92 -34.61 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.309 0.959 . . . . 2.34 110.419 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.43 -45.29 84.83 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.042 1.337 . . . . 4.76 112.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.14 -20.39 61.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.535 1.134 . . . . 2.88 113.478 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.55 -57.58 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.324 1.05 . . . . 1.73 111.543 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.07 -23.69 65.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.584 1.154 . . . . 3.05 112.161 -174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 73.4 m -68.11 -19.12 64.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.32 1.048 . . . . 2.61 113.713 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.16 -25.22 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.999 0.92 . . . . 3.71 111.176 171.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.0 m 72.63 -33.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 129.801 3.24 . . . . 5.38 114.272 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.8 p -99.56 19.25 16.09 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 3.56 111.863 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.09 165.41 43.17 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.477 1.111 . . . . 2.89 108.314 159.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 51.62 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.154 2.569 . . . . 4.09 110.947 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.61 -173.84 0.16 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.775 2.83 . . . . 4.56 113.784 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 45.5 tp -140.55 117.39 11.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.153 -1.054 . . . . 1.78 108.153 150.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.0 m -106.56 96.03 13.19 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.288 1.035 . . . . 1.64 108.651 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.12 144.12 33.23 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.205 1.937 . . . . 1.2 110.535 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.25 147.11 43.35 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.542 0.687 . . . . 2.72 110.806 171.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -112.92 121.09 43.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.895 1.278 . . . . 2.25 108.234 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.35 118.03 40.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.738 -1.578 . . . . 1.51 106.738 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.57 137.99 38.9 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.567 0.698 . . . . 1.98 110.679 162.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.1 pt -114.6 24.48 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.835 1.254 . . . . 2.07 111.092 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -97.69 0.7 0.09 OUTLIER Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 129.337 3.055 . . . . 5.17 118.586 -161.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.48 120.55 7.77 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 123.405 2.252 . . . . 2.53 111.727 -165.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 149.23 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 130.425 3.49 . . . . 4.44 110.402 -171.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -35.46 3.56 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.014 1.116 . . . . 4.96 114.014 173.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.4 163.72 12.41 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.35 1.611 . . . . 4.89 115.35 -166.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -138.95 153.36 48.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.512 -1.222 . . . . 2.75 112.536 -164.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -45.61 -43.95 12.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.87 1.268 . . . . 4.52 112.34 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.61 -44.24 62.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.612 1.565 . . . . 3.69 112.853 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.84 97.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.34 1.427 . . . . 1.29 111.229 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.69 -33.99 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.537 -0.727 . . . . 1.88 110.543 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.83 78.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.554 1.07 . . . . 1.19 112.638 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -62.43 -53.47 54.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.835 1.198 . . . . 3.55 109.983 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -55.83 -46.61 78.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 5.11 112.448 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.5 t -62.24 -45.72 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.555 -1.341 . . . . 1.49 111.397 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.03 -39.18 91.44 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 118.315 -0.85 . . . . 5.43 113.086 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -78.19 -37.28 45.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.059 1.3 . . . . 4.02 112.436 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -68.4 -59.68 3.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.536 -0.745 . . . . 3.03 112.484 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 174.85 157.28 0.35 Allowed Pre-proline 0 N--CA 1.484 1.257 0 N-CA-C 115.173 1.546 . . . . 1.93 115.173 170.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.19 -8.93 18.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.762 2.975 . . . . 2.23 114.552 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -86.16 -0.03 54.73 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 119.95 1.25 . . . . 2.85 112.78 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 29.9 tp -94.41 151.04 19.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.995 1.318 . . . . 1.88 109.912 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 87.7 t -133.43 132.43 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.98 1.712 . . . . 1.83 108.313 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.6 105.36 1.42 Allowed Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.082 0.848 . . . . 1.12 112.068 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.91 147.4 25.59 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.7 1.2 . . . . 2.1 112.453 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 65.4 p -140.49 149.73 42.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.488 1.915 . . . . 2.92 111.164 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -131.44 -170.72 12.7 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.151 1.358 . . . . 1.6 110.856 160.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.9 t -84.33 174.59 10.01 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.622 0.711 . . . . 2.63 109.146 152.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -52.26 -24.45 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.026 1.33 . . . . 6.41 113.603 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -74.86 -52.33 11.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.87 2.468 . . . . 2.83 110.784 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.07 -25.84 64.64 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.272 -1.517 . . . . 3.97 111.96 171.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 33.3 t -62.98 -38.95 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 117.22 -1.371 . . . . 1.79 110.991 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.8 -52.53 65.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.451 1.478 . . . . 3.94 109.042 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -49.98 -57.28 7.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.606 1.094 . . . . 2.52 112.02 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.48 -29.19 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.315 1.416 . . . . 3.01 113.002 -170.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.38 -42.33 79.28 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.831 -0.543 . . . . 1.74 110.732 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -72.02 -33.93 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.854 2.062 . . . . 4.68 112.573 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -54.87 -30.72 58.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.039 1.336 . . . . 2.56 114.487 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -118.22 3.72 11.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.616 1.166 . . . . 3.06 113.099 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.75 39.92 16.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.204 2.202 . . . . 6.31 112.91 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.17 155.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.867 0.867 . . . . 2.61 112.131 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -104.58 148.98 25.91 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.591 1.556 . . . . 3.51 114.084 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -170.37 150.12 3.48 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.837 2.855 . . . . 3.57 109.497 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.2 m -157.78 144.45 13.11 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 124.979 1.312 . . . . 3.24 111.623 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.06 154.04 37.31 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.508 2.139 . . . . 2.85 111.414 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -69.92 176.02 33.85 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 123.886 0.755 . . . . 3.16 114.259 171.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.64 -27.93 10.32 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.431 2.754 . . . . 4.83 112.63 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt 62.7 54.69 2.29 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.378 1.871 . . . . 4.15 114.882 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . 0.256 0.8 OUTLIER -141.51 -155.21 0.57 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 113.366 0.876 . . . . 7.47 113.366 172.105 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.258 17.3 mt-10 49.26 -82.39 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.862 2.065 . . . . 9.38 111.772 -148.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -93.2 -47.93 6.7 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.273 1.029 . . . . 8.18 112.029 168.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -178.65 -1.52 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 127.031 2.132 . . . . 5.28 113.248 -168.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -29.11 98.93 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 116.948 2.203 . . . . 6.46 116.948 -147.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -93.21 41.1 1.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.746 -1.116 . . . . 4.77 111.887 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.5 HD13 ' H ' ' A' ' 258' ' ' VAL . 0.5 OUTLIER -65.54 160.61 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 121.245 -0.909 . . . . 2.85 110.255 162.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.5 ' H ' HD13 ' A' ' 257' ' ' ILE . 41.1 t -153.74 128.03 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.566 1.947 . . . . 3.15 106.568 172.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.19 146.41 49.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.556 1.542 . . . . 3.28 112.196 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -148.77 129.51 14.16 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.135 0.974 . . . . 2.34 111.237 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.6 m -54.45 -31.15 54.91 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.93 1.085 . . . . 3.33 113.93 -171.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 69.74 -20.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.42 1.888 . . . . 4.16 114.402 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 84.4 mt -54.94 138.78 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.082 0.953 . . . . 2.34 110.504 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.7 mtm -99.78 141.2 32.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.324 -1.307 . . . . 2.57 110.46 162.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -99.21 140.32 33.55 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.241 0.616 . . . . 3.29 110.006 168.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 21.6 tp -99.1 117.04 32.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.919 0.888 . . . . 1.94 108.918 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.48 141.99 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.795 -1.187 . . . . 2.26 107.795 169.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.41 168.28 34.78 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.23 0.919 . . . . 1.59 115.156 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.66 61.25 7.44 Favored 'Trans proline' 0 C--N 1.351 0.695 1 C-N-CA 126.063 4.509 . . . . 3.03 110.722 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.54 -67.45 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.091 1.356 . . . . 4.13 108.232 -149.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.61 -23.22 2.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.07 -1.406 . . . . 2.38 115.046 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.59 172.25 11.07 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.335 1.567 . . . . 4.44 113.219 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -88.56 137.64 32.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.755 2.022 . . . . 5.4 111.429 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.22 -30.15 4.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.055 1.872 . . . . 2.39 116.055 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -164.68 155.98 15.22 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.686 1.585 . . . . 2.52 112.995 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 146.09 31.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.728 0.811 . . . . 6.15 112.825 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.37 159.92 40.05 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.344 1.058 . . . . 2.78 111.771 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.48 -174.37 29.04 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.347 1.451 . . . . 2.83 110.213 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -73.83 38.57 0.1 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.29 2.236 . . . . 3.59 114.637 -167.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -121.48 -43.25 2.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.542 1.537 . . . . 5.45 109.91 167.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -87.32 118.59 26.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.449 1.5 . . . . 4.36 108.945 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -73.42 177.92 4.93 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.264 -0.897 . . . . 6.06 108.709 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 12.7 tmtt? -54.45 -47.33 73.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.301 1.223 . . . . 1.81 114.301 -170.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -32.8 85.39 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-N 118.414 0.552 . . . . 1.52 112.757 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.08 -22.84 62.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.357 1.063 . . . . 3.47 113.078 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.04 -49.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.111 -0.993 . . . . 1.49 109.923 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.79 88.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.544 -0.723 . . . . 1.4 112.657 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.49 66.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.361 1.245 . . . . 1.55 114.361 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.3 p -74.72 -44.82 48.01 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.296 -0.878 . . . . 1.53 111.544 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.01 -40.34 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 120.142 1.337 . . . . 1.35 110.93 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.97 -5.36 9.22 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 114.663 1.357 . . . . 2.01 114.663 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.1 m -96.41 -47.93 5.78 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.288 1.435 . . . . 1.97 110.087 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -65.21 -24.94 67.49 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.619 1.168 . . . . 2.91 113.301 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -55.78 -35.71 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.549 2.34 . . . . 4.77 113.9 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -59.4 -43.23 95.91 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 116.838 -1.553 . . . . 6.61 111.913 -172.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.61 -61.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.133 1.889 . . . . 2.38 110.519 161.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.24 74.24 3.97 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 122.795 1.283 . . . . 3.75 113.722 -169.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -97.29 150.13 21.3 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.375 2.27 . . . . 9.2 110.831 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -76.64 -13.01 60.09 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.589 1.7 . . . . 8.42 115.589 -173.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -132.91 -45.51 0.86 Allowed 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.545 1.683 . . . . 9.21 115.545 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.251 1.158 0 C-N-CA 130.026 3.33 . . . . 8.24 108.944 -152.642 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 117.711 -1.138 . . . . 20.32 109.873 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -165.25 151.86 10.27 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.289 1.435 . . . . 16.56 110.35 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t 155.25 -168.0 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 1 C-N-CA 132.033 4.133 . . . . 13.2 107.82 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.06 -2.09 77.08 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 116.457 1.343 . . . . 10.65 116.457 162.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.98 115.77 8.0 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-N 119.534 1.667 . . . . 9.78 112.04 -175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.73 -175.99 2.99 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.202 2.601 . . . . 9.76 111.667 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.45 164.68 32.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.607 1.963 . . . . 7.84 109.214 171.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.7 tp -166.25 153.46 9.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.065 2.146 . . . . 7.28 108.264 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.45 175.36 22.32 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.881 1.229 . . . . 3.23 114.498 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.72 61.73 0.65 Allowed Glycine 0 CA--C 1.531 1.053 0 N-CA-C 109.531 -1.428 . . . . 3.42 109.531 162.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.93 144.31 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.613 2.208 . . . . 2.48 112.968 -151.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -86.33 175.09 8.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.288 1.518 . . . . 2.29 114.092 -166.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -148.19 106.37 3.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.983 1.313 . . . . 3.24 108.607 165.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mp -148.57 165.17 32.05 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.682 1.593 . . . . 2.43 110.137 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.2 m -107.95 134.07 51.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.763 1.225 . . . . 1.6 111.904 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -73.61 160.27 31.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.494 1.118 . . . . 2.09 112.216 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -60.6 -20.01 59.4 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 121.508 -0.745 . . . . 1.61 112.486 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.2 m -78.43 -60.02 2.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.35 1.86 . . . . 3.26 109.822 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.85 -14.9 0.69 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 116.11 1.204 . . . . 2.34 116.11 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.2 133.67 44.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.829 1.815 . . . . 3.92 109.973 171.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -82.31 129.5 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.119 -1.067 . . . . 5.68 108.119 157.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -140.37 175.99 9.14 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.818 1.247 . . . . 3.57 112.806 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.6 p -140.77 172.45 12.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 128.583 2.753 . . . . 2.68 109.383 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.83 -25.03 62.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.128 0.788 . . . . 3.91 113.128 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -75.07 -11.59 60.13 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 119.938 -1.726 . . . . 7.5 113.979 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.73 -28.87 21.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.866 1.666 . . . . 4.19 111.636 164.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -108.58 -2.47 18.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.535 1.68 . . . . 3.72 115.535 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.9 mt -77.56 -176.64 4.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.9 1.227 . . . . 4.3 109.777 165.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.7 10.86 Favored Glycine 0 N--CA 1.48 1.573 0 O-C-N 120.889 -1.132 . . . . 2.53 114.991 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -126.18 168.88 13.44 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.048 2.939 . . . . 3.79 108.252 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.521 ' CD1' ' HD3' ' A' ' 269' ' ' PRO . 53.9 m95 -81.77 140.39 34.27 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.445 1.02 . . . . 2.42 109.807 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.498 HD12 ' HB ' ' A' ' 197' ' ' THR . 0.8 OUTLIER -123.6 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.203 -0.936 . . . . 2.97 112.438 177.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.17 100.63 10.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.935 -1.135 . . . . 3.58 107.935 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.2 mt -96.26 127.75 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.743 -0.836 . . . . 1.82 108.743 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -139.95 143.82 36.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.122 0.969 . . . . 2.44 111.94 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.81 127.21 53.51 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.674 1.19 . . . . 2.25 112.34 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -147.47 163.96 28.74 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.506 1.05 . . . . 1.34 112.654 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.95 -179.04 6.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 117.745 0.772 . . . . 3.1 111.313 168.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 174.89 5.67 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.963 -1.125 . . . . 3.49 107.963 152.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 73.92 -24.76 0.2 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.516 1.526 . . . . 7.01 113.921 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 83.6 m -52.42 159.69 1.54 Allowed Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 120.648 1.567 . . . . 2.88 113.293 161.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.54 -173.44 1.8 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.386 3.39 . . . . 3.99 111.474 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.44 -2.46 1.05 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.248 2.219 . . . . 6.34 115.904 -157.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.29 -60.41 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.362 1.465 . . . . 4.32 110.163 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 15.6 m -52.43 -44.02 93.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.372 -1.299 . . . . 3.08 114.212 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.63 -39.59 0.51 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.435 2.09 . . . . 1.88 113.774 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.41 -32.62 68.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 122.171 2.26 . . . . 4.33 112.086 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -60.11 -44.98 94.46 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.506 -1.371 . . . . 3.54 111.484 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.77 -39.46 91.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.02 0.928 . . . . 3.2 111.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -72.81 -25.98 61.34 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.417 -1.427 . . . . 6.77 114.06 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -56.03 -56.96 14.44 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.431 -1.418 . . . . 2.81 109.812 165.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 10.0 ptp -64.7 -30.9 71.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.013 -0.994 . . . . 3.71 113.093 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.2 mt -75.16 -48.34 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 121.773 2.079 . . . . 3.11 109.821 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.52 ' HB3' ' HZ1' ' A' ' 283' ' ' LYS . 3.5 mp0 -68.07 -16.63 64.1 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.252 1.387 . . . . 6.54 111.776 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.421 HG21 ' HB ' ' A' ' 286' ' ' ILE . 24.9 t -69.84 -30.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.95 1.25 . . . . 1.86 112.584 163.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.82 -46.03 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 121.061 1.755 . . . . 2.39 110.257 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.23 -37.35 77.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.332 1.053 . . . . 4.63 113.153 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -57.53 -46.1 84.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 3.56 111.721 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.8 mt -71.87 -33.3 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.711 1.204 . . . . 1.84 114.232 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.44 -29.47 61.69 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.429 1.892 . . . . 3.2 112.359 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.5 t -68.52 -14.67 63.16 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.471 -1.393 . . . . 3.05 113.562 170.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.43 45.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 127.069 2.147 . . . . 4.17 108.666 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.06 4.3 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.617 2.767 . . . . 6.4 116.252 -159.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 78.0 p -78.21 -24.33 47.1 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.94 -1.1 . . . . 4.66 112.382 166.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 194' ' ' PRO . 11.6 mt -56.33 142.63 67.74 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 118.72 0.691 . . . . 3.98 111.046 169.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 159' ' ' TRP . 1.7 Cg_endo -81.77 46.63 2.28 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.604 4.203 . . . . 5.07 112.233 -174.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 72.88 101.21 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.633 1.682 . . . . 5.63 112.725 145.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 84.76 4.99 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.387 1.475 . . . . 2.35 111.012 -160.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 160' ' ' LEU . 56.8 m -79.95 122.31 83.09 Favored Pre-proline 0 N--CA 1.478 0.94 0 O-C-N 120.84 -1.163 . . . . 1.43 112.094 -173.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.04 124.43 1.79 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.381 2.721 . . . . 1.08 111.97 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 tp -126.58 93.96 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.085 1.354 . . . . 2.59 110.327 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.77 115.39 14.3 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.94 -0.763 . . . . 2.14 108.94 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.94 112.51 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.793 1.237 . . . . 1.59 108.584 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -83.88 135.03 34.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.649 -1.16 . . . . 1.98 109.55 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.7 34.95 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.582 1.153 . . . . 1.71 112.657 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -121.55 44.49 0.79 Allowed Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 127.158 2.183 . . . . 3.71 111.97 -173.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -77.71 35.15 0.5 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.231 3.287 . . . . 2.16 113.811 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -91.34 -16.59 27.23 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.204 -0.426 . . . . 5.43 110.406 150.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.49 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.494 2.405 . . . . 7.59 117.494 -171.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -79.73 52.48 1.45 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.317 1.847 . . . . 4.03 114.619 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.1 m -55.5 129.79 40.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.388 1.075 . . . . 2.49 110.785 -167.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -41.62 -48.51 4.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.363 1.465 . . . . 3.0 113.922 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -26.07 43.98 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.993 1.109 . . . . 4.07 113.993 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.11 86.44 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 1.86 110.83 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.84 -30.76 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.351 1.06 . . . . 2.12 112.613 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.31 74.38 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.408 1.458 . . . . 1.43 113.09 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 -44.73 58.02 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.699 0.799 . . . . 3.13 111.201 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -55.9 -39.98 72.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.476 1.51 . . . . 3.93 111.517 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.401 HG21 ' HA3' ' A' ' 226' ' ' GLY . 45.0 t -65.15 -20.72 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.053 1.741 . . . . 1.38 113.583 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -111.69 -21.55 11.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.46 1.652 . . . . 8.54 115.46 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.73 -19.13 58.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.377 0.989 . . . . 3.9 113.044 168.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -74.14 -87.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.707 1.603 . . . . 3.78 110.147 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.2 t -148.61 132.1 8.33 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.646 -1.283 . . . . 2.73 110.121 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.07 -19.44 45.37 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.382 2.055 . . . . 3.27 114.663 -156.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -84.61 2.69 40.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.713 1.375 . . . . 2.78 114.713 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.2 tp -72.55 147.3 46.07 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.624 1.102 . . . . 1.96 113.083 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 2.3 p -118.31 130.97 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.668 1.587 . . . . 2.45 108.66 160.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.401 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -99.45 160.82 19.75 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 123.919 0.771 . . . . 1.27 111.909 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -153.36 114.04 4.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.497 -1.297 . . . . 3.92 107.497 -166.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.0 m -112.88 152.65 29.04 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.24 2.216 . . . . 2.54 107.877 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -144.51 146.29 16.6 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 121.819 -0.551 . . . . 2.97 112.71 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -63.51 154.3 32.84 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.057 0.928 . . . . 2.49 109.693 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.476 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -47.23 -33.25 5.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.929 1.292 . . . . 7.57 113.38 -170.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.44 -50.57 58.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.874 1.215 . . . . 5.27 112.411 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.62 -44.7 90.04 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.961 -1.087 . . . . 3.43 111.967 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 15.6 m -70.95 -22.32 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 113.844 1.053 . . . . 2.63 113.844 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.68 -53.09 37.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.847 1.203 . . . . 3.55 108.808 164.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -55.82 -57.82 10.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.361 -0.828 . . . . 3.66 112.378 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.97 -35.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 119.356 0.98 . . . . 2.12 113.323 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.42 67.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.063 0.945 . . . . 2.1 111.477 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -70.21 -26.49 63.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.626 1.57 . . . . 3.41 112.433 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.8 -62.89 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.695 1.198 . . . . 2.6 113.367 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -67.5 -33.78 75.79 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.038 -1.039 . . . . 3.15 112.735 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.259 2.2 ptp180 109.16 117.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 1 C-N-CA 132.411 4.284 . . . . 9.01 109.777 179.365 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.83 153.61 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.027 2.131 . . . . 4.08 110.473 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -119.53 135.98 54.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.73 0.412 . . . . 4.63 110.163 148.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -165.91 166.18 17.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.167 1.787 . . . . 4.2 111.323 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 48.9 p -113.16 165.8 12.46 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.46 1.504 . . . . 4.68 112.743 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.27 143.63 17.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.595 2.197 . . . . 4.43 111.046 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -72.25 136.07 23.28 Favored Glycine 0 CA--C 1.542 1.747 0 CA-C-O 118.026 -1.43 . . . . 2.96 112.14 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.59 -23.82 9.45 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.159 2.573 . . . . 5.46 116.283 -167.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt 59.95 30.5 20.01 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 120.736 1.607 . . . . 5.76 113.985 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -140.0 153.48 46.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.227 1.811 . . . . 6.86 110.454 -169.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 110.98 -52.49 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 131.305 3.842 . . . . 7.86 110.05 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -140.73 -49.82 0.44 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.573 1.549 . . . . 6.9 109.196 162.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -176.85 -29.37 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.98 3.312 . . . . 6.49 108.988 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -60.42 152.82 24.56 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.34 2.256 . . . . 7.18 113.66 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -163.41 -179.31 6.44 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.504 2.038 . . . . 3.6 116.504 -166.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt -138.84 163.93 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.711 2.004 . . . . 4.37 108.52 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.56 148.42 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.627 1.571 . . . . 3.3 109.108 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -86.28 135.19 33.64 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.312 -0.996 . . . . 4.03 108.312 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.62 139.85 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.59 1.156 . . . . 2.7 111.274 -169.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -68.42 -14.94 63.35 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.977 2.214 . . . . 3.8 116.977 -165.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 28.3 mt 50.8 56.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 120.169 1.349 . . . . 4.7 110.36 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.0 mt -112.31 147.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.128 1.371 . . . . 2.53 109.986 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.0 ttp -114.49 144.8 42.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.622 1.969 . . . . 4.25 109.856 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -107.14 136.26 47.29 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.242 -0.912 . . . . 2.54 110.874 163.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 39.2 tp -94.95 106.97 19.0 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.967 0.907 . . . . 2.17 108.85 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.3 mp -86.84 135.58 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.501 -1.666 . . . . 2.16 106.501 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.49 165.29 24.77 Favored Glycine 0 CA--C 1.539 1.593 0 N-CA-C 111.587 -0.605 . . . . 1.81 111.587 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.521 ' HD3' ' CD1' ' A' ' 159' ' ' TRP . 21.0 Cg_endo -67.5 9.92 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 125.181 3.921 . . . . 2.92 114.16 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -141.93 -1.03 1.27 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.904 2.482 . . . . 5.04 111.492 -167.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 163.34 156.56 8.71 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.105 0.859 . . . . 3.55 114.483 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -74.71 -22.05 59.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.08 1.352 . . . . 5.8 114.638 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.87 108.17 9.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.133 -0.979 . . . . 3.95 111.32 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 -36.76 4.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.572 1.149 . . . . 3.18 111.152 170.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -157.45 178.63 10.08 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.98 2.112 . . . . 2.3 110.479 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -155.26 138.3 15.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.311 1.444 . . . . 3.61 113.354 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.8 -151.35 0.39 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.166 1.387 . . . . 2.75 110.968 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.85 -127.05 7.92 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.849 2.166 . . . . 3.5 108.492 -171.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -53.44 156.25 2.55 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.078 1.351 . . . . 2.87 113.11 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.6 -40.84 0.39 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.772 2.429 . . . . 4.33 112.459 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -63.41 108.84 1.43 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.982 1.313 . . . . 4.71 112.709 -174.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.61 141.66 57.64 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.331 -0.856 . . . . 7.34 108.845 177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.52 ' HZ1' ' HB3' ' A' ' 182' ' ' GLN . 13.1 tmtt? -48.59 -53.57 17.9 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.205 -1.559 . . . . 2.62 114.449 -165.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.3 -14.41 71.56 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 115.707 1.043 . . . . 1.64 115.707 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.3 -38.87 82.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.033 1.417 . . . . 3.65 110.439 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ILE . . . . . 0.421 ' HB ' HG21 ' A' ' 183' ' ' VAL . 37.6 mt -60.7 -48.54 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.65 0.78 . . . . 1.48 109.259 174.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.73 77.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 119.121 -0.466 . . . . 1.27 111.858 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.79 90.39 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.712 1.004 . . . . 1.62 113.712 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 86.8 p -60.01 -48.59 81.07 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.581 -0.699 . . . . 1.62 111.795 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.13 -31.69 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.658 -1.276 . . . . 1.37 111.368 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.0 64.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.957 0.903 . . . . 1.78 113.093 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.6 m -70.71 -46.09 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.539 -0.726 . . . . 2.26 109.597 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -69.72 -27.89 65.35 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.844 1.053 . . . . 2.56 113.844 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.7 ttt -59.98 -40.17 88.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.413 1.485 . . . . 4.24 112.167 166.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.07 36.78 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 117.36 -1.305 . . . . 5.3 113.348 -173.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.53 -57.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.408 2.739 . . . . 3.01 112.379 158.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.67 28.61 8.51 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.439 1.644 . . . . 4.1 115.439 -154.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -33.48 -53.67 0.41 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.667 1.987 . . . . 8.14 114.612 165.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 62.7 mttt 53.36 177.63 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.716 1.206 . . . . 12.33 111.334 -158.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 21.6 mttt 54.97 -62.14 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.953 2.101 . . . . 7.85 114.815 -166.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 C-N-CA 129.216 3.006 . . . . 6.89 112.213 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 118.218 -0.896 . . . . 13.85 109.91 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -72.61 144.48 47.83 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.631 0.65 . . . . 13.29 111.461 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 t 161.5 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 131.305 3.842 . . . . 11.09 108.127 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.06 1.45 6.89 Favored Glycine 0 N--CA 1.476 1.322 0 N-CA-C 117.852 1.901 . . . . 9.05 117.852 163.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -97.42 106.94 35.88 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 119.626 1.713 . . . . 9.41 112.548 -162.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -81.03 148.32 17.03 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.637 2.891 . . . . 7.9 112.688 170.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 38.9 tp -112.6 -18.7 12.31 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.443 1.275 . . . . 8.4 114.443 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.07 33.39 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 118.211 2.671 . . . . 8.68 118.211 -154.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 125.51 126.95 3.05 Favored Glycine 0 N--CA 1.471 1.013 0 O-C-N 120.647 -1.283 . . . . 3.61 114.158 166.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.71 148.34 31.94 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.734 1.159 . . . . 2.35 112.307 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.65 174.77 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.127 3.218 . . . . 3.35 112.171 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.76 173.38 15.36 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.973 1.709 . . . . 2.88 109.843 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.71 32.21 4.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.618 0.97 . . . . 3.68 113.618 172.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.3 mt -51.72 149.3 4.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 3.02 112.563 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -108.38 142.35 38.85 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.396 1.078 . . . . 1.37 109.731 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.3 t -91.32 165.09 13.61 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.295 1.038 . . . . 2.43 113.245 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -61.2 -25.37 67.0 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 2.24 114.124 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -83.12 0.93 42.89 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.249 1.82 . . . . 3.09 114.178 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.94 -6.37 73.04 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.227 1.394 . . . . 2.02 115.555 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -73.63 132.95 43.32 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.347 1.073 . . . . 4.08 111.293 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -82.52 105.3 13.46 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.092 -1.005 . . . . 4.44 108.494 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -179.1 4.3 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.976 1.31 . . . . 2.94 113.614 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 62.3 p -146.54 166.16 27.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.035 2.534 . . . . 2.37 109.005 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.31 -38.17 76.55 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.449 0.568 . . . . 4.08 112.343 173.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -81.78 4.25 22.8 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.89 1.441 . . . . 6.93 114.89 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.81 -41.33 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.622 0.769 . . . . 3.46 109.828 160.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -84.5 -29.19 26.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.756 1.391 . . . . 3.33 114.756 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.89 101.96 0.43 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.781 1.232 . . . . 4.09 110.23 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 144.2 -20.97 2.09 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.643 1.116 . . . . 2.79 113.48 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.67 170.45 7.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.876 -0.787 . . . . 3.52 108.876 152.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -82.42 127.4 33.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.478 0.581 . . . . 2.12 109.856 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.48 145.94 44.88 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.636 0.653 . . . . 3.36 112.506 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.1 mt -107.19 121.61 44.87 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.09 1.356 . . . . 2.53 108.01 158.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.5 118.66 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.267 0.627 . . . . 2.11 109.626 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -122.9 149.88 43.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.305 1.442 . . . . 2.45 114.015 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -99.19 120.54 39.69 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 2.5 112.524 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.96 155.71 15.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.515 1.055 . . . . 1.57 113.791 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -114.08 -43.75 3.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.362 1.065 . . . . 2.93 111.865 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.5 m 67.71 -18.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 126.453 1.901 . . . . 4.0 114.835 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -71.93 -18.86 61.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.319 1.048 . . . . 7.22 111.326 160.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.54 164.38 58.33 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.768 1.227 . . . . 2.48 111.741 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -78.82 -146.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.433 2.755 . . . . 3.73 109.387 164.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.53 57.72 0.13 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.872 3.269 . . . . 5.59 113.348 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.5 t -115.24 -84.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 126.849 2.06 . . . . 3.65 108.073 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -47.59 98.34 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 117.062 -1.447 . . . . 1.87 113.761 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.46 -23.57 43.67 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.029 1.82 . . . . 1.54 114.219 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.78 -56.55 14.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.82 0.848 . . . . 4.19 109.961 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -60.75 -39.89 90.4 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 2.83 112.129 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.452 HD22 ' CG ' ' A' ' 220' ' ' PHE . 5.1 tt -55.58 -39.58 70.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.82 1.248 . . . . 2.72 112.036 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . 0.263 0.3 OUTLIER -75.77 -34.02 60.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.144 0.884 . . . . 3.03 112.305 175.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -55.65 -46.12 77.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.283 -1.511 . . . . 4.78 111.643 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.4 ptp -67.89 -28.53 67.59 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.728 0.64 . . . . 2.67 112.728 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.23 -38.09 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.295 -0.878 . . . . 1.79 111.018 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.446 ' OE1' ' HE3' ' A' ' 283' ' ' LYS . 73.9 mt-30 -62.57 -40.43 96.85 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.297 -0.859 . . . . 3.15 111.931 171.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . 0.259 4.4 m -72.31 -28.93 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.218 1.372 . . . . 2.98 113.243 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.2 t -63.07 -52.83 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.793 1.179 . . . . 2.07 111.717 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -74.92 -19.97 59.9 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.155 0.798 . . . . 5.18 113.155 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -64.93 -55.59 18.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.596 0.758 . . . . 3.28 111.241 164.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.25 -37.37 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.111 1.365 . . . . 2.15 112.902 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.51 -35.56 65.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.49 1.516 . . . . 3.21 112.205 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.9 t -72.34 -18.2 61.78 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.931 1.085 . . . . 3.25 113.931 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.43 HG22 HG22 ' A' ' 192' ' ' THR . 11.8 mt -94.36 75.38 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.357 1.463 . . . . 3.68 107.795 -175.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -3.55 0.06 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 128.111 2.565 . . . . 4.66 116.623 -162.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.43 HG22 HG22 ' A' ' 190' ' ' ILE . 15.1 t -71.59 -22.44 61.73 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.378 1.871 . . . . 6.18 113.071 167.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.4 151.74 59.75 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.434 1.016 . . . . 3.98 111.195 166.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 -40.11 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.074 2.516 . . . . 3.23 110.779 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -172.74 -179.89 2.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.235 2.614 . . . . 4.48 109.331 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.0 tp -149.27 73.26 1.19 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.799 1.24 . . . . 1.92 109.948 160.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -63.03 119.96 56.82 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 121.077 -1.015 . . . . 1.33 110.717 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.93 128.37 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.29 1.993 . . . . 1.15 110.459 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.6 tp -115.81 115.36 26.15 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.663 1.585 . . . . 2.78 110.735 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -87.24 126.52 34.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.174 0.99 . . . . 2.45 109.884 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.79 119.53 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.429 -0.952 . . . . 1.27 108.429 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.8 t -79.1 139.49 38.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.956 -0.565 . . . . 2.0 111.632 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -124.19 21.76 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.916 1.286 . . . . 1.86 113.119 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -111.52 61.66 0.5 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.803 1.241 . . . . 3.56 113.647 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.17 73.17 5.6 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.18 2.587 . . . . 2.41 110.255 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -153.32 -37.15 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.101 1.36 . . . . 5.42 112.555 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.09 7.36 0.91 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.081 1.141 . . . . 4.98 114.081 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 177.73 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.987 -0.445 . . . . 3.46 110.828 157.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 32.8 m -155.95 136.9 13.57 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.025 -1.047 . . . . 2.42 108.181 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.448 ' HZ3' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -51.76 -44.86 63.5 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.013 0.925 . . . . 3.9 112.216 177.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.448 ' CD ' ' HZ3' ' A' ' 210' ' ' LYS . 17.7 mp0 -60.35 -40.24 90.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.083 1.753 . . . . 3.57 112.776 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.98 69.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.227 -0.921 . . . . 1.6 112.346 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.61 -43.24 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.919 0.888 . . . . 2.01 110.654 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.56 66.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.219 1.008 . . . . 1.28 112.484 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 0.7 OUTLIER -71.21 -46.79 60.43 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.19 0.996 . . . . 3.48 112.331 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.79 -37.11 86.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.467 1.507 . . . . 4.17 111.422 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -50.64 -44.9 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.877 2.071 . . . . 1.2 112.987 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 7.7 mtmp? -55.23 -45.53 75.97 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.662 0.664 . . . . 4.18 112.386 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -20.46 60.12 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 124.363 1.04 . . . . 5.16 112.211 -163.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.452 ' CG ' HD22 ' A' ' 177' ' ' LEU . 68.9 m-85 -86.16 -48.24 8.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.012 0.925 . . . . 2.39 111.993 168.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 87.8 p -174.04 127.89 0.46 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.753 -1.118 . . . . 2.62 110.902 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.15 76.59 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.661 2.907 . . . . 3.17 109.244 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 178.18 -28.27 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.996 2.919 . . . . 2.3 111.005 -163.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.451 ' CD1' HD21 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -67.93 143.96 55.43 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.917 1.687 . . . . 2.29 110.722 164.175 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.72 133.97 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.378 1.471 . . . . 2.39 109.797 170.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.51 115.66 3.58 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 123.841 0.734 . . . . 1.07 112.181 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.87 148.67 27.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.365 1.066 . . . . 2.51 111.455 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 71.9 p -136.59 161.61 35.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.986 1.314 . . . . 2.23 110.635 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.6 23.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 124.659 1.123 . . . . 2.88 110.372 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.6 t -60.57 166.53 3.13 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.507 1.123 . . . . 3.23 111.293 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -38.36 7.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.306 1.042 . . . . 6.62 112.528 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.5 mp0 -67.15 -42.03 85.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.408 2.283 . . . . 3.75 111.751 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -71.16 -34.37 70.91 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.036 -1.04 . . . . 4.09 111.667 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.71 -38.89 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 118.363 -0.827 . . . . 2.5 109.669 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -70.66 -41.85 71.55 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.859 -1.067 . . . . 3.43 111.748 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -54.51 -50.04 68.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.293 1.861 . . . . 2.5 110.752 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.44 -55.13 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.715 0.806 . . . . 2.26 111.821 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.86 62.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.959 0.904 . . . . 1.69 113.439 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -87.86 -30.26 20.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.675 1.59 . . . . 4.34 112.305 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.24 13.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.109 1.322 . . . . 1.68 111.206 168.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -76.96 -14.42 59.85 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.603 0.964 . . . . 3.41 113.603 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 76.77 62.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.112 2.165 . . . . 5.28 112.881 159.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.86 145.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.341 1.457 . . . . 3.68 111.979 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.74 135.88 40.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.02 0.914 . . . . 3.7 113.033 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -145.64 136.36 24.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.881 2.872 . . . . 5.68 108.077 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.3 t -121.25 105.08 39.99 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.097 0.959 . . . . 2.89 109.921 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.72 101.32 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.505 2.137 . . . . 3.13 108.845 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -66.67 148.36 50.51 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 119.617 -0.546 . . . . 2.28 113.052 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -67.96 146.7 72.24 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.039 2.492 . . . . 3.37 109.631 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -78.72 140.9 38.25 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.765 0.654 . . . . 5.43 112.765 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -150.84 165.76 32.61 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.506 1.523 . . . . 5.96 111.733 -159.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 60.98 -45.4 0.12 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 130.948 3.699 . . . . 7.7 114.612 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -163.98 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.002 2.121 . . . . 7.44 110.108 168.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -167.65 36.23 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.701 1.2 . . . . 7.13 113.634 -174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -135.4 172.83 12.45 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 119.329 -2.107 . . . . 5.31 113.187 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -164.21 168.17 19.19 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.275 1.43 . . . . 3.8 112.169 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.75 162.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.193 1.397 . . . . 2.62 109.019 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 t -128.18 137.68 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.791 2.037 . . . . 3.34 108.374 -169.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.96 119.2 21.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 107.049 -1.463 . . . . 4.51 107.049 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.17 131.6 54.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.747 -0.834 . . . . 2.02 108.747 168.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 56.7 m -53.24 -47.82 68.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.718 0.807 . . . . 3.6 112.566 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.5 mt 82.6 98.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.169 2.588 . . . . 3.8 108.339 -172.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.42 146.26 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.4 1.48 . . . . 3.17 107.146 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.1 ttm -119.47 128.54 54.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.794 1.638 . . . . 2.57 108.516 159.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -98.08 139.62 33.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.74 -0.6 . . . . 3.6 111.109 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.78 113.98 26.32 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.671 -1.233 . . . . 2.28 107.671 169.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 tp -106.28 125.84 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.922 -1.14 . . . . 4.15 107.922 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.49 165.21 48.01 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.604 -0.599 . . . . 1.66 111.604 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.34 48.64 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.507 3.471 . . . . 2.8 110.49 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -165.96 -50.51 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.077 1.751 . . . . 4.47 110.209 -156.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 151.49 -178.29 28.91 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 115.772 1.069 . . . . 3.21 115.772 166.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 50.33 -132.15 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.987 2.115 . . . . 4.72 114.225 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.36 131.49 54.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.147 0.979 . . . . 4.27 109.333 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.0 -29.18 23.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.056 0.943 . . . . 2.97 110.591 169.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -162.4 158.81 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.105 2.162 . . . . 2.21 109.428 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -134.59 99.28 4.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.021 1.391 . . . . 3.8 111.04 -170.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -95.53 110.96 22.96 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.177 -0.952 . . . . 2.62 110.1 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -75.34 -165.13 15.13 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.12 -1.192 . . . . 3.29 110.12 163.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -74.62 -26.19 59.73 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.749 -1.442 . . . . 3.54 112.309 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -46.96 -41.78 16.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 128.231 2.612 . . . . 6.34 117.479 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 151.57 33.76 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.051 1.741 . . . . 8.26 113.548 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.711 -1.243 . . . . 6.23 109.331 159.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.446 ' HE3' ' OE1' ' A' ' 182' ' ' GLN . 13.5 tmtt? -65.37 -44.72 86.73 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.709 -1.244 . . . . 1.91 113.672 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.55 -30.43 76.53 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 123.278 0.466 . . . . 1.72 112.398 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -63.66 -24.55 67.83 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.007 1.323 . . . . 2.84 113.489 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 13.8 mt -79.89 -30.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.901 1.228 . . . . 1.36 111.341 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.9 72.5 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.951 -1.093 . . . . 1.14 110.552 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.44 83.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.02 1.118 . . . . 1.43 114.02 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 70.9 p -63.57 -49.28 74.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.131 0.878 . . . . 1.32 111.137 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.91 -36.62 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.016 -1.052 . . . . 1.23 111.508 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.21 -6.18 4.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.721 1.209 . . . . 1.89 114.203 168.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 40.0 m -101.88 -44.38 5.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.843 1.657 . . . . 1.67 110.472 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -63.38 -28.23 69.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.636 1.174 . . . . 2.91 113.166 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -48.82 -40.84 30.8 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 125.988 1.715 . . . . 5.12 111.506 165.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -60.91 -40.44 74.52 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.414 -1.755 . . . . 6.1 112.829 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.6 -58.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.947 2.431 . . . . 1.87 113.525 163.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -83.78 8.86 13.4 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.81 1.781 . . . . 2.84 115.81 -165.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.28 153.67 2.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.734 2.014 . . . . 8.28 114.314 175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -66.25 -42.36 88.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.302 -1.332 . . . . 7.24 113.72 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -155.73 -94.38 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.981 2.512 . . . . 9.36 110.001 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.237 0.444 0 CA-C-O 116.775 -1.583 . . . . 8.06 109.424 134.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 118.12 -0.943 . . . . 14.86 109.913 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -76.76 77.85 3.38 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.902 0.774 . . . . 12.44 109.107 174.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -160.45 146.98 15.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.806 0.842 . . . . 10.88 110.065 -158.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.01 -81.77 1.72 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.108 0.861 . . . . 10.98 112.911 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -76.9 146.65 76.18 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 113.211 0.819 . . . . 11.09 113.211 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -69.95 160.48 49.49 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.376 2.051 . . . . 9.85 108.906 151.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tt -41.45 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.101 1.76 . . . . 7.74 113.79 -164.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.6 tp 60.43 156.42 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 128.127 2.571 . . . . 7.0 113.604 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.03 21.26 63.49 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 120.764 -1.21 . . . . 3.7 113.673 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.79 127.75 10.62 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.841 -1.533 . . . . 2.31 110.357 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.91 142.78 35.58 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.682 2.255 . . . . 2.88 111.435 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -93.87 168.13 11.18 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.595 -1.184 . . . . 2.41 111.663 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.6 m -140.6 78.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.109 1.364 . . . . 2.45 110.012 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.56 147.5 40.64 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.38 0.672 . . . . 1.92 111.234 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -75.91 131.84 39.9 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.291 2.236 . . . . 1.42 110.183 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.9 p -92.61 160.97 14.77 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.033 1.333 . . . . 1.93 112.162 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -64.91 -6.62 8.77 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.332 1.453 . . . . 1.38 114.638 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.2 m -66.75 -60.62 2.52 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.625 1.17 . . . . 2.87 109.093 162.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 160.13 0.48 0.07 OUTLIER Glycine 0 CA--C 1.534 1.255 0 N-CA-C 116.446 1.338 . . . . 2.55 116.446 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.34 165.48 33.93 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.751 1.775 . . . . 4.67 113.567 -170.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.72 120.78 25.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.819 2.448 . . . . 4.53 113.79 -167.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -99.63 171.58 7.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.228 1.411 . . . . 5.1 111.324 165.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.6 p -130.16 157.3 42.81 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.27 1.428 . . . . 2.16 110.176 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.6 -41.96 43.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.269 1.428 . . . . 3.54 111.455 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.56 -26.4 63.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.648 1.579 . . . . 8.16 113.765 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -80.06 -33.09 39.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.169 1.349 . . . . 3.01 112.193 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.72 -23.17 58.55 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.79 0.663 . . . . 2.94 112.79 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.63 131.69 51.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.852 1.261 . . . . 3.53 111.048 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 108.72 -25.42 19.25 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.522 1.534 . . . . 2.56 112.726 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -88.23 -152.47 0.22 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.575 1.55 . . . . 3.73 108.726 165.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.8 157.56 44.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.307 1.043 . . . . 2.28 110.659 163.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.14 152.96 28.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.915 0.864 . . . . 2.37 113.011 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.8 pp -106.52 155.15 19.9 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.825 1.25 . . . . 3.81 107.853 165.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.75 123.23 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.439 -0.949 . . . . 1.76 108.439 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -123.05 154.3 38.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.719 1.208 . . . . 2.9 111.677 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -108.84 116.7 32.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.845 0.858 . . . . 2.12 109.601 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.74 162.43 33.26 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.923 1.249 . . . . 2.48 113.585 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.08 -44.97 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 115.947 -1.978 . . . . 4.09 114.759 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t 136.95 177.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 131.426 3.89 . . . . 5.22 110.118 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 77.46 -15.27 0.76 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 127.841 2.456 . . . . 7.2 112.958 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.3 p -51.36 155.59 2.41 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 125.321 1.448 . . . . 2.52 112.179 155.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.88 74.44 5.52 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.642 2.894 . . . . 4.0 109.75 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 69.25 -7.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.665 2.386 . . . . 4.15 114.628 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 95.6 t -46.57 -55.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.854 2.462 . . . . 2.9 113.485 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.99 -67.49 0.52 Allowed Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 118.051 -0.976 . . . . 1.78 111.367 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.72 -40.63 21.63 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.944 1.763 . . . . 1.51 113.938 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -58.22 -43.33 87.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.869 1.213 . . . . 3.15 111.686 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -84.6 -34.46 23.14 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.232 -0.918 . . . . 3.18 112.931 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.6 -35.62 80.13 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.293 1.406 . . . . 3.65 112.082 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -47.73 -51.01 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.449 1.1 . . . . 3.35 111.226 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -60.88 -38.32 85.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.053 -1.029 . . . . 2.89 111.789 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -70.13 -41.47 73.87 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.386 -0.821 . . . . 5.08 112.702 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.47 -53.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.722 1.146 . . . . 1.66 109.048 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -55.65 -13.79 1.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.285 1.434 . . . . 4.07 114.573 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 t -97.99 -46.77 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.088 2.155 . . . . 2.0 112.942 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 21.3 m -62.25 -25.53 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.426 1.466 . . . . 3.52 112.311 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -70.88 -22.16 62.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.318 0.647 . . . . 4.13 112.68 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -79.71 -19.66 48.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.066 1.347 . . . . 2.56 111.789 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 43.3 mm -81.36 -58.97 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 1.8 109.746 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -32.86 74.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.15 1.78 . . . . 3.45 113.544 -170.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 t -69.49 -20.18 63.73 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.898 1.279 . . . . 3.24 112.87 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.2 mm -91.84 89.24 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.589 -1.319 . . . . 4.05 108.352 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.5 p -60.74 69.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.353 2.261 . . . . 5.52 113.76 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 175.73 -29.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.527 2.731 . . . . 4.26 111.777 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.15 159.07 68.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.605 0.762 . . . . 3.36 110.824 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.25 160.16 17.64 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.299 2.666 . . . . 3.29 109.486 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.0 134.76 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.167 0.508 . . . . 3.89 111.652 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -95.87 95.71 8.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.027 -1.471 . . . . 2.66 107.027 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 m -68.56 124.59 90.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 108.549 -0.908 . . . . 1.46 108.549 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.07 118.15 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.486 2.124 . . . . 0.89 110.476 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.79 121.08 43.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.273 1.429 . . . . 2.27 110.487 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.12 112.38 19.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.571 1.148 . . . . 3.15 110.216 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.67 110.11 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.045 1.338 . . . . 1.46 110.505 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 m -90.0 96.03 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.132 -0.98 . . . . 2.55 111.581 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.03 -2.77 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 116.359 1.985 . . . . 2.21 116.359 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -117.9 60.84 3.63 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 119.929 1.241 . . . . 4.13 110.572 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.1 149.25 40.95 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.178 2.585 . . . . 2.19 109.506 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 114.13 -43.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 129.682 3.193 . . . . 5.2 108.974 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -35.77 36.67 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.1 -0.375 . . . . 6.2 111.895 160.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.18 151.06 20.82 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.685 1.194 . . . . 4.59 110.964 167.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.4 p -132.42 154.76 49.52 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 124.819 1.248 . . . . 3.03 109.28 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -48.42 -43.24 34.06 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.561 1.144 . . . . 3.14 112.032 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -81.0 -26.07 36.76 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.082 1.141 . . . . 3.27 114.082 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.86 68.84 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.249 0.932 . . . . 1.53 110.266 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.5 mm -65.41 -36.08 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 117.706 -1.14 . . . . 1.96 110.816 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.2 66.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.784 1.629 . . . . 1.35 113.148 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -73.2 -49.53 27.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.378 0.671 . . . . 3.28 112.339 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.33 -41.04 65.33 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.94 -1.1 . . . . 2.92 112.088 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.485 HG21 ' HA3' ' A' ' 226' ' ' GLY . 25.5 t -62.96 -50.92 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.262 1.825 . . . . 1.82 112.294 172.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -59.34 -40.44 86.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.087 0.955 . . . . 3.97 111.248 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -33.22 71.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.481 1.512 . . . . 4.66 112.25 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.88 -13.21 61.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.049 1.129 . . . . 3.46 114.049 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.6 p 139.92 149.57 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 130.744 3.618 . . . . 2.53 111.816 168.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.26 5.65 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.36 2.706 . . . . 1.75 113.865 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.63 -24.74 23.85 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.769 1.168 . . . . 1.89 112.784 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.4 146.31 32.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.399 -1.438 . . . . 2.04 112.765 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.5 127.09 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.17 0.588 . . . . 2.13 111.862 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -99.68 129.94 10.06 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.81 110.813 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.2 113.62 26.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.264 -1.384 . . . . 1.96 107.264 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.4 m -141.15 68.84 1.34 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.633 1.573 . . . . 3.28 108.633 -164.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -91.15 -174.06 43.67 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.741 1.163 . . . . 1.73 112.405 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -75.79 163.32 27.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.918 1.287 . . . . 2.5 112.418 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.5 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 36.9 ttm180 -43.02 -31.58 0.55 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.255 2.622 . . . . 5.73 114.433 173.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -77.14 -38.02 52.76 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.957 1.303 . . . . 4.26 113.311 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.33 -45.99 85.45 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.102 -0.999 . . . . 3.97 109.145 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.5 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 19.5 m -70.16 -18.51 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.247 1.203 . . . . 2.84 114.247 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.14 -40.86 71.11 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.055 -1.028 . . . . 3.57 112.178 168.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -61.96 -50.86 70.44 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.883 -0.511 . . . . 2.65 111.565 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 234' ' ' VAL . 3.1 p -66.38 -24.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 120.359 -0.536 . . . . 1.85 112.195 -176.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.39 67.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.441 1.096 . . . . 2.41 112.025 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -36.7 63.82 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.47 0.915 . . . . 3.48 113.47 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.55 -26.51 65.45 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.972 1.471 . . . . 1.67 114.972 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.96 10.27 1.75 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.244 1.572 . . . . 3.01 115.244 -168.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 74.39 -58.68 0.58 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.252 2.621 . . . . 5.42 110.765 -165.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 55.8 t 63.58 -64.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 128.143 2.577 . . . . 3.56 111.185 -165.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 30.7 t80 58.38 62.11 2.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.572 1.549 . . . . 5.35 113.251 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -68.13 148.53 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.319 -0.863 . . . . 3.71 111.234 165.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 m -107.25 98.38 22.48 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 121.464 -0.772 . . . . 3.64 109.862 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -80.57 113.24 2.82 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.039 1.826 . . . . 2.59 112.172 -171.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.98 148.9 40.34 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 111.345 -0.702 . . . . 2.4 111.345 167.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.86 173.52 13.37 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.495 2.797 . . . . 3.45 111.589 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -66.22 122.88 18.46 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 118.538 -0.744 . . . . 5.06 109.913 161.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.73 167.19 30.78 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.208 1.559 . . . . 5.76 115.208 -165.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.261 14.1 tt0 48.96 -68.55 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 131.588 3.955 . . . . 7.16 115.81 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -153.97 57.21 0.73 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.898 1.679 . . . . 6.94 111.189 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 85.54 14.75 0.16 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.211 2.604 . . . . 5.64 113.118 169.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -70.05 174.21 5.66 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.693 -1.254 . . . . 3.9 111.135 165.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -162.3 76.16 0.46 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.098 2.559 . . . . 3.41 107.786 -168.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.303 0.2 OUTLIER -81.5 58.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.569 -1.332 . . . . 2.97 113.074 -158.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.76 130.5 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.281 1.432 . . . . 3.2 110.693 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.71 155.67 16.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.837 2.055 . . . . 3.61 112.482 169.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -131.98 81.56 1.97 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.086 0.954 . . . . 2.26 112.796 164.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -73.32 95.74 2.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.252 1.421 . . . . 4.59 111.826 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 158.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 116.062 1.875 . . . . 6.35 116.062 -174.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.4 tt -95.78 156.24 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 128.107 2.563 . . . . 3.91 109.761 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 35.8 ttm -96.99 145.82 25.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.785 1.234 . . . . 2.34 110.39 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -113.68 144.65 42.57 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.707 1.203 . . . . 3.8 112.275 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 13.6 tp -110.05 128.02 55.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.647 1.179 . . . . 2.09 108.689 165.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.89 143.04 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.557 -1.275 . . . . 1.77 107.557 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -108.56 176.31 20.05 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.142 0.877 . . . . 1.58 112.481 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 66.93 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.917 3.745 . . . . 2.58 109.053 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -160.22 -56.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.502 1.521 . . . . 4.27 110.487 -161.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 153.79 -134.4 4.34 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.504 0.573 . . . . 2.48 113.529 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.03 -39.76 69.49 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.849 1.426 . . . . 4.56 114.849 -150.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.4 p90 179.91 150.07 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.757 2.423 . . . . 5.05 109.225 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.91 -21.87 13.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.074 1.35 . . . . 3.59 111.505 164.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -152.46 163.16 40.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 2.6 112.234 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -158.12 131.86 7.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.727 2.011 . . . . 5.68 110.609 172.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.87 154.94 30.61 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.14 -0.975 . . . . 3.14 112.286 -171.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.66 163.17 40.21 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 122.114 0.841 . . . . 2.96 112.762 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -68.23 114.11 6.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.827 -1.546 . . . . 4.99 106.827 150.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 155.76 -14.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 129.619 3.168 . . . . 5.08 113.341 -165.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -90.41 130.94 36.43 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.966 -1.084 . . . . 4.69 113.118 -171.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -72.61 122.72 21.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.771 1.228 . . . . 6.91 108.338 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.61 -55.24 1.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.531 2.049 . . . . 2.33 116.531 -155.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -60.58 -17.16 47.61 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.427 1.013 . . . . 1.32 114.918 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.18 -30.0 70.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.479 1.14 . . . . 3.48 112.644 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.5 mt -82.76 -41.8 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.982 0.913 . . . . 1.23 108.947 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.1 -41.32 64.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.39 0.541 . . . . 1.19 112.093 168.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.49 -43.45 94.1 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.145 1.165 . . . . 1.56 114.145 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.8 p -68.53 -41.84 79.3 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.29 1.405 . . . . 1.73 111.582 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 38.2 mt -56.39 -52.39 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.374 0.988 . . . . 1.55 110.829 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.81 65.15 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.235 0.828 . . . . 1.98 113.235 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 88.7 m -70.84 -48.23 55.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.98 1.312 . . . . 1.96 110.75 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -67.16 -29.38 69.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.425 1.011 . . . . 2.57 113.434 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -19.8 63.06 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.465 1.506 . . . . 6.47 114.135 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -71.79 -45.45 12.25 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.499 -1.715 . . . . 6.08 114.157 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.45 -58.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.373 2.715 . . . . 2.12 111.722 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -85.86 119.94 26.72 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.364 -0.835 . . . . 2.98 110.916 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? 89.02 -87.05 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.625 2.37 . . . . 10.94 112.904 163.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -155.38 120.66 4.91 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.093 1.357 . . . . 6.95 113.113 -166.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 151.17 37.83 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.74 2.126 . . . . 10.72 116.74 -173.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.482 1.156 0 C-N-CA 125.1 1.36 . . . . 11.62 109.053 147.379 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 117.76 -1.114 . . . . 16.66 109.901 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -163.15 167.06 22.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.1 1.36 . . . . 13.57 110.044 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -171.84 166.01 6.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.1 2.56 . . . . 12.14 108.716 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.26 -172.1 34.51 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.738 1.161 . . . . 9.69 113.18 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -126.91 121.82 23.11 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.403 1.081 . . . . 9.19 110.817 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.86 139.11 42.55 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.423 2.082 . . . . 6.64 109.595 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 tt -173.93 153.25 2.1 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.884 2.474 . . . . 6.68 107.806 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.6 mt -127.08 146.79 50.24 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.449 1.5 . . . . 6.71 108.258 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.7 -131.81 26.47 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.315 -0.714 . . . . 3.37 111.315 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 134.09 165.4 10.96 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.135 1.826 . . . . 2.26 112.929 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.05 159.45 53.87 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.774 2.983 . . . . 2.51 111.762 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -138.98 172.04 13.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.875 1.27 . . . . 2.36 110.779 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 p -141.12 18.94 2.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.506 1.669 . . . . 2.58 115.506 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.83 154.89 41.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.933 1.349 . . . . 1.92 114.396 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.9 m -91.68 147.2 23.17 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.628 1.171 . . . . 1.51 109.149 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.8 p -78.89 156.11 28.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.087 1.355 . . . . 2.55 112.549 -173.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -50.68 -25.7 4.59 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 113.906 -1.497 . . . . 2.08 113.427 162.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.0 m -72.97 -64.78 0.9 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.207 1.803 . . . . 3.24 109.513 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.01 55.0 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.488 1.518 . . . . 2.78 112.645 -169.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.22 144.84 9.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.803 2.041 . . . . 3.7 108.335 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -89.85 126.11 35.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.706 1.139 . . . . 4.93 112.047 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -112.68 162.94 15.14 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.473 -1.392 . . . . 3.1 112.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.6 p -136.04 -179.21 5.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.648 1.979 . . . . 2.59 109.784 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -68.54 -22.21 64.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.218 1.007 . . . . 4.38 112.668 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -32.2 66.95 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.865 1.061 . . . . 5.27 113.865 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.14 -37.95 84.69 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.926 1.29 . . . . 3.19 111.435 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -107.84 20.99 18.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.557 1.543 . . . . 3.66 114.284 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -80.46 167.58 19.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.379 -0.826 . . . . 3.23 110.59 167.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.89 14.21 75.74 Favored Glycine 0 N--CA 1.478 1.499 0 O-C-N 120.663 -1.273 . . . . 2.75 114.348 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -162.17 151.52 15.84 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.675 2.79 . . . . 2.81 106.743 -172.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -71.76 129.57 38.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.932 1.242 . . . . 1.67 111.647 -173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.57 133.52 53.78 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.525 1.13 . . . . 2.69 110.911 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.24 126.42 53.58 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.86 1.264 . . . . 2.7 108.415 165.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.9 mt -120.35 119.39 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.479 -0.934 . . . . 1.96 108.479 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -113.29 141.36 47.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 3.22 111.559 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -108.32 126.76 53.21 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.981 0.912 . . . . 2.21 111.802 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.486 ' HA3' ' SG ' ' A' ' 173' ' ' CYS . . . -169.95 -179.77 41.79 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.319 1.438 . . . . 1.33 113.605 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.76 137.91 26.8 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.014 1.407 . . . . 3.74 112.333 -177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.8 t -74.97 70.6 2.01 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.761 1.267 . . . . 3.43 112.249 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.4 -31.25 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.107 0.963 . . . . 7.6 111.138 -149.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 14.1 m -47.9 143.13 6.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.732 1.213 . . . . 2.06 112.316 161.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.88 -59.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.971 2.448 . . . . 3.96 109.999 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.15 137.99 21.23 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.426 -0.953 . . . . 5.37 108.426 136.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.4 t -162.21 -55.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.553 3.141 . . . . 3.14 107.283 169.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.486 ' SG ' ' HA3' ' A' ' 165' ' ' GLY . 1.7 m -57.3 -65.31 1.83 Allowed Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.775 1.63 . . . . 1.61 113.237 173.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 173' ' ' CYS . 51.3 Cg_exo -53.64 -44.97 44.48 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.957 2.438 . . . . 1.86 114.73 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -47.98 -46.11 32.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.067 1.747 . . . . 3.75 112.067 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 281' ' ' LYS . 1.2 mm-40 -77.5 -40.3 43.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.791 1.178 . . . . 2.64 112.829 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.7 76.6 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.063 -1.023 . . . . 2.86 111.997 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.07 -59.6 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.618 1.967 . . . . 3.38 110.223 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -62.84 -37.61 87.48 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.541 -1.349 . . . . 4.79 111.346 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.66 -27.28 64.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.493 1.117 . . . . 4.22 113.642 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.8 mm -69.05 -55.58 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 120.005 1.275 . . . . 2.14 109.972 171.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -68.29 -17.99 64.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.771 1.623 . . . . 4.85 111.724 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.53 -44.59 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.553 1.07 . . . . 1.57 111.007 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.31 -27.19 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 121.081 1.764 . . . . 2.46 112.88 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.74 -48.3 55.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.952 1.701 . . . . 4.42 113.278 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.73 -32.89 72.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.329 -0.857 . . . . 3.37 112.341 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.83 -50.39 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.931 0.892 . . . . 2.26 111.424 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.38 -22.71 57.29 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.672 1.124 . . . . 5.59 112.747 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.3 m -65.08 -11.45 39.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.287 -0.883 . . . . 3.24 113.268 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.95 -20.23 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 4.17 111.179 164.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.295 70.3 p 128.77 -11.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 1 C-N-CA 132.475 4.31 . . . . 6.32 115.337 152.585 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 t -178.77 71.4 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.065 1.346 . . . . 3.98 112.042 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.97 158.71 52.78 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 121.181 -0.949 . . . . 3.5 111.628 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.86 -9.85 18.2 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.789 2.326 . . . . 3.41 111.912 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . 0.269 17.5 t0 100.81 152.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 130.398 3.479 . . . . 4.21 114.058 162.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 134.12 55.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.175 1.79 . . . . 2.01 112.074 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.7 m -110.42 121.36 41.59 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.946 1.298 . . . . 1.28 109.796 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -89.3 126.43 1.6 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.941 3.094 . . . . 0.94 110.74 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.3 106.29 12.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.519 1.928 . . . . 2.53 110.783 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 115.24 26.17 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.51 -0.744 . . . . 2.88 109.681 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -89.61 112.21 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.198 0.999 . . . . 1.78 109.502 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 6.2 t -71.25 122.23 19.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.755 -0.657 . . . . 1.77 109.908 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.0 pt -106.79 48.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.806 1.642 . . . . 2.24 109.662 162.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -104.54 31.41 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.258 1.823 . . . . 4.27 113.39 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.63 -17.89 56.94 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 124.331 3.354 . . . . 2.62 114.234 -162.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -62.81 -23.95 67.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.944 1.298 . . . . 5.55 113.331 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.0 8.91 0.66 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 116.209 1.929 . . . . 6.76 116.209 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -42.11 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.881 3.272 . . . . 4.64 115.462 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.3 m -88.83 125.51 34.94 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 120.801 -1.187 . . . . 2.46 108.761 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -41.09 65.71 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.835 0.854 . . . . 4.2 113.176 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -73.76 -43.03 60.21 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-O 117.306 -1.33 . . . . 5.75 112.699 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.25 60.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.4 1.909 . . . . 1.69 112.621 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.08 -32.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 118.465 -0.779 . . . . 2.4 112.4 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.64 88.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.473 1.488 . . . . 1.36 111.352 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.93 -54.64 44.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.747 1.619 . . . . 3.8 108.698 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -47.88 -48.44 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.307 0.958 . . . . 3.27 112.9 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.9 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.072 0.851 . . . . 1.23 111.847 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -19.79 63.26 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.293 1.22 . . . . 5.23 114.293 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -69.69 -24.66 63.62 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.347 0.976 . . . . 3.68 112.171 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -89.46 -72.8 0.54 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 2.85 112.571 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 85.8 p -173.51 153.26 2.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 120.711 -1.243 . . . . 2.03 112.869 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.62 -1.68 11.41 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.167 2.578 . . . . 2.09 114.518 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -95.2 2.4 54.95 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.096 1.316 . . . . 2.19 112.573 170.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.0 tp -89.73 139.74 30.27 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.715 -1.241 . . . . 2.0 110.424 173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.29 136.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.512 1.125 . . . . 3.02 108.814 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.73 150.79 18.24 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 124.187 0.898 . . . . 1.24 110.996 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.0 155.98 35.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.987 1.315 . . . . 2.27 110.491 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.6 p -129.1 169.71 14.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.615 2.366 . . . . 2.46 109.484 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.96 148.47 14.23 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 115.879 1.112 . . . . 2.14 115.879 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -62.47 143.29 57.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.662 -0.769 . . . . 2.07 109.395 162.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.31 -21.85 66.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.194 1.183 . . . . 7.39 114.194 -161.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.4 mp0 -65.24 -45.36 84.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.645 1.578 . . . . 2.67 111.133 170.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -81.81 -33.9 30.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.905 1.282 . . . . 3.41 111.71 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.05 -36.77 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 118.605 -0.712 . . . . 1.91 111.179 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.38 -45.95 88.7 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.667 -1.158 . . . . 2.91 109.765 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -50.36 -54.21 23.39 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.291 1.405 . . . . 2.43 112.337 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.21 -38.88 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.931 1.241 . . . . 2.27 113.321 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.19 -34.28 77.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.649 0.779 . . . . 1.79 112.296 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -88.98 -32.63 17.54 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.791 2.437 . . . . 3.39 113.198 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.19 70.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.566 1.075 . . . . 1.79 110.537 165.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -85.16 9.7 14.25 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.406 1.082 . . . . 2.75 112.946 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 35.81 46.81 0.35 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.58 2.752 . . . . 4.82 115.053 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.95 136.38 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 109.386 -0.598 . . . . 3.08 109.386 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.22 129.64 37.82 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.174 -0.328 . . . . 4.03 111.352 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.27 108.53 0.73 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.36 1.864 . . . . 4.24 109.764 -160.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 149.7 37.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.062 1.134 . . . . 3.58 114.062 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.23 148.77 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.474 2.782 . . . . 4.73 110.812 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -110.75 165.08 12.15 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.852 1.215 . . . . 4.05 114.265 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -79.4 -176.03 3.05 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 125.015 3.81 . . . . 3.93 111.829 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 250' ' ' LYS . 21.0 mmmt -114.72 130.91 56.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.081 1.752 . . . . 5.44 111.046 164.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.6 p30 173.19 -39.66 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.196 2.198 . . . . 6.38 109.79 -165.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.14 156.33 37.47 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.671 0.748 . . . . 8.33 110.612 136.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -86.58 -37.67 17.9 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.572 0.749 . . . . 7.89 111.209 -161.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.303 2.1 tp10 -169.14 45.5 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.603 2.361 . . . . 8.64 112.665 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -121.99 163.0 20.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.362 1.465 . . . . 4.88 108.593 149.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -149.49 149.17 30.34 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.144 -0.687 . . . . 5.81 109.144 131.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 20.7 tt -72.75 76.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.552 -1.343 . . . . 3.35 110.45 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.7 t -44.94 130.86 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 127.104 2.162 . . . . 2.86 112.726 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -70.26 137.41 50.77 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.732 1.213 . . . . 4.24 111.707 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.12 137.63 19.83 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.865 -1.061 . . . . 1.71 109.703 163.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t -64.23 -24.01 67.51 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.145 1.165 . . . . 3.93 114.145 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.269 0.7 OUTLIER 67.12 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 128.789 2.836 . . . . 4.03 112.966 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.27 145.29 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.129 -1.607 . . . . 3.15 112.766 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 140.81 32.9 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 127.318 2.247 . . . . 2.95 109.638 164.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.65 145.08 41.86 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.732 0.813 . . . . 3.18 112.501 154.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.6 tp -100.51 130.69 46.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.012 1.725 . . . . 1.95 110.019 168.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.62 133.63 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.672 -1.973 . . . . 2.06 105.672 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 -177.48 19.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.168 -0.373 . . . . 1.87 112.168 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.41 42.77 1.36 Allowed 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.742 2.961 . . . . 2.97 110.818 172.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -177.76 -67.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.837 2.455 . . . . 5.2 111.009 -163.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -135.67 142.0 13.26 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 114.704 0.642 . . . . 3.89 114.704 -158.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -86.75 161.21 18.52 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.395 1.478 . . . . 7.23 114.467 -173.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 63.0 53.2 2.4 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.372 1.869 . . . . 4.2 111.974 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 55.5 tp -92.11 -33.46 14.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.564 1.146 . . . . 2.58 112.645 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -162.31 163.34 28.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.045 1.738 . . . . 2.29 109.734 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.66 142.73 11.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.164 0.985 . . . . 4.14 113.604 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -140.2 136.23 33.21 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.125 -0.985 . . . . 3.15 112.22 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.54 -171.27 45.04 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.913 -0.875 . . . . 2.6 110.913 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.59 139.44 58.77 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.505 -1.294 . . . . 3.5 107.505 147.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 14.3 t30 149.29 -59.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 129.292 3.037 . . . . 4.88 108.233 -171.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -72.85 158.36 35.68 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.56 0.578 . . . . 7.87 112.56 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -100.44 177.54 5.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.824 1.25 . . . . 5.64 110.541 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -53.25 -48.77 67.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.736 1.214 . . . . 1.78 113.803 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.74 86.08 Favored Glycine 0 N--CA 1.469 0.857 0 CA-C-N 118.416 0.553 . . . . 1.42 112.272 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.92 -28.8 64.77 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.692 1.197 . . . . 3.04 112.785 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.5 mt -69.31 -33.21 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.611 -0.681 . . . . 1.87 110.717 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -79.5 -49.47 12.22 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.063 0.847 . . . . 1.54 112.108 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.21 -32.26 73.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.778 1.231 . . . . 1.37 113.938 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.7 p -58.68 -61.62 2.47 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.095 0.958 . . . . 1.39 111.221 167.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.0 mt -52.78 -45.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.898 1.279 . . . . 1.37 111.357 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.16 -5.77 24.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.257 1.423 . . . . 1.64 114.209 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.3 m -89.11 -54.89 3.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.102 0.961 . . . . 1.66 108.732 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.54 -27.55 26.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.654 1.582 . . . . 2.61 114.321 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -51.03 -22.5 2.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.884 2.473 . . . . 4.21 114.779 170.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -98.8 -36.69 0.24 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.811 2.044 . . . . 6.39 116.387 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.36 -32.91 2.74 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.151 2.567 . . . . 2.57 111.729 166.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 -171.88 2.15 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.49 0.586 . . . . 3.27 110.008 149.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -167.23 175.35 7.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.64 1.576 . . . . 8.13 110.576 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -60.27 131.27 50.26 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.378 -1.452 . . . . 7.81 112.709 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -66.02 -33.73 76.48 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.891 0.876 . . . . 9.38 112.302 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 C--O 1.245 0.829 1 C-N-CA 133.082 4.553 . . . . 11.05 106.422 -158.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 117.451 -1.261 . . . . 14.66 108.821 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -73.96 80.17 1.67 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 120.609 1.549 . . . . 14.58 108.593 163.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.3 p -159.65 122.96 3.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.87 1.668 . . . . 12.19 109.221 -162.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.25 164.01 39.61 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.051 0.834 . . . . 9.69 113.649 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -172.64 148.58 1.82 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.259 1.424 . . . . 11.11 111.011 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.07 126.1 17.24 Favored 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 107.484 -1.775 . . . . 7.01 107.484 155.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.75 39.66 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.506 1.122 . . . . 7.88 111.295 -166.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.44 54.62 2.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.982 1.313 . . . . 6.01 109.612 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.44 -165.9 48.86 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 111.181 -0.768 . . . . 3.33 111.181 -154.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -150.06 130.51 3.3 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 118.648 -1.085 . . . . 2.55 112.661 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -69.47 160.14 50.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.027 2.484 . . . . 2.7 110.772 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -128.85 -155.08 0.68 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.399 1.48 . . . . 2.69 110.57 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -160.17 147.21 16.11 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.801 -1.187 . . . . 3.46 109.659 148.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 tp -156.82 167.27 30.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.049 0.94 . . . . 2.97 110.054 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -109.63 140.51 43.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.732 0.813 . . . . 2.43 110.41 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.1 p -72.08 164.86 25.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.446 1.098 . . . . 2.28 111.396 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -57.58 -12.49 2.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.96 2.504 . . . . 1.63 114.15 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 t -119.83 16.79 12.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.233 2.213 . . . . 3.26 112.537 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.79 -17.32 36.56 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 116.762 1.465 . . . . 2.31 116.762 164.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.28 140.98 55.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.464 1.632 . . . . 4.06 109.808 168.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.26 135.29 56.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.45 1.5 . . . . 8.81 108.694 167.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -142.2 119.09 11.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.025 -1.672 . . . . 3.25 112.705 170.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 94.4 m -132.37 143.26 49.72 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 127.582 2.353 . . . . 3.19 107.336 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.77 -29.3 70.04 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.193 0.997 . . . . 5.64 113.373 -174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 5.21 50.51 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.199 1.555 . . . . 7.81 115.199 174.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -41.47 6.57 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.738 0.699 . . . . 2.83 112.165 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.9 40.46 1.0 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.265 0.839 . . . . 6.38 113.265 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 tp -83.88 169.8 14.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.049 1.34 . . . . 3.33 112.898 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.82 -12.93 51.05 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.368 -1.457 . . . . 2.57 114.798 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 175.62 5.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.111 2.964 . . . . 3.81 109.916 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -88.97 80.31 7.1 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.023 1.283 . . . . 2.18 113.017 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.3 mt -67.29 140.67 57.33 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.849 0.86 . . . . 2.81 112.753 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 28.1 tp -139.16 108.74 6.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.113 1.765 . . . . 2.38 108.518 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.21 131.88 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.305 1.042 . . . . 1.89 108.515 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -128.16 155.42 44.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.681 1.192 . . . . 2.59 109.284 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -121.28 115.82 23.7 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.106 0.963 . . . . 2.22 109.063 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.22 176.12 21.52 Favored Glycine 0 N--CA 1.467 0.708 0 CA-C-O 122.452 1.029 . . . . 1.5 115.139 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -93.95 138.0 32.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.105 0.962 . . . . 3.25 109.9 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -70.54 14.05 0.15 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.338 -0.851 . . . . 3.91 111.872 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -141.81 -73.19 0.32 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.419 -1.425 . . . . 8.56 108.914 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 1.8 t 70.11 174.71 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.793 2.037 . . . . 2.82 111.817 -174.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.403 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 31.9 Cg_endo -67.63 -73.17 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.659 2.906 . . . . 3.85 109.623 143.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.68 16.65 0.08 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.462 1.505 . . . . 4.73 113.08 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.409 HG12 HE22 ' A' ' 279' ' ' GLN . 92.1 t -84.95 -49.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 119.894 -1.754 . . . . 2.86 110.715 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 64.4 m -50.77 -44.54 85.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 116.356 -1.783 . . . . 1.49 114.387 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.01 -34.82 57.48 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 122.57 1.953 . . . . 1.16 113.048 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.88 -38.27 76.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.568 1.531 . . . . 3.2 111.868 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.27 -34.67 73.07 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.314 -1.491 . . . . 3.15 112.665 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.5 tp -68.88 -42.95 76.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.363 1.065 . . . . 2.98 111.067 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.51 -45.34 66.18 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.255 1.422 . . . . 3.35 111.543 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -53.78 -59.61 4.39 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.631 -1.293 . . . . 3.15 111.863 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 5.7 ptp -64.84 -34.53 78.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.361 -0.837 . . . . 2.34 113.194 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -60.86 -52.91 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 118.108 -0.948 . . . . 1.8 110.734 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.416 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 43.1 mt-30 -68.11 -25.63 65.4 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.753 1.615 . . . . 3.77 110.692 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.51 -41.13 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.05 -0.976 . . . . 1.73 112.634 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.91 -31.87 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.827 1.194 . . . . 2.56 112.217 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.15 -42.85 99.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.265 1.426 . . . . 4.22 111.951 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.15 -54.87 23.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.557 1.543 . . . . 3.04 112.214 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.41 -35.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.556 0.947 . . . . 2.52 113.556 -163.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.03 -37.32 74.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.166 0.986 . . . . 3.53 111.099 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -68.18 -15.46 63.59 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.114 -0.991 . . . . 2.58 112.946 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.15 -0.05 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 119.838 -1.789 . . . . 2.94 111.651 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.0 m 77.28 -24.08 0.23 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.045 1.498 . . . . 4.08 115.045 144.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.474 HG21 ' HG2' ' A' ' 298' ' ' ARG . 61.8 m -102.65 -0.04 32.47 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.174 1.352 . . . . 4.27 112.133 164.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.27 124.86 91.38 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.206 -1.405 . . . . 3.4 107.206 157.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 -26.43 23.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.414 1.409 . . . . 3.82 109.934 160.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.43 175.5 3.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.956 1.702 . . . . 4.0 112.499 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 16.9 tp -137.44 117.64 13.54 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.368 -2.086 . . . . 1.7 105.368 143.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.2 m -103.06 106.55 51.43 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 119.778 1.172 . . . . 1.31 110.746 -172.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.14 117.08 4.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.642 2.228 . . . . 0.86 111.292 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 12.1 tp -99.86 94.71 6.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.675 2.39 . . . . 2.28 108.58 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -84.04 104.22 13.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.835 -0.802 . . . . 2.49 108.835 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 44.0 mm -79.48 110.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.575 -0.898 . . . . 1.88 108.575 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 75.7 m -82.16 114.17 20.5 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.132 -0.98 . . . . 3.04 111.001 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.19 2.05 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.095 1.517 . . . . 1.74 115.095 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.01 69.63 1.18 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.756 1.223 . . . . 2.97 110.722 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -79.02 38.14 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.508 3.472 . . . . 2.47 111.501 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -136.4 144.63 44.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.475 2.31 . . . . 3.8 105.566 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.95 -37.13 0.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.696 1.599 . . . . 5.06 112.829 -172.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -68.82 161.91 27.53 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.841 1.656 . . . . 4.56 111.595 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.73 152.41 51.74 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.469 1.128 . . . . 3.49 109.568 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -67.27 -21.27 65.72 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.257 0.836 . . . . 5.65 113.257 -167.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 0.5 OUTLIER -101.12 -19.89 15.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.879 2.472 . . . . 3.91 113.298 171.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.81 95.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.184 1.811 . . . . 1.58 110.893 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.69 -35.06 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.694 0.627 . . . . 3.26 112.694 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.39 -21.51 62.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.165 1.172 . . . . 1.96 114.165 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -79.21 -44.7 21.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.136 0.974 . . . . 3.94 111.102 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -43.9 72.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.542 1.137 . . . . 3.8 111.435 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.4 t -54.6 -44.1 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.731 1.212 . . . . 1.75 112.548 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.25 -35.16 73.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.988 -1.006 . . . . 6.93 112.972 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.22 -47.83 72.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.555 1.142 . . . . 3.39 111.933 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -83.74 -36.67 23.47 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.628 1.344 . . . . 2.7 114.628 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.0 m 154.05 137.31 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 129.451 3.101 . . . . 2.05 112.277 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.19 -8.08 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.037 2.492 . . . . 1.92 114.706 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -78.64 -11.88 59.99 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.584 1.083 . . . . 2.25 112.939 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.65 114.09 23.07 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.387 1.475 . . . . 2.6 107.765 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 18.6 m -96.93 131.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.998 -0.438 . . . . 2.44 110.467 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.54 105.7 2.91 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.733 1.158 . . . . 1.09 111.838 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.34 127.25 37.75 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.768 1.227 . . . . 2.66 110.064 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.2 p -151.15 140.8 21.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.094 1.758 . . . . 3.25 111.374 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.96 -139.64 2.87 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.159 0.885 . . . . 1.85 111.576 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.55 159.06 31.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.159 1.784 . . . . 3.62 110.499 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -65.17 -36.31 83.8 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.103 -0.373 . . . . 6.53 110.331 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -49.9 -55.51 14.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.584 2.354 . . . . 2.99 111.473 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -71.44 -26.98 62.96 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.858 -1.151 . . . . 4.3 113.531 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.55 -38.01 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.358 1.463 . . . . 2.32 110.61 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.39 -32.84 58.79 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.767 1.227 . . . . 5.22 109.884 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -60.16 -57.68 11.78 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.121 -0.942 . . . . 2.6 110.326 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.59 -33.51 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.608 1.095 . . . . 2.24 112.322 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.11 -54.3 36.06 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.741 -0.599 . . . . 1.62 110.64 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -70.07 -33.75 72.3 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 117.846 -1.073 . . . . 4.23 112.502 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.06 93.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.557 1.143 . . . . 1.65 113.017 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.83 2.75 55.86 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.69 1.196 . . . . 2.66 114.045 173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 77.32 24.17 0.84 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.249 2.62 . . . . 4.69 114.799 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.0 140.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.88 1.272 . . . . 2.58 110.747 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -110.07 138.28 46.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.23 1.012 . . . . 4.16 112.554 164.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.56 175.38 10.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.479 1.912 . . . . 3.67 110.456 162.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -163.26 150.65 10.93 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.4 1.08 . . . . 3.62 112.2 165.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.24 165.08 26.16 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.667 2.911 . . . . 2.97 110.755 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.19 153.43 52.92 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.185 0.898 . . . . 2.43 113.963 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -85.74 2.17 7.73 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.196 3.264 . . . . 4.86 115.209 -173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.493 ' HZ1' ' CD ' ' A' ' 254' ' ' GLU . 0.9 OUTLIER 67.33 46.02 1.52 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 120.591 1.541 . . . . 5.27 113.127 -176.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -77.38 160.6 28.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.022 1.729 . . . . 8.49 112.083 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 61.05 -58.74 0.09 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 129.391 3.076 . . . . 8.58 113.518 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 175.41 -32.5 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 130.381 3.472 . . . . 8.84 111.248 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.493 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 9.2 tp10 -137.91 45.91 2.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.685 1.194 . . . . 6.18 112.794 -172.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -75.38 138.36 41.67 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.751 0.786 . . . . 7.35 112.049 157.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -149.32 71.73 1.13 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.854 -1.066 . . . . 3.61 109.52 148.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.4 tp -67.14 175.52 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 O-C-N 121.667 -0.646 . . . . 3.08 111.495 165.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -167.45 75.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 119.316 -2.115 . . . . 4.35 108.972 -157.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -111.81 142.63 43.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.055 0.931 . . . . 5.53 111.305 -153.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -145.81 125.05 12.95 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.178 1.177 . . . . 1.88 114.178 -158.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 53.0 m -84.77 -48.82 9.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.017 0.927 . . . . 4.21 109.666 168.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.323 0.2 OUTLIER 43.36 -150.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.828 1.651 . . . . 6.34 113.622 -174.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 8.8 tt -179.58 161.86 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 129.089 2.956 . . . . 4.3 107.412 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 57.5 mtp -119.52 139.44 52.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.961 1.304 . . . . 2.0 109.957 158.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -120.63 136.72 54.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.94 0.896 . . . . 3.57 110.989 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.0 tt -102.22 118.99 38.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.603 1.561 . . . . 2.16 107.968 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.4 135.21 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.129 0.972 . . . . 1.94 109.326 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.16 147.9 50.42 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.108 -1.197 . . . . 1.68 110.108 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 62.1 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.013 3.142 . . . . 3.36 109.066 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -174.28 -66.67 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 5.1 110.977 -150.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -156.11 -68.77 0.01 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 117.289 1.676 . . . . 3.42 117.289 -157.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.43 -178.42 7.32 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.723 1.609 . . . . 6.23 109.667 -168.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -70.52 145.73 50.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.143 1.164 . . . . 3.47 114.143 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -132.1 1.99 3.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.372 1.469 . . . . 2.44 113.073 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -160.36 144.21 13.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.104 1.761 . . . . 2.82 108.128 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -154.2 147.13 24.46 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.712 1.205 . . . . 3.85 110.664 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.27 147.28 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.083 1.353 . . . . 3.06 107.806 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -81.87 -152.21 9.77 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 109.485 -1.446 . . . . 3.92 109.485 167.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.409 HE22 HG12 ' A' ' 172' ' ' VAL . 3.0 mt-30 -79.91 67.02 5.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.675 -1.231 . . . . 5.33 107.675 151.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.6 153.63 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.22 2.208 . . . . 5.27 112.657 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 89.19 123.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.411 2.284 . . . . 4.87 107.569 -139.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.1 mtt85 -81.15 -177.4 6.44 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.769 -1.197 . . . . 6.09 107.769 158.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -61.4 -40.26 93.73 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.539 -1.35 . . . . 1.85 113.757 -171.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.58 -38.39 94.62 Favored Glycine 0 N--CA 1.473 1.103 0 O-C-N 121.467 -0.77 . . . . 1.7 112.022 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.19 -16.34 63.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.859 1.263 . . . . 3.19 113.471 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.42 -46.96 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.957 -1.089 . . . . 1.37 110.841 169.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.69 79.02 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.291 -0.881 . . . . 1.2 112.015 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.68 -31.83 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.866 1.061 . . . . 1.46 113.866 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.9 p -75.5 -41.92 54.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.62 1.1 . . . . 1.51 111.372 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.39 -43.63 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.143 0.883 . . . . 1.82 111.458 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.02 68.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.928 0.891 . . . . 1.41 113.249 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.2 m -76.6 -52.19 10.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.274 1.029 . . . . 1.64 109.978 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -61.2 -34.13 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 2.07 112.378 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.6 ttt -55.66 -33.67 64.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.221 1.008 . . . . 4.53 111.754 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -58.72 -54.35 57.17 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 116.145 -1.883 . . . . 4.4 112.605 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.68 -51.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.8 3.0 . . . . 2.1 113.136 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -74.24 14.35 0.45 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.046 1.128 . . . . 3.15 114.046 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.474 ' HG2' HG21 ' A' ' 192' ' ' THR . 5.5 ttp-105 -57.44 110.3 0.84 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.923 1.689 . . . . 8.65 112.689 -163.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -71.19 -7.71 48.61 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.484 2.031 . . . . 9.92 116.484 -157.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.72 -15.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 117.602 2.445 . . . . 8.06 117.602 171.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.483 1.198 0 C-N-CA 125.281 1.432 . . . . 7.0 111.798 -174.483 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 118.0 -1.0 . . . . 20.25 109.999 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -78.05 -167.37 1.0 Allowed 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.475 0.58 . . . . 15.45 109.701 156.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.1 t -141.75 -178.88 5.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.238 1.415 . . . . 12.45 110.982 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.07 175.41 50.04 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.878 1.227 . . . . 10.75 113.806 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -76.33 148.39 80.57 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 121.535 -0.979 . . . . 9.6 110.806 170.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 106.24 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.033 1.822 . . . . 7.33 109.492 170.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 73.92 -32.53 0.24 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.677 2.391 . . . . 10.85 114.116 171.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.56 80.04 1.97 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.809 1.244 . . . . 6.8 110.871 -176.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.26 123.89 4.18 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.366 1.936 . . . . 3.46 112.367 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -133.4 117.52 1.92 Allowed Glycine 0 CA--C 1.536 1.398 0 CA-C-O 117.332 -1.816 . . . . 2.35 110.74 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.99 168.26 15.58 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.663 2.909 . . . . 2.41 112.733 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -135.62 150.7 49.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 2.91 111.174 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -141.08 75.4 1.5 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.605 -1.309 . . . . 2.24 111.63 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.93 153.38 32.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 3.46 112.41 -166.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.2 m -79.72 128.22 33.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.822 1.249 . . . . 1.46 108.475 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.8 t -80.35 146.51 31.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.979 0.912 . . . . 2.59 110.843 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -56.02 -19.89 14.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.644 2.378 . . . . 1.63 114.598 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.3 t -72.12 -38.98 69.17 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 118.232 -0.89 . . . . 3.09 112.153 170.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 116.41 70.12 0.44 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.724 1.631 . . . . 2.51 113.084 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.91 159.53 15.92 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.176 2.19 . . . . 4.06 107.635 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -109.55 123.69 49.84 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 121.193 1.815 . . . . 5.33 111.4 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -114.55 159.4 20.44 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.833 1.049 . . . . 4.29 113.833 175.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 m -139.7 158.15 44.59 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.181 2.592 . . . . 2.86 106.863 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.98 -39.31 81.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.175 0.99 . . . . 4.35 113.541 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.21 -13.06 58.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.826 1.417 . . . . 6.97 114.826 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -77.21 -47.11 21.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.214 0.915 . . . . 4.37 110.168 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.25 -33.99 55.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.932 1.293 . . . . 3.49 111.469 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 157' ' ' GLY . 0.6 OUTLIER 73.38 149.7 0.1 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.593 2.757 . . . . 6.18 108.983 -168.67 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 156' ' ' LEU . . . -71.67 -4.88 59.26 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.353 -1.467 . . . . 5.97 115.433 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -27.02 61.68 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 1 C-N-CA 132.84 4.456 . . . . 3.14 119.659 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 80.5 m95 66.18 35.36 6.12 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.174 1.79 . . . . 2.0 112.008 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 mp -71.24 132.64 45.25 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.531 -0.731 . . . . 3.42 110.092 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.45 111.89 24.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.762 1.625 . . . . 2.53 107.028 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.38 124.91 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.683 -0.858 . . . . 2.18 108.683 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -127.25 130.05 48.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.096 2.158 . . . . 2.7 112.142 -166.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.65 93.76 5.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.232 0.613 . . . . 2.56 111.831 -172.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.86 -174.86 14.01 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.018 1.77 . . . . 1.89 114.972 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.54 179.37 6.6 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.468 1.507 . . . . 4.9 111.906 -167.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.9 m -58.78 -32.47 69.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 115.758 -2.068 . . . . 4.01 116.254 -168.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.6 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.459 2.392 . . . . 10.28 117.459 -172.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.2 m -58.14 120.21 41.35 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-N 121.781 2.082 . . . . 4.18 114.396 -154.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.68 71.11 7.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.146 2.564 . . . . 5.75 114.117 -160.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -153.41 -117.39 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.314 2.246 . . . . 6.84 106.851 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 p -54.29 -31.23 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.143 1.777 . . . . 3.99 114.792 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.72 17.36 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 117.494 -1.241 . . . . 2.09 110.289 -173.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.48 -27.11 5.43 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.121 2.547 . . . . 1.25 113.813 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -70.92 -49.79 41.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.625 1.102 . . . . 3.17 111.659 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . 0.274 6.4 mt-10 -72.85 -14.28 61.46 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 119.67 -1.893 . . . . 2.97 112.627 174.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.47 -32.12 70.83 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.728 -1.233 . . . . 2.82 112.577 163.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -49.06 78.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.511 1.05 . . . . 4.9 108.85 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -58.46 -48.09 81.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.103 -0.951 . . . . 3.18 110.607 -175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.3 ptp -63.78 -43.53 96.1 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.724 1.602 . . . . 2.95 113.642 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.41 -53.34 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.438 -0.578 . . . . 1.98 109.438 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.425 ' HB3' ' HZ1' ' A' ' 283' ' ' LYS . 2.2 mp0 -70.56 -24.1 62.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 117.162 -1.399 . . . . 5.31 110.932 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.35 -50.79 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 121.911 2.141 . . . . 1.71 111.59 165.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.02 -31.06 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 120.685 1.584 . . . . 2.6 113.017 -173.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -83.09 -29.4 28.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.913 1.079 . . . . 4.73 113.913 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -73.17 -23.09 60.39 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.627 -1.296 . . . . 5.86 112.729 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.55 -50.8 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.474 1.909 . . . . 2.85 111.862 164.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.36 -38.29 73.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.821 1.648 . . . . 4.1 112.605 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.1 t -61.24 -22.02 64.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.583 1.553 . . . . 3.4 112.381 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 mm -79.31 11.92 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 O-C-N 120.432 -1.418 . . . . 4.49 111.261 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.7 m 89.63 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.107 2.563 . . . . 5.61 113.445 151.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.295 1.1 t -161.09 37.94 0.15 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.625 1.203 . . . . 3.98 114.109 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.06 168.8 13.71 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.433 -0.792 . . . . 4.91 111.637 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 120.03 6.92 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.697 1.598 . . . . 5.53 108.959 167.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.93 119.57 13.47 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.804 1.288 . . . . 3.99 110.633 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.2 tp -85.0 97.17 9.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.611 1.565 . . . . 2.33 108.341 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.6 m -77.06 115.14 46.09 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 117.824 -1.084 . . . . 2.21 110.317 -169.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.78 121.15 2.44 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.067 2.511 . . . . 0.93 112.163 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.8 tp -118.75 103.92 10.11 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.59 1.556 . . . . 2.52 110.863 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -86.81 125.48 33.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.877 0.871 . . . . 2.7 111.011 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.69 107.17 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.437 1.095 . . . . 1.81 109.869 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.23 96.64 3.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.198 0.523 . . . . 1.94 110.543 175.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.3 pt -87.0 28.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.228 -0.92 . . . . 2.85 113.405 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -128.68 46.35 2.15 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.828 1.651 . . . . 4.93 114.477 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.12 88.72 0.57 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.827 3.685 . . . . 2.98 109.753 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 231' ' ' ARG . 2.9 mt-10 162.27 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.188 1.795 . . . . 5.15 113.559 -159.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.91 9.14 4.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.739 1.216 . . . . 5.09 113.532 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -99.5 -137.65 0.31 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.558 2.343 . . . . 5.12 111.528 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m 155.31 137.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 1 C-N-CA 133.653 4.781 . . . . 2.44 104.739 169.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -41.51 -53.77 3.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.237 1.015 . . . . 2.91 112.242 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -70.11 -25.91 63.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.499 1.52 . . . . 3.74 114.386 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.94 -43.04 56.37 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.467 -1.395 . . . . 1.79 111.898 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 mm -64.66 -39.96 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 118.217 -0.897 . . . . 1.94 110.147 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.47 61.33 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.678 1.126 . . . . 1.59 113.188 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -69.82 -44.18 70.5 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.492 1.042 . . . . 3.5 111.465 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.1 -34.24 77.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.548 0.613 . . . . 2.64 112.434 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.87 -41.9 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.456 1.503 . . . . 1.93 111.557 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -46.16 89.77 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.099 -1.001 . . . . 5.37 110.732 174.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -43.12 -53.15 5.12 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.32 1.848 . . . . 4.14 112.034 -163.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -71.07 -73.03 0.19 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.899 1.28 . . . . 2.54 113.554 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.7 m -176.41 150.17 0.98 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.235 1.414 . . . . 2.56 112.292 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.87 5.41 3.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.49 3.46 . . . . 1.86 114.983 -165.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.47 -17.09 62.38 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.932 -1.105 . . . . 3.04 112.57 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.97 135.16 35.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.475 1.51 . . . . 1.89 112.539 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.73 136.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.301 1.441 . . . . 1.87 108.823 168.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.55 133.76 11.82 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.16 0.886 . . . . 1.47 112.408 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.8 mp -109.62 142.32 40.9 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.914 1.685 . . . . 2.36 111.005 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.0 p -149.64 167.11 27.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.891 2.876 . . . . 3.63 109.696 -166.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 172.58 -155.87 24.03 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.289 0.947 . . . . 1.86 111.226 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.1 t -96.68 172.85 7.64 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.931 1.348 . . . . 2.35 110.597 163.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 206' ' ' GLU . 40.9 ttm-85 -49.36 -30.07 7.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.871 2.069 . . . . 5.74 113.274 177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.42 -53.2 25.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.353 1.461 . . . . 3.78 111.789 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.18 -41.87 84.83 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.065 -1.022 . . . . 3.55 111.466 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.5 t -67.67 -29.96 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.994 0.917 . . . . 2.14 112.456 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.43 -49.79 74.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.733 -1.127 . . . . 3.26 108.883 173.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -56.63 -55.65 31.31 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.457 1.026 . . . . 3.71 111.862 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.85 -35.43 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.525 0.565 . . . . 3.19 112.525 -172.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.11 -44.76 68.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.927 0.491 . . . . 1.45 111.086 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -73.29 -36.08 66.24 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.302 1.841 . . . . 3.35 112.508 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.64 -54.09 47.4 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.591 1.156 . . . . 2.67 112.372 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -85.09 2.43 43.46 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.327 0.651 . . . . 2.68 112.451 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 58.47 39.94 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.712 2.405 . . . . 5.66 113.091 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.2 m -69.89 -25.98 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.429 1.27 . . . . 3.49 114.429 -161.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 81.1 t80 66.67 141.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.67 1.988 . . . . 3.85 115.097 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.62 159.78 27.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.469 2.308 . . . . 3.64 109.401 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.6 t -164.09 134.32 3.21 Favored Pre-proline 0 N--CA 1.477 0.92 0 O-C-N 120.977 -1.077 . . . . 3.33 112.331 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.67 141.28 21.85 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.414 2.743 . . . . 2.92 112.282 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.95 164.85 51.88 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.079 0.847 . . . . 2.57 114.75 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -82.58 -164.12 0.25 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.741 3.628 . . . . 4.54 110.873 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -87.54 133.22 33.82 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.154 -0.684 . . . . 6.32 109.154 151.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -147.93 152.87 38.27 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.88 0.872 . . . . 8.53 109.622 171.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 55.83 -52.62 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 129.104 2.961 . . . . 9.59 113.819 -157.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -163.33 -51.96 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.018 2.127 . . . . 6.78 110.047 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -162.32 67.26 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.764 1.626 . . . . 5.52 111.014 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -67.28 162.62 22.32 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.894 -1.129 . . . . 4.41 111.701 148.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -146.76 62.54 1.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.202 -0.936 . . . . 3.75 112.325 161.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp -57.47 164.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.615 1.166 . . . . 2.8 112.009 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.7 t -149.83 136.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 105.786 -1.931 . . . . 2.93 105.786 172.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -66.16 134.36 52.59 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.398 1.079 . . . . 3.47 110.509 172.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -154.34 114.49 3.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.985 0.914 . . . . 2.47 111.371 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.8 p -67.64 -22.98 65.29 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.321 1.448 . . . . 3.15 114.274 -170.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 tp 76.48 -5.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 127.912 2.485 . . . . 5.32 114.025 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.8 mt -49.5 133.54 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.154 1.782 . . . . 3.22 111.602 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 11.6 ptm -141.44 143.78 34.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 113.564 -1.653 . . . . 2.37 111.131 -163.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -127.64 145.2 50.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.907 0.883 . . . . 2.81 111.801 -162.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.88 125.66 38.63 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.513 1.125 . . . . 1.89 109.127 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -100.48 135.6 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.969 1.308 . . . . 2.0 108.149 170.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.38 -177.24 45.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.725 1.155 . . . . 1.89 111.454 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.77 54.48 4.5 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.967 3.111 . . . . 2.57 114.271 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -166.8 -54.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.648 1.979 . . . . 6.47 111.193 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 147.5 -20.81 1.51 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.658 0.623 . . . . 2.5 114.658 -160.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.39 144.56 57.08 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.175 0.99 . . . . 7.02 111.778 165.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -74.67 155.95 37.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.23 1.012 . . . . 4.3 112.491 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -36.94 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.606 0.762 . . . . 3.13 112.842 174.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -165.52 172.44 12.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.759 1.224 . . . . 2.08 111.133 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.26 164.54 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.331 1.452 . . . . 3.23 112.945 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.03 -179.21 7.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.737 1.615 . . . . 2.52 111.322 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 119.36 146.33 7.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.326 1.441 . . . . 2.7 113.702 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 40.75 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 1 C-N-CA 132.526 4.33 . . . . 4.2 118.135 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.43 -46.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.702 -1.249 . . . . 4.85 112.755 -173.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.27 90.03 0.9 Allowed 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.346 -0.846 . . . . 4.64 110.582 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -67.29 161.26 25.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.405 1.882 . . . . 5.2 112.641 -165.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HZ1' ' HB3' ' A' ' 182' ' ' GLN . 0.9 OUTLIER -42.07 -59.04 1.88 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.691 1.996 . . . . 3.47 115.388 -168.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.92 -34.05 76.21 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.292 -0.88 . . . . 1.48 113.159 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.97 -31.56 72.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.124 1.37 . . . . 3.65 111.934 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.6 mt -58.16 -56.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.227 -0.921 . . . . 1.16 109.519 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.88 -40.42 76.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.366 0.506 . . . . 1.22 112.366 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.85 87.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.862 0.865 . . . . 1.41 113.227 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.6 p -63.7 -43.44 96.6 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.298 -0.876 . . . . 1.22 111.983 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 49.3 mt -64.71 -37.0 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.036 -1.04 . . . . 1.67 111.436 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.7 -22.84 65.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.304 1.041 . . . . 1.74 113.429 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 39.7 m -71.12 -48.35 52.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.163 -0.68 . . . . 1.84 109.163 169.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -67.38 -26.07 66.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.113 1.365 . . . . 2.7 113.503 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -25.3 63.21 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.888 -1.132 . . . . 5.48 111.8 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -57.19 -40.71 86.78 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 117.364 -1.303 . . . . 4.83 112.608 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.22 -60.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.852 2.368 . . . . 3.3 111.448 160.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.45 31.11 6.02 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.565 1.321 . . . . 5.13 114.565 -156.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.4 136.07 4.32 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.05 -1.032 . . . . 7.33 112.259 172.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -168.13 0.15 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.075 1.75 . . . . 7.55 111.489 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -159.48 24.14 0.19 Allowed 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.384 -1.447 . . . . 11.62 112.701 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.477 0.878 1 C-N-CA 133.207 4.603 . . . . 12.3 106.246 -159.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 118.111 -0.947 . . . . 16.89 108.782 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -159.97 171.41 19.42 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.336 1.454 . . . . 14.26 109.741 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -167.48 163.15 14.82 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.955 1.702 . . . . 11.6 110.161 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.81 -165.32 12.12 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.909 1.242 . . . . 9.6 113.782 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -148.41 151.68 37.09 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.103 1.361 . . . . 10.16 111.364 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.73 174.36 12.81 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.992 2.462 . . . . 7.38 110.397 163.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 135' ' ' LEU . 1.8 pt? -109.75 173.86 6.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.312 1.445 . . . . 6.76 111.301 167.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.19 136.03 39.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.262 1.025 . . . . 5.99 108.61 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.35 -136.59 50.88 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.743 0.687 . . . . 3.29 112.535 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 173.68 164.98 29.73 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.095 0.855 . . . . 2.33 113.898 170.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.51 -170.79 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.292 3.328 . . . . 2.37 110.049 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -146.46 177.81 8.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.686 1.195 . . . . 2.2 111.081 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -144.38 34.07 1.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.549 1.315 . . . . 2.62 114.549 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mp -64.83 156.29 31.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.649 1.214 . . . . 2.15 112.636 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -92.72 142.74 27.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.173 1.389 . . . . 1.61 109.05 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -83.62 166.21 18.35 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.861 1.265 . . . . 2.07 111.757 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -3.84 2.32 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.197 1.799 . . . . 1.63 114.958 173.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.6 m -79.03 -36.86 40.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.837 1.655 . . . . 3.21 111.729 164.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.08 11.89 30.92 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.704 1.621 . . . . 1.95 113.679 -164.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 141.07 43.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.122 1.369 . . . . 3.4 110.406 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.33 112.74 24.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.26 1.424 . . . . 5.34 111.46 -164.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.87 158.52 16.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.139 1.375 . . . . 3.08 112.663 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.2 p -115.54 -179.82 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.311 2.245 . . . . 2.53 108.739 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -38.19 88.74 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.844 -0.535 . . . . 3.6 111.841 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -77.88 -6.58 54.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.107 1.521 . . . . 6.46 115.107 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.28 -29.89 70.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.05 0.94 . . . . 2.86 111.724 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -100.14 -11.88 20.1 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.095 1.517 . . . . 3.07 115.095 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.34 108.2 1.54 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.579 1.151 . . . . 3.68 111.563 -170.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.13 2.67 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.811 1.196 . . . . 2.79 112.888 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.21 163.85 17.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.193 0.997 . . . . 3.57 109.268 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -78.49 138.53 38.48 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.523 -0.736 . . . . 2.0 109.494 161.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.23 144.02 36.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.161 0.982 . . . . 3.11 113.523 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.16 117.88 24.04 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.592 1.157 . . . . 2.67 108.729 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.9 mt -101.93 127.13 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.059 0.943 . . . . 1.74 109.125 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.64 142.14 39.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.73 0.776 . . . . 3.34 111.168 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -99.72 126.9 45.85 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.321 1.049 . . . . 2.22 108.97 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.39 169.34 26.43 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 124.292 0.995 . . . . 1.32 114.721 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -120.07 171.24 8.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.317 1.847 . . . . 4.22 108.018 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 71.2 m -53.82 -12.22 0.51 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.666 2.469 . . . . 3.49 117.666 -166.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -177.22 -27.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 122.427 2.376 . . . . 10.01 116.776 167.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 61.6 m 60.85 174.62 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 117.548 2.425 . . . . 2.86 117.548 167.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.21 164.41 30.45 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.236 1.957 . . . . 3.07 109.865 154.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.09 46.63 0.32 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.086 2.554 . . . . 4.37 113.932 -165.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 94.8 t -111.86 -53.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 127.584 2.354 . . . . 2.9 109.07 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 34.6 t -64.16 -60.84 7.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.187 0.995 . . . . 1.71 112.922 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.69 -24.95 47.13 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.25 1.967 . . . . 1.4 112.635 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -71.2 -55.21 8.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.441 1.096 . . . . 2.81 111.254 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -65.26 -25.84 67.83 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.279 -0.888 . . . . 3.21 112.194 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -65.17 -34.42 78.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.018 -0.991 . . . . 3.21 110.695 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.89 -43.04 59.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.44 1.473 . . . . 3.54 111.788 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -50.22 -39.3 44.09 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.452 -1.405 . . . . 3.58 112.162 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.79 -50.41 43.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.914 1.286 . . . . 3.12 112.426 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.77 -37.16 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 120.789 1.631 . . . . 1.87 112.025 -174.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.531 ' C ' ' HE3' ' A' ' 283' ' ' LYS . 54.3 mt-30 -56.09 -27.57 54.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.84 1.2 . . . . 3.48 111.522 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 36.0 t -68.75 -20.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 120.586 -1.321 . . . . 2.2 111.771 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.9 t -67.28 -38.82 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.856 0.753 . . . . 2.15 109.479 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -49.99 74.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.486 1.114 . . . . 5.03 110.963 171.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.27 -25.54 63.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.5 1.12 . . . . 3.03 113.781 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.15 -45.33 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.986 1.715 . . . . 2.26 112.703 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.36 -32.37 66.7 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.476 1.035 . . . . 3.69 111.1 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -20.23 63.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.565 1.546 . . . . 2.92 112.901 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.08 -16.94 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 120.897 -1.127 . . . . 3.41 111.701 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.5 t 56.47 -7.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.694 3.197 . . . . 5.14 118.633 165.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 67.4 p -109.18 9.25 26.08 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 120.802 1.637 . . . . 3.52 114.411 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.92 160.92 29.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.226 1.81 . . . . 3.23 112.847 -168.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -82.8 51.56 3.74 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.282 3.321 . . . . 3.52 110.729 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.1 t0 57.94 -175.84 0.08 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.332 2.253 . . . . 4.48 115.405 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.94 118.06 28.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.969 1.308 . . . . 1.97 108.63 155.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.5 m -98.88 99.92 8.76 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.437 1.495 . . . . 1.22 109.983 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.09 133.02 17.46 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.96 2.44 . . . . 0.9 111.649 170.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.38 89.21 3.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.103 2.161 . . . . 2.51 108.161 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -83.7 130.86 34.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.716 0.806 . . . . 1.91 109.575 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.7 mt -108.55 122.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.892 0.877 . . . . 1.71 109.855 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.4 m -67.34 119.61 12.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.587 0.755 . . . . 2.43 110.839 166.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.29 -3.55 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 120.955 -1.091 . . . . 2.58 113.721 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -111.81 57.34 0.46 Allowed Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 127.381 2.272 . . . . 4.24 113.554 -170.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.94 75.9 2.62 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.866 3.711 . . . . 2.75 109.966 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -173.42 -35.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.846 2.458 . . . . 3.61 111.473 -169.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.34 32.52 2.83 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.028 0.931 . . . . 5.76 112.388 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -119.99 173.29 7.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.912 2.485 . . . . 4.01 109.673 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.3 m -169.2 139.98 2.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.275 2.63 . . . . 2.89 107.143 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -36.61 66.82 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.434 0.901 . . . . 3.44 113.434 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -79.59 -28.0 41.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.893 2.077 . . . . 3.85 112.67 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.45 42.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.797 0.726 . . . . 2.03 110.084 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.1 tp -62.01 -31.6 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.72 0.408 . . . . 2.31 111.989 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.62 95.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.184 -0.948 . . . . 1.24 111.826 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -69.21 -29.22 67.13 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.196 0.813 . . . . 4.21 113.196 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -68.1 -48.36 65.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.544 1.138 . . . . 3.61 110.778 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.1 t -52.2 -45.74 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.166 -0.959 . . . . 1.31 111.519 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -59.88 -18.67 46.25 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.39 1.476 . . . . 5.22 113.188 176.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.91 -48.03 80.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.959 1.708 . . . . 4.77 110.927 171.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -87.82 -53.2 4.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.347 0.869 . . . . 2.84 113.347 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.7 p -177.33 159.61 1.39 Allowed Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.634 -1.291 . . . . 3.22 112.91 -159.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -86.24 -16.0 4.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.716 2.944 . . . . 2.08 113.807 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -85.61 -4.44 59.16 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.788 1.176 . . . . 2.35 113.52 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.89 136.79 36.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.942 0.897 . . . . 2.33 111.171 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 t -110.99 131.36 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.574 -1.269 . . . . 2.02 107.574 163.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.73 114.65 4.59 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 109.497 -1.441 . . . . 1.01 109.497 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.4 144.35 33.21 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.665 0.786 . . . . 2.13 110.756 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -157.79 -179.7 8.39 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.641 1.576 . . . . 2.6 110.785 -172.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 167.42 -116.69 0.69 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.255 -1.138 . . . . 1.84 110.255 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.5 p -128.0 168.0 15.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.613 1.165 . . . . 3.04 112.211 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -39.36 46.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.67 0.788 . . . . 5.79 111.248 -177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 2.2 mp0 -59.76 -54.23 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.293 2.237 . . . . 3.52 113.131 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -69.46 -31.68 70.13 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.879 -1.138 . . . . 4.98 111.831 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.43 -29.61 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 117.944 -1.027 . . . . 1.68 111.625 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.29 -42.53 88.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.031 1.287 . . . . 3.18 110.227 162.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -56.49 -50.5 71.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 117.987 -1.006 . . . . 2.85 112.622 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.4 m -71.2 -26.86 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 120.583 1.538 . . . . 2.48 114.576 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.451 ' HB1' HG22 ' A' ' 243' ' ' VAL . . . -65.57 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.615 1.098 . . . . 1.51 112.628 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -105.09 -21.76 13.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.772 3.229 . . . . 5.96 113.467 -167.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.72 -28.99 64.06 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.472 1.033 . . . . 1.97 112.268 162.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.08 -127.06 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.402 1.081 . . . . 2.66 109.404 164.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -164.78 74.71 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.572 1.149 . . . . 5.7 110.145 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.451 HG22 ' HB1' ' A' ' 238' ' ' ALA . 7.5 m -83.63 173.92 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 111.765 0.283 . . . . 3.45 111.765 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.423 ' CD2' HG22 ' A' ' 261' ' ' THR . 13.0 p90 -147.8 154.19 40.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.126 1.371 . . . . 6.75 110.737 166.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -154.94 125.43 6.89 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.524 1.53 . . . . 4.32 111.176 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.6 t -106.74 110.54 63.76 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 120.795 -1.19 . . . . 3.89 109.257 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.99 144.52 38.3 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.524 2.149 . . . . 3.21 111.367 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -87.73 -173.65 48.01 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.892 1.234 . . . . 3.02 115.092 -175.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.58 53.97 4.97 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 125.048 3.832 . . . . 5.27 112.579 -172.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 250' ' ' LYS 0.26 0.0 OUTLIER -63.1 123.5 18.76 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.85 -1.156 . . . . 4.99 110.989 177.369 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 103.22 -8.88 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.318 1 C-N-CA 131.755 4.022 . . . . 10.06 113.309 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -81.88 -48.65 11.27 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.985 1.266 . . . . 10.28 112.591 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -156.65 49.33 0.47 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.561 0.949 . . . . 8.72 113.561 -170.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 76.99 -1.05 2.88 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 127.776 2.431 . . . . 8.38 112.802 171.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.67 151.06 21.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.34 1.456 . . . . 4.97 114.496 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.96 71.55 0.68 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 113.964 -1.471 . . . . 3.22 109.431 145.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.0 tp -83.95 154.07 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.384 -0.823 . . . . 2.93 111.639 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.7 134.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 129.449 3.099 . . . . 2.94 105.635 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.83 168.0 14.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.162 0.982 . . . . 3.22 110.397 165.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -150.46 36.26 0.65 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.079 0.943 . . . . 3.65 110.907 168.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.423 HG22 ' CD2' ' A' ' 244' ' ' TYR 0.266 13.7 p 65.51 -134.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.54 2.336 . . . . 3.55 110.999 -171.418 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 176.19 -17.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 129.029 2.932 . . . . 5.21 110.795 -163.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.4 mt -69.92 134.03 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.57 1.148 . . . . 2.79 109.546 170.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.8 ttm -119.6 137.49 53.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.3 1.84 . . . . 2.94 108.206 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.97 127.59 51.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.677 0.791 . . . . 3.52 112.18 -159.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.83 130.74 48.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.595 1.158 . . . . 1.95 112.075 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.9 151.3 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.296 1.838 . . . . 1.82 106.297 166.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -142.55 -135.07 3.02 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 121.268 -0.895 . . . . 1.99 113.0 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.11 1.61 7.02 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.654 2.903 . . . . 2.46 113.545 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.87 -47.0 55.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.23 2.212 . . . . 5.61 113.723 172.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.88 13.09 54.45 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 117.628 -1.651 . . . . 3.01 116.746 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.57 -70.7 0.35 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.065 1.432 . . . . 4.16 111.883 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -166.69 146.96 5.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.164 0.985 . . . . 4.64 111.915 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 -33.01 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.424 1.639 . . . . 2.72 115.424 -170.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -168.52 167.94 11.33 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.11 1.323 . . . . 2.56 112.76 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.45 152.55 32.11 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.694 1.738 . . . . 3.21 115.694 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -120.33 163.71 17.42 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.888 1.275 . . . . 2.64 110.481 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -167.08 102.56 0.19 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.326 -0.859 . . . . 4.08 111.765 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 64.15 164.06 0.13 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.24 1.416 . . . . 3.68 110.965 -162.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 37.8 t30 77.1 -57.2 0.52 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.309 1.843 . . . . 5.83 112.467 165.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? 49.71 19.97 0.47 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.085 2.154 . . . . 9.88 116.226 162.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.39 142.38 56.98 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 119.139 -2.226 . . . . 5.61 110.612 -163.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.531 ' HE3' ' C ' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -46.03 -52.18 12.36 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.192 0.997 . . . . 2.38 113.593 -170.097 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.37 -23.28 71.71 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.506 -1.164 . . . . 1.45 114.647 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -74.07 -49.14 25.38 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.494 1.647 . . . . 3.36 110.378 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.66 -47.73 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.324 0.649 . . . . 1.28 109.389 174.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.96 75.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.207 -0.901 . . . . 1.35 112.516 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.43 91.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.925 1.239 . . . . 1.3 112.752 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 91.5 p -60.02 -57.35 13.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.932 0.333 . . . . 1.36 111.562 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.34 -35.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.754 -1.216 . . . . 1.45 110.993 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.37 73.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.825 1.25 . . . . 1.85 113.921 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 14.4 t -76.25 -33.27 59.18 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.182 1.356 . . . . 2.88 111.452 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -70.87 -24.59 62.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.976 0.91 . . . . 2.18 113.26 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.5 mtt -54.1 -40.95 67.73 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.432 -1.418 . . . . 5.8 111.467 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -59.01 -45.09 99.59 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 115.714 -2.089 . . . . 4.43 114.557 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.85 -7.55 11.32 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.606 2.87 . . . . 2.26 114.429 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -119.85 -154.65 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 120.027 1.285 . . . . 3.43 113.4 -171.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -69.59 121.59 17.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.027 -1.671 . . . . 11.07 111.354 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -164.3 0.51 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.821 1.786 . . . . 9.57 115.821 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 79.4 mttt 34.91 45.57 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 127.379 2.271 . . . . 10.12 116.4 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.255 1.373 0 C-N-CA 129.598 3.159 . . . . 8.61 107.686 -170.532 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 118.044 -0.979 . . . . 19.06 109.83 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -63.95 157.58 24.57 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.879 0.763 . . . . 17.03 110.758 164.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 t -175.82 167.33 3.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.595 2.758 . . . . 13.93 108.666 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 93.36 159.75 34.88 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.763 1.173 . . . . 12.0 113.264 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -173.84 155.03 2.4 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.558 1.543 . . . . 13.64 111.903 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.25 150.9 29.47 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.771 2.314 . . . . 11.07 112.167 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.6 tt -171.45 134.84 0.88 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 129.733 3.213 . . . . 9.78 106.588 162.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 tp -164.57 -178.69 5.51 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.013 0.925 . . . . 5.36 111.118 -168.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.08 155.26 19.18 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.179 1.371 . . . . 3.72 110.098 154.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.1 -84.28 0.36 Allowed Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.216 -1.325 . . . . 4.17 112.1 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.57 148.02 90.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.837 2.358 . . . . 4.02 112.136 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -151.23 171.76 16.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 3.21 111.988 -174.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 p -139.04 42.28 2.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.954 1.835 . . . . 3.7 115.954 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.49 152.64 21.34 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 119.902 -1.749 . . . . 3.57 112.699 -170.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.9 m -92.14 139.65 30.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.682 1.193 . . . . 2.47 110.155 -173.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.2 p -84.38 159.79 20.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.037 0.935 . . . . 2.51 112.587 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -9.36 2.07 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.479 1.512 . . . . 1.82 115.0 169.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 99.7 m -71.68 -53.68 12.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.463 1.105 . . . . 3.72 109.858 164.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.63 -10.84 8.0 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.358 1.933 . . . . 3.05 113.619 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 148.73 27.96 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 124.83 1.252 . . . . 5.14 111.112 171.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 97.59 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.695 1.198 . . . . 6.15 111.663 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -95.66 161.94 13.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.178 1.177 . . . . 4.7 114.178 -171.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -112.43 169.5 8.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.2 1.8 . . . . 2.88 110.773 164.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -41.87 -42.68 2.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.914 2.486 . . . . 4.1 113.213 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -82.04 -22.68 36.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.168 1.173 . . . . 7.17 114.168 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.24 -14.39 60.92 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.928 0.871 . . . . 3.86 111.936 165.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -102.88 9.96 38.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.968 2.507 . . . . 3.16 114.782 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.35 156.38 26.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.614 1.552 . . . . 3.17 115.003 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.59 43.05 Favored Glycine 0 N--CA 1.478 1.463 0 C-N-CA 124.818 1.199 . . . . 2.66 115.656 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -140.39 162.68 34.74 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.917 2.487 . . . . 3.3 109.695 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.8 131.6 43.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.259 0.552 . . . . 2.14 111.943 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.8 mt -108.09 125.39 51.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.035 1.334 . . . . 2.75 109.781 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.443 HD11 ' HG ' ' A' ' 196' ' ' LEU . 4.8 mp -121.57 103.99 9.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.624 1.169 . . . . 3.41 108.094 -173.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.3 mt -117.67 124.97 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.934 0.893 . . . . 2.01 109.934 -155.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -142.37 155.12 45.12 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.007 1.323 . . . . 2.25 112.159 -165.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.87 122.63 39.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.752 1.221 . . . . 2.8 111.114 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.69 -154.66 8.25 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.538 1.066 . . . . 1.26 112.653 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -168.02 169.32 11.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.721 1.608 . . . . 3.51 111.42 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.27 13.5 t -77.97 30.9 0.17 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 119.602 -1.936 . . . . 4.13 112.75 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -97.43 -29.79 13.29 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.777 1.631 . . . . 7.23 113.775 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 60.4 m -104.72 153.11 39.5 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 116.221 1.934 . . . . 2.88 116.221 -165.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.21 -22.27 2.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.886 3.058 . . . . 4.49 113.534 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -140.65 -58.19 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.948 1.092 . . . . 4.79 113.948 -171.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.7 p -60.36 -32.41 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.675 1.59 . . . . 3.29 114.687 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.8 m -74.89 -66.11 0.47 Allowed Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.167 0.894 . . . . 1.51 112.129 161.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 -28.5 68.92 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.713 1.608 . . . . 1.16 115.154 -166.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -71.32 -30.47 66.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.762 1.619 . . . . 3.04 112.49 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.67 -40.48 72.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.808 0.731 . . . . 3.12 110.448 168.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.45 -37.66 74.38 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.873 1.215 . . . . 3.26 113.05 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.03 -58.82 5.89 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.315 1.446 . . . . 4.21 110.205 165.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -56.68 -40.98 76.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.081 1.352 . . . . 3.23 112.972 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 48.3 mtp -60.62 -40.75 93.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.929 1.692 . . . . 2.89 112.529 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.6 tp -87.41 -37.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.693 1.588 . . . . 2.62 112.678 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -53.2 -43.28 67.08 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 124.762 1.225 . . . . 3.48 110.704 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.86 -13.56 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 113.801 1.037 . . . . 2.07 113.801 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.2 -23.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.998 -1.064 . . . . 2.0 111.603 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -50.37 67.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.746 0.818 . . . . 4.68 112.187 -170.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.54 -19.1 65.24 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.673 1.589 . . . . 3.37 114.115 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -56.49 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 120.914 -1.116 . . . . 2.51 109.347 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.78 -36.99 82.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.605 1.162 . . . . 4.0 112.159 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -71.87 -7.61 49.49 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.773 1.027 . . . . 3.36 113.773 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.5 mm -103.34 -29.72 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.128 0.876 . . . . 4.7 111.095 168.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.0 m 72.73 -25.88 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 127.56 2.344 . . . . 6.15 114.211 157.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 56.0 m -74.81 -2.67 27.67 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.794 3.237 . . . . 3.93 112.673 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 mp -99.26 157.66 33.64 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.594 1.558 . . . . 3.32 110.075 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.46 143.68 48.14 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.28 1.987 . . . . 3.62 108.183 155.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.26 159.31 3.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 116.078 1.881 . . . . 3.5 116.078 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.443 ' HG ' HD11 ' A' ' 161' ' ' LEU . 7.1 mp -99.19 95.52 7.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.246 -1.39 . . . . 2.84 107.246 157.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.4 m -86.95 112.04 44.63 Favored Pre-proline 0 N--CA 1.475 0.786 0 N-CA-C 108.126 -1.065 . . . . 1.28 108.126 168.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -86.82 136.86 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.789 2.326 . . . . 0.89 109.86 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.15 123.11 16.6 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.484 1.135 . . . . 3.6 112.442 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -109.45 133.15 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.535 1.534 . . . . 2.21 110.554 -160.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 36.3 mm -99.55 122.01 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.154 0.981 . . . . 1.83 110.516 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 95.6 p -74.07 124.61 26.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.102 0.561 . . . . 3.53 110.097 165.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.5 pt -94.05 -18.05 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.322 1.601 . . . . 2.2 115.322 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -119.48 59.38 5.17 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 120.419 1.463 . . . . 2.67 114.367 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.54 99.57 0.21 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.43 2.087 . . . . 2.68 107.393 165.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 165.65 -45.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.986 2.515 . . . . 4.46 108.523 -147.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 -18.19 0.6 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.927 1.455 . . . . 5.56 114.927 151.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.66 136.77 54.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.847 1.203 . . . . 4.3 109.394 155.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.2 t -154.0 155.73 36.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 3.5 112.384 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -58.1 -47.04 84.47 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.484 1.914 . . . . 2.8 113.983 -163.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -71.66 -38.69 70.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.328 1.422 . . . . 3.54 112.77 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.7 93.99 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.221 -0.924 . . . . 1.46 111.14 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 mm -61.3 -39.77 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.057 0.943 . . . . 1.87 111.736 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.45 86.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.629 1.104 . . . . 1.44 112.309 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -62.55 -52.71 62.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.922 0.783 . . . . 3.2 111.811 168.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -55.58 -32.17 62.81 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.726 1.21 . . . . 2.95 113.519 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 224' ' ' LEU . 2.4 t -65.35 -58.16 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.02 2.128 . . . . 1.3 112.576 166.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -52.91 -48.14 67.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.953 0.901 . . . . 3.82 112.181 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.63 -20.46 58.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.231 0.957 . . . . 5.02 112.627 -162.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -79.86 -56.14 4.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.79 0.723 . . . . 2.84 110.875 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.8 m 169.14 132.25 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 127.297 2.239 . . . . 2.32 112.208 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.19 7.34 1.44 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.394 3.396 . . . . 3.11 116.094 -168.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -67.94 -35.33 78.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.205 1.366 . . . . 2.36 110.768 159.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 217' ' ' VAL . 7.0 tt -62.08 118.51 7.43 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.258 -1.386 . . . . 2.11 107.258 173.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.85 131.38 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.098 -1.075 . . . . 2.04 108.098 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -93.51 127.78 9.18 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.117 -1.593 . . . . 1.09 109.117 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.48 144.92 50.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.837 0.827 . . . . 2.27 111.291 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 26.1 p -140.36 176.15 9.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.706 2.002 . . . . 2.81 109.255 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -175.69 -154.55 11.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.183 -1.967 . . . . 2.23 108.183 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.5 p -81.94 171.99 13.8 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.331 0.586 . . . . 4.05 110.615 167.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -63.07 -23.99 67.7 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.756 -0.59 . . . . 6.76 112.085 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 16.2 mp0 -80.8 -31.12 35.81 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.536 1.934 . . . . 3.88 111.913 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.15 -41.51 73.74 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.916 -1.115 . . . . 4.96 109.691 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.99 -38.69 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.268 -0.895 . . . . 2.39 111.92 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.09 -39.32 79.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.423 -0.799 . . . . 3.71 111.143 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -52.33 -58.87 5.32 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.737 -1.125 . . . . 3.59 110.377 173.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.26 -31.61 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.79 1.177 . . . . 2.85 113.17 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.97 -50.75 38.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.54 1.064 . . . . 2.36 111.37 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -36.95 74.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.003 1.721 . . . . 7.97 112.402 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.21 65.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.689 1.132 . . . . 2.69 110.724 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -76.17 -7.85 55.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.555 0.742 . . . . 2.93 112.827 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 26.3 ttp-105 71.06 38.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.567 2.347 . . . . 7.69 112.431 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.69 138.92 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.365 1.466 . . . . 4.28 108.659 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -105.85 136.86 44.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.222 0.534 . . . . 4.66 111.177 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -89.85 144.2 26.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.897 0.479 . . . . 3.16 109.912 164.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 t -119.69 94.2 48.26 Favored Pre-proline 0 N--CA 1.477 0.906 0 O-C-N 120.895 -1.128 . . . . 3.31 112.704 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.78 138.76 9.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.362 2.708 . . . . 2.91 113.149 -171.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.49 -177.64 51.25 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 123.78 0.705 . . . . 2.47 112.503 163.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -82.59 151.08 14.94 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.393 2.729 . . . . 3.23 110.615 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.1 128.55 19.27 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.961 1.304 . . . . 5.04 112.034 159.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -129.82 162.66 28.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.455 0.702 . . . . 6.46 112.194 174.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 39.34 -109.41 0.08 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.763 2.025 . . . . 8.2 111.989 -158.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -106.37 -38.81 6.1 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.883 0.765 . . . . 8.99 112.069 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -170.17 75.05 0.08 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 127.151 2.18 . . . . 7.83 109.655 167.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -94.07 162.58 13.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.647 -1.16 . . . . 3.77 109.729 132.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . 0.262 6.9 p90 173.25 160.02 0.13 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.515 2.326 . . . . 3.94 112.397 140.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.4 tp -105.39 148.73 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.054 1.342 . . . . 3.03 111.338 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.9 132.61 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.452 -2.055 . . . . 3.27 105.452 161.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.42 139.17 43.81 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.561 0.618 . . . . 4.11 111.298 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -131.41 93.9 3.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.936 0.894 . . . . 2.3 110.876 161.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.7 t -48.2 122.53 5.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.525 0.73 . . . . 4.94 110.266 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 10.5 pt -88.07 101.1 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.816 0.817 . . . . 4.78 112.372 -165.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.1 mt -132.57 127.04 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.973 1.309 . . . . 2.79 108.05 162.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.8 ptm -94.0 130.48 40.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.268 0.627 . . . . 2.78 109.734 162.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -97.92 135.14 40.08 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.215 -0.928 . . . . 3.26 111.233 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 108.96 19.68 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.269 -1.012 . . . . 2.09 108.269 168.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.7 mm -93.73 135.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.627 -1.249 . . . . 2.91 107.627 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.08 176.61 29.86 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 122.872 0.272 . . . . 1.92 112.535 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.4 39.96 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 125.256 3.97 . . . . 2.64 112.153 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -161.11 -36.45 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.3 2.24 . . . . 4.89 113.53 -158.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.86 0.0 21.34 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 117.169 -1.906 . . . . 3.1 116.307 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -99.4 157.94 16.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.898 1.849 . . . . 5.33 111.195 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -74.28 108.21 6.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.111 1.365 . . . . 3.9 110.386 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.33 -28.59 16.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.575 0.75 . . . . 2.68 112.275 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -170.79 -179.71 2.93 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.756 1.622 . . . . 2.66 111.842 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -158.87 157.71 32.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.648 1.979 . . . . 3.99 112.321 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -147.7 -179.46 6.9 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.517 1.927 . . . . 2.83 111.394 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.75 -100.87 0.23 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.816 1.198 . . . . 4.16 112.362 174.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -67.38 -30.28 70.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.937 -1.331 . . . . 4.66 113.461 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.95 137.39 50.32 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.758 0.823 . . . . 4.58 109.508 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.54 86.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.641 0.777 . . . . 4.33 110.641 -143.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -89.02 -164.38 1.13 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.83 1.652 . . . . 9.69 109.227 156.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -29.61 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.636 2.374 . . . . 2.24 116.446 -168.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.71 -20.95 72.99 Favored Glycine 0 N--CA 1.476 1.327 0 CA-C-N 118.945 0.793 . . . . 1.8 112.74 -168.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -18.73 30.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.386 0.674 . . . . 5.06 112.168 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.92 -49.69 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.105 -0.997 . . . . 1.45 109.379 156.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.47 70.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.144 0.883 . . . . 1.36 113.169 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.22 60.06 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.279 1.215 . . . . 1.36 114.279 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 64.3 p -69.56 -52.55 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.618 -0.676 . . . . 1.74 111.689 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.5 mm -58.48 -42.51 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.256 -0.903 . . . . 1.93 109.708 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.08 -11.97 23.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.087 1.755 . . . . 2.09 114.248 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.9 m -97.39 -54.95 2.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.084 1.354 . . . . 1.95 109.566 170.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -64.09 -25.58 68.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.362 1.465 . . . . 2.5 113.986 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 mmm -65.53 -20.51 66.37 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.525 1.13 . . . . 4.76 113.987 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -62.45 -48.58 86.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 116.12 -1.895 . . . . 4.8 112.257 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.35 -43.71 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.61 2.207 . . . . 1.93 112.05 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.14 53.2 2.74 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.105 1.15 . . . . 2.58 114.105 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 114.53 -98.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 130.258 3.423 . . . . 10.73 111.477 165.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -151.88 165.07 35.67 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.215 1.191 . . . . 10.31 114.215 -159.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.7 -49.94 0.59 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.593 1.157 . . . . 13.83 109.69 168.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.247 0.948 0 C-N-CA 128.445 2.698 . . . . 9.8 107.951 150.407 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 118.376 -0.821 . . . . 24.81 110.287 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -68.45 168.91 11.78 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.875 0.761 . . . . 19.08 110.936 159.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 t -138.08 168.11 20.41 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.032 1.733 . . . . 17.53 108.256 154.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.51 -156.72 34.62 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.027 1.299 . . . . 13.32 113.949 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . 0.279 1.5 mptm? 118.88 -59.21 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.379 1 C-N-CA 132.901 4.48 . . . . 13.13 110.894 176.365 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.89 165.75 31.92 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.713 1.609 . . . . 8.61 109.437 153.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 pp -175.86 163.39 2.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.831 2.852 . . . . 7.54 108.638 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.9 mt -124.71 -113.63 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.236 1.414 . . . . 6.68 110.394 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.44 18.11 28.4 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.288 1.423 . . . . 4.86 114.907 -173.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.24 111.79 4.47 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.066 -1.408 . . . . 2.73 111.314 -170.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.5 157.59 28.85 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.976 2.451 . . . . 3.16 112.403 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -131.13 168.85 16.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.327 1.851 . . . . 2.92 111.538 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.4 p -125.49 22.12 7.72 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.772 2.138 . . . . 3.6 116.772 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.92 162.34 29.17 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.837 1.051 . . . . 2.05 113.837 -163.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 142.6 30.69 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.536 1.534 . . . . 2.02 109.8 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 m -98.53 140.26 33.04 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.089 1.756 . . . . 2.88 110.243 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -47.53 -20.86 0.27 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.405 2.682 . . . . 1.78 116.445 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.4 t -90.08 -7.39 53.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.802 1.241 . . . . 3.73 113.798 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.21 38.43 4.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.433 1.015 . . . . 3.46 113.265 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.49 -172.99 3.56 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.226 1.41 . . . . 5.24 110.016 172.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -152.9 136.82 16.26 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.459 1.027 . . . . 6.78 109.709 -156.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.545 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 8.8 mptt -132.16 167.28 20.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.747 1.758 . . . . 4.24 115.747 -168.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 88.2 m -164.91 156.17 14.86 Favored 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 132.732 4.413 . . . . 3.09 105.232 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.51 -42.27 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.808 1.185 . . . . 3.69 113.049 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -3.93 9.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.156 1.539 . . . . 8.35 115.156 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -87.36 -20.08 27.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.742 1.217 . . . . 3.11 112.767 166.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.545 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 7.8 m-85 -109.0 -20.45 13.03 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.039 1.496 . . . . 3.4 115.039 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 137.14 31.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.204 1.402 . . . . 3.3 112.304 -171.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.85 58.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.81 1.195 . . . . 2.26 112.778 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -107.34 165.4 11.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.697 1.999 . . . . 3.28 108.296 161.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -89.61 137.48 32.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.136 -0.69 . . . . 2.19 109.136 170.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.5 pp -137.47 154.3 49.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.513 0.673 . . . . 2.73 112.471 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.5 mt -121.45 114.79 21.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.147 1.779 . . . . 2.28 109.141 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.75 120.94 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.341 0.973 . . . . 2.33 108.959 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.13 134.34 54.75 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.261 1.025 . . . . 2.22 111.478 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.38 118.19 36.34 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.632 0.773 . . . . 3.24 110.164 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.67 -178.41 15.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.294 1.426 . . . . 1.62 114.806 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -144.61 124.06 13.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.594 0.757 . . . . 3.8 111.206 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 1.5 p -81.08 28.77 0.35 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.318 -1.489 . . . . 3.31 114.679 -174.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -146.16 39.38 1.1 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 127.076 2.151 . . . . 7.46 109.322 162.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.97 147.42 94.22 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 116.133 1.901 . . . . 2.85 116.133 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -76.68 63.89 7.42 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.819 3.013 . . . . 4.66 110.2 157.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 66.37 -18.2 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 130.022 3.329 . . . . 4.5 116.66 163.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.51 -30.16 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.244 -0.91 . . . . 3.57 112.782 -170.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 17.5 m -58.58 -64.41 2.9 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 116.745 -1.598 . . . . 1.62 112.03 166.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -63.27 -26.32 71.88 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.756 1.663 . . . . 1.42 113.88 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.55 -59.69 3.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.924 1.238 . . . . 3.04 111.308 171.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.66 -29.68 69.04 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.576 0.751 . . . . 3.48 111.936 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.94 -28.18 67.25 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.376 -1.452 . . . . 3.28 112.423 170.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -69.93 -49.66 49.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.354 0.979 . . . . 3.9 109.378 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -55.69 -39.47 71.04 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.788 -1.195 . . . . 3.96 112.004 176.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.3 ttm -55.78 -48.73 74.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.298 1.839 . . . . 2.85 111.714 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 12.6 mm -66.06 -37.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 120.362 1.437 . . . . 1.52 110.464 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -62.33 -31.97 72.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.049 -1.453 . . . . 3.14 113.321 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.3 p -86.39 -34.77 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.788 1.176 . . . . 2.49 114.151 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.4 t -57.14 -44.45 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.896 1.226 . . . . 2.66 111.32 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.67 -31.38 66.73 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.124 0.97 . . . . 4.52 112.67 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -64.23 -49.69 70.94 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.992 -1.067 . . . . 2.93 112.195 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 187' ' ' ILE . 5.4 mm -64.86 -38.7 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.093 0.957 . . . . 2.53 113.397 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.12 -42.57 90.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.422 1.089 . . . . 2.89 110.315 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.1 t -70.46 -11.52 60.98 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.999 1.111 . . . . 2.81 113.999 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.21 -23.51 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.82 1.191 . . . . 3.18 110.84 169.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 67.07 -20.47 0.11 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.025 2.53 . . . . 4.09 115.714 167.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 48.2 p -67.42 -39.14 85.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.523 -1.361 . . . . 5.73 110.885 165.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.96 158.48 75.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.207 1.403 . . . . 4.49 111.444 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.57 -32.56 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.156 2.57 . . . . 3.23 113.812 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 t70 160.04 153.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.584 3.554 . . . . 3.66 108.748 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 36.0 tp -123.11 90.21 3.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.439 1.496 . . . . 2.06 107.958 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.2 m -75.03 125.64 89.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 O-C-N 121.069 -1.02 . . . . 1.59 110.265 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.46 133.37 4.54 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.093 2.528 . . . . 0.86 111.183 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.29 97.73 5.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.238 1.415 . . . . 3.11 109.12 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -84.03 129.99 34.89 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.267 1.027 . . . . 2.48 109.847 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.03 129.82 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.498 1.119 . . . . 1.77 109.03 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.6 t -92.69 117.62 30.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.152 0.581 . . . . 2.88 111.53 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -90.01 40.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.145 -0.972 . . . . 1.94 112.321 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -121.39 55.22 5.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.522 1.129 . . . . 3.3 112.624 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.95 66.94 8.7 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 125.064 3.843 . . . . 2.57 111.956 -166.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -151.97 -63.08 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.064 1.746 . . . . 6.72 109.282 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.04 27.1 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 6.46 113.334 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -80.95 156.36 26.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.889 0.852 . . . . 4.93 112.348 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 m -170.02 129.72 0.95 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.137 2.575 . . . . 2.9 106.639 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -52.57 -43.34 65.2 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.995 0.918 . . . . 4.25 112.347 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -64.28 -32.99 74.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.419 1.888 . . . . 3.74 114.228 172.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.51 72.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.954 1.252 . . . . 1.74 111.341 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.29 -40.2 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.882 -0.511 . . . . 1.73 110.357 169.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.07 68.46 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.333 -0.841 . . . . 1.98 113.096 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.8 -51.6 64.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.369 0.986 . . . . 5.17 111.65 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -57.15 -41.84 79.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.545 0.688 . . . . 4.94 111.539 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.3 t -65.35 -15.9 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.883 0.873 . . . . 1.34 112.521 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.66 -39.23 12.59 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 119.716 -1.865 . . . . 5.64 113.349 166.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.56 -53.66 48.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.193 1.397 . . . . 4.9 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -76.26 -52.34 10.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.996 0.739 . . . . 2.63 112.996 -171.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.8 t -179.44 145.23 0.42 Allowed Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.152 1.381 . . . . 1.99 110.514 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.83 -16.12 37.13 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.793 2.329 . . . . 2.28 114.27 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -72.22 -20.86 61.49 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.443 1.474 . . . . 1.99 112.974 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.6 tp -68.86 149.04 49.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.26 1.424 . . . . 1.98 113.346 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.81 141.12 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.151 0.981 . . . . 2.27 110.82 166.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.45 114.28 3.6 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.678 -1.369 . . . . 1.28 109.678 175.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.22 145.14 36.35 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.446 0.698 . . . . 2.5 109.871 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.9 m -154.46 163.71 39.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.391 1.076 . . . . 2.85 109.155 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -150.05 170.76 30.08 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 124.022 0.82 . . . . 1.88 111.345 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -61.4 162.44 7.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 3.22 110.342 164.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -48.28 -31.76 6.39 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.694 1.198 . . . . 7.99 113.741 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -67.98 -43.33 79.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.023 1.729 . . . . 3.48 111.873 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.07 -34.0 68.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.407 1.083 . . . . 3.25 111.19 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.23 -39.51 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 118.485 -0.769 . . . . 2.14 110.504 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.31 -43.06 92.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 117.539 -1.22 . . . . 3.32 110.219 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -52.59 -59.04 4.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.87 1.214 . . . . 3.55 111.306 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.7 -34.28 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.145 0.884 . . . . 3.5 112.675 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.71 86.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.681 -0.637 . . . . 2.34 111.817 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -76.74 -41.7 44.0 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.824 2.45 . . . . 4.49 112.081 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.04 50.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.055 1.342 . . . . 2.84 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.48 -2.32 57.92 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.165 0.802 . . . . 4.38 113.165 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 62.77 42.58 7.89 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.274 1.83 . . . . 6.87 112.011 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.3 m -73.79 148.97 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.828 1.251 . . . . 3.33 112.079 -165.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -76.23 132.33 39.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.812 0.845 . . . . 3.41 112.568 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -171.73 161.6 6.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.124 2.17 . . . . 3.61 111.721 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 33.4 t -150.53 108.7 3.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.941 1.296 . . . . 3.04 110.799 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.3 128.54 2.63 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.791 2.327 . . . . 2.81 112.446 -172.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -90.38 146.3 18.52 Favored Glycine 0 CA--C 1.541 1.685 0 C-N-CA 124.24 0.924 . . . . 2.96 112.303 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.89 173.64 13.67 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.469 2.78 . . . . 4.84 110.077 170.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.574 ' HE2' ' CD1' ' A' ' 256' ' ' TYR . 9.7 mmtp -67.13 127.84 34.11 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.933 -0.479 . . . . 6.98 111.144 169.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -77.64 -29.91 51.93 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.758 0.823 . . . . 6.36 112.373 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.47 -77.12 0.34 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.794 1.638 . . . . 8.31 109.777 159.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -121.16 -56.53 1.91 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.373 1.069 . . . . 8.21 113.513 -173.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.85 49.19 1.14 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.475 1.11 . . . . 9.15 110.613 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -138.87 152.44 47.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.599 -0.728 . . . . 4.98 109.162 156.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.574 ' CD1' ' HE2' ' A' ' 250' ' ' LYS . 0.2 OUTLIER 164.44 163.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 129.499 3.12 . . . . 6.41 109.733 -163.089 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.1 tp -135.13 139.4 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.152 -0.968 . . . . 3.17 108.619 167.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.58 110.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 105.28 -2.118 . . . . 3.14 105.28 155.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.82 138.41 57.32 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.001 -1.111 . . . . 3.27 108.001 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -156.42 152.15 27.15 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.71 -1.244 . . . . 2.18 113.743 -166.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 58.5 p 3.71 -57.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 131.485 3.914 . . . . 4.88 119.541 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 62.52 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 128.9 2.88 . . . . 4.51 112.868 -160.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.4 pt -84.5 146.59 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 114.826 1.417 . . . . 3.32 114.826 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ttm -111.62 135.4 52.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.028 2.531 . . . . 2.23 108.871 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 135.37 47.23 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.157 -0.964 . . . . 3.03 113.386 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.84 118.82 25.57 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.026 0.93 . . . . 2.09 109.312 164.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.32 131.48 47.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.137 -1.801 . . . . 2.15 106.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -79.01 178.43 53.6 Favored Glycine 0 CA--C 1.536 1.404 0 N-CA-C 113.835 0.294 . . . . 1.91 113.835 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -74.69 58.08 4.56 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.413 3.409 . . . . 2.67 108.712 163.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.81 -63.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.938 1.695 . . . . 4.47 109.511 -149.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.17 -22.55 9.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.469 1.509 . . . . 3.39 114.995 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -83.15 169.44 15.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.867 1.334 . . . . 4.0 112.207 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -83.17 134.32 34.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.149 0.98 . . . . 5.1 111.249 169.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.69 -24.66 9.5 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.011 1.115 . . . . 3.62 114.011 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -160.3 166.75 28.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.047 1.339 . . . . 3.18 111.187 161.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -131.01 140.46 50.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.709 1.204 . . . . 3.76 112.764 172.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.1 -172.51 2.23 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.288 2.235 . . . . 2.77 108.532 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.55 73.11 0.5 Allowed Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.581 1.086 . . . . 3.29 110.758 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 88.63 151.03 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.104 2.962 . . . . 3.94 112.809 176.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.4 t30 69.16 -43.64 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.909 2.884 . . . . 4.83 115.624 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.32 113.44 4.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.23 0.923 . . . . 5.08 110.106 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 150.84 38.23 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.902 -0.499 . . . . 6.12 110.411 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -57.94 -36.46 72.55 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 119.66 -1.9 . . . . 1.99 115.178 -168.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.36 80.23 Favored Glycine 0 N--CA 1.483 1.778 0 O-C-N 120.661 -1.274 . . . . 2.11 116.038 170.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.58 -36.43 29.04 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.149 1.78 . . . . 4.72 110.308 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.86 -41.88 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.681 0.792 . . . . 1.65 108.908 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.84 96.18 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.301 0.852 . . . . 1.87 113.301 170.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.25 84.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.437 1.017 . . . . 2.1 113.224 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 p -68.7 -44.85 73.06 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 1.96 111.696 172.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.82 -35.12 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 119.992 1.269 . . . . 2.0 112.373 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.25 65.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.459 -1.401 . . . . 2.61 113.043 170.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.2 m -81.88 -44.51 16.75 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.796 0.838 . . . . 2.76 109.805 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -62.28 -25.08 67.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.551 1.14 . . . . 2.93 112.994 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 ttt -58.67 -34.74 71.58 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.114 0.966 . . . . 4.99 112.127 167.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -53.4 -49.01 90.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 116.62 -1.657 . . . . 4.21 113.945 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.62 -56.78 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.38 2.054 . . . . 3.69 111.702 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -88.17 29.81 0.92 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.982 1.475 . . . . 4.43 114.982 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 117.78 7.2 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.771 -1.205 . . . . 8.23 109.205 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -100.94 -31.89 10.91 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.078 1.51 . . . . 10.74 115.078 -146.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.41 27.3 0.29 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.345 1.458 . . . . 6.93 111.354 -175.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 C--O 1.243 0.761 0 C-N-CA 130.756 3.623 . . . . 6.84 105.058 -138.865 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 118.081 -0.961 . . . . 21.84 110.054 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -156.07 168.77 26.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.747 1.219 . . . . 17.69 109.988 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -144.49 -170.52 3.4 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.624 1.57 . . . . 16.52 110.429 -169.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.08 170.11 42.65 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.205 0.907 . . . . 12.85 114.237 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -167.92 141.57 2.77 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.01 1.724 . . . . 11.16 110.217 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.56 149.25 61.52 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.083 1.855 . . . . 7.68 109.177 163.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.3 mt -147.88 167.22 25.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.891 1.676 . . . . 7.22 110.037 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.94 150.05 31.3 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.563 1.945 . . . . 5.88 108.858 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.05 -138.68 37.27 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.14 -1.184 . . . . 3.92 110.14 -165.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.67 161.91 32.63 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-O 118.944 -0.92 . . . . 2.6 114.355 167.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -93.28 171.35 2.07 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.346 3.364 . . . . 3.5 112.102 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.99 166.82 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.839 1.256 . . . . 3.45 111.349 162.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 m -140.58 29.68 1.93 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.098 1.518 . . . . 2.79 115.098 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -54.65 148.46 12.55 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.355 1.243 . . . . 2.42 114.355 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.1 m -72.31 139.31 47.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.369 1.468 . . . . 1.55 108.929 168.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.1 m -108.33 154.71 21.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.757 1.623 . . . . 3.56 109.126 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -60.25 -17.78 44.26 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.12 1.155 . . . . 2.24 114.12 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -65.04 -23.18 67.12 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.286 2.234 . . . . 4.5 113.749 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.21 -6.05 53.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.794 1.664 . . . . 2.06 114.134 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.25 174.25 9.22 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 4.22 111.972 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.19 130.56 48.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.003 0.521 . . . . 6.81 109.685 160.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -102.0 172.66 6.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.6 0.76 . . . . 3.35 110.678 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.72 154.48 13.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.734 2.014 . . . . 3.22 107.655 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -45.9 -26.25 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.45 2.3 . . . . 4.16 114.401 164.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -98.94 -1.06 40.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.171 1.545 . . . . 6.25 115.171 173.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.74 -59.97 2.1 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.549 -0.908 . . . . 3.41 108.549 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -62.04 -30.95 71.32 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.389 0.885 . . . . 3.87 113.389 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.78 -108.64 0.45 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.326 1.85 . . . . 4.98 110.566 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -135.78 105.67 0.54 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.489 -2.644 . . . . 3.62 106.489 165.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -107.01 -26.01 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.504 -1.236 . . . . 3.64 114.319 166.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.542 ' CD1' HD23 ' A' ' 193' ' ' LEU . 49.1 m95 117.77 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 1 C-N-CA 132.185 4.194 . . . . 2.2 109.02 -161.35 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.23 135.73 43.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.442 1.097 . . . . 2.95 109.836 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 10.1 mt -118.73 104.8 10.93 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.832 1.653 . . . . 2.68 106.908 168.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.9 pt -99.61 135.79 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.308 0.243 . . . . 3.61 111.283 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -140.37 143.8 35.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.428 1.091 . . . . 3.45 112.324 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -123.75 117.34 24.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.433 1.493 . . . . 2.8 109.37 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.55 -177.74 15.16 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.612 1.101 . . . . 1.68 114.333 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 135.5 46.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.363 1.465 . . . . 3.71 109.972 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 m -79.39 59.09 2.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.2 1.4 . . . . 3.43 110.189 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -152.59 -104.7 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.88 2.472 . . . . 7.56 107.597 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.5 OUTLIER 69.6 152.8 0.14 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 130.147 3.379 . . . . 3.01 116.887 173.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 60.6 Cg_endo -92.03 -17.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.497 2.798 . . . . 3.75 113.366 159.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 168.79 -37.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.385 1.448 . . . . 4.66 113.245 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -25.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 115.581 1.697 . . . . 3.32 115.581 -160.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 m -66.89 -62.25 4.02 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.59 1.086 . . . . 1.86 111.47 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.2 -25.43 57.73 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.508 1.472 . . . . 1.17 113.781 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.63 -23.68 67.34 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.272 1.212 . . . . 3.04 114.272 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -101.32 -18.79 15.91 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.977 1.262 . . . . 3.83 113.867 162.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.53 -43.54 98.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.661 1.573 . . . . 2.8 111.195 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.07 -55.29 18.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 3.41 112.128 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -62.55 -45.44 92.95 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.347 -1.471 . . . . 2.83 111.335 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ttm -56.24 -41.23 75.41 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.586 1.955 . . . . 2.38 112.138 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.6 mm -59.98 -54.38 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.483 -0.932 . . . . 1.99 108.483 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.476 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 63.0 mt-30 -63.51 -27.45 69.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 117.877 -1.058 . . . . 3.08 112.592 -174.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.6 -37.21 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 120.932 1.697 . . . . 2.01 111.872 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -20.14 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.733 0.813 . . . . 2.97 112.766 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -46.05 82.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.794 1.237 . . . . 4.85 111.314 170.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -66.95 -39.48 87.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.82 0.282 . . . . 2.98 111.558 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.445 HG23 HD22 ' A' ' 193' ' ' LEU . 8.4 mm -65.85 -46.21 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.661 -0.649 . . . . 2.13 112.448 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -65.9 -35.78 81.57 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.233 0.469 . . . . 3.74 110.713 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.7 m -73.57 -23.12 59.91 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.325 1.231 . . . . 2.92 114.325 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 11.0 mm -81.83 -28.29 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.261 1.424 . . . . 3.0 110.467 167.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.4 m 67.17 -12.4 0.24 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.905 2.482 . . . . 4.82 114.242 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 58.0 m -84.43 -30.31 25.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.549 1.94 . . . . 3.82 112.128 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.542 HD23 ' CD1' ' A' ' 159' ' ' TRP . 7.0 mp -63.46 159.73 48.44 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.67 1.188 . . . . 4.0 109.788 173.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -61.76 -46.04 15.14 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.392 1.394 . . . . 3.72 109.31 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -168.09 -178.55 3.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.126 2.57 . . . . 3.96 109.537 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 51.8 tp -125.67 123.57 39.23 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.563 -1.643 . . . . 2.05 106.563 150.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.8 m -106.27 98.89 20.97 Favored Pre-proline 0 N--CA 1.465 0.298 0 C-N-CA 124.67 1.188 . . . . 1.17 108.952 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.09 137.19 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.444 . . . . 0.95 109.737 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.91 111.18 9.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 123.061 1.41 . . . . 3.71 112.899 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.69 134.73 34.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.215 1.806 . . . . 2.72 109.676 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.3 mt -120.36 131.78 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.154 1.782 . . . . 1.57 106.984 168.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.37 126.22 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.741 0.701 . . . . 3.04 110.367 170.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.1 pt -98.96 16.77 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.531 1.133 . . . . 2.16 113.176 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.91 44.82 0.2 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 127.395 2.278 . . . . 3.58 114.25 168.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.59 -8.64 21.87 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.414 2.742 . . . . 2.09 115.163 -169.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.23 0.4 0.27 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.321 1.848 . . . . 5.29 114.223 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.77 30.55 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.321 2.648 . . . . 4.56 111.412 -165.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.77 -174.75 3.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.146 1.379 . . . . 3.99 111.057 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.5 t -162.36 151.08 14.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.673 1.225 . . . . 4.02 112.891 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.53 -34.92 59.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.746 1.618 . . . . 2.75 112.825 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.57 71.31 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.797 1.239 . . . . 3.62 114.05 174.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.34 74.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.923 1.238 . . . . 1.75 110.862 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.4 mm -60.39 -43.56 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.131 0.972 . . . . 1.95 111.616 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.53 89.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.341 0.656 . . . . 1.38 111.74 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.425 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 6.3 t30 -65.32 -43.84 89.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.526 -0.734 . . . . 3.16 112.188 173.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -56.51 -41.39 76.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.736 0.815 . . . . 2.98 111.404 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.3 -46.09 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.271 1.428 . . . . 1.15 111.996 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 8.3 mtmp? -52.51 -55.13 24.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.673 1.124 . . . . 4.14 112.73 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -33.62 59.91 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.822 0.675 . . . . 4.65 112.822 -160.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -73.95 -36.42 64.62 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.507 0.594 . . . . 2.95 111.613 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 m 153.38 136.15 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 129.886 3.274 . . . . 3.13 110.829 161.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -68.28 1.95 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.63 2.887 . . . . 2.55 114.47 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -66.69 -16.44 64.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 121.154 -0.966 . . . . 2.1 112.145 162.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.5 tp -80.75 145.36 31.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.654 1.581 . . . . 1.8 111.805 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.9 t -102.02 137.6 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.589 1.156 . . . . 1.87 109.572 167.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.86 132.42 9.86 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.442 1.02 . . . . 1.14 111.731 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.88 151.6 48.18 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.737 1.215 . . . . 2.44 112.211 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -166.16 -158.29 0.33 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.854 2.462 . . . . 2.95 109.135 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 152.75 -115.34 0.68 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 108.834 -1.706 . . . . 1.86 108.834 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.2 p -113.42 166.49 11.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.838 0.828 . . . . 3.25 111.656 166.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.62 -33.65 47.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.158 1.783 . . . . 6.91 113.084 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -67.62 -43.55 80.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.068 0.947 . . . . 2.93 112.112 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -70.31 -40.37 74.25 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.356 0.98 . . . . 5.51 111.577 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.6 t -55.27 -38.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.863 0.865 . . . . 2.07 111.988 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.5 -45.82 64.9 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 117.385 -1.293 . . . . 4.03 110.301 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -52.04 -53.96 35.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.026 1.739 . . . . 3.26 111.342 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.09 -32.31 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 113.226 0.824 . . . . 2.61 113.226 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.65 -47.93 61.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.907 -1.12 . . . . 2.36 111.306 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -70.87 -34.06 71.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.611 2.764 . . . . 4.19 112.147 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.13 9.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.332 1.453 . . . . 2.32 111.195 169.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.32 8.68 8.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.043 0.757 . . . . 3.24 113.043 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 42.44 43.92 3.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.258 2.223 . . . . 5.08 113.251 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 263' ' ' ILE . 7.9 p -69.72 -30.2 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 118.444 -0.789 . . . . 4.77 112.711 -172.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.7 t80 67.32 156.49 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.368 1.867 . . . . 3.38 113.9 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -176.88 164.44 2.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.476 2.711 . . . . 3.29 109.558 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.5 t -154.77 99.16 2.42 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 121.546 -0.721 . . . . 3.19 111.017 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -95.63 154.33 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.141 3.228 . . . . 3.1 112.252 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.95 169.17 52.87 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 116.304 -0.407 . . . . 2.83 112.969 166.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -81.11 136.89 10.48 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.856 3.037 . . . . 5.13 110.057 168.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 138.46 58.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.503 1.297 . . . . 5.39 114.503 -172.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -130.41 178.05 6.89 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.833 1.653 . . . . 8.02 111.836 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.264 17.5 tt0 40.0 -108.69 0.08 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.553 3.141 . . . . 8.17 112.572 -170.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -81.32 -60.84 2.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.217 1.407 . . . . 9.52 109.888 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.28 36.5 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.197 1.399 . . . . 8.95 112.633 -176.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -103.83 155.19 18.81 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.962 0.887 . . . . 4.25 111.903 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -179.92 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.308 2.643 . . . . 6.31 113.464 -168.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 33.8 mm 70.49 157.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.855 2.062 . . . . 3.83 111.367 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.25 140.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.243 1.417 . . . . 4.66 108.894 170.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -63.18 108.83 1.35 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.428 1.491 . . . . 4.68 109.951 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -75.97 10.48 1.86 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.495 1.918 . . . . 5.49 115.558 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.0 m -74.69 95.7 2.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.826 1.25 . . . . 5.95 109.807 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.93 156.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.9 1.28 . . . . 4.93 111.053 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.436 ' H ' HG23 ' A' ' 243' ' ' VAL . 70.8 mt -133.97 134.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.282 1.433 . . . . 2.67 109.342 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 89.5 mtp -89.89 145.5 25.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.926 0.891 . . . . 2.29 111.045 171.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -126.21 153.4 44.73 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.332 1.053 . . . . 2.8 112.354 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 10.6 tp -103.62 131.63 50.59 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.044 1.738 . . . . 2.03 109.996 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 130.71 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 107.524 -1.287 . . . . 1.91 107.524 162.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.4 179.84 53.15 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.682 1.134 . . . . 2.27 114.425 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.435 ' HB2' ' HE3' ' A' ' 299' ' ' LYS . 14.0 Cg_endo -91.89 75.46 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.251 3.301 . . . . 3.97 110.367 -178.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.7 t70 177.19 -77.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.647 -1.615 . . . . 4.78 108.822 -135.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.79 -16.63 2.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 117.359 -1.801 . . . . 2.88 115.156 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.83 168.57 9.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.532 1.666 . . . . 4.83 114.397 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.46 150.97 29.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.056 2.142 . . . . 6.21 113.534 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.0 mt -136.64 -38.73 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.424 1.638 . . . . 2.64 115.424 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -166.36 167.45 15.85 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.616 1.098 . . . . 2.65 113.306 -168.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.29 158.82 43.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.923 1.289 . . . . 5.19 113.911 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.05 177.21 9.33 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.202 1.401 . . . . 2.38 114.207 -170.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.9 -177.1 22.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.179 2.8 . . . . 3.35 109.736 -169.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -55.34 1.14 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 119.785 3.254 . . . . 4.37 119.785 -166.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -111.63 -6.45 14.37 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.402 1.63 . . . . 5.29 115.402 165.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -116.79 89.27 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.459 1.104 . . . . 4.39 109.965 157.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.7 mtt85 -82.88 -167.85 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.134 1.774 . . . . 6.01 110.062 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.6 tmtt? -40.21 -57.71 1.65 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.148 1.779 . . . . 2.33 115.149 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.51 -38.37 51.99 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 123.437 0.542 . . . . 1.85 112.031 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.11 -33.05 75.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.894 0.877 . . . . 4.45 112.289 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 30.2 mt -68.4 -56.15 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.505 0.722 . . . . 1.64 110.049 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.06 78.7 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.096 0.776 . . . . 1.85 113.096 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -71.37 -33.86 69.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.631 1.173 . . . . 2.46 113.732 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.9 p -68.78 -45.27 71.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.662 -1.161 . . . . 1.87 111.288 168.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.6 mt -56.31 -42.28 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.41 1.459 . . . . 1.47 111.492 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.56 -28.5 69.68 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.141 -0.974 . . . . 1.95 113.342 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.5 m -73.1 -43.6 61.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.318 1.047 . . . . 2.71 110.132 172.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -64.68 -25.91 68.15 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.722 1.209 . . . . 3.16 112.353 172.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.1 ttp -69.93 -16.81 63.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.638 1.575 . . . . 4.51 112.676 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -51.77 77.56 Favored Pre-proline 0 CA--C 1.553 1.086 0 O-C-N 120.195 -1.566 . . . . 6.62 110.438 174.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.0 -51.61 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.074 1.849 . . . . 2.46 111.038 166.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.92 44.2 0.98 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.596 1.332 . . . . 3.27 114.596 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -64.88 148.77 50.77 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.341 -0.85 . . . . 8.9 109.279 163.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 269' ' ' PRO . 63.1 mttm -146.36 172.58 13.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.504 1.122 . . . . 9.71 109.933 174.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 83.3 mttt 75.89 -10.19 1.31 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 128.337 2.655 . . . . 7.73 113.048 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 29.4 m . . . . . 0 C--O 1.252 1.197 1 C-N-CA 133.763 4.825 . . . . 7.92 107.255 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 117.919 -1.039 . . . . 28.8 108.759 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -161.85 -178.67 6.64 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.103 1.761 . . . . 24.0 109.524 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.1 t -165.61 173.38 10.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.444 2.298 . . . . 21.14 108.454 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.57 -163.49 31.22 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.38 0.99 . . . . 16.62 113.686 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -151.5 161.67 28.95 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.818 1.647 . . . . 13.48 110.838 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.75 -177.53 3.19 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.14 2.56 . . . . 9.88 110.166 162.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 tt -149.88 123.19 8.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.735 1.214 . . . . 8.3 107.938 167.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.5 tp -161.77 -17.22 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.747 1.619 . . . . 7.3 114.023 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.18 126.58 41.87 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.65 1.02 . . . . 3.76 115.65 -165.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.92 125.03 5.4 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.918 1.723 . . . . 3.42 110.091 171.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.34 165.0 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.256 2.637 . . . . 3.35 112.691 -170.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -91.45 159.91 15.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.77 1.228 . . . . 3.17 109.007 166.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 m -142.31 57.23 1.46 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 120.159 1.345 . . . . 2.27 114.145 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.81 166.24 12.29 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 119.69 -1.882 . . . . 3.51 113.814 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 m -89.75 152.76 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.493 1.917 . . . . 2.37 108.762 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.5 p -95.87 161.25 14.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.395 1.093 . . . . 2.82 112.524 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -52.72 -33.7 49.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.612 2.365 . . . . 2.11 113.461 170.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.5 p -76.0 -47.61 24.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.098 1.359 . . . . 4.35 111.5 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.07 39.25 0.46 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.407 1.003 . . . . 3.0 114.672 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 -179.66 3.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.712 1.605 . . . . 3.46 109.059 170.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.53 97.28 3.53 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.128 1.331 . . . . 5.14 110.697 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.06 159.69 15.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.761 1.224 . . . . 3.14 112.411 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 153' ' ' LYS . 67.7 m -139.16 149.74 44.8 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.33 1.852 . . . . 3.91 107.167 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -25.13 61.2 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.105 0.955 . . . . 3.89 112.702 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.452 ' H ' HG22 ' A' ' 151' ' ' THR . 1.5 mmmp? -68.26 -18.34 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.552 1.686 . . . . 5.57 115.552 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.4 -48.11 36.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.852 1.261 . . . . 3.23 109.341 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -89.47 13.34 14.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.643 1.177 . . . . 3.42 113.187 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.78 118.46 6.67 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.344 -1.472 . . . . 5.17 109.683 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 104.89 -8.66 46.37 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 123.656 0.646 . . . . 3.31 114.38 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -80.77 -154.65 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.223 1.409 . . . . 3.44 111.412 -170.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -126.16 119.45 27.55 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.289 -1.507 . . . . 2.14 107.215 154.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.25 45.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.012 0.91 . . . . 3.38 111.701 -173.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 mt -131.37 135.56 47.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.219 1.807 . . . . 3.25 108.964 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.65 132.66 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.667 0.787 . . . . 2.47 110.007 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -139.88 148.91 42.74 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.265 1.426 . . . . 2.63 112.217 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -114.92 118.76 34.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.398 1.479 . . . . 3.2 108.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -124.48 160.53 19.07 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 116.858 1.503 . . . . 2.0 116.858 -166.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -100.53 22.62 11.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.532 2.333 . . . . 5.0 110.366 165.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 34.3 m 70.51 -66.59 0.28 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.02 2.528 . . . . 5.14 110.972 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -108.5 -29.04 8.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 117.696 -1.145 . . . . 9.83 113.147 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER 61.22 -172.03 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.699 1.199 . . . . 2.25 113.284 -176.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 89.3 Cg_endo -69.06 61.18 1.34 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.57 2.18 . . . . 3.61 110.161 139.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 65.25 -4.23 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 129.817 3.247 . . . . 4.44 115.808 166.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.11 -33.43 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 117.878 -1.058 . . . . 3.06 113.847 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.5 m -48.24 -60.68 4.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 120.452 1.478 . . . . 1.41 112.454 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 -24.35 42.42 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.427 2.085 . . . . 1.29 114.414 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.3 -43.96 96.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.971 1.26 . . . . 3.08 111.398 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.54 -35.17 75.19 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.128 -0.983 . . . . 3.44 111.571 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 -56.36 20.1 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.828 1.251 . . . . 3.04 111.651 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.02 -43.97 94.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.057 0.844 . . . . 3.79 110.267 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -54.07 -39.46 66.3 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.035 -1.666 . . . . 4.09 113.016 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ptp -68.74 -34.82 76.27 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.988 1.722 . . . . 2.76 113.771 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.2 mm -66.02 -42.78 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 120.34 1.427 . . . . 1.96 111.436 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.404 ' HB3' ' CD ' ' A' ' 283' ' ' LYS . 83.8 mm-40 -63.3 -37.97 89.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.606 1.562 . . . . 3.41 110.847 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.53 -45.47 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.674 -0.642 . . . . 2.69 111.989 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.59 -40.09 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.253 1.021 . . . . 2.2 113.04 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -58.06 7.48 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.048 1.339 . . . . 6.22 111.91 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.05 -40.12 92.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.417 0.525 . . . . 4.67 112.417 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 56.3 mt -59.9 -48.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.339 1.856 . . . . 3.41 112.651 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.07 -48.38 81.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.946 1.298 . . . . 3.46 109.371 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.8 t -68.92 -6.07 25.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.952 2.101 . . . . 3.92 114.409 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 191' ' ' THR . 32.8 mm -56.62 -48.61 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 119.626 1.103 . . . . 4.9 110.291 171.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 190' ' ' ILE . 32.9 p -171.55 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.464 2.394 . . . . 6.45 117.464 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.253 5.7 t 102.36 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.065 1.746 . . . . 5.23 107.438 -121.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.3 mp -93.39 161.86 29.57 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.456 -0.778 . . . . 3.62 110.495 136.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -86.16 35.84 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.199 3.932 . . . . 3.73 111.308 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 t0 70.0 174.72 0.29 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.143 2.577 . . . . 4.22 114.022 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.09 134.97 44.99 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.088 1.755 . . . . 3.04 108.1 166.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.8 m -107.43 100.71 35.39 Favored Pre-proline 0 N--CA 1.47 0.575 0 C-N-CA 123.619 0.767 . . . . 1.79 110.2 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.7 127.34 4.26 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.001 2.468 . . . . 1.57 111.099 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.02 108.52 19.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.749 2.02 . . . . 2.85 109.174 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -99.55 113.68 26.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.159 -0.682 . . . . 3.09 109.159 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.18 119.46 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.198 -0.667 . . . . 2.58 109.198 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.7 m -80.45 133.53 35.87 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.431 -0.793 . . . . 2.97 111.513 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.447 ' HA ' HG11 ' A' ' 234' ' ' VAL . 37.4 pt -82.23 -1.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 114.093 1.146 . . . . 2.66 114.093 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.65 48.89 0.23 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 127.425 2.29 . . . . 3.12 114.026 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.63 -6.79 19.28 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.636 2.224 . . . . 4.23 113.458 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -81.8 -2.76 51.99 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.303 0.956 . . . . 4.32 112.845 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.79 -27.48 1.29 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.62 1.341 . . . . 6.11 114.62 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -109.15 141.21 41.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.216 1.371 . . . . 6.79 111.915 172.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 82.7 p -95.64 159.71 14.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.551 1.167 . . . . 3.72 112.805 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -54.77 -36.71 65.16 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.193 1.397 . . . . 3.51 112.335 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -71.93 -33.51 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.112 1.365 . . . . 3.07 112.877 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.27 91.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.586 1.084 . . . . 1.78 112.248 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . 0.269 4.3 tp -70.57 -23.54 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 121.123 -0.986 . . . . 3.05 113.142 173.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.85 -42.61 94.75 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.563 -1.336 . . . . 1.86 111.924 167.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -58.57 -41.01 84.7 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.436 -0.79 . . . . 4.88 112.082 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -62.63 -45.62 92.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.676 1.191 . . . . 3.55 112.136 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.6 t -52.21 -44.31 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.036 -1.04 . . . . 1.97 111.55 169.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -13.1 62.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.361 1.245 . . . . 5.49 114.361 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -79.1 -47.05 16.82 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.419 1.463 . . . . 4.36 110.666 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -95.19 -50.23 5.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.581 0.956 . . . . 3.46 113.581 -172.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 170.52 141.06 0.09 OUTLIER Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 124.715 1.206 . . . . 2.48 113.293 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.57 -5.64 17.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.794 2.996 . . . . 1.81 114.217 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -71.83 -16.91 62.17 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.948 1.249 . . . . 2.15 112.959 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.06 132.35 44.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.335 0.97 . . . . 2.06 109.892 174.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.9 119.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.943 -1.502 . . . . 1.92 106.943 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.96 134.83 12.7 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 107.949 -2.061 . . . . 1.33 107.949 163.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.02 151.18 39.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.991 0.916 . . . . 2.57 110.399 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 229' ' ' GLY . 11.6 m -152.76 -179.9 8.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.166 2.186 . . . . 3.15 107.332 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.446 ' H ' HG22 ' A' ' 228' ' ' THR . . . 171.85 -132.34 2.4 Favored Glycine 0 N--CA 1.468 0.792 0 O-C-N 120.175 -1.578 . . . . 3.23 110.619 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.5 p -96.88 155.34 16.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.291 -1.003 . . . . 2.96 108.291 155.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.31 -26.82 65.33 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 117.912 -1.042 . . . . 6.48 111.818 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -66.38 -34.35 77.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.424 1.465 . . . . 3.49 111.802 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.25 -37.78 75.01 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.026 -1.047 . . . . 3.32 111.439 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.447 HG11 ' HA ' ' A' ' 203' ' ' ILE . 21.5 t -64.89 -33.73 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 122.128 -0.357 . . . . 2.51 111.191 173.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.16 -35.39 71.62 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.35 1.06 . . . . 3.37 111.0 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -57.7 -54.18 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.086 0.857 . . . . 2.74 110.76 174.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.11 -33.97 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.098 0.777 . . . . 1.89 113.098 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.47 -48.31 75.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.153 0.981 . . . . 1.87 111.792 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -32.81 69.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.353 2.261 . . . . 4.65 112.869 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.47 -67.01 0.48 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.525 1.057 . . . . 2.54 110.138 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -72.36 4.14 4.03 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.389 1.255 . . . . 2.54 114.389 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 58.96 44.72 16.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.29 1.836 . . . . 5.31 113.799 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.41 144.81 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.57 -0.706 . . . . 3.42 111.401 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.09 136.93 33.82 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.789 -0.57 . . . . 3.59 110.701 165.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -162.05 161.68 28.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.021 1.729 . . . . 3.38 111.322 176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.4 m -164.26 115.1 0.95 Allowed Pre-proline 0 N--CA 1.478 0.952 0 O-C-N 121.055 -1.028 . . . . 2.68 112.644 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -88.63 140.18 4.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.426 2.751 . . . . 2.81 113.771 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.59 119.45 6.12 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 110.239 -1.144 . . . . 2.88 110.239 163.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.63 -21.02 15.12 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.05 2.5 . . . . 5.01 116.544 -167.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 151.58 60.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 130.06 3.344 . . . . 5.2 110.653 -175.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.09 148.68 21.94 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.46 1.904 . . . . 6.4 111.731 -166.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.13 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 130.347 3.459 . . . . 7.93 117.777 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 30.6 t70 179.07 -49.32 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 129.929 3.292 . . . . 5.87 110.124 160.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -168.88 130.92 1.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.535 1.934 . . . . 5.47 110.098 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -179.43 -64.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.843 2.057 . . . . 4.32 110.762 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.1 t80 69.45 42.25 1.18 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.115 1.766 . . . . 3.6 113.616 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.4 132.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 119.296 -2.128 . . . . 2.72 111.838 170.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.78 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.156 1.383 . . . . 3.23 108.524 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.22 148.23 35.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 3.31 112.03 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -150.86 154.32 37.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.57 1.548 . . . . 2.04 110.896 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 t -59.62 153.56 19.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.495 0.718 . . . . 3.36 111.46 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.83 58.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 122.635 1.207 . . . . 3.97 108.17 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.1 mt -133.79 132.58 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.384 1.473 . . . . 2.62 108.698 -172.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 40.5 mtp -102.88 135.18 45.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.708 2.003 . . . . 2.86 111.737 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -102.54 135.19 44.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.022 1.329 . . . . 4.02 111.152 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.09 124.55 41.14 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.307 0.958 . . . . 3.74 109.54 171.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.92 131.39 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.076 -1.453 . . . . 2.69 107.076 158.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -138.45 -133.95 3.14 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.734 -1.037 . . . . 2.44 112.293 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -77.33 79.75 3.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.813 2.342 . . . . 3.84 109.922 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -171.84 -64.39 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.984 2.914 . . . . 5.9 108.346 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.27 7.23 35.39 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.958 -1.468 . . . . 4.68 116.585 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -138.26 -47.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.267 1.534 . . . . 5.54 113.443 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -168.19 156.87 8.97 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 3.61 112.53 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -151.54 -42.64 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.887 1.069 . . . . 3.28 113.887 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -170.88 172.76 5.46 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.479 1.912 . . . . 3.44 110.415 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -145.96 157.46 43.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.201 -0.937 . . . . 2.99 112.636 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' PHE . . . . . 0.437 ' CD2' HG23 ' A' ' 286' ' ' ILE . 0.1 OUTLIER -152.88 -167.63 2.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.04 1.736 . . . . 3.26 110.477 -170.428 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.92 -115.41 1.25 Allowed Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.017 1.294 . . . . 2.73 110.866 164.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.91 -7.59 1.79 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.805 1.409 . . . . 3.61 114.805 175.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -145.64 157.94 43.91 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.075 0.852 . . . . 5.21 111.045 163.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 72.47 131.29 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.959 2.104 . . . . 5.67 108.894 -143.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.67 175.63 5.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.881 2.072 . . . . 7.3 111.607 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.404 ' CD ' ' HB3' ' A' ' 182' ' ' GLN . 2.1 tmtt? -29.35 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 126.593 1.957 . . . . 2.38 113.886 -174.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.83 -19.72 69.81 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-O 119.418 -0.657 . . . . 2.16 113.839 -175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -63.88 -37.07 86.05 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.099 1.449 . . . . 3.32 111.175 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 277' ' ' PHE . 96.6 mt -68.43 -50.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.806 0.842 . . . . 2.18 110.986 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.82 88.81 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.042 -0.411 . . . . 2.33 111.601 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.29 80.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.538 . . . . 2.22 113.453 173.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.5 p -60.57 -43.27 97.51 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.832 1.196 . . . . 2.2 111.501 167.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.48 -33.77 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.445 -1.409 . . . . 2.33 111.997 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.51 -25.03 65.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.92 1.288 . . . . 2.51 113.272 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.8 m -75.16 -46.61 33.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.262 1.025 . . . . 2.46 109.896 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -59.2 -26.44 64.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.372 1.469 . . . . 3.1 112.832 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -59.93 -25.29 65.03 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.739 -1.226 . . . . 4.6 113.154 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -61.54 -51.75 74.77 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 117.213 -1.375 . . . . 4.77 111.824 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.71 -55.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.586 2.191 . . . . 3.55 111.463 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -81.53 77.35 8.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.011 1.324 . . . . 4.12 111.295 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -53.14 152.14 4.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.22 1.408 . . . . 9.11 112.824 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.53 154.27 8.9 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.695 -0.628 . . . . 6.49 112.629 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -88.91 -84.63 0.21 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.055 -1.461 . . . . 12.24 107.055 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.795 -1.574 . . . . 10.61 110.956 139.316 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 106.695 -1.594 . . . . 16.25 106.695 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -60.51 163.39 5.36 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 119.045 0.838 . . . . 14.05 109.693 142.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -165.99 154.93 11.46 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.703 1.601 . . . . 11.6 109.866 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.96 173.06 42.79 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.752 0.692 . . . . 10.07 111.656 165.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -150.94 116.01 3.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.039 1.336 . . . . 9.0 109.769 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.6 152.12 82.69 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.089 1.859 . . . . 7.33 109.278 167.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 tt -68.39 -82.57 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.864 0.866 . . . . 9.64 111.619 -166.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.0 mt -147.76 -153.53 0.5 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 129.018 2.927 . . . . 7.24 107.447 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.76 178.76 37.94 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.86 1.219 . . . . 4.52 113.876 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -156.6 134.17 3.93 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.734 -1.592 . . . . 3.97 110.152 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.65 159.97 41.8 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.728 2.285 . . . . 3.48 111.176 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -136.85 165.95 24.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.377 1.071 . . . . 2.71 111.909 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 p -146.04 112.33 5.81 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.771 -1.206 . . . . 2.38 112.154 157.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.08 146.91 27.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.99 0.9 . . . . 2.13 111.585 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.2 m -83.43 130.38 35.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.174 1.39 . . . . 1.74 107.572 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -84.08 168.31 16.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.483 -1.386 . . . . 2.1 112.2 -171.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -60.13 -30.28 69.19 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.818 1.247 . . . . 1.92 112.837 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 t -91.99 13.52 18.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.633 1.573 . . . . 3.05 113.129 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.98 88.01 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 119.124 0.875 . . . . 1.91 115.075 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -91.79 -168.63 2.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.04 1.736 . . . . 3.44 109.964 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -157.71 114.39 2.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 121.947 2.158 . . . . 5.05 113.401 -169.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -109.06 167.94 9.73 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.584 1.698 . . . . 2.96 115.584 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 39.9 p -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.462 2.705 . . . . 2.29 110.133 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.31 -56.95 2.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.557 1.543 . . . . 4.31 113.159 172.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -0.7 3.89 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.918 1.821 . . . . 7.14 115.918 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -81.44 -40.06 23.92 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.424 1.466 . . . . 2.95 110.134 165.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.1 -32.05 17.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.597 1.332 . . . . 3.26 114.597 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.92 109.6 1.51 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.376 0.989 . . . . 4.26 110.108 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.67 1.99 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 124.461 1.029 . . . . 2.45 113.322 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -94.96 172.28 8.25 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.079 -1.082 . . . . 3.06 108.079 154.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -85.0 138.94 32.14 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.548 -0.538 . . . . 2.14 109.548 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.04 155.39 45.4 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.466 1.127 . . . . 2.85 113.499 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.58 127.58 52.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.579 1.552 . . . . 2.39 108.114 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.4 mt -112.74 118.08 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.97 -0.752 . . . . 1.84 108.97 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -125.49 142.68 51.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.056 1.742 . . . . 2.43 111.161 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.85 111.98 24.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.255 1.422 . . . . 2.33 111.059 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.56 -176.07 15.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.937 1.732 . . . . 1.41 113.332 -173.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -154.56 14.13 0.43 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.578 2.066 . . . . 3.9 116.578 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m 72.81 -25.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.66 1.584 . . . . 3.01 113.987 166.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -77.06 -25.68 52.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.781 1.173 . . . . 7.31 112.037 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.51 123.52 74.26 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.337 1.455 . . . . 2.95 111.547 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -90.74 -0.43 5.1 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.167 2.578 . . . . 4.09 113.155 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -125.39 -89.25 0.57 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.138 1.375 . . . . 6.32 109.504 -162.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.55 -31.18 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 117.222 -1.37 . . . . 4.21 114.181 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.6 m -59.82 -50.77 85.06 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 121.766 2.076 . . . . 1.42 111.844 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.52 -43.58 26.73 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.782 1.655 . . . . 1.14 113.23 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.4 -30.52 53.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.818 1.19 . . . . 3.2 113.162 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.438 ' HA ' ' HE2' ' A' ' 179' ' ' LYS . 5.5 mm-40 -70.28 -36.05 74.14 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.762 -1.211 . . . . 3.06 111.737 166.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.7 mt -61.3 -49.25 77.78 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.978 1.263 . . . . 2.84 111.409 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.44 -46.28 76.76 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.346 1.058 . . . . 4.04 111.953 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 176' ' ' GLU . 14.6 mtmm -53.67 -57.37 11.06 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.222 -0.924 . . . . 3.1 111.245 172.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.1 ptp -66.99 -19.36 65.7 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.036 1.124 . . . . 2.52 114.036 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.566 1.53 . . . . 1.76 110.389 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.515 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 72.9 mt-30 -62.76 -27.01 68.99 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.437 1.017 . . . . 3.17 111.908 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 t -61.65 -32.0 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.464 1.106 . . . . 1.64 113.131 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -31.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.864 1.211 . . . . 3.03 111.582 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -50.75 72.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.973 1.309 . . . . 5.19 110.08 167.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -65.76 1.97 1.16 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.256 2.622 . . . . 2.7 115.55 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 58.2 mt -123.22 -57.56 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 130.087 3.355 . . . . 2.39 110.587 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.76 -37.64 73.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.757 2.023 . . . . 3.9 112.44 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t -61.42 -27.87 68.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.751 1.22 . . . . 3.12 110.819 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.5 mm -77.46 7.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 O-C-N 120.464 -1.398 . . . . 3.97 111.195 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 67.8 m 82.54 -33.28 0.09 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.204 2.202 . . . . 5.32 113.693 147.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.2 m -153.73 45.96 0.62 Allowed 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.863 -1.148 . . . . 4.71 111.301 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.38 -175.51 0.6 Allowed Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.064 0.945 . . . . 4.18 111.437 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -83.45 136.97 7.83 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.512 2.142 . . . . 4.46 109.517 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.86 133.1 37.02 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.516 0.562 . . . . 3.91 112.516 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 14.1 tp -105.19 116.67 32.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.347 1.859 . . . . 1.71 111.173 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.0 m -103.09 99.1 13.22 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.81 1.244 . . . . 1.25 110.096 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -72.44 138.09 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.304 2.002 . . . . 1.08 112.661 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -117.95 110.93 18.31 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.797 2.039 . . . . 2.79 109.308 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -97.09 115.72 28.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.022 0.929 . . . . 2.37 109.069 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 90.3 mt -97.02 120.79 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.207 1.003 . . . . 1.69 109.845 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.2 m -69.19 132.19 46.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.611 0.364 . . . . 1.98 111.303 168.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.04 -5.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 114.536 1.31 . . . . 1.57 114.536 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -113.76 47.45 0.39 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 125.08 1.352 . . . . 3.74 113.265 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.03 73.98 3.6 Favored 'Trans proline' 0 C--N 1.363 1.337 1 C-N-CA 125.854 4.37 . . . . 2.17 112.714 -165.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -169.75 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.878 2.871 . . . . 4.23 107.298 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -7.86 12.73 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.168 1.173 . . . . 7.95 114.168 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.08 107.21 15.05 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 121.002 1.728 . . . . 3.88 111.207 160.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.6 t -82.32 154.68 25.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.596 1.158 . . . . 2.91 113.086 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.68 -39.32 80.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.713 1.375 . . . . 5.98 114.713 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 214' ' ' ALA . 6.9 mm-40 -80.08 -19.67 46.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.775 1.17 . . . . 5.84 113.632 173.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.76 68.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.21 1.823 . . . . 1.72 110.261 170.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 3.0 mm -54.39 -51.91 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.256 0.622 . . . . 2.29 111.351 165.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.508 ' HB3' ' HA ' ' A' ' 211' ' ' GLU . . . -64.98 -29.12 70.02 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.257 -1.354 . . . . 1.34 113.832 -175.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -70.42 -48.95 53.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.439 1.927 . . . . 3.34 110.556 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.36 -41.44 65.83 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.682 0.793 . . . . 3.61 111.571 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.95 -53.29 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 125.511 1.524 . . . . 1.64 113.598 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -57.07 -40.86 77.68 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.382 1.073 . . . . 5.92 112.883 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.97 -53.12 51.32 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.925 2.09 . . . . 3.49 111.228 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.65 -36.81 85.46 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.503 1.298 . . . . 3.18 114.503 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.1 m 148.38 148.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 128.681 2.792 . . . . 2.33 113.581 167.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.15 9.66 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.201 3.268 . . . . 2.77 116.525 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -91.22 -9.24 45.99 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 120.989 1.722 . . . . 2.72 113.17 161.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 66.8 tp -84.08 147.12 27.55 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.667 1.187 . . . . 1.79 109.842 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 t -130.56 138.64 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.474 1.11 . . . . 1.93 108.503 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.82 122.18 7.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.234 -1.546 . . . . 1.09 109.234 169.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.34 140.11 39.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.283 1.033 . . . . 2.36 108.945 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.0 p -151.72 -172.6 4.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.621 1.969 . . . . 2.86 109.399 -165.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.14 -155.84 10.16 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 123.121 0.391 . . . . 2.24 113.088 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 232' ' ' GLU . 5.3 t -73.81 -177.08 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.546 -1.279 . . . . 2.57 107.546 136.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -44.91 -39.43 5.43 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.288 1.035 . . . . 6.64 111.817 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.444 ' H ' HG23 ' A' ' 230' ' ' THR . 4.2 mp0 -70.41 -37.65 74.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.555 1.07 . . . . 2.87 113.601 -165.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.8 -30.56 68.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.805 1.639 . . . . 3.53 111.511 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.43 -38.94 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.862 0.865 . . . . 1.67 111.136 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.72 -50.07 75.27 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.736 -1.209 . . . . 3.89 107.736 171.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -54.93 -61.58 2.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.612 -1.185 . . . . 2.6 112.959 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.62 -34.33 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.598 1.545 . . . . 1.99 113.232 -166.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.22 96.18 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.279 -0.888 . . . . 1.53 110.535 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -73.47 -32.85 64.55 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.884 1.673 . . . . 4.11 112.846 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.43 97.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.794 1.179 . . . . 1.99 112.007 171.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -84.03 1.97 41.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.698 0.799 . . . . 2.52 112.946 171.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.54 22.05 9.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.001 2.121 . . . . 6.69 113.991 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.0 m -86.99 164.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.647 0.779 . . . . 2.85 110.181 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -155.38 168.99 25.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.776 1.23 . . . . 4.95 111.989 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -161.98 128.58 3.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.336 0.655 . . . . 4.1 110.869 -163.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.8 m -110.27 110.38 58.28 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-O 118.598 -0.715 . . . . 2.71 111.835 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.1 146.31 20.02 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.828 2.352 . . . . 2.96 111.839 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.76 155.2 38.8 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-O 119.504 -0.609 . . . . 2.64 113.11 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -81.5 35.86 0.6 Allowed 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.829 3.686 . . . . 3.78 111.806 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 65.83 172.76 0.23 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.08 2.152 . . . . 5.29 112.6 -156.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -153.5 160.98 42.67 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.08 2.152 . . . . 7.7 107.846 173.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -72.37 -16.1 61.86 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.193 1.553 . . . . 8.31 115.193 -158.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.95 2.17 44.08 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.553 1.141 . . . . 11.17 112.765 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 80.23 11.58 1.08 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.166 2.586 . . . . 6.83 113.133 171.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.32 162.36 4.75 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.876 2.07 . . . . 4.55 115.653 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -139.86 70.63 1.36 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.885 1.326 . . . . 3.53 114.444 160.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.14 153.31 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.559 1.543 . . . . 4.12 110.303 159.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.85 150.54 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.055 1.742 . . . . 2.96 106.919 163.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.13 155.66 34.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.114 -0.698 . . . . 3.71 109.114 164.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -140.47 87.7 2.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.53 0.681 . . . . 1.99 110.865 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.5 t -74.51 76.57 1.95 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 124.037 1.875 . . . . 5.54 109.379 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.1 pp -132.25 172.65 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.167 1.787 . . . . 6.89 109.532 -172.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 11.3 tt -141.42 164.59 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.198 -0.939 . . . . 2.77 109.121 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 22.6 ttm -99.13 141.28 32.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.571 1.078 . . . . 2.76 110.229 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -109.66 148.73 30.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.352 1.061 . . . . 2.57 112.792 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 127.0 46.32 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.649 1.58 . . . . 2.69 108.208 163.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 156.48 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.149 1.379 . . . . 2.11 108.334 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -155.5 -134.45 1.86 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.505 1.05 . . . . 1.85 111.977 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -85.86 36.4 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.852 3.701 . . . . 3.32 112.412 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -120.61 -38.52 2.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.739 2.015 . . . . 6.79 114.889 -164.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.29 2.46 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.086 -1.206 . . . . 3.27 110.086 -158.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.32 -2.95 3.08 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.717 1.377 . . . . 4.32 114.717 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -138.88 76.79 1.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.632 1.173 . . . . 3.7 112.001 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -34.87 17.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.161 0.984 . . . . 3.05 111.824 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -168.96 174.77 6.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.828 2.851 . . . . 2.32 108.441 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -153.86 150.02 27.96 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.64 -1.287 . . . . 2.8 111.715 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.95 114.03 21.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.352 1.061 . . . . 2.47 108.885 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.98 42.2 3.05 Favored Glycine 0 N--CA 1.464 0.542 0 CA-C-O 118.324 -1.265 . . . . 3.73 111.467 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . 0.266 3.5 pt20 44.17 45.16 6.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.011 1.724 . . . . 4.02 112.186 -170.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -139.63 -37.41 0.49 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.755 1.761 . . . . 5.25 115.755 -164.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -63.84 135.32 56.5 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.356 -1.465 . . . . 4.43 109.098 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -76.71 171.22 15.05 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 121.395 1.907 . . . . 8.0 109.193 163.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -48.33 -43.97 33.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.935 0.894 . . . . 2.02 113.167 -177.335 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -57.18 -36.34 74.62 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.942 1.258 . . . . 1.58 114.951 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -86.83 -18.08 31.83 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.421 1.61 . . . . 4.05 112.774 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 69.1 mt -69.22 -55.75 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.052 -1.092 . . . . 1.37 108.052 170.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.35 95.59 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.087 0.773 . . . . 1.69 113.087 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.39 90.63 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.83 1.195 . . . . 1.9 112.47 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.4 p -61.59 -43.83 98.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.567 1.076 . . . . 1.51 112.142 170.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.86 -47.11 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.637 1.108 . . . . 1.47 110.723 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.54 -30.72 70.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.309 0.959 . . . . 1.58 113.061 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.2 m -68.37 -50.27 54.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.433 1.093 . . . . 2.36 109.89 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -70.27 -34.04 72.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.761 1.225 . . . . 2.55 113.449 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -60.66 -33.82 73.38 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.288 1.835 . . . . 4.04 112.84 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -59.6 -52.44 74.03 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 116.785 -1.579 . . . . 4.43 112.985 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.91 -44.5 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.274 2.649 . . . . 2.98 111.589 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.16 62.65 7.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.625 1.17 . . . . 2.88 111.038 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -43.0 132.27 4.03 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.618 1.567 . . . . 8.15 114.591 -166.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -171.23 0.12 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.253 1.421 . . . . 6.96 114.569 175.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 48.21 0.16 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 116.603 2.075 . . . . 8.25 116.603 -173.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.489 1.493 1 C-N-CA 132.402 4.281 . . . . 7.39 110.583 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 106.72 -1.585 . . . . 14.52 106.72 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -62.84 175.81 0.78 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.595 1.089 . . . . 17.14 110.162 138.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.9 m -108.12 158.58 17.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.901 1.68 . . . . 13.35 109.362 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.6 -118.83 1.32 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.082 -1.207 . . . . 12.89 110.082 167.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -55.12 129.33 67.24 Favored Pre-proline 0 CA--C 1.554 1.115 0 O-C-N 121.493 -1.004 . . . . 12.14 111.399 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.17 63.5 8.71 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.432 2.755 . . . . 12.0 108.876 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.1 tp -160.55 140.42 11.12 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.443 0.697 . . . . 10.27 111.177 -162.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.3 tt -170.4 -58.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.236 1.814 . . . . 6.23 109.665 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.31 -146.4 18.99 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.932 -0.867 . . . . 2.87 110.932 -172.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.96 166.63 21.08 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.195 0.902 . . . . 2.77 113.088 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.4 148.92 30.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.029 2.486 . . . . 3.25 111.854 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -130.68 125.16 33.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.6 1.16 . . . . 2.9 111.302 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -109.81 46.57 1.0 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.448 -1.407 . . . . 2.69 111.983 -162.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -85.35 155.25 21.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.573 1.549 . . . . 2.95 111.792 -160.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.3 m -79.83 133.78 36.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.302 1.041 . . . . 1.86 109.868 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.2 p -81.94 160.65 23.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 123.061 1.41 . . . . 2.68 112.655 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -2.73 1.57 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.773 2.029 . . . . 1.74 114.905 168.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 t -100.37 -41.31 7.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.953 0.901 . . . . 3.73 110.961 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.28 -0.77 7.05 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 125.154 1.359 . . . . 1.95 115.546 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.09 157.81 35.38 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.102 0.951 . . . . 3.78 108.544 163.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.451 HH12 ' CD ' ' A' ' 233' ' ' GLU . 87.5 mtt-85 -92.13 134.24 35.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.749 -1.219 . . . . 7.35 110.857 174.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -138.47 136.02 35.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.706 1.002 . . . . 3.09 113.706 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 149.1 51.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 128.57 2.748 . . . . 3.31 109.469 -164.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -32.42 -43.59 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.582 2.353 . . . . 4.02 114.389 158.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.02 -25.73 68.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.23 1.412 . . . . 7.78 113.227 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -89.4 -28.22 19.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.406 1.082 . . . . 2.93 111.521 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -80.58 -16.85 53.13 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.808 1.04 . . . . 2.82 113.808 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 111.31 1.39 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.865 1.266 . . . . 3.67 111.945 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.35 -24.13 4.48 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.092 1.329 . . . . 2.72 112.796 -171.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.15 -162.11 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 117.825 0.813 . . . . 3.74 109.11 149.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -105.66 153.3 22.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.618 1.167 . . . . 1.84 110.115 168.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 pp -135.37 134.95 40.3 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.402 -0.811 . . . . 2.49 110.918 173.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.59 132.07 54.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.296 1.838 . . . . 3.01 107.499 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.13 129.3 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.398 1.079 . . . . 2.23 110.441 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -106.74 145.82 31.59 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.755 2.022 . . . . 2.55 111.523 163.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -112.3 118.28 34.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.557 1.143 . . . . 2.38 112.793 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.89 164.15 27.9 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 117.059 1.584 . . . . 1.56 117.059 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -26.97 11.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.129 1.772 . . . . 3.76 112.929 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 89.1 m 118.66 109.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.202 3.801 . . . . 3.07 109.997 163.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . 0.346 1.5 t-160 41.12 52.01 3.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.725 2.01 . . . . 10.34 114.241 -161.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.76 149.63 41.3 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 126.219 1.808 . . . . 4.16 109.993 159.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.03 -17.85 21.85 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.795 2.33 . . . . 4.8 114.361 -156.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -42.15 42.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.248 1.019 . . . . 11.16 112.528 -162.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 p 174.6 3.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 127.139 2.176 . . . . 4.79 114.623 -163.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . 0.251 46.9 t -57.93 -66.79 1.13 Allowed Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 115.423 1.638 . . . . 1.85 115.423 -147.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.34 -17.63 39.36 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.212 2.608 . . . . 1.76 113.246 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -69.35 -31.42 69.85 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 117.881 -1.057 . . . . 6.74 112.844 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -87.86 -20.12 26.47 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 121.164 1.802 . . . . 3.17 113.323 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -47.42 85.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.41 -1.431 . . . . 2.61 109.681 164.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.99 -51.27 64.43 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.49 1.516 . . . . 4.58 111.256 171.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -67.75 -21.53 65.27 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.673 -1.267 . . . . 3.44 113.666 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.9 ttp -67.47 -32.26 72.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.1 0.864 . . . . 2.99 112.362 164.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.58 -53.28 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 119.914 -1.742 . . . . 2.92 108.973 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.45 21.79 0.1 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.711 1.375 . . . . 3.32 114.711 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.46 -40.77 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 120.569 1.531 . . . . 3.42 111.912 147.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.9 t -57.66 -49.41 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.254 0.933 . . . . 2.02 110.428 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -59.83 -32.23 70.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.152 1.781 . . . . 3.62 113.168 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -81.45 -35.12 30.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 2.55 113.012 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.9 mt -62.92 -49.54 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.279 0.632 . . . . 2.77 109.601 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -62.92 -35.14 79.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.658 2.383 . . . . 3.54 111.585 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -66.54 -13.47 61.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.411 1.263 . . . . 2.94 114.411 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 87.6 mt -100.33 96.68 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.541 -1.349 . . . . 4.04 108.309 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.4 m -65.11 69.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.31 2.244 . . . . 5.3 112.529 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 176.2 -28.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.372 1.869 . . . . 4.13 112.78 -165.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.11 148.19 47.06 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 119.789 1.177 . . . . 3.59 112.139 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.24 142.87 15.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.398 2.732 . . . . 3.2 109.318 168.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -69.45 162.3 27.7 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.579 1.696 . . . . 3.82 115.579 -163.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 35.3 tp -119.51 96.07 5.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.128 2.171 . . . . 2.49 108.917 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.6 m -72.84 123.47 89.61 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-O 118.193 -0.908 . . . . 1.92 109.609 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.15 118.6 2.67 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.503 2.802 . . . . 1.11 111.118 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.9 mt -108.91 126.03 52.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.231 1.412 . . . . 3.86 110.482 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -104.04 130.56 51.73 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.468 1.107 . . . . 2.06 109.227 168.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.47 124.8 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.752 0.787 . . . . 1.64 111.444 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.6 m -66.07 129.95 41.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.924 0.89 . . . . 2.1 111.899 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.29 -17.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 114.831 1.419 . . . . 2.35 114.831 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -117.06 44.63 0.46 Allowed Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 125.23 1.412 . . . . 4.58 112.406 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.31 83.22 1.51 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.776 2.984 . . . . 2.58 113.778 -166.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -155.68 28.53 0.38 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.794 2.038 . . . . 5.17 110.501 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -156.54 -35.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.055 1.132 . . . . 4.51 114.055 -166.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -98.69 83.91 3.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.602 1.961 . . . . 3.51 111.088 -167.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 m -49.77 138.24 14.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.678 1.191 . . . . 2.39 109.588 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -43.04 -41.46 3.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.202 1.401 . . . . 3.26 113.283 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.34 -37.66 74.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.804 2.842 . . . . 6.52 113.365 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.12 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.16 0.984 . . . . 1.61 111.218 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.0 -46.44 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 118.968 -0.539 . . . . 1.54 110.49 167.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.67 69.38 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.559 1.072 . . . . 1.85 112.579 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.431 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 4.4 t30 -63.75 -51.54 64.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.389 0.995 . . . . 4.59 112.184 172.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -60.82 -41.46 95.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.586 1.555 . . . . 3.14 112.117 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.5 t -61.26 -46.63 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.318 1.047 . . . . 1.41 111.368 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 5.9 ttpp -58.48 -35.23 71.86 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.957 0.903 . . . . 5.26 112.827 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -64.11 -19.67 65.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.343 1.057 . . . . 4.59 113.075 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -91.84 -64.19 1.15 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.381 1.072 . . . . 2.59 112.959 171.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t 174.02 145.2 0.2 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 126.271 1.828 . . . . 2.27 109.692 -168.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.55 -5.38 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.382 2.721 . . . . 1.85 113.92 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -77.74 -8.72 58.37 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.638 1.108 . . . . 1.95 113.635 169.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.46 143.87 33.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.508 1.049 . . . . 3.91 112.191 173.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.97 133.75 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.337 1.455 . . . . 1.85 108.999 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -112.71 128.51 8.49 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.995 -0.842 . . . . 1.08 110.995 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.7 mp -123.83 144.92 49.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.211 1.004 . . . . 2.11 110.88 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.3 t -161.02 -161.0 0.78 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.289 2.236 . . . . 2.66 108.201 -170.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 159.54 -114.64 0.62 Allowed Glycine 0 N--CA 1.465 0.628 0 C-N-CA 124.779 1.181 . . . . 2.71 110.898 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.3 p -137.28 174.16 10.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.263 1.425 . . . . 3.65 109.852 165.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -23.56 63.63 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.596 0.962 . . . . 7.8 113.596 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -68.24 -41.08 81.71 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.455 1.502 . . . . 3.41 111.287 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.451 ' CD ' HH12 ' A' ' 149' ' ' ARG . 45.1 mt-10 -69.03 -37.82 78.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.117 0.871 . . . . 4.66 110.897 170.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -27.61 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 117.774 -1.108 . . . . 2.62 113.36 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.06 -41.62 92.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.839 1.199 . . . . 5.03 110.308 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -60.29 -54.47 45.37 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 3.5 111.75 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.18 -40.91 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.127 0.876 . . . . 2.05 111.771 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.9 73.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.97 0.508 . . . . 2.35 111.318 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.64 -34.55 69.87 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.061 1.744 . . . . 6.13 112.963 -177.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.08 -58.5 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.457 1.103 . . . . 2.47 111.792 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.77 0.67 22.8 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.475 0.917 . . . . 2.71 113.475 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.0 ttt85 45.06 38.94 3.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.752 2.821 . . . . 7.22 113.696 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.8 m -78.81 133.64 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.529 0.732 . . . . 3.34 110.278 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.79 148.57 25.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.733 0.813 . . . . 4.99 111.235 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -172.05 163.03 5.99 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.645 1.978 . . . . 3.6 110.675 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.4 t -160.6 135.58 5.59 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-O 117.902 -1.047 . . . . 4.39 111.204 172.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.02 156.38 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.162 1.908 . . . . 3.45 110.665 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -89.2 165.12 32.59 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.384 0.992 . . . . 2.26 113.609 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -77.17 -171.32 1.12 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.3 2.667 . . . . 3.2 109.783 168.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -82.09 131.95 35.24 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.922 -0.77 . . . . 4.4 108.922 150.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -140.84 35.94 1.78 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.775 1.63 . . . . 7.27 108.732 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 253' ' ' ASP . 3.0 tm-20 173.74 166.12 0.18 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.308 3.043 . . . . 7.02 105.91 -151.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.402 ' H ' ' CD ' ' A' ' 252' ' ' GLU . 4.6 t70 -76.25 -27.11 56.6 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.768 1.227 . . . . 5.79 111.484 -176.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.26 3.66 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 117.172 2.286 . . . . 5.24 117.172 163.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.63 147.28 22.86 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 122.572 2.442 . . . . 4.26 112.579 169.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.55 92.66 2.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.178 0.99 . . . . 4.28 110.826 149.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 82.1 mt -57.85 145.03 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.067 -1.021 . . . . 3.39 109.483 158.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.94 158.78 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 3.18 110.481 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -101.39 141.06 34.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.911 1.684 . . . . 4.32 110.115 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.45 149.61 17.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.104 1.52 . . . . 2.18 115.104 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -51.97 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.752 2.021 . . . . 4.4 111.859 172.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.55 52.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.276 1.431 . . . . 5.75 112.24 168.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mt -136.06 128.18 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.254 1.422 . . . . 2.67 107.914 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 60.5 mtp -99.07 159.55 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.114 1.766 . . . . 2.35 110.252 174.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -135.75 146.28 47.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.908 1.077 . . . . 2.78 113.908 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.3 tp -104.59 130.06 52.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.977 1.311 . . . . 2.49 110.059 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.3 mt -111.13 142.21 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 106.997 -1.482 . . . . 4.0 106.997 150.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -114.08 -171.75 17.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.627 0.632 . . . . 1.99 113.817 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.53 70.86 6.69 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.305 3.337 . . . . 2.61 108.623 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -167.72 -62.21 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.001 1.72 . . . . 4.2 110.025 -169.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.02 -112.19 0.83 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.603 -0.726 . . . . 2.5 113.633 -162.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.54 123.11 28.89 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.512 0.931 . . . . 4.19 113.512 -149.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.5 t80 35.43 63.42 0.53 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.646 1.978 . . . . 3.6 114.393 156.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.0 tp -86.64 -4.02 59.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.423 0.897 . . . . 3.36 113.423 -166.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.85 150.11 4.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.911 2.085 . . . . 2.66 110.167 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -126.48 123.85 38.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.452 1.12 . . . . 3.49 111.078 161.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.63 86.81 3.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.134 1.374 . . . . 3.62 107.546 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.59 161.77 48.37 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.829 -1.309 . . . . 3.57 109.829 164.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -50.2 -16.03 0.28 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.554 1.687 . . . . 3.35 115.554 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -19.78 61.5 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 120.5 -1.375 . . . . 5.81 114.346 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -93.49 123.1 36.57 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.437 -1.415 . . . . 5.42 109.075 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -169.91 1.92 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.2 1.0 . . . . 5.88 108.789 167.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -30.85 -60.24 0.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.836 1.654 . . . . 3.02 113.527 170.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.04 84.07 Favored Glycine 0 N--CA 1.472 1.066 0 O-C-N 121.307 -0.871 . . . . 2.27 112.798 -166.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -76.38 -31.87 58.25 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.598 1.559 . . . . 3.0 111.562 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.32 -56.94 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.138 -0.689 . . . . 1.82 109.138 165.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.48 -43.35 88.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.624 0.972 . . . . 1.56 113.624 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.11 77.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.331 0.652 . . . . 1.89 112.469 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 16.4 p -66.84 -48.03 70.16 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.052 1.13 . . . . 1.69 114.052 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.13 -33.07 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.075 1.761 . . . . 1.71 112.168 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.0 71.84 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.906 0.776 . . . . 1.9 112.834 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 84.1 m -68.27 -41.84 80.46 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.634 0.652 . . . . 1.87 110.513 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -65.84 -27.1 67.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.544 1.137 . . . . 2.37 113.753 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.3 mmt -70.59 -10.78 60.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.577 0.955 . . . . 6.25 113.577 170.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.64 -50.41 1.27 Allowed Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 116.69 -1.624 . . . . 5.79 114.582 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.93 -37.12 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.41 2.073 . . . . 1.96 111.935 173.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.13 148.02 26.27 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.272 1.034 . . . . 2.84 112.256 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 74.47 -34.88 0.28 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.563 1.945 . . . . 11.8 116.107 161.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -150.01 -72.84 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.891 2.132 . . . . 6.81 115.565 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 39.4 pttt 151.21 -26.78 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.27 1 C-N-CA 132.757 4.423 . . . . 11.13 111.653 -163.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.487 1.415 0 C-N-CA 130.87 3.668 . . . . 11.19 106.569 -142.168 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 117.714 -1.136 . . . . 16.33 108.709 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -59.93 -45.01 93.98 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.944 1.247 . . . . 18.42 109.746 163.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.8 p -77.17 156.72 31.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.978 2.111 . . . . 13.8 111.563 164.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 118.81 124.77 3.35 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.881 1.705 . . . . 10.45 111.943 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm 166.4 143.46 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 130.151 3.381 . . . . 11.64 109.509 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.72 -178.37 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.669 2.912 . . . . 8.76 110.83 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.8 mp 66.06 85.21 0.14 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.535 2.334 . . . . 10.71 111.415 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.88 -46.5 84.61 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.765 0.826 . . . . 6.26 109.209 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.57 -14.05 4.59 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 127.186 2.327 . . . . 5.24 114.704 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.24 73.04 1.08 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.028 -1.229 . . . . 3.41 110.028 -158.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.89 129.16 6.13 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.558 2.172 . . . . 4.03 111.366 -170.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.46 162.65 33.95 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.579 1.952 . . . . 3.16 110.554 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.3 p -144.96 57.38 1.27 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.029 -1.045 . . . . 3.04 111.249 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.74 160.4 14.5 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.714 1.206 . . . . 2.6 113.935 -166.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -87.23 135.54 33.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.244 1.418 . . . . 1.73 111.205 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.7 p -97.03 162.95 13.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 122.82 1.295 . . . . 2.72 112.89 176.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -63.31 -20.43 65.47 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.265 1.426 . . . . 1.66 114.546 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.0 t -88.36 -4.79 58.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.815 1.246 . . . . 3.84 113.24 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.96 2.4 62.61 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 119.547 1.067 . . . . 2.25 115.525 171.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.33 154.9 17.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.789 1.235 . . . . 4.7 109.637 170.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.22 112.54 24.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.259 1.824 . . . . 4.96 109.593 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -78.79 165.78 23.18 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.301 -1.499 . . . . 4.01 112.249 177.451 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.4 m -154.67 144.74 21.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.708 1.203 . . . . 3.39 108.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -48.73 -41.49 32.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.566 1.147 . . . . 4.26 112.484 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.92 -2.45 27.06 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.516 1.673 . . . . 8.26 115.516 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -34.58 16.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 120.353 1.433 . . . . 4.36 112.335 168.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -94.23 -29.9 14.86 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.382 1.253 . . . . 3.59 114.382 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.79 124.72 23.72 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.656 1.571 . . . . 5.98 109.198 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.87 -18.4 26.6 Favored Glycine 0 N--CA 1.477 1.397 0 C-N-CA 124.211 0.91 . . . . 3.92 112.349 -160.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.17 167.84 9.63 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.018 2.527 . . . . 5.36 108.08 167.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -82.09 99.99 9.52 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.575 -1.328 . . . . 2.1 110.45 163.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 160' ' ' LEU . 1.6 pt? -96.37 140.38 31.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.409 0.623 . . . . 3.7 110.096 167.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 tt -125.02 113.55 17.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.112 -1.81 . . . . 2.72 106.112 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.17 136.97 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 3.6 111.068 -170.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -123.19 129.61 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.861 1.665 . . . . 2.97 110.688 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -99.93 102.62 14.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.576 1.15 . . . . 2.91 112.795 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.91 163.63 13.77 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.895 1.236 . . . . 1.56 114.756 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -124.34 116.66 22.96 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.966 0.906 . . . . 3.35 110.723 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.1 m -58.89 129.31 41.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.709 -1.589 . . . . 4.32 106.709 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 90.03 -1.16 0.28 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.124 2.17 . . . . 7.13 113.791 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 158.17 85.8 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 119.925 1.239 . . . . 2.33 110.103 157.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.51 -177.26 3.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.149 3.233 . . . . 2.87 112.153 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.16 1.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.404 1.882 . . . . 5.21 115.876 -171.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.24 -38.17 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.987 1.715 . . . . 3.72 110.727 172.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -60.49 9.87 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.603 1.161 . . . . 1.47 111.603 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.57 -23.75 49.45 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.897 1.731 . . . . 1.24 113.943 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -51.62 -52.02 51.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.801 1.637 . . . . 3.62 113.422 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -80.35 -25.78 39.03 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.874 -1.141 . . . . 3.05 112.955 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.21 -44.9 71.14 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.212 1.005 . . . . 2.62 110.936 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -48.1 -54.37 13.43 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.729 1.612 . . . . 5.21 110.912 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -66.64 -28.09 68.2 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.535 -1.353 . . . . 4.19 113.009 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 46.9 ttp -65.85 -39.47 90.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 117.524 -1.227 . . . . 3.47 111.429 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.33 -45.9 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 120.948 1.704 . . . . 1.75 110.722 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.5 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.124 -0.941 . . . . 4.93 112.387 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.88 -29.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.945 1.702 . . . . 1.93 110.731 168.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.77 -46.49 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.721 0.808 . . . . 2.0 109.532 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.66 -43.82 80.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.115 2.566 . . . . 4.11 113.14 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.21 -42.26 96.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.221 1.809 . . . . 2.89 112.041 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.3 mt -68.62 -40.7 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.158 0.983 . . . . 2.18 112.121 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -61.42 -31.44 71.37 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.828 1.251 . . . . 3.78 111.226 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.6 m -72.12 -21.64 61.44 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.49 -0.756 . . . . 3.14 112.874 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.52 63.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.349 -1.469 . . . . 4.3 108.131 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 75.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.659 1.984 . . . . 5.87 113.021 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.6 m 174.43 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.856 3.663 . . . . 4.12 111.239 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.28 154.18 54.13 Favored Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 121.613 2.006 . . . . 3.23 111.434 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.52 -55.13 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.719 2.279 . . . . 3.44 110.242 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -178.73 170.94 1.53 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 129.991 3.316 . . . . 3.95 108.099 168.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.3 tt -118.96 115.28 24.03 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.067 -1.827 . . . . 2.74 106.067 150.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.3 m -95.65 108.16 38.21 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 118.041 -0.98 . . . . 2.27 109.226 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.38 122.75 2.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.212 2.608 . . . . 1.05 111.171 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.0 tp -118.5 100.14 7.27 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.303 1.041 . . . . 2.34 110.469 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -84.65 120.92 26.94 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.651 -0.5 . . . . 2.21 109.651 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.9 mt -102.28 103.84 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.413 1.485 . . . . 2.72 107.161 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.8 t -97.59 132.85 42.87 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.648 -0.658 . . . . 2.98 111.125 170.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.2 pt -102.89 13.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.1 1.76 . . . . 1.78 114.665 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.23 32.39 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 116.098 1.888 . . . . 3.72 116.098 -173.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -7.83 21.9 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 123.417 2.256 . . . . 2.6 114.247 -171.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -85.68 41.39 0.9 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.264 1.025 . . . . 4.46 110.8 167.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 16.1 ttm105 -178.94 -58.25 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 131.128 3.771 . . . . 4.76 109.107 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.75 171.31 15.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.946 1.299 . . . . 4.31 111.455 -175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.1 t -149.3 153.13 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.148 -0.97 . . . . 3.2 112.305 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -41.87 50.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.818 1.647 . . . . 2.95 111.951 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -67.94 -36.44 80.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.547 1.539 . . . . 3.81 112.535 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.63 -44.5 64.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.52 1.055 . . . . 1.22 111.081 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.58 -43.06 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.353 1.061 . . . . 1.67 111.717 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.34 80.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.232 1.013 . . . . 1.27 113.115 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -70.96 -42.68 69.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.496 0.718 . . . . 4.14 111.742 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -62.65 -41.03 98.84 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.913 0.885 . . . . 2.82 111.596 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.38 -51.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.449 1.9 . . . . 1.31 112.327 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -56.77 -34.42 67.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.283 1.033 . . . . 4.86 113.372 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.96 -48.01 67.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.945 0.339 . . . . 5.05 110.547 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -72.86 21.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 3.02 114.389 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.3 p 106.43 147.42 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.656 1 C-N-CA 131.792 4.037 . . . . 2.68 112.504 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.16 -1.82 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.078 2.519 . . . . 1.6 113.329 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -90.29 -7.85 52.39 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.287 0.949 . . . . 2.48 112.793 171.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 136.36 46.72 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.523 -1.361 . . . . 2.75 111.565 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.21 121.48 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.543 0.737 . . . . 2.1 109.263 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.55 125.05 8.16 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.542 -1.423 . . . . 1.06 109.542 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.62 130.15 41.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.977 1.711 . . . . 4.3 108.817 -173.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -163.71 -163.05 0.76 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.511 1.924 . . . . 4.0 109.849 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.51 -149.01 6.88 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.448 1.023 . . . . 1.64 112.015 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -74.08 166.16 23.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.842 0.821 . . . . 2.54 110.488 159.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -47.8 -38.19 15.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.602 1.161 . . . . 5.96 113.069 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -70.85 -29.46 65.6 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.153 1.381 . . . . 3.48 111.743 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.03 -36.21 61.9 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 3.51 111.72 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.52 -35.78 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 118.836 -0.602 . . . . 2.24 111.189 170.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.55 -48.07 70.82 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.682 -1.628 . . . . 2.57 110.095 165.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -46.94 -57.78 4.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 121.555 1.979 . . . . 2.25 111.438 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.67 -39.33 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.304 0.956 . . . . 2.37 112.77 -173.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -35.5 72.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.965 0.802 . . . . 1.55 112.585 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -74.28 -40.01 62.59 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.886 2.074 . . . . 3.08 111.575 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.49 81.49 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 1.56 112.648 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.35 -6.74 59.23 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.478 0.711 . . . . 2.8 112.897 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.73 39.17 29.92 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.827 2.051 . . . . 6.07 112.708 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.2 -39.75 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.079 -1.013 . . . . 3.41 111.918 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 29.4 t80 64.47 130.6 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.198 1.799 . . . . 4.74 112.77 -165.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -116.2 152.57 33.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.002 0.921 . . . . 3.22 110.653 164.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.0 t -106.92 107.0 59.75 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.479 -0.772 . . . . 2.75 110.457 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.86 131.35 16.89 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.364 2.043 . . . . 2.74 109.993 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -88.34 -174.71 47.52 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.489 1.042 . . . . 2.3 114.819 -175.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.25 176.32 10.21 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.389 3.393 . . . . 3.81 113.107 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -118.5 137.49 53.16 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.165 2.186 . . . . 4.14 109.52 164.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.25 -79.53 0.46 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 118.382 -0.818 . . . . 5.68 110.754 -163.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -67.78 -69.42 0.32 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.243 0.929 . . . . 7.08 112.009 168.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.22 -72.6 0.06 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.841 0.682 . . . . 7.17 112.841 -168.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -114.05 -32.38 6.05 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.468 -0.77 . . . . 8.19 112.753 -161.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.36 169.82 17.64 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 113.771 1.026 . . . . 6.23 113.771 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 37.6 p90 177.18 161.26 0.44 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.566 2.346 . . . . 3.91 111.524 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.5 mm -121.08 148.93 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.575 1.55 . . . . 4.08 108.741 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.45 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 106.402 -1.703 . . . . 3.37 106.402 162.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -104.1 163.85 12.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.188 1.795 . . . . 3.58 111.569 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 158.82 33.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.534 1.133 . . . . 2.11 113.022 -158.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 49.3 p -59.19 -16.5 20.84 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.836 1.421 . . . . 3.24 114.836 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 263' ' ' ILE 0.347 10.6 tt 43.54 -143.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.819 1.248 . . . . 4.07 109.404 -147.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 262' ' ' ILE . 73.8 mt 76.18 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.285 1.834 . . . . 3.39 110.992 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -118.78 149.66 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.625 -1.17 . . . . 3.25 110.443 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.41 144.38 45.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.966 0.906 . . . . 4.02 112.749 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.1 tp -97.41 128.4 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.709 1.203 . . . . 1.99 108.52 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.31 142.24 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.207 -1.775 . . . . 2.49 106.207 161.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -132.64 -168.06 11.91 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.207 0.843 . . . . 2.56 115.207 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.63 58.84 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.652 1 C-N-CA 125.442 4.095 . . . . 4.88 110.801 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -154.39 -55.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.109 1.364 . . . . 7.12 108.292 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.07 138.36 4.47 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.09 1.328 . . . . 5.44 113.316 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 64.64 -168.61 0.21 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.388 1.475 . . . . 5.56 112.697 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -74.13 99.44 3.37 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.79 -1.194 . . . . 5.17 112.259 -173.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -24.55 27.9 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.758 1.623 . . . . 3.74 112.231 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -165.46 175.14 9.3 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.05 1.74 . . . . 2.33 110.326 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -153.29 166.49 32.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.817 1.647 . . . . 4.51 112.869 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -143.01 150.9 40.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.527 1.531 . . . . 2.58 110.196 -173.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.28 166.8 15.42 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.711 -1.049 . . . . 3.38 111.989 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -24.66 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 134.236 5.014 . . . . 3.95 119.885 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.94 -41.18 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.829 2.452 . . . . 5.36 110.21 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -76.56 113.05 13.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.335 0.97 . . . . 4.34 109.844 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.8 ttm105 -66.65 167.09 11.67 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.861 -1.15 . . . . 5.63 109.101 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -50.56 -44.84 56.73 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.25 -1.531 . . . . 2.28 113.279 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -58.15 -39.68 92.61 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.553 -0.582 . . . . 1.87 112.302 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.53 -28.55 46.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.007 1.114 . . . . 4.49 114.007 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.5 mt -58.46 -49.24 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.708 1.14 . . . . 2.3 109.002 168.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.02 91.9 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.391 0.886 . . . . 1.25 113.391 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.85 -32.03 69.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.588 0.755 . . . . 1.2 112.881 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -52.71 64.29 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.709 0.633 . . . . 1.57 112.709 168.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.35 -38.94 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.399 -1.438 . . . . 1.28 111.255 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.09 -8.77 25.6 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.079 1.352 . . . . 1.65 114.194 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 92.9 m -92.19 -48.92 6.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.053 1.341 . . . . 1.73 110.318 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -69.13 -23.34 63.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.681 0.993 . . . . 2.21 113.681 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 27.3 ttt -55.93 -26.42 47.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.163 1.785 . . . . 4.31 113.866 164.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -69.59 -46.8 26.14 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.247 -1.835 . . . . 6.72 112.464 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -59.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.22 1.946 . . . . 1.9 110.927 167.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -96.07 125.42 40.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.7 1.0 . . . . 3.78 113.7 -166.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.58 -176.64 2.95 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.777 1.631 . . . . 8.54 111.964 -173.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -120.86 145.11 47.97 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 128.383 2.673 . . . . 8.81 106.906 165.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 34.4 mttt 92.55 -44.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 130.534 3.534 . . . . 8.95 110.517 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.251 1.171 0 C-N-CA 129.804 3.242 . . . . 11.39 106.206 154.898 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 118.173 -0.917 . . . . 18.94 110.062 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.429 ' CZ ' ' HE2' ' A' ' 133' ' ' LYS . 44.5 t80 -156.85 151.77 26.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.472 1.109 . . . . 15.52 110.027 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t 175.78 -162.53 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.452 2.701 . . . . 13.62 108.836 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.33 49.69 9.11 Favored Glycine 0 N--CA 1.467 0.764 0 C-N-CA 125.128 1.347 . . . . 10.05 112.307 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.429 ' HE2' ' CZ ' ' A' ' 130' ' ' PHE . 38.2 mmtm -135.88 73.59 59.57 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.204 1.402 . . . . 9.53 111.473 -176.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.04 167.47 26.65 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.487 2.791 . . . . 6.72 110.74 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.5 mt -132.98 37.69 3.41 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.352 1.861 . . . . 7.81 110.166 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 tt -65.12 81.11 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.629 1.972 . . . . 9.61 112.73 -172.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 92.03 96.38 1.35 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.498 1.999 . . . . 5.57 110.041 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.62 111.61 4.08 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.199 -1.334 . . . . 3.22 110.267 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.72 138.25 6.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.399 2.099 . . . . 2.96 112.467 -163.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -162.22 165.72 26.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.447 1.899 . . . . 2.97 110.846 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.7 p -137.01 92.75 2.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.351 -0.843 . . . . 3.4 110.543 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mt -104.24 139.95 38.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.153 1.381 . . . . 2.42 111.632 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 84.8 m -67.97 135.45 52.38 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.997 0.904 . . . . 2.38 110.503 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 157.96 18.16 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.859 -1.151 . . . . 2.72 110.459 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 2.9 0.89 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.413 1.085 . . . . 1.89 113.502 165.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 m -89.96 -45.14 9.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.138 1.375 . . . . 2.85 110.8 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.31 38.47 1.11 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.987 1.279 . . . . 2.34 113.473 -168.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.87 174.82 10.05 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.905 2.082 . . . . 4.88 107.588 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -125.86 106.63 9.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 121.258 1.844 . . . . 7.1 112.551 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -99.34 153.91 18.6 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.204 1.187 . . . . 3.82 114.204 -171.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.0 p -123.03 148.2 45.82 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.345 2.658 . . . . 2.52 108.626 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -46.65 -51.75 15.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.507 1.123 . . . . 3.54 113.622 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -71.95 6.17 2.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.653 2.094 . . . . 7.21 116.653 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.11 -55.09 8.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.407 1.003 . . . . 3.78 110.76 162.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.5 -31.44 26.47 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.832 1.049 . . . . 3.02 113.832 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.04 118.73 5.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.328 1.051 . . . . 4.03 111.079 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 123.62 -27.38 5.74 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 124.114 0.864 . . . . 2.45 111.299 -167.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -84.21 166.87 17.19 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.352 -0.981 . . . . 3.77 108.352 143.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -78.54 110.17 13.39 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.728 -0.607 . . . . 2.1 112.451 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.4 mt -91.45 140.62 29.58 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.156 0.979 . . . . 2.8 112.916 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -137.43 121.66 18.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.679 1.992 . . . . 2.61 107.408 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.0 mt -126.09 131.87 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.53 0.732 . . . . 1.77 110.718 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -147.53 153.54 39.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.379 1.472 . . . . 2.67 113.068 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.44 123.06 42.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.518 1.527 . . . . 2.56 110.514 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.82 -176.95 36.23 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.21 0.844 . . . . 1.41 115.21 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -156.47 139.21 15.14 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.123 0.962 . . . . 3.82 112.946 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 t -82.2 74.5 9.17 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.424 1.011 . . . . 4.87 110.36 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 169.79 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 129.568 3.147 . . . . 7.05 110.538 -163.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.7 t -51.11 151.85 4.44 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.911 1.284 . . . . 2.21 113.844 159.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.38 64.18 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.314 3.343 . . . . 3.74 111.009 165.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.3 t0 69.59 -14.59 0.33 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.763 3.225 . . . . 4.9 114.821 162.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.37 -34.36 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 120.584 -1.323 . . . . 3.31 111.395 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.7 m -59.28 -54.34 57.18 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.317 -1.325 . . . . 2.32 114.415 167.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -67.36 -26.71 41.04 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.011 1.807 . . . . 1.72 114.154 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -66.38 -42.98 87.15 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.909 1.686 . . . . 3.53 110.814 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.73 -36.92 80.07 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.378 -0.826 . . . . 3.78 111.474 168.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 180' ' ' MET . 0.7 OUTLIER -69.56 -40.8 76.58 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.264 1.026 . . . . 2.64 112.694 178.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -57.76 11.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.148 1.379 . . . . 3.21 108.433 170.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -54.2 -37.51 64.63 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 120.174 -1.579 . . . . 3.91 113.74 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.434 ' HG2' ' HA ' ' A' ' 177' ' ' LEU . 23.9 ptp -68.73 -41.82 78.47 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 117.058 -1.448 . . . . 2.51 112.408 169.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.38 -44.66 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 121.212 1.824 . . . . 1.68 109.807 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -62.95 -29.71 71.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.214 -1.374 . . . . 3.01 113.558 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 p -86.95 -32.41 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.688 1.131 . . . . 2.62 113.394 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.03 -46.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 120.707 1.594 . . . . 2.33 110.78 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -31.54 68.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.571 1.148 . . . . 4.65 113.41 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -78.2 -13.63 59.78 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.174 -0.954 . . . . 2.66 113.328 174.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.6 mm -85.35 -55.29 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.635 1.574 . . . . 1.91 109.921 167.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -50.69 -39.3 50.88 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.406 1.482 . . . . 3.92 113.092 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -60.3 -29.41 68.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.316 1.046 . . . . 2.9 112.483 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.88 56.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 120.607 -1.308 . . . . 3.35 107.612 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -36.58 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 130.001 3.32 . . . . 4.42 118.775 -168.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -27.66 63.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.816 1.189 . . . . 4.53 111.536 172.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.84 163.01 69.72 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.127 1.771 . . . . 3.64 112.527 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -99.15 -172.35 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.924 3.083 . . . . 3.84 113.67 -166.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.48 62.73 4.68 Favored 'General case' 0 CA--C 1.549 0.942 1 C-N-CA 132.304 4.241 . . . . 5.54 116.667 -156.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.2 tp -59.76 96.94 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.67 -1.268 . . . . 1.86 112.809 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.3 m -96.35 117.86 65.84 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 125.567 1.547 . . . . 1.32 110.084 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -87.44 124.91 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.968 2.446 . . . . 0.88 111.926 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.79 102.55 9.2 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.989 2.116 . . . . 2.4 109.598 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -99.83 133.98 43.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.154 1.381 . . . . 2.46 111.618 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.82 126.19 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.556 0.742 . . . . 1.52 108.998 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 62.2 p -90.59 111.7 23.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.08 1.352 . . . . 2.52 110.733 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.3 pt -106.38 10.81 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 115.034 1.494 . . . . 1.89 115.034 -162.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -115.63 52.41 0.83 Allowed Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.595 1.158 . . . . 3.3 111.405 169.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.2 132.37 25.81 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.635 2.223 . . . . 2.58 109.188 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 128.19 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 130.334 3.454 . . . . 5.35 107.384 -163.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 -38.24 2.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.51 -0.757 . . . . 4.89 112.617 166.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.61 101.54 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.411 1.005 . . . . 4.56 108.672 160.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 48.0 m -115.82 149.37 38.68 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.372 1.469 . . . . 2.34 109.368 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -54.9 1.33 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.674 1.19 . . . . 3.42 112.148 170.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -69.03 -37.41 78.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.854 1.262 . . . . 3.19 112.94 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.71 -39.86 76.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.479 0.712 . . . . 1.48 111.793 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.07 -34.62 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.539 0.736 . . . . 1.72 110.556 175.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.0 75.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 118.693 -0.67 . . . . 1.44 111.889 170.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.6 -47.44 60.14 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.343 0.974 . . . . 4.38 112.281 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -53.42 -40.98 65.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.675 1.19 . . . . 3.8 111.485 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.4 t -64.64 -50.68 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.762 1.225 . . . . 1.38 112.017 170.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -57.28 -27.56 62.22 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.735 1.214 . . . . 5.21 113.754 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.36 -56.75 4.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.078 1.751 . . . . 3.7 111.656 174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -79.3 -38.44 35.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.328 1.233 . . . . 3.36 114.328 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 m 167.71 129.72 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 127.13 2.172 . . . . 2.02 112.806 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.77 -0.26 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.375 2.717 . . . . 1.72 113.516 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.68 -26.37 68.62 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.277 0.944 . . . . 4.33 113.418 162.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.18 133.42 35.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.164 0.893 . . . . 2.1 112.788 -165.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.82 122.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.876 1.27 . . . . 1.84 107.768 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.11 132.35 10.9 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.181 -1.168 . . . . 0.87 110.181 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.14 143.62 48.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 2.43 109.607 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.3 m -143.08 176.27 9.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 128.813 2.845 . . . . 2.84 106.676 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 168.11 -179.85 41.04 Favored Glycine 0 N--CA 1.472 1.056 0 O-C-N 120.436 -1.415 . . . . 1.91 114.364 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.0 t -75.42 163.47 27.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.264 0.625 . . . . 2.88 111.053 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.415 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -49.55 -21.42 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.419 2.288 . . . . 7.14 115.684 176.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -66.9 -51.46 55.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.137 1.375 . . . . 2.96 111.175 166.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -68.55 -43.86 75.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.242 1.017 . . . . 4.47 111.354 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.1 m -74.55 -19.94 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 114.186 1.18 . . . . 2.91 114.186 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.83 -57.54 4.52 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.807 1.185 . . . . 2.84 108.602 161.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.15 -55.41 10.42 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.223 1.409 . . . . 3.47 112.29 -173.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.37 -40.78 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 118.923 0.783 . . . . 2.12 112.94 -171.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.17 75.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.611 0.764 . . . . 1.64 110.436 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -70.6 -34.23 71.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 3.79 112.678 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.16 -58.0 5.14 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.384 1.474 . . . . 2.34 112.579 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -1.87 13.99 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.631 0.974 . . . . 2.56 113.631 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.02 32.17 6.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.29 2.236 . . . . 5.9 113.013 165.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.56 155.66 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.664 1.185 . . . . 3.43 110.149 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -74.14 137.87 43.49 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.276 0.56 . . . . 4.28 112.041 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -164.83 141.7 6.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.58 2.752 . . . . 5.32 109.481 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 129.83 2.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 117.936 -1.031 . . . . 4.97 112.586 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -69.19 141.66 48.18 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.407 2.738 . . . . 4.77 110.689 171.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -115.86 -170.25 15.88 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.068 0.842 . . . . 3.7 114.471 -172.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -81.3 -174.14 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.19 3.26 . . . . 3.76 112.105 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 255' ' ' ASP . 25.6 mmmt -60.7 148.32 39.09 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.879 -0.6 . . . . 4.34 111.016 157.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -142.98 153.88 43.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.192 0.997 . . . . 8.06 111.522 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 58.86 -59.22 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 128.451 2.7 . . . . 7.7 112.519 -157.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -167.15 -52.63 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.987 2.915 . . . . 6.47 109.108 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -133.84 5.95 3.67 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.107 1.521 . . . . 5.41 115.107 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.446 ' O ' ' HE3' ' A' ' 250' ' ' LYS . 8.1 t70 -79.66 178.84 7.86 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 119.667 -1.896 . . . . 4.24 110.339 164.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -132.32 106.18 7.76 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.036 -1.665 . . . . 3.73 109.323 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.91 146.14 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 122.032 0.92 . . . . 4.42 110.464 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.32 128.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.132 2.173 . . . . 3.77 105.556 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -105.19 152.05 23.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.637 0.732 . . . . 3.75 111.713 -170.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -165.18 152.46 10.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.548 1.166 . . . . 2.65 114.024 -169.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 99.2 m -59.21 120.42 9.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.182 -1.372 . . . . 3.9 108.698 164.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.29 135.73 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.023 -1.473 . . . . 3.57 107.023 146.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.2 mt 135.65 127.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.108 1 C-N-CA 131.964 4.106 . . . . 2.9 109.454 176.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -100.6 150.79 22.34 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.682 1.993 . . . . 2.64 110.756 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -118.22 132.13 56.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.014 1.326 . . . . 3.4 112.196 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 8.8 tt -90.69 125.88 35.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.181 0.991 . . . . 2.21 111.091 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 143.82 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 127.629 2.372 . . . . 1.73 108.684 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.32 149.11 49.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.541 -1.144 . . . . 1.92 111.209 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.77 63.8 6.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.122 3.215 . . . . 2.88 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 153.72 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 131.36 3.864 . . . . 8.25 113.91 173.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 168.92 149.9 6.43 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 120.455 1.48 . . . . 3.32 116.023 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . 0.283 60.7 mt-10 41.33 -145.32 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.549 2.74 . . . . 4.18 113.87 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -148.54 155.49 41.2 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.044 1.293 . . . . 3.84 113.869 -163.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.84 -37.53 4.82 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.261 1.424 . . . . 2.64 111.912 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -145.32 170.85 15.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.43 1.092 . . . . 4.19 112.735 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -158.86 133.32 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.808 1.243 . . . . 3.85 111.519 160.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -178.1 -122.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.179 2.192 . . . . 3.78 111.118 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 95.79 -94.48 1.69 Allowed Glycine 0 N--CA 1.469 0.862 0 N-CA-C 109.479 -1.448 . . . . 3.61 109.479 -168.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.08 139.39 41.62 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 117.646 0.723 . . . . 3.4 111.104 168.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 80.82 -1.6 1.83 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.895 2.478 . . . . 5.32 113.311 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 121.21 36.1 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.032 1.733 . . . . 6.28 110.134 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -72.04 141.84 49.28 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.774 -1.204 . . . . 6.95 108.31 166.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -41.07 31.54 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.117 1.895 . . . . 1.73 116.117 -160.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.25 -18.77 71.64 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 119.787 1.176 . . . . 1.29 114.833 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.75 -33.89 76.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.899 -0.766 . . . . 2.95 110.777 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.6 -46.84 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.952 0.901 . . . . 1.66 109.101 172.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.97 72.39 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.685 1.129 . . . . 1.4 112.409 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.27 70.57 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.821 1.045 . . . . 1.6 113.821 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 5.7 p -87.43 -41.6 13.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.653 0.612 . . . . 1.95 112.653 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mt -52.03 -38.8 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.418 1.087 . . . . 1.47 111.01 169.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -51.73 -31.5 26.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.911 1.078 . . . . 2.2 113.911 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 19.6 p -75.26 -32.72 61.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.073 0.949 . . . . 3.75 112.036 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -72.42 -32.01 65.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.19 0.996 . . . . 2.82 112.372 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.19 -32.77 70.86 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.522 1.129 . . . . 6.6 112.299 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -49.94 -51.32 62.28 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 116.307 -1.806 . . . . 5.53 113.365 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.81 -44.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.218 2.612 . . . . 2.59 113.367 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -92.4 123.1 35.47 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.888 1.222 . . . . 3.08 114.146 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 78.81 -64.16 0.26 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 127.258 2.223 . . . . 13.47 112.962 155.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -137.32 111.37 8.35 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.872 0.869 . . . . 7.15 110.61 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -17.46 22.99 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 117.298 2.333 . . . . 9.74 117.298 -165.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.486 1.356 1 C-N-CA 133.606 4.762 . . . . 10.1 106.348 -149.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 117.702 -1.142 . . . . 17.38 110.255 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -49.48 -48.67 47.65 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.108 1.521 . . . . 13.42 115.108 -168.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.6 t -77.53 51.31 0.88 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.01 1.324 . . . . 11.65 112.811 178.113 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.12 164.09 42.02 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.471 1.034 . . . . 9.88 111.684 167.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt 179.44 152.25 0.54 Allowed Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.887 2.075 . . . . 8.97 111.554 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.06 159.77 37.2 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.418 2.745 . . . . 7.47 110.634 168.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.2 mp -121.05 134.67 55.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.884 1.273 . . . . 7.95 108.766 172.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.05 -36.9 7.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.944 0.897 . . . . 5.94 112.258 176.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 165.69 -158.93 32.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.89 1.71 . . . . 2.8 110.66 -169.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 134.3 -159.9 23.97 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.433 1.016 . . . . 3.06 113.585 174.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.78 156.61 39.58 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.206 2.604 . . . . 3.22 113.804 -168.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -138.91 169.14 18.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.54 2.336 . . . . 2.72 109.199 174.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.9 m -138.53 69.47 1.38 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.727 -1.233 . . . . 2.79 112.482 -176.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.22 172.65 7.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.441 1.097 . . . . 2.59 112.333 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.0 m -103.42 158.52 16.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.501 1.52 . . . . 1.68 109.525 173.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.3 m -107.94 159.79 16.27 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.939 1.296 . . . . 2.5 111.612 -172.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -55.23 -9.74 0.47 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 115.793 1.775 . . . . 1.72 115.793 176.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 t -113.53 7.35 17.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.951 2.1 . . . . 3.78 113.622 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.49 -10.41 69.06 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.575 1.56 . . . . 1.84 115.842 173.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.99 148.71 25.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.772 1.229 . . . . 3.48 111.984 -177.146 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.63 115.14 28.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.56 1.544 . . . . 6.08 111.249 -173.14 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 161.66 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.462 1.505 . . . . 4.11 112.742 -168.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.5 m -154.18 148.5 26.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.001 0.92 . . . . 3.02 111.176 -152.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -36.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.041 2.136 . . . . 3.16 112.569 165.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.421 ' HZ2' ' CG ' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -69.82 3.19 2.72 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.712 1.375 . . . . 7.11 114.712 -177.502 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' ' 153' ' ' LYS . 5.7 m-20 -108.04 -24.43 11.59 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.335 1.854 . . . . 3.29 112.822 173.034 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -84.64 -15.93 43.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.865 1.061 . . . . 3.32 113.865 165.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.03 154.43 9.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.207 1.403 . . . . 3.7 112.929 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.19 -20.11 21.79 Favored Glycine 0 N--CA 1.478 1.495 0 C-N-CA 126.622 2.058 . . . . 2.44 113.679 -174.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.01 173.68 6.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.277 1.831 . . . . 3.63 108.412 165.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -67.76 110.87 3.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.226 -0.657 . . . . 1.75 109.226 170.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.4 tp -99.16 120.66 39.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.185 0.993 . . . . 2.47 109.207 -172.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -104.69 116.21 31.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.158 1.383 . . . . 3.73 107.884 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.54 102.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.27 -1.011 . . . . 2.37 108.27 -178.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -100.21 148.91 24.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.024 1.73 . . . . 2.38 111.429 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.16 117.26 29.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.094 . . . . 2.33 110.743 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.97 153.64 23.4 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 115.777 1.071 . . . . 1.5 115.777 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.34 60.82 5.89 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.344 -1.092 . . . . 3.61 112.561 -170.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.7 m 64.1 -20.55 0.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 128.174 2.59 . . . . 4.57 115.551 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 176.83 -50.23 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 128.688 2.795 . . . . 9.98 110.101 -166.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.511 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.1 OUTLIER 61.0 177.8 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.881 1.272 . . . . 2.65 112.7 -164.533 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.511 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 39.7 Cg_endo -88.92 -132.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.88 3.053 . . . . 3.18 107.341 159.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -80.56 61.98 4.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.717 1.207 . . . . 5.06 112.403 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.75 -83.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.594 1.557 . . . . 3.61 110.365 175.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.4 m -49.87 -48.31 78.17 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.739 1.755 . . . . 2.04 115.739 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.77 -25.47 23.91 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.563 2.176 . . . . 1.35 113.732 -169.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.68 -52.93 63.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.973 1.709 . . . . 3.06 110.806 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.57 -26.05 61.57 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.848 -1.158 . . . . 2.81 111.963 171.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -45.6 78.53 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.465 -1.397 . . . . 2.37 111.849 -177.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.93 -41.01 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.227 1.376 . . . . 4.88 111.033 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 183' ' ' VAL . 43.0 mttp -60.68 -47.85 84.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.594 1.558 . . . . 3.47 110.706 174.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.85 -57.13 13.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.351 1.46 . . . . 2.74 111.428 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.26 -47.66 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.085 1.311 . . . . 2.47 111.786 -172.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -63.13 -28.6 70.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.921 0.782 . . . . 3.18 110.889 -173.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.613 HG21 ' HB ' ' A' ' 286' ' ' ILE . 55.1 t -63.34 -27.5 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 116.846 -1.55 . . . . 1.64 113.304 -178.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.744 HG23 ' H ' ' A' ' 196' ' ' LEU . 3.4 p -67.43 -32.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 121.276 1.853 . . . . 3.07 111.365 171.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -87.78 -15.25 37.45 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.794 0.838 . . . . 5.49 112.95 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.6 -13.17 59.98 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.676 -1.265 . . . . 3.37 113.004 164.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.59 -58.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.679 1.591 . . . . 2.0 111.675 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -63.44 -38.64 91.92 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.31 1.414 . . . . 3.28 112.671 -176.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 7.9 t -67.79 -11.23 58.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.582 2.753 . . . . 3.02 113.835 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.99 -25.86 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.391 -1.443 . . . . 4.77 113.157 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t 174.29 -42.14 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.466 2.306 . . . . 5.18 112.126 167.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.9 m 173.83 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 130.557 3.543 . . . . 5.88 105.052 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.7 mp -103.05 173.65 3.34 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.291 0.636 . . . . 4.82 111.345 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.44 154.46 21.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.567 2.178 . . . . 3.98 110.801 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.39 142.64 32.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.068 0.937 . . . . 3.66 111.83 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.744 ' H ' HG23 ' A' ' 184' ' ' VAL . 48.3 tp -104.79 63.89 0.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.479 2.312 . . . . 1.96 108.188 175.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.1 m -57.66 115.46 10.99 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.142 -0.932 . . . . 1.72 110.39 -166.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -86.92 116.06 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.729 2.286 . . . . 0.93 112.134 -173.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.43 117.44 34.1 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.693 1.597 . . . . 2.42 109.518 178.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -97.99 114.27 26.36 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.269 1.028 . . . . 2.31 110.124 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -83.21 122.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.256 -1.016 . . . . 1.94 108.256 165.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.53 128.98 34.94 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.854 -0.738 . . . . 1.8 111.243 166.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 pt -104.66 28.81 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 125.285 1.434 . . . . 2.13 113.261 178.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -122.8 47.44 1.57 Allowed Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 127.907 2.483 . . . . 3.41 112.942 -176.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.67 82.6 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.19 1 C-N-CA 126.206 4.604 . . . . 2.76 111.817 -172.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 175.38 -33.33 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.293 1.437 . . . . 3.98 114.406 -160.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -151.25 11.13 0.61 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.392 1.256 . . . . 5.19 114.392 170.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -70.11 54.49 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 130.888 3.675 . . . . 5.04 112.284 172.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 98.7 m -60.3 137.89 58.05 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.297 1.839 . . . . 2.06 110.464 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -43.35 -55.16 4.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.242 1.417 . . . . 4.03 112.984 -178.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -66.04 -33.53 76.01 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.119 1.768 . . . . 3.13 114.096 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.52 -36.14 73.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.961 1.255 . . . . 1.33 111.596 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.82 -36.6 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.186 0.995 . . . . 1.8 110.848 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.9 70.71 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.092 0.86 . . . . 1.28 112.061 168.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -66.24 -47.29 74.26 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.334 -0.853 . . . . 4.48 111.837 171.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -65.87 -32.56 74.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.933 0.716 . . . . 3.7 112.933 178.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.54 -49.0 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.13 0.972 . . . . 1.17 111.34 166.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.571 1.148 . . . . 4.57 113.515 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -62.43 -33.35 74.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.43 1.092 . . . . 4.85 112.164 177.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -98.73 -63.25 1.14 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.484 0.92 . . . . 2.71 113.484 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.4 m 170.89 145.72 0.12 Allowed Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 126.717 2.007 . . . . 2.42 112.197 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.94 4.71 2.99 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.545 3.497 . . . . 1.94 114.556 -175.018 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -71.36 -23.72 61.96 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 119.687 1.13 . . . . 2.15 111.494 163.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.1 tt -87.35 145.13 26.45 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.463 1.505 . . . . 2.12 111.096 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.6 m -130.18 139.77 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.666 1.186 . . . . 2.69 110.951 175.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.94 130.94 9.62 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.544 1.069 . . . . 0.9 111.708 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.82 143.84 51.11 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.159 0.984 . . . . 2.35 113.243 -173.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.8 p -147.37 169.39 19.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.078 2.151 . . . . 2.49 112.16 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -179.02 -178.94 48.59 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.332 1.92 . . . . 1.9 110.45 -176.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -63.96 163.02 12.85 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.532 1.166 . . . . 2.37 111.636 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.7 mtt-85 -47.58 -35.22 8.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.055 1.342 . . . . 5.87 112.738 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.3 mp0 -72.05 -37.1 69.75 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.582 1.953 . . . . 2.91 112.147 178.172 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -70.39 -42.66 71.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.711 -1.243 . . . . 3.48 111.345 176.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.4 t -63.36 -36.9 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.414 0.686 . . . . 1.77 110.98 173.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.03 -44.51 84.45 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.757 -0.639 . . . . 3.08 110.457 174.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -55.82 -50.94 69.16 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.232 0.924 . . . . 2.82 111.787 176.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.26 -36.07 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.703 0.683 . . . . 2.21 112.216 -175.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.99 92.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.827 0.739 . . . . 1.82 111.624 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.9 ttm105 -67.36 -38.78 85.35 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.927 1.291 . . . . 3.36 112.255 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.57 70.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.371 0.987 . . . . 2.01 112.076 178.053 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -88.63 12.58 14.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.199 1.4 . . . . 2.67 113.893 176.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 46.19 37.86 4.39 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.008 2.123 . . . . 6.71 115.28 -176.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.62 145.08 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.715 2.006 . . . . 3.36 112.577 -173.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -80.63 139.2 36.35 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.562 1.319 . . . . 3.4 114.562 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -155.03 158.95 39.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.451 1.5 . . . . 4.12 111.878 154.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 41.2 m -126.7 125.53 24.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.329 1.852 . . . . 3.76 107.883 167.025 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.77 147.67 45.08 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.04 2.494 . . . . 3.61 111.062 -178.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.73 151.63 39.68 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 114.599 0.599 . . . . 2.84 114.599 -167.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -86.89 -149.61 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.762 3.641 . . . . 4.14 109.479 173.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' A' ' 254' ' ' GLU . 5.7 mmpt? -122.36 143.74 49.46 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.19 -0.944 . . . . 5.52 108.628 154.149 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -88.4 -166.63 1.64 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 118.862 -0.59 . . . . 7.83 111.317 166.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -82.37 -19.19 39.69 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.646 1.35 . . . . 9.52 114.646 -172.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.35 -84.55 0.23 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.86 1.264 . . . . 7.27 110.408 173.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 23.1 tp10 -166.54 18.23 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.532 2.333 . . . . 5.52 111.247 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.64 149.48 48.88 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 119.684 -1.885 . . . . 4.82 113.427 178.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -129.54 60.32 1.58 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.44 1.496 . . . . 4.52 112.047 174.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.86 108.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 120.414 -1.429 . . . . 4.58 111.765 170.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.5 143.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.53 1.532 . . . . 3.0 108.17 164.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.5 160.09 23.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.131 0.972 . . . . 3.45 110.672 173.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.55 154.39 0.38 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.494 -1.379 . . . . 2.72 112.959 -134.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -68.59 -30.72 69.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 117.285 2.328 . . . . 4.77 117.285 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.7 pt 39.4 34.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 126.556 1.942 . . . . 3.9 116.045 -172.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 19.1 mt -113.9 144.26 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 2.32 110.113 -177.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.7 143.04 31.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.481 0.712 . . . . 4.8 111.289 156.513 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -97.87 132.79 43.15 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.723 0.809 . . . . 3.19 111.096 162.329 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -93.14 93.63 8.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.759 1.224 . . . . 1.91 109.829 178.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.17 127.44 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.875 1.27 . . . . 1.69 108.672 175.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.51 161.97 54.24 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 110.851 -0.899 . . . . 1.43 110.851 172.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -65.23 -8.83 19.77 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.376 2.051 . . . . 3.03 113.794 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -107.23 29.74 6.85 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.097 1.759 . . . . 5.61 112.093 170.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.16 -42.04 3.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.663 1.601 . . . . 2.42 116.399 161.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -78.74 151.76 31.88 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.351 1.576 . . . . 5.67 111.369 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -89.53 144.05 26.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.033 -1.042 . . . . 3.32 113.738 -177.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -23.94 14.83 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.867 1.267 . . . . 2.74 112.881 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -168.25 170.01 10.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.887 1.275 . . . . 2.39 111.016 -167.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -153.56 140.1 18.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.847 0.859 . . . . 3.64 112.432 175.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 277' ' ' PHE . . . . . 0.545 ' CE1' ' HE2' ' A' ' 281' ' ' LYS . 13.2 m-85 -137.06 130.3 31.11 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.653 -0.654 . . . . 3.01 111.91 -169.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.12 91.83 0.08 OUTLIER Glycine 0 N--CA 1.471 0.985 0 N-CA-C 115.221 0.848 . . . . 4.17 115.221 174.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 137.32 127.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 1 C-N-CA 132.823 4.449 . . . . 3.39 107.073 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -40.51 98.91 0.01 OUTLIER 'General case' 0 C--O 1.237 0.409 0 O-C-N 124.763 1.289 . . . . 8.64 113.752 -140.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.545 ' HE2' ' CE1' ' A' ' 277' ' ' PHE . 45.7 tttp -78.95 -18.22 54.15 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.442 -0.786 . . . . 4.34 111.488 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.39 120.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.13 2.572 . . . . 5.71 108.583 -177.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -26.05 -77.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.673 2.389 . . . . 2.86 114.815 -176.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.53 -13.14 49.51 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 115.439 0.936 . . . . 1.91 115.439 -175.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.74 -30.76 40.94 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.218 2.009 . . . . 3.49 112.532 172.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 286' ' ' ILE . . . . . 0.613 ' HB ' HG21 ' A' ' 183' ' ' VAL . 21.8 mt -60.03 -40.65 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.136 -0.977 . . . . 1.58 108.859 165.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.12 -51.42 64.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.24 -0.41 . . . . 1.24 111.88 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.87 78.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.226 1.195 . . . . 1.66 114.226 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.5 p -67.33 -50.11 61.38 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 1.78 111.761 172.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.63 -38.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.742 1.156 . . . . 1.32 112.491 174.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.4 -16.18 33.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.743 1.217 . . . . 1.55 114.254 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.7 m -81.27 -47.86 12.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 1.72 110.281 167.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -67.32 -27.64 67.32 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.24 1.016 . . . . 2.81 113.641 -178.076 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 76.4 mtm -71.61 -23.41 61.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.378 -1.451 . . . . 4.91 113.498 174.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.16 -35.25 11.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 116.29 -1.814 . . . . 4.07 114.048 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.89 -41.39 1.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.912 2.076 . . . . 1.84 112.577 162.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.76 -157.19 0.11 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.837 1.791 . . . . 3.26 115.837 -169.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -60.22 123.13 16.27 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 119.992 -1.693 . . . . 10.3 110.939 174.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt 63.45 115.15 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.524 2.33 . . . . 8.38 114.519 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -45.78 16.87 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.066 -0.97 . . . . 11.71 111.164 175.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.256 1.418 0 C-N-CA 129.929 3.291 . . . . 10.74 105.803 -174.825 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 118.275 -0.869 . . . . 18.41 110.27 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -159.08 145.59 16.85 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.318 1.447 . . . . 15.52 109.597 178.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.0 m -137.81 48.89 1.99 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.879 0.871 . . . . 14.98 111.505 -165.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.37 31.84 0.56 Allowed Glycine 0 N--CA 1.478 1.468 0 C-N-CA 125.046 1.308 . . . . 11.41 115.609 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -134.13 65.23 68.63 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.087 1.355 . . . . 9.86 111.821 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.27 86.08 1.18 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.41 2.74 . . . . 9.7 111.081 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 74.93 -63.79 0.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 128.016 2.527 . . . . 11.15 112.705 172.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp 63.37 -174.78 0.16 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.295 2.638 . . . . 5.63 113.169 178.475 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -175.21 -42.46 0.05 OUTLIER Glycine 0 N--CA 1.469 0.889 0 N-CA-C 115.879 1.112 . . . . 3.7 115.879 166.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.49 -172.86 45.29 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 118.087 0.943 . . . . 2.43 113.329 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.28 151.49 26.47 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.44 2.76 . . . . 3.19 112.525 -167.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -81.52 155.79 25.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.881 0.872 . . . . 2.99 110.143 166.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.4 ' H ' ' NE2' ' A' ' 236' ' ' GLN . 21.5 t -142.41 101.52 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.686 -1.259 . . . . 2.85 108.916 167.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.89 162.49 32.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.191 1.396 . . . . 2.41 110.733 -170.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.9 m -84.27 133.53 34.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.465 0.706 . . . . 1.92 109.58 172.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.2 t -98.2 162.76 13.03 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.593 1.557 . . . . 2.8 109.974 177.323 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -65.37 -9.42 24.74 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.192 1.553 . . . . 2.02 115.192 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.7 p -73.44 -21.94 60.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.159 1.384 . . . . 3.12 113.292 166.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.85 -9.54 63.95 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.626 1.584 . . . . 1.75 113.401 -170.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -65.91 148.64 51.48 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.677 1.238 . . . . 4.79 110.508 170.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.66 109.08 20.9 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.684 0.793 . . . . 6.02 109.152 171.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.06 167.81 10.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.463 1.905 . . . . 3.61 113.742 -161.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -148.73 165.42 31.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.466 1.507 . . . . 2.75 110.44 -178.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -47.28 -45.05 23.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.901 2.08 . . . . 3.81 113.09 175.224 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -80.49 -4.49 54.06 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.165 1.172 . . . . 5.6 114.165 -176.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.37 -47.47 7.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.768 1.627 . . . . 3.96 109.16 163.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -75.46 11.13 1.35 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.823 1.786 . . . . 3.34 115.823 -176.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tp -78.67 -170.51 2.14 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.716 1.606 . . . . 4.4 113.238 -172.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.3 -36.04 1.54 Allowed Glycine 0 N--CA 1.479 1.505 0 C-N-CA 125.681 1.61 . . . . 3.53 114.463 176.099 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -76.86 -179.53 5.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.791 1.236 . . . . 4.01 111.448 162.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -91.35 149.54 21.69 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.673 0.749 . . . . 1.91 109.734 156.242 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.4 tp -136.89 140.28 42.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.519 0.728 . . . . 3.53 111.111 -173.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.41 138.63 51.69 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.674 1.19 . . . . 2.69 108.042 164.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.7 mt -123.65 131.89 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.473 1.109 . . . . 2.59 108.525 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -134.37 138.85 45.2 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.002 1.321 . . . . 2.42 111.834 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -102.54 117.97 35.84 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.498 1.119 . . . . 2.53 111.22 175.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.77 -178.36 15.97 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.098 0.856 . . . . 1.21 114.289 173.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -136.12 119.58 16.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.136 0.975 . . . . 3.58 110.847 -168.049 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 m -71.36 20.5 0.05 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.167 1.787 . . . . 2.69 113.407 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -124.48 -16.33 6.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.203 1.801 . . . . 7.11 111.351 168.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 38.4 t -63.53 136.91 96.92 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 119.531 1.059 . . . . 2.29 112.349 -171.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.25 99.69 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.332 2.688 . . . . 3.2 109.621 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 74.88 -35.8 0.3 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.141 2.576 . . . . 4.13 114.777 155.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 72.4 t -54.55 -56.73 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.472 1.509 . . . . 2.54 110.836 176.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 33.4 m -53.85 -57.59 17.0 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.65 -1.166 . . . . 1.82 113.316 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.74 -39.48 4.6 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.768 1.645 . . . . 1.61 114.223 -175.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -41.02 70.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.235 1.38 . . . . 3.06 111.888 -178.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -30.38 69.42 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.433 1.015 . . . . 2.98 111.28 176.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.8 tp -69.87 -35.31 74.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 2.84 112.323 173.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -42.98 90.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.987 0.812 . . . . 3.7 110.314 170.166 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -54.33 -35.62 62.89 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 119.995 -1.69 . . . . 2.99 112.012 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.3 ttp -70.17 -28.02 64.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.914 1.079 . . . . 2.88 113.914 171.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.95 -52.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.803 1.638 . . . . 1.57 109.781 167.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -56.1 -27.0 52.01 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.201 1.001 . . . . 3.84 112.022 -176.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 t -64.56 -29.99 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 117.402 -1.285 . . . . 1.83 111.729 176.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.91 -44.55 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.679 2.036 . . . . 2.38 111.892 -175.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.89 -43.73 98.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.761 1.624 . . . . 3.49 111.631 174.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.18 -38.98 84.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.507 1.523 . . . . 3.95 111.811 170.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 -49.38 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.801 1.64 . . . . 2.74 112.906 -177.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.68 -28.13 68.85 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.528 1.513 . . . . 5.61 109.762 176.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.0 t -67.84 -13.47 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.793 1.405 . . . . 5.14 114.793 172.126 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.32 -26.55 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.608 1.549 . . . . 5.99 111.04 169.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.305 60.9 p 119.65 50.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 1 C-N-CA 133.119 4.567 . . . . 7.97 111.119 -175.469 . . . . . . . . 3 2 . 1 . 022 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.423 0.6 OUTLIER 79.16 67.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.658 1.983 . . . . 4.81 114.67 146.52 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.04 166.82 0.37 Allowed Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 126.651 1.98 . . . . 4.35 111.52 160.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.37 -55.43 0.37 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.183 1.815 . . . . 3.71 109.296 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -169.65 158.22 7.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.288 3.035 . . . . 4.65 107.22 160.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.3 tp -112.77 106.91 15.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.945 1.298 . . . . 1.95 110.889 166.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -78.7 130.51 70.54 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.675 -0.678 . . . . 1.94 110.411 170.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.52 114.91 1.02 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.451 2.768 . . . . 1.1 109.908 159.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.84 111.28 23.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.375 1.47 . . . . 3.0 108.641 174.531 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -91.97 124.83 36.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 1.92 110.043 174.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.25 119.97 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.788 0.835 . . . . 1.36 108.81 167.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -83.24 130.39 35.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.186 -0.461 . . . . 2.11 109.989 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -104.62 16.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.559 0.948 . . . . 1.94 113.559 171.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.11 14.57 0.04 OUTLIER Pre-proline 0 CA--C 1.573 1.841 0 C-N-CA 127.926 2.49 . . . . 3.35 117.17 177.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -80.41 53.56 4.82 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 123.863 2.415 . . . . 2.7 113.171 -177.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -83.91 -41.33 17.51 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.143 -0.688 . . . . 4.58 109.143 141.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.76 0.53 4.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.088 1.355 . . . . 6.58 114.181 -171.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -93.2 156.75 16.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.886 1.274 . . . . 4.34 110.91 174.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -137.5 147.92 45.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 2.68 111.02 -176.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.2 -34.31 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.157 -0.929 . . . . 3.0 111.774 173.207 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -66.21 -44.1 84.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.593 1.957 . . . . 3.17 112.522 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.05 78.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.469 1.032 . . . . 1.28 111.193 174.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.94 -41.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.694 0.798 . . . . 1.74 111.415 174.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.46 -15.81 30.35 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.933 1.086 . . . . 1.71 113.933 176.079 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.59 -47.11 7.28 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.403 1.456 . . . . 4.03 113.149 165.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.09 -37.73 47.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.93 1.692 . . . . 2.91 111.565 175.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.0 t -43.56 -56.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.305 2.242 . . . . 1.63 112.792 167.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.14 -31.55 67.86 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.785 0.661 . . . . 4.16 112.785 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -63.36 -23.86 67.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.35 1.06 . . . . 4.03 111.643 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.95 -45.36 10.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.63 0.974 . . . . 3.14 113.63 168.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.2 p -174.33 167.59 2.2 Favored Pre-proline 0 N--CA 1.476 0.851 0 O-C-N 120.497 -1.377 . . . . 2.77 113.764 -168.103 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.59 2.54 8.27 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.485 2.79 . . . . 3.55 113.959 165.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.43 -26.24 6.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.953 1.464 . . . . 2.04 114.953 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.69 148.48 48.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.193 0.997 . . . . 2.21 111.217 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.43 132.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.24 1.016 . . . . 2.37 109.738 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.0 110.4 2.76 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.085 0.85 . . . . 1.32 111.606 -170.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp -108.99 144.88 36.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.5 1.12 . . . . 2.81 111.949 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.01 178.51 10.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.761 1.624 . . . . 2.86 108.892 -175.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.95 -140.64 3.39 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 108.498 -1.841 . . . . 1.88 108.498 166.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 65.7 p -80.36 176.43 9.78 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.446 1.498 . . . . 2.56 111.988 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.408 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -62.02 -21.68 65.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 118.346 -0.835 . . . . 8.18 112.78 165.788 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.408 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 22.2 mp0 -71.19 -39.44 71.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.105 1.362 . . . . 2.92 111.431 171.387 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -64.12 -42.95 96.64 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.051 -1.031 . . . . 3.75 111.616 173.033 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.5 t -59.47 -43.66 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.818 0.699 . . . . 1.81 110.769 173.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.25 -49.78 70.57 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.024 -0.988 . . . . 3.66 108.725 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' A' ' 141' ' ' SER . 5.0 tt0 -47.12 -56.91 5.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.41 -0.805 . . . . 3.48 111.242 174.015 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.9 m -76.87 -27.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.877 1.065 . . . . 2.65 113.877 -168.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.83 -40.17 55.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.525 0.602 . . . . 1.66 111.549 172.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -75.01 -33.71 61.84 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.62 1.968 . . . . 3.92 111.801 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -49.58 -72.51 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.561 1.073 . . . . 2.22 110.956 167.255 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -85.21 9.24 15.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.063 1.505 . . . . 3.39 115.063 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.92 18.8 11.18 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.47 1.508 . . . . 8.29 113.715 171.11 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 m -67.89 -15.09 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 117.435 2.383 . . . . 3.08 117.435 -145.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.4 t80 60.83 131.54 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.086 2.555 . . . . 3.47 116.898 -174.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -160.54 165.68 30.41 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.873 2.469 . . . . 3.24 109.391 170.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.3 t -154.49 134.51 8.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 121.291 -0.88 . . . . 3.15 110.813 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.44 144.51 10.31 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.913 2.409 . . . . 2.72 112.977 -173.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.3 130.64 38.2 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 110.76 -0.936 . . . . 2.74 110.76 163.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.74 149.91 21.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.624 2.216 . . . . 3.14 112.208 -166.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -75.27 38.96 0.14 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 127.615 2.366 . . . . 5.3 113.149 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -135.29 -23.29 1.48 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.183 1.179 . . . . 7.92 114.183 -142.105 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -88.68 -34.15 17.31 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.914 0.886 . . . . 8.47 113.163 -176.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -173.28 -57.44 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.3 2.64 . . . . 5.5 107.86 165.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.3 134.23 0.52 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.931 2.092 . . . . 5.46 110.959 157.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -166.36 173.5 9.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.997 1.719 . . . . 3.9 112.152 176.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.56 49.88 0.82 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.748 1.619 . . . . 3.65 111.416 170.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.2 tp -56.68 161.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 119.364 -2.085 . . . . 2.76 110.263 159.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.73 146.73 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.181 -0.95 . . . . 4.49 109.869 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.62 143.78 28.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.924 1.29 . . . . 3.99 109.15 161.045 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.9 145.01 8.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.167 1.387 . . . . 2.79 111.129 -172.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.7 p -62.19 -22.35 65.84 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.963 1.097 . . . . 3.48 113.963 171.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 279' ' ' GLN 0.334 0.1 OUTLIER 49.12 62.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.769 1.747 . . . . 3.93 110.715 -174.473 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.1 mm -118.92 152.44 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.283 2.233 . . . . 2.64 110.94 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.0 mtp -132.93 155.67 48.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.418 2.687 . . . . 2.33 109.376 -175.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -117.29 143.74 45.6 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.746 1.017 . . . . 3.54 113.746 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.76 127.5 42.79 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.906 1.682 . . . . 2.93 107.322 168.22 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.6 130.87 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.497 0.719 . . . . 2.87 109.073 171.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.13 173.16 37.4 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.921 0.772 . . . . 2.15 112.285 177.39 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.05 68.16 6.63 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.185 3.257 . . . . 3.27 111.085 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -167.83 -56.69 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.325 1.85 . . . . 5.47 109.729 -164.347 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 144.12 165.05 10.75 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.191 1.236 . . . . 3.27 116.191 170.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 70.65 -86.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.054 1.741 . . . . 8.41 111.976 165.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.72 157.01 9.9 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.779 1.632 . . . . 5.65 112.281 -173.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -39.38 0.6 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.395 1.478 . . . . 3.96 111.579 -175.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.33 176.01 13.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.756 2.023 . . . . 3.68 108.538 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -135.39 150.05 49.8 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.211 1.004 . . . . 3.22 112.437 178.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -133.18 -170.02 2.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.591 1.557 . . . . 3.06 110.477 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.91 -157.75 14.73 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.521 1.057 . . . . 2.84 110.888 -171.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 262' ' ' ILE . 12.0 tp-100 -71.91 90.71 1.14 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.546 0.943 . . . . 4.94 113.546 -164.116 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.1 p30 165.71 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 130.267 3.427 . . . . 7.4 112.984 164.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.94 108.91 7.04 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.368 -0.832 . . . . 6.23 108.934 170.062 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.427 ' HD2' ' H ' ' A' ' 282' ' ' ARG . 0.5 OUTLIER -78.71 135.5 37.17 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.19 0.996 . . . . 8.86 109.672 -172.572 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -21.24 -66.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.121 2.267 . . . . 3.0 117.121 -163.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.33 -20.41 65.32 Favored Glycine 0 N--CA 1.48 1.607 0 CA-C-N 119.944 1.247 . . . . 2.24 114.733 -173.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.94 -22.5 66.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.633 1.173 . . . . 4.43 111.642 172.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.41 -48.69 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.822 -1.173 . . . . 1.9 109.729 175.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.25 92.26 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.179 0.807 . . . . 1.84 113.179 173.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.93 74.19 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.984 0.735 . . . . 1.89 112.984 178.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 14.1 p -72.33 -44.07 63.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.72 -1.238 . . . . 1.89 111.677 170.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.9 -34.52 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.742 1.155 . . . . 1.91 111.985 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.38 47.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.613 1.338 . . . . 2.38 114.613 171.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.9 m -80.6 -48.45 12.66 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.115 0.87 . . . . 3.21 110.413 170.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -64.85 -28.29 69.45 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.849 1.26 . . . . 3.06 112.55 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.0 ttp -58.86 -20.0 46.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.225 2.61 . . . . 4.75 113.457 170.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -72.23 -50.41 8.75 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.824 -1.56 . . . . 6.22 111.936 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.27 -54.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 123.26 2.64 . . . . 3.16 112.966 169.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.65 126.27 33.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.554 0.742 . . . . 3.77 110.618 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -80.27 174.79 11.25 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.211 1.56 . . . . 7.14 115.211 -166.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -108.34 -79.59 0.58 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.713 1.205 . . . . 8.03 112.211 -170.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -132.64 -32.47 1.29 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.067 2.147 . . . . 8.82 109.56 177.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.247 0.97 0 C-N-CA 123.681 0.793 . . . . 7.82 109.445 128.053 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 118.161 -0.924 . . . . 16.3 110.016 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -146.08 133.24 20.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.185 0.994 . . . . 16.2 108.729 172.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.1 p -158.53 119.41 3.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.278 1.431 . . . . 12.0 108.577 -170.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.72 -61.84 3.96 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.086 0.851 . . . . 10.64 113.761 177.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -154.76 167.46 13.94 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.826 1.251 . . . . 12.51 113.089 -170.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -81.18 -151.13 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 125.266 3.978 . . . . 8.63 109.578 170.215 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.8 -22.03 63.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.179 1.548 . . . . 10.0 115.179 -173.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.8 tp 91.0 141.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 129.441 3.097 . . . . 6.82 111.826 171.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.54 -170.36 37.25 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.616 1.103 . . . . 2.59 113.256 169.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.6 89.94 0.65 Allowed Glycine 0 CA--C 1.537 1.46 0 CA-C-O 118.428 -1.207 . . . . 2.69 114.365 -176.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.01 150.79 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.707 2.271 . . . . 2.56 110.289 168.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -156.01 165.25 37.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.752 0.821 . . . . 2.45 112.122 -167.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.8 m -121.41 137.99 54.47 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.722 -0.611 . . . . 2.38 109.999 147.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 mt -142.8 153.5 43.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.3 1.04 . . . . 3.04 109.575 168.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.3 m -93.25 150.75 20.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.886 0.874 . . . . 1.43 108.76 174.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.9 p -96.34 163.03 13.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 2.18 112.17 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -61.74 -16.8 52.48 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.075 1.139 . . . . 1.6 114.075 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -87.23 -43.7 12.0 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 117.566 -1.207 . . . . 3.2 111.368 168.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.9 5.98 1.57 Allowed Glycine 0 N--CA 1.474 1.185 0 N-CA-C 119.145 2.418 . . . . 1.77 119.145 158.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.4 158.0 19.11 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 121.419 2.609 . . . . 3.99 111.944 172.145 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -111.54 120.49 42.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.207 1.403 . . . . 5.77 110.963 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.407 ' HE3' HD21 ' A' ' 227' ' ' LEU . 0.0 OUTLIER -144.63 167.49 22.43 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.539 1.311 . . . . 5.3 114.539 -168.191 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.4 p -120.85 173.92 6.93 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.744 2.818 . . . . 2.24 111.742 -171.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.05 -31.63 72.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.276 0.63 . . . . 3.86 112.629 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -19.3 65.13 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.96 -1.088 . . . . 8.57 112.388 174.163 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -85.89 -43.78 12.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.868 0.867 . . . . 3.66 111.138 172.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -67.41 -25.88 66.15 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.596 1.332 . . . . 3.19 114.596 175.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 49.15 42.52 21.51 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.442 2.297 . . . . 5.3 112.486 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.3 -74.44 0.06 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.169 2.319 . . . . 5.67 113.286 -173.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 63.12 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.352 2.261 . . . . 3.59 111.803 -175.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -167.82 92.28 0.36 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.605 2.762 . . . . 1.8 109.172 173.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.05 131.06 53.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.764 1.226 . . . . 3.44 113.569 -174.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.49 124.77 49.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.113 1.365 . . . . 2.51 108.525 166.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.421 HD12 HD13 ' A' ' 267' ' ' ILE . 29.3 mt -126.84 114.35 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.238 1.015 . . . . 2.08 109.822 -164.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -122.43 139.91 53.32 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.701 1.0 . . . . 2.51 113.701 -174.14 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -96.36 109.31 21.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.727 0.811 . . . . 2.58 109.549 172.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.48 146.67 18.13 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.058 1.314 . . . . 1.23 113.471 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 204' ' ' ASP . 1.2 m-85 -81.54 61.12 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.13 0.972 . . . . 4.45 111.317 -174.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.3 p 45.84 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.071 2.148 . . . . 4.45 110.894 -170.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -103.62 116.72 32.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.29 0.95 . . . . 9.07 108.957 155.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.43 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 1.8 t -44.29 -174.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 130.954 3.702 . . . . 2.46 115.089 169.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 13.3 Cg_endo -47.31 -70.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.77 1.646 . . . . 3.67 109.776 138.37 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -167.66 21.77 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.84 1.793 . . . . 5.09 115.84 166.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 -34.71 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.318 -1.489 . . . . 2.61 111.766 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 90.1 m -44.2 -55.53 9.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.649 -1.643 . . . . 1.43 112.823 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.7 -29.35 60.01 Favored 'Trans proline' 0 C--N 1.354 0.817 0 CA-C-N 122.308 1.86 . . . . 1.18 114.092 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -75.58 -38.93 58.77 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.374 0.988 . . . . 3.61 112.216 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.51 -37.27 65.73 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.564 -1.335 . . . . 2.99 111.979 171.138 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.0 tt -55.85 -43.91 77.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.396 1.078 . . . . 3.88 111.492 169.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.22 -35.04 74.55 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.628 1.103 . . . . 3.16 112.466 -177.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -62.79 -45.18 93.84 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.587 -1.321 . . . . 3.27 111.238 173.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.7 ptp -68.81 -21.44 64.32 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 117.596 -1.192 . . . . 2.38 114.199 173.355 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.1 -57.23 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 120.586 1.539 . . . . 2.09 109.322 166.031 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -59.45 -19.81 50.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.325 1.45 . . . . 4.53 113.169 -177.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.78 -29.6 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.562 1.074 . . . . 1.7 113.758 170.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.04 -36.56 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 121.361 1.891 . . . . 2.59 110.706 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -50.56 36.56 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.57 1.948 . . . . 6.74 112.248 166.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -67.05 -36.58 82.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.603 0.761 . . . . 4.05 112.073 178.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mm -69.42 -45.98 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.995 1.318 . . . . 2.21 111.238 -177.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -66.04 -33.61 76.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 4.99 110.475 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.2 t -70.36 -8.15 48.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.657 1.183 . . . . 4.75 113.848 171.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.5 mm -79.19 -38.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.978 1.263 . . . . 3.84 110.287 165.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 57.87 -23.38 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 129.386 3.074 . . . . 4.16 116.082 -176.175 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 p -75.92 -20.79 57.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.249 -1.532 . . . . 5.17 112.942 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.83 173.64 1.98 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.367 1.467 . . . . 3.85 113.316 169.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.74 -40.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.831 2.354 . . . . 3.75 111.914 169.441 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 30.0 t70 165.08 165.07 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.86 2.864 . . . . 4.02 108.908 -159.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.75 122.54 36.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.312 -0.995 . . . . 2.1 108.312 153.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 m -101.05 114.96 65.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 109.374 -0.602 . . . . 1.87 109.374 173.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.95 142.99 15.99 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.27 1.98 . . . . 1.08 109.918 166.209 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.4 146.07 43.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 122.912 1.339 . . . . 2.52 112.433 170.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -114.44 130.82 56.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.913 -1.494 . . . . 2.45 109.623 -170.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 68.5 mt -107.13 117.97 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.743 1.217 . . . . 1.5 109.668 174.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.8 p -73.13 136.09 44.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.134 0.574 . . . . 3.19 110.699 167.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.7 pt -121.15 31.85 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.472 1.509 . . . . 1.59 111.634 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 166' ' ' PHE . 16.3 p-10 -161.74 65.59 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.908 1.283 . . . . 4.16 111.261 -158.158 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.35 -19.76 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.653 2.236 . . . . 2.83 113.427 -171.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.31 41.86 0.19 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.118 1.367 . . . . 4.44 111.966 168.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.0 -14.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 130.04 3.336 . . . . 5.51 114.257 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.83 159.93 8.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.563 1.074 . . . . 4.7 112.515 161.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.7 m -154.18 127.0 8.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 106.722 -1.584 . . . . 2.01 106.722 155.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -52.01 -43.86 63.87 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.535 1.134 . . . . 2.99 112.283 -177.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -70.23 -30.23 67.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.662 1.185 . . . . 3.51 114.194 172.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.33 -39.47 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.195 1.361 . . . . 1.46 111.715 176.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.19 -24.6 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.873 -1.142 . . . . 2.23 110.891 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.18 67.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 119.91 -1.744 . . . . 1.52 112.938 166.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -77.26 -35.67 55.11 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.397 1.079 . . . . 3.62 111.847 168.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.71 -36.09 81.84 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.549 -0.719 . . . . 6.37 111.563 176.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.6 t -54.5 -24.47 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 120.984 -1.073 . . . . 2.2 112.349 169.529 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -87.38 -22.31 25.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.544 -1.348 . . . . 5.62 114.134 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.82 -45.06 68.71 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.248 0.931 . . . . 4.82 110.307 165.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -105.1 -26.5 12.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.138 1.903 . . . . 3.49 116.138 -159.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 46.4 p 143.38 147.49 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 128.722 2.809 . . . . 2.49 113.413 169.453 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 66.43 5.42 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.023 3.148 . . . . 2.78 109.684 166.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.414 ' O ' ' HE2' ' A' ' 223' ' ' LYS . 0.1 OUTLIER -166.06 -31.66 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.047 2.139 . . . . 3.44 110.854 -171.431 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.47 145.92 48.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.412 0.551 . . . . 2.37 111.165 158.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.77 133.02 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.868 1.667 . . . . 1.83 106.891 162.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.71 128.71 9.66 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.346 -1.102 . . . . 0.83 110.346 176.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.407 HD21 ' HE3' ' A' ' 150' ' ' LYS . 5.4 mp -127.57 130.47 49.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.278 1.031 . . . . 2.31 111.538 -176.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -144.03 -178.95 6.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.613 1.565 . . . . 2.28 111.675 -167.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 176.74 -167.82 39.45 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.4 1.0 . . . . 1.53 113.766 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -84.0 157.29 21.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.772 1.229 . . . . 2.56 110.414 174.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -61.27 -20.57 63.01 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.068 1.507 . . . . 7.6 115.068 -169.534 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -70.33 -40.65 74.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.672 1.589 . . . . 2.98 111.175 172.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.39 -32.6 62.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.664 1.185 . . . . 3.41 111.745 173.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.67 -38.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 118.206 -0.902 . . . . 1.81 110.989 166.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.03 -44.5 92.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.133 1.333 . . . . 3.08 110.362 171.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -49.67 -57.28 7.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.667 1.121 . . . . 2.41 110.934 172.425 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 32.6 m -74.11 -37.66 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.917 1.235 . . . . 3.07 113.261 -171.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.73 74.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.648 0.379 . . . . 1.96 111.65 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -95.68 -23.22 17.1 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.353 1.461 . . . . 3.83 113.555 -175.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.02 75.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.351 1.432 . . . . 2.16 110.768 164.33 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -82.55 -11.94 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.632 1.173 . . . . 2.93 114.098 174.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 71.64 37.19 1.13 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.279 1.832 . . . . 8.15 112.451 165.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 m -94.13 141.0 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.266 1.426 . . . . 2.64 112.328 -175.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -76.47 154.17 34.93 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.298 0.851 . . . . 5.79 113.298 171.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.01 149.53 16.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.923 1.689 . . . . 3.92 109.729 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.3 t -155.54 145.01 15.28 Favored Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 121.454 -0.779 . . . . 4.39 110.987 171.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.36 165.12 28.03 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.387 2.058 . . . . 4.49 109.628 151.081 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -86.01 -178.09 49.99 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 124.356 0.979 . . . . 3.36 114.426 174.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.78 66.24 8.13 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.984 3.789 . . . . 4.87 113.804 -169.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.484 ' HZ1' ' CD ' ' A' ' 254' ' ' GLU . 0.2 OUTLIER -60.09 115.47 3.49 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.986 -1.071 . . . . 5.35 109.976 166.276 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 15.8 t70 121.72 -15.57 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 1 C-N-CA 131.724 4.009 . . . . 9.48 111.65 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -81.75 0.13 40.5 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.571 1.323 . . . . 10.61 114.571 176.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 16.0 t70 172.57 -87.91 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.265 3.026 . . . . 7.31 107.167 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.484 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 14.6 tp10 -169.73 25.75 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.13 2.572 . . . . 6.13 110.706 -176.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -48.69 151.27 1.2 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.91 1.684 . . . . 4.59 115.16 -175.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.41 50.91 1.29 Allowed 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.046 -1.034 . . . . 6.62 113.655 156.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 11.8 mm -61.52 153.11 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.547 -0.72 . . . . 3.38 109.261 159.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 30.7 m -154.88 141.67 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 128.018 2.527 . . . . 4.82 104.855 171.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -157.81 157.44 33.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.369 0.986 . . . . 4.86 113.299 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -160.44 -179.11 7.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.916 1.686 . . . . 2.28 113.686 -163.125 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.3 p -74.35 -15.11 60.95 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 116.899 2.185 . . . . 3.67 116.899 -176.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 56.86 11.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.15 1.78 . . . . 4.13 115.292 177.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 1.6 pp -95.65 148.13 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 119.997 -1.689 . . . . 4.51 114.384 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.5 ttp -122.51 121.76 37.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.806 2.442 . . . . 2.32 109.408 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -85.16 146.33 27.17 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.549 -0.719 . . . . 2.69 111.362 176.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.4 tp -109.1 127.51 54.22 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.918 1.287 . . . . 2.02 109.92 168.47 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.421 HD13 HD12 ' A' ' 162' ' ' ILE . 1.9 mp -119.19 124.75 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.912 2.085 . . . . 1.72 106.131 171.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.95 -162.66 36.9 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 109.618 -1.393 . . . . 1.64 109.618 164.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -85.02 54.48 3.94 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 120.392 2.096 . . . . 2.5 109.799 178.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.06 -34.77 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.486 1.515 . . . . 5.64 114.157 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.66 29.69 59.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.695 -1.058 . . . . 4.31 113.623 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -147.52 -39.02 0.19 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.034 1.417 . . . . 4.69 113.853 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.32 0.0 OUTLIER 102.74 152.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 132.368 4.267 . . . . 3.48 111.407 -171.944 . . . . . . . . 4 3 . 1 . 023 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 56.9 tp -129.48 -35.24 1.75 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.346 1.239 . . . . 2.89 114.346 -155.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -166.05 172.36 11.48 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.505 1.522 . . . . 2.84 111.026 -174.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -156.21 145.96 21.06 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.62 -1.3 . . . . 3.45 113.908 174.05 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -136.84 173.72 11.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.292 1.837 . . . . 2.66 111.447 -163.166 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.41 -169.06 36.13 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 125.807 1.67 . . . . 2.34 111.803 175.328 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -36.52 124.41 0.82 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.061 1.745 . . . . 3.52 113.071 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.9 t30 98.49 -34.94 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 130.315 3.446 . . . . 4.55 112.681 -174.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.71 109.87 0.89 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.31 1.414 . . . . 4.41 110.611 178.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.5 145.56 41.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.15 -0.969 . . . . 6.91 109.453 -171.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -56.17 -50.54 70.89 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.407 -1.433 . . . . 2.31 113.549 -168.645 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.28 -13.18 70.19 Favored Glycine 0 N--CA 1.479 1.565 0 O-C-N 121.463 -0.773 . . . . 1.82 114.926 175.136 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -86.72 -19.4 29.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.826 1.25 . . . . 5.32 111.046 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.23 -51.32 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 120.586 -1.322 . . . . 1.82 109.595 157.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -37.51 75.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 118.261 -0.876 . . . . 2.12 112.954 176.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.687 1.131 . . . . 2.36 112.831 173.425 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -48.89 79.87 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.422 -0.799 . . . . 1.99 112.157 169.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.64 -30.44 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.079 0.854 . . . . 1.84 111.504 179.108 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.34 -7.22 22.99 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.585 -1.322 . . . . 2.73 114.053 173.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 31.2 m -80.47 -57.04 3.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.026 0.931 . . . . 3.58 108.834 160.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -62.31 -26.8 68.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.312 1.845 . . . . 2.69 114.487 -174.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 31.7 mtt -55.86 -30.13 60.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.597 1.159 . . . . 5.14 111.619 170.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -59.71 -47.11 98.27 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.406 -1.759 . . . . 5.06 111.38 -176.247 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.26 -58.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.872 2.381 . . . . 3.53 113.403 163.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.83 17.89 17.05 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 116.669 2.1 . . . . 3.52 116.669 -157.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 -53.77 164.99 0.48 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.956 -1.09 . . . . 7.17 111.415 159.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -90.16 -13.52 35.46 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 119.933 -1.73 . . . . 10.31 115.356 -173.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -166.91 -110.24 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.538 1.935 . . . . 7.11 107.774 -163.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.06 -0.971 . . . . 6.83 110.781 134.393 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 118.227 -0.892 . . . . 17.07 109.97 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -65.51 150.5 48.27 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.539 0.609 . . . . 14.99 109.686 154.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -145.23 131.39 19.42 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.958 1.703 . . . . 12.09 107.711 176.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -156.39 134.16 3.96 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 123.66 0.647 . . . . 10.21 112.362 176.307 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -169.62 72.51 0.68 Allowed Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.531 1.132 . . . . 9.56 113.463 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.89 178.73 6.07 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.567 2.845 . . . . 7.82 111.366 175.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.7 tp -155.36 153.46 30.51 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.976 1.71 . . . . 7.17 109.241 177.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 pp -162.82 -176.54 5.0 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.245 1.818 . . . . 7.02 110.555 -171.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.83 -47.56 3.81 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 124.83 1.205 . . . . 4.06 113.533 172.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.36 51.33 53.43 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-O 118.118 -1.379 . . . . 2.57 111.973 -166.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.67 142.06 62.58 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.078 2.518 . . . . 2.59 112.706 -167.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -116.45 168.44 10.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.201 1.8 . . . . 2.77 111.264 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 p -148.5 85.48 1.51 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.84 1.256 . . . . 2.89 111.28 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.64 143.84 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.208 1.003 . . . . 2.04 110.791 175.474 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 p -75.38 150.28 38.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 3.46 111.863 171.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 p -96.0 120.68 36.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.621 1.969 . . . . 2.29 108.273 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.5 m170 51.15 24.79 2.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.195 1.554 . . . . 3.26 115.195 177.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.379 0.6 OUTLIER 31.36 39.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.509 2.724 . . . . 9.9 115.491 -155.695 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -110.82 -28.71 3.83 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.833 2.158 . . . . 2.83 113.051 -178.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -155.3 179.81 8.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.808 1.304 . . . . 4.03 112.28 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -118.6 111.23 18.31 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.446 1.098 . . . . 7.17 111.033 -159.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -119.71 168.9 10.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.462 1.601 . . . . 3.13 115.171 167.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.7 m -158.79 158.05 32.81 Favored 'General case' 0 C--N 1.326 -0.422 1 C-N-CA 132.099 4.16 . . . . 2.91 103.962 -169.358 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -41.74 -52.34 3.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.624 1.17 . . . . 3.35 112.86 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -82.75 -8.56 59.58 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.338 1.607 . . . . 6.45 115.338 178.19 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -75.93 -18.76 59.23 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.399 1.454 . . . . 4.08 111.631 165.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -97.69 -40.44 8.58 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.103 1.361 . . . . 3.73 114.124 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.98 154.28 19.32 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.39 0.995 . . . . 4.0 113.533 -170.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.47 10.25 22.05 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.878 1.704 . . . . 2.73 112.708 -158.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.54 160.89 18.17 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.218 2.607 . . . . 3.12 107.758 -176.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -83.33 121.91 27.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.624 -0.673 . . . . 2.12 110.823 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.61 135.29 39.64 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.242 1.02 . . . . 2.78 111.304 -176.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -115.16 126.15 54.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.487 1.515 . . . . 2.26 107.897 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.7 mt -129.4 118.49 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.413 0.685 . . . . 1.7 109.941 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -120.68 145.09 47.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.349 1.459 . . . . 2.74 112.934 -175.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -114.67 97.61 6.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.232 1.413 . . . . 2.08 110.87 -177.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.61 -160.52 10.69 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.592 1.567 . . . . 1.51 115.423 -169.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -156.03 159.41 39.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.434 1.494 . . . . 4.61 110.746 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 p -69.49 127.04 31.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.014 -1.679 . . . . 3.45 110.287 172.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 73.2 -43.78 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.429 2.292 . . . . 8.19 111.821 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.4 t 86.59 177.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 127.277 2.231 . . . . 2.54 111.419 -166.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -40.7 -69.69 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.458 2.772 . . . . 4.23 111.493 130.084 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . 0.26 1.1 m-20 171.24 58.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 128.417 2.687 . . . . 4.93 111.366 170.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.81 -27.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.869 1.268 . . . . 3.82 114.02 174.159 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.36 -37.19 19.53 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 115.852 -2.023 . . . . 2.43 113.854 162.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.52 -80.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.336 2.024 . . . . 1.91 111.051 166.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.19 -29.01 69.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.676 0.991 . . . . 4.41 113.676 -165.119 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.63 -41.68 59.96 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.255 -1.528 . . . . 3.66 112.691 177.007 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.4 -36.76 74.25 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.299 -1.334 . . . . 3.04 110.521 172.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -57.14 -43.99 82.98 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.733 1.606 . . . . 6.08 111.806 173.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -60.84 -55.27 35.02 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.712 -1.243 . . . . 3.16 112.219 168.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.67 -24.66 62.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.078 1.14 . . . . 4.41 114.078 -170.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -56.7 -37.88 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.258 1.39 . . . . 1.74 111.279 169.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.98 -28.68 66.83 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.379 -0.819 . . . . 3.04 110.609 176.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.8 -34.68 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.454 1.024 . . . . 2.03 111.355 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.82 -37.73 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.598 1.09 . . . . 2.37 111.439 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -32.51 58.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.364 0.983 . . . . 4.61 113.298 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -60.21 -26.26 66.24 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.596 1.558 . . . . 3.54 112.946 170.169 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -90.16 -55.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.104 1.762 . . . . 2.14 112.387 175.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.15 -30.45 71.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.819 2.048 . . . . 3.16 113.133 -175.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.1 t -66.07 -12.8 57.87 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.786 -1.196 . . . . 2.95 112.894 169.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.0 mm -121.56 44.41 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.15 1.78 . . . . 4.56 108.186 -178.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.24 0.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.5 3.52 . . . . 6.42 118.419 -158.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.3 p -69.08 -18.99 64.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.88 1.272 . . . . 4.32 113.047 157.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.41 163.15 43.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 127.28 2.232 . . . . 4.55 109.908 169.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.41 162.21 11.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.514 2.143 . . . . 5.29 114.178 -148.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.55 94.5 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.71 1.604 . . . . 6.16 111.606 -172.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.3 mp -93.86 116.6 29.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.111 0.964 . . . . 2.43 112.722 -175.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.6 m -107.59 111.82 62.58 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.261 1.024 . . . . 1.35 110.89 171.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -88.05 122.9 1.62 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.954 3.102 . . . . 1.01 112.254 177.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.64 122.83 47.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.742 2.417 . . . . 2.95 110.529 -178.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -102.06 121.08 41.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.943 0.897 . . . . 2.36 111.182 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.45 119.99 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.602 1.161 . . . . 1.63 108.331 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.1 p -78.65 131.35 36.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.285 -0.884 . . . . 2.02 110.581 164.242 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.43 -21.73 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 115.547 1.684 . . . . 2.71 115.547 -176.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -125.74 75.23 70.59 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 124.525 1.13 . . . . 4.98 109.194 -177.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.45 98.51 0.4 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.683 3.588 . . . . 2.0 109.31 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -162.31 -24.04 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.102 1.149 . . . . 4.53 114.102 -166.018 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.45 9.16 0.54 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.176 1.176 . . . . 4.92 114.176 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -111.8 75.33 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 129.645 3.178 . . . . 3.81 108.798 -173.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.29 155.96 30.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.04 1.4 . . . . 2.73 114.363 -163.231 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.84 -50.42 7.91 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.409 2.283 . . . . 3.29 114.784 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -85.93 -35.0 20.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.808 1.643 . . . . 4.72 112.321 174.822 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.24 71.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.367 0.985 . . . . 1.95 113.501 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 18.9 mm -64.53 -42.64 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.842 1.201 . . . . 1.63 111.675 170.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.3 -22.54 66.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.734 0.814 . . . . 1.87 112.897 176.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -83.41 -44.73 14.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.699 1.6 . . . . 4.03 112.027 168.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -53.26 -35.83 60.46 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.648 1.579 . . . . 2.77 111.922 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -52.47 -43.91 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.415 1.486 . . . . 1.46 113.617 167.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -67.03 -47.44 71.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 117.807 -1.092 . . . . 6.4 111.982 -176.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -43.19 63.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.507 1.523 . . . . 4.19 111.917 177.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -70.28 -62.71 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.858 0.463 . . . . 3.3 111.53 175.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.8 m 169.73 145.57 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.534 2.734 . . . . 2.17 110.833 177.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.59 -6.52 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.585 2.857 . . . . 1.62 114.709 -177.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.41 -10.4 59.43 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.709 1.141 . . . . 3.57 113.581 170.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.85 137.93 34.23 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.624 1.17 . . . . 2.05 111.557 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -113.36 129.92 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.255 1.022 . . . . 1.73 109.561 -174.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.09 129.37 9.87 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.841 -0.904 . . . . 1.09 110.841 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.82 156.9 18.67 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.868 -0.79 . . . . 2.53 108.868 168.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.3 m -150.39 126.91 10.82 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.223 -1.399 . . . . 3.3 107.223 171.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.58 -145.04 4.05 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.094 1.807 . . . . 1.99 111.189 -174.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -121.75 174.72 6.67 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.301 1.051 . . . . 2.54 110.91 165.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.26 -18.09 14.72 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.627 1.171 . . . . 8.2 113.327 -174.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.48 -41.99 19.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.194 2.198 . . . . 3.44 112.153 -173.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.83 -31.75 66.85 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.286 -1.509 . . . . 3.71 110.702 166.007 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.8 -35.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.364 -0.827 . . . . 1.74 110.916 172.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -58.78 -57.01 14.93 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 117.632 -1.175 . . . . 2.74 109.778 163.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -49.87 -56.33 10.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.219 1.372 . . . . 3.19 112.514 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.55 -29.51 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.288 0.495 . . . . 2.07 111.771 -171.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.32 -50.8 20.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.647 0.779 . . . . 1.65 111.525 171.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -56.15 -49.12 74.85 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.148 2.579 . . . . 3.09 111.398 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.78 77.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.551 0.74 . . . . 2.04 112.947 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -94.64 14.43 21.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.233 1.413 . . . . 2.77 113.363 176.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 61.6 12.26 4.4 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.134 2.174 . . . . 5.47 115.111 176.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.99 140.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.393 1.477 . . . . 2.84 111.254 -177.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -109.52 173.43 6.33 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.542 1.537 . . . . 4.7 112.481 174.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -121.59 148.55 44.38 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.008 0.923 . . . . 3.89 111.534 176.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -128.95 63.14 65.61 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.159 0.984 . . . . 4.79 111.654 176.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 138.98 42.83 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.598 2.198 . . . . 3.23 110.332 176.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.64 152.57 37.46 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 119.676 -0.513 . . . . 3.25 113.342 -176.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -62.95 157.43 48.67 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.796 2.998 . . . . 4.68 110.566 175.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 -0.29 45.34 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 122.677 1.227 . . . . 6.05 111.6 175.125 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.22 43.07 1.08 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.228 2.211 . . . . 7.63 112.277 -147.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -156.94 -40.8 0.07 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.208 1.803 . . . . 8.44 110.71 -170.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -152.26 -53.83 0.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.667 1.187 . . . . 6.33 109.646 165.378 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 172.92 -45.6 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 129.222 3.009 . . . . 5.63 110.232 169.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 11.1 t70 1.85 113.09 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 129.108 2.963 . . . . 5.14 118.215 -169.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.89 40.99 0.78 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 120.272 -1.517 . . . . 3.74 114.731 -178.452 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.08 128.71 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.778 -1.201 . . . . 3.35 109.919 157.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.1 153.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.304 1.442 . . . . 3.91 107.902 170.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.57 174.85 11.05 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 122.752 1.263 . . . . 5.75 112.273 -174.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 167.54 11.13 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.889 -1.132 . . . . 2.19 112.737 -143.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.1 t -68.09 -20.25 64.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.318 1.97 . . . . 4.03 116.318 -171.005 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.5 mt 47.9 55.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.914 1.686 . . . . 4.49 111.593 -177.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.6 mt -137.79 139.77 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.518 1.527 . . . . 2.58 110.348 -178.372 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.66 120.46 39.72 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.51 2.724 . . . . 3.27 109.326 161.306 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -88.31 135.11 33.61 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.136 0.574 . . . . 2.56 111.266 165.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.4 tt -103.41 120.67 41.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.699 2.0 . . . . 2.29 109.441 174.719 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.92 143.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 127.271 2.229 . . . . 2.08 108.167 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.34 178.23 18.49 Favored Glycine 0 CA--C 1.545 1.914 0 C-N-CA 123.931 0.777 . . . . 1.82 113.95 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 -42.97 2.15 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.6 2.866 . . . . 4.06 112.904 -174.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -142.87 84.53 1.84 Allowed 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 107.092 -1.447 . . . . 7.71 107.092 161.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.17 -150.85 6.78 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.232 1.872 . . . . 2.54 110.315 -176.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -122.78 -162.57 1.03 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.008 0.923 . . . . 4.18 111.217 -179.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -52.58 134.94 35.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.076 0.941 . . . . 4.18 110.43 173.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.37 -33.02 1.13 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.428 1.491 . . . . 2.95 110.328 -169.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -155.28 172.83 17.54 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.828 2.051 . . . . 2.41 110.481 175.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -162.21 148.01 13.04 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.616 -1.303 . . . . 3.7 114.257 176.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -132.47 128.24 36.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.887 1.275 . . . . 2.35 110.706 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -101.88 -176.62 28.11 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.79 0.709 . . . . 2.64 112.282 165.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -52.3 154.29 2.49 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.418 0.687 . . . . 4.26 110.588 167.2 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.3 t30 81.83 -17.86 0.52 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.737 2.415 . . . . 6.11 112.196 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -69.54 107.94 3.6 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.238 -1.539 . . . . 6.06 110.532 161.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -66.14 144.54 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.502 1.144 . . . . 7.45 109.785 176.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -32.49 65.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.051 . . . . 2.47 113.839 -167.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.18 86.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.01 -0.883 . . . . 1.44 113.489 -178.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.36 -18.03 61.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.359 1.579 . . . . 3.21 112.944 174.231 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.8 mt -70.01 -47.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.457 -0.777 . . . . 1.21 109.201 172.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.78 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.08 0.552 . . . . 1.23 112.065 170.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.89 81.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.567 0.951 . . . . 1.45 113.567 173.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 52.2 p -65.5 -47.18 76.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.996 0.817 . . . . 1.42 111.669 172.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.62 -39.63 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 120.74 -1.225 . . . . 1.91 110.638 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.07 72.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.907 0.883 . . . . 1.74 113.159 171.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.1 m -71.59 -48.08 50.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.219 1.008 . . . . 2.14 110.333 174.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -70.74 -20.27 62.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.206 1.003 . . . . 2.3 113.075 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.1 mmm -66.49 -33.67 76.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.193 1.397 . . . . 3.81 113.255 162.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -52.63 -40.2 74.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 116.358 -1.782 . . . . 5.41 113.13 -176.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.26 -60.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.196 2.597 . . . . 2.29 111.544 162.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -86.28 47.25 1.44 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.823 1.416 . . . . 3.09 114.823 -165.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.23 135.22 57.66 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.832 -1.167 . . . . 9.68 111.658 176.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -53.85 -21.18 7.05 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.966 1.839 . . . . 7.9 115.966 176.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 35.53 1.19 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.917 0.887 . . . . 10.27 113.172 -175.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 127.626 2.37 . . . . 9.7 114.428 178.676 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 118.209 -0.9 . . . . 27.12 110.241 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -64.02 157.64 24.66 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.981 0.81 . . . . 23.06 111.037 167.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.2 t -170.17 46.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.393 1.477 . . . . 19.27 111.871 -170.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.09 149.23 43.97 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.712 -0.618 . . . . 16.47 112.326 173.499 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -148.03 156.37 43.76 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.426 1.89 . . . . 15.62 110.45 174.03 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.16 164.48 33.77 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.896 2.398 . . . . 11.97 110.52 167.52 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.6 tp -164.04 150.7 11.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.568 1.947 . . . . 9.51 109.11 -177.091 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . 0.269 0.8 OUTLIER 102.61 -142.3 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 131.018 3.727 . . . . 5.51 107.896 -174.38 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.77 151.75 20.31 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.135 1.334 . . . . 3.0 113.764 -173.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.33 98.92 1.42 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.237 -1.313 . . . . 2.51 112.486 -177.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.58 154.18 30.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.206 2.604 . . . . 3.43 111.939 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -160.82 154.31 22.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.579 1.151 . . . . 3.01 111.651 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 t -138.17 95.58 3.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.951 -1.093 . . . . 2.53 112.874 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.63 162.9 14.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.115 1.366 . . . . 2.72 112.153 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.4 m -98.14 142.6 29.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.53 1.132 . . . . 1.52 110.779 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.9 m -98.29 164.7 12.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.184 1.793 . . . . 2.65 112.049 -171.253 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -61.17 -5.37 1.49 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 117.649 2.463 . . . . 2.63 117.649 -170.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -35.02 6.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 121.023 1.738 . . . . 4.19 111.29 165.007 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.47 11.61 0.45 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.719 2.104 . . . . 2.36 115.185 -177.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -84.04 129.28 34.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.057 2.143 . . . . 5.48 110.051 -176.112 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -69.2 130.2 41.98 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.52 -1.363 . . . . 4.66 110.012 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 158.72 24.61 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.441 . . . . 2.89 109.834 168.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.6 p -152.02 162.94 40.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.573 1.549 . . . . 2.34 110.233 -167.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -46.63 -49.68 18.72 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.792 1.237 . . . . 5.08 112.034 166.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -79.48 4.23 16.26 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.536 1.31 . . . . 7.44 114.536 -172.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.08 -30.34 16.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.966 1.706 . . . . 3.6 111.452 169.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -103.38 -16.24 15.68 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.988 1.477 . . . . 4.4 114.988 -177.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 tt -75.08 88.88 2.43 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.386 1.088 . . . . 5.14 110.304 -171.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 164.78 -30.55 0.23 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.783 1.658 . . . . 3.21 111.923 -167.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -103.76 -179.6 4.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 4.42 111.453 159.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -85.06 140.72 30.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.023 0.529 . . . . 3.91 110.366 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 pp -134.28 153.39 51.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.139 0.976 . . . . 4.06 111.09 175.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.61 138.45 54.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.754 1.222 . . . . 3.82 109.072 171.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.3 mt -111.59 130.16 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.103 -0.703 . . . . 2.7 109.103 177.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -120.61 142.25 49.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.932 1.293 . . . . 2.93 110.508 164.106 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.69 123.49 50.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.064 1.345 . . . . 2.5 110.107 171.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -160.38 146.77 13.03 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.459 -0.634 . . . . 2.16 113.541 175.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.87 18.35 14.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.381 1.623 . . . . 4.17 115.381 -171.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.2 m 66.99 -15.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.603 1.961 . . . . 3.56 114.048 173.158 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -111.2 16.38 21.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.898 2.079 . . . . 7.81 112.684 -167.158 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.58 171.49 6.97 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.937 1.695 . . . . 2.69 114.538 176.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.14 -176.92 1.46 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.117 2.544 . . . . 3.14 110.479 150.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.36 64.56 2.13 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 5.9 113.139 -172.144 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 80.5 t -130.97 -45.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.964 2.105 . . . . 3.71 109.728 174.306 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.4 t -62.71 -52.04 67.6 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.855 1.262 . . . . 1.79 112.591 172.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.5 -34.71 25.24 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.981 1.788 . . . . 1.36 113.077 172.071 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.538 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 13.4 tm-20 -64.89 -40.41 95.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.99 1.268 . . . . 2.69 112.384 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.424 -1.423 . . . . 2.37 111.594 171.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 37.4 mt -62.72 -37.4 86.4 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.215 0.916 . . . . 2.89 112.859 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.68 4.67 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.18 0.9 . . . . 3.39 110.336 174.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.538 ' HZ2' ' CD ' ' A' ' 175' ' ' GLU . 30.0 mtmm -57.53 -28.72 63.75 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.773 -1.204 . . . . 2.64 112.713 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.34 -49.11 72.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.016 0.826 . . . . 3.17 111.664 168.553 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.35 -36.19 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 119.636 1.107 . . . . 1.88 110.627 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.28 -23.31 35.68 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.326 0.862 . . . . 3.3 113.326 171.154 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.83 -38.52 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.69 1.132 . . . . 1.88 110.718 173.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.35 -40.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.328 1.051 . . . . 1.94 110.921 -179.173 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.81 -53.94 34.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.458 1.503 . . . . 5.31 110.971 169.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -69.74 -34.27 73.61 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 112.494 0.553 . . . . 4.02 112.494 -174.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.34 -40.35 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.056 1.342 . . . . 2.12 112.952 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.68 -34.83 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.294 0.497 . . . . 3.3 111.79 168.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.2 t -64.89 -36.01 82.99 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.711 -1.243 . . . . 3.23 112.658 172.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.42 -3.06 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.332 1.853 . . . . 3.79 112.216 167.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.329 73.1 p 124.43 -9.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 1 C-N-CA 132.796 4.438 . . . . 5.72 114.945 152.696 . . . . . . . . 3 2 . 1 . 025 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.7 t 143.01 -18.53 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 129.824 3.25 . . . . 7.08 113.675 178.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.3 -146.4 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.655 -1.641 . . . . 4.76 109.561 -172.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.75 -42.11 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 124.079 2.493 . . . . 3.62 109.467 146.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.5 t70 161.8 157.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 1 C-N-CA 132.216 4.206 . . . . 4.14 107.973 174.324 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.28 90.07 3.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.904 0.882 . . . . 2.57 108.786 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 35.9 m -66.02 117.54 43.5 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 108.28 -1.007 . . . . 2.61 108.28 178.075 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -91.01 127.34 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.175 1.917 . . . . 1.47 110.085 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.0 tp -121.23 108.42 13.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.555 1.142 . . . . 2.67 109.983 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -90.06 123.38 33.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.378 1.071 . . . . 2.49 109.594 169.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.2 mt -111.36 125.25 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.404 -0.961 . . . . 1.39 108.404 171.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.6 t -96.03 144.29 26.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.794 -0.566 . . . . 2.32 110.6 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.429 ' HA ' HG21 ' A' ' 234' ' ' VAL . 25.0 pt -108.5 3.99 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.877 1.066 . . . . 2.08 113.877 -174.085 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.24 77.35 1.55 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.661 1.184 . . . . 3.0 112.435 -169.476 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.77 -9.33 18.27 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.006 1.804 . . . . 3.56 111.834 166.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -70.33 -4.87 24.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.998 2.119 . . . . 3.46 114.153 174.046 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -9.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.813 2.523 . . . . 4.72 117.813 178.236 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.99 97.23 10.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.611 2.005 . . . . 4.44 110.039 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 m -74.28 128.94 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.978 -0.749 . . . . 2.53 108.978 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -54.15 8.64 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.425 1.49 . . . . 3.06 111.597 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -68.25 -23.42 64.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.269 1.428 . . . . 3.68 113.741 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.16 -44.64 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.439 -1.413 . . . . 2.07 111.247 172.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.07 -37.48 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.818 0.847 . . . . 2.76 110.397 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.76 -33.76 36.52 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.822 1.045 . . . . 2.05 113.822 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -80.38 -49.49 11.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.752 -0.592 . . . . 4.68 111.926 175.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -49.49 -37.57 26.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.674 1.19 . . . . 3.03 113.385 171.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.474 HG21 ' HA3' ' A' ' 226' ' ' GLY . 39.0 t -62.37 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.675 1.59 . . . . 1.82 112.134 173.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -56.02 -48.3 76.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.977 0.911 . . . . 4.88 112.474 -178.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -19.42 62.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.367 1.467 . . . . 7.48 112.604 -174.27 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -53.94 7.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.406 0.682 . . . . 3.17 111.017 164.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.6 t -167.96 139.29 2.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.253 1.021 . . . . 3.09 111.503 167.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.69 0.81 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.036 2.491 . . . . 2.29 114.078 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -86.6 -16.3 37.15 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 120.051 1.296 . . . . 3.03 113.064 165.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.62 143.88 34.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.25 1.42 . . . . 2.06 110.948 -177.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.46 145.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.404 0.681 . . . . 2.37 110.269 164.078 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.474 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -117.02 124.84 6.29 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 124.054 0.835 . . . . 0.85 111.383 173.034 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 11.1 mp -117.39 145.95 43.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.817 1.247 . . . . 2.14 111.438 -179.383 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.3 p -149.92 174.94 12.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.211 2.604 . . . . 2.31 109.964 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.35 -152.11 8.09 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.497 -1.441 . . . . 1.83 109.497 158.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.8 p -64.3 165.33 9.7 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.62 1.568 . . . . 2.64 112.571 162.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.87 -36.37 62.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.315 -0.857 . . . . 7.11 110.698 169.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.09 -45.91 69.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.877 2.071 . . . . 3.34 112.667 176.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.98 -47.82 84.24 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.178 -0.951 . . . . 4.71 110.803 173.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 203' ' ' ILE . 0.9 OUTLIER -75.46 -17.03 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.152 1.168 . . . . 2.33 114.152 -178.553 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.55 -43.83 97.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.337 0.971 . . . . 3.12 109.78 168.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.92 -53.18 61.26 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.061 -0.495 . . . . 3.04 111.096 -176.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.36 -23.75 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 112.752 0.649 . . . . 2.08 112.752 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.04 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.561 0.745 . . . . 2.01 112.83 171.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -70.4 -41.54 72.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.559 2.343 . . . . 4.28 111.528 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.58 -46.2 63.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.983 1.713 . . . . 2.06 112.795 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.42 -126.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.881 0.764 . . . . 3.16 110.389 171.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.17 61.65 0.7 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.593 -1.317 . . . . 6.06 111.783 -172.114 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.36 156.87 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.075 0.95 . . . . 4.26 109.228 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -152.8 169.71 22.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.113 2.565 . . . . 4.65 109.165 -173.493 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -165.77 153.9 11.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.993 1.317 . . . . 4.87 111.148 -177.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.4 t -149.56 138.31 12.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.912 1.685 . . . . 5.55 108.254 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.28 151.07 15.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.155 2.57 . . . . 5.27 111.947 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -72.37 123.38 9.2 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.717 -1.046 . . . . 4.64 110.716 172.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.66 14.56 2.14 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.583 2.855 . . . . 4.77 112.921 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp 92.36 141.73 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 130.845 3.658 . . . . 6.95 110.096 -154.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -153.56 155.53 36.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.536 1.134 . . . . 7.92 109.205 164.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 62.92 -51.39 0.19 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.546 2.738 . . . . 10.09 113.425 -166.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -173.38 -49.02 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.2 2.2 . . . . 8.49 110.861 169.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -143.18 124.44 14.6 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.176 1.39 . . . . 7.97 110.291 -172.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -178.27 153.7 0.78 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.373 2.269 . . . . 4.27 111.527 -166.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -145.36 76.08 1.46 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.13 0.967 . . . . 5.03 110.679 151.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.5 tt -73.22 175.34 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.714 1.205 . . . . 3.44 110.996 167.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.7 t -151.64 158.77 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 127.554 2.341 . . . . 3.94 106.208 172.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -85.55 150.6 24.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.398 1.479 . . . . 5.25 112.37 169.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -148.1 150.29 33.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.828 1.047 . . . . 2.38 113.828 153.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.24 164.05 1.01 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.058 1.343 . . . . 3.87 110.486 171.292 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.2 tp -143.19 155.11 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.997 1.319 . . . . 4.15 109.175 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.7 mt 108.48 141.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 130.987 3.715 . . . . 3.04 107.901 -162.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 mtt -101.15 136.21 41.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.501 1.12 . . . . 3.81 108.822 167.017 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -111.53 126.28 54.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.651 0.78 . . . . 4.38 110.75 -172.377 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 14.0 tp -99.9 123.72 44.45 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.872 1.269 . . . . 2.33 110.562 -175.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.85 131.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.571 -1.27 . . . . 2.93 107.571 174.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.59 169.28 25.81 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.562 0.601 . . . . 3.41 112.737 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.97 71.21 5.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.077 3.184 . . . . 4.06 108.236 167.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -156.51 -59.86 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.764 1.626 . . . . 6.14 108.536 -162.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.78 -38.86 0.2 Allowed Glycine 0 C--N 1.345 1.045 0 N-CA-C 115.51 0.964 . . . . 4.12 115.51 170.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -157.01 -151.4 0.32 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.333 1.235 . . . . 6.17 114.333 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -70.26 109.87 4.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.094 1.358 . . . . 4.97 111.278 -173.189 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 tt -99.45 -21.37 16.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.308 1.043 . . . . 3.6 111.642 179.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.24 160.08 38.28 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.726 2.01 . . . . 2.68 109.618 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -165.39 123.01 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.507 1.523 . . . . 3.52 111.754 177.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -139.31 136.14 34.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.548 1.539 . . . . 3.21 111.687 -165.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.41 145.99 13.44 Favored Glycine 0 N--CA 1.471 1.033 0 O-C-N 120.661 -1.274 . . . . 3.02 116.033 -174.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 64.24 -105.31 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.358 1.863 . . . . 3.63 110.642 171.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.91 87.49 0.25 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.147 1.379 . . . . 6.21 112.161 -176.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.99 130.56 0.08 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 128.737 2.815 . . . . 8.71 111.067 178.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -90.61 158.92 16.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.555 1.942 . . . . 6.62 110.201 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -40.04 80.04 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.373 1.62 . . . . 2.27 115.373 -164.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.91 -24.19 71.4 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 118.129 0.422 . . . . 1.48 113.185 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.17 -39.94 93.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.04 0.92 . . . . 3.61 111.384 175.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 46.9 mt -70.55 -42.15 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.74 0.816 . . . . 1.36 110.541 177.14 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.84 90.93 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.831 -0.543 . . . . 1.47 111.2 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.06 87.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.05 1.34 . . . . 1.61 113.716 173.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.0 p -64.98 -45.43 85.69 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.483 1.492 . . . . 1.71 110.889 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.8 -40.8 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 120.898 -1.127 . . . . 2.06 111.686 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.32 -25.05 67.44 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.645 -1.284 . . . . 2.32 113.188 171.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.9 m -73.48 -43.05 61.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.003 . . . . 2.17 110.598 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -70.55 -25.64 63.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.66 0.784 . . . . 2.72 112.83 174.536 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.454 ' SD ' ' HE2' ' A' ' 299' ' ' LYS . 1.3 ttp -69.02 -22.58 64.05 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.749 -1.219 . . . . 4.33 113.221 165.499 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -55.78 -42.73 97.6 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 116.632 -1.652 . . . . 4.55 112.838 177.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.43 -51.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.342 2.695 . . . . 2.42 111.968 163.035 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -83.97 68.25 9.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.38 1.086 . . . . 3.06 112.37 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -59.09 129.26 41.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.251 1.82 . . . . 7.93 113.91 -169.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.454 ' HE2' ' SD ' ' A' ' 294' ' ' MET . 0.0 OUTLIER -9.01 -86.14 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.938 2.895 . . . . 7.9 114.924 -173.119 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -135.82 25.58 3.35 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.925 2.49 . . . . 8.16 108.302 171.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.253 1.275 1 C-N-CA 132.906 4.483 . . . . 7.9 108.956 -153.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 118.248 -0.882 . . . . 16.69 110.035 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -67.32 160.76 26.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.135 0.574 . . . . 13.59 111.043 170.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 t -172.05 -177.34 1.86 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.657 1.983 . . . . 13.23 109.722 -176.291 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.06 -168.14 46.54 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.811 1.196 . . . . 11.19 113.835 175.081 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.12 126.32 1.98 Allowed Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.541 1.136 . . . . 13.26 111.398 -178.242 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.62 65.8 8.62 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.34 2.693 . . . . 8.77 109.495 172.231 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -165.27 39.44 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.977 1.311 . . . . 9.52 110.804 -170.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.0 tp -83.58 45.0 1.01 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.805 1.242 . . . . 7.6 111.295 -177.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.78 -159.4 33.04 Favored Glycine 0 N--CA 1.464 0.549 0 C-N-CA 124.744 1.164 . . . . 4.06 113.977 -177.651 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.62 -110.48 3.86 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 117.869 -1.517 . . . . 3.1 111.512 -175.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -78.98 167.92 21.39 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.442 2.761 . . . . 3.11 114.645 -168.534 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -158.01 163.04 38.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.954 2.102 . . . . 2.37 110.974 -169.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.7 t -126.65 116.95 21.79 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.989 -1.07 . . . . 2.72 110.401 161.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.485 ' HB2' HD23 ' A' ' 227' ' ' LEU . 2.1 mp -135.96 160.24 39.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.098 0.952 . . . . 2.67 112.363 -178.565 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m -82.88 136.56 34.56 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.177 1.791 . . . . 1.84 109.764 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.9 t -97.38 158.7 15.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.954 1.302 . . . . 2.98 111.894 -178.402 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -14.98 57.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.475 1.657 . . . . 1.65 115.475 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.4 -11.51 59.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.635 1.574 . . . . 3.06 112.404 171.325 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.89 -26.17 16.53 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.873 1.701 . . . . 2.72 114.538 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.82 -142.61 0.1 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.005 1.322 . . . . 6.39 111.216 176.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.2 ttm105 -140.76 157.97 44.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 122.807 1.289 . . . . 6.13 113.287 -159.112 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -140.06 149.13 42.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.691 1.596 . . . . 4.06 112.471 169.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.7 p -118.3 162.38 18.37 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.03 1.332 . . . . 2.33 109.741 158.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.93 -42.79 63.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.961 1.705 . . . . 3.64 112.595 176.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -47.43 -30.29 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.946 1.699 . . . . 8.28 113.908 171.351 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.45 -5.15 43.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.046 1.338 . . . . 3.07 112.85 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.71 -25.14 14.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.625 1.17 . . . . 3.01 112.619 163.075 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.37 142.11 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.114 1.765 . . . . 3.89 112.596 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.85 35.13 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.055 0.782 . . . . 2.65 115.055 173.737 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -139.19 -166.88 2.12 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.705 1.602 . . . . 3.41 108.943 172.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -90.69 70.02 6.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.083 0.945 . . . . 2.44 109.003 171.283 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.55 151.78 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.278 -0.638 . . . . 2.67 109.278 175.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.8 tp -148.23 122.69 9.72 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.789 -0.569 . . . . 2.78 109.577 -173.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -109.59 115.02 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 122.787 0.435 . . . . 1.73 111.732 -169.457 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.89 146.05 41.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.844 1.658 . . . . 2.69 112.62 173.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -111.65 118.54 35.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.687 1.195 . . . . 2.32 110.068 174.656 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.36 153.93 23.78 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.327 0.965 . . . . 1.3 114.888 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -81.06 -29.33 35.03 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.977 1.311 . . . . 4.26 112.819 176.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.3 m 96.78 123.7 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.899 2.879 . . . . 3.12 107.352 -173.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 72.11 -46.25 0.64 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.152 2.181 . . . . 8.77 113.357 -178.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.709 ' HB3' ' H ' ' A' ' 171' ' ' ASP . 1.3 m 58.7 -172.28 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.214 1.405 . . . . 2.29 113.018 -173.123 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.17 -43.2 9.12 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.039 1.826 . . . . 2.96 110.368 144.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.709 ' H ' ' HB3' ' A' ' 169' ' ' CYS . 9.5 p30 -154.5 -53.68 0.1 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.419 1.888 . . . . 6.59 115.353 -159.287 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.64 -35.82 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 114.978 1.473 . . . . 3.85 114.978 -159.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -46.29 -64.78 0.83 Allowed Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 120.245 1.384 . . . . 1.9 111.386 167.349 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.5 -32.21 32.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.678 2.252 . . . . 1.49 113.053 -177.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -59.81 -49.78 76.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.472 1.033 . . . . 4.08 111.429 175.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.36 -30.63 53.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.451 0.908 . . . . 3.98 113.451 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.6 -41.05 76.34 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.259 -0.901 . . . . 2.43 111.075 168.263 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.95 -47.48 86.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.892 0.769 . . . . 3.82 111.572 176.66 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -53.22 54.87 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.379 -1.451 . . . . 3.59 110.74 170.914 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.7 ttp -59.36 -40.7 87.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.189 1.396 . . . . 2.55 112.714 -175.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.5 mm -71.64 -53.85 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 1.75 110.174 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.584 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 67.4 mt-30 -62.86 -34.54 77.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.818 0.735 . . . . 3.71 110.269 -172.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 t -52.01 -31.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.525 -1.226 . . . . 1.48 112.853 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.49 -34.8 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.941 1.7 . . . . 2.82 111.352 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -37.54 82.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.699 0.681 . . . . 5.86 112.307 -177.024 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -84.85 -33.53 22.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.949 1.299 . . . . 3.94 112.143 -178.449 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.76 -40.19 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.503 1.121 . . . . 1.68 111.384 172.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -73.49 -48.2 35.22 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 117.969 0.35 . . . . 4.81 111.233 171.083 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 55.5 m -70.01 -20.86 63.25 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.437 1.643 . . . . 3.67 115.437 -171.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.1 mm -74.23 -53.4 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.684 1.129 . . . . 4.9 112.301 -178.762 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.4 p -150.6 13.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.943 1.297 . . . . 7.6 113.413 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 6.1 t 52.67 66.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.379 2.272 . . . . 6.39 110.819 -173.589 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -53.7 158.2 3.33 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.834 1.654 . . . . 3.18 111.589 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -77.12 38.45 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.211 3.274 . . . . 2.84 112.467 178.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . 0.265 5.0 t0 76.13 138.45 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 131.555 3.942 . . . . 4.66 117.412 167.613 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.04 110.12 21.59 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.021 2.129 . . . . 3.74 107.691 170.585 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -110.94 96.4 29.18 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 124.671 1.189 . . . . 1.74 109.693 -175.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.3 125.62 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.317 2.678 . . . . 0.85 113.626 -173.154 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.0 tp -104.55 118.65 37.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.114 1.765 . . . . 2.29 109.339 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -104.76 132.02 51.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.749 1.22 . . . . 2.44 109.495 176.549 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.1 mm -114.42 133.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.522 1.529 . . . . 1.62 110.427 177.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.4 m -67.19 -172.95 0.23 Allowed 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 115.158 1.54 . . . . 2.68 115.158 170.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.3 pt -144.99 -34.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.439 -1.413 . . . . 2.61 114.747 175.55 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -130.92 71.82 82.2 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.73 1.612 . . . . 3.22 111.288 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.95 -1.44 2.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 124.982 3.788 . . . . 3.02 115.657 -172.189 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.26 -6.51 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.495 1.043 . . . . 4.36 113.343 160.732 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -132.63 -60.83 0.87 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.39 1.476 . . . . 5.58 114.145 -173.821 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.54 74.7 9.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.836 1.303 . . . . 4.04 110.906 -172.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.4 t -65.01 154.7 36.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.185 1.469 . . . . 2.53 112.11 -170.561 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -56.16 -32.74 64.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.331 1.852 . . . . 6.25 113.626 -171.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -77.2 -39.36 49.02 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.809 2.844 . . . . 4.55 110.803 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.98 77.57 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.863 0.865 . . . . 1.37 111.235 172.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.55 -42.95 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 1.61 110.631 168.52 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.17 96.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.719 -0.658 . . . . 1.14 112.118 175.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -61.72 -50.39 72.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.78 1.173 . . . . 3.66 111.617 171.098 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.08 -42.52 72.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.413 1.485 . . . . 3.19 111.807 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.18 -46.32 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.325 1.05 . . . . 1.39 112.234 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.424 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -63.82 -25.43 68.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.449 0.907 . . . . 4.79 113.449 -176.651 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.424 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 7.0 mm-40 -83.98 -40.31 18.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.138 0.881 . . . . 5.18 112.411 175.394 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -76.22 -45.51 32.64 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.969 1.099 . . . . 3.04 113.969 -176.402 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 153.14 146.52 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 128.99 2.916 . . . . 2.37 112.985 173.328 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.69 8.19 2.04 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.42 3.413 . . . . 2.23 115.702 -175.29 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -76.4 -18.0 59.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.057 1.299 . . . . 2.35 112.509 163.297 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.72 139.05 39.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.428 1.091 . . . . 2.46 111.237 171.819 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.66 138.58 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.426 1.09 . . . . 2.33 108.954 161.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.66 125.41 8.57 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.889 1.233 . . . . 1.12 111.464 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 142' ' ' LEU . 3.9 mp -108.19 129.88 55.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.672 1.189 . . . . 2.4 110.249 176.082 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t 174.29 122.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.421 2.288 . . . . 2.91 110.037 -167.396 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.46 -62.19 0.12 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 124.368 0.985 . . . . 2.93 112.221 176.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.0 p -145.16 171.1 15.01 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.281 1.832 . . . . 2.58 109.192 -176.167 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -31.59 69.4 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.78 -0.575 . . . . 7.21 111.245 178.503 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -70.71 -51.77 25.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 2.79 112.632 -176.457 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . 0.32 0.0 OUTLIER -80.03 -29.09 39.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.09 1.313 . . . . 3.93 113.659 -174.833 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.37 -53.01 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.0 0.92 . . . . 2.36 111.324 157.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.37 -23.07 61.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.947 -1.096 . . . . 3.69 113.525 -175.335 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -57.74 6.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.213 0.915 . . . . 2.79 110.118 163.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.68 -21.08 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 118.445 0.566 . . . . 2.23 111.929 -171.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.261 1.024 . . . . 1.54 110.367 167.234 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -44.34 65.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.187 1.395 . . . . 5.48 111.946 173.621 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -53.03 -43.77 66.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.868 1.213 . . . . 1.7 112.473 175.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -96.71 11.22 36.28 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.921 1.082 . . . . 2.41 113.921 178.516 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 41.73 45.8 3.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.846 2.458 . . . . 6.37 114.955 -177.152 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 13.3 m -67.89 159.48 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.587 1.155 . . . . 3.12 112.516 -170.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -101.67 102.39 13.06 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.225 0.536 . . . . 3.71 110.946 163.291 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -102.69 143.37 32.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.271 -0.64 . . . . 3.38 109.271 154.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.6 m -70.13 137.52 87.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 121.569 -0.707 . . . . 4.08 112.307 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.59 119.32 5.87 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 107.396 -1.809 . . . . 4.96 107.396 154.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.73 160.6 53.65 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 114.015 0.366 . . . . 3.62 114.015 -171.064 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.51 -171.57 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.078 3.186 . . . . 3.94 111.239 176.546 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 254' ' ' GLU . 0.0 OUTLIER -77.59 -18.52 56.77 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.759 -1.213 . . . . 7.48 113.138 163.046 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.1 -158.92 0.32 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.839 2.056 . . . . 6.93 113.239 178.738 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -64.62 -22.17 66.91 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.041 0.837 . . . . 7.43 113.243 175.327 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -149.08 -49.31 0.15 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.83 1.419 . . . . 7.98 114.83 173.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 250' ' ' LYS . 7.3 tp10 -179.37 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.637 1.975 . . . . 9.68 111.439 -165.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -75.86 56.09 0.93 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.999 1.719 . . . . 7.7 114.15 -170.116 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -58.91 138.67 57.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 116.659 2.096 . . . . 4.8 116.659 -160.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 47.0 pt -56.71 148.53 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.255 0.55 . . . . 4.14 111.715 166.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.6 m -124.22 147.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.684 1.594 . . . . 3.12 107.368 166.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.59 165.56 18.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.154 1.382 . . . . 5.25 108.883 172.985 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -150.41 143.0 24.53 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.031 1.122 . . . . 2.27 114.031 175.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.3 t -151.6 149.99 29.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.108 0.963 . . . . 4.35 109.562 167.118 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.2 174.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.614 1.966 . . . . 6.64 110.799 -159.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.99 140.63 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.47 -1.678 . . . . 3.52 106.47 152.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.4 ttt -94.92 127.99 41.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.017 1.327 . . . . 2.19 108.863 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -111.06 134.9 52.29 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 3.9 114.293 -165.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.53 107.07 17.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.048 1.339 . . . . 3.05 109.242 171.32 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.01 110.5 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 105.267 -2.123 . . . . 1.99 105.267 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.93 -168.57 44.02 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 113.601 0.2 . . . . 1.86 113.601 -168.225 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.31 71.18 5.29 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.763 2.975 . . . . 3.51 109.275 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -155.13 -60.11 0.11 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.456 1.502 . . . . 4.68 110.145 -159.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.04 -31.03 4.41 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.116 -1.38 . . . . 3.18 114.716 -178.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -113.12 -61.43 1.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.759 1.279 . . . . 5.1 112.42 -175.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -170.16 145.3 2.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.337 -0.852 . . . . 6.95 112.625 -162.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.81 -44.55 1.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.211 1.004 . . . . 3.3 113.574 176.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -159.33 158.93 33.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 2.87 111.547 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -119.54 125.1 48.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.826 1.25 . . . . 4.29 110.919 172.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 104.22 14.01 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.197 -1.038 . . . . 2.95 108.197 178.136 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -74.47 157.01 50.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.016 -1.234 . . . . 3.15 110.016 162.129 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.3 57.44 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.683 1.593 . . . . 4.1 111.537 175.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -156.63 -31.96 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.152 1.781 . . . . 5.44 113.186 -171.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.76 131.91 46.96 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.244 -0.91 . . . . 4.69 109.43 170.454 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -82.85 155.68 24.01 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.423 1.889 . . . . 7.88 109.794 172.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.584 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 9.3 tmtt? -38.91 -54.03 1.68 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.403 1.881 . . . . 2.08 114.687 -172.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.27 -36.8 93.67 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.142 -0.81 . . . . 1.4 113.63 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.3 -27.3 64.28 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.677 1.738 . . . . 3.32 112.763 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 95.0 mt -69.02 -48.81 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.196 0.998 . . . . 1.4 110.094 176.502 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.3 -45.2 85.33 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.303 0.483 . . . . 1.23 112.303 174.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.93 67.65 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 1.85 114.403 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 p -67.37 -47.99 68.75 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.017 -1.052 . . . . 1.69 111.327 168.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.93 -36.64 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.727 -1.233 . . . . 1.67 112.182 173.43 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.78 67.6 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.364 -1.46 . . . . 1.96 113.175 172.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.4 m -75.62 -51.76 12.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.888 0.875 . . . . 2.25 109.319 172.259 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -61.33 -26.42 67.79 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.536 1.535 . . . . 2.8 113.985 176.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.1 ttp -66.59 -15.01 63.13 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.724 -1.235 . . . . 4.74 112.99 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -59.9 -51.95 77.05 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 116.962 -1.494 . . . . 5.06 111.513 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.55 -58.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.867 2.378 . . . . 2.34 112.368 166.411 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -79.98 66.42 5.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.215 1.406 . . . . 3.19 111.724 -176.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.08 158.17 1.16 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.94 1.296 . . . . 8.46 113.753 -177.18 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -52.88 152.77 3.71 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.041 -1.037 . . . . 8.08 112.201 168.646 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -56.11 -43.47 78.17 Favored 'General case' 0 CA--C 1.55 0.959 0 O-C-N 121.19 -0.944 . . . . 10.7 112.725 177.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.49 1.916 . . . . 9.25 111.136 172.232 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 118.462 -0.78 . . . . 19.6 109.077 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -69.3 171.19 8.92 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 118.838 0.745 . . . . 17.72 110.116 154.044 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.7 t -162.78 -173.03 3.32 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.333 1.453 . . . . 13.36 110.229 -174.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.03 -91.67 1.01 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.077 -1.209 . . . . 10.2 110.077 -177.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt 157.4 133.26 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 130.916 3.686 . . . . 10.95 111.474 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -87.87 171.46 5.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.528 2.819 . . . . 8.55 110.835 168.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.18 177.63 4.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.561 1.544 . . . . 7.02 109.044 159.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.02 143.2 51.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.668 1.187 . . . . 7.26 110.539 177.255 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.84 -143.26 21.33 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.064 0.84 . . . . 3.48 112.271 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.19 -156.25 15.78 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.554 1.073 . . . . 3.0 114.518 173.365 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -82.11 -178.74 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.703 3.602 . . . . 3.0 112.413 -175.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -170.85 168.52 7.17 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.47 2.708 . . . . 2.74 108.762 -176.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -134.34 32.09 3.42 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.734 -1.229 . . . . 3.58 112.744 167.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.71 146.3 21.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 123.446 1.593 . . . . 2.05 111.304 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 m -108.39 140.39 41.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.788 -1.551 . . . . 1.71 109.19 -168.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.4 m -90.74 148.21 22.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.412 1.885 . . . . 3.25 110.459 -167.451 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -55.69 -13.08 1.47 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 117.347 2.351 . . . . 2.51 117.347 -170.468 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.4 t -86.11 -27.39 24.69 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 4.2 113.605 170.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.97 26.91 1.63 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.789 1.662 . . . . 2.56 116.172 -177.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.13 139.94 51.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.393 2.096 . . . . 3.38 111.203 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -96.04 123.69 39.74 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.188 2.195 . . . . 6.27 110.739 -170.76 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 164.24 14.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.385 0.674 . . . . 3.25 111.292 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -128.02 -179.51 5.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.586 1.154 . . . . 2.62 108.184 167.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -38.8 -65.8 0.33 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.141 1.777 . . . . 4.99 113.217 163.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 13.28 0.36 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.191 1.922 . . . . 9.06 116.191 -172.437 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -90.68 -26.91 19.34 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.573 -1.33 . . . . 3.47 112.26 158.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -113.36 -9.15 13.4 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.093 1.757 . . . . 2.78 114.345 -178.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tt -111.5 120.95 43.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.354 2.261 . . . . 3.83 109.539 -175.048 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.33 -39.81 1.75 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.101 2.286 . . . . 2.54 109.708 -170.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -78.62 -156.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.762 0.825 . . . . 3.59 109.988 138.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.04 155.79 27.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.834 1.253 . . . . 2.32 112.165 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.66 149.7 34.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.508 1.299 . . . . 2.34 114.508 170.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.42 137.8 38.35 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.163 1.785 . . . . 2.51 107.859 164.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.2 mt -123.11 139.0 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.465 1.106 . . . . 1.72 108.271 177.265 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -151.99 149.2 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.427 1.491 . . . . 2.52 111.372 177.603 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -104.02 118.42 36.62 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.923 0.889 . . . . 2.23 109.92 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -168.96 156.59 28.03 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.693 1.616 . . . . 2.32 114.312 -171.177 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.29 171.33 12.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.551 -0.97 . . . . 3.98 113.572 -155.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m -96.27 18.42 13.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.353 0.871 . . . . 3.04 113.353 -172.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -106.2 -3.51 21.27 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.069 -1.019 . . . . 8.24 113.266 170.533 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.8 OUTLIER -74.34 160.47 81.27 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 127.526 2.33 . . . . 2.32 115.4 -171.819 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 40.3 Cg_endo -79.27 -160.17 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.235 3.29 . . . . 3.8 110.764 156.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.68 -10.17 7.93 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.45 2.3 . . . . 4.81 115.459 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -78.45 -32.28 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 118.495 -0.764 . . . . 3.68 112.412 -170.374 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.69 -61.03 6.34 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 117.147 -1.406 . . . . 1.57 112.31 166.198 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.1 -36.75 56.66 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.583 2.188 . . . . 1.88 114.315 -175.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -54.91 -60.08 3.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.953 1.301 . . . . 3.83 110.95 171.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.82 -35.88 75.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.324 0.65 . . . . 2.7 112.174 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.49 -33.41 64.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.878 1.671 . . . . 2.79 112.416 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -61.34 2.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.158 1.345 . . . . 5.52 108.35 170.717 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -38.59 67.36 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.786 -0.571 . . . . 6.7 110.829 -175.261 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 11.4 ttm -64.88 -45.69 84.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.717 1.207 . . . . 2.75 113.065 177.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.7 pt -76.96 -28.79 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 120.34 1.427 . . . . 3.65 110.854 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.523 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 0.6 OUTLIER -80.4 -34.44 36.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.175 0.443 . . . . 4.31 110.604 -175.444 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.4 -40.71 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.696 0.799 . . . . 1.87 112.517 176.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 22.4 m -64.29 -39.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.276 0.944 . . . . 3.16 111.94 -175.215 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.04 -41.24 91.12 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.841 -1.162 . . . . 5.0 112.463 173.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.01 -19.54 64.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.497 1.519 . . . . 2.95 113.482 179.52 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.39 -58.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.977 1.711 . . . . 2.13 112.08 173.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.34 -28.4 69.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.845 0.831 . . . . 4.45 112.358 -170.146 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.7 m -71.07 -16.95 62.61 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.232 -0.918 . . . . 4.65 113.346 176.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.2 mm -80.63 64.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.335 -1.358 . . . . 3.97 107.335 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.9 t -47.02 -12.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 129.751 3.22 . . . . 5.98 118.181 -157.476 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.0 m -73.98 -22.95 59.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.825 1.65 . . . . 4.04 111.874 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.7 mt -74.83 162.23 74.38 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.364 1.866 . . . . 3.72 113.583 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.63 154.59 27.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.596 2.864 . . . . 3.07 110.375 168.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.35 133.22 38.8 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.483 1.913 . . . . 5.0 113.649 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.5 107.86 19.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.247 1.819 . . . . 2.16 111.383 -175.101 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.2 m -72.86 131.91 83.54 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.449 -1.407 . . . . 1.78 111.194 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -91.56 94.7 0.21 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.166 3.244 . . . . 1.28 111.342 165.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.24 101.26 11.53 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.742 0.782 . . . . 2.32 112.492 -173.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -93.03 126.03 37.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.212 1.405 . . . . 2.89 110.632 -177.813 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.21 119.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.226 1.01 . . . . 2.12 110.145 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.5 m -98.87 162.49 13.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.573 1.149 . . . . 2.62 112.677 175.286 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.2 pt -147.83 -13.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.91 2.189 . . . . 1.64 116.91 -148.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -94.38 93.38 0.93 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 120.618 1.554 . . . . 3.78 107.495 170.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.37 -22.32 52.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.762 1.641 . . . . 2.53 112.499 -177.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -63.22 -14.85 53.98 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.109 1.364 . . . . 4.01 114.611 170.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -161.64 -10.91 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 118.7 2.852 . . . . 5.08 118.7 -170.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -75.36 65.44 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.352 2.342 . . . . 4.81 111.862 170.339 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.0 m -65.07 136.92 57.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.57 1.948 . . . . 2.67 111.076 -176.043 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -38.22 -64.59 0.4 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.197 1.799 . . . . 3.51 113.411 175.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -65.96 -25.08 66.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.245 1.418 . . . . 3.33 113.73 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.59 -47.03 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.434 1.015 . . . . 1.89 110.814 175.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 38.5 mm -57.23 -45.22 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.22 1.008 . . . . 1.95 110.405 170.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.81 -46.55 67.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.834 0.853 . . . . 2.3 112.467 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -68.78 -46.18 69.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.33 0.514 . . . . 3.11 111.876 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -54.64 -49.28 70.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.81 1.244 . . . . 3.1 111.353 176.552 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.5 t -55.27 -49.32 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.555 1.942 . . . . 2.51 111.33 172.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -30.43 71.5 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.081 -1.438 . . . . 5.93 114.254 -177.224 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -68.74 -29.95 68.47 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.278 1.399 . . . . 4.04 112.083 175.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -81.8 -54.07 5.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.907 0.483 . . . . 3.1 111.509 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.9 p -169.85 148.96 3.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 121.591 -0.693 . . . . 2.79 111.445 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.53 -7.41 20.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.359 2.706 . . . . 2.92 113.278 173.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -85.01 -21.34 29.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.277 1.031 . . . . 2.64 112.997 176.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.42 143.91 48.34 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.661 1.185 . . . . 2.43 111.378 -178.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.62 134.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.882 0.873 . . . . 2.99 111.216 172.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.66 124.79 6.66 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.28 1.419 . . . . 1.34 111.763 -178.276 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -108.76 139.65 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.348 1.459 . . . . 2.38 110.901 -178.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 t -139.54 164.38 30.04 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.81 1.644 . . . . 2.77 110.678 176.783 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.31 171.95 39.97 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.67 1.605 . . . . 1.88 112.166 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -64.84 160.26 20.76 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.736 0.814 . . . . 2.12 110.529 168.648 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -50.07 -35.74 26.49 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.864 0.866 . . . . 5.43 113.167 -174.49 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.1 mp0 -67.22 -38.5 85.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.003 1.721 . . . . 2.88 110.108 -178.318 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.09 -40.84 52.16 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.599 1.16 . . . . 4.33 113.022 172.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.48 -42.62 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.869 -0.419 . . . . 1.66 109.869 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -75.35 -29.45 59.93 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.129 -0.938 . . . . 3.05 112.653 175.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -60.21 -59.69 5.01 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.625 2.011 . . . . 2.38 110.261 167.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.22 -30.6 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 118.466 0.576 . . . . 2.06 111.986 -171.198 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.45 -52.34 14.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.996 0.816 . . . . 1.69 112.216 173.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -76.54 -32.55 58.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.592 1.157 . . . . 3.74 112.936 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.72 78.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.539 1.136 . . . . 1.7 111.242 173.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -73.2 -1.89 19.52 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.24 -0.912 . . . . 2.29 113.03 168.62 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 45.61 39.68 5.18 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.372 2.669 . . . . 7.27 114.471 -176.345 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 p -71.37 137.6 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.195 -0.668 . . . . 2.88 109.195 174.105 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -75.46 130.65 39.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.87 0.367 . . . . 4.07 110.88 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -148.84 144.39 26.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.185 1.394 . . . . 4.05 109.956 172.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.0 m -149.48 106.35 3.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 O-C-N 121.493 -0.755 . . . . 4.29 112.133 -171.412 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.35 142.35 10.6 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.447 2.765 . . . . 3.05 113.055 -177.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.23 122.66 6.22 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.088 -1.396 . . . . 2.97 110.322 166.567 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.73 115.47 4.34 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.774 2.316 . . . . 6.01 110.19 -176.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -160.05 -170.35 2.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.92 1.288 . . . . 7.1 112.539 -167.042 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -142.13 -174.9 4.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.981 2.513 . . . . 9.38 109.371 -169.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -114.01 133.54 55.44 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.785 1.234 . . . . 16.24 109.067 177.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.6 t0 107.23 -1.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 131.389 3.876 . . . . 7.55 111.041 -163.372 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -135.05 -40.94 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.678 1.591 . . . . 9.05 110.634 166.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 30.3 t0 72.1 -168.54 0.14 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.362 1.865 . . . . 5.42 110.962 177.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -167.51 -162.57 0.46 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.408 -1.433 . . . . 3.5 111.935 -161.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.4 tt -157.45 164.85 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.106 1.762 . . . . 3.52 108.059 157.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.39 140.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.278 -1.378 . . . . 3.89 107.278 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.7 147.71 47.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.261 0.553 . . . . 4.56 110.996 167.207 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -143.26 136.25 27.84 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.618 0.767 . . . . 2.56 110.13 158.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -66.2 131.37 46.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.811 -1.181 . . . . 3.78 110.339 174.298 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.457 ' CD1' ' H ' ' A' ' 262' ' ' ILE 0.253 0.0 OUTLIER -82.52 64.48 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 123.172 1.463 . . . . 4.93 112.653 -171.091 . . . . . . . . 4 4 . 1 . 027 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.63 127.09 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.04 1.336 . . . . 2.17 111.402 -176.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.7 mmm -88.09 137.66 32.13 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.552 1.541 . . . . 2.42 109.411 158.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -114.14 131.56 56.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 2.73 109.524 168.51 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.05 121.45 41.4 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.901 0.88 . . . . 2.3 108.685 173.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.08 117.89 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.052 -1.462 . . . . 1.65 107.052 172.731 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.51 -137.12 5.76 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 109.357 -1.497 . . . . 1.67 109.357 167.066 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -81.19 3.67 7.62 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.391 2.06 . . . . 3.59 112.381 170.197 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -31.37 53.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.954 1.302 . . . . 4.86 112.744 -176.795 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.98 1.85 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.07 1.319 . . . . 2.94 113.345 -170.027 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -77.86 19.26 0.41 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.983 1.713 . . . . 4.67 115.04 -166.344 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 92.1 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 129.972 3.309 . . . . 4.11 110.676 173.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.32 -33.29 10.78 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.727 1.211 . . . . 2.85 111.144 176.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -168.97 167.12 10.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.139 2.175 . . . . 2.72 108.325 -168.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -161.47 146.04 13.28 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.444 1.098 . . . . 4.39 112.288 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -129.91 115.22 16.88 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.914 0.886 . . . . 2.74 109.862 -175.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.32 110.75 4.09 Favored Glycine 0 N--CA 1.465 0.616 0 N-CA-C 109.652 -1.379 . . . . 3.5 109.652 173.1 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.482 ' HG3' ' H ' ' A' ' 280' ' ' ASN . 16.2 tp60 76.44 166.32 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.483 1.913 . . . . 4.17 110.949 -167.722 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.482 ' H ' ' HG3' ' A' ' 279' ' ' GLN . 53.4 t-20 -42.03 -48.46 4.63 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.094 2.557 . . . . 9.21 113.408 -169.714 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 59.0 tttp 67.95 -23.29 0.12 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.566 1.946 . . . . 5.35 113.89 -172.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 102.3 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.319 3.448 . . . . 5.84 107.259 -174.026 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.523 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -34.78 -60.07 0.46 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.285 2.234 . . . . 2.45 113.25 179.012 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.8 -19.38 69.41 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.256 -1.302 . . . . 1.59 115.755 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.84 -26.11 49.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.739 2.27 . . . . 3.91 112.981 177.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.85 -40.47 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.735 -0.839 . . . . 2.46 108.735 169.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.31 77.54 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.484 0.584 . . . . 1.49 111.461 169.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.41 -39.21 85.52 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.196 1.184 . . . . 1.51 114.196 176.032 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.9 p -70.0 -46.95 64.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.108 0.867 . . . . 1.74 111.571 175.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.8 mt -54.82 -44.18 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.954 . . . . 1.53 110.77 171.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.408 -1.433 . . . . 1.68 113.701 178.406 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 57.4 m -76.95 -47.88 19.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.079 0.952 . . . . 2.06 109.93 170.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -62.73 -31.78 72.77 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.338 1.055 . . . . 2.75 112.288 175.47 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.56 24.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.633 1.573 . . . . 5.86 112.749 168.372 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.47 -57.16 0.31 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 116.337 -1.792 . . . . 5.79 111.801 152.209 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.17 -49.48 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.251 2.634 . . . . 2.55 113.133 176.469 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.33 70.42 10.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.863 0.756 . . . . 3.19 111.712 -176.158 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 72.76 -168.16 0.12 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.879 1.272 . . . . 10.63 109.318 -174.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -158.33 157.67 32.86 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.999 -1.063 . . . . 10.07 113.141 -169.227 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.609 ' HE3' ' H ' ' A' ' 300' ' ' LYS . 0.0 OUTLIER -66.29 -27.87 68.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.357 1.463 . . . . 11.93 113.278 -174.724 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--O 1.253 1.285 0 C-N-CA 128.56 2.744 . . . . 9.13 107.287 170.325 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 117.867 -1.063 . . . . 22.04 109.82 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -63.89 139.34 58.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.018 0.827 . . . . 17.94 110.024 163.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.3 t 144.77 -173.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.274 1 C-N-CA 132.108 4.163 . . . . 16.94 108.114 -176.22 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.83 -133.53 15.58 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.982 0.801 . . . . 14.74 112.521 172.007 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.22 154.86 2.69 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 127.392 2.277 . . . . 12.84 110.887 174.063 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.52 171.89 17.23 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.017 2.478 . . . . 10.44 110.627 166.757 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.9 mt -98.62 152.27 19.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.297 1.039 . . . . 11.74 109.961 167.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 75.6 mt -117.43 -166.87 1.23 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.577 1.551 . . . . 7.7 110.966 -175.343 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -141.91 177.01 21.69 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 115.852 1.101 . . . . 3.52 115.852 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.62 -91.62 0.94 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.833 1.682 . . . . 3.55 110.494 -168.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.55 161.78 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.905 2.403 . . . . 3.6 113.279 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -156.08 179.43 9.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.85 2.46 . . . . 2.92 108.366 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.2 m -140.31 117.27 11.09 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.957 -1.714 . . . . 3.11 111.528 157.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.72 161.65 28.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.694 1.997 . . . . 2.62 108.39 176.325 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.4 t -87.31 146.62 25.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.467 0.651 . . . . 2.69 110.93 173.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.9 p -92.85 159.28 15.44 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 123.152 1.454 . . . . 2.37 112.409 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -56.82 -26.86 59.05 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.127 -0.983 . . . . 1.99 112.474 163.068 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.0 p -71.72 -20.29 61.93 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.367 1.247 . . . . 4.18 114.367 169.133 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.77 11.16 54.24 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 120.287 1.403 . . . . 1.96 115.163 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -88.76 -175.37 4.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.673 1.589 . . . . 4.06 110.136 170.492 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -131.56 121.72 24.9 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.887 1.275 . . . . 5.75 108.969 168.561 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -132.72 156.39 47.11 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.903 1.075 . . . . 3.9 113.903 -162.233 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -108.0 164.16 12.52 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.37 1.868 . . . . 3.14 109.63 171.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -39.61 -55.77 1.8 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.63 2.372 . . . . 4.18 112.42 159.803 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -74.34 -15.66 60.94 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.537 1.31 . . . . 8.02 114.537 -174.362 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.74 -42.64 77.29 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.824 1.193 . . . . 3.04 110.988 166.208 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.68 11.19 3.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.385 1.254 . . . . 2.98 114.385 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.36 -169.49 0.82 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.662 1.185 . . . . 4.19 111.763 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 76.41 8.35 85.67 Favored Glycine 0 N--CA 1.482 1.702 0 O-C-N 120.517 -1.364 . . . . 3.85 114.56 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.55 154.96 27.51 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.361 2.664 . . . . 3.57 107.593 -171.286 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -68.07 125.09 25.25 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.314 0.507 . . . . 2.48 110.071 170.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.7 mt -105.86 125.72 51.33 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.963 0.887 . . . . 3.09 111.652 177.107 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.04 92.22 3.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.865 1.666 . . . . 3.13 106.748 176.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.85 121.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.787 1.235 . . . . 2.63 110.199 -167.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -128.98 153.6 47.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.542 1.312 . . . . 3.55 114.542 -175.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.85 102.13 9.7 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.109 1.763 . . . . 2.84 112.31 175.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.02 171.31 17.72 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.396 1.474 . . . . 2.34 113.329 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -111.42 -12.99 13.95 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.765 0.654 . . . . 3.7 112.765 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.0 m 58.04 47.53 14.62 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.137 1.446 . . . . 4.19 108.891 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -150.4 -56.65 0.17 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 114.638 -1.164 . . . . 7.65 110.738 -161.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.3 m -70.4 141.03 87.87 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.156 0.982 . . . . 2.45 111.219 -170.21 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.22 -17.54 21.58 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.907 1.738 . . . . 4.17 111.243 166.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.51 -76.57 0.54 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.779 1.632 . . . . 5.3 112.673 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.29 -54.44 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.486 1.114 . . . . 2.76 111.945 -162.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.5 m -47.25 -60.7 3.64 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.325 -1.321 . . . . 1.68 112.596 176.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.24 -34.55 27.3 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.657 1.571 . . . . 1.27 113.127 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -67.08 -33.43 75.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 121.092 1.769 . . . . 3.75 112.097 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -31.2 37.67 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.299 -1.501 . . . . 3.49 113.521 170.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -43.74 98.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.967 1.307 . . . . 2.63 111.171 174.204 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.24 -46.34 76.03 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 3.47 111.055 172.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -66.51 -33.69 76.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.186 0.81 . . . . 3.69 113.186 174.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 69.7 mtp -61.18 -42.6 98.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.017 1.281 . . . . 3.54 111.915 169.328 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.9 mm -75.41 -61.97 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.971 -0.751 . . . . 1.87 108.971 -172.06 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.26 -12.41 28.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.748 1.219 . . . . 3.1 114.225 -165.068 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.13 -39.67 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.648 1.179 . . . . 1.62 111.044 171.064 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.11 -53.86 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.021 1.282 . . . . 2.38 110.205 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.8 -20.03 61.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.256 1.422 . . . . 4.49 112.064 -171.354 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -79.32 -38.13 35.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.796 1.239 . . . . 2.6 111.909 167.206 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.82 -49.54 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.782 1.401 . . . . 2.14 114.782 -168.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -33.52 75.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.571 1.532 . . . . 4.49 109.74 179.35 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -19.83 42.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.527 1.931 . . . . 3.01 114.714 173.714 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.46 -14.34 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.321 -1.487 . . . . 4.44 112.494 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m 157.64 -33.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 130.422 3.489 . . . . 6.18 112.832 164.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 7.1 t 157.34 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.16 3.384 . . . . 5.97 110.785 166.589 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.44 ' O ' ' HE2' ' A' ' 300' ' ' LYS . 0.2 OUTLIER -46.07 147.09 1.88 Allowed Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 114.302 -1.317 . . . . 3.78 111.493 169.679 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.28 -44.25 19.77 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.372 2.715 . . . . 3.57 112.459 -159.527 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.12 153.67 0.23 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.895 2.878 . . . . 4.5 108.669 161.722 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.16 128.11 29.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.044 0.537 . . . . 2.64 109.704 171.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.4 m -124.84 119.1 25.65 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.704 1.202 . . . . 1.63 108.562 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.73 133.63 10.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.001 2.467 . . . . 1.05 110.127 172.267 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.84 97.25 4.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.832 1.253 . . . . 2.48 109.336 -169.219 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -94.27 133.04 38.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.97 1.308 . . . . 2.51 110.661 -173.175 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 54.0 mt -122.62 129.43 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.586 1.155 . . . . 1.71 109.41 176.407 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -83.03 137.35 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.656 -0.653 . . . . 2.54 112.409 171.673 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 pt -81.74 3.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.891 1.071 . . . . 2.78 113.891 172.469 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.78 80.14 12.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 115.937 1.829 . . . . 5.12 115.937 -172.63 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -80.14 63.21 8.72 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.295 3.33 . . . . 2.57 112.12 174.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -108.74 -50.26 3.04 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.565 -1.198 . . . . 3.88 108.343 139.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.39 -6.32 28.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.793 1.775 . . . . 4.73 115.793 -170.736 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -76.46 28.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.715 1.598 . . . . 5.42 114.75 -177.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.2 m -61.29 134.74 57.29 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.486 -0.759 . . . . 3.67 109.746 -141.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -39.37 9.14 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.828 1.418 . . . . 3.7 114.828 -161.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -85.74 -28.31 24.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.655 0.983 . . . . 4.06 113.655 178.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.81 91.78 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 1.65 111.44 166.585 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.6 -41.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.485 0.714 . . . . 2.6 112.274 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.64 -38.79 75.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.297 0.953 . . . . 1.31 111.677 170.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -68.69 -38.29 80.19 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.062 0.764 . . . . 3.98 113.062 173.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.61 -37.9 87.92 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.023 0.829 . . . . 3.03 111.217 174.756 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.6 t -56.61 -47.94 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.951 -1.093 . . . . 1.3 111.721 170.583 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -79.84 19.9 0.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.493 1.294 . . . . 4.61 114.493 174.698 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -92.48 -59.88 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.572 -1.33 . . . . 3.9 109.557 160.171 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -80.79 -53.17 6.73 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.449 1.277 . . . . 3.4 114.449 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.3 t -177.35 132.02 0.35 Allowed Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.135 1.374 . . . . 2.26 109.031 -174.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.37 -5.72 16.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.184 2.589 . . . . 1.92 113.081 -176.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -76.55 -8.56 57.46 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.333 0.969 . . . . 3.67 113.401 171.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.48 131.04 44.11 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.32 0.964 . . . . 1.82 110.09 169.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.3 t -99.97 129.2 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.757 -1.201 . . . . 2.23 107.757 171.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.48 134.48 11.9 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.951 -0.86 . . . . 1.35 110.951 172.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.2 161.0 22.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.911 0.884 . . . . 2.28 112.129 171.27 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 9.7 t -162.72 -168.96 1.93 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 129.449 3.1 . . . . 2.77 108.165 -176.063 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 173.58 -147.43 9.48 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 120.305 1.411 . . . . 1.91 110.418 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.9 p -90.37 164.91 14.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.494 -0.928 . . . . 3.12 108.494 157.239 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -30.17 69.57 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.523 -0.751 . . . . 7.85 112.523 -173.719 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -56.09 -35.61 67.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.861 1.664 . . . . 3.45 113.114 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.38 -35.77 54.14 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.792 -1.193 . . . . 3.66 112.534 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.04 -35.1 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.009 0.524 . . . . 2.09 110.657 171.208 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -30.45 67.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.226 1.01 . . . . 3.69 111.318 174.144 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -60.41 3.91 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.405 1.082 . . . . 2.57 110.798 162.428 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' A' ' 240' ' ' ALA . 6.9 p -71.51 -16.28 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.942 1.247 . . . . 2.55 112.806 -168.474 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.78 -39.62 69.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.974 0.91 . . . . 1.76 110.255 173.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.05 -49.58 76.79 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.384 -0.817 . . . . 3.53 110.478 163.348 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 237' ' ' VAL . . . -60.9 -16.51 42.91 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 116.501 2.037 . . . . 2.95 116.501 -170.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -129.75 15.56 5.87 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.118 . . . . 2.87 113.671 173.269 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 56.61 43.32 25.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.136 1.374 . . . . 5.52 112.678 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.51 126.72 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.623 1.569 . . . . 2.89 108.511 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -94.14 149.78 20.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.127 1.371 . . . . 4.53 111.577 175.52 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -165.23 127.88 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.635 1.974 . . . . 5.02 110.056 -174.136 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.1 t -136.42 79.2 42.69 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.826 1.65 . . . . 3.72 111.8 -171.071 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.47 138.0 21.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.66 2.907 . . . . 3.21 113.877 -170.661 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -91.02 -173.03 43.78 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 125.521 1.534 . . . . 3.29 112.829 163.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -87.27 171.37 6.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.139 3.226 . . . . 3.8 112.702 -174.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -114.38 24.09 12.22 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 126.06 1.744 . . . . 7.8 114.846 -166.761 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -72.51 -28.98 63.21 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 118.471 2.767 . . . . 8.5 118.471 -140.757 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.59 -26.53 14.37 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.115 1.325 . . . . 7.42 114.217 -176.131 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -159.7 -45.72 0.05 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.42 1.488 . . . . 8.22 109.923 172.112 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -179.69 -43.86 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.027 3.331 . . . . 9.21 110.058 174.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -6.68 74.16 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.861 2.064 . . . . 4.35 114.859 -152.492 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.37 94.86 0.98 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.923 -1.035 . . . . 3.99 112.088 -155.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 28.1 mm -77.04 78.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.791 -0.818 . . . . 4.42 108.791 169.053 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.37 146.64 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.414 -1.699 . . . . 4.07 106.414 151.723 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.66 -174.68 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.326 1.06 . . . . 4.62 111.315 162.562 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -146.87 151.31 36.85 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.08 -1.013 . . . . 2.27 111.453 138.339 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.1 m -60.09 128.47 36.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.055 1.342 . . . . 3.38 109.309 165.077 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 15.4 pt -104.07 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.56 1.544 . . . . 5.15 111.579 -177.276 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.3 mm -128.72 141.12 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.491 1.117 . . . . 2.99 109.954 177.266 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 7.9 ttp -124.35 128.31 48.9 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.621 1.968 . . . . 2.72 109.167 173.527 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.72 141.39 32.58 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.318 1.047 . . . . 3.02 112.053 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -104.19 110.86 23.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.632 1.173 . . . . 2.61 110.215 174.266 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.0 138.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.477 1.511 . . . . 2.28 109.38 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.92 160.53 37.19 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.351 -0.694 . . . . 2.18 114.089 -178.014 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.53 64.52 4.64 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.593 3.529 . . . . 3.86 109.192 167.105 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.02 -60.69 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.807 1.643 . . . . 4.79 108.254 -154.735 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 171.59 -70.25 0.12 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 123.798 0.714 . . . . 3.34 112.464 -178.349 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -118.11 -175.75 2.92 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.594 0.711 . . . . 5.98 112.812 -161.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -85.05 145.74 27.53 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.329 0.863 . . . . 3.73 113.329 -176.043 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 pp -141.93 0.86 1.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.398 1.629 . . . . 3.32 115.398 -178.549 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -157.46 171.54 20.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.742 1.617 . . . . 3.17 110.005 171.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -155.67 156.84 35.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.347 1.459 . . . . 3.64 113.362 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -147.9 177.6 9.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.796 1.638 . . . . 2.64 113.18 -168.327 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.09 -164.89 37.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 128.188 2.804 . . . . 3.15 108.93 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -28.16 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.133 0.967 . . . . 3.58 113.225 179.164 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.29 -8.91 58.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 114.336 1.236 . . . . 4.69 114.336 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -135.44 98.32 3.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 4.54 108.419 171.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.32 -172.31 4.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.357 0.663 . . . . 5.94 112.518 -164.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -50.12 74.89 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.166 -1.584 . . . . 2.06 114.862 -159.08 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.89 -28.68 70.24 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.624 0.647 . . . . 1.76 111.809 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.68 -26.86 60.12 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.282 1.033 . . . . 4.28 112.808 177.007 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.38 -51.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.861 0.865 . . . . 1.27 109.724 167.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.13 93.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.14 0.576 . . . . 1.74 111.603 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.91 95.49 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.534 1.134 . . . . 2.3 113.882 177.714 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 25.1 p -71.73 -39.0 70.4 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.766 1.166 . . . . 1.92 111.982 174.235 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.11 -40.0 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.335 1.425 . . . . 1.81 111.772 176.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.36 -22.0 66.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.26 1.024 . . . . 2.73 113.216 171.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 95.0 m -78.64 -40.27 34.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.928 0.891 . . . . 3.19 110.673 170.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.53 -21.79 64.55 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.74 1.216 . . . . 2.8 112.974 174.431 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -63.88 -33.26 75.3 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.848 -1.157 . . . . 4.8 112.522 166.656 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -60.75 -36.22 33.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 116.409 -1.757 . . . . 5.53 114.814 -172.528 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -86.41 -8.65 7.31 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.508 2.805 . . . . 3.31 114.452 167.665 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -94.99 -171.08 2.34 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.54 1.536 . . . . 4.69 112.471 179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -108.05 168.55 9.21 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.716 -1.24 . . . . 8.29 111.184 159.589 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.96 -152.62 0.48 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.942 1.297 . . . . 7.68 110.232 179.03 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 193' ' ' LEU . 12.0 mtmt -64.95 99.29 0.34 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 107.022 -1.473 . . . . 9.93 107.022 147.192 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.1 t . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 128.522 2.729 . . . . 7.88 113.715 -162.901 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 118.29 -0.862 . . . . 20.69 110.15 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -73.7 -175.21 1.98 Allowed 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.463 0.477 . . . . 20.14 110.254 156.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.6 t -151.47 166.34 31.39 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.824 1.65 . . . . 15.67 109.58 170.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.59 -161.75 27.02 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.903 1.24 . . . . 12.67 114.553 -171.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -151.13 132.01 7.42 Favored Pre-proline 0 CA--C 1.546 0.817 0 O-C-N 121.589 -0.948 . . . . 12.51 111.824 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -79.87 156.88 24.02 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.874 2.383 . . . . 7.54 110.203 168.333 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.8 155.96 47.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.659 1.583 . . . . 10.81 108.324 168.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 136' ' ' LEU . 1.4 pt? -86.89 164.26 16.69 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.352 1.061 . . . . 5.94 113.402 -179.046 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 158.25 -171.02 35.08 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.733 2.111 . . . . 3.31 109.871 -174.79 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.78 63.72 0.61 Allowed Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.24 -1.311 . . . . 3.2 111.458 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.95 135.9 66.08 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.606 2.871 . . . . 3.56 112.084 -169.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -140.91 176.92 8.41 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.571 -1.65 . . . . 2.9 112.516 -168.107 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.8 t -127.73 132.86 49.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.634 1.974 . . . . 3.68 106.168 159.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 tp -164.56 143.18 6.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.977 0.911 . . . . 2.36 110.319 -176.487 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.0 m -93.81 140.29 29.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.746 0.703 . . . . 1.55 109.617 -174.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.0 m -101.5 139.32 37.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.829 1.652 . . . . 3.59 110.634 -178.66 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -16.35 1.37 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.597 2.759 . . . . 2.0 116.842 -169.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 t -76.65 -35.79 57.76 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.468 1.031 . . . . 3.51 112.127 172.054 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.32 68.42 0.44 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.403 1.477 . . . . 2.82 112.257 -166.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.67 148.21 6.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.164 1.785 . . . . 4.88 108.747 171.292 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -108.36 115.85 30.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.717 1.207 . . . . 4.39 111.662 -175.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -104.5 163.27 12.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.836 1.254 . . . . 4.23 112.574 -173.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -119.84 160.73 22.09 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.613 1.965 . . . . 3.25 108.054 162.057 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -49.3 -37.37 23.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.0 1.72 . . . . 4.64 111.552 169.352 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -71.23 -31.48 67.62 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.876 1.065 . . . . 7.75 113.876 -177.555 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.29 -3.77 33.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.101 0.864 . . . . 4.84 113.33 175.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -33.01 59.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.383 0.883 . . . . 4.48 113.383 160.124 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.12 178.78 0.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.966 1.306 . . . . 5.5 113.856 -173.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 8.98 75.44 Favored Glycine 0 N--CA 1.474 1.206 0 O-C-N 121.172 -0.955 . . . . 2.93 113.228 -166.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -156.14 165.45 36.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.088 1.755 . . . . 3.39 109.428 -177.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -69.51 112.25 5.9 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.965 -0.459 . . . . 2.19 112.206 177.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -98.52 122.65 41.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.613 1.165 . . . . 2.77 110.981 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -118.13 109.16 16.07 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.505 -1.665 . . . . 3.0 106.505 176.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.3 pt -111.81 126.82 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.093 0.405 . . . . 3.89 112.093 -170.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.31 149.17 51.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 2.66 112.208 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -122.77 121.27 35.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.428 1.091 . . . . 2.82 109.927 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.38 -178.37 16.95 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 1.68 116.123 -169.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.5 151.34 50.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.683 1.193 . . . . 3.6 111.686 175.366 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.9 p -53.63 -30.9 45.09 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.19 1.396 . . . . 4.04 113.831 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -143.17 94.42 2.62 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 108.952 -0.758 . . . . 7.86 108.952 150.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.448 ' C ' ' H ' ' A' ' 171' ' ' ASP . 9.2 t -38.31 166.77 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 128.377 2.671 . . . . 2.36 115.613 160.715 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -65.54 43.71 0.16 Allowed 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.537 2.825 . . . . 3.59 111.815 146.351 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 169' ' ' CYS 0.28 29.8 m-20 58.03 11.87 1.62 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.154 2.982 . . . . 4.96 116.75 173.913 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.6 -35.99 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.975 0.91 . . . . 2.47 110.708 169.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 38.5 m -53.07 -56.24 25.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.635 -1.65 . . . . 1.78 114.272 175.548 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.0 -43.47 11.69 Favored 'Trans proline' 0 C--N 1.351 0.7 0 CA-C-N 122.472 1.918 . . . . 1.53 112.149 177.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -51.52 -46.27 63.21 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.826 1.65 . . . . 2.9 112.573 174.17 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.89 -45.26 24.65 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.121 -0.987 . . . . 2.49 112.316 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -62.49 -29.05 70.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.955 -1.091 . . . . 2.49 112.313 -177.388 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -60.42 -52.19 66.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.769 0.828 . . . . 4.0 111.84 168.03 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -58.08 -50.8 72.2 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 120.17 -1.581 . . . . 2.84 110.801 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -57.22 -53.75 54.57 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.705 -0.664 . . . . 3.73 110.99 175.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 181' ' ' ILE . 5.7 tp -68.08 -38.35 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.479 1.49 . . . . 2.53 111.197 -170.858 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.598 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 62.1 mt-30 -65.85 -24.08 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 118.1 -0.952 . . . . 2.91 112.168 179.03 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.18 -19.21 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 120.669 1.577 . . . . 2.66 113.732 173.067 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.25 -40.0 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.11 1.323 . . . . 2.13 109.394 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -55.4 -48.69 73.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.551 1.541 . . . . 3.95 112.401 172.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -70.3 -36.46 74.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.994 0.918 . . . . 3.44 112.83 -177.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -77.76 -27.72 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.083 -1.011 . . . . 2.04 112.823 177.456 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.79 -48.74 79.27 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.244 1.018 . . . . 3.35 109.133 165.678 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.6 t -64.49 -26.73 68.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.405 0.891 . . . . 2.97 113.405 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.0 -30.87 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.604 1.161 . . . . 3.36 111.786 172.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.4 m 73.47 -36.32 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.788 2.035 . . . . 4.32 113.553 167.365 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 80.1 p -78.94 24.3 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.644 1.978 . . . . 5.63 113.11 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.2 mt -134.21 156.28 79.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.345 1.858 . . . . 4.34 110.456 174.069 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.83 -75.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.131 2.554 . . . . 3.01 109.625 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.61 167.28 30.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.842 2.057 . . . . 3.47 108.06 162.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.17 114.7 26.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.275 1.43 . . . . 1.81 108.705 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.5 m -108.38 94.58 13.84 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 123.312 0.645 . . . . 2.02 110.887 -168.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.98 131.06 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.813 2.342 . . . . 1.61 110.885 170.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.01 139.19 49.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.533 1.159 . . . . 3.8 111.621 168.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -109.94 123.65 50.01 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.51 1.924 . . . . 2.53 109.272 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.9 mt -108.79 115.02 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.887 0.875 . . . . 1.75 109.554 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.0 t -83.71 104.69 14.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 2.58 108.649 176.504 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.5 pt -79.27 35.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 122.013 0.911 . . . . 1.88 111.823 -178.729 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -126.93 46.94 2.2 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 127.291 2.236 . . . . 3.9 111.301 -160.056 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -13.26 36.89 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.456 2.77 . . . . 2.46 114.302 -163.104 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -76.88 9.93 2.58 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.906 1.283 . . . . 3.99 113.33 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -163.44 25.08 0.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.866 1.432 . . . . 4.49 114.866 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -71.21 152.79 43.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.112 0.958 . . . . 5.7 111.814 172.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 4.4 m -154.81 122.47 5.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.079 1.752 . . . . 2.75 106.499 164.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -46.56 -48.08 19.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.796 1.238 . . . . 3.98 113.105 -170.801 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.43 -30.47 61.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.547 1.139 . . . . 5.12 113.525 177.631 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.14 73.66 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.066 -1.021 . . . . 1.83 110.755 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.15 -42.94 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 2.66 110.444 173.489 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.7 77.21 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.333 0.653 . . . . 1.7 112.586 176.072 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -65.66 -45.97 80.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.452 0.701 . . . . 4.38 112.56 176.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -49.98 -45.22 51.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.027 0.931 . . . . 2.78 111.387 170.404 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.4 t -72.56 -39.7 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.74 1.015 . . . . 2.16 113.74 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -57.68 -50.5 72.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.214 -0.898 . . . . 4.09 113.291 -176.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -69.6 -17.25 63.52 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.318 1.229 . . . . 6.61 114.318 -165.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.82 -32.62 72.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.195 0.907 . . . . 2.5 112.639 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 t 138.2 129.25 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 131.032 3.733 . . . . 2.83 109.711 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.32 8.13 1.25 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.549 2.833 . . . . 2.25 116.018 -166.082 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -73.19 -16.06 61.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.036 1.289 . . . . 2.36 112.73 161.158 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.04 137.56 43.48 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.449 -0.782 . . . . 1.79 109.223 166.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.57 148.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.377 0.671 . . . . 2.47 112.156 171.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.69 138.68 15.1 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 124.501 1.048 . . . . 1.04 112.865 -177.101 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.83 148.32 40.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 114.758 1.392 . . . . 2.07 114.758 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.2 p -155.12 170.61 21.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.576 2.35 . . . . 2.29 110.19 -179.206 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.39 -173.63 37.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.612 1.101 . . . . 1.94 111.447 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.8 t -65.27 162.99 16.24 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.161 0.48 . . . . 2.61 110.553 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -56.64 -31.84 64.75 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.34 -0.85 . . . . 6.54 112.233 -176.716 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.9 mp0 -72.14 -35.75 69.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.799 2.04 . . . . 3.68 111.045 178.499 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.66 -39.72 76.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.747 -0.595 . . . . 3.15 111.881 169.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.21 -36.47 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.965 0.906 . . . . 2.19 111.951 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.15 -46.24 43.65 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.473 1.033 . . . . 4.24 110.113 173.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -46.08 -50.68 14.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.622 0.769 . . . . 3.31 110.8 173.256 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.44 -43.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.123 0.969 . . . . 2.48 111.803 -174.208 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.55 87.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.806 0.842 . . . . 2.02 111.906 173.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -32.09 35.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.236 1.814 . . . . 6.21 113.013 -177.281 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.56 -60.86 2.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.835 1.254 . . . . 2.16 112.235 176.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -74.68 -6.13 47.01 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.578 0.955 . . . . 2.46 113.578 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 66.66 54.89 0.81 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.63 1.972 . . . . 5.1 113.319 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.07 152.27 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.759 2.024 . . . . 3.29 110.54 177.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -103.67 145.93 29.33 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.009 1.114 . . . . 4.91 114.009 -176.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -129.87 142.63 50.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.536 1.934 . . . . 3.81 111.354 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 42.4 t -128.92 106.14 18.28 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 124.059 0.944 . . . . 4.56 111.136 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.74 153.28 8.75 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.478 2.785 . . . . 3.45 111.138 170.386 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.9 175.26 47.86 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 114.75 0.66 . . . . 3.36 114.75 176.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -85.69 -168.42 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 124.695 3.596 . . . . 4.66 110.908 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -105.06 120.55 41.76 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.841 -0.8 . . . . 4.47 108.841 148.036 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -151.61 156.15 39.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.487 1.515 . . . . 7.46 109.227 175.245 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 63.11 -48.81 0.21 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.594 2.758 . . . . 8.51 112.318 -160.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -173.9 -55.24 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.793 3.237 . . . . 6.47 109.223 170.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -142.11 19.1 2.1 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.274 1.03 . . . . 5.95 113.103 -159.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -46.56 139.95 4.72 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.413 -1.43 . . . . 4.87 113.518 175.023 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -143.85 48.42 1.41 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.611 1.564 . . . . 5.54 111.676 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.61 150.17 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.883 -1.136 . . . . 3.26 110.917 155.011 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.3 m -156.44 152.63 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.024 1.73 . . . . 5.22 107.605 -178.24 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -150.86 145.18 25.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.964 1.364 . . . . 5.94 112.077 -179.359 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -133.13 95.99 3.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.413 1.085 . . . . 2.34 109.92 170.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 t -72.54 58.26 0.42 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.852 1.661 . . . . 5.76 110.461 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.4 pp -113.09 158.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 122.472 1.13 . . . . 5.53 113.827 -167.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.7 pt -107.55 163.63 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.328 1.451 . . . . 3.89 109.014 161.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 76.5 mtp -97.51 159.01 15.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.739 0.816 . . . . 2.66 109.869 161.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.32 142.02 45.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.414 0.686 . . . . 2.82 111.116 165.464 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.2 tp -92.12 118.07 30.46 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 106.535 -1.654 . . . . 2.04 106.535 158.481 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.18 136.02 31.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.617 -1.623 . . . . 2.79 106.617 164.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.48 172.07 45.82 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 2.21 111.968 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.17 -13.44 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.191 2.594 . . . . 3.49 113.094 177.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -113.57 -0.14 14.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 129.713 3.205 . . . . 4.42 112.178 -176.34 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 108.34 -148.67 16.78 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.917 1.722 . . . . 4.28 113.072 -176.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.81 158.64 0.13 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.428 2.691 . . . . 5.91 116.543 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.86 85.78 6.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.813 1.245 . . . . 3.92 108.854 172.388 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.3 tt -86.31 -36.06 19.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.005 0.922 . . . . 3.2 111.834 -163.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -159.24 159.88 34.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.895 1.678 . . . . 2.61 109.413 175.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -136.46 147.34 47.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 122.676 1.227 . . . . 3.94 113.3 172.888 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.67 156.34 44.4 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.843 1.257 . . . . 2.39 111.101 -162.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.21 170.82 42.63 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.874 1.702 . . . . 2.75 110.036 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.88 -25.35 42.19 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.913 2.19 . . . . 4.48 116.913 -149.625 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.85 -21.35 25.06 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.512 1.301 . . . . 5.97 114.512 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -57.93 107.07 0.42 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.769 1.628 . . . . 4.09 108.593 178.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -74.93 143.8 43.55 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.395 -1.441 . . . . 6.36 109.813 -157.174 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.1 tmtt? -42.79 -53.0 4.8 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 121.095 1.77 . . . . 2.0 113.438 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -18.38 74.92 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.361 0.904 . . . . 1.58 115.361 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -31.78 17.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.877 1.271 . . . . 4.62 111.395 174.43 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.2 mt -56.36 -43.5 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.103 -0.998 . . . . 1.47 109.901 161.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.46 -53.17 58.75 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.54 0.57 . . . . 1.26 112.54 170.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.05 72.1 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.562 1.319 . . . . 1.5 114.562 -177.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.9 p -68.92 -48.83 62.33 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.446 -0.783 . . . . 1.75 111.07 170.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.24 -34.05 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.28 1.4 . . . . 1.49 111.709 176.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.35 -21.18 62.92 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.118 0.967 . . . . 1.51 113.494 172.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 100.0 m -76.98 -45.65 26.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.722 0.809 . . . . 1.9 109.537 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -62.83 -21.11 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.855 1.262 . . . . 2.44 113.402 174.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -66.5 -23.49 66.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.086 1.355 . . . . 4.27 113.287 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -59.8 -45.48 98.36 Favored Pre-proline 0 N--CA 1.477 0.891 0 O-C-N 119.971 -1.706 . . . . 5.0 113.277 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.6 -57.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.554 2.169 . . . . 2.12 111.491 164.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -83.63 23.47 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.029 1.862 . . . . 3.65 116.029 -167.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 ptt85 -57.3 125.68 23.87 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.606 1.563 . . . . 8.89 111.752 174.686 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -75.75 142.53 42.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.087 1.355 . . . . 7.45 109.238 166.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 130.22 43.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 117.38 -1.295 . . . . 9.39 108.518 158.565 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.479 0.997 0 CA-C-N 120.281 1.4 . . . . 8.08 112.532 -179.828 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 117.008 -1.472 . . . . 16.67 107.681 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -49.91 -44.52 50.26 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.544 1.52 . . . . 14.25 111.183 166.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 t -123.31 -173.19 2.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.571 1.149 . . . . 11.46 110.535 158.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.34 117.0 1.35 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.059 1.79 . . . . 10.12 111.031 -172.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -165.36 71.25 1.36 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 125.972 1.709 . . . . 11.59 111.648 -171.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -83.75 176.85 6.64 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.222 3.282 . . . . 8.64 112.393 -171.522 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.17 -176.9 5.54 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.682 2.393 . . . . 7.34 109.335 177.084 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.26 174.25 7.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.974 0.806 . . . . 8.11 111.697 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.27 -151.62 21.61 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.383 0.992 . . . . 3.02 111.852 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.9 97.33 1.79 Allowed Glycine 0 CA--C 1.532 1.11 0 N-CA-C 108.149 -1.98 . . . . 3.48 108.149 -161.381 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.33 134.94 25.73 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.667 2.245 . . . . 3.97 111.772 -161.531 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -75.51 -179.97 4.92 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.497 1.519 . . . . 2.34 113.194 -172.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.2 m -157.83 62.1 0.47 Allowed 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.246 -1.534 . . . . 3.25 112.695 177.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -98.8 160.74 14.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.556 1.142 . . . . 2.21 110.511 -177.581 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -103.42 139.86 38.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.635 1.574 . . . . 1.69 111.656 -164.635 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -94.59 158.93 15.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.877 1.799 . . . . 2.24 115.706 -167.677 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.461 ' O ' ' HE3' ' A' ' 210' ' ' LYS . 0.3 OUTLIER -57.39 -21.7 37.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.481 1.912 . . . . 1.93 113.327 164.349 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -71.76 -68.85 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.194 1.398 . . . . 3.18 109.086 160.198 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.28 -12.44 1.6 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 124.769 1.176 . . . . 1.85 115.114 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.3 153.94 41.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.812 1.306 . . . . 4.2 110.626 166.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -85.26 135.14 34.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.449 -0.574 . . . . 5.21 109.449 153.164 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -120.27 153.86 35.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.833 0.853 . . . . 3.18 110.198 178.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.1 p -141.14 156.46 45.95 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.701 1.2 . . . . 2.52 110.705 -166.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.09 13.61 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.189 0.996 . . . . 3.93 113.444 168.339 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -103.67 -32.11 9.55 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.225 -1.547 . . . . 7.56 112.684 167.52 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -96.81 -22.59 16.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.646 1.178 . . . . 3.28 112.731 177.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -77.83 -15.31 59.16 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.573 0.953 . . . . 3.05 113.573 162.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.37 133.65 56.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.618 1.167 . . . . 3.43 110.551 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.32 6.68 88.51 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.273 -0.892 . . . . 2.33 114.199 -176.144 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -84.98 -155.73 0.22 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.088 1.444 . . . . 3.3 110.449 163.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -136.12 111.56 9.2 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.003 -1.481 . . . . 1.9 107.003 153.065 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.22 148.3 41.33 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.483 1.135 . . . . 2.51 113.163 -173.243 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.43 114.86 27.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.69 1.596 . . . . 2.83 106.977 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.47 111.31 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.035 -1.839 . . . . 3.07 106.035 -177.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -108.91 139.99 43.0 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.163 0.982 . . . . 2.23 113.278 -173.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -111.68 92.94 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.579 2.352 . . . . 2.15 110.877 175.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -130.69 154.47 20.72 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.426 1.965 . . . . 1.6 109.681 166.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.53 ' CE2' HG11 ' A' ' 258' ' ' VAL . 22.3 m-85 -97.18 157.0 16.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.688 0.744 . . . . 5.83 111.093 -175.482 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 53.1 p -70.66 -3.71 19.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.388 -1.445 . . . . 3.61 113.336 172.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -67.74 -47.2 69.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.215 1.806 . . . . 7.57 114.316 -178.393 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.9 m -102.92 119.62 54.98 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.448 1.022 . . . . 2.64 113.504 -150.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -90.85 44.34 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.353 2.702 . . . . 5.42 111.16 174.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.88 -104.45 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.138 -1.43 . . . . 6.05 107.138 -157.32 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.11 -66.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.221 1.808 . . . . 3.43 114.2 171.473 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 87.6 m -51.49 -48.74 85.7 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.868 1.433 . . . . 1.7 114.868 -174.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.25 -31.63 14.06 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.399 2.066 . . . . 1.27 113.571 175.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -64.37 -36.04 82.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.399 1.454 . . . . 3.39 110.734 171.596 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -33.71 76.46 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.546 -1.346 . . . . 3.18 112.809 174.625 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.15 -36.96 75.11 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.336 -0.84 . . . . 2.71 112.11 171.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -60.24 3.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.937 1.295 . . . . 4.59 111.423 -178.621 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -20.01 66.15 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 119.623 -1.923 . . . . 3.05 113.713 175.803 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 29.8 ttm -70.89 -45.02 65.08 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.636 1.107 . . . . 2.3 111.217 172.316 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -57.33 -47.57 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.311 -0.868 . . . . 2.61 110.076 174.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -54.58 -20.76 8.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.201 1.186 . . . . 4.86 114.201 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.73 -25.79 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.336 1.235 . . . . 2.35 114.336 177.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -54.46 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.62 1.1 . . . . 2.46 108.84 165.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -57.13 -37.87 72.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.475 1.11 . . . . 4.69 113.034 177.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.29 -40.73 50.88 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.345 -0.847 . . . . 2.93 112.814 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mt -66.86 -34.8 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.876 0.762 . . . . 1.83 110.833 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.81 -44.89 76.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.541 1.136 . . . . 3.66 111.588 167.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -64.67 -27.59 69.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.393 -1.442 . . . . 3.21 112.862 177.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.86 -19.69 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.218 1.407 . . . . 3.72 112.022 172.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.3 m 73.96 -35.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 127.225 2.21 . . . . 5.38 114.212 162.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -97.63 4.14 50.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.802 1.641 . . . . 4.48 112.96 178.186 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.73 152.07 37.94 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.255 -1.017 . . . . 3.23 108.255 158.413 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -94.95 -23.18 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.742 2.295 . . . . 3.79 114.474 -162.658 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.7 t70 170.65 150.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.333 2.653 . . . . 3.66 110.334 -173.539 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 11.0 tp -132.28 100.39 5.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.182 1.793 . . . . 2.2 108.376 156.691 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 m -81.71 121.71 79.77 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-O 118.118 -0.944 . . . . 1.72 110.906 -178.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.24 117.96 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.128 3.218 . . . . 1.48 110.409 168.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.32 119.12 34.69 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 2.49 109.224 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -102.76 112.66 25.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.983 0.913 . . . . 2.5 110.66 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.481 HG22 HG23 ' A' ' 203' ' ' ILE . 9.5 mm -82.55 122.51 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 107.254 -1.387 . . . . 1.51 107.254 165.321 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.9 p -71.66 -29.46 64.64 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.499 1.666 . . . . 3.13 115.499 -175.429 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 201' ' ' ILE 0.329 14.1 pt 53.2 -6.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 119.825 3.269 . . . . 3.08 119.825 168.752 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -119.87 62.27 7.75 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.485 1.914 . . . . 3.56 112.196 161.398 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -59.3 140.49 94.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 107.95 -1.596 . . . . 2.4 107.95 161.137 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 108.8 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.394 3.878 . . . . 4.88 112.357 -174.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -107.61 4.74 26.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.161 0.892 . . . . 5.33 112.303 163.163 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.41 -179.44 7.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.39 1.476 . . . . 5.58 112.246 -175.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.6 m -167.27 129.67 1.68 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 128.129 2.572 . . . . 2.27 105.791 162.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 145' ' ' HIS . 1.2 tmtp? -54.08 -43.47 70.36 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.472 0.709 . . . . 3.13 112.478 -175.461 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -67.81 -31.52 71.43 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.741 1.617 . . . . 3.1 113.256 173.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.02 73.79 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.566 -1.334 . . . . 1.29 111.768 175.596 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.94 -38.15 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.537 0.735 . . . . 2.41 111.036 170.246 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.9 69.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.838 0.745 . . . . 1.56 112.822 174.692 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.01 -49.33 52.47 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.357 -0.84 . . . . 4.48 111.584 170.061 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.16 -30.94 71.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.708 0.633 . . . . 2.88 112.708 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.58 -60.21 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.005 1.322 . . . . 1.6 110.92 162.521 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -62.18 -30.74 71.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.388 0.884 . . . . 5.36 113.388 -174.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.22 -34.94 72.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.23 1.412 . . . . 4.63 111.964 -177.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -108.67 -21.41 12.71 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.689 1.366 . . . . 3.39 114.689 -174.183 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.4 p 159.17 151.38 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.888 2.475 . . . . 2.58 112.015 167.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.54 -3.29 10.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.861 2.374 . . . . 2.06 114.413 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -87.07 -8.62 56.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.008 1.276 . . . . 2.12 113.395 171.788 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.64 123.19 18.2 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.029 -1.669 . . . . 2.88 109.567 171.847 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.36 116.17 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.293 -1.002 . . . . 2.6 108.293 165.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.57 141.51 15.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.458 1.028 . . . . 1.12 111.271 -177.174 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.44 151.29 37.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.961 1.097 . . . . 2.77 113.961 -175.229 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 25.5 p -133.53 170.78 15.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.588 3.155 . . . . 3.07 108.908 -176.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.81 161.06 15.04 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.902 1.715 . . . . 2.03 109.455 -173.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.4 p -69.03 169.11 12.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.048 1.424 . . . . 3.01 112.266 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -40.7 -43.4 1.95 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.973 1.709 . . . . 5.57 112.732 170.256 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -67.53 -38.38 84.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.505 1.122 . . . . 3.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.51 -47.63 59.53 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.119 -0.988 . . . . 3.47 111.453 174.477 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.1 m -65.6 -24.77 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.851 0.686 . . . . 2.85 112.851 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.11 -33.43 29.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.194 0.906 . . . . 3.03 112.34 169.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -59.61 -51.48 69.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.42 1.464 . . . . 2.6 110.655 171.146 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.52 -20.64 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.31 0.485 . . . . 2.1 112.31 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.4 -54.37 14.77 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.947 0.794 . . . . 2.0 110.789 167.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.75 -45.09 82.22 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.258 1.423 . . . . 3.12 111.844 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.41 -56.45 14.96 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.335 1.054 . . . . 2.22 112.404 -175.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.53 10.72 26.73 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.122 -0.986 . . . . 3.31 113.576 176.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 61.24 33.45 19.13 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.343 1.457 . . . . 5.2 113.655 177.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.32 147.96 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.535 2.334 . . . . 2.99 110.447 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -119.83 153.16 36.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.421 1.105 . . . . 5.85 113.413 168.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -124.45 146.33 48.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 6.26 109.317 171.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 259' ' ' ASP . 26.2 m -123.51 72.29 49.56 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.721 1.208 . . . . 3.69 110.329 -179.269 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.66 125.03 10.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.603 2.202 . . . . 3.03 111.574 -171.381 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.96 136.33 14.15 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.454 -1.192 . . . . 2.43 111.377 178.551 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -80.98 58.1 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.17 3.246 . . . . 4.31 109.851 177.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt 72.24 164.22 0.28 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.967 2.507 . . . . 5.2 113.997 -157.489 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -149.39 149.59 31.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.079 1.752 . . . . 8.69 109.52 176.705 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 54.82 -63.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.468 2.307 . . . . 8.17 112.485 -149.276 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 169.85 -38.88 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 131.293 3.837 . . . . 6.85 108.792 -172.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.63 -28.51 12.46 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.658 1.725 . . . . 7.09 115.658 -173.846 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.49 154.77 32.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.006 1.276 . . . . 4.18 111.721 179.051 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.84 79.75 1.44 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.039 -1.038 . . . . 4.32 109.771 166.568 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.97 167.14 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.817 1.247 . . . . 2.95 112.744 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 166' ' ' PHE . 58.6 t -149.62 129.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 105.392 -2.077 . . . . 3.2 105.392 156.672 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 246' ' ' SER . 0.8 OUTLIER -87.16 158.34 19.17 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.267 0.94 . . . . 3.63 110.451 167.809 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.06 132.98 7.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.499 1.296 . . . . 2.44 114.499 -153.884 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.72 -12.8 37.71 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.713 2.116 . . . . 3.65 116.713 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.31 5.8 tt 43.48 55.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 126.211 1.804 . . . . 3.37 115.441 169.26 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.3 mm -103.46 146.41 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.694 1.198 . . . . 2.92 111.005 174.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 77.3 mtp -108.3 117.11 33.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.789 1.636 . . . . 2.33 109.987 158.102 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.76 135.68 39.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.975 0.91 . . . . 2.59 112.694 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 56.6 tp -93.61 118.23 31.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.283 1.033 . . . . 2.17 110.998 178.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.4 148.88 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.43 1.092 . . . . 2.36 108.333 169.449 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -175.32 -142.17 4.02 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.481 -1.177 . . . . 2.79 112.43 -172.545 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -88.56 70.43 2.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.399 2.733 . . . . 3.02 110.069 -171.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -169.96 -67.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.113 1.365 . . . . 4.66 108.678 -163.247 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.82 -4.54 69.39 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 116.543 -2.254 . . . . 2.96 116.658 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.44 -47.84 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.497 2.148 . . . . 6.05 111.742 176.339 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 162.24 121.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.436 2.694 . . . . 4.31 111.051 171.556 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.83 -46.9 6.69 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.207 0.817 . . . . 4.27 113.207 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.74 164.18 9.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.526 1.93 . . . . 2.57 109.237 -170.246 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -158.39 135.02 9.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.838 1.255 . . . . 3.66 112.993 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -114.57 118.49 33.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.608 1.163 . . . . 2.35 108.711 -176.158 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.12 112.5 3.47 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 118.936 -0.924 . . . . 3.82 111.386 -174.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 52.62 60.72 3.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.47 1.129 . . . . 3.11 108.723 -155.162 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.7 p30 42.68 -147.58 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.401 2.28 . . . . 7.41 114.244 -172.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -147.31 -4.93 0.51 Allowed 'General case' 0 CA--C 1.549 0.91 0 O-C-N 120.297 -1.502 . . . . 4.56 114.018 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 72.61 136.39 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.03 2.932 . . . . 8.01 109.243 -163.498 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -47.53 63.81 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.375 1.621 . . . . 2.66 115.375 -155.345 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.82 -17.14 73.0 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 123.925 0.774 . . . . 1.62 114.518 -175.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.71 -29.02 61.05 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.327 1.063 . . . . 5.44 111.582 174.42 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.09 -40.72 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.585 -0.697 . . . . 1.52 109.477 174.144 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.99 88.09 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.951 -0.468 . . . . 1.49 111.599 171.666 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.06 79.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.185 0.809 . . . . 1.87 113.185 176.32 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 60.5 p -59.74 -60.2 4.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.514 0.726 . . . . 2.21 111.721 174.09 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.4 mm -58.92 -35.52 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 119.305 0.957 . . . . 2.81 111.95 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.28 73.69 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.483 -0.761 . . . . 1.8 112.932 175.166 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.8 m -76.09 -36.51 58.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.999 1.32 . . . . 2.01 110.806 173.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.038 0.835 . . . . 3.08 112.025 173.683 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 32.5 mmt -65.55 -10.2 33.04 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.667 -1.27 . . . . 5.4 114.043 168.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -57.07 2.88 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.39 -1.766 . . . . 7.47 112.081 172.381 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.55 -51.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.043 2.495 . . . . 2.4 112.738 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -72.08 169.66 15.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.839 0.856 . . . . 3.38 110.948 176.192 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 36.6 mmt-85 -113.91 144.33 43.23 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.604 -1.31 . . . . 8.75 112.521 -167.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -68.8 146.23 53.07 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.267 1.827 . . . . 7.23 111.562 176.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -128.83 54.36 1.79 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.529 1.059 . . . . 10.94 111.042 176.338 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 C--O 1.255 1.367 0 C-N-CA 129.966 3.306 . . . . 9.0 107.768 -147.097 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.424 0 CA-C-O 118.25 -1.305 . . . . 2.67 110.518 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.63 147.87 36.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.191 1.928 . . . . 3.23 110.164 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.41 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 5.2 p90 -143.88 154.19 43.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.602 0.761 . . . . 3.55 111.062 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 m -122.87 15.74 10.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.595 1.702 . . . . 2.63 115.595 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.41 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 7.3 mp -69.37 147.89 50.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.152 2.181 . . . . 2.38 112.419 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.31 151.09 24.97 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.713 1.605 . . . . 2.25 109.971 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 146' ' ' THR . 0.6 OUTLIER -95.64 161.83 13.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.656 1.217 . . . . 2.87 111.971 175.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 6.3 p-80 -45.49 -28.24 0.88 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.257 2.623 . . . . 1.41 115.248 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.636 ' H ' HG23 ' A' ' 144' ' ' THR . 10.3 m -72.02 -20.1 61.75 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.451 1.9 . . . . 2.9 113.456 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.33 11.78 56.87 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.073 1.32 . . . . 2.29 114.559 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.5 -162.73 0.98 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.929 1.291 . . . . 4.32 110.45 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -144.07 103.74 4.05 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.496 1.044 . . . . 4.39 113.06 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 175.68 5.49 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.682 1.364 . . . . 4.76 114.682 173.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.4 p -137.19 -179.28 5.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.446 2.298 . . . . 2.3 111.092 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.44 -26.94 62.03 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.703 -1.248 . . . . 3.59 112.916 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -94.68 -19.45 20.41 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.051 1.871 . . . . 7.12 116.051 -167.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -71.21 -28.79 64.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.26 1.391 . . . . 3.03 112.102 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -96.04 40.83 1.11 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.276 1.03 . . . . 4.33 112.535 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.64 169.15 13.34 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.254 -0.903 . . . . 5.37 112.409 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 75.93 -10.05 15.66 Favored Glycine 0 CA--C 1.54 1.635 0 O-C-N 120.517 -1.365 . . . . 2.4 116.319 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -116.02 156.23 26.69 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.671 2.388 . . . . 3.25 110.094 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -70.88 100.31 1.92 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.569 1.077 . . . . 1.6 111.176 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.9 mt -83.85 134.57 34.7 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.138 0.971 . . . . 2.54 109.907 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.69 112.59 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.42 -1.696 . . . . 2.77 106.42 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.1 pt -114.77 122.21 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.079 0.552 . . . . 2.77 109.547 -165.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -111.79 143.74 42.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.791 1.236 . . . . 2.56 112.024 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.02 104.5 12.76 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.414 1.486 . . . . 2.0 108.681 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -120.5 -176.18 15.6 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.39 1.471 . . . . 1.36 114.852 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -157.5 115.75 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.739 2.015 . . . . 3.76 106.406 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.6 m -76.28 71.89 3.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.215 1.406 . . . . 3.49 110.178 -166.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 173.79 -48.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.17 2.588 . . . . 6.46 110.338 -158.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 52.1 -161.86 0.01 OUTLIER Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.664 2.385 . . . . 3.94 115.321 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -71.66 -74.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 124.7 3.6 . . . . 4.73 110.619 120.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -163.68 30.17 0.08 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.482 1.037 . . . . 4.22 113.735 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.8 -17.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 115.311 1.597 . . . . 3.18 115.311 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 29.7 m -49.7 -48.3 77.11 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 116.354 -1.784 . . . . 1.58 112.888 155.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.14 -39.89 9.73 Favored 'Trans proline' 0 C--N 1.354 0.825 0 CA-C-N 122.751 2.018 . . . . 1.66 112.206 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.67 -48.49 81.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.381 1.072 . . . . 3.52 111.076 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.447 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 4.9 tp10 -75.44 -22.38 57.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.012 0.925 . . . . 3.74 112.871 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.25 -37.65 78.07 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 116.762 -1.589 . . . . 2.73 110.897 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -52.53 65.24 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.236 1.835 . . . . 5.24 109.41 170.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 38.8 mtmt -63.35 -39.35 94.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.409 0.522 . . . . 3.17 112.409 -174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.6 ttm -57.41 -49.0 77.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.493 1.517 . . . . 3.41 111.518 167.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.25 -41.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.568 1.147 . . . . 2.03 113.105 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.486 ' HG3' ' HE2' ' A' ' 283' ' ' LYS . 35.6 mm-40 -70.88 -50.67 32.57 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.02 1.282 . . . . 3.93 109.159 173.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -17.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.879 1.437 . . . . 2.27 114.879 -169.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.81 -45.72 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 119.441 1.019 . . . . 2.3 110.931 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.21 -25.67 18.55 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.259 0.466 . . . . 6.05 112.259 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -65.07 -29.36 70.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.781 1.232 . . . . 2.83 113.055 166.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -45.22 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 118.508 -0.758 . . . . 2.19 112.767 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -30.92 71.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.145 1.339 . . . . 4.84 110.924 174.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.3 t -60.78 -24.47 65.81 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.298 1.839 . . . . 3.01 113.184 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.44 -26.58 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.113 -1.617 . . . . 5.05 110.403 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.7 m 76.85 -36.72 0.26 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.31 2.244 . . . . 4.22 112.966 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.4 m -73.48 -22.96 60.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.396 1.478 . . . . 5.34 113.1 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.3 156.46 81.45 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 121.18 -0.95 . . . . 3.7 110.808 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.66 -62.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.713 2.275 . . . . 3.28 109.338 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -171.21 157.08 4.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.613 3.565 . . . . 4.64 107.909 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.94 125.68 48.68 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.975 -0.75 . . . . 2.49 108.975 156.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.8 m -112.55 111.51 51.96 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.105 1.362 . . . . 1.41 110.062 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.71 134.08 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.734 2.956 . . . . 1.15 111.717 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.65 116.32 25.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.425 1.09 . . . . 2.21 109.778 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.24 112.93 24.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 2.67 109.679 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.7 mm -99.7 123.58 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.494 -1.298 . . . . 1.99 107.494 166.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 9.8 t -90.64 153.79 20.05 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.565 -0.709 . . . . 2.44 109.861 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.9 pt -115.95 -2.23 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.015 1.117 . . . . 2.02 114.015 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -119.54 74.71 17.33 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 120.144 1.338 . . . . 3.48 110.287 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.5 160.38 50.01 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.507 2.805 . . . . 3.31 110.722 -169.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 77.53 -51.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.237 2.615 . . . . 7.49 109.392 -172.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 207' ' ' ARG . 1.5 mpt_? -63.62 -52.3 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.507 1.123 . . . . 6.15 109.43 172.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.4 83.21 5.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.369 1.08 . . . . 5.19 109.178 159.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -64.94 132.61 49.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.289 -0.869 . . . . 3.2 109.136 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -43.93 -50.22 8.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.623 1.169 . . . . 3.24 112.895 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -27.02 61.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.353 1.242 . . . . 3.62 114.353 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.18 87.96 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.052 -1.03 . . . . 2.07 110.651 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.78 -36.0 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.929 0.892 . . . . 2.22 110.35 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -57.48 -17.83 15.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.572 1.149 . . . . 1.21 113.757 166.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -88.89 -47.9 7.84 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.991 -1.068 . . . . 4.49 112.792 167.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -58.19 -38.47 76.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.116 0.966 . . . . 3.7 112.576 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.4 t -54.28 -60.44 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.963 1.705 . . . . 1.29 110.68 165.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -66.16 -40.8 90.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.517 1.527 . . . . 4.18 114.698 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.92 -28.9 58.19 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.03 1.122 . . . . 3.45 114.03 -172.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -77.96 -53.01 7.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.461 0.573 . . . . 4.11 112.024 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.1 t -169.42 136.84 1.49 Allowed Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.422 1.089 . . . . 2.34 110.916 168.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.91 -4.64 11.71 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.247 2.631 . . . . 1.57 113.996 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -71.29 -14.25 62.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.964 1.256 . . . . 2.45 113.521 170.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.81 140.75 55.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.361 1.064 . . . . 3.09 112.58 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.3 t -118.36 130.88 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.998 1.319 . . . . 1.92 108.578 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -124.54 121.56 4.42 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.683 0.659 . . . . 1.12 114.051 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.77 159.46 15.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.921 1.288 . . . . 3.05 113.215 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -152.86 150.47 29.35 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.517 1.927 . . . . 2.44 108.899 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -172.09 165.24 37.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.952 -2.059 . . . . 1.8 107.952 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -70.55 172.63 8.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.877 0.839 . . . . 2.92 111.959 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.462 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 30.4 ptt180 -43.01 -38.81 2.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.412 1.485 . . . . 7.89 113.691 173.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -64.68 -37.94 89.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.095 1.358 . . . . 3.09 111.669 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.77 -44.65 22.81 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.653 1.181 . . . . 2.86 113.281 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.8 m -65.97 -27.11 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.074 0.397 . . . . 2.9 111.739 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.77 -45.68 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.269 -0.872 . . . . 3.1 112.054 165.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -50.0 -58.39 5.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.862 1.21 . . . . 3.28 110.981 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.72 -25.69 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.181 0.9 . . . . 2.25 112.023 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.77 -40.35 72.69 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.983 -0.448 . . . . 1.46 110.292 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -71.2 -38.32 72.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.23 1.012 . . . . 4.89 112.237 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -44.48 85.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.354 1.462 . . . . 2.13 113.82 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -100.89 5.82 43.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.462 1.105 . . . . 2.15 113.523 170.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 64.2 37.89 8.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.787 2.035 . . . . 5.25 113.732 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.32 151.18 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.694 0.798 . . . . 2.51 111.749 -173.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 140.36 36.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.811 0.845 . . . . 4.22 112.318 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.45 165.67 26.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.5 2.32 . . . . 4.61 109.875 168.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.69 106.29 1.06 Allowed Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 121.249 -0.907 . . . . 2.79 110.781 175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -94.98 134.29 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.411 2.741 . . . . 2.49 112.632 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.415 0 C-N-CA 125.309 1.433 . . . . 2.33 111.144 174.213 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 108.747 -0.835 . . . . 4.82 108.747 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp -49.86 152.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 126.621 1.968 . . . . 3.33 113.849 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.48 130.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.221 1.408 . . . . 3.32 108.145 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.69 141.15 31.68 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.654 1.582 . . . . 3.74 110.709 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -126.82 155.67 42.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.707 0.765 . . . . 2.38 111.549 165.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.7 m -62.78 113.44 3.04 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 3.66 109.6 168.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.31 44.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.316 1.046 . . . . 4.21 112.849 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.7 mt -132.95 135.5 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.123 0.969 . . . . 2.51 110.653 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.3 ptp -104.01 142.96 33.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.112 1.365 . . . . 2.59 110.911 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -99.88 141.71 32.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.346 1.058 . . . . 2.39 112.019 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -101.8 119.34 38.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.884 1.274 . . . . 2.57 109.243 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 63.4 mt -100.16 138.16 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.915 1.686 . . . . 2.22 107.887 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 171.45 42.05 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.54 1.067 . . . . 1.61 111.515 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -82.7 66.1 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.249 2.633 . . . . 2.6 109.367 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -177.52 -69.17 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.553 2.341 . . . . 4.94 108.988 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 160.55 -21.61 0.24 Allowed Glycine 0 CA--C 1.538 1.527 0 N-CA-C 117.02 1.568 . . . . 2.48 117.02 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.76 152.89 44.73 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.965 1.382 . . . . 6.66 112.429 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -99.45 129.51 45.64 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.38 -1.45 . . . . 4.36 112.271 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.95 -18.07 10.23 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.74 1.385 . . . . 3.04 114.74 -167.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -162.98 171.46 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.633 1.173 . . . . 2.67 110.987 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -148.51 149.02 30.9 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.144 1.377 . . . . 2.9 111.527 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . 0.435 ' CZ ' HG23 ' A' ' 286' ' ' ILE . 1.4 m-85 -130.0 105.0 7.68 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.105 1.362 . . . . 2.48 109.737 -173.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -86.01 153.27 26.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.225 -1.95 . . . . 2.33 108.225 153.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -17.05 2.99 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 117.279 2.326 . . . . 4.65 117.279 -164.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -63.2 -27.47 69.38 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.943 1.09 . . . . 5.04 113.943 169.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -92.87 96.0 9.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.025 1.73 . . . . 4.52 109.744 165.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.15 176.87 8.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.737 1.615 . . . . 4.99 112.753 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.486 ' HE2' ' HG3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -57.28 -27.3 62.0 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.022 1.86 . . . . 2.27 116.022 -169.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.7 -36.2 53.83 Favored Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.527 -0.733 . . . . 1.36 112.07 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.77 -31.8 46.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.082 1.753 . . . . 3.57 111.216 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . 0.435 HG23 ' CZ ' ' A' ' 277' ' ' PHE . 79.0 mt -64.85 -45.44 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 1.34 110.077 166.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.55 87.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.175 0.898 . . . . 1.44 111.095 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.91 97.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.087 0.858 . . . . 1.87 113.092 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 94.2 p -74.55 -38.42 62.73 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.99 -1.069 . . . . 1.56 113.414 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.01 -35.64 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.662 1.573 . . . . 1.38 111.707 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.01 -18.77 63.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.531 -1.356 . . . . 1.69 113.479 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.1 m -74.83 -55.1 6.17 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.407 -0.808 . . . . 1.89 109.737 167.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -64.55 -22.58 67.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.876 1.67 . . . . 2.71 113.555 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -42.09 46.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.814 1.646 . . . . 5.26 112.157 165.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -64.21 -55.36 31.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 116.419 -1.753 . . . . 5.27 113.249 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.47 -38.34 1.97 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.284 1.989 . . . . 3.05 112.686 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 17.66 7.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.752 1.019 . . . . 3.22 113.752 -173.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 7.12 113.198 -164.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.425 0 CA-C-O 118.593 -1.115 . . . . 2.85 114.388 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.75 149.71 54.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.99 3.127 . . . . 3.0 112.134 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.508 ' HB2' HG22 ' A' ' 237' ' ' VAL . 37.9 p90 -154.88 172.69 17.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.24 1.016 . . . . 2.96 112.128 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.8 m -143.42 119.9 11.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.91 -1.515 . . . . 3.29 106.91 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.432 ' HB2' HG21 ' A' ' 237' ' ' VAL . 12.6 tp -157.35 140.21 15.1 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.561 0.619 . . . . 2.56 111.432 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.1 m -74.43 146.67 42.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.626 0.727 . . . . 1.79 109.44 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.7 m -99.35 139.81 34.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.509 1.124 . . . . 2.91 110.77 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.46 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -51.67 -36.54 46.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.896 2.078 . . . . 2.24 113.117 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -108.09 -1.11 20.7 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.046 1.738 . . . . 3.24 111.968 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.15 -125.56 1.62 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 119.151 0.887 . . . . 2.81 111.789 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.0 -160.94 1.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.146 1.378 . . . . 4.2 110.715 -157.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.28 97.11 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.34 1.056 . . . . 6.13 111.653 -168.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.26 149.61 33.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.697 1.599 . . . . 3.45 110.911 172.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 58.5 p -140.12 141.42 36.11 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.439 2.296 . . . . 2.37 107.498 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -28.04 -69.36 0.05 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.978 1.711 . . . . 3.75 115.369 -171.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -65.86 0.04 2.01 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 116.913 2.19 . . . . 7.48 116.913 -174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.39 -54.91 29.38 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 119.848 1.204 . . . . 3.14 110.161 162.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -91.21 -28.0 18.11 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.703 1.001 . . . . 3.31 113.703 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 59.37 4.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.596 1.159 . . . . 6.27 112.609 -168.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -108.94 0.07 31.79 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.086 1.803 . . . . 2.42 113.138 162.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -153.46 175.12 13.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.859 2.064 . . . . 3.92 108.993 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -66.42 118.33 9.91 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.12 0.968 . . . . 1.73 112.748 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 mp -107.85 147.34 31.05 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.598 0.759 . . . . 3.2 112.206 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.0 mp -111.94 118.02 34.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.308 1.843 . . . . 2.7 107.527 166.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.2 mt -118.79 124.47 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.672 0.789 . . . . 1.93 110.102 -173.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -127.88 139.98 52.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.874 1.27 . . . . 2.22 113.23 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.7 120.32 42.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.903 1.281 . . . . 2.39 110.636 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -145.6 -175.51 18.75 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 116.108 1.203 . . . . 1.4 116.108 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.43 ' CD2' HG22 ' A' ' 258' ' ' VAL . 21.6 t80 -139.65 133.77 31.09 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 123.63 1.681 . . . . 3.55 113.718 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 23.41 0.07 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.743 2.017 . . . . 3.0 114.036 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -165.66 32.83 0.05 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.125 2.17 . . . . 6.75 110.403 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 82.2 m -54.27 159.1 3.31 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.15 -1.594 . . . . 2.17 111.941 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.21 68.93 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.164 2.576 . . . . 3.1 108.455 159.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 68.07 -17.49 0.17 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.996 3.318 . . . . 5.45 115.626 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.0 t -43.87 -65.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.646 1.978 . . . . 3.23 113.146 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 28.1 m -58.41 -50.37 88.4 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 116.579 -1.676 . . . . 1.61 114.285 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.72 -34.23 51.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.955 2.091 . . . . 2.11 114.159 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.82 -36.59 64.98 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.394 0.997 . . . . 3.75 111.885 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.87 -35.28 72.31 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.44 -1.412 . . . . 3.72 112.563 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.67 -27.33 67.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 117.23 -1.367 . . . . 3.13 112.51 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -62.78 1.3 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.997 1.271 . . . . 3.35 109.053 167.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -58.23 -21.09 46.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.694 -1.254 . . . . 4.26 113.215 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.0 mmm -79.79 -41.46 26.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.047 1.499 . . . . 5.45 115.047 165.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.94 -31.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 122.477 2.399 . . . . 1.95 110.5 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -37.31 -41.6 0.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.484 1.914 . . . . 3.28 112.854 162.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.2 -22.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 1.95 111.775 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.61 -39.27 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.932 0.787 . . . . 1.83 109.55 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.25 -44.15 95.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.27 1.028 . . . . 4.08 111.011 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -71.42 -7.82 49.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.83 1.652 . . . . 3.3 114.867 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.2 mt -119.85 -48.35 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 118.088 -0.958 . . . . 1.9 113.427 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.64 -27.35 67.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.925 1.239 . . . . 3.77 111.711 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.9 t -70.65 -11.3 60.86 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.845 -1.159 . . . . 3.03 113.743 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 34.3 mm -90.61 86.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 120.441 -1.412 . . . . 3.55 108.71 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 81.0 p -63.98 60.54 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.387 2.675 . . . . 4.6 115.41 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 10.5 t -173.18 -24.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 129.907 3.283 . . . . 4.41 110.871 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.17 156.02 8.13 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.774 -1.204 . . . . 3.01 109.934 151.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.44 -66.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.378 -1.816 . . . . 3.36 107.378 162.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.15 173.2 2.64 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.269 3.027 . . . . 3.62 109.791 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 tp -119.2 110.17 16.72 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.858 0.863 . . . . 1.96 111.1 161.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.8 m -92.78 120.05 67.48 Favored Pre-proline 0 N--CA 1.482 1.128 0 O-C-N 120.939 -1.1 . . . . 1.29 111.467 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -93.63 131.12 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.538 2.825 . . . . 0.97 112.571 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.97 119.49 30.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.854 2.062 . . . . 2.52 110.472 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -99.8 136.16 40.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.01 1.724 . . . . 2.75 110.8 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.06 126.26 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.576 1.55 . . . . 1.47 109.204 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 92.0 p -84.01 141.79 30.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.214 0.531 . . . . 2.38 110.23 165.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.9 pt -108.53 19.96 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.029 -1.044 . . . . 1.9 112.841 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -118.05 77.06 12.08 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.816 2.046 . . . . 3.33 110.897 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.38 83.06 2.33 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.285 3.323 . . . . 3.28 109.713 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.45 -124.18 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.601 1.961 . . . . 4.72 106.283 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.99 11.25 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 117.965 2.58 . . . . 6.94 117.965 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -89.74 150.89 22.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.782 -1.824 . . . . 3.4 111.049 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.1 p -142.71 144.9 32.88 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.486 1.136 . . . . 2.84 112.252 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -42.97 -55.47 3.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.088 2.155 . . . . 3.87 111.952 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -70.57 -34.0 71.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.159 0.983 . . . . 4.21 113.221 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.99 68.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.311 1.414 . . . . 1.78 111.224 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.3 mm -58.62 -39.19 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 119.407 -0.33 . . . . 1.52 111.612 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.9 -29.46 60.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.978 1.311 . . . . 1.75 113.805 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -90.26 -38.69 13.25 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.778 0.831 . . . . 4.85 112.983 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.17 -38.74 80.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.271 1.428 . . . . 2.88 111.787 174.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.9 t -54.55 -34.19 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.477 1.511 . . . . 1.1 113.541 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.32 -35.68 78.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.151 -0.928 . . . . 5.43 111.939 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.2 -36.43 81.72 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 124.396 1.06 . . . . 4.01 111.223 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.9 -44.03 61.74 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.934 0.788 . . . . 3.6 113.033 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.5 m 150.42 143.1 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 130.056 3.342 . . . . 2.3 111.042 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.26 -0.97 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.495 2.797 . . . . 1.65 115.908 -167.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.86 -14.7 60.7 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 120.631 1.56 . . . . 2.94 112.546 168.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.98 127.67 33.49 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.628 -1.295 . . . . 2.59 111.917 -170.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.9 124.35 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.448 -1.686 . . . . 2.3 106.448 171.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.46 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -103.8 127.01 8.98 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 108.672 -1.771 . . . . 1.11 108.672 170.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.28 150.53 32.32 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.968 0.507 . . . . 2.84 110.253 167.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.3 t -167.07 176.08 7.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.397 2.279 . . . . 3.12 108.971 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.63 34.22 Favored Glycine 0 N--CA 1.468 0.83 0 O-C-N 120.771 -1.206 . . . . 1.76 115.2 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -73.81 161.88 29.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.332 1.053 . . . . 2.29 111.164 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -43.88 67.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.745 0.818 . . . . 7.02 111.246 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.58 1.552 . . . . 3.87 112.969 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.12 -46.68 49.84 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.54 -0.725 . . . . 3.22 111.675 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.19 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 119.155 -0.45 . . . . 1.68 111.372 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.61 -39.61 80.79 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.321 0.964 . . . . 3.9 112.127 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -62.72 -49.13 76.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.016 1.28 . . . . 3.33 110.909 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 140' ' ' PHE . 54.4 t -64.77 -48.22 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.794 0.838 . . . . 2.87 111.909 -171.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.52 -50.53 51.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.868 0.867 . . . . 1.41 110.396 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -72.62 -27.34 62.09 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 117.461 -1.257 . . . . 3.64 113.556 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.51 65.32 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.864 1.211 . . . . 1.74 111.037 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -84.3 12.1 7.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.454 1.102 . . . . 2.26 113.569 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 65.71 -41.72 0.34 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.781 2.832 . . . . 6.36 115.021 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.3 t 18.85 103.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 131.622 3.969 . . . . 2.6 115.907 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -71.47 142.47 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.917 0.887 . . . . 3.47 113.201 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -169.73 155.29 5.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.737 2.015 . . . . 3.99 110.273 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -148.45 106.58 3.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.424 0.69 . . . . 2.8 109.795 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.61 138.45 15.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.337 2.025 . . . . 2.71 110.243 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.268 0 CA-C-O 119.646 -0.53 . . . . 2.44 112.418 -176.157 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 18.6 t80 . . . . . 0 CA--C 1.544 0.718 0 CA-C-O 121.167 0.508 . . . . 3.58 111.324 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 tp -71.31 156.81 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.974 0.909 . . . . 2.73 111.208 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 166' ' ' PHE . 4.3 m -151.16 166.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.481 1.912 . . . . 3.37 109.894 172.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.97 158.99 26.52 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.859 2.864 . . . . 3.76 111.01 169.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 161.2 9.34 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.066 1.746 . . . . 2.21 113.943 -166.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 29.0 p -60.89 -42.31 97.75 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.194 1.553 . . . . 4.34 115.194 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.29 0.3 OUTLIER 54.55 41.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.261 1.424 . . . . 3.92 112.815 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.53 140.77 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 120.459 -1.401 . . . . 2.48 110.67 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 58.7 tpp -99.88 115.89 30.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.348 1.859 . . . . 2.86 109.172 165.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -95.03 148.59 22.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.102 -1.624 . . . . 3.17 112.373 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -99.42 126.06 45.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.553 1.141 . . . . 2.29 109.619 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.2 mm -107.94 126.96 64.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 108.221 -1.029 . . . . 2.36 108.221 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.72 160.53 53.02 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 117.969 -1.462 . . . . 2.06 110.163 162.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.78 -11.8 19.22 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.134 3.223 . . . . 3.64 113.911 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.5 -41.82 88.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.727 2.811 . . . . 4.13 110.573 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.95 31.43 2.69 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.065 1.317 . . . . 3.04 115.723 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -142.84 164.04 31.18 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.684 1.242 . . . . 4.75 112.177 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -67.44 125.75 27.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 5.26 112.505 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.4 tt -118.52 -24.23 6.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.383 1.473 . . . . 3.34 112.405 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -165.53 171.92 12.65 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.49 2.316 . . . . 2.8 109.234 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -159.24 158.76 33.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.497 1.119 . . . . 4.04 113.673 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.85 -179.85 7.31 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.594 1.958 . . . . 2.54 112.055 -165.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.3 -145.34 16.91 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.05 1.786 . . . . 3.72 109.91 -171.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -54.5 3.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 118.942 2.942 . . . . 3.84 118.942 -161.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -135.96 -45.35 0.65 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.288 -1.508 . . . . 4.49 112.132 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -79.19 86.31 4.99 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.935 -1.103 . . . . 4.53 110.458 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.07 155.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.003 2.521 . . . . 5.78 114.901 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -41.7 -70.22 0.11 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.016 2.127 . . . . 2.86 116.143 -172.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.31 -24.95 75.54 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 122.564 1.091 . . . . 1.86 111.284 -170.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -70.14 -23.91 63.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.377 1.871 . . . . 5.29 111.317 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.24 -51.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.258 -0.901 . . . . 1.74 110.752 162.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.1 71.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.38 0.991 . . . . 1.45 111.939 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.77 73.79 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.25 1.204 . . . . 1.86 114.25 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.6 p -75.04 -37.63 61.66 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.842 -1.161 . . . . 1.86 112.644 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mm -56.61 -47.65 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 119.943 1.247 . . . . 1.98 110.842 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.17 -18.16 60.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.063 1.134 . . . . 1.68 114.063 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.5 m -84.05 -40.94 17.74 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.447 1.099 . . . . 2.2 110.984 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -69.94 -29.29 66.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.181 0.993 . . . . 2.65 113.516 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.66 19.25 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.536 -1.353 . . . . 6.25 114.197 164.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -74.43 -58.98 1.71 Allowed Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.471 -1.728 . . . . 5.93 111.303 152.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.85 -48.8 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.842 2.362 . . . . 2.62 112.518 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -68.75 121.89 17.44 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.033 0.833 . . . . 3.45 110.677 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 123.451 0.7 . . . . 8.33 112.13 -178.904 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.2 0 CA-C-O 118.327 -1.263 . . . . 3.81 113.169 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.54 142.43 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.315 2.01 . . . . 3.11 112.772 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -108.34 175.19 5.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.361 -1.29 . . . . 2.9 111.567 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -141.35 22.07 2.21 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.709 1.744 . . . . 3.44 115.709 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.32 165.4 23.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.748 1.219 . . . . 2.82 110.825 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.1 m -117.3 151.65 36.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.861 2.064 . . . . 2.43 109.171 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.3 p -86.28 158.99 19.56 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.642 1.211 . . . . 1.93 113.206 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -59.77 -21.59 60.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.91 1.684 . . . . 1.39 113.225 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.8 m -72.08 -39.49 68.95 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.65 1.18 . . . . 3.04 110.166 172.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 120.07 -8.36 11.51 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.53 1.538 . . . . 1.94 114.47 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -83.11 147.64 27.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.149 0.974 . . . . 4.14 109.879 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -87.72 125.41 34.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.229 -0.656 . . . . 4.25 109.229 163.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.27 134.94 36.7 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.974 1.31 . . . . 3.77 109.62 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.9 p -109.83 166.29 11.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.682 1.593 . . . . 3.42 112.352 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.96 2.65 0.49 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.829 2.452 . . . . 3.34 114.817 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -7.51 12.58 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.244 1.202 . . . . 7.26 114.244 165.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.59 -44.55 64.26 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.713 1.142 . . . . 3.02 110.063 161.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -78.02 10.59 2.77 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.834 1.42 . . . . 3.99 114.834 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.82 108.39 1.17 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 5.24 110.101 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.09 -8.69 6.33 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.507 1.051 . . . . 3.8 114.629 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -129.07 158.97 37.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.944 1.372 . . . . 4.71 110.48 165.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.464 ' CE3' ' HD3' ' A' ' 269' ' ' PRO . 94.7 m95 -67.8 118.97 11.76 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.451 0.7 . . . . 3.19 112.555 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.78 109.14 21.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.782 1.633 . . . . 3.07 109.582 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.61 98.25 7.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.118 -0.697 . . . . 3.21 109.118 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -95.35 126.97 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.903 1.281 . . . . 1.98 108.998 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -140.55 150.1 43.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.787 1.235 . . . . 2.44 113.658 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -123.09 112.74 18.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.941 1.296 . . . . 2.37 111.053 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.18 142.62 13.68 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.151 1.358 . . . . 1.41 112.023 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -92.11 129.1 38.14 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.131 0.965 . . . . 4.14 112.27 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.1 m -75.72 66.77 2.08 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.643 1.577 . . . . 3.86 111.285 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -174.91 -28.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.801 2.841 . . . . 7.22 112.441 -171.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 m -67.03 160.54 69.71 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 117.452 2.39 . . . . 2.38 117.452 -163.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.96 -168.09 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.882 3.722 . . . . 3.01 110.724 159.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.72 -7.04 3.02 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.521 2.415 . . . . 4.15 117.521 -151.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 74.0 t -65.0 -60.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.895 1.278 . . . . 2.69 108.761 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 23.8 m -49.53 -60.41 4.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.733 -1.127 . . . . 1.74 113.028 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.39 -30.57 19.15 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-O 116.105 -1.706 . . . . 1.24 113.715 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.15 -45.97 65.69 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.996 2.18 . . . . 3.21 110.492 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -61.44 -33.22 73.35 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.25 0.932 . . . . 3.05 112.068 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -48.6 64.67 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.659 -0.651 . . . . 2.32 111.939 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -41.29 94.13 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.828 -1.17 . . . . 3.75 111.07 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -46.96 -52.14 15.36 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 119.943 -1.723 . . . . 2.84 112.209 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.4 ptp -70.77 -8.34 51.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.492 1.664 . . . . 2.5 115.492 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mm -75.78 -60.04 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.414 1.461 . . . . 1.92 108.686 161.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.72 -38.74 56.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.256 0.836 . . . . 3.02 113.256 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.1 t -60.02 -19.02 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 117.823 -1.084 . . . . 2.15 112.756 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.68 -53.93 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.699 1.59 . . . . 2.54 110.558 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.62 -27.58 67.02 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.643 1.177 . . . . 4.03 111.883 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -71.48 -19.63 62.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.928 1.291 . . . . 3.76 113.427 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.64 -56.99 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.279 1.431 . . . . 2.28 113.845 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.86 -30.7 71.35 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.783 0.801 . . . . 5.5 109.261 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.9 m -60.31 -12.26 8.65 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.88 2.472 . . . . 4.05 115.163 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.5 mm -79.01 -39.45 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.871 -1.143 . . . . 4.99 112.139 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.3 m -176.82 2.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.632 1.573 . . . . 7.88 114.349 -158.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.2 m 77.2 41.59 0.15 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.059 2.544 . . . . 5.37 111.065 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.2 150.46 0.27 Allowed Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 128.987 2.915 . . . . 3.34 113.949 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.32 -43.25 58.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.485 2.79 . . . . 3.26 113.569 -170.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.3 t70 161.34 154.45 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 131.532 3.933 . . . . 3.58 107.648 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.58 111.71 17.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.495 0.718 . . . . 3.12 109.913 168.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.8 m -105.45 112.25 64.81 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.535 1.134 . . . . 1.97 108.596 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.33 137.67 23.7 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.112 1.875 . . . . 1.25 109.002 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.277 1.5 pt? -136.18 118.44 15.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.644 1.212 . . . . 3.22 110.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.05 125.91 54.9 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.657 1.583 . . . . 2.0 110.201 -157.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.55 120.44 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.405 -0.961 . . . . 1.59 108.405 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.2 t -72.38 -15.24 61.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.795 1.405 . . . . 3.25 114.795 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . 0.287 43.8 pt 51.7 9.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 128.539 2.735 . . . . 2.12 117.912 170.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -111.16 56.54 0.38 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.221 1.408 . . . . 3.5 114.502 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.04 69.99 7.26 Favored 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.406 4.071 . . . . 3.74 112.685 -167.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -171.2 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.5 2.32 . . . . 4.04 109.673 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -17.69 10.1 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.23 1.412 . . . . 8.18 112.82 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.4 153.31 2.2 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.696 1.598 . . . . 4.62 112.912 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.4 m -144.59 125.33 14.2 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.299 -0.876 . . . . 2.47 109.854 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -48.33 -47.72 36.75 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.467 1.907 . . . . 3.06 112.793 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -68.77 -33.21 73.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.231 1.197 . . . . 3.81 114.231 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.91 84.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.483 1.492 . . . . 1.65 110.941 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.66 -34.46 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.276 0.63 . . . . 1.56 111.857 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.35 -19.31 64.52 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.066 -1.021 . . . . 1.75 113.697 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -84.98 -42.64 14.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.957 1.253 . . . . 3.17 112.992 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -57.04 -35.26 69.09 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.153 1.381 . . . . 2.57 112.133 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.53 -37.03 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.238 1.415 . . . . 1.33 113.078 169.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -70.96 -51.27 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.799 -1.188 . . . . 5.25 112.204 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.49 -18.42 62.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.619 1.567 . . . . 4.08 113.769 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -80.55 -79.4 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.734 0.697 . . . . 3.0 109.676 154.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 178.23 139.69 0.25 Allowed Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.307 1.843 . . . . 1.97 110.304 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.45 5.9 1.77 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.15 3.233 . . . . 2.16 114.942 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -18.27 63.5 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.841 -1.162 . . . . 3.48 112.763 161.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.6 tp -78.78 138.13 38.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.18 1.792 . . . . 2.11 111.224 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 26.2 t -101.88 130.35 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.042 0.937 . . . . 1.8 108.881 158.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.58 132.91 11.11 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.798 -0.921 . . . . 0.83 110.798 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.5 144.97 50.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.131 0.972 . . . . 2.29 112.926 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.6 t -149.1 176.44 10.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.204 2.202 . . . . 2.68 111.194 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 165.37 -168.15 39.25 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 127.141 2.305 . . . . 2.04 109.374 -170.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.3 174.59 10.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.053 1.426 . . . . 3.48 111.373 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -47.86 -38.37 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.59 0.756 . . . . 8.46 112.168 170.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -36.11 47.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.809 0.732 . . . . 5.7 112.572 -169.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -70.37 -33.57 71.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.242 -1.537 . . . . 3.79 111.847 170.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.96 -31.68 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.726 0.81 . . . . 2.03 110.816 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.72 -32.3 41.19 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.941 0.791 . . . . 3.18 112.664 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.42 -53.17 60.83 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.113 -0.992 . . . . 3.16 109.736 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.2 p -62.2 -27.71 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 119.426 -0.321 . . . . 2.64 111.812 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.61 -46.18 66.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.248 0.931 . . . . 2.13 111.518 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -58.83 -53.83 53.99 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.576 1.55 . . . . 3.73 111.066 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.39 65.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.973 1.309 . . . . 2.73 114.362 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -117.4 3.82 12.51 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.575 1.324 . . . . 2.69 114.575 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 57.6 31.19 19.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.085 1.354 . . . . 5.23 113.421 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.38 161.99 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.58 1.152 . . . . 3.23 110.325 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -146.22 154.9 42.26 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.592 0.96 . . . . 5.84 113.592 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.62 110.81 6.96 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.991 1.716 . . . . 6.88 110.669 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -104.73 124.16 37.79 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 120.66 -1.275 . . . . 3.12 113.158 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.39 130.27 14.86 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.302 2.001 . . . . 3.25 113.274 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 C-N-CA 124.191 0.9 . . . . 2.47 110.912 173.659 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 3.1 t80 . . . . . 0 CA--C 1.549 0.917 0 CA-C-O 121.565 0.698 . . . . 4.71 111.938 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 tt -124.07 168.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.842 1.657 . . . . 4.21 111.223 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.24 135.75 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 4.07 105.214 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 169.33 1.67 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.205 1.002 . . . . 4.29 112.113 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -153.87 126.8 8.3 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.524 -0.735 . . . . 2.12 111.518 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.3 p -59.37 118.74 6.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.676 0.79 . . . . 3.57 110.265 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 11.1 tp -78.41 59.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.177 1.391 . . . . 4.15 113.657 -168.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.0 mm -109.2 138.01 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.78 1.232 . . . . 2.45 111.806 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.3 ttt -121.33 134.75 55.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.02 1.728 . . . . 2.38 108.992 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.48 141.77 44.61 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.762 0.825 . . . . 2.77 111.927 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.92 116.87 31.01 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.164 0.986 . . . . 1.91 109.983 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.0 136.93 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.683 1.193 . . . . 1.88 107.835 166.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.52 168.9 48.53 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 123.792 0.711 . . . . 2.25 114.59 -168.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.464 ' HD3' ' CE3' ' A' ' 159' ' ' TRP . 42.0 Cg_endo -77.3 56.09 5.35 Favored 'Trans proline' 0 CA--C 1.539 0.749 1 C-N-CA 125.964 4.443 . . . . 4.02 109.38 173.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -162.1 -55.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.753 -0.658 . . . . 4.81 111.252 -143.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 154.19 -54.33 0.44 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.093 -1.393 . . . . 3.56 112.611 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -130.06 -174.23 3.26 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.806 1.303 . . . . 5.87 114.326 -162.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -80.37 142.97 33.9 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.995 -1.066 . . . . 4.9 113.525 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.67 -25.91 0.89 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.453 1.279 . . . . 2.91 114.453 -157.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -162.78 165.91 24.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.672 2.389 . . . . 2.54 109.247 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -155.81 150.54 26.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.53 1.308 . . . . 3.59 114.53 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -126.89 119.49 26.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.307 1.443 . . . . 2.46 109.339 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -111.12 72.77 0.21 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 108.993 -1.643 . . . . 4.03 108.993 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 41.37 -134.68 0.28 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.215 1.406 . . . . 3.66 111.308 -155.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.2 t30 70.6 -65.8 0.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.593 2.357 . . . . 4.65 114.615 167.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -66.01 120.36 13.01 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.546 1.138 . . . . 5.28 110.376 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -77.97 138.46 38.86 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.611 -1.305 . . . . 9.33 110.238 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.7 -47.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.486 3.143 . . . . 2.92 119.486 -158.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -15.81 57.82 Favored Glycine 0 N--CA 1.476 1.363 0 CA-C-N 119.748 1.158 . . . . 1.93 112.698 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.15 -24.09 65.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.482 0.919 . . . . 3.25 113.482 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.15 -41.61 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.59 1.086 . . . . 1.62 109.005 172.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.8 99.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.94 -0.553 . . . . 1.34 111.478 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.11 98.27 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.842 1.053 . . . . 1.55 113.842 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.1 p -70.03 -47.29 62.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.2 1.364 . . . . 1.43 111.763 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.02 -34.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 120.065 1.302 . . . . 1.49 112.448 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.9 76.02 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.93 -1.106 . . . . 1.73 112.999 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 38.9 m -70.22 -45.45 66.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.267 1.027 . . . . 1.98 109.394 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -65.59 -28.46 69.15 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 2.83 113.06 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -19.83 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.94 -1.1 . . . . 4.54 112.546 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -46.23 95.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.759 -1.591 . . . . 5.92 112.401 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.8 -45.56 0.1 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.168 2.578 . . . . 2.72 113.989 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.18 170.51 14.81 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.937 1.244 . . . . 3.52 114.093 -174.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 . . . . . 0 N--CA 1.477 0.893 0 O-C-N 120.497 -1.377 . . . . 7.67 112.265 -178.433 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.217 0 CA-C-O 118.983 -0.898 . . . . 2.55 113.855 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.52 144.85 62.43 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.168 2.579 . . . . 3.39 110.618 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -95.71 177.69 5.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.397 1.479 . . . . 2.91 112.524 -169.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.9 m -129.64 22.62 5.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.865 1.431 . . . . 2.28 114.865 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.41 157.9 15.8 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.32 1.048 . . . . 2.63 112.839 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' ARG . 58.3 m -101.03 148.21 25.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.892 1.677 . . . . 1.54 110.606 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.3 p -81.36 166.69 20.22 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.735 1.614 . . . . 2.33 113.49 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -61.3 -23.05 65.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.948 2.099 . . . . 2.04 113.152 169.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.7 m -73.93 -61.5 1.83 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.312 1.045 . . . . 3.2 108.183 167.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 141.53 -1.22 1.81 Allowed Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.914 1.245 . . . . 2.34 115.936 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.12 145.59 29.14 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.584 1.192 . . . . 4.16 109.781 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 0.9 OUTLIER -96.7 74.28 2.72 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.106 2.563 . . . . 5.52 112.533 -178.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -81.03 89.79 5.96 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.287 -0.883 . . . . 6.18 112.734 -166.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.6 p -68.57 127.59 33.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.345 1.058 . . . . 3.11 110.278 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -1.28 12.05 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 117.806 2.521 . . . . 6.19 117.806 -155.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -77.58 4.48 11.2 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 120.944 -1.098 . . . . 6.7 112.954 164.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -73.28 -71.89 0.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.633 2.773 . . . . 3.74 114.375 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -69.57 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.397 1.879 . . . . 4.46 114.441 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.0 -32.68 71.09 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.795 2.038 . . . . 3.39 114.442 -157.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.08 2.02 87.67 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.482 0.953 . . . . 2.35 115.482 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -96.55 -138.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.92 1.688 . . . . 3.3 109.189 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -140.89 140.82 34.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.851 1.26 . . . . 1.72 109.967 164.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.89 151.61 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.922 1.082 . . . . 2.86 113.922 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.22 119.22 34.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.863 1.665 . . . . 2.43 108.148 163.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.1 mt -109.88 110.22 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.61 -0.885 . . . . 1.69 108.61 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -113.35 153.98 27.63 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.272 1.829 . . . . 2.95 113.431 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -127.34 97.88 5.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.081 1.352 . . . . 2.51 112.859 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.54 -176.91 14.65 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 128.205 2.812 . . . . 1.83 112.35 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -113.32 141.11 47.41 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.818 1.647 . . . . 3.52 112.165 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -65.49 113.42 4.14 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.823 -1.173 . . . . 3.04 110.939 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 73.7 m80 63.75 35.0 11.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.075 1.75 . . . . 10.13 112.348 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 49.9 t -59.1 157.2 22.87 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.225 1.41 . . . . 2.99 111.594 163.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.66 177.34 1.33 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.621 2.881 . . . . 3.13 112.031 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.38 -3.27 0.9 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.12 2.637 . . . . 5.26 118.12 -148.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.45 -59.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.049 1.739 . . . . 3.01 110.353 171.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.8 m -53.76 -58.73 11.93 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 118.055 -0.974 . . . . 1.86 112.606 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.85 -29.9 41.14 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.575 1.517 . . . . 1.94 113.805 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -60.62 -53.1 61.49 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 121.09 1.768 . . . . 3.99 111.211 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.46 0.704 . . . . 3.39 112.023 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.22 -28.87 61.45 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.354 -1.467 . . . . 3.01 112.357 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -56.93 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.264 1.025 . . . . 4.09 108.612 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -45.34 72.47 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.438 -0.789 . . . . 5.77 111.676 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 47.1 ttp -57.93 -45.0 87.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.854 2.061 . . . . 3.58 112.408 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.78 -45.16 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.608 1.094 . . . . 1.74 110.652 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -69.11 -27.37 65.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.229 1.377 . . . . 5.02 110.654 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.41 -47.83 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 120.622 1.556 . . . . 1.74 110.591 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.8 -42.54 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.515 1.052 . . . . 3.73 113.269 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -76.29 -25.94 55.37 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.443 1.02 . . . . 5.8 113.337 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -63.98 -31.12 72.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.382 1.473 . . . . 2.98 113.474 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.46 -41.76 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.649 1.18 . . . . 2.09 112.167 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.0 -27.92 61.99 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.132 0.967 . . . . 4.47 112.218 167.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.8 m -70.57 -9.76 57.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.381 1.072 . . . . 3.96 113.06 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 14.8 mm -85.75 58.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.437 -1.414 . . . . 4.17 109.097 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.1 m -58.77 85.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.781 1.632 . . . . 5.49 112.293 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m 171.0 -32.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.962 3.705 . . . . 4.1 108.386 -167.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 294' ' ' MET . 46.2 mt -73.25 162.01 76.47 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.193 -0.432 . . . . 4.31 111.231 143.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -81.74 -154.15 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.77 3.646 . . . . 3.17 108.569 154.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.83 158.35 25.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.217 1.562 . . . . 3.9 115.217 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.09 94.1 4.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.077 1.351 . . . . 1.93 109.35 161.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.9 m -76.68 121.72 85.32 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 120.643 -1.286 . . . . 1.47 110.206 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.29 126.66 2.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.442 2.761 . . . . 0.9 111.544 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 tt -125.04 112.51 16.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.784 1.234 . . . . 2.54 110.505 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -100.66 124.24 45.99 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.526 1.131 . . . . 2.07 110.698 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.92 120.4 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.482 -0.933 . . . . 1.59 108.482 170.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.3 t -82.15 106.46 14.06 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.504 -0.924 . . . . 2.04 108.504 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.71 12.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.955 1.302 . . . . 2.43 113.032 -176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -113.69 27.77 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.295 2.638 . . . . 3.62 114.532 -171.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.41 -13.68 41.03 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.733 2.955 . . . . 2.41 116.218 -154.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.67 1.8 43.8 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.963 1.098 . . . . 4.56 113.963 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.289 2.2 ppt_? -137.28 0.82 2.36 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.137 1.532 . . . . 5.86 115.137 158.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.27 -173.05 0.05 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.117 1.767 . . . . 3.53 110.413 152.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -178.83 132.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.387 3.075 . . . . 2.71 105.533 -172.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmpt? -56.98 -30.78 64.42 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.278 0.844 . . . . 3.34 113.278 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -35.13 52.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.456 1.503 . . . . 3.33 114.025 169.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.05 78.1 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.352 -1.467 . . . . 1.96 111.897 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -70.37 -32.66 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.43 0.559 . . . . 2.46 112.085 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.78 -35.21 80.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.934 1.243 . . . . 1.73 112.368 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.09 -40.13 75.16 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.513 -0.742 . . . . 4.24 111.832 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.84 -42.08 97.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.992 0.917 . . . . 3.42 111.983 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.0 t -54.67 -50.76 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.771 0.714 . . . . 1.53 111.368 168.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.13 -23.4 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.962 1.305 . . . . 4.94 114.035 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -70.91 -22.62 62.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.461 1.504 . . . . 4.88 113.211 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -108.54 -52.72 2.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.225 1.01 . . . . 2.52 112.766 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 t 178.99 143.13 0.31 Allowed Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.82 1.648 . . . . 2.06 109.97 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.63 -9.62 23.36 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.683 2.255 . . . . 2.1 113.158 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.55 -18.1 62.92 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.226 0.921 . . . . 2.62 113.203 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.35 127.29 32.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.231 -0.918 . . . . 2.35 110.59 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.54 121.89 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.294 -1.002 . . . . 2.18 108.294 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.56 139.45 14.72 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.917 -0.873 . . . . 1.1 110.917 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mp -132.97 147.28 52.28 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.599 1.2 . . . . 2.09 112.298 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 13.5 t -150.37 -174.06 4.64 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.085 1.754 . . . . 3.48 109.926 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 149.01 -64.5 0.4 Allowed Glycine 0 N--CA 1.474 1.202 0 N-CA-C 115.626 1.01 . . . . 2.45 115.626 170.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.1 t -160.07 145.78 15.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.322 1.061 . . . . 3.52 112.702 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -48.72 -42.5 35.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.275 2.23 . . . . 5.93 112.511 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.89 -27.19 67.3 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.011 1.732 . . . . 4.26 114.456 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -35.79 25.82 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.495 . . . . 4.46 112.052 172.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.29 -41.49 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.024 0.53 . . . . 2.71 110.639 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.2 -40.36 95.83 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.184 -0.912 . . . . 3.29 111.307 170.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -58.17 -51.12 71.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.346 1.43 . . . . 2.88 111.684 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -25.4 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.251 0.932 . . . . 2.97 112.604 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.44 -53.03 18.06 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.161 -0.962 . . . . 2.12 111.724 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -64.0 -31.9 73.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.163 2.185 . . . . 3.87 111.762 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.29 62.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.73 1.612 . . . . 2.14 115.042 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.45 3.04 7.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.178 0.807 . . . . 2.59 113.178 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 74.06 34.63 0.84 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.359 2.264 . . . . 5.38 112.355 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 147.84 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.235 1.814 . . . . 3.14 110.886 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.54 140.21 48.94 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.047 1.339 . . . . 4.11 112.844 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.55 162.59 41.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.195 1.798 . . . . 7.34 110.71 161.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.5 m -127.69 88.44 53.45 Favored Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 123.733 0.813 . . . . 2.82 110.655 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 144.76 22.85 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.844 2.363 . . . . 4.51 110.068 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.492 0 CA-C-O 118.615 -1.103 . . . . 4.32 112.84 -177.409 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 22.3 p90 . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 121.413 0.625 . . . . 4.69 111.919 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.5 tp -72.36 136.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.056 -1.028 . . . . 3.13 109.825 167.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.52 144.73 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.573 1.549 . . . . 5.88 110.863 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.19 150.75 39.79 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.625 1.202 . . . . 3.62 113.03 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 162.6 8.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.615 1.566 . . . . 2.83 112.911 -153.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -38.39 57.93 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.071 -1.442 . . . . 3.82 114.447 -171.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.0 mt 66.03 29.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 123.258 1.504 . . . . 4.69 110.302 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.6 mm -126.06 149.47 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 127.191 2.196 . . . . 3.99 108.954 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.43 146.17 51.94 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.328 1.451 . . . . 2.6 114.122 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -97.94 137.39 36.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.16 1.784 . . . . 2.7 110.746 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.37 107.73 19.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.385 1.474 . . . . 2.5 108.465 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.73 125.21 47.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.165 0.986 . . . . 1.89 108.677 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.5 173.25 42.01 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.986 -0.896 . . . . 1.57 111.905 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.12 78.32 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.287 3.325 . . . . 2.65 110.803 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.13 -47.43 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 131.335 3.854 . . . . 5.38 109.871 -173.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.61 -9.92 21.71 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.467 -1.741 . . . . 3.51 116.236 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -82.87 153.27 25.21 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 119.888 1.844 . . . . 4.97 110.901 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -80.18 120.8 24.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.414 -0.804 . . . . 3.45 111.099 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.5 pp -104.29 -3.31 24.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.468 1.107 . . . . 2.99 113.758 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -157.18 164.29 37.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.899 2.08 . . . . 2.18 108.707 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.68 135.25 6.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.241 1.416 . . . . 3.64 111.755 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.03 -160.5 0.91 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.214 1.806 . . . . 2.75 109.355 -168.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.96 -132.47 3.57 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 109.826 -1.31 . . . . 3.29 109.826 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -53.05 152.1 4.37 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.827 0.822 . . . . 3.57 112.711 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 75.7 -18.48 0.45 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.317 1.847 . . . . 5.73 112.501 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 146.99 26.24 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.588 -1.32 . . . . 6.73 109.911 158.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -107.42 154.73 20.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.309 -0.869 . . . . 5.82 110.983 -167.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -47.55 -55.52 9.04 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 2.29 112.795 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.67 -19.08 76.28 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 115.238 0.855 . . . . 1.53 115.238 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -78.37 -41.82 32.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.171 1.389 . . . . 4.25 111.193 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.69 -42.77 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.475 -0.565 . . . . 1.39 109.475 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.91 81.65 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.686 -0.634 . . . . 1.34 112.145 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.06 -37.52 86.04 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.767 1.025 . . . . 1.47 113.767 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.8 p -67.33 -49.01 65.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.523 1.056 . . . . 1.3 111.074 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.98 -37.82 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.235 -0.915 . . . . 1.58 111.693 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.82 67.05 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.735 -1.228 . . . . 1.5 113.747 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.7 m -78.27 -50.02 12.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.471 1.108 . . . . 1.73 110.203 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -62.86 -31.31 72.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.811 1.244 . . . . 2.43 112.985 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . 0.408 ' HG3' HD21 ' A' ' 193' ' ' LEU . 62.1 ttp -56.36 -18.73 11.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.929 1.692 . . . . 4.25 113.25 168.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.22 -56.55 3.21 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.631 -1.652 . . . . 5.1 112.981 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.12 -39.82 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.866 2.377 . . . . 2.68 112.996 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -93.15 121.5 34.57 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 122.137 0.97 . . . . 3.25 111.116 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 127.567 2.347 . . . . 9.76 112.556 167.804 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 118.859 -0.967 . . . . 2.89 111.527 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.78 177.73 8.46 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.812 3.008 . . . . 2.9 109.924 165.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -156.26 166.39 33.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.164 0.983 . . . . 2.63 113.298 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.2 m -156.97 72.69 0.73 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.537 -1.352 . . . . 3.88 112.364 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.38 166.98 10.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.631 1.172 . . . . 3.81 111.88 -167.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.3 m -99.57 143.34 29.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.471 1.108 . . . . 1.73 109.154 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 146' ' ' THR . 0.8 OUTLIER -110.27 162.28 14.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.889 0.852 . . . . 3.03 111.652 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -41.0 -28.76 0.09 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.742 2.417 . . . . 1.53 116.264 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.494 ' H ' HG23 ' A' ' 144' ' ' THR . 11.4 m -77.08 -22.3 53.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.842 2.457 . . . . 3.1 114.088 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.25 70.64 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.954 1.264 . . . . 1.96 113.612 -167.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 161.05 30.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.111 1.764 . . . . 3.9 110.71 168.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -124.16 141.26 52.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.641 1.177 . . . . 4.81 112.222 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -133.88 145.94 50.1 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.325 -0.86 . . . . 3.01 111.993 -173.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.1 p -128.28 167.02 17.49 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.117 1.767 . . . . 3.03 110.089 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -61.36 -10.07 6.55 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.197 0.814 . . . . 4.76 113.197 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -37.09 28.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.5 0.926 . . . . 5.75 113.5 170.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.51 -32.68 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.768 1.227 . . . . 3.08 111.47 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -93.98 -0.11 55.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.362 1.615 . . . . 3.12 115.362 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.34 174.76 9.12 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 119.59 1.086 . . . . 3.62 112.039 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.21 3.34 60.94 Favored Glycine 0 N--CA 1.478 1.47 0 N-CA-C 116.259 1.264 . . . . 2.48 116.259 165.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -130.77 164.34 25.34 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.96 2.104 . . . . 3.01 109.144 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -70.19 132.97 46.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.726 1.148 . . . . 2.76 109.105 157.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.46 144.62 38.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.801 0.81 . . . . 3.21 112.496 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.7 mt -114.95 120.52 40.19 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.383 1.873 . . . . 2.42 106.169 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.9 pt -115.98 112.59 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.184 -1.043 . . . . 3.25 108.184 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -100.47 127.95 46.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.712 1.605 . . . . 3.15 112.263 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -100.87 82.6 2.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.313 1.445 . . . . 2.17 109.721 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -95.16 164.4 24.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 113.665 -1.607 . . . . 1.61 111.279 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.01 -170.45 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.022 -1.103 . . . . 3.95 108.022 157.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.3 m -146.3 95.04 2.55 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.324 1.849 . . . . 3.46 107.141 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -169.05 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.451 1.649 . . . . 7.29 115.451 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 170' ' ' PRO . 37.6 m -79.78 -179.88 1.58 Allowed Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.298 1.439 . . . . 2.93 111.446 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 169' ' ' CYS . 57.2 Cg_endo -76.9 -129.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.242 2.628 . . . . 4.5 108.585 157.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 50.57 0.13 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.377 2.671 . . . . 5.6 114.367 -173.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.9 -60.17 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.214 1.805 . . . . 4.03 109.873 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 63.8 m -46.96 -44.92 49.8 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-O 117.375 -1.297 . . . . 3.63 114.476 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.57 -9.11 6.94 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.432 2.755 . . . . 1.66 114.865 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.69 -67.2 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.375 1.443 . . . . 4.04 111.213 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.45 -21.18 65.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.359 0.981 . . . . 3.1 113.04 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -47.08 81.62 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.199 0.6 . . . . 2.61 110.468 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -40.31 95.32 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.688 -1.258 . . . . 3.5 111.481 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -55.24 24.1 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.074 -1.016 . . . . 2.92 110.947 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.37 -16.13 62.94 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.446 0.906 . . . . 2.99 113.446 -176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.9 mm -69.36 -56.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.835 1.198 . . . . 1.56 109.985 162.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.516 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 80.8 mt-30 -60.51 -22.58 63.73 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.284 1.402 . . . . 3.17 113.185 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.82 -28.02 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.113 -0.992 . . . . 1.76 111.264 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.92 -34.61 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.309 0.959 . . . . 2.34 110.419 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.43 -45.29 84.83 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.042 1.337 . . . . 4.76 112.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.14 -20.39 61.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.535 1.134 . . . . 2.88 113.478 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.55 -57.58 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.324 1.05 . . . . 1.73 111.543 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.07 -23.69 65.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.584 1.154 . . . . 3.05 112.161 -174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 73.4 m -68.11 -19.12 64.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.32 1.048 . . . . 2.61 113.713 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.16 -25.22 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.999 0.92 . . . . 3.71 111.176 171.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.0 m 72.63 -33.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 129.801 3.24 . . . . 5.38 114.272 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.8 p -99.56 19.25 16.09 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 3.56 111.863 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.09 165.41 43.17 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.477 1.111 . . . . 2.89 108.314 159.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 51.62 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.154 2.569 . . . . 4.09 110.947 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.61 -173.84 0.16 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.775 2.83 . . . . 4.56 113.784 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 45.5 tp -140.55 117.39 11.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.153 -1.054 . . . . 1.78 108.153 150.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.0 m -106.56 96.03 13.19 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.288 1.035 . . . . 1.64 108.651 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.12 144.12 33.23 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.205 1.937 . . . . 1.2 110.535 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.25 147.11 43.35 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.542 0.687 . . . . 2.72 110.806 171.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -112.92 121.09 43.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.895 1.278 . . . . 2.25 108.234 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.35 118.03 40.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.738 -1.578 . . . . 1.51 106.738 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.57 137.99 38.9 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.567 0.698 . . . . 1.98 110.679 162.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.1 pt -114.6 24.48 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.835 1.254 . . . . 2.07 111.092 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -97.69 0.7 0.09 OUTLIER Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 129.337 3.055 . . . . 5.17 118.586 -161.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.48 120.55 7.77 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 123.405 2.252 . . . . 2.53 111.727 -165.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 149.23 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 130.425 3.49 . . . . 4.44 110.402 -171.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -35.46 3.56 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.014 1.116 . . . . 4.96 114.014 173.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.4 163.72 12.41 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.35 1.611 . . . . 4.89 115.35 -166.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -138.95 153.36 48.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.512 -1.222 . . . . 2.75 112.536 -164.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -45.61 -43.95 12.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.87 1.268 . . . . 4.52 112.34 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.61 -44.24 62.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.612 1.565 . . . . 3.69 112.853 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.84 97.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.34 1.427 . . . . 1.29 111.229 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.69 -33.99 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.537 -0.727 . . . . 1.88 110.543 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.83 78.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.554 1.07 . . . . 1.19 112.638 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -62.43 -53.47 54.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.835 1.198 . . . . 3.55 109.983 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -55.83 -46.61 78.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 5.11 112.448 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.5 t -62.24 -45.72 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.555 -1.341 . . . . 1.49 111.397 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.03 -39.18 91.44 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 118.315 -0.85 . . . . 5.43 113.086 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -78.19 -37.28 45.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.059 1.3 . . . . 4.02 112.436 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -68.4 -59.68 3.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.536 -0.745 . . . . 3.03 112.484 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 174.85 157.28 0.35 Allowed Pre-proline 0 N--CA 1.484 1.257 0 N-CA-C 115.173 1.546 . . . . 1.93 115.173 170.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.19 -8.93 18.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.762 2.975 . . . . 2.23 114.552 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -86.16 -0.03 54.73 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 119.95 1.25 . . . . 2.85 112.78 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 29.9 tp -94.41 151.04 19.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.995 1.318 . . . . 1.88 109.912 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 87.7 t -133.43 132.43 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.98 1.712 . . . . 1.83 108.313 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.6 105.36 1.42 Allowed Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.082 0.848 . . . . 1.12 112.068 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.91 147.4 25.59 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.7 1.2 . . . . 2.1 112.453 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 65.4 p -140.49 149.73 42.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.488 1.915 . . . . 2.92 111.164 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -131.44 -170.72 12.7 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.151 1.358 . . . . 1.6 110.856 160.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.9 t -84.33 174.59 10.01 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.622 0.711 . . . . 2.63 109.146 152.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -52.26 -24.45 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.026 1.33 . . . . 6.41 113.603 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -74.86 -52.33 11.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.87 2.468 . . . . 2.83 110.784 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.07 -25.84 64.64 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.272 -1.517 . . . . 3.97 111.96 171.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 33.3 t -62.98 -38.95 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 117.22 -1.371 . . . . 1.79 110.991 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.8 -52.53 65.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.451 1.478 . . . . 3.94 109.042 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -49.98 -57.28 7.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.606 1.094 . . . . 2.52 112.02 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.48 -29.19 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.315 1.416 . . . . 3.01 113.002 -170.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.38 -42.33 79.28 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.831 -0.543 . . . . 1.74 110.732 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -72.02 -33.93 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.854 2.062 . . . . 4.68 112.573 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -54.87 -30.72 58.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.039 1.336 . . . . 2.56 114.487 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -118.22 3.72 11.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.616 1.166 . . . . 3.06 113.099 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.75 39.92 16.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.204 2.202 . . . . 6.31 112.91 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.17 155.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.867 0.867 . . . . 2.61 112.131 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -104.58 148.98 25.91 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.591 1.556 . . . . 3.51 114.084 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -170.37 150.12 3.48 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.837 2.855 . . . . 3.57 109.497 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.2 m -157.78 144.45 13.11 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 124.979 1.312 . . . . 3.24 111.623 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.06 154.04 37.31 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.508 2.139 . . . . 2.85 111.414 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.728 0 C-N-CA 123.886 0.755 . . . . 3.16 114.259 171.622 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 111.887 0.328 . . . . 4.77 111.887 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.5 HD13 ' H ' ' A' ' 258' ' ' VAL . 0.5 OUTLIER -65.54 160.61 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 121.245 -0.909 . . . . 2.85 110.255 162.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.5 ' H ' HD13 ' A' ' 257' ' ' ILE . 41.1 t -153.74 128.03 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.566 1.947 . . . . 3.15 106.568 172.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.19 146.41 49.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.556 1.542 . . . . 3.28 112.196 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -148.77 129.51 14.16 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.135 0.974 . . . . 2.34 111.237 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.6 m -54.45 -31.15 54.91 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.93 1.085 . . . . 3.33 113.93 -171.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 69.74 -20.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.42 1.888 . . . . 4.16 114.402 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 84.4 mt -54.94 138.78 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.082 0.953 . . . . 2.34 110.504 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.7 mtm -99.78 141.2 32.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.324 -1.307 . . . . 2.57 110.46 162.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -99.21 140.32 33.55 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.241 0.616 . . . . 3.29 110.006 168.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 21.6 tp -99.1 117.04 32.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.919 0.888 . . . . 1.94 108.918 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.48 141.99 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.795 -1.187 . . . . 2.26 107.795 169.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.41 168.28 34.78 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.23 0.919 . . . . 1.59 115.156 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.66 61.25 7.44 Favored 'Trans proline' 0 C--N 1.351 0.695 1 C-N-CA 126.063 4.509 . . . . 3.03 110.722 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.54 -67.45 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.091 1.356 . . . . 4.13 108.232 -149.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.61 -23.22 2.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.07 -1.406 . . . . 2.38 115.046 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.59 172.25 11.07 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.335 1.567 . . . . 4.44 113.219 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -88.56 137.64 32.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.755 2.022 . . . . 5.4 111.429 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.22 -30.15 4.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.055 1.872 . . . . 2.39 116.055 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -164.68 155.98 15.22 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.686 1.585 . . . . 2.52 112.995 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 146.09 31.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.728 0.811 . . . . 6.15 112.825 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.37 159.92 40.05 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.344 1.058 . . . . 2.78 111.771 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.48 -174.37 29.04 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.347 1.451 . . . . 2.83 110.213 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -73.83 38.57 0.1 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.29 2.236 . . . . 3.59 114.637 -167.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -121.48 -43.25 2.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.542 1.537 . . . . 5.45 109.91 167.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -87.32 118.59 26.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.449 1.5 . . . . 4.36 108.945 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -73.42 177.92 4.93 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.264 -0.897 . . . . 6.06 108.709 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 12.7 tmtt? -54.45 -47.33 73.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.301 1.223 . . . . 1.81 114.301 -170.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -32.8 85.39 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-N 118.414 0.552 . . . . 1.52 112.757 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.08 -22.84 62.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.357 1.063 . . . . 3.47 113.078 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.04 -49.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.111 -0.993 . . . . 1.49 109.923 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.79 88.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.544 -0.723 . . . . 1.4 112.657 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.49 66.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.361 1.245 . . . . 1.55 114.361 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.3 p -74.72 -44.82 48.01 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.296 -0.878 . . . . 1.53 111.544 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.01 -40.34 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 120.142 1.337 . . . . 1.35 110.93 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.97 -5.36 9.22 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 114.663 1.357 . . . . 2.01 114.663 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.1 m -96.41 -47.93 5.78 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.288 1.435 . . . . 1.97 110.087 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -65.21 -24.94 67.49 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.619 1.168 . . . . 2.91 113.301 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -55.78 -35.71 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.549 2.34 . . . . 4.77 113.9 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -59.4 -43.23 95.91 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 116.838 -1.553 . . . . 6.61 111.913 -172.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.61 -61.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.133 1.889 . . . . 2.38 110.519 161.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.24 74.24 3.97 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 122.795 1.283 . . . . 3.75 113.722 -169.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 127.375 2.27 . . . . 9.2 110.831 173.704 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 N-CA-C 109.531 -1.428 . . . . 3.42 109.531 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.93 144.31 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.613 2.208 . . . . 2.48 112.968 -151.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -86.33 175.09 8.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.288 1.518 . . . . 2.29 114.092 -166.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -148.19 106.37 3.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.983 1.313 . . . . 3.24 108.607 165.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mp -148.57 165.17 32.05 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.682 1.593 . . . . 2.43 110.137 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.2 m -107.95 134.07 51.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.763 1.225 . . . . 1.6 111.904 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -73.61 160.27 31.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.494 1.118 . . . . 2.09 112.216 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -60.6 -20.01 59.4 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 121.508 -0.745 . . . . 1.61 112.486 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.2 m -78.43 -60.02 2.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.35 1.86 . . . . 3.26 109.822 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.85 -14.9 0.69 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 116.11 1.204 . . . . 2.34 116.11 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.2 133.67 44.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.829 1.815 . . . . 3.92 109.973 171.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -82.31 129.5 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.119 -1.067 . . . . 5.68 108.119 157.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -140.37 175.99 9.14 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.818 1.247 . . . . 3.57 112.806 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.6 p -140.77 172.45 12.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 128.583 2.753 . . . . 2.68 109.383 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.83 -25.03 62.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.128 0.788 . . . . 3.91 113.128 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -75.07 -11.59 60.13 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 119.938 -1.726 . . . . 7.5 113.979 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.73 -28.87 21.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.866 1.666 . . . . 4.19 111.636 164.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -108.58 -2.47 18.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.535 1.68 . . . . 3.72 115.535 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.9 mt -77.56 -176.64 4.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.9 1.227 . . . . 4.3 109.777 165.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.7 10.86 Favored Glycine 0 N--CA 1.48 1.573 0 O-C-N 120.889 -1.132 . . . . 2.53 114.991 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -126.18 168.88 13.44 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.048 2.939 . . . . 3.79 108.252 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.521 ' CD1' ' HD3' ' A' ' 269' ' ' PRO . 53.9 m95 -81.77 140.39 34.27 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.445 1.02 . . . . 2.42 109.807 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.498 HD12 ' HB ' ' A' ' 197' ' ' THR . 0.8 OUTLIER -123.6 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.203 -0.936 . . . . 2.97 112.438 177.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.17 100.63 10.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.935 -1.135 . . . . 3.58 107.935 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.2 mt -96.26 127.75 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.743 -0.836 . . . . 1.82 108.743 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -139.95 143.82 36.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.122 0.969 . . . . 2.44 111.94 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.81 127.21 53.51 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.674 1.19 . . . . 2.25 112.34 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -147.47 163.96 28.74 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.506 1.05 . . . . 1.34 112.654 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.95 -179.04 6.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 117.745 0.772 . . . . 3.1 111.313 168.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 174.89 5.67 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.963 -1.125 . . . . 3.49 107.963 152.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 73.92 -24.76 0.2 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.516 1.526 . . . . 7.01 113.921 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 83.6 m -52.42 159.69 1.54 Allowed Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 120.648 1.567 . . . . 2.88 113.293 161.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.54 -173.44 1.8 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.386 3.39 . . . . 3.99 111.474 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.44 -2.46 1.05 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.248 2.219 . . . . 6.34 115.904 -157.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.29 -60.41 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.362 1.465 . . . . 4.32 110.163 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 15.6 m -52.43 -44.02 93.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.372 -1.299 . . . . 3.08 114.212 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.63 -39.59 0.51 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.435 2.09 . . . . 1.88 113.774 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.41 -32.62 68.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 122.171 2.26 . . . . 4.33 112.086 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -60.11 -44.98 94.46 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.506 -1.371 . . . . 3.54 111.484 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.77 -39.46 91.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.02 0.928 . . . . 3.2 111.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -72.81 -25.98 61.34 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.417 -1.427 . . . . 6.77 114.06 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -56.03 -56.96 14.44 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.431 -1.418 . . . . 2.81 109.812 165.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 10.0 ptp -64.7 -30.9 71.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.013 -0.994 . . . . 3.71 113.093 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.2 mt -75.16 -48.34 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 121.773 2.079 . . . . 3.11 109.821 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.52 ' HB3' ' HZ1' ' A' ' 283' ' ' LYS . 3.5 mp0 -68.07 -16.63 64.1 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.252 1.387 . . . . 6.54 111.776 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.421 HG21 ' HB ' ' A' ' 286' ' ' ILE . 24.9 t -69.84 -30.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.95 1.25 . . . . 1.86 112.584 163.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.82 -46.03 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 121.061 1.755 . . . . 2.39 110.257 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.23 -37.35 77.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.332 1.053 . . . . 4.63 113.153 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -57.53 -46.1 84.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 3.56 111.721 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.8 mt -71.87 -33.3 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.711 1.204 . . . . 1.84 114.232 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.44 -29.47 61.69 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.429 1.892 . . . . 3.2 112.359 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.5 t -68.52 -14.67 63.16 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.471 -1.393 . . . . 3.05 113.562 170.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.43 45.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 127.069 2.147 . . . . 4.17 108.666 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.06 4.3 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.617 2.767 . . . . 6.4 116.252 -159.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 78.0 p -78.21 -24.33 47.1 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.94 -1.1 . . . . 4.66 112.382 166.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 194' ' ' PRO . 11.6 mt -56.33 142.63 67.74 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 118.72 0.691 . . . . 3.98 111.046 169.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 159' ' ' TRP . 1.7 Cg_endo -81.77 46.63 2.28 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.604 4.203 . . . . 5.07 112.233 -174.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 72.88 101.21 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.633 1.682 . . . . 5.63 112.725 145.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 84.76 4.99 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.387 1.475 . . . . 2.35 111.012 -160.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 160' ' ' LEU . 56.8 m -79.95 122.31 83.09 Favored Pre-proline 0 N--CA 1.478 0.94 0 O-C-N 120.84 -1.163 . . . . 1.43 112.094 -173.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.04 124.43 1.79 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.381 2.721 . . . . 1.08 111.97 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 tp -126.58 93.96 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.085 1.354 . . . . 2.59 110.327 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.77 115.39 14.3 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.94 -0.763 . . . . 2.14 108.94 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.94 112.51 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.793 1.237 . . . . 1.59 108.584 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -83.88 135.03 34.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.649 -1.16 . . . . 1.98 109.55 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.7 34.95 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.582 1.153 . . . . 1.71 112.657 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -121.55 44.49 0.79 Allowed Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 127.158 2.183 . . . . 3.71 111.97 -173.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -77.71 35.15 0.5 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.231 3.287 . . . . 2.16 113.811 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -91.34 -16.59 27.23 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.204 -0.426 . . . . 5.43 110.406 150.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.49 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.494 2.405 . . . . 7.59 117.494 -171.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -79.73 52.48 1.45 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.317 1.847 . . . . 4.03 114.619 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.1 m -55.5 129.79 40.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.388 1.075 . . . . 2.49 110.785 -167.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -41.62 -48.51 4.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.363 1.465 . . . . 3.0 113.922 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -26.07 43.98 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.993 1.109 . . . . 4.07 113.993 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.11 86.44 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 1.86 110.83 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.84 -30.76 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.351 1.06 . . . . 2.12 112.613 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.31 74.38 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.408 1.458 . . . . 1.43 113.09 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 -44.73 58.02 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.699 0.799 . . . . 3.13 111.201 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -55.9 -39.98 72.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.476 1.51 . . . . 3.93 111.517 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.401 HG21 ' HA3' ' A' ' 226' ' ' GLY . 45.0 t -65.15 -20.72 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.053 1.741 . . . . 1.38 113.583 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -111.69 -21.55 11.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.46 1.652 . . . . 8.54 115.46 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.73 -19.13 58.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.377 0.989 . . . . 3.9 113.044 168.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -74.14 -87.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.707 1.603 . . . . 3.78 110.147 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.2 t -148.61 132.1 8.33 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.646 -1.283 . . . . 2.73 110.121 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.07 -19.44 45.37 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.382 2.055 . . . . 3.27 114.663 -156.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -84.61 2.69 40.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.713 1.375 . . . . 2.78 114.713 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.2 tp -72.55 147.3 46.07 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.624 1.102 . . . . 1.96 113.083 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 2.3 p -118.31 130.97 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.668 1.587 . . . . 2.45 108.66 160.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.401 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -99.45 160.82 19.75 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 123.919 0.771 . . . . 1.27 111.909 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -153.36 114.04 4.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.497 -1.297 . . . . 3.92 107.497 -166.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.0 m -112.88 152.65 29.04 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.24 2.216 . . . . 2.54 107.877 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -144.51 146.29 16.6 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 121.819 -0.551 . . . . 2.97 112.71 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -63.51 154.3 32.84 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.057 0.928 . . . . 2.49 109.693 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.476 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -47.23 -33.25 5.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.929 1.292 . . . . 7.57 113.38 -170.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.44 -50.57 58.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.874 1.215 . . . . 5.27 112.411 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.62 -44.7 90.04 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.961 -1.087 . . . . 3.43 111.967 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 15.6 m -70.95 -22.32 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 113.844 1.053 . . . . 2.63 113.844 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.68 -53.09 37.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.847 1.203 . . . . 3.55 108.808 164.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -55.82 -57.82 10.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.361 -0.828 . . . . 3.66 112.378 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.97 -35.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 119.356 0.98 . . . . 2.12 113.323 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.42 67.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.063 0.945 . . . . 2.1 111.477 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -70.21 -26.49 63.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.626 1.57 . . . . 3.41 112.433 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.8 -62.89 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.695 1.198 . . . . 2.6 113.367 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -67.5 -33.78 75.79 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.038 -1.039 . . . . 3.15 112.735 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.259 2.2 ptp180 109.16 117.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 1 C-N-CA 132.411 4.284 . . . . 9.01 109.777 179.365 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.83 153.61 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.027 2.131 . . . . 4.08 110.473 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -119.53 135.98 54.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.73 0.412 . . . . 4.63 110.163 148.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -165.91 166.18 17.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.167 1.787 . . . . 4.2 111.323 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 48.9 p -113.16 165.8 12.46 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.46 1.504 . . . . 4.68 112.743 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.27 143.63 17.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.595 2.197 . . . . 4.43 111.046 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.747 0 CA-C-O 118.026 -1.43 . . . . 2.96 112.14 177.222 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 43.3 p90 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 116.504 2.038 . . . . 3.6 116.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt -138.84 163.93 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.711 2.004 . . . . 4.37 108.52 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.56 148.42 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.627 1.571 . . . . 3.3 109.108 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -86.28 135.19 33.64 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.312 -0.996 . . . . 4.03 108.312 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.62 139.85 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.59 1.156 . . . . 2.7 111.274 -169.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -68.42 -14.94 63.35 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.977 2.214 . . . . 3.8 116.977 -165.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 28.3 mt 50.8 56.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 120.169 1.349 . . . . 4.7 110.36 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.0 mt -112.31 147.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.128 1.371 . . . . 2.53 109.986 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.0 ttp -114.49 144.8 42.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.622 1.969 . . . . 4.25 109.856 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -107.14 136.26 47.29 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.242 -0.912 . . . . 2.54 110.874 163.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 39.2 tp -94.95 106.97 19.0 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.967 0.907 . . . . 2.17 108.85 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.3 mp -86.84 135.58 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.501 -1.666 . . . . 2.16 106.501 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.49 165.29 24.77 Favored Glycine 0 CA--C 1.539 1.593 0 N-CA-C 111.587 -0.605 . . . . 1.81 111.587 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.521 ' HD3' ' CD1' ' A' ' 159' ' ' TRP . 21.0 Cg_endo -67.5 9.92 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 125.181 3.921 . . . . 2.92 114.16 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -141.93 -1.03 1.27 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.904 2.482 . . . . 5.04 111.492 -167.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 163.34 156.56 8.71 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.105 0.859 . . . . 3.55 114.483 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -74.71 -22.05 59.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.08 1.352 . . . . 5.8 114.638 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.87 108.17 9.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.133 -0.979 . . . . 3.95 111.32 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 -36.76 4.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.572 1.149 . . . . 3.18 111.152 170.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -157.45 178.63 10.08 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.98 2.112 . . . . 2.3 110.479 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -155.26 138.3 15.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.311 1.444 . . . . 3.61 113.354 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.8 -151.35 0.39 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.166 1.387 . . . . 2.75 110.968 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.85 -127.05 7.92 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.849 2.166 . . . . 3.5 108.492 -171.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -53.44 156.25 2.55 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.078 1.351 . . . . 2.87 113.11 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.6 -40.84 0.39 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.772 2.429 . . . . 4.33 112.459 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -63.41 108.84 1.43 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.982 1.313 . . . . 4.71 112.709 -174.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.61 141.66 57.64 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.331 -0.856 . . . . 7.34 108.845 177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.52 ' HZ1' ' HB3' ' A' ' 182' ' ' GLN . 13.1 tmtt? -48.59 -53.57 17.9 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.205 -1.559 . . . . 2.62 114.449 -165.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.3 -14.41 71.56 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 115.707 1.043 . . . . 1.64 115.707 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.3 -38.87 82.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.033 1.417 . . . . 3.65 110.439 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . 0.421 ' HB ' HG21 ' A' ' 183' ' ' VAL . 37.6 mt -60.7 -48.54 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.65 0.78 . . . . 1.48 109.259 174.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.73 77.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 119.121 -0.466 . . . . 1.27 111.858 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.79 90.39 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.712 1.004 . . . . 1.62 113.712 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 86.8 p -60.01 -48.59 81.07 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.581 -0.699 . . . . 1.62 111.795 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.13 -31.69 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.658 -1.276 . . . . 1.37 111.368 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.0 64.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.957 0.903 . . . . 1.78 113.093 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.6 m -70.71 -46.09 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.539 -0.726 . . . . 2.26 109.597 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -69.72 -27.89 65.35 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.844 1.053 . . . . 2.56 113.844 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.7 ttt -59.98 -40.17 88.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.413 1.485 . . . . 4.24 112.167 166.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.07 36.78 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 117.36 -1.305 . . . . 5.3 113.348 -173.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.53 -57.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.408 2.739 . . . . 3.01 112.379 158.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.67 28.61 8.51 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.439 1.644 . . . . 4.1 115.439 -154.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 126.667 1.987 . . . . 8.14 114.612 165.117 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.617 0 CA-C-O 118.548 -1.14 . . . . 2.35 112.307 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.65 174.77 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.127 3.218 . . . . 3.35 112.171 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.76 173.38 15.36 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.973 1.709 . . . . 2.88 109.843 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.71 32.21 4.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.618 0.97 . . . . 3.68 113.618 172.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.3 mt -51.72 149.3 4.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 3.02 112.563 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -108.38 142.35 38.85 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.396 1.078 . . . . 1.37 109.731 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.3 t -91.32 165.09 13.61 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.295 1.038 . . . . 2.43 113.245 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -61.2 -25.37 67.0 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 2.24 114.124 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -83.12 0.93 42.89 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.249 1.82 . . . . 3.09 114.178 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.94 -6.37 73.04 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.227 1.394 . . . . 2.02 115.555 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -73.63 132.95 43.32 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.347 1.073 . . . . 4.08 111.293 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -82.52 105.3 13.46 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.092 -1.005 . . . . 4.44 108.494 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -179.1 4.3 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.976 1.31 . . . . 2.94 113.614 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 62.3 p -146.54 166.16 27.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.035 2.534 . . . . 2.37 109.005 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.31 -38.17 76.55 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.449 0.568 . . . . 4.08 112.343 173.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -81.78 4.25 22.8 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.89 1.441 . . . . 6.93 114.89 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.81 -41.33 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.622 0.769 . . . . 3.46 109.828 160.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -84.5 -29.19 26.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.756 1.391 . . . . 3.33 114.756 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.89 101.96 0.43 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.781 1.232 . . . . 4.09 110.23 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 144.2 -20.97 2.09 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.643 1.116 . . . . 2.79 113.48 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.67 170.45 7.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.876 -0.787 . . . . 3.52 108.876 152.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -82.42 127.4 33.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.478 0.581 . . . . 2.12 109.856 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.48 145.94 44.88 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.636 0.653 . . . . 3.36 112.506 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.1 mt -107.19 121.61 44.87 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.09 1.356 . . . . 2.53 108.01 158.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.5 118.66 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.267 0.627 . . . . 2.11 109.626 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -122.9 149.88 43.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.305 1.442 . . . . 2.45 114.015 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -99.19 120.54 39.69 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 2.5 112.524 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.96 155.71 15.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.515 1.055 . . . . 1.57 113.791 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -114.08 -43.75 3.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.362 1.065 . . . . 2.93 111.865 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.5 m 67.71 -18.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 126.453 1.901 . . . . 4.0 114.835 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -71.93 -18.86 61.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.319 1.048 . . . . 7.22 111.326 160.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.54 164.38 58.33 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.768 1.227 . . . . 2.48 111.741 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -78.82 -146.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.433 2.755 . . . . 3.73 109.387 164.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.53 57.72 0.13 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.872 3.269 . . . . 5.59 113.348 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.5 t -115.24 -84.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 126.849 2.06 . . . . 3.65 108.073 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -47.59 98.34 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 117.062 -1.447 . . . . 1.87 113.761 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.46 -23.57 43.67 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.029 1.82 . . . . 1.54 114.219 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.78 -56.55 14.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.82 0.848 . . . . 4.19 109.961 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -60.75 -39.89 90.4 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 2.83 112.129 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.452 HD22 ' CG ' ' A' ' 220' ' ' PHE . 5.1 tt -55.58 -39.58 70.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.82 1.248 . . . . 2.72 112.036 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . 0.263 0.3 OUTLIER -75.77 -34.02 60.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.144 0.884 . . . . 3.03 112.305 175.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -55.65 -46.12 77.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.283 -1.511 . . . . 4.78 111.643 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.4 ptp -67.89 -28.53 67.59 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.728 0.64 . . . . 2.67 112.728 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.23 -38.09 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.295 -0.878 . . . . 1.79 111.018 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.446 ' OE1' ' HE3' ' A' ' 283' ' ' LYS . 73.9 mt-30 -62.57 -40.43 96.85 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.297 -0.859 . . . . 3.15 111.931 171.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . 0.259 4.4 m -72.31 -28.93 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.218 1.372 . . . . 2.98 113.243 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.2 t -63.07 -52.83 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.793 1.179 . . . . 2.07 111.717 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -74.92 -19.97 59.9 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.155 0.798 . . . . 5.18 113.155 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -64.93 -55.59 18.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.596 0.758 . . . . 3.28 111.241 164.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.25 -37.37 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.111 1.365 . . . . 2.15 112.902 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.51 -35.56 65.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.49 1.516 . . . . 3.21 112.205 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.9 t -72.34 -18.2 61.78 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.931 1.085 . . . . 3.25 113.931 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.43 HG22 HG22 ' A' ' 192' ' ' THR . 11.8 mt -94.36 75.38 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.357 1.463 . . . . 3.68 107.795 -175.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -3.55 0.06 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 128.111 2.565 . . . . 4.66 116.623 -162.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.43 HG22 HG22 ' A' ' 190' ' ' ILE . 15.1 t -71.59 -22.44 61.73 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.378 1.871 . . . . 6.18 113.071 167.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.4 151.74 59.75 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.434 1.016 . . . . 3.98 111.195 166.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 -40.11 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.074 2.516 . . . . 3.23 110.779 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -172.74 -179.89 2.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.235 2.614 . . . . 4.48 109.331 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.0 tp -149.27 73.26 1.19 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.799 1.24 . . . . 1.92 109.948 160.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -63.03 119.96 56.82 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 121.077 -1.015 . . . . 1.33 110.717 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.93 128.37 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.29 1.993 . . . . 1.15 110.459 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.6 tp -115.81 115.36 26.15 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.663 1.585 . . . . 2.78 110.735 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -87.24 126.52 34.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.174 0.99 . . . . 2.45 109.884 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.79 119.53 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.429 -0.952 . . . . 1.27 108.429 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.8 t -79.1 139.49 38.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.956 -0.565 . . . . 2.0 111.632 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -124.19 21.76 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.916 1.286 . . . . 1.86 113.119 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -111.52 61.66 0.5 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.803 1.241 . . . . 3.56 113.647 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.17 73.17 5.6 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.18 2.587 . . . . 2.41 110.255 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -153.32 -37.15 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.101 1.36 . . . . 5.42 112.555 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.09 7.36 0.91 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.081 1.141 . . . . 4.98 114.081 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 177.73 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.987 -0.445 . . . . 3.46 110.828 157.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 32.8 m -155.95 136.9 13.57 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.025 -1.047 . . . . 2.42 108.181 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.448 ' HZ3' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -51.76 -44.86 63.5 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.013 0.925 . . . . 3.9 112.216 177.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . 0.448 ' CD ' ' HZ3' ' A' ' 210' ' ' LYS . 17.7 mp0 -60.35 -40.24 90.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.083 1.753 . . . . 3.57 112.776 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.98 69.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.227 -0.921 . . . . 1.6 112.346 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.61 -43.24 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.919 0.888 . . . . 2.01 110.654 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.56 66.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.219 1.008 . . . . 1.28 112.484 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 0.7 OUTLIER -71.21 -46.79 60.43 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.19 0.996 . . . . 3.48 112.331 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.79 -37.11 86.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.467 1.507 . . . . 4.17 111.422 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -50.64 -44.9 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.877 2.071 . . . . 1.2 112.987 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 7.7 mtmp? -55.23 -45.53 75.97 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.662 0.664 . . . . 4.18 112.386 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -20.46 60.12 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 124.363 1.04 . . . . 5.16 112.211 -163.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . 0.452 ' CG ' HD22 ' A' ' 177' ' ' LEU . 68.9 m-85 -86.16 -48.24 8.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.012 0.925 . . . . 2.39 111.993 168.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 87.8 p -174.04 127.89 0.46 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.753 -1.118 . . . . 2.62 110.902 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.15 76.59 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.661 2.907 . . . . 3.17 109.244 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 178.18 -28.27 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.996 2.919 . . . . 2.3 111.005 -163.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.451 ' CD1' HD21 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -67.93 143.96 55.43 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.917 1.687 . . . . 2.29 110.722 164.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.72 133.97 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.378 1.471 . . . . 2.39 109.797 170.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.51 115.66 3.58 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 123.841 0.734 . . . . 1.07 112.181 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.87 148.67 27.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.365 1.066 . . . . 2.51 111.455 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 71.9 p -136.59 161.61 35.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.986 1.314 . . . . 2.23 110.635 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.6 23.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 124.659 1.123 . . . . 2.88 110.372 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.6 t -60.57 166.53 3.13 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.507 1.123 . . . . 3.23 111.293 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -38.36 7.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.306 1.042 . . . . 6.62 112.528 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.5 mp0 -67.15 -42.03 85.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.408 2.283 . . . . 3.75 111.751 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -71.16 -34.37 70.91 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.036 -1.04 . . . . 4.09 111.667 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.71 -38.89 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 118.363 -0.827 . . . . 2.5 109.669 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -70.66 -41.85 71.55 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.859 -1.067 . . . . 3.43 111.748 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -54.51 -50.04 68.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.293 1.861 . . . . 2.5 110.752 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.44 -55.13 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.715 0.806 . . . . 2.26 111.821 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.86 62.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.959 0.904 . . . . 1.69 113.439 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -87.86 -30.26 20.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.675 1.59 . . . . 4.34 112.305 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.24 13.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.109 1.322 . . . . 1.68 111.206 168.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -76.96 -14.42 59.85 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.603 0.964 . . . . 3.41 113.603 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 76.77 62.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.112 2.165 . . . . 5.28 112.881 159.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.86 145.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.341 1.457 . . . . 3.68 111.979 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.74 135.88 40.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.02 0.914 . . . . 3.7 113.033 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -145.64 136.36 24.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.881 2.872 . . . . 5.68 108.077 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.3 t -121.25 105.08 39.99 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.097 0.959 . . . . 2.89 109.921 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.72 101.32 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.505 2.137 . . . . 3.13 108.845 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 CA-C-O 119.617 -0.546 . . . . 2.28 113.052 -177.509 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 28.4 p90 . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 122.331 1.063 . . . . 3.8 112.169 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.75 162.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.193 1.397 . . . . 2.62 109.019 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 t -128.18 137.68 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.791 2.037 . . . . 3.34 108.374 -169.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.96 119.2 21.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 107.049 -1.463 . . . . 4.51 107.049 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.17 131.6 54.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.747 -0.834 . . . . 2.02 108.747 168.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 56.7 m -53.24 -47.82 68.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.718 0.807 . . . . 3.6 112.566 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.5 mt 82.6 98.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.169 2.588 . . . . 3.8 108.339 -172.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.42 146.26 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.4 1.48 . . . . 3.17 107.146 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.1 ttm -119.47 128.54 54.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.794 1.638 . . . . 2.57 108.516 159.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -98.08 139.62 33.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.74 -0.6 . . . . 3.6 111.109 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.78 113.98 26.32 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.671 -1.233 . . . . 2.28 107.671 169.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 tp -106.28 125.84 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.922 -1.14 . . . . 4.15 107.922 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.49 165.21 48.01 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.604 -0.599 . . . . 1.66 111.604 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.34 48.64 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.507 3.471 . . . . 2.8 110.49 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -165.96 -50.51 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.077 1.751 . . . . 4.47 110.209 -156.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 151.49 -178.29 28.91 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 115.772 1.069 . . . . 3.21 115.772 166.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 50.33 -132.15 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.987 2.115 . . . . 4.72 114.225 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.36 131.49 54.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.147 0.979 . . . . 4.27 109.333 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.0 -29.18 23.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.056 0.943 . . . . 2.97 110.591 169.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -162.4 158.81 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.105 2.162 . . . . 2.21 109.428 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -134.59 99.28 4.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.021 1.391 . . . . 3.8 111.04 -170.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -95.53 110.96 22.96 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.177 -0.952 . . . . 2.62 110.1 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -75.34 -165.13 15.13 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.12 -1.192 . . . . 3.29 110.12 163.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -74.62 -26.19 59.73 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.749 -1.442 . . . . 3.54 112.309 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -46.96 -41.78 16.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 128.231 2.612 . . . . 6.34 117.479 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 151.57 33.76 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.051 1.741 . . . . 8.26 113.548 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.711 -1.243 . . . . 6.23 109.331 159.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.446 ' HE3' ' OE1' ' A' ' 182' ' ' GLN . 13.5 tmtt? -65.37 -44.72 86.73 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.709 -1.244 . . . . 1.91 113.672 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.55 -30.43 76.53 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 123.278 0.466 . . . . 1.72 112.398 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -63.66 -24.55 67.83 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.007 1.323 . . . . 2.84 113.489 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 13.8 mt -79.89 -30.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.901 1.228 . . . . 1.36 111.341 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.9 72.5 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.951 -1.093 . . . . 1.14 110.552 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.44 83.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.02 1.118 . . . . 1.43 114.02 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 70.9 p -63.57 -49.28 74.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.131 0.878 . . . . 1.32 111.137 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.91 -36.62 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.016 -1.052 . . . . 1.23 111.508 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.21 -6.18 4.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.721 1.209 . . . . 1.89 114.203 168.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 40.0 m -101.88 -44.38 5.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.843 1.657 . . . . 1.67 110.472 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -63.38 -28.23 69.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.636 1.174 . . . . 2.91 113.166 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -48.82 -40.84 30.8 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 125.988 1.715 . . . . 5.12 111.506 165.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -60.91 -40.44 74.52 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.414 -1.755 . . . . 6.1 112.829 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.6 -58.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.947 2.431 . . . . 1.87 113.525 163.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -83.78 8.86 13.4 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.81 1.781 . . . . 2.84 115.81 -165.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.806 0 C-N-CA 126.734 2.014 . . . . 8.28 114.314 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-O 117.841 -1.533 . . . . 2.31 110.357 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.91 142.78 35.58 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.682 2.255 . . . . 2.88 111.435 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -93.87 168.13 11.18 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.595 -1.184 . . . . 2.41 111.663 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.6 m -140.6 78.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.109 1.364 . . . . 2.45 110.012 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.56 147.5 40.64 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.38 0.672 . . . . 1.92 111.234 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -75.91 131.84 39.9 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.291 2.236 . . . . 1.42 110.183 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.9 p -92.61 160.97 14.77 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.033 1.333 . . . . 1.93 112.162 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -64.91 -6.62 8.77 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.332 1.453 . . . . 1.38 114.638 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.2 m -66.75 -60.62 2.52 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.625 1.17 . . . . 2.87 109.093 162.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 160.13 0.48 0.07 OUTLIER Glycine 0 CA--C 1.534 1.255 0 N-CA-C 116.446 1.338 . . . . 2.55 116.446 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.34 165.48 33.93 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.751 1.775 . . . . 4.67 113.567 -170.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.72 120.78 25.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.819 2.448 . . . . 4.53 113.79 -167.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -99.63 171.58 7.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.228 1.411 . . . . 5.1 111.324 165.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.6 p -130.16 157.3 42.81 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.27 1.428 . . . . 2.16 110.176 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.6 -41.96 43.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.269 1.428 . . . . 3.54 111.455 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.56 -26.4 63.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.648 1.579 . . . . 8.16 113.765 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -80.06 -33.09 39.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.169 1.349 . . . . 3.01 112.193 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.72 -23.17 58.55 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.79 0.663 . . . . 2.94 112.79 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.63 131.69 51.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.852 1.261 . . . . 3.53 111.048 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 108.72 -25.42 19.25 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.522 1.534 . . . . 2.56 112.726 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -88.23 -152.47 0.22 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.575 1.55 . . . . 3.73 108.726 165.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.8 157.56 44.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.307 1.043 . . . . 2.28 110.659 163.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.14 152.96 28.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.915 0.864 . . . . 2.37 113.011 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.8 pp -106.52 155.15 19.9 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.825 1.25 . . . . 3.81 107.853 165.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.75 123.23 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.439 -0.949 . . . . 1.76 108.439 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -123.05 154.3 38.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.719 1.208 . . . . 2.9 111.677 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -108.84 116.7 32.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.845 0.858 . . . . 2.12 109.601 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.74 162.43 33.26 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.923 1.249 . . . . 2.48 113.585 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.08 -44.97 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 115.947 -1.978 . . . . 4.09 114.759 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t 136.95 177.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 131.426 3.89 . . . . 5.22 110.118 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 77.46 -15.27 0.76 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 127.841 2.456 . . . . 7.2 112.958 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.3 p -51.36 155.59 2.41 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 125.321 1.448 . . . . 2.52 112.179 155.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.88 74.44 5.52 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.642 2.894 . . . . 4.0 109.75 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 69.25 -7.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.665 2.386 . . . . 4.15 114.628 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 95.6 t -46.57 -55.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.854 2.462 . . . . 2.9 113.485 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.99 -67.49 0.52 Allowed Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 118.051 -0.976 . . . . 1.78 111.367 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.72 -40.63 21.63 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.944 1.763 . . . . 1.51 113.938 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -58.22 -43.33 87.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.869 1.213 . . . . 3.15 111.686 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -84.6 -34.46 23.14 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.232 -0.918 . . . . 3.18 112.931 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.6 -35.62 80.13 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.293 1.406 . . . . 3.65 112.082 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -47.73 -51.01 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.449 1.1 . . . . 3.35 111.226 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -60.88 -38.32 85.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.053 -1.029 . . . . 2.89 111.789 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -70.13 -41.47 73.87 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.386 -0.821 . . . . 5.08 112.702 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.47 -53.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.722 1.146 . . . . 1.66 109.048 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -55.65 -13.79 1.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.285 1.434 . . . . 4.07 114.573 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 t -97.99 -46.77 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.088 2.155 . . . . 2.0 112.942 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 21.3 m -62.25 -25.53 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.426 1.466 . . . . 3.52 112.311 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -70.88 -22.16 62.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.318 0.647 . . . . 4.13 112.68 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -79.71 -19.66 48.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.066 1.347 . . . . 2.56 111.789 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 43.3 mm -81.36 -58.97 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 1.8 109.746 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -32.86 74.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.15 1.78 . . . . 3.45 113.544 -170.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 t -69.49 -20.18 63.73 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.898 1.279 . . . . 3.24 112.87 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.2 mm -91.84 89.24 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.589 -1.319 . . . . 4.05 108.352 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.5 p -60.74 69.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.353 2.261 . . . . 5.52 113.76 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 175.73 -29.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.527 2.731 . . . . 4.26 111.777 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.15 159.07 68.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.605 0.762 . . . . 3.36 110.824 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.25 160.16 17.64 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.299 2.666 . . . . 3.29 109.486 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.0 134.76 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.167 0.508 . . . . 3.89 111.652 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -95.87 95.71 8.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.027 -1.471 . . . . 2.66 107.027 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 m -68.56 124.59 90.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 108.549 -0.908 . . . . 1.46 108.549 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.07 118.15 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.486 2.124 . . . . 0.89 110.476 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.79 121.08 43.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.273 1.429 . . . . 2.27 110.487 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.12 112.38 19.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.571 1.148 . . . . 3.15 110.216 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.67 110.11 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.045 1.338 . . . . 1.46 110.505 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 m -90.0 96.03 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.132 -0.98 . . . . 2.55 111.581 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.03 -2.77 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 116.359 1.985 . . . . 2.21 116.359 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -117.9 60.84 3.63 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 119.929 1.241 . . . . 4.13 110.572 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.1 149.25 40.95 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.178 2.585 . . . . 2.19 109.506 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 114.13 -43.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 129.682 3.193 . . . . 5.2 108.974 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -35.77 36.67 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.1 -0.375 . . . . 6.2 111.895 160.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.18 151.06 20.82 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.685 1.194 . . . . 4.59 110.964 167.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.4 p -132.42 154.76 49.52 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 124.819 1.248 . . . . 3.03 109.28 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -48.42 -43.24 34.06 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.561 1.144 . . . . 3.14 112.032 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -81.0 -26.07 36.76 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.082 1.141 . . . . 3.27 114.082 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.86 68.84 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.249 0.932 . . . . 1.53 110.266 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.5 mm -65.41 -36.08 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 117.706 -1.14 . . . . 1.96 110.816 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.2 66.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.784 1.629 . . . . 1.35 113.148 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -73.2 -49.53 27.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.378 0.671 . . . . 3.28 112.339 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.33 -41.04 65.33 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.94 -1.1 . . . . 2.92 112.088 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.485 HG21 ' HA3' ' A' ' 226' ' ' GLY . 25.5 t -62.96 -50.92 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.262 1.825 . . . . 1.82 112.294 172.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -59.34 -40.44 86.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.087 0.955 . . . . 3.97 111.248 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -33.22 71.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.481 1.512 . . . . 4.66 112.25 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.88 -13.21 61.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.049 1.129 . . . . 3.46 114.049 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.6 p 139.92 149.57 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 130.744 3.618 . . . . 2.53 111.816 168.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.26 5.65 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.36 2.706 . . . . 1.75 113.865 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.63 -24.74 23.85 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.769 1.168 . . . . 1.89 112.784 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.4 146.31 32.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.399 -1.438 . . . . 2.04 112.765 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.5 127.09 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.17 0.588 . . . . 2.13 111.862 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -99.68 129.94 10.06 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.81 110.813 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.2 113.62 26.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.264 -1.384 . . . . 1.96 107.264 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.4 m -141.15 68.84 1.34 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.633 1.573 . . . . 3.28 108.633 -164.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -91.15 -174.06 43.67 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.741 1.163 . . . . 1.73 112.405 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -75.79 163.32 27.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.918 1.287 . . . . 2.5 112.418 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.5 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 36.9 ttm180 -43.02 -31.58 0.55 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.255 2.622 . . . . 5.73 114.433 173.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -77.14 -38.02 52.76 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.957 1.303 . . . . 4.26 113.311 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.33 -45.99 85.45 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.102 -0.999 . . . . 3.97 109.145 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.5 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 19.5 m -70.16 -18.51 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.247 1.203 . . . . 2.84 114.247 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.14 -40.86 71.11 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.055 -1.028 . . . . 3.57 112.178 168.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -61.96 -50.86 70.44 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.883 -0.511 . . . . 2.65 111.565 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 234' ' ' VAL . 3.1 p -66.38 -24.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 120.359 -0.536 . . . . 1.85 112.195 -176.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.39 67.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.441 1.096 . . . . 2.41 112.025 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -36.7 63.82 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.47 0.915 . . . . 3.48 113.47 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.55 -26.51 65.45 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.972 1.471 . . . . 1.67 114.972 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.96 10.27 1.75 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.244 1.572 . . . . 3.01 115.244 -168.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 74.39 -58.68 0.58 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.252 2.621 . . . . 5.42 110.765 -165.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 55.8 t 63.58 -64.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 128.143 2.577 . . . . 3.56 111.185 -165.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 30.7 t80 58.38 62.11 2.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.572 1.549 . . . . 5.35 113.251 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -68.13 148.53 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.319 -0.863 . . . . 3.71 111.234 165.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 m -107.25 98.38 22.48 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 121.464 -0.772 . . . . 3.64 109.862 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -80.57 113.24 2.82 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.039 1.826 . . . . 2.59 112.172 -171.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.503 0 N-CA-C 111.345 -0.702 . . . . 2.4 111.345 167.771 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.7 t80 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 107.786 -1.191 . . . . 3.41 107.786 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.303 0.2 OUTLIER -81.5 58.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.569 -1.332 . . . . 2.97 113.074 -158.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.76 130.5 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.281 1.432 . . . . 3.2 110.693 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.71 155.67 16.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.837 2.055 . . . . 3.61 112.482 169.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -131.98 81.56 1.97 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.086 0.954 . . . . 2.26 112.796 164.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -73.32 95.74 2.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.252 1.421 . . . . 4.59 111.826 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 158.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 116.062 1.875 . . . . 6.35 116.062 -174.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.4 tt -95.78 156.24 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 128.107 2.563 . . . . 3.91 109.761 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 35.8 ttm -96.99 145.82 25.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.785 1.234 . . . . 2.34 110.39 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -113.68 144.65 42.57 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.707 1.203 . . . . 3.8 112.275 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 13.6 tp -110.05 128.02 55.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.647 1.179 . . . . 2.09 108.689 165.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.89 143.04 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.557 -1.275 . . . . 1.77 107.557 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -108.56 176.31 20.05 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.142 0.877 . . . . 1.58 112.481 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 66.93 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.917 3.745 . . . . 2.58 109.053 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -160.22 -56.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.502 1.521 . . . . 4.27 110.487 -161.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 153.79 -134.4 4.34 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.504 0.573 . . . . 2.48 113.529 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.03 -39.76 69.49 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.849 1.426 . . . . 4.56 114.849 -150.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.4 p90 179.91 150.07 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.757 2.423 . . . . 5.05 109.225 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.91 -21.87 13.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.074 1.35 . . . . 3.59 111.505 164.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -152.46 163.16 40.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 2.6 112.234 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -158.12 131.86 7.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.727 2.011 . . . . 5.68 110.609 172.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.87 154.94 30.61 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.14 -0.975 . . . . 3.14 112.286 -171.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.66 163.17 40.21 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 122.114 0.841 . . . . 2.96 112.762 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -68.23 114.11 6.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.827 -1.546 . . . . 4.99 106.827 150.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 155.76 -14.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 129.619 3.168 . . . . 5.08 113.341 -165.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -90.41 130.94 36.43 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.966 -1.084 . . . . 4.69 113.118 -171.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -72.61 122.72 21.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.771 1.228 . . . . 6.91 108.338 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.61 -55.24 1.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.531 2.049 . . . . 2.33 116.531 -155.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -60.58 -17.16 47.61 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.427 1.013 . . . . 1.32 114.918 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.18 -30.0 70.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.479 1.14 . . . . 3.48 112.644 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.5 mt -82.76 -41.8 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.982 0.913 . . . . 1.23 108.947 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.1 -41.32 64.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.39 0.541 . . . . 1.19 112.093 168.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.49 -43.45 94.1 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.145 1.165 . . . . 1.56 114.145 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.8 p -68.53 -41.84 79.3 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.29 1.405 . . . . 1.73 111.582 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 38.2 mt -56.39 -52.39 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.374 0.988 . . . . 1.55 110.829 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.81 65.15 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.235 0.828 . . . . 1.98 113.235 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 88.7 m -70.84 -48.23 55.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.98 1.312 . . . . 1.96 110.75 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -67.16 -29.38 69.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.425 1.011 . . . . 2.57 113.434 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -19.8 63.06 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.465 1.506 . . . . 6.47 114.135 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -71.79 -45.45 12.25 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.499 -1.715 . . . . 6.08 114.157 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.45 -58.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.373 2.715 . . . . 2.12 111.722 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -85.86 119.94 26.72 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.364 -0.835 . . . . 2.98 110.916 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 N--CA 1.472 0.648 0 C-N-CA 127.625 2.37 . . . . 10.94 112.904 163.484 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 N-CA-C 112.929 -0.069 . . . . 2.26 112.929 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.05 159.45 53.87 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.774 2.983 . . . . 2.51 111.762 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -138.98 172.04 13.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.875 1.27 . . . . 2.36 110.779 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 p -141.12 18.94 2.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.506 1.669 . . . . 2.58 115.506 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.83 154.89 41.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.933 1.349 . . . . 1.92 114.396 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.9 m -91.68 147.2 23.17 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.628 1.171 . . . . 1.51 109.149 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.8 p -78.89 156.11 28.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.087 1.355 . . . . 2.55 112.549 -173.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -50.68 -25.7 4.59 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 113.906 -1.497 . . . . 2.08 113.427 162.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.0 m -72.97 -64.78 0.9 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.207 1.803 . . . . 3.24 109.513 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.01 55.0 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.488 1.518 . . . . 2.78 112.645 -169.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.22 144.84 9.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.803 2.041 . . . . 3.7 108.335 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -89.85 126.11 35.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.706 1.139 . . . . 4.93 112.047 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -112.68 162.94 15.14 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.473 -1.392 . . . . 3.1 112.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.6 p -136.04 -179.21 5.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.648 1.979 . . . . 2.59 109.784 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -68.54 -22.21 64.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.218 1.007 . . . . 4.38 112.668 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -32.2 66.95 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.865 1.061 . . . . 5.27 113.865 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.14 -37.95 84.69 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.926 1.29 . . . . 3.19 111.435 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -107.84 20.99 18.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.557 1.543 . . . . 3.66 114.284 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -80.46 167.58 19.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.379 -0.826 . . . . 3.23 110.59 167.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.89 14.21 75.74 Favored Glycine 0 N--CA 1.478 1.499 0 O-C-N 120.663 -1.273 . . . . 2.75 114.348 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -162.17 151.52 15.84 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.675 2.79 . . . . 2.81 106.743 -172.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -71.76 129.57 38.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.932 1.242 . . . . 1.67 111.647 -173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.57 133.52 53.78 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.525 1.13 . . . . 2.69 110.911 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.24 126.42 53.58 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.86 1.264 . . . . 2.7 108.415 165.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.9 mt -120.35 119.39 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.479 -0.934 . . . . 1.96 108.479 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -113.29 141.36 47.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 3.22 111.559 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -108.32 126.76 53.21 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.981 0.912 . . . . 2.21 111.802 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.486 ' HA3' ' SG ' ' A' ' 173' ' ' CYS . . . -169.95 -179.77 41.79 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.319 1.438 . . . . 1.33 113.605 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.76 137.91 26.8 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.014 1.407 . . . . 3.74 112.333 -177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.8 t -74.97 70.6 2.01 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.761 1.267 . . . . 3.43 112.249 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.4 -31.25 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.107 0.963 . . . . 7.6 111.138 -149.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 14.1 m -47.9 143.13 6.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.732 1.213 . . . . 2.06 112.316 161.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.88 -59.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.971 2.448 . . . . 3.96 109.999 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.15 137.99 21.23 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.426 -0.953 . . . . 5.37 108.426 136.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.4 t -162.21 -55.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.553 3.141 . . . . 3.14 107.283 169.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.486 ' SG ' ' HA3' ' A' ' 165' ' ' GLY . 1.7 m -57.3 -65.31 1.83 Allowed Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.775 1.63 . . . . 1.61 113.237 173.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 173' ' ' CYS . 51.3 Cg_exo -53.64 -44.97 44.48 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.957 2.438 . . . . 1.86 114.73 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -47.98 -46.11 32.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.067 1.747 . . . . 3.75 112.067 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 281' ' ' LYS . 1.2 mm-40 -77.5 -40.3 43.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.791 1.178 . . . . 2.64 112.829 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.7 76.6 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.063 -1.023 . . . . 2.86 111.997 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.07 -59.6 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.618 1.967 . . . . 3.38 110.223 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -62.84 -37.61 87.48 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.541 -1.349 . . . . 4.79 111.346 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.66 -27.28 64.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.493 1.117 . . . . 4.22 113.642 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.8 mm -69.05 -55.58 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 120.005 1.275 . . . . 2.14 109.972 171.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -68.29 -17.99 64.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.771 1.623 . . . . 4.85 111.724 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.53 -44.59 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.553 1.07 . . . . 1.57 111.007 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.31 -27.19 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 121.081 1.764 . . . . 2.46 112.88 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.74 -48.3 55.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.952 1.701 . . . . 4.42 113.278 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.73 -32.89 72.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.329 -0.857 . . . . 3.37 112.341 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.83 -50.39 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.931 0.892 . . . . 2.26 111.424 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.38 -22.71 57.29 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.672 1.124 . . . . 5.59 112.747 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.3 m -65.08 -11.45 39.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.287 -0.883 . . . . 3.24 113.268 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.95 -20.23 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 4.17 111.179 164.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.295 70.3 p 128.77 -11.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 1 C-N-CA 132.475 4.31 . . . . 6.32 115.337 152.585 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 t -178.77 71.4 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.065 1.346 . . . . 3.98 112.042 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.97 158.71 52.78 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 121.181 -0.949 . . . . 3.5 111.628 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.86 -9.85 18.2 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.789 2.326 . . . . 3.41 111.912 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . 0.269 17.5 t0 100.81 152.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 130.398 3.479 . . . . 4.21 114.058 162.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 134.12 55.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.175 1.79 . . . . 2.01 112.074 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.7 m -110.42 121.36 41.59 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.946 1.298 . . . . 1.28 109.796 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -89.3 126.43 1.6 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.941 3.094 . . . . 0.94 110.74 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.3 106.29 12.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.519 1.928 . . . . 2.53 110.783 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 115.24 26.17 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.51 -0.744 . . . . 2.88 109.681 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -89.61 112.21 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.198 0.999 . . . . 1.78 109.502 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 6.2 t -71.25 122.23 19.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.755 -0.657 . . . . 1.77 109.908 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.0 pt -106.79 48.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.806 1.642 . . . . 2.24 109.662 162.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -104.54 31.41 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.258 1.823 . . . . 4.27 113.39 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.63 -17.89 56.94 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 124.331 3.354 . . . . 2.62 114.234 -162.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -62.81 -23.95 67.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.944 1.298 . . . . 5.55 113.331 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.0 8.91 0.66 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 116.209 1.929 . . . . 6.76 116.209 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -42.11 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.881 3.272 . . . . 4.64 115.462 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.3 m -88.83 125.51 34.94 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 120.801 -1.187 . . . . 2.46 108.761 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -41.09 65.71 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.835 0.854 . . . . 4.2 113.176 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -73.76 -43.03 60.21 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-O 117.306 -1.33 . . . . 5.75 112.699 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.25 60.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.4 1.909 . . . . 1.69 112.621 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.08 -32.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 118.465 -0.779 . . . . 2.4 112.4 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.64 88.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.473 1.488 . . . . 1.36 111.352 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.93 -54.64 44.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.747 1.619 . . . . 3.8 108.698 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -47.88 -48.44 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.307 0.958 . . . . 3.27 112.9 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.9 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.072 0.851 . . . . 1.23 111.847 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -19.79 63.26 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.293 1.22 . . . . 5.23 114.293 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -69.69 -24.66 63.62 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.347 0.976 . . . . 3.68 112.171 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -89.46 -72.8 0.54 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 2.85 112.571 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 85.8 p -173.51 153.26 2.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 120.711 -1.243 . . . . 2.03 112.869 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.62 -1.68 11.41 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.167 2.578 . . . . 2.09 114.518 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -95.2 2.4 54.95 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.096 1.316 . . . . 2.19 112.573 170.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.0 tp -89.73 139.74 30.27 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.715 -1.241 . . . . 2.0 110.424 173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.29 136.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.512 1.125 . . . . 3.02 108.814 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.73 150.79 18.24 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 124.187 0.898 . . . . 1.24 110.996 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.0 155.98 35.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.987 1.315 . . . . 2.27 110.491 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.6 p -129.1 169.71 14.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.615 2.366 . . . . 2.46 109.484 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.96 148.47 14.23 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 115.879 1.112 . . . . 2.14 115.879 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -62.47 143.29 57.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.662 -0.769 . . . . 2.07 109.395 162.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.31 -21.85 66.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.194 1.183 . . . . 7.39 114.194 -161.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.4 mp0 -65.24 -45.36 84.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.645 1.578 . . . . 2.67 111.133 170.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -81.81 -33.9 30.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.905 1.282 . . . . 3.41 111.71 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.05 -36.77 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 118.605 -0.712 . . . . 1.91 111.179 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.38 -45.95 88.7 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.667 -1.158 . . . . 2.91 109.765 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -50.36 -54.21 23.39 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.291 1.405 . . . . 2.43 112.337 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.21 -38.88 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.931 1.241 . . . . 2.27 113.321 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.19 -34.28 77.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.649 0.779 . . . . 1.79 112.296 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -88.98 -32.63 17.54 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.791 2.437 . . . . 3.39 113.198 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.19 70.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.566 1.075 . . . . 1.79 110.537 165.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -85.16 9.7 14.25 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.406 1.082 . . . . 2.75 112.946 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 35.81 46.81 0.35 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.58 2.752 . . . . 4.82 115.053 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.95 136.38 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 109.386 -0.598 . . . . 3.08 109.386 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.22 129.64 37.82 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.174 -0.328 . . . . 4.03 111.352 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.27 108.53 0.73 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.36 1.864 . . . . 4.24 109.764 -160.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 149.7 37.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.062 1.134 . . . . 3.58 114.062 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.23 148.77 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.474 2.782 . . . . 4.73 110.812 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 C-N-CA 124.852 1.215 . . . . 4.05 114.265 -178.437 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 47.1 p90 . . . . . 0 C--O 1.237 0.415 0 N-CA-C 109.144 -0.687 . . . . 5.81 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 20.7 tt -72.75 76.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.552 -1.343 . . . . 3.35 110.45 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.7 t -44.94 130.86 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 127.104 2.162 . . . . 2.86 112.726 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -70.26 137.41 50.77 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.732 1.213 . . . . 4.24 111.707 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.12 137.63 19.83 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.865 -1.061 . . . . 1.71 109.703 163.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t -64.23 -24.01 67.51 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.145 1.165 . . . . 3.93 114.145 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.269 0.7 OUTLIER 67.12 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 128.789 2.836 . . . . 4.03 112.966 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.27 145.29 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.129 -1.607 . . . . 3.15 112.766 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 140.81 32.9 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 127.318 2.247 . . . . 2.95 109.638 164.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.65 145.08 41.86 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.732 0.813 . . . . 3.18 112.501 154.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.6 tp -100.51 130.69 46.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.012 1.725 . . . . 1.95 110.019 168.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.62 133.63 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.672 -1.973 . . . . 2.06 105.672 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 -177.48 19.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.168 -0.373 . . . . 1.87 112.168 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.41 42.77 1.36 Allowed 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.742 2.961 . . . . 2.97 110.818 172.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -177.76 -67.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.837 2.455 . . . . 5.2 111.009 -163.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -135.67 142.0 13.26 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 114.704 0.642 . . . . 3.89 114.704 -158.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -86.75 161.21 18.52 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.395 1.478 . . . . 7.23 114.467 -173.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 63.0 53.2 2.4 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.372 1.869 . . . . 4.2 111.974 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 55.5 tp -92.11 -33.46 14.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.564 1.146 . . . . 2.58 112.645 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -162.31 163.34 28.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.045 1.738 . . . . 2.29 109.734 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.66 142.73 11.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.164 0.985 . . . . 4.14 113.604 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -140.2 136.23 33.21 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.125 -0.985 . . . . 3.15 112.22 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.54 -171.27 45.04 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.913 -0.875 . . . . 2.6 110.913 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.59 139.44 58.77 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.505 -1.294 . . . . 3.5 107.505 147.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 14.3 t30 149.29 -59.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 129.292 3.037 . . . . 4.88 108.233 -171.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -72.85 158.36 35.68 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.56 0.578 . . . . 7.87 112.56 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -100.44 177.54 5.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.824 1.25 . . . . 5.64 110.541 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -53.25 -48.77 67.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.736 1.214 . . . . 1.78 113.803 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.74 86.08 Favored Glycine 0 N--CA 1.469 0.857 0 CA-C-N 118.416 0.553 . . . . 1.42 112.272 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.92 -28.8 64.77 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.692 1.197 . . . . 3.04 112.785 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.5 mt -69.31 -33.21 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.611 -0.681 . . . . 1.87 110.717 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -79.5 -49.47 12.22 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.063 0.847 . . . . 1.54 112.108 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.21 -32.26 73.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.778 1.231 . . . . 1.37 113.938 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.7 p -58.68 -61.62 2.47 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.095 0.958 . . . . 1.39 111.221 167.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.0 mt -52.78 -45.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.898 1.279 . . . . 1.37 111.357 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.16 -5.77 24.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.257 1.423 . . . . 1.64 114.209 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.3 m -89.11 -54.89 3.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.102 0.961 . . . . 1.66 108.732 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.54 -27.55 26.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.654 1.582 . . . . 2.61 114.321 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -51.03 -22.5 2.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.884 2.473 . . . . 4.21 114.779 170.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -98.8 -36.69 0.24 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.811 2.044 . . . . 6.39 116.387 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.36 -32.91 2.74 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.151 2.567 . . . . 2.57 111.729 166.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 -171.88 2.15 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.49 0.586 . . . . 3.27 110.008 149.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? . . . . . 0 N--CA 1.478 0.942 0 C-N-CA 125.64 1.576 . . . . 8.13 110.576 175.192 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.406 0 CA-C-O 118.648 -1.085 . . . . 2.55 112.661 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -69.47 160.14 50.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.027 2.484 . . . . 2.7 110.772 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -128.85 -155.08 0.68 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.399 1.48 . . . . 2.69 110.57 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -160.17 147.21 16.11 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.801 -1.187 . . . . 3.46 109.659 148.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 tp -156.82 167.27 30.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.049 0.94 . . . . 2.97 110.054 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -109.63 140.51 43.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.732 0.813 . . . . 2.43 110.41 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.1 p -72.08 164.86 25.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.446 1.098 . . . . 2.28 111.396 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -57.58 -12.49 2.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.96 2.504 . . . . 1.63 114.15 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 t -119.83 16.79 12.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.233 2.213 . . . . 3.26 112.537 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.79 -17.32 36.56 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 116.762 1.465 . . . . 2.31 116.762 164.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.28 140.98 55.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.464 1.632 . . . . 4.06 109.808 168.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.26 135.29 56.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.45 1.5 . . . . 8.81 108.694 167.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -142.2 119.09 11.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.025 -1.672 . . . . 3.25 112.705 170.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 94.4 m -132.37 143.26 49.72 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 127.582 2.353 . . . . 3.19 107.336 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.77 -29.3 70.04 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.193 0.997 . . . . 5.64 113.373 -174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 5.21 50.51 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.199 1.555 . . . . 7.81 115.199 174.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -41.47 6.57 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.738 0.699 . . . . 2.83 112.165 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.9 40.46 1.0 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.265 0.839 . . . . 6.38 113.265 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 tp -83.88 169.8 14.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.049 1.34 . . . . 3.33 112.898 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.82 -12.93 51.05 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.368 -1.457 . . . . 2.57 114.798 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 175.62 5.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.111 2.964 . . . . 3.81 109.916 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -88.97 80.31 7.1 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.023 1.283 . . . . 2.18 113.017 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.3 mt -67.29 140.67 57.33 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.849 0.86 . . . . 2.81 112.753 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 28.1 tp -139.16 108.74 6.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.113 1.765 . . . . 2.38 108.518 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.21 131.88 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.305 1.042 . . . . 1.89 108.515 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -128.16 155.42 44.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.681 1.192 . . . . 2.59 109.284 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -121.28 115.82 23.7 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.106 0.963 . . . . 2.22 109.063 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.22 176.12 21.52 Favored Glycine 0 N--CA 1.467 0.708 0 CA-C-O 122.452 1.029 . . . . 1.5 115.139 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -93.95 138.0 32.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.105 0.962 . . . . 3.25 109.9 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -70.54 14.05 0.15 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.338 -0.851 . . . . 3.91 111.872 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -141.81 -73.19 0.32 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.419 -1.425 . . . . 8.56 108.914 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 1.8 t 70.11 174.71 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.793 2.037 . . . . 2.82 111.817 -174.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.403 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 31.9 Cg_endo -67.63 -73.17 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.659 2.906 . . . . 3.85 109.623 143.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.68 16.65 0.08 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.462 1.505 . . . . 4.73 113.08 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.409 HG12 HE22 ' A' ' 279' ' ' GLN . 92.1 t -84.95 -49.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 119.894 -1.754 . . . . 2.86 110.715 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 64.4 m -50.77 -44.54 85.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 116.356 -1.783 . . . . 1.49 114.387 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.01 -34.82 57.48 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 122.57 1.953 . . . . 1.16 113.048 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.88 -38.27 76.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.568 1.531 . . . . 3.2 111.868 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.27 -34.67 73.07 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.314 -1.491 . . . . 3.15 112.665 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.5 tp -68.88 -42.95 76.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.363 1.065 . . . . 2.98 111.067 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.51 -45.34 66.18 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.255 1.422 . . . . 3.35 111.543 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -53.78 -59.61 4.39 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.631 -1.293 . . . . 3.15 111.863 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 5.7 ptp -64.84 -34.53 78.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.361 -0.837 . . . . 2.34 113.194 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -60.86 -52.91 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 118.108 -0.948 . . . . 1.8 110.734 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.416 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 43.1 mt-30 -68.11 -25.63 65.4 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.753 1.615 . . . . 3.77 110.692 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.51 -41.13 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.05 -0.976 . . . . 1.73 112.634 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.91 -31.87 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.827 1.194 . . . . 2.56 112.217 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.15 -42.85 99.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.265 1.426 . . . . 4.22 111.951 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.15 -54.87 23.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.557 1.543 . . . . 3.04 112.214 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.41 -35.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.556 0.947 . . . . 2.52 113.556 -163.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.03 -37.32 74.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.166 0.986 . . . . 3.53 111.099 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -68.18 -15.46 63.59 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.114 -0.991 . . . . 2.58 112.946 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.15 -0.05 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 119.838 -1.789 . . . . 2.94 111.651 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.0 m 77.28 -24.08 0.23 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.045 1.498 . . . . 4.08 115.045 144.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.474 HG21 ' HG2' ' A' ' 298' ' ' ARG . 61.8 m -102.65 -0.04 32.47 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.174 1.352 . . . . 4.27 112.133 164.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.27 124.86 91.38 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.206 -1.405 . . . . 3.4 107.206 157.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 -26.43 23.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.414 1.409 . . . . 3.82 109.934 160.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.43 175.5 3.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.956 1.702 . . . . 4.0 112.499 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 16.9 tp -137.44 117.64 13.54 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.368 -2.086 . . . . 1.7 105.368 143.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.2 m -103.06 106.55 51.43 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 119.778 1.172 . . . . 1.31 110.746 -172.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.14 117.08 4.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.642 2.228 . . . . 0.86 111.292 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 12.1 tp -99.86 94.71 6.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.675 2.39 . . . . 2.28 108.58 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -84.04 104.22 13.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.835 -0.802 . . . . 2.49 108.835 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 44.0 mm -79.48 110.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.575 -0.898 . . . . 1.88 108.575 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 75.7 m -82.16 114.17 20.5 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.132 -0.98 . . . . 3.04 111.001 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.19 2.05 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.095 1.517 . . . . 1.74 115.095 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.01 69.63 1.18 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.756 1.223 . . . . 2.97 110.722 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -79.02 38.14 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.508 3.472 . . . . 2.47 111.501 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -136.4 144.63 44.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.475 2.31 . . . . 3.8 105.566 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.95 -37.13 0.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.696 1.599 . . . . 5.06 112.829 -172.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -68.82 161.91 27.53 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.841 1.656 . . . . 4.56 111.595 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.73 152.41 51.74 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.469 1.128 . . . . 3.49 109.568 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -67.27 -21.27 65.72 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.257 0.836 . . . . 5.65 113.257 -167.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 0.5 OUTLIER -101.12 -19.89 15.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.879 2.472 . . . . 3.91 113.298 171.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.81 95.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.184 1.811 . . . . 1.58 110.893 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.69 -35.06 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.694 0.627 . . . . 3.26 112.694 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.39 -21.51 62.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.165 1.172 . . . . 1.96 114.165 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -79.21 -44.7 21.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.136 0.974 . . . . 3.94 111.102 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -43.9 72.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.542 1.137 . . . . 3.8 111.435 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.4 t -54.6 -44.1 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.731 1.212 . . . . 1.75 112.548 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.25 -35.16 73.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.988 -1.006 . . . . 6.93 112.972 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.22 -47.83 72.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.555 1.142 . . . . 3.39 111.933 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -83.74 -36.67 23.47 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.628 1.344 . . . . 2.7 114.628 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.0 m 154.05 137.31 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 129.451 3.101 . . . . 2.05 112.277 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.19 -8.08 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.037 2.492 . . . . 1.92 114.706 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -78.64 -11.88 59.99 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.584 1.083 . . . . 2.25 112.939 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.65 114.09 23.07 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.387 1.475 . . . . 2.6 107.765 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 18.6 m -96.93 131.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.998 -0.438 . . . . 2.44 110.467 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.54 105.7 2.91 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.733 1.158 . . . . 1.09 111.838 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.34 127.25 37.75 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.768 1.227 . . . . 2.66 110.064 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.2 p -151.15 140.8 21.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.094 1.758 . . . . 3.25 111.374 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.96 -139.64 2.87 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.159 0.885 . . . . 1.85 111.576 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.55 159.06 31.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.159 1.784 . . . . 3.62 110.499 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -65.17 -36.31 83.8 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.103 -0.373 . . . . 6.53 110.331 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -49.9 -55.51 14.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.584 2.354 . . . . 2.99 111.473 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -71.44 -26.98 62.96 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.858 -1.151 . . . . 4.3 113.531 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.55 -38.01 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.358 1.463 . . . . 2.32 110.61 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.39 -32.84 58.79 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.767 1.227 . . . . 5.22 109.884 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -60.16 -57.68 11.78 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.121 -0.942 . . . . 2.6 110.326 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.59 -33.51 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.608 1.095 . . . . 2.24 112.322 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.11 -54.3 36.06 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.741 -0.599 . . . . 1.62 110.64 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -70.07 -33.75 72.3 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 117.846 -1.073 . . . . 4.23 112.502 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.06 93.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.557 1.143 . . . . 1.65 113.017 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.83 2.75 55.86 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.69 1.196 . . . . 2.66 114.045 173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 77.32 24.17 0.84 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.249 2.62 . . . . 4.69 114.799 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.0 140.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.88 1.272 . . . . 2.58 110.747 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -110.07 138.28 46.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.23 1.012 . . . . 4.16 112.554 164.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.56 175.38 10.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.479 1.912 . . . . 3.67 110.456 162.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -163.26 150.65 10.93 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.4 1.08 . . . . 3.62 112.2 165.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.24 165.08 26.16 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.667 2.911 . . . . 2.97 110.755 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.623 0 C-N-CA 124.185 0.898 . . . . 2.43 113.963 178.884 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.695 0.76 . . . . 3.61 109.52 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.4 tp -67.14 175.52 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 O-C-N 121.667 -0.646 . . . . 3.08 111.495 165.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -167.45 75.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 119.316 -2.115 . . . . 4.35 108.972 -157.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -111.81 142.63 43.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.055 0.931 . . . . 5.53 111.305 -153.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -145.81 125.05 12.95 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.178 1.177 . . . . 1.88 114.178 -158.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 53.0 m -84.77 -48.82 9.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.017 0.927 . . . . 4.21 109.666 168.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.323 0.2 OUTLIER 43.36 -150.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.828 1.651 . . . . 6.34 113.622 -174.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 8.8 tt -179.58 161.86 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 129.089 2.956 . . . . 4.3 107.412 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 57.5 mtp -119.52 139.44 52.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.961 1.304 . . . . 2.0 109.957 158.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -120.63 136.72 54.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.94 0.896 . . . . 3.57 110.989 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.0 tt -102.22 118.99 38.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.603 1.561 . . . . 2.16 107.968 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.4 135.21 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.129 0.972 . . . . 1.94 109.326 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.16 147.9 50.42 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.108 -1.197 . . . . 1.68 110.108 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 62.1 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.013 3.142 . . . . 3.36 109.066 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -174.28 -66.67 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 5.1 110.977 -150.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -156.11 -68.77 0.01 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 117.289 1.676 . . . . 3.42 117.289 -157.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.43 -178.42 7.32 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.723 1.609 . . . . 6.23 109.667 -168.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -70.52 145.73 50.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.143 1.164 . . . . 3.47 114.143 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -132.1 1.99 3.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.372 1.469 . . . . 2.44 113.073 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -160.36 144.21 13.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.104 1.761 . . . . 2.82 108.128 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -154.2 147.13 24.46 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.712 1.205 . . . . 3.85 110.664 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.27 147.28 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.083 1.353 . . . . 3.06 107.806 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -81.87 -152.21 9.77 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 109.485 -1.446 . . . . 3.92 109.485 167.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.409 HE22 HG12 ' A' ' 172' ' ' VAL . 3.0 mt-30 -79.91 67.02 5.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.675 -1.231 . . . . 5.33 107.675 151.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.6 153.63 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.22 2.208 . . . . 5.27 112.657 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 89.19 123.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.411 2.284 . . . . 4.87 107.569 -139.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.1 mtt85 -81.15 -177.4 6.44 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.769 -1.197 . . . . 6.09 107.769 158.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -61.4 -40.26 93.73 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.539 -1.35 . . . . 1.85 113.757 -171.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.58 -38.39 94.62 Favored Glycine 0 N--CA 1.473 1.103 0 O-C-N 121.467 -0.77 . . . . 1.7 112.022 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.19 -16.34 63.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.859 1.263 . . . . 3.19 113.471 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.42 -46.96 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.957 -1.089 . . . . 1.37 110.841 169.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.69 79.02 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.291 -0.881 . . . . 1.2 112.015 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.68 -31.83 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.866 1.061 . . . . 1.46 113.866 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.9 p -75.5 -41.92 54.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.62 1.1 . . . . 1.51 111.372 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.39 -43.63 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.143 0.883 . . . . 1.82 111.458 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.02 68.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.928 0.891 . . . . 1.41 113.249 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.2 m -76.6 -52.19 10.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.274 1.029 . . . . 1.64 109.978 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -61.2 -34.13 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 2.07 112.378 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.6 ttt -55.66 -33.67 64.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.221 1.008 . . . . 4.53 111.754 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -58.72 -54.35 57.17 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 116.145 -1.883 . . . . 4.4 112.605 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.68 -51.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.8 3.0 . . . . 2.1 113.136 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -74.24 14.35 0.45 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.046 1.128 . . . . 3.15 114.046 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.474 ' HG2' HG21 ' A' ' 192' ' ' THR . 5.5 ttp-105 . . . . . 0 CA--C 1.516 -0.35 0 C-N-CA 125.923 1.689 . . . . 8.65 112.689 -163.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.398 0 CA-C-O 117.332 -1.816 . . . . 2.35 110.74 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.99 168.26 15.58 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.663 2.909 . . . . 2.41 112.733 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -135.62 150.7 49.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 2.91 111.174 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -141.08 75.4 1.5 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.605 -1.309 . . . . 2.24 111.63 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.93 153.38 32.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 3.46 112.41 -166.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.2 m -79.72 128.22 33.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.822 1.249 . . . . 1.46 108.475 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.8 t -80.35 146.51 31.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.979 0.912 . . . . 2.59 110.843 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -56.02 -19.89 14.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.644 2.378 . . . . 1.63 114.598 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.3 t -72.12 -38.98 69.17 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 118.232 -0.89 . . . . 3.09 112.153 170.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 116.41 70.12 0.44 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.724 1.631 . . . . 2.51 113.084 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.91 159.53 15.92 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.176 2.19 . . . . 4.06 107.635 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -109.55 123.69 49.84 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 121.193 1.815 . . . . 5.33 111.4 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -114.55 159.4 20.44 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.833 1.049 . . . . 4.29 113.833 175.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 m -139.7 158.15 44.59 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.181 2.592 . . . . 2.86 106.863 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.98 -39.31 81.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.175 0.99 . . . . 4.35 113.541 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.21 -13.06 58.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.826 1.417 . . . . 6.97 114.826 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -77.21 -47.11 21.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.214 0.915 . . . . 4.37 110.168 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.25 -33.99 55.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.932 1.293 . . . . 3.49 111.469 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 157' ' ' GLY . 0.6 OUTLIER 73.38 149.7 0.1 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.593 2.757 . . . . 6.18 108.983 -168.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 156' ' ' LEU . . . -71.67 -4.88 59.26 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.353 -1.467 . . . . 5.97 115.433 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -27.02 61.68 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 1 C-N-CA 132.84 4.456 . . . . 3.14 119.659 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 80.5 m95 66.18 35.36 6.12 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.174 1.79 . . . . 2.0 112.008 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 mp -71.24 132.64 45.25 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.531 -0.731 . . . . 3.42 110.092 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.45 111.89 24.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.762 1.625 . . . . 2.53 107.028 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.38 124.91 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.683 -0.858 . . . . 2.18 108.683 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -127.25 130.05 48.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.096 2.158 . . . . 2.7 112.142 -166.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.65 93.76 5.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.232 0.613 . . . . 2.56 111.831 -172.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.86 -174.86 14.01 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.018 1.77 . . . . 1.89 114.972 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.54 179.37 6.6 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.468 1.507 . . . . 4.9 111.906 -167.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.9 m -58.78 -32.47 69.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 115.758 -2.068 . . . . 4.01 116.254 -168.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.6 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.459 2.392 . . . . 10.28 117.459 -172.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.2 m -58.14 120.21 41.35 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-N 121.781 2.082 . . . . 4.18 114.396 -154.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.68 71.11 7.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.146 2.564 . . . . 5.75 114.117 -160.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -153.41 -117.39 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.314 2.246 . . . . 6.84 106.851 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 p -54.29 -31.23 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.143 1.777 . . . . 3.99 114.792 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.72 17.36 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 117.494 -1.241 . . . . 2.09 110.289 -173.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.48 -27.11 5.43 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.121 2.547 . . . . 1.25 113.813 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -70.92 -49.79 41.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.625 1.102 . . . . 3.17 111.659 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . 0.274 6.4 mt-10 -72.85 -14.28 61.46 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 119.67 -1.893 . . . . 2.97 112.627 174.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.47 -32.12 70.83 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.728 -1.233 . . . . 2.82 112.577 163.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -49.06 78.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.511 1.05 . . . . 4.9 108.85 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -58.46 -48.09 81.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.103 -0.951 . . . . 3.18 110.607 -175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.3 ptp -63.78 -43.53 96.1 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.724 1.602 . . . . 2.95 113.642 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.41 -53.34 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.438 -0.578 . . . . 1.98 109.438 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.425 ' HB3' ' HZ1' ' A' ' 283' ' ' LYS . 2.2 mp0 -70.56 -24.1 62.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 117.162 -1.399 . . . . 5.31 110.932 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.35 -50.79 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 121.911 2.141 . . . . 1.71 111.59 165.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.02 -31.06 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 120.685 1.584 . . . . 2.6 113.017 -173.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -83.09 -29.4 28.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.913 1.079 . . . . 4.73 113.913 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -73.17 -23.09 60.39 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.627 -1.296 . . . . 5.86 112.729 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.55 -50.8 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.474 1.909 . . . . 2.85 111.862 164.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.36 -38.29 73.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.821 1.648 . . . . 4.1 112.605 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.1 t -61.24 -22.02 64.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.583 1.553 . . . . 3.4 112.381 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 mm -79.31 11.92 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 O-C-N 120.432 -1.418 . . . . 4.49 111.261 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.7 m 89.63 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.107 2.563 . . . . 5.61 113.445 151.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.295 1.1 t -161.09 37.94 0.15 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.625 1.203 . . . . 3.98 114.109 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.06 168.8 13.71 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.433 -0.792 . . . . 4.91 111.637 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 120.03 6.92 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.697 1.598 . . . . 5.53 108.959 167.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.93 119.57 13.47 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.804 1.288 . . . . 3.99 110.633 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.2 tp -85.0 97.17 9.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.611 1.565 . . . . 2.33 108.341 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.6 m -77.06 115.14 46.09 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 117.824 -1.084 . . . . 2.21 110.317 -169.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.78 121.15 2.44 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.067 2.511 . . . . 0.93 112.163 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.8 tp -118.75 103.92 10.11 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.59 1.556 . . . . 2.52 110.863 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -86.81 125.48 33.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.877 0.871 . . . . 2.7 111.011 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.69 107.17 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.437 1.095 . . . . 1.81 109.869 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.23 96.64 3.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.198 0.523 . . . . 1.94 110.543 175.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.3 pt -87.0 28.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.228 -0.92 . . . . 2.85 113.405 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -128.68 46.35 2.15 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.828 1.651 . . . . 4.93 114.477 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.12 88.72 0.57 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.827 3.685 . . . . 2.98 109.753 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 231' ' ' ARG . 2.9 mt-10 162.27 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.188 1.795 . . . . 5.15 113.559 -159.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.91 9.14 4.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.739 1.216 . . . . 5.09 113.532 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -99.5 -137.65 0.31 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.558 2.343 . . . . 5.12 111.528 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m 155.31 137.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 1 C-N-CA 133.653 4.781 . . . . 2.44 104.739 169.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -41.51 -53.77 3.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.237 1.015 . . . . 2.91 112.242 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -70.11 -25.91 63.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.499 1.52 . . . . 3.74 114.386 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.94 -43.04 56.37 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.467 -1.395 . . . . 1.79 111.898 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 mm -64.66 -39.96 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 118.217 -0.897 . . . . 1.94 110.147 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.47 61.33 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.678 1.126 . . . . 1.59 113.188 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -69.82 -44.18 70.5 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.492 1.042 . . . . 3.5 111.465 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.1 -34.24 77.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.548 0.613 . . . . 2.64 112.434 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.87 -41.9 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.456 1.503 . . . . 1.93 111.557 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -46.16 89.77 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.099 -1.001 . . . . 5.37 110.732 174.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -43.12 -53.15 5.12 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.32 1.848 . . . . 4.14 112.034 -163.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -71.07 -73.03 0.19 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.899 1.28 . . . . 2.54 113.554 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.7 m -176.41 150.17 0.98 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.235 1.414 . . . . 2.56 112.292 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.87 5.41 3.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.49 3.46 . . . . 1.86 114.983 -165.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.47 -17.09 62.38 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.932 -1.105 . . . . 3.04 112.57 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.97 135.16 35.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.475 1.51 . . . . 1.89 112.539 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.73 136.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.301 1.441 . . . . 1.87 108.823 168.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.55 133.76 11.82 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.16 0.886 . . . . 1.47 112.408 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.8 mp -109.62 142.32 40.9 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.914 1.685 . . . . 2.36 111.005 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.0 p -149.64 167.11 27.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.891 2.876 . . . . 3.63 109.696 -166.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 172.58 -155.87 24.03 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.289 0.947 . . . . 1.86 111.226 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.1 t -96.68 172.85 7.64 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.931 1.348 . . . . 2.35 110.597 163.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 206' ' ' GLU . 40.9 ttm-85 -49.36 -30.07 7.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.871 2.069 . . . . 5.74 113.274 177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.42 -53.2 25.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.353 1.461 . . . . 3.78 111.789 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.18 -41.87 84.83 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.065 -1.022 . . . . 3.55 111.466 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.5 t -67.67 -29.96 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.994 0.917 . . . . 2.14 112.456 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.43 -49.79 74.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.733 -1.127 . . . . 3.26 108.883 173.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -56.63 -55.65 31.31 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.457 1.026 . . . . 3.71 111.862 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.85 -35.43 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.525 0.565 . . . . 3.19 112.525 -172.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.11 -44.76 68.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.927 0.491 . . . . 1.45 111.086 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -73.29 -36.08 66.24 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.302 1.841 . . . . 3.35 112.508 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.64 -54.09 47.4 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.591 1.156 . . . . 2.67 112.372 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -85.09 2.43 43.46 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.327 0.651 . . . . 2.68 112.451 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 58.47 39.94 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.712 2.405 . . . . 5.66 113.091 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.2 m -69.89 -25.98 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.429 1.27 . . . . 3.49 114.429 -161.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 81.1 t80 66.67 141.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.67 1.988 . . . . 3.85 115.097 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.62 159.78 27.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.469 2.308 . . . . 3.64 109.401 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.6 t -164.09 134.32 3.21 Favored Pre-proline 0 N--CA 1.477 0.92 0 O-C-N 120.977 -1.077 . . . . 3.33 112.331 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.67 141.28 21.85 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.414 2.743 . . . . 2.92 112.282 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.445 0 C-N-CA 124.079 0.847 . . . . 2.57 114.75 -177.06 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 CA--C 1.546 0.807 0 CA-C-O 121.858 0.837 . . . . 3.75 112.325 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp -57.47 164.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.615 1.166 . . . . 2.8 112.009 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.7 t -149.83 136.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 105.786 -1.931 . . . . 2.93 105.786 172.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -66.16 134.36 52.59 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.398 1.079 . . . . 3.47 110.509 172.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -154.34 114.49 3.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.985 0.914 . . . . 2.47 111.371 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.8 p -67.64 -22.98 65.29 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.321 1.448 . . . . 3.15 114.274 -170.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 tp 76.48 -5.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 127.912 2.485 . . . . 5.32 114.025 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.8 mt -49.5 133.54 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.154 1.782 . . . . 3.22 111.602 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 11.6 ptm -141.44 143.78 34.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 113.564 -1.653 . . . . 2.37 111.131 -163.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -127.64 145.2 50.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.907 0.883 . . . . 2.81 111.801 -162.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.88 125.66 38.63 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.513 1.125 . . . . 1.89 109.127 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -100.48 135.6 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.969 1.308 . . . . 2.0 108.149 170.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.38 -177.24 45.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.725 1.155 . . . . 1.89 111.454 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.77 54.48 4.5 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.967 3.111 . . . . 2.57 114.271 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -166.8 -54.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.648 1.979 . . . . 6.47 111.193 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 147.5 -20.81 1.51 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.658 0.623 . . . . 2.5 114.658 -160.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.39 144.56 57.08 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.175 0.99 . . . . 7.02 111.778 165.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -74.67 155.95 37.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.23 1.012 . . . . 4.3 112.491 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -36.94 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.606 0.762 . . . . 3.13 112.842 174.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -165.52 172.44 12.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.759 1.224 . . . . 2.08 111.133 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.26 164.54 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.331 1.452 . . . . 3.23 112.945 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.03 -179.21 7.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.737 1.615 . . . . 2.52 111.322 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 119.36 146.33 7.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.326 1.441 . . . . 2.7 113.702 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 40.75 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 1 C-N-CA 132.526 4.33 . . . . 4.2 118.135 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.43 -46.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.702 -1.249 . . . . 4.85 112.755 -173.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.27 90.03 0.9 Allowed 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.346 -0.846 . . . . 4.64 110.582 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -67.29 161.26 25.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.405 1.882 . . . . 5.2 112.641 -165.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HZ1' ' HB3' ' A' ' 182' ' ' GLN . 0.9 OUTLIER -42.07 -59.04 1.88 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.691 1.996 . . . . 3.47 115.388 -168.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.92 -34.05 76.21 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.292 -0.88 . . . . 1.48 113.159 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.97 -31.56 72.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.124 1.37 . . . . 3.65 111.934 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.6 mt -58.16 -56.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.227 -0.921 . . . . 1.16 109.519 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.88 -40.42 76.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.366 0.506 . . . . 1.22 112.366 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.85 87.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.862 0.865 . . . . 1.41 113.227 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.6 p -63.7 -43.44 96.6 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.298 -0.876 . . . . 1.22 111.983 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 49.3 mt -64.71 -37.0 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.036 -1.04 . . . . 1.67 111.436 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.7 -22.84 65.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.304 1.041 . . . . 1.74 113.429 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 39.7 m -71.12 -48.35 52.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.163 -0.68 . . . . 1.84 109.163 169.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -67.38 -26.07 66.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.113 1.365 . . . . 2.7 113.503 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -25.3 63.21 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.888 -1.132 . . . . 5.48 111.8 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -57.19 -40.71 86.78 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 117.364 -1.303 . . . . 4.83 112.608 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.22 -60.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.852 2.368 . . . . 3.3 111.448 160.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.45 31.11 6.02 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.565 1.321 . . . . 5.13 114.565 -156.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 O-C-N 121.05 -1.032 . . . . 7.33 112.259 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 119.43 -0.65 . . . . 2.33 113.898 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.51 -170.79 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.292 3.328 . . . . 2.37 110.049 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -146.46 177.81 8.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.686 1.195 . . . . 2.2 111.081 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -144.38 34.07 1.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.549 1.315 . . . . 2.62 114.549 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mp -64.83 156.29 31.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.649 1.214 . . . . 2.15 112.636 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -92.72 142.74 27.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.173 1.389 . . . . 1.61 109.05 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -83.62 166.21 18.35 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.861 1.265 . . . . 2.07 111.757 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -3.84 2.32 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.197 1.799 . . . . 1.63 114.958 173.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.6 m -79.03 -36.86 40.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.837 1.655 . . . . 3.21 111.729 164.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.08 11.89 30.92 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.704 1.621 . . . . 1.95 113.679 -164.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 141.07 43.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.122 1.369 . . . . 3.4 110.406 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.33 112.74 24.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.26 1.424 . . . . 5.34 111.46 -164.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.87 158.52 16.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.139 1.375 . . . . 3.08 112.663 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.2 p -115.54 -179.82 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.311 2.245 . . . . 2.53 108.739 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -38.19 88.74 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.844 -0.535 . . . . 3.6 111.841 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -77.88 -6.58 54.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.107 1.521 . . . . 6.46 115.107 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.28 -29.89 70.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.05 0.94 . . . . 2.86 111.724 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -100.14 -11.88 20.1 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.095 1.517 . . . . 3.07 115.095 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.34 108.2 1.54 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.579 1.151 . . . . 3.68 111.563 -170.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.13 2.67 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.811 1.196 . . . . 2.79 112.888 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.21 163.85 17.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.193 0.997 . . . . 3.57 109.268 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -78.49 138.53 38.48 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.523 -0.736 . . . . 2.0 109.494 161.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.23 144.02 36.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.161 0.982 . . . . 3.11 113.523 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.16 117.88 24.04 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.592 1.157 . . . . 2.67 108.729 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.9 mt -101.93 127.13 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.059 0.943 . . . . 1.74 109.125 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.64 142.14 39.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.73 0.776 . . . . 3.34 111.168 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -99.72 126.9 45.85 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.321 1.049 . . . . 2.22 108.97 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.39 169.34 26.43 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 124.292 0.995 . . . . 1.32 114.721 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -120.07 171.24 8.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.317 1.847 . . . . 4.22 108.018 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 71.2 m -53.82 -12.22 0.51 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.666 2.469 . . . . 3.49 117.666 -166.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -177.22 -27.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 122.427 2.376 . . . . 10.01 116.776 167.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 61.6 m 60.85 174.62 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 117.548 2.425 . . . . 2.86 117.548 167.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.21 164.41 30.45 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.236 1.957 . . . . 3.07 109.865 154.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.09 46.63 0.32 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.086 2.554 . . . . 4.37 113.932 -165.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 94.8 t -111.86 -53.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 127.584 2.354 . . . . 2.9 109.07 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 34.6 t -64.16 -60.84 7.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.187 0.995 . . . . 1.71 112.922 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.69 -24.95 47.13 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.25 1.967 . . . . 1.4 112.635 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -71.2 -55.21 8.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.441 1.096 . . . . 2.81 111.254 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -65.26 -25.84 67.83 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.279 -0.888 . . . . 3.21 112.194 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -65.17 -34.42 78.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.018 -0.991 . . . . 3.21 110.695 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.89 -43.04 59.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.44 1.473 . . . . 3.54 111.788 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -50.22 -39.3 44.09 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.452 -1.405 . . . . 3.58 112.162 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.79 -50.41 43.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.914 1.286 . . . . 3.12 112.426 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.77 -37.16 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 120.789 1.631 . . . . 1.87 112.025 -174.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.531 ' C ' ' HE3' ' A' ' 283' ' ' LYS . 54.3 mt-30 -56.09 -27.57 54.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.84 1.2 . . . . 3.48 111.522 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 36.0 t -68.75 -20.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 120.586 -1.321 . . . . 2.2 111.771 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.9 t -67.28 -38.82 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.856 0.753 . . . . 2.15 109.479 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -49.99 74.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.486 1.114 . . . . 5.03 110.963 171.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.27 -25.54 63.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.5 1.12 . . . . 3.03 113.781 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.15 -45.33 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.986 1.715 . . . . 2.26 112.703 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.36 -32.37 66.7 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.476 1.035 . . . . 3.69 111.1 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -20.23 63.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.565 1.546 . . . . 2.92 112.901 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.08 -16.94 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 120.897 -1.127 . . . . 3.41 111.701 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.5 t 56.47 -7.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.694 3.197 . . . . 5.14 118.633 165.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 67.4 p -109.18 9.25 26.08 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 120.802 1.637 . . . . 3.52 114.411 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.92 160.92 29.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.226 1.81 . . . . 3.23 112.847 -168.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -82.8 51.56 3.74 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.282 3.321 . . . . 3.52 110.729 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.1 t0 57.94 -175.84 0.08 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.332 2.253 . . . . 4.48 115.405 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.94 118.06 28.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.969 1.308 . . . . 1.97 108.63 155.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.5 m -98.88 99.92 8.76 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.437 1.495 . . . . 1.22 109.983 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.09 133.02 17.46 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.96 2.44 . . . . 0.9 111.649 170.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.38 89.21 3.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.103 2.161 . . . . 2.51 108.161 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -83.7 130.86 34.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.716 0.806 . . . . 1.91 109.575 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.7 mt -108.55 122.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.892 0.877 . . . . 1.71 109.855 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.4 m -67.34 119.61 12.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.587 0.755 . . . . 2.43 110.839 166.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.29 -3.55 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 120.955 -1.091 . . . . 2.58 113.721 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -111.81 57.34 0.46 Allowed Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 127.381 2.272 . . . . 4.24 113.554 -170.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.94 75.9 2.62 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.866 3.711 . . . . 2.75 109.966 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -173.42 -35.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.846 2.458 . . . . 3.61 111.473 -169.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.34 32.52 2.83 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.028 0.931 . . . . 5.76 112.388 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -119.99 173.29 7.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.912 2.485 . . . . 4.01 109.673 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.3 m -169.2 139.98 2.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.275 2.63 . . . . 2.89 107.143 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -36.61 66.82 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.434 0.901 . . . . 3.44 113.434 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -79.59 -28.0 41.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.893 2.077 . . . . 3.85 112.67 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.45 42.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.797 0.726 . . . . 2.03 110.084 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.1 tp -62.01 -31.6 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.72 0.408 . . . . 2.31 111.989 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.62 95.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.184 -0.948 . . . . 1.24 111.826 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -69.21 -29.22 67.13 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.196 0.813 . . . . 4.21 113.196 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -68.1 -48.36 65.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.544 1.138 . . . . 3.61 110.778 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.1 t -52.2 -45.74 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.166 -0.959 . . . . 1.31 111.519 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -59.88 -18.67 46.25 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.39 1.476 . . . . 5.22 113.188 176.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.91 -48.03 80.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.959 1.708 . . . . 4.77 110.927 171.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -87.82 -53.2 4.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.347 0.869 . . . . 2.84 113.347 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.7 p -177.33 159.61 1.39 Allowed Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.634 -1.291 . . . . 3.22 112.91 -159.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -86.24 -16.0 4.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.716 2.944 . . . . 2.08 113.807 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -85.61 -4.44 59.16 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.788 1.176 . . . . 2.35 113.52 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.89 136.79 36.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.942 0.897 . . . . 2.33 111.171 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 t -110.99 131.36 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.574 -1.269 . . . . 2.02 107.574 163.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.73 114.65 4.59 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 109.497 -1.441 . . . . 1.01 109.497 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.4 144.35 33.21 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.665 0.786 . . . . 2.13 110.756 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -157.79 -179.7 8.39 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.641 1.576 . . . . 2.6 110.785 -172.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 167.42 -116.69 0.69 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.255 -1.138 . . . . 1.84 110.255 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.5 p -128.0 168.0 15.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.613 1.165 . . . . 3.04 112.211 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -39.36 46.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.67 0.788 . . . . 5.79 111.248 -177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 2.2 mp0 -59.76 -54.23 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.293 2.237 . . . . 3.52 113.131 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -69.46 -31.68 70.13 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.879 -1.138 . . . . 4.98 111.831 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.43 -29.61 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 117.944 -1.027 . . . . 1.68 111.625 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.29 -42.53 88.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.031 1.287 . . . . 3.18 110.227 162.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -56.49 -50.5 71.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 117.987 -1.006 . . . . 2.85 112.622 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.4 m -71.2 -26.86 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 120.583 1.538 . . . . 2.48 114.576 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.451 ' HB1' HG22 ' A' ' 243' ' ' VAL . . . -65.57 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.615 1.098 . . . . 1.51 112.628 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -105.09 -21.76 13.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.772 3.229 . . . . 5.96 113.467 -167.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.72 -28.99 64.06 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.472 1.033 . . . . 1.97 112.268 162.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.08 -127.06 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.402 1.081 . . . . 2.66 109.404 164.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -164.78 74.71 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.572 1.149 . . . . 5.7 110.145 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.451 HG22 ' HB1' ' A' ' 238' ' ' ALA . 7.5 m -83.63 173.92 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 111.765 0.283 . . . . 3.45 111.765 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.423 ' CD2' HG22 ' A' ' 261' ' ' THR . 13.0 p90 -147.8 154.19 40.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.126 1.371 . . . . 6.75 110.737 166.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -154.94 125.43 6.89 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.524 1.53 . . . . 4.32 111.176 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.6 t -106.74 110.54 63.76 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 120.795 -1.19 . . . . 3.89 109.257 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.99 144.52 38.3 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.524 2.149 . . . . 3.21 111.367 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.365 0 C-N-CA 124.892 1.234 . . . . 3.02 115.092 -175.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 109.431 -0.581 . . . . 3.22 109.431 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.0 tp -83.95 154.07 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.384 -0.823 . . . . 2.93 111.639 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.7 134.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 129.449 3.099 . . . . 2.94 105.635 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.83 168.0 14.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.162 0.982 . . . . 3.22 110.397 165.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -150.46 36.26 0.65 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.079 0.943 . . . . 3.65 110.907 168.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.423 HG22 ' CD2' ' A' ' 244' ' ' TYR 0.266 13.7 p 65.51 -134.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.54 2.336 . . . . 3.55 110.999 -171.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 176.19 -17.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 129.029 2.932 . . . . 5.21 110.795 -163.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.4 mt -69.92 134.03 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.57 1.148 . . . . 2.79 109.546 170.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.8 ttm -119.6 137.49 53.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.3 1.84 . . . . 2.94 108.206 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.97 127.59 51.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.677 0.791 . . . . 3.52 112.18 -159.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.83 130.74 48.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.595 1.158 . . . . 1.95 112.075 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.9 151.3 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.296 1.838 . . . . 1.82 106.297 166.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -142.55 -135.07 3.02 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 121.268 -0.895 . . . . 1.99 113.0 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.11 1.61 7.02 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.654 2.903 . . . . 2.46 113.545 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.87 -47.0 55.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.23 2.212 . . . . 5.61 113.723 172.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.88 13.09 54.45 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 117.628 -1.651 . . . . 3.01 116.746 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.57 -70.7 0.35 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.065 1.432 . . . . 4.16 111.883 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -166.69 146.96 5.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.164 0.985 . . . . 4.64 111.915 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 -33.01 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.424 1.639 . . . . 2.72 115.424 -170.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -168.52 167.94 11.33 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.11 1.323 . . . . 2.56 112.76 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.45 152.55 32.11 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.694 1.738 . . . . 3.21 115.694 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -120.33 163.71 17.42 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.888 1.275 . . . . 2.64 110.481 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -167.08 102.56 0.19 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.326 -0.859 . . . . 4.08 111.765 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 64.15 164.06 0.13 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.24 1.416 . . . . 3.68 110.965 -162.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 37.8 t30 77.1 -57.2 0.52 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.309 1.843 . . . . 5.83 112.467 165.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? 49.71 19.97 0.47 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.085 2.154 . . . . 9.88 116.226 162.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.39 142.38 56.98 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 119.139 -2.226 . . . . 5.61 110.612 -163.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.531 ' HE3' ' C ' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -46.03 -52.18 12.36 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.192 0.997 . . . . 2.38 113.593 -170.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.37 -23.28 71.71 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.506 -1.164 . . . . 1.45 114.647 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -74.07 -49.14 25.38 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.494 1.647 . . . . 3.36 110.378 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.66 -47.73 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.324 0.649 . . . . 1.28 109.389 174.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.96 75.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.207 -0.901 . . . . 1.35 112.516 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.43 91.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.925 1.239 . . . . 1.3 112.752 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 91.5 p -60.02 -57.35 13.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.932 0.333 . . . . 1.36 111.562 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.34 -35.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.754 -1.216 . . . . 1.45 110.993 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.37 73.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.825 1.25 . . . . 1.85 113.921 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 14.4 t -76.25 -33.27 59.18 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.182 1.356 . . . . 2.88 111.452 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -70.87 -24.59 62.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.976 0.91 . . . . 2.18 113.26 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.5 mtt -54.1 -40.95 67.73 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.432 -1.418 . . . . 5.8 111.467 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -59.01 -45.09 99.59 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 115.714 -2.089 . . . . 4.43 114.557 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.85 -7.55 11.32 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.606 2.87 . . . . 2.26 114.429 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -119.85 -154.65 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 120.027 1.285 . . . . 3.43 113.4 -171.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 . . . . . 0 CA--C 1.538 0.488 0 O-C-N 120.027 -1.671 . . . . 11.07 111.354 -174.052 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.356 0 CA-C-O 118.216 -1.325 . . . . 4.17 112.1 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.57 148.02 90.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.837 2.358 . . . . 4.02 112.136 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -151.23 171.76 16.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 3.21 111.988 -174.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 p -139.04 42.28 2.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.954 1.835 . . . . 3.7 115.954 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.49 152.64 21.34 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 119.902 -1.749 . . . . 3.57 112.699 -170.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.9 m -92.14 139.65 30.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.682 1.193 . . . . 2.47 110.155 -173.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.2 p -84.38 159.79 20.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.037 0.935 . . . . 2.51 112.587 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -9.36 2.07 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.479 1.512 . . . . 1.82 115.0 169.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 99.7 m -71.68 -53.68 12.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.463 1.105 . . . . 3.72 109.858 164.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.63 -10.84 8.0 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.358 1.933 . . . . 3.05 113.619 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 148.73 27.96 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 124.83 1.252 . . . . 5.14 111.112 171.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 97.59 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.695 1.198 . . . . 6.15 111.663 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -95.66 161.94 13.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.178 1.177 . . . . 4.7 114.178 -171.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -112.43 169.5 8.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.2 1.8 . . . . 2.88 110.773 164.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -41.87 -42.68 2.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.914 2.486 . . . . 4.1 113.213 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -82.04 -22.68 36.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.168 1.173 . . . . 7.17 114.168 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.24 -14.39 60.92 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.928 0.871 . . . . 3.86 111.936 165.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -102.88 9.96 38.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.968 2.507 . . . . 3.16 114.782 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.35 156.38 26.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.614 1.552 . . . . 3.17 115.003 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.59 43.05 Favored Glycine 0 N--CA 1.478 1.463 0 C-N-CA 124.818 1.199 . . . . 2.66 115.656 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -140.39 162.68 34.74 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.917 2.487 . . . . 3.3 109.695 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.8 131.6 43.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.259 0.552 . . . . 2.14 111.943 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.8 mt -108.09 125.39 51.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.035 1.334 . . . . 2.75 109.781 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.443 HD11 ' HG ' ' A' ' 196' ' ' LEU . 4.8 mp -121.57 103.99 9.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.624 1.169 . . . . 3.41 108.094 -173.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.3 mt -117.67 124.97 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.934 0.893 . . . . 2.01 109.934 -155.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -142.37 155.12 45.12 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.007 1.323 . . . . 2.25 112.159 -165.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.87 122.63 39.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.752 1.221 . . . . 2.8 111.114 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.69 -154.66 8.25 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.538 1.066 . . . . 1.26 112.653 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -168.02 169.32 11.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.721 1.608 . . . . 3.51 111.42 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.27 13.5 t -77.97 30.9 0.17 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 119.602 -1.936 . . . . 4.13 112.75 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -97.43 -29.79 13.29 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.777 1.631 . . . . 7.23 113.775 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 60.4 m -104.72 153.11 39.5 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 116.221 1.934 . . . . 2.88 116.221 -165.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.21 -22.27 2.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.886 3.058 . . . . 4.49 113.534 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -140.65 -58.19 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.948 1.092 . . . . 4.79 113.948 -171.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.7 p -60.36 -32.41 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.675 1.59 . . . . 3.29 114.687 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.8 m -74.89 -66.11 0.47 Allowed Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.167 0.894 . . . . 1.51 112.129 161.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 -28.5 68.92 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.713 1.608 . . . . 1.16 115.154 -166.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -71.32 -30.47 66.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.762 1.619 . . . . 3.04 112.49 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.67 -40.48 72.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.808 0.731 . . . . 3.12 110.448 168.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.45 -37.66 74.38 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.873 1.215 . . . . 3.26 113.05 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.03 -58.82 5.89 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.315 1.446 . . . . 4.21 110.205 165.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -56.68 -40.98 76.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.081 1.352 . . . . 3.23 112.972 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 48.3 mtp -60.62 -40.75 93.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.929 1.692 . . . . 2.89 112.529 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.6 tp -87.41 -37.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.693 1.588 . . . . 2.62 112.678 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -53.2 -43.28 67.08 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 124.762 1.225 . . . . 3.48 110.704 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.86 -13.56 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 113.801 1.037 . . . . 2.07 113.801 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.2 -23.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.998 -1.064 . . . . 2.0 111.603 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -50.37 67.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.746 0.818 . . . . 4.68 112.187 -170.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.54 -19.1 65.24 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.673 1.589 . . . . 3.37 114.115 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -56.49 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 120.914 -1.116 . . . . 2.51 109.347 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.78 -36.99 82.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.605 1.162 . . . . 4.0 112.159 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -71.87 -7.61 49.49 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.773 1.027 . . . . 3.36 113.773 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.5 mm -103.34 -29.72 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.128 0.876 . . . . 4.7 111.095 168.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.0 m 72.73 -25.88 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 127.56 2.344 . . . . 6.15 114.211 157.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 56.0 m -74.81 -2.67 27.67 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.794 3.237 . . . . 3.93 112.673 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 mp -99.26 157.66 33.64 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.594 1.558 . . . . 3.32 110.075 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.46 143.68 48.14 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.28 1.987 . . . . 3.62 108.183 155.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.26 159.31 3.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 116.078 1.881 . . . . 3.5 116.078 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.443 ' HG ' HD11 ' A' ' 161' ' ' LEU . 7.1 mp -99.19 95.52 7.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.246 -1.39 . . . . 2.84 107.246 157.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.4 m -86.95 112.04 44.63 Favored Pre-proline 0 N--CA 1.475 0.786 0 N-CA-C 108.126 -1.065 . . . . 1.28 108.126 168.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -86.82 136.86 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.789 2.326 . . . . 0.89 109.86 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.15 123.11 16.6 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.484 1.135 . . . . 3.6 112.442 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -109.45 133.15 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.535 1.534 . . . . 2.21 110.554 -160.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 36.3 mm -99.55 122.01 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.154 0.981 . . . . 1.83 110.516 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 95.6 p -74.07 124.61 26.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.102 0.561 . . . . 3.53 110.097 165.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.5 pt -94.05 -18.05 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.322 1.601 . . . . 2.2 115.322 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -119.48 59.38 5.17 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 120.419 1.463 . . . . 2.67 114.367 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.54 99.57 0.21 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.43 2.087 . . . . 2.68 107.393 165.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 165.65 -45.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.986 2.515 . . . . 4.46 108.523 -147.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 -18.19 0.6 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.927 1.455 . . . . 5.56 114.927 151.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.66 136.77 54.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.847 1.203 . . . . 4.3 109.394 155.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.2 t -154.0 155.73 36.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 3.5 112.384 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -58.1 -47.04 84.47 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.484 1.914 . . . . 2.8 113.983 -163.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -71.66 -38.69 70.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.328 1.422 . . . . 3.54 112.77 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.7 93.99 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.221 -0.924 . . . . 1.46 111.14 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 mm -61.3 -39.77 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.057 0.943 . . . . 1.87 111.736 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.45 86.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.629 1.104 . . . . 1.44 112.309 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -62.55 -52.71 62.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.922 0.783 . . . . 3.2 111.811 168.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -55.58 -32.17 62.81 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.726 1.21 . . . . 2.95 113.519 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 224' ' ' LEU . 2.4 t -65.35 -58.16 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.02 2.128 . . . . 1.3 112.576 166.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -52.91 -48.14 67.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.953 0.901 . . . . 3.82 112.181 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.63 -20.46 58.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.231 0.957 . . . . 5.02 112.627 -162.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -79.86 -56.14 4.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.79 0.723 . . . . 2.84 110.875 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.8 m 169.14 132.25 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 127.297 2.239 . . . . 2.32 112.208 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.19 7.34 1.44 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.394 3.396 . . . . 3.11 116.094 -168.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -67.94 -35.33 78.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.205 1.366 . . . . 2.36 110.768 159.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 217' ' ' VAL . 7.0 tt -62.08 118.51 7.43 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.258 -1.386 . . . . 2.11 107.258 173.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.85 131.38 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.098 -1.075 . . . . 2.04 108.098 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -93.51 127.78 9.18 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.117 -1.593 . . . . 1.09 109.117 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.48 144.92 50.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.837 0.827 . . . . 2.27 111.291 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 26.1 p -140.36 176.15 9.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.706 2.002 . . . . 2.81 109.255 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -175.69 -154.55 11.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.183 -1.967 . . . . 2.23 108.183 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.5 p -81.94 171.99 13.8 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.331 0.586 . . . . 4.05 110.615 167.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -63.07 -23.99 67.7 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.756 -0.59 . . . . 6.76 112.085 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 16.2 mp0 -80.8 -31.12 35.81 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.536 1.934 . . . . 3.88 111.913 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.15 -41.51 73.74 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.916 -1.115 . . . . 4.96 109.691 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.99 -38.69 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.268 -0.895 . . . . 2.39 111.92 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.09 -39.32 79.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.423 -0.799 . . . . 3.71 111.143 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -52.33 -58.87 5.32 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.737 -1.125 . . . . 3.59 110.377 173.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.26 -31.61 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.79 1.177 . . . . 2.85 113.17 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.97 -50.75 38.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.54 1.064 . . . . 2.36 111.37 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -36.95 74.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.003 1.721 . . . . 7.97 112.402 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.21 65.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.689 1.132 . . . . 2.69 110.724 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -76.17 -7.85 55.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.555 0.742 . . . . 2.93 112.827 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 26.3 ttp-105 71.06 38.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.567 2.347 . . . . 7.69 112.431 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.69 138.92 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.365 1.466 . . . . 4.28 108.659 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -105.85 136.86 44.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.222 0.534 . . . . 4.66 111.177 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -89.85 144.2 26.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.897 0.479 . . . . 3.16 109.912 164.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 t -119.69 94.2 48.26 Favored Pre-proline 0 N--CA 1.477 0.906 0 O-C-N 120.895 -1.128 . . . . 3.31 112.704 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.78 138.76 9.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.362 2.708 . . . . 2.91 113.149 -171.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.636 0 C-N-CA 123.78 0.705 . . . . 2.47 112.503 163.947 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . 0.262 6.9 p90 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 122.338 1.066 . . . . 3.94 112.397 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.4 tp -105.39 148.73 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.054 1.342 . . . . 3.03 111.338 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.9 132.61 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.452 -2.055 . . . . 3.27 105.452 161.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.42 139.17 43.81 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.561 0.618 . . . . 4.11 111.298 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -131.41 93.9 3.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.936 0.894 . . . . 2.3 110.876 161.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.7 t -48.2 122.53 5.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.525 0.73 . . . . 4.94 110.266 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 10.5 pt -88.07 101.1 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.816 0.817 . . . . 4.78 112.372 -165.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.1 mt -132.57 127.04 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.973 1.309 . . . . 2.79 108.05 162.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.8 ptm -94.0 130.48 40.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.268 0.627 . . . . 2.78 109.734 162.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -97.92 135.14 40.08 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.215 -0.928 . . . . 3.26 111.233 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 108.96 19.68 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.269 -1.012 . . . . 2.09 108.269 168.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.7 mm -93.73 135.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.627 -1.249 . . . . 2.91 107.627 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.08 176.61 29.86 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 122.872 0.272 . . . . 1.92 112.535 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.4 39.96 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 125.256 3.97 . . . . 2.64 112.153 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -161.11 -36.45 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.3 2.24 . . . . 4.89 113.53 -158.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.86 0.0 21.34 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 117.169 -1.906 . . . . 3.1 116.307 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -99.4 157.94 16.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.898 1.849 . . . . 5.33 111.195 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -74.28 108.21 6.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.111 1.365 . . . . 3.9 110.386 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.33 -28.59 16.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.575 0.75 . . . . 2.68 112.275 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -170.79 -179.71 2.93 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.756 1.622 . . . . 2.66 111.842 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -158.87 157.71 32.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.648 1.979 . . . . 3.99 112.321 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -147.7 -179.46 6.9 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.517 1.927 . . . . 2.83 111.394 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.75 -100.87 0.23 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.816 1.198 . . . . 4.16 112.362 174.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -67.38 -30.28 70.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.937 -1.331 . . . . 4.66 113.461 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.95 137.39 50.32 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.758 0.823 . . . . 4.58 109.508 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.54 86.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.641 0.777 . . . . 4.33 110.641 -143.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -89.02 -164.38 1.13 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.83 1.652 . . . . 9.69 109.227 156.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -29.61 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.636 2.374 . . . . 2.24 116.446 -168.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.71 -20.95 72.99 Favored Glycine 0 N--CA 1.476 1.327 0 CA-C-N 118.945 0.793 . . . . 1.8 112.74 -168.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -18.73 30.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.386 0.674 . . . . 5.06 112.168 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.92 -49.69 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.105 -0.997 . . . . 1.45 109.379 156.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.47 70.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.144 0.883 . . . . 1.36 113.169 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.22 60.06 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.279 1.215 . . . . 1.36 114.279 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 64.3 p -69.56 -52.55 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.618 -0.676 . . . . 1.74 111.689 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.5 mm -58.48 -42.51 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.256 -0.903 . . . . 1.93 109.708 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.08 -11.97 23.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.087 1.755 . . . . 2.09 114.248 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.9 m -97.39 -54.95 2.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.084 1.354 . . . . 1.95 109.566 170.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -64.09 -25.58 68.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.362 1.465 . . . . 2.5 113.986 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 mmm -65.53 -20.51 66.37 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.525 1.13 . . . . 4.76 113.987 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -62.45 -48.58 86.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 116.12 -1.895 . . . . 4.8 112.257 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.35 -43.71 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.61 2.207 . . . . 1.93 112.05 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.14 53.2 2.74 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.105 1.15 . . . . 2.58 114.105 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 . . . . . 0 N--CA 1.479 0.982 0 C-N-CA 130.258 3.423 . . . . 10.73 111.477 165.449 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 CA-C-O 118.066 -1.408 . . . . 2.73 111.314 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.5 157.59 28.85 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.976 2.451 . . . . 3.16 112.403 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -131.13 168.85 16.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.327 1.851 . . . . 2.92 111.538 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.4 p -125.49 22.12 7.72 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.772 2.138 . . . . 3.6 116.772 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.92 162.34 29.17 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.837 1.051 . . . . 2.05 113.837 -163.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 142.6 30.69 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.536 1.534 . . . . 2.02 109.8 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 m -98.53 140.26 33.04 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.089 1.756 . . . . 2.88 110.243 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -47.53 -20.86 0.27 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.405 2.682 . . . . 1.78 116.445 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.4 t -90.08 -7.39 53.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.802 1.241 . . . . 3.73 113.798 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.21 38.43 4.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.433 1.015 . . . . 3.46 113.265 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.49 -172.99 3.56 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.226 1.41 . . . . 5.24 110.016 172.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -152.9 136.82 16.26 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.459 1.027 . . . . 6.78 109.709 -156.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.545 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 8.8 mptt -132.16 167.28 20.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.747 1.758 . . . . 4.24 115.747 -168.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 88.2 m -164.91 156.17 14.86 Favored 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 132.732 4.413 . . . . 3.09 105.232 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.51 -42.27 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.808 1.185 . . . . 3.69 113.049 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -3.93 9.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.156 1.539 . . . . 8.35 115.156 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -87.36 -20.08 27.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.742 1.217 . . . . 3.11 112.767 166.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.545 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 7.8 m-85 -109.0 -20.45 13.03 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.039 1.496 . . . . 3.4 115.039 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 137.14 31.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.204 1.402 . . . . 3.3 112.304 -171.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.85 58.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.81 1.195 . . . . 2.26 112.778 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -107.34 165.4 11.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.697 1.999 . . . . 3.28 108.296 161.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -89.61 137.48 32.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.136 -0.69 . . . . 2.19 109.136 170.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.5 pp -137.47 154.3 49.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.513 0.673 . . . . 2.73 112.471 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.5 mt -121.45 114.79 21.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.147 1.779 . . . . 2.28 109.141 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.75 120.94 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.341 0.973 . . . . 2.33 108.959 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.13 134.34 54.75 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.261 1.025 . . . . 2.22 111.478 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.38 118.19 36.34 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.632 0.773 . . . . 3.24 110.164 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.67 -178.41 15.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.294 1.426 . . . . 1.62 114.806 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -144.61 124.06 13.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.594 0.757 . . . . 3.8 111.206 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 1.5 p -81.08 28.77 0.35 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.318 -1.489 . . . . 3.31 114.679 -174.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -146.16 39.38 1.1 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 127.076 2.151 . . . . 7.46 109.322 162.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.97 147.42 94.22 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 116.133 1.901 . . . . 2.85 116.133 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -76.68 63.89 7.42 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.819 3.013 . . . . 4.66 110.2 157.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 66.37 -18.2 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 130.022 3.329 . . . . 4.5 116.66 163.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.51 -30.16 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.244 -0.91 . . . . 3.57 112.782 -170.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 17.5 m -58.58 -64.41 2.9 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 116.745 -1.598 . . . . 1.62 112.03 166.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -63.27 -26.32 71.88 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.756 1.663 . . . . 1.42 113.88 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.55 -59.69 3.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.924 1.238 . . . . 3.04 111.308 171.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.66 -29.68 69.04 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.576 0.751 . . . . 3.48 111.936 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.94 -28.18 67.25 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.376 -1.452 . . . . 3.28 112.423 170.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -69.93 -49.66 49.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.354 0.979 . . . . 3.9 109.378 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -55.69 -39.47 71.04 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.788 -1.195 . . . . 3.96 112.004 176.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.3 ttm -55.78 -48.73 74.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.298 1.839 . . . . 2.85 111.714 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 12.6 mm -66.06 -37.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 120.362 1.437 . . . . 1.52 110.464 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -62.33 -31.97 72.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.049 -1.453 . . . . 3.14 113.321 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.3 p -86.39 -34.77 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.788 1.176 . . . . 2.49 114.151 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.4 t -57.14 -44.45 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.896 1.226 . . . . 2.66 111.32 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.67 -31.38 66.73 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.124 0.97 . . . . 4.52 112.67 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -64.23 -49.69 70.94 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.992 -1.067 . . . . 2.93 112.195 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 187' ' ' ILE . 5.4 mm -64.86 -38.7 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.093 0.957 . . . . 2.53 113.397 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.12 -42.57 90.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.422 1.089 . . . . 2.89 110.315 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.1 t -70.46 -11.52 60.98 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.999 1.111 . . . . 2.81 113.999 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.21 -23.51 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.82 1.191 . . . . 3.18 110.84 169.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 67.07 -20.47 0.11 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.025 2.53 . . . . 4.09 115.714 167.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 48.2 p -67.42 -39.14 85.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.523 -1.361 . . . . 5.73 110.885 165.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.96 158.48 75.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.207 1.403 . . . . 4.49 111.444 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.57 -32.56 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.156 2.57 . . . . 3.23 113.812 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 t70 160.04 153.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.584 3.554 . . . . 3.66 108.748 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 36.0 tp -123.11 90.21 3.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.439 1.496 . . . . 2.06 107.958 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.2 m -75.03 125.64 89.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 O-C-N 121.069 -1.02 . . . . 1.59 110.265 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.46 133.37 4.54 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.093 2.528 . . . . 0.86 111.183 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.29 97.73 5.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.238 1.415 . . . . 3.11 109.12 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -84.03 129.99 34.89 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.267 1.027 . . . . 2.48 109.847 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.03 129.82 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.498 1.119 . . . . 1.77 109.03 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.6 t -92.69 117.62 30.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.152 0.581 . . . . 2.88 111.53 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -90.01 40.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.145 -0.972 . . . . 1.94 112.321 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -121.39 55.22 5.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.522 1.129 . . . . 3.3 112.624 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.95 66.94 8.7 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 125.064 3.843 . . . . 2.57 111.956 -166.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -151.97 -63.08 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.064 1.746 . . . . 6.72 109.282 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.04 27.1 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 6.46 113.334 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -80.95 156.36 26.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.889 0.852 . . . . 4.93 112.348 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 m -170.02 129.72 0.95 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.137 2.575 . . . . 2.9 106.639 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -52.57 -43.34 65.2 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.995 0.918 . . . . 4.25 112.347 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -64.28 -32.99 74.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.419 1.888 . . . . 3.74 114.228 172.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.51 72.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.954 1.252 . . . . 1.74 111.341 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.29 -40.2 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.882 -0.511 . . . . 1.73 110.357 169.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.07 68.46 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.333 -0.841 . . . . 1.98 113.096 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.8 -51.6 64.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.369 0.986 . . . . 5.17 111.65 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -57.15 -41.84 79.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.545 0.688 . . . . 4.94 111.539 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.3 t -65.35 -15.9 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.883 0.873 . . . . 1.34 112.521 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.66 -39.23 12.59 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 119.716 -1.865 . . . . 5.64 113.349 166.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.56 -53.66 48.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.193 1.397 . . . . 4.9 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -76.26 -52.34 10.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.996 0.739 . . . . 2.63 112.996 -171.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.8 t -179.44 145.23 0.42 Allowed Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.152 1.381 . . . . 1.99 110.514 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.83 -16.12 37.13 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.793 2.329 . . . . 2.28 114.27 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -72.22 -20.86 61.49 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.443 1.474 . . . . 1.99 112.974 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.6 tp -68.86 149.04 49.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.26 1.424 . . . . 1.98 113.346 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.81 141.12 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.151 0.981 . . . . 2.27 110.82 166.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.45 114.28 3.6 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.678 -1.369 . . . . 1.28 109.678 175.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.22 145.14 36.35 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.446 0.698 . . . . 2.5 109.871 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.9 m -154.46 163.71 39.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.391 1.076 . . . . 2.85 109.155 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -150.05 170.76 30.08 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 124.022 0.82 . . . . 1.88 111.345 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -61.4 162.44 7.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 3.22 110.342 164.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -48.28 -31.76 6.39 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.694 1.198 . . . . 7.99 113.741 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -67.98 -43.33 79.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.023 1.729 . . . . 3.48 111.873 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.07 -34.0 68.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.407 1.083 . . . . 3.25 111.19 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.23 -39.51 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 118.485 -0.769 . . . . 2.14 110.504 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.31 -43.06 92.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 117.539 -1.22 . . . . 3.32 110.219 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -52.59 -59.04 4.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.87 1.214 . . . . 3.55 111.306 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.7 -34.28 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.145 0.884 . . . . 3.5 112.675 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.71 86.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.681 -0.637 . . . . 2.34 111.817 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -76.74 -41.7 44.0 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.824 2.45 . . . . 4.49 112.081 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.04 50.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.055 1.342 . . . . 2.84 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.48 -2.32 57.92 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.165 0.802 . . . . 4.38 113.165 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 62.77 42.58 7.89 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.274 1.83 . . . . 6.87 112.011 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.3 m -73.79 148.97 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.828 1.251 . . . . 3.33 112.079 -165.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -76.23 132.33 39.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.812 0.845 . . . . 3.41 112.568 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -171.73 161.6 6.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.124 2.17 . . . . 3.61 111.721 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 33.4 t -150.53 108.7 3.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.941 1.296 . . . . 3.04 110.799 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.3 128.54 2.63 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.791 2.327 . . . . 2.81 112.446 -172.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.685 0 C-N-CA 124.24 0.924 . . . . 2.96 112.303 171.777 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.776 0.798 . . . . 6.41 109.733 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.1 tp -135.13 139.4 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.152 -0.968 . . . . 3.17 108.619 167.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.58 110.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 105.28 -2.118 . . . . 3.14 105.28 155.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.82 138.41 57.32 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.001 -1.111 . . . . 3.27 108.001 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -156.42 152.15 27.15 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.71 -1.244 . . . . 2.18 113.743 -166.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 58.5 p 3.71 -57.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 131.485 3.914 . . . . 4.88 119.541 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 62.52 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 128.9 2.88 . . . . 4.51 112.868 -160.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.4 pt -84.5 146.59 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 114.826 1.417 . . . . 3.32 114.826 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ttm -111.62 135.4 52.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.028 2.531 . . . . 2.23 108.871 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 135.37 47.23 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.157 -0.964 . . . . 3.03 113.386 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.84 118.82 25.57 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.026 0.93 . . . . 2.09 109.312 164.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.32 131.48 47.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.137 -1.801 . . . . 2.15 106.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -79.01 178.43 53.6 Favored Glycine 0 CA--C 1.536 1.404 0 N-CA-C 113.835 0.294 . . . . 1.91 113.835 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -74.69 58.08 4.56 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.413 3.409 . . . . 2.67 108.712 163.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.81 -63.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.938 1.695 . . . . 4.47 109.511 -149.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.17 -22.55 9.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.469 1.509 . . . . 3.39 114.995 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -83.15 169.44 15.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.867 1.334 . . . . 4.0 112.207 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -83.17 134.32 34.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.149 0.98 . . . . 5.1 111.249 169.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.69 -24.66 9.5 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.011 1.115 . . . . 3.62 114.011 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -160.3 166.75 28.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.047 1.339 . . . . 3.18 111.187 161.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -131.01 140.46 50.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.709 1.204 . . . . 3.76 112.764 172.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.1 -172.51 2.23 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.288 2.235 . . . . 2.77 108.532 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.55 73.11 0.5 Allowed Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.581 1.086 . . . . 3.29 110.758 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 88.63 151.03 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.104 2.962 . . . . 3.94 112.809 176.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.4 t30 69.16 -43.64 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.909 2.884 . . . . 4.83 115.624 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.32 113.44 4.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.23 0.923 . . . . 5.08 110.106 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 150.84 38.23 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.902 -0.499 . . . . 6.12 110.411 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -57.94 -36.46 72.55 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 119.66 -1.9 . . . . 1.99 115.178 -168.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.36 80.23 Favored Glycine 0 N--CA 1.483 1.778 0 O-C-N 120.661 -1.274 . . . . 2.11 116.038 170.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.58 -36.43 29.04 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.149 1.78 . . . . 4.72 110.308 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.86 -41.88 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.681 0.792 . . . . 1.65 108.908 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.84 96.18 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.301 0.852 . . . . 1.87 113.301 170.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.25 84.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.437 1.017 . . . . 2.1 113.224 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 p -68.7 -44.85 73.06 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 1.96 111.696 172.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.82 -35.12 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 119.992 1.269 . . . . 2.0 112.373 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.25 65.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.459 -1.401 . . . . 2.61 113.043 170.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.2 m -81.88 -44.51 16.75 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.796 0.838 . . . . 2.76 109.805 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -62.28 -25.08 67.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.551 1.14 . . . . 2.93 112.994 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 ttt -58.67 -34.74 71.58 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.114 0.966 . . . . 4.99 112.127 167.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -53.4 -49.01 90.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 116.62 -1.657 . . . . 4.21 113.945 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.62 -56.78 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.38 2.054 . . . . 3.69 111.702 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -88.17 29.81 0.92 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.982 1.475 . . . . 4.43 114.982 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.609 0 O-C-N 120.771 -1.205 . . . . 8.23 109.205 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.483 0 CA-C-O 118.944 -0.92 . . . . 2.6 114.355 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -93.28 171.35 2.07 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.346 3.364 . . . . 3.5 112.102 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.99 166.82 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.839 1.256 . . . . 3.45 111.349 162.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 m -140.58 29.68 1.93 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.098 1.518 . . . . 2.79 115.098 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -54.65 148.46 12.55 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.355 1.243 . . . . 2.42 114.355 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.1 m -72.31 139.31 47.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.369 1.468 . . . . 1.55 108.929 168.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.1 m -108.33 154.71 21.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.757 1.623 . . . . 3.56 109.126 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -60.25 -17.78 44.26 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.12 1.155 . . . . 2.24 114.12 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -65.04 -23.18 67.12 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.286 2.234 . . . . 4.5 113.749 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.21 -6.05 53.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.794 1.664 . . . . 2.06 114.134 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.25 174.25 9.22 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 4.22 111.972 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.19 130.56 48.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.003 0.521 . . . . 6.81 109.685 160.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -102.0 172.66 6.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.6 0.76 . . . . 3.35 110.678 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.72 154.48 13.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.734 2.014 . . . . 3.22 107.655 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -45.9 -26.25 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.45 2.3 . . . . 4.16 114.401 164.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -98.94 -1.06 40.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.171 1.545 . . . . 6.25 115.171 173.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.74 -59.97 2.1 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.549 -0.908 . . . . 3.41 108.549 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -62.04 -30.95 71.32 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.389 0.885 . . . . 3.87 113.389 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.78 -108.64 0.45 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.326 1.85 . . . . 4.98 110.566 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -135.78 105.67 0.54 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.489 -2.644 . . . . 3.62 106.489 165.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -107.01 -26.01 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.504 -1.236 . . . . 3.64 114.319 166.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.542 ' CD1' HD23 ' A' ' 193' ' ' LEU . 49.1 m95 117.77 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 1 C-N-CA 132.185 4.194 . . . . 2.2 109.02 -161.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.23 135.73 43.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.442 1.097 . . . . 2.95 109.836 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 10.1 mt -118.73 104.8 10.93 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.832 1.653 . . . . 2.68 106.908 168.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.9 pt -99.61 135.79 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.308 0.243 . . . . 3.61 111.283 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -140.37 143.8 35.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.428 1.091 . . . . 3.45 112.324 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -123.75 117.34 24.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.433 1.493 . . . . 2.8 109.37 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.55 -177.74 15.16 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.612 1.101 . . . . 1.68 114.333 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 135.5 46.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.363 1.465 . . . . 3.71 109.972 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 m -79.39 59.09 2.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.2 1.4 . . . . 3.43 110.189 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -152.59 -104.7 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.88 2.472 . . . . 7.56 107.597 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.5 OUTLIER 69.6 152.8 0.14 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 130.147 3.379 . . . . 3.01 116.887 173.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 60.6 Cg_endo -92.03 -17.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.497 2.798 . . . . 3.75 113.366 159.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 168.79 -37.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.385 1.448 . . . . 4.66 113.245 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -25.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 115.581 1.697 . . . . 3.32 115.581 -160.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 m -66.89 -62.25 4.02 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.59 1.086 . . . . 1.86 111.47 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.2 -25.43 57.73 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.508 1.472 . . . . 1.17 113.781 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.63 -23.68 67.34 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.272 1.212 . . . . 3.04 114.272 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -101.32 -18.79 15.91 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.977 1.262 . . . . 3.83 113.867 162.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.53 -43.54 98.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.661 1.573 . . . . 2.8 111.195 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.07 -55.29 18.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 3.41 112.128 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -62.55 -45.44 92.95 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.347 -1.471 . . . . 2.83 111.335 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ttm -56.24 -41.23 75.41 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.586 1.955 . . . . 2.38 112.138 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.6 mm -59.98 -54.38 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.483 -0.932 . . . . 1.99 108.483 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.476 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 63.0 mt-30 -63.51 -27.45 69.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 117.877 -1.058 . . . . 3.08 112.592 -174.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.6 -37.21 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 120.932 1.697 . . . . 2.01 111.872 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -20.14 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.733 0.813 . . . . 2.97 112.766 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -46.05 82.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.794 1.237 . . . . 4.85 111.314 170.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -66.95 -39.48 87.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.82 0.282 . . . . 2.98 111.558 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.445 HG23 HD22 ' A' ' 193' ' ' LEU . 8.4 mm -65.85 -46.21 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.661 -0.649 . . . . 2.13 112.448 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -65.9 -35.78 81.57 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.233 0.469 . . . . 3.74 110.713 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.7 m -73.57 -23.12 59.91 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.325 1.231 . . . . 2.92 114.325 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 11.0 mm -81.83 -28.29 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.261 1.424 . . . . 3.0 110.467 167.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.4 m 67.17 -12.4 0.24 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.905 2.482 . . . . 4.82 114.242 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 58.0 m -84.43 -30.31 25.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.549 1.94 . . . . 3.82 112.128 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.542 HD23 ' CD1' ' A' ' 159' ' ' TRP . 7.0 mp -63.46 159.73 48.44 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.67 1.188 . . . . 4.0 109.788 173.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -61.76 -46.04 15.14 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.392 1.394 . . . . 3.72 109.31 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -168.09 -178.55 3.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.126 2.57 . . . . 3.96 109.537 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 51.8 tp -125.67 123.57 39.23 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.563 -1.643 . . . . 2.05 106.563 150.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.8 m -106.27 98.89 20.97 Favored Pre-proline 0 N--CA 1.465 0.298 0 C-N-CA 124.67 1.188 . . . . 1.17 108.952 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.09 137.19 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.444 . . . . 0.95 109.737 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.91 111.18 9.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 123.061 1.41 . . . . 3.71 112.899 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.69 134.73 34.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.215 1.806 . . . . 2.72 109.676 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.3 mt -120.36 131.78 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.154 1.782 . . . . 1.57 106.984 168.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.37 126.22 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.741 0.701 . . . . 3.04 110.367 170.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.1 pt -98.96 16.77 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.531 1.133 . . . . 2.16 113.176 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.91 44.82 0.2 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 127.395 2.278 . . . . 3.58 114.25 168.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.59 -8.64 21.87 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.414 2.742 . . . . 2.09 115.163 -169.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.23 0.4 0.27 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.321 1.848 . . . . 5.29 114.223 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.77 30.55 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.321 2.648 . . . . 4.56 111.412 -165.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.77 -174.75 3.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.146 1.379 . . . . 3.99 111.057 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.5 t -162.36 151.08 14.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.673 1.225 . . . . 4.02 112.891 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.53 -34.92 59.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.746 1.618 . . . . 2.75 112.825 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.57 71.31 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.797 1.239 . . . . 3.62 114.05 174.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.34 74.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.923 1.238 . . . . 1.75 110.862 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.4 mm -60.39 -43.56 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.131 0.972 . . . . 1.95 111.616 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.53 89.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.341 0.656 . . . . 1.38 111.74 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.425 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 6.3 t30 -65.32 -43.84 89.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.526 -0.734 . . . . 3.16 112.188 173.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -56.51 -41.39 76.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.736 0.815 . . . . 2.98 111.404 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.3 -46.09 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.271 1.428 . . . . 1.15 111.996 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 8.3 mtmp? -52.51 -55.13 24.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.673 1.124 . . . . 4.14 112.73 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -33.62 59.91 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.822 0.675 . . . . 4.65 112.822 -160.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -73.95 -36.42 64.62 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.507 0.594 . . . . 2.95 111.613 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 m 153.38 136.15 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 129.886 3.274 . . . . 3.13 110.829 161.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -68.28 1.95 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.63 2.887 . . . . 2.55 114.47 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -66.69 -16.44 64.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 121.154 -0.966 . . . . 2.1 112.145 162.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.5 tp -80.75 145.36 31.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.654 1.581 . . . . 1.8 111.805 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.9 t -102.02 137.6 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.589 1.156 . . . . 1.87 109.572 167.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.86 132.42 9.86 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.442 1.02 . . . . 1.14 111.731 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.88 151.6 48.18 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.737 1.215 . . . . 2.44 112.211 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -166.16 -158.29 0.33 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.854 2.462 . . . . 2.95 109.135 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 152.75 -115.34 0.68 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 108.834 -1.706 . . . . 1.86 108.834 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.2 p -113.42 166.49 11.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.838 0.828 . . . . 3.25 111.656 166.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.62 -33.65 47.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.158 1.783 . . . . 6.91 113.084 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -67.62 -43.55 80.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.068 0.947 . . . . 2.93 112.112 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -70.31 -40.37 74.25 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.356 0.98 . . . . 5.51 111.577 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.6 t -55.27 -38.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.863 0.865 . . . . 2.07 111.988 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.5 -45.82 64.9 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 117.385 -1.293 . . . . 4.03 110.301 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -52.04 -53.96 35.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.026 1.739 . . . . 3.26 111.342 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.09 -32.31 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 113.226 0.824 . . . . 2.61 113.226 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.65 -47.93 61.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.907 -1.12 . . . . 2.36 111.306 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -70.87 -34.06 71.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.611 2.764 . . . . 4.19 112.147 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.13 9.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.332 1.453 . . . . 2.32 111.195 169.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.32 8.68 8.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.043 0.757 . . . . 3.24 113.043 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 42.44 43.92 3.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.258 2.223 . . . . 5.08 113.251 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 263' ' ' ILE . 7.9 p -69.72 -30.2 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 118.444 -0.789 . . . . 4.77 112.711 -172.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.7 t80 67.32 156.49 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.368 1.867 . . . . 3.38 113.9 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -176.88 164.44 2.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.476 2.711 . . . . 3.29 109.558 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.5 t -154.77 99.16 2.42 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 121.546 -0.721 . . . . 3.19 111.017 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -95.63 154.33 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.141 3.228 . . . . 3.1 112.252 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.895 0 CA-C-N 116.304 -0.407 . . . . 2.83 112.969 166.077 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 13.6 p90 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 113.464 0.912 . . . . 6.31 113.464 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 33.8 mm 70.49 157.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.855 2.062 . . . . 3.83 111.367 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.25 140.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.243 1.417 . . . . 4.66 108.894 170.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -63.18 108.83 1.35 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.428 1.491 . . . . 4.68 109.951 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -75.97 10.48 1.86 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.495 1.918 . . . . 5.49 115.558 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.0 m -74.69 95.7 2.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.826 1.25 . . . . 5.95 109.807 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.93 156.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.9 1.28 . . . . 4.93 111.053 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.436 ' H ' HG23 ' A' ' 243' ' ' VAL . 70.8 mt -133.97 134.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.282 1.433 . . . . 2.67 109.342 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 89.5 mtp -89.89 145.5 25.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.926 0.891 . . . . 2.29 111.045 171.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -126.21 153.4 44.73 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.332 1.053 . . . . 2.8 112.354 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 10.6 tp -103.62 131.63 50.59 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.044 1.738 . . . . 2.03 109.996 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 130.71 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 107.524 -1.287 . . . . 1.91 107.524 162.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.4 179.84 53.15 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.682 1.134 . . . . 2.27 114.425 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -91.89 75.46 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.251 3.301 . . . . 3.97 110.367 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.7 t70 177.19 -77.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.647 -1.615 . . . . 4.78 108.822 -135.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.79 -16.63 2.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 117.359 -1.801 . . . . 2.88 115.156 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.83 168.57 9.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.532 1.666 . . . . 4.83 114.397 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.46 150.97 29.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.056 2.142 . . . . 6.21 113.534 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.0 mt -136.64 -38.73 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.424 1.638 . . . . 2.64 115.424 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -166.36 167.45 15.85 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.616 1.098 . . . . 2.65 113.306 -168.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.29 158.82 43.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.923 1.289 . . . . 5.19 113.911 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.05 177.21 9.33 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.202 1.401 . . . . 2.38 114.207 -170.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.9 -177.1 22.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.179 2.8 . . . . 3.35 109.736 -169.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -55.34 1.14 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 119.785 3.254 . . . . 4.37 119.785 -166.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -111.63 -6.45 14.37 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.402 1.63 . . . . 5.29 115.402 165.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -116.79 89.27 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.459 1.104 . . . . 4.39 109.965 157.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.7 mtt85 -82.88 -167.85 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.134 1.774 . . . . 6.01 110.062 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.6 tmtt? -40.21 -57.71 1.65 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.148 1.779 . . . . 2.33 115.149 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.51 -38.37 51.99 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 123.437 0.542 . . . . 1.85 112.031 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.11 -33.05 75.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.894 0.877 . . . . 4.45 112.289 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 30.2 mt -68.4 -56.15 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.505 0.722 . . . . 1.64 110.049 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.06 78.7 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.096 0.776 . . . . 1.85 113.096 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -71.37 -33.86 69.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.631 1.173 . . . . 2.46 113.732 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.9 p -68.78 -45.27 71.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.662 -1.161 . . . . 1.87 111.288 168.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.6 mt -56.31 -42.28 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.41 1.459 . . . . 1.47 111.492 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.56 -28.5 69.68 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.141 -0.974 . . . . 1.95 113.342 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.5 m -73.1 -43.6 61.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.318 1.047 . . . . 2.71 110.132 172.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -64.68 -25.91 68.15 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.722 1.209 . . . . 3.16 112.353 172.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.1 ttp -69.93 -16.81 63.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.638 1.575 . . . . 4.51 112.676 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -51.77 77.56 Favored Pre-proline 0 CA--C 1.553 1.086 0 O-C-N 120.195 -1.566 . . . . 6.62 110.438 174.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.0 -51.61 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.074 1.849 . . . . 2.46 111.038 166.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.92 44.2 0.98 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.596 1.332 . . . . 3.27 114.596 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 . . . . . 0 N--CA 1.467 0.419 0 O-C-N 121.341 -0.85 . . . . 8.9 109.279 163.658 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 117.656 -1.636 . . . . 3.42 110.091 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.34 165.0 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.256 2.637 . . . . 3.35 112.691 -170.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -91.45 159.91 15.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.77 1.228 . . . . 3.17 109.007 166.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 m -142.31 57.23 1.46 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 120.159 1.345 . . . . 2.27 114.145 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.81 166.24 12.29 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 119.69 -1.882 . . . . 3.51 113.814 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 m -89.75 152.76 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.493 1.917 . . . . 2.37 108.762 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.5 p -95.87 161.25 14.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.395 1.093 . . . . 2.82 112.524 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -52.72 -33.7 49.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.612 2.365 . . . . 2.11 113.461 170.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.5 p -76.0 -47.61 24.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.098 1.359 . . . . 4.35 111.5 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.07 39.25 0.46 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.407 1.003 . . . . 3.0 114.672 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 -179.66 3.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.712 1.605 . . . . 3.46 109.059 170.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.53 97.28 3.53 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.128 1.331 . . . . 5.14 110.697 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.06 159.69 15.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.761 1.224 . . . . 3.14 112.411 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 153' ' ' LYS . 67.7 m -139.16 149.74 44.8 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.33 1.852 . . . . 3.91 107.167 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -25.13 61.2 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.105 0.955 . . . . 3.89 112.702 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.452 ' H ' HG22 ' A' ' 151' ' ' THR . 1.5 mmmp? -68.26 -18.34 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.552 1.686 . . . . 5.57 115.552 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.4 -48.11 36.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.852 1.261 . . . . 3.23 109.341 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -89.47 13.34 14.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.643 1.177 . . . . 3.42 113.187 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.78 118.46 6.67 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.344 -1.472 . . . . 5.17 109.683 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 104.89 -8.66 46.37 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 123.656 0.646 . . . . 3.31 114.38 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -80.77 -154.65 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.223 1.409 . . . . 3.44 111.412 -170.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -126.16 119.45 27.55 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.289 -1.507 . . . . 2.14 107.215 154.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.25 45.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.012 0.91 . . . . 3.38 111.701 -173.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 mt -131.37 135.56 47.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.219 1.807 . . . . 3.25 108.964 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.65 132.66 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.667 0.787 . . . . 2.47 110.007 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -139.88 148.91 42.74 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.265 1.426 . . . . 2.63 112.217 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -114.92 118.76 34.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.398 1.479 . . . . 3.2 108.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -124.48 160.53 19.07 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 116.858 1.503 . . . . 2.0 116.858 -166.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -100.53 22.62 11.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.532 2.333 . . . . 5.0 110.366 165.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 34.3 m 70.51 -66.59 0.28 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.02 2.528 . . . . 5.14 110.972 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -108.5 -29.04 8.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 117.696 -1.145 . . . . 9.83 113.147 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER 61.22 -172.03 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.699 1.199 . . . . 2.25 113.284 -176.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 89.3 Cg_endo -69.06 61.18 1.34 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.57 2.18 . . . . 3.61 110.161 139.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 65.25 -4.23 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 129.817 3.247 . . . . 4.44 115.808 166.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.11 -33.43 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 117.878 -1.058 . . . . 3.06 113.847 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.5 m -48.24 -60.68 4.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 120.452 1.478 . . . . 1.41 112.454 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 -24.35 42.42 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.427 2.085 . . . . 1.29 114.414 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.3 -43.96 96.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.971 1.26 . . . . 3.08 111.398 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.54 -35.17 75.19 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.128 -0.983 . . . . 3.44 111.571 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 -56.36 20.1 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.828 1.251 . . . . 3.04 111.651 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.02 -43.97 94.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.057 0.844 . . . . 3.79 110.267 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -54.07 -39.46 66.3 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.035 -1.666 . . . . 4.09 113.016 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ptp -68.74 -34.82 76.27 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.988 1.722 . . . . 2.76 113.771 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.2 mm -66.02 -42.78 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 120.34 1.427 . . . . 1.96 111.436 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.404 ' HB3' ' CD ' ' A' ' 283' ' ' LYS . 83.8 mm-40 -63.3 -37.97 89.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.606 1.562 . . . . 3.41 110.847 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.53 -45.47 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.674 -0.642 . . . . 2.69 111.989 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.59 -40.09 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.253 1.021 . . . . 2.2 113.04 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -58.06 7.48 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.048 1.339 . . . . 6.22 111.91 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.05 -40.12 92.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.417 0.525 . . . . 4.67 112.417 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 56.3 mt -59.9 -48.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.339 1.856 . . . . 3.41 112.651 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.07 -48.38 81.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.946 1.298 . . . . 3.46 109.371 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.8 t -68.92 -6.07 25.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.952 2.101 . . . . 3.92 114.409 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 191' ' ' THR . 32.8 mm -56.62 -48.61 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 119.626 1.103 . . . . 4.9 110.291 171.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 190' ' ' ILE . 32.9 p -171.55 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.464 2.394 . . . . 6.45 117.464 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.253 5.7 t 102.36 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.065 1.746 . . . . 5.23 107.438 -121.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.3 mp -93.39 161.86 29.57 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.456 -0.778 . . . . 3.62 110.495 136.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -86.16 35.84 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.199 3.932 . . . . 3.73 111.308 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 t0 70.0 174.72 0.29 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.143 2.577 . . . . 4.22 114.022 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.09 134.97 44.99 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.088 1.755 . . . . 3.04 108.1 166.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.8 m -107.43 100.71 35.39 Favored Pre-proline 0 N--CA 1.47 0.575 0 C-N-CA 123.619 0.767 . . . . 1.79 110.2 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.7 127.34 4.26 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.001 2.468 . . . . 1.57 111.099 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.02 108.52 19.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.749 2.02 . . . . 2.85 109.174 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -99.55 113.68 26.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.159 -0.682 . . . . 3.09 109.159 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.18 119.46 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.198 -0.667 . . . . 2.58 109.198 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.7 m -80.45 133.53 35.87 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.431 -0.793 . . . . 2.97 111.513 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.447 ' HA ' HG11 ' A' ' 234' ' ' VAL . 37.4 pt -82.23 -1.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 114.093 1.146 . . . . 2.66 114.093 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.65 48.89 0.23 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 127.425 2.29 . . . . 3.12 114.026 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.63 -6.79 19.28 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.636 2.224 . . . . 4.23 113.458 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -81.8 -2.76 51.99 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.303 0.956 . . . . 4.32 112.845 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.79 -27.48 1.29 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.62 1.341 . . . . 6.11 114.62 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -109.15 141.21 41.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.216 1.371 . . . . 6.79 111.915 172.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 82.7 p -95.64 159.71 14.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.551 1.167 . . . . 3.72 112.805 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -54.77 -36.71 65.16 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.193 1.397 . . . . 3.51 112.335 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -71.93 -33.51 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.112 1.365 . . . . 3.07 112.877 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.27 91.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.586 1.084 . . . . 1.78 112.248 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . 0.269 4.3 tp -70.57 -23.54 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 121.123 -0.986 . . . . 3.05 113.142 173.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.85 -42.61 94.75 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.563 -1.336 . . . . 1.86 111.924 167.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -58.57 -41.01 84.7 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.436 -0.79 . . . . 4.88 112.082 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -62.63 -45.62 92.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.676 1.191 . . . . 3.55 112.136 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.6 t -52.21 -44.31 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.036 -1.04 . . . . 1.97 111.55 169.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -13.1 62.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.361 1.245 . . . . 5.49 114.361 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -79.1 -47.05 16.82 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.419 1.463 . . . . 4.36 110.666 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -95.19 -50.23 5.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.581 0.956 . . . . 3.46 113.581 -172.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 170.52 141.06 0.09 OUTLIER Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 124.715 1.206 . . . . 2.48 113.293 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.57 -5.64 17.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.794 2.996 . . . . 1.81 114.217 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -71.83 -16.91 62.17 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.948 1.249 . . . . 2.15 112.959 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.06 132.35 44.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.335 0.97 . . . . 2.06 109.892 174.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.9 119.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.943 -1.502 . . . . 1.92 106.943 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.96 134.83 12.7 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 107.949 -2.061 . . . . 1.33 107.949 163.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.02 151.18 39.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.991 0.916 . . . . 2.57 110.399 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 229' ' ' GLY . 11.6 m -152.76 -179.9 8.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.166 2.186 . . . . 3.15 107.332 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.446 ' H ' HG22 ' A' ' 228' ' ' THR . . . 171.85 -132.34 2.4 Favored Glycine 0 N--CA 1.468 0.792 0 O-C-N 120.175 -1.578 . . . . 3.23 110.619 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.5 p -96.88 155.34 16.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.291 -1.003 . . . . 2.96 108.291 155.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.31 -26.82 65.33 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 117.912 -1.042 . . . . 6.48 111.818 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -66.38 -34.35 77.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.424 1.465 . . . . 3.49 111.802 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.25 -37.78 75.01 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.026 -1.047 . . . . 3.32 111.439 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.447 HG11 ' HA ' ' A' ' 203' ' ' ILE . 21.5 t -64.89 -33.73 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 122.128 -0.357 . . . . 2.51 111.191 173.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.16 -35.39 71.62 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.35 1.06 . . . . 3.37 111.0 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -57.7 -54.18 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.086 0.857 . . . . 2.74 110.76 174.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.11 -33.97 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.098 0.777 . . . . 1.89 113.098 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.47 -48.31 75.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.153 0.981 . . . . 1.87 111.792 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -32.81 69.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.353 2.261 . . . . 4.65 112.869 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.47 -67.01 0.48 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.525 1.057 . . . . 2.54 110.138 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -72.36 4.14 4.03 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.389 1.255 . . . . 2.54 114.389 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 58.96 44.72 16.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.29 1.836 . . . . 5.31 113.799 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.41 144.81 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.57 -0.706 . . . . 3.42 111.401 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.09 136.93 33.82 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.789 -0.57 . . . . 3.59 110.701 165.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -162.05 161.68 28.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.021 1.729 . . . . 3.38 111.322 176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.4 m -164.26 115.1 0.95 Allowed Pre-proline 0 N--CA 1.478 0.952 0 O-C-N 121.055 -1.028 . . . . 2.68 112.644 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -88.63 140.18 4.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.426 2.751 . . . . 2.81 113.771 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.524 0 N-CA-C 110.239 -1.144 . . . . 2.88 110.239 163.754 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 113.616 0.969 . . . . 3.6 113.616 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.4 132.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 119.296 -2.128 . . . . 2.72 111.838 170.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.78 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.156 1.383 . . . . 3.23 108.524 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.22 148.23 35.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 3.31 112.03 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -150.86 154.32 37.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.57 1.548 . . . . 2.04 110.896 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 t -59.62 153.56 19.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.495 0.718 . . . . 3.36 111.46 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.83 58.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 122.635 1.207 . . . . 3.97 108.17 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.1 mt -133.79 132.58 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.384 1.473 . . . . 2.62 108.698 -172.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 40.5 mtp -102.88 135.18 45.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.708 2.003 . . . . 2.86 111.737 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -102.54 135.19 44.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.022 1.329 . . . . 4.02 111.152 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.09 124.55 41.14 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.307 0.958 . . . . 3.74 109.54 171.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.92 131.39 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.076 -1.453 . . . . 2.69 107.076 158.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -138.45 -133.95 3.14 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.734 -1.037 . . . . 2.44 112.293 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -77.33 79.75 3.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.813 2.342 . . . . 3.84 109.922 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -171.84 -64.39 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.984 2.914 . . . . 5.9 108.346 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.27 7.23 35.39 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.958 -1.468 . . . . 4.68 116.585 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -138.26 -47.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.267 1.534 . . . . 5.54 113.443 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -168.19 156.87 8.97 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 3.61 112.53 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -151.54 -42.64 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.887 1.069 . . . . 3.28 113.887 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -170.88 172.76 5.46 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.479 1.912 . . . . 3.44 110.415 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -145.96 157.46 43.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.201 -0.937 . . . . 2.99 112.636 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . 0.437 ' CD2' HG23 ' A' ' 286' ' ' ILE . 0.1 OUTLIER -152.88 -167.63 2.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.04 1.736 . . . . 3.26 110.477 -170.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.92 -115.41 1.25 Allowed Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.017 1.294 . . . . 2.73 110.866 164.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.91 -7.59 1.79 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.805 1.409 . . . . 3.61 114.805 175.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -145.64 157.94 43.91 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.075 0.852 . . . . 5.21 111.045 163.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 72.47 131.29 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.959 2.104 . . . . 5.67 108.894 -143.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.67 175.63 5.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.881 2.072 . . . . 7.3 111.607 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.404 ' CD ' ' HB3' ' A' ' 182' ' ' GLN . 2.1 tmtt? -29.35 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 126.593 1.957 . . . . 2.38 113.886 -174.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.83 -19.72 69.81 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-O 119.418 -0.657 . . . . 2.16 113.839 -175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -63.88 -37.07 86.05 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.099 1.449 . . . . 3.32 111.175 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 277' ' ' PHE . 96.6 mt -68.43 -50.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.806 0.842 . . . . 2.18 110.986 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.82 88.81 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.042 -0.411 . . . . 2.33 111.601 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.29 80.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.538 . . . . 2.22 113.453 173.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.5 p -60.57 -43.27 97.51 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.832 1.196 . . . . 2.2 111.501 167.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.48 -33.77 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.445 -1.409 . . . . 2.33 111.997 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.51 -25.03 65.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.92 1.288 . . . . 2.51 113.272 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.8 m -75.16 -46.61 33.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.262 1.025 . . . . 2.46 109.896 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -59.2 -26.44 64.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.372 1.469 . . . . 3.1 112.832 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -59.93 -25.29 65.03 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.739 -1.226 . . . . 4.6 113.154 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -61.54 -51.75 74.77 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 117.213 -1.375 . . . . 4.77 111.824 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.71 -55.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.586 2.191 . . . . 3.55 111.463 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -81.53 77.35 8.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.011 1.324 . . . . 4.12 111.295 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 125.22 1.408 . . . . 9.11 112.824 -177.695 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.259 0 CA-C-O 117.734 -1.592 . . . . 3.97 110.152 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.65 159.97 41.8 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.728 2.285 . . . . 3.48 111.176 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -136.85 165.95 24.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.377 1.071 . . . . 2.71 111.909 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 p -146.04 112.33 5.81 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.771 -1.206 . . . . 2.38 112.154 157.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.08 146.91 27.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.99 0.9 . . . . 2.13 111.585 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.2 m -83.43 130.38 35.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.174 1.39 . . . . 1.74 107.572 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -84.08 168.31 16.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.483 -1.386 . . . . 2.1 112.2 -171.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -60.13 -30.28 69.19 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.818 1.247 . . . . 1.92 112.837 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 t -91.99 13.52 18.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.633 1.573 . . . . 3.05 113.129 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.98 88.01 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 119.124 0.875 . . . . 1.91 115.075 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -91.79 -168.63 2.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.04 1.736 . . . . 3.44 109.964 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -157.71 114.39 2.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 121.947 2.158 . . . . 5.05 113.401 -169.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -109.06 167.94 9.73 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.584 1.698 . . . . 2.96 115.584 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 39.9 p -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.462 2.705 . . . . 2.29 110.133 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.31 -56.95 2.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.557 1.543 . . . . 4.31 113.159 172.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -0.7 3.89 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.918 1.821 . . . . 7.14 115.918 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -81.44 -40.06 23.92 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.424 1.466 . . . . 2.95 110.134 165.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.1 -32.05 17.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.597 1.332 . . . . 3.26 114.597 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.92 109.6 1.51 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.376 0.989 . . . . 4.26 110.108 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.67 1.99 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 124.461 1.029 . . . . 2.45 113.322 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -94.96 172.28 8.25 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.079 -1.082 . . . . 3.06 108.079 154.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -85.0 138.94 32.14 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.548 -0.538 . . . . 2.14 109.548 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.04 155.39 45.4 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.466 1.127 . . . . 2.85 113.499 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.58 127.58 52.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.579 1.552 . . . . 2.39 108.114 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.4 mt -112.74 118.08 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.97 -0.752 . . . . 1.84 108.97 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -125.49 142.68 51.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.056 1.742 . . . . 2.43 111.161 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.85 111.98 24.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.255 1.422 . . . . 2.33 111.059 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.56 -176.07 15.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.937 1.732 . . . . 1.41 113.332 -173.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -154.56 14.13 0.43 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.578 2.066 . . . . 3.9 116.578 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m 72.81 -25.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.66 1.584 . . . . 3.01 113.987 166.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -77.06 -25.68 52.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.781 1.173 . . . . 7.31 112.037 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.51 123.52 74.26 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.337 1.455 . . . . 2.95 111.547 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -90.74 -0.43 5.1 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.167 2.578 . . . . 4.09 113.155 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -125.39 -89.25 0.57 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.138 1.375 . . . . 6.32 109.504 -162.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.55 -31.18 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 117.222 -1.37 . . . . 4.21 114.181 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.6 m -59.82 -50.77 85.06 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 121.766 2.076 . . . . 1.42 111.844 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.52 -43.58 26.73 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.782 1.655 . . . . 1.14 113.23 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.4 -30.52 53.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.818 1.19 . . . . 3.2 113.162 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.438 ' HA ' ' HE2' ' A' ' 179' ' ' LYS . 5.5 mm-40 -70.28 -36.05 74.14 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.762 -1.211 . . . . 3.06 111.737 166.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.7 mt -61.3 -49.25 77.78 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.978 1.263 . . . . 2.84 111.409 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.44 -46.28 76.76 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.346 1.058 . . . . 4.04 111.953 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 176' ' ' GLU . 14.6 mtmm -53.67 -57.37 11.06 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.222 -0.924 . . . . 3.1 111.245 172.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.1 ptp -66.99 -19.36 65.7 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.036 1.124 . . . . 2.52 114.036 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.566 1.53 . . . . 1.76 110.389 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.515 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 72.9 mt-30 -62.76 -27.01 68.99 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.437 1.017 . . . . 3.17 111.908 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 t -61.65 -32.0 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.464 1.106 . . . . 1.64 113.131 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -31.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.864 1.211 . . . . 3.03 111.582 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -50.75 72.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.973 1.309 . . . . 5.19 110.08 167.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -65.76 1.97 1.16 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.256 2.622 . . . . 2.7 115.55 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 58.2 mt -123.22 -57.56 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 130.087 3.355 . . . . 2.39 110.587 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.76 -37.64 73.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.757 2.023 . . . . 3.9 112.44 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t -61.42 -27.87 68.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.751 1.22 . . . . 3.12 110.819 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.5 mm -77.46 7.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 O-C-N 120.464 -1.398 . . . . 3.97 111.195 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 67.8 m 82.54 -33.28 0.09 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.204 2.202 . . . . 5.32 113.693 147.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.2 m -153.73 45.96 0.62 Allowed 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.863 -1.148 . . . . 4.71 111.301 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.38 -175.51 0.6 Allowed Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.064 0.945 . . . . 4.18 111.437 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -83.45 136.97 7.83 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.512 2.142 . . . . 4.46 109.517 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.86 133.1 37.02 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.516 0.562 . . . . 3.91 112.516 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 14.1 tp -105.19 116.67 32.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.347 1.859 . . . . 1.71 111.173 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.0 m -103.09 99.1 13.22 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.81 1.244 . . . . 1.25 110.096 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -72.44 138.09 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.304 2.002 . . . . 1.08 112.661 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -117.95 110.93 18.31 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.797 2.039 . . . . 2.79 109.308 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -97.09 115.72 28.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.022 0.929 . . . . 2.37 109.069 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 90.3 mt -97.02 120.79 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.207 1.003 . . . . 1.69 109.845 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.2 m -69.19 132.19 46.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.611 0.364 . . . . 1.98 111.303 168.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.04 -5.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 114.536 1.31 . . . . 1.57 114.536 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -113.76 47.45 0.39 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 125.08 1.352 . . . . 3.74 113.265 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.03 73.98 3.6 Favored 'Trans proline' 0 C--N 1.363 1.337 1 C-N-CA 125.854 4.37 . . . . 2.17 112.714 -165.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -169.75 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.878 2.871 . . . . 4.23 107.298 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -7.86 12.73 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.168 1.173 . . . . 7.95 114.168 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.08 107.21 15.05 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 121.002 1.728 . . . . 3.88 111.207 160.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.6 t -82.32 154.68 25.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.596 1.158 . . . . 2.91 113.086 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.68 -39.32 80.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.713 1.375 . . . . 5.98 114.713 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 214' ' ' ALA . 6.9 mm-40 -80.08 -19.67 46.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.775 1.17 . . . . 5.84 113.632 173.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.76 68.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.21 1.823 . . . . 1.72 110.261 170.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 3.0 mm -54.39 -51.91 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.256 0.622 . . . . 2.29 111.351 165.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.508 ' HB3' ' HA ' ' A' ' 211' ' ' GLU . . . -64.98 -29.12 70.02 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.257 -1.354 . . . . 1.34 113.832 -175.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -70.42 -48.95 53.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.439 1.927 . . . . 3.34 110.556 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.36 -41.44 65.83 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.682 0.793 . . . . 3.61 111.571 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.95 -53.29 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 125.511 1.524 . . . . 1.64 113.598 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -57.07 -40.86 77.68 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.382 1.073 . . . . 5.92 112.883 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.97 -53.12 51.32 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.925 2.09 . . . . 3.49 111.228 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.65 -36.81 85.46 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.503 1.298 . . . . 3.18 114.503 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.1 m 148.38 148.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 128.681 2.792 . . . . 2.33 113.581 167.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.15 9.66 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.201 3.268 . . . . 2.77 116.525 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -91.22 -9.24 45.99 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 120.989 1.722 . . . . 2.72 113.17 161.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 66.8 tp -84.08 147.12 27.55 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.667 1.187 . . . . 1.79 109.842 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 t -130.56 138.64 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.474 1.11 . . . . 1.93 108.503 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.82 122.18 7.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.234 -1.546 . . . . 1.09 109.234 169.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.34 140.11 39.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.283 1.033 . . . . 2.36 108.945 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.0 p -151.72 -172.6 4.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.621 1.969 . . . . 2.86 109.399 -165.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.14 -155.84 10.16 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 123.121 0.391 . . . . 2.24 113.088 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 232' ' ' GLU . 5.3 t -73.81 -177.08 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.546 -1.279 . . . . 2.57 107.546 136.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -44.91 -39.43 5.43 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.288 1.035 . . . . 6.64 111.817 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.444 ' H ' HG23 ' A' ' 230' ' ' THR . 4.2 mp0 -70.41 -37.65 74.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.555 1.07 . . . . 2.87 113.601 -165.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.8 -30.56 68.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.805 1.639 . . . . 3.53 111.511 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.43 -38.94 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.862 0.865 . . . . 1.67 111.136 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.72 -50.07 75.27 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.736 -1.209 . . . . 3.89 107.736 171.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -54.93 -61.58 2.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.612 -1.185 . . . . 2.6 112.959 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.62 -34.33 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.598 1.545 . . . . 1.99 113.232 -166.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.22 96.18 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.279 -0.888 . . . . 1.53 110.535 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -73.47 -32.85 64.55 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.884 1.673 . . . . 4.11 112.846 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.43 97.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.794 1.179 . . . . 1.99 112.007 171.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -84.03 1.97 41.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.698 0.799 . . . . 2.52 112.946 171.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.54 22.05 9.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.001 2.121 . . . . 6.69 113.991 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.0 m -86.99 164.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.647 0.779 . . . . 2.85 110.181 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -155.38 168.99 25.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.776 1.23 . . . . 4.95 111.989 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -161.98 128.58 3.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.336 0.655 . . . . 4.1 110.869 -163.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.8 m -110.27 110.38 58.28 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-O 118.598 -0.715 . . . . 2.71 111.835 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.1 146.31 20.02 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.828 2.352 . . . . 2.96 111.839 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.69 0 CA-C-O 119.504 -0.609 . . . . 2.64 113.11 176.618 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 24.0 t80 . . . . . 0 CA--C 1.55 0.956 0 CA-C-O 122.885 1.326 . . . . 3.53 114.444 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.14 153.31 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.559 1.543 . . . . 4.12 110.303 159.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.85 150.54 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.055 1.742 . . . . 2.96 106.919 163.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.13 155.66 34.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.114 -0.698 . . . . 3.71 109.114 164.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -140.47 87.7 2.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.53 0.681 . . . . 1.99 110.865 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.5 t -74.51 76.57 1.95 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 124.037 1.875 . . . . 5.54 109.379 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.1 pp -132.25 172.65 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.167 1.787 . . . . 6.89 109.532 -172.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 11.3 tt -141.42 164.59 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.198 -0.939 . . . . 2.77 109.121 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 22.6 ttm -99.13 141.28 32.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.571 1.078 . . . . 2.76 110.229 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -109.66 148.73 30.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.352 1.061 . . . . 2.57 112.792 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 127.0 46.32 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.649 1.58 . . . . 2.69 108.208 163.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 156.48 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.149 1.379 . . . . 2.11 108.334 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -155.5 -134.45 1.86 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.505 1.05 . . . . 1.85 111.977 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -85.86 36.4 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.852 3.701 . . . . 3.32 112.412 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -120.61 -38.52 2.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.739 2.015 . . . . 6.79 114.889 -164.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.29 2.46 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.086 -1.206 . . . . 3.27 110.086 -158.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.32 -2.95 3.08 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.717 1.377 . . . . 4.32 114.717 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -138.88 76.79 1.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.632 1.173 . . . . 3.7 112.001 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -34.87 17.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.161 0.984 . . . . 3.05 111.824 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -168.96 174.77 6.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.828 2.851 . . . . 2.32 108.441 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -153.86 150.02 27.96 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.64 -1.287 . . . . 2.8 111.715 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.95 114.03 21.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.352 1.061 . . . . 2.47 108.885 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.98 42.2 3.05 Favored Glycine 0 N--CA 1.464 0.542 0 CA-C-O 118.324 -1.265 . . . . 3.73 111.467 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . 0.266 3.5 pt20 44.17 45.16 6.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.011 1.724 . . . . 4.02 112.186 -170.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -139.63 -37.41 0.49 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.755 1.761 . . . . 5.25 115.755 -164.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -63.84 135.32 56.5 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.356 -1.465 . . . . 4.43 109.098 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -76.71 171.22 15.05 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 121.395 1.907 . . . . 8.0 109.193 163.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -48.33 -43.97 33.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.935 0.894 . . . . 2.02 113.167 -177.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -57.18 -36.34 74.62 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.942 1.258 . . . . 1.58 114.951 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -86.83 -18.08 31.83 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.421 1.61 . . . . 4.05 112.774 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 69.1 mt -69.22 -55.75 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.052 -1.092 . . . . 1.37 108.052 170.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.35 95.59 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.087 0.773 . . . . 1.69 113.087 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.39 90.63 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.83 1.195 . . . . 1.9 112.47 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.4 p -61.59 -43.83 98.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.567 1.076 . . . . 1.51 112.142 170.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.86 -47.11 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.637 1.108 . . . . 1.47 110.723 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.54 -30.72 70.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.309 0.959 . . . . 1.58 113.061 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.2 m -68.37 -50.27 54.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.433 1.093 . . . . 2.36 109.89 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -70.27 -34.04 72.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.761 1.225 . . . . 2.55 113.449 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -60.66 -33.82 73.38 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.288 1.835 . . . . 4.04 112.84 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -59.6 -52.44 74.03 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 116.785 -1.579 . . . . 4.43 112.985 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.91 -44.5 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.274 2.649 . . . . 2.98 111.589 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.16 62.65 7.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.625 1.17 . . . . 2.88 111.038 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 . . . . . 0 N--CA 1.471 0.611 0 C-N-CA 125.618 1.567 . . . . 8.15 114.591 -166.213 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.144 0 CA-C-O 119.042 -0.866 . . . . 2.77 113.088 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.4 148.92 30.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.029 2.486 . . . . 3.25 111.854 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -130.68 125.16 33.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.6 1.16 . . . . 2.9 111.302 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -109.81 46.57 1.0 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.448 -1.407 . . . . 2.69 111.983 -162.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -85.35 155.25 21.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.573 1.549 . . . . 2.95 111.792 -160.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.3 m -79.83 133.78 36.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.302 1.041 . . . . 1.86 109.868 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.2 p -81.94 160.65 23.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 123.061 1.41 . . . . 2.68 112.655 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -2.73 1.57 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.773 2.029 . . . . 1.74 114.905 168.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 t -100.37 -41.31 7.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.953 0.901 . . . . 3.73 110.961 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.28 -0.77 7.05 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 125.154 1.359 . . . . 1.95 115.546 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.09 157.81 35.38 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.102 0.951 . . . . 3.78 108.544 163.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.451 HH12 ' CD ' ' A' ' 233' ' ' GLU . 87.5 mtt-85 -92.13 134.24 35.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.749 -1.219 . . . . 7.35 110.857 174.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -138.47 136.02 35.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.706 1.002 . . . . 3.09 113.706 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 149.1 51.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 128.57 2.748 . . . . 3.31 109.469 -164.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -32.42 -43.59 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.582 2.353 . . . . 4.02 114.389 158.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.02 -25.73 68.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.23 1.412 . . . . 7.78 113.227 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -89.4 -28.22 19.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.406 1.082 . . . . 2.93 111.521 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -80.58 -16.85 53.13 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.808 1.04 . . . . 2.82 113.808 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 111.31 1.39 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.865 1.266 . . . . 3.67 111.945 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.35 -24.13 4.48 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.092 1.329 . . . . 2.72 112.796 -171.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.15 -162.11 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 117.825 0.813 . . . . 3.74 109.11 149.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -105.66 153.3 22.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.618 1.167 . . . . 1.84 110.115 168.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 pp -135.37 134.95 40.3 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.402 -0.811 . . . . 2.49 110.918 173.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.59 132.07 54.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.296 1.838 . . . . 3.01 107.499 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.13 129.3 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.398 1.079 . . . . 2.23 110.441 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -106.74 145.82 31.59 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.755 2.022 . . . . 2.55 111.523 163.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -112.3 118.28 34.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.557 1.143 . . . . 2.38 112.793 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.89 164.15 27.9 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 117.059 1.584 . . . . 1.56 117.059 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -26.97 11.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.129 1.772 . . . . 3.76 112.929 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 89.1 m 118.66 109.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.202 3.801 . . . . 3.07 109.997 163.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . 0.346 1.5 t-160 41.12 52.01 3.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.725 2.01 . . . . 10.34 114.241 -161.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.76 149.63 41.3 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 126.219 1.808 . . . . 4.16 109.993 159.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.03 -17.85 21.85 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.795 2.33 . . . . 4.8 114.361 -156.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -42.15 42.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.248 1.019 . . . . 11.16 112.528 -162.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 p 174.6 3.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 127.139 2.176 . . . . 4.79 114.623 -163.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . 0.251 46.9 t -57.93 -66.79 1.13 Allowed Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 115.423 1.638 . . . . 1.85 115.423 -147.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.34 -17.63 39.36 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.212 2.608 . . . . 1.76 113.246 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -69.35 -31.42 69.85 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 117.881 -1.057 . . . . 6.74 112.844 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -87.86 -20.12 26.47 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 121.164 1.802 . . . . 3.17 113.323 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -47.42 85.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.41 -1.431 . . . . 2.61 109.681 164.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.99 -51.27 64.43 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.49 1.516 . . . . 4.58 111.256 171.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -67.75 -21.53 65.27 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.673 -1.267 . . . . 3.44 113.666 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.9 ttp -67.47 -32.26 72.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.1 0.864 . . . . 2.99 112.362 164.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.58 -53.28 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 119.914 -1.742 . . . . 2.92 108.973 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.45 21.79 0.1 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.711 1.375 . . . . 3.32 114.711 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.46 -40.77 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 120.569 1.531 . . . . 3.42 111.912 147.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.9 t -57.66 -49.41 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.254 0.933 . . . . 2.02 110.428 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -59.83 -32.23 70.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.152 1.781 . . . . 3.62 113.168 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -81.45 -35.12 30.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 2.55 113.012 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.9 mt -62.92 -49.54 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.279 0.632 . . . . 2.77 109.601 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -62.92 -35.14 79.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.658 2.383 . . . . 3.54 111.585 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -66.54 -13.47 61.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.411 1.263 . . . . 2.94 114.411 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 87.6 mt -100.33 96.68 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.541 -1.349 . . . . 4.04 108.309 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.4 m -65.11 69.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.31 2.244 . . . . 5.3 112.529 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 176.2 -28.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.372 1.869 . . . . 4.13 112.78 -165.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.11 148.19 47.06 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 119.789 1.177 . . . . 3.59 112.139 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.24 142.87 15.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.398 2.732 . . . . 3.2 109.318 168.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -69.45 162.3 27.7 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.579 1.696 . . . . 3.82 115.579 -163.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 35.3 tp -119.51 96.07 5.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.128 2.171 . . . . 2.49 108.917 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.6 m -72.84 123.47 89.61 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-O 118.193 -0.908 . . . . 1.92 109.609 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.15 118.6 2.67 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.503 2.802 . . . . 1.11 111.118 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.9 mt -108.91 126.03 52.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.231 1.412 . . . . 3.86 110.482 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -104.04 130.56 51.73 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.468 1.107 . . . . 2.06 109.227 168.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.47 124.8 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.752 0.787 . . . . 1.64 111.444 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.6 m -66.07 129.95 41.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.924 0.89 . . . . 2.1 111.899 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.29 -17.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 114.831 1.419 . . . . 2.35 114.831 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -117.06 44.63 0.46 Allowed Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 125.23 1.412 . . . . 4.58 112.406 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.31 83.22 1.51 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.776 2.984 . . . . 2.58 113.778 -166.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -155.68 28.53 0.38 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.794 2.038 . . . . 5.17 110.501 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -156.54 -35.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.055 1.132 . . . . 4.51 114.055 -166.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -98.69 83.91 3.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.602 1.961 . . . . 3.51 111.088 -167.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 m -49.77 138.24 14.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.678 1.191 . . . . 2.39 109.588 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -43.04 -41.46 3.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.202 1.401 . . . . 3.26 113.283 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.34 -37.66 74.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.804 2.842 . . . . 6.52 113.365 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.12 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.16 0.984 . . . . 1.61 111.218 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.0 -46.44 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 118.968 -0.539 . . . . 1.54 110.49 167.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.67 69.38 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.559 1.072 . . . . 1.85 112.579 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.431 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 4.4 t30 -63.75 -51.54 64.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.389 0.995 . . . . 4.59 112.184 172.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -60.82 -41.46 95.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.586 1.555 . . . . 3.14 112.117 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.5 t -61.26 -46.63 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.318 1.047 . . . . 1.41 111.368 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 5.9 ttpp -58.48 -35.23 71.86 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.957 0.903 . . . . 5.26 112.827 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -64.11 -19.67 65.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.343 1.057 . . . . 4.59 113.075 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -91.84 -64.19 1.15 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.381 1.072 . . . . 2.59 112.959 171.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t 174.02 145.2 0.2 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 126.271 1.828 . . . . 2.27 109.692 -168.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.55 -5.38 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.382 2.721 . . . . 1.85 113.92 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -77.74 -8.72 58.37 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.638 1.108 . . . . 1.95 113.635 169.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.46 143.87 33.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.508 1.049 . . . . 3.91 112.191 173.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.97 133.75 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.337 1.455 . . . . 1.85 108.999 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -112.71 128.51 8.49 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.995 -0.842 . . . . 1.08 110.995 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.7 mp -123.83 144.92 49.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.211 1.004 . . . . 2.11 110.88 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.3 t -161.02 -161.0 0.78 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.289 2.236 . . . . 2.66 108.201 -170.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 159.54 -114.64 0.62 Allowed Glycine 0 N--CA 1.465 0.628 0 C-N-CA 124.779 1.181 . . . . 2.71 110.898 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.3 p -137.28 174.16 10.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.263 1.425 . . . . 3.65 109.852 165.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -23.56 63.63 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.596 0.962 . . . . 7.8 113.596 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -68.24 -41.08 81.71 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.455 1.502 . . . . 3.41 111.287 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.451 ' CD ' HH12 ' A' ' 149' ' ' ARG . 45.1 mt-10 -69.03 -37.82 78.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.117 0.871 . . . . 4.66 110.897 170.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -27.61 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 117.774 -1.108 . . . . 2.62 113.36 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.06 -41.62 92.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.839 1.199 . . . . 5.03 110.308 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -60.29 -54.47 45.37 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 3.5 111.75 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.18 -40.91 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.127 0.876 . . . . 2.05 111.771 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.9 73.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.97 0.508 . . . . 2.35 111.318 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.64 -34.55 69.87 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.061 1.744 . . . . 6.13 112.963 -177.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.08 -58.5 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.457 1.103 . . . . 2.47 111.792 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.77 0.67 22.8 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.475 0.917 . . . . 2.71 113.475 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.0 ttt85 45.06 38.94 3.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.752 2.821 . . . . 7.22 113.696 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.8 m -78.81 133.64 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.529 0.732 . . . . 3.34 110.278 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.79 148.57 25.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.733 0.813 . . . . 4.99 111.235 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -172.05 163.03 5.99 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.645 1.978 . . . . 3.6 110.675 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.4 t -160.6 135.58 5.59 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-O 117.902 -1.047 . . . . 4.39 111.204 172.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.02 156.38 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.162 1.908 . . . . 3.45 110.665 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.588 0 C-N-CA 124.384 0.992 . . . . 2.26 113.609 177.859 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.0 p90 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 122.178 0.99 . . . . 4.28 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 82.1 mt -57.85 145.03 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.067 -1.021 . . . . 3.39 109.483 158.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.94 158.78 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 3.18 110.481 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -101.39 141.06 34.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.911 1.684 . . . . 4.32 110.115 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.45 149.61 17.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.104 1.52 . . . . 2.18 115.104 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -51.97 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.752 2.021 . . . . 4.4 111.859 172.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.55 52.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.276 1.431 . . . . 5.75 112.24 168.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mt -136.06 128.18 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.254 1.422 . . . . 2.67 107.914 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 60.5 mtp -99.07 159.55 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.114 1.766 . . . . 2.35 110.252 174.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -135.75 146.28 47.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.908 1.077 . . . . 2.78 113.908 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.3 tp -104.59 130.06 52.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.977 1.311 . . . . 2.49 110.059 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.3 mt -111.13 142.21 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 106.997 -1.482 . . . . 4.0 106.997 150.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -114.08 -171.75 17.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.627 0.632 . . . . 1.99 113.817 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.53 70.86 6.69 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.305 3.337 . . . . 2.61 108.623 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -167.72 -62.21 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.001 1.72 . . . . 4.2 110.025 -169.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.02 -112.19 0.83 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.603 -0.726 . . . . 2.5 113.633 -162.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.54 123.11 28.89 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.512 0.931 . . . . 4.19 113.512 -149.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.5 t80 35.43 63.42 0.53 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.646 1.978 . . . . 3.6 114.393 156.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.0 tp -86.64 -4.02 59.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.423 0.897 . . . . 3.36 113.423 -166.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.85 150.11 4.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.911 2.085 . . . . 2.66 110.167 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -126.48 123.85 38.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.452 1.12 . . . . 3.49 111.078 161.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.63 86.81 3.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.134 1.374 . . . . 3.62 107.546 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.59 161.77 48.37 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.829 -1.309 . . . . 3.57 109.829 164.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -50.2 -16.03 0.28 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.554 1.687 . . . . 3.35 115.554 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -19.78 61.5 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 120.5 -1.375 . . . . 5.81 114.346 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -93.49 123.1 36.57 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.437 -1.415 . . . . 5.42 109.075 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -169.91 1.92 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.2 1.0 . . . . 5.88 108.789 167.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -30.85 -60.24 0.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.836 1.654 . . . . 3.02 113.527 170.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.04 84.07 Favored Glycine 0 N--CA 1.472 1.066 0 O-C-N 121.307 -0.871 . . . . 2.27 112.798 -166.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -76.38 -31.87 58.25 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.598 1.559 . . . . 3.0 111.562 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.32 -56.94 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.138 -0.689 . . . . 1.82 109.138 165.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.48 -43.35 88.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.624 0.972 . . . . 1.56 113.624 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.11 77.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.331 0.652 . . . . 1.89 112.469 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 16.4 p -66.84 -48.03 70.16 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.052 1.13 . . . . 1.69 114.052 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.13 -33.07 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.075 1.761 . . . . 1.71 112.168 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.0 71.84 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.906 0.776 . . . . 1.9 112.834 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 84.1 m -68.27 -41.84 80.46 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.634 0.652 . . . . 1.87 110.513 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -65.84 -27.1 67.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.544 1.137 . . . . 2.37 113.753 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.3 mmt -70.59 -10.78 60.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.577 0.955 . . . . 6.25 113.577 170.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.64 -50.41 1.27 Allowed Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 116.69 -1.624 . . . . 5.79 114.582 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.93 -37.12 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.41 2.073 . . . . 1.96 111.935 173.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.13 148.02 26.27 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.272 1.034 . . . . 2.84 112.256 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 126.563 1.945 . . . . 11.8 116.107 161.413 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.238 0 N-CA-C 110.028 -1.229 . . . . 3.41 110.028 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.89 129.16 6.13 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.558 2.172 . . . . 4.03 111.366 -170.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.46 162.65 33.95 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.579 1.952 . . . . 3.16 110.554 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.3 p -144.96 57.38 1.27 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.029 -1.045 . . . . 3.04 111.249 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.74 160.4 14.5 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.714 1.206 . . . . 2.6 113.935 -166.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -87.23 135.54 33.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.244 1.418 . . . . 1.73 111.205 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.7 p -97.03 162.95 13.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 122.82 1.295 . . . . 2.72 112.89 176.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -63.31 -20.43 65.47 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.265 1.426 . . . . 1.66 114.546 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.0 t -88.36 -4.79 58.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.815 1.246 . . . . 3.84 113.24 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.96 2.4 62.61 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 119.547 1.067 . . . . 2.25 115.525 171.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.33 154.9 17.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.789 1.235 . . . . 4.7 109.637 170.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.22 112.54 24.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.259 1.824 . . . . 4.96 109.593 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -78.79 165.78 23.18 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.301 -1.499 . . . . 4.01 112.249 177.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.4 m -154.67 144.74 21.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.708 1.203 . . . . 3.39 108.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -48.73 -41.49 32.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.566 1.147 . . . . 4.26 112.484 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.92 -2.45 27.06 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.516 1.673 . . . . 8.26 115.516 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -34.58 16.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 120.353 1.433 . . . . 4.36 112.335 168.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -94.23 -29.9 14.86 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.382 1.253 . . . . 3.59 114.382 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.79 124.72 23.72 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.656 1.571 . . . . 5.98 109.198 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.87 -18.4 26.6 Favored Glycine 0 N--CA 1.477 1.397 0 C-N-CA 124.211 0.91 . . . . 3.92 112.349 -160.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.17 167.84 9.63 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.018 2.527 . . . . 5.36 108.08 167.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -82.09 99.99 9.52 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.575 -1.328 . . . . 2.1 110.45 163.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 160' ' ' LEU . 1.6 pt? -96.37 140.38 31.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.409 0.623 . . . . 3.7 110.096 167.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 tt -125.02 113.55 17.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.112 -1.81 . . . . 2.72 106.112 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.17 136.97 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 3.6 111.068 -170.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -123.19 129.61 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.861 1.665 . . . . 2.97 110.688 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -99.93 102.62 14.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.576 1.15 . . . . 2.91 112.795 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.91 163.63 13.77 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.895 1.236 . . . . 1.56 114.756 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -124.34 116.66 22.96 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.966 0.906 . . . . 3.35 110.723 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.1 m -58.89 129.31 41.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.709 -1.589 . . . . 4.32 106.709 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 90.03 -1.16 0.28 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.124 2.17 . . . . 7.13 113.791 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 158.17 85.8 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 119.925 1.239 . . . . 2.33 110.103 157.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.51 -177.26 3.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.149 3.233 . . . . 2.87 112.153 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.16 1.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.404 1.882 . . . . 5.21 115.876 -171.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.24 -38.17 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.987 1.715 . . . . 3.72 110.727 172.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -60.49 9.87 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.603 1.161 . . . . 1.47 111.603 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.57 -23.75 49.45 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.897 1.731 . . . . 1.24 113.943 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -51.62 -52.02 51.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.801 1.637 . . . . 3.62 113.422 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -80.35 -25.78 39.03 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.874 -1.141 . . . . 3.05 112.955 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.21 -44.9 71.14 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.212 1.005 . . . . 2.62 110.936 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -48.1 -54.37 13.43 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.729 1.612 . . . . 5.21 110.912 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -66.64 -28.09 68.2 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.535 -1.353 . . . . 4.19 113.009 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 46.9 ttp -65.85 -39.47 90.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 117.524 -1.227 . . . . 3.47 111.429 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.33 -45.9 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 120.948 1.704 . . . . 1.75 110.722 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.5 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.124 -0.941 . . . . 4.93 112.387 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.88 -29.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.945 1.702 . . . . 1.93 110.731 168.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.77 -46.49 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.721 0.808 . . . . 2.0 109.532 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.66 -43.82 80.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.115 2.566 . . . . 4.11 113.14 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.21 -42.26 96.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.221 1.809 . . . . 2.89 112.041 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.3 mt -68.62 -40.7 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.158 0.983 . . . . 2.18 112.121 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -61.42 -31.44 71.37 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.828 1.251 . . . . 3.78 111.226 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.6 m -72.12 -21.64 61.44 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.49 -0.756 . . . . 3.14 112.874 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.52 63.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.349 -1.469 . . . . 4.3 108.131 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 75.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.659 1.984 . . . . 5.87 113.021 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.6 m 174.43 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.856 3.663 . . . . 4.12 111.239 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.28 154.18 54.13 Favored Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 121.613 2.006 . . . . 3.23 111.434 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.52 -55.13 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.719 2.279 . . . . 3.44 110.242 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -178.73 170.94 1.53 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 129.991 3.316 . . . . 3.95 108.099 168.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.3 tt -118.96 115.28 24.03 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.067 -1.827 . . . . 2.74 106.067 150.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.3 m -95.65 108.16 38.21 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 118.041 -0.98 . . . . 2.27 109.226 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.38 122.75 2.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.212 2.608 . . . . 1.05 111.171 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.0 tp -118.5 100.14 7.27 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.303 1.041 . . . . 2.34 110.469 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -84.65 120.92 26.94 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.651 -0.5 . . . . 2.21 109.651 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.9 mt -102.28 103.84 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.413 1.485 . . . . 2.72 107.161 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.8 t -97.59 132.85 42.87 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.648 -0.658 . . . . 2.98 111.125 170.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.2 pt -102.89 13.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.1 1.76 . . . . 1.78 114.665 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.23 32.39 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 116.098 1.888 . . . . 3.72 116.098 -173.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -7.83 21.9 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 123.417 2.256 . . . . 2.6 114.247 -171.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -85.68 41.39 0.9 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.264 1.025 . . . . 4.46 110.8 167.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 16.1 ttm105 -178.94 -58.25 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 131.128 3.771 . . . . 4.76 109.107 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.75 171.31 15.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.946 1.299 . . . . 4.31 111.455 -175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.1 t -149.3 153.13 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.148 -0.97 . . . . 3.2 112.305 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -41.87 50.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.818 1.647 . . . . 2.95 111.951 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -67.94 -36.44 80.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.547 1.539 . . . . 3.81 112.535 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.63 -44.5 64.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.52 1.055 . . . . 1.22 111.081 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.58 -43.06 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.353 1.061 . . . . 1.67 111.717 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.34 80.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.232 1.013 . . . . 1.27 113.115 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -70.96 -42.68 69.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.496 0.718 . . . . 4.14 111.742 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -62.65 -41.03 98.84 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.913 0.885 . . . . 2.82 111.596 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.38 -51.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.449 1.9 . . . . 1.31 112.327 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -56.77 -34.42 67.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.283 1.033 . . . . 4.86 113.372 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.96 -48.01 67.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.945 0.339 . . . . 5.05 110.547 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -72.86 21.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 3.02 114.389 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.3 p 106.43 147.42 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.656 1 C-N-CA 131.792 4.037 . . . . 2.68 112.504 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.16 -1.82 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.078 2.519 . . . . 1.6 113.329 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -90.29 -7.85 52.39 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.287 0.949 . . . . 2.48 112.793 171.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 136.36 46.72 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.523 -1.361 . . . . 2.75 111.565 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.21 121.48 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.543 0.737 . . . . 2.1 109.263 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.55 125.05 8.16 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.542 -1.423 . . . . 1.06 109.542 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.62 130.15 41.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.977 1.711 . . . . 4.3 108.817 -173.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -163.71 -163.05 0.76 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.511 1.924 . . . . 4.0 109.849 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.51 -149.01 6.88 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.448 1.023 . . . . 1.64 112.015 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -74.08 166.16 23.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.842 0.821 . . . . 2.54 110.488 159.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -47.8 -38.19 15.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.602 1.161 . . . . 5.96 113.069 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -70.85 -29.46 65.6 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.153 1.381 . . . . 3.48 111.743 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.03 -36.21 61.9 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 3.51 111.72 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.52 -35.78 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 118.836 -0.602 . . . . 2.24 111.189 170.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.55 -48.07 70.82 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.682 -1.628 . . . . 2.57 110.095 165.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -46.94 -57.78 4.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 121.555 1.979 . . . . 2.25 111.438 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.67 -39.33 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.304 0.956 . . . . 2.37 112.77 -173.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -35.5 72.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.965 0.802 . . . . 1.55 112.585 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -74.28 -40.01 62.59 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.886 2.074 . . . . 3.08 111.575 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.49 81.49 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 1.56 112.648 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.35 -6.74 59.23 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.478 0.711 . . . . 2.8 112.897 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.73 39.17 29.92 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.827 2.051 . . . . 6.07 112.708 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.2 -39.75 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.079 -1.013 . . . . 3.41 111.918 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 29.4 t80 64.47 130.6 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.198 1.799 . . . . 4.74 112.77 -165.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -116.2 152.57 33.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.002 0.921 . . . . 3.22 110.653 164.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.0 t -106.92 107.0 59.75 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.479 -0.772 . . . . 2.75 110.457 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.86 131.35 16.89 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.364 2.043 . . . . 2.74 109.993 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.515 0 C-N-CA 124.489 1.042 . . . . 2.3 114.819 -175.437 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 37.6 p90 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.816 0.341 . . . . 3.91 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.5 mm -121.08 148.93 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.575 1.55 . . . . 4.08 108.741 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.45 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 106.402 -1.703 . . . . 3.37 106.402 162.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -104.1 163.85 12.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.188 1.795 . . . . 3.58 111.569 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 158.82 33.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.534 1.133 . . . . 2.11 113.022 -158.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 49.3 p -59.19 -16.5 20.84 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.836 1.421 . . . . 3.24 114.836 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 263' ' ' ILE 0.347 10.6 tt 43.54 -143.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.819 1.248 . . . . 4.07 109.404 -147.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 262' ' ' ILE . 73.8 mt 76.18 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.285 1.834 . . . . 3.39 110.992 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -118.78 149.66 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.625 -1.17 . . . . 3.25 110.443 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.41 144.38 45.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.966 0.906 . . . . 4.02 112.749 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.1 tp -97.41 128.4 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.709 1.203 . . . . 1.99 108.52 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.31 142.24 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.207 -1.775 . . . . 2.49 106.207 161.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -132.64 -168.06 11.91 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.207 0.843 . . . . 2.56 115.207 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.63 58.84 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.652 1 C-N-CA 125.442 4.095 . . . . 4.88 110.801 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -154.39 -55.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.109 1.364 . . . . 7.12 108.292 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.07 138.36 4.47 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.09 1.328 . . . . 5.44 113.316 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 64.64 -168.61 0.21 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.388 1.475 . . . . 5.56 112.697 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -74.13 99.44 3.37 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.79 -1.194 . . . . 5.17 112.259 -173.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -24.55 27.9 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.758 1.623 . . . . 3.74 112.231 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -165.46 175.14 9.3 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.05 1.74 . . . . 2.33 110.326 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -153.29 166.49 32.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.817 1.647 . . . . 4.51 112.869 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -143.01 150.9 40.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.527 1.531 . . . . 2.58 110.196 -173.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.28 166.8 15.42 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.711 -1.049 . . . . 3.38 111.989 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -24.66 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 134.236 5.014 . . . . 3.95 119.885 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.94 -41.18 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.829 2.452 . . . . 5.36 110.21 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -76.56 113.05 13.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.335 0.97 . . . . 4.34 109.844 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.8 ttm105 -66.65 167.09 11.67 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.861 -1.15 . . . . 5.63 109.101 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -50.56 -44.84 56.73 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.25 -1.531 . . . . 2.28 113.279 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -58.15 -39.68 92.61 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.553 -0.582 . . . . 1.87 112.302 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.53 -28.55 46.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.007 1.114 . . . . 4.49 114.007 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.5 mt -58.46 -49.24 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.708 1.14 . . . . 2.3 109.002 168.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.02 91.9 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.391 0.886 . . . . 1.25 113.391 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.85 -32.03 69.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.588 0.755 . . . . 1.2 112.881 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -52.71 64.29 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.709 0.633 . . . . 1.57 112.709 168.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.35 -38.94 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.399 -1.438 . . . . 1.28 111.255 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.09 -8.77 25.6 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.079 1.352 . . . . 1.65 114.194 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 92.9 m -92.19 -48.92 6.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.053 1.341 . . . . 1.73 110.318 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -69.13 -23.34 63.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.681 0.993 . . . . 2.21 113.681 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 27.3 ttt -55.93 -26.42 47.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.163 1.785 . . . . 4.31 113.866 164.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -69.59 -46.8 26.14 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.247 -1.835 . . . . 6.72 112.464 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -59.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.22 1.946 . . . . 1.9 110.927 167.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -96.07 125.42 40.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.7 1.0 . . . . 3.78 113.7 -166.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.777 1.631 . . . . 8.54 111.964 -173.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.241 0 CA-C-O 118.199 -1.334 . . . . 3.22 110.267 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.72 138.25 6.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.399 2.099 . . . . 2.96 112.467 -163.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -162.22 165.72 26.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.447 1.899 . . . . 2.97 110.846 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.7 p -137.01 92.75 2.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.351 -0.843 . . . . 3.4 110.543 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mt -104.24 139.95 38.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.153 1.381 . . . . 2.42 111.632 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 84.8 m -67.97 135.45 52.38 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.997 0.904 . . . . 2.38 110.503 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 157.96 18.16 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.859 -1.151 . . . . 2.72 110.459 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 2.9 0.89 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.413 1.085 . . . . 1.89 113.502 165.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 m -89.96 -45.14 9.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.138 1.375 . . . . 2.85 110.8 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.31 38.47 1.11 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.987 1.279 . . . . 2.34 113.473 -168.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.87 174.82 10.05 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.905 2.082 . . . . 4.88 107.588 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -125.86 106.63 9.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 121.258 1.844 . . . . 7.1 112.551 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -99.34 153.91 18.6 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.204 1.187 . . . . 3.82 114.204 -171.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.0 p -123.03 148.2 45.82 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.345 2.658 . . . . 2.52 108.626 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -46.65 -51.75 15.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.507 1.123 . . . . 3.54 113.622 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -71.95 6.17 2.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.653 2.094 . . . . 7.21 116.653 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.11 -55.09 8.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.407 1.003 . . . . 3.78 110.76 162.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.5 -31.44 26.47 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.832 1.049 . . . . 3.02 113.832 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.04 118.73 5.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.328 1.051 . . . . 4.03 111.079 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 123.62 -27.38 5.74 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 124.114 0.864 . . . . 2.45 111.299 -167.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -84.21 166.87 17.19 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.352 -0.981 . . . . 3.77 108.352 143.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -78.54 110.17 13.39 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.728 -0.607 . . . . 2.1 112.451 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.4 mt -91.45 140.62 29.58 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.156 0.979 . . . . 2.8 112.916 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -137.43 121.66 18.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.679 1.992 . . . . 2.61 107.408 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.0 mt -126.09 131.87 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.53 0.732 . . . . 1.77 110.718 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -147.53 153.54 39.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.379 1.472 . . . . 2.67 113.068 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.44 123.06 42.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.518 1.527 . . . . 2.56 110.514 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.82 -176.95 36.23 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.21 0.844 . . . . 1.41 115.21 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -156.47 139.21 15.14 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.123 0.962 . . . . 3.82 112.946 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 t -82.2 74.5 9.17 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.424 1.011 . . . . 4.87 110.36 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 169.79 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 129.568 3.147 . . . . 7.05 110.538 -163.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.7 t -51.11 151.85 4.44 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.911 1.284 . . . . 2.21 113.844 159.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.38 64.18 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.314 3.343 . . . . 3.74 111.009 165.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.3 t0 69.59 -14.59 0.33 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.763 3.225 . . . . 4.9 114.821 162.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.37 -34.36 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 120.584 -1.323 . . . . 3.31 111.395 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.7 m -59.28 -54.34 57.18 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.317 -1.325 . . . . 2.32 114.415 167.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -67.36 -26.71 41.04 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.011 1.807 . . . . 1.72 114.154 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -66.38 -42.98 87.15 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.909 1.686 . . . . 3.53 110.814 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.73 -36.92 80.07 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.378 -0.826 . . . . 3.78 111.474 168.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 180' ' ' MET . 0.7 OUTLIER -69.56 -40.8 76.58 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.264 1.026 . . . . 2.64 112.694 178.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -57.76 11.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.148 1.379 . . . . 3.21 108.433 170.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -54.2 -37.51 64.63 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 120.174 -1.579 . . . . 3.91 113.74 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.434 ' HG2' ' HA ' ' A' ' 177' ' ' LEU . 23.9 ptp -68.73 -41.82 78.47 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 117.058 -1.448 . . . . 2.51 112.408 169.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.38 -44.66 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 121.212 1.824 . . . . 1.68 109.807 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -62.95 -29.71 71.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.214 -1.374 . . . . 3.01 113.558 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 p -86.95 -32.41 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.688 1.131 . . . . 2.62 113.394 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.03 -46.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 120.707 1.594 . . . . 2.33 110.78 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -31.54 68.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.571 1.148 . . . . 4.65 113.41 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -78.2 -13.63 59.78 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.174 -0.954 . . . . 2.66 113.328 174.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.6 mm -85.35 -55.29 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.635 1.574 . . . . 1.91 109.921 167.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -50.69 -39.3 50.88 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.406 1.482 . . . . 3.92 113.092 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -60.3 -29.41 68.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.316 1.046 . . . . 2.9 112.483 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.88 56.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 120.607 -1.308 . . . . 3.35 107.612 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -36.58 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 130.001 3.32 . . . . 4.42 118.775 -168.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -27.66 63.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.816 1.189 . . . . 4.53 111.536 172.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.84 163.01 69.72 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.127 1.771 . . . . 3.64 112.527 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -99.15 -172.35 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.924 3.083 . . . . 3.84 113.67 -166.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.48 62.73 4.68 Favored 'General case' 0 CA--C 1.549 0.942 1 C-N-CA 132.304 4.241 . . . . 5.54 116.667 -156.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.2 tp -59.76 96.94 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.67 -1.268 . . . . 1.86 112.809 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.3 m -96.35 117.86 65.84 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 125.567 1.547 . . . . 1.32 110.084 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -87.44 124.91 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.968 2.446 . . . . 0.88 111.926 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.79 102.55 9.2 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.989 2.116 . . . . 2.4 109.598 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -99.83 133.98 43.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.154 1.381 . . . . 2.46 111.618 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.82 126.19 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.556 0.742 . . . . 1.52 108.998 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 62.2 p -90.59 111.7 23.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.08 1.352 . . . . 2.52 110.733 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.3 pt -106.38 10.81 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 115.034 1.494 . . . . 1.89 115.034 -162.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -115.63 52.41 0.83 Allowed Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.595 1.158 . . . . 3.3 111.405 169.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.2 132.37 25.81 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.635 2.223 . . . . 2.58 109.188 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 128.19 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 130.334 3.454 . . . . 5.35 107.384 -163.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 -38.24 2.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.51 -0.757 . . . . 4.89 112.617 166.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.61 101.54 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.411 1.005 . . . . 4.56 108.672 160.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 48.0 m -115.82 149.37 38.68 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.372 1.469 . . . . 2.34 109.368 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -54.9 1.33 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.674 1.19 . . . . 3.42 112.148 170.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -69.03 -37.41 78.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.854 1.262 . . . . 3.19 112.94 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.71 -39.86 76.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.479 0.712 . . . . 1.48 111.793 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.07 -34.62 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.539 0.736 . . . . 1.72 110.556 175.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.0 75.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 118.693 -0.67 . . . . 1.44 111.889 170.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.6 -47.44 60.14 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.343 0.974 . . . . 4.38 112.281 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -53.42 -40.98 65.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.675 1.19 . . . . 3.8 111.485 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.4 t -64.64 -50.68 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.762 1.225 . . . . 1.38 112.017 170.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -57.28 -27.56 62.22 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.735 1.214 . . . . 5.21 113.754 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.36 -56.75 4.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.078 1.751 . . . . 3.7 111.656 174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -79.3 -38.44 35.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.328 1.233 . . . . 3.36 114.328 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 m 167.71 129.72 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 127.13 2.172 . . . . 2.02 112.806 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.77 -0.26 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.375 2.717 . . . . 1.72 113.516 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.68 -26.37 68.62 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.277 0.944 . . . . 4.33 113.418 162.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.18 133.42 35.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.164 0.893 . . . . 2.1 112.788 -165.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.82 122.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.876 1.27 . . . . 1.84 107.768 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.11 132.35 10.9 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.181 -1.168 . . . . 0.87 110.181 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.14 143.62 48.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 2.43 109.607 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.3 m -143.08 176.27 9.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 128.813 2.845 . . . . 2.84 106.676 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 168.11 -179.85 41.04 Favored Glycine 0 N--CA 1.472 1.056 0 O-C-N 120.436 -1.415 . . . . 1.91 114.364 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.0 t -75.42 163.47 27.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.264 0.625 . . . . 2.88 111.053 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.415 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -49.55 -21.42 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.419 2.288 . . . . 7.14 115.684 176.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -66.9 -51.46 55.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.137 1.375 . . . . 2.96 111.175 166.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -68.55 -43.86 75.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.242 1.017 . . . . 4.47 111.354 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.1 m -74.55 -19.94 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 114.186 1.18 . . . . 2.91 114.186 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.83 -57.54 4.52 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.807 1.185 . . . . 2.84 108.602 161.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.15 -55.41 10.42 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.223 1.409 . . . . 3.47 112.29 -173.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.37 -40.78 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 118.923 0.783 . . . . 2.12 112.94 -171.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.17 75.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.611 0.764 . . . . 1.64 110.436 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -70.6 -34.23 71.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 3.79 112.678 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.16 -58.0 5.14 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.384 1.474 . . . . 2.34 112.579 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -1.87 13.99 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.631 0.974 . . . . 2.56 113.631 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.02 32.17 6.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.29 2.236 . . . . 5.9 113.013 165.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.56 155.66 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.664 1.185 . . . . 3.43 110.149 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -74.14 137.87 43.49 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.276 0.56 . . . . 4.28 112.041 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -164.83 141.7 6.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.58 2.752 . . . . 5.32 109.481 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 129.83 2.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 117.936 -1.031 . . . . 4.97 112.586 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -69.19 141.66 48.18 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.407 2.738 . . . . 4.77 110.689 171.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.427 0 C-N-CA 124.068 0.842 . . . . 3.7 114.471 -172.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.2 t80 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 109.323 -0.621 . . . . 3.73 109.323 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.91 146.14 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 122.032 0.92 . . . . 4.42 110.464 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.32 128.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.132 2.173 . . . . 3.77 105.556 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -105.19 152.05 23.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.637 0.732 . . . . 3.75 111.713 -170.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -165.18 152.46 10.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.548 1.166 . . . . 2.65 114.024 -169.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 99.2 m -59.21 120.42 9.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.182 -1.372 . . . . 3.9 108.698 164.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.29 135.73 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.023 -1.473 . . . . 3.57 107.023 146.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.2 mt 135.65 127.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.108 1 C-N-CA 131.964 4.106 . . . . 2.9 109.454 176.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -100.6 150.79 22.34 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.682 1.993 . . . . 2.64 110.756 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -118.22 132.13 56.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.014 1.326 . . . . 3.4 112.196 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 8.8 tt -90.69 125.88 35.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.181 0.991 . . . . 2.21 111.091 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 143.82 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 127.629 2.372 . . . . 1.73 108.684 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.32 149.11 49.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.541 -1.144 . . . . 1.92 111.209 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.77 63.8 6.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.122 3.215 . . . . 2.88 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 153.72 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 131.36 3.864 . . . . 8.25 113.91 173.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 168.92 149.9 6.43 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 120.455 1.48 . . . . 3.32 116.023 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . 0.283 60.7 mt-10 41.33 -145.32 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.549 2.74 . . . . 4.18 113.87 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -148.54 155.49 41.2 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.044 1.293 . . . . 3.84 113.869 -163.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.84 -37.53 4.82 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.261 1.424 . . . . 2.64 111.912 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -145.32 170.85 15.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.43 1.092 . . . . 4.19 112.735 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -158.86 133.32 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.808 1.243 . . . . 3.85 111.519 160.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -178.1 -122.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.179 2.192 . . . . 3.78 111.118 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 95.79 -94.48 1.69 Allowed Glycine 0 N--CA 1.469 0.862 0 N-CA-C 109.479 -1.448 . . . . 3.61 109.479 -168.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.08 139.39 41.62 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 117.646 0.723 . . . . 3.4 111.104 168.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 80.82 -1.6 1.83 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.895 2.478 . . . . 5.32 113.311 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 121.21 36.1 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.032 1.733 . . . . 6.28 110.134 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -72.04 141.84 49.28 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.774 -1.204 . . . . 6.95 108.31 166.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -41.07 31.54 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.117 1.895 . . . . 1.73 116.117 -160.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.25 -18.77 71.64 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 119.787 1.176 . . . . 1.29 114.833 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.75 -33.89 76.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.899 -0.766 . . . . 2.95 110.777 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.6 -46.84 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.952 0.901 . . . . 1.66 109.101 172.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.97 72.39 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.685 1.129 . . . . 1.4 112.409 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.27 70.57 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.821 1.045 . . . . 1.6 113.821 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 5.7 p -87.43 -41.6 13.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.653 0.612 . . . . 1.95 112.653 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mt -52.03 -38.8 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.418 1.087 . . . . 1.47 111.01 169.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -51.73 -31.5 26.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.911 1.078 . . . . 2.2 113.911 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 19.6 p -75.26 -32.72 61.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.073 0.949 . . . . 3.75 112.036 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -72.42 -32.01 65.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.19 0.996 . . . . 2.82 112.372 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.19 -32.77 70.86 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.522 1.129 . . . . 6.6 112.299 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -49.94 -51.32 62.28 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 116.307 -1.806 . . . . 5.53 113.365 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.81 -44.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.218 2.612 . . . . 2.59 113.367 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -92.4 123.1 35.47 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.888 1.222 . . . . 3.08 114.146 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 127.258 2.223 . . . . 13.47 112.962 155.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 CA-C-O 118.963 -0.909 . . . . 3.06 113.585 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.78 156.61 39.58 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.206 2.604 . . . . 3.22 113.804 -168.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -138.91 169.14 18.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.54 2.336 . . . . 2.72 109.199 174.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.9 m -138.53 69.47 1.38 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.727 -1.233 . . . . 2.79 112.482 -176.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.22 172.65 7.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.441 1.097 . . . . 2.59 112.333 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.0 m -103.42 158.52 16.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.501 1.52 . . . . 1.68 109.525 173.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.3 m -107.94 159.79 16.27 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.939 1.296 . . . . 2.5 111.612 -172.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -55.23 -9.74 0.47 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 115.793 1.775 . . . . 1.72 115.793 176.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 t -113.53 7.35 17.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.951 2.1 . . . . 3.78 113.622 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.49 -10.41 69.06 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.575 1.56 . . . . 1.84 115.842 173.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.99 148.71 25.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.772 1.229 . . . . 3.48 111.984 -177.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.63 115.14 28.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.56 1.544 . . . . 6.08 111.249 -173.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 161.66 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.462 1.505 . . . . 4.11 112.742 -168.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.5 m -154.18 148.5 26.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.001 0.92 . . . . 3.02 111.176 -152.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -36.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.041 2.136 . . . . 3.16 112.569 165.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.421 ' HZ2' ' CG ' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -69.82 3.19 2.72 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.712 1.375 . . . . 7.11 114.712 -177.502 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' ' 153' ' ' LYS . 5.7 m-20 -108.04 -24.43 11.59 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.335 1.854 . . . . 3.29 112.822 173.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -84.64 -15.93 43.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.865 1.061 . . . . 3.32 113.865 165.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.03 154.43 9.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.207 1.403 . . . . 3.7 112.929 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.19 -20.11 21.79 Favored Glycine 0 N--CA 1.478 1.495 0 C-N-CA 126.622 2.058 . . . . 2.44 113.679 -174.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.01 173.68 6.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.277 1.831 . . . . 3.63 108.412 165.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -67.76 110.87 3.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.226 -0.657 . . . . 1.75 109.226 170.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.4 tp -99.16 120.66 39.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.185 0.993 . . . . 2.47 109.207 -172.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -104.69 116.21 31.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.158 1.383 . . . . 3.73 107.884 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.54 102.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.27 -1.011 . . . . 2.37 108.27 -178.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -100.21 148.91 24.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.024 1.73 . . . . 2.38 111.429 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.16 117.26 29.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.094 . . . . 2.33 110.743 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.97 153.64 23.4 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 115.777 1.071 . . . . 1.5 115.777 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.34 60.82 5.89 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.344 -1.092 . . . . 3.61 112.561 -170.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.7 m 64.1 -20.55 0.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 128.174 2.59 . . . . 4.57 115.551 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 176.83 -50.23 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 128.688 2.795 . . . . 9.98 110.101 -166.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.511 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.1 OUTLIER 61.0 177.8 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.881 1.272 . . . . 2.65 112.7 -164.533 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.511 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 39.7 Cg_endo -88.92 -132.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.88 3.053 . . . . 3.18 107.341 159.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -80.56 61.98 4.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.717 1.207 . . . . 5.06 112.403 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.75 -83.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.594 1.557 . . . . 3.61 110.365 175.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.4 m -49.87 -48.31 78.17 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.739 1.755 . . . . 2.04 115.739 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.77 -25.47 23.91 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.563 2.176 . . . . 1.35 113.732 -169.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.68 -52.93 63.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.973 1.709 . . . . 3.06 110.806 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.57 -26.05 61.57 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.848 -1.158 . . . . 2.81 111.963 171.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -45.6 78.53 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.465 -1.397 . . . . 2.37 111.849 -177.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.93 -41.01 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.227 1.376 . . . . 4.88 111.033 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 183' ' ' VAL . 43.0 mttp -60.68 -47.85 84.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.594 1.558 . . . . 3.47 110.706 174.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.85 -57.13 13.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.351 1.46 . . . . 2.74 111.428 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.26 -47.66 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.085 1.311 . . . . 2.47 111.786 -172.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -63.13 -28.6 70.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.921 0.782 . . . . 3.18 110.889 -173.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.613 HG21 ' HB ' ' A' ' 286' ' ' ILE . 55.1 t -63.34 -27.5 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 116.846 -1.55 . . . . 1.64 113.304 -178.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.744 HG23 ' H ' ' A' ' 196' ' ' LEU . 3.4 p -67.43 -32.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 121.276 1.853 . . . . 3.07 111.365 171.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -87.78 -15.25 37.45 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.794 0.838 . . . . 5.49 112.95 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.6 -13.17 59.98 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.676 -1.265 . . . . 3.37 113.004 164.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.59 -58.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.679 1.591 . . . . 2.0 111.675 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -63.44 -38.64 91.92 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.31 1.414 . . . . 3.28 112.671 -176.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 7.9 t -67.79 -11.23 58.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.582 2.753 . . . . 3.02 113.835 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.99 -25.86 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.391 -1.443 . . . . 4.77 113.157 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t 174.29 -42.14 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.466 2.306 . . . . 5.18 112.126 167.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.9 m 173.83 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 130.557 3.543 . . . . 5.88 105.052 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.7 mp -103.05 173.65 3.34 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.291 0.636 . . . . 4.82 111.345 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.44 154.46 21.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.567 2.178 . . . . 3.98 110.801 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.39 142.64 32.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.068 0.937 . . . . 3.66 111.83 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.744 ' H ' HG23 ' A' ' 184' ' ' VAL . 48.3 tp -104.79 63.89 0.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.479 2.312 . . . . 1.96 108.188 175.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.1 m -57.66 115.46 10.99 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.142 -0.932 . . . . 1.72 110.39 -166.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -86.92 116.06 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.729 2.286 . . . . 0.93 112.134 -173.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.43 117.44 34.1 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.693 1.597 . . . . 2.42 109.518 178.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -97.99 114.27 26.36 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.269 1.028 . . . . 2.31 110.124 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -83.21 122.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.256 -1.016 . . . . 1.94 108.256 165.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.53 128.98 34.94 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.854 -0.738 . . . . 1.8 111.243 166.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 pt -104.66 28.81 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 125.285 1.434 . . . . 2.13 113.261 178.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -122.8 47.44 1.57 Allowed Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 127.907 2.483 . . . . 3.41 112.942 -176.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.67 82.6 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.19 1 C-N-CA 126.206 4.604 . . . . 2.76 111.817 -172.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 175.38 -33.33 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.293 1.437 . . . . 3.98 114.406 -160.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -151.25 11.13 0.61 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.392 1.256 . . . . 5.19 114.392 170.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -70.11 54.49 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 130.888 3.675 . . . . 5.04 112.284 172.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 98.7 m -60.3 137.89 58.05 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.297 1.839 . . . . 2.06 110.464 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -43.35 -55.16 4.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.242 1.417 . . . . 4.03 112.984 -178.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -66.04 -33.53 76.01 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.119 1.768 . . . . 3.13 114.096 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.52 -36.14 73.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.961 1.255 . . . . 1.33 111.596 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.82 -36.6 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.186 0.995 . . . . 1.8 110.848 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.9 70.71 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.092 0.86 . . . . 1.28 112.061 168.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -66.24 -47.29 74.26 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.334 -0.853 . . . . 4.48 111.837 171.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -65.87 -32.56 74.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.933 0.716 . . . . 3.7 112.933 178.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.54 -49.0 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.13 0.972 . . . . 1.17 111.34 166.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.571 1.148 . . . . 4.57 113.515 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -62.43 -33.35 74.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.43 1.092 . . . . 4.85 112.164 177.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -98.73 -63.25 1.14 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.484 0.92 . . . . 2.71 113.484 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.4 m 170.89 145.72 0.12 Allowed Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 126.717 2.007 . . . . 2.42 112.197 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.94 4.71 2.99 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.545 3.497 . . . . 1.94 114.556 -175.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -71.36 -23.72 61.96 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 119.687 1.13 . . . . 2.15 111.494 163.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.1 tt -87.35 145.13 26.45 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.463 1.505 . . . . 2.12 111.096 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.6 m -130.18 139.77 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.666 1.186 . . . . 2.69 110.951 175.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.94 130.94 9.62 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.544 1.069 . . . . 0.9 111.708 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.82 143.84 51.11 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.159 0.984 . . . . 2.35 113.243 -173.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.8 p -147.37 169.39 19.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.078 2.151 . . . . 2.49 112.16 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -179.02 -178.94 48.59 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.332 1.92 . . . . 1.9 110.45 -176.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -63.96 163.02 12.85 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.532 1.166 . . . . 2.37 111.636 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.7 mtt-85 -47.58 -35.22 8.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.055 1.342 . . . . 5.87 112.738 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.3 mp0 -72.05 -37.1 69.75 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.582 1.953 . . . . 2.91 112.147 178.172 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -70.39 -42.66 71.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.711 -1.243 . . . . 3.48 111.345 176.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.4 t -63.36 -36.9 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.414 0.686 . . . . 1.77 110.98 173.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.03 -44.51 84.45 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.757 -0.639 . . . . 3.08 110.457 174.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -55.82 -50.94 69.16 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.232 0.924 . . . . 2.82 111.787 176.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.26 -36.07 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.703 0.683 . . . . 2.21 112.216 -175.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.99 92.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.827 0.739 . . . . 1.82 111.624 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.9 ttm105 -67.36 -38.78 85.35 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.927 1.291 . . . . 3.36 112.255 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.57 70.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.371 0.987 . . . . 2.01 112.076 178.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -88.63 12.58 14.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.199 1.4 . . . . 2.67 113.893 176.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 46.19 37.86 4.39 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.008 2.123 . . . . 6.71 115.28 -176.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.62 145.08 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.715 2.006 . . . . 3.36 112.577 -173.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -80.63 139.2 36.35 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.562 1.319 . . . . 3.4 114.562 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -155.03 158.95 39.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.451 1.5 . . . . 4.12 111.878 154.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 41.2 m -126.7 125.53 24.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.329 1.852 . . . . 3.76 107.883 167.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.77 147.67 45.08 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.04 2.494 . . . . 3.61 111.062 -178.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 N-CA-C 114.599 0.599 . . . . 2.84 114.599 -167.91 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 33.4 t80 . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 121.154 0.502 . . . . 4.52 112.047 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.86 108.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 120.414 -1.429 . . . . 4.58 111.765 170.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.5 143.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.53 1.532 . . . . 3.0 108.17 164.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.5 160.09 23.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.131 0.972 . . . . 3.45 110.672 173.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.55 154.39 0.38 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.494 -1.379 . . . . 2.72 112.959 -134.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -68.59 -30.72 69.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 117.285 2.328 . . . . 4.77 117.285 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.7 pt 39.4 34.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 126.556 1.942 . . . . 3.9 116.045 -172.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 19.1 mt -113.9 144.26 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 2.32 110.113 -177.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.7 143.04 31.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.481 0.712 . . . . 4.8 111.289 156.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -97.87 132.79 43.15 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.723 0.809 . . . . 3.19 111.096 162.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -93.14 93.63 8.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.759 1.224 . . . . 1.91 109.829 178.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.17 127.44 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.875 1.27 . . . . 1.69 108.672 175.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.51 161.97 54.24 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 110.851 -0.899 . . . . 1.43 110.851 172.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -65.23 -8.83 19.77 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.376 2.051 . . . . 3.03 113.794 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -107.23 29.74 6.85 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.097 1.759 . . . . 5.61 112.093 170.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.16 -42.04 3.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.663 1.601 . . . . 2.42 116.399 161.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -78.74 151.76 31.88 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.351 1.576 . . . . 5.67 111.369 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -89.53 144.05 26.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.033 -1.042 . . . . 3.32 113.738 -177.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -23.94 14.83 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.867 1.267 . . . . 2.74 112.881 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -168.25 170.01 10.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.887 1.275 . . . . 2.39 111.016 -167.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -153.56 140.1 18.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.847 0.859 . . . . 3.64 112.432 175.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . 0.545 ' CE1' ' HE2' ' A' ' 281' ' ' LYS . 13.2 m-85 -137.06 130.3 31.11 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.653 -0.654 . . . . 3.01 111.91 -169.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.12 91.83 0.08 OUTLIER Glycine 0 N--CA 1.471 0.985 0 N-CA-C 115.221 0.848 . . . . 4.17 115.221 174.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 137.32 127.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 1 C-N-CA 132.823 4.449 . . . . 3.39 107.073 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -40.51 98.91 0.01 OUTLIER 'General case' 0 C--O 1.237 0.409 0 O-C-N 124.763 1.289 . . . . 8.64 113.752 -140.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.545 ' HE2' ' CE1' ' A' ' 277' ' ' PHE . 45.7 tttp -78.95 -18.22 54.15 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.442 -0.786 . . . . 4.34 111.488 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.39 120.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.13 2.572 . . . . 5.71 108.583 -177.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -26.05 -77.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.673 2.389 . . . . 2.86 114.815 -176.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.53 -13.14 49.51 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 115.439 0.936 . . . . 1.91 115.439 -175.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.74 -30.76 40.94 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.218 2.009 . . . . 3.49 112.532 172.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . 0.613 ' HB ' HG21 ' A' ' 183' ' ' VAL . 21.8 mt -60.03 -40.65 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.136 -0.977 . . . . 1.58 108.859 165.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.12 -51.42 64.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.24 -0.41 . . . . 1.24 111.88 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.87 78.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.226 1.195 . . . . 1.66 114.226 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.5 p -67.33 -50.11 61.38 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 1.78 111.761 172.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.63 -38.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.742 1.156 . . . . 1.32 112.491 174.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.4 -16.18 33.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.743 1.217 . . . . 1.55 114.254 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.7 m -81.27 -47.86 12.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 1.72 110.281 167.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -67.32 -27.64 67.32 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.24 1.016 . . . . 2.81 113.641 -178.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 76.4 mtm -71.61 -23.41 61.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.378 -1.451 . . . . 4.91 113.498 174.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.16 -35.25 11.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 116.29 -1.814 . . . . 4.07 114.048 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.89 -41.39 1.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.912 2.076 . . . . 1.84 112.577 162.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.76 -157.19 0.11 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.837 1.791 . . . . 3.26 115.837 -169.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 N--CA 1.476 0.829 0 O-C-N 119.992 -1.693 . . . . 10.3 110.939 174.304 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.516 0 CA-C-O 119.919 -0.378 . . . . 2.43 113.329 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.28 151.49 26.47 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.44 2.76 . . . . 3.19 112.525 -167.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -81.52 155.79 25.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.881 0.872 . . . . 2.99 110.143 166.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.4 ' H ' ' NE2' ' A' ' 236' ' ' GLN . 21.5 t -142.41 101.52 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.686 -1.259 . . . . 2.85 108.916 167.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.89 162.49 32.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.191 1.396 . . . . 2.41 110.733 -170.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.9 m -84.27 133.53 34.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.465 0.706 . . . . 1.92 109.58 172.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.2 t -98.2 162.76 13.03 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.593 1.557 . . . . 2.8 109.974 177.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -65.37 -9.42 24.74 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.192 1.553 . . . . 2.02 115.192 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.7 p -73.44 -21.94 60.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.159 1.384 . . . . 3.12 113.292 166.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.85 -9.54 63.95 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.626 1.584 . . . . 1.75 113.401 -170.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -65.91 148.64 51.48 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.677 1.238 . . . . 4.79 110.508 170.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.66 109.08 20.9 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.684 0.793 . . . . 6.02 109.152 171.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.06 167.81 10.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.463 1.905 . . . . 3.61 113.742 -161.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -148.73 165.42 31.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.466 1.507 . . . . 2.75 110.44 -178.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -47.28 -45.05 23.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.901 2.08 . . . . 3.81 113.09 175.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -80.49 -4.49 54.06 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.165 1.172 . . . . 5.6 114.165 -176.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.37 -47.47 7.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.768 1.627 . . . . 3.96 109.16 163.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -75.46 11.13 1.35 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.823 1.786 . . . . 3.34 115.823 -176.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tp -78.67 -170.51 2.14 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.716 1.606 . . . . 4.4 113.238 -172.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.3 -36.04 1.54 Allowed Glycine 0 N--CA 1.479 1.505 0 C-N-CA 125.681 1.61 . . . . 3.53 114.463 176.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -76.86 -179.53 5.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.791 1.236 . . . . 4.01 111.448 162.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -91.35 149.54 21.69 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.673 0.749 . . . . 1.91 109.734 156.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.4 tp -136.89 140.28 42.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.519 0.728 . . . . 3.53 111.111 -173.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.41 138.63 51.69 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.674 1.19 . . . . 2.69 108.042 164.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.7 mt -123.65 131.89 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.473 1.109 . . . . 2.59 108.525 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -134.37 138.85 45.2 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.002 1.321 . . . . 2.42 111.834 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -102.54 117.97 35.84 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.498 1.119 . . . . 2.53 111.22 175.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.77 -178.36 15.97 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.098 0.856 . . . . 1.21 114.289 173.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -136.12 119.58 16.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.136 0.975 . . . . 3.58 110.847 -168.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 m -71.36 20.5 0.05 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.167 1.787 . . . . 2.69 113.407 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -124.48 -16.33 6.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.203 1.801 . . . . 7.11 111.351 168.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 38.4 t -63.53 136.91 96.92 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 119.531 1.059 . . . . 2.29 112.349 -171.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.25 99.69 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.332 2.688 . . . . 3.2 109.621 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 74.88 -35.8 0.3 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.141 2.576 . . . . 4.13 114.777 155.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 72.4 t -54.55 -56.73 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.472 1.509 . . . . 2.54 110.836 176.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 33.4 m -53.85 -57.59 17.0 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.65 -1.166 . . . . 1.82 113.316 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.74 -39.48 4.6 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.768 1.645 . . . . 1.61 114.223 -175.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -41.02 70.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.235 1.38 . . . . 3.06 111.888 -178.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -30.38 69.42 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.433 1.015 . . . . 2.98 111.28 176.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.8 tp -69.87 -35.31 74.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 2.84 112.323 173.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -42.98 90.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.987 0.812 . . . . 3.7 110.314 170.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -54.33 -35.62 62.89 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 119.995 -1.69 . . . . 2.99 112.012 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.3 ttp -70.17 -28.02 64.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.914 1.079 . . . . 2.88 113.914 171.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.95 -52.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.803 1.638 . . . . 1.57 109.781 167.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -56.1 -27.0 52.01 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.201 1.001 . . . . 3.84 112.022 -176.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 t -64.56 -29.99 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 117.402 -1.285 . . . . 1.83 111.729 176.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.91 -44.55 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.679 2.036 . . . . 2.38 111.892 -175.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.89 -43.73 98.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.761 1.624 . . . . 3.49 111.631 174.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.18 -38.98 84.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.507 1.523 . . . . 3.95 111.811 170.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 -49.38 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.801 1.64 . . . . 2.74 112.906 -177.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.68 -28.13 68.85 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.528 1.513 . . . . 5.61 109.762 176.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.0 t -67.84 -13.47 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.793 1.405 . . . . 5.14 114.793 172.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.32 -26.55 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.608 1.549 . . . . 5.99 111.04 169.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.305 60.9 p 119.65 50.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 1 C-N-CA 133.119 4.567 . . . . 7.97 111.119 -175.469 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.423 0.6 OUTLIER 79.16 67.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.658 1.983 . . . . 4.81 114.67 146.52 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.04 166.82 0.37 Allowed Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 126.651 1.98 . . . . 4.35 111.52 160.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.37 -55.43 0.37 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.183 1.815 . . . . 3.71 109.296 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -169.65 158.22 7.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.288 3.035 . . . . 4.65 107.22 160.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.3 tp -112.77 106.91 15.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.945 1.298 . . . . 1.95 110.889 166.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -78.7 130.51 70.54 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.675 -0.678 . . . . 1.94 110.411 170.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.52 114.91 1.02 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.451 2.768 . . . . 1.1 109.908 159.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.84 111.28 23.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.375 1.47 . . . . 3.0 108.641 174.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -91.97 124.83 36.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 1.92 110.043 174.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.25 119.97 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.788 0.835 . . . . 1.36 108.81 167.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -83.24 130.39 35.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.186 -0.461 . . . . 2.11 109.989 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -104.62 16.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.559 0.948 . . . . 1.94 113.559 171.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.11 14.57 0.04 OUTLIER Pre-proline 0 CA--C 1.573 1.841 0 C-N-CA 127.926 2.49 . . . . 3.35 117.17 177.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -80.41 53.56 4.82 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 123.863 2.415 . . . . 2.7 113.171 -177.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -83.91 -41.33 17.51 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.143 -0.688 . . . . 4.58 109.143 141.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.76 0.53 4.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.088 1.355 . . . . 6.58 114.181 -171.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -93.2 156.75 16.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.886 1.274 . . . . 4.34 110.91 174.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -137.5 147.92 45.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 2.68 111.02 -176.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.2 -34.31 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.157 -0.929 . . . . 3.0 111.774 173.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -66.21 -44.1 84.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.593 1.957 . . . . 3.17 112.522 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.05 78.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.469 1.032 . . . . 1.28 111.193 174.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.94 -41.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.694 0.798 . . . . 1.74 111.415 174.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.46 -15.81 30.35 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.933 1.086 . . . . 1.71 113.933 176.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.59 -47.11 7.28 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.403 1.456 . . . . 4.03 113.149 165.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.09 -37.73 47.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.93 1.692 . . . . 2.91 111.565 175.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.0 t -43.56 -56.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.305 2.242 . . . . 1.63 112.792 167.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.14 -31.55 67.86 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.785 0.661 . . . . 4.16 112.785 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -63.36 -23.86 67.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.35 1.06 . . . . 4.03 111.643 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.95 -45.36 10.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.63 0.974 . . . . 3.14 113.63 168.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.2 p -174.33 167.59 2.2 Favored Pre-proline 0 N--CA 1.476 0.851 0 O-C-N 120.497 -1.377 . . . . 2.77 113.764 -168.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.59 2.54 8.27 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.485 2.79 . . . . 3.55 113.959 165.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.43 -26.24 6.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.953 1.464 . . . . 2.04 114.953 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.69 148.48 48.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.193 0.997 . . . . 2.21 111.217 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.43 132.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.24 1.016 . . . . 2.37 109.738 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.0 110.4 2.76 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.085 0.85 . . . . 1.32 111.606 -170.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp -108.99 144.88 36.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.5 1.12 . . . . 2.81 111.949 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.01 178.51 10.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.761 1.624 . . . . 2.86 108.892 -175.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.95 -140.64 3.39 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 108.498 -1.841 . . . . 1.88 108.498 166.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 65.7 p -80.36 176.43 9.78 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.446 1.498 . . . . 2.56 111.988 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.408 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -62.02 -21.68 65.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 118.346 -0.835 . . . . 8.18 112.78 165.788 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.408 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 22.2 mp0 -71.19 -39.44 71.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.105 1.362 . . . . 2.92 111.431 171.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -64.12 -42.95 96.64 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.051 -1.031 . . . . 3.75 111.616 173.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.5 t -59.47 -43.66 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.818 0.699 . . . . 1.81 110.769 173.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.25 -49.78 70.57 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.024 -0.988 . . . . 3.66 108.725 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' A' ' 141' ' ' SER . 5.0 tt0 -47.12 -56.91 5.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.41 -0.805 . . . . 3.48 111.242 174.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.9 m -76.87 -27.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.877 1.065 . . . . 2.65 113.877 -168.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.83 -40.17 55.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.525 0.602 . . . . 1.66 111.549 172.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -75.01 -33.71 61.84 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.62 1.968 . . . . 3.92 111.801 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -49.58 -72.51 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.561 1.073 . . . . 2.22 110.956 167.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -85.21 9.24 15.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.063 1.505 . . . . 3.39 115.063 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.92 18.8 11.18 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.47 1.508 . . . . 8.29 113.715 171.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 m -67.89 -15.09 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 117.435 2.383 . . . . 3.08 117.435 -145.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.4 t80 60.83 131.54 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.086 2.555 . . . . 3.47 116.898 -174.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -160.54 165.68 30.41 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.873 2.469 . . . . 3.24 109.391 170.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.3 t -154.49 134.51 8.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 121.291 -0.88 . . . . 3.15 110.813 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.44 144.51 10.31 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.913 2.409 . . . . 2.72 112.977 -173.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 N-CA-C 110.76 -0.936 . . . . 2.74 110.76 163.821 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.94 0 CA-C-O 121.791 0.805 . . . . 3.65 111.416 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.2 tp -56.68 161.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 119.364 -2.085 . . . . 2.76 110.263 159.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.73 146.73 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.181 -0.95 . . . . 4.49 109.869 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.62 143.78 28.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.924 1.29 . . . . 3.99 109.15 161.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.9 145.01 8.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.167 1.387 . . . . 2.79 111.129 -172.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.7 p -62.19 -22.35 65.84 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.963 1.097 . . . . 3.48 113.963 171.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 279' ' ' GLN 0.334 0.1 OUTLIER 49.12 62.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.769 1.747 . . . . 3.93 110.715 -174.473 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.1 mm -118.92 152.44 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.283 2.233 . . . . 2.64 110.94 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.0 mtp -132.93 155.67 48.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.418 2.687 . . . . 2.33 109.376 -175.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -117.29 143.74 45.6 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.746 1.017 . . . . 3.54 113.746 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.76 127.5 42.79 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.906 1.682 . . . . 2.93 107.322 168.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.6 130.87 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.497 0.719 . . . . 2.87 109.073 171.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.13 173.16 37.4 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.921 0.772 . . . . 2.15 112.285 177.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.05 68.16 6.63 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.185 3.257 . . . . 3.27 111.085 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -167.83 -56.69 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.325 1.85 . . . . 5.47 109.729 -164.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 144.12 165.05 10.75 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.191 1.236 . . . . 3.27 116.191 170.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 70.65 -86.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.054 1.741 . . . . 8.41 111.976 165.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.72 157.01 9.9 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.779 1.632 . . . . 5.65 112.281 -173.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -39.38 0.6 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.395 1.478 . . . . 3.96 111.579 -175.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.33 176.01 13.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.756 2.023 . . . . 3.68 108.538 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -135.39 150.05 49.8 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.211 1.004 . . . . 3.22 112.437 178.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -133.18 -170.02 2.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.591 1.557 . . . . 3.06 110.477 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.91 -157.75 14.73 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.521 1.057 . . . . 2.84 110.888 -171.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 262' ' ' ILE . 12.0 tp-100 -71.91 90.71 1.14 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.546 0.943 . . . . 4.94 113.546 -164.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.1 p30 165.71 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 130.267 3.427 . . . . 7.4 112.984 164.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.94 108.91 7.04 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.368 -0.832 . . . . 6.23 108.934 170.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.427 ' HD2' ' H ' ' A' ' 282' ' ' ARG . 0.5 OUTLIER -78.71 135.5 37.17 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.19 0.996 . . . . 8.86 109.672 -172.572 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -21.24 -66.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.121 2.267 . . . . 3.0 117.121 -163.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.33 -20.41 65.32 Favored Glycine 0 N--CA 1.48 1.607 0 CA-C-N 119.944 1.247 . . . . 2.24 114.733 -173.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.94 -22.5 66.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.633 1.173 . . . . 4.43 111.642 172.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.41 -48.69 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.822 -1.173 . . . . 1.9 109.729 175.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.25 92.26 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.179 0.807 . . . . 1.84 113.179 173.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.93 74.19 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.984 0.735 . . . . 1.89 112.984 178.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 14.1 p -72.33 -44.07 63.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.72 -1.238 . . . . 1.89 111.677 170.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.9 -34.52 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.742 1.155 . . . . 1.91 111.985 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.38 47.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.613 1.338 . . . . 2.38 114.613 171.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.9 m -80.6 -48.45 12.66 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.115 0.87 . . . . 3.21 110.413 170.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -64.85 -28.29 69.45 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.849 1.26 . . . . 3.06 112.55 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.0 ttp -58.86 -20.0 46.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.225 2.61 . . . . 4.75 113.457 170.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -72.23 -50.41 8.75 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.824 -1.56 . . . . 6.22 111.936 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.27 -54.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 123.26 2.64 . . . . 3.16 112.966 169.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.65 126.27 33.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.554 0.742 . . . . 3.77 110.618 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 115.211 1.56 . . . . 7.14 115.211 -166.2 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.46 0 CA-C-O 118.428 -1.207 . . . . 2.69 114.365 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.01 150.79 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.707 2.271 . . . . 2.56 110.289 168.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -156.01 165.25 37.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.752 0.821 . . . . 2.45 112.122 -167.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.435 ' H ' ' NE2' ' A' ' 236' ' ' GLN . 73.8 m -121.41 137.99 54.47 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.722 -0.611 . . . . 2.38 109.999 147.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 mt -142.8 153.5 43.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.3 1.04 . . . . 3.04 109.575 168.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.3 m -93.25 150.75 20.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.886 0.874 . . . . 1.43 108.76 174.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.9 p -96.34 163.03 13.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 2.18 112.17 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -61.74 -16.8 52.48 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.075 1.139 . . . . 1.6 114.075 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -87.23 -43.7 12.0 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 117.566 -1.207 . . . . 3.2 111.368 168.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.9 5.98 1.57 Allowed Glycine 0 N--CA 1.474 1.185 0 N-CA-C 119.145 2.418 . . . . 1.77 119.145 158.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.4 158.0 19.11 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 121.419 2.609 . . . . 3.99 111.944 172.145 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -111.54 120.49 42.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.207 1.403 . . . . 5.77 110.963 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.407 ' HE3' HD21 ' A' ' 227' ' ' LEU . 0.0 OUTLIER -144.63 167.49 22.43 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.539 1.311 . . . . 5.3 114.539 -168.191 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.4 p -120.85 173.92 6.93 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.744 2.818 . . . . 2.24 111.742 -171.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.05 -31.63 72.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.276 0.63 . . . . 3.86 112.629 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -19.3 65.13 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.96 -1.088 . . . . 8.57 112.388 174.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -85.89 -43.78 12.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.868 0.867 . . . . 3.66 111.138 172.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -67.41 -25.88 66.15 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.596 1.332 . . . . 3.19 114.596 175.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 49.15 42.52 21.51 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.442 2.297 . . . . 5.3 112.486 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.3 -74.44 0.06 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.169 2.319 . . . . 5.67 113.286 -173.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 63.12 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.352 2.261 . . . . 3.59 111.803 -175.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -167.82 92.28 0.36 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.605 2.762 . . . . 1.8 109.172 173.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.05 131.06 53.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.764 1.226 . . . . 3.44 113.569 -174.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.49 124.77 49.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.113 1.365 . . . . 2.51 108.525 166.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.421 HD12 HD13 ' A' ' 267' ' ' ILE . 29.3 mt -126.84 114.35 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.238 1.015 . . . . 2.08 109.822 -164.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -122.43 139.91 53.32 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.701 1.0 . . . . 2.51 113.701 -174.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -96.36 109.31 21.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.727 0.811 . . . . 2.58 109.549 172.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.48 146.67 18.13 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.058 1.314 . . . . 1.23 113.471 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 204' ' ' ASP . 1.2 m-85 -81.54 61.12 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.13 0.972 . . . . 4.45 111.317 -174.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.3 p 45.84 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.071 2.148 . . . . 4.45 110.894 -170.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -103.62 116.72 32.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.29 0.95 . . . . 9.07 108.957 155.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.43 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 1.8 t -44.29 -174.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 130.954 3.702 . . . . 2.46 115.089 169.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 13.3 Cg_endo -47.31 -70.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.77 1.646 . . . . 3.67 109.776 138.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -167.66 21.77 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.84 1.793 . . . . 5.09 115.84 166.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 -34.71 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.318 -1.489 . . . . 2.61 111.766 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 90.1 m -44.2 -55.53 9.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.649 -1.643 . . . . 1.43 112.823 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.7 -29.35 60.01 Favored 'Trans proline' 0 C--N 1.354 0.817 0 CA-C-N 122.308 1.86 . . . . 1.18 114.092 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -75.58 -38.93 58.77 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.374 0.988 . . . . 3.61 112.216 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.51 -37.27 65.73 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.564 -1.335 . . . . 2.99 111.979 171.138 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.0 tt -55.85 -43.91 77.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.396 1.078 . . . . 3.88 111.492 169.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.22 -35.04 74.55 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.628 1.103 . . . . 3.16 112.466 -177.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -62.79 -45.18 93.84 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.587 -1.321 . . . . 3.27 111.238 173.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.7 ptp -68.81 -21.44 64.32 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 117.596 -1.192 . . . . 2.38 114.199 173.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.1 -57.23 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 120.586 1.539 . . . . 2.09 109.322 166.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -59.45 -19.81 50.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.325 1.45 . . . . 4.53 113.169 -177.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.78 -29.6 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.562 1.074 . . . . 1.7 113.758 170.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.04 -36.56 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 121.361 1.891 . . . . 2.59 110.706 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -50.56 36.56 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.57 1.948 . . . . 6.74 112.248 166.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -67.05 -36.58 82.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.603 0.761 . . . . 4.05 112.073 178.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mm -69.42 -45.98 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.995 1.318 . . . . 2.21 111.238 -177.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -66.04 -33.61 76.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 4.99 110.475 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.2 t -70.36 -8.15 48.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.657 1.183 . . . . 4.75 113.848 171.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.5 mm -79.19 -38.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.978 1.263 . . . . 3.84 110.287 165.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 57.87 -23.38 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 129.386 3.074 . . . . 4.16 116.082 -176.175 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 p -75.92 -20.79 57.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.249 -1.532 . . . . 5.17 112.942 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.83 173.64 1.98 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.367 1.467 . . . . 3.85 113.316 169.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.74 -40.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.831 2.354 . . . . 3.75 111.914 169.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 30.0 t70 165.08 165.07 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.86 2.864 . . . . 4.02 108.908 -159.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.75 122.54 36.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.312 -0.995 . . . . 2.1 108.312 153.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 m -101.05 114.96 65.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 109.374 -0.602 . . . . 1.87 109.374 173.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.95 142.99 15.99 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.27 1.98 . . . . 1.08 109.918 166.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.4 146.07 43.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 122.912 1.339 . . . . 2.52 112.433 170.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -114.44 130.82 56.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.913 -1.494 . . . . 2.45 109.623 -170.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 68.5 mt -107.13 117.97 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.743 1.217 . . . . 1.5 109.668 174.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.8 p -73.13 136.09 44.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.134 0.574 . . . . 3.19 110.699 167.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.7 pt -121.15 31.85 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.472 1.509 . . . . 1.59 111.634 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 166' ' ' PHE . 16.3 p-10 -161.74 65.59 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.908 1.283 . . . . 4.16 111.261 -158.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.35 -19.76 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.653 2.236 . . . . 2.83 113.427 -171.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.31 41.86 0.19 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.118 1.367 . . . . 4.44 111.966 168.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.0 -14.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 130.04 3.336 . . . . 5.51 114.257 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.83 159.93 8.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.563 1.074 . . . . 4.7 112.515 161.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.7 m -154.18 127.0 8.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 106.722 -1.584 . . . . 2.01 106.722 155.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -52.01 -43.86 63.87 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.535 1.134 . . . . 2.99 112.283 -177.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -70.23 -30.23 67.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.662 1.185 . . . . 3.51 114.194 172.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.33 -39.47 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.195 1.361 . . . . 1.46 111.715 176.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.19 -24.6 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.873 -1.142 . . . . 2.23 110.891 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.18 67.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 119.91 -1.744 . . . . 1.52 112.938 166.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -77.26 -35.67 55.11 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.397 1.079 . . . . 3.62 111.847 168.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.71 -36.09 81.84 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.549 -0.719 . . . . 6.37 111.563 176.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.6 t -54.5 -24.47 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 120.984 -1.073 . . . . 2.2 112.349 169.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -87.38 -22.31 25.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.544 -1.348 . . . . 5.62 114.134 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.82 -45.06 68.71 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.248 0.931 . . . . 4.82 110.307 165.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -105.1 -26.5 12.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.138 1.903 . . . . 3.49 116.138 -159.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 46.4 p 143.38 147.49 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 128.722 2.809 . . . . 2.49 113.413 169.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 66.43 5.42 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.023 3.148 . . . . 2.78 109.684 166.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.414 ' O ' ' HE2' ' A' ' 223' ' ' LYS . 0.1 OUTLIER -166.06 -31.66 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.047 2.139 . . . . 3.44 110.854 -171.431 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.47 145.92 48.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.412 0.551 . . . . 2.37 111.165 158.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.77 133.02 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.868 1.667 . . . . 1.83 106.891 162.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.71 128.71 9.66 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.346 -1.102 . . . . 0.83 110.346 176.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.407 HD21 ' HE3' ' A' ' 150' ' ' LYS . 5.4 mp -127.57 130.47 49.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.278 1.031 . . . . 2.31 111.538 -176.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -144.03 -178.95 6.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.613 1.565 . . . . 2.28 111.675 -167.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 176.74 -167.82 39.45 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.4 1.0 . . . . 1.53 113.766 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -84.0 157.29 21.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.772 1.229 . . . . 2.56 110.414 174.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -61.27 -20.57 63.01 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.068 1.507 . . . . 7.6 115.068 -169.534 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -70.33 -40.65 74.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.672 1.589 . . . . 2.98 111.175 172.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.39 -32.6 62.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.664 1.185 . . . . 3.41 111.745 173.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.67 -38.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 118.206 -0.902 . . . . 1.81 110.989 166.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.03 -44.5 92.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.133 1.333 . . . . 3.08 110.362 171.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.435 ' NE2' ' H ' ' A' ' 141' ' ' SER . 9.6 tt0 -49.67 -57.28 7.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.667 1.121 . . . . 2.41 110.934 172.425 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 32.6 m -74.11 -37.66 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.917 1.235 . . . . 3.07 113.261 -171.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.73 74.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.648 0.379 . . . . 1.96 111.65 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -95.68 -23.22 17.1 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.353 1.461 . . . . 3.83 113.555 -175.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.02 75.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.351 1.432 . . . . 2.16 110.768 164.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -82.55 -11.94 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.632 1.173 . . . . 2.93 114.098 174.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 71.64 37.19 1.13 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.279 1.832 . . . . 8.15 112.451 165.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 m -94.13 141.0 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.266 1.426 . . . . 2.64 112.328 -175.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -76.47 154.17 34.93 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.298 0.851 . . . . 5.79 113.298 171.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.01 149.53 16.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.923 1.689 . . . . 3.92 109.729 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.3 t -155.54 145.01 15.28 Favored Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 121.454 -0.779 . . . . 4.39 110.987 171.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.36 165.12 28.03 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.387 2.058 . . . . 4.49 109.628 151.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.684 0 C-N-CA 124.356 0.979 . . . . 3.36 114.426 174.754 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 113.655 0.983 . . . . 6.62 113.655 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 11.8 mm -61.52 153.11 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.547 -0.72 . . . . 3.38 109.261 159.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 30.7 m -154.88 141.67 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 128.018 2.527 . . . . 4.82 104.855 171.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -157.81 157.44 33.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.369 0.986 . . . . 4.86 113.299 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -160.44 -179.11 7.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.916 1.686 . . . . 2.28 113.686 -163.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.3 p -74.35 -15.11 60.95 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 116.899 2.185 . . . . 3.67 116.899 -176.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 56.86 11.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.15 1.78 . . . . 4.13 115.292 177.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 1.6 pp -95.65 148.13 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 119.997 -1.689 . . . . 4.51 114.384 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.5 ttp -122.51 121.76 37.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.806 2.442 . . . . 2.32 109.408 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -85.16 146.33 27.17 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.549 -0.719 . . . . 2.69 111.362 176.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.4 tp -109.1 127.51 54.22 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.918 1.287 . . . . 2.02 109.92 168.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.421 HD13 HD12 ' A' ' 162' ' ' ILE . 1.9 mp -119.19 124.75 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.912 2.085 . . . . 1.72 106.131 171.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.95 -162.66 36.9 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 109.618 -1.393 . . . . 1.64 109.618 164.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -85.02 54.48 3.94 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 120.392 2.096 . . . . 2.5 109.799 178.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.06 -34.77 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.486 1.515 . . . . 5.64 114.157 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.66 29.69 59.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.695 -1.058 . . . . 4.31 113.623 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -147.52 -39.02 0.19 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.034 1.417 . . . . 4.69 113.853 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.32 0.0 OUTLIER 102.74 152.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 132.368 4.267 . . . . 3.48 111.407 -171.944 . . . . . . . . 4 3 . 1 . 023 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 56.9 tp -129.48 -35.24 1.75 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.346 1.239 . . . . 2.89 114.346 -155.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -166.05 172.36 11.48 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.505 1.522 . . . . 2.84 111.026 -174.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -156.21 145.96 21.06 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.62 -1.3 . . . . 3.45 113.908 174.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -136.84 173.72 11.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.292 1.837 . . . . 2.66 111.447 -163.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.41 -169.06 36.13 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 125.807 1.67 . . . . 2.34 111.803 175.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -36.52 124.41 0.82 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.061 1.745 . . . . 3.52 113.071 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.9 t30 98.49 -34.94 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 130.315 3.446 . . . . 4.55 112.681 -174.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.71 109.87 0.89 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.31 1.414 . . . . 4.41 110.611 178.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.5 145.56 41.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.15 -0.969 . . . . 6.91 109.453 -171.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -56.17 -50.54 70.89 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.407 -1.433 . . . . 2.31 113.549 -168.645 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.28 -13.18 70.19 Favored Glycine 0 N--CA 1.479 1.565 0 O-C-N 121.463 -0.773 . . . . 1.82 114.926 175.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -86.72 -19.4 29.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.826 1.25 . . . . 5.32 111.046 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.23 -51.32 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 120.586 -1.322 . . . . 1.82 109.595 157.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -37.51 75.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 118.261 -0.876 . . . . 2.12 112.954 176.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.687 1.131 . . . . 2.36 112.831 173.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -48.89 79.87 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.422 -0.799 . . . . 1.99 112.157 169.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.64 -30.44 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.079 0.854 . . . . 1.84 111.504 179.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.34 -7.22 22.99 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.585 -1.322 . . . . 2.73 114.053 173.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 31.2 m -80.47 -57.04 3.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.026 0.931 . . . . 3.58 108.834 160.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -62.31 -26.8 68.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.312 1.845 . . . . 2.69 114.487 -174.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 31.7 mtt -55.86 -30.13 60.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.597 1.159 . . . . 5.14 111.619 170.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -59.71 -47.11 98.27 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.406 -1.759 . . . . 5.06 111.38 -176.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.26 -58.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.872 2.381 . . . . 3.53 113.403 163.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.83 17.89 17.05 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 116.669 2.1 . . . . 3.52 116.669 -157.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 . . . . . 0 N--CA 1.478 0.926 0 O-C-N 120.956 -1.09 . . . . 7.17 111.415 159.739 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.673 0 CA-C-O 118.118 -1.379 . . . . 2.57 111.973 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.67 142.06 62.58 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.078 2.518 . . . . 2.59 112.706 -167.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -116.45 168.44 10.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.201 1.8 . . . . 2.77 111.264 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 p -148.5 85.48 1.51 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.84 1.256 . . . . 2.89 111.28 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.64 143.84 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.208 1.003 . . . . 2.04 110.791 175.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 p -75.38 150.28 38.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 3.46 111.863 171.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 p -96.0 120.68 36.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.621 1.969 . . . . 2.29 108.273 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.5 m170 51.15 24.79 2.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.195 1.554 . . . . 3.26 115.195 177.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.379 0.6 OUTLIER 31.36 39.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.509 2.724 . . . . 9.9 115.491 -155.695 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -110.82 -28.71 3.83 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.833 2.158 . . . . 2.83 113.051 -178.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -155.3 179.81 8.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.808 1.304 . . . . 4.03 112.28 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -118.6 111.23 18.31 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.446 1.098 . . . . 7.17 111.033 -159.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -119.71 168.9 10.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.462 1.601 . . . . 3.13 115.171 167.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.7 m -158.79 158.05 32.81 Favored 'General case' 0 C--N 1.326 -0.422 1 C-N-CA 132.099 4.16 . . . . 2.91 103.962 -169.358 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -41.74 -52.34 3.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.624 1.17 . . . . 3.35 112.86 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -82.75 -8.56 59.58 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.338 1.607 . . . . 6.45 115.338 178.19 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -75.93 -18.76 59.23 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.399 1.454 . . . . 4.08 111.631 165.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -97.69 -40.44 8.58 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.103 1.361 . . . . 3.73 114.124 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.98 154.28 19.32 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.39 0.995 . . . . 4.0 113.533 -170.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.47 10.25 22.05 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.878 1.704 . . . . 2.73 112.708 -158.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.54 160.89 18.17 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.218 2.607 . . . . 3.12 107.758 -176.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -83.33 121.91 27.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.624 -0.673 . . . . 2.12 110.823 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.61 135.29 39.64 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.242 1.02 . . . . 2.78 111.304 -176.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -115.16 126.15 54.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.487 1.515 . . . . 2.26 107.897 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.7 mt -129.4 118.49 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.413 0.685 . . . . 1.7 109.941 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -120.68 145.09 47.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.349 1.459 . . . . 2.74 112.934 -175.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -114.67 97.61 6.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.232 1.413 . . . . 2.08 110.87 -177.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.61 -160.52 10.69 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.592 1.567 . . . . 1.51 115.423 -169.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -156.03 159.41 39.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.434 1.494 . . . . 4.61 110.746 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 p -69.49 127.04 31.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.014 -1.679 . . . . 3.45 110.287 172.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 73.2 -43.78 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.429 2.292 . . . . 8.19 111.821 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.4 t 86.59 177.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 127.277 2.231 . . . . 2.54 111.419 -166.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -40.7 -69.69 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.458 2.772 . . . . 4.23 111.493 130.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . 0.26 1.1 m-20 171.24 58.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 128.417 2.687 . . . . 4.93 111.366 170.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.81 -27.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.869 1.268 . . . . 3.82 114.02 174.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.36 -37.19 19.53 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 115.852 -2.023 . . . . 2.43 113.854 162.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.52 -80.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.336 2.024 . . . . 1.91 111.051 166.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.19 -29.01 69.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.676 0.991 . . . . 4.41 113.676 -165.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.63 -41.68 59.96 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.255 -1.528 . . . . 3.66 112.691 177.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.4 -36.76 74.25 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.299 -1.334 . . . . 3.04 110.521 172.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -57.14 -43.99 82.98 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.733 1.606 . . . . 6.08 111.806 173.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -60.84 -55.27 35.02 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.712 -1.243 . . . . 3.16 112.219 168.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.67 -24.66 62.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.078 1.14 . . . . 4.41 114.078 -170.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -56.7 -37.88 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.258 1.39 . . . . 1.74 111.279 169.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.98 -28.68 66.83 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.379 -0.819 . . . . 3.04 110.609 176.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.8 -34.68 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.454 1.024 . . . . 2.03 111.355 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.82 -37.73 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.598 1.09 . . . . 2.37 111.439 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -32.51 58.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.364 0.983 . . . . 4.61 113.298 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -60.21 -26.26 66.24 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.596 1.558 . . . . 3.54 112.946 170.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -90.16 -55.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.104 1.762 . . . . 2.14 112.387 175.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.15 -30.45 71.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.819 2.048 . . . . 3.16 113.133 -175.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.1 t -66.07 -12.8 57.87 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.786 -1.196 . . . . 2.95 112.894 169.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.0 mm -121.56 44.41 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.15 1.78 . . . . 4.56 108.186 -178.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.24 0.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.5 3.52 . . . . 6.42 118.419 -158.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.3 p -69.08 -18.99 64.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.88 1.272 . . . . 4.32 113.047 157.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.41 163.15 43.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 127.28 2.232 . . . . 4.55 109.908 169.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.41 162.21 11.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.514 2.143 . . . . 5.29 114.178 -148.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.55 94.5 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.71 1.604 . . . . 6.16 111.606 -172.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.3 mp -93.86 116.6 29.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.111 0.964 . . . . 2.43 112.722 -175.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.6 m -107.59 111.82 62.58 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.261 1.024 . . . . 1.35 110.89 171.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -88.05 122.9 1.62 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.954 3.102 . . . . 1.01 112.254 177.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.64 122.83 47.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.742 2.417 . . . . 2.95 110.529 -178.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -102.06 121.08 41.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.943 0.897 . . . . 2.36 111.182 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.45 119.99 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.602 1.161 . . . . 1.63 108.331 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.1 p -78.65 131.35 36.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.285 -0.884 . . . . 2.02 110.581 164.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.43 -21.73 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 115.547 1.684 . . . . 2.71 115.547 -176.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -125.74 75.23 70.59 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 124.525 1.13 . . . . 4.98 109.194 -177.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.45 98.51 0.4 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.683 3.588 . . . . 2.0 109.31 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -162.31 -24.04 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.102 1.149 . . . . 4.53 114.102 -166.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.45 9.16 0.54 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.176 1.176 . . . . 4.92 114.176 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -111.8 75.33 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 129.645 3.178 . . . . 3.81 108.798 -173.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.29 155.96 30.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.04 1.4 . . . . 2.73 114.363 -163.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.84 -50.42 7.91 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.409 2.283 . . . . 3.29 114.784 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -85.93 -35.0 20.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.808 1.643 . . . . 4.72 112.321 174.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.24 71.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.367 0.985 . . . . 1.95 113.501 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 18.9 mm -64.53 -42.64 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.842 1.201 . . . . 1.63 111.675 170.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.3 -22.54 66.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.734 0.814 . . . . 1.87 112.897 176.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -83.41 -44.73 14.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.699 1.6 . . . . 4.03 112.027 168.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -53.26 -35.83 60.46 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.648 1.579 . . . . 2.77 111.922 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -52.47 -43.91 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.415 1.486 . . . . 1.46 113.617 167.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -67.03 -47.44 71.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 117.807 -1.092 . . . . 6.4 111.982 -176.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -43.19 63.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.507 1.523 . . . . 4.19 111.917 177.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -70.28 -62.71 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.858 0.463 . . . . 3.3 111.53 175.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.8 m 169.73 145.57 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.534 2.734 . . . . 2.17 110.833 177.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.59 -6.52 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.585 2.857 . . . . 1.62 114.709 -177.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.41 -10.4 59.43 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.709 1.141 . . . . 3.57 113.581 170.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.85 137.93 34.23 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.624 1.17 . . . . 2.05 111.557 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -113.36 129.92 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.255 1.022 . . . . 1.73 109.561 -174.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.09 129.37 9.87 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.841 -0.904 . . . . 1.09 110.841 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.82 156.9 18.67 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.868 -0.79 . . . . 2.53 108.868 168.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.3 m -150.39 126.91 10.82 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.223 -1.399 . . . . 3.3 107.223 171.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.58 -145.04 4.05 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.094 1.807 . . . . 1.99 111.189 -174.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -121.75 174.72 6.67 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.301 1.051 . . . . 2.54 110.91 165.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.26 -18.09 14.72 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.627 1.171 . . . . 8.2 113.327 -174.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.48 -41.99 19.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.194 2.198 . . . . 3.44 112.153 -173.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.83 -31.75 66.85 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.286 -1.509 . . . . 3.71 110.702 166.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.8 -35.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.364 -0.827 . . . . 1.74 110.916 172.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -58.78 -57.01 14.93 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 117.632 -1.175 . . . . 2.74 109.778 163.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -49.87 -56.33 10.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.219 1.372 . . . . 3.19 112.514 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.55 -29.51 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.288 0.495 . . . . 2.07 111.771 -171.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.32 -50.8 20.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.647 0.779 . . . . 1.65 111.525 171.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -56.15 -49.12 74.85 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.148 2.579 . . . . 3.09 111.398 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.78 77.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.551 0.74 . . . . 2.04 112.947 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -94.64 14.43 21.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.233 1.413 . . . . 2.77 113.363 176.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 61.6 12.26 4.4 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.134 2.174 . . . . 5.47 115.111 176.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.99 140.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.393 1.477 . . . . 2.84 111.254 -177.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -109.52 173.43 6.33 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.542 1.537 . . . . 4.7 112.481 174.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -121.59 148.55 44.38 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.008 0.923 . . . . 3.89 111.534 176.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -128.95 63.14 65.61 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.159 0.984 . . . . 4.79 111.654 176.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 138.98 42.83 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.598 2.198 . . . . 3.23 110.332 176.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.411 0 CA-C-O 119.676 -0.513 . . . . 3.25 113.342 -176.017 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.731 1.382 . . . . 3.74 114.731 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.08 128.71 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.778 -1.201 . . . . 3.35 109.919 157.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.1 153.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.304 1.442 . . . . 3.91 107.902 170.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.57 174.85 11.05 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 122.752 1.263 . . . . 5.75 112.273 -174.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 167.54 11.13 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.889 -1.132 . . . . 2.19 112.737 -143.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.1 t -68.09 -20.25 64.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.318 1.97 . . . . 4.03 116.318 -171.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.5 mt 47.9 55.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.914 1.686 . . . . 4.49 111.593 -177.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.6 mt -137.79 139.77 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.518 1.527 . . . . 2.58 110.348 -178.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.66 120.46 39.72 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.51 2.724 . . . . 3.27 109.326 161.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -88.31 135.11 33.61 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.136 0.574 . . . . 2.56 111.266 165.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.4 tt -103.41 120.67 41.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.699 2.0 . . . . 2.29 109.441 174.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.92 143.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 127.271 2.229 . . . . 2.08 108.167 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.34 178.23 18.49 Favored Glycine 0 CA--C 1.545 1.914 0 C-N-CA 123.931 0.777 . . . . 1.82 113.95 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 -42.97 2.15 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.6 2.866 . . . . 4.06 112.904 -174.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -142.87 84.53 1.84 Allowed 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 107.092 -1.447 . . . . 7.71 107.092 161.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.17 -150.85 6.78 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.232 1.872 . . . . 2.54 110.315 -176.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -122.78 -162.57 1.03 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.008 0.923 . . . . 4.18 111.217 -179.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -52.58 134.94 35.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.076 0.941 . . . . 4.18 110.43 173.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.37 -33.02 1.13 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.428 1.491 . . . . 2.95 110.328 -169.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -155.28 172.83 17.54 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.828 2.051 . . . . 2.41 110.481 175.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -162.21 148.01 13.04 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.616 -1.303 . . . . 3.7 114.257 176.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -132.47 128.24 36.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.887 1.275 . . . . 2.35 110.706 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -101.88 -176.62 28.11 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.79 0.709 . . . . 2.64 112.282 165.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -52.3 154.29 2.49 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.418 0.687 . . . . 4.26 110.588 167.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.3 t30 81.83 -17.86 0.52 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.737 2.415 . . . . 6.11 112.196 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -69.54 107.94 3.6 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.238 -1.539 . . . . 6.06 110.532 161.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -66.14 144.54 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.502 1.144 . . . . 7.45 109.785 176.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -32.49 65.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.051 . . . . 2.47 113.839 -167.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.18 86.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.01 -0.883 . . . . 1.44 113.489 -178.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.36 -18.03 61.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.359 1.579 . . . . 3.21 112.944 174.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.8 mt -70.01 -47.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.457 -0.777 . . . . 1.21 109.201 172.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.78 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.08 0.552 . . . . 1.23 112.065 170.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.89 81.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.567 0.951 . . . . 1.45 113.567 173.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 52.2 p -65.5 -47.18 76.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.996 0.817 . . . . 1.42 111.669 172.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.62 -39.63 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 120.74 -1.225 . . . . 1.91 110.638 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.07 72.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.907 0.883 . . . . 1.74 113.159 171.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.1 m -71.59 -48.08 50.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.219 1.008 . . . . 2.14 110.333 174.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -70.74 -20.27 62.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.206 1.003 . . . . 2.3 113.075 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.1 mmm -66.49 -33.67 76.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.193 1.397 . . . . 3.81 113.255 162.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -52.63 -40.2 74.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 116.358 -1.782 . . . . 5.41 113.13 -176.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.26 -60.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.196 2.597 . . . . 2.29 111.544 162.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -86.28 47.25 1.44 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.823 1.416 . . . . 3.09 114.823 -165.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.787 0 O-C-N 120.832 -1.167 . . . . 9.68 111.658 176.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.286 0 CA-C-O 118.237 -1.313 . . . . 2.51 112.486 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.58 154.18 30.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.206 2.604 . . . . 3.43 111.939 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -160.82 154.31 22.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.579 1.151 . . . . 3.01 111.651 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 t -138.17 95.58 3.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.951 -1.093 . . . . 2.53 112.874 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.63 162.9 14.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.115 1.366 . . . . 2.72 112.153 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.4 m -98.14 142.6 29.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.53 1.132 . . . . 1.52 110.779 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.9 m -98.29 164.7 12.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.184 1.793 . . . . 2.65 112.049 -171.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -61.17 -5.37 1.49 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 117.649 2.463 . . . . 2.63 117.649 -170.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -35.02 6.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 121.023 1.738 . . . . 4.19 111.29 165.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.47 11.61 0.45 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.719 2.104 . . . . 2.36 115.185 -177.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -84.04 129.28 34.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.057 2.143 . . . . 5.48 110.051 -176.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -69.2 130.2 41.98 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.52 -1.363 . . . . 4.66 110.012 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 158.72 24.61 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.441 . . . . 2.89 109.834 168.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.6 p -152.02 162.94 40.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.573 1.549 . . . . 2.34 110.233 -167.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -46.63 -49.68 18.72 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.792 1.237 . . . . 5.08 112.034 166.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -79.48 4.23 16.26 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.536 1.31 . . . . 7.44 114.536 -172.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.08 -30.34 16.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.966 1.706 . . . . 3.6 111.452 169.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -103.38 -16.24 15.68 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.988 1.477 . . . . 4.4 114.988 -177.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 tt -75.08 88.88 2.43 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.386 1.088 . . . . 5.14 110.304 -171.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 164.78 -30.55 0.23 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.783 1.658 . . . . 3.21 111.923 -167.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -103.76 -179.6 4.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 4.42 111.453 159.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -85.06 140.72 30.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.023 0.529 . . . . 3.91 110.366 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 pp -134.28 153.39 51.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.139 0.976 . . . . 4.06 111.09 175.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.61 138.45 54.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.754 1.222 . . . . 3.82 109.072 171.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.3 mt -111.59 130.16 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.103 -0.703 . . . . 2.7 109.103 177.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -120.61 142.25 49.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.932 1.293 . . . . 2.93 110.508 164.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.69 123.49 50.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.064 1.345 . . . . 2.5 110.107 171.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -160.38 146.77 13.03 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.459 -0.634 . . . . 2.16 113.541 175.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.87 18.35 14.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.381 1.623 . . . . 4.17 115.381 -171.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.2 m 66.99 -15.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.603 1.961 . . . . 3.56 114.048 173.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -111.2 16.38 21.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.898 2.079 . . . . 7.81 112.684 -167.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.58 171.49 6.97 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.937 1.695 . . . . 2.69 114.538 176.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.14 -176.92 1.46 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.117 2.544 . . . . 3.14 110.479 150.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.36 64.56 2.13 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 5.9 113.139 -172.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 80.5 t -130.97 -45.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.964 2.105 . . . . 3.71 109.728 174.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.4 t -62.71 -52.04 67.6 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.855 1.262 . . . . 1.79 112.591 172.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.5 -34.71 25.24 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.981 1.788 . . . . 1.36 113.077 172.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.538 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 13.4 tm-20 -64.89 -40.41 95.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.99 1.268 . . . . 2.69 112.384 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.424 -1.423 . . . . 2.37 111.594 171.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 37.4 mt -62.72 -37.4 86.4 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.215 0.916 . . . . 2.89 112.859 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.68 4.67 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.18 0.9 . . . . 3.39 110.336 174.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.538 ' HZ2' ' CD ' ' A' ' 175' ' ' GLU . 30.0 mtmm -57.53 -28.72 63.75 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.773 -1.204 . . . . 2.64 112.713 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.34 -49.11 72.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.016 0.826 . . . . 3.17 111.664 168.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.35 -36.19 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 119.636 1.107 . . . . 1.88 110.627 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.28 -23.31 35.68 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.326 0.862 . . . . 3.3 113.326 171.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.83 -38.52 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.69 1.132 . . . . 1.88 110.718 173.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.35 -40.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.328 1.051 . . . . 1.94 110.921 -179.173 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.81 -53.94 34.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.458 1.503 . . . . 5.31 110.971 169.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -69.74 -34.27 73.61 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 112.494 0.553 . . . . 4.02 112.494 -174.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.34 -40.35 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.056 1.342 . . . . 2.12 112.952 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.68 -34.83 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.294 0.497 . . . . 3.3 111.79 168.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.2 t -64.89 -36.01 82.99 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.711 -1.243 . . . . 3.23 112.658 172.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.42 -3.06 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.332 1.853 . . . . 3.79 112.216 167.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.329 73.1 p 124.43 -9.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 1 C-N-CA 132.796 4.438 . . . . 5.72 114.945 152.696 . . . . . . . . 3 2 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.7 t 143.01 -18.53 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 129.824 3.25 . . . . 7.08 113.675 178.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.3 -146.4 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.655 -1.641 . . . . 4.76 109.561 -172.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.75 -42.11 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 124.079 2.493 . . . . 3.62 109.467 146.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.5 t70 161.8 157.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 1 C-N-CA 132.216 4.206 . . . . 4.14 107.973 174.324 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.28 90.07 3.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.904 0.882 . . . . 2.57 108.786 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 35.9 m -66.02 117.54 43.5 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 108.28 -1.007 . . . . 2.61 108.28 178.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -91.01 127.34 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.175 1.917 . . . . 1.47 110.085 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.0 tp -121.23 108.42 13.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.555 1.142 . . . . 2.67 109.983 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -90.06 123.38 33.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.378 1.071 . . . . 2.49 109.594 169.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.2 mt -111.36 125.25 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.404 -0.961 . . . . 1.39 108.404 171.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.6 t -96.03 144.29 26.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.794 -0.566 . . . . 2.32 110.6 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.429 ' HA ' HG21 ' A' ' 234' ' ' VAL . 25.0 pt -108.5 3.99 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.877 1.066 . . . . 2.08 113.877 -174.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.24 77.35 1.55 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.661 1.184 . . . . 3.0 112.435 -169.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.77 -9.33 18.27 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.006 1.804 . . . . 3.56 111.834 166.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -70.33 -4.87 24.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.998 2.119 . . . . 3.46 114.153 174.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -9.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.813 2.523 . . . . 4.72 117.813 178.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.99 97.23 10.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.611 2.005 . . . . 4.44 110.039 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 m -74.28 128.94 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.978 -0.749 . . . . 2.53 108.978 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -54.15 8.64 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.425 1.49 . . . . 3.06 111.597 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -68.25 -23.42 64.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.269 1.428 . . . . 3.68 113.741 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.16 -44.64 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.439 -1.413 . . . . 2.07 111.247 172.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.07 -37.48 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.818 0.847 . . . . 2.76 110.397 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.76 -33.76 36.52 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.822 1.045 . . . . 2.05 113.822 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -80.38 -49.49 11.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.752 -0.592 . . . . 4.68 111.926 175.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -49.49 -37.57 26.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.674 1.19 . . . . 3.03 113.385 171.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.474 HG21 ' HA3' ' A' ' 226' ' ' GLY . 39.0 t -62.37 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.675 1.59 . . . . 1.82 112.134 173.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -56.02 -48.3 76.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.977 0.911 . . . . 4.88 112.474 -178.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -19.42 62.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.367 1.467 . . . . 7.48 112.604 -174.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -53.94 7.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.406 0.682 . . . . 3.17 111.017 164.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.6 t -167.96 139.29 2.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.253 1.021 . . . . 3.09 111.503 167.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.69 0.81 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.036 2.491 . . . . 2.29 114.078 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -86.6 -16.3 37.15 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 120.051 1.296 . . . . 3.03 113.064 165.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.62 143.88 34.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.25 1.42 . . . . 2.06 110.948 -177.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.46 145.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.404 0.681 . . . . 2.37 110.269 164.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.474 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -117.02 124.84 6.29 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 124.054 0.835 . . . . 0.85 111.383 173.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 11.1 mp -117.39 145.95 43.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.817 1.247 . . . . 2.14 111.438 -179.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.3 p -149.92 174.94 12.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.211 2.604 . . . . 2.31 109.964 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.35 -152.11 8.09 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.497 -1.441 . . . . 1.83 109.497 158.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.8 p -64.3 165.33 9.7 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.62 1.568 . . . . 2.64 112.571 162.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.87 -36.37 62.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.315 -0.857 . . . . 7.11 110.698 169.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.09 -45.91 69.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.877 2.071 . . . . 3.34 112.667 176.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.98 -47.82 84.24 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.178 -0.951 . . . . 4.71 110.803 173.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 203' ' ' ILE . 0.9 OUTLIER -75.46 -17.03 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.152 1.168 . . . . 2.33 114.152 -178.553 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.55 -43.83 97.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.337 0.971 . . . . 3.12 109.78 168.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.92 -53.18 61.26 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.061 -0.495 . . . . 3.04 111.096 -176.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.36 -23.75 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 112.752 0.649 . . . . 2.08 112.752 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.04 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.561 0.745 . . . . 2.01 112.83 171.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -70.4 -41.54 72.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.559 2.343 . . . . 4.28 111.528 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.58 -46.2 63.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.983 1.713 . . . . 2.06 112.795 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.42 -126.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.881 0.764 . . . . 3.16 110.389 171.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.17 61.65 0.7 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.593 -1.317 . . . . 6.06 111.783 -172.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.36 156.87 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.075 0.95 . . . . 4.26 109.228 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -152.8 169.71 22.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.113 2.565 . . . . 4.65 109.165 -173.493 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -165.77 153.9 11.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.993 1.317 . . . . 4.87 111.148 -177.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.4 t -149.56 138.31 12.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.912 1.685 . . . . 5.55 108.254 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.28 151.07 15.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.155 2.57 . . . . 5.27 111.947 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.305 0 CA-C-O 118.717 -1.046 . . . . 4.64 110.716 172.465 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 122.13 0.967 . . . . 5.03 110.679 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.5 tt -73.22 175.34 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.714 1.205 . . . . 3.44 110.996 167.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.7 t -151.64 158.77 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 127.554 2.341 . . . . 3.94 106.208 172.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -85.55 150.6 24.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.398 1.479 . . . . 5.25 112.37 169.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -148.1 150.29 33.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.828 1.047 . . . . 2.38 113.828 153.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.24 164.05 1.01 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.058 1.343 . . . . 3.87 110.486 171.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.2 tp -143.19 155.11 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.997 1.319 . . . . 4.15 109.175 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.7 mt 108.48 141.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 130.987 3.715 . . . . 3.04 107.901 -162.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 mtt -101.15 136.21 41.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.501 1.12 . . . . 3.81 108.822 167.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -111.53 126.28 54.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.651 0.78 . . . . 4.38 110.75 -172.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 14.0 tp -99.9 123.72 44.45 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.872 1.269 . . . . 2.33 110.562 -175.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.85 131.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.571 -1.27 . . . . 2.93 107.571 174.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.59 169.28 25.81 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.562 0.601 . . . . 3.41 112.737 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.97 71.21 5.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.077 3.184 . . . . 4.06 108.236 167.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -156.51 -59.86 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.764 1.626 . . . . 6.14 108.536 -162.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.78 -38.86 0.2 Allowed Glycine 0 C--N 1.345 1.045 0 N-CA-C 115.51 0.964 . . . . 4.12 115.51 170.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -157.01 -151.4 0.32 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.333 1.235 . . . . 6.17 114.333 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -70.26 109.87 4.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.094 1.358 . . . . 4.97 111.278 -173.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 tt -99.45 -21.37 16.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.308 1.043 . . . . 3.6 111.642 179.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.24 160.08 38.28 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.726 2.01 . . . . 2.68 109.618 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -165.39 123.01 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.507 1.523 . . . . 3.52 111.754 177.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -139.31 136.14 34.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.548 1.539 . . . . 3.21 111.687 -165.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.41 145.99 13.44 Favored Glycine 0 N--CA 1.471 1.033 0 O-C-N 120.661 -1.274 . . . . 3.02 116.033 -174.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 64.24 -105.31 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.358 1.863 . . . . 3.63 110.642 171.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.91 87.49 0.25 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.147 1.379 . . . . 6.21 112.161 -176.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.99 130.56 0.08 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 128.737 2.815 . . . . 8.71 111.067 178.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -90.61 158.92 16.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.555 1.942 . . . . 6.62 110.201 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -40.04 80.04 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.373 1.62 . . . . 2.27 115.373 -164.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.91 -24.19 71.4 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 118.129 0.422 . . . . 1.48 113.185 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.17 -39.94 93.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.04 0.92 . . . . 3.61 111.384 175.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 46.9 mt -70.55 -42.15 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.74 0.816 . . . . 1.36 110.541 177.14 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.84 90.93 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.831 -0.543 . . . . 1.47 111.2 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.06 87.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.05 1.34 . . . . 1.61 113.716 173.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.0 p -64.98 -45.43 85.69 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.483 1.492 . . . . 1.71 110.889 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.8 -40.8 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 120.898 -1.127 . . . . 2.06 111.686 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.32 -25.05 67.44 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.645 -1.284 . . . . 2.32 113.188 171.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.9 m -73.48 -43.05 61.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.003 . . . . 2.17 110.598 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -70.55 -25.64 63.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.66 0.784 . . . . 2.72 112.83 174.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.3 ttp -69.02 -22.58 64.05 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.749 -1.219 . . . . 4.33 113.221 165.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -55.78 -42.73 97.6 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 116.632 -1.652 . . . . 4.55 112.838 177.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.43 -51.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.342 2.695 . . . . 2.42 111.968 163.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -83.97 68.25 9.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.38 1.086 . . . . 3.06 112.37 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 126.251 1.82 . . . . 7.93 113.91 -169.169 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.369 0 CA-C-O 117.869 -1.517 . . . . 3.1 111.512 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -78.98 167.92 21.39 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.442 2.761 . . . . 3.11 114.645 -168.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -158.01 163.04 38.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.954 2.102 . . . . 2.37 110.974 -169.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.7 t -126.65 116.95 21.79 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.989 -1.07 . . . . 2.72 110.401 161.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.485 ' HB2' HD23 ' A' ' 227' ' ' LEU . 2.1 mp -135.96 160.24 39.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.098 0.952 . . . . 2.67 112.363 -178.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m -82.88 136.56 34.56 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.177 1.791 . . . . 1.84 109.764 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.9 t -97.38 158.7 15.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.954 1.302 . . . . 2.98 111.894 -178.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -14.98 57.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.475 1.657 . . . . 1.65 115.475 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.4 -11.51 59.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.635 1.574 . . . . 3.06 112.404 171.325 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.89 -26.17 16.53 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.873 1.701 . . . . 2.72 114.538 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.82 -142.61 0.1 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.005 1.322 . . . . 6.39 111.216 176.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.2 ttm105 -140.76 157.97 44.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 122.807 1.289 . . . . 6.13 113.287 -159.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -140.06 149.13 42.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.691 1.596 . . . . 4.06 112.471 169.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.7 p -118.3 162.38 18.37 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.03 1.332 . . . . 2.33 109.741 158.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.93 -42.79 63.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.961 1.705 . . . . 3.64 112.595 176.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -47.43 -30.29 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.946 1.699 . . . . 8.28 113.908 171.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.45 -5.15 43.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.046 1.338 . . . . 3.07 112.85 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.71 -25.14 14.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.625 1.17 . . . . 3.01 112.619 163.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.37 142.11 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.114 1.765 . . . . 3.89 112.596 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.85 35.13 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.055 0.782 . . . . 2.65 115.055 173.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -139.19 -166.88 2.12 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.705 1.602 . . . . 3.41 108.943 172.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -90.69 70.02 6.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.083 0.945 . . . . 2.44 109.003 171.283 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.55 151.78 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.278 -0.638 . . . . 2.67 109.278 175.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.8 tp -148.23 122.69 9.72 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.789 -0.569 . . . . 2.78 109.577 -173.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -109.59 115.02 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 122.787 0.435 . . . . 1.73 111.732 -169.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.89 146.05 41.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.844 1.658 . . . . 2.69 112.62 173.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -111.65 118.54 35.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.687 1.195 . . . . 2.32 110.068 174.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.36 153.93 23.78 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.327 0.965 . . . . 1.3 114.888 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -81.06 -29.33 35.03 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.977 1.311 . . . . 4.26 112.819 176.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.3 m 96.78 123.7 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.899 2.879 . . . . 3.12 107.352 -173.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 72.11 -46.25 0.64 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.152 2.181 . . . . 8.77 113.357 -178.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.709 ' HB3' ' H ' ' A' ' 171' ' ' ASP . 1.3 m 58.7 -172.28 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.214 1.405 . . . . 2.29 113.018 -173.123 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.17 -43.2 9.12 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.039 1.826 . . . . 2.96 110.368 144.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.709 ' H ' ' HB3' ' A' ' 169' ' ' CYS . 9.5 p30 -154.5 -53.68 0.1 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.419 1.888 . . . . 6.59 115.353 -159.287 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.64 -35.82 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 114.978 1.473 . . . . 3.85 114.978 -159.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -46.29 -64.78 0.83 Allowed Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 120.245 1.384 . . . . 1.9 111.386 167.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.5 -32.21 32.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.678 2.252 . . . . 1.49 113.053 -177.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -59.81 -49.78 76.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.472 1.033 . . . . 4.08 111.429 175.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.36 -30.63 53.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.451 0.908 . . . . 3.98 113.451 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.6 -41.05 76.34 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.259 -0.901 . . . . 2.43 111.075 168.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.95 -47.48 86.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.892 0.769 . . . . 3.82 111.572 176.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -53.22 54.87 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.379 -1.451 . . . . 3.59 110.74 170.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.7 ttp -59.36 -40.7 87.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.189 1.396 . . . . 2.55 112.714 -175.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.5 mm -71.64 -53.85 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 1.75 110.174 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.584 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 67.4 mt-30 -62.86 -34.54 77.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.818 0.735 . . . . 3.71 110.269 -172.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 t -52.01 -31.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.525 -1.226 . . . . 1.48 112.853 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.49 -34.8 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.941 1.7 . . . . 2.82 111.352 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -37.54 82.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.699 0.681 . . . . 5.86 112.307 -177.024 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -84.85 -33.53 22.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.949 1.299 . . . . 3.94 112.143 -178.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.76 -40.19 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.503 1.121 . . . . 1.68 111.384 172.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -73.49 -48.2 35.22 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 117.969 0.35 . . . . 4.81 111.233 171.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 55.5 m -70.01 -20.86 63.25 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.437 1.643 . . . . 3.67 115.437 -171.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.1 mm -74.23 -53.4 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.684 1.129 . . . . 4.9 112.301 -178.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.4 p -150.6 13.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.943 1.297 . . . . 7.6 113.413 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 6.1 t 52.67 66.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.379 2.272 . . . . 6.39 110.819 -173.589 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -53.7 158.2 3.33 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.834 1.654 . . . . 3.18 111.589 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -77.12 38.45 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.211 3.274 . . . . 2.84 112.467 178.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . 0.265 5.0 t0 76.13 138.45 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 131.555 3.942 . . . . 4.66 117.412 167.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.04 110.12 21.59 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.021 2.129 . . . . 3.74 107.691 170.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -110.94 96.4 29.18 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 124.671 1.189 . . . . 1.74 109.693 -175.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.3 125.62 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.317 2.678 . . . . 0.85 113.626 -173.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.0 tp -104.55 118.65 37.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.114 1.765 . . . . 2.29 109.339 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -104.76 132.02 51.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.749 1.22 . . . . 2.44 109.495 176.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.1 mm -114.42 133.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.522 1.529 . . . . 1.62 110.427 177.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.4 m -67.19 -172.95 0.23 Allowed 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 115.158 1.54 . . . . 2.68 115.158 170.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.3 pt -144.99 -34.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.439 -1.413 . . . . 2.61 114.747 175.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -130.92 71.82 82.2 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.73 1.612 . . . . 3.22 111.288 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.95 -1.44 2.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 124.982 3.788 . . . . 3.02 115.657 -172.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.26 -6.51 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.495 1.043 . . . . 4.36 113.343 160.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -132.63 -60.83 0.87 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.39 1.476 . . . . 5.58 114.145 -173.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.54 74.7 9.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.836 1.303 . . . . 4.04 110.906 -172.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.4 t -65.01 154.7 36.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.185 1.469 . . . . 2.53 112.11 -170.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -56.16 -32.74 64.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.331 1.852 . . . . 6.25 113.626 -171.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -77.2 -39.36 49.02 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.809 2.844 . . . . 4.55 110.803 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.98 77.57 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.863 0.865 . . . . 1.37 111.235 172.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.55 -42.95 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 1.61 110.631 168.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.17 96.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.719 -0.658 . . . . 1.14 112.118 175.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -61.72 -50.39 72.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.78 1.173 . . . . 3.66 111.617 171.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.08 -42.52 72.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.413 1.485 . . . . 3.19 111.807 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.18 -46.32 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.325 1.05 . . . . 1.39 112.234 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.424 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -63.82 -25.43 68.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.449 0.907 . . . . 4.79 113.449 -176.651 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.424 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 7.0 mm-40 -83.98 -40.31 18.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.138 0.881 . . . . 5.18 112.411 175.394 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -76.22 -45.51 32.64 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.969 1.099 . . . . 3.04 113.969 -176.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 153.14 146.52 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 128.99 2.916 . . . . 2.37 112.985 173.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.69 8.19 2.04 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.42 3.413 . . . . 2.23 115.702 -175.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -76.4 -18.0 59.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.057 1.299 . . . . 2.35 112.509 163.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.72 139.05 39.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.428 1.091 . . . . 2.46 111.237 171.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.66 138.58 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.426 1.09 . . . . 2.33 108.954 161.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.66 125.41 8.57 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.889 1.233 . . . . 1.12 111.464 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 142' ' ' LEU . 3.9 mp -108.19 129.88 55.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.672 1.189 . . . . 2.4 110.249 176.082 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t 174.29 122.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.421 2.288 . . . . 2.91 110.037 -167.396 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.46 -62.19 0.12 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 124.368 0.985 . . . . 2.93 112.221 176.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.0 p -145.16 171.1 15.01 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.281 1.832 . . . . 2.58 109.192 -176.167 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -31.59 69.4 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.78 -0.575 . . . . 7.21 111.245 178.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -70.71 -51.77 25.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 2.79 112.632 -176.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . 0.32 0.0 OUTLIER -80.03 -29.09 39.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.09 1.313 . . . . 3.93 113.659 -174.833 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.37 -53.01 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.0 0.92 . . . . 2.36 111.324 157.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.37 -23.07 61.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.947 -1.096 . . . . 3.69 113.525 -175.335 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -57.74 6.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.213 0.915 . . . . 2.79 110.118 163.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.68 -21.08 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 118.445 0.566 . . . . 2.23 111.929 -171.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.261 1.024 . . . . 1.54 110.367 167.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -44.34 65.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.187 1.395 . . . . 5.48 111.946 173.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -53.03 -43.77 66.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.868 1.213 . . . . 1.7 112.473 175.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -96.71 11.22 36.28 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.921 1.082 . . . . 2.41 113.921 178.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 41.73 45.8 3.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.846 2.458 . . . . 6.37 114.955 -177.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 13.3 m -67.89 159.48 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.587 1.155 . . . . 3.12 112.516 -170.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -101.67 102.39 13.06 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.225 0.536 . . . . 3.71 110.946 163.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -102.69 143.37 32.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.271 -0.64 . . . . 3.38 109.271 154.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.6 m -70.13 137.52 87.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 121.569 -0.707 . . . . 4.08 112.307 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.59 119.32 5.87 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 107.396 -1.809 . . . . 4.96 107.396 154.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.549 0 N-CA-C 114.015 0.366 . . . . 3.62 114.015 -171.064 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 25.0 p90 . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 116.659 2.096 . . . . 4.8 116.659 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 47.0 pt -56.71 148.53 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.255 0.55 . . . . 4.14 111.715 166.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.6 m -124.22 147.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.684 1.594 . . . . 3.12 107.368 166.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.59 165.56 18.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.154 1.382 . . . . 5.25 108.883 172.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -150.41 143.0 24.53 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.031 1.122 . . . . 2.27 114.031 175.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.3 t -151.6 149.99 29.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.108 0.963 . . . . 4.35 109.562 167.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.2 174.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.614 1.966 . . . . 6.64 110.799 -159.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.99 140.63 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.47 -1.678 . . . . 3.52 106.47 152.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.4 ttt -94.92 127.99 41.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.017 1.327 . . . . 2.19 108.863 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -111.06 134.9 52.29 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 3.9 114.293 -165.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.53 107.07 17.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.048 1.339 . . . . 3.05 109.242 171.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.01 110.5 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 105.267 -2.123 . . . . 1.99 105.267 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.93 -168.57 44.02 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 113.601 0.2 . . . . 1.86 113.601 -168.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.31 71.18 5.29 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.763 2.975 . . . . 3.51 109.275 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -155.13 -60.11 0.11 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.456 1.502 . . . . 4.68 110.145 -159.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.04 -31.03 4.41 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.116 -1.38 . . . . 3.18 114.716 -178.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -113.12 -61.43 1.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.759 1.279 . . . . 5.1 112.42 -175.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -170.16 145.3 2.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.337 -0.852 . . . . 6.95 112.625 -162.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.81 -44.55 1.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.211 1.004 . . . . 3.3 113.574 176.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -159.33 158.93 33.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 2.87 111.547 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -119.54 125.1 48.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.826 1.25 . . . . 4.29 110.919 172.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 104.22 14.01 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.197 -1.038 . . . . 2.95 108.197 178.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -74.47 157.01 50.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.016 -1.234 . . . . 3.15 110.016 162.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.3 57.44 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.683 1.593 . . . . 4.1 111.537 175.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -156.63 -31.96 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.152 1.781 . . . . 5.44 113.186 -171.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.76 131.91 46.96 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.244 -0.91 . . . . 4.69 109.43 170.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -82.85 155.68 24.01 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.423 1.889 . . . . 7.88 109.794 172.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.584 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 9.3 tmtt? -38.91 -54.03 1.68 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.403 1.881 . . . . 2.08 114.687 -172.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.27 -36.8 93.67 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.142 -0.81 . . . . 1.4 113.63 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.3 -27.3 64.28 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.677 1.738 . . . . 3.32 112.763 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 95.0 mt -69.02 -48.81 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.196 0.998 . . . . 1.4 110.094 176.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.3 -45.2 85.33 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.303 0.483 . . . . 1.23 112.303 174.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.93 67.65 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 1.85 114.403 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 p -67.37 -47.99 68.75 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.017 -1.052 . . . . 1.69 111.327 168.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.93 -36.64 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.727 -1.233 . . . . 1.67 112.182 173.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.78 67.6 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.364 -1.46 . . . . 1.96 113.175 172.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.4 m -75.62 -51.76 12.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.888 0.875 . . . . 2.25 109.319 172.259 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -61.33 -26.42 67.79 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.536 1.535 . . . . 2.8 113.985 176.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.1 ttp -66.59 -15.01 63.13 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.724 -1.235 . . . . 4.74 112.99 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -59.9 -51.95 77.05 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 116.962 -1.494 . . . . 5.06 111.513 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.55 -58.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.867 2.378 . . . . 2.34 112.368 166.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -79.98 66.42 5.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.215 1.406 . . . . 3.19 111.724 -176.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 124.94 1.296 . . . . 8.46 113.753 -177.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.554 0 CA-C-O 119.104 -0.831 . . . . 3.0 114.518 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -82.11 -178.74 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.703 3.602 . . . . 3.0 112.413 -175.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -170.85 168.52 7.17 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.47 2.708 . . . . 2.74 108.762 -176.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -134.34 32.09 3.42 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.734 -1.229 . . . . 3.58 112.744 167.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.71 146.3 21.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 123.446 1.593 . . . . 2.05 111.304 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 m -108.39 140.39 41.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.788 -1.551 . . . . 1.71 109.19 -168.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.4 m -90.74 148.21 22.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.412 1.885 . . . . 3.25 110.459 -167.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -55.69 -13.08 1.47 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 117.347 2.351 . . . . 2.51 117.347 -170.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.4 t -86.11 -27.39 24.69 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 4.2 113.605 170.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.97 26.91 1.63 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.789 1.662 . . . . 2.56 116.172 -177.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.13 139.94 51.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.393 2.096 . . . . 3.38 111.203 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -96.04 123.69 39.74 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.188 2.195 . . . . 6.27 110.739 -170.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 164.24 14.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.385 0.674 . . . . 3.25 111.292 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -128.02 -179.51 5.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.586 1.154 . . . . 2.62 108.184 167.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -38.8 -65.8 0.33 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.141 1.777 . . . . 4.99 113.217 163.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 13.28 0.36 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.191 1.922 . . . . 9.06 116.191 -172.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -90.68 -26.91 19.34 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.573 -1.33 . . . . 3.47 112.26 158.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -113.36 -9.15 13.4 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.093 1.757 . . . . 2.78 114.345 -178.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tt -111.5 120.95 43.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.354 2.261 . . . . 3.83 109.539 -175.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.33 -39.81 1.75 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.101 2.286 . . . . 2.54 109.708 -170.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -78.62 -156.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.762 0.825 . . . . 3.59 109.988 138.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.04 155.79 27.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.834 1.253 . . . . 2.32 112.165 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.66 149.7 34.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.508 1.299 . . . . 2.34 114.508 170.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.42 137.8 38.35 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.163 1.785 . . . . 2.51 107.859 164.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.2 mt -123.11 139.0 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.465 1.106 . . . . 1.72 108.271 177.265 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -151.99 149.2 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.427 1.491 . . . . 2.52 111.372 177.603 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -104.02 118.42 36.62 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.923 0.889 . . . . 2.23 109.92 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -168.96 156.59 28.03 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.693 1.616 . . . . 2.32 114.312 -171.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.29 171.33 12.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.551 -0.97 . . . . 3.98 113.572 -155.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m -96.27 18.42 13.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.353 0.871 . . . . 3.04 113.353 -172.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -106.2 -3.51 21.27 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.069 -1.019 . . . . 8.24 113.266 170.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.8 OUTLIER -74.34 160.47 81.27 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 127.526 2.33 . . . . 2.32 115.4 -171.819 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 40.3 Cg_endo -79.27 -160.17 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.235 3.29 . . . . 3.8 110.764 156.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.68 -10.17 7.93 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.45 2.3 . . . . 4.81 115.459 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -78.45 -32.28 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 118.495 -0.764 . . . . 3.68 112.412 -170.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.69 -61.03 6.34 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 117.147 -1.406 . . . . 1.57 112.31 166.198 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.1 -36.75 56.66 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.583 2.188 . . . . 1.88 114.315 -175.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -54.91 -60.08 3.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.953 1.301 . . . . 3.83 110.95 171.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.82 -35.88 75.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.324 0.65 . . . . 2.7 112.174 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.49 -33.41 64.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.878 1.671 . . . . 2.79 112.416 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -61.34 2.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.158 1.345 . . . . 5.52 108.35 170.717 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -38.59 67.36 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.786 -0.571 . . . . 6.7 110.829 -175.261 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 11.4 ttm -64.88 -45.69 84.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.717 1.207 . . . . 2.75 113.065 177.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.7 pt -76.96 -28.79 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 120.34 1.427 . . . . 3.65 110.854 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.523 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 0.6 OUTLIER -80.4 -34.44 36.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.175 0.443 . . . . 4.31 110.604 -175.444 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.4 -40.71 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.696 0.799 . . . . 1.87 112.517 176.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 22.4 m -64.29 -39.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.276 0.944 . . . . 3.16 111.94 -175.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.04 -41.24 91.12 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.841 -1.162 . . . . 5.0 112.463 173.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.01 -19.54 64.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.497 1.519 . . . . 2.95 113.482 179.52 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.39 -58.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.977 1.711 . . . . 2.13 112.08 173.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.34 -28.4 69.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.845 0.831 . . . . 4.45 112.358 -170.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.7 m -71.07 -16.95 62.61 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.232 -0.918 . . . . 4.65 113.346 176.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.2 mm -80.63 64.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.335 -1.358 . . . . 3.97 107.335 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.9 t -47.02 -12.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 129.751 3.22 . . . . 5.98 118.181 -157.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.0 m -73.98 -22.95 59.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.825 1.65 . . . . 4.04 111.874 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.7 mt -74.83 162.23 74.38 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.364 1.866 . . . . 3.72 113.583 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.63 154.59 27.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.596 2.864 . . . . 3.07 110.375 168.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.35 133.22 38.8 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.483 1.913 . . . . 5.0 113.649 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.5 107.86 19.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.247 1.819 . . . . 2.16 111.383 -175.101 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.2 m -72.86 131.91 83.54 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.449 -1.407 . . . . 1.78 111.194 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -91.56 94.7 0.21 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.166 3.244 . . . . 1.28 111.342 165.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.24 101.26 11.53 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.742 0.782 . . . . 2.32 112.492 -173.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -93.03 126.03 37.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.212 1.405 . . . . 2.89 110.632 -177.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.21 119.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.226 1.01 . . . . 2.12 110.145 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.5 m -98.87 162.49 13.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.573 1.149 . . . . 2.62 112.677 175.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.2 pt -147.83 -13.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.91 2.189 . . . . 1.64 116.91 -148.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -94.38 93.38 0.93 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 120.618 1.554 . . . . 3.78 107.495 170.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.37 -22.32 52.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.762 1.641 . . . . 2.53 112.499 -177.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -63.22 -14.85 53.98 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.109 1.364 . . . . 4.01 114.611 170.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -161.64 -10.91 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 118.7 2.852 . . . . 5.08 118.7 -170.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -75.36 65.44 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.352 2.342 . . . . 4.81 111.862 170.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.0 m -65.07 136.92 57.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.57 1.948 . . . . 2.67 111.076 -176.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -38.22 -64.59 0.4 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.197 1.799 . . . . 3.51 113.411 175.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -65.96 -25.08 66.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.245 1.418 . . . . 3.33 113.73 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.59 -47.03 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.434 1.015 . . . . 1.89 110.814 175.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 38.5 mm -57.23 -45.22 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.22 1.008 . . . . 1.95 110.405 170.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.81 -46.55 67.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.834 0.853 . . . . 2.3 112.467 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -68.78 -46.18 69.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.33 0.514 . . . . 3.11 111.876 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -54.64 -49.28 70.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.81 1.244 . . . . 3.1 111.353 176.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.5 t -55.27 -49.32 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.555 1.942 . . . . 2.51 111.33 172.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -30.43 71.5 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.081 -1.438 . . . . 5.93 114.254 -177.224 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -68.74 -29.95 68.47 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.278 1.399 . . . . 4.04 112.083 175.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -81.8 -54.07 5.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.907 0.483 . . . . 3.1 111.509 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.9 p -169.85 148.96 3.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 121.591 -0.693 . . . . 2.79 111.445 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.53 -7.41 20.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.359 2.706 . . . . 2.92 113.278 173.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -85.01 -21.34 29.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.277 1.031 . . . . 2.64 112.997 176.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.42 143.91 48.34 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.661 1.185 . . . . 2.43 111.378 -178.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.62 134.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.882 0.873 . . . . 2.99 111.216 172.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.66 124.79 6.66 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.28 1.419 . . . . 1.34 111.763 -178.276 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -108.76 139.65 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.348 1.459 . . . . 2.38 110.901 -178.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 t -139.54 164.38 30.04 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.81 1.644 . . . . 2.77 110.678 176.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.31 171.95 39.97 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.67 1.605 . . . . 1.88 112.166 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -64.84 160.26 20.76 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.736 0.814 . . . . 2.12 110.529 168.648 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -50.07 -35.74 26.49 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.864 0.866 . . . . 5.43 113.167 -174.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.1 mp0 -67.22 -38.5 85.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.003 1.721 . . . . 2.88 110.108 -178.318 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.09 -40.84 52.16 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.599 1.16 . . . . 4.33 113.022 172.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.48 -42.62 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.869 -0.419 . . . . 1.66 109.869 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -75.35 -29.45 59.93 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.129 -0.938 . . . . 3.05 112.653 175.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -60.21 -59.69 5.01 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.625 2.011 . . . . 2.38 110.261 167.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.22 -30.6 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 118.466 0.576 . . . . 2.06 111.986 -171.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.45 -52.34 14.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.996 0.816 . . . . 1.69 112.216 173.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -76.54 -32.55 58.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.592 1.157 . . . . 3.74 112.936 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.72 78.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.539 1.136 . . . . 1.7 111.242 173.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -73.2 -1.89 19.52 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.24 -0.912 . . . . 2.29 113.03 168.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 45.61 39.68 5.18 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.372 2.669 . . . . 7.27 114.471 -176.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 p -71.37 137.6 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.195 -0.668 . . . . 2.88 109.195 174.105 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -75.46 130.65 39.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.87 0.367 . . . . 4.07 110.88 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -148.84 144.39 26.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.185 1.394 . . . . 4.05 109.956 172.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.0 m -149.48 106.35 3.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 O-C-N 121.493 -0.755 . . . . 4.29 112.133 -171.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.35 142.35 10.6 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.447 2.765 . . . . 3.05 113.055 -177.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.514 0 CA-C-O 118.088 -1.396 . . . . 2.97 110.322 166.567 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.4 p90 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.866 0.841 . . . . 3.5 111.935 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.4 tt -157.45 164.85 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.106 1.762 . . . . 3.52 108.059 157.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.39 140.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.278 -1.378 . . . . 3.89 107.278 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.7 147.71 47.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.261 0.553 . . . . 4.56 110.996 167.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -143.26 136.25 27.84 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.618 0.767 . . . . 2.56 110.13 158.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -66.2 131.37 46.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.811 -1.181 . . . . 3.78 110.339 174.298 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.457 ' CD1' ' H ' ' A' ' 262' ' ' ILE 0.253 0.0 OUTLIER -82.52 64.48 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 123.172 1.463 . . . . 4.93 112.653 -171.091 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.63 127.09 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.04 1.336 . . . . 2.17 111.402 -176.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.7 mmm -88.09 137.66 32.13 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.552 1.541 . . . . 2.42 109.411 158.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -114.14 131.56 56.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 2.73 109.524 168.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.05 121.45 41.4 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.901 0.88 . . . . 2.3 108.685 173.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.08 117.89 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.052 -1.462 . . . . 1.65 107.052 172.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.51 -137.12 5.76 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 109.357 -1.497 . . . . 1.67 109.357 167.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -81.19 3.67 7.62 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.391 2.06 . . . . 3.59 112.381 170.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -31.37 53.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.954 1.302 . . . . 4.86 112.744 -176.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.98 1.85 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.07 1.319 . . . . 2.94 113.345 -170.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -77.86 19.26 0.41 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.983 1.713 . . . . 4.67 115.04 -166.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 92.1 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 129.972 3.309 . . . . 4.11 110.676 173.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.32 -33.29 10.78 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.727 1.211 . . . . 2.85 111.144 176.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -168.97 167.12 10.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.139 2.175 . . . . 2.72 108.325 -168.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -161.47 146.04 13.28 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.444 1.098 . . . . 4.39 112.288 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -129.91 115.22 16.88 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.914 0.886 . . . . 2.74 109.862 -175.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.32 110.75 4.09 Favored Glycine 0 N--CA 1.465 0.616 0 N-CA-C 109.652 -1.379 . . . . 3.5 109.652 173.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.482 ' HG3' ' H ' ' A' ' 280' ' ' ASN . 16.2 tp60 76.44 166.32 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.483 1.913 . . . . 4.17 110.949 -167.722 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.482 ' H ' ' HG3' ' A' ' 279' ' ' GLN . 53.4 t-20 -42.03 -48.46 4.63 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.094 2.557 . . . . 9.21 113.408 -169.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 59.0 tttp 67.95 -23.29 0.12 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.566 1.946 . . . . 5.35 113.89 -172.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 102.3 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.319 3.448 . . . . 5.84 107.259 -174.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.523 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -34.78 -60.07 0.46 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.285 2.234 . . . . 2.45 113.25 179.012 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.8 -19.38 69.41 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.256 -1.302 . . . . 1.59 115.755 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.84 -26.11 49.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.739 2.27 . . . . 3.91 112.981 177.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.85 -40.47 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.735 -0.839 . . . . 2.46 108.735 169.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.31 77.54 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.484 0.584 . . . . 1.49 111.461 169.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.41 -39.21 85.52 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.196 1.184 . . . . 1.51 114.196 176.032 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.9 p -70.0 -46.95 64.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.108 0.867 . . . . 1.74 111.571 175.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.8 mt -54.82 -44.18 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.954 . . . . 1.53 110.77 171.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.408 -1.433 . . . . 1.68 113.701 178.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 57.4 m -76.95 -47.88 19.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.079 0.952 . . . . 2.06 109.93 170.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -62.73 -31.78 72.77 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.338 1.055 . . . . 2.75 112.288 175.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.56 24.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.633 1.573 . . . . 5.86 112.749 168.372 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.47 -57.16 0.31 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 116.337 -1.792 . . . . 5.79 111.801 152.209 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.17 -49.48 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.251 2.634 . . . . 2.55 113.133 176.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.33 70.42 10.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.863 0.756 . . . . 3.19 111.712 -176.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 . . . . . 0 CA--C 1.549 0.933 0 C-N-CA 124.879 1.272 . . . . 10.63 109.318 -174.83 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 N-CA-C 110.494 -1.042 . . . . 3.55 110.494 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.55 161.78 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.905 2.403 . . . . 3.6 113.279 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -156.08 179.43 9.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.85 2.46 . . . . 2.92 108.366 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.2 m -140.31 117.27 11.09 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.957 -1.714 . . . . 3.11 111.528 157.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.72 161.65 28.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.694 1.997 . . . . 2.62 108.39 176.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.4 t -87.31 146.62 25.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.467 0.651 . . . . 2.69 110.93 173.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.9 p -92.85 159.28 15.44 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 123.152 1.454 . . . . 2.37 112.409 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -56.82 -26.86 59.05 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.127 -0.983 . . . . 1.99 112.474 163.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.0 p -71.72 -20.29 61.93 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.367 1.247 . . . . 4.18 114.367 169.133 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.77 11.16 54.24 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 120.287 1.403 . . . . 1.96 115.163 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -88.76 -175.37 4.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.673 1.589 . . . . 4.06 110.136 170.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -131.56 121.72 24.9 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.887 1.275 . . . . 5.75 108.969 168.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -132.72 156.39 47.11 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.903 1.075 . . . . 3.9 113.903 -162.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -108.0 164.16 12.52 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.37 1.868 . . . . 3.14 109.63 171.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -39.61 -55.77 1.8 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.63 2.372 . . . . 4.18 112.42 159.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -74.34 -15.66 60.94 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.537 1.31 . . . . 8.02 114.537 -174.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.74 -42.64 77.29 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.824 1.193 . . . . 3.04 110.988 166.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.68 11.19 3.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.385 1.254 . . . . 2.98 114.385 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.36 -169.49 0.82 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.662 1.185 . . . . 4.19 111.763 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 76.41 8.35 85.67 Favored Glycine 0 N--CA 1.482 1.702 0 O-C-N 120.517 -1.364 . . . . 3.85 114.56 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.55 154.96 27.51 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.361 2.664 . . . . 3.57 107.593 -171.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -68.07 125.09 25.25 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.314 0.507 . . . . 2.48 110.071 170.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.7 mt -105.86 125.72 51.33 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.963 0.887 . . . . 3.09 111.652 177.107 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.04 92.22 3.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.865 1.666 . . . . 3.13 106.748 176.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.85 121.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.787 1.235 . . . . 2.63 110.199 -167.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -128.98 153.6 47.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.542 1.312 . . . . 3.55 114.542 -175.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.85 102.13 9.7 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.109 1.763 . . . . 2.84 112.31 175.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.02 171.31 17.72 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.396 1.474 . . . . 2.34 113.329 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -111.42 -12.99 13.95 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.765 0.654 . . . . 3.7 112.765 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.0 m 58.04 47.53 14.62 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.137 1.446 . . . . 4.19 108.891 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -150.4 -56.65 0.17 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 114.638 -1.164 . . . . 7.65 110.738 -161.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.3 m -70.4 141.03 87.87 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.156 0.982 . . . . 2.45 111.219 -170.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.22 -17.54 21.58 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.907 1.738 . . . . 4.17 111.243 166.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.51 -76.57 0.54 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.779 1.632 . . . . 5.3 112.673 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.29 -54.44 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.486 1.114 . . . . 2.76 111.945 -162.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.5 m -47.25 -60.7 3.64 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.325 -1.321 . . . . 1.68 112.596 176.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.24 -34.55 27.3 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.657 1.571 . . . . 1.27 113.127 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -67.08 -33.43 75.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 121.092 1.769 . . . . 3.75 112.097 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -31.2 37.67 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.299 -1.501 . . . . 3.49 113.521 170.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -43.74 98.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.967 1.307 . . . . 2.63 111.171 174.204 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.24 -46.34 76.03 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 3.47 111.055 172.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -66.51 -33.69 76.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.186 0.81 . . . . 3.69 113.186 174.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 69.7 mtp -61.18 -42.6 98.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.017 1.281 . . . . 3.54 111.915 169.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.9 mm -75.41 -61.97 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.971 -0.751 . . . . 1.87 108.971 -172.06 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.26 -12.41 28.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.748 1.219 . . . . 3.1 114.225 -165.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.13 -39.67 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.648 1.179 . . . . 1.62 111.044 171.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.11 -53.86 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.021 1.282 . . . . 2.38 110.205 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.8 -20.03 61.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.256 1.422 . . . . 4.49 112.064 -171.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -79.32 -38.13 35.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.796 1.239 . . . . 2.6 111.909 167.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.82 -49.54 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.782 1.401 . . . . 2.14 114.782 -168.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -33.52 75.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.571 1.532 . . . . 4.49 109.74 179.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -19.83 42.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.527 1.931 . . . . 3.01 114.714 173.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.46 -14.34 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.321 -1.487 . . . . 4.44 112.494 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m 157.64 -33.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 130.422 3.489 . . . . 6.18 112.832 164.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 7.1 t 157.34 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.16 3.384 . . . . 5.97 110.785 166.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.07 147.09 1.88 Allowed Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 114.302 -1.317 . . . . 3.78 111.493 169.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.28 -44.25 19.77 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.372 2.715 . . . . 3.57 112.459 -159.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.12 153.67 0.23 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.895 2.878 . . . . 4.5 108.669 161.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.16 128.11 29.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.044 0.537 . . . . 2.64 109.704 171.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.4 m -124.84 119.1 25.65 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.704 1.202 . . . . 1.63 108.562 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.73 133.63 10.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.001 2.467 . . . . 1.05 110.127 172.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.84 97.25 4.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.832 1.253 . . . . 2.48 109.336 -169.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -94.27 133.04 38.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.97 1.308 . . . . 2.51 110.661 -173.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 54.0 mt -122.62 129.43 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.586 1.155 . . . . 1.71 109.41 176.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -83.03 137.35 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.656 -0.653 . . . . 2.54 112.409 171.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 pt -81.74 3.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.891 1.071 . . . . 2.78 113.891 172.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.78 80.14 12.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 115.937 1.829 . . . . 5.12 115.937 -172.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -80.14 63.21 8.72 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.295 3.33 . . . . 2.57 112.12 174.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -108.74 -50.26 3.04 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.565 -1.198 . . . . 3.88 108.343 139.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.39 -6.32 28.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.793 1.775 . . . . 4.73 115.793 -170.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -76.46 28.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.715 1.598 . . . . 5.42 114.75 -177.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.2 m -61.29 134.74 57.29 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.486 -0.759 . . . . 3.67 109.746 -141.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -39.37 9.14 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.828 1.418 . . . . 3.7 114.828 -161.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -85.74 -28.31 24.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.655 0.983 . . . . 4.06 113.655 178.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.81 91.78 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 1.65 111.44 166.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.6 -41.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.485 0.714 . . . . 2.6 112.274 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.64 -38.79 75.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.297 0.953 . . . . 1.31 111.677 170.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -68.69 -38.29 80.19 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.062 0.764 . . . . 3.98 113.062 173.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.61 -37.9 87.92 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.023 0.829 . . . . 3.03 111.217 174.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.6 t -56.61 -47.94 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.951 -1.093 . . . . 1.3 111.721 170.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -79.84 19.9 0.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.493 1.294 . . . . 4.61 114.493 174.698 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -92.48 -59.88 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.572 -1.33 . . . . 3.9 109.557 160.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -80.79 -53.17 6.73 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.449 1.277 . . . . 3.4 114.449 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.3 t -177.35 132.02 0.35 Allowed Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.135 1.374 . . . . 2.26 109.031 -174.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.37 -5.72 16.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.184 2.589 . . . . 1.92 113.081 -176.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -76.55 -8.56 57.46 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.333 0.969 . . . . 3.67 113.401 171.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.48 131.04 44.11 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.32 0.964 . . . . 1.82 110.09 169.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.3 t -99.97 129.2 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.757 -1.201 . . . . 2.23 107.757 171.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.48 134.48 11.9 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.951 -0.86 . . . . 1.35 110.951 172.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.2 161.0 22.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.911 0.884 . . . . 2.28 112.129 171.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 9.7 t -162.72 -168.96 1.93 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 129.449 3.1 . . . . 2.77 108.165 -176.063 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 173.58 -147.43 9.48 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 120.305 1.411 . . . . 1.91 110.418 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.9 p -90.37 164.91 14.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.494 -0.928 . . . . 3.12 108.494 157.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -30.17 69.57 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.523 -0.751 . . . . 7.85 112.523 -173.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -56.09 -35.61 67.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.861 1.664 . . . . 3.45 113.114 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.38 -35.77 54.14 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.792 -1.193 . . . . 3.66 112.534 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.04 -35.1 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.009 0.524 . . . . 2.09 110.657 171.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -30.45 67.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.226 1.01 . . . . 3.69 111.318 174.144 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -60.41 3.91 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.405 1.082 . . . . 2.57 110.798 162.428 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' A' ' 240' ' ' ALA . 6.9 p -71.51 -16.28 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.942 1.247 . . . . 2.55 112.806 -168.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.78 -39.62 69.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.974 0.91 . . . . 1.76 110.255 173.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.05 -49.58 76.79 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.384 -0.817 . . . . 3.53 110.478 163.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 237' ' ' VAL . . . -60.9 -16.51 42.91 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 116.501 2.037 . . . . 2.95 116.501 -170.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -129.75 15.56 5.87 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.118 . . . . 2.87 113.671 173.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 56.61 43.32 25.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.136 1.374 . . . . 5.52 112.678 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.51 126.72 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.623 1.569 . . . . 2.89 108.511 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -94.14 149.78 20.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.127 1.371 . . . . 4.53 111.577 175.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -165.23 127.88 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.635 1.974 . . . . 5.02 110.056 -174.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.1 t -136.42 79.2 42.69 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.826 1.65 . . . . 3.72 111.8 -171.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.47 138.0 21.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.66 2.907 . . . . 3.21 113.877 -170.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.76 0 C-N-CA 125.521 1.534 . . . . 3.29 112.829 163.784 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 121.489 0.662 . . . . 3.99 112.088 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 28.1 mm -77.04 78.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.791 -0.818 . . . . 4.42 108.791 169.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.37 146.64 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.414 -1.699 . . . . 4.07 106.414 151.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.66 -174.68 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.326 1.06 . . . . 4.62 111.315 162.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -146.87 151.31 36.85 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.08 -1.013 . . . . 2.27 111.453 138.339 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.1 m -60.09 128.47 36.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.055 1.342 . . . . 3.38 109.309 165.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 15.4 pt -104.07 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.56 1.544 . . . . 5.15 111.579 -177.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.3 mm -128.72 141.12 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.491 1.117 . . . . 2.99 109.954 177.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 7.9 ttp -124.35 128.31 48.9 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.621 1.968 . . . . 2.72 109.167 173.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.72 141.39 32.58 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.318 1.047 . . . . 3.02 112.053 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -104.19 110.86 23.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.632 1.173 . . . . 2.61 110.215 174.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.0 138.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.477 1.511 . . . . 2.28 109.38 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.92 160.53 37.19 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.351 -0.694 . . . . 2.18 114.089 -178.014 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.53 64.52 4.64 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.593 3.529 . . . . 3.86 109.192 167.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.02 -60.69 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.807 1.643 . . . . 4.79 108.254 -154.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 171.59 -70.25 0.12 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 123.798 0.714 . . . . 3.34 112.464 -178.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -118.11 -175.75 2.92 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.594 0.711 . . . . 5.98 112.812 -161.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -85.05 145.74 27.53 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.329 0.863 . . . . 3.73 113.329 -176.043 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 pp -141.93 0.86 1.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.398 1.629 . . . . 3.32 115.398 -178.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -157.46 171.54 20.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.742 1.617 . . . . 3.17 110.005 171.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -155.67 156.84 35.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.347 1.459 . . . . 3.64 113.362 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -147.9 177.6 9.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.796 1.638 . . . . 2.64 113.18 -168.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.09 -164.89 37.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 128.188 2.804 . . . . 3.15 108.93 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -56.51 -28.16 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.133 0.967 . . . . 3.58 113.225 179.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.29 -8.91 58.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 114.336 1.236 . . . . 4.69 114.336 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -135.44 98.32 3.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 4.54 108.419 171.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.32 -172.31 4.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.357 0.663 . . . . 5.94 112.518 -164.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -50.12 74.89 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.166 -1.584 . . . . 2.06 114.862 -159.08 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.89 -28.68 70.24 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.624 0.647 . . . . 1.76 111.809 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.68 -26.86 60.12 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.282 1.033 . . . . 4.28 112.808 177.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.38 -51.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.861 0.865 . . . . 1.27 109.724 167.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.13 93.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.14 0.576 . . . . 1.74 111.603 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.91 95.49 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.534 1.134 . . . . 2.3 113.882 177.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 25.1 p -71.73 -39.0 70.4 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.766 1.166 . . . . 1.92 111.982 174.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.11 -40.0 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.335 1.425 . . . . 1.81 111.772 176.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.36 -22.0 66.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.26 1.024 . . . . 2.73 113.216 171.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 95.0 m -78.64 -40.27 34.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.928 0.891 . . . . 3.19 110.673 170.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.53 -21.79 64.55 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.74 1.216 . . . . 2.8 112.974 174.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -63.88 -33.26 75.3 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.848 -1.157 . . . . 4.8 112.522 166.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -60.75 -36.22 33.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 116.409 -1.757 . . . . 5.53 114.814 -172.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -86.41 -8.65 7.31 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.508 2.805 . . . . 3.31 114.452 167.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -94.99 -171.08 2.34 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.54 1.536 . . . . 4.69 112.471 179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 . . . . . 0 N--CA 1.471 0.591 0 O-C-N 120.716 -1.24 . . . . 8.29 111.184 159.589 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.881 0 CA-C-O 118.24 -1.311 . . . . 3.2 111.458 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.95 135.9 66.08 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.606 2.871 . . . . 3.56 112.084 -169.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -140.91 176.92 8.41 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.571 -1.65 . . . . 2.9 112.516 -168.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.8 t -127.73 132.86 49.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.634 1.974 . . . . 3.68 106.168 159.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 tp -164.56 143.18 6.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.977 0.911 . . . . 2.36 110.319 -176.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.0 m -93.81 140.29 29.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.746 0.703 . . . . 1.55 109.617 -174.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.0 m -101.5 139.32 37.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.829 1.652 . . . . 3.59 110.634 -178.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -16.35 1.37 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.597 2.759 . . . . 2.0 116.842 -169.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 t -76.65 -35.79 57.76 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.468 1.031 . . . . 3.51 112.127 172.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.32 68.42 0.44 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.403 1.477 . . . . 2.82 112.257 -166.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.67 148.21 6.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.164 1.785 . . . . 4.88 108.747 171.292 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -108.36 115.85 30.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.717 1.207 . . . . 4.39 111.662 -175.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -104.5 163.27 12.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.836 1.254 . . . . 4.23 112.574 -173.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -119.84 160.73 22.09 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.613 1.965 . . . . 3.25 108.054 162.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -49.3 -37.37 23.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.0 1.72 . . . . 4.64 111.552 169.352 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -71.23 -31.48 67.62 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.876 1.065 . . . . 7.75 113.876 -177.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.29 -3.77 33.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.101 0.864 . . . . 4.84 113.33 175.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -33.01 59.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.383 0.883 . . . . 4.48 113.383 160.124 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.12 178.78 0.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.966 1.306 . . . . 5.5 113.856 -173.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 8.98 75.44 Favored Glycine 0 N--CA 1.474 1.206 0 O-C-N 121.172 -0.955 . . . . 2.93 113.228 -166.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -156.14 165.45 36.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.088 1.755 . . . . 3.39 109.428 -177.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -69.51 112.25 5.9 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.965 -0.459 . . . . 2.19 112.206 177.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -98.52 122.65 41.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.613 1.165 . . . . 2.77 110.981 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -118.13 109.16 16.07 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.505 -1.665 . . . . 3.0 106.505 176.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.3 pt -111.81 126.82 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.093 0.405 . . . . 3.89 112.093 -170.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.31 149.17 51.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 2.66 112.208 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -122.77 121.27 35.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.428 1.091 . . . . 2.82 109.927 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.38 -178.37 16.95 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 1.68 116.123 -169.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.5 151.34 50.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.683 1.193 . . . . 3.6 111.686 175.366 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.9 p -53.63 -30.9 45.09 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.19 1.396 . . . . 4.04 113.831 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -143.17 94.42 2.62 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 108.952 -0.758 . . . . 7.86 108.952 150.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.448 ' C ' ' H ' ' A' ' 171' ' ' ASP . 9.2 t -38.31 166.77 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 128.377 2.671 . . . . 2.36 115.613 160.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -65.54 43.71 0.16 Allowed 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.537 2.825 . . . . 3.59 111.815 146.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 169' ' ' CYS 0.28 29.8 m-20 58.03 11.87 1.62 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.154 2.982 . . . . 4.96 116.75 173.913 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.6 -35.99 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.975 0.91 . . . . 2.47 110.708 169.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 38.5 m -53.07 -56.24 25.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.635 -1.65 . . . . 1.78 114.272 175.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.0 -43.47 11.69 Favored 'Trans proline' 0 C--N 1.351 0.7 0 CA-C-N 122.472 1.918 . . . . 1.53 112.149 177.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -51.52 -46.27 63.21 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.826 1.65 . . . . 2.9 112.573 174.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.89 -45.26 24.65 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.121 -0.987 . . . . 2.49 112.316 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -62.49 -29.05 70.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.955 -1.091 . . . . 2.49 112.313 -177.388 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -60.42 -52.19 66.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.769 0.828 . . . . 4.0 111.84 168.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -58.08 -50.8 72.2 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 120.17 -1.581 . . . . 2.84 110.801 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -57.22 -53.75 54.57 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.705 -0.664 . . . . 3.73 110.99 175.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 181' ' ' ILE . 5.7 tp -68.08 -38.35 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.479 1.49 . . . . 2.53 111.197 -170.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.598 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 62.1 mt-30 -65.85 -24.08 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 118.1 -0.952 . . . . 2.91 112.168 179.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.18 -19.21 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 120.669 1.577 . . . . 2.66 113.732 173.067 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.25 -40.0 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.11 1.323 . . . . 2.13 109.394 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -55.4 -48.69 73.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.551 1.541 . . . . 3.95 112.401 172.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -70.3 -36.46 74.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.994 0.918 . . . . 3.44 112.83 -177.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -77.76 -27.72 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.083 -1.011 . . . . 2.04 112.823 177.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.79 -48.74 79.27 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.244 1.018 . . . . 3.35 109.133 165.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.6 t -64.49 -26.73 68.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.405 0.891 . . . . 2.97 113.405 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.0 -30.87 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.604 1.161 . . . . 3.36 111.786 172.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.4 m 73.47 -36.32 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.788 2.035 . . . . 4.32 113.553 167.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 80.1 p -78.94 24.3 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.644 1.978 . . . . 5.63 113.11 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.2 mt -134.21 156.28 79.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.345 1.858 . . . . 4.34 110.456 174.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.83 -75.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.131 2.554 . . . . 3.01 109.625 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.61 167.28 30.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.842 2.057 . . . . 3.47 108.06 162.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.17 114.7 26.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.275 1.43 . . . . 1.81 108.705 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.5 m -108.38 94.58 13.84 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 123.312 0.645 . . . . 2.02 110.887 -168.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.98 131.06 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.813 2.342 . . . . 1.61 110.885 170.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.01 139.19 49.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.533 1.159 . . . . 3.8 111.621 168.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -109.94 123.65 50.01 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.51 1.924 . . . . 2.53 109.272 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.9 mt -108.79 115.02 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.887 0.875 . . . . 1.75 109.554 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.0 t -83.71 104.69 14.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 2.58 108.649 176.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.5 pt -79.27 35.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 122.013 0.911 . . . . 1.88 111.823 -178.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -126.93 46.94 2.2 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 127.291 2.236 . . . . 3.9 111.301 -160.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -13.26 36.89 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.456 2.77 . . . . 2.46 114.302 -163.104 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -76.88 9.93 2.58 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.906 1.283 . . . . 3.99 113.33 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -163.44 25.08 0.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.866 1.432 . . . . 4.49 114.866 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -71.21 152.79 43.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.112 0.958 . . . . 5.7 111.814 172.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 4.4 m -154.81 122.47 5.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.079 1.752 . . . . 2.75 106.499 164.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -46.56 -48.08 19.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.796 1.238 . . . . 3.98 113.105 -170.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.43 -30.47 61.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.547 1.139 . . . . 5.12 113.525 177.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.14 73.66 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.066 -1.021 . . . . 1.83 110.755 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.15 -42.94 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 2.66 110.444 173.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.7 77.21 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.333 0.653 . . . . 1.7 112.586 176.072 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -65.66 -45.97 80.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.452 0.701 . . . . 4.38 112.56 176.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -49.98 -45.22 51.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.027 0.931 . . . . 2.78 111.387 170.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.4 t -72.56 -39.7 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.74 1.015 . . . . 2.16 113.74 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -57.68 -50.5 72.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.214 -0.898 . . . . 4.09 113.291 -176.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -69.6 -17.25 63.52 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.318 1.229 . . . . 6.61 114.318 -165.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.82 -32.62 72.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.195 0.907 . . . . 2.5 112.639 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 t 138.2 129.25 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 131.032 3.733 . . . . 2.83 109.711 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.32 8.13 1.25 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.549 2.833 . . . . 2.25 116.018 -166.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -73.19 -16.06 61.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.036 1.289 . . . . 2.36 112.73 161.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.04 137.56 43.48 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.449 -0.782 . . . . 1.79 109.223 166.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.57 148.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.377 0.671 . . . . 2.47 112.156 171.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.69 138.68 15.1 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 124.501 1.048 . . . . 1.04 112.865 -177.101 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.83 148.32 40.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 114.758 1.392 . . . . 2.07 114.758 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.2 p -155.12 170.61 21.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.576 2.35 . . . . 2.29 110.19 -179.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.39 -173.63 37.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.612 1.101 . . . . 1.94 111.447 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.8 t -65.27 162.99 16.24 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.161 0.48 . . . . 2.61 110.553 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -56.64 -31.84 64.75 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.34 -0.85 . . . . 6.54 112.233 -176.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.9 mp0 -72.14 -35.75 69.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.799 2.04 . . . . 3.68 111.045 178.499 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.66 -39.72 76.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.747 -0.595 . . . . 3.15 111.881 169.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.21 -36.47 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.965 0.906 . . . . 2.19 111.951 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.15 -46.24 43.65 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.473 1.033 . . . . 4.24 110.113 173.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -46.08 -50.68 14.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.622 0.769 . . . . 3.31 110.8 173.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.44 -43.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.123 0.969 . . . . 2.48 111.803 -174.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.55 87.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.806 0.842 . . . . 2.02 111.906 173.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -32.09 35.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.236 1.814 . . . . 6.21 113.013 -177.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.56 -60.86 2.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.835 1.254 . . . . 2.16 112.235 176.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -74.68 -6.13 47.01 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.578 0.955 . . . . 2.46 113.578 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 66.66 54.89 0.81 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.63 1.972 . . . . 5.1 113.319 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.07 152.27 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.759 2.024 . . . . 3.29 110.54 177.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -103.67 145.93 29.33 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.009 1.114 . . . . 4.91 114.009 -176.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -129.87 142.63 50.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.536 1.934 . . . . 3.81 111.354 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 42.4 t -128.92 106.14 18.28 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 124.059 0.944 . . . . 4.56 111.136 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.74 153.28 8.75 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.478 2.785 . . . . 3.45 111.138 170.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.591 0 N-CA-C 114.75 0.66 . . . . 3.36 114.75 176.305 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.547 0.837 0 CA-C-O 122.195 0.998 . . . . 5.54 111.676 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.61 150.17 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.883 -1.136 . . . . 3.26 110.917 155.011 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.3 m -156.44 152.63 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.024 1.73 . . . . 5.22 107.605 -178.24 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -150.86 145.18 25.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.964 1.364 . . . . 5.94 112.077 -179.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -133.13 95.99 3.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.413 1.085 . . . . 2.34 109.92 170.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 t -72.54 58.26 0.42 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.852 1.661 . . . . 5.76 110.461 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.4 pp -113.09 158.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 122.472 1.13 . . . . 5.53 113.827 -167.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.7 pt -107.55 163.63 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.328 1.451 . . . . 3.89 109.014 161.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 76.5 mtp -97.51 159.01 15.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.739 0.816 . . . . 2.66 109.869 161.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.32 142.02 45.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.414 0.686 . . . . 2.82 111.116 165.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.2 tp -92.12 118.07 30.46 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 106.535 -1.654 . . . . 2.04 106.535 158.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.18 136.02 31.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.617 -1.623 . . . . 2.79 106.617 164.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.48 172.07 45.82 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 2.21 111.968 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.17 -13.44 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.191 2.594 . . . . 3.49 113.094 177.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -113.57 -0.14 14.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 129.713 3.205 . . . . 4.42 112.178 -176.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 108.34 -148.67 16.78 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.917 1.722 . . . . 4.28 113.072 -176.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.81 158.64 0.13 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.428 2.691 . . . . 5.91 116.543 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.86 85.78 6.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.813 1.245 . . . . 3.92 108.854 172.388 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.3 tt -86.31 -36.06 19.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.005 0.922 . . . . 3.2 111.834 -163.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -159.24 159.88 34.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.895 1.678 . . . . 2.61 109.413 175.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -136.46 147.34 47.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 122.676 1.227 . . . . 3.94 113.3 172.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.67 156.34 44.4 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.843 1.257 . . . . 2.39 111.101 -162.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.21 170.82 42.63 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.874 1.702 . . . . 2.75 110.036 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.88 -25.35 42.19 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.913 2.19 . . . . 4.48 116.913 -149.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.85 -21.35 25.06 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.512 1.301 . . . . 5.97 114.512 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -57.93 107.07 0.42 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.769 1.628 . . . . 4.09 108.593 178.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -74.93 143.8 43.55 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.395 -1.441 . . . . 6.36 109.813 -157.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.1 tmtt? -42.79 -53.0 4.8 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 121.095 1.77 . . . . 2.0 113.438 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -18.38 74.92 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.361 0.904 . . . . 1.58 115.361 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -31.78 17.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.877 1.271 . . . . 4.62 111.395 174.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.2 mt -56.36 -43.5 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.103 -0.998 . . . . 1.47 109.901 161.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.46 -53.17 58.75 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.54 0.57 . . . . 1.26 112.54 170.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.05 72.1 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.562 1.319 . . . . 1.5 114.562 -177.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.9 p -68.92 -48.83 62.33 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.446 -0.783 . . . . 1.75 111.07 170.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.24 -34.05 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.28 1.4 . . . . 1.49 111.709 176.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.35 -21.18 62.92 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.118 0.967 . . . . 1.51 113.494 172.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 100.0 m -76.98 -45.65 26.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.722 0.809 . . . . 1.9 109.537 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -62.83 -21.11 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.855 1.262 . . . . 2.44 113.402 174.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -66.5 -23.49 66.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.086 1.355 . . . . 4.27 113.287 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -59.8 -45.48 98.36 Favored Pre-proline 0 N--CA 1.477 0.891 0 O-C-N 119.971 -1.706 . . . . 5.0 113.277 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.6 -57.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.554 2.169 . . . . 2.12 111.491 164.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -83.63 23.47 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.029 1.862 . . . . 3.65 116.029 -167.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 ptt85 . . . . . 0 N--CA 1.471 0.618 0 C-N-CA 125.606 1.563 . . . . 8.89 111.752 174.686 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 N-CA-C 108.149 -1.98 . . . . 3.48 108.149 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.33 134.94 25.73 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.667 2.245 . . . . 3.97 111.772 -161.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -75.51 -179.97 4.92 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.497 1.519 . . . . 2.34 113.194 -172.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.2 m -157.83 62.1 0.47 Allowed 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.246 -1.534 . . . . 3.25 112.695 177.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -98.8 160.74 14.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.556 1.142 . . . . 2.21 110.511 -177.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -103.42 139.86 38.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.635 1.574 . . . . 1.69 111.656 -164.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -94.59 158.93 15.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.877 1.799 . . . . 2.24 115.706 -167.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.461 ' O ' ' HE3' ' A' ' 210' ' ' LYS . 0.3 OUTLIER -57.39 -21.7 37.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.481 1.912 . . . . 1.93 113.327 164.349 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -71.76 -68.85 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.194 1.398 . . . . 3.18 109.086 160.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.28 -12.44 1.6 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 124.769 1.176 . . . . 1.85 115.114 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.3 153.94 41.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.812 1.306 . . . . 4.2 110.626 166.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -85.26 135.14 34.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.449 -0.574 . . . . 5.21 109.449 153.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -120.27 153.86 35.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.833 0.853 . . . . 3.18 110.198 178.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.1 p -141.14 156.46 45.95 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.701 1.2 . . . . 2.52 110.705 -166.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.09 13.61 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.189 0.996 . . . . 3.93 113.444 168.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -103.67 -32.11 9.55 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.225 -1.547 . . . . 7.56 112.684 167.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -96.81 -22.59 16.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.646 1.178 . . . . 3.28 112.731 177.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -77.83 -15.31 59.16 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.573 0.953 . . . . 3.05 113.573 162.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.37 133.65 56.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.618 1.167 . . . . 3.43 110.551 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.32 6.68 88.51 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.273 -0.892 . . . . 2.33 114.199 -176.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -84.98 -155.73 0.22 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.088 1.444 . . . . 3.3 110.449 163.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -136.12 111.56 9.2 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.003 -1.481 . . . . 1.9 107.003 153.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.22 148.3 41.33 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.483 1.135 . . . . 2.51 113.163 -173.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.43 114.86 27.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.69 1.596 . . . . 2.83 106.977 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.47 111.31 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.035 -1.839 . . . . 3.07 106.035 -177.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -108.91 139.99 43.0 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.163 0.982 . . . . 2.23 113.278 -173.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -111.68 92.94 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.579 2.352 . . . . 2.15 110.877 175.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -130.69 154.47 20.72 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.426 1.965 . . . . 1.6 109.681 166.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.53 ' CE2' HG11 ' A' ' 258' ' ' VAL . 22.3 m-85 -97.18 157.0 16.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.688 0.744 . . . . 5.83 111.093 -175.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 53.1 p -70.66 -3.71 19.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.388 -1.445 . . . . 3.61 113.336 172.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -67.74 -47.2 69.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.215 1.806 . . . . 7.57 114.316 -178.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.9 m -102.92 119.62 54.98 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.448 1.022 . . . . 2.64 113.504 -150.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -90.85 44.34 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.353 2.702 . . . . 5.42 111.16 174.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.88 -104.45 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.138 -1.43 . . . . 6.05 107.138 -157.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.11 -66.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.221 1.808 . . . . 3.43 114.2 171.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 87.6 m -51.49 -48.74 85.7 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.868 1.433 . . . . 1.7 114.868 -174.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.25 -31.63 14.06 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.399 2.066 . . . . 1.27 113.571 175.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -64.37 -36.04 82.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.399 1.454 . . . . 3.39 110.734 171.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -33.71 76.46 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.546 -1.346 . . . . 3.18 112.809 174.625 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.15 -36.96 75.11 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.336 -0.84 . . . . 2.71 112.11 171.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -60.24 3.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.937 1.295 . . . . 4.59 111.423 -178.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -20.01 66.15 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 119.623 -1.923 . . . . 3.05 113.713 175.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 29.8 ttm -70.89 -45.02 65.08 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.636 1.107 . . . . 2.3 111.217 172.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -57.33 -47.57 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.311 -0.868 . . . . 2.61 110.076 174.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -54.58 -20.76 8.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.201 1.186 . . . . 4.86 114.201 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.73 -25.79 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.336 1.235 . . . . 2.35 114.336 177.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -54.46 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.62 1.1 . . . . 2.46 108.84 165.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -57.13 -37.87 72.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.475 1.11 . . . . 4.69 113.034 177.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.29 -40.73 50.88 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.345 -0.847 . . . . 2.93 112.814 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mt -66.86 -34.8 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.876 0.762 . . . . 1.83 110.833 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.81 -44.89 76.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.541 1.136 . . . . 3.66 111.588 167.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -64.67 -27.59 69.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.393 -1.442 . . . . 3.21 112.862 177.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.86 -19.69 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.218 1.407 . . . . 3.72 112.022 172.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.3 m 73.96 -35.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 127.225 2.21 . . . . 5.38 114.212 162.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -97.63 4.14 50.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.802 1.641 . . . . 4.48 112.96 178.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.73 152.07 37.94 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.255 -1.017 . . . . 3.23 108.255 158.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -94.95 -23.18 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.742 2.295 . . . . 3.79 114.474 -162.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.7 t70 170.65 150.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.333 2.653 . . . . 3.66 110.334 -173.539 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 11.0 tp -132.28 100.39 5.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.182 1.793 . . . . 2.2 108.376 156.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 m -81.71 121.71 79.77 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-O 118.118 -0.944 . . . . 1.72 110.906 -178.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.24 117.96 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.128 3.218 . . . . 1.48 110.409 168.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.32 119.12 34.69 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 2.49 109.224 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -102.76 112.66 25.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.983 0.913 . . . . 2.5 110.66 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.481 HG22 HG23 ' A' ' 203' ' ' ILE . 9.5 mm -82.55 122.51 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 107.254 -1.387 . . . . 1.51 107.254 165.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.9 p -71.66 -29.46 64.64 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.499 1.666 . . . . 3.13 115.499 -175.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 201' ' ' ILE 0.329 14.1 pt 53.2 -6.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 119.825 3.269 . . . . 3.08 119.825 168.752 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -119.87 62.27 7.75 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.485 1.914 . . . . 3.56 112.196 161.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -59.3 140.49 94.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 107.95 -1.596 . . . . 2.4 107.95 161.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 108.8 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.394 3.878 . . . . 4.88 112.357 -174.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -107.61 4.74 26.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.161 0.892 . . . . 5.33 112.303 163.163 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.41 -179.44 7.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.39 1.476 . . . . 5.58 112.246 -175.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.6 m -167.27 129.67 1.68 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 128.129 2.572 . . . . 2.27 105.791 162.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 145' ' ' HIS . 1.2 tmtp? -54.08 -43.47 70.36 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.472 0.709 . . . . 3.13 112.478 -175.461 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -67.81 -31.52 71.43 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.741 1.617 . . . . 3.1 113.256 173.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.02 73.79 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.566 -1.334 . . . . 1.29 111.768 175.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.94 -38.15 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.537 0.735 . . . . 2.41 111.036 170.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.9 69.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.838 0.745 . . . . 1.56 112.822 174.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.01 -49.33 52.47 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.357 -0.84 . . . . 4.48 111.584 170.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.16 -30.94 71.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.708 0.633 . . . . 2.88 112.708 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.58 -60.21 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.005 1.322 . . . . 1.6 110.92 162.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -62.18 -30.74 71.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.388 0.884 . . . . 5.36 113.388 -174.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.22 -34.94 72.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.23 1.412 . . . . 4.63 111.964 -177.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -108.67 -21.41 12.71 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.689 1.366 . . . . 3.39 114.689 -174.183 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.4 p 159.17 151.38 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.888 2.475 . . . . 2.58 112.015 167.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.54 -3.29 10.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.861 2.374 . . . . 2.06 114.413 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -87.07 -8.62 56.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.008 1.276 . . . . 2.12 113.395 171.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.64 123.19 18.2 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.029 -1.669 . . . . 2.88 109.567 171.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.36 116.17 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.293 -1.002 . . . . 2.6 108.293 165.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.57 141.51 15.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.458 1.028 . . . . 1.12 111.271 -177.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.44 151.29 37.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.961 1.097 . . . . 2.77 113.961 -175.229 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 25.5 p -133.53 170.78 15.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.588 3.155 . . . . 3.07 108.908 -176.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.81 161.06 15.04 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.902 1.715 . . . . 2.03 109.455 -173.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.4 p -69.03 169.11 12.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.048 1.424 . . . . 3.01 112.266 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -40.7 -43.4 1.95 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.973 1.709 . . . . 5.57 112.732 170.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -67.53 -38.38 84.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.505 1.122 . . . . 3.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.51 -47.63 59.53 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.119 -0.988 . . . . 3.47 111.453 174.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.1 m -65.6 -24.77 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.851 0.686 . . . . 2.85 112.851 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.11 -33.43 29.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.194 0.906 . . . . 3.03 112.34 169.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -59.61 -51.48 69.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.42 1.464 . . . . 2.6 110.655 171.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.52 -20.64 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.31 0.485 . . . . 2.1 112.31 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.4 -54.37 14.77 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.947 0.794 . . . . 2.0 110.789 167.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.75 -45.09 82.22 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.258 1.423 . . . . 3.12 111.844 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.41 -56.45 14.96 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.335 1.054 . . . . 2.22 112.404 -175.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.53 10.72 26.73 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.122 -0.986 . . . . 3.31 113.576 176.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 61.24 33.45 19.13 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.343 1.457 . . . . 5.2 113.655 177.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.32 147.96 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.535 2.334 . . . . 2.99 110.447 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -119.83 153.16 36.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.421 1.105 . . . . 5.85 113.413 168.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -124.45 146.33 48.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 6.26 109.317 171.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 259' ' ' ASP . 26.2 m -123.51 72.29 49.56 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.721 1.208 . . . . 3.69 110.329 -179.269 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.66 125.03 10.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.603 2.202 . . . . 3.03 111.574 -171.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.414 0 CA-C-O 118.454 -1.192 . . . . 2.43 111.377 178.551 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.887 0.851 . . . . 4.32 109.771 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.97 167.14 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.817 1.247 . . . . 2.95 112.744 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 166' ' ' PHE . 58.6 t -149.62 129.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 105.392 -2.077 . . . . 3.2 105.392 156.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 246' ' ' SER . 0.8 OUTLIER -87.16 158.34 19.17 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.267 0.94 . . . . 3.63 110.451 167.809 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.06 132.98 7.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.499 1.296 . . . . 2.44 114.499 -153.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.72 -12.8 37.71 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.713 2.116 . . . . 3.65 116.713 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.31 5.8 tt 43.48 55.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 126.211 1.804 . . . . 3.37 115.441 169.26 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.3 mm -103.46 146.41 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.694 1.198 . . . . 2.92 111.005 174.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 77.3 mtp -108.3 117.11 33.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.789 1.636 . . . . 2.33 109.987 158.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.76 135.68 39.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.975 0.91 . . . . 2.59 112.694 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 56.6 tp -93.61 118.23 31.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.283 1.033 . . . . 2.17 110.998 178.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.4 148.88 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.43 1.092 . . . . 2.36 108.333 169.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -175.32 -142.17 4.02 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.481 -1.177 . . . . 2.79 112.43 -172.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -88.56 70.43 2.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.399 2.733 . . . . 3.02 110.069 -171.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -169.96 -67.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.113 1.365 . . . . 4.66 108.678 -163.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.82 -4.54 69.39 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 116.543 -2.254 . . . . 2.96 116.658 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.44 -47.84 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.497 2.148 . . . . 6.05 111.742 176.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 162.24 121.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.436 2.694 . . . . 4.31 111.051 171.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.83 -46.9 6.69 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.207 0.817 . . . . 4.27 113.207 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.74 164.18 9.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.526 1.93 . . . . 2.57 109.237 -170.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -158.39 135.02 9.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.838 1.255 . . . . 3.66 112.993 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -114.57 118.49 33.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.608 1.163 . . . . 2.35 108.711 -176.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.12 112.5 3.47 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 118.936 -0.924 . . . . 3.82 111.386 -174.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 52.62 60.72 3.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.47 1.129 . . . . 3.11 108.723 -155.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.7 p30 42.68 -147.58 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.401 2.28 . . . . 7.41 114.244 -172.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -147.31 -4.93 0.51 Allowed 'General case' 0 CA--C 1.549 0.91 0 O-C-N 120.297 -1.502 . . . . 4.56 114.018 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 72.61 136.39 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.03 2.932 . . . . 8.01 109.243 -163.498 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -47.53 63.81 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.375 1.621 . . . . 2.66 115.375 -155.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.82 -17.14 73.0 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 123.925 0.774 . . . . 1.62 114.518 -175.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.71 -29.02 61.05 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.327 1.063 . . . . 5.44 111.582 174.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.09 -40.72 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.585 -0.697 . . . . 1.52 109.477 174.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.99 88.09 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.951 -0.468 . . . . 1.49 111.599 171.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.06 79.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.185 0.809 . . . . 1.87 113.185 176.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 60.5 p -59.74 -60.2 4.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.514 0.726 . . . . 2.21 111.721 174.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.4 mm -58.92 -35.52 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 119.305 0.957 . . . . 2.81 111.95 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.28 73.69 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.483 -0.761 . . . . 1.8 112.932 175.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.8 m -76.09 -36.51 58.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.999 1.32 . . . . 2.01 110.806 173.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.038 0.835 . . . . 3.08 112.025 173.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 32.5 mmt -65.55 -10.2 33.04 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.667 -1.27 . . . . 5.4 114.043 168.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -57.07 2.88 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.39 -1.766 . . . . 7.47 112.081 172.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.55 -51.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.043 2.495 . . . . 2.4 112.738 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -72.08 169.66 15.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.839 0.856 . . . . 3.38 110.948 176.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 36.6 mmt-85 . . . . . 0 N--CA 1.474 0.728 0 O-C-N 120.604 -1.31 . . . . 8.75 112.521 -167.622 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 118.462 -0.78 . . . . 18.41 110.106 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -81.53 46.9 1.0 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.425 1.09 . . . . 16.77 113.257 -173.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -161.54 0.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.837 2.055 . . . . 12.51 110.595 -175.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.51 -176.78 27.28 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.138 -0.976 . . . . 10.27 113.322 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.5 mttp 107.83 -32.64 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 130.549 3.54 . . . . 11.06 116.806 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -82.28 179.7 5.3 Favored 'Trans proline' 0 C--N 1.355 0.898 0 CA-C-N 122.992 2.104 . . . . 8.44 111.077 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -52.65 129.28 28.92 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.953 1.701 . . . . 11.24 111.433 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 136' ' ' LEU . 1.4 pt? -118.7 -167.1 1.32 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.85 1.66 . . . . 7.82 113.629 -173.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.31 137.51 3.09 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.496 1.522 . . . . 4.01 111.189 -172.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.4 114.09 5.24 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.25 -1.305 . . . . 2.67 110.518 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.63 147.87 36.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.191 1.928 . . . . 3.23 110.164 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.41 ' HD1' ' H ' ' A' ' 142' ' ' LEU . 5.2 p90 -143.88 154.19 43.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.602 0.761 . . . . 3.55 111.062 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 m -122.87 15.74 10.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.595 1.702 . . . . 2.63 115.595 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.41 ' H ' ' HD1' ' A' ' 140' ' ' PHE . 7.3 mp -69.37 147.89 50.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.152 2.181 . . . . 2.38 112.419 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.31 151.09 24.97 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.713 1.605 . . . . 2.25 109.971 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 146' ' ' THR . 0.6 OUTLIER -95.64 161.83 13.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.656 1.217 . . . . 2.87 111.971 175.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 6.3 p-80 -45.49 -28.24 0.88 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.257 2.623 . . . . 1.41 115.248 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.636 ' H ' HG23 ' A' ' 144' ' ' THR . 10.3 m -72.02 -20.1 61.75 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.451 1.9 . . . . 2.9 113.456 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.33 11.78 56.87 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.073 1.32 . . . . 2.29 114.559 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.5 -162.73 0.98 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.929 1.291 . . . . 4.32 110.45 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -144.07 103.74 4.05 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.496 1.044 . . . . 4.39 113.06 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 175.68 5.49 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 114.682 1.364 . . . . 4.76 114.682 173.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.4 p -137.19 -179.28 5.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.446 2.298 . . . . 2.3 111.092 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.44 -26.94 62.03 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.703 -1.248 . . . . 3.59 112.916 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -94.68 -19.45 20.41 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.051 1.871 . . . . 7.12 116.051 -167.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -71.21 -28.79 64.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.26 1.391 . . . . 3.03 112.102 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -96.04 40.83 1.11 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.276 1.03 . . . . 4.33 112.535 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.64 169.15 13.34 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.254 -0.903 . . . . 5.37 112.409 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 75.93 -10.05 15.66 Favored Glycine 0 CA--C 1.54 1.635 0 O-C-N 120.517 -1.365 . . . . 2.4 116.319 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -116.02 156.23 26.69 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.671 2.388 . . . . 3.25 110.094 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -70.88 100.31 1.92 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.569 1.077 . . . . 1.6 111.176 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.9 mt -83.85 134.57 34.7 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.138 0.971 . . . . 2.54 109.907 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.69 112.59 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.42 -1.696 . . . . 2.77 106.42 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.1 pt -114.77 122.21 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.079 0.552 . . . . 2.77 109.547 -165.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -111.79 143.74 42.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.791 1.236 . . . . 2.56 112.024 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.02 104.5 12.76 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.414 1.486 . . . . 2.0 108.681 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -120.5 -176.18 15.6 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.39 1.471 . . . . 1.36 114.852 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -157.5 115.75 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.739 2.015 . . . . 3.76 106.406 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.6 m -76.28 71.89 3.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.215 1.406 . . . . 3.49 110.178 -166.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 173.79 -48.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.17 2.588 . . . . 6.46 110.338 -158.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 52.1 -161.86 0.01 OUTLIER Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.664 2.385 . . . . 3.94 115.321 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -71.66 -74.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 124.7 3.6 . . . . 4.73 110.619 120.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -163.68 30.17 0.08 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.482 1.037 . . . . 4.22 113.735 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.8 -17.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 115.311 1.597 . . . . 3.18 115.311 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 29.7 m -49.7 -48.3 77.11 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 116.354 -1.784 . . . . 1.58 112.888 155.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.14 -39.89 9.73 Favored 'Trans proline' 0 C--N 1.354 0.825 0 CA-C-N 122.751 2.018 . . . . 1.66 112.206 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.67 -48.49 81.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.381 1.072 . . . . 3.52 111.076 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.447 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 4.9 tp10 -75.44 -22.38 57.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.012 0.925 . . . . 3.74 112.871 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.25 -37.65 78.07 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 116.762 -1.589 . . . . 2.73 110.897 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -52.53 65.24 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.236 1.835 . . . . 5.24 109.41 170.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 176' ' ' GLU . 38.8 mtmt -63.35 -39.35 94.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.409 0.522 . . . . 3.17 112.409 -174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 38.6 ttm -57.41 -49.0 77.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.493 1.517 . . . . 3.41 111.518 167.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.25 -41.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.568 1.147 . . . . 2.03 113.105 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.486 ' HG3' ' HE2' ' A' ' 283' ' ' LYS . 35.6 mm-40 -70.88 -50.67 32.57 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.02 1.282 . . . . 3.93 109.159 173.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -17.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.879 1.437 . . . . 2.27 114.879 -169.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.81 -45.72 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 119.441 1.019 . . . . 2.3 110.931 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -92.21 -25.67 18.55 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.259 0.466 . . . . 6.05 112.259 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -65.07 -29.36 70.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.781 1.232 . . . . 2.83 113.055 166.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.74 -45.22 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 118.508 -0.758 . . . . 2.19 112.767 177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -30.92 71.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.145 1.339 . . . . 4.84 110.924 174.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.3 t -60.78 -24.47 65.81 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.298 1.839 . . . . 3.01 113.184 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.44 -26.58 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.113 -1.617 . . . . 5.05 110.403 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.7 m 76.85 -36.72 0.26 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.31 2.244 . . . . 4.22 112.966 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.4 m -73.48 -22.96 60.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.396 1.478 . . . . 5.34 113.1 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.3 156.46 81.45 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 121.18 -0.95 . . . . 3.7 110.808 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.66 -62.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.713 2.275 . . . . 3.28 109.338 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -171.21 157.08 4.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.613 3.565 . . . . 4.64 107.909 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.94 125.68 48.68 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.975 -0.75 . . . . 2.49 108.975 156.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.8 m -112.55 111.51 51.96 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.105 1.362 . . . . 1.41 110.062 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.71 134.08 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.734 2.956 . . . . 1.15 111.717 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.65 116.32 25.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.425 1.09 . . . . 2.21 109.778 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.24 112.93 24.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 2.67 109.679 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.7 mm -99.7 123.58 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.494 -1.298 . . . . 1.99 107.494 166.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 9.8 t -90.64 153.79 20.05 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.565 -0.709 . . . . 2.44 109.861 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.9 pt -115.95 -2.23 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.015 1.117 . . . . 2.02 114.015 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -119.54 74.71 17.33 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 120.144 1.338 . . . . 3.48 110.287 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.5 160.38 50.01 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.507 2.805 . . . . 3.31 110.722 -169.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 77.53 -51.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.237 2.615 . . . . 7.49 109.392 -172.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 207' ' ' ARG . 1.5 mpt_? -63.62 -52.3 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.507 1.123 . . . . 6.15 109.43 172.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.4 83.21 5.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.369 1.08 . . . . 5.19 109.178 159.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.6 m -64.94 132.61 49.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.289 -0.869 . . . . 3.2 109.136 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -43.93 -50.22 8.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.623 1.169 . . . . 3.24 112.895 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -27.02 61.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.353 1.242 . . . . 3.62 114.353 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.7 -39.18 87.96 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.052 -1.03 . . . . 2.07 110.651 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.78 -36.0 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.929 0.892 . . . . 2.22 110.35 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . . . -57.48 -17.83 15.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.572 1.149 . . . . 1.21 113.757 166.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -88.89 -47.9 7.84 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.991 -1.068 . . . . 4.49 112.792 167.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -58.19 -38.47 76.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.116 0.966 . . . . 3.7 112.576 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.4 t -54.28 -60.44 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.963 1.705 . . . . 1.29 110.68 165.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -66.16 -40.8 90.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.517 1.527 . . . . 4.18 114.698 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.92 -28.9 58.19 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.03 1.122 . . . . 3.45 114.03 -172.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -77.96 -53.01 7.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.461 0.573 . . . . 4.11 112.024 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.1 t -169.42 136.84 1.49 Allowed Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.422 1.089 . . . . 2.34 110.916 168.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.91 -4.64 11.71 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.247 2.631 . . . . 1.57 113.996 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -71.29 -14.25 62.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.964 1.256 . . . . 2.45 113.521 170.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.81 140.75 55.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.361 1.064 . . . . 3.09 112.58 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.3 t -118.36 130.88 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.998 1.319 . . . . 1.92 108.578 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -124.54 121.56 4.42 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.683 0.659 . . . . 1.12 114.051 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.77 159.46 15.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.921 1.288 . . . . 3.05 113.215 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -152.86 150.47 29.35 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.517 1.927 . . . . 2.44 108.899 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -172.09 165.24 37.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.952 -2.059 . . . . 1.8 107.952 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.7 p -70.55 172.63 8.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.877 0.839 . . . . 2.92 111.959 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.462 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 30.4 ptt180 -43.01 -38.81 2.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.412 1.485 . . . . 7.89 113.691 173.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -64.68 -37.94 89.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.095 1.358 . . . . 3.09 111.669 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.77 -44.65 22.81 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.653 1.181 . . . . 2.86 113.281 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.8 m -65.97 -27.11 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.074 0.397 . . . . 2.9 111.739 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.77 -45.68 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.269 -0.872 . . . . 3.1 112.054 165.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -50.0 -58.39 5.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.862 1.21 . . . . 3.28 110.981 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.72 -25.69 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.181 0.9 . . . . 2.25 112.023 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.77 -40.35 72.69 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.983 -0.448 . . . . 1.46 110.292 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -71.2 -38.32 72.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.23 1.012 . . . . 4.89 112.237 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -44.48 85.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.354 1.462 . . . . 2.13 113.82 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -100.89 5.82 43.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.462 1.105 . . . . 2.15 113.523 170.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 64.2 37.89 8.51 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.787 2.035 . . . . 5.25 113.732 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.32 151.18 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.694 0.798 . . . . 2.51 111.749 -173.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 140.36 36.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.811 0.845 . . . . 4.22 112.318 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.45 165.67 26.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.5 2.32 . . . . 4.61 109.875 168.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.69 106.29 1.06 Allowed Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 121.249 -0.907 . . . . 2.79 110.781 175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -94.98 134.29 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.411 2.741 . . . . 2.49 112.632 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.44 115.84 4.71 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.309 1.433 . . . . 2.33 111.144 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.24 161.52 32.07 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.266 2.644 . . . . 5.1 111.631 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 143.16 51.44 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.014 1.116 . . . . 7.65 114.014 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -115.9 -72.21 0.7 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 117.99 -1.005 . . . . 7.92 111.482 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -67.89 -58.15 5.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.972 1.26 . . . . 7.76 110.159 166.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . 0.251 24.5 p30 166.71 -36.23 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 128.926 2.89 . . . . 6.32 115.032 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -91.42 50.6 1.76 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.868 1.318 . . . . 8.34 111.928 -173.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -161.77 146.01 12.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.483 1.513 . . . . 6.0 110.059 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -166.75 49.7 0.07 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.854 2.462 . . . . 4.82 108.747 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.7 tp -49.86 152.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 126.621 1.968 . . . . 3.33 113.849 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.48 130.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.221 1.408 . . . . 3.32 108.145 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -83.69 141.15 31.68 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.654 1.582 . . . . 3.74 110.709 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -126.82 155.67 42.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.707 0.765 . . . . 2.38 111.549 165.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.7 m -62.78 113.44 3.04 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.707 0.803 . . . . 3.66 109.6 168.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.31 44.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.316 1.046 . . . . 4.21 112.849 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 54.7 mt -132.95 135.5 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.123 0.969 . . . . 2.51 110.653 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.3 ptp -104.01 142.96 33.54 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.112 1.365 . . . . 2.59 110.911 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -99.88 141.71 32.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.346 1.058 . . . . 2.39 112.019 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -101.8 119.34 38.64 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.884 1.274 . . . . 2.57 109.243 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 63.4 mt -100.16 138.16 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.915 1.686 . . . . 2.22 107.887 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 171.45 42.05 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.54 1.067 . . . . 1.61 111.515 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -82.7 66.1 8.06 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.249 2.633 . . . . 2.6 109.367 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -177.52 -69.17 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.553 2.341 . . . . 4.94 108.988 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 160.55 -21.61 0.24 Allowed Glycine 0 CA--C 1.538 1.527 0 N-CA-C 117.02 1.568 . . . . 2.48 117.02 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.76 152.89 44.73 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.965 1.382 . . . . 6.66 112.429 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -99.45 129.51 45.64 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.38 -1.45 . . . . 4.36 112.271 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.95 -18.07 10.23 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.74 1.385 . . . . 3.04 114.74 -167.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -162.98 171.46 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.633 1.173 . . . . 2.67 110.987 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -148.51 149.02 30.9 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.144 1.377 . . . . 2.9 111.527 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . 0.435 ' CZ ' HG23 ' A' ' 286' ' ' ILE . 1.4 m-85 -130.0 105.0 7.68 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.105 1.362 . . . . 2.48 109.737 -173.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -86.01 153.27 26.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.225 -1.95 . . . . 2.33 108.225 153.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -17.05 2.99 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 117.279 2.326 . . . . 4.65 117.279 -164.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -63.2 -27.47 69.38 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.943 1.09 . . . . 5.04 113.943 169.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -92.87 96.0 9.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.025 1.73 . . . . 4.52 109.744 165.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.15 176.87 8.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.737 1.615 . . . . 4.99 112.753 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.486 ' HE2' ' HG3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -57.28 -27.3 62.0 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.022 1.86 . . . . 2.27 116.022 -169.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.7 -36.2 53.83 Favored Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.527 -0.733 . . . . 1.36 112.07 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.77 -31.8 46.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.082 1.753 . . . . 3.57 111.216 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . 0.435 HG23 ' CZ ' ' A' ' 277' ' ' PHE . 79.0 mt -64.85 -45.44 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.494 0.718 . . . . 1.34 110.077 166.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.55 87.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.175 0.898 . . . . 1.44 111.095 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.91 97.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.087 0.858 . . . . 1.87 113.092 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 94.2 p -74.55 -38.42 62.73 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.99 -1.069 . . . . 1.56 113.414 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.01 -35.64 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.662 1.573 . . . . 1.38 111.707 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.01 -18.77 63.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.531 -1.356 . . . . 1.69 113.479 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 53.1 m -74.83 -55.1 6.17 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.407 -0.808 . . . . 1.89 109.737 167.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -64.55 -22.58 67.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.876 1.67 . . . . 2.71 113.555 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -42.09 46.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.814 1.646 . . . . 5.26 112.157 165.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -64.21 -55.36 31.91 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 116.419 -1.753 . . . . 5.27 113.249 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.47 -38.34 1.97 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.284 1.989 . . . . 3.05 112.686 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 17.66 7.02 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.752 1.019 . . . . 3.22 113.752 -173.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.95 134.06 55.32 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 7.12 113.198 -164.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -109.76 -179.0 3.68 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.959 1.304 . . . . 11.37 111.967 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 81.0 mttt 58.21 -134.02 1.08 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 117.309 -1.329 . . . . 7.29 110.226 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 C--O 1.248 1.016 0 C-N-CA 125.812 1.645 . . . . 7.12 113.929 -172.303 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 116.785 -1.579 . . . . 17.21 108.232 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -64.1 -51.42 64.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.74 1.609 . . . . 14.13 108.904 152.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.7 m -59.68 135.37 57.66 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.387 1.475 . . . . 13.11 110.495 165.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -159.88 -178.92 34.3 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 127.135 2.302 . . . . 10.01 110.76 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.99 147.38 10.29 Favored Pre-proline 0 N--CA 1.476 0.829 0 CA-C-O 117.819 -1.086 . . . . 10.01 111.932 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.35 160.09 50.71 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.522 2.148 . . . . 7.42 110.682 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 mt -158.94 161.3 36.72 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.769 2.027 . . . . 9.46 107.986 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mp -134.18 -162.62 1.27 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.405 1.082 . . . . 5.87 110.243 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.72 163.17 19.92 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.747 1.165 . . . . 3.82 112.05 -159.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.14 81.66 0.3 Allowed Glycine 0 CA--C 1.537 1.425 0 CA-C-O 118.593 -1.115 . . . . 2.85 114.388 -172.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.75 149.71 54.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.99 3.127 . . . . 3.0 112.134 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.508 ' HB2' HG22 ' A' ' 237' ' ' VAL . 37.9 p90 -154.88 172.69 17.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.24 1.016 . . . . 2.96 112.128 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.8 m -143.42 119.9 11.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.91 -1.515 . . . . 3.29 106.91 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.432 ' HB2' HG21 ' A' ' 237' ' ' VAL . 12.6 tp -157.35 140.21 15.1 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.561 0.619 . . . . 2.56 111.432 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.1 m -74.43 146.67 42.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.626 0.727 . . . . 1.79 109.44 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.7 m -99.35 139.81 34.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.509 1.124 . . . . 2.91 110.77 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.46 ' CE1' ' H ' ' A' ' 226' ' ' GLY . 0.0 OUTLIER -51.67 -36.54 46.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.896 2.078 . . . . 2.24 113.117 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -108.09 -1.11 20.7 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.046 1.738 . . . . 3.24 111.968 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.15 -125.56 1.62 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 119.151 0.887 . . . . 2.81 111.789 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.0 -160.94 1.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.146 1.378 . . . . 4.2 110.715 -157.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.28 97.11 1.94 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.34 1.056 . . . . 6.13 111.653 -168.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.26 149.61 33.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.697 1.599 . . . . 3.45 110.911 172.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 58.5 p -140.12 141.42 36.11 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.439 2.296 . . . . 2.37 107.498 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -28.04 -69.36 0.05 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.978 1.711 . . . . 3.75 115.369 -171.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -65.86 0.04 2.01 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 116.913 2.19 . . . . 7.48 116.913 -174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.39 -54.91 29.38 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 119.848 1.204 . . . . 3.14 110.161 162.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -91.21 -28.0 18.11 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.703 1.001 . . . . 3.31 113.703 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 59.37 4.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.596 1.159 . . . . 6.27 112.609 -168.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -108.94 0.07 31.79 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.086 1.803 . . . . 2.42 113.138 162.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -153.46 175.12 13.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.859 2.064 . . . . 3.92 108.993 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -66.42 118.33 9.91 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.12 0.968 . . . . 1.73 112.748 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 mp -107.85 147.34 31.05 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.598 0.759 . . . . 3.2 112.206 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.0 mp -111.94 118.02 34.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.308 1.843 . . . . 2.7 107.527 166.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.2 mt -118.79 124.47 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.672 0.789 . . . . 1.93 110.102 -173.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -127.88 139.98 52.29 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.874 1.27 . . . . 2.22 113.23 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.7 120.32 42.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.903 1.281 . . . . 2.39 110.636 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -145.6 -175.51 18.75 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 116.108 1.203 . . . . 1.4 116.108 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.43 ' CD2' HG22 ' A' ' 258' ' ' VAL . 21.6 t80 -139.65 133.77 31.09 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 123.63 1.681 . . . . 3.55 113.718 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 23.41 0.07 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.743 2.017 . . . . 3.0 114.036 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -165.66 32.83 0.05 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.125 2.17 . . . . 6.75 110.403 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 82.2 m -54.27 159.1 3.31 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.15 -1.594 . . . . 2.17 111.941 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.21 68.93 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.164 2.576 . . . . 3.1 108.455 159.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 68.07 -17.49 0.17 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.996 3.318 . . . . 5.45 115.626 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.0 t -43.87 -65.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.646 1.978 . . . . 3.23 113.146 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 28.1 m -58.41 -50.37 88.4 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 116.579 -1.676 . . . . 1.61 114.285 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.72 -34.23 51.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.955 2.091 . . . . 2.11 114.159 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.82 -36.59 64.98 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.394 0.997 . . . . 3.75 111.885 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.87 -35.28 72.31 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.44 -1.412 . . . . 3.72 112.563 172.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.67 -27.33 67.58 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 117.23 -1.367 . . . . 3.13 112.51 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -62.78 1.3 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.997 1.271 . . . . 3.35 109.053 167.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -58.23 -21.09 46.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.694 -1.254 . . . . 4.26 113.215 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.0 mmm -79.79 -41.46 26.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.047 1.499 . . . . 5.45 115.047 165.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.94 -31.02 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 122.477 2.399 . . . . 1.95 110.5 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -37.31 -41.6 0.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.484 1.914 . . . . 3.28 112.854 162.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.2 -22.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 1.95 111.775 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.61 -39.27 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 118.932 0.787 . . . . 1.83 109.55 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.25 -44.15 95.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.27 1.028 . . . . 4.08 111.011 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -71.42 -7.82 49.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.83 1.652 . . . . 3.3 114.867 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.2 mt -119.85 -48.35 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 118.088 -0.958 . . . . 1.9 113.427 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.64 -27.35 67.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.925 1.239 . . . . 3.77 111.711 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.9 t -70.65 -11.3 60.86 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.845 -1.159 . . . . 3.03 113.743 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 34.3 mm -90.61 86.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 120.441 -1.412 . . . . 3.55 108.71 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 81.0 p -63.98 60.54 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.387 2.675 . . . . 4.6 115.41 -169.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 10.5 t -173.18 -24.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 129.907 3.283 . . . . 4.41 110.871 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.17 156.02 8.13 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.774 -1.204 . . . . 3.01 109.934 151.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.44 -66.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 N-CA-C 107.378 -1.816 . . . . 3.36 107.378 162.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.15 173.2 2.64 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.269 3.027 . . . . 3.62 109.791 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 tp -119.2 110.17 16.72 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.858 0.863 . . . . 1.96 111.1 161.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.8 m -92.78 120.05 67.48 Favored Pre-proline 0 N--CA 1.482 1.128 0 O-C-N 120.939 -1.1 . . . . 1.29 111.467 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -93.63 131.12 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.538 2.825 . . . . 0.97 112.571 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.97 119.49 30.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.854 2.062 . . . . 2.52 110.472 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -99.8 136.16 40.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.01 1.724 . . . . 2.75 110.8 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.06 126.26 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.576 1.55 . . . . 1.47 109.204 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 92.0 p -84.01 141.79 30.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.214 0.531 . . . . 2.38 110.23 165.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.9 pt -108.53 19.96 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.029 -1.044 . . . . 1.9 112.841 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -118.05 77.06 12.08 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.816 2.046 . . . . 3.33 110.897 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.38 83.06 2.33 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.285 3.323 . . . . 3.28 109.713 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.45 -124.18 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.601 1.961 . . . . 4.72 106.283 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.99 11.25 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 117.965 2.58 . . . . 6.94 117.965 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -89.74 150.89 22.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.782 -1.824 . . . . 3.4 111.049 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.1 p -142.71 144.9 32.88 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.486 1.136 . . . . 2.84 112.252 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -42.97 -55.47 3.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.088 2.155 . . . . 3.87 111.952 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -70.57 -34.0 71.71 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.159 0.983 . . . . 4.21 113.221 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.99 68.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.311 1.414 . . . . 1.78 111.224 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.3 mm -58.62 -39.19 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 119.407 -0.33 . . . . 1.52 111.612 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.9 -29.46 60.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.978 1.311 . . . . 1.75 113.805 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -90.26 -38.69 13.25 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.778 0.831 . . . . 4.85 112.983 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.17 -38.74 80.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.271 1.428 . . . . 2.88 111.787 174.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.9 t -54.55 -34.19 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.477 1.511 . . . . 1.1 113.541 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.32 -35.68 78.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.151 -0.928 . . . . 5.43 111.939 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.2 -36.43 81.72 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 124.396 1.06 . . . . 4.01 111.223 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.9 -44.03 61.74 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.934 0.788 . . . . 3.6 113.033 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.5 m 150.42 143.1 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 130.056 3.342 . . . . 2.3 111.042 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.26 -0.97 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.495 2.797 . . . . 1.65 115.908 -167.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.86 -14.7 60.7 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 120.631 1.56 . . . . 2.94 112.546 168.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.98 127.67 33.49 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.628 -1.295 . . . . 2.59 111.917 -170.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.9 124.35 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.448 -1.686 . . . . 2.3 106.448 171.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.46 ' H ' ' CE1' ' A' ' 145' ' ' HIS . . . -103.8 127.01 8.98 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 108.672 -1.771 . . . . 1.11 108.672 170.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.28 150.53 32.32 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.968 0.507 . . . . 2.84 110.253 167.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.3 t -167.07 176.08 7.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.397 2.279 . . . . 3.12 108.971 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.63 34.22 Favored Glycine 0 N--CA 1.468 0.83 0 O-C-N 120.771 -1.206 . . . . 1.76 115.2 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -73.81 161.88 29.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.332 1.053 . . . . 2.29 111.164 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -43.88 67.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.745 0.818 . . . . 7.02 111.246 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.58 1.552 . . . . 3.87 112.969 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.12 -46.68 49.84 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.54 -0.725 . . . . 3.22 111.675 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.19 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 119.155 -0.45 . . . . 1.68 111.372 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.61 -39.61 80.79 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.321 0.964 . . . . 3.9 112.127 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -62.72 -49.13 76.27 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 120.016 1.28 . . . . 3.33 110.909 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 140' ' ' PHE . 54.4 t -64.77 -48.22 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.794 0.838 . . . . 2.87 111.909 -171.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.52 -50.53 51.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.868 0.867 . . . . 1.41 110.396 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -72.62 -27.34 62.09 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 117.461 -1.257 . . . . 3.64 113.556 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.51 65.32 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.864 1.211 . . . . 1.74 111.037 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -84.3 12.1 7.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.454 1.102 . . . . 2.26 113.569 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 65.71 -41.72 0.34 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.781 2.832 . . . . 6.36 115.021 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.3 t 18.85 103.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 131.622 3.969 . . . . 2.6 115.907 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -71.47 142.47 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.917 0.887 . . . . 3.47 113.201 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -169.73 155.29 5.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.737 2.015 . . . . 3.99 110.273 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -148.45 106.58 3.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.424 0.69 . . . . 2.8 109.795 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.61 138.45 15.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.337 2.025 . . . . 2.71 110.243 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.99 139.96 23.38 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.646 -0.53 . . . . 2.44 112.418 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.16 16.94 1.28 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.925 3.083 . . . . 3.19 112.851 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 115.86 156.43 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 1 C-N-CA 132.762 4.425 . . . . 5.32 109.312 -159.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -95.0 -132.32 0.17 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.481 1.912 . . . . 8.98 109.926 171.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.31 -17.64 64.68 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.206 1.402 . . . . 8.37 114.055 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -164.41 -71.34 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.496 1.519 . . . . 6.09 110.063 175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -120.64 -19.04 7.58 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.056 1.132 . . . . 5.41 114.056 -167.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.2 139.66 54.56 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 119.555 -1.966 . . . . 4.86 112.079 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -85.91 82.78 8.01 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.125 -0.984 . . . . 3.58 111.324 170.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 tp -71.31 156.81 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.974 0.909 . . . . 2.73 111.208 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 166' ' ' PHE . 4.3 m -151.16 166.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.481 1.912 . . . . 3.37 109.894 172.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.97 158.99 26.52 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.859 2.864 . . . . 3.76 111.01 169.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 161.2 9.34 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.066 1.746 . . . . 2.21 113.943 -166.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 29.0 p -60.89 -42.31 97.75 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.194 1.553 . . . . 4.34 115.194 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.29 0.3 OUTLIER 54.55 41.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.261 1.424 . . . . 3.92 112.815 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.53 140.77 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 120.459 -1.401 . . . . 2.48 110.67 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 58.7 tpp -99.88 115.89 30.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.348 1.859 . . . . 2.86 109.172 165.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -95.03 148.59 22.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.102 -1.624 . . . . 3.17 112.373 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -99.42 126.06 45.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.553 1.141 . . . . 2.29 109.619 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.2 mm -107.94 126.96 64.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 108.221 -1.029 . . . . 2.36 108.221 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.72 160.53 53.02 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 117.969 -1.462 . . . . 2.06 110.163 162.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.78 -11.8 19.22 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.134 3.223 . . . . 3.64 113.911 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.5 -41.82 88.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.727 2.811 . . . . 4.13 110.573 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.95 31.43 2.69 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.065 1.317 . . . . 3.04 115.723 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -142.84 164.04 31.18 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.684 1.242 . . . . 4.75 112.177 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -67.44 125.75 27.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 5.26 112.505 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.4 tt -118.52 -24.23 6.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.383 1.473 . . . . 3.34 112.405 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -165.53 171.92 12.65 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.49 2.316 . . . . 2.8 109.234 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -159.24 158.76 33.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.497 1.119 . . . . 4.04 113.673 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.85 -179.85 7.31 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.594 1.958 . . . . 2.54 112.055 -165.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.3 -145.34 16.91 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.05 1.786 . . . . 3.72 109.91 -171.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -54.5 3.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 118.942 2.942 . . . . 3.84 118.942 -161.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -135.96 -45.35 0.65 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.288 -1.508 . . . . 4.49 112.132 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -79.19 86.31 4.99 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.935 -1.103 . . . . 4.53 110.458 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.07 155.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.003 2.521 . . . . 5.78 114.901 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -41.7 -70.22 0.11 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.016 2.127 . . . . 2.86 116.143 -172.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -72.31 -24.95 75.54 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 122.564 1.091 . . . . 1.86 111.284 -170.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -70.14 -23.91 63.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.377 1.871 . . . . 5.29 111.317 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.24 -51.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.258 -0.901 . . . . 1.74 110.752 162.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.1 71.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.38 0.991 . . . . 1.45 111.939 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.77 73.79 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.25 1.204 . . . . 1.86 114.25 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.6 p -75.04 -37.63 61.66 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.842 -1.161 . . . . 1.86 112.644 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mm -56.61 -47.65 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 119.943 1.247 . . . . 1.98 110.842 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.17 -18.16 60.14 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.063 1.134 . . . . 1.68 114.063 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.5 m -84.05 -40.94 17.74 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.447 1.099 . . . . 2.2 110.984 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -69.94 -29.29 66.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.181 0.993 . . . . 2.65 113.516 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.66 19.25 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.536 -1.353 . . . . 6.25 114.197 164.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -74.43 -58.98 1.71 Allowed Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.471 -1.728 . . . . 5.93 111.303 152.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.85 -48.8 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.842 2.362 . . . . 2.62 112.518 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -68.75 121.89 17.44 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.033 0.833 . . . . 3.45 110.677 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -63.15 149.17 45.96 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.451 0.7 . . . . 8.33 112.13 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -90.27 -172.06 3.32 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.379 1.072 . . . . 9.67 110.9 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -79.54 74.35 6.19 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.555 -1.341 . . . . 7.38 107.529 149.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.482 1.168 1 C-N-CA 132.021 4.128 . . . . 7.2 111.214 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 118.209 -0.9 . . . . 20.16 110.371 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -156.0 156.99 35.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.356 1.062 . . . . 16.49 110.857 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.1 t 175.5 65.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 129.114 2.966 . . . . 15.42 108.146 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.13 142.52 19.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.06 0.838 . . . . 11.99 112.005 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.85 143.88 8.65 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.431 1.492 . . . . 14.87 110.937 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -83.79 -174.11 1.81 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.665 2.91 . . . . 7.9 110.25 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.3 tp -85.29 153.0 22.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.237 -0.653 . . . . 9.44 109.237 155.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.0 tp -145.23 157.04 44.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.945 1.298 . . . . 7.45 109.087 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -146.13 -173.17 17.13 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 125.729 1.633 . . . . 3.03 111.97 174.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.33 -84.07 0.35 Allowed Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.327 -1.263 . . . . 3.81 113.169 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -76.54 142.43 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.315 2.01 . . . . 3.11 112.772 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -108.34 175.19 5.56 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.361 -1.29 . . . . 2.9 111.567 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -141.35 22.07 2.21 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.709 1.744 . . . . 3.44 115.709 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.32 165.4 23.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.748 1.219 . . . . 2.82 110.825 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.1 m -117.3 151.65 36.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.861 2.064 . . . . 2.43 109.171 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.3 p -86.28 158.99 19.56 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.642 1.211 . . . . 1.93 113.206 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -59.77 -21.59 60.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.91 1.684 . . . . 1.39 113.225 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.8 m -72.08 -39.49 68.95 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.65 1.18 . . . . 3.04 110.166 172.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 120.07 -8.36 11.51 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.53 1.538 . . . . 1.94 114.47 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -83.11 147.64 27.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.149 0.974 . . . . 4.14 109.879 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -87.72 125.41 34.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.229 -0.656 . . . . 4.25 109.229 163.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.27 134.94 36.7 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.974 1.31 . . . . 3.77 109.62 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.9 p -109.83 166.29 11.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.682 1.593 . . . . 3.42 112.352 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.96 2.65 0.49 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.829 2.452 . . . . 3.34 114.817 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -7.51 12.58 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.244 1.202 . . . . 7.26 114.244 165.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.59 -44.55 64.26 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.713 1.142 . . . . 3.02 110.063 161.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -78.02 10.59 2.77 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.834 1.42 . . . . 3.99 114.834 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.82 108.39 1.17 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 5.24 110.101 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.09 -8.69 6.33 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.507 1.051 . . . . 3.8 114.629 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -129.07 158.97 37.44 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.944 1.372 . . . . 4.71 110.48 165.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.464 ' CE3' ' HD3' ' A' ' 269' ' ' PRO . 94.7 m95 -67.8 118.97 11.76 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.451 0.7 . . . . 3.19 112.555 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.78 109.14 21.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.782 1.633 . . . . 3.07 109.582 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.61 98.25 7.94 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.118 -0.697 . . . . 3.21 109.118 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -95.35 126.97 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.903 1.281 . . . . 1.98 108.998 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -140.55 150.1 43.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.787 1.235 . . . . 2.44 113.658 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -123.09 112.74 18.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.941 1.296 . . . . 2.37 111.053 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.18 142.62 13.68 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.151 1.358 . . . . 1.41 112.023 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -92.11 129.1 38.14 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.131 0.965 . . . . 4.14 112.27 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.1 m -75.72 66.77 2.08 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.643 1.577 . . . . 3.86 111.285 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -174.91 -28.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.801 2.841 . . . . 7.22 112.441 -171.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 16.9 m -67.03 160.54 69.71 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 117.452 2.39 . . . . 2.38 117.452 -163.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.96 -168.09 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.882 3.722 . . . . 3.01 110.724 159.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.72 -7.04 3.02 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.521 2.415 . . . . 4.15 117.521 -151.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 74.0 t -65.0 -60.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.895 1.278 . . . . 2.69 108.761 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 23.8 m -49.53 -60.41 4.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.733 -1.127 . . . . 1.74 113.028 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.39 -30.57 19.15 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-O 116.105 -1.706 . . . . 1.24 113.715 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.15 -45.97 65.69 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.996 2.18 . . . . 3.21 110.492 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -61.44 -33.22 73.35 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.25 0.932 . . . . 3.05 112.068 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -48.6 64.67 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.659 -0.651 . . . . 2.32 111.939 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -41.29 94.13 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.828 -1.17 . . . . 3.75 111.07 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -46.96 -52.14 15.36 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 119.943 -1.723 . . . . 2.84 112.209 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.4 ptp -70.77 -8.34 51.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.492 1.664 . . . . 2.5 115.492 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mm -75.78 -60.04 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.414 1.461 . . . . 1.92 108.686 161.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.72 -38.74 56.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.256 0.836 . . . . 3.02 113.256 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.1 t -60.02 -19.02 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 117.823 -1.084 . . . . 2.15 112.756 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.68 -53.93 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.699 1.59 . . . . 2.54 110.558 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.62 -27.58 67.02 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.643 1.177 . . . . 4.03 111.883 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -71.48 -19.63 62.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.928 1.291 . . . . 3.76 113.427 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.64 -56.99 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.279 1.431 . . . . 2.28 113.845 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.86 -30.7 71.35 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.783 0.801 . . . . 5.5 109.261 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 68.9 m -60.31 -12.26 8.65 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.88 2.472 . . . . 4.05 115.163 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.5 mm -79.01 -39.45 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.871 -1.143 . . . . 4.99 112.139 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.3 m -176.82 2.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.632 1.573 . . . . 7.88 114.349 -158.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.2 m 77.2 41.59 0.15 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.059 2.544 . . . . 5.37 111.065 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.2 150.46 0.27 Allowed Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 128.987 2.915 . . . . 3.34 113.949 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.32 -43.25 58.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.485 2.79 . . . . 3.26 113.569 -170.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.3 t70 161.34 154.45 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 131.532 3.933 . . . . 3.58 107.648 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.58 111.71 17.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.495 0.718 . . . . 3.12 109.913 168.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 90.8 m -105.45 112.25 64.81 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 124.535 1.134 . . . . 1.97 108.596 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.33 137.67 23.7 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.112 1.875 . . . . 1.25 109.002 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . 0.277 1.5 pt? -136.18 118.44 15.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.644 1.212 . . . . 3.22 110.865 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.05 125.91 54.9 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.657 1.583 . . . . 2.0 110.201 -157.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.55 120.44 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.405 -0.961 . . . . 1.59 108.405 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.2 t -72.38 -15.24 61.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.795 1.405 . . . . 3.25 114.795 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . 0.287 43.8 pt 51.7 9.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 128.539 2.735 . . . . 2.12 117.912 170.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -111.16 56.54 0.38 Allowed Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.221 1.408 . . . . 3.5 114.502 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.04 69.99 7.26 Favored 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.406 4.071 . . . . 3.74 112.685 -167.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -171.2 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.5 2.32 . . . . 4.04 109.673 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -17.69 10.1 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.23 1.412 . . . . 8.18 112.82 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.4 153.31 2.2 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.696 1.598 . . . . 4.62 112.912 167.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.4 m -144.59 125.33 14.2 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.299 -0.876 . . . . 2.47 109.854 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -48.33 -47.72 36.75 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.467 1.907 . . . . 3.06 112.793 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -68.77 -33.21 73.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.231 1.197 . . . . 3.81 114.231 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.91 84.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.483 1.492 . . . . 1.65 110.941 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.66 -34.46 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.276 0.63 . . . . 1.56 111.857 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.35 -19.31 64.52 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.066 -1.021 . . . . 1.75 113.697 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -84.98 -42.64 14.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.957 1.253 . . . . 3.17 112.992 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -57.04 -35.26 69.09 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.153 1.381 . . . . 2.57 112.133 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.53 -37.03 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.238 1.415 . . . . 1.33 113.078 169.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -70.96 -51.27 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.799 -1.188 . . . . 5.25 112.204 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.49 -18.42 62.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.619 1.567 . . . . 4.08 113.769 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -80.55 -79.4 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.734 0.697 . . . . 3.0 109.676 154.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.7 t 178.23 139.69 0.25 Allowed Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.307 1.843 . . . . 1.97 110.304 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.45 5.9 1.77 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.15 3.233 . . . . 2.16 114.942 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -18.27 63.5 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.841 -1.162 . . . . 3.48 112.763 161.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.6 tp -78.78 138.13 38.06 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.18 1.792 . . . . 2.11 111.224 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 26.2 t -101.88 130.35 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.042 0.937 . . . . 1.8 108.881 158.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.58 132.91 11.11 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.798 -0.921 . . . . 0.83 110.798 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.5 144.97 50.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.131 0.972 . . . . 2.29 112.926 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.6 t -149.1 176.44 10.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.204 2.202 . . . . 2.68 111.194 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 165.37 -168.15 39.25 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 127.141 2.305 . . . . 2.04 109.374 -170.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.3 174.59 10.58 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.053 1.426 . . . . 3.48 111.373 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -47.86 -38.37 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.59 0.756 . . . . 8.46 112.168 170.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -36.11 47.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.809 0.732 . . . . 5.7 112.572 -169.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -70.37 -33.57 71.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.242 -1.537 . . . . 3.79 111.847 170.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 47.0 t -66.96 -31.68 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.726 0.81 . . . . 2.03 110.816 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.72 -32.3 41.19 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.941 0.791 . . . . 3.18 112.664 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -60.42 -53.17 60.83 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.113 -0.992 . . . . 3.16 109.736 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.2 p -62.2 -27.71 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 119.426 -0.321 . . . . 2.64 111.812 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.61 -46.18 66.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.248 0.931 . . . . 2.13 111.518 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -58.83 -53.83 53.99 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.576 1.55 . . . . 3.73 111.066 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.39 65.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.973 1.309 . . . . 2.73 114.362 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -117.4 3.82 12.51 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.575 1.324 . . . . 2.69 114.575 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 57.6 31.19 19.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.085 1.354 . . . . 5.23 113.421 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.38 161.99 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.58 1.152 . . . . 3.23 110.325 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -146.22 154.9 42.26 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.592 0.96 . . . . 5.84 113.592 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.62 110.81 6.96 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.991 1.716 . . . . 6.88 110.669 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t -104.73 124.16 37.79 Favored Pre-proline 0 N--CA 1.475 0.801 0 O-C-N 120.66 -1.275 . . . . 3.12 113.158 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.39 130.27 14.86 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.302 2.001 . . . . 3.25 113.274 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.6 133.29 12.91 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.191 0.9 . . . . 2.47 110.912 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.66 61.93 8.38 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.669 2.913 . . . . 4.04 109.244 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp 100.03 177.18 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 131.355 3.862 . . . . 6.7 112.58 -166.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -143.32 20.85 1.9 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 128.018 2.527 . . . . 11.01 110.289 165.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 173.73 -140.42 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.185 1 C-N-CA 132.071 4.149 . . . . 7.45 104.486 -163.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -129.95 -2.84 4.62 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 122.082 2.219 . . . . 7.73 113.79 151.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -92.76 -41.47 10.11 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.272 -1.518 . . . . 6.86 112.515 155.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -88.87 170.26 10.87 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.084 1.354 . . . . 5.27 114.091 -171.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -159.63 128.32 5.09 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.646 1.978 . . . . 4.71 111.938 -161.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 tt -124.07 168.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.842 1.657 . . . . 4.21 111.223 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.24 135.75 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 4.07 105.214 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 169.33 1.67 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.205 1.002 . . . . 4.29 112.113 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -153.87 126.8 8.3 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.524 -0.735 . . . . 2.12 111.518 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.3 p -59.37 118.74 6.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.676 0.79 . . . . 3.57 110.265 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 11.1 tp -78.41 59.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.177 1.391 . . . . 4.15 113.657 -168.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.0 mm -109.2 138.01 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.78 1.232 . . . . 2.45 111.806 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 3.3 ttt -121.33 134.75 55.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.02 1.728 . . . . 2.38 108.992 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.48 141.77 44.61 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.762 0.825 . . . . 2.77 111.927 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.92 116.87 31.01 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.164 0.986 . . . . 1.91 109.983 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.0 136.93 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.683 1.193 . . . . 1.88 107.835 166.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -82.52 168.9 48.53 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 123.792 0.711 . . . . 2.25 114.59 -168.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.464 ' HD3' ' CE3' ' A' ' 159' ' ' TRP . 42.0 Cg_endo -77.3 56.09 5.35 Favored 'Trans proline' 0 CA--C 1.539 0.749 1 C-N-CA 125.964 4.443 . . . . 4.02 109.38 173.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -162.1 -55.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.753 -0.658 . . . . 4.81 111.252 -143.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 154.19 -54.33 0.44 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.093 -1.393 . . . . 3.56 112.611 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -130.06 -174.23 3.26 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.806 1.303 . . . . 5.87 114.326 -162.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -80.37 142.97 33.9 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.995 -1.066 . . . . 4.9 113.525 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.67 -25.91 0.89 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.453 1.279 . . . . 2.91 114.453 -157.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -162.78 165.91 24.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.672 2.389 . . . . 2.54 109.247 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -155.81 150.54 26.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.53 1.308 . . . . 3.59 114.53 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -126.89 119.49 26.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.307 1.443 . . . . 2.46 109.339 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -111.12 72.77 0.21 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 108.993 -1.643 . . . . 4.03 108.993 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 41.37 -134.68 0.28 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.215 1.406 . . . . 3.66 111.308 -155.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.2 t30 70.6 -65.8 0.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.593 2.357 . . . . 4.65 114.615 167.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -66.01 120.36 13.01 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.546 1.138 . . . . 5.28 110.376 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -77.97 138.46 38.86 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.611 -1.305 . . . . 9.33 110.238 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.7 -47.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.486 3.143 . . . . 2.92 119.486 -158.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -15.81 57.82 Favored Glycine 0 N--CA 1.476 1.363 0 CA-C-N 119.748 1.158 . . . . 1.93 112.698 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.15 -24.09 65.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.482 0.919 . . . . 3.25 113.482 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.15 -41.61 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.59 1.086 . . . . 1.62 109.005 172.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.8 99.1 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.94 -0.553 . . . . 1.34 111.478 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.11 98.27 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.842 1.053 . . . . 1.55 113.842 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.1 p -70.03 -47.29 62.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.2 1.364 . . . . 1.43 111.763 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.02 -34.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 120.065 1.302 . . . . 1.49 112.448 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.9 76.02 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.93 -1.106 . . . . 1.73 112.999 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 38.9 m -70.22 -45.45 66.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.267 1.027 . . . . 1.98 109.394 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -65.59 -28.46 69.15 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 2.83 113.06 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -19.83 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.94 -1.1 . . . . 4.54 112.546 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -46.23 95.76 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 116.759 -1.591 . . . . 5.92 112.401 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.8 -45.56 0.1 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.168 2.578 . . . . 2.72 113.989 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.18 170.51 14.81 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.937 1.244 . . . . 3.52 114.093 -174.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -128.22 -179.91 5.26 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.497 -1.377 . . . . 7.67 112.265 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -121.05 -178.35 3.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.755 1.222 . . . . 7.57 113.99 -158.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -28.77 70.21 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.948 0.721 . . . . 8.98 112.948 158.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--O 1.251 1.178 0 C-N-CA 130.448 3.499 . . . . 9.99 107.669 176.267 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 117.775 -1.107 . . . . 17.81 109.85 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -165.01 163.71 20.66 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.234 1.414 . . . . 14.42 110.268 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 t -174.9 172.93 2.81 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.121 2.569 . . . . 11.84 108.9 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 123.78 153.56 8.71 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.899 1.714 . . . . 9.68 112.231 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -159.94 116.46 1.51 Allowed Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 121.523 -0.986 . . . . 11.19 112.195 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.47 167.26 15.39 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.383 2.722 . . . . 7.21 111.062 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 pp -166.77 164.93 16.56 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.285 2.634 . . . . 8.3 109.229 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.8 mt -146.09 179.03 7.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.099 1.36 . . . . 5.27 110.657 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.01 156.95 6.7 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.343 1.449 . . . . 2.59 113.088 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -146.3 78.89 0.24 Allowed Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.329 -1.101 . . . . 2.55 113.855 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.52 144.85 62.43 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.168 2.579 . . . . 3.39 110.618 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -95.71 177.69 5.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.397 1.479 . . . . 2.91 112.524 -169.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.9 m -129.64 22.62 5.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.865 1.431 . . . . 2.28 114.865 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.41 157.9 15.8 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.32 1.048 . . . . 2.63 112.839 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' ARG . 58.3 m -101.03 148.21 25.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.892 1.677 . . . . 1.54 110.606 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.3 p -81.36 166.69 20.22 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.735 1.614 . . . . 2.33 113.49 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -61.3 -23.05 65.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.948 2.099 . . . . 2.04 113.152 169.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.7 m -73.93 -61.5 1.83 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.312 1.045 . . . . 3.2 108.183 167.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 141.53 -1.22 1.81 Allowed Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.914 1.245 . . . . 2.34 115.936 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.12 145.59 29.14 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.584 1.192 . . . . 4.16 109.781 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 0.9 OUTLIER -96.7 74.28 2.72 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.106 2.563 . . . . 5.52 112.533 -178.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -81.03 89.79 5.96 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.287 -0.883 . . . . 6.18 112.734 -166.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.6 p -68.57 127.59 33.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.345 1.058 . . . . 3.11 110.278 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -1.28 12.05 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 117.806 2.521 . . . . 6.19 117.806 -155.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -77.58 4.48 11.2 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 120.944 -1.098 . . . . 6.7 112.954 164.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -73.28 -71.89 0.28 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.633 2.773 . . . . 3.74 114.375 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -69.57 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.397 1.879 . . . . 4.46 114.441 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.0 -32.68 71.09 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.795 2.038 . . . . 3.39 114.442 -157.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.08 2.02 87.67 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.482 0.953 . . . . 2.35 115.482 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -96.55 -138.24 0.26 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.92 1.688 . . . . 3.3 109.189 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -140.89 140.82 34.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.851 1.26 . . . . 1.72 109.967 164.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.89 151.61 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.922 1.082 . . . . 2.86 113.922 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.22 119.22 34.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.863 1.665 . . . . 2.43 108.148 163.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.1 mt -109.88 110.22 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.61 -0.885 . . . . 1.69 108.61 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -113.35 153.98 27.63 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.272 1.829 . . . . 2.95 113.431 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -127.34 97.88 5.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.081 1.352 . . . . 2.51 112.859 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -126.54 -176.91 14.65 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 128.205 2.812 . . . . 1.83 112.35 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -113.32 141.11 47.41 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.818 1.647 . . . . 3.52 112.165 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -65.49 113.42 4.14 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.823 -1.173 . . . . 3.04 110.939 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 73.7 m80 63.75 35.0 11.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.075 1.75 . . . . 10.13 112.348 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 49.9 t -59.1 157.2 22.87 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.225 1.41 . . . . 2.99 111.594 163.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.66 177.34 1.33 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.621 2.881 . . . . 3.13 112.031 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.38 -3.27 0.9 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.12 2.637 . . . . 5.26 118.12 -148.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.45 -59.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.049 1.739 . . . . 3.01 110.353 171.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.8 m -53.76 -58.73 11.93 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 118.055 -0.974 . . . . 1.86 112.606 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.85 -29.9 41.14 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.575 1.517 . . . . 1.94 113.805 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -60.62 -53.1 61.49 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 121.09 1.768 . . . . 3.99 111.211 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.46 0.704 . . . . 3.39 112.023 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.22 -28.87 61.45 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.354 -1.467 . . . . 3.01 112.357 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -56.93 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.264 1.025 . . . . 4.09 108.612 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -45.34 72.47 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.438 -0.789 . . . . 5.77 111.676 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 47.1 ttp -57.93 -45.0 87.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.854 2.061 . . . . 3.58 112.408 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.0 mm -66.78 -45.16 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.608 1.094 . . . . 1.74 110.652 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -69.11 -27.37 65.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.229 1.377 . . . . 5.02 110.654 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.41 -47.83 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 120.622 1.556 . . . . 1.74 110.591 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.8 -42.54 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.515 1.052 . . . . 3.73 113.269 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -76.29 -25.94 55.37 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.443 1.02 . . . . 5.8 113.337 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -63.98 -31.12 72.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.382 1.473 . . . . 2.98 113.474 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.46 -41.76 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.649 1.18 . . . . 2.09 112.167 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.0 -27.92 61.99 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.132 0.967 . . . . 4.47 112.218 167.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 67.8 m -70.57 -9.76 57.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.381 1.072 . . . . 3.96 113.06 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 14.8 mm -85.75 58.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.437 -1.414 . . . . 4.17 109.097 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.1 m -58.77 85.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.781 1.632 . . . . 5.49 112.293 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m 171.0 -32.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.962 3.705 . . . . 4.1 108.386 -167.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 294' ' ' MET . 46.2 mt -73.25 162.01 76.47 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.193 -0.432 . . . . 4.31 111.231 143.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -81.74 -154.15 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.77 3.646 . . . . 3.17 108.569 154.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.83 158.35 25.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.217 1.562 . . . . 3.9 115.217 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.2 tp -107.09 94.1 4.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.077 1.351 . . . . 1.93 109.35 161.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.9 m -76.68 121.72 85.32 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 120.643 -1.286 . . . . 1.47 110.206 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.29 126.66 2.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.442 2.761 . . . . 0.9 111.544 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 tt -125.04 112.51 16.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.784 1.234 . . . . 2.54 110.505 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -100.66 124.24 45.99 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.526 1.131 . . . . 2.07 110.698 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.92 120.4 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.482 -0.933 . . . . 1.59 108.482 170.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.3 t -82.15 106.46 14.06 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.504 -0.924 . . . . 2.04 108.504 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.71 12.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.955 1.302 . . . . 2.43 113.032 -176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -113.69 27.77 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.295 2.638 . . . . 3.62 114.532 -171.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.41 -13.68 41.03 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.733 2.955 . . . . 2.41 116.218 -154.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.67 1.8 43.8 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.963 1.098 . . . . 4.56 113.963 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . 0.289 2.2 ppt_? -137.28 0.82 2.36 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.137 1.532 . . . . 5.86 115.137 158.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.27 -173.05 0.05 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.117 1.767 . . . . 3.53 110.413 152.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -178.83 132.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.387 3.075 . . . . 2.71 105.533 -172.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.6 tmpt? -56.98 -30.78 64.42 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.278 0.844 . . . . 3.34 113.278 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -35.13 52.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.456 1.503 . . . . 3.33 114.025 169.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.05 78.1 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.352 -1.467 . . . . 1.96 111.897 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -70.37 -32.66 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.43 0.559 . . . . 2.46 112.085 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.78 -35.21 80.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.934 1.243 . . . . 1.73 112.368 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.09 -40.13 75.16 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.513 -0.742 . . . . 4.24 111.832 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.84 -42.08 97.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.992 0.917 . . . . 3.42 111.983 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 4.0 t -54.67 -50.76 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.771 0.714 . . . . 1.53 111.368 168.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.13 -23.4 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.962 1.305 . . . . 4.94 114.035 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -70.91 -22.62 62.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.461 1.504 . . . . 4.88 113.211 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -108.54 -52.72 2.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.225 1.01 . . . . 2.52 112.766 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 t 178.99 143.13 0.31 Allowed Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.82 1.648 . . . . 2.06 109.97 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.63 -9.62 23.36 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.683 2.255 . . . . 2.1 113.158 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.55 -18.1 62.92 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.226 0.921 . . . . 2.62 113.203 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.35 127.29 32.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.231 -0.918 . . . . 2.35 110.59 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.54 121.89 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.294 -1.002 . . . . 2.18 108.294 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.56 139.45 14.72 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.917 -0.873 . . . . 1.1 110.917 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mp -132.97 147.28 52.28 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.599 1.2 . . . . 2.09 112.298 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 13.5 t -150.37 -174.06 4.64 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.085 1.754 . . . . 3.48 109.926 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 149.01 -64.5 0.4 Allowed Glycine 0 N--CA 1.474 1.202 0 N-CA-C 115.626 1.01 . . . . 2.45 115.626 170.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.1 t -160.07 145.78 15.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.322 1.061 . . . . 3.52 112.702 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -48.72 -42.5 35.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.275 2.23 . . . . 5.93 112.511 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.89 -27.19 67.3 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.011 1.732 . . . . 4.26 114.456 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -35.79 25.82 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.495 . . . . 4.46 112.052 172.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.29 -41.49 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.024 0.53 . . . . 2.71 110.639 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.2 -40.36 95.83 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.184 -0.912 . . . . 3.29 111.307 170.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -58.17 -51.12 71.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.346 1.43 . . . . 2.88 111.684 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -25.4 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.251 0.932 . . . . 2.97 112.604 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.44 -53.03 18.06 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.161 -0.962 . . . . 2.12 111.724 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -64.0 -31.9 73.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.163 2.185 . . . . 3.87 111.762 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.29 62.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.73 1.612 . . . . 2.14 115.042 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.45 3.04 7.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.178 0.807 . . . . 2.59 113.178 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 74.06 34.63 0.84 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.359 2.264 . . . . 5.38 112.355 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 147.84 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.235 1.814 . . . . 3.14 110.886 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -114.54 140.21 48.94 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.047 1.339 . . . . 4.11 112.844 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.55 162.59 41.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.195 1.798 . . . . 7.34 110.71 161.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.5 m -127.69 88.44 53.45 Favored Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 123.733 0.813 . . . . 2.82 110.655 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 144.76 22.85 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.844 2.363 . . . . 4.51 110.068 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -95.53 138.36 13.91 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 118.615 -1.103 . . . . 4.32 112.84 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.33 73.76 5.38 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.117 3.211 . . . . 7.02 109.289 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' A' ' 250' ' ' LYS . 2.9 mmpt? -148.87 172.6 14.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.908 2.483 . . . . 8.43 114.788 -164.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -171.39 155.82 4.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.993 2.117 . . . . 11.96 109.107 -147.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.99 138.82 48.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.623 0.769 . . . . 15.78 112.306 -168.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.2 t0 99.59 -5.43 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 130.589 3.556 . . . . 6.84 111.652 -172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -126.4 -40.16 1.98 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.566 1.146 . . . . 9.52 110.854 159.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 30.6 t0 67.73 -173.24 0.19 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.218 2.207 . . . . 4.4 111.317 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -152.61 140.84 20.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.709 -1.244 . . . . 4.69 111.919 164.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.5 tp -72.36 136.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.056 -1.028 . . . . 3.13 109.825 167.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.52 144.73 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.573 1.549 . . . . 5.88 110.863 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.19 150.75 39.79 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.625 1.202 . . . . 3.62 113.03 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 162.6 8.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.615 1.566 . . . . 2.83 112.911 -153.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -38.39 57.93 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.071 -1.442 . . . . 3.82 114.447 -171.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.0 mt 66.03 29.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 123.258 1.504 . . . . 4.69 110.302 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 17.6 mm -126.06 149.47 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 127.191 2.196 . . . . 3.99 108.954 -174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.43 146.17 51.94 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.328 1.451 . . . . 2.6 114.122 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -97.94 137.39 36.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.16 1.784 . . . . 2.7 110.746 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.37 107.73 19.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.385 1.474 . . . . 2.5 108.465 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.73 125.21 47.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.165 0.986 . . . . 1.89 108.677 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.5 173.25 42.01 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.986 -0.896 . . . . 1.57 111.905 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.12 78.32 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.287 3.325 . . . . 2.65 110.803 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.13 -47.43 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 131.335 3.854 . . . . 5.38 109.871 -173.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 114.61 -9.92 21.71 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.467 -1.741 . . . . 3.51 116.236 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -82.87 153.27 25.21 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 119.888 1.844 . . . . 4.97 110.901 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -80.18 120.8 24.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.414 -0.804 . . . . 3.45 111.099 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.5 pp -104.29 -3.31 24.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.468 1.107 . . . . 2.99 113.758 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -157.18 164.29 37.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.899 2.08 . . . . 2.18 108.707 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.68 135.25 6.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.241 1.416 . . . . 3.64 111.755 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.03 -160.5 0.91 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.214 1.806 . . . . 2.75 109.355 -168.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.96 -132.47 3.57 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 109.826 -1.31 . . . . 3.29 109.826 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -53.05 152.1 4.37 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.827 0.822 . . . . 3.57 112.711 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 75.7 -18.48 0.45 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.317 1.847 . . . . 5.73 112.501 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 146.99 26.24 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.588 -1.32 . . . . 6.73 109.911 158.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -107.42 154.73 20.91 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.309 -0.869 . . . . 5.82 110.983 -167.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -47.55 -55.52 9.04 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 2.29 112.795 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.67 -19.08 76.28 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 115.238 0.855 . . . . 1.53 115.238 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -78.37 -41.82 32.21 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.171 1.389 . . . . 4.25 111.193 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.69 -42.77 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.475 -0.565 . . . . 1.39 109.475 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.91 81.65 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.686 -0.634 . . . . 1.34 112.145 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.06 -37.52 86.04 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.767 1.025 . . . . 1.47 113.767 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 4.8 p -67.33 -49.01 65.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.523 1.056 . . . . 1.3 111.074 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.98 -37.82 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.235 -0.915 . . . . 1.58 111.693 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.82 67.05 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.735 -1.228 . . . . 1.5 113.747 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.7 m -78.27 -50.02 12.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.471 1.108 . . . . 1.73 110.203 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -62.86 -31.31 72.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.811 1.244 . . . . 2.43 112.985 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.408 ' HG3' HD21 ' A' ' 193' ' ' LEU . 62.1 ttp -56.36 -18.73 11.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.929 1.692 . . . . 4.25 113.25 168.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.22 -56.55 3.21 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 116.631 -1.652 . . . . 5.1 112.981 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.12 -39.82 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.866 2.377 . . . . 2.68 112.996 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -93.15 121.5 34.57 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 122.137 0.97 . . . . 3.25 111.116 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? 83.13 -100.82 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.567 2.347 . . . . 9.76 112.556 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.421 ' HZ2' ' C ' ' A' ' 301' ' ' SER . 1.5 ttmt 1.36 -117.63 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 129.231 3.012 . . . . 10.45 117.523 -166.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -149.56 13.65 0.84 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 126.858 2.063 . . . . 8.66 112.718 -174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.421 ' C ' ' HZ2' ' A' ' 299' ' ' LYS . 51.0 m . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 128.033 2.533 . . . . 10.69 108.171 -135.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 118.135 -0.936 . . . . 15.71 108.764 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 177.08 152.89 0.21 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.796 1.639 . . . . 15.04 109.275 -158.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.73 176.38 4.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.865 2.066 . . . . 11.08 109.088 -165.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.68 -5.6 68.9 Favored Glycine 0 N--CA 1.473 1.123 0 N-CA-C 116.537 1.375 . . . . 8.74 116.537 162.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -54.49 115.75 9.28 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 119.826 1.813 . . . . 9.47 111.618 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -81.43 170.96 14.1 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.38 2.72 . . . . 6.97 111.732 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -156.72 -66.74 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.226 1.41 . . . . 7.92 110.529 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.3 mp 71.15 -80.81 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.745 2.418 . . . . 5.33 110.329 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -111.42 -149.28 11.4 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.839 1.685 . . . . 3.46 112.665 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -142.69 154.46 25.25 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.19 1.376 . . . . 2.89 111.527 165.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.78 177.73 8.46 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.812 3.008 . . . . 2.9 109.924 165.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -156.26 166.39 33.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.164 0.983 . . . . 2.63 113.298 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.2 m -156.97 72.69 0.73 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.537 -1.352 . . . . 3.88 112.364 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.38 166.98 10.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.631 1.172 . . . . 3.81 111.88 -167.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.3 m -99.57 143.34 29.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.471 1.108 . . . . 1.73 109.154 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 146' ' ' THR . 0.8 OUTLIER -110.27 162.28 14.77 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.889 0.852 . . . . 3.03 111.652 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -41.0 -28.76 0.09 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.742 2.417 . . . . 1.53 116.264 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.494 ' H ' HG23 ' A' ' 144' ' ' THR . 11.4 m -77.08 -22.3 53.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.842 2.457 . . . . 3.1 114.088 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.25 70.64 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.954 1.264 . . . . 1.96 113.612 -167.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 161.05 30.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.111 1.764 . . . . 3.9 110.71 168.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -124.16 141.26 52.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.641 1.177 . . . . 4.81 112.222 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -133.88 145.94 50.1 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.325 -0.86 . . . . 3.01 111.993 -173.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.1 p -128.28 167.02 17.49 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.117 1.767 . . . . 3.03 110.089 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -61.36 -10.07 6.55 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.197 0.814 . . . . 4.76 113.197 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -37.09 28.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.5 0.926 . . . . 5.75 113.5 170.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.51 -32.68 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.768 1.227 . . . . 3.08 111.47 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -93.98 -0.11 55.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.362 1.615 . . . . 3.12 115.362 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.34 174.76 9.12 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 119.59 1.086 . . . . 3.62 112.039 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.21 3.34 60.94 Favored Glycine 0 N--CA 1.478 1.47 0 N-CA-C 116.259 1.264 . . . . 2.48 116.259 165.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -130.77 164.34 25.34 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.96 2.104 . . . . 3.01 109.144 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -70.19 132.97 46.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.726 1.148 . . . . 2.76 109.105 157.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.46 144.62 38.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.801 0.81 . . . . 3.21 112.496 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.7 mt -114.95 120.52 40.19 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 126.383 1.873 . . . . 2.42 106.169 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.9 pt -115.98 112.59 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.184 -1.043 . . . . 3.25 108.184 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -100.47 127.95 46.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.712 1.605 . . . . 3.15 112.263 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -100.87 82.6 2.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.313 1.445 . . . . 2.17 109.721 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -95.16 164.4 24.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 113.665 -1.607 . . . . 1.61 111.279 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.01 -170.45 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.022 -1.103 . . . . 3.95 108.022 157.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.3 m -146.3 95.04 2.55 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.324 1.849 . . . . 3.46 107.141 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -169.05 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.451 1.649 . . . . 7.29 115.451 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 170' ' ' PRO . 37.6 m -79.78 -179.88 1.58 Allowed Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.298 1.439 . . . . 2.93 111.446 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 169' ' ' CYS . 57.2 Cg_endo -76.9 -129.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.242 2.628 . . . . 4.5 108.585 157.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 50.57 0.13 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.377 2.671 . . . . 5.6 114.367 -173.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.9 -60.17 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.214 1.805 . . . . 4.03 109.873 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 63.8 m -46.96 -44.92 49.8 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-O 117.375 -1.297 . . . . 3.63 114.476 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.57 -9.11 6.94 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.432 2.755 . . . . 1.66 114.865 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.69 -67.2 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.375 1.443 . . . . 4.04 111.213 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.45 -21.18 65.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.359 0.981 . . . . 3.1 113.04 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -47.08 81.62 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.199 0.6 . . . . 2.61 110.468 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -40.31 95.32 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.688 -1.258 . . . . 3.5 111.481 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -55.24 24.1 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.074 -1.016 . . . . 2.92 110.947 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.37 -16.13 62.94 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.446 0.906 . . . . 2.99 113.446 -176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.9 mm -69.36 -56.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.835 1.198 . . . . 1.56 109.985 162.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.516 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 80.8 mt-30 -60.51 -22.58 63.73 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.284 1.402 . . . . 3.17 113.185 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.82 -28.02 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.113 -0.992 . . . . 1.76 111.264 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.92 -34.61 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.309 0.959 . . . . 2.34 110.419 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.43 -45.29 84.83 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.042 1.337 . . . . 4.76 112.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.14 -20.39 61.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.535 1.134 . . . . 2.88 113.478 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.55 -57.58 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.324 1.05 . . . . 1.73 111.543 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.07 -23.69 65.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.584 1.154 . . . . 3.05 112.161 -174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 73.4 m -68.11 -19.12 64.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.32 1.048 . . . . 2.61 113.713 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.16 -25.22 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.999 0.92 . . . . 3.71 111.176 171.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.0 m 72.63 -33.53 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 129.801 3.24 . . . . 5.38 114.272 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 35.8 p -99.56 19.25 16.09 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 3.56 111.863 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.09 165.41 43.17 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.477 1.111 . . . . 2.89 108.314 159.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 51.62 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.154 2.569 . . . . 4.09 110.947 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.61 -173.84 0.16 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.775 2.83 . . . . 4.56 113.784 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 45.5 tp -140.55 117.39 11.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.153 -1.054 . . . . 1.78 108.153 150.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.0 m -106.56 96.03 13.19 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.288 1.035 . . . . 1.64 108.651 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.12 144.12 33.23 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.205 1.937 . . . . 1.2 110.535 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.25 147.11 43.35 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.542 0.687 . . . . 2.72 110.806 171.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -112.92 121.09 43.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.895 1.278 . . . . 2.25 108.234 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.35 118.03 40.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.738 -1.578 . . . . 1.51 106.738 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.57 137.99 38.9 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.567 0.698 . . . . 1.98 110.679 162.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.1 pt -114.6 24.48 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.835 1.254 . . . . 2.07 111.092 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -97.69 0.7 0.09 OUTLIER Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 129.337 3.055 . . . . 5.17 118.586 -161.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.48 120.55 7.77 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 123.405 2.252 . . . . 2.53 111.727 -165.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 149.23 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 130.425 3.49 . . . . 4.44 110.402 -171.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -35.46 3.56 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.014 1.116 . . . . 4.96 114.014 173.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.4 163.72 12.41 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.35 1.611 . . . . 4.89 115.35 -166.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -138.95 153.36 48.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.512 -1.222 . . . . 2.75 112.536 -164.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -45.61 -43.95 12.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.87 1.268 . . . . 4.52 112.34 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.61 -44.24 62.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.612 1.565 . . . . 3.69 112.853 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.84 97.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.34 1.427 . . . . 1.29 111.229 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.69 -33.99 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.537 -0.727 . . . . 1.88 110.543 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.75 -34.83 78.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.554 1.07 . . . . 1.19 112.638 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -62.43 -53.47 54.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.835 1.198 . . . . 3.55 109.983 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -55.83 -46.61 78.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 5.11 112.448 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.5 t -62.24 -45.72 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.555 -1.341 . . . . 1.49 111.397 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.03 -39.18 91.44 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 118.315 -0.85 . . . . 5.43 113.086 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -78.19 -37.28 45.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.059 1.3 . . . . 4.02 112.436 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -68.4 -59.68 3.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.536 -0.745 . . . . 3.03 112.484 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 174.85 157.28 0.35 Allowed Pre-proline 0 N--CA 1.484 1.257 0 N-CA-C 115.173 1.546 . . . . 1.93 115.173 170.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.19 -8.93 18.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.762 2.975 . . . . 2.23 114.552 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -86.16 -0.03 54.73 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 119.95 1.25 . . . . 2.85 112.78 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 29.9 tp -94.41 151.04 19.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.995 1.318 . . . . 1.88 109.912 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 87.7 t -133.43 132.43 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.98 1.712 . . . . 1.83 108.313 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -115.6 105.36 1.42 Allowed Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.082 0.848 . . . . 1.12 112.068 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.91 147.4 25.59 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.7 1.2 . . . . 2.1 112.453 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 65.4 p -140.49 149.73 42.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.488 1.915 . . . . 2.92 111.164 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -131.44 -170.72 12.7 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.151 1.358 . . . . 1.6 110.856 160.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.9 t -84.33 174.59 10.01 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.622 0.711 . . . . 2.63 109.146 152.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -52.26 -24.45 7.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.026 1.33 . . . . 6.41 113.603 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -74.86 -52.33 11.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.87 2.468 . . . . 2.83 110.784 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.07 -25.84 64.64 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.272 -1.517 . . . . 3.97 111.96 171.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 33.3 t -62.98 -38.95 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 117.22 -1.371 . . . . 1.79 110.991 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.8 -52.53 65.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.451 1.478 . . . . 3.94 109.042 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -49.98 -57.28 7.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.606 1.094 . . . . 2.52 112.02 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.48 -29.19 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.315 1.416 . . . . 3.01 113.002 -170.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.38 -42.33 79.28 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.831 -0.543 . . . . 1.74 110.732 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -72.02 -33.93 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.854 2.062 . . . . 4.68 112.573 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -54.87 -30.72 58.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.039 1.336 . . . . 2.56 114.487 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -118.22 3.72 11.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.616 1.166 . . . . 3.06 113.099 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.75 39.92 16.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.204 2.202 . . . . 6.31 112.91 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.17 155.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.867 0.867 . . . . 2.61 112.131 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -104.58 148.98 25.91 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.591 1.556 . . . . 3.51 114.084 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -170.37 150.12 3.48 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.837 2.855 . . . . 3.57 109.497 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.2 m -157.78 144.45 13.11 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 124.979 1.312 . . . . 3.24 111.623 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.06 154.04 37.31 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.508 2.139 . . . . 2.85 111.414 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -69.92 176.02 33.85 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 123.886 0.755 . . . . 3.16 114.259 171.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.64 -27.93 10.32 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.431 2.754 . . . . 4.83 112.63 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt 62.7 54.69 2.29 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.378 1.871 . . . . 4.15 114.882 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . 0.256 0.8 OUTLIER -141.51 -155.21 0.57 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 113.366 0.876 . . . . 7.47 113.366 172.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.258 17.3 mt-10 49.26 -82.39 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.862 2.065 . . . . 9.38 111.772 -148.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -93.2 -47.93 6.7 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.273 1.029 . . . . 8.18 112.029 168.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -178.65 -1.52 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 127.031 2.132 . . . . 5.28 113.248 -168.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -29.11 98.93 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 116.948 2.203 . . . . 6.46 116.948 -147.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -93.21 41.1 1.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.746 -1.116 . . . . 4.77 111.887 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.5 HD13 ' H ' ' A' ' 258' ' ' VAL . 0.5 OUTLIER -65.54 160.61 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 121.245 -0.909 . . . . 2.85 110.255 162.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.5 ' H ' HD13 ' A' ' 257' ' ' ILE . 41.1 t -153.74 128.03 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.566 1.947 . . . . 3.15 106.568 172.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.19 146.41 49.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.556 1.542 . . . . 3.28 112.196 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -148.77 129.51 14.16 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.135 0.974 . . . . 2.34 111.237 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.6 m -54.45 -31.15 54.91 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.93 1.085 . . . . 3.33 113.93 -171.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 69.74 -20.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.42 1.888 . . . . 4.16 114.402 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 84.4 mt -54.94 138.78 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.082 0.953 . . . . 2.34 110.504 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.7 mtm -99.78 141.2 32.91 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.324 -1.307 . . . . 2.57 110.46 162.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -99.21 140.32 33.55 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.241 0.616 . . . . 3.29 110.006 168.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 21.6 tp -99.1 117.04 32.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.919 0.888 . . . . 1.94 108.918 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.48 141.99 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.795 -1.187 . . . . 2.26 107.795 169.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.41 168.28 34.78 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.23 0.919 . . . . 1.59 115.156 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.66 61.25 7.44 Favored 'Trans proline' 0 C--N 1.351 0.695 1 C-N-CA 126.063 4.509 . . . . 3.03 110.722 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.54 -67.45 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.091 1.356 . . . . 4.13 108.232 -149.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.61 -23.22 2.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.07 -1.406 . . . . 2.38 115.046 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -85.59 172.25 11.07 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.335 1.567 . . . . 4.44 113.219 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -88.56 137.64 32.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.755 2.022 . . . . 5.4 111.429 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.22 -30.15 4.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.055 1.872 . . . . 2.39 116.055 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -164.68 155.98 15.22 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.686 1.585 . . . . 2.52 112.995 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.2 146.09 31.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.728 0.811 . . . . 6.15 112.825 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.37 159.92 40.05 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.344 1.058 . . . . 2.78 111.771 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.48 -174.37 29.04 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.347 1.451 . . . . 2.83 110.213 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -73.83 38.57 0.1 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.29 2.236 . . . . 3.59 114.637 -167.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -121.48 -43.25 2.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.542 1.537 . . . . 5.45 109.91 167.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -87.32 118.59 26.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.449 1.5 . . . . 4.36 108.945 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -73.42 177.92 4.93 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.264 -0.897 . . . . 6.06 108.709 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 12.7 tmtt? -54.45 -47.33 73.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.301 1.223 . . . . 1.81 114.301 -170.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.56 -32.8 85.39 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-N 118.414 0.552 . . . . 1.52 112.757 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.08 -22.84 62.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.357 1.063 . . . . 3.47 113.078 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.04 -49.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.111 -0.993 . . . . 1.49 109.923 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.82 -44.79 88.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.544 -0.723 . . . . 1.4 112.657 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.49 66.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.361 1.245 . . . . 1.55 114.361 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.3 p -74.72 -44.82 48.01 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.296 -0.878 . . . . 1.53 111.544 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.01 -40.34 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 120.142 1.337 . . . . 1.35 110.93 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.97 -5.36 9.22 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 114.663 1.357 . . . . 2.01 114.663 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 89.1 m -96.41 -47.93 5.78 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.288 1.435 . . . . 1.97 110.087 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -65.21 -24.94 67.49 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.619 1.168 . . . . 2.91 113.301 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -55.78 -35.71 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.549 2.34 . . . . 4.77 113.9 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -59.4 -43.23 95.91 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 116.838 -1.553 . . . . 6.61 111.913 -172.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.61 -61.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.133 1.889 . . . . 2.38 110.519 161.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.24 74.24 3.97 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 122.795 1.283 . . . . 3.75 113.722 -169.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -97.29 150.13 21.3 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.375 2.27 . . . . 9.2 110.831 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -76.64 -13.01 60.09 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.589 1.7 . . . . 8.42 115.589 -173.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -132.91 -45.51 0.86 Allowed 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.545 1.683 . . . . 9.21 115.545 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.251 1.158 0 C-N-CA 130.026 3.33 . . . . 8.24 108.944 -152.642 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 117.711 -1.138 . . . . 20.32 109.873 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -165.25 151.86 10.27 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.289 1.435 . . . . 16.56 110.35 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t 155.25 -168.0 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 1 C-N-CA 132.033 4.133 . . . . 13.2 107.82 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.06 -2.09 77.08 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 116.457 1.343 . . . . 10.65 116.457 162.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.98 115.77 8.0 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-N 119.534 1.667 . . . . 9.78 112.04 -175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.73 -175.99 2.99 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.202 2.601 . . . . 9.76 111.667 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.45 164.68 32.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.607 1.963 . . . . 7.84 109.214 171.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.7 tp -166.25 153.46 9.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.065 2.146 . . . . 7.28 108.264 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.45 175.36 22.32 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.881 1.229 . . . . 3.23 114.498 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.72 61.73 0.65 Allowed Glycine 0 CA--C 1.531 1.053 0 N-CA-C 109.531 -1.428 . . . . 3.42 109.531 162.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.93 144.31 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.613 2.208 . . . . 2.48 112.968 -151.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -86.33 175.09 8.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.288 1.518 . . . . 2.29 114.092 -166.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -148.19 106.37 3.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.983 1.313 . . . . 3.24 108.607 165.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mp -148.57 165.17 32.05 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.682 1.593 . . . . 2.43 110.137 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.2 m -107.95 134.07 51.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.763 1.225 . . . . 1.6 111.904 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -73.61 160.27 31.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.494 1.118 . . . . 2.09 112.216 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -60.6 -20.01 59.4 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 121.508 -0.745 . . . . 1.61 112.486 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.2 m -78.43 -60.02 2.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.35 1.86 . . . . 3.26 109.822 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.85 -14.9 0.69 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 116.11 1.204 . . . . 2.34 116.11 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.2 133.67 44.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.829 1.815 . . . . 3.92 109.973 171.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -82.31 129.5 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.119 -1.067 . . . . 5.68 108.119 157.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -140.37 175.99 9.14 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.818 1.247 . . . . 3.57 112.806 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.6 p -140.77 172.45 12.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 128.583 2.753 . . . . 2.68 109.383 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.83 -25.03 62.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.128 0.788 . . . . 3.91 113.128 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -75.07 -11.59 60.13 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 119.938 -1.726 . . . . 7.5 113.979 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.73 -28.87 21.48 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.866 1.666 . . . . 4.19 111.636 164.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -108.58 -2.47 18.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.535 1.68 . . . . 3.72 115.535 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.9 mt -77.56 -176.64 4.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.9 1.227 . . . . 4.3 109.777 165.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.7 10.86 Favored Glycine 0 N--CA 1.48 1.573 0 O-C-N 120.889 -1.132 . . . . 2.53 114.991 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -126.18 168.88 13.44 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.048 2.939 . . . . 3.79 108.252 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.521 ' CD1' ' HD3' ' A' ' 269' ' ' PRO . 53.9 m95 -81.77 140.39 34.27 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.445 1.02 . . . . 2.42 109.807 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.498 HD12 ' HB ' ' A' ' 197' ' ' THR . 0.8 OUTLIER -123.6 141.2 52.24 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.203 -0.936 . . . . 2.97 112.438 177.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.17 100.63 10.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.935 -1.135 . . . . 3.58 107.935 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.2 mt -96.26 127.75 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.743 -0.836 . . . . 1.82 108.743 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -139.95 143.82 36.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.122 0.969 . . . . 2.44 111.94 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.81 127.21 53.51 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.674 1.19 . . . . 2.25 112.34 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -147.47 163.96 28.74 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.506 1.05 . . . . 1.34 112.654 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.95 -179.04 6.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 117.745 0.772 . . . . 3.1 111.313 168.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 174.89 5.67 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.963 -1.125 . . . . 3.49 107.963 152.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 73.92 -24.76 0.2 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.516 1.526 . . . . 7.01 113.921 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 83.6 m -52.42 159.69 1.54 Allowed Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 120.648 1.567 . . . . 2.88 113.293 161.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.54 -173.44 1.8 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.386 3.39 . . . . 3.99 111.474 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.44 -2.46 1.05 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.248 2.219 . . . . 6.34 115.904 -157.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.29 -60.41 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.362 1.465 . . . . 4.32 110.163 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 15.6 m -52.43 -44.02 93.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.372 -1.299 . . . . 3.08 114.212 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.63 -39.59 0.51 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.435 2.09 . . . . 1.88 113.774 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.41 -32.62 68.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 122.171 2.26 . . . . 4.33 112.086 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -60.11 -44.98 94.46 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.506 -1.371 . . . . 3.54 111.484 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.77 -39.46 91.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.02 0.928 . . . . 3.2 111.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -72.81 -25.98 61.34 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.417 -1.427 . . . . 6.77 114.06 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -56.03 -56.96 14.44 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.431 -1.418 . . . . 2.81 109.812 165.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 10.0 ptp -64.7 -30.9 71.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.013 -0.994 . . . . 3.71 113.093 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.2 mt -75.16 -48.34 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 121.773 2.079 . . . . 3.11 109.821 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.52 ' HB3' ' HZ1' ' A' ' 283' ' ' LYS . 3.5 mp0 -68.07 -16.63 64.1 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.252 1.387 . . . . 6.54 111.776 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.421 HG21 ' HB ' ' A' ' 286' ' ' ILE . 24.9 t -69.84 -30.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 119.95 1.25 . . . . 1.86 112.584 163.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.82 -46.03 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 121.061 1.755 . . . . 2.39 110.257 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.23 -37.35 77.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.332 1.053 . . . . 4.63 113.153 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -57.53 -46.1 84.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 3.56 111.721 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.8 mt -71.87 -33.3 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.711 1.204 . . . . 1.84 114.232 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.44 -29.47 61.69 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.429 1.892 . . . . 3.2 112.359 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.5 t -68.52 -14.67 63.16 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.471 -1.393 . . . . 3.05 113.562 170.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.43 45.01 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 127.069 2.147 . . . . 4.17 108.666 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.06 4.3 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.617 2.767 . . . . 6.4 116.252 -159.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 78.0 p -78.21 -24.33 47.1 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.94 -1.1 . . . . 4.66 112.382 166.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 194' ' ' PRO . 11.6 mt -56.33 142.63 67.74 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 118.72 0.691 . . . . 3.98 111.046 169.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 159' ' ' TRP . 1.7 Cg_endo -81.77 46.63 2.28 Favored 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 125.604 4.203 . . . . 5.07 112.233 -174.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 72.88 101.21 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.633 1.682 . . . . 5.63 112.725 145.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 84.76 4.99 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.387 1.475 . . . . 2.35 111.012 -160.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 160' ' ' LEU . 56.8 m -79.95 122.31 83.09 Favored Pre-proline 0 N--CA 1.478 0.94 0 O-C-N 120.84 -1.163 . . . . 1.43 112.094 -173.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.04 124.43 1.79 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.381 2.721 . . . . 1.08 111.97 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 23.7 tp -126.58 93.96 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.085 1.354 . . . . 2.59 110.327 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.77 115.39 14.3 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.94 -0.763 . . . . 2.14 108.94 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.94 112.51 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.793 1.237 . . . . 1.59 108.584 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -83.88 135.03 34.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.649 -1.16 . . . . 1.98 109.55 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.7 34.95 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.582 1.153 . . . . 1.71 112.657 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -121.55 44.49 0.79 Allowed Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 127.158 2.183 . . . . 3.71 111.97 -173.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -77.71 35.15 0.5 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.231 3.287 . . . . 2.16 113.811 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -91.34 -16.59 27.23 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.204 -0.426 . . . . 5.43 110.406 150.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.49 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.494 2.405 . . . . 7.59 117.494 -171.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -79.73 52.48 1.45 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.317 1.847 . . . . 4.03 114.619 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 54.1 m -55.5 129.79 40.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.388 1.075 . . . . 2.49 110.785 -167.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -41.62 -48.51 4.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.363 1.465 . . . . 3.0 113.922 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -26.07 43.98 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.993 1.109 . . . . 4.07 113.993 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.11 86.44 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 1.86 110.83 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.84 -30.76 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.351 1.06 . . . . 2.12 112.613 174.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.31 74.38 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.408 1.458 . . . . 1.43 113.09 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 -44.73 58.02 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.699 0.799 . . . . 3.13 111.201 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -55.9 -39.98 72.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.476 1.51 . . . . 3.93 111.517 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.401 HG21 ' HA3' ' A' ' 226' ' ' GLY . 45.0 t -65.15 -20.72 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.053 1.741 . . . . 1.38 113.583 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -111.69 -21.55 11.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.46 1.652 . . . . 8.54 115.46 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.73 -19.13 58.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.377 0.989 . . . . 3.9 113.044 168.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -74.14 -87.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.707 1.603 . . . . 3.78 110.147 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.2 t -148.61 132.1 8.33 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.646 -1.283 . . . . 2.73 110.121 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.07 -19.44 45.37 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.382 2.055 . . . . 3.27 114.663 -156.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -84.61 2.69 40.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.713 1.375 . . . . 2.78 114.713 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.2 tp -72.55 147.3 46.07 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.624 1.102 . . . . 1.96 113.083 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 2.3 p -118.31 130.97 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.668 1.587 . . . . 2.45 108.66 160.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.401 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -99.45 160.82 19.75 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 123.919 0.771 . . . . 1.27 111.909 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -153.36 114.04 4.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.497 -1.297 . . . . 3.92 107.497 -166.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 52.0 m -112.88 152.65 29.04 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.24 2.216 . . . . 2.54 107.877 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -144.51 146.29 16.6 Favored Glycine 0 N--CA 1.467 0.73 0 O-C-N 121.819 -0.551 . . . . 2.97 112.71 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.2 t -63.51 154.3 32.84 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.057 0.928 . . . . 2.49 109.693 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.476 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -47.23 -33.25 5.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.929 1.292 . . . . 7.57 113.38 -170.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.44 -50.57 58.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.874 1.215 . . . . 5.27 112.411 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.62 -44.7 90.04 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.961 -1.087 . . . . 3.43 111.967 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 15.6 m -70.95 -22.32 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 113.844 1.053 . . . . 2.63 113.844 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.68 -53.09 37.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.847 1.203 . . . . 3.55 108.808 164.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -55.82 -57.82 10.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.361 -0.828 . . . . 3.66 112.378 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.97 -35.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 119.356 0.98 . . . . 2.12 113.323 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.42 67.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.063 0.945 . . . . 2.1 111.477 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -70.21 -26.49 63.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.626 1.57 . . . . 3.41 112.433 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.8 -62.89 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.695 1.198 . . . . 2.6 113.367 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -67.5 -33.78 75.79 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.038 -1.039 . . . . 3.15 112.735 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . 0.259 2.2 ptp180 109.16 117.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 1 C-N-CA 132.411 4.284 . . . . 9.01 109.777 179.365 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.83 153.61 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.027 2.131 . . . . 4.08 110.473 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -119.53 135.98 54.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.73 0.412 . . . . 4.63 110.163 148.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -165.91 166.18 17.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.167 1.787 . . . . 4.2 111.323 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 48.9 p -113.16 165.8 12.46 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.46 1.504 . . . . 4.68 112.743 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.27 143.63 17.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.595 2.197 . . . . 4.43 111.046 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -72.25 136.07 23.28 Favored Glycine 0 CA--C 1.542 1.747 0 CA-C-O 118.026 -1.43 . . . . 2.96 112.14 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.59 -23.82 9.45 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.159 2.573 . . . . 5.46 116.283 -167.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt 59.95 30.5 20.01 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 120.736 1.607 . . . . 5.76 113.985 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -140.0 153.48 46.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.227 1.811 . . . . 6.86 110.454 -169.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 110.98 -52.49 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 131.305 3.842 . . . . 7.86 110.05 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -140.73 -49.82 0.44 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.573 1.549 . . . . 6.9 109.196 162.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -176.85 -29.37 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.98 3.312 . . . . 6.49 108.988 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -60.42 152.82 24.56 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.34 2.256 . . . . 7.18 113.66 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -163.41 -179.31 6.44 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.504 2.038 . . . . 3.6 116.504 -166.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.0 tt -138.84 163.93 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.711 2.004 . . . . 4.37 108.52 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.56 148.42 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.627 1.571 . . . . 3.3 109.108 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -86.28 135.19 33.64 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.312 -0.996 . . . . 4.03 108.312 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.62 139.85 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.59 1.156 . . . . 2.7 111.274 -169.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -68.42 -14.94 63.35 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.977 2.214 . . . . 3.8 116.977 -165.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 28.3 mt 50.8 56.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 120.169 1.349 . . . . 4.7 110.36 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.0 mt -112.31 147.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.128 1.371 . . . . 2.53 109.986 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.0 ttp -114.49 144.8 42.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.622 1.969 . . . . 4.25 109.856 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -107.14 136.26 47.29 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.242 -0.912 . . . . 2.54 110.874 163.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 39.2 tp -94.95 106.97 19.0 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.967 0.907 . . . . 2.17 108.85 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.3 mp -86.84 135.58 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.501 -1.666 . . . . 2.16 106.501 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.49 165.29 24.77 Favored Glycine 0 CA--C 1.539 1.593 0 N-CA-C 111.587 -0.605 . . . . 1.81 111.587 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.521 ' HD3' ' CD1' ' A' ' 159' ' ' TRP . 21.0 Cg_endo -67.5 9.92 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 125.181 3.921 . . . . 2.92 114.16 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -141.93 -1.03 1.27 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.904 2.482 . . . . 5.04 111.492 -167.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 163.34 156.56 8.71 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.105 0.859 . . . . 3.55 114.483 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -74.71 -22.05 59.04 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.08 1.352 . . . . 5.8 114.638 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.87 108.17 9.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.133 -0.979 . . . . 3.95 111.32 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 -36.76 4.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.572 1.149 . . . . 3.18 111.152 170.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -157.45 178.63 10.08 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.98 2.112 . . . . 2.3 110.479 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -155.26 138.3 15.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.311 1.444 . . . . 3.61 113.354 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.8 -151.35 0.39 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.166 1.387 . . . . 2.75 110.968 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.85 -127.05 7.92 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.849 2.166 . . . . 3.5 108.492 -171.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -53.44 156.25 2.55 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.078 1.351 . . . . 2.87 113.11 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.6 -40.84 0.39 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.772 2.429 . . . . 4.33 112.459 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -63.41 108.84 1.43 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.982 1.313 . . . . 4.71 112.709 -174.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.61 141.66 57.64 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.331 -0.856 . . . . 7.34 108.845 177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.52 ' HZ1' ' HB3' ' A' ' 182' ' ' GLN . 13.1 tmtt? -48.59 -53.57 17.9 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.205 -1.559 . . . . 2.62 114.449 -165.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.3 -14.41 71.56 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 115.707 1.043 . . . . 1.64 115.707 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.3 -38.87 82.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.033 1.417 . . . . 3.65 110.439 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . 0.421 ' HB ' HG21 ' A' ' 183' ' ' VAL . 37.6 mt -60.7 -48.54 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.65 0.78 . . . . 1.48 109.259 174.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.73 77.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 119.121 -0.466 . . . . 1.27 111.858 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.79 90.39 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.712 1.004 . . . . 1.62 113.712 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 86.8 p -60.01 -48.59 81.07 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.581 -0.699 . . . . 1.62 111.795 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.13 -31.69 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.658 -1.276 . . . . 1.37 111.368 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.0 64.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.957 0.903 . . . . 1.78 113.093 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.6 m -70.71 -46.09 63.72 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.539 -0.726 . . . . 2.26 109.597 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -69.72 -27.89 65.35 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.844 1.053 . . . . 2.56 113.844 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.7 ttt -59.98 -40.17 88.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.413 1.485 . . . . 4.24 112.167 166.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.07 36.78 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 117.36 -1.305 . . . . 5.3 113.348 -173.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.53 -57.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.408 2.739 . . . . 3.01 112.379 158.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.67 28.61 8.51 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.439 1.644 . . . . 4.1 115.439 -154.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -33.48 -53.67 0.41 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.667 1.987 . . . . 8.14 114.612 165.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 62.7 mttt 53.36 177.63 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.716 1.206 . . . . 12.33 111.334 -158.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 21.6 mttt 54.97 -62.14 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.953 2.101 . . . . 7.85 114.815 -166.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 C-N-CA 129.216 3.006 . . . . 6.89 112.213 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 118.218 -0.896 . . . . 13.85 109.91 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -72.61 144.48 47.83 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.631 0.65 . . . . 13.29 111.461 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 t 161.5 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 131.305 3.842 . . . . 11.09 108.127 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.06 1.45 6.89 Favored Glycine 0 N--CA 1.476 1.322 0 N-CA-C 117.852 1.901 . . . . 9.05 117.852 163.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -97.42 106.94 35.88 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 119.626 1.713 . . . . 9.41 112.548 -162.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -81.03 148.32 17.03 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.637 2.891 . . . . 7.9 112.688 170.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 38.9 tp -112.6 -18.7 12.31 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.443 1.275 . . . . 8.4 114.443 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.07 33.39 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 118.211 2.671 . . . . 8.68 118.211 -154.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 125.51 126.95 3.05 Favored Glycine 0 N--CA 1.471 1.013 0 O-C-N 120.647 -1.283 . . . . 3.61 114.158 166.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.71 148.34 31.94 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.734 1.159 . . . . 2.35 112.307 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.65 174.77 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.127 3.218 . . . . 3.35 112.171 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.76 173.38 15.36 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.973 1.709 . . . . 2.88 109.843 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.71 32.21 4.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.618 0.97 . . . . 3.68 113.618 172.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.3 mt -51.72 149.3 4.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 3.02 112.563 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.0 m -108.38 142.35 38.85 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.396 1.078 . . . . 1.37 109.731 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.3 t -91.32 165.09 13.61 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.295 1.038 . . . . 2.43 113.245 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -61.2 -25.37 67.0 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 2.24 114.124 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -83.12 0.93 42.89 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.249 1.82 . . . . 3.09 114.178 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.94 -6.37 73.04 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.227 1.394 . . . . 2.02 115.555 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -73.63 132.95 43.32 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.347 1.073 . . . . 4.08 111.293 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -82.52 105.3 13.46 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.092 -1.005 . . . . 4.44 108.494 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -179.1 4.3 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.976 1.31 . . . . 2.94 113.614 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 62.3 p -146.54 166.16 27.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.035 2.534 . . . . 2.37 109.005 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.31 -38.17 76.55 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.449 0.568 . . . . 4.08 112.343 173.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -81.78 4.25 22.8 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.89 1.441 . . . . 6.93 114.89 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.81 -41.33 30.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.622 0.769 . . . . 3.46 109.828 160.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -84.5 -29.19 26.2 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.756 1.391 . . . . 3.33 114.756 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.89 101.96 0.43 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.781 1.232 . . . . 4.09 110.23 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 144.2 -20.97 2.09 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.643 1.116 . . . . 2.79 113.48 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.67 170.45 7.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.876 -0.787 . . . . 3.52 108.876 152.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -82.42 127.4 33.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.478 0.581 . . . . 2.12 109.856 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.48 145.94 44.88 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.636 0.653 . . . . 3.36 112.506 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.1 mt -107.19 121.61 44.87 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.09 1.356 . . . . 2.53 108.01 158.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.5 mt -115.5 118.66 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.267 0.627 . . . . 2.11 109.626 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -122.9 149.88 43.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.305 1.442 . . . . 2.45 114.015 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -99.19 120.54 39.69 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 2.5 112.524 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -118.96 155.71 15.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.515 1.055 . . . . 1.57 113.791 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -114.08 -43.75 3.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.362 1.065 . . . . 2.93 111.865 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.5 m 67.71 -18.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 126.453 1.901 . . . . 4.0 114.835 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -71.93 -18.86 61.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.319 1.048 . . . . 7.22 111.326 160.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.54 164.38 58.33 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.768 1.227 . . . . 2.48 111.741 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -78.82 -146.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.433 2.755 . . . . 3.73 109.387 164.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.53 57.72 0.13 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.872 3.269 . . . . 5.59 113.348 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.5 t -115.24 -84.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 126.849 2.06 . . . . 3.65 108.073 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -55.63 -47.59 98.34 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 117.062 -1.447 . . . . 1.87 113.761 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.46 -23.57 43.67 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.029 1.82 . . . . 1.54 114.219 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.78 -56.55 14.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.82 0.848 . . . . 4.19 109.961 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -60.75 -39.89 90.4 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 2.83 112.129 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.452 HD22 ' CG ' ' A' ' 220' ' ' PHE . 5.1 tt -55.58 -39.58 70.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.82 1.248 . . . . 2.72 112.036 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . 0.263 0.3 OUTLIER -75.77 -34.02 60.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.144 0.884 . . . . 3.03 112.305 175.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -55.65 -46.12 77.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.283 -1.511 . . . . 4.78 111.643 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.4 ptp -67.89 -28.53 67.59 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.728 0.64 . . . . 2.67 112.728 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.23 -38.09 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.295 -0.878 . . . . 1.79 111.018 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.446 ' OE1' ' HE3' ' A' ' 283' ' ' LYS . 73.9 mt-30 -62.57 -40.43 96.85 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.297 -0.859 . . . . 3.15 111.931 171.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . 0.259 4.4 m -72.31 -28.93 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.218 1.372 . . . . 2.98 113.243 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.2 t -63.07 -52.83 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.793 1.179 . . . . 2.07 111.717 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -74.92 -19.97 59.9 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.155 0.798 . . . . 5.18 113.155 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -64.93 -55.59 18.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.596 0.758 . . . . 3.28 111.241 164.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.25 -37.37 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.111 1.365 . . . . 2.15 112.902 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.51 -35.56 65.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.49 1.516 . . . . 3.21 112.205 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.9 t -72.34 -18.2 61.78 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.931 1.085 . . . . 3.25 113.931 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.43 HG22 HG22 ' A' ' 192' ' ' THR . 11.8 mt -94.36 75.38 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.357 1.463 . . . . 3.68 107.795 -175.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -3.55 0.06 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 128.111 2.565 . . . . 4.66 116.623 -162.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.43 HG22 HG22 ' A' ' 190' ' ' ILE . 15.1 t -71.59 -22.44 61.73 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.378 1.871 . . . . 6.18 113.071 167.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.4 151.74 59.75 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.434 1.016 . . . . 3.98 111.195 166.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 -40.11 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.074 2.516 . . . . 3.23 110.779 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -172.74 -179.89 2.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.235 2.614 . . . . 4.48 109.331 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.0 tp -149.27 73.26 1.19 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.799 1.24 . . . . 1.92 109.948 160.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.5 m -63.03 119.96 56.82 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 121.077 -1.015 . . . . 1.33 110.717 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.93 128.37 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.29 1.993 . . . . 1.15 110.459 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 26.6 tp -115.81 115.36 26.15 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.663 1.585 . . . . 2.78 110.735 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -87.24 126.52 34.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.174 0.99 . . . . 2.45 109.884 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.79 119.53 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.429 -0.952 . . . . 1.27 108.429 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.8 t -79.1 139.49 38.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.956 -0.565 . . . . 2.0 111.632 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.9 pt -124.19 21.76 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.916 1.286 . . . . 1.86 113.119 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -111.52 61.66 0.5 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.803 1.241 . . . . 3.56 113.647 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.17 73.17 5.6 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.18 2.587 . . . . 2.41 110.255 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -153.32 -37.15 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.101 1.36 . . . . 5.42 112.555 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.09 7.36 0.91 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.081 1.141 . . . . 4.98 114.081 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 177.73 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.987 -0.445 . . . . 3.46 110.828 157.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 32.8 m -155.95 136.9 13.57 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.025 -1.047 . . . . 2.42 108.181 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.448 ' HZ3' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -51.76 -44.86 63.5 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.013 0.925 . . . . 3.9 112.216 177.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.448 ' CD ' ' HZ3' ' A' ' 210' ' ' LYS . 17.7 mp0 -60.35 -40.24 90.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.083 1.753 . . . . 3.57 112.776 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.98 69.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.227 -0.921 . . . . 1.6 112.346 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.61 -43.24 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.919 0.888 . . . . 2.01 110.654 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.56 66.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.219 1.008 . . . . 1.28 112.484 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 0.7 OUTLIER -71.21 -46.79 60.43 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.19 0.996 . . . . 3.48 112.331 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -64.79 -37.11 86.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.467 1.507 . . . . 4.17 111.422 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -50.64 -44.9 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.877 2.071 . . . . 1.2 112.987 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 7.7 mtmp? -55.23 -45.53 75.97 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.662 0.664 . . . . 4.18 112.386 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -20.46 60.12 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 124.363 1.04 . . . . 5.16 112.211 -163.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.452 ' CG ' HD22 ' A' ' 177' ' ' LEU . 68.9 m-85 -86.16 -48.24 8.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.012 0.925 . . . . 2.39 111.993 168.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 87.8 p -174.04 127.89 0.46 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.753 -1.118 . . . . 2.62 110.902 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.15 76.59 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.661 2.907 . . . . 3.17 109.244 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 178.18 -28.27 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.996 2.919 . . . . 2.3 111.005 -163.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.451 ' CD1' HD21 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -67.93 143.96 55.43 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.917 1.687 . . . . 2.29 110.722 164.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.72 133.97 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.378 1.471 . . . . 2.39 109.797 170.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.51 115.66 3.58 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 123.841 0.734 . . . . 1.07 112.181 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.87 148.67 27.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.365 1.066 . . . . 2.51 111.455 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 71.9 p -136.59 161.61 35.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.986 1.314 . . . . 2.23 110.635 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -160.48 152.6 23.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 124.659 1.123 . . . . 2.88 110.372 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.6 t -60.57 166.53 3.13 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.507 1.123 . . . . 3.23 111.293 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -38.36 7.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.306 1.042 . . . . 6.62 112.528 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 23.5 mp0 -67.15 -42.03 85.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.408 2.283 . . . . 3.75 111.751 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -71.16 -34.37 70.91 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.036 -1.04 . . . . 4.09 111.667 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.71 -38.89 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 118.363 -0.827 . . . . 2.5 109.669 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -70.66 -41.85 71.55 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.859 -1.067 . . . . 3.43 111.748 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -54.51 -50.04 68.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.293 1.861 . . . . 2.5 110.752 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.44 -55.13 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.715 0.806 . . . . 2.26 111.821 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -72.13 -26.86 62.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.959 0.904 . . . . 1.69 113.439 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -87.86 -30.26 20.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.675 1.59 . . . . 4.34 112.305 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.24 13.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.109 1.322 . . . . 1.68 111.206 168.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -76.96 -14.42 59.85 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.603 0.964 . . . . 3.41 113.603 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 76.77 62.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.112 2.165 . . . . 5.28 112.881 159.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.86 145.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.341 1.457 . . . . 3.68 111.979 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.74 135.88 40.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.02 0.914 . . . . 3.7 113.033 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -145.64 136.36 24.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.881 2.872 . . . . 5.68 108.077 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.3 t -121.25 105.08 39.99 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.097 0.959 . . . . 2.89 109.921 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.72 101.32 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.505 2.137 . . . . 3.13 108.845 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -66.67 148.36 50.51 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 119.617 -0.546 . . . . 2.28 113.052 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -67.96 146.7 72.24 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.039 2.492 . . . . 3.37 109.631 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -78.72 140.9 38.25 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.765 0.654 . . . . 5.43 112.765 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -150.84 165.76 32.61 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.506 1.523 . . . . 5.96 111.733 -159.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 60.98 -45.4 0.12 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 130.948 3.699 . . . . 7.7 114.612 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -163.98 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.002 2.121 . . . . 7.44 110.108 168.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -167.65 36.23 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.701 1.2 . . . . 7.13 113.634 -174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -135.4 172.83 12.45 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 119.329 -2.107 . . . . 5.31 113.187 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -164.21 168.17 19.19 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.275 1.43 . . . . 3.8 112.169 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.75 162.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.193 1.397 . . . . 2.62 109.019 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.3 t -128.18 137.68 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.791 2.037 . . . . 3.34 108.374 -169.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.96 119.2 21.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 107.049 -1.463 . . . . 4.51 107.049 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.17 131.6 54.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.747 -0.834 . . . . 2.02 108.747 168.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 56.7 m -53.24 -47.82 68.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.718 0.807 . . . . 3.6 112.566 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.5 mt 82.6 98.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.169 2.588 . . . . 3.8 108.339 -172.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.2 mt -134.42 146.26 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.4 1.48 . . . . 3.17 107.146 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.1 ttm -119.47 128.54 54.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.794 1.638 . . . . 2.57 108.516 159.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -98.08 139.62 33.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.74 -0.6 . . . . 3.6 111.109 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.78 113.98 26.32 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.671 -1.233 . . . . 2.28 107.671 169.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 tp -106.28 125.84 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.922 -1.14 . . . . 4.15 107.922 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.49 165.21 48.01 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.604 -0.599 . . . . 1.66 111.604 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -78.34 48.64 2.78 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.507 3.471 . . . . 2.8 110.49 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -165.96 -50.51 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.077 1.751 . . . . 4.47 110.209 -156.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 151.49 -178.29 28.91 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 115.772 1.069 . . . . 3.21 115.772 166.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 50.33 -132.15 1.86 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.987 2.115 . . . . 4.72 114.225 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.36 131.49 54.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.147 0.979 . . . . 4.27 109.333 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.0 -29.18 23.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.056 0.943 . . . . 2.97 110.591 169.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -162.4 158.81 24.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.105 2.162 . . . . 2.21 109.428 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -134.59 99.28 4.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.021 1.391 . . . . 3.8 111.04 -170.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -95.53 110.96 22.96 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.177 -0.952 . . . . 2.62 110.1 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -75.34 -165.13 15.13 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.12 -1.192 . . . . 3.29 110.12 163.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -74.62 -26.19 59.73 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.749 -1.442 . . . . 3.54 112.309 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -46.96 -41.78 16.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 128.231 2.612 . . . . 6.34 117.479 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 151.57 33.76 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.051 1.741 . . . . 8.26 113.548 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.711 -1.243 . . . . 6.23 109.331 159.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.446 ' HE3' ' OE1' ' A' ' 182' ' ' GLN . 13.5 tmtt? -65.37 -44.72 86.73 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.709 -1.244 . . . . 1.91 113.672 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -62.55 -30.43 76.53 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 123.278 0.466 . . . . 1.72 112.398 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -63.66 -24.55 67.83 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.007 1.323 . . . . 2.84 113.489 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 13.8 mt -79.89 -30.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.901 1.228 . . . . 1.36 111.341 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -69.98 -42.9 72.5 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.951 -1.093 . . . . 1.14 110.552 166.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.33 -37.44 83.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.02 1.118 . . . . 1.43 114.02 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 70.9 p -63.57 -49.28 74.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.131 0.878 . . . . 1.32 111.137 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.91 -36.62 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.016 -1.052 . . . . 1.23 111.508 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.21 -6.18 4.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.721 1.209 . . . . 1.89 114.203 168.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 40.0 m -101.88 -44.38 5.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.843 1.657 . . . . 1.67 110.472 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -63.38 -28.23 69.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.636 1.174 . . . . 2.91 113.166 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -48.82 -40.84 30.8 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 125.988 1.715 . . . . 5.12 111.506 165.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -60.91 -40.44 74.52 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.414 -1.755 . . . . 6.1 112.829 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.6 -58.32 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.947 2.431 . . . . 1.87 113.525 163.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -83.78 8.86 13.4 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 115.81 1.781 . . . . 2.84 115.81 -165.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.28 153.67 2.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.734 2.014 . . . . 8.28 114.314 175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -66.25 -42.36 88.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.302 -1.332 . . . . 7.24 113.72 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -155.73 -94.38 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.981 2.512 . . . . 9.36 110.001 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.237 0.444 0 CA-C-O 116.775 -1.583 . . . . 8.06 109.424 134.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 118.12 -0.943 . . . . 14.86 109.913 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -76.76 77.85 3.38 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.902 0.774 . . . . 12.44 109.107 174.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 m -160.45 146.98 15.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.806 0.842 . . . . 10.88 110.065 -158.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.01 -81.77 1.72 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.108 0.861 . . . . 10.98 112.911 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -76.9 146.65 76.18 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 113.211 0.819 . . . . 11.09 113.211 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -69.95 160.48 49.49 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.376 2.051 . . . . 9.85 108.906 151.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tt -41.45 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.101 1.76 . . . . 7.74 113.79 -164.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.6 tp 60.43 156.42 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 128.127 2.571 . . . . 7.0 113.604 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.03 21.26 63.49 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 120.764 -1.21 . . . . 3.7 113.673 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.79 127.75 10.62 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.841 -1.533 . . . . 2.31 110.357 -174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.91 142.78 35.58 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.682 2.255 . . . . 2.88 111.435 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -93.87 168.13 11.18 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.595 -1.184 . . . . 2.41 111.663 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.6 m -140.6 78.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.109 1.364 . . . . 2.45 110.012 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.56 147.5 40.64 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.38 0.672 . . . . 1.92 111.234 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -75.91 131.84 39.9 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.291 2.236 . . . . 1.42 110.183 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.9 p -92.61 160.97 14.77 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.033 1.333 . . . . 1.93 112.162 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -64.91 -6.62 8.77 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.332 1.453 . . . . 1.38 114.638 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.2 m -66.75 -60.62 2.52 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.625 1.17 . . . . 2.87 109.093 162.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 160.13 0.48 0.07 OUTLIER Glycine 0 CA--C 1.534 1.255 0 N-CA-C 116.446 1.338 . . . . 2.55 116.446 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.34 165.48 33.93 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.751 1.775 . . . . 4.67 113.567 -170.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.72 120.78 25.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.819 2.448 . . . . 4.53 113.79 -167.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -99.63 171.58 7.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.228 1.411 . . . . 5.1 111.324 165.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.6 p -130.16 157.3 42.81 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.27 1.428 . . . . 2.16 110.176 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.6 -41.96 43.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.269 1.428 . . . . 3.54 111.455 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.56 -26.4 63.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.648 1.579 . . . . 8.16 113.765 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -80.06 -33.09 39.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.169 1.349 . . . . 3.01 112.193 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.72 -23.17 58.55 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.79 0.663 . . . . 2.94 112.79 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.63 131.69 51.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.852 1.261 . . . . 3.53 111.048 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 108.72 -25.42 19.25 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.522 1.534 . . . . 2.56 112.726 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -88.23 -152.47 0.22 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.575 1.55 . . . . 3.73 108.726 165.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.8 157.56 44.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.307 1.043 . . . . 2.28 110.659 163.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.14 152.96 28.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.915 0.864 . . . . 2.37 113.011 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.8 pp -106.52 155.15 19.9 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.825 1.25 . . . . 3.81 107.853 165.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.75 123.23 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.439 -0.949 . . . . 1.76 108.439 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -123.05 154.3 38.7 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.719 1.208 . . . . 2.9 111.677 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -108.84 116.7 32.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.845 0.858 . . . . 2.12 109.601 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.74 162.43 33.26 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.923 1.249 . . . . 2.48 113.585 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.08 -44.97 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 115.947 -1.978 . . . . 4.09 114.759 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t 136.95 177.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 131.426 3.89 . . . . 5.22 110.118 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 77.46 -15.27 0.76 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 127.841 2.456 . . . . 7.2 112.958 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.3 p -51.36 155.59 2.41 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 125.321 1.448 . . . . 2.52 112.179 155.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.88 74.44 5.52 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.642 2.894 . . . . 4.0 109.75 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 69.25 -7.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.665 2.386 . . . . 4.15 114.628 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 95.6 t -46.57 -55.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.854 2.462 . . . . 2.9 113.485 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.99 -67.49 0.52 Allowed Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 118.051 -0.976 . . . . 1.78 111.367 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.72 -40.63 21.63 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.944 1.763 . . . . 1.51 113.938 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -58.22 -43.33 87.64 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.869 1.213 . . . . 3.15 111.686 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -84.6 -34.46 23.14 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.232 -0.918 . . . . 3.18 112.931 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.6 -35.62 80.13 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.293 1.406 . . . . 3.65 112.082 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -47.73 -51.01 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.449 1.1 . . . . 3.35 111.226 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -60.88 -38.32 85.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.053 -1.029 . . . . 2.89 111.789 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -70.13 -41.47 73.87 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.386 -0.821 . . . . 5.08 112.702 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.7 mm -57.47 -53.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 119.722 1.146 . . . . 1.66 109.048 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -55.65 -13.79 1.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.285 1.434 . . . . 4.07 114.573 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 t -97.99 -46.77 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.088 2.155 . . . . 2.0 112.942 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 21.3 m -62.25 -25.53 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.426 1.466 . . . . 3.52 112.311 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -70.88 -22.16 62.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.318 0.647 . . . . 4.13 112.68 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -79.71 -19.66 48.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.066 1.347 . . . . 2.56 111.789 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 43.3 mm -81.36 -58.97 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 1.8 109.746 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.03 -32.86 74.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.15 1.78 . . . . 3.45 113.544 -170.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 t -69.49 -20.18 63.73 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.898 1.279 . . . . 3.24 112.87 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.2 mm -91.84 89.24 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.589 -1.319 . . . . 4.05 108.352 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.5 p -60.74 69.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.353 2.261 . . . . 5.52 113.76 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 175.73 -29.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.527 2.731 . . . . 4.26 111.777 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.15 159.07 68.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.605 0.762 . . . . 3.36 110.824 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.25 160.16 17.64 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.299 2.666 . . . . 3.29 109.486 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.0 134.76 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.167 0.508 . . . . 3.89 111.652 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -95.87 95.71 8.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.027 -1.471 . . . . 2.66 107.027 161.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 m -68.56 124.59 90.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 108.549 -0.908 . . . . 1.46 108.549 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -86.07 118.15 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.486 2.124 . . . . 0.89 110.476 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.79 121.08 43.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.273 1.429 . . . . 2.27 110.487 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.12 112.38 19.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.571 1.148 . . . . 3.15 110.216 -166.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.67 110.11 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.045 1.338 . . . . 1.46 110.505 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.5 m -90.0 96.03 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.132 -0.98 . . . . 2.55 111.581 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.03 -2.77 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 116.359 1.985 . . . . 2.21 116.359 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -117.9 60.84 3.63 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 119.929 1.241 . . . . 4.13 110.572 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.1 149.25 40.95 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.178 2.585 . . . . 2.19 109.506 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 114.13 -43.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 129.682 3.193 . . . . 5.2 108.974 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -35.77 36.67 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.1 -0.375 . . . . 6.2 111.895 160.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.18 151.06 20.82 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.685 1.194 . . . . 4.59 110.964 167.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.4 p -132.42 154.76 49.52 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 124.819 1.248 . . . . 3.03 109.28 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -48.42 -43.24 34.06 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.561 1.144 . . . . 3.14 112.032 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -81.0 -26.07 36.76 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.082 1.141 . . . . 3.27 114.082 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.86 68.84 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.249 0.932 . . . . 1.53 110.266 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.5 mm -65.41 -36.08 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 117.706 -1.14 . . . . 1.96 110.816 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.2 66.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.784 1.629 . . . . 1.35 113.148 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -73.2 -49.53 27.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.378 0.671 . . . . 3.28 112.339 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.33 -41.04 65.33 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.94 -1.1 . . . . 2.92 112.088 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.485 HG21 ' HA3' ' A' ' 226' ' ' GLY . 25.5 t -62.96 -50.92 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.262 1.825 . . . . 1.82 112.294 172.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -59.34 -40.44 86.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.087 0.955 . . . . 3.97 111.248 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -33.22 71.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.481 1.512 . . . . 4.66 112.25 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.88 -13.21 61.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.049 1.129 . . . . 3.46 114.049 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.6 p 139.92 149.57 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 130.744 3.618 . . . . 2.53 111.816 168.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.26 5.65 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.36 2.706 . . . . 1.75 113.865 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.63 -24.74 23.85 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.769 1.168 . . . . 1.89 112.784 165.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.4 146.31 32.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.399 -1.438 . . . . 2.04 112.765 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.5 127.09 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.17 0.588 . . . . 2.13 111.862 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -99.68 129.94 10.06 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.81 110.813 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.2 113.62 26.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.264 -1.384 . . . . 1.96 107.264 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.4 m -141.15 68.84 1.34 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.633 1.573 . . . . 3.28 108.633 -164.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -91.15 -174.06 43.67 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.741 1.163 . . . . 1.73 112.405 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.4 t -75.79 163.32 27.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.918 1.287 . . . . 2.5 112.418 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.5 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 36.9 ttm180 -43.02 -31.58 0.55 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.255 2.622 . . . . 5.73 114.433 173.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -77.14 -38.02 52.76 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.957 1.303 . . . . 4.26 113.311 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.33 -45.99 85.45 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.102 -0.999 . . . . 3.97 109.145 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.5 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 19.5 m -70.16 -18.51 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.247 1.203 . . . . 2.84 114.247 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.14 -40.86 71.11 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.055 -1.028 . . . . 3.57 112.178 168.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -61.96 -50.86 70.44 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.883 -0.511 . . . . 2.65 111.565 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 234' ' ' VAL . 3.1 p -66.38 -24.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 120.359 -0.536 . . . . 1.85 112.195 -176.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.39 67.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.441 1.096 . . . . 2.41 112.025 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -36.7 63.82 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.47 0.915 . . . . 3.48 113.47 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.55 -26.51 65.45 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.972 1.471 . . . . 1.67 114.972 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.96 10.27 1.75 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.244 1.572 . . . . 3.01 115.244 -168.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 74.39 -58.68 0.58 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.252 2.621 . . . . 5.42 110.765 -165.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 55.8 t 63.58 -64.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 128.143 2.577 . . . . 3.56 111.185 -165.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 30.7 t80 58.38 62.11 2.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.572 1.549 . . . . 5.35 113.251 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -68.13 148.53 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.319 -0.863 . . . . 3.71 111.234 165.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 m -107.25 98.38 22.48 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 121.464 -0.772 . . . . 3.64 109.862 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -80.57 113.24 2.82 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.039 1.826 . . . . 2.59 112.172 -171.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.98 148.9 40.34 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 111.345 -0.702 . . . . 2.4 111.345 167.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.86 173.52 13.37 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.495 2.797 . . . . 3.45 111.589 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -66.22 122.88 18.46 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 118.538 -0.744 . . . . 5.06 109.913 161.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.73 167.19 30.78 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.208 1.559 . . . . 5.76 115.208 -165.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.261 14.1 tt0 48.96 -68.55 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 131.588 3.955 . . . . 7.16 115.81 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -153.97 57.21 0.73 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.898 1.679 . . . . 6.94 111.189 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 85.54 14.75 0.16 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.211 2.604 . . . . 5.64 113.118 169.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -70.05 174.21 5.66 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.693 -1.254 . . . . 3.9 111.135 165.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -162.3 76.16 0.46 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.098 2.559 . . . . 3.41 107.786 -168.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . 0.303 0.2 OUTLIER -81.5 58.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.569 -1.332 . . . . 2.97 113.074 -158.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.76 130.5 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.281 1.432 . . . . 3.2 110.693 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.71 155.67 16.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.837 2.055 . . . . 3.61 112.482 169.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -131.98 81.56 1.97 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.086 0.954 . . . . 2.26 112.796 164.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -73.32 95.74 2.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.252 1.421 . . . . 4.59 111.826 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 158.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 116.062 1.875 . . . . 6.35 116.062 -174.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.4 tt -95.78 156.24 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 128.107 2.563 . . . . 3.91 109.761 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 35.8 ttm -96.99 145.82 25.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.785 1.234 . . . . 2.34 110.39 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -113.68 144.65 42.57 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.707 1.203 . . . . 3.8 112.275 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 13.6 tp -110.05 128.02 55.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.647 1.179 . . . . 2.09 108.689 165.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.89 143.04 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.557 -1.275 . . . . 1.77 107.557 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -108.56 176.31 20.05 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.142 0.877 . . . . 1.58 112.481 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 66.93 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.917 3.745 . . . . 2.58 109.053 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -160.22 -56.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.502 1.521 . . . . 4.27 110.487 -161.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 153.79 -134.4 4.34 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.504 0.573 . . . . 2.48 113.529 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.03 -39.76 69.49 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.849 1.426 . . . . 4.56 114.849 -150.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.4 p90 179.91 150.07 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.757 2.423 . . . . 5.05 109.225 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.91 -21.87 13.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.074 1.35 . . . . 3.59 111.505 164.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -152.46 163.16 40.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 2.6 112.234 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -158.12 131.86 7.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.727 2.011 . . . . 5.68 110.609 172.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -156.87 154.94 30.61 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.14 -0.975 . . . . 3.14 112.286 -171.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.66 163.17 40.21 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 122.114 0.841 . . . . 2.96 112.762 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -68.23 114.11 6.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.827 -1.546 . . . . 4.99 106.827 150.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 155.76 -14.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 129.619 3.168 . . . . 5.08 113.341 -165.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -90.41 130.94 36.43 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.966 -1.084 . . . . 4.69 113.118 -171.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -72.61 122.72 21.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.771 1.228 . . . . 6.91 108.338 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.61 -55.24 1.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.531 2.049 . . . . 2.33 116.531 -155.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -60.58 -17.16 47.61 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.427 1.013 . . . . 1.32 114.918 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -61.18 -30.0 70.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.479 1.14 . . . . 3.48 112.644 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 41.5 mt -82.76 -41.8 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.982 0.913 . . . . 1.23 108.947 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.1 -41.32 64.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.39 0.541 . . . . 1.19 112.093 168.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.49 -43.45 94.1 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.145 1.165 . . . . 1.56 114.145 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.8 p -68.53 -41.84 79.3 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.29 1.405 . . . . 1.73 111.582 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 38.2 mt -56.39 -52.39 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.374 0.988 . . . . 1.55 110.829 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.81 65.15 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.235 0.828 . . . . 1.98 113.235 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 88.7 m -70.84 -48.23 55.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.98 1.312 . . . . 1.96 110.75 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -67.16 -29.38 69.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.425 1.011 . . . . 2.57 113.434 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -19.8 63.06 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.465 1.506 . . . . 6.47 114.135 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -71.79 -45.45 12.25 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.499 -1.715 . . . . 6.08 114.157 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.45 -58.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.373 2.715 . . . . 2.12 111.722 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -85.86 119.94 26.72 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.364 -0.835 . . . . 2.98 110.916 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? 89.02 -87.05 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.625 2.37 . . . . 10.94 112.904 163.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -155.38 120.66 4.91 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.093 1.357 . . . . 6.95 113.113 -166.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 151.17 37.83 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.74 2.126 . . . . 10.72 116.74 -173.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.482 1.156 0 C-N-CA 125.1 1.36 . . . . 11.62 109.053 147.379 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 117.76 -1.114 . . . . 16.66 109.901 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -163.15 167.06 22.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.1 1.36 . . . . 13.57 110.044 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -171.84 166.01 6.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.1 2.56 . . . . 12.14 108.716 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.26 -172.1 34.51 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.738 1.161 . . . . 9.69 113.18 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -126.91 121.82 23.11 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.403 1.081 . . . . 9.19 110.817 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.86 139.11 42.55 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.423 2.082 . . . . 6.64 109.595 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 tt -173.93 153.25 2.1 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.884 2.474 . . . . 6.68 107.806 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.6 mt -127.08 146.79 50.24 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.449 1.5 . . . . 6.71 108.258 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.7 -131.81 26.47 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.315 -0.714 . . . . 3.37 111.315 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 134.09 165.4 10.96 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.135 1.826 . . . . 2.26 112.929 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.05 159.45 53.87 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.774 2.983 . . . . 2.51 111.762 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -138.98 172.04 13.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.875 1.27 . . . . 2.36 110.779 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 p -141.12 18.94 2.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.506 1.669 . . . . 2.58 115.506 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.83 154.89 41.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.933 1.349 . . . . 1.92 114.396 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.9 m -91.68 147.2 23.17 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.628 1.171 . . . . 1.51 109.149 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.8 p -78.89 156.11 28.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.087 1.355 . . . . 2.55 112.549 -173.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -50.68 -25.7 4.59 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 113.906 -1.497 . . . . 2.08 113.427 162.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 86.0 m -72.97 -64.78 0.9 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.207 1.803 . . . . 3.24 109.513 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 134.01 55.0 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.488 1.518 . . . . 2.78 112.645 -169.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.22 144.84 9.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.803 2.041 . . . . 3.7 108.335 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -89.85 126.11 35.58 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.706 1.139 . . . . 4.93 112.047 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -112.68 162.94 15.14 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.473 -1.392 . . . . 3.1 112.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.6 p -136.04 -179.21 5.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.648 1.979 . . . . 2.59 109.784 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -68.54 -22.21 64.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.218 1.007 . . . . 4.38 112.668 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -32.2 66.95 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.865 1.061 . . . . 5.27 113.865 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.14 -37.95 84.69 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.926 1.29 . . . . 3.19 111.435 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -107.84 20.99 18.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.557 1.543 . . . . 3.66 114.284 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -80.46 167.58 19.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.379 -0.826 . . . . 3.23 110.59 167.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.89 14.21 75.74 Favored Glycine 0 N--CA 1.478 1.499 0 O-C-N 120.663 -1.273 . . . . 2.75 114.348 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -162.17 151.52 15.84 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.675 2.79 . . . . 2.81 106.743 -172.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -71.76 129.57 38.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.932 1.242 . . . . 1.67 111.647 -173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.57 133.52 53.78 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.525 1.13 . . . . 2.69 110.911 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -116.24 126.42 53.58 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.86 1.264 . . . . 2.7 108.415 165.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.9 mt -120.35 119.39 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.479 -0.934 . . . . 1.96 108.479 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -113.29 141.36 47.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 3.22 111.559 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -108.32 126.76 53.21 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.981 0.912 . . . . 2.21 111.802 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.486 ' HA3' ' SG ' ' A' ' 173' ' ' CYS . . . -169.95 -179.77 41.79 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.319 1.438 . . . . 1.33 113.605 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.76 137.91 26.8 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.014 1.407 . . . . 3.74 112.333 -177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.8 t -74.97 70.6 2.01 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.761 1.267 . . . . 3.43 112.249 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.4 -31.25 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.107 0.963 . . . . 7.6 111.138 -149.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 14.1 m -47.9 143.13 6.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.732 1.213 . . . . 2.06 112.316 161.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.88 -59.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.971 2.448 . . . . 3.96 109.999 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.15 137.99 21.23 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.426 -0.953 . . . . 5.37 108.426 136.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 3.4 t -162.21 -55.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.553 3.141 . . . . 3.14 107.283 169.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.486 ' SG ' ' HA3' ' A' ' 165' ' ' GLY . 1.7 m -57.3 -65.31 1.83 Allowed Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.775 1.63 . . . . 1.61 113.237 173.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 173' ' ' CYS . 51.3 Cg_exo -53.64 -44.97 44.48 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.957 2.438 . . . . 1.86 114.73 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -47.98 -46.11 32.22 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.067 1.747 . . . . 3.75 112.067 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 281' ' ' LYS . 1.2 mm-40 -77.5 -40.3 43.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.791 1.178 . . . . 2.64 112.829 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.7 76.6 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.063 -1.023 . . . . 2.86 111.997 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.07 -59.6 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.618 1.967 . . . . 3.38 110.223 165.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -62.84 -37.61 87.48 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.541 -1.349 . . . . 4.79 111.346 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -58.66 -27.28 64.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.493 1.117 . . . . 4.22 113.642 172.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.8 mm -69.05 -55.58 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 120.005 1.275 . . . . 2.14 109.972 171.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -68.29 -17.99 64.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.771 1.623 . . . . 4.85 111.724 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.53 -44.59 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.553 1.07 . . . . 1.57 111.007 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.31 -27.19 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 121.081 1.764 . . . . 2.46 112.88 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.74 -48.3 55.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.952 1.701 . . . . 4.42 113.278 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.73 -32.89 72.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.329 -0.857 . . . . 3.37 112.341 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.83 -50.39 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.931 0.892 . . . . 2.26 111.424 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.38 -22.71 57.29 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.672 1.124 . . . . 5.59 112.747 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.3 m -65.08 -11.45 39.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.287 -0.883 . . . . 3.24 113.268 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.95 -20.23 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 4.17 111.179 164.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.295 70.3 p 128.77 -11.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 1 C-N-CA 132.475 4.31 . . . . 6.32 115.337 152.585 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 t -178.77 71.4 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.065 1.346 . . . . 3.98 112.042 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.97 158.71 52.78 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 121.181 -0.949 . . . . 3.5 111.628 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.86 -9.85 18.2 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.789 2.326 . . . . 3.41 111.912 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . 0.269 17.5 t0 100.81 152.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 130.398 3.479 . . . . 4.21 114.058 162.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 134.12 55.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.175 1.79 . . . . 2.01 112.074 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.7 m -110.42 121.36 41.59 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.946 1.298 . . . . 1.28 109.796 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -89.3 126.43 1.6 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.941 3.094 . . . . 0.94 110.74 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.3 106.29 12.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.519 1.928 . . . . 2.53 110.783 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 115.24 26.17 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.51 -0.744 . . . . 2.88 109.681 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -89.61 112.21 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.198 0.999 . . . . 1.78 109.502 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 6.2 t -71.25 122.23 19.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.755 -0.657 . . . . 1.77 109.908 165.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.0 pt -106.79 48.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.806 1.642 . . . . 2.24 109.662 162.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -104.54 31.41 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.258 1.823 . . . . 4.27 113.39 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.63 -17.89 56.94 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 124.331 3.354 . . . . 2.62 114.234 -162.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -62.81 -23.95 67.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.944 1.298 . . . . 5.55 113.331 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.0 8.91 0.66 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 116.209 1.929 . . . . 6.76 116.209 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -42.11 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.881 3.272 . . . . 4.64 115.462 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.3 m -88.83 125.51 34.94 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 120.801 -1.187 . . . . 2.46 108.761 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -41.09 65.71 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.835 0.854 . . . . 4.2 113.176 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -73.76 -43.03 60.21 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-O 117.306 -1.33 . . . . 5.75 112.699 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.25 60.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.4 1.909 . . . . 1.69 112.621 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.08 -32.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 118.465 -0.779 . . . . 2.4 112.4 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.64 88.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.473 1.488 . . . . 1.36 111.352 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -58.93 -54.64 44.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.747 1.619 . . . . 3.8 108.698 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -47.88 -48.44 31.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.307 0.958 . . . . 3.27 112.9 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.9 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.072 0.851 . . . . 1.23 111.847 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -19.79 63.26 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.293 1.22 . . . . 5.23 114.293 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -69.69 -24.66 63.62 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.347 0.976 . . . . 3.68 112.171 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -89.46 -72.8 0.54 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 2.85 112.571 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 85.8 p -173.51 153.26 2.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 120.711 -1.243 . . . . 2.03 112.869 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.62 -1.68 11.41 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.167 2.578 . . . . 2.09 114.518 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -95.2 2.4 54.95 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.096 1.316 . . . . 2.19 112.573 170.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.0 tp -89.73 139.74 30.27 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.715 -1.241 . . . . 2.0 110.424 173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.29 136.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.512 1.125 . . . . 3.02 108.814 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.73 150.79 18.24 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 124.187 0.898 . . . . 1.24 110.996 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.0 155.98 35.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.987 1.315 . . . . 2.27 110.491 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.6 p -129.1 169.71 14.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.615 2.366 . . . . 2.46 109.484 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.96 148.47 14.23 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 115.879 1.112 . . . . 2.14 115.879 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -62.47 143.29 57.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.662 -0.769 . . . . 2.07 109.395 162.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.31 -21.85 66.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.194 1.183 . . . . 7.39 114.194 -161.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 22.4 mp0 -65.24 -45.36 84.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.645 1.578 . . . . 2.67 111.133 170.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -81.81 -33.9 30.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.905 1.282 . . . . 3.41 111.71 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.05 -36.77 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 118.605 -0.712 . . . . 1.91 111.179 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.38 -45.95 88.7 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.667 -1.158 . . . . 2.91 109.765 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -50.36 -54.21 23.39 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.291 1.405 . . . . 2.43 112.337 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.21 -38.88 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.931 1.241 . . . . 2.27 113.321 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.19 -34.28 77.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.649 0.779 . . . . 1.79 112.296 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -88.98 -32.63 17.54 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.791 2.437 . . . . 3.39 113.198 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.19 70.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.566 1.075 . . . . 1.79 110.537 165.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -85.16 9.7 14.25 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.406 1.082 . . . . 2.75 112.946 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 35.81 46.81 0.35 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.58 2.752 . . . . 4.82 115.053 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.95 136.38 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 109.386 -0.598 . . . . 3.08 109.386 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.22 129.64 37.82 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.174 -0.328 . . . . 4.03 111.352 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.27 108.53 0.73 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.36 1.864 . . . . 4.24 109.764 -160.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 149.7 37.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.062 1.134 . . . . 3.58 114.062 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.23 148.77 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.474 2.782 . . . . 4.73 110.812 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -110.75 165.08 12.15 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.852 1.215 . . . . 4.05 114.265 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -79.4 -176.03 3.05 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 125.015 3.81 . . . . 3.93 111.829 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 250' ' ' LYS . 21.0 mmmt -114.72 130.91 56.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.081 1.752 . . . . 5.44 111.046 164.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.6 p30 173.19 -39.66 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.196 2.198 . . . . 6.38 109.79 -165.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.14 156.33 37.47 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.671 0.748 . . . . 8.33 110.612 136.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -86.58 -37.67 17.9 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.572 0.749 . . . . 7.89 111.209 -161.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.303 2.1 tp10 -169.14 45.5 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.603 2.361 . . . . 8.64 112.665 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -121.99 163.0 20.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.362 1.465 . . . . 4.88 108.593 149.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -149.49 149.17 30.34 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.144 -0.687 . . . . 5.81 109.144 131.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 20.7 tt -72.75 76.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.552 -1.343 . . . . 3.35 110.45 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.7 t -44.94 130.86 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 127.104 2.162 . . . . 2.86 112.726 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -70.26 137.41 50.77 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.732 1.213 . . . . 4.24 111.707 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.12 137.63 19.83 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.865 -1.061 . . . . 1.71 109.703 163.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t -64.23 -24.01 67.51 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.145 1.165 . . . . 3.93 114.145 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.269 0.7 OUTLIER 67.12 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 128.789 2.836 . . . . 4.03 112.966 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.8 tt -156.27 145.29 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.129 -1.607 . . . . 3.15 112.766 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 140.81 32.9 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 127.318 2.247 . . . . 2.95 109.638 164.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.65 145.08 41.86 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.732 0.813 . . . . 3.18 112.501 154.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.6 tp -100.51 130.69 46.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.012 1.725 . . . . 1.95 110.019 168.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.62 133.63 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.672 -1.973 . . . . 2.06 105.672 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.94 -177.48 19.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.168 -0.373 . . . . 1.87 112.168 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.41 42.77 1.36 Allowed 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.742 2.961 . . . . 2.97 110.818 172.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -177.76 -67.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.837 2.455 . . . . 5.2 111.009 -163.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -135.67 142.0 13.26 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 114.704 0.642 . . . . 3.89 114.704 -158.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -86.75 161.21 18.52 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.395 1.478 . . . . 7.23 114.467 -173.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 63.0 53.2 2.4 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.372 1.869 . . . . 4.2 111.974 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 55.5 tp -92.11 -33.46 14.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.564 1.146 . . . . 2.58 112.645 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -162.31 163.34 28.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.045 1.738 . . . . 2.29 109.734 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.66 142.73 11.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.164 0.985 . . . . 4.14 113.604 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -140.2 136.23 33.21 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.125 -0.985 . . . . 3.15 112.22 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.54 -171.27 45.04 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.913 -0.875 . . . . 2.6 110.913 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -63.59 139.44 58.77 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.505 -1.294 . . . . 3.5 107.505 147.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 14.3 t30 149.29 -59.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 129.292 3.037 . . . . 4.88 108.233 -171.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -72.85 158.36 35.68 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.56 0.578 . . . . 7.87 112.56 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -100.44 177.54 5.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.824 1.25 . . . . 5.64 110.541 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -53.25 -48.77 67.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.736 1.214 . . . . 1.78 113.803 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.74 86.08 Favored Glycine 0 N--CA 1.469 0.857 0 CA-C-N 118.416 0.553 . . . . 1.42 112.272 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.92 -28.8 64.77 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.692 1.197 . . . . 3.04 112.785 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 38.5 mt -69.31 -33.21 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.611 -0.681 . . . . 1.87 110.717 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -79.5 -49.47 12.22 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.063 0.847 . . . . 1.54 112.108 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.21 -32.26 73.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.778 1.231 . . . . 1.37 113.938 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 6.7 p -58.68 -61.62 2.47 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.095 0.958 . . . . 1.39 111.221 167.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 68.0 mt -52.78 -45.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.898 1.279 . . . . 1.37 111.357 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.16 -5.77 24.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.257 1.423 . . . . 1.64 114.209 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 86.3 m -89.11 -54.89 3.91 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.102 0.961 . . . . 1.66 108.732 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -53.54 -27.55 26.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.654 1.582 . . . . 2.61 114.321 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -51.03 -22.5 2.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.884 2.473 . . . . 4.21 114.779 170.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -98.8 -36.69 0.24 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.811 2.044 . . . . 6.39 116.387 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.36 -32.91 2.74 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.151 2.567 . . . . 2.57 111.729 166.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 -171.88 2.15 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.49 0.586 . . . . 3.27 110.008 149.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -167.23 175.35 7.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.64 1.576 . . . . 8.13 110.576 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -60.27 131.27 50.26 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.378 -1.452 . . . . 7.81 112.709 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -66.02 -33.73 76.48 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.891 0.876 . . . . 9.38 112.302 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 C--O 1.245 0.829 1 C-N-CA 133.082 4.553 . . . . 11.05 106.422 -158.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 117.451 -1.261 . . . . 14.66 108.821 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -73.96 80.17 1.67 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 120.609 1.549 . . . . 14.58 108.593 163.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.3 p -159.65 122.96 3.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.87 1.668 . . . . 12.19 109.221 -162.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.25 164.01 39.61 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.051 0.834 . . . . 9.69 113.649 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -172.64 148.58 1.82 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.259 1.424 . . . . 11.11 111.011 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.07 126.1 17.24 Favored 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 107.484 -1.775 . . . . 7.01 107.484 155.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.75 39.66 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.506 1.122 . . . . 7.88 111.295 -166.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.44 54.62 2.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.982 1.313 . . . . 6.01 109.612 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.44 -165.9 48.86 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 111.181 -0.768 . . . . 3.33 111.181 -154.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -150.06 130.51 3.3 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 118.648 -1.085 . . . . 2.55 112.661 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -69.47 160.14 50.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.027 2.484 . . . . 2.7 110.772 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -128.85 -155.08 0.68 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.399 1.48 . . . . 2.69 110.57 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -160.17 147.21 16.11 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.801 -1.187 . . . . 3.46 109.659 148.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 tp -156.82 167.27 30.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.049 0.94 . . . . 2.97 110.054 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -109.63 140.51 43.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.732 0.813 . . . . 2.43 110.41 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.1 p -72.08 164.86 25.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.446 1.098 . . . . 2.28 111.396 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -57.58 -12.49 2.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.96 2.504 . . . . 1.63 114.15 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 t -119.83 16.79 12.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.233 2.213 . . . . 3.26 112.537 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.79 -17.32 36.56 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 116.762 1.465 . . . . 2.31 116.762 164.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.28 140.98 55.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.464 1.632 . . . . 4.06 109.808 168.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.26 135.29 56.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.45 1.5 . . . . 8.81 108.694 167.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -142.2 119.09 11.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.025 -1.672 . . . . 3.25 112.705 170.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 94.4 m -132.37 143.26 49.72 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 127.582 2.353 . . . . 3.19 107.336 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.77 -29.3 70.04 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.193 0.997 . . . . 5.64 113.373 -174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 5.21 50.51 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.199 1.555 . . . . 7.81 115.199 174.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -41.47 6.57 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.738 0.699 . . . . 2.83 112.165 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.9 40.46 1.0 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.265 0.839 . . . . 6.38 113.265 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 tp -83.88 169.8 14.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.049 1.34 . . . . 3.33 112.898 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.82 -12.93 51.05 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.368 -1.457 . . . . 2.57 114.798 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 175.62 5.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.111 2.964 . . . . 3.81 109.916 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -88.97 80.31 7.1 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.023 1.283 . . . . 2.18 113.017 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.3 mt -67.29 140.67 57.33 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.849 0.86 . . . . 2.81 112.753 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 28.1 tp -139.16 108.74 6.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.113 1.765 . . . . 2.38 108.518 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.21 131.88 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.305 1.042 . . . . 1.89 108.515 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -128.16 155.42 44.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.681 1.192 . . . . 2.59 109.284 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -121.28 115.82 23.7 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.106 0.963 . . . . 2.22 109.063 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.22 176.12 21.52 Favored Glycine 0 N--CA 1.467 0.708 0 CA-C-O 122.452 1.029 . . . . 1.5 115.139 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -93.95 138.0 32.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.105 0.962 . . . . 3.25 109.9 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -70.54 14.05 0.15 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.338 -0.851 . . . . 3.91 111.872 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -141.81 -73.19 0.32 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.419 -1.425 . . . . 8.56 108.914 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 1.8 t 70.11 174.71 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.793 2.037 . . . . 2.82 111.817 -174.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.403 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 31.9 Cg_endo -67.63 -73.17 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.659 2.906 . . . . 3.85 109.623 143.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.68 16.65 0.08 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.462 1.505 . . . . 4.73 113.08 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.409 HG12 HE22 ' A' ' 279' ' ' GLN . 92.1 t -84.95 -49.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 119.894 -1.754 . . . . 2.86 110.715 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 64.4 m -50.77 -44.54 85.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 116.356 -1.783 . . . . 1.49 114.387 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.01 -34.82 57.48 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 122.57 1.953 . . . . 1.16 113.048 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.88 -38.27 76.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.568 1.531 . . . . 3.2 111.868 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.27 -34.67 73.07 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.314 -1.491 . . . . 3.15 112.665 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.5 tp -68.88 -42.95 76.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.363 1.065 . . . . 2.98 111.067 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.51 -45.34 66.18 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.255 1.422 . . . . 3.35 111.543 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -53.78 -59.61 4.39 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.631 -1.293 . . . . 3.15 111.863 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 5.7 ptp -64.84 -34.53 78.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.361 -0.837 . . . . 2.34 113.194 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 23.7 mm -60.86 -52.91 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 118.108 -0.948 . . . . 1.8 110.734 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.416 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 43.1 mt-30 -68.11 -25.63 65.4 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.753 1.615 . . . . 3.77 110.692 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.51 -41.13 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.05 -0.976 . . . . 1.73 112.634 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.91 -31.87 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.827 1.194 . . . . 2.56 112.217 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.15 -42.85 99.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.265 1.426 . . . . 4.22 111.951 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.15 -54.87 23.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.557 1.543 . . . . 3.04 112.214 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 tp -72.41 -35.3 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.556 0.947 . . . . 2.52 113.556 -163.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.03 -37.32 74.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.166 0.986 . . . . 3.53 111.099 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -68.18 -15.46 63.59 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.114 -0.991 . . . . 2.58 112.946 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.15 -0.05 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 119.838 -1.789 . . . . 2.94 111.651 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.0 m 77.28 -24.08 0.23 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.045 1.498 . . . . 4.08 115.045 144.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.474 HG21 ' HG2' ' A' ' 298' ' ' ARG . 61.8 m -102.65 -0.04 32.47 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.174 1.352 . . . . 4.27 112.133 164.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.27 124.86 91.38 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.206 -1.405 . . . . 3.4 107.206 157.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 -26.43 23.57 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.414 1.409 . . . . 3.82 109.934 160.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.43 175.5 3.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.956 1.702 . . . . 4.0 112.499 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 16.9 tp -137.44 117.64 13.54 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.368 -2.086 . . . . 1.7 105.368 143.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 54.2 m -103.06 106.55 51.43 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 119.778 1.172 . . . . 1.31 110.746 -172.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.14 117.08 4.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.642 2.228 . . . . 0.86 111.292 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 12.1 tp -99.86 94.71 6.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.675 2.39 . . . . 2.28 108.58 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -84.04 104.22 13.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.835 -0.802 . . . . 2.49 108.835 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 44.0 mm -79.48 110.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.575 -0.898 . . . . 1.88 108.575 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 75.7 m -82.16 114.17 20.5 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.132 -0.98 . . . . 3.04 111.001 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.19 2.05 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.095 1.517 . . . . 1.74 115.095 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.01 69.63 1.18 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.756 1.223 . . . . 2.97 110.722 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -79.02 38.14 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.508 3.472 . . . . 2.47 111.501 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -136.4 144.63 44.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 127.475 2.31 . . . . 3.8 105.566 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.95 -37.13 0.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.696 1.599 . . . . 5.06 112.829 -172.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -68.82 161.91 27.53 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.841 1.656 . . . . 4.56 111.595 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.73 152.41 51.74 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.469 1.128 . . . . 3.49 109.568 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -67.27 -21.27 65.72 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.257 0.836 . . . . 5.65 113.257 -167.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 0.5 OUTLIER -101.12 -19.89 15.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.879 2.472 . . . . 3.91 113.298 171.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.81 95.66 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.184 1.811 . . . . 1.58 110.893 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.69 -35.06 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.694 0.627 . . . . 3.26 112.694 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.39 -21.51 62.85 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.165 1.172 . . . . 1.96 114.165 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -79.21 -44.7 21.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.136 0.974 . . . . 3.94 111.102 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -43.9 72.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.542 1.137 . . . . 3.8 111.435 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.4 t -54.6 -44.1 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.731 1.212 . . . . 1.75 112.548 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.25 -35.16 73.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.988 -1.006 . . . . 6.93 112.972 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.22 -47.83 72.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.555 1.142 . . . . 3.39 111.933 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -83.74 -36.67 23.47 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.628 1.344 . . . . 2.7 114.628 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.0 m 154.05 137.31 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 129.451 3.101 . . . . 2.05 112.277 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.19 -8.08 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.037 2.492 . . . . 1.92 114.706 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -78.64 -11.88 59.99 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.584 1.083 . . . . 2.25 112.939 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.65 114.09 23.07 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.387 1.475 . . . . 2.6 107.765 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 18.6 m -96.93 131.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.998 -0.438 . . . . 2.44 110.467 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.54 105.7 2.91 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.733 1.158 . . . . 1.09 111.838 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.34 127.25 37.75 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.768 1.227 . . . . 2.66 110.064 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.2 p -151.15 140.8 21.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.094 1.758 . . . . 3.25 111.374 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.96 -139.64 2.87 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.159 0.885 . . . . 1.85 111.576 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.55 159.06 31.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.159 1.784 . . . . 3.62 110.499 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -65.17 -36.31 83.8 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.103 -0.373 . . . . 6.53 110.331 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -49.9 -55.51 14.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.584 2.354 . . . . 2.99 111.473 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -71.44 -26.98 62.96 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.858 -1.151 . . . . 4.3 113.531 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.55 -38.01 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.358 1.463 . . . . 2.32 110.61 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.39 -32.84 58.79 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.767 1.227 . . . . 5.22 109.884 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -60.16 -57.68 11.78 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 118.121 -0.942 . . . . 2.6 110.326 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.59 -33.51 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.608 1.095 . . . . 2.24 112.322 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.11 -54.3 36.06 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.741 -0.599 . . . . 1.62 110.64 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -70.07 -33.75 72.3 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 117.846 -1.073 . . . . 4.23 112.502 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.06 93.28 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.557 1.143 . . . . 1.65 113.017 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.83 2.75 55.86 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.69 1.196 . . . . 2.66 114.045 173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 77.32 24.17 0.84 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.249 2.62 . . . . 4.69 114.799 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.0 140.29 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.88 1.272 . . . . 2.58 110.747 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -110.07 138.28 46.67 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.23 1.012 . . . . 4.16 112.554 164.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.56 175.38 10.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.479 1.912 . . . . 3.67 110.456 162.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.2 m -163.26 150.65 10.93 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.4 1.08 . . . . 3.62 112.2 165.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.24 165.08 26.16 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.667 2.911 . . . . 2.97 110.755 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.19 153.43 52.92 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.185 0.898 . . . . 2.43 113.963 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -85.74 2.17 7.73 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.196 3.264 . . . . 4.86 115.209 -173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.493 ' HZ1' ' CD ' ' A' ' 254' ' ' GLU . 0.9 OUTLIER 67.33 46.02 1.52 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 120.591 1.541 . . . . 5.27 113.127 -176.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -77.38 160.6 28.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.022 1.729 . . . . 8.49 112.083 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 61.05 -58.74 0.09 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 129.391 3.076 . . . . 8.58 113.518 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 175.41 -32.5 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 130.381 3.472 . . . . 8.84 111.248 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.493 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 9.2 tp10 -137.91 45.91 2.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.685 1.194 . . . . 6.18 112.794 -172.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -75.38 138.36 41.67 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.751 0.786 . . . . 7.35 112.049 157.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -149.32 71.73 1.13 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.854 -1.066 . . . . 3.61 109.52 148.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.4 tp -67.14 175.52 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 O-C-N 121.667 -0.646 . . . . 3.08 111.495 165.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -167.45 75.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 119.316 -2.115 . . . . 4.35 108.972 -157.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -111.81 142.63 43.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.055 0.931 . . . . 5.53 111.305 -153.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -145.81 125.05 12.95 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.178 1.177 . . . . 1.88 114.178 -158.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 53.0 m -84.77 -48.82 9.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.017 0.927 . . . . 4.21 109.666 168.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.323 0.2 OUTLIER 43.36 -150.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.828 1.651 . . . . 6.34 113.622 -174.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 8.8 tt -179.58 161.86 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 129.089 2.956 . . . . 4.3 107.412 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 57.5 mtp -119.52 139.44 52.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.961 1.304 . . . . 2.0 109.957 158.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -120.63 136.72 54.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.94 0.896 . . . . 3.57 110.989 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 7.0 tt -102.22 118.99 38.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.603 1.561 . . . . 2.16 107.968 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.4 135.21 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.129 0.972 . . . . 1.94 109.326 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -63.16 147.9 50.42 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.108 -1.197 . . . . 1.68 110.108 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 62.1 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.013 3.142 . . . . 3.36 109.066 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -174.28 -66.67 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 5.1 110.977 -150.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -156.11 -68.77 0.01 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 117.289 1.676 . . . . 3.42 117.289 -157.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.43 -178.42 7.32 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.723 1.609 . . . . 6.23 109.667 -168.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -70.52 145.73 50.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.143 1.164 . . . . 3.47 114.143 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -132.1 1.99 3.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.372 1.469 . . . . 2.44 113.073 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -160.36 144.21 13.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.104 1.761 . . . . 2.82 108.128 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -154.2 147.13 24.46 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.712 1.205 . . . . 3.85 110.664 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.27 147.28 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.083 1.353 . . . . 3.06 107.806 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -81.87 -152.21 9.77 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 109.485 -1.446 . . . . 3.92 109.485 167.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.409 HE22 HG12 ' A' ' 172' ' ' VAL . 3.0 mt-30 -79.91 67.02 5.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.675 -1.231 . . . . 5.33 107.675 151.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.6 153.63 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.22 2.208 . . . . 5.27 112.657 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 89.19 123.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.411 2.284 . . . . 4.87 107.569 -139.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 25.1 mtt85 -81.15 -177.4 6.44 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.769 -1.197 . . . . 6.09 107.769 158.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -61.4 -40.26 93.73 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.539 -1.35 . . . . 1.85 113.757 -171.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.58 -38.39 94.62 Favored Glycine 0 N--CA 1.473 1.103 0 O-C-N 121.467 -0.77 . . . . 1.7 112.022 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.19 -16.34 63.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.859 1.263 . . . . 3.19 113.471 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.42 -46.96 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.957 -1.089 . . . . 1.37 110.841 169.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.69 79.02 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.291 -0.881 . . . . 1.2 112.015 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.68 -31.83 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.866 1.061 . . . . 1.46 113.866 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.9 p -75.5 -41.92 54.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.62 1.1 . . . . 1.51 111.372 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.39 -43.63 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.143 0.883 . . . . 1.82 111.458 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -62.55 -26.02 68.35 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.928 0.891 . . . . 1.41 113.249 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.2 m -76.6 -52.19 10.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.274 1.029 . . . . 1.64 109.978 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -61.2 -34.13 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 2.07 112.378 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.6 ttt -55.66 -33.67 64.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.221 1.008 . . . . 4.53 111.754 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -58.72 -54.35 57.17 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 116.145 -1.883 . . . . 4.4 112.605 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.68 -51.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.8 3.0 . . . . 2.1 113.136 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -74.24 14.35 0.45 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.046 1.128 . . . . 3.15 114.046 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.474 ' HG2' HG21 ' A' ' 192' ' ' THR . 5.5 ttp-105 -57.44 110.3 0.84 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.923 1.689 . . . . 8.65 112.689 -163.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -71.19 -7.71 48.61 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.484 2.031 . . . . 9.92 116.484 -157.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.72 -15.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 117.602 2.445 . . . . 8.06 117.602 171.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.483 1.198 0 C-N-CA 125.281 1.432 . . . . 7.0 111.798 -174.483 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 118.0 -1.0 . . . . 20.25 109.999 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -78.05 -167.37 1.0 Allowed 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.475 0.58 . . . . 15.45 109.701 156.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.1 t -141.75 -178.88 5.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.238 1.415 . . . . 12.45 110.982 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.07 175.41 50.04 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.878 1.227 . . . . 10.75 113.806 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -76.33 148.39 80.57 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 121.535 -0.979 . . . . 9.6 110.806 170.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 106.24 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.033 1.822 . . . . 7.33 109.492 170.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 73.92 -32.53 0.24 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.677 2.391 . . . . 10.85 114.116 171.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.56 80.04 1.97 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.809 1.244 . . . . 6.8 110.871 -176.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.26 123.89 4.18 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.366 1.936 . . . . 3.46 112.367 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -133.4 117.52 1.92 Allowed Glycine 0 CA--C 1.536 1.398 0 CA-C-O 117.332 -1.816 . . . . 2.35 110.74 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.99 168.26 15.58 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.663 2.909 . . . . 2.41 112.733 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -135.62 150.7 49.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 2.91 111.174 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 t -141.08 75.4 1.5 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.605 -1.309 . . . . 2.24 111.63 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.93 153.38 32.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 3.46 112.41 -166.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.2 m -79.72 128.22 33.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.822 1.249 . . . . 1.46 108.475 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.8 t -80.35 146.51 31.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.979 0.912 . . . . 2.59 110.843 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -56.02 -19.89 14.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.644 2.378 . . . . 1.63 114.598 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.3 t -72.12 -38.98 69.17 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 118.232 -0.89 . . . . 3.09 112.153 170.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 116.41 70.12 0.44 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.724 1.631 . . . . 2.51 113.084 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.91 159.53 15.92 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.176 2.19 . . . . 4.06 107.635 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -109.55 123.69 49.84 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 121.193 1.815 . . . . 5.33 111.4 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -114.55 159.4 20.44 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.833 1.049 . . . . 4.29 113.833 175.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 m -139.7 158.15 44.59 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.181 2.592 . . . . 2.86 106.863 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.98 -39.31 81.39 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.175 0.99 . . . . 4.35 113.541 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.21 -13.06 58.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.826 1.417 . . . . 6.97 114.826 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -77.21 -47.11 21.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.214 0.915 . . . . 4.37 110.168 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.25 -33.99 55.88 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.932 1.293 . . . . 3.49 111.469 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 157' ' ' GLY . 0.6 OUTLIER 73.38 149.7 0.1 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.593 2.757 . . . . 6.18 108.983 -168.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 156' ' ' LEU . . . -71.67 -4.88 59.26 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.353 -1.467 . . . . 5.97 115.433 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -27.02 61.68 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 1 C-N-CA 132.84 4.456 . . . . 3.14 119.659 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 80.5 m95 66.18 35.36 6.12 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.174 1.79 . . . . 2.0 112.008 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 mp -71.24 132.64 45.25 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.531 -0.731 . . . . 3.42 110.092 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.45 111.89 24.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.762 1.625 . . . . 2.53 107.028 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.38 124.91 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.683 -0.858 . . . . 2.18 108.683 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -127.25 130.05 48.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.096 2.158 . . . . 2.7 112.142 -166.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.65 93.76 5.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.232 0.613 . . . . 2.56 111.831 -172.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.86 -174.86 14.01 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.018 1.77 . . . . 1.89 114.972 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.54 179.37 6.6 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.468 1.507 . . . . 4.9 111.906 -167.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.9 m -58.78 -32.47 69.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 115.758 -2.068 . . . . 4.01 116.254 -168.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.6 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.459 2.392 . . . . 10.28 117.459 -172.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.2 m -58.14 120.21 41.35 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-N 121.781 2.082 . . . . 4.18 114.396 -154.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.68 71.11 7.23 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.146 2.564 . . . . 5.75 114.117 -160.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -153.41 -117.39 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.314 2.246 . . . . 6.84 106.851 172.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 6.2 p -54.29 -31.23 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.143 1.777 . . . . 3.99 114.792 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.72 17.36 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 117.494 -1.241 . . . . 2.09 110.289 -173.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.48 -27.11 5.43 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.121 2.547 . . . . 1.25 113.813 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -70.92 -49.79 41.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.625 1.102 . . . . 3.17 111.659 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . 0.274 6.4 mt-10 -72.85 -14.28 61.46 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 119.67 -1.893 . . . . 2.97 112.627 174.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.47 -32.12 70.83 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.728 -1.233 . . . . 2.82 112.577 163.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -49.06 78.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.511 1.05 . . . . 4.9 108.85 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -58.46 -48.09 81.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.103 -0.951 . . . . 3.18 110.607 -175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.3 ptp -63.78 -43.53 96.1 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.724 1.602 . . . . 2.95 113.642 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.41 -53.34 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.438 -0.578 . . . . 1.98 109.438 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.425 ' HB3' ' HZ1' ' A' ' 283' ' ' LYS . 2.2 mp0 -70.56 -24.1 62.73 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 117.162 -1.399 . . . . 5.31 110.932 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.35 -50.79 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 121.911 2.141 . . . . 1.71 111.59 165.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.02 -31.06 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 120.685 1.584 . . . . 2.6 113.017 -173.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -83.09 -29.4 28.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.913 1.079 . . . . 4.73 113.913 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -73.17 -23.09 60.39 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.627 -1.296 . . . . 5.86 112.729 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.55 -50.8 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.474 1.909 . . . . 2.85 111.862 164.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.36 -38.29 73.97 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.821 1.648 . . . . 4.1 112.605 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.1 t -61.24 -22.02 64.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.583 1.553 . . . . 3.4 112.381 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 mm -79.31 11.92 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 O-C-N 120.432 -1.418 . . . . 4.49 111.261 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.7 m 89.63 -38.76 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.107 2.563 . . . . 5.61 113.445 151.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.295 1.1 t -161.09 37.94 0.15 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.625 1.203 . . . . 3.98 114.109 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.06 168.8 13.71 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.433 -0.792 . . . . 4.91 111.637 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.37 120.03 6.92 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.697 1.598 . . . . 5.53 108.959 167.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.93 119.57 13.47 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.804 1.288 . . . . 3.99 110.633 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.2 tp -85.0 97.17 9.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.611 1.565 . . . . 2.33 108.341 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.6 m -77.06 115.14 46.09 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 117.824 -1.084 . . . . 2.21 110.317 -169.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.78 121.15 2.44 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.067 2.511 . . . . 0.93 112.163 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.8 tp -118.75 103.92 10.11 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.59 1.556 . . . . 2.52 110.863 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -86.81 125.48 33.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.877 0.871 . . . . 2.7 111.011 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.69 107.17 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.437 1.095 . . . . 1.81 109.869 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.23 96.64 3.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.198 0.523 . . . . 1.94 110.543 175.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.3 pt -87.0 28.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.228 -0.92 . . . . 2.85 113.405 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -128.68 46.35 2.15 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.828 1.651 . . . . 4.93 114.477 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.12 88.72 0.57 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.827 3.685 . . . . 2.98 109.753 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 231' ' ' ARG . 2.9 mt-10 162.27 -28.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.188 1.795 . . . . 5.15 113.559 -159.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -131.91 9.14 4.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.739 1.216 . . . . 5.09 113.532 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -99.5 -137.65 0.31 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.558 2.343 . . . . 5.12 111.528 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m 155.31 137.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 1 C-N-CA 133.653 4.781 . . . . 2.44 104.739 169.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -41.51 -53.77 3.34 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.237 1.015 . . . . 2.91 112.242 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -70.11 -25.91 63.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.499 1.52 . . . . 3.74 114.386 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.94 -43.04 56.37 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.467 -1.395 . . . . 1.79 111.898 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 mm -64.66 -39.96 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 118.217 -0.897 . . . . 1.94 110.147 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.47 61.33 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.678 1.126 . . . . 1.59 113.188 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -69.82 -44.18 70.5 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.492 1.042 . . . . 3.5 111.465 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.1 -34.24 77.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.548 0.613 . . . . 2.64 112.434 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.87 -41.9 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.456 1.503 . . . . 1.93 111.557 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -46.16 89.77 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.099 -1.001 . . . . 5.37 110.732 174.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -43.12 -53.15 5.12 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.32 1.848 . . . . 4.14 112.034 -163.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -71.07 -73.03 0.19 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.899 1.28 . . . . 2.54 113.554 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.7 m -176.41 150.17 0.98 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.235 1.414 . . . . 2.56 112.292 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.87 5.41 3.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.49 3.46 . . . . 1.86 114.983 -165.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.47 -17.09 62.38 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.932 -1.105 . . . . 3.04 112.57 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.97 135.16 35.4 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.475 1.51 . . . . 1.89 112.539 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.73 136.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.301 1.441 . . . . 1.87 108.823 168.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.55 133.76 11.82 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.16 0.886 . . . . 1.47 112.408 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.8 mp -109.62 142.32 40.9 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.914 1.685 . . . . 2.36 111.005 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 46.0 p -149.64 167.11 27.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.891 2.876 . . . . 3.63 109.696 -166.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 172.58 -155.87 24.03 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.289 0.947 . . . . 1.86 111.226 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.1 t -96.68 172.85 7.64 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.931 1.348 . . . . 2.35 110.597 163.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 206' ' ' GLU . 40.9 ttm-85 -49.36 -30.07 7.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.871 2.069 . . . . 5.74 113.274 177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.42 -53.2 25.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.353 1.461 . . . . 3.78 111.789 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.18 -41.87 84.83 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.065 -1.022 . . . . 3.55 111.466 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 12.5 t -67.67 -29.96 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.994 0.917 . . . . 2.14 112.456 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.43 -49.79 74.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.733 -1.127 . . . . 3.26 108.883 173.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -56.63 -55.65 31.31 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.457 1.026 . . . . 3.71 111.862 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.1 m -67.85 -35.43 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.525 0.565 . . . . 3.19 112.525 -172.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.11 -44.76 68.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.927 0.491 . . . . 1.45 111.086 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -73.29 -36.08 66.24 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.302 1.841 . . . . 3.35 112.508 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.64 -54.09 47.4 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.591 1.156 . . . . 2.67 112.372 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -85.09 2.43 43.46 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.327 0.651 . . . . 2.68 112.451 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 58.47 39.94 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.712 2.405 . . . . 5.66 113.091 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.2 m -69.89 -25.98 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.429 1.27 . . . . 3.49 114.429 -161.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 81.1 t80 66.67 141.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.67 1.988 . . . . 3.85 115.097 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -161.62 159.78 27.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.469 2.308 . . . . 3.64 109.401 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.6 t -164.09 134.32 3.21 Favored Pre-proline 0 N--CA 1.477 0.92 0 O-C-N 120.977 -1.077 . . . . 3.33 112.331 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.67 141.28 21.85 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.414 2.743 . . . . 2.92 112.282 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.95 164.85 51.88 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.079 0.847 . . . . 2.57 114.75 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -82.58 -164.12 0.25 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.741 3.628 . . . . 4.54 110.873 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -87.54 133.22 33.82 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.154 -0.684 . . . . 6.32 109.154 151.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -147.93 152.87 38.27 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.88 0.872 . . . . 8.53 109.622 171.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 55.83 -52.62 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 129.104 2.961 . . . . 9.59 113.819 -157.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -163.33 -51.96 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.018 2.127 . . . . 6.78 110.047 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -162.32 67.26 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.764 1.626 . . . . 5.52 111.014 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -67.28 162.62 22.32 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.894 -1.129 . . . . 4.41 111.701 148.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -146.76 62.54 1.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.202 -0.936 . . . . 3.75 112.325 161.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.7 tp -57.47 164.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.615 1.166 . . . . 2.8 112.009 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.7 t -149.83 136.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 105.786 -1.931 . . . . 2.93 105.786 172.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -66.16 134.36 52.59 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.398 1.079 . . . . 3.47 110.509 172.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -154.34 114.49 3.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.985 0.914 . . . . 2.47 111.371 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.8 p -67.64 -22.98 65.29 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.321 1.448 . . . . 3.15 114.274 -170.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 tp 76.48 -5.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 127.912 2.485 . . . . 5.32 114.025 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 61.8 mt -49.5 133.54 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.154 1.782 . . . . 3.22 111.602 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 11.6 ptm -141.44 143.78 34.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 113.564 -1.653 . . . . 2.37 111.131 -163.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -127.64 145.2 50.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.907 0.883 . . . . 2.81 111.801 -162.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.3 tp -93.88 125.66 38.63 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.513 1.125 . . . . 1.89 109.127 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -100.48 135.6 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.969 1.308 . . . . 2.0 108.149 170.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.38 -177.24 45.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.725 1.155 . . . . 1.89 111.454 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.77 54.48 4.5 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.967 3.111 . . . . 2.57 114.271 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -166.8 -54.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.648 1.979 . . . . 6.47 111.193 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 147.5 -20.81 1.51 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 114.658 0.623 . . . . 2.5 114.658 -160.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.39 144.56 57.08 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.175 0.99 . . . . 7.02 111.778 165.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -74.67 155.95 37.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.23 1.012 . . . . 4.3 112.491 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -36.94 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.606 0.762 . . . . 3.13 112.842 174.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -165.52 172.44 12.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.759 1.224 . . . . 2.08 111.133 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.26 164.54 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.331 1.452 . . . . 3.23 112.945 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.03 -179.21 7.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.737 1.615 . . . . 2.52 111.322 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 119.36 146.33 7.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.326 1.441 . . . . 2.7 113.702 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 40.75 17.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 1 C-N-CA 132.526 4.33 . . . . 4.2 118.135 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.43 -46.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.702 -1.249 . . . . 4.85 112.755 -173.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.27 90.03 0.9 Allowed 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.346 -0.846 . . . . 4.64 110.582 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -67.29 161.26 25.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.405 1.882 . . . . 5.2 112.641 -165.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HZ1' ' HB3' ' A' ' 182' ' ' GLN . 0.9 OUTLIER -42.07 -59.04 1.88 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.691 1.996 . . . . 3.47 115.388 -168.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.92 -34.05 76.21 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.292 -0.88 . . . . 1.48 113.159 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -66.97 -31.56 72.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.124 1.37 . . . . 3.65 111.934 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.6 mt -58.16 -56.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.227 -0.921 . . . . 1.16 109.519 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.88 -40.42 76.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.366 0.506 . . . . 1.22 112.366 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.85 87.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.862 0.865 . . . . 1.41 113.227 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 77.6 p -63.7 -43.44 96.6 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.298 -0.876 . . . . 1.22 111.983 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 49.3 mt -64.71 -37.0 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.036 -1.04 . . . . 1.67 111.436 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.7 -22.84 65.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.304 1.041 . . . . 1.74 113.429 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 39.7 m -71.12 -48.35 52.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.163 -0.68 . . . . 1.84 109.163 169.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -67.38 -26.07 66.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.113 1.365 . . . . 2.7 113.503 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -25.3 63.21 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.888 -1.132 . . . . 5.48 111.8 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -57.19 -40.71 86.78 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 117.364 -1.303 . . . . 4.83 112.608 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.22 -60.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.852 2.368 . . . . 3.3 111.448 160.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.45 31.11 6.02 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.565 1.321 . . . . 5.13 114.565 -156.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.4 136.07 4.32 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.05 -1.032 . . . . 7.33 112.259 172.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -168.13 0.15 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.075 1.75 . . . . 7.55 111.489 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -159.48 24.14 0.19 Allowed 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.384 -1.447 . . . . 11.62 112.701 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.477 0.878 1 C-N-CA 133.207 4.603 . . . . 12.3 106.246 -159.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 118.111 -0.947 . . . . 16.89 108.782 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -159.97 171.41 19.42 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.336 1.454 . . . . 14.26 109.741 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -167.48 163.15 14.82 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.955 1.702 . . . . 11.6 110.161 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.81 -165.32 12.12 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.909 1.242 . . . . 9.6 113.782 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -148.41 151.68 37.09 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.103 1.361 . . . . 10.16 111.364 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.73 174.36 12.81 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.992 2.462 . . . . 7.38 110.397 163.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 135' ' ' LEU . 1.8 pt? -109.75 173.86 6.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.312 1.445 . . . . 6.76 111.301 167.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.19 136.03 39.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.262 1.025 . . . . 5.99 108.61 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.35 -136.59 50.88 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.743 0.687 . . . . 3.29 112.535 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 173.68 164.98 29.73 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.095 0.855 . . . . 2.33 113.898 170.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.51 -170.79 1.06 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.292 3.328 . . . . 2.37 110.049 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -146.46 177.81 8.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.686 1.195 . . . . 2.2 111.081 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -144.38 34.07 1.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.549 1.315 . . . . 2.62 114.549 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 mp -64.83 156.29 31.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.649 1.214 . . . . 2.15 112.636 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -92.72 142.74 27.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.173 1.389 . . . . 1.61 109.05 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -83.62 166.21 18.35 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.861 1.265 . . . . 2.07 111.757 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -3.84 2.32 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.197 1.799 . . . . 1.63 114.958 173.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.6 m -79.03 -36.86 40.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.837 1.655 . . . . 3.21 111.729 164.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.08 11.89 30.92 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.704 1.621 . . . . 1.95 113.679 -164.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 141.07 43.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.122 1.369 . . . . 3.4 110.406 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.33 112.74 24.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.26 1.424 . . . . 5.34 111.46 -164.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.87 158.52 16.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.139 1.375 . . . . 3.08 112.663 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.2 p -115.54 -179.82 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.311 2.245 . . . . 2.53 108.739 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -38.19 88.74 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.844 -0.535 . . . . 3.6 111.841 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -77.88 -6.58 54.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.107 1.521 . . . . 6.46 115.107 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.28 -29.89 70.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.05 0.94 . . . . 2.86 111.724 163.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -100.14 -11.88 20.1 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.095 1.517 . . . . 3.07 115.095 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.34 108.2 1.54 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.579 1.151 . . . . 3.68 111.563 -170.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.13 2.67 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.811 1.196 . . . . 2.79 112.888 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.21 163.85 17.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.193 0.997 . . . . 3.57 109.268 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -78.49 138.53 38.48 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.523 -0.736 . . . . 2.0 109.494 161.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.23 144.02 36.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 122.161 0.982 . . . . 3.11 113.523 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.16 117.88 24.04 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.592 1.157 . . . . 2.67 108.729 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.9 mt -101.93 127.13 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.059 0.943 . . . . 1.74 109.125 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.64 142.14 39.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.73 0.776 . . . . 3.34 111.168 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -99.72 126.9 45.85 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.321 1.049 . . . . 2.22 108.97 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.39 169.34 26.43 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 124.292 0.995 . . . . 1.32 114.721 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -120.07 171.24 8.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.317 1.847 . . . . 4.22 108.018 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 71.2 m -53.82 -12.22 0.51 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.666 2.469 . . . . 3.49 117.666 -166.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -177.22 -27.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 122.427 2.376 . . . . 10.01 116.776 167.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 61.6 m 60.85 174.62 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 117.548 2.425 . . . . 2.86 117.548 167.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.21 164.41 30.45 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.236 1.957 . . . . 3.07 109.865 154.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.09 46.63 0.32 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.086 2.554 . . . . 4.37 113.932 -165.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 94.8 t -111.86 -53.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 127.584 2.354 . . . . 2.9 109.07 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 34.6 t -64.16 -60.84 7.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.187 0.995 . . . . 1.71 112.922 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.69 -24.95 47.13 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.25 1.967 . . . . 1.4 112.635 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -71.2 -55.21 8.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.441 1.096 . . . . 2.81 111.254 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -65.26 -25.84 67.83 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.279 -0.888 . . . . 3.21 112.194 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -65.17 -34.42 78.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.018 -0.991 . . . . 3.21 110.695 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.89 -43.04 59.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.44 1.473 . . . . 3.54 111.788 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -50.22 -39.3 44.09 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.452 -1.405 . . . . 3.58 112.162 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.79 -50.41 43.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.914 1.286 . . . . 3.12 112.426 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.77 -37.16 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 120.789 1.631 . . . . 1.87 112.025 -174.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.531 ' C ' ' HE3' ' A' ' 283' ' ' LYS . 54.3 mt-30 -56.09 -27.57 54.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.84 1.2 . . . . 3.48 111.522 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 36.0 t -68.75 -20.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 120.586 -1.321 . . . . 2.2 111.771 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 35.9 t -67.28 -38.82 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.856 0.753 . . . . 2.15 109.479 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -49.99 74.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.486 1.114 . . . . 5.03 110.963 171.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.27 -25.54 63.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.5 1.12 . . . . 3.03 113.781 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.15 -45.33 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.986 1.715 . . . . 2.26 112.703 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.36 -32.37 66.7 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.476 1.035 . . . . 3.69 111.1 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.7 t -61.54 -20.23 63.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.565 1.546 . . . . 2.92 112.901 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.08 -16.94 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 120.897 -1.127 . . . . 3.41 111.701 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.5 t 56.47 -7.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.694 3.197 . . . . 5.14 118.633 165.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 67.4 p -109.18 9.25 26.08 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 120.802 1.637 . . . . 3.52 114.411 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.92 160.92 29.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.226 1.81 . . . . 3.23 112.847 -168.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -82.8 51.56 3.74 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.282 3.321 . . . . 3.52 110.729 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.1 t0 57.94 -175.84 0.08 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.332 2.253 . . . . 4.48 115.405 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.94 118.06 28.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.969 1.308 . . . . 1.97 108.63 155.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.5 m -98.88 99.92 8.76 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.437 1.495 . . . . 1.22 109.983 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.09 133.02 17.46 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.96 2.44 . . . . 0.9 111.649 170.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.38 89.21 3.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.103 2.161 . . . . 2.51 108.161 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -83.7 130.86 34.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.716 0.806 . . . . 1.91 109.575 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.7 mt -108.55 122.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.892 0.877 . . . . 1.71 109.855 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.4 m -67.34 119.61 12.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.587 0.755 . . . . 2.43 110.839 166.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.29 -3.55 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 120.955 -1.091 . . . . 2.58 113.721 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -111.81 57.34 0.46 Allowed Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 127.381 2.272 . . . . 4.24 113.554 -170.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.94 75.9 2.62 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.866 3.711 . . . . 2.75 109.966 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -173.42 -35.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.846 2.458 . . . . 3.61 111.473 -169.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.34 32.52 2.83 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.028 0.931 . . . . 5.76 112.388 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -119.99 173.29 7.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.912 2.485 . . . . 4.01 109.673 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.3 m -169.2 139.98 2.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.275 2.63 . . . . 2.89 107.143 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -36.61 66.82 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.434 0.901 . . . . 3.44 113.434 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -79.59 -28.0 41.1 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.893 2.077 . . . . 3.85 112.67 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.45 42.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.797 0.726 . . . . 2.03 110.084 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.1 tp -62.01 -31.6 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.72 0.408 . . . . 2.31 111.989 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.62 95.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.184 -0.948 . . . . 1.24 111.826 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -69.21 -29.22 67.13 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.196 0.813 . . . . 4.21 113.196 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -68.1 -48.36 65.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.544 1.138 . . . . 3.61 110.778 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 10.1 t -52.2 -45.74 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.166 -0.959 . . . . 1.31 111.519 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -59.88 -18.67 46.25 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.39 1.476 . . . . 5.22 113.188 176.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.91 -48.03 80.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.959 1.708 . . . . 4.77 110.927 171.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -87.82 -53.2 4.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.347 0.869 . . . . 2.84 113.347 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.7 p -177.33 159.61 1.39 Allowed Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.634 -1.291 . . . . 3.22 112.91 -159.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -86.24 -16.0 4.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.716 2.944 . . . . 2.08 113.807 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -85.61 -4.44 59.16 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.788 1.176 . . . . 2.35 113.52 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.89 136.79 36.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.942 0.897 . . . . 2.33 111.171 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 t -110.99 131.36 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.574 -1.269 . . . . 2.02 107.574 163.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.73 114.65 4.59 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 109.497 -1.441 . . . . 1.01 109.497 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.4 144.35 33.21 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.665 0.786 . . . . 2.13 110.756 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -157.79 -179.7 8.39 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.641 1.576 . . . . 2.6 110.785 -172.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 167.42 -116.69 0.69 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.255 -1.138 . . . . 1.84 110.255 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.5 p -128.0 168.0 15.91 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.613 1.165 . . . . 3.04 112.211 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -39.36 46.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.67 0.788 . . . . 5.79 111.248 -177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 2.2 mp0 -59.76 -54.23 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.293 2.237 . . . . 3.52 113.131 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -69.46 -31.68 70.13 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.879 -1.138 . . . . 4.98 111.831 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.43 -29.61 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 117.944 -1.027 . . . . 1.68 111.625 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.29 -42.53 88.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.031 1.287 . . . . 3.18 110.227 162.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -56.49 -50.5 71.59 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 117.987 -1.006 . . . . 2.85 112.622 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.4 m -71.2 -26.86 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 120.583 1.538 . . . . 2.48 114.576 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.451 ' HB1' HG22 ' A' ' 243' ' ' VAL . . . -65.57 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.615 1.098 . . . . 1.51 112.628 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -105.09 -21.76 13.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.772 3.229 . . . . 5.96 113.467 -167.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.72 -28.99 64.06 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.472 1.033 . . . . 1.97 112.268 162.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.08 -127.06 0.15 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.402 1.081 . . . . 2.66 109.404 164.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -164.78 74.71 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.572 1.149 . . . . 5.7 110.145 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.451 HG22 ' HB1' ' A' ' 238' ' ' ALA . 7.5 m -83.63 173.92 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 111.765 0.283 . . . . 3.45 111.765 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.423 ' CD2' HG22 ' A' ' 261' ' ' THR . 13.0 p90 -147.8 154.19 40.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.126 1.371 . . . . 6.75 110.737 166.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -154.94 125.43 6.89 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.524 1.53 . . . . 4.32 111.176 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 38.6 t -106.74 110.54 63.76 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 120.795 -1.19 . . . . 3.89 109.257 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.99 144.52 38.3 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.524 2.149 . . . . 3.21 111.367 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -87.73 -173.65 48.01 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.892 1.234 . . . . 3.02 115.092 -175.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.58 53.97 4.97 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 125.048 3.832 . . . . 5.27 112.579 -172.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 250' ' ' LYS 0.26 0.0 OUTLIER -63.1 123.5 18.76 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.85 -1.156 . . . . 4.99 110.989 177.369 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 103.22 -8.88 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.318 1 C-N-CA 131.755 4.022 . . . . 10.06 113.309 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -81.88 -48.65 11.27 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.985 1.266 . . . . 10.28 112.591 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -156.65 49.33 0.47 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.561 0.949 . . . . 8.72 113.561 -170.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 76.99 -1.05 2.88 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 127.776 2.431 . . . . 8.38 112.802 171.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.67 151.06 21.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.34 1.456 . . . . 4.97 114.496 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.96 71.55 0.68 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 113.964 -1.471 . . . . 3.22 109.431 145.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.0 tp -83.95 154.07 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.384 -0.823 . . . . 2.93 111.639 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.7 134.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 129.449 3.099 . . . . 2.94 105.635 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.83 168.0 14.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.162 0.982 . . . . 3.22 110.397 165.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -150.46 36.26 0.65 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.079 0.943 . . . . 3.65 110.907 168.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.423 HG22 ' CD2' ' A' ' 244' ' ' TYR 0.266 13.7 p 65.51 -134.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.54 2.336 . . . . 3.55 110.999 -171.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 176.19 -17.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 129.029 2.932 . . . . 5.21 110.795 -163.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 62.4 mt -69.92 134.03 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.57 1.148 . . . . 2.79 109.546 170.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.8 ttm -119.6 137.49 53.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.3 1.84 . . . . 2.94 108.206 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.97 127.59 51.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.677 0.791 . . . . 3.52 112.18 -159.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 19.3 tp -101.83 130.74 48.36 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.595 1.158 . . . . 1.95 112.075 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.9 151.3 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.296 1.838 . . . . 1.82 106.297 166.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -142.55 -135.07 3.02 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 121.268 -0.895 . . . . 1.99 113.0 175.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.11 1.61 7.02 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.654 2.903 . . . . 2.46 113.545 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.87 -47.0 55.93 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.23 2.212 . . . . 5.61 113.723 172.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.88 13.09 54.45 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 117.628 -1.651 . . . . 3.01 116.746 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.57 -70.7 0.35 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.065 1.432 . . . . 4.16 111.883 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -166.69 146.96 5.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.164 0.985 . . . . 4.64 111.915 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.45 -33.01 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.424 1.639 . . . . 2.72 115.424 -170.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -168.52 167.94 11.33 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.11 1.323 . . . . 2.56 112.76 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.45 152.55 32.11 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.694 1.738 . . . . 3.21 115.694 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -120.33 163.71 17.42 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.888 1.275 . . . . 2.64 110.481 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -167.08 102.56 0.19 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.326 -0.859 . . . . 4.08 111.765 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 64.15 164.06 0.13 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.24 1.416 . . . . 3.68 110.965 -162.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 37.8 t30 77.1 -57.2 0.52 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.309 1.843 . . . . 5.83 112.467 165.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? 49.71 19.97 0.47 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 127.085 2.154 . . . . 9.88 116.226 162.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.39 142.38 56.98 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 119.139 -2.226 . . . . 5.61 110.612 -163.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.531 ' HE3' ' C ' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -46.03 -52.18 12.36 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.192 0.997 . . . . 2.38 113.593 -170.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.37 -23.28 71.71 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.506 -1.164 . . . . 1.45 114.647 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -74.07 -49.14 25.38 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.494 1.647 . . . . 3.36 110.378 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.66 -47.73 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.324 0.649 . . . . 1.28 109.389 174.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.96 75.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.207 -0.901 . . . . 1.35 112.516 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.43 91.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.925 1.239 . . . . 1.3 112.752 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 91.5 p -60.02 -57.35 13.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.932 0.333 . . . . 1.36 111.562 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.34 -35.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.754 -1.216 . . . . 1.45 110.993 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.37 73.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.825 1.25 . . . . 1.85 113.921 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 14.4 t -76.25 -33.27 59.18 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.182 1.356 . . . . 2.88 111.452 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -70.87 -24.59 62.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.976 0.91 . . . . 2.18 113.26 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.5 mtt -54.1 -40.95 67.73 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.432 -1.418 . . . . 5.8 111.467 163.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -59.01 -45.09 99.59 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 115.714 -2.089 . . . . 4.43 114.557 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.85 -7.55 11.32 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.606 2.87 . . . . 2.26 114.429 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -119.85 -154.65 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 120.027 1.285 . . . . 3.43 113.4 -171.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -69.59 121.59 17.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.027 -1.671 . . . . 11.07 111.354 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -164.3 0.51 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.821 1.786 . . . . 9.57 115.821 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 79.4 mttt 34.91 45.57 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 127.379 2.271 . . . . 10.12 116.4 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.255 1.373 0 C-N-CA 129.598 3.159 . . . . 8.61 107.686 -170.532 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 118.044 -0.979 . . . . 19.06 109.83 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -63.95 157.58 24.57 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.879 0.763 . . . . 17.03 110.758 164.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 t -175.82 167.33 3.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.595 2.758 . . . . 13.93 108.666 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 93.36 159.75 34.88 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.763 1.173 . . . . 12.0 113.264 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -173.84 155.03 2.4 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.558 1.543 . . . . 13.64 111.903 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.25 150.9 29.47 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.771 2.314 . . . . 11.07 112.167 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.6 tt -171.45 134.84 0.88 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 129.733 3.213 . . . . 9.78 106.588 162.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 tp -164.57 -178.69 5.51 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.013 0.925 . . . . 5.36 111.118 -168.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.08 155.26 19.18 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.179 1.371 . . . . 3.72 110.098 154.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.1 -84.28 0.36 Allowed Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.216 -1.325 . . . . 4.17 112.1 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.57 148.02 90.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.837 2.358 . . . . 4.02 112.136 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -151.23 171.76 16.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 3.21 111.988 -174.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 p -139.04 42.28 2.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.954 1.835 . . . . 3.7 115.954 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.49 152.64 21.34 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 119.902 -1.749 . . . . 3.57 112.699 -170.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.9 m -92.14 139.65 30.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.682 1.193 . . . . 2.47 110.155 -173.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.2 p -84.38 159.79 20.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.037 0.935 . . . . 2.51 112.587 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -9.36 2.07 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.479 1.512 . . . . 1.82 115.0 169.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 99.7 m -71.68 -53.68 12.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.463 1.105 . . . . 3.72 109.858 164.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.63 -10.84 8.0 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.358 1.933 . . . . 3.05 113.619 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 148.73 27.96 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 124.83 1.252 . . . . 5.14 111.112 171.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 97.59 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.695 1.198 . . . . 6.15 111.663 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -95.66 161.94 13.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.178 1.177 . . . . 4.7 114.178 -171.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -112.43 169.5 8.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.2 1.8 . . . . 2.88 110.773 164.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -41.87 -42.68 2.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.914 2.486 . . . . 4.1 113.213 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -82.04 -22.68 36.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.168 1.173 . . . . 7.17 114.168 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.24 -14.39 60.92 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.928 0.871 . . . . 3.86 111.936 165.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -102.88 9.96 38.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.968 2.507 . . . . 3.16 114.782 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.35 156.38 26.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.614 1.552 . . . . 3.17 115.003 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.59 43.05 Favored Glycine 0 N--CA 1.478 1.463 0 C-N-CA 124.818 1.199 . . . . 2.66 115.656 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -140.39 162.68 34.74 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.917 2.487 . . . . 3.3 109.695 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.8 131.6 43.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.259 0.552 . . . . 2.14 111.943 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.8 mt -108.09 125.39 51.53 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.035 1.334 . . . . 2.75 109.781 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.443 HD11 ' HG ' ' A' ' 196' ' ' LEU . 4.8 mp -121.57 103.99 9.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.624 1.169 . . . . 3.41 108.094 -173.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.3 mt -117.67 124.97 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.934 0.893 . . . . 2.01 109.934 -155.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -142.37 155.12 45.12 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.007 1.323 . . . . 2.25 112.159 -165.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.87 122.63 39.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.752 1.221 . . . . 2.8 111.114 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.69 -154.66 8.25 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.538 1.066 . . . . 1.26 112.653 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -168.02 169.32 11.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.721 1.608 . . . . 3.51 111.42 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.27 13.5 t -77.97 30.9 0.17 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 119.602 -1.936 . . . . 4.13 112.75 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -97.43 -29.79 13.29 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.777 1.631 . . . . 7.23 113.775 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 60.4 m -104.72 153.11 39.5 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 116.221 1.934 . . . . 2.88 116.221 -165.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.21 -22.27 2.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.886 3.058 . . . . 4.49 113.534 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -140.65 -58.19 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.948 1.092 . . . . 4.79 113.948 -171.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.7 p -60.36 -32.41 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.675 1.59 . . . . 3.29 114.687 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 6.8 m -74.89 -66.11 0.47 Allowed Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.167 0.894 . . . . 1.51 112.129 161.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.69 -28.5 68.92 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.713 1.608 . . . . 1.16 115.154 -166.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -71.32 -30.47 66.26 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.762 1.619 . . . . 3.04 112.49 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.67 -40.48 72.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.808 0.731 . . . . 3.12 110.448 168.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.45 -37.66 74.38 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.873 1.215 . . . . 3.26 113.05 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.03 -58.82 5.89 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.315 1.446 . . . . 4.21 110.205 165.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -56.68 -40.98 76.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.081 1.352 . . . . 3.23 112.972 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 48.3 mtp -60.62 -40.75 93.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.929 1.692 . . . . 2.89 112.529 172.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 9.6 tp -87.41 -37.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.693 1.588 . . . . 2.62 112.678 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -53.2 -43.28 67.08 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 124.762 1.225 . . . . 3.48 110.704 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.86 -13.56 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 113.801 1.037 . . . . 2.07 113.801 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.2 -23.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.998 -1.064 . . . . 2.0 111.603 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -50.37 67.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.746 0.818 . . . . 4.68 112.187 -170.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.54 -19.1 65.24 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.673 1.589 . . . . 3.37 114.115 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -56.49 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 120.914 -1.116 . . . . 2.51 109.347 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.78 -36.99 82.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.605 1.162 . . . . 4.0 112.159 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -71.87 -7.61 49.49 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.773 1.027 . . . . 3.36 113.773 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 20.5 mm -103.34 -29.72 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.128 0.876 . . . . 4.7 111.095 168.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.0 m 72.73 -25.88 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 127.56 2.344 . . . . 6.15 114.211 157.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 56.0 m -74.81 -2.67 27.67 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.794 3.237 . . . . 3.93 112.673 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 mp -99.26 157.66 33.64 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.594 1.558 . . . . 3.32 110.075 -174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.46 143.68 48.14 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.28 1.987 . . . . 3.62 108.183 155.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.26 159.31 3.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 116.078 1.881 . . . . 3.5 116.078 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.443 ' HG ' HD11 ' A' ' 161' ' ' LEU . 7.1 mp -99.19 95.52 7.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.246 -1.39 . . . . 2.84 107.246 157.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.4 m -86.95 112.04 44.63 Favored Pre-proline 0 N--CA 1.475 0.786 0 N-CA-C 108.126 -1.065 . . . . 1.28 108.126 168.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -86.82 136.86 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.789 2.326 . . . . 0.89 109.86 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.15 123.11 16.6 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.484 1.135 . . . . 3.6 112.442 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -109.45 133.15 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.535 1.534 . . . . 2.21 110.554 -160.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 36.3 mm -99.55 122.01 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.154 0.981 . . . . 1.83 110.516 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 95.6 p -74.07 124.61 26.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.102 0.561 . . . . 3.53 110.097 165.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.5 pt -94.05 -18.05 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.322 1.601 . . . . 2.2 115.322 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -119.48 59.38 5.17 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 120.419 1.463 . . . . 2.67 114.367 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.54 99.57 0.21 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.43 2.087 . . . . 2.68 107.393 165.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 165.65 -45.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.986 2.515 . . . . 4.46 108.523 -147.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 -18.19 0.6 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.927 1.455 . . . . 5.56 114.927 151.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.66 136.77 54.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.847 1.203 . . . . 4.3 109.394 155.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.2 t -154.0 155.73 36.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 3.5 112.384 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -58.1 -47.04 84.47 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.484 1.914 . . . . 2.8 113.983 -163.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -71.66 -38.69 70.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.328 1.422 . . . . 3.54 112.77 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.7 93.99 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.221 -0.924 . . . . 1.46 111.14 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 mm -61.3 -39.77 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.057 0.943 . . . . 1.87 111.736 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.45 86.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.629 1.104 . . . . 1.44 112.309 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -62.55 -52.71 62.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.922 0.783 . . . . 3.2 111.811 168.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -55.58 -32.17 62.81 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.726 1.21 . . . . 2.95 113.519 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 224' ' ' LEU . 2.4 t -65.35 -58.16 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.02 2.128 . . . . 1.3 112.576 166.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -52.91 -48.14 67.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.953 0.901 . . . . 3.82 112.181 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.63 -20.46 58.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.231 0.957 . . . . 5.02 112.627 -162.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -79.86 -56.14 4.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.79 0.723 . . . . 2.84 110.875 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.8 m 169.14 132.25 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 127.297 2.239 . . . . 2.32 112.208 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.19 7.34 1.44 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.394 3.396 . . . . 3.11 116.094 -168.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -67.94 -35.33 78.22 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 120.205 1.366 . . . . 2.36 110.768 159.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 217' ' ' VAL . 7.0 tt -62.08 118.51 7.43 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.258 -1.386 . . . . 2.11 107.258 173.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.85 131.38 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.098 -1.075 . . . . 2.04 108.098 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -93.51 127.78 9.18 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.117 -1.593 . . . . 1.09 109.117 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.48 144.92 50.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.837 0.827 . . . . 2.27 111.291 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 26.1 p -140.36 176.15 9.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.706 2.002 . . . . 2.81 109.255 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -175.69 -154.55 11.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.183 -1.967 . . . . 2.23 108.183 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.5 p -81.94 171.99 13.8 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.331 0.586 . . . . 4.05 110.615 167.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -63.07 -23.99 67.7 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.756 -0.59 . . . . 6.76 112.085 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 232' ' ' GLU . 16.2 mp0 -80.8 -31.12 35.81 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.536 1.934 . . . . 3.88 111.913 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.15 -41.51 73.74 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.916 -1.115 . . . . 4.96 109.691 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.99 -38.69 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.268 -0.895 . . . . 2.39 111.92 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.09 -39.32 79.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.423 -0.799 . . . . 3.71 111.143 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -52.33 -58.87 5.32 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.737 -1.125 . . . . 3.59 110.377 173.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.26 -31.61 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.79 1.177 . . . . 2.85 113.17 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.97 -50.75 38.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.54 1.064 . . . . 2.36 111.37 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -36.95 74.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.003 1.721 . . . . 7.97 112.402 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.21 65.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.689 1.132 . . . . 2.69 110.724 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -76.17 -7.85 55.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.555 0.742 . . . . 2.93 112.827 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 26.3 ttp-105 71.06 38.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.567 2.347 . . . . 7.69 112.431 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.69 138.92 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.365 1.466 . . . . 4.28 108.659 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -105.85 136.86 44.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.222 0.534 . . . . 4.66 111.177 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -89.85 144.2 26.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.897 0.479 . . . . 3.16 109.912 164.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 t -119.69 94.2 48.26 Favored Pre-proline 0 N--CA 1.477 0.906 0 O-C-N 120.895 -1.128 . . . . 3.31 112.704 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.78 138.76 9.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.362 2.708 . . . . 2.91 113.149 -171.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.49 -177.64 51.25 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 123.78 0.705 . . . . 2.47 112.503 163.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -82.59 151.08 14.94 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.393 2.729 . . . . 3.23 110.615 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.1 128.55 19.27 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.961 1.304 . . . . 5.04 112.034 159.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -129.82 162.66 28.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.455 0.702 . . . . 6.46 112.194 174.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 39.34 -109.41 0.08 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.763 2.025 . . . . 8.2 111.989 -158.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -106.37 -38.81 6.1 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.883 0.765 . . . . 8.99 112.069 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -170.17 75.05 0.08 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 127.151 2.18 . . . . 7.83 109.655 167.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -94.07 162.58 13.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.647 -1.16 . . . . 3.77 109.729 132.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . 0.262 6.9 p90 173.25 160.02 0.13 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.515 2.326 . . . . 3.94 112.397 140.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.4 tp -105.39 148.73 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.054 1.342 . . . . 3.03 111.338 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.9 132.61 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.452 -2.055 . . . . 3.27 105.452 161.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.42 139.17 43.81 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.561 0.618 . . . . 4.11 111.298 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -131.41 93.9 3.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.936 0.894 . . . . 2.3 110.876 161.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.7 t -48.2 122.53 5.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.525 0.73 . . . . 4.94 110.266 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 10.5 pt -88.07 101.1 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.816 0.817 . . . . 4.78 112.372 -165.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.1 mt -132.57 127.04 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.973 1.309 . . . . 2.79 108.05 162.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.8 ptm -94.0 130.48 40.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.268 0.627 . . . . 2.78 109.734 162.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -97.92 135.14 40.08 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.215 -0.928 . . . . 3.26 111.233 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 108.96 19.68 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.269 -1.012 . . . . 2.09 108.269 168.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.7 mm -93.73 135.8 27.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.627 -1.249 . . . . 2.91 107.627 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -69.08 176.61 29.86 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 122.872 0.272 . . . . 1.92 112.535 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.4 39.96 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 125.256 3.97 . . . . 2.64 112.153 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -161.11 -36.45 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.3 2.24 . . . . 4.89 113.53 -158.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 115.86 0.0 21.34 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 117.169 -1.906 . . . . 3.1 116.307 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -99.4 157.94 16.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.898 1.849 . . . . 5.33 111.195 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -74.28 108.21 6.93 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.111 1.365 . . . . 3.9 110.386 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.33 -28.59 16.1 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.575 0.75 . . . . 2.68 112.275 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -170.79 -179.71 2.93 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.756 1.622 . . . . 2.66 111.842 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -158.87 157.71 32.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.648 1.979 . . . . 3.99 112.321 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -147.7 -179.46 6.9 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.517 1.927 . . . . 2.83 111.394 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.75 -100.87 0.23 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.816 1.198 . . . . 4.16 112.362 174.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -67.38 -30.28 70.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.937 -1.331 . . . . 4.66 113.461 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.95 137.39 50.32 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.758 0.823 . . . . 4.58 109.508 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.54 86.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.641 0.777 . . . . 4.33 110.641 -143.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -89.02 -164.38 1.13 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.83 1.652 . . . . 9.69 109.227 156.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -29.61 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.636 2.374 . . . . 2.24 116.446 -168.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -77.71 -20.95 72.99 Favored Glycine 0 N--CA 1.476 1.327 0 CA-C-N 118.945 0.793 . . . . 1.8 112.74 -168.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -18.73 30.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.386 0.674 . . . . 5.06 112.168 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.92 -49.69 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.105 -0.997 . . . . 1.45 109.379 156.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.47 70.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.144 0.883 . . . . 1.36 113.169 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.22 60.06 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.279 1.215 . . . . 1.36 114.279 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 64.3 p -69.56 -52.55 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.618 -0.676 . . . . 1.74 111.689 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.5 mm -58.48 -42.51 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.256 -0.903 . . . . 1.93 109.708 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.08 -11.97 23.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.087 1.755 . . . . 2.09 114.248 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.9 m -97.39 -54.95 2.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.084 1.354 . . . . 1.95 109.566 170.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -64.09 -25.58 68.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.362 1.465 . . . . 2.5 113.986 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 35.7 mmm -65.53 -20.51 66.37 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.525 1.13 . . . . 4.76 113.987 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -62.45 -48.58 86.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 116.12 -1.895 . . . . 4.8 112.257 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.35 -43.71 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.61 2.207 . . . . 1.93 112.05 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.14 53.2 2.74 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.105 1.15 . . . . 2.58 114.105 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 114.53 -98.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 130.258 3.423 . . . . 10.73 111.477 165.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -151.88 165.07 35.67 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.215 1.191 . . . . 10.31 114.215 -159.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.7 -49.94 0.59 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.593 1.157 . . . . 13.83 109.69 168.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.247 0.948 0 C-N-CA 128.445 2.698 . . . . 9.8 107.951 150.407 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 118.376 -0.821 . . . . 24.81 110.287 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -68.45 168.91 11.78 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.875 0.761 . . . . 19.08 110.936 159.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 t -138.08 168.11 20.41 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.032 1.733 . . . . 17.53 108.256 154.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.51 -156.72 34.62 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.027 1.299 . . . . 13.32 113.949 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . 0.279 1.5 mptm? 118.88 -59.21 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.379 1 C-N-CA 132.901 4.48 . . . . 13.13 110.894 176.365 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.89 165.75 31.92 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.713 1.609 . . . . 8.61 109.437 153.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 pp -175.86 163.39 2.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.831 2.852 . . . . 7.54 108.638 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.9 mt -124.71 -113.63 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.236 1.414 . . . . 6.68 110.394 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.44 18.11 28.4 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.288 1.423 . . . . 4.86 114.907 -173.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.24 111.79 4.47 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.066 -1.408 . . . . 2.73 111.314 -170.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.5 157.59 28.85 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.976 2.451 . . . . 3.16 112.403 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -131.13 168.85 16.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.327 1.851 . . . . 2.92 111.538 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.4 p -125.49 22.12 7.72 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.772 2.138 . . . . 3.6 116.772 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.1 mp -73.92 162.34 29.17 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.837 1.051 . . . . 2.05 113.837 -163.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 142.6 30.69 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.536 1.534 . . . . 2.02 109.8 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.0 m -98.53 140.26 33.04 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.089 1.756 . . . . 2.88 110.243 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -47.53 -20.86 0.27 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.405 2.682 . . . . 1.78 116.445 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.4 t -90.08 -7.39 53.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.802 1.241 . . . . 3.73 113.798 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.21 38.43 4.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.433 1.015 . . . . 3.46 113.265 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.49 -172.99 3.56 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.226 1.41 . . . . 5.24 110.016 172.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -152.9 136.82 16.26 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.459 1.027 . . . . 6.78 109.709 -156.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.545 ' HE2' ' CE2' ' A' ' 155' ' ' TYR . 8.8 mptt -132.16 167.28 20.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.747 1.758 . . . . 4.24 115.747 -168.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 88.2 m -164.91 156.17 14.86 Favored 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 132.732 4.413 . . . . 3.09 105.232 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -52.51 -42.27 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.808 1.185 . . . . 3.69 113.049 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -3.93 9.73 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.156 1.539 . . . . 8.35 115.156 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -87.36 -20.08 27.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.742 1.217 . . . . 3.11 112.767 166.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.545 ' CE2' ' HE2' ' A' ' 150' ' ' LYS . 7.8 m-85 -109.0 -20.45 13.03 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.039 1.496 . . . . 3.4 115.039 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 137.14 31.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.204 1.402 . . . . 3.3 112.304 -171.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.85 58.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.81 1.195 . . . . 2.26 112.778 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -107.34 165.4 11.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.697 1.999 . . . . 3.28 108.296 161.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -89.61 137.48 32.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.136 -0.69 . . . . 2.19 109.136 170.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.5 pp -137.47 154.3 49.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.513 0.673 . . . . 2.73 112.471 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.5 mt -121.45 114.79 21.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.147 1.779 . . . . 2.28 109.141 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.75 120.94 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.341 0.973 . . . . 2.33 108.959 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.13 134.34 54.75 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.261 1.025 . . . . 2.22 111.478 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.38 118.19 36.34 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.632 0.773 . . . . 3.24 110.164 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.67 -178.41 15.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.294 1.426 . . . . 1.62 114.806 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -144.61 124.06 13.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.594 0.757 . . . . 3.8 111.206 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.268 1.5 p -81.08 28.77 0.35 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.318 -1.489 . . . . 3.31 114.679 -174.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -146.16 39.38 1.1 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 127.076 2.151 . . . . 7.46 109.322 162.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.97 147.42 94.22 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 116.133 1.901 . . . . 2.85 116.133 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -76.68 63.89 7.42 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.819 3.013 . . . . 4.66 110.2 157.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 66.37 -18.2 0.11 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 130.022 3.329 . . . . 4.5 116.66 163.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.51 -30.16 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.244 -0.91 . . . . 3.57 112.782 -170.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 17.5 m -58.58 -64.41 2.9 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 116.745 -1.598 . . . . 1.62 112.03 166.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -63.27 -26.32 71.88 Favored 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 121.756 1.663 . . . . 1.42 113.88 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.55 -59.69 3.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.924 1.238 . . . . 3.04 111.308 171.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.66 -29.68 69.04 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.576 0.751 . . . . 3.48 111.936 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.94 -28.18 67.25 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.376 -1.452 . . . . 3.28 112.423 170.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -69.93 -49.66 49.72 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.354 0.979 . . . . 3.9 109.378 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -55.69 -39.47 71.04 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.788 -1.195 . . . . 3.96 112.004 176.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.3 ttm -55.78 -48.73 74.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.298 1.839 . . . . 2.85 111.714 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 12.6 mm -66.06 -37.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 120.362 1.437 . . . . 1.52 110.464 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -62.33 -31.97 72.67 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.049 -1.453 . . . . 3.14 113.321 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.3 p -86.39 -34.77 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.788 1.176 . . . . 2.49 114.151 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 14.4 t -57.14 -44.45 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.896 1.226 . . . . 2.66 111.32 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.67 -31.38 66.73 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.124 0.97 . . . . 4.52 112.67 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -64.23 -49.69 70.94 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.992 -1.067 . . . . 2.93 112.195 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 187' ' ' ILE . 5.4 mm -64.86 -38.7 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.093 0.957 . . . . 2.53 113.397 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.12 -42.57 90.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.422 1.089 . . . . 2.89 110.315 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.1 t -70.46 -11.52 60.98 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.999 1.111 . . . . 2.81 113.999 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.21 -23.51 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.82 1.191 . . . . 3.18 110.84 169.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 67.07 -20.47 0.11 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.025 2.53 . . . . 4.09 115.714 167.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 48.2 p -67.42 -39.14 85.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.523 -1.361 . . . . 5.73 110.885 165.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.96 158.48 75.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.207 1.403 . . . . 4.49 111.444 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.57 -32.56 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.156 2.57 . . . . 3.23 113.812 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 t70 160.04 153.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.584 3.554 . . . . 3.66 108.748 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 36.0 tp -123.11 90.21 3.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.439 1.496 . . . . 2.06 107.958 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.2 m -75.03 125.64 89.05 Favored Pre-proline 0 N--CA 1.474 0.739 0 O-C-N 121.069 -1.02 . . . . 1.59 110.265 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.46 133.37 4.54 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.093 2.528 . . . . 0.86 111.183 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.29 97.73 5.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.238 1.415 . . . . 3.11 109.12 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -84.03 129.99 34.89 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.267 1.027 . . . . 2.48 109.847 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.03 129.82 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.498 1.119 . . . . 1.77 109.03 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 5.6 t -92.69 117.62 30.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.152 0.581 . . . . 2.88 111.53 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -90.01 40.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.145 -0.972 . . . . 1.94 112.321 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -121.39 55.22 5.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.522 1.129 . . . . 3.3 112.624 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.95 66.94 8.7 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 125.064 3.843 . . . . 2.57 111.956 -166.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -151.97 -63.08 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.064 1.746 . . . . 6.72 109.282 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.04 27.1 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 6.46 113.334 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -80.95 156.36 26.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.889 0.852 . . . . 4.93 112.348 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 m -170.02 129.72 0.95 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.137 2.575 . . . . 2.9 106.639 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -52.57 -43.34 65.2 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.995 0.918 . . . . 4.25 112.347 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -64.28 -32.99 74.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.419 1.888 . . . . 3.74 114.228 172.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.51 72.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.954 1.252 . . . . 1.74 111.341 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.29 -40.2 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.882 -0.511 . . . . 1.73 110.357 169.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.07 68.46 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 118.333 -0.841 . . . . 1.98 113.096 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -63.8 -51.6 64.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.369 0.986 . . . . 5.17 111.65 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -57.15 -41.84 79.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.545 0.688 . . . . 4.94 111.539 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.3 t -65.35 -15.9 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.883 0.873 . . . . 1.34 112.521 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.66 -39.23 12.59 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 119.716 -1.865 . . . . 5.64 113.349 166.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.56 -53.66 48.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.193 1.397 . . . . 4.9 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -76.26 -52.34 10.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.996 0.739 . . . . 2.63 112.996 -171.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.8 t -179.44 145.23 0.42 Allowed Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 125.152 1.381 . . . . 1.99 110.514 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.83 -16.12 37.13 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.793 2.329 . . . . 2.28 114.27 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -72.22 -20.86 61.49 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.443 1.474 . . . . 1.99 112.974 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.6 tp -68.86 149.04 49.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.26 1.424 . . . . 1.98 113.346 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.81 141.12 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.151 0.981 . . . . 2.27 110.82 166.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.45 114.28 3.6 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.678 -1.369 . . . . 1.28 109.678 175.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.22 145.14 36.35 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.446 0.698 . . . . 2.5 109.871 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.9 m -154.46 163.71 39.77 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.391 1.076 . . . . 2.85 109.155 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -150.05 170.76 30.08 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 124.022 0.82 . . . . 1.88 111.345 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -61.4 162.44 7.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 3.22 110.342 164.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -48.28 -31.76 6.39 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.694 1.198 . . . . 7.99 113.741 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -67.98 -43.33 79.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.023 1.729 . . . . 3.48 111.873 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -72.07 -34.0 68.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.407 1.083 . . . . 3.25 111.19 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.23 -39.51 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 118.485 -0.769 . . . . 2.14 110.504 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.31 -43.06 92.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 117.539 -1.22 . . . . 3.32 110.219 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -52.59 -59.04 4.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.87 1.214 . . . . 3.55 111.306 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.7 -34.28 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.145 0.884 . . . . 3.5 112.675 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.71 86.75 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.681 -0.637 . . . . 2.34 111.817 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -76.74 -41.7 44.0 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.824 2.45 . . . . 4.49 112.081 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.04 50.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.055 1.342 . . . . 2.84 111.45 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.48 -2.32 57.92 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.165 0.802 . . . . 4.38 113.165 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 62.77 42.58 7.89 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.274 1.83 . . . . 6.87 112.011 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.3 m -73.79 148.97 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.828 1.251 . . . . 3.33 112.079 -165.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -76.23 132.33 39.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.812 0.845 . . . . 3.41 112.568 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -171.73 161.6 6.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.124 2.17 . . . . 3.61 111.721 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 33.4 t -150.53 108.7 3.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.941 1.296 . . . . 3.04 110.799 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.3 128.54 2.63 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.791 2.327 . . . . 2.81 112.446 -172.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -90.38 146.3 18.52 Favored Glycine 0 CA--C 1.541 1.685 0 C-N-CA 124.24 0.924 . . . . 2.96 112.303 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.89 173.64 13.67 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.469 2.78 . . . . 4.84 110.077 170.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.574 ' HE2' ' CD1' ' A' ' 256' ' ' TYR . 9.7 mmtp -67.13 127.84 34.11 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.933 -0.479 . . . . 6.98 111.144 169.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -77.64 -29.91 51.93 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.758 0.823 . . . . 6.36 112.373 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.47 -77.12 0.34 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.794 1.638 . . . . 8.31 109.777 159.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -121.16 -56.53 1.91 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.373 1.069 . . . . 8.21 113.513 -173.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.85 49.19 1.14 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.475 1.11 . . . . 9.15 110.613 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -138.87 152.44 47.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.599 -0.728 . . . . 4.98 109.162 156.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.574 ' CD1' ' HE2' ' A' ' 250' ' ' LYS . 0.2 OUTLIER 164.44 163.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 129.499 3.12 . . . . 6.41 109.733 -163.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 1.1 tp -135.13 139.4 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.152 -0.968 . . . . 3.17 108.619 167.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.58 110.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 105.28 -2.118 . . . . 3.14 105.28 155.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.82 138.41 57.32 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.001 -1.111 . . . . 3.27 108.001 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -156.42 152.15 27.15 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.71 -1.244 . . . . 2.18 113.743 -166.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 58.5 p 3.71 -57.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 131.485 3.914 . . . . 4.88 119.541 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 62.52 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 128.9 2.88 . . . . 4.51 112.868 -160.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 36.4 pt -84.5 146.59 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 114.826 1.417 . . . . 3.32 114.826 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.2 ttm -111.62 135.4 52.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.028 2.531 . . . . 2.23 108.871 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 135.37 47.23 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.157 -0.964 . . . . 3.03 113.386 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.84 118.82 25.57 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.026 0.93 . . . . 2.09 109.312 164.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.32 131.48 47.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.137 -1.801 . . . . 2.15 106.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -79.01 178.43 53.6 Favored Glycine 0 CA--C 1.536 1.404 0 N-CA-C 113.835 0.294 . . . . 1.91 113.835 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -74.69 58.08 4.56 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.413 3.409 . . . . 2.67 108.712 163.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.81 -63.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.938 1.695 . . . . 4.47 109.511 -149.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.17 -22.55 9.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.469 1.509 . . . . 3.39 114.995 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -83.15 169.44 15.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.867 1.334 . . . . 4.0 112.207 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -83.17 134.32 34.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.149 0.98 . . . . 5.1 111.249 169.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.69 -24.66 9.5 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.011 1.115 . . . . 3.62 114.011 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -160.3 166.75 28.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.047 1.339 . . . . 3.18 111.187 161.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -131.01 140.46 50.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.709 1.204 . . . . 3.76 112.764 172.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.1 -172.51 2.23 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.288 2.235 . . . . 2.77 108.532 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.55 73.11 0.5 Allowed Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.581 1.086 . . . . 3.29 110.758 -170.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 88.63 151.03 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.104 2.962 . . . . 3.94 112.809 176.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.4 t30 69.16 -43.64 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.909 2.884 . . . . 4.83 115.624 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.32 113.44 4.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.23 0.923 . . . . 5.08 110.106 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 150.84 38.23 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.902 -0.499 . . . . 6.12 110.411 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -57.94 -36.46 72.55 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 119.66 -1.9 . . . . 1.99 115.178 -168.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.36 80.23 Favored Glycine 0 N--CA 1.483 1.778 0 O-C-N 120.661 -1.274 . . . . 2.11 116.038 170.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.58 -36.43 29.04 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.149 1.78 . . . . 4.72 110.308 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.86 -41.88 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.681 0.792 . . . . 1.65 108.908 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.84 96.18 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.301 0.852 . . . . 1.87 113.301 170.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.25 84.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.437 1.017 . . . . 2.1 113.224 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.8 p -68.7 -44.85 73.06 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 1.96 111.696 172.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.82 -35.12 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 119.992 1.269 . . . . 2.0 112.373 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.25 65.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.459 -1.401 . . . . 2.61 113.043 170.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 85.2 m -81.88 -44.51 16.75 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.796 0.838 . . . . 2.76 109.805 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -62.28 -25.08 67.65 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.551 1.14 . . . . 2.93 112.994 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 3.7 ttt -58.67 -34.74 71.58 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.114 0.966 . . . . 4.99 112.127 167.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -53.4 -49.01 90.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 116.62 -1.657 . . . . 4.21 113.945 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.62 -56.78 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.38 2.054 . . . . 3.69 111.702 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -88.17 29.81 0.92 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.982 1.475 . . . . 4.43 114.982 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 117.78 7.2 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.771 -1.205 . . . . 8.23 109.205 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -100.94 -31.89 10.91 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.078 1.51 . . . . 10.74 115.078 -146.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.41 27.3 0.29 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.345 1.458 . . . . 6.93 111.354 -175.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 C--O 1.243 0.761 0 C-N-CA 130.756 3.623 . . . . 6.84 105.058 -138.865 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 118.081 -0.961 . . . . 21.84 110.054 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -156.07 168.77 26.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.747 1.219 . . . . 17.69 109.988 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -144.49 -170.52 3.4 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.624 1.57 . . . . 16.52 110.429 -169.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.08 170.11 42.65 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.205 0.907 . . . . 12.85 114.237 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -167.92 141.57 2.77 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.01 1.724 . . . . 11.16 110.217 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.56 149.25 61.52 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.083 1.855 . . . . 7.68 109.177 163.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.3 mt -147.88 167.22 25.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.891 1.676 . . . . 7.22 110.037 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.94 150.05 31.3 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.563 1.945 . . . . 5.88 108.858 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.05 -138.68 37.27 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.14 -1.184 . . . . 3.92 110.14 -165.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.67 161.91 32.63 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-O 118.944 -0.92 . . . . 2.6 114.355 167.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -93.28 171.35 2.07 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.346 3.364 . . . . 3.5 112.102 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.99 166.82 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.839 1.256 . . . . 3.45 111.349 162.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 m -140.58 29.68 1.93 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.098 1.518 . . . . 2.79 115.098 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.9 mp -54.65 148.46 12.55 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.355 1.243 . . . . 2.42 114.355 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.1 m -72.31 139.31 47.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.369 1.468 . . . . 1.55 108.929 168.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.1 m -108.33 154.71 21.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.757 1.623 . . . . 3.56 109.126 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -60.25 -17.78 44.26 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.12 1.155 . . . . 2.24 114.12 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -65.04 -23.18 67.12 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.286 2.234 . . . . 4.5 113.749 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.21 -6.05 53.16 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.794 1.664 . . . . 2.06 114.134 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.25 174.25 9.22 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 4.22 111.972 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.19 130.56 48.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.003 0.521 . . . . 6.81 109.685 160.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -102.0 172.66 6.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.6 0.76 . . . . 3.35 110.678 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.72 154.48 13.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.734 2.014 . . . . 3.22 107.655 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -45.9 -26.25 0.66 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.45 2.3 . . . . 4.16 114.401 164.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -98.94 -1.06 40.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.171 1.545 . . . . 6.25 115.171 173.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.74 -59.97 2.1 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.549 -0.908 . . . . 3.41 108.549 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -62.04 -30.95 71.32 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.389 0.885 . . . . 3.87 113.389 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.78 -108.64 0.45 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.326 1.85 . . . . 4.98 110.566 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -135.78 105.67 0.54 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.489 -2.644 . . . . 3.62 106.489 165.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -107.01 -26.01 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.504 -1.236 . . . . 3.64 114.319 166.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.542 ' CD1' HD23 ' A' ' 193' ' ' LEU . 49.1 m95 117.77 86.46 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 1 C-N-CA 132.185 4.194 . . . . 2.2 109.02 -161.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.23 135.73 43.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.442 1.097 . . . . 2.95 109.836 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 10.1 mt -118.73 104.8 10.93 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.832 1.653 . . . . 2.68 106.908 168.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.9 pt -99.61 135.79 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.308 0.243 . . . . 3.61 111.283 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -140.37 143.8 35.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.428 1.091 . . . . 3.45 112.324 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -123.75 117.34 24.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.433 1.493 . . . . 2.8 109.37 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -134.55 -177.74 15.16 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.612 1.101 . . . . 1.68 114.333 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.12 135.5 46.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.363 1.465 . . . . 3.71 109.972 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 m -79.39 59.09 2.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.2 1.4 . . . . 3.43 110.189 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -152.59 -104.7 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.88 2.472 . . . . 7.56 107.597 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.5 OUTLIER 69.6 152.8 0.14 Allowed Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 130.147 3.379 . . . . 3.01 116.887 173.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 60.6 Cg_endo -92.03 -17.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.497 2.798 . . . . 3.75 113.366 159.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 168.79 -37.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.385 1.448 . . . . 4.66 113.245 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -25.35 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 115.581 1.697 . . . . 3.32 115.581 -160.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 7.8 m -66.89 -62.25 4.02 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.59 1.086 . . . . 1.86 111.47 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.2 -25.43 57.73 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.508 1.472 . . . . 1.17 113.781 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.63 -23.68 67.34 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.272 1.212 . . . . 3.04 114.272 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -101.32 -18.79 15.91 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.977 1.262 . . . . 3.83 113.867 162.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.53 -43.54 98.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.661 1.573 . . . . 2.8 111.195 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.07 -55.29 18.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 3.41 112.128 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -62.55 -45.44 92.95 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.347 -1.471 . . . . 2.83 111.335 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ttm -56.24 -41.23 75.41 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.586 1.955 . . . . 2.38 112.138 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 7.6 mm -59.98 -54.38 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.483 -0.932 . . . . 1.99 108.483 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.476 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 63.0 mt-30 -63.51 -27.45 69.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 117.877 -1.058 . . . . 3.08 112.592 -174.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.6 -37.21 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 120.932 1.697 . . . . 2.01 111.872 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -20.14 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.733 0.813 . . . . 2.97 112.766 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -46.05 82.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.794 1.237 . . . . 4.85 111.314 170.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -66.95 -39.48 87.3 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 117.82 0.282 . . . . 2.98 111.558 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.445 HG23 HD22 ' A' ' 193' ' ' LEU . 8.4 mm -65.85 -46.21 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.661 -0.649 . . . . 2.13 112.448 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -65.9 -35.78 81.57 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.233 0.469 . . . . 3.74 110.713 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 49.7 m -73.57 -23.12 59.91 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.325 1.231 . . . . 2.92 114.325 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 11.0 mm -81.83 -28.29 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.261 1.424 . . . . 3.0 110.467 167.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.4 m 67.17 -12.4 0.24 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.905 2.482 . . . . 4.82 114.242 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 58.0 m -84.43 -30.31 25.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.549 1.94 . . . . 3.82 112.128 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.542 HD23 ' CD1' ' A' ' 159' ' ' TRP . 7.0 mp -63.46 159.73 48.44 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.67 1.188 . . . . 4.0 109.788 173.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -61.76 -46.04 15.14 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.392 1.394 . . . . 3.72 109.31 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -168.09 -178.55 3.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.126 2.57 . . . . 3.96 109.537 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 51.8 tp -125.67 123.57 39.23 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.563 -1.643 . . . . 2.05 106.563 150.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.8 m -106.27 98.89 20.97 Favored Pre-proline 0 N--CA 1.465 0.298 0 C-N-CA 124.67 1.188 . . . . 1.17 108.952 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.09 137.19 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.444 . . . . 0.95 109.737 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.91 111.18 9.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 123.061 1.41 . . . . 3.71 112.899 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.69 134.73 34.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.215 1.806 . . . . 2.72 109.676 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 52.3 mt -120.36 131.78 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.154 1.782 . . . . 1.57 106.984 168.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.37 126.22 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.741 0.701 . . . . 3.04 110.367 170.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.1 pt -98.96 16.77 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.531 1.133 . . . . 2.16 113.176 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.91 44.82 0.2 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 127.395 2.278 . . . . 3.58 114.25 168.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.59 -8.64 21.87 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.414 2.742 . . . . 2.09 115.163 -169.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.23 0.4 0.27 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.321 1.848 . . . . 5.29 114.223 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.77 30.55 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.321 2.648 . . . . 4.56 111.412 -165.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.77 -174.75 3.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.146 1.379 . . . . 3.99 111.057 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.5 t -162.36 151.08 14.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.673 1.225 . . . . 4.02 112.891 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.53 -34.92 59.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.746 1.618 . . . . 2.75 112.825 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.57 71.31 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.797 1.239 . . . . 3.62 114.05 174.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.34 74.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.923 1.238 . . . . 1.75 110.862 176.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 50.4 mm -60.39 -43.56 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.131 0.972 . . . . 1.95 111.616 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.53 89.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.341 0.656 . . . . 1.38 111.74 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.425 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 6.3 t30 -65.32 -43.84 89.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.526 -0.734 . . . . 3.16 112.188 173.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -56.51 -41.39 76.6 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.736 0.815 . . . . 2.98 111.404 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.3 -46.09 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.271 1.428 . . . . 1.15 111.996 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 8.3 mtmp? -52.51 -55.13 24.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.673 1.124 . . . . 4.14 112.73 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -33.62 59.91 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.822 0.675 . . . . 4.65 112.822 -160.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -73.95 -36.42 64.62 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.507 0.594 . . . . 2.95 111.613 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 m 153.38 136.15 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 129.886 3.274 . . . . 3.13 110.829 161.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -68.28 1.95 3.14 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.63 2.887 . . . . 2.55 114.47 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -66.69 -16.44 64.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 121.154 -0.966 . . . . 2.1 112.145 162.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 56.5 tp -80.75 145.36 31.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.654 1.581 . . . . 1.8 111.805 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.9 t -102.02 137.6 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.589 1.156 . . . . 1.87 109.572 167.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -117.86 132.42 9.86 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.442 1.02 . . . . 1.14 111.731 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.88 151.6 48.18 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.737 1.215 . . . . 2.44 112.211 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 11.8 t -166.16 -158.29 0.33 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.854 2.462 . . . . 2.95 109.135 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 152.75 -115.34 0.68 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 108.834 -1.706 . . . . 1.86 108.834 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.2 p -113.42 166.49 11.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.838 0.828 . . . . 3.25 111.656 166.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.62 -33.65 47.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.158 1.783 . . . . 6.91 113.084 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -67.62 -43.55 80.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.068 0.947 . . . . 2.93 112.112 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -70.31 -40.37 74.25 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.356 0.98 . . . . 5.51 111.577 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.6 t -55.27 -38.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.863 0.865 . . . . 2.07 111.988 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.5 -45.82 64.9 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 117.385 -1.293 . . . . 4.03 110.301 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -52.04 -53.96 35.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.026 1.739 . . . . 3.26 111.342 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.09 -32.31 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 113.226 0.824 . . . . 2.61 113.226 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.65 -47.93 61.62 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.907 -1.12 . . . . 2.36 111.306 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -70.87 -34.06 71.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.611 2.764 . . . . 4.19 112.147 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.13 9.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.332 1.453 . . . . 2.32 111.195 169.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.32 8.68 8.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.043 0.757 . . . . 3.24 113.043 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 42.44 43.92 3.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.258 2.223 . . . . 5.08 113.251 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 263' ' ' ILE . 7.9 p -69.72 -30.2 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 118.444 -0.789 . . . . 4.77 112.711 -172.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 67.7 t80 67.32 156.49 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.368 1.867 . . . . 3.38 113.9 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -176.88 164.44 2.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.476 2.711 . . . . 3.29 109.558 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.5 t -154.77 99.16 2.42 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 121.546 -0.721 . . . . 3.19 111.017 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -95.63 154.33 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.141 3.228 . . . . 3.1 112.252 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.95 169.17 52.87 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 116.304 -0.407 . . . . 2.83 112.969 166.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -81.11 136.89 10.48 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.856 3.037 . . . . 5.13 110.057 168.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 138.46 58.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.503 1.297 . . . . 5.39 114.503 -172.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -130.41 178.05 6.89 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.833 1.653 . . . . 8.02 111.836 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . 0.264 17.5 tt0 40.0 -108.69 0.08 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.553 3.141 . . . . 8.17 112.572 -170.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -81.32 -60.84 2.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.217 1.407 . . . . 9.52 109.888 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.28 36.5 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.197 1.399 . . . . 8.95 112.633 -176.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -103.83 155.19 18.81 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.962 0.887 . . . . 4.25 111.903 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -179.92 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.308 2.643 . . . . 6.31 113.464 -168.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 33.8 mm 70.49 157.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.855 2.062 . . . . 3.83 111.367 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.25 140.12 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.243 1.417 . . . . 4.66 108.894 170.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -63.18 108.83 1.35 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.428 1.491 . . . . 4.68 109.951 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -75.97 10.48 1.86 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.495 1.918 . . . . 5.49 115.558 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.0 m -74.69 95.7 2.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.826 1.25 . . . . 5.95 109.807 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.93 156.28 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.9 1.28 . . . . 4.93 111.053 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.436 ' H ' HG23 ' A' ' 243' ' ' VAL . 70.8 mt -133.97 134.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.282 1.433 . . . . 2.67 109.342 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 89.5 mtp -89.89 145.5 25.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.926 0.891 . . . . 2.29 111.045 171.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -126.21 153.4 44.73 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.332 1.053 . . . . 2.8 112.354 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 10.6 tp -103.62 131.63 50.59 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.044 1.738 . . . . 2.03 109.996 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.75 130.71 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 107.524 -1.287 . . . . 1.91 107.524 162.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.4 179.84 53.15 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.682 1.134 . . . . 2.27 114.425 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.435 ' HB2' ' HE3' ' A' ' 299' ' ' LYS . 14.0 Cg_endo -91.89 75.46 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.251 3.301 . . . . 3.97 110.367 -178.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.7 t70 177.19 -77.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.647 -1.615 . . . . 4.78 108.822 -135.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 143.79 -16.63 2.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 117.359 -1.801 . . . . 2.88 115.156 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.83 168.57 9.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.532 1.666 . . . . 4.83 114.397 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.46 150.97 29.54 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.056 2.142 . . . . 6.21 113.534 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.0 mt -136.64 -38.73 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.424 1.638 . . . . 2.64 115.424 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -166.36 167.45 15.85 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.616 1.098 . . . . 2.65 113.306 -168.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.29 158.82 43.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.923 1.289 . . . . 5.19 113.911 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.05 177.21 9.33 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.202 1.401 . . . . 2.38 114.207 -170.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.9 -177.1 22.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.179 2.8 . . . . 3.35 109.736 -169.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -55.34 1.14 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 119.785 3.254 . . . . 4.37 119.785 -166.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -111.63 -6.45 14.37 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.402 1.63 . . . . 5.29 115.402 165.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -116.79 89.27 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.459 1.104 . . . . 4.39 109.965 157.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 18.7 mtt85 -82.88 -167.85 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.134 1.774 . . . . 6.01 110.062 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.6 tmtt? -40.21 -57.71 1.65 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.148 1.779 . . . . 2.33 115.149 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.51 -38.37 51.99 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 123.437 0.542 . . . . 1.85 112.031 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.11 -33.05 75.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.894 0.877 . . . . 4.45 112.289 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 30.2 mt -68.4 -56.15 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.505 0.722 . . . . 1.64 110.049 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.06 78.7 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.096 0.776 . . . . 1.85 113.096 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -71.37 -33.86 69.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.631 1.173 . . . . 2.46 113.732 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.9 p -68.78 -45.27 71.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.662 -1.161 . . . . 1.87 111.288 168.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 82.6 mt -56.31 -42.28 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.41 1.459 . . . . 1.47 111.492 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.56 -28.5 69.68 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.141 -0.974 . . . . 1.95 113.342 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.5 m -73.1 -43.6 61.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.318 1.047 . . . . 2.71 110.132 172.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -64.68 -25.91 68.15 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.722 1.209 . . . . 3.16 112.353 172.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 59.1 ttp -69.93 -16.81 63.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.638 1.575 . . . . 4.51 112.676 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -51.77 77.56 Favored Pre-proline 0 CA--C 1.553 1.086 0 O-C-N 120.195 -1.566 . . . . 6.62 110.438 174.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.0 -51.61 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.074 1.849 . . . . 2.46 111.038 166.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.92 44.2 0.98 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.596 1.332 . . . . 3.27 114.596 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -64.88 148.77 50.77 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.341 -0.85 . . . . 8.9 109.279 163.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 269' ' ' PRO . 63.1 mttm -146.36 172.58 13.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.504 1.122 . . . . 9.71 109.933 174.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 83.3 mttt 75.89 -10.19 1.31 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 128.337 2.655 . . . . 7.73 113.048 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 29.4 m . . . . . 0 C--O 1.252 1.197 1 C-N-CA 133.763 4.825 . . . . 7.92 107.255 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 117.919 -1.039 . . . . 28.8 108.759 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -161.85 -178.67 6.64 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.103 1.761 . . . . 24.0 109.524 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.1 t -165.61 173.38 10.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.444 2.298 . . . . 21.14 108.454 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 154.57 -163.49 31.22 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.38 0.99 . . . . 16.62 113.686 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -151.5 161.67 28.95 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.818 1.647 . . . . 13.48 110.838 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.75 -177.53 3.19 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.14 2.56 . . . . 9.88 110.166 162.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 tt -149.88 123.19 8.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.735 1.214 . . . . 8.3 107.938 167.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.5 tp -161.77 -17.22 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.747 1.619 . . . . 7.3 114.023 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.18 126.58 41.87 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.65 1.02 . . . . 3.76 115.65 -165.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.92 125.03 5.4 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.918 1.723 . . . . 3.42 110.091 171.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.34 165.0 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.256 2.637 . . . . 3.35 112.691 -170.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -91.45 159.91 15.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.77 1.228 . . . . 3.17 109.007 166.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 m -142.31 57.23 1.46 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 120.159 1.345 . . . . 2.27 114.145 170.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -93.81 166.24 12.29 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 119.69 -1.882 . . . . 3.51 113.814 -171.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 m -89.75 152.76 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.493 1.917 . . . . 2.37 108.762 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.5 p -95.87 161.25 14.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.395 1.093 . . . . 2.82 112.524 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -52.72 -33.7 49.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.612 2.365 . . . . 2.11 113.461 170.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.5 p -76.0 -47.61 24.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.098 1.359 . . . . 4.35 111.5 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.07 39.25 0.46 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.407 1.003 . . . . 3.0 114.672 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 -179.66 3.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.712 1.605 . . . . 3.46 109.059 170.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.53 97.28 3.53 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.128 1.331 . . . . 5.14 110.697 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.06 159.69 15.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.761 1.224 . . . . 3.14 112.411 -177.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 153' ' ' LYS . 67.7 m -139.16 149.74 44.8 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.33 1.852 . . . . 3.91 107.167 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -25.13 61.2 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.105 0.955 . . . . 3.89 112.702 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.452 ' H ' HG22 ' A' ' 151' ' ' THR . 1.5 mmmp? -68.26 -18.34 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.552 1.686 . . . . 5.57 115.552 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.4 -48.11 36.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.852 1.261 . . . . 3.23 109.341 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -89.47 13.34 14.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.643 1.177 . . . . 3.42 113.187 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.78 118.46 6.67 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.344 -1.472 . . . . 5.17 109.683 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 104.89 -8.66 46.37 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 123.656 0.646 . . . . 3.31 114.38 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -80.77 -154.65 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.223 1.409 . . . . 3.44 111.412 -170.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -126.16 119.45 27.55 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.289 -1.507 . . . . 2.14 107.215 154.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.25 45.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.012 0.91 . . . . 3.38 111.701 -173.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.1 mt -131.37 135.56 47.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.219 1.807 . . . . 3.25 108.964 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.65 132.66 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.667 0.787 . . . . 2.47 110.007 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -139.88 148.91 42.74 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.265 1.426 . . . . 2.63 112.217 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -114.92 118.76 34.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.398 1.479 . . . . 3.2 108.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -124.48 160.53 19.07 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 116.858 1.503 . . . . 2.0 116.858 -166.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -100.53 22.62 11.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.532 2.333 . . . . 5.0 110.366 165.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 34.3 m 70.51 -66.59 0.28 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.02 2.528 . . . . 5.14 110.972 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -108.5 -29.04 8.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 117.696 -1.145 . . . . 9.83 113.147 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER 61.22 -172.03 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.699 1.199 . . . . 2.25 113.284 -176.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 89.3 Cg_endo -69.06 61.18 1.34 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.57 2.18 . . . . 3.61 110.161 139.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 65.25 -4.23 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 129.817 3.247 . . . . 4.44 115.808 166.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.11 -33.43 42.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 117.878 -1.058 . . . . 3.06 113.847 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.5 m -48.24 -60.68 4.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 120.452 1.478 . . . . 1.41 112.454 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 -24.35 42.42 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.427 2.085 . . . . 1.29 114.414 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.3 -43.96 96.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.971 1.26 . . . . 3.08 111.398 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.54 -35.17 75.19 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.128 -0.983 . . . . 3.44 111.571 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 -56.36 20.1 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.828 1.251 . . . . 3.04 111.651 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.02 -43.97 94.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.057 0.844 . . . . 3.79 110.267 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -54.07 -39.46 66.3 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.035 -1.666 . . . . 4.09 113.016 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 7.6 ptp -68.74 -34.82 76.27 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.988 1.722 . . . . 2.76 113.771 170.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.2 mm -66.02 -42.78 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 120.34 1.427 . . . . 1.96 111.436 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.404 ' HB3' ' CD ' ' A' ' 283' ' ' LYS . 83.8 mm-40 -63.3 -37.97 89.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.606 1.562 . . . . 3.41 110.847 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.7 t -63.53 -45.47 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.674 -0.642 . . . . 2.69 111.989 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.59 -40.09 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.253 1.021 . . . . 2.2 113.04 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -58.06 7.48 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.048 1.339 . . . . 6.22 111.91 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.05 -40.12 92.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.417 0.525 . . . . 4.67 112.417 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 56.3 mt -59.9 -48.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.339 1.856 . . . . 3.41 112.651 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.07 -48.38 81.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.946 1.298 . . . . 3.46 109.371 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.8 t -68.92 -6.07 25.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.952 2.101 . . . . 3.92 114.409 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 191' ' ' THR . 32.8 mm -56.62 -48.61 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 119.626 1.103 . . . . 4.9 110.291 171.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 190' ' ' ILE . 32.9 p -171.55 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.464 2.394 . . . . 6.45 117.464 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.253 5.7 t 102.36 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.065 1.746 . . . . 5.23 107.438 -121.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.3 mp -93.39 161.86 29.57 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.456 -0.778 . . . . 3.62 110.495 136.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -86.16 35.84 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.199 3.932 . . . . 3.73 111.308 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.3 t0 70.0 174.72 0.29 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 128.143 2.577 . . . . 4.22 114.022 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.5 tt -133.09 134.97 44.99 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.088 1.755 . . . . 3.04 108.1 166.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.8 m -107.43 100.71 35.39 Favored Pre-proline 0 N--CA 1.47 0.575 0 C-N-CA 123.619 0.767 . . . . 1.79 110.2 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.7 127.34 4.26 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.001 2.468 . . . . 1.57 111.099 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.02 108.52 19.73 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.749 2.02 . . . . 2.85 109.174 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -99.55 113.68 26.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.159 -0.682 . . . . 3.09 109.159 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.18 119.46 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.198 -0.667 . . . . 2.58 109.198 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.7 m -80.45 133.53 35.87 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.431 -0.793 . . . . 2.97 111.513 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.447 ' HA ' HG11 ' A' ' 234' ' ' VAL . 37.4 pt -82.23 -1.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 114.093 1.146 . . . . 2.66 114.093 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.65 48.89 0.23 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 127.425 2.29 . . . . 3.12 114.026 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.63 -6.79 19.28 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.636 2.224 . . . . 4.23 113.458 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -81.8 -2.76 51.99 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.303 0.956 . . . . 4.32 112.845 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.79 -27.48 1.29 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.62 1.341 . . . . 6.11 114.62 175.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -109.15 141.21 41.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.216 1.371 . . . . 6.79 111.915 172.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 82.7 p -95.64 159.71 14.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.551 1.167 . . . . 3.72 112.805 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -54.77 -36.71 65.16 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.193 1.397 . . . . 3.51 112.335 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -71.93 -33.51 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.112 1.365 . . . . 3.07 112.877 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.27 91.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.586 1.084 . . . . 1.78 112.248 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . 0.269 4.3 tp -70.57 -23.54 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 121.123 -0.986 . . . . 3.05 113.142 173.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.85 -42.61 94.75 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.563 -1.336 . . . . 1.86 111.924 167.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -58.57 -41.01 84.7 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.436 -0.79 . . . . 4.88 112.082 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -62.63 -45.62 92.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.676 1.191 . . . . 3.55 112.136 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.6 t -52.21 -44.31 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.036 -1.04 . . . . 1.97 111.55 169.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -13.1 62.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.361 1.245 . . . . 5.49 114.361 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -79.1 -47.05 16.82 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.419 1.463 . . . . 4.36 110.666 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -95.19 -50.23 5.15 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.581 0.956 . . . . 3.46 113.581 -172.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m 170.52 141.06 0.09 OUTLIER Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 124.715 1.206 . . . . 2.48 113.293 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.57 -5.64 17.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.794 2.996 . . . . 1.81 114.217 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -71.83 -16.91 62.17 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.948 1.249 . . . . 2.15 112.959 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.06 132.35 44.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.335 0.97 . . . . 2.06 109.892 174.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.9 119.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.943 -1.502 . . . . 1.92 106.943 164.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -87.96 134.83 12.7 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 107.949 -2.061 . . . . 1.33 107.949 163.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.02 151.18 39.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.991 0.916 . . . . 2.57 110.399 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 229' ' ' GLY . 11.6 m -152.76 -179.9 8.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.166 2.186 . . . . 3.15 107.332 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.446 ' H ' HG22 ' A' ' 228' ' ' THR . . . 171.85 -132.34 2.4 Favored Glycine 0 N--CA 1.468 0.792 0 O-C-N 120.175 -1.578 . . . . 3.23 110.619 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.5 p -96.88 155.34 16.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.291 -1.003 . . . . 2.96 108.291 155.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.31 -26.82 65.33 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 117.912 -1.042 . . . . 6.48 111.818 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -66.38 -34.35 77.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.424 1.465 . . . . 3.49 111.802 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.25 -37.78 75.01 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.026 -1.047 . . . . 3.32 111.439 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.447 HG11 ' HA ' ' A' ' 203' ' ' ILE . 21.5 t -64.89 -33.73 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 122.128 -0.357 . . . . 2.51 111.191 173.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.16 -35.39 71.62 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.35 1.06 . . . . 3.37 111.0 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -57.7 -54.18 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.086 0.857 . . . . 2.74 110.76 174.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.11 -33.97 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.098 0.777 . . . . 1.89 113.098 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.47 -48.31 75.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.153 0.981 . . . . 1.87 111.792 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -32.81 69.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.353 2.261 . . . . 4.65 112.869 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.47 -67.01 0.48 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.525 1.057 . . . . 2.54 110.138 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -72.36 4.14 4.03 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.389 1.255 . . . . 2.54 114.389 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 58.96 44.72 16.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.29 1.836 . . . . 5.31 113.799 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.41 144.81 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.57 -0.706 . . . . 3.42 111.401 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.09 136.93 33.82 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.789 -0.57 . . . . 3.59 110.701 165.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -162.05 161.68 28.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.021 1.729 . . . . 3.38 111.322 176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.4 m -164.26 115.1 0.95 Allowed Pre-proline 0 N--CA 1.478 0.952 0 O-C-N 121.055 -1.028 . . . . 2.68 112.644 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -88.63 140.18 4.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.426 2.751 . . . . 2.81 113.771 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.59 119.45 6.12 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 110.239 -1.144 . . . . 2.88 110.239 163.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.63 -21.02 15.12 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.05 2.5 . . . . 5.01 116.544 -167.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 151.58 60.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 130.06 3.344 . . . . 5.2 110.653 -175.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.09 148.68 21.94 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.46 1.904 . . . . 6.4 111.731 -166.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.13 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 130.347 3.459 . . . . 7.93 117.777 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 30.6 t70 179.07 -49.32 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 129.929 3.292 . . . . 5.87 110.124 160.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -168.88 130.92 1.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.535 1.934 . . . . 5.47 110.098 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -179.43 -64.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.843 2.057 . . . . 4.32 110.762 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.1 t80 69.45 42.25 1.18 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.115 1.766 . . . . 3.6 113.616 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.4 132.8 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 119.296 -2.128 . . . . 2.72 111.838 170.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.78 127.21 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.156 1.383 . . . . 3.23 108.524 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.22 148.23 35.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.892 1.277 . . . . 3.31 112.03 172.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -150.86 154.32 37.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.57 1.548 . . . . 2.04 110.896 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 t -59.62 153.56 19.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.495 0.718 . . . . 3.36 111.46 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.83 58.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 122.635 1.207 . . . . 3.97 108.17 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 71.1 mt -133.79 132.58 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.384 1.473 . . . . 2.62 108.698 -172.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 40.5 mtp -102.88 135.18 45.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.708 2.003 . . . . 2.86 111.737 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -102.54 135.19 44.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.022 1.329 . . . . 4.02 111.152 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.09 124.55 41.14 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.307 0.958 . . . . 3.74 109.54 171.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.92 131.39 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.076 -1.453 . . . . 2.69 107.076 158.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -138.45 -133.95 3.14 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.734 -1.037 . . . . 2.44 112.293 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -77.33 79.75 3.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.813 2.342 . . . . 3.84 109.922 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -171.84 -64.39 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.984 2.914 . . . . 5.9 108.346 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.27 7.23 35.39 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.958 -1.468 . . . . 4.68 116.585 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -138.26 -47.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.267 1.534 . . . . 5.54 113.443 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -168.19 156.87 8.97 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 3.61 112.53 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 1.7 tt -151.54 -42.64 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.887 1.069 . . . . 3.28 113.887 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -170.88 172.76 5.46 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.479 1.912 . . . . 3.44 110.415 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -145.96 157.46 43.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.201 -0.937 . . . . 2.99 112.636 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . 0.437 ' CD2' HG23 ' A' ' 286' ' ' ILE . 0.1 OUTLIER -152.88 -167.63 2.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.04 1.736 . . . . 3.26 110.477 -170.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.92 -115.41 1.25 Allowed Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.017 1.294 . . . . 2.73 110.866 164.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.91 -7.59 1.79 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.805 1.409 . . . . 3.61 114.805 175.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -145.64 157.94 43.91 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.075 0.852 . . . . 5.21 111.045 163.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 72.47 131.29 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.959 2.104 . . . . 5.67 108.894 -143.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.67 175.63 5.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.881 2.072 . . . . 7.3 111.607 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.404 ' CD ' ' HB3' ' A' ' 182' ' ' GLN . 2.1 tmtt? -29.35 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 126.593 1.957 . . . . 2.38 113.886 -174.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.83 -19.72 69.81 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-O 119.418 -0.657 . . . . 2.16 113.839 -175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -63.88 -37.07 86.05 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.099 1.449 . . . . 3.32 111.175 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 277' ' ' PHE . 96.6 mt -68.43 -50.33 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.806 0.842 . . . . 2.18 110.986 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.82 88.81 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.042 -0.411 . . . . 2.33 111.601 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.29 80.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.538 . . . . 2.22 113.453 173.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.5 p -60.57 -43.27 97.51 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.832 1.196 . . . . 2.2 111.501 167.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.48 -33.77 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.445 -1.409 . . . . 2.33 111.997 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.51 -25.03 65.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.92 1.288 . . . . 2.51 113.272 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.8 m -75.16 -46.61 33.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.262 1.025 . . . . 2.46 109.896 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -59.2 -26.44 64.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.372 1.469 . . . . 3.1 112.832 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -59.93 -25.29 65.03 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.739 -1.226 . . . . 4.6 113.154 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -61.54 -51.75 74.77 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 117.213 -1.375 . . . . 4.77 111.824 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.71 -55.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.586 2.191 . . . . 3.55 111.463 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -81.53 77.35 8.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.011 1.324 . . . . 4.12 111.295 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -53.14 152.14 4.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.22 1.408 . . . . 9.11 112.824 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.53 154.27 8.9 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.695 -0.628 . . . . 6.49 112.629 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -88.91 -84.63 0.21 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.055 -1.461 . . . . 12.24 107.055 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.795 -1.574 . . . . 10.61 110.956 139.316 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 106.695 -1.594 . . . . 16.25 106.695 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -60.51 163.39 5.36 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 119.045 0.838 . . . . 14.05 109.693 142.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -165.99 154.93 11.46 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.703 1.601 . . . . 11.6 109.866 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.96 173.06 42.79 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.752 0.692 . . . . 10.07 111.656 165.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -150.94 116.01 3.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.039 1.336 . . . . 9.0 109.769 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.6 152.12 82.69 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.089 1.859 . . . . 7.33 109.278 167.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 tt -68.39 -82.57 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.864 0.866 . . . . 9.64 111.619 -166.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.0 mt -147.76 -153.53 0.5 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 129.018 2.927 . . . . 7.24 107.447 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.76 178.76 37.94 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.86 1.219 . . . . 4.52 113.876 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -156.6 134.17 3.93 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.734 -1.592 . . . . 3.97 110.152 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.65 159.97 41.8 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.728 2.285 . . . . 3.48 111.176 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -136.85 165.95 24.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.377 1.071 . . . . 2.71 111.909 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 p -146.04 112.33 5.81 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.771 -1.206 . . . . 2.38 112.154 157.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.08 146.91 27.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.99 0.9 . . . . 2.13 111.585 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.2 m -83.43 130.38 35.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.174 1.39 . . . . 1.74 107.572 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -84.08 168.31 16.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.483 -1.386 . . . . 2.1 112.2 -171.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -60.13 -30.28 69.19 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.818 1.247 . . . . 1.92 112.837 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 t -91.99 13.52 18.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.633 1.573 . . . . 3.05 113.129 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.98 88.01 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 119.124 0.875 . . . . 1.91 115.075 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -91.79 -168.63 2.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.04 1.736 . . . . 3.44 109.964 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -157.71 114.39 2.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 121.947 2.158 . . . . 5.05 113.401 -169.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -109.06 167.94 9.73 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.584 1.698 . . . . 2.96 115.584 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 39.9 p -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.462 2.705 . . . . 2.29 110.133 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.31 -56.95 2.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.557 1.543 . . . . 4.31 113.159 172.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -0.7 3.89 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.918 1.821 . . . . 7.14 115.918 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -81.44 -40.06 23.92 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.424 1.466 . . . . 2.95 110.134 165.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.1 -32.05 17.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.597 1.332 . . . . 3.26 114.597 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.92 109.6 1.51 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.376 0.989 . . . . 4.26 110.108 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 139.96 -34.67 1.99 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 124.461 1.029 . . . . 2.45 113.322 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -94.96 172.28 8.25 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.079 -1.082 . . . . 3.06 108.079 154.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -85.0 138.94 32.14 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.548 -0.538 . . . . 2.14 109.548 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.04 155.39 45.4 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 122.466 1.127 . . . . 2.85 113.499 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.58 127.58 52.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.579 1.552 . . . . 2.39 108.114 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 44.4 mt -112.74 118.08 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.97 -0.752 . . . . 1.84 108.97 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -125.49 142.68 51.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.056 1.742 . . . . 2.43 111.161 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.85 111.98 24.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.255 1.422 . . . . 2.33 111.059 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.56 -176.07 15.58 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.937 1.732 . . . . 1.41 113.332 -173.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -154.56 14.13 0.43 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.578 2.066 . . . . 3.9 116.578 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m 72.81 -25.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.66 1.584 . . . . 3.01 113.987 166.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -77.06 -25.68 52.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.781 1.173 . . . . 7.31 112.037 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.51 123.52 74.26 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.337 1.455 . . . . 2.95 111.547 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -90.74 -0.43 5.1 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.167 2.578 . . . . 4.09 113.155 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -125.39 -89.25 0.57 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.138 1.375 . . . . 6.32 109.504 -162.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.55 -31.18 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 117.222 -1.37 . . . . 4.21 114.181 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.6 m -59.82 -50.77 85.06 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 121.766 2.076 . . . . 1.42 111.844 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.52 -43.58 26.73 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.782 1.655 . . . . 1.14 113.23 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.4 -30.52 53.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.818 1.19 . . . . 3.2 113.162 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.438 ' HA ' ' HE2' ' A' ' 179' ' ' LYS . 5.5 mm-40 -70.28 -36.05 74.14 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.762 -1.211 . . . . 3.06 111.737 166.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.7 mt -61.3 -49.25 77.78 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.978 1.263 . . . . 2.84 111.409 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.44 -46.28 76.76 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.346 1.058 . . . . 4.04 111.953 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 176' ' ' GLU . 14.6 mtmm -53.67 -57.37 11.06 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.222 -0.924 . . . . 3.1 111.245 172.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.1 ptp -66.99 -19.36 65.7 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.036 1.124 . . . . 2.52 114.036 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.566 1.53 . . . . 1.76 110.389 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.515 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 72.9 mt-30 -62.76 -27.01 68.99 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.437 1.017 . . . . 3.17 111.908 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 t -61.65 -32.0 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.464 1.106 . . . . 1.64 113.131 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -31.41 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.864 1.211 . . . . 3.03 111.582 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -50.75 72.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.973 1.309 . . . . 5.19 110.08 167.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -65.76 1.97 1.16 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.256 2.622 . . . . 2.7 115.55 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 58.2 mt -123.22 -57.56 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 130.087 3.355 . . . . 2.39 110.587 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.76 -37.64 73.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.757 2.023 . . . . 3.9 112.44 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t -61.42 -27.87 68.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.751 1.22 . . . . 3.12 110.819 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.5 mm -77.46 7.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 O-C-N 120.464 -1.398 . . . . 3.97 111.195 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 67.8 m 82.54 -33.28 0.09 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.204 2.202 . . . . 5.32 113.693 147.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.2 m -153.73 45.96 0.62 Allowed 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.863 -1.148 . . . . 4.71 111.301 173.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.38 -175.51 0.6 Allowed Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.064 0.945 . . . . 4.18 111.437 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -83.45 136.97 7.83 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.512 2.142 . . . . 4.46 109.517 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.86 133.1 37.02 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.516 0.562 . . . . 3.91 112.516 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 14.1 tp -105.19 116.67 32.34 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.347 1.859 . . . . 1.71 111.173 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.0 m -103.09 99.1 13.22 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.81 1.244 . . . . 1.25 110.096 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -72.44 138.09 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.304 2.002 . . . . 1.08 112.661 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -117.95 110.93 18.31 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.797 2.039 . . . . 2.79 109.308 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -97.09 115.72 28.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.022 0.929 . . . . 2.37 109.069 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 90.3 mt -97.02 120.79 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.207 1.003 . . . . 1.69 109.845 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.2 m -69.19 132.19 46.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.611 0.364 . . . . 1.98 111.303 168.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.04 -5.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 114.536 1.31 . . . . 1.57 114.536 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -113.76 47.45 0.39 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 125.08 1.352 . . . . 3.74 113.265 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -74.03 73.98 3.6 Favored 'Trans proline' 0 C--N 1.363 1.337 1 C-N-CA 125.854 4.37 . . . . 2.17 112.714 -165.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -169.75 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.878 2.871 . . . . 4.23 107.298 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -7.86 12.73 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.168 1.173 . . . . 7.95 114.168 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.08 107.21 15.05 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 121.002 1.728 . . . . 3.88 111.207 160.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.6 t -82.32 154.68 25.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.596 1.158 . . . . 2.91 113.086 -171.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.68 -39.32 80.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.713 1.375 . . . . 5.98 114.713 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 214' ' ' ALA . 6.9 mm-40 -80.08 -19.67 46.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.775 1.17 . . . . 5.84 113.632 173.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.76 68.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.21 1.823 . . . . 1.72 110.261 170.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 3.0 mm -54.39 -51.91 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.256 0.622 . . . . 2.29 111.351 165.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.508 ' HB3' ' HA ' ' A' ' 211' ' ' GLU . . . -64.98 -29.12 70.02 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.257 -1.354 . . . . 1.34 113.832 -175.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -70.42 -48.95 53.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.439 1.927 . . . . 3.34 110.556 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.36 -41.44 65.83 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.682 0.793 . . . . 3.61 111.571 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.95 -53.29 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 125.511 1.524 . . . . 1.64 113.598 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -57.07 -40.86 77.68 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.382 1.073 . . . . 5.92 112.883 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.97 -53.12 51.32 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.925 2.09 . . . . 3.49 111.228 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.65 -36.81 85.46 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.503 1.298 . . . . 3.18 114.503 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.1 m 148.38 148.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 128.681 2.792 . . . . 2.33 113.581 167.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.15 9.66 1.08 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 124.201 3.268 . . . . 2.77 116.525 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -91.22 -9.24 45.99 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 120.989 1.722 . . . . 2.72 113.17 161.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 66.8 tp -84.08 147.12 27.55 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.667 1.187 . . . . 1.79 109.842 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.0 t -130.56 138.64 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.474 1.11 . . . . 1.93 108.503 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.82 122.18 7.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.234 -1.546 . . . . 1.09 109.234 169.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.34 140.11 39.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.283 1.033 . . . . 2.36 108.945 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.0 p -151.72 -172.6 4.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.621 1.969 . . . . 2.86 109.399 -165.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.14 -155.84 10.16 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 123.121 0.391 . . . . 2.24 113.088 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 232' ' ' GLU . 5.3 t -73.81 -177.08 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.546 -1.279 . . . . 2.57 107.546 136.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -44.91 -39.43 5.43 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.288 1.035 . . . . 6.64 111.817 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.444 ' H ' HG23 ' A' ' 230' ' ' THR . 4.2 mp0 -70.41 -37.65 74.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.555 1.07 . . . . 2.87 113.601 -165.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.8 -30.56 68.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.805 1.639 . . . . 3.53 111.511 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.43 -38.94 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.862 0.865 . . . . 1.67 111.136 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.72 -50.07 75.27 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 107.736 -1.209 . . . . 3.89 107.736 171.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -54.93 -61.58 2.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.612 -1.185 . . . . 2.6 112.959 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.62 -34.33 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.598 1.545 . . . . 1.99 113.232 -166.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.22 96.18 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.279 -0.888 . . . . 1.53 110.535 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -73.47 -32.85 64.55 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.884 1.673 . . . . 4.11 112.846 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.43 97.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.794 1.179 . . . . 1.99 112.007 171.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -84.03 1.97 41.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.698 0.799 . . . . 2.52 112.946 171.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.54 22.05 9.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.001 2.121 . . . . 6.69 113.991 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.0 m -86.99 164.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.647 0.779 . . . . 2.85 110.181 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -155.38 168.99 25.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.776 1.23 . . . . 4.95 111.989 -174.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -161.98 128.58 3.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.336 0.655 . . . . 4.1 110.869 -163.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.8 m -110.27 110.38 58.28 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-O 118.598 -0.715 . . . . 2.71 111.835 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.1 146.31 20.02 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.828 2.352 . . . . 2.96 111.839 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.76 155.2 38.8 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-O 119.504 -0.609 . . . . 2.64 113.11 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -81.5 35.86 0.6 Allowed 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.829 3.686 . . . . 3.78 111.806 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 65.83 172.76 0.23 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.08 2.152 . . . . 5.29 112.6 -156.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -153.5 160.98 42.67 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.08 2.152 . . . . 7.7 107.846 173.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -72.37 -16.1 61.86 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.193 1.553 . . . . 8.31 115.193 -158.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.95 2.17 44.08 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.553 1.141 . . . . 11.17 112.765 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 80.23 11.58 1.08 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.166 2.586 . . . . 6.83 113.133 171.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.32 162.36 4.75 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.876 2.07 . . . . 4.55 115.653 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -139.86 70.63 1.36 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.885 1.326 . . . . 3.53 114.444 160.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.14 153.31 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.559 1.543 . . . . 4.12 110.303 159.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.85 150.54 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.055 1.742 . . . . 2.96 106.919 163.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.13 155.66 34.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.114 -0.698 . . . . 3.71 109.114 164.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -140.47 87.7 2.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.53 0.681 . . . . 1.99 110.865 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.5 t -74.51 76.57 1.95 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 124.037 1.875 . . . . 5.54 109.379 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.1 pp -132.25 172.65 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.167 1.787 . . . . 6.89 109.532 -172.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 11.3 tt -141.42 164.59 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.198 -0.939 . . . . 2.77 109.121 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 22.6 ttm -99.13 141.28 32.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.571 1.078 . . . . 2.76 110.229 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -109.66 148.73 30.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.352 1.061 . . . . 2.57 112.792 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 127.0 46.32 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.649 1.58 . . . . 2.69 108.208 163.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 156.48 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.149 1.379 . . . . 2.11 108.334 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -155.5 -134.45 1.86 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.505 1.05 . . . . 1.85 111.977 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -85.86 36.4 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.852 3.701 . . . . 3.32 112.412 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -120.61 -38.52 2.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.739 2.015 . . . . 6.79 114.889 -164.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.29 2.46 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.086 -1.206 . . . . 3.27 110.086 -158.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.32 -2.95 3.08 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.717 1.377 . . . . 4.32 114.717 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -138.88 76.79 1.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.632 1.173 . . . . 3.7 112.001 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -34.87 17.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.161 0.984 . . . . 3.05 111.824 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -168.96 174.77 6.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.828 2.851 . . . . 2.32 108.441 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -153.86 150.02 27.96 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.64 -1.287 . . . . 2.8 111.715 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.95 114.03 21.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.352 1.061 . . . . 2.47 108.885 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -83.98 42.2 3.05 Favored Glycine 0 N--CA 1.464 0.542 0 CA-C-O 118.324 -1.265 . . . . 3.73 111.467 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . 0.266 3.5 pt20 44.17 45.16 6.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.011 1.724 . . . . 4.02 112.186 -170.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -139.63 -37.41 0.49 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.755 1.761 . . . . 5.25 115.755 -164.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -63.84 135.32 56.5 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.356 -1.465 . . . . 4.43 109.098 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -76.71 171.22 15.05 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 121.395 1.907 . . . . 8.0 109.193 163.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -48.33 -43.97 33.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.935 0.894 . . . . 2.02 113.167 -177.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -57.18 -36.34 74.62 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.942 1.258 . . . . 1.58 114.951 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -86.83 -18.08 31.83 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.421 1.61 . . . . 4.05 112.774 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 69.1 mt -69.22 -55.75 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.052 -1.092 . . . . 1.37 108.052 170.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.35 95.59 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.087 0.773 . . . . 1.69 113.087 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.39 90.63 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.83 1.195 . . . . 1.9 112.47 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 96.4 p -61.59 -43.83 98.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.567 1.076 . . . . 1.51 112.142 170.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 70.9 mt -58.86 -47.11 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.637 1.108 . . . . 1.47 110.723 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.54 -30.72 70.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.309 0.959 . . . . 1.58 113.061 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.2 m -68.37 -50.27 54.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.433 1.093 . . . . 2.36 109.89 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -70.27 -34.04 72.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.761 1.225 . . . . 2.55 113.449 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -60.66 -33.82 73.38 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.288 1.835 . . . . 4.04 112.84 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -59.6 -52.44 74.03 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 116.785 -1.579 . . . . 4.43 112.985 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.91 -44.5 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.274 2.649 . . . . 2.98 111.589 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.16 62.65 7.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.625 1.17 . . . . 2.88 111.038 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -43.0 132.27 4.03 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.618 1.567 . . . . 8.15 114.591 -166.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -171.23 0.12 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.253 1.421 . . . . 6.96 114.569 175.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 48.21 0.16 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 116.603 2.075 . . . . 8.25 116.603 -173.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.489 1.493 1 C-N-CA 132.402 4.281 . . . . 7.39 110.583 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 106.72 -1.585 . . . . 14.52 106.72 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -62.84 175.81 0.78 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.595 1.089 . . . . 17.14 110.162 138.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.9 m -108.12 158.58 17.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.901 1.68 . . . . 13.35 109.362 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.6 -118.83 1.32 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.082 -1.207 . . . . 12.89 110.082 167.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -55.12 129.33 67.24 Favored Pre-proline 0 CA--C 1.554 1.115 0 O-C-N 121.493 -1.004 . . . . 12.14 111.399 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.17 63.5 8.71 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.432 2.755 . . . . 12.0 108.876 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.1 tp -160.55 140.42 11.12 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.443 0.697 . . . . 10.27 111.177 -162.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.3 tt -170.4 -58.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.236 1.814 . . . . 6.23 109.665 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.31 -146.4 18.99 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.932 -0.867 . . . . 2.87 110.932 -172.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.96 166.63 21.08 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.195 0.902 . . . . 2.77 113.088 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.4 148.92 30.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.029 2.486 . . . . 3.25 111.854 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -130.68 125.16 33.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.6 1.16 . . . . 2.9 111.302 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -109.81 46.57 1.0 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.448 -1.407 . . . . 2.69 111.983 -162.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -85.35 155.25 21.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.573 1.549 . . . . 2.95 111.792 -160.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.3 m -79.83 133.78 36.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.302 1.041 . . . . 1.86 109.868 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 72.2 p -81.94 160.65 23.31 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 123.061 1.41 . . . . 2.68 112.655 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -2.73 1.57 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.773 2.029 . . . . 1.74 114.905 168.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 t -100.37 -41.31 7.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.953 0.901 . . . . 3.73 110.961 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.28 -0.77 7.05 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 125.154 1.359 . . . . 1.95 115.546 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.09 157.81 35.38 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.102 0.951 . . . . 3.78 108.544 163.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.451 HH12 ' CD ' ' A' ' 233' ' ' GLU . 87.5 mtt-85 -92.13 134.24 35.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.749 -1.219 . . . . 7.35 110.857 174.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -138.47 136.02 35.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.706 1.002 . . . . 3.09 113.706 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.25 149.1 51.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 128.57 2.748 . . . . 3.31 109.469 -164.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -32.42 -43.59 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.582 2.353 . . . . 4.02 114.389 158.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.02 -25.73 68.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.23 1.412 . . . . 7.78 113.227 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -89.4 -28.22 19.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.406 1.082 . . . . 2.93 111.521 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -80.58 -16.85 53.13 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.808 1.04 . . . . 2.82 113.808 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 111.31 1.39 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.865 1.266 . . . . 3.67 111.945 -171.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.35 -24.13 4.48 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.092 1.329 . . . . 2.72 112.796 -171.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -97.15 -162.11 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 117.825 0.813 . . . . 3.74 109.11 149.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -105.66 153.3 22.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.618 1.167 . . . . 1.84 110.115 168.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 pp -135.37 134.95 40.3 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.402 -0.811 . . . . 2.49 110.918 173.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.59 132.07 54.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.296 1.838 . . . . 3.01 107.499 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.13 129.3 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.398 1.079 . . . . 2.23 110.441 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -106.74 145.82 31.59 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.755 2.022 . . . . 2.55 111.523 163.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -112.3 118.28 34.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.557 1.143 . . . . 2.38 112.793 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.89 164.15 27.9 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 117.059 1.584 . . . . 1.56 117.059 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -26.97 11.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.129 1.772 . . . . 3.76 112.929 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 89.1 m 118.66 109.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.202 3.801 . . . . 3.07 109.997 163.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . 0.346 1.5 t-160 41.12 52.01 3.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.725 2.01 . . . . 10.34 114.241 -161.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.76 149.63 41.3 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 126.219 1.808 . . . . 4.16 109.993 159.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.03 -17.85 21.85 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.795 2.33 . . . . 4.8 114.361 -156.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -42.15 42.29 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.248 1.019 . . . . 11.16 112.528 -162.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 p 174.6 3.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 127.139 2.176 . . . . 4.79 114.623 -163.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . 0.251 46.9 t -57.93 -66.79 1.13 Allowed Pre-proline 0 CA--C 1.56 1.342 0 N-CA-C 115.423 1.638 . . . . 1.85 115.423 -147.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.34 -17.63 39.36 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.212 2.608 . . . . 1.76 113.246 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -69.35 -31.42 69.85 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 117.881 -1.057 . . . . 6.74 112.844 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -87.86 -20.12 26.47 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 121.164 1.802 . . . . 3.17 113.323 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -47.42 85.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.41 -1.431 . . . . 2.61 109.681 164.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.99 -51.27 64.43 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.49 1.516 . . . . 4.58 111.256 171.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -67.75 -21.53 65.27 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.673 -1.267 . . . . 3.44 113.666 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.9 ttp -67.47 -32.26 72.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.1 0.864 . . . . 2.99 112.362 164.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.58 -53.28 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 119.914 -1.742 . . . . 2.92 108.973 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.45 21.79 0.1 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.711 1.375 . . . . 3.32 114.711 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.46 -40.77 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 120.569 1.531 . . . . 3.42 111.912 147.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 92.9 t -57.66 -49.41 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.254 0.933 . . . . 2.02 110.428 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -59.83 -32.23 70.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.152 1.781 . . . . 3.62 113.168 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -81.45 -35.12 30.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 2.55 113.012 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 76.9 mt -62.92 -49.54 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.279 0.632 . . . . 2.77 109.601 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -62.92 -35.14 79.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.658 2.383 . . . . 3.54 111.585 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.2 m -66.54 -13.47 61.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.411 1.263 . . . . 2.94 114.411 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 87.6 mt -100.33 96.68 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.541 -1.349 . . . . 4.04 108.309 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.4 m -65.11 69.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.31 2.244 . . . . 5.3 112.529 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 176.2 -28.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.372 1.869 . . . . 4.13 112.78 -165.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.11 148.19 47.06 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 119.789 1.177 . . . . 3.59 112.139 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.24 142.87 15.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.398 2.732 . . . . 3.2 109.318 168.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -69.45 162.3 27.7 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.579 1.696 . . . . 3.82 115.579 -163.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 35.3 tp -119.51 96.07 5.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.128 2.171 . . . . 2.49 108.917 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 99.6 m -72.84 123.47 89.61 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-O 118.193 -0.908 . . . . 1.92 109.609 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.15 118.6 2.67 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.503 2.802 . . . . 1.11 111.118 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.9 mt -108.91 126.03 52.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.231 1.412 . . . . 3.86 110.482 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -104.04 130.56 51.73 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.468 1.107 . . . . 2.06 109.227 168.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.47 124.8 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.752 0.787 . . . . 1.64 111.444 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.6 m -66.07 129.95 41.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.924 0.89 . . . . 2.1 111.899 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.29 -17.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 114.831 1.419 . . . . 2.35 114.831 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -117.06 44.63 0.46 Allowed Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 125.23 1.412 . . . . 4.58 112.406 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.31 83.22 1.51 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.776 2.984 . . . . 2.58 113.778 -166.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -155.68 28.53 0.38 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.794 2.038 . . . . 5.17 110.501 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -156.54 -35.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.055 1.132 . . . . 4.51 114.055 -166.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -98.69 83.91 3.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.602 1.961 . . . . 3.51 111.088 -167.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 m -49.77 138.24 14.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.678 1.191 . . . . 2.39 109.588 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -43.04 -41.46 3.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.202 1.401 . . . . 3.26 113.283 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.34 -37.66 74.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.804 2.842 . . . . 6.52 113.365 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.12 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.16 0.984 . . . . 1.61 111.218 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.0 -46.44 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 118.968 -0.539 . . . . 1.54 110.49 167.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.67 69.38 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.559 1.072 . . . . 1.85 112.579 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.431 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 4.4 t30 -63.75 -51.54 64.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.389 0.995 . . . . 4.59 112.184 172.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -60.82 -41.46 95.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.586 1.555 . . . . 3.14 112.117 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.5 t -61.26 -46.63 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.318 1.047 . . . . 1.41 111.368 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 215' ' ' ASN . 5.9 ttpp -58.48 -35.23 71.86 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.957 0.903 . . . . 5.26 112.827 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -64.11 -19.67 65.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.343 1.057 . . . . 4.59 113.075 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -91.84 -64.19 1.15 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.381 1.072 . . . . 2.59 112.959 171.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t 174.02 145.2 0.2 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 126.271 1.828 . . . . 2.27 109.692 -168.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.55 -5.38 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.382 2.721 . . . . 1.85 113.92 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -77.74 -8.72 58.37 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.638 1.108 . . . . 1.95 113.635 169.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.46 143.87 33.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.508 1.049 . . . . 3.91 112.191 173.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.97 133.75 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.337 1.455 . . . . 1.85 108.999 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -112.71 128.51 8.49 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.995 -0.842 . . . . 1.08 110.995 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.7 mp -123.83 144.92 49.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.211 1.004 . . . . 2.11 110.88 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.3 t -161.02 -161.0 0.78 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.289 2.236 . . . . 2.66 108.201 -170.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 159.54 -114.64 0.62 Allowed Glycine 0 N--CA 1.465 0.628 0 C-N-CA 124.779 1.181 . . . . 2.71 110.898 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.3 p -137.28 174.16 10.91 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.263 1.425 . . . . 3.65 109.852 165.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -23.56 63.63 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.596 0.962 . . . . 7.8 113.596 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -68.24 -41.08 81.71 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.455 1.502 . . . . 3.41 111.287 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.451 ' CD ' HH12 ' A' ' 149' ' ' ARG . 45.1 mt-10 -69.03 -37.82 78.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.117 0.871 . . . . 4.66 110.897 170.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -27.61 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 117.774 -1.108 . . . . 2.62 113.36 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.06 -41.62 92.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.839 1.199 . . . . 5.03 110.308 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -60.29 -54.47 45.37 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 3.5 111.75 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.18 -40.91 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.127 0.876 . . . . 2.05 111.771 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.9 73.96 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.97 0.508 . . . . 2.35 111.318 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.64 -34.55 69.87 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.061 1.744 . . . . 6.13 112.963 -177.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.08 -58.5 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.457 1.103 . . . . 2.47 111.792 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.77 0.67 22.8 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.475 0.917 . . . . 2.71 113.475 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.0 ttt85 45.06 38.94 3.42 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.752 2.821 . . . . 7.22 113.696 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.8 m -78.81 133.64 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.529 0.732 . . . . 3.34 110.278 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.79 148.57 25.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.733 0.813 . . . . 4.99 111.235 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -172.05 163.03 5.99 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.645 1.978 . . . . 3.6 110.675 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 32.4 t -160.6 135.58 5.59 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-O 117.902 -1.047 . . . . 4.39 111.204 172.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.02 156.38 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.162 1.908 . . . . 3.45 110.665 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -89.2 165.12 32.59 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.384 0.992 . . . . 2.26 113.609 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -77.17 -171.32 1.12 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.3 2.667 . . . . 3.2 109.783 168.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -82.09 131.95 35.24 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.922 -0.77 . . . . 4.4 108.922 150.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -140.84 35.94 1.78 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.775 1.63 . . . . 7.27 108.732 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 253' ' ' ASP . 3.0 tm-20 173.74 166.12 0.18 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.308 3.043 . . . . 7.02 105.91 -151.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.402 ' H ' ' CD ' ' A' ' 252' ' ' GLU . 4.6 t70 -76.25 -27.11 56.6 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.768 1.227 . . . . 5.79 111.484 -176.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.26 3.66 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 117.172 2.286 . . . . 5.24 117.172 163.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.63 147.28 22.86 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 122.572 2.442 . . . . 4.26 112.579 169.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.55 92.66 2.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.178 0.99 . . . . 4.28 110.826 149.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 82.1 mt -57.85 145.03 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.067 -1.021 . . . . 3.39 109.483 158.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.94 158.78 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.398 1.479 . . . . 3.18 110.481 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -101.39 141.06 34.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.911 1.684 . . . . 4.32 110.115 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.45 149.61 17.23 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.104 1.52 . . . . 2.18 115.104 175.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 69.5 m -51.97 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.752 2.021 . . . . 4.4 111.859 172.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.55 52.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.276 1.431 . . . . 5.75 112.24 168.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mt -136.06 128.18 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.254 1.422 . . . . 2.67 107.914 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 60.5 mtp -99.07 159.55 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.114 1.766 . . . . 2.35 110.252 174.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -135.75 146.28 47.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.908 1.077 . . . . 2.78 113.908 -172.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.3 tp -104.59 130.06 52.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.977 1.311 . . . . 2.49 110.059 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.3 mt -111.13 142.21 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 106.997 -1.482 . . . . 4.0 106.997 150.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -114.08 -171.75 17.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.627 0.632 . . . . 1.99 113.817 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.53 70.86 6.69 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.305 3.337 . . . . 2.61 108.623 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -167.72 -62.21 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.001 1.72 . . . . 4.2 110.025 -169.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 139.02 -112.19 0.83 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 115.603 -0.726 . . . . 2.5 113.633 -162.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -82.54 123.11 28.89 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.512 0.931 . . . . 4.19 113.512 -149.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.5 t80 35.43 63.42 0.53 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.646 1.978 . . . . 3.6 114.393 156.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.0 tp -86.64 -4.02 59.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.423 0.897 . . . . 3.36 113.423 -166.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -168.85 150.11 4.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.911 2.085 . . . . 2.66 110.167 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -126.48 123.85 38.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.452 1.12 . . . . 3.49 111.078 161.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.63 86.81 3.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.134 1.374 . . . . 3.62 107.546 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.59 161.77 48.37 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.829 -1.309 . . . . 3.57 109.829 164.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -50.2 -16.03 0.28 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.554 1.687 . . . . 3.35 115.554 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -19.78 61.5 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 120.5 -1.375 . . . . 5.81 114.346 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -93.49 123.1 36.57 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.437 -1.415 . . . . 5.42 109.075 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -169.91 1.92 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.2 1.0 . . . . 5.88 108.789 167.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -30.85 -60.24 0.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.836 1.654 . . . . 3.02 113.527 170.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.04 84.07 Favored Glycine 0 N--CA 1.472 1.066 0 O-C-N 121.307 -0.871 . . . . 2.27 112.798 -166.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -76.38 -31.87 58.25 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.598 1.559 . . . . 3.0 111.562 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.32 -56.94 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.138 -0.689 . . . . 1.82 109.138 165.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.48 -43.35 88.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.624 0.972 . . . . 1.56 113.624 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.11 77.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.331 0.652 . . . . 1.89 112.469 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 16.4 p -66.84 -48.03 70.16 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.052 1.13 . . . . 1.69 114.052 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.13 -33.07 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.075 1.761 . . . . 1.71 112.168 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.0 71.84 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.906 0.776 . . . . 1.9 112.834 169.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 84.1 m -68.27 -41.84 80.46 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.634 0.652 . . . . 1.87 110.513 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -65.84 -27.1 67.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.544 1.137 . . . . 2.37 113.753 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.3 mmt -70.59 -10.78 60.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.577 0.955 . . . . 6.25 113.577 170.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.64 -50.41 1.27 Allowed Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 116.69 -1.624 . . . . 5.79 114.582 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.93 -37.12 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.41 2.073 . . . . 1.96 111.935 173.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.13 148.02 26.27 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.272 1.034 . . . . 2.84 112.256 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 74.47 -34.88 0.28 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.563 1.945 . . . . 11.8 116.107 161.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -150.01 -72.84 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.891 2.132 . . . . 6.81 115.565 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 39.4 pttt 151.21 -26.78 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.27 1 C-N-CA 132.757 4.423 . . . . 11.13 111.653 -163.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.487 1.415 0 C-N-CA 130.87 3.668 . . . . 11.19 106.569 -142.168 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 117.714 -1.136 . . . . 16.33 108.709 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -59.93 -45.01 93.98 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.944 1.247 . . . . 18.42 109.746 163.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.8 p -77.17 156.72 31.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.978 2.111 . . . . 13.8 111.563 164.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 118.81 124.77 3.35 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.881 1.705 . . . . 10.45 111.943 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm 166.4 143.46 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 130.151 3.381 . . . . 11.64 109.509 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -82.72 -178.37 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.669 2.912 . . . . 8.76 110.83 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.8 mp 66.06 85.21 0.14 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.535 2.334 . . . . 10.71 111.415 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.88 -46.5 84.61 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.765 0.826 . . . . 6.26 109.209 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.57 -14.05 4.59 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 127.186 2.327 . . . . 5.24 114.704 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.24 73.04 1.08 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.028 -1.229 . . . . 3.41 110.028 -158.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.89 129.16 6.13 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.558 2.172 . . . . 4.03 111.366 -170.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.46 162.65 33.95 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.579 1.952 . . . . 3.16 110.554 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.3 p -144.96 57.38 1.27 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.029 -1.045 . . . . 3.04 111.249 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.74 160.4 14.5 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.714 1.206 . . . . 2.6 113.935 -166.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -87.23 135.54 33.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.244 1.418 . . . . 1.73 111.205 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.7 p -97.03 162.95 13.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 122.82 1.295 . . . . 2.72 112.89 176.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -63.31 -20.43 65.47 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.265 1.426 . . . . 1.66 114.546 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.0 t -88.36 -4.79 58.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.815 1.246 . . . . 3.84 113.24 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.96 2.4 62.61 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 119.547 1.067 . . . . 2.25 115.525 171.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.33 154.9 17.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.789 1.235 . . . . 4.7 109.637 170.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.22 112.54 24.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.259 1.824 . . . . 4.96 109.593 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -78.79 165.78 23.18 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.301 -1.499 . . . . 4.01 112.249 177.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.4 m -154.67 144.74 21.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.708 1.203 . . . . 3.39 108.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -48.73 -41.49 32.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.566 1.147 . . . . 4.26 112.484 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.92 -2.45 27.06 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.516 1.673 . . . . 8.26 115.516 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -34.58 16.4 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 120.353 1.433 . . . . 4.36 112.335 168.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -94.23 -29.9 14.86 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.382 1.253 . . . . 3.59 114.382 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.79 124.72 23.72 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.656 1.571 . . . . 5.98 109.198 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.87 -18.4 26.6 Favored Glycine 0 N--CA 1.477 1.397 0 C-N-CA 124.211 0.91 . . . . 3.92 112.349 -160.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.17 167.84 9.63 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.018 2.527 . . . . 5.36 108.08 167.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -82.09 99.99 9.52 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.575 -1.328 . . . . 2.1 110.45 163.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 160' ' ' LEU . 1.6 pt? -96.37 140.38 31.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.409 0.623 . . . . 3.7 110.096 167.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 tt -125.02 113.55 17.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.112 -1.81 . . . . 2.72 106.112 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.17 136.97 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 3.6 111.068 -170.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -123.19 129.61 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.861 1.665 . . . . 2.97 110.688 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -99.93 102.62 14.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.576 1.15 . . . . 2.91 112.795 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.91 163.63 13.77 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.895 1.236 . . . . 1.56 114.756 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -124.34 116.66 22.96 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.966 0.906 . . . . 3.35 110.723 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 23.1 m -58.89 129.31 41.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.709 -1.589 . . . . 4.32 106.709 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 90.03 -1.16 0.28 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.124 2.17 . . . . 7.13 113.791 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.23 158.17 85.8 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 119.925 1.239 . . . . 2.33 110.103 157.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.51 -177.26 3.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.149 3.233 . . . . 2.87 112.153 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.16 1.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.404 1.882 . . . . 5.21 115.876 -171.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.24 -38.17 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.987 1.715 . . . . 3.72 110.727 172.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -60.49 9.87 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.603 1.161 . . . . 1.47 111.603 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.57 -23.75 49.45 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.897 1.731 . . . . 1.24 113.943 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -51.62 -52.02 51.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.801 1.637 . . . . 3.62 113.422 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -80.35 -25.78 39.03 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.874 -1.141 . . . . 3.05 112.955 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.21 -44.9 71.14 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.212 1.005 . . . . 2.62 110.936 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -48.1 -54.37 13.43 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.729 1.612 . . . . 5.21 110.912 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -66.64 -28.09 68.2 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.535 -1.353 . . . . 4.19 113.009 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 46.9 ttp -65.85 -39.47 90.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 117.524 -1.227 . . . . 3.47 111.429 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -55.33 -45.9 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 120.948 1.704 . . . . 1.75 110.722 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.5 -11.78 61.15 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.124 -0.941 . . . . 4.93 112.387 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.88 -29.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.945 1.702 . . . . 1.93 110.731 168.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.77 -46.49 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.721 0.808 . . . . 2.0 109.532 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.66 -43.82 80.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.115 2.566 . . . . 4.11 113.14 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.21 -42.26 96.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.221 1.809 . . . . 2.89 112.041 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.3 mt -68.62 -40.7 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.158 0.983 . . . . 2.18 112.121 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -61.42 -31.44 71.37 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.828 1.251 . . . . 3.78 111.226 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.6 m -72.12 -21.64 61.44 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.49 -0.756 . . . . 3.14 112.874 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.52 63.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.349 -1.469 . . . . 4.3 108.131 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 75.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.659 1.984 . . . . 5.87 113.021 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.6 m 174.43 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.856 3.663 . . . . 4.12 111.239 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.28 154.18 54.13 Favored Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 121.613 2.006 . . . . 3.23 111.434 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.52 -55.13 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.719 2.279 . . . . 3.44 110.242 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -178.73 170.94 1.53 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 129.991 3.316 . . . . 3.95 108.099 168.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.3 tt -118.96 115.28 24.03 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.067 -1.827 . . . . 2.74 106.067 150.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.3 m -95.65 108.16 38.21 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 118.041 -0.98 . . . . 2.27 109.226 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.38 122.75 2.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.212 2.608 . . . . 1.05 111.171 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.0 tp -118.5 100.14 7.27 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.303 1.041 . . . . 2.34 110.469 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -84.65 120.92 26.94 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.651 -0.5 . . . . 2.21 109.651 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.9 mt -102.28 103.84 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.413 1.485 . . . . 2.72 107.161 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 3.8 t -97.59 132.85 42.87 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.648 -0.658 . . . . 2.98 111.125 170.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.2 pt -102.89 13.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.1 1.76 . . . . 1.78 114.665 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.23 32.39 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 116.098 1.888 . . . . 3.72 116.098 -173.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 -7.83 21.9 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 123.417 2.256 . . . . 2.6 114.247 -171.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -85.68 41.39 0.9 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.264 1.025 . . . . 4.46 110.8 167.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 16.1 ttm105 -178.94 -58.25 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 131.128 3.771 . . . . 4.76 109.107 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.75 171.31 15.34 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.946 1.299 . . . . 4.31 111.455 -175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.1 t -149.3 153.13 37.03 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.148 -0.97 . . . . 3.2 112.305 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -41.87 50.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.818 1.647 . . . . 2.95 111.951 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -67.94 -36.44 80.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.547 1.539 . . . . 3.81 112.535 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.63 -44.5 64.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.52 1.055 . . . . 1.22 111.081 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 12.5 mm -53.58 -43.06 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.353 1.061 . . . . 1.67 111.717 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.34 80.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.232 1.013 . . . . 1.27 113.115 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -70.96 -42.68 69.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.496 0.718 . . . . 4.14 111.742 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -62.65 -41.03 98.84 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.913 0.885 . . . . 2.82 111.596 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.38 -51.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.449 1.9 . . . . 1.31 112.327 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -56.77 -34.42 67.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.283 1.033 . . . . 4.86 113.372 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.96 -48.01 67.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.945 0.339 . . . . 5.05 110.547 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -72.86 21.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 3.02 114.389 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.3 p 106.43 147.42 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.656 1 C-N-CA 131.792 4.037 . . . . 2.68 112.504 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.16 -1.82 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.078 2.519 . . . . 1.6 113.329 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -90.29 -7.85 52.39 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.287 0.949 . . . . 2.48 112.793 171.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 136.36 46.72 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.523 -1.361 . . . . 2.75 111.565 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.21 121.48 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.543 0.737 . . . . 2.1 109.263 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -94.55 125.05 8.16 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.542 -1.423 . . . . 1.06 109.542 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.62 130.15 41.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.977 1.711 . . . . 4.3 108.817 -173.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.6 t -163.71 -163.05 0.76 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.511 1.924 . . . . 4.0 109.849 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.51 -149.01 6.88 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.448 1.023 . . . . 1.64 112.015 174.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.8 t -74.08 166.16 23.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.842 0.821 . . . . 2.54 110.488 159.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -47.8 -38.19 15.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.602 1.161 . . . . 5.96 113.069 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -70.85 -29.46 65.6 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.153 1.381 . . . . 3.48 111.743 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.03 -36.21 61.9 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 3.51 111.72 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.52 -35.78 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 118.836 -0.602 . . . . 2.24 111.189 170.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.55 -48.07 70.82 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.682 -1.628 . . . . 2.57 110.095 165.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -46.94 -57.78 4.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 121.555 1.979 . . . . 2.25 111.438 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.67 -39.33 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.304 0.956 . . . . 2.37 112.77 -173.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -35.5 72.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.965 0.802 . . . . 1.55 112.585 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -74.28 -40.01 62.59 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.886 2.074 . . . . 3.08 111.575 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.49 81.49 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 1.56 112.648 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.35 -6.74 59.23 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.478 0.711 . . . . 2.8 112.897 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.73 39.17 29.92 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.827 2.051 . . . . 6.07 112.708 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.2 -39.75 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.079 -1.013 . . . . 3.41 111.918 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 29.4 t80 64.47 130.6 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.198 1.799 . . . . 4.74 112.77 -165.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -116.2 152.57 33.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.002 0.921 . . . . 3.22 110.653 164.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.0 t -106.92 107.0 59.75 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.479 -0.772 . . . . 2.75 110.457 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.86 131.35 16.89 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.364 2.043 . . . . 2.74 109.993 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -88.34 -174.71 47.52 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.489 1.042 . . . . 2.3 114.819 -175.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.25 176.32 10.21 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.389 3.393 . . . . 3.81 113.107 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -118.5 137.49 53.16 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.165 2.186 . . . . 4.14 109.52 164.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.25 -79.53 0.46 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 118.382 -0.818 . . . . 5.68 110.754 -163.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -67.78 -69.42 0.32 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.243 0.929 . . . . 7.08 112.009 168.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.22 -72.6 0.06 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.841 0.682 . . . . 7.17 112.841 -168.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -114.05 -32.38 6.05 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.468 -0.77 . . . . 8.19 112.753 -161.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.36 169.82 17.64 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 113.771 1.026 . . . . 6.23 113.771 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 37.6 p90 177.18 161.26 0.44 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.566 2.346 . . . . 3.91 111.524 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.5 mm -121.08 148.93 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.575 1.55 . . . . 4.08 108.741 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.45 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 106.402 -1.703 . . . . 3.37 106.402 162.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -104.1 163.85 12.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.188 1.795 . . . . 3.58 111.569 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 158.82 33.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.534 1.133 . . . . 2.11 113.022 -158.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 49.3 p -59.19 -16.5 20.84 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.836 1.421 . . . . 3.24 114.836 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 263' ' ' ILE 0.347 10.6 tt 43.54 -143.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.819 1.248 . . . . 4.07 109.404 -147.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 262' ' ' ILE . 73.8 mt 76.18 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.285 1.834 . . . . 3.39 110.992 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -118.78 149.66 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.625 -1.17 . . . . 3.25 110.443 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.41 144.38 45.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.966 0.906 . . . . 4.02 112.749 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 28.1 tp -97.41 128.4 44.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.709 1.203 . . . . 1.99 108.52 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.31 142.24 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.207 -1.775 . . . . 2.49 106.207 161.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -132.64 -168.06 11.91 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.207 0.843 . . . . 2.56 115.207 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.63 58.84 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.652 1 C-N-CA 125.442 4.095 . . . . 4.88 110.801 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -154.39 -55.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.109 1.364 . . . . 7.12 108.292 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.07 138.36 4.47 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.09 1.328 . . . . 5.44 113.316 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 64.64 -168.61 0.21 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.388 1.475 . . . . 5.56 112.697 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -74.13 99.44 3.37 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.79 -1.194 . . . . 5.17 112.259 -173.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -24.55 27.9 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.758 1.623 . . . . 3.74 112.231 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -165.46 175.14 9.3 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.05 1.74 . . . . 2.33 110.326 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -153.29 166.49 32.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.817 1.647 . . . . 4.51 112.869 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -143.01 150.9 40.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.527 1.531 . . . . 2.58 110.196 -173.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.28 166.8 15.42 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.711 -1.049 . . . . 3.38 111.989 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -24.66 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 134.236 5.014 . . . . 3.95 119.885 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.94 -41.18 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.829 2.452 . . . . 5.36 110.21 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -76.56 113.05 13.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.335 0.97 . . . . 4.34 109.844 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 27.8 ttm105 -66.65 167.09 11.67 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.861 -1.15 . . . . 5.63 109.101 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -50.56 -44.84 56.73 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.25 -1.531 . . . . 2.28 113.279 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -58.15 -39.68 92.61 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.553 -0.582 . . . . 1.87 112.302 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.53 -28.55 46.15 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.007 1.114 . . . . 4.49 114.007 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 80.5 mt -58.46 -49.24 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 119.708 1.14 . . . . 2.3 109.002 168.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.02 91.9 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.391 0.886 . . . . 1.25 113.391 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -58.85 -32.03 69.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.588 0.755 . . . . 1.2 112.881 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -52.71 64.29 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.709 0.633 . . . . 1.57 112.709 168.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.35 -38.94 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.399 -1.438 . . . . 1.28 111.255 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.09 -8.77 25.6 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.079 1.352 . . . . 1.65 114.194 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 92.9 m -92.19 -48.92 6.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.053 1.341 . . . . 1.73 110.318 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -69.13 -23.34 63.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.681 0.993 . . . . 2.21 113.681 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 27.3 ttt -55.93 -26.42 47.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.163 1.785 . . . . 4.31 113.866 164.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -69.59 -46.8 26.14 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.247 -1.835 . . . . 6.72 112.464 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.92 -59.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.22 1.946 . . . . 1.9 110.927 167.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -96.07 125.42 40.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.7 1.0 . . . . 3.78 113.7 -166.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.58 -176.64 2.95 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.777 1.631 . . . . 8.54 111.964 -173.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -120.86 145.11 47.97 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 128.383 2.673 . . . . 8.81 106.906 165.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 34.4 mttt 92.55 -44.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 130.534 3.534 . . . . 8.95 110.517 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.251 1.171 0 C-N-CA 129.804 3.242 . . . . 11.39 106.206 154.898 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 118.173 -0.917 . . . . 18.94 110.062 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.429 ' CZ ' ' HE2' ' A' ' 133' ' ' LYS . 44.5 t80 -156.85 151.77 26.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.472 1.109 . . . . 15.52 110.027 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t 175.78 -162.53 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.452 2.701 . . . . 13.62 108.836 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.33 49.69 9.11 Favored Glycine 0 N--CA 1.467 0.764 0 C-N-CA 125.128 1.347 . . . . 10.05 112.307 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.429 ' HE2' ' CZ ' ' A' ' 130' ' ' PHE . 38.2 mmtm -135.88 73.59 59.57 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.204 1.402 . . . . 9.53 111.473 -176.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.04 167.47 26.65 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.487 2.791 . . . . 6.72 110.74 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.5 mt -132.98 37.69 3.41 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.352 1.861 . . . . 7.81 110.166 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 tt -65.12 81.11 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.629 1.972 . . . . 9.61 112.73 -172.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 92.03 96.38 1.35 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.498 1.999 . . . . 5.57 110.041 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.62 111.61 4.08 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.199 -1.334 . . . . 3.22 110.267 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.72 138.25 6.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.399 2.099 . . . . 2.96 112.467 -163.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -162.22 165.72 26.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.447 1.899 . . . . 2.97 110.846 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.7 p -137.01 92.75 2.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.351 -0.843 . . . . 3.4 110.543 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mt -104.24 139.95 38.54 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.153 1.381 . . . . 2.42 111.632 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 84.8 m -67.97 135.45 52.38 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.997 0.904 . . . . 2.38 110.503 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 157.96 18.16 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.859 -1.151 . . . . 2.72 110.459 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 2.9 0.89 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.413 1.085 . . . . 1.89 113.502 165.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 m -89.96 -45.14 9.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.138 1.375 . . . . 2.85 110.8 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.31 38.47 1.11 Allowed Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.987 1.279 . . . . 2.34 113.473 -168.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.87 174.82 10.05 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.905 2.082 . . . . 4.88 107.588 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -125.86 106.63 9.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 121.258 1.844 . . . . 7.1 112.551 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -99.34 153.91 18.6 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.204 1.187 . . . . 3.82 114.204 -171.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.0 p -123.03 148.2 45.82 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.345 2.658 . . . . 2.52 108.626 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -46.65 -51.75 15.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.507 1.123 . . . . 3.54 113.622 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -71.95 6.17 2.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.653 2.094 . . . . 7.21 116.653 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.11 -55.09 8.93 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.407 1.003 . . . . 3.78 110.76 162.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.5 -31.44 26.47 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.832 1.049 . . . . 3.02 113.832 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.04 118.73 5.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.328 1.051 . . . . 4.03 111.079 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 123.62 -27.38 5.74 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 124.114 0.864 . . . . 2.45 111.299 -167.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -84.21 166.87 17.19 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.352 -0.981 . . . . 3.77 108.352 143.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -78.54 110.17 13.39 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.728 -0.607 . . . . 2.1 112.451 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.4 mt -91.45 140.62 29.58 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.156 0.979 . . . . 2.8 112.916 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -137.43 121.66 18.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.679 1.992 . . . . 2.61 107.408 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 43.0 mt -126.09 131.87 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.53 0.732 . . . . 1.77 110.718 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -147.53 153.54 39.62 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.379 1.472 . . . . 2.67 113.068 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.44 123.06 42.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.518 1.527 . . . . 2.56 110.514 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.82 -176.95 36.23 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.21 0.844 . . . . 1.41 115.21 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -156.47 139.21 15.14 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.123 0.962 . . . . 3.82 112.946 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 t -82.2 74.5 9.17 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.424 1.011 . . . . 4.87 110.36 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 169.79 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 129.568 3.147 . . . . 7.05 110.538 -163.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.7 t -51.11 151.85 4.44 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.911 1.284 . . . . 2.21 113.844 159.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.38 64.18 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.314 3.343 . . . . 3.74 111.009 165.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.3 t0 69.59 -14.59 0.33 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.763 3.225 . . . . 4.9 114.821 162.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.37 -34.36 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 120.584 -1.323 . . . . 3.31 111.395 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 22.7 m -59.28 -54.34 57.18 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.317 -1.325 . . . . 2.32 114.415 167.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -67.36 -26.71 41.04 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.011 1.807 . . . . 1.72 114.154 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -66.38 -42.98 87.15 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.909 1.686 . . . . 3.53 110.814 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.73 -36.92 80.07 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.378 -0.826 . . . . 3.78 111.474 168.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 180' ' ' MET . 0.7 OUTLIER -69.56 -40.8 76.58 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.264 1.026 . . . . 2.64 112.694 178.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -57.76 11.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.148 1.379 . . . . 3.21 108.433 170.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -54.2 -37.51 64.63 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 120.174 -1.579 . . . . 3.91 113.74 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.434 ' HG2' ' HA ' ' A' ' 177' ' ' LEU . 23.9 ptp -68.73 -41.82 78.47 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 117.058 -1.448 . . . . 2.51 112.408 169.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.38 -44.66 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 121.212 1.824 . . . . 1.68 109.807 171.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -62.95 -29.71 71.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.214 -1.374 . . . . 3.01 113.558 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.7 p -86.95 -32.41 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.688 1.131 . . . . 2.62 113.394 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.03 -46.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 120.707 1.594 . . . . 2.33 110.78 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -31.54 68.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.571 1.148 . . . . 4.65 113.41 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -78.2 -13.63 59.78 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.174 -0.954 . . . . 2.66 113.328 174.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.6 mm -85.35 -55.29 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.635 1.574 . . . . 1.91 109.921 167.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -50.69 -39.3 50.88 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.406 1.482 . . . . 3.92 113.092 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -60.3 -29.41 68.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.316 1.046 . . . . 2.9 112.483 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.88 56.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 120.607 -1.308 . . . . 3.35 107.612 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -36.58 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 130.001 3.32 . . . . 4.42 118.775 -168.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -27.66 63.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.816 1.189 . . . . 4.53 111.536 172.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.84 163.01 69.72 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.127 1.771 . . . . 3.64 112.527 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -99.15 -172.35 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.924 3.083 . . . . 3.84 113.67 -166.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.48 62.73 4.68 Favored 'General case' 0 CA--C 1.549 0.942 1 C-N-CA 132.304 4.241 . . . . 5.54 116.667 -156.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.2 tp -59.76 96.94 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 O-C-N 120.67 -1.268 . . . . 1.86 112.809 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.3 m -96.35 117.86 65.84 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 125.567 1.547 . . . . 1.32 110.084 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -87.44 124.91 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.968 2.446 . . . . 0.88 111.926 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.79 102.55 9.2 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.989 2.116 . . . . 2.4 109.598 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -99.83 133.98 43.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.154 1.381 . . . . 2.46 111.618 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.82 126.19 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.556 0.742 . . . . 1.52 108.998 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 62.2 p -90.59 111.7 23.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.08 1.352 . . . . 2.52 110.733 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 7.3 pt -106.38 10.81 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 115.034 1.494 . . . . 1.89 115.034 -162.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -115.63 52.41 0.83 Allowed Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.595 1.158 . . . . 3.3 111.405 169.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.2 132.37 25.81 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.635 2.223 . . . . 2.58 109.188 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 128.19 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 130.334 3.454 . . . . 5.35 107.384 -163.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 -38.24 2.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.51 -0.757 . . . . 4.89 112.617 166.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.61 101.54 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.411 1.005 . . . . 4.56 108.672 160.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 48.0 m -115.82 149.37 38.68 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.372 1.469 . . . . 2.34 109.368 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -54.9 1.33 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.674 1.19 . . . . 3.42 112.148 170.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -69.03 -37.41 78.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.854 1.262 . . . . 3.19 112.94 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.71 -39.86 76.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.479 0.712 . . . . 1.48 111.793 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.07 -34.62 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.539 0.736 . . . . 1.72 110.556 175.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.0 75.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 118.693 -0.67 . . . . 1.44 111.889 170.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.6 -47.44 60.14 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.343 0.974 . . . . 4.38 112.281 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -53.42 -40.98 65.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.675 1.19 . . . . 3.8 111.485 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.4 t -64.64 -50.68 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.762 1.225 . . . . 1.38 112.017 170.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -57.28 -27.56 62.22 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.735 1.214 . . . . 5.21 113.754 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.36 -56.75 4.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.078 1.751 . . . . 3.7 111.656 174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -79.3 -38.44 35.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.328 1.233 . . . . 3.36 114.328 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 m 167.71 129.72 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 127.13 2.172 . . . . 2.02 112.806 170.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.77 -0.26 3.68 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.375 2.717 . . . . 1.72 113.516 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.68 -26.37 68.62 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.277 0.944 . . . . 4.33 113.418 162.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.18 133.42 35.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.164 0.893 . . . . 2.1 112.788 -165.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.82 122.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.876 1.27 . . . . 1.84 107.768 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.11 132.35 10.9 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.181 -1.168 . . . . 0.87 110.181 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.14 143.62 48.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 2.43 109.607 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.3 m -143.08 176.27 9.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 128.813 2.845 . . . . 2.84 106.676 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 168.11 -179.85 41.04 Favored Glycine 0 N--CA 1.472 1.056 0 O-C-N 120.436 -1.415 . . . . 1.91 114.364 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.0 t -75.42 163.47 27.39 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.264 0.625 . . . . 2.88 111.053 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.415 ' HA ' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -49.55 -21.42 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.419 2.288 . . . . 7.14 115.684 176.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -66.9 -51.46 55.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.137 1.375 . . . . 2.96 111.175 166.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -68.55 -43.86 75.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.242 1.017 . . . . 4.47 111.354 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 231' ' ' ARG . 9.1 m -74.55 -19.94 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 114.186 1.18 . . . . 2.91 114.186 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.83 -57.54 4.52 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.807 1.185 . . . . 2.84 108.602 161.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.15 -55.41 10.42 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.223 1.409 . . . . 3.47 112.29 -173.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.37 -40.78 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 118.923 0.783 . . . . 2.12 112.94 -171.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.17 75.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.611 0.764 . . . . 1.64 110.436 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -70.6 -34.23 71.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 3.79 112.678 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.16 -58.0 5.14 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.384 1.474 . . . . 2.34 112.579 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -1.87 13.99 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.631 0.974 . . . . 2.56 113.631 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.02 32.17 6.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.29 2.236 . . . . 5.9 113.013 165.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.56 155.66 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.664 1.185 . . . . 3.43 110.149 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -74.14 137.87 43.49 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.276 0.56 . . . . 4.28 112.041 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -164.83 141.7 6.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.58 2.752 . . . . 5.32 109.481 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 129.83 2.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 117.936 -1.031 . . . . 4.97 112.586 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -69.19 141.66 48.18 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.407 2.738 . . . . 4.77 110.689 171.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -115.86 -170.25 15.88 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.068 0.842 . . . . 3.7 114.471 -172.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -81.3 -174.14 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.19 3.26 . . . . 3.76 112.105 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 255' ' ' ASP . 25.6 mmmt -60.7 148.32 39.09 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.879 -0.6 . . . . 4.34 111.016 157.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -142.98 153.88 43.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.192 0.997 . . . . 8.06 111.522 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 58.86 -59.22 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 128.451 2.7 . . . . 7.7 112.519 -157.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -167.15 -52.63 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.987 2.915 . . . . 6.47 109.108 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -133.84 5.95 3.67 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.107 1.521 . . . . 5.41 115.107 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.446 ' O ' ' HE3' ' A' ' 250' ' ' LYS . 8.1 t70 -79.66 178.84 7.86 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 119.667 -1.896 . . . . 4.24 110.339 164.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -132.32 106.18 7.76 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.036 -1.665 . . . . 3.73 109.323 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.91 146.14 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 122.032 0.92 . . . . 4.42 110.464 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.32 128.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.132 2.173 . . . . 3.77 105.556 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -105.19 152.05 23.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.637 0.732 . . . . 3.75 111.713 -170.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -165.18 152.46 10.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.548 1.166 . . . . 2.65 114.024 -169.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 99.2 m -59.21 120.42 9.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.182 -1.372 . . . . 3.9 108.698 164.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.29 135.73 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.023 -1.473 . . . . 3.57 107.023 146.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.2 mt 135.65 127.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.108 1 C-N-CA 131.964 4.106 . . . . 2.9 109.454 176.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 5.2 ptm -100.6 150.79 22.34 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.682 1.993 . . . . 2.64 110.756 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -118.22 132.13 56.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.014 1.326 . . . . 3.4 112.196 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 8.8 tt -90.69 125.88 35.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.181 0.991 . . . . 2.21 111.091 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 143.82 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 127.629 2.372 . . . . 1.73 108.684 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.32 149.11 49.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.541 -1.144 . . . . 1.92 111.209 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.77 63.8 6.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.122 3.215 . . . . 2.88 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 153.72 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 131.36 3.864 . . . . 8.25 113.91 173.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 168.92 149.9 6.43 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 120.455 1.48 . . . . 3.32 116.023 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . 0.283 60.7 mt-10 41.33 -145.32 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.549 2.74 . . . . 4.18 113.87 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -148.54 155.49 41.2 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.044 1.293 . . . . 3.84 113.869 -163.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.84 -37.53 4.82 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.261 1.424 . . . . 2.64 111.912 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -145.32 170.85 15.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.43 1.092 . . . . 4.19 112.735 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -158.86 133.32 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.808 1.243 . . . . 3.85 111.519 160.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -178.1 -122.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.179 2.192 . . . . 3.78 111.118 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 95.79 -94.48 1.69 Allowed Glycine 0 N--CA 1.469 0.862 0 N-CA-C 109.479 -1.448 . . . . 3.61 109.479 -168.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.08 139.39 41.62 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 117.646 0.723 . . . . 3.4 111.104 168.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 80.82 -1.6 1.83 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.895 2.478 . . . . 5.32 113.311 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 121.21 36.1 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.032 1.733 . . . . 6.28 110.134 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -72.04 141.84 49.28 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.774 -1.204 . . . . 6.95 108.31 166.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -41.07 31.54 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 116.117 1.895 . . . . 1.73 116.117 -160.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.25 -18.77 71.64 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 119.787 1.176 . . . . 1.29 114.833 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.75 -33.89 76.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.899 -0.766 . . . . 2.95 110.777 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.6 -46.84 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.952 0.901 . . . . 1.66 109.101 172.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.91 -48.97 72.39 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.685 1.129 . . . . 1.4 112.409 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.27 70.57 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.821 1.045 . . . . 1.6 113.821 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 5.7 p -87.43 -41.6 13.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.653 0.612 . . . . 1.95 112.653 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 33.0 mt -52.03 -38.8 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.418 1.087 . . . . 1.47 111.01 169.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -51.73 -31.5 26.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.911 1.078 . . . . 2.2 113.911 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 19.6 p -75.26 -32.72 61.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.073 0.949 . . . . 3.75 112.036 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -72.42 -32.01 65.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.19 0.996 . . . . 2.82 112.372 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.19 -32.77 70.86 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.522 1.129 . . . . 6.6 112.299 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -49.94 -51.32 62.28 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 116.307 -1.806 . . . . 5.53 113.365 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.81 -44.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.218 2.612 . . . . 2.59 113.367 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -92.4 123.1 35.47 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.888 1.222 . . . . 3.08 114.146 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 78.81 -64.16 0.26 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 127.258 2.223 . . . . 13.47 112.962 155.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -137.32 111.37 8.35 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.872 0.869 . . . . 7.15 110.61 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -17.46 22.99 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 117.298 2.333 . . . . 9.74 117.298 -165.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.486 1.356 1 C-N-CA 133.606 4.762 . . . . 10.1 106.348 -149.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 117.702 -1.142 . . . . 17.38 110.255 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -49.48 -48.67 47.65 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.108 1.521 . . . . 13.42 115.108 -168.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.6 t -77.53 51.31 0.88 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.01 1.324 . . . . 11.65 112.811 178.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -83.12 164.09 42.02 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.471 1.034 . . . . 9.88 111.684 167.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt 179.44 152.25 0.54 Allowed Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.887 2.075 . . . . 8.97 111.554 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.06 159.77 37.2 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.418 2.745 . . . . 7.47 110.634 168.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.2 mp -121.05 134.67 55.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.884 1.273 . . . . 7.95 108.766 172.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.05 -36.9 7.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.944 0.897 . . . . 5.94 112.258 176.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 165.69 -158.93 32.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.89 1.71 . . . . 2.8 110.66 -169.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 134.3 -159.9 23.97 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.433 1.016 . . . . 3.06 113.585 174.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.78 156.61 39.58 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.206 2.604 . . . . 3.22 113.804 -168.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -138.91 169.14 18.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.54 2.336 . . . . 2.72 109.199 174.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.9 m -138.53 69.47 1.38 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.727 -1.233 . . . . 2.79 112.482 -176.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.22 172.65 7.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.441 1.097 . . . . 2.59 112.333 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.0 m -103.42 158.52 16.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.501 1.52 . . . . 1.68 109.525 173.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.3 m -107.94 159.79 16.27 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.939 1.296 . . . . 2.5 111.612 -172.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -55.23 -9.74 0.47 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 115.793 1.775 . . . . 1.72 115.793 176.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 t -113.53 7.35 17.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.951 2.1 . . . . 3.78 113.622 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.49 -10.41 69.06 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 125.575 1.56 . . . . 1.84 115.842 173.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.99 148.71 25.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.772 1.229 . . . . 3.48 111.984 -177.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.63 115.14 28.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.56 1.544 . . . . 6.08 111.249 -173.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 161.66 37.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.462 1.505 . . . . 4.11 112.742 -168.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.5 m -154.18 148.5 26.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.001 0.92 . . . . 3.02 111.176 -152.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -36.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.041 2.136 . . . . 3.16 112.569 165.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.421 ' HZ2' ' CG ' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -69.82 3.19 2.72 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.712 1.375 . . . . 7.11 114.712 -177.502 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' ' 153' ' ' LYS . 5.7 m-20 -108.04 -24.43 11.59 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.335 1.854 . . . . 3.29 112.822 173.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -84.64 -15.93 43.73 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.865 1.061 . . . . 3.32 113.865 165.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.0 tp -57.03 154.43 9.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.207 1.403 . . . . 3.7 112.929 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.19 -20.11 21.79 Favored Glycine 0 N--CA 1.478 1.495 0 C-N-CA 126.622 2.058 . . . . 2.44 113.679 -174.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.01 173.68 6.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.277 1.831 . . . . 3.63 108.412 165.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -67.76 110.87 3.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.226 -0.657 . . . . 1.75 109.226 170.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.4 tp -99.16 120.66 39.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.185 0.993 . . . . 2.47 109.207 -172.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 tt -104.69 116.21 31.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.158 1.383 . . . . 3.73 107.884 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.54 102.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.27 -1.011 . . . . 2.37 108.27 -178.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -100.21 148.91 24.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.024 1.73 . . . . 2.38 111.429 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -116.16 117.26 29.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.094 . . . . 2.33 110.743 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.97 153.64 23.4 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 115.777 1.071 . . . . 1.5 115.777 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -88.34 60.82 5.89 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.344 -1.092 . . . . 3.61 112.561 -170.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 14.7 m 64.1 -20.55 0.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 128.174 2.59 . . . . 4.57 115.551 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 176.83 -50.23 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 128.688 2.795 . . . . 9.98 110.101 -166.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.511 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.1 OUTLIER 61.0 177.8 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.881 1.272 . . . . 2.65 112.7 -164.533 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.511 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 39.7 Cg_endo -88.92 -132.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.88 3.053 . . . . 3.18 107.341 159.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -80.56 61.98 4.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.717 1.207 . . . . 5.06 112.403 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.75 -83.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.594 1.557 . . . . 3.61 110.365 175.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 94.4 m -49.87 -48.31 78.17 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.739 1.755 . . . . 2.04 115.739 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.77 -25.47 23.91 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.563 2.176 . . . . 1.35 113.732 -169.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.68 -52.93 63.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.973 1.709 . . . . 3.06 110.806 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.57 -26.05 61.57 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.848 -1.158 . . . . 2.81 111.963 171.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -45.6 78.53 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.465 -1.397 . . . . 2.37 111.849 -177.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.93 -41.01 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.227 1.376 . . . . 4.88 111.033 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 183' ' ' VAL . 43.0 mttp -60.68 -47.85 84.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.594 1.558 . . . . 3.47 110.706 174.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -60.85 -57.13 13.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.351 1.46 . . . . 2.74 111.428 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.26 -47.66 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.085 1.311 . . . . 2.47 111.786 -172.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -63.13 -28.6 70.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.921 0.782 . . . . 3.18 110.889 -173.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.613 HG21 ' HB ' ' A' ' 286' ' ' ILE . 55.1 t -63.34 -27.5 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 116.846 -1.55 . . . . 1.64 113.304 -178.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.744 HG23 ' H ' ' A' ' 196' ' ' LEU . 3.4 p -67.43 -32.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 121.276 1.853 . . . . 3.07 111.365 171.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -87.78 -15.25 37.45 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.794 0.838 . . . . 5.49 112.95 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -77.6 -13.17 59.98 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.676 -1.265 . . . . 3.37 113.004 164.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.59 -58.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.679 1.591 . . . . 2.0 111.675 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -63.44 -38.64 91.92 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.31 1.414 . . . . 3.28 112.671 -176.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 7.9 t -67.79 -11.23 58.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.582 2.753 . . . . 3.02 113.835 -177.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.99 -25.86 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.391 -1.443 . . . . 4.77 113.157 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t 174.29 -42.14 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.466 2.306 . . . . 5.18 112.126 167.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.9 m 173.83 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 130.557 3.543 . . . . 5.88 105.052 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.7 mp -103.05 173.65 3.34 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.291 0.636 . . . . 4.82 111.345 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.44 154.46 21.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.567 2.178 . . . . 3.98 110.801 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.39 142.64 32.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.068 0.937 . . . . 3.66 111.83 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.744 ' H ' HG23 ' A' ' 184' ' ' VAL . 48.3 tp -104.79 63.89 0.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.479 2.312 . . . . 1.96 108.188 175.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.1 m -57.66 115.46 10.99 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-O 118.142 -0.932 . . . . 1.72 110.39 -166.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -86.92 116.06 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.729 2.286 . . . . 0.93 112.134 -173.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.43 117.44 34.1 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.693 1.597 . . . . 2.42 109.518 178.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -97.99 114.27 26.36 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.269 1.028 . . . . 2.31 110.124 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.6 mm -83.21 122.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.256 -1.016 . . . . 1.94 108.256 165.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.53 128.98 34.94 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.854 -0.738 . . . . 1.8 111.243 166.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 pt -104.66 28.81 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 125.285 1.434 . . . . 2.13 113.261 178.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -122.8 47.44 1.57 Allowed Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 127.907 2.483 . . . . 3.41 112.942 -176.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.67 82.6 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.19 1 C-N-CA 126.206 4.604 . . . . 2.76 111.817 -172.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 175.38 -33.33 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.293 1.437 . . . . 3.98 114.406 -160.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -151.25 11.13 0.61 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.392 1.256 . . . . 5.19 114.392 170.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -70.11 54.49 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 130.888 3.675 . . . . 5.04 112.284 172.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 98.7 m -60.3 137.89 58.05 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.297 1.839 . . . . 2.06 110.464 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -43.35 -55.16 4.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.242 1.417 . . . . 4.03 112.984 -178.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -66.04 -33.53 76.01 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.119 1.768 . . . . 3.13 114.096 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.52 -36.14 73.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.961 1.255 . . . . 1.33 111.596 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.82 -36.6 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.186 0.995 . . . . 1.8 110.848 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.9 70.71 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.092 0.86 . . . . 1.28 112.061 168.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -66.24 -47.29 74.26 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.334 -0.853 . . . . 4.48 111.837 171.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -65.87 -32.56 74.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.933 0.716 . . . . 3.7 112.933 178.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.54 -49.0 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.13 0.972 . . . . 1.17 111.34 166.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -65.46 -27.2 68.34 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.571 1.148 . . . . 4.57 113.515 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -62.43 -33.35 74.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.43 1.092 . . . . 4.85 112.164 177.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -98.73 -63.25 1.14 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.484 0.92 . . . . 2.71 113.484 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.4 m 170.89 145.72 0.12 Allowed Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 126.717 2.007 . . . . 2.42 112.197 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.94 4.71 2.99 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.545 3.497 . . . . 1.94 114.556 -175.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -71.36 -23.72 61.96 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 119.687 1.13 . . . . 2.15 111.494 163.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.1 tt -87.35 145.13 26.45 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.463 1.505 . . . . 2.12 111.096 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.6 m -130.18 139.77 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.666 1.186 . . . . 2.69 110.951 175.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.94 130.94 9.62 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.544 1.069 . . . . 0.9 111.708 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.82 143.84 51.11 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.159 0.984 . . . . 2.35 113.243 -173.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 48.8 p -147.37 169.39 19.58 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.078 2.151 . . . . 2.49 112.16 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -179.02 -178.94 48.59 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.332 1.92 . . . . 1.9 110.45 -176.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -63.96 163.02 12.85 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.532 1.166 . . . . 2.37 111.636 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.7 mtt-85 -47.58 -35.22 8.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.055 1.342 . . . . 5.87 112.738 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.3 mp0 -72.05 -37.1 69.75 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.582 1.953 . . . . 2.91 112.147 178.172 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -70.39 -42.66 71.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.711 -1.243 . . . . 3.48 111.345 176.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.4 t -63.36 -36.9 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.414 0.686 . . . . 1.77 110.98 173.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.03 -44.51 84.45 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.757 -0.639 . . . . 3.08 110.457 174.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -55.82 -50.94 69.16 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.232 0.924 . . . . 2.82 111.787 176.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.26 -36.07 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.703 0.683 . . . . 2.21 112.216 -175.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.99 92.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.827 0.739 . . . . 1.82 111.624 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 5.9 ttm105 -67.36 -38.78 85.35 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.927 1.291 . . . . 3.36 112.255 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.57 70.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.371 0.987 . . . . 2.01 112.076 178.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -88.63 12.58 14.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.199 1.4 . . . . 2.67 113.893 176.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 46.19 37.86 4.39 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.008 2.123 . . . . 6.71 115.28 -176.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.62 145.08 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.715 2.006 . . . . 3.36 112.577 -173.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -80.63 139.2 36.35 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.562 1.319 . . . . 3.4 114.562 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -155.03 158.95 39.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.451 1.5 . . . . 4.12 111.878 154.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 41.2 m -126.7 125.53 24.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.329 1.852 . . . . 3.76 107.883 167.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.77 147.67 45.08 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.04 2.494 . . . . 3.61 111.062 -178.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.73 151.63 39.68 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 114.599 0.599 . . . . 2.84 114.599 -167.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -86.89 -149.61 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.762 3.641 . . . . 4.14 109.479 173.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' A' ' 254' ' ' GLU . 5.7 mmpt? -122.36 143.74 49.46 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.19 -0.944 . . . . 5.52 108.628 154.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -88.4 -166.63 1.64 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 118.862 -0.59 . . . . 7.83 111.317 166.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -82.37 -19.19 39.69 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.646 1.35 . . . . 9.52 114.646 -172.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.35 -84.55 0.23 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.86 1.264 . . . . 7.27 110.408 173.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 23.1 tp10 -166.54 18.23 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.532 2.333 . . . . 5.52 111.247 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.64 149.48 48.88 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 119.684 -1.885 . . . . 4.82 113.427 178.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -129.54 60.32 1.58 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.44 1.496 . . . . 4.52 112.047 174.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.86 108.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 120.414 -1.429 . . . . 4.58 111.765 170.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.5 143.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.53 1.532 . . . . 3.0 108.17 164.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.5 160.09 23.87 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.131 0.972 . . . . 3.45 110.672 173.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.55 154.39 0.38 Allowed 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.494 -1.379 . . . . 2.72 112.959 -134.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -68.59 -30.72 69.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 117.285 2.328 . . . . 4.77 117.285 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.7 pt 39.4 34.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 126.556 1.942 . . . . 3.9 116.045 -172.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 19.1 mt -113.9 144.26 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 2.32 110.113 -177.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.7 143.04 31.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.481 0.712 . . . . 4.8 111.289 156.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -97.87 132.79 43.15 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.723 0.809 . . . . 3.19 111.096 162.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.8 tp -93.14 93.63 8.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.759 1.224 . . . . 1.91 109.829 178.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.17 127.44 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.875 1.27 . . . . 1.69 108.672 175.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.51 161.97 54.24 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 110.851 -0.899 . . . . 1.43 110.851 172.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -65.23 -8.83 19.77 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.376 2.051 . . . . 3.03 113.794 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -107.23 29.74 6.85 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.097 1.759 . . . . 5.61 112.093 170.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.16 -42.04 3.03 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.663 1.601 . . . . 2.42 116.399 161.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -78.74 151.76 31.88 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.351 1.576 . . . . 5.67 111.369 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -89.53 144.05 26.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.033 -1.042 . . . . 3.32 113.738 -177.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -23.94 14.83 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.867 1.267 . . . . 2.74 112.881 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -168.25 170.01 10.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.887 1.275 . . . . 2.39 111.016 -167.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -153.56 140.1 18.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.847 0.859 . . . . 3.64 112.432 175.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . 0.545 ' CE1' ' HE2' ' A' ' 281' ' ' LYS . 13.2 m-85 -137.06 130.3 31.11 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.653 -0.654 . . . . 3.01 111.91 -169.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.12 91.83 0.08 OUTLIER Glycine 0 N--CA 1.471 0.985 0 N-CA-C 115.221 0.848 . . . . 4.17 115.221 174.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 137.32 127.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 1 C-N-CA 132.823 4.449 . . . . 3.39 107.073 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -40.51 98.91 0.01 OUTLIER 'General case' 0 C--O 1.237 0.409 0 O-C-N 124.763 1.289 . . . . 8.64 113.752 -140.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.545 ' HE2' ' CE1' ' A' ' 277' ' ' PHE . 45.7 tttp -78.95 -18.22 54.15 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.442 -0.786 . . . . 4.34 111.488 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.39 120.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.13 2.572 . . . . 5.71 108.583 -177.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -26.05 -77.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.673 2.389 . . . . 2.86 114.815 -176.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.53 -13.14 49.51 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 115.439 0.936 . . . . 1.91 115.439 -175.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.74 -30.76 40.94 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.218 2.009 . . . . 3.49 112.532 172.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . 0.613 ' HB ' HG21 ' A' ' 183' ' ' VAL . 21.8 mt -60.03 -40.65 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.136 -0.977 . . . . 1.58 108.859 165.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.12 -51.42 64.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.24 -0.41 . . . . 1.24 111.88 173.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.87 78.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.226 1.195 . . . . 1.66 114.226 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.5 p -67.33 -50.11 61.38 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 1.78 111.761 172.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.63 -38.81 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.742 1.156 . . . . 1.32 112.491 174.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.4 -16.18 33.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.743 1.217 . . . . 1.55 114.254 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 73.7 m -81.27 -47.86 12.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 1.72 110.281 167.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -67.32 -27.64 67.32 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.24 1.016 . . . . 2.81 113.641 -178.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 76.4 mtm -71.61 -23.41 61.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.378 -1.451 . . . . 4.91 113.498 174.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.16 -35.25 11.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 116.29 -1.814 . . . . 4.07 114.048 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.89 -41.39 1.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.912 2.076 . . . . 1.84 112.577 162.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -78.76 -157.19 0.11 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.837 1.791 . . . . 3.26 115.837 -169.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -60.22 123.13 16.27 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 119.992 -1.693 . . . . 10.3 110.939 174.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt 63.45 115.15 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.524 2.33 . . . . 8.38 114.519 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -45.78 16.87 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.066 -0.97 . . . . 11.71 111.164 175.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.256 1.418 0 C-N-CA 129.929 3.291 . . . . 10.74 105.803 -174.825 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 118.275 -0.869 . . . . 18.41 110.27 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -159.08 145.59 16.85 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.318 1.447 . . . . 15.52 109.597 178.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.0 m -137.81 48.89 1.99 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.879 0.871 . . . . 14.98 111.505 -165.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.37 31.84 0.56 Allowed Glycine 0 N--CA 1.478 1.468 0 C-N-CA 125.046 1.308 . . . . 11.41 115.609 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -134.13 65.23 68.63 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.087 1.355 . . . . 9.86 111.821 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.27 86.08 1.18 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.41 2.74 . . . . 9.7 111.081 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 74.93 -63.79 0.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 128.016 2.527 . . . . 11.15 112.705 172.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp 63.37 -174.78 0.16 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.295 2.638 . . . . 5.63 113.169 178.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -175.21 -42.46 0.05 OUTLIER Glycine 0 N--CA 1.469 0.889 0 N-CA-C 115.879 1.112 . . . . 3.7 115.879 166.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.49 -172.86 45.29 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 118.087 0.943 . . . . 2.43 113.329 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.28 151.49 26.47 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.44 2.76 . . . . 3.19 112.525 -167.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -81.52 155.79 25.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.881 0.872 . . . . 2.99 110.143 166.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.4 ' H ' ' NE2' ' A' ' 236' ' ' GLN . 21.5 t -142.41 101.52 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.686 -1.259 . . . . 2.85 108.916 167.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.89 162.49 32.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.191 1.396 . . . . 2.41 110.733 -170.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.9 m -84.27 133.53 34.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.465 0.706 . . . . 1.92 109.58 172.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.2 t -98.2 162.76 13.03 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.593 1.557 . . . . 2.8 109.974 177.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -65.37 -9.42 24.74 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.192 1.553 . . . . 2.02 115.192 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.7 p -73.44 -21.94 60.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.159 1.384 . . . . 3.12 113.292 166.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 97.85 -9.54 63.95 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.626 1.584 . . . . 1.75 113.401 -170.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -65.91 148.64 51.48 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.677 1.238 . . . . 4.79 110.508 170.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.66 109.08 20.9 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.684 0.793 . . . . 6.02 109.152 171.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.06 167.81 10.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.463 1.905 . . . . 3.61 113.742 -161.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -148.73 165.42 31.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.466 1.507 . . . . 2.75 110.44 -178.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -47.28 -45.05 23.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.901 2.08 . . . . 3.81 113.09 175.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -80.49 -4.49 54.06 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 114.165 1.172 . . . . 5.6 114.165 -176.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.37 -47.47 7.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.768 1.627 . . . . 3.96 109.16 163.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -75.46 11.13 1.35 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.823 1.786 . . . . 3.34 115.823 -176.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 tp -78.67 -170.51 2.14 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.716 1.606 . . . . 4.4 113.238 -172.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.3 -36.04 1.54 Allowed Glycine 0 N--CA 1.479 1.505 0 C-N-CA 125.681 1.61 . . . . 3.53 114.463 176.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -76.86 -179.53 5.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.791 1.236 . . . . 4.01 111.448 162.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -91.35 149.54 21.69 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.673 0.749 . . . . 1.91 109.734 156.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.4 tp -136.89 140.28 42.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.519 0.728 . . . . 3.53 111.111 -173.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.41 138.63 51.69 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.674 1.19 . . . . 2.69 108.042 164.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.7 mt -123.65 131.89 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.473 1.109 . . . . 2.59 108.525 176.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -134.37 138.85 45.2 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.002 1.321 . . . . 2.42 111.834 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -102.54 117.97 35.84 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.498 1.119 . . . . 2.53 111.22 175.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -137.77 -178.36 15.97 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.098 0.856 . . . . 1.21 114.289 173.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -136.12 119.58 16.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.136 0.975 . . . . 3.58 110.847 -168.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 m -71.36 20.5 0.05 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.167 1.787 . . . . 2.69 113.407 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -124.48 -16.33 6.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.203 1.801 . . . . 7.11 111.351 168.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 38.4 t -63.53 136.91 96.92 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 119.531 1.059 . . . . 2.29 112.349 -171.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.25 99.69 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.332 2.688 . . . . 3.2 109.621 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 74.88 -35.8 0.3 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.141 2.576 . . . . 4.13 114.777 155.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 72.4 t -54.55 -56.73 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.472 1.509 . . . . 2.54 110.836 176.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 33.4 m -53.85 -57.59 17.0 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.65 -1.166 . . . . 1.82 113.316 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.74 -39.48 4.6 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.768 1.645 . . . . 1.61 114.223 -175.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -41.02 70.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.235 1.38 . . . . 3.06 111.888 -178.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -30.38 69.42 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.433 1.015 . . . . 2.98 111.28 176.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.8 tp -69.87 -35.31 74.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 2.84 112.323 173.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -42.98 90.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.987 0.812 . . . . 3.7 110.314 170.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -54.33 -35.62 62.89 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 119.995 -1.69 . . . . 2.99 112.012 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 40.3 ttp -70.17 -28.02 64.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.914 1.079 . . . . 2.88 113.914 171.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.95 -52.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.803 1.638 . . . . 1.57 109.781 167.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -56.1 -27.0 52.01 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.201 1.001 . . . . 3.84 112.022 -176.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 t -64.56 -29.99 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 117.402 -1.285 . . . . 1.83 111.729 176.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.91 -44.55 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.679 2.036 . . . . 2.38 111.892 -175.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.89 -43.73 98.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.761 1.624 . . . . 3.49 111.631 174.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.18 -38.98 84.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.507 1.523 . . . . 3.95 111.811 170.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 -49.38 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.801 1.64 . . . . 2.74 112.906 -177.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.68 -28.13 68.85 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.528 1.513 . . . . 5.61 109.762 176.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.0 t -67.84 -13.47 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.793 1.405 . . . . 5.14 114.793 172.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.32 -26.55 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.608 1.549 . . . . 5.99 111.04 169.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.305 60.9 p 119.65 50.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 1 C-N-CA 133.119 4.567 . . . . 7.97 111.119 -175.469 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.423 0.6 OUTLIER 79.16 67.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.658 1.983 . . . . 4.81 114.67 146.52 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.04 166.82 0.37 Allowed Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 126.651 1.98 . . . . 4.35 111.52 160.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.37 -55.43 0.37 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.183 1.815 . . . . 3.71 109.296 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -169.65 158.22 7.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.288 3.035 . . . . 4.65 107.22 160.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 23.3 tp -112.77 106.91 15.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.945 1.298 . . . . 1.95 110.889 166.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.8 m -78.7 130.51 70.54 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.675 -0.678 . . . . 1.94 110.411 170.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.52 114.91 1.02 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.451 2.768 . . . . 1.1 109.908 159.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.84 111.28 23.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.375 1.47 . . . . 3.0 108.641 174.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -91.97 124.83 36.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 1.92 110.043 174.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.25 119.97 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.788 0.835 . . . . 1.36 108.81 167.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 t -83.24 130.39 35.08 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.186 -0.461 . . . . 2.11 109.989 163.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -104.62 16.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.559 0.948 . . . . 1.94 113.559 171.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.11 14.57 0.04 OUTLIER Pre-proline 0 CA--C 1.573 1.841 0 C-N-CA 127.926 2.49 . . . . 3.35 117.17 177.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -80.41 53.56 4.82 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 123.863 2.415 . . . . 2.7 113.171 -177.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -83.91 -41.33 17.51 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.143 -0.688 . . . . 4.58 109.143 141.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.76 0.53 4.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.088 1.355 . . . . 6.58 114.181 -171.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -93.2 156.75 16.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.886 1.274 . . . . 4.34 110.91 174.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -137.5 147.92 45.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 2.68 111.02 -176.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.2 -34.31 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.157 -0.929 . . . . 3.0 111.774 173.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -66.21 -44.1 84.84 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.593 1.957 . . . . 3.17 112.522 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.05 78.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.469 1.032 . . . . 1.28 111.193 174.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.94 -41.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.694 0.798 . . . . 1.74 111.415 174.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.46 -15.81 30.35 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.933 1.086 . . . . 1.71 113.933 176.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.59 -47.11 7.28 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.403 1.456 . . . . 4.03 113.149 165.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.09 -37.73 47.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.93 1.692 . . . . 2.91 111.565 175.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 5.0 t -43.56 -56.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.305 2.242 . . . . 1.63 112.792 167.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.14 -31.55 67.86 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.785 0.661 . . . . 4.16 112.785 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -63.36 -23.86 67.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.35 1.06 . . . . 4.03 111.643 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.95 -45.36 10.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.63 0.974 . . . . 3.14 113.63 168.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.2 p -174.33 167.59 2.2 Favored Pre-proline 0 N--CA 1.476 0.851 0 O-C-N 120.497 -1.377 . . . . 2.77 113.764 -168.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.59 2.54 8.27 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.485 2.79 . . . . 3.55 113.959 165.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.43 -26.24 6.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.953 1.464 . . . . 2.04 114.953 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.69 148.48 48.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.193 0.997 . . . . 2.21 111.217 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.43 132.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.24 1.016 . . . . 2.37 109.738 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.0 110.4 2.76 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.085 0.85 . . . . 1.32 111.606 -170.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp -108.99 144.88 36.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.5 1.12 . . . . 2.81 111.949 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.01 178.51 10.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.761 1.624 . . . . 2.86 108.892 -175.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.95 -140.64 3.39 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 108.498 -1.841 . . . . 1.88 108.498 166.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 65.7 p -80.36 176.43 9.78 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.446 1.498 . . . . 2.56 111.988 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.408 ' HE ' ' CD ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -62.02 -21.68 65.08 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 118.346 -0.835 . . . . 8.18 112.78 165.788 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.408 ' CD ' ' HE ' ' A' ' 231' ' ' ARG . 22.2 mp0 -71.19 -39.44 71.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.105 1.362 . . . . 2.92 111.431 171.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -64.12 -42.95 96.64 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.051 -1.031 . . . . 3.75 111.616 173.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.5 t -59.47 -43.66 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.818 0.699 . . . . 1.81 110.769 173.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.25 -49.78 70.57 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.024 -0.988 . . . . 3.66 108.725 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' A' ' 141' ' ' SER . 5.0 tt0 -47.12 -56.91 5.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.41 -0.805 . . . . 3.48 111.242 174.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.9 m -76.87 -27.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.877 1.065 . . . . 2.65 113.877 -168.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -75.83 -40.17 55.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.525 0.602 . . . . 1.66 111.549 172.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -75.01 -33.71 61.84 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.62 1.968 . . . . 3.92 111.801 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -49.58 -72.51 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.561 1.073 . . . . 2.22 110.956 167.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -85.21 9.24 15.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.063 1.505 . . . . 3.39 115.063 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.92 18.8 11.18 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.47 1.508 . . . . 8.29 113.715 171.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 m -67.89 -15.09 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 117.435 2.383 . . . . 3.08 117.435 -145.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 90.4 t80 60.83 131.54 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 128.086 2.555 . . . . 3.47 116.898 -174.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -160.54 165.68 30.41 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.873 2.469 . . . . 3.24 109.391 170.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.3 t -154.49 134.51 8.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 121.291 -0.88 . . . . 3.15 110.813 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.44 144.51 10.31 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.913 2.409 . . . . 2.72 112.977 -173.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -64.3 130.64 38.2 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 110.76 -0.936 . . . . 2.74 110.76 163.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.74 149.91 21.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.624 2.216 . . . . 3.14 112.208 -166.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -75.27 38.96 0.14 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 127.615 2.366 . . . . 5.3 113.149 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -135.29 -23.29 1.48 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.183 1.179 . . . . 7.92 114.183 -142.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -88.68 -34.15 17.31 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.914 0.886 . . . . 8.47 113.163 -176.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -173.28 -57.44 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.3 2.64 . . . . 5.5 107.86 165.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.3 134.23 0.52 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.931 2.092 . . . . 5.46 110.959 157.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -166.36 173.5 9.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.997 1.719 . . . . 3.9 112.152 176.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.56 49.88 0.82 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.748 1.619 . . . . 3.65 111.416 170.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.2 tp -56.68 161.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 119.364 -2.085 . . . . 2.76 110.263 159.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.73 146.73 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.181 -0.95 . . . . 4.49 109.869 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.62 143.78 28.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.924 1.29 . . . . 3.99 109.15 161.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.9 145.01 8.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.167 1.387 . . . . 2.79 111.129 -172.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.7 p -62.19 -22.35 65.84 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.963 1.097 . . . . 3.48 113.963 171.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 279' ' ' GLN 0.334 0.1 OUTLIER 49.12 62.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 123.769 1.747 . . . . 3.93 110.715 -174.473 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.1 mm -118.92 152.44 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.283 2.233 . . . . 2.64 110.94 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 42.0 mtp -132.93 155.67 48.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.418 2.687 . . . . 2.33 109.376 -175.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -117.29 143.74 45.6 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.746 1.017 . . . . 3.54 113.746 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.76 127.5 42.79 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.906 1.682 . . . . 2.93 107.322 168.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.6 130.87 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.497 0.719 . . . . 2.87 109.073 171.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.13 173.16 37.4 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.921 0.772 . . . . 2.15 112.285 177.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.05 68.16 6.63 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.185 3.257 . . . . 3.27 111.085 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -167.83 -56.69 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.325 1.85 . . . . 5.47 109.729 -164.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 144.12 165.05 10.75 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.191 1.236 . . . . 3.27 116.191 170.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 70.65 -86.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.054 1.741 . . . . 8.41 111.976 165.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.72 157.01 9.9 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.779 1.632 . . . . 5.65 112.281 -173.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -39.38 0.6 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.395 1.478 . . . . 3.96 111.579 -175.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.33 176.01 13.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.756 2.023 . . . . 3.68 108.538 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -135.39 150.05 49.8 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.211 1.004 . . . . 3.22 112.437 178.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -133.18 -170.02 2.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.591 1.557 . . . . 3.06 110.477 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.91 -157.75 14.73 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.521 1.057 . . . . 2.84 110.888 -171.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 262' ' ' ILE . 12.0 tp-100 -71.91 90.71 1.14 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.546 0.943 . . . . 4.94 113.546 -164.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 6.1 p30 165.71 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 130.267 3.427 . . . . 7.4 112.984 164.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.94 108.91 7.04 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.368 -0.832 . . . . 6.23 108.934 170.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.427 ' HD2' ' H ' ' A' ' 282' ' ' ARG . 0.5 OUTLIER -78.71 135.5 37.17 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.19 0.996 . . . . 8.86 109.672 -172.572 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -21.24 -66.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 117.121 2.267 . . . . 3.0 117.121 -163.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.33 -20.41 65.32 Favored Glycine 0 N--CA 1.48 1.607 0 CA-C-N 119.944 1.247 . . . . 2.24 114.733 -173.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.94 -22.5 66.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.633 1.173 . . . . 4.43 111.642 172.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.41 -48.69 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.822 -1.173 . . . . 1.9 109.729 175.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.25 92.26 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.179 0.807 . . . . 1.84 113.179 173.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.93 74.19 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.984 0.735 . . . . 1.89 112.984 178.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 14.1 p -72.33 -44.07 63.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.72 -1.238 . . . . 1.89 111.677 170.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.9 -34.52 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.742 1.155 . . . . 1.91 111.985 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.54 -19.38 47.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.613 1.338 . . . . 2.38 114.613 171.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.9 m -80.6 -48.45 12.66 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.115 0.87 . . . . 3.21 110.413 170.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -64.85 -28.29 69.45 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.849 1.26 . . . . 3.06 112.55 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.0 ttp -58.86 -20.0 46.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.225 2.61 . . . . 4.75 113.457 170.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -72.23 -50.41 8.75 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.824 -1.56 . . . . 6.22 111.936 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.27 -54.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 123.26 2.64 . . . . 3.16 112.966 169.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.65 126.27 33.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.554 0.742 . . . . 3.77 110.618 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -80.27 174.79 11.25 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.211 1.56 . . . . 7.14 115.211 -166.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -108.34 -79.59 0.58 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.713 1.205 . . . . 8.03 112.211 -170.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -132.64 -32.47 1.29 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.067 2.147 . . . . 8.82 109.56 177.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.247 0.97 0 C-N-CA 123.681 0.793 . . . . 7.82 109.445 128.053 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 118.161 -0.924 . . . . 16.3 110.016 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -146.08 133.24 20.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.185 0.994 . . . . 16.2 108.729 172.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.1 p -158.53 119.41 3.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.278 1.431 . . . . 12.0 108.577 -170.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.72 -61.84 3.96 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.086 0.851 . . . . 10.64 113.761 177.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -154.76 167.46 13.94 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.826 1.251 . . . . 12.51 113.089 -170.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -81.18 -151.13 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 125.266 3.978 . . . . 8.63 109.578 170.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.8 -22.03 63.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 115.179 1.548 . . . . 10.0 115.179 -173.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.8 tp 91.0 141.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 129.441 3.097 . . . . 6.82 111.826 171.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.54 -170.36 37.25 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.616 1.103 . . . . 2.59 113.256 169.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.6 89.94 0.65 Allowed Glycine 0 CA--C 1.537 1.46 0 CA-C-O 118.428 -1.207 . . . . 2.69 114.365 -176.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.01 150.79 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.707 2.271 . . . . 2.56 110.289 168.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -156.01 165.25 37.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.752 0.821 . . . . 2.45 112.122 -167.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.435 ' H ' ' NE2' ' A' ' 236' ' ' GLN . 73.8 m -121.41 137.99 54.47 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.722 -0.611 . . . . 2.38 109.999 147.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 65.3 mt -142.8 153.5 43.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.3 1.04 . . . . 3.04 109.575 168.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.3 m -93.25 150.75 20.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.886 0.874 . . . . 1.43 108.76 174.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.9 p -96.34 163.03 13.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.842 1.257 . . . . 2.18 112.17 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -61.74 -16.8 52.48 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.075 1.139 . . . . 1.6 114.075 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -87.23 -43.7 12.0 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 117.566 -1.207 . . . . 3.2 111.368 168.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.9 5.98 1.57 Allowed Glycine 0 N--CA 1.474 1.185 0 N-CA-C 119.145 2.418 . . . . 1.77 119.145 158.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.4 158.0 19.11 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 121.419 2.609 . . . . 3.99 111.944 172.145 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -111.54 120.49 42.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.207 1.403 . . . . 5.77 110.963 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.407 ' HE3' HD21 ' A' ' 227' ' ' LEU . 0.0 OUTLIER -144.63 167.49 22.43 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.539 1.311 . . . . 5.3 114.539 -168.191 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.4 p -120.85 173.92 6.93 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.744 2.818 . . . . 2.24 111.742 -171.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.05 -31.63 72.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.276 0.63 . . . . 3.86 112.629 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -19.3 65.13 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.96 -1.088 . . . . 8.57 112.388 174.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -85.89 -43.78 12.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.868 0.867 . . . . 3.66 111.138 172.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -67.41 -25.88 66.15 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.596 1.332 . . . . 3.19 114.596 175.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 49.15 42.52 21.51 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.442 2.297 . . . . 5.3 112.486 -177.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.3 -74.44 0.06 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.169 2.319 . . . . 5.67 113.286 -173.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 63.12 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.352 2.261 . . . . 3.59 111.803 -175.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -167.82 92.28 0.36 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.605 2.762 . . . . 1.8 109.172 173.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.05 131.06 53.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.764 1.226 . . . . 3.44 113.569 -174.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.49 124.77 49.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.113 1.365 . . . . 2.51 108.525 166.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.421 HD12 HD13 ' A' ' 267' ' ' ILE . 29.3 mt -126.84 114.35 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.238 1.015 . . . . 2.08 109.822 -164.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -122.43 139.91 53.32 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.701 1.0 . . . . 2.51 113.701 -174.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -96.36 109.31 21.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.727 0.811 . . . . 2.58 109.549 172.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.48 146.67 18.13 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.058 1.314 . . . . 1.23 113.471 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 204' ' ' ASP . 1.2 m-85 -81.54 61.12 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.13 0.972 . . . . 4.45 111.317 -174.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.3 p 45.84 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.071 2.148 . . . . 4.45 110.894 -170.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -103.62 116.72 32.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.29 0.95 . . . . 9.07 108.957 155.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.43 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 1.8 t -44.29 -174.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 130.954 3.702 . . . . 2.46 115.089 169.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 13.3 Cg_endo -47.31 -70.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.77 1.646 . . . . 3.67 109.776 138.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -167.66 21.77 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.84 1.793 . . . . 5.09 115.84 166.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 -34.71 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.318 -1.489 . . . . 2.61 111.766 -176.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 90.1 m -44.2 -55.53 9.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 116.649 -1.643 . . . . 1.43 112.823 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.7 -29.35 60.01 Favored 'Trans proline' 0 C--N 1.354 0.817 0 CA-C-N 122.308 1.86 . . . . 1.18 114.092 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -75.58 -38.93 58.77 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.374 0.988 . . . . 3.61 112.216 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.51 -37.27 65.73 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.564 -1.335 . . . . 2.99 111.979 171.138 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.0 tt -55.85 -43.91 77.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.396 1.078 . . . . 3.88 111.492 169.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.22 -35.04 74.55 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.628 1.103 . . . . 3.16 112.466 -177.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -62.79 -45.18 93.84 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.587 -1.321 . . . . 3.27 111.238 173.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 3.7 ptp -68.81 -21.44 64.32 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 117.596 -1.192 . . . . 2.38 114.199 173.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.1 -57.23 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 120.586 1.539 . . . . 2.09 109.322 166.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -59.45 -19.81 50.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.325 1.45 . . . . 4.53 113.169 -177.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.78 -29.6 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.562 1.074 . . . . 1.7 113.758 170.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.04 -36.56 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 121.361 1.891 . . . . 2.59 110.706 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -50.56 36.56 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.57 1.948 . . . . 6.74 112.248 166.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -67.05 -36.58 82.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.603 0.761 . . . . 4.05 112.073 178.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.2 mm -69.42 -45.98 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.995 1.318 . . . . 2.21 111.238 -177.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -66.04 -33.61 76.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 4.99 110.475 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 27.2 t -70.36 -8.15 48.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.657 1.183 . . . . 4.75 113.848 171.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 42.5 mm -79.19 -38.44 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.978 1.263 . . . . 3.84 110.287 165.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 57.87 -23.38 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 129.386 3.074 . . . . 4.16 116.082 -176.175 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 p -75.92 -20.79 57.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.249 -1.532 . . . . 5.17 112.942 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.83 173.64 1.98 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.367 1.467 . . . . 3.85 113.316 169.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.74 -40.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.831 2.354 . . . . 3.75 111.914 169.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 30.0 t70 165.08 165.07 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.86 2.864 . . . . 4.02 108.908 -159.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.75 122.54 36.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.312 -0.995 . . . . 2.1 108.312 153.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 m -101.05 114.96 65.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 109.374 -0.602 . . . . 1.87 109.374 173.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.95 142.99 15.99 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.27 1.98 . . . . 1.08 109.918 166.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.4 146.07 43.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 122.912 1.339 . . . . 2.52 112.433 170.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -114.44 130.82 56.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.913 -1.494 . . . . 2.45 109.623 -170.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 68.5 mt -107.13 117.97 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.743 1.217 . . . . 1.5 109.668 174.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.8 p -73.13 136.09 44.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.134 0.574 . . . . 3.19 110.699 167.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.7 pt -121.15 31.85 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.472 1.509 . . . . 1.59 111.634 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 166' ' ' PHE . 16.3 p-10 -161.74 65.59 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.908 1.283 . . . . 4.16 111.261 -158.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.35 -19.76 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.653 2.236 . . . . 2.83 113.427 -171.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.31 41.86 0.19 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.118 1.367 . . . . 4.44 111.966 168.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.0 -14.7 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 130.04 3.336 . . . . 5.51 114.257 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.83 159.93 8.3 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.563 1.074 . . . . 4.7 112.515 161.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.7 m -154.18 127.0 8.19 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 106.722 -1.584 . . . . 2.01 106.722 155.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -52.01 -43.86 63.87 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.535 1.134 . . . . 2.99 112.283 -177.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -70.23 -30.23 67.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.662 1.185 . . . . 3.51 114.194 172.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.33 -39.47 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.195 1.361 . . . . 1.46 111.715 176.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.19 -24.6 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.873 -1.142 . . . . 2.23 110.891 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.18 67.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 119.91 -1.744 . . . . 1.52 112.938 166.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -77.26 -35.67 55.11 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.397 1.079 . . . . 3.62 111.847 168.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.71 -36.09 81.84 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.549 -0.719 . . . . 6.37 111.563 176.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.6 t -54.5 -24.47 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 120.984 -1.073 . . . . 2.2 112.349 169.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -87.38 -22.31 25.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.544 -1.348 . . . . 5.62 114.134 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.82 -45.06 68.71 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.248 0.931 . . . . 4.82 110.307 165.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -105.1 -26.5 12.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.138 1.903 . . . . 3.49 116.138 -159.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 46.4 p 143.38 147.49 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 128.722 2.809 . . . . 2.49 113.413 169.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 66.43 5.42 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.023 3.148 . . . . 2.78 109.684 166.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.414 ' O ' ' HE2' ' A' ' 223' ' ' LYS . 0.1 OUTLIER -166.06 -31.66 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.047 2.139 . . . . 3.44 110.854 -171.431 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.47 145.92 48.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.412 0.551 . . . . 2.37 111.165 158.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.77 133.02 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.868 1.667 . . . . 1.83 106.891 162.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -99.71 128.71 9.66 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.346 -1.102 . . . . 0.83 110.346 176.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.407 HD21 ' HE3' ' A' ' 150' ' ' LYS . 5.4 mp -127.57 130.47 49.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.278 1.031 . . . . 2.31 111.538 -176.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -144.03 -178.95 6.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.613 1.565 . . . . 2.28 111.675 -167.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 176.74 -167.82 39.45 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.4 1.0 . . . . 1.53 113.766 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -84.0 157.29 21.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.772 1.229 . . . . 2.56 110.414 174.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -61.27 -20.57 63.01 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.068 1.507 . . . . 7.6 115.068 -169.534 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 32.5 mp0 -70.33 -40.65 74.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.672 1.589 . . . . 2.98 111.175 172.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.39 -32.6 62.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.664 1.185 . . . . 3.41 111.745 173.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.67 -38.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 118.206 -0.902 . . . . 1.81 110.989 166.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.03 -44.5 92.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.133 1.333 . . . . 3.08 110.362 171.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.435 ' NE2' ' H ' ' A' ' 141' ' ' SER . 9.6 tt0 -49.67 -57.28 7.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.667 1.121 . . . . 2.41 110.934 172.425 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 32.6 m -74.11 -37.66 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.917 1.235 . . . . 3.07 113.261 -171.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.73 74.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.648 0.379 . . . . 1.96 111.65 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -95.68 -23.22 17.1 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.353 1.461 . . . . 3.83 113.555 -175.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.02 75.25 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.351 1.432 . . . . 2.16 110.768 164.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -82.55 -11.94 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.632 1.173 . . . . 2.93 114.098 174.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 71.64 37.19 1.13 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.279 1.832 . . . . 8.15 112.451 165.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 m -94.13 141.0 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.266 1.426 . . . . 2.64 112.328 -175.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -76.47 154.17 34.93 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.298 0.851 . . . . 5.79 113.298 171.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.01 149.53 16.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.923 1.689 . . . . 3.92 109.729 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.3 t -155.54 145.01 15.28 Favored Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 121.454 -0.779 . . . . 4.39 110.987 171.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.36 165.12 28.03 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.387 2.058 . . . . 4.49 109.628 151.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -86.01 -178.09 49.99 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 124.356 0.979 . . . . 3.36 114.426 174.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.78 66.24 8.13 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.984 3.789 . . . . 4.87 113.804 -169.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.484 ' HZ1' ' CD ' ' A' ' 254' ' ' GLU . 0.2 OUTLIER -60.09 115.47 3.49 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.986 -1.071 . . . . 5.35 109.976 166.276 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 15.8 t70 121.72 -15.57 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 1 C-N-CA 131.724 4.009 . . . . 9.48 111.65 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -81.75 0.13 40.5 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.571 1.323 . . . . 10.61 114.571 176.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 16.0 t70 172.57 -87.91 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.265 3.026 . . . . 7.31 107.167 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.484 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 14.6 tp10 -169.73 25.75 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.13 2.572 . . . . 6.13 110.706 -176.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -48.69 151.27 1.2 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.91 1.684 . . . . 4.59 115.16 -175.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.41 50.91 1.29 Allowed 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.046 -1.034 . . . . 6.62 113.655 156.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 11.8 mm -61.52 153.11 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.547 -0.72 . . . . 3.38 109.261 159.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 30.7 m -154.88 141.67 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 128.018 2.527 . . . . 4.82 104.855 171.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -157.81 157.44 33.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.369 0.986 . . . . 4.86 113.299 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -160.44 -179.11 7.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.916 1.686 . . . . 2.28 113.686 -163.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.3 p -74.35 -15.11 60.95 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 116.899 2.185 . . . . 3.67 116.899 -176.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 56.86 11.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.15 1.78 . . . . 4.13 115.292 177.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 1.6 pp -95.65 148.13 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 119.997 -1.689 . . . . 4.51 114.384 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.5 ttp -122.51 121.76 37.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.806 2.442 . . . . 2.32 109.408 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -85.16 146.33 27.17 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.549 -0.719 . . . . 2.69 111.362 176.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 26.4 tp -109.1 127.51 54.22 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.918 1.287 . . . . 2.02 109.92 168.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.421 HD13 HD12 ' A' ' 162' ' ' ILE . 1.9 mp -119.19 124.75 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.912 2.085 . . . . 1.72 106.131 171.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.95 -162.66 36.9 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 109.618 -1.393 . . . . 1.64 109.618 164.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -85.02 54.48 3.94 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 120.392 2.096 . . . . 2.5 109.799 178.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -109.06 -34.77 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.486 1.515 . . . . 5.64 114.157 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.66 29.69 59.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.695 -1.058 . . . . 4.31 113.623 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -147.52 -39.02 0.19 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.034 1.417 . . . . 4.69 113.853 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.32 0.0 OUTLIER 102.74 152.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 1 C-N-CA 132.368 4.267 . . . . 3.48 111.407 -171.944 . . . . . . . . 4 3 . 1 . 023 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 56.9 tp -129.48 -35.24 1.75 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.346 1.239 . . . . 2.89 114.346 -155.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -166.05 172.36 11.48 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.505 1.522 . . . . 2.84 111.026 -174.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -156.21 145.96 21.06 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.62 -1.3 . . . . 3.45 113.908 174.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -136.84 173.72 11.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.292 1.837 . . . . 2.66 111.447 -163.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.41 -169.06 36.13 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 125.807 1.67 . . . . 2.34 111.803 175.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -36.52 124.41 0.82 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.061 1.745 . . . . 3.52 113.071 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 48.9 t30 98.49 -34.94 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 130.315 3.446 . . . . 4.55 112.681 -174.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.71 109.87 0.89 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.31 1.414 . . . . 4.41 110.611 178.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.5 145.56 41.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.15 -0.969 . . . . 6.91 109.453 -171.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -56.17 -50.54 70.89 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.407 -1.433 . . . . 2.31 113.549 -168.645 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.28 -13.18 70.19 Favored Glycine 0 N--CA 1.479 1.565 0 O-C-N 121.463 -0.773 . . . . 1.82 114.926 175.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -86.72 -19.4 29.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.826 1.25 . . . . 5.32 111.046 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.23 -51.32 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 120.586 -1.322 . . . . 1.82 109.595 157.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -58.34 -37.51 75.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 118.261 -0.876 . . . . 2.12 112.954 176.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.687 1.131 . . . . 2.36 112.831 173.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -48.89 79.87 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.422 -0.799 . . . . 1.99 112.157 169.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.64 -30.44 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.079 0.854 . . . . 1.84 111.504 179.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.34 -7.22 22.99 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.585 -1.322 . . . . 2.73 114.053 173.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 31.2 m -80.47 -57.04 3.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.026 0.931 . . . . 3.58 108.834 160.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -62.31 -26.8 68.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.312 1.845 . . . . 2.69 114.487 -174.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 31.7 mtt -55.86 -30.13 60.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.597 1.159 . . . . 5.14 111.619 170.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -59.71 -47.11 98.27 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.406 -1.759 . . . . 5.06 111.38 -176.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.26 -58.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.872 2.381 . . . . 3.53 113.403 163.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.83 17.89 17.05 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 116.669 2.1 . . . . 3.52 116.669 -157.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 -53.77 164.99 0.48 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.956 -1.09 . . . . 7.17 111.415 159.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -90.16 -13.52 35.46 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 119.933 -1.73 . . . . 10.31 115.356 -173.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -166.91 -110.24 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.538 1.935 . . . . 7.11 107.774 -163.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.06 -0.971 . . . . 6.83 110.781 134.393 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 118.227 -0.892 . . . . 17.07 109.97 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -65.51 150.5 48.27 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.539 0.609 . . . . 14.99 109.686 154.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -145.23 131.39 19.42 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.958 1.703 . . . . 12.09 107.711 176.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -156.39 134.16 3.96 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 123.66 0.647 . . . . 10.21 112.362 176.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -169.62 72.51 0.68 Allowed Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.531 1.132 . . . . 9.56 113.463 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.89 178.73 6.07 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.567 2.845 . . . . 7.82 111.366 175.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.7 tp -155.36 153.46 30.51 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.976 1.71 . . . . 7.17 109.241 177.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 pp -162.82 -176.54 5.0 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.245 1.818 . . . . 7.02 110.555 -171.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.83 -47.56 3.81 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 124.83 1.205 . . . . 4.06 113.533 172.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.36 51.33 53.43 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-O 118.118 -1.379 . . . . 2.57 111.973 -166.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.67 142.06 62.58 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.078 2.518 . . . . 2.59 112.706 -167.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -116.45 168.44 10.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.201 1.8 . . . . 2.77 111.264 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 p -148.5 85.48 1.51 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.84 1.256 . . . . 2.89 111.28 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.64 143.84 48.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.208 1.003 . . . . 2.04 110.791 175.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 p -75.38 150.28 38.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 3.46 111.863 171.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 p -96.0 120.68 36.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.621 1.969 . . . . 2.29 108.273 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.5 m170 51.15 24.79 2.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.195 1.554 . . . . 3.26 115.195 177.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.379 0.6 OUTLIER 31.36 39.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.509 2.724 . . . . 9.9 115.491 -155.695 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -110.82 -28.71 3.83 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.833 2.158 . . . . 2.83 113.051 -178.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -155.3 179.81 8.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.808 1.304 . . . . 4.03 112.28 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -118.6 111.23 18.31 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.446 1.098 . . . . 7.17 111.033 -159.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -119.71 168.9 10.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.462 1.601 . . . . 3.13 115.171 167.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.7 m -158.79 158.05 32.81 Favored 'General case' 0 C--N 1.326 -0.422 1 C-N-CA 132.099 4.16 . . . . 2.91 103.962 -169.358 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -41.74 -52.34 3.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.624 1.17 . . . . 3.35 112.86 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -82.75 -8.56 59.58 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.338 1.607 . . . . 6.45 115.338 178.19 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -75.93 -18.76 59.23 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.399 1.454 . . . . 4.08 111.631 165.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -97.69 -40.44 8.58 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.103 1.361 . . . . 3.73 114.124 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.98 154.28 19.32 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.39 0.995 . . . . 4.0 113.533 -170.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 110.47 10.25 22.05 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.878 1.704 . . . . 2.73 112.708 -158.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.54 160.89 18.17 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.218 2.607 . . . . 3.12 107.758 -176.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -83.33 121.91 27.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.624 -0.673 . . . . 2.12 110.823 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.61 135.29 39.64 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.242 1.02 . . . . 2.78 111.304 -176.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -115.16 126.15 54.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.487 1.515 . . . . 2.26 107.897 171.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.7 mt -129.4 118.49 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.413 0.685 . . . . 1.7 109.941 -168.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -120.68 145.09 47.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.349 1.459 . . . . 2.74 112.934 -175.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -114.67 97.61 6.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.232 1.413 . . . . 2.08 110.87 -177.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.61 -160.52 10.69 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.592 1.567 . . . . 1.51 115.423 -169.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -156.03 159.41 39.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.434 1.494 . . . . 4.61 110.746 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 p -69.49 127.04 31.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.014 -1.679 . . . . 3.45 110.287 172.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 73.2 -43.78 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.429 2.292 . . . . 8.19 111.821 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 4.4 t 86.59 177.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 127.277 2.231 . . . . 2.54 111.419 -166.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -40.7 -69.69 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.458 2.772 . . . . 4.23 111.493 130.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . 0.26 1.1 m-20 171.24 58.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 128.417 2.687 . . . . 4.93 111.366 170.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.81 -27.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.869 1.268 . . . . 3.82 114.02 174.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.36 -37.19 19.53 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 115.852 -2.023 . . . . 2.43 113.854 162.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.52 -80.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.336 2.024 . . . . 1.91 111.051 166.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.19 -29.01 69.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.676 0.991 . . . . 4.41 113.676 -165.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.63 -41.68 59.96 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.255 -1.528 . . . . 3.66 112.691 177.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.4 -36.76 74.25 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.299 -1.334 . . . . 3.04 110.521 172.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -57.14 -43.99 82.98 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.733 1.606 . . . . 6.08 111.806 173.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -60.84 -55.27 35.02 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.712 -1.243 . . . . 3.16 112.219 168.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.67 -24.66 62.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.078 1.14 . . . . 4.41 114.078 -170.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.2 mp -56.7 -37.88 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.258 1.39 . . . . 1.74 111.279 169.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.98 -28.68 66.83 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.379 -0.819 . . . . 3.04 110.609 176.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.8 -34.68 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.454 1.024 . . . . 2.03 111.355 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.1 p -70.82 -37.73 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.598 1.09 . . . . 2.37 111.439 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -32.51 58.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.364 0.983 . . . . 4.61 113.298 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -60.21 -26.26 66.24 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.596 1.558 . . . . 3.54 112.946 170.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -90.16 -55.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.104 1.762 . . . . 2.14 112.387 175.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.15 -30.45 71.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.819 2.048 . . . . 3.16 113.133 -175.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.1 t -66.07 -12.8 57.87 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.786 -1.196 . . . . 2.95 112.894 169.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.0 mm -121.56 44.41 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.15 1.78 . . . . 4.56 108.186 -178.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.24 0.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.5 3.52 . . . . 6.42 118.419 -158.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.3 p -69.08 -18.99 64.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.88 1.272 . . . . 4.32 113.047 157.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.41 163.15 43.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 127.28 2.232 . . . . 4.55 109.908 169.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.41 162.21 11.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.514 2.143 . . . . 5.29 114.178 -148.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.55 94.5 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.71 1.604 . . . . 6.16 111.606 -172.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.3 mp -93.86 116.6 29.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.111 0.964 . . . . 2.43 112.722 -175.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 7.6 m -107.59 111.82 62.58 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 124.261 1.024 . . . . 1.35 110.89 171.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -88.05 122.9 1.62 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.954 3.102 . . . . 1.01 112.254 177.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.64 122.83 47.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.742 2.417 . . . . 2.95 110.529 -178.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -102.06 121.08 41.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.943 0.897 . . . . 2.36 111.182 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.45 119.99 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.602 1.161 . . . . 1.63 108.331 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 2.1 p -78.65 131.35 36.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.285 -0.884 . . . . 2.02 110.581 164.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.43 -21.73 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 115.547 1.684 . . . . 2.71 115.547 -176.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -125.74 75.23 70.59 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 124.525 1.13 . . . . 4.98 109.194 -177.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.45 98.51 0.4 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 124.683 3.588 . . . . 2.0 109.31 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -162.31 -24.04 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.102 1.149 . . . . 4.53 114.102 -166.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.45 9.16 0.54 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.176 1.176 . . . . 4.92 114.176 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -111.8 75.33 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 129.645 3.178 . . . . 3.81 108.798 -173.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.29 155.96 30.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.04 1.4 . . . . 2.73 114.363 -163.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.84 -50.42 7.91 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.409 2.283 . . . . 3.29 114.784 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 211' ' ' GLU . 0.0 OUTLIER -85.93 -35.0 20.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.808 1.643 . . . . 4.72 112.321 174.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.24 71.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.367 0.985 . . . . 1.95 113.501 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 18.9 mm -64.53 -42.64 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 119.842 1.201 . . . . 1.63 111.675 170.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.3 -22.54 66.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.734 0.814 . . . . 1.87 112.897 176.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -83.41 -44.73 14.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.699 1.6 . . . . 4.03 112.027 168.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -53.26 -35.83 60.46 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.648 1.579 . . . . 2.77 111.922 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.1 t -52.47 -43.91 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.415 1.486 . . . . 1.46 113.617 167.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -67.03 -47.44 71.41 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 117.807 -1.092 . . . . 6.4 111.982 -176.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -43.19 63.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.507 1.523 . . . . 4.19 111.917 177.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -70.28 -62.71 1.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.858 0.463 . . . . 3.3 111.53 175.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.8 m 169.73 145.57 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.534 2.734 . . . . 2.17 110.833 177.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.59 -6.52 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.585 2.857 . . . . 1.62 114.709 -177.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.41 -10.4 59.43 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.709 1.141 . . . . 3.57 113.581 170.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.85 137.93 34.23 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.624 1.17 . . . . 2.05 111.557 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -113.36 129.92 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.255 1.022 . . . . 1.73 109.561 -174.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.09 129.37 9.87 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.841 -0.904 . . . . 1.09 110.841 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.82 156.9 18.67 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.868 -0.79 . . . . 2.53 108.868 168.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.3 m -150.39 126.91 10.82 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.223 -1.399 . . . . 3.3 107.223 171.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -149.58 -145.04 4.05 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.094 1.807 . . . . 1.99 111.189 -174.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.9 t -121.75 174.72 6.67 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.301 1.051 . . . . 2.54 110.91 165.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.26 -18.09 14.72 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.627 1.171 . . . . 8.2 113.327 -174.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.48 -41.99 19.04 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.194 2.198 . . . . 3.44 112.153 -173.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.83 -31.75 66.85 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.286 -1.509 . . . . 3.71 110.702 166.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.8 -35.99 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.364 -0.827 . . . . 1.74 110.916 172.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -58.78 -57.01 14.93 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 117.632 -1.175 . . . . 2.74 109.778 163.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -49.87 -56.33 10.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.219 1.372 . . . . 3.19 112.514 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.55 -29.51 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.288 0.495 . . . . 2.07 111.771 -171.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.32 -50.8 20.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.647 0.779 . . . . 1.65 111.525 171.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -56.15 -49.12 74.85 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.148 2.579 . . . . 3.09 111.398 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.78 77.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.551 0.74 . . . . 2.04 112.947 176.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -94.64 14.43 21.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.233 1.413 . . . . 2.77 113.363 176.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 61.6 12.26 4.4 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.134 2.174 . . . . 5.47 115.111 176.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.99 140.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.393 1.477 . . . . 2.84 111.254 -177.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -109.52 173.43 6.33 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.542 1.537 . . . . 4.7 112.481 174.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -121.59 148.55 44.38 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.008 0.923 . . . . 3.89 111.534 176.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -128.95 63.14 65.61 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.159 0.984 . . . . 4.79 111.654 176.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 138.98 42.83 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.598 2.198 . . . . 3.23 110.332 176.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.64 152.57 37.46 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 119.676 -0.513 . . . . 3.25 113.342 -176.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -62.95 157.43 48.67 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.796 2.998 . . . . 4.68 110.566 175.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 -0.29 45.34 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 122.677 1.227 . . . . 6.05 111.6 175.125 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.22 43.07 1.08 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.228 2.211 . . . . 7.63 112.277 -147.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -156.94 -40.8 0.07 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.208 1.803 . . . . 8.44 110.71 -170.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -152.26 -53.83 0.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.667 1.187 . . . . 6.33 109.646 165.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 172.92 -45.6 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 129.222 3.009 . . . . 5.63 110.232 169.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 11.1 t70 1.85 113.09 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 129.108 2.963 . . . . 5.14 118.215 -169.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.89 40.99 0.78 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 120.272 -1.517 . . . . 3.74 114.731 -178.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.08 128.71 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.778 -1.201 . . . . 3.35 109.919 157.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.1 153.55 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.304 1.442 . . . . 3.91 107.902 170.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.57 174.85 11.05 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 122.752 1.263 . . . . 5.75 112.273 -174.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 167.54 11.13 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.889 -1.132 . . . . 2.19 112.737 -143.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.1 t -68.09 -20.25 64.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.318 1.97 . . . . 4.03 116.318 -171.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.5 mt 47.9 55.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 125.914 1.686 . . . . 4.49 111.593 -177.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.6 mt -137.79 139.77 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.518 1.527 . . . . 2.58 110.348 -178.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.66 120.46 39.72 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.51 2.724 . . . . 3.27 109.326 161.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -88.31 135.11 33.61 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.136 0.574 . . . . 2.56 111.266 165.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 9.4 tt -103.41 120.67 41.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.699 2.0 . . . . 2.29 109.441 174.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.92 143.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 127.271 2.229 . . . . 2.08 108.167 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -67.34 178.23 18.49 Favored Glycine 0 CA--C 1.545 1.914 0 C-N-CA 123.931 0.777 . . . . 1.82 113.95 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 -42.97 2.15 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.6 2.866 . . . . 4.06 112.904 -174.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -142.87 84.53 1.84 Allowed 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 107.092 -1.447 . . . . 7.71 107.092 161.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.17 -150.85 6.78 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.232 1.872 . . . . 2.54 110.315 -176.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -122.78 -162.57 1.03 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.008 0.923 . . . . 4.18 111.217 -179.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -52.58 134.94 35.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.076 0.941 . . . . 4.18 110.43 173.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.37 -33.02 1.13 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.428 1.491 . . . . 2.95 110.328 -169.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -155.28 172.83 17.54 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.828 2.051 . . . . 2.41 110.481 175.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -162.21 148.01 13.04 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.616 -1.303 . . . . 3.7 114.257 176.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -132.47 128.24 36.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.887 1.275 . . . . 2.35 110.706 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -101.88 -176.62 28.11 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.79 0.709 . . . . 2.64 112.282 165.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -52.3 154.29 2.49 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.418 0.687 . . . . 4.26 110.588 167.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 16.3 t30 81.83 -17.86 0.52 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.737 2.415 . . . . 6.11 112.196 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -69.54 107.94 3.6 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.238 -1.539 . . . . 6.06 110.532 161.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -66.14 144.54 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.502 1.144 . . . . 7.45 109.785 176.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -32.49 65.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.051 . . . . 2.47 113.839 -167.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.18 86.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.01 -0.883 . . . . 1.44 113.489 -178.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.36 -18.03 61.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.359 1.579 . . . . 3.21 112.944 174.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 36.8 mt -70.01 -47.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.457 -0.777 . . . . 1.21 109.201 172.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.78 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.08 0.552 . . . . 1.23 112.065 170.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.89 81.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.567 0.951 . . . . 1.45 113.567 173.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 52.2 p -65.5 -47.18 76.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.996 0.817 . . . . 1.42 111.669 172.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.62 -39.63 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 120.74 -1.225 . . . . 1.91 110.638 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.07 72.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.907 0.883 . . . . 1.74 113.159 171.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.1 m -71.59 -48.08 50.56 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.219 1.008 . . . . 2.14 110.333 174.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -70.74 -20.27 62.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.206 1.003 . . . . 2.3 113.075 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 23.1 mmm -66.49 -33.67 76.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.193 1.397 . . . . 3.81 113.255 162.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -52.63 -40.2 74.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 116.358 -1.782 . . . . 5.41 113.13 -176.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.26 -60.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.196 2.597 . . . . 2.29 111.544 162.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -86.28 47.25 1.44 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.823 1.416 . . . . 3.09 114.823 -165.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.23 135.22 57.66 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.832 -1.167 . . . . 9.68 111.658 176.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -53.85 -21.18 7.05 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.966 1.839 . . . . 7.9 115.966 176.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 35.53 1.19 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.917 0.887 . . . . 10.27 113.172 -175.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 127.626 2.37 . . . . 9.7 114.428 178.676 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 118.209 -0.9 . . . . 27.12 110.241 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -64.02 157.64 24.66 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.981 0.81 . . . . 23.06 111.037 167.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.2 t -170.17 46.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.393 1.477 . . . . 19.27 111.871 -170.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.09 149.23 43.97 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.712 -0.618 . . . . 16.47 112.326 173.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -148.03 156.37 43.76 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.426 1.89 . . . . 15.62 110.45 174.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.16 164.48 33.77 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.896 2.398 . . . . 11.97 110.52 167.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.6 tp -164.04 150.7 11.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.568 1.947 . . . . 9.51 109.11 -177.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . 0.269 0.8 OUTLIER 102.61 -142.3 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 131.018 3.727 . . . . 5.51 107.896 -174.38 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.77 151.75 20.31 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.135 1.334 . . . . 3.0 113.764 -173.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.33 98.92 1.42 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.237 -1.313 . . . . 2.51 112.486 -177.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.58 154.18 30.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.206 2.604 . . . . 3.43 111.939 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -160.82 154.31 22.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.579 1.151 . . . . 3.01 111.651 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 t -138.17 95.58 3.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.951 -1.093 . . . . 2.53 112.874 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -111.63 162.9 14.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.115 1.366 . . . . 2.72 112.153 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.4 m -98.14 142.6 29.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.53 1.132 . . . . 1.52 110.779 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.9 m -98.29 164.7 12.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.184 1.793 . . . . 2.65 112.049 -171.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -61.17 -5.37 1.49 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 117.649 2.463 . . . . 2.63 117.649 -170.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -35.02 6.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 121.023 1.738 . . . . 4.19 111.29 165.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.47 11.61 0.45 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.719 2.104 . . . . 2.36 115.185 -177.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -84.04 129.28 34.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.057 2.143 . . . . 5.48 110.051 -176.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -69.2 130.2 41.98 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.52 -1.363 . . . . 4.66 110.012 167.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 158.72 24.61 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.441 . . . . 2.89 109.834 168.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.6 p -152.02 162.94 40.31 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.573 1.549 . . . . 2.34 110.233 -167.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -46.63 -49.68 18.72 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.792 1.237 . . . . 5.08 112.034 166.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -79.48 4.23 16.26 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.536 1.31 . . . . 7.44 114.536 -172.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.08 -30.34 16.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.966 1.706 . . . . 3.6 111.452 169.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -103.38 -16.24 15.68 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.988 1.477 . . . . 4.4 114.988 -177.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 tt -75.08 88.88 2.43 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.386 1.088 . . . . 5.14 110.304 -171.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 164.78 -30.55 0.23 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.783 1.658 . . . . 3.21 111.923 -167.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -103.76 -179.6 4.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 4.42 111.453 159.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -85.06 140.72 30.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.023 0.529 . . . . 3.91 110.366 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 pp -134.28 153.39 51.9 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.139 0.976 . . . . 4.06 111.09 175.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.61 138.45 54.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.754 1.222 . . . . 3.82 109.072 171.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.3 mt -111.59 130.16 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.103 -0.703 . . . . 2.7 109.103 177.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -120.61 142.25 49.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.932 1.293 . . . . 2.93 110.508 164.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.69 123.49 50.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.064 1.345 . . . . 2.5 110.107 171.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -160.38 146.77 13.03 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-O 119.459 -0.634 . . . . 2.16 113.541 175.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.87 18.35 14.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.381 1.623 . . . . 4.17 115.381 -171.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.2 m 66.99 -15.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.603 1.961 . . . . 3.56 114.048 173.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -111.2 16.38 21.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.898 2.079 . . . . 7.81 112.684 -167.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.58 171.49 6.97 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.937 1.695 . . . . 2.69 114.538 176.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.14 -176.92 1.46 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.117 2.544 . . . . 3.14 110.479 150.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.36 64.56 2.13 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 5.9 113.139 -172.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 80.5 t -130.97 -45.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.964 2.105 . . . . 3.71 109.728 174.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.4 t -62.71 -52.04 67.6 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.855 1.262 . . . . 1.79 112.591 172.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.5 -34.71 25.24 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.981 1.788 . . . . 1.36 113.077 172.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.538 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 13.4 tm-20 -64.89 -40.41 95.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.99 1.268 . . . . 2.69 112.384 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.424 -1.423 . . . . 2.37 111.594 171.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 37.4 mt -62.72 -37.4 86.4 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.215 0.916 . . . . 2.89 112.859 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.68 4.67 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.18 0.9 . . . . 3.39 110.336 174.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.538 ' HZ2' ' CD ' ' A' ' 175' ' ' GLU . 30.0 mtmm -57.53 -28.72 63.75 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.773 -1.204 . . . . 2.64 112.713 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.34 -49.11 72.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.016 0.826 . . . . 3.17 111.664 168.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.35 -36.19 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 119.636 1.107 . . . . 1.88 110.627 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -56.28 -23.31 35.68 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.326 0.862 . . . . 3.3 113.326 171.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.83 -38.52 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.69 1.132 . . . . 1.88 110.718 173.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.35 -40.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.328 1.051 . . . . 1.94 110.921 -179.173 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.81 -53.94 34.48 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.458 1.503 . . . . 5.31 110.971 169.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -69.74 -34.27 73.61 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 112.494 0.553 . . . . 4.02 112.494 -174.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.34 -40.35 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.056 1.342 . . . . 2.12 112.952 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.68 -34.83 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.294 0.497 . . . . 3.3 111.79 168.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.2 t -64.89 -36.01 82.99 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.711 -1.243 . . . . 3.23 112.658 172.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.42 -3.06 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.332 1.853 . . . . 3.79 112.216 167.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . 0.329 73.1 p 124.43 -9.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 1 C-N-CA 132.796 4.438 . . . . 5.72 114.945 152.696 . . . . . . . . 3 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.7 t 143.01 -18.53 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 129.824 3.25 . . . . 7.08 113.675 178.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.3 -146.4 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.655 -1.641 . . . . 4.76 109.561 -172.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.75 -42.11 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 124.079 2.493 . . . . 3.62 109.467 146.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.5 t70 161.8 157.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 1 C-N-CA 132.216 4.206 . . . . 4.14 107.973 174.324 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.28 90.07 3.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.904 0.882 . . . . 2.57 108.786 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 35.9 m -66.02 117.54 43.5 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 108.28 -1.007 . . . . 2.61 108.28 178.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -91.01 127.34 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.175 1.917 . . . . 1.47 110.085 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.0 tp -121.23 108.42 13.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.555 1.142 . . . . 2.67 109.983 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -90.06 123.38 33.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.378 1.071 . . . . 2.49 109.594 169.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.2 mt -111.36 125.25 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.404 -0.961 . . . . 1.39 108.404 171.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.6 t -96.03 144.29 26.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.794 -0.566 . . . . 2.32 110.6 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.429 ' HA ' HG21 ' A' ' 234' ' ' VAL . 25.0 pt -108.5 3.99 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.877 1.066 . . . . 2.08 113.877 -174.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.24 77.35 1.55 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.661 1.184 . . . . 3.0 112.435 -169.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.77 -9.33 18.27 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.006 1.804 . . . . 3.56 111.834 166.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -70.33 -4.87 24.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.998 2.119 . . . . 3.46 114.153 174.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -9.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.813 2.523 . . . . 4.72 117.813 178.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.99 97.23 10.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.611 2.005 . . . . 4.44 110.039 178.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 m -74.28 128.94 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.978 -0.749 . . . . 2.53 108.978 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -54.15 8.64 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.425 1.49 . . . . 3.06 111.597 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -68.25 -23.42 64.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.269 1.428 . . . . 3.68 113.741 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.16 -44.64 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.439 -1.413 . . . . 2.07 111.247 172.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.07 -37.48 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.818 0.847 . . . . 2.76 110.397 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -51.76 -33.76 36.52 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.822 1.045 . . . . 2.05 113.822 174.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -80.38 -49.49 11.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.752 -0.592 . . . . 4.68 111.926 175.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -49.49 -37.57 26.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.674 1.19 . . . . 3.03 113.385 171.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.474 HG21 ' HA3' ' A' ' 226' ' ' GLY . 39.0 t -62.37 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.675 1.59 . . . . 1.82 112.134 173.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -56.02 -48.3 76.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.977 0.911 . . . . 4.88 112.474 -178.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -19.42 62.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.367 1.467 . . . . 7.48 112.604 -174.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -53.94 7.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.406 0.682 . . . . 3.17 111.017 164.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.6 t -167.96 139.29 2.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.253 1.021 . . . . 3.09 111.503 167.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.69 0.81 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.036 2.491 . . . . 2.29 114.078 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -86.6 -16.3 37.15 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 120.051 1.296 . . . . 3.03 113.064 165.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.62 143.88 34.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.25 1.42 . . . . 2.06 110.948 -177.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.46 145.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.404 0.681 . . . . 2.37 110.269 164.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.474 ' HA3' HG21 ' A' ' 217' ' ' VAL . . . -117.02 124.84 6.29 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 124.054 0.835 . . . . 0.85 111.383 173.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 11.1 mp -117.39 145.95 43.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.817 1.247 . . . . 2.14 111.438 -179.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 63.3 p -149.92 174.94 12.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.211 2.604 . . . . 2.31 109.964 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.35 -152.11 8.09 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.497 -1.441 . . . . 1.83 109.497 158.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.8 p -64.3 165.33 9.7 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.62 1.568 . . . . 2.64 112.571 162.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.87 -36.37 62.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.315 -0.857 . . . . 7.11 110.698 169.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.09 -45.91 69.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.877 2.071 . . . . 3.34 112.667 176.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.98 -47.82 84.24 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.178 -0.951 . . . . 4.71 110.803 173.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 203' ' ' ILE . 0.9 OUTLIER -75.46 -17.03 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.152 1.168 . . . . 2.33 114.152 -178.553 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.55 -43.83 97.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.337 0.971 . . . . 3.12 109.78 168.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.92 -53.18 61.26 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.061 -0.495 . . . . 3.04 111.096 -176.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.36 -23.75 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 112.752 0.649 . . . . 2.08 112.752 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.04 55.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.561 0.745 . . . . 2.01 112.83 171.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -70.4 -41.54 72.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.559 2.343 . . . . 4.28 111.528 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.58 -46.2 63.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.983 1.713 . . . . 2.06 112.795 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.42 -126.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.881 0.764 . . . . 3.16 110.389 171.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.17 61.65 0.7 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.593 -1.317 . . . . 6.06 111.783 -172.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.36 156.87 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.075 0.95 . . . . 4.26 109.228 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -152.8 169.71 22.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.113 2.565 . . . . 4.65 109.165 -173.493 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -165.77 153.9 11.01 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.993 1.317 . . . . 4.87 111.148 -177.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.4 t -149.56 138.31 12.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.912 1.685 . . . . 5.55 108.254 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.28 151.07 15.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.155 2.57 . . . . 5.27 111.947 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -72.37 123.38 9.2 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.717 -1.046 . . . . 4.64 110.716 172.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.66 14.56 2.14 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.583 2.855 . . . . 4.77 112.921 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp 92.36 141.73 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 130.845 3.658 . . . . 6.95 110.096 -154.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -153.56 155.53 36.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.536 1.134 . . . . 7.92 109.205 164.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 62.92 -51.39 0.19 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.546 2.738 . . . . 10.09 113.425 -166.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -173.38 -49.02 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.2 2.2 . . . . 8.49 110.861 169.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -143.18 124.44 14.6 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.176 1.39 . . . . 7.97 110.291 -172.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -178.27 153.7 0.78 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.373 2.269 . . . . 4.27 111.527 -166.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -145.36 76.08 1.46 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.13 0.967 . . . . 5.03 110.679 151.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.5 tt -73.22 175.34 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.714 1.205 . . . . 3.44 110.996 167.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.7 t -151.64 158.77 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 127.554 2.341 . . . . 3.94 106.208 172.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -85.55 150.6 24.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.398 1.479 . . . . 5.25 112.37 169.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -148.1 150.29 33.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.828 1.047 . . . . 2.38 113.828 153.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.24 164.05 1.01 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.058 1.343 . . . . 3.87 110.486 171.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 8.2 tp -143.19 155.11 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.997 1.319 . . . . 4.15 109.175 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 66.7 mt 108.48 141.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 130.987 3.715 . . . . 3.04 107.901 -162.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 mtt -101.15 136.21 41.37 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.501 1.12 . . . . 3.81 108.822 167.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -111.53 126.28 54.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.651 0.78 . . . . 4.38 110.75 -172.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 14.0 tp -99.9 123.72 44.45 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.872 1.269 . . . . 2.33 110.562 -175.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.85 131.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 107.571 -1.27 . . . . 2.93 107.571 174.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -96.59 169.28 25.81 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.562 0.601 . . . . 3.41 112.737 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.97 71.21 5.06 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.077 3.184 . . . . 4.06 108.236 167.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -156.51 -59.86 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.764 1.626 . . . . 6.14 108.536 -162.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.78 -38.86 0.2 Allowed Glycine 0 C--N 1.345 1.045 0 N-CA-C 115.51 0.964 . . . . 4.12 115.51 170.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -157.01 -151.4 0.32 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.333 1.235 . . . . 6.17 114.333 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -70.26 109.87 4.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.094 1.358 . . . . 4.97 111.278 -173.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 tt -99.45 -21.37 16.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.308 1.043 . . . . 3.6 111.642 179.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.24 160.08 38.28 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.726 2.01 . . . . 2.68 109.618 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -165.39 123.01 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.507 1.523 . . . . 3.52 111.754 177.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -139.31 136.14 34.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.548 1.539 . . . . 3.21 111.687 -165.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.41 145.99 13.44 Favored Glycine 0 N--CA 1.471 1.033 0 O-C-N 120.661 -1.274 . . . . 3.02 116.033 -174.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 64.24 -105.31 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.358 1.863 . . . . 3.63 110.642 171.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.91 87.49 0.25 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.147 1.379 . . . . 6.21 112.161 -176.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.99 130.56 0.08 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 128.737 2.815 . . . . 8.71 111.067 178.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -90.61 158.92 16.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.555 1.942 . . . . 6.62 110.201 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -40.04 80.04 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.373 1.62 . . . . 2.27 115.373 -164.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.91 -24.19 71.4 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 118.129 0.422 . . . . 1.48 113.185 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.17 -39.94 93.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.04 0.92 . . . . 3.61 111.384 175.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 46.9 mt -70.55 -42.15 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.74 0.816 . . . . 1.36 110.541 177.14 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.84 90.93 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.831 -0.543 . . . . 1.47 111.2 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.06 87.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.05 1.34 . . . . 1.61 113.716 173.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.0 p -64.98 -45.43 85.69 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.483 1.492 . . . . 1.71 110.889 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.8 -40.8 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 120.898 -1.127 . . . . 2.06 111.686 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.32 -25.05 67.44 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.645 -1.284 . . . . 2.32 113.188 171.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 97.9 m -73.48 -43.05 61.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.003 . . . . 2.17 110.598 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -70.55 -25.64 63.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.66 0.784 . . . . 2.72 112.83 174.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.454 ' SD ' ' HE2' ' A' ' 299' ' ' LYS . 1.3 ttp -69.02 -22.58 64.05 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.749 -1.219 . . . . 4.33 113.221 165.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -55.78 -42.73 97.6 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-O 116.632 -1.652 . . . . 4.55 112.838 177.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.43 -51.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.342 2.695 . . . . 2.42 111.968 163.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -83.97 68.25 9.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.38 1.086 . . . . 3.06 112.37 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -59.09 129.26 41.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.251 1.82 . . . . 7.93 113.91 -169.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.454 ' HE2' ' SD ' ' A' ' 294' ' ' MET . 0.0 OUTLIER -9.01 -86.14 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.938 2.895 . . . . 7.9 114.924 -173.119 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -135.82 25.58 3.35 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.925 2.49 . . . . 8.16 108.302 171.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.253 1.275 1 C-N-CA 132.906 4.483 . . . . 7.9 108.956 -153.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 118.248 -0.882 . . . . 16.69 110.035 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -67.32 160.76 26.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.135 0.574 . . . . 13.59 111.043 170.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 t -172.05 -177.34 1.86 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.657 1.983 . . . . 13.23 109.722 -176.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.06 -168.14 46.54 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.811 1.196 . . . . 11.19 113.835 175.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.12 126.32 1.98 Allowed Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.541 1.136 . . . . 13.26 111.398 -178.242 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.62 65.8 8.62 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.34 2.693 . . . . 8.77 109.495 172.231 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -165.27 39.44 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.977 1.311 . . . . 9.52 110.804 -170.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.0 tp -83.58 45.0 1.01 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.805 1.242 . . . . 7.6 111.295 -177.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.78 -159.4 33.04 Favored Glycine 0 N--CA 1.464 0.549 0 C-N-CA 124.744 1.164 . . . . 4.06 113.977 -177.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.62 -110.48 3.86 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 117.869 -1.517 . . . . 3.1 111.512 -175.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -78.98 167.92 21.39 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.442 2.761 . . . . 3.11 114.645 -168.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -158.01 163.04 38.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.954 2.102 . . . . 2.37 110.974 -169.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.7 t -126.65 116.95 21.79 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.989 -1.07 . . . . 2.72 110.401 161.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.485 ' HB2' HD23 ' A' ' 227' ' ' LEU . 2.1 mp -135.96 160.24 39.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.098 0.952 . . . . 2.67 112.363 -178.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m -82.88 136.56 34.56 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.177 1.791 . . . . 1.84 109.764 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.9 t -97.38 158.7 15.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.954 1.302 . . . . 2.98 111.894 -178.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -14.98 57.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.475 1.657 . . . . 1.65 115.475 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.4 -11.51 59.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.635 1.574 . . . . 3.06 112.404 171.325 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.89 -26.17 16.53 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.873 1.701 . . . . 2.72 114.538 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.82 -142.61 0.1 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.005 1.322 . . . . 6.39 111.216 176.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.2 ttm105 -140.76 157.97 44.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 122.807 1.289 . . . . 6.13 113.287 -159.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -140.06 149.13 42.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.691 1.596 . . . . 4.06 112.471 169.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 44.7 p -118.3 162.38 18.37 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.03 1.332 . . . . 2.33 109.741 158.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.93 -42.79 63.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.961 1.705 . . . . 3.64 112.595 176.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -47.43 -30.29 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.946 1.699 . . . . 8.28 113.908 171.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.45 -5.15 43.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.046 1.338 . . . . 3.07 112.85 -174.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.71 -25.14 14.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.625 1.17 . . . . 3.01 112.619 163.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.37 142.11 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.114 1.765 . . . . 3.89 112.596 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.85 35.13 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.055 0.782 . . . . 2.65 115.055 173.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -139.19 -166.88 2.12 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.705 1.602 . . . . 3.41 108.943 172.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -90.69 70.02 6.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.083 0.945 . . . . 2.44 109.003 171.283 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.55 151.78 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.278 -0.638 . . . . 2.67 109.278 175.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.8 tp -148.23 122.69 9.72 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.789 -0.569 . . . . 2.78 109.577 -173.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -109.59 115.02 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 122.787 0.435 . . . . 1.73 111.732 -169.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -114.89 146.05 41.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.844 1.658 . . . . 2.69 112.62 173.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -111.65 118.54 35.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.687 1.195 . . . . 2.32 110.068 174.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.36 153.93 23.78 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.327 0.965 . . . . 1.3 114.888 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -81.06 -29.33 35.03 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.977 1.311 . . . . 4.26 112.819 176.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 96.3 m 96.78 123.7 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 128.899 2.879 . . . . 3.12 107.352 -173.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 72.11 -46.25 0.64 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.152 2.181 . . . . 8.77 113.357 -178.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.709 ' HB3' ' H ' ' A' ' 171' ' ' ASP . 1.3 m 58.7 -172.28 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.214 1.405 . . . . 2.29 113.018 -173.123 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.17 -43.2 9.12 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.039 1.826 . . . . 2.96 110.368 144.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.709 ' H ' ' HB3' ' A' ' 169' ' ' CYS . 9.5 p30 -154.5 -53.68 0.1 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.419 1.888 . . . . 6.59 115.353 -159.287 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.64 -35.82 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 114.978 1.473 . . . . 3.85 114.978 -159.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -46.29 -64.78 0.83 Allowed Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 120.245 1.384 . . . . 1.9 111.386 167.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.5 -32.21 32.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.678 2.252 . . . . 1.49 113.053 -177.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -59.81 -49.78 76.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.472 1.033 . . . . 4.08 111.429 175.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.36 -30.63 53.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.451 0.908 . . . . 3.98 113.451 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.6 -41.05 76.34 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.259 -0.901 . . . . 2.43 111.075 168.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.95 -47.48 86.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.892 0.769 . . . . 3.82 111.572 176.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -53.22 54.87 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.379 -1.451 . . . . 3.59 110.74 170.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 9.7 ttp -59.36 -40.7 87.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.189 1.396 . . . . 2.55 112.714 -175.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.5 mm -71.64 -53.85 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.971 0.908 . . . . 1.75 110.174 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.584 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 67.4 mt-30 -62.86 -34.54 77.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.818 0.735 . . . . 3.71 110.269 -172.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 t -52.01 -31.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 117.525 -1.226 . . . . 1.48 112.853 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.49 -34.8 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 120.941 1.7 . . . . 2.82 111.352 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -37.54 82.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.699 0.681 . . . . 5.86 112.307 -177.024 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -84.85 -33.53 22.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.949 1.299 . . . . 3.94 112.143 -178.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.76 -40.19 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.503 1.121 . . . . 1.68 111.384 172.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -73.49 -48.2 35.22 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 117.969 0.35 . . . . 4.81 111.233 171.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 55.5 m -70.01 -20.86 63.25 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.437 1.643 . . . . 3.67 115.437 -171.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.1 mm -74.23 -53.4 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.684 1.129 . . . . 4.9 112.301 -178.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.4 p -150.6 13.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.943 1.297 . . . . 7.6 113.413 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 6.1 t 52.67 66.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.379 2.272 . . . . 6.39 110.819 -173.589 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -53.7 158.2 3.33 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.834 1.654 . . . . 3.18 111.589 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -77.12 38.45 0.65 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.211 3.274 . . . . 2.84 112.467 178.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . 0.265 5.0 t0 76.13 138.45 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 131.555 3.942 . . . . 4.66 117.412 167.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.04 110.12 21.59 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.021 2.129 . . . . 3.74 107.691 170.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.8 m -110.94 96.4 29.18 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 124.671 1.189 . . . . 1.74 109.693 -175.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.3 125.62 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.317 2.678 . . . . 0.85 113.626 -173.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 31.0 tp -104.55 118.65 37.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.114 1.765 . . . . 2.29 109.339 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -104.76 132.02 51.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.749 1.22 . . . . 2.44 109.495 176.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.1 mm -114.42 133.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.522 1.529 . . . . 1.62 110.427 177.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.4 m -67.19 -172.95 0.23 Allowed 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 115.158 1.54 . . . . 2.68 115.158 170.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.3 pt -144.99 -34.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.439 -1.413 . . . . 2.61 114.747 175.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -130.92 71.82 82.2 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.73 1.612 . . . . 3.22 111.288 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.95 -1.44 2.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 124.982 3.788 . . . . 3.02 115.657 -172.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.26 -6.51 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 119.495 1.043 . . . . 4.36 113.343 160.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -132.63 -60.83 0.87 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.39 1.476 . . . . 5.58 114.145 -173.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.54 74.7 9.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.836 1.303 . . . . 4.04 110.906 -172.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.4 t -65.01 154.7 36.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.185 1.469 . . . . 2.53 112.11 -170.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -56.16 -32.74 64.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.331 1.852 . . . . 6.25 113.626 -171.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -77.2 -39.36 49.02 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.809 2.844 . . . . 4.55 110.803 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.58 -38.98 77.57 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.863 0.865 . . . . 1.37 111.235 172.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.55 -42.95 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.065 0.946 . . . . 1.61 110.631 168.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.17 96.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.719 -0.658 . . . . 1.14 112.118 175.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -61.72 -50.39 72.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.78 1.173 . . . . 3.66 111.617 171.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.08 -42.52 72.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.413 1.485 . . . . 3.19 111.807 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 32.2 t -63.18 -46.32 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.325 1.05 . . . . 1.39 112.234 170.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.424 ' HZ2' ' CD ' ' A' ' 219' ' ' GLU . 0.2 OUTLIER -63.82 -25.43 68.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.449 0.907 . . . . 4.79 113.449 -176.651 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.424 ' CD ' ' HZ2' ' A' ' 218' ' ' LYS . 7.0 mm-40 -83.98 -40.31 18.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.138 0.881 . . . . 5.18 112.411 175.394 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -76.22 -45.51 32.64 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.969 1.099 . . . . 3.04 113.969 -176.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.8 m 153.14 146.52 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 128.99 2.916 . . . . 2.37 112.985 173.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.69 8.19 2.04 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.42 3.413 . . . . 2.23 115.702 -175.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -76.4 -18.0 59.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.057 1.299 . . . . 2.35 112.509 163.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.72 139.05 39.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.428 1.091 . . . . 2.46 111.237 171.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.3 t -127.66 138.58 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.426 1.09 . . . . 2.33 108.954 161.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.66 125.41 8.57 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.889 1.233 . . . . 1.12 111.464 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 142' ' ' LEU . 3.9 mp -108.19 129.88 55.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.672 1.189 . . . . 2.4 110.249 176.082 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t 174.29 122.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.421 2.288 . . . . 2.91 110.037 -167.396 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -128.46 -62.19 0.12 Allowed Glycine 0 N--CA 1.469 0.841 0 C-N-CA 124.368 0.985 . . . . 2.93 112.221 176.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.0 p -145.16 171.1 15.01 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.281 1.832 . . . . 2.58 109.192 -176.167 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -31.59 69.4 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.78 -0.575 . . . . 7.21 111.245 178.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -70.71 -51.77 25.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 2.79 112.632 -176.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . 0.32 0.0 OUTLIER -80.03 -29.09 39.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.09 1.313 . . . . 3.93 113.659 -174.833 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.37 -53.01 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.0 0.92 . . . . 2.36 111.324 157.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.37 -23.07 61.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.947 -1.096 . . . . 3.69 113.525 -175.335 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -57.74 6.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.213 0.915 . . . . 2.79 110.118 163.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.68 -21.08 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 118.445 0.566 . . . . 2.23 111.929 -171.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.261 1.024 . . . . 1.54 110.367 167.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -44.34 65.62 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.187 1.395 . . . . 5.48 111.946 173.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -53.03 -43.77 66.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.868 1.213 . . . . 1.7 112.473 175.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -96.71 11.22 36.28 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.921 1.082 . . . . 2.41 113.921 178.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 41.73 45.8 3.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.846 2.458 . . . . 6.37 114.955 -177.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 13.3 m -67.89 159.48 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.587 1.155 . . . . 3.12 112.516 -170.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -101.67 102.39 13.06 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.225 0.536 . . . . 3.71 110.946 163.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -102.69 143.37 32.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.271 -0.64 . . . . 3.38 109.271 154.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.6 m -70.13 137.52 87.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 121.569 -0.707 . . . . 4.08 112.307 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.59 119.32 5.87 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 107.396 -1.809 . . . . 4.96 107.396 154.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.73 160.6 53.65 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 114.015 0.366 . . . . 3.62 114.015 -171.064 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.51 -171.57 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.078 3.186 . . . . 3.94 111.239 176.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 254' ' ' GLU . 0.0 OUTLIER -77.59 -18.52 56.77 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.759 -1.213 . . . . 7.48 113.138 163.046 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.1 -158.92 0.32 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.839 2.056 . . . . 6.93 113.239 178.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -64.62 -22.17 66.91 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.041 0.837 . . . . 7.43 113.243 175.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -149.08 -49.31 0.15 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.83 1.419 . . . . 7.98 114.83 173.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 250' ' ' LYS . 7.3 tp10 -179.37 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.637 1.975 . . . . 9.68 111.439 -165.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -75.86 56.09 0.93 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.999 1.719 . . . . 7.7 114.15 -170.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -58.91 138.67 57.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 116.659 2.096 . . . . 4.8 116.659 -160.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 47.0 pt -56.71 148.53 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.255 0.55 . . . . 4.14 111.715 166.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.6 m -124.22 147.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.684 1.594 . . . . 3.12 107.368 166.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.59 165.56 18.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.154 1.382 . . . . 5.25 108.883 172.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -150.41 143.0 24.53 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.031 1.122 . . . . 2.27 114.031 175.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.3 t -151.6 149.99 29.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.108 0.963 . . . . 4.35 109.562 167.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.2 174.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.614 1.966 . . . . 6.64 110.799 -159.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.1 mm -106.99 140.63 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.47 -1.678 . . . . 3.52 106.47 152.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 2.4 ttt -94.92 127.99 41.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.017 1.327 . . . . 2.19 108.863 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -111.06 134.9 52.29 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 3.9 114.293 -165.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.53 107.07 17.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.048 1.339 . . . . 3.05 109.242 171.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.01 110.5 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 105.267 -2.123 . . . . 1.99 105.267 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.93 -168.57 44.02 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 113.601 0.2 . . . . 1.86 113.601 -168.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.31 71.18 5.29 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.763 2.975 . . . . 3.51 109.275 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -155.13 -60.11 0.11 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.456 1.502 . . . . 4.68 110.145 -159.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.04 -31.03 4.41 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.116 -1.38 . . . . 3.18 114.716 -178.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -113.12 -61.43 1.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.759 1.279 . . . . 5.1 112.42 -175.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -170.16 145.3 2.78 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.337 -0.852 . . . . 6.95 112.625 -162.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.81 -44.55 1.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.211 1.004 . . . . 3.3 113.574 176.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -159.33 158.93 33.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 2.87 111.547 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -119.54 125.1 48.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.826 1.25 . . . . 4.29 110.919 172.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 104.22 14.01 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.197 -1.038 . . . . 2.95 108.197 178.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -74.47 157.01 50.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.016 -1.234 . . . . 3.15 110.016 162.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.3 57.44 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.683 1.593 . . . . 4.1 111.537 175.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -156.63 -31.96 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.152 1.781 . . . . 5.44 113.186 -171.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.76 131.91 46.96 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.244 -0.91 . . . . 4.69 109.43 170.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -82.85 155.68 24.01 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.423 1.889 . . . . 7.88 109.794 172.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.584 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 9.3 tmtt? -38.91 -54.03 1.68 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.403 1.881 . . . . 2.08 114.687 -172.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -64.27 -36.8 93.67 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.142 -0.81 . . . . 1.4 113.63 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.3 -27.3 64.28 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.677 1.738 . . . . 3.32 112.763 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 95.0 mt -69.02 -48.81 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.196 0.998 . . . . 1.4 110.094 176.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.3 -45.2 85.33 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.303 0.483 . . . . 1.23 112.303 174.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.93 67.65 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 1.85 114.403 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 p -67.37 -47.99 68.75 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.017 -1.052 . . . . 1.69 111.327 168.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.93 -36.64 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.727 -1.233 . . . . 1.67 112.182 173.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.78 67.6 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.364 -1.46 . . . . 1.96 113.175 172.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 91.4 m -75.62 -51.76 12.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.888 0.875 . . . . 2.25 109.319 172.259 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -61.33 -26.42 67.79 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.536 1.535 . . . . 2.8 113.985 176.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.1 ttp -66.59 -15.01 63.13 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.724 -1.235 . . . . 4.74 112.99 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -59.9 -51.95 77.05 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 116.962 -1.494 . . . . 5.06 111.513 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.55 -58.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.867 2.378 . . . . 2.34 112.368 166.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -79.98 66.42 5.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.215 1.406 . . . . 3.19 111.724 -176.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.08 158.17 1.16 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.94 1.296 . . . . 8.46 113.753 -177.18 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -52.88 152.77 3.71 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.041 -1.037 . . . . 8.08 112.201 168.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -56.11 -43.47 78.17 Favored 'General case' 0 CA--C 1.55 0.959 0 O-C-N 121.19 -0.944 . . . . 10.7 112.725 177.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.49 1.916 . . . . 9.25 111.136 172.232 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 118.462 -0.78 . . . . 19.6 109.077 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -69.3 171.19 8.92 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 118.838 0.745 . . . . 17.72 110.116 154.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.7 t -162.78 -173.03 3.32 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.333 1.453 . . . . 13.36 110.229 -174.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.03 -91.67 1.01 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.077 -1.209 . . . . 10.2 110.077 -177.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt 157.4 133.26 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 130.916 3.686 . . . . 10.95 111.474 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -87.87 171.46 5.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.528 2.819 . . . . 8.55 110.835 168.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.18 177.63 4.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.561 1.544 . . . . 7.02 109.044 159.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.02 143.2 51.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.668 1.187 . . . . 7.26 110.539 177.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.84 -143.26 21.33 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.064 0.84 . . . . 3.48 112.271 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.19 -156.25 15.78 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.554 1.073 . . . . 3.0 114.518 173.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -82.11 -178.74 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.703 3.602 . . . . 3.0 112.413 -175.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -170.85 168.52 7.17 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.47 2.708 . . . . 2.74 108.762 -176.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -134.34 32.09 3.42 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.734 -1.229 . . . . 3.58 112.744 167.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.71 146.3 21.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 123.446 1.593 . . . . 2.05 111.304 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.6 m -108.39 140.39 41.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.788 -1.551 . . . . 1.71 109.19 -168.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.4 m -90.74 148.21 22.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.412 1.885 . . . . 3.25 110.459 -167.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -55.69 -13.08 1.47 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 117.347 2.351 . . . . 2.51 117.347 -170.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.4 t -86.11 -27.39 24.69 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 4.2 113.605 170.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.97 26.91 1.63 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.789 1.662 . . . . 2.56 116.172 -177.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.13 139.94 51.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.393 2.096 . . . . 3.38 111.203 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -96.04 123.69 39.74 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.188 2.195 . . . . 6.27 110.739 -170.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 164.24 14.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.385 0.674 . . . . 3.25 111.292 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -128.02 -179.51 5.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.586 1.154 . . . . 2.62 108.184 167.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -38.8 -65.8 0.33 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.141 1.777 . . . . 4.99 113.217 163.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 13.28 0.36 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.191 1.922 . . . . 9.06 116.191 -172.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -90.68 -26.91 19.34 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 120.573 -1.33 . . . . 3.47 112.26 158.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -113.36 -9.15 13.4 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.093 1.757 . . . . 2.78 114.345 -178.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tt -111.5 120.95 43.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.354 2.261 . . . . 3.83 109.539 -175.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.33 -39.81 1.75 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 127.101 2.286 . . . . 2.54 109.708 -170.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -78.62 -156.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.762 0.825 . . . . 3.59 109.988 138.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.04 155.79 27.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.834 1.253 . . . . 2.32 112.165 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.66 149.7 34.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.508 1.299 . . . . 2.34 114.508 170.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.42 137.8 38.35 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.163 1.785 . . . . 2.51 107.859 164.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.2 mt -123.11 139.0 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.465 1.106 . . . . 1.72 108.271 177.265 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -151.99 149.2 28.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.427 1.491 . . . . 2.52 111.372 177.603 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -104.02 118.42 36.62 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.923 0.889 . . . . 2.23 109.92 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -168.96 156.59 28.03 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.693 1.616 . . . . 2.32 114.312 -171.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.29 171.33 12.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.551 -0.97 . . . . 3.98 113.572 -155.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 17.4 m -96.27 18.42 13.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.353 0.871 . . . . 3.04 113.353 -172.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -106.2 -3.51 21.27 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.069 -1.019 . . . . 8.24 113.266 170.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 170' ' ' PRO . 0.8 OUTLIER -74.34 160.47 81.27 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 127.526 2.33 . . . . 2.32 115.4 -171.819 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 169' ' ' CYS . 40.3 Cg_endo -79.27 -160.17 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.235 3.29 . . . . 3.8 110.764 156.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.68 -10.17 7.93 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.45 2.3 . . . . 4.81 115.459 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 4.5 p -78.45 -32.28 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 118.495 -0.764 . . . . 3.68 112.412 -170.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.69 -61.03 6.34 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 117.147 -1.406 . . . . 1.57 112.31 166.198 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.1 -36.75 56.66 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.583 2.188 . . . . 1.88 114.315 -175.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -54.91 -60.08 3.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.953 1.301 . . . . 3.83 110.95 171.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.82 -35.88 75.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.324 0.65 . . . . 2.7 112.174 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.49 -33.41 64.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.878 1.671 . . . . 2.79 112.416 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -61.34 2.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.158 1.345 . . . . 5.52 108.35 170.717 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -38.59 67.36 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.786 -0.571 . . . . 6.7 110.829 -175.261 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 11.4 ttm -64.88 -45.69 84.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.717 1.207 . . . . 2.75 113.065 177.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.7 pt -76.96 -28.79 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 120.34 1.427 . . . . 3.65 110.854 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.523 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 0.6 OUTLIER -80.4 -34.44 36.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.175 0.443 . . . . 4.31 110.604 -175.444 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.4 -40.71 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.696 0.799 . . . . 1.87 112.517 176.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 22.4 m -64.29 -39.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.276 0.944 . . . . 3.16 111.94 -175.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.04 -41.24 91.12 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.841 -1.162 . . . . 5.0 112.463 173.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.01 -19.54 64.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.497 1.519 . . . . 2.95 113.482 179.52 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.39 -58.38 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.977 1.711 . . . . 2.13 112.08 173.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -63.34 -28.4 69.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.845 0.831 . . . . 4.45 112.358 -170.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.7 m -71.07 -16.95 62.61 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.232 -0.918 . . . . 4.65 113.346 176.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 21.2 mm -80.63 64.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.335 -1.358 . . . . 3.97 107.335 168.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.9 t -47.02 -12.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 129.751 3.22 . . . . 5.98 118.181 -157.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.0 m -73.98 -22.95 59.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.825 1.65 . . . . 4.04 111.874 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.7 mt -74.83 162.23 74.38 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.364 1.866 . . . . 3.72 113.583 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.63 154.59 27.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.596 2.864 . . . . 3.07 110.375 168.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -77.35 133.22 38.8 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.483 1.913 . . . . 5.0 113.649 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.5 107.86 19.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.247 1.819 . . . . 2.16 111.383 -175.101 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 79.2 m -72.86 131.91 83.54 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.449 -1.407 . . . . 1.78 111.194 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -91.56 94.7 0.21 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.166 3.244 . . . . 1.28 111.342 165.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.24 101.26 11.53 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.742 0.782 . . . . 2.32 112.492 -173.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -93.03 126.03 37.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.212 1.405 . . . . 2.89 110.632 -177.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.21 119.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.226 1.01 . . . . 2.12 110.145 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.5 m -98.87 162.49 13.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.573 1.149 . . . . 2.62 112.677 175.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.2 pt -147.83 -13.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.91 2.189 . . . . 1.64 116.91 -148.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -94.38 93.38 0.93 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 120.618 1.554 . . . . 3.78 107.495 170.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.37 -22.32 52.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.762 1.641 . . . . 2.53 112.499 -177.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -63.22 -14.85 53.98 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.109 1.364 . . . . 4.01 114.611 170.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -161.64 -10.91 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 118.7 2.852 . . . . 5.08 118.7 -170.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -75.36 65.44 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 122.352 2.342 . . . . 4.81 111.862 170.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 51.0 m -65.07 136.92 57.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.57 1.948 . . . . 2.67 111.076 -176.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -38.22 -64.59 0.4 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.197 1.799 . . . . 3.51 113.411 175.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -65.96 -25.08 66.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.245 1.418 . . . . 3.33 113.73 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.59 -47.03 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.434 1.015 . . . . 1.89 110.814 175.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 38.5 mm -57.23 -45.22 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.22 1.008 . . . . 1.95 110.405 170.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -52.81 -46.55 67.74 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.834 0.853 . . . . 2.3 112.467 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -68.78 -46.18 69.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.33 0.514 . . . . 3.11 111.876 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -54.64 -49.28 70.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.81 1.244 . . . . 3.1 111.353 176.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.5 t -55.27 -49.32 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.555 1.942 . . . . 2.51 111.33 172.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -30.43 71.5 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.081 -1.438 . . . . 5.93 114.254 -177.224 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -68.74 -29.95 68.47 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.278 1.399 . . . . 4.04 112.083 175.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -81.8 -54.07 5.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.907 0.483 . . . . 3.1 111.509 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.9 p -169.85 148.96 3.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 121.591 -0.693 . . . . 2.79 111.445 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.53 -7.41 20.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.359 2.706 . . . . 2.92 113.278 173.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -85.01 -21.34 29.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.277 1.031 . . . . 2.64 112.997 176.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.42 143.91 48.34 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.661 1.185 . . . . 2.43 111.378 -178.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.62 134.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.882 0.873 . . . . 2.99 111.216 172.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.66 124.79 6.66 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.28 1.419 . . . . 1.34 111.763 -178.276 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -108.76 139.65 43.28 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.348 1.459 . . . . 2.38 110.901 -178.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 t -139.54 164.38 30.04 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.81 1.644 . . . . 2.77 110.678 176.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -164.31 171.95 39.97 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.67 1.605 . . . . 1.88 112.166 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -64.84 160.26 20.76 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.736 0.814 . . . . 2.12 110.529 168.648 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -50.07 -35.74 26.49 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.864 0.866 . . . . 5.43 113.167 -174.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.1 mp0 -67.22 -38.5 85.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.003 1.721 . . . . 2.88 110.108 -178.318 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.09 -40.84 52.16 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.599 1.16 . . . . 4.33 113.022 172.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.48 -42.62 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.869 -0.419 . . . . 1.66 109.869 171.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -75.35 -29.45 59.93 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.129 -0.938 . . . . 3.05 112.653 175.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -60.21 -59.69 5.01 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.625 2.011 . . . . 2.38 110.261 167.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.22 -30.6 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 118.466 0.576 . . . . 2.06 111.986 -171.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.45 -52.34 14.03 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.996 0.816 . . . . 1.69 112.216 173.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -76.54 -32.55 58.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.592 1.157 . . . . 3.74 112.936 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.72 78.63 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.539 1.136 . . . . 1.7 111.242 173.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -73.2 -1.89 19.52 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.24 -0.912 . . . . 2.29 113.03 168.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 45.61 39.68 5.18 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.372 2.669 . . . . 7.27 114.471 -176.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 p -71.37 137.6 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.195 -0.668 . . . . 2.88 109.195 174.105 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -75.46 130.65 39.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.87 0.367 . . . . 4.07 110.88 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -148.84 144.39 26.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.185 1.394 . . . . 4.05 109.956 172.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.0 m -149.48 106.35 3.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 O-C-N 121.493 -0.755 . . . . 4.29 112.133 -171.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.35 142.35 10.6 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.447 2.765 . . . . 3.05 113.055 -177.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.23 122.66 6.22 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.088 -1.396 . . . . 2.97 110.322 166.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.73 115.47 4.34 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.774 2.316 . . . . 6.01 110.19 -176.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -160.05 -170.35 2.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.92 1.288 . . . . 7.1 112.539 -167.042 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -142.13 -174.9 4.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.981 2.513 . . . . 9.38 109.371 -169.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -114.01 133.54 55.44 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.785 1.234 . . . . 16.24 109.067 177.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.6 t0 107.23 -1.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 131.389 3.876 . . . . 7.55 111.041 -163.372 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -135.05 -40.94 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.678 1.591 . . . . 9.05 110.634 166.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 30.3 t0 72.1 -168.54 0.14 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.362 1.865 . . . . 5.42 110.962 177.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -167.51 -162.57 0.46 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.408 -1.433 . . . . 3.5 111.935 -161.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 14.4 tt -157.45 164.85 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.106 1.762 . . . . 3.52 108.059 157.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.39 140.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.278 -1.378 . . . . 3.89 107.278 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.7 147.71 47.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.261 0.553 . . . . 4.56 110.996 167.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -143.26 136.25 27.84 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.618 0.767 . . . . 2.56 110.13 158.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -66.2 131.37 46.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.811 -1.181 . . . . 3.78 110.339 174.298 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.457 ' CD1' ' H ' ' A' ' 262' ' ' ILE 0.253 0.0 OUTLIER -82.52 64.48 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 123.172 1.463 . . . . 4.93 112.653 -171.091 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.63 127.09 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.04 1.336 . . . . 2.17 111.402 -176.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 4.7 mmm -88.09 137.66 32.13 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.552 1.541 . . . . 2.42 109.411 158.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -114.14 131.56 56.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 2.73 109.524 168.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.05 121.45 41.4 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.901 0.88 . . . . 2.3 108.685 173.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.08 117.89 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.052 -1.462 . . . . 1.65 107.052 172.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.51 -137.12 5.76 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 109.357 -1.497 . . . . 1.67 109.357 167.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -81.19 3.67 7.62 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.391 2.06 . . . . 3.59 112.381 170.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -31.37 53.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.954 1.302 . . . . 4.86 112.744 -176.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.98 1.85 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.07 1.319 . . . . 2.94 113.345 -170.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -77.86 19.26 0.41 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.983 1.713 . . . . 4.67 115.04 -166.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 92.1 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 129.972 3.309 . . . . 4.11 110.676 173.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.32 -33.29 10.78 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.727 1.211 . . . . 2.85 111.144 176.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -168.97 167.12 10.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.139 2.175 . . . . 2.72 108.325 -168.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -161.47 146.04 13.28 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.444 1.098 . . . . 4.39 112.288 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -129.91 115.22 16.88 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.914 0.886 . . . . 2.74 109.862 -175.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.32 110.75 4.09 Favored Glycine 0 N--CA 1.465 0.616 0 N-CA-C 109.652 -1.379 . . . . 3.5 109.652 173.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.482 ' HG3' ' H ' ' A' ' 280' ' ' ASN . 16.2 tp60 76.44 166.32 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.483 1.913 . . . . 4.17 110.949 -167.722 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.482 ' H ' ' HG3' ' A' ' 279' ' ' GLN . 53.4 t-20 -42.03 -48.46 4.63 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.094 2.557 . . . . 9.21 113.408 -169.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 59.0 tttp 67.95 -23.29 0.12 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.566 1.946 . . . . 5.35 113.89 -172.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 102.3 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 130.319 3.448 . . . . 5.84 107.259 -174.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.523 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -34.78 -60.07 0.46 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.285 2.234 . . . . 2.45 113.25 179.012 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -66.8 -19.38 69.41 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.256 -1.302 . . . . 1.59 115.755 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -77.84 -26.11 49.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.739 2.27 . . . . 3.91 112.981 177.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.85 -40.47 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.735 -0.839 . . . . 2.46 108.735 169.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.31 77.54 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.484 0.584 . . . . 1.49 111.461 169.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.41 -39.21 85.52 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.196 1.184 . . . . 1.51 114.196 176.032 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 18.9 p -70.0 -46.95 64.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.108 0.867 . . . . 1.74 111.571 175.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.8 mt -54.82 -44.18 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.086 0.954 . . . . 1.53 110.77 171.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.408 -1.433 . . . . 1.68 113.701 178.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 57.4 m -76.95 -47.88 19.66 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.079 0.952 . . . . 2.06 109.93 170.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -62.73 -31.78 72.77 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.338 1.055 . . . . 2.75 112.288 175.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.56 24.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.633 1.573 . . . . 5.86 112.749 168.372 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -87.47 -57.16 0.31 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 116.337 -1.792 . . . . 5.79 111.801 152.209 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.17 -49.48 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.251 2.634 . . . . 2.55 113.133 176.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.33 70.42 10.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.863 0.756 . . . . 3.19 111.712 -176.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 72.76 -168.16 0.12 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.879 1.272 . . . . 10.63 109.318 -174.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -158.33 157.67 32.86 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.999 -1.063 . . . . 10.07 113.141 -169.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.609 ' HE3' ' H ' ' A' ' 300' ' ' LYS . 0.0 OUTLIER -66.29 -27.87 68.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.357 1.463 . . . . 11.93 113.278 -174.724 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--O 1.253 1.285 0 C-N-CA 128.56 2.744 . . . . 9.13 107.287 170.325 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 117.867 -1.063 . . . . 22.04 109.82 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -63.89 139.34 58.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.018 0.827 . . . . 17.94 110.024 163.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.3 t 144.77 -173.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.274 1 C-N-CA 132.108 4.163 . . . . 16.94 108.114 -176.22 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.83 -133.53 15.58 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.982 0.801 . . . . 14.74 112.521 172.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.22 154.86 2.69 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 127.392 2.277 . . . . 12.84 110.887 174.063 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.52 171.89 17.23 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.017 2.478 . . . . 10.44 110.627 166.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.9 mt -98.62 152.27 19.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.297 1.039 . . . . 11.74 109.961 167.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 75.6 mt -117.43 -166.87 1.23 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.577 1.551 . . . . 7.7 110.966 -175.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -141.91 177.01 21.69 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 115.852 1.101 . . . . 3.52 115.852 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.62 -91.62 0.94 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.833 1.682 . . . . 3.55 110.494 -168.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.55 161.78 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.905 2.403 . . . . 3.6 113.279 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -156.08 179.43 9.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.85 2.46 . . . . 2.92 108.366 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.2 m -140.31 117.27 11.09 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.957 -1.714 . . . . 3.11 111.528 157.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.72 161.65 28.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.694 1.997 . . . . 2.62 108.39 176.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.4 t -87.31 146.62 25.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.467 0.651 . . . . 2.69 110.93 173.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 71.9 p -92.85 159.28 15.44 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 123.152 1.454 . . . . 2.37 112.409 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -56.82 -26.86 59.05 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.127 -0.983 . . . . 1.99 112.474 163.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.0 p -71.72 -20.29 61.93 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.367 1.247 . . . . 4.18 114.367 169.133 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.77 11.16 54.24 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 120.287 1.403 . . . . 1.96 115.163 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -88.76 -175.37 4.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.673 1.589 . . . . 4.06 110.136 170.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -131.56 121.72 24.9 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.887 1.275 . . . . 5.75 108.969 168.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -132.72 156.39 47.11 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.903 1.075 . . . . 3.9 113.903 -162.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -108.0 164.16 12.52 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.37 1.868 . . . . 3.14 109.63 171.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -39.61 -55.77 1.8 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.63 2.372 . . . . 4.18 112.42 159.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -74.34 -15.66 60.94 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.537 1.31 . . . . 8.02 114.537 -174.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.74 -42.64 77.29 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.824 1.193 . . . . 3.04 110.988 166.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -79.68 11.19 3.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.385 1.254 . . . . 2.98 114.385 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.36 -169.49 0.82 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.662 1.185 . . . . 4.19 111.763 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 76.41 8.35 85.67 Favored Glycine 0 N--CA 1.482 1.702 0 O-C-N 120.517 -1.364 . . . . 3.85 114.56 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.55 154.96 27.51 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.361 2.664 . . . . 3.57 107.593 -171.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -68.07 125.09 25.25 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.314 0.507 . . . . 2.48 110.071 170.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 34.7 mt -105.86 125.72 51.33 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.963 0.887 . . . . 3.09 111.652 177.107 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.0 tp -107.04 92.22 3.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.865 1.666 . . . . 3.13 106.748 176.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.85 121.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.787 1.235 . . . . 2.63 110.199 -167.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -128.98 153.6 47.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.542 1.312 . . . . 3.55 114.542 -175.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.85 102.13 9.7 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.109 1.763 . . . . 2.84 112.31 175.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.02 171.31 17.72 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.396 1.474 . . . . 2.34 113.329 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -111.42 -12.99 13.95 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.765 0.654 . . . . 3.7 112.765 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.0 m 58.04 47.53 14.62 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.137 1.446 . . . . 4.19 108.891 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -150.4 -56.65 0.17 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 114.638 -1.164 . . . . 7.65 110.738 -161.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.3 m -70.4 141.03 87.87 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.156 0.982 . . . . 2.45 111.219 -170.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.22 -17.54 21.58 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.907 1.738 . . . . 4.17 111.243 166.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.51 -76.57 0.54 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.779 1.632 . . . . 5.3 112.673 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.29 -54.44 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.486 1.114 . . . . 2.76 111.945 -162.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 97.5 m -47.25 -60.7 3.64 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.325 -1.321 . . . . 1.68 112.596 176.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.24 -34.55 27.3 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.657 1.571 . . . . 1.27 113.127 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -67.08 -33.43 75.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 121.092 1.769 . . . . 3.75 112.097 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -31.2 37.67 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.299 -1.501 . . . . 3.49 113.521 170.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -43.74 98.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.967 1.307 . . . . 2.63 111.171 174.204 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.24 -46.34 76.03 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 3.47 111.055 172.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -66.51 -33.69 76.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.186 0.81 . . . . 3.69 113.186 174.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 69.7 mtp -61.18 -42.6 98.87 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.017 1.281 . . . . 3.54 111.915 169.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.9 mm -75.41 -61.97 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.971 -0.751 . . . . 1.87 108.971 -172.06 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.26 -12.41 28.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.748 1.219 . . . . 3.1 114.225 -165.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.13 -39.67 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.648 1.179 . . . . 1.62 111.044 171.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.11 -53.86 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 120.021 1.282 . . . . 2.38 110.205 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.8 -20.03 61.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.256 1.422 . . . . 4.49 112.064 -171.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -79.32 -38.13 35.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.796 1.239 . . . . 2.6 111.909 167.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.82 -49.54 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.782 1.401 . . . . 2.14 114.782 -168.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -33.52 75.48 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.571 1.532 . . . . 4.49 109.74 179.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -19.83 42.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.527 1.931 . . . . 3.01 114.714 173.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.46 -14.34 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.321 -1.487 . . . . 4.44 112.494 175.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m 157.64 -33.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 130.422 3.489 . . . . 6.18 112.832 164.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . 0.386 7.1 t 157.34 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.16 3.384 . . . . 5.97 110.785 166.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.44 ' O ' ' HE2' ' A' ' 300' ' ' LYS . 0.2 OUTLIER -46.07 147.09 1.88 Allowed Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 114.302 -1.317 . . . . 3.78 111.493 169.679 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.28 -44.25 19.77 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.372 2.715 . . . . 3.57 112.459 -159.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.12 153.67 0.23 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.895 2.878 . . . . 4.5 108.669 161.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.16 128.11 29.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.044 0.537 . . . . 2.64 109.704 171.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.4 m -124.84 119.1 25.65 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.704 1.202 . . . . 1.63 108.562 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.73 133.63 10.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.001 2.467 . . . . 1.05 110.127 172.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.84 97.25 4.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.832 1.253 . . . . 2.48 109.336 -169.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -94.27 133.04 38.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.97 1.308 . . . . 2.51 110.661 -173.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 54.0 mt -122.62 129.43 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.586 1.155 . . . . 1.71 109.41 176.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -83.03 137.35 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.656 -0.653 . . . . 2.54 112.409 171.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 pt -81.74 3.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.891 1.071 . . . . 2.78 113.891 172.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.78 80.14 12.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 115.937 1.829 . . . . 5.12 115.937 -172.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -80.14 63.21 8.72 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.295 3.33 . . . . 2.57 112.12 174.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -108.74 -50.26 3.04 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.565 -1.198 . . . . 3.88 108.343 139.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.39 -6.32 28.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.793 1.775 . . . . 4.73 115.793 -170.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -76.46 28.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.715 1.598 . . . . 5.42 114.75 -177.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.2 m -61.29 134.74 57.29 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.486 -0.759 . . . . 3.67 109.746 -141.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -39.37 9.14 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.828 1.418 . . . . 3.7 114.828 -161.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -85.74 -28.31 24.69 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.655 0.983 . . . . 4.06 113.655 178.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.81 91.78 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 1.65 111.44 166.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.6 -41.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.485 0.714 . . . . 2.6 112.274 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.64 -38.79 75.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.297 0.953 . . . . 1.31 111.677 170.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -68.69 -38.29 80.19 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.062 0.764 . . . . 3.98 113.062 173.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.61 -37.9 87.92 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.023 0.829 . . . . 3.03 111.217 174.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.6 t -56.61 -47.94 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.951 -1.093 . . . . 1.3 111.721 170.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -79.84 19.9 0.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.493 1.294 . . . . 4.61 114.493 174.698 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -92.48 -59.88 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.572 -1.33 . . . . 3.9 109.557 160.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -80.79 -53.17 6.73 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.449 1.277 . . . . 3.4 114.449 -171.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.3 t -177.35 132.02 0.35 Allowed Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.135 1.374 . . . . 2.26 109.031 -174.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.37 -5.72 16.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.184 2.589 . . . . 1.92 113.081 -176.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -76.55 -8.56 57.46 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.333 0.969 . . . . 3.67 113.401 171.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.48 131.04 44.11 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.32 0.964 . . . . 1.82 110.09 169.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.3 t -99.97 129.2 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.757 -1.201 . . . . 2.23 107.757 171.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.48 134.48 11.9 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.951 -0.86 . . . . 1.35 110.951 172.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.2 161.0 22.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.911 0.884 . . . . 2.28 112.129 171.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 9.7 t -162.72 -168.96 1.93 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 129.449 3.1 . . . . 2.77 108.165 -176.063 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 173.58 -147.43 9.48 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 120.305 1.411 . . . . 1.91 110.418 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.9 p -90.37 164.91 14.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.494 -0.928 . . . . 3.12 108.494 157.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -30.17 69.57 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.523 -0.751 . . . . 7.85 112.523 -173.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -56.09 -35.61 67.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.861 1.664 . . . . 3.45 113.114 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.38 -35.77 54.14 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.792 -1.193 . . . . 3.66 112.534 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.04 -35.1 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.009 0.524 . . . . 2.09 110.657 171.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -30.45 67.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.226 1.01 . . . . 3.69 111.318 174.144 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -60.41 3.91 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.405 1.082 . . . . 2.57 110.798 162.428 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' A' ' 240' ' ' ALA . 6.9 p -71.51 -16.28 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.942 1.247 . . . . 2.55 112.806 -168.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -71.78 -39.62 69.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.974 0.91 . . . . 1.76 110.255 173.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.05 -49.58 76.79 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.384 -0.817 . . . . 3.53 110.478 163.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 237' ' ' VAL . . . -60.9 -16.51 42.91 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 116.501 2.037 . . . . 2.95 116.501 -170.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -129.75 15.56 5.87 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.118 . . . . 2.87 113.671 173.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 56.61 43.32 25.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.136 1.374 . . . . 5.52 112.678 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.51 126.72 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.623 1.569 . . . . 2.89 108.511 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -94.14 149.78 20.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.127 1.371 . . . . 4.53 111.577 175.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -165.23 127.88 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.635 1.974 . . . . 5.02 110.056 -174.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 31.1 t -136.42 79.2 42.69 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.826 1.65 . . . . 3.72 111.8 -171.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.47 138.0 21.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.66 2.907 . . . . 3.21 113.877 -170.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -91.02 -173.03 43.78 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 125.521 1.534 . . . . 3.29 112.829 163.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -87.27 171.37 6.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.139 3.226 . . . . 3.8 112.702 -174.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -114.38 24.09 12.22 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 126.06 1.744 . . . . 7.8 114.846 -166.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -72.51 -28.98 63.21 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 118.471 2.767 . . . . 8.5 118.471 -140.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.59 -26.53 14.37 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.115 1.325 . . . . 7.42 114.217 -176.131 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -159.7 -45.72 0.05 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.42 1.488 . . . . 8.22 109.923 172.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -179.69 -43.86 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.027 3.331 . . . . 9.21 110.058 174.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -6.68 74.16 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.861 2.064 . . . . 4.35 114.859 -152.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.37 94.86 0.98 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.923 -1.035 . . . . 3.99 112.088 -155.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 28.1 mm -77.04 78.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.791 -0.818 . . . . 4.42 108.791 169.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.37 146.64 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.414 -1.699 . . . . 4.07 106.414 151.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.66 -174.68 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.326 1.06 . . . . 4.62 111.315 162.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -146.87 151.31 36.85 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.08 -1.013 . . . . 2.27 111.453 138.339 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.1 m -60.09 128.47 36.95 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.055 1.342 . . . . 3.38 109.309 165.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 15.4 pt -104.07 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.56 1.544 . . . . 5.15 111.579 -177.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 6.3 mm -128.72 141.12 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.491 1.117 . . . . 2.99 109.954 177.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 7.9 ttp -124.35 128.31 48.9 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.621 1.968 . . . . 2.72 109.167 173.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.72 141.39 32.58 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.318 1.047 . . . . 3.02 112.053 179.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -104.19 110.86 23.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.632 1.173 . . . . 2.61 110.215 174.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.0 138.66 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.477 1.511 . . . . 2.28 109.38 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.92 160.53 37.19 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.351 -0.694 . . . . 2.18 114.089 -178.014 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.53 64.52 4.64 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.593 3.529 . . . . 3.86 109.192 167.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.02 -60.69 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.807 1.643 . . . . 4.79 108.254 -154.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 171.59 -70.25 0.12 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 123.798 0.714 . . . . 3.34 112.464 -178.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -118.11 -175.75 2.92 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.594 0.711 . . . . 5.98 112.812 -161.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -85.05 145.74 27.53 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.329 0.863 . . . . 3.73 113.329 -176.043 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.6 pp -141.93 0.86 1.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.398 1.629 . . . . 3.32 115.398 -178.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -157.46 171.54 20.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.742 1.617 . . . . 3.17 110.005 171.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -155.67 156.84 35.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.347 1.459 . . . . 3.64 113.362 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -147.9 177.6 9.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.796 1.638 . . . . 2.64 113.18 -168.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.09 -164.89 37.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 128.188 2.804 . . . . 3.15 108.93 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -56.51 -28.16 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.133 0.967 . . . . 3.58 113.225 179.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.29 -8.91 58.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 114.336 1.236 . . . . 4.69 114.336 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -135.44 98.32 3.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.247 1.419 . . . . 4.54 108.419 171.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.32 -172.31 4.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.357 0.663 . . . . 5.94 112.518 -164.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -50.12 74.89 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.166 -1.584 . . . . 2.06 114.862 -159.08 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.89 -28.68 70.24 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 118.624 0.647 . . . . 1.76 111.809 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.68 -26.86 60.12 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.282 1.033 . . . . 4.28 112.808 177.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.38 -51.45 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.861 0.865 . . . . 1.27 109.724 167.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.13 93.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.14 0.576 . . . . 1.74 111.603 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.91 95.49 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.534 1.134 . . . . 2.3 113.882 177.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 25.1 p -71.73 -39.0 70.4 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.766 1.166 . . . . 1.92 111.982 174.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.11 -40.0 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.335 1.425 . . . . 1.81 111.772 176.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.36 -22.0 66.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.26 1.024 . . . . 2.73 113.216 171.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 95.0 m -78.64 -40.27 34.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.928 0.891 . . . . 3.19 110.673 170.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -68.53 -21.79 64.55 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.74 1.216 . . . . 2.8 112.974 174.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 2.0 ttp -63.88 -33.26 75.3 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.848 -1.157 . . . . 4.8 112.522 166.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -60.75 -36.22 33.15 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 116.409 -1.757 . . . . 5.53 114.814 -172.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -86.41 -8.65 7.31 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.508 2.805 . . . . 3.31 114.452 167.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -94.99 -171.08 2.34 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.54 1.536 . . . . 4.69 112.471 179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -108.05 168.55 9.21 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.716 -1.24 . . . . 8.29 111.184 159.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.96 -152.62 0.48 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.942 1.297 . . . . 7.68 110.232 179.03 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 193' ' ' LEU . 12.0 mtmt -64.95 99.29 0.34 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 107.022 -1.473 . . . . 9.93 107.022 147.192 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 22.1 t . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 128.522 2.729 . . . . 7.88 113.715 -162.901 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 118.29 -0.862 . . . . 20.69 110.15 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -73.7 -175.21 1.98 Allowed 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.463 0.477 . . . . 20.14 110.254 156.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.6 t -151.47 166.34 31.39 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.824 1.65 . . . . 15.67 109.58 170.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.59 -161.75 27.02 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.903 1.24 . . . . 12.67 114.553 -171.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -151.13 132.01 7.42 Favored Pre-proline 0 CA--C 1.546 0.817 0 O-C-N 121.589 -0.948 . . . . 12.51 111.824 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -79.87 156.88 24.02 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.874 2.383 . . . . 7.54 110.203 168.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.8 155.96 47.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.659 1.583 . . . . 10.81 108.324 168.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 136' ' ' LEU . 1.4 pt? -86.89 164.26 16.69 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.352 1.061 . . . . 5.94 113.402 -179.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 158.25 -171.02 35.08 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.733 2.111 . . . . 3.31 109.871 -174.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.78 63.72 0.61 Allowed Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.24 -1.311 . . . . 3.2 111.458 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.95 135.9 66.08 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.606 2.871 . . . . 3.56 112.084 -169.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -140.91 176.92 8.41 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.571 -1.65 . . . . 2.9 112.516 -168.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.8 t -127.73 132.86 49.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.634 1.974 . . . . 3.68 106.168 159.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 tp -164.56 143.18 6.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.977 0.911 . . . . 2.36 110.319 -176.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.0 m -93.81 140.29 29.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.746 0.703 . . . . 1.55 109.617 -174.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.0 m -101.5 139.32 37.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.829 1.652 . . . . 3.59 110.634 -178.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -16.35 1.37 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.597 2.759 . . . . 2.0 116.842 -169.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 t -76.65 -35.79 57.76 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.468 1.031 . . . . 3.51 112.127 172.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.32 68.42 0.44 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.403 1.477 . . . . 2.82 112.257 -166.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.67 148.21 6.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.164 1.785 . . . . 4.88 108.747 171.292 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -108.36 115.85 30.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.717 1.207 . . . . 4.39 111.662 -175.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -104.5 163.27 12.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.836 1.254 . . . . 4.23 112.574 -173.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -119.84 160.73 22.09 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.613 1.965 . . . . 3.25 108.054 162.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -49.3 -37.37 23.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.0 1.72 . . . . 4.64 111.552 169.352 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -71.23 -31.48 67.62 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.876 1.065 . . . . 7.75 113.876 -177.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.29 -3.77 33.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.101 0.864 . . . . 4.84 113.33 175.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.23 -33.01 59.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.383 0.883 . . . . 4.48 113.383 160.124 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.12 178.78 0.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.966 1.306 . . . . 5.5 113.856 -173.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 8.98 75.44 Favored Glycine 0 N--CA 1.474 1.206 0 O-C-N 121.172 -0.955 . . . . 2.93 113.228 -166.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -156.14 165.45 36.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.088 1.755 . . . . 3.39 109.428 -177.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -69.51 112.25 5.9 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.965 -0.459 . . . . 2.19 112.206 177.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -98.52 122.65 41.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.613 1.165 . . . . 2.77 110.981 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -118.13 109.16 16.07 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.505 -1.665 . . . . 3.0 106.505 176.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.3 pt -111.81 126.82 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.093 0.405 . . . . 3.89 112.093 -170.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.31 149.17 51.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 2.66 112.208 -177.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -122.77 121.27 35.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.428 1.091 . . . . 2.82 109.927 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.38 -178.37 16.95 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 1.68 116.123 -169.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.5 151.34 50.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.683 1.193 . . . . 3.6 111.686 175.366 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 73.9 p -53.63 -30.9 45.09 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.19 1.396 . . . . 4.04 113.831 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -143.17 94.42 2.62 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 108.952 -0.758 . . . . 7.86 108.952 150.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.448 ' C ' ' H ' ' A' ' 171' ' ' ASP . 9.2 t -38.31 166.77 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 128.377 2.671 . . . . 2.36 115.613 160.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -65.54 43.71 0.16 Allowed 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.537 2.825 . . . . 3.59 111.815 146.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 169' ' ' CYS 0.28 29.8 m-20 58.03 11.87 1.62 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 129.154 2.982 . . . . 4.96 116.75 173.913 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.6 -35.99 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.975 0.91 . . . . 2.47 110.708 169.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 38.5 m -53.07 -56.24 25.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.635 -1.65 . . . . 1.78 114.272 175.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.0 -43.47 11.69 Favored 'Trans proline' 0 C--N 1.351 0.7 0 CA-C-N 122.472 1.918 . . . . 1.53 112.149 177.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -51.52 -46.27 63.21 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.826 1.65 . . . . 2.9 112.573 174.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.89 -45.26 24.65 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.121 -0.987 . . . . 2.49 112.316 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -62.49 -29.05 70.26 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.955 -1.091 . . . . 2.49 112.313 -177.388 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -60.42 -52.19 66.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.769 0.828 . . . . 4.0 111.84 168.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -58.08 -50.8 72.2 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 120.17 -1.581 . . . . 2.84 110.801 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -57.22 -53.75 54.57 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.705 -0.664 . . . . 3.73 110.99 175.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 181' ' ' ILE . 5.7 tp -68.08 -38.35 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.479 1.49 . . . . 2.53 111.197 -170.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.598 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 62.1 mt-30 -65.85 -24.08 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 118.1 -0.952 . . . . 2.91 112.168 179.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.18 -19.21 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 120.669 1.577 . . . . 2.66 113.732 173.067 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.25 -40.0 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.11 1.323 . . . . 2.13 109.394 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -55.4 -48.69 73.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.551 1.541 . . . . 3.95 112.401 172.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -70.3 -36.46 74.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.994 0.918 . . . . 3.44 112.83 -177.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -77.76 -27.72 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.083 -1.011 . . . . 2.04 112.823 177.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.79 -48.74 79.27 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.244 1.018 . . . . 3.35 109.133 165.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.6 t -64.49 -26.73 68.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.405 0.891 . . . . 2.97 113.405 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.1 mm -59.0 -30.87 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.604 1.161 . . . . 3.36 111.786 172.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.4 m 73.47 -36.32 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.788 2.035 . . . . 4.32 113.553 167.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 80.1 p -78.94 24.3 0.31 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.644 1.978 . . . . 5.63 113.11 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.2 mt -134.21 156.28 79.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.345 1.858 . . . . 4.34 110.456 174.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.83 -75.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.131 2.554 . . . . 3.01 109.625 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.61 167.28 30.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.842 2.057 . . . . 3.47 108.06 162.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.17 114.7 26.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.275 1.43 . . . . 1.81 108.705 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 91.5 m -108.38 94.58 13.84 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 123.312 0.645 . . . . 2.02 110.887 -168.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.98 131.06 5.86 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.813 2.342 . . . . 1.61 110.885 170.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.01 139.19 49.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.533 1.159 . . . . 3.8 111.621 168.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -109.94 123.65 50.01 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.51 1.924 . . . . 2.53 109.272 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.9 mt -108.79 115.02 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.887 0.875 . . . . 1.75 109.554 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.0 t -83.71 104.69 14.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 2.58 108.649 176.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.5 pt -79.27 35.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 122.013 0.911 . . . . 1.88 111.823 -178.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -126.93 46.94 2.2 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 127.291 2.236 . . . . 3.9 111.301 -160.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -13.26 36.89 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.456 2.77 . . . . 2.46 114.302 -163.104 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -76.88 9.93 2.58 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.906 1.283 . . . . 3.99 113.33 174.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -163.44 25.08 0.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.866 1.432 . . . . 4.49 114.866 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -71.21 152.79 43.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.112 0.958 . . . . 5.7 111.814 172.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 4.4 m -154.81 122.47 5.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.079 1.752 . . . . 2.75 106.499 164.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -46.56 -48.08 19.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.796 1.238 . . . . 3.98 113.105 -170.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.43 -30.47 61.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.547 1.139 . . . . 5.12 113.525 177.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.14 73.66 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.066 -1.021 . . . . 1.83 110.755 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.15 -42.94 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 2.66 110.444 173.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.7 77.21 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.333 0.653 . . . . 1.7 112.586 176.072 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -65.66 -45.97 80.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.452 0.701 . . . . 4.38 112.56 176.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -49.98 -45.22 51.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.027 0.931 . . . . 2.78 111.387 170.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.4 t -72.56 -39.7 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.74 1.015 . . . . 2.16 113.74 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -57.68 -50.5 72.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.214 -0.898 . . . . 4.09 113.291 -176.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -69.6 -17.25 63.52 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.318 1.229 . . . . 6.61 114.318 -165.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.82 -32.62 72.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.195 0.907 . . . . 2.5 112.639 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 t 138.2 129.25 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 131.032 3.733 . . . . 2.83 109.711 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.32 8.13 1.25 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.549 2.833 . . . . 2.25 116.018 -166.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -73.19 -16.06 61.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.036 1.289 . . . . 2.36 112.73 161.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.04 137.56 43.48 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.449 -0.782 . . . . 1.79 109.223 166.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.57 148.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.377 0.671 . . . . 2.47 112.156 171.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -113.69 138.68 15.1 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 124.501 1.048 . . . . 1.04 112.865 -177.101 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.83 148.32 40.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 114.758 1.392 . . . . 2.07 114.758 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.2 p -155.12 170.61 21.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.576 2.35 . . . . 2.29 110.19 -179.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.39 -173.63 37.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.612 1.101 . . . . 1.94 111.447 179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.8 t -65.27 162.99 16.24 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.161 0.48 . . . . 2.61 110.553 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -56.64 -31.84 64.75 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.34 -0.85 . . . . 6.54 112.233 -176.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 18.9 mp0 -72.14 -35.75 69.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.799 2.04 . . . . 3.68 111.045 178.499 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.66 -39.72 76.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.747 -0.595 . . . . 3.15 111.881 169.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.21 -36.47 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.965 0.906 . . . . 2.19 111.951 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.15 -46.24 43.65 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.473 1.033 . . . . 4.24 110.113 173.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -46.08 -50.68 14.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.622 0.769 . . . . 3.31 110.8 173.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.44 -43.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.123 0.969 . . . . 2.48 111.803 -174.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.55 87.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.806 0.842 . . . . 2.02 111.906 173.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.83 -32.09 35.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.236 1.814 . . . . 6.21 113.013 -177.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.56 -60.86 2.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.835 1.254 . . . . 2.16 112.235 176.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -74.68 -6.13 47.01 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.578 0.955 . . . . 2.46 113.578 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 66.66 54.89 0.81 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.63 1.972 . . . . 5.1 113.319 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.07 152.27 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.759 2.024 . . . . 3.29 110.54 177.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -103.67 145.93 29.33 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.009 1.114 . . . . 4.91 114.009 -176.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -129.87 142.63 50.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.536 1.934 . . . . 3.81 111.354 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 42.4 t -128.92 106.14 18.28 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 124.059 0.944 . . . . 4.56 111.136 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.74 153.28 8.75 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.478 2.785 . . . . 3.45 111.138 170.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.9 175.26 47.86 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 114.75 0.66 . . . . 3.36 114.75 176.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -85.69 -168.42 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 124.695 3.596 . . . . 4.66 110.908 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -105.06 120.55 41.76 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.841 -0.8 . . . . 4.47 108.841 148.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -151.61 156.15 39.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.487 1.515 . . . . 7.46 109.227 175.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 63.11 -48.81 0.21 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.594 2.758 . . . . 8.51 112.318 -160.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -173.9 -55.24 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.793 3.237 . . . . 6.47 109.223 170.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -142.11 19.1 2.1 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.274 1.03 . . . . 5.95 113.103 -159.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -46.56 139.95 4.72 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.413 -1.43 . . . . 4.87 113.518 175.023 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -143.85 48.42 1.41 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.611 1.564 . . . . 5.54 111.676 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.61 150.17 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.883 -1.136 . . . . 3.26 110.917 155.011 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.3 m -156.44 152.63 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.024 1.73 . . . . 5.22 107.605 -178.24 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -150.86 145.18 25.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.964 1.364 . . . . 5.94 112.077 -179.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -133.13 95.99 3.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.413 1.085 . . . . 2.34 109.92 170.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.0 t -72.54 58.26 0.42 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.852 1.661 . . . . 5.76 110.461 173.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.4 pp -113.09 158.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 122.472 1.13 . . . . 5.53 113.827 -167.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 29.7 pt -107.55 163.63 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.328 1.451 . . . . 3.89 109.014 161.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 76.5 mtp -97.51 159.01 15.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.739 0.816 . . . . 2.66 109.869 161.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.32 142.02 45.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.414 0.686 . . . . 2.82 111.116 165.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 49.2 tp -92.12 118.07 30.46 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 106.535 -1.654 . . . . 2.04 106.535 158.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.18 136.02 31.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.617 -1.623 . . . . 2.79 106.617 164.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -71.48 172.07 45.82 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 2.21 111.968 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.17 -13.44 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.191 2.594 . . . . 3.49 113.094 177.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -113.57 -0.14 14.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 129.713 3.205 . . . . 4.42 112.178 -176.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 108.34 -148.67 16.78 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.917 1.722 . . . . 4.28 113.072 -176.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.81 158.64 0.13 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.428 2.691 . . . . 5.91 116.543 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -88.86 85.78 6.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.813 1.245 . . . . 3.92 108.854 172.388 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 2.3 tt -86.31 -36.06 19.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.005 0.922 . . . . 3.2 111.834 -163.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -159.24 159.88 34.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.895 1.678 . . . . 2.61 109.413 175.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -136.46 147.34 47.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 122.676 1.227 . . . . 3.94 113.3 172.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.67 156.34 44.4 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.843 1.257 . . . . 2.39 111.101 -162.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -179.21 170.82 42.63 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.874 1.702 . . . . 2.75 110.036 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.88 -25.35 42.19 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.913 2.19 . . . . 4.48 116.913 -149.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.85 -21.35 25.06 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.512 1.301 . . . . 5.97 114.512 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -57.93 107.07 0.42 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.769 1.628 . . . . 4.09 108.593 178.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -74.93 143.8 43.55 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.395 -1.441 . . . . 6.36 109.813 -157.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 14.1 tmtt? -42.79 -53.0 4.8 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 121.095 1.77 . . . . 2.0 113.438 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.24 -18.38 74.92 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.361 0.904 . . . . 1.58 115.361 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -31.78 17.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.877 1.271 . . . . 4.62 111.395 174.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 66.2 mt -56.36 -43.5 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.103 -0.998 . . . . 1.47 109.901 161.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.46 -53.17 58.75 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.54 0.57 . . . . 1.26 112.54 170.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.05 72.1 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.562 1.319 . . . . 1.5 114.562 -177.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.9 p -68.92 -48.83 62.33 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.446 -0.783 . . . . 1.75 111.07 170.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.24 -34.05 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.28 1.4 . . . . 1.49 111.709 176.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.35 -21.18 62.92 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.118 0.967 . . . . 1.51 113.494 172.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 100.0 m -76.98 -45.65 26.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.722 0.809 . . . . 1.9 109.537 169.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -62.83 -21.11 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.855 1.262 . . . . 2.44 113.402 174.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -66.5 -23.49 66.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.086 1.355 . . . . 4.27 113.287 167.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -59.8 -45.48 98.36 Favored Pre-proline 0 N--CA 1.477 0.891 0 O-C-N 119.971 -1.706 . . . . 5.0 113.277 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.6 -57.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.554 2.169 . . . . 2.12 111.491 164.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -83.63 23.47 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.029 1.862 . . . . 3.65 116.029 -167.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.8 ptt85 -57.3 125.68 23.87 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.606 1.563 . . . . 8.89 111.752 174.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -75.75 142.53 42.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.087 1.355 . . . . 7.45 109.238 166.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 130.22 43.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 117.38 -1.295 . . . . 9.39 108.518 158.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.479 0.997 0 CA-C-N 120.281 1.4 . . . . 8.08 112.532 -179.828 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 117.008 -1.472 . . . . 16.67 107.681 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -49.91 -44.52 50.26 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.544 1.52 . . . . 14.25 111.183 166.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 t -123.31 -173.19 2.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.571 1.149 . . . . 11.46 110.535 158.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.34 117.0 1.35 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.059 1.79 . . . . 10.12 111.031 -172.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -165.36 71.25 1.36 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 125.972 1.709 . . . . 11.59 111.648 -171.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -83.75 176.85 6.64 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.222 3.282 . . . . 8.64 112.393 -171.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.17 -176.9 5.54 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.682 2.393 . . . . 7.34 109.335 177.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.26 174.25 7.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.974 0.806 . . . . 8.11 111.697 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.27 -151.62 21.61 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.383 0.992 . . . . 3.02 111.852 -179.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.9 97.33 1.79 Allowed Glycine 0 CA--C 1.532 1.11 0 N-CA-C 108.149 -1.98 . . . . 3.48 108.149 -161.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.33 134.94 25.73 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.667 2.245 . . . . 3.97 111.772 -161.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -75.51 -179.97 4.92 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.497 1.519 . . . . 2.34 113.194 -172.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.2 m -157.83 62.1 0.47 Allowed 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.246 -1.534 . . . . 3.25 112.695 177.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -98.8 160.74 14.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.556 1.142 . . . . 2.21 110.511 -177.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -103.42 139.86 38.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.635 1.574 . . . . 1.69 111.656 -164.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 34.4 p -94.59 158.93 15.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.877 1.799 . . . . 2.24 115.706 -167.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.461 ' O ' ' HE3' ' A' ' 210' ' ' LYS . 0.3 OUTLIER -57.39 -21.7 37.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.481 1.912 . . . . 1.93 113.327 164.349 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -71.76 -68.85 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.194 1.398 . . . . 3.18 109.086 160.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.28 -12.44 1.6 Allowed Glycine 0 N--CA 1.472 1.081 0 C-N-CA 124.769 1.176 . . . . 1.85 115.114 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.3 153.94 41.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.812 1.306 . . . . 4.2 110.626 166.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -85.26 135.14 34.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.449 -0.574 . . . . 5.21 109.449 153.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -120.27 153.86 35.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.833 0.853 . . . . 3.18 110.198 178.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.1 p -141.14 156.46 45.95 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.701 1.2 . . . . 2.52 110.705 -166.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.09 13.61 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.189 0.996 . . . . 3.93 113.444 168.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -103.67 -32.11 9.55 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.225 -1.547 . . . . 7.56 112.684 167.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -96.81 -22.59 16.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.646 1.178 . . . . 3.28 112.731 177.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -77.83 -15.31 59.16 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.573 0.953 . . . . 3.05 113.573 162.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.37 133.65 56.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.618 1.167 . . . . 3.43 110.551 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.32 6.68 88.51 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.273 -0.892 . . . . 2.33 114.199 -176.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -84.98 -155.73 0.22 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.088 1.444 . . . . 3.3 110.449 163.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -136.12 111.56 9.2 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.003 -1.481 . . . . 1.9 107.003 153.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.22 148.3 41.33 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.483 1.135 . . . . 2.51 113.163 -173.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.43 114.86 27.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.69 1.596 . . . . 2.83 106.977 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.47 111.31 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 106.035 -1.839 . . . . 3.07 106.035 -177.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -108.91 139.99 43.0 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.163 0.982 . . . . 2.23 113.278 -173.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -111.68 92.94 4.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.579 2.352 . . . . 2.15 110.877 175.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -130.69 154.47 20.72 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.426 1.965 . . . . 1.6 109.681 166.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.53 ' CE2' HG11 ' A' ' 258' ' ' VAL . 22.3 m-85 -97.18 157.0 16.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.688 0.744 . . . . 5.83 111.093 -175.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 53.1 p -70.66 -3.71 19.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.388 -1.445 . . . . 3.61 113.336 172.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -67.74 -47.2 69.95 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.215 1.806 . . . . 7.57 114.316 -178.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.9 m -102.92 119.62 54.98 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.448 1.022 . . . . 2.64 113.504 -150.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -90.85 44.34 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.353 2.702 . . . . 5.42 111.16 174.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.88 -104.45 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.138 -1.43 . . . . 6.05 107.138 -157.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.11 -66.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.221 1.808 . . . . 3.43 114.2 171.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 87.6 m -51.49 -48.74 85.7 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.868 1.433 . . . . 1.7 114.868 -174.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.25 -31.63 14.06 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.399 2.066 . . . . 1.27 113.571 175.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -64.37 -36.04 82.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.399 1.454 . . . . 3.39 110.734 171.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -33.71 76.46 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.546 -1.346 . . . . 3.18 112.809 174.625 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.15 -36.96 75.11 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.336 -0.84 . . . . 2.71 112.11 171.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.62 -60.24 3.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.937 1.295 . . . . 4.59 111.423 -178.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -20.01 66.15 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 119.623 -1.923 . . . . 3.05 113.713 175.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 29.8 ttm -70.89 -45.02 65.08 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.636 1.107 . . . . 2.3 111.217 172.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.6 mm -57.33 -47.57 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.311 -0.868 . . . . 2.61 110.076 174.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -54.58 -20.76 8.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.201 1.186 . . . . 4.86 114.201 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.73 -25.79 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.336 1.235 . . . . 2.35 114.336 177.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -54.46 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.62 1.1 . . . . 2.46 108.84 165.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -57.13 -37.87 72.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.475 1.11 . . . . 4.69 113.034 177.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.29 -40.73 50.88 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.345 -0.847 . . . . 2.93 112.814 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mt -66.86 -34.8 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.876 0.762 . . . . 1.83 110.833 178.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.81 -44.89 76.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.541 1.136 . . . . 3.66 111.588 167.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.8 t -64.67 -27.59 69.03 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.393 -1.442 . . . . 3.21 112.862 177.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.86 -19.69 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.218 1.407 . . . . 3.72 112.022 172.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.3 m 73.96 -35.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 127.225 2.21 . . . . 5.38 114.212 162.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -97.63 4.14 50.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.802 1.641 . . . . 4.48 112.96 178.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.73 152.07 37.94 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.255 -1.017 . . . . 3.23 108.255 158.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -94.95 -23.18 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.742 2.295 . . . . 3.79 114.474 -162.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.7 t70 170.65 150.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.333 2.653 . . . . 3.66 110.334 -173.539 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 11.0 tp -132.28 100.39 5.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.182 1.793 . . . . 2.2 108.376 156.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 m -81.71 121.71 79.77 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-O 118.118 -0.944 . . . . 1.72 110.906 -178.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.24 117.96 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.128 3.218 . . . . 1.48 110.409 168.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.32 119.12 34.69 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 2.49 109.224 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -102.76 112.66 25.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.983 0.913 . . . . 2.5 110.66 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.481 HG22 HG23 ' A' ' 203' ' ' ILE . 9.5 mm -82.55 122.51 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 107.254 -1.387 . . . . 1.51 107.254 165.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.9 p -71.66 -29.46 64.64 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.499 1.666 . . . . 3.13 115.499 -175.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 201' ' ' ILE 0.329 14.1 pt 53.2 -6.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 119.825 3.269 . . . . 3.08 119.825 168.752 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -119.87 62.27 7.75 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.485 1.914 . . . . 3.56 112.196 161.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -59.3 140.49 94.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 107.95 -1.596 . . . . 2.4 107.95 161.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 108.8 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.394 3.878 . . . . 4.88 112.357 -174.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -107.61 4.74 26.24 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.161 0.892 . . . . 5.33 112.303 163.163 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.41 -179.44 7.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.39 1.476 . . . . 5.58 112.246 -175.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.6 m -167.27 129.67 1.68 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 128.129 2.572 . . . . 2.27 105.791 162.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 145' ' ' HIS . 1.2 tmtp? -54.08 -43.47 70.36 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.472 0.709 . . . . 3.13 112.478 -175.461 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -67.81 -31.52 71.43 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.741 1.617 . . . . 3.1 113.256 173.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.02 73.79 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.566 -1.334 . . . . 1.29 111.768 175.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.94 -38.15 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.537 0.735 . . . . 2.41 111.036 170.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.9 69.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.838 0.745 . . . . 1.56 112.822 174.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.01 -49.33 52.47 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.357 -0.84 . . . . 4.48 111.584 170.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.16 -30.94 71.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.708 0.633 . . . . 2.88 112.708 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.58 -60.21 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.005 1.322 . . . . 1.6 110.92 162.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -62.18 -30.74 71.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.388 0.884 . . . . 5.36 113.388 -174.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.22 -34.94 72.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.23 1.412 . . . . 4.63 111.964 -177.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -108.67 -21.41 12.71 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.689 1.366 . . . . 3.39 114.689 -174.183 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.4 p 159.17 151.38 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.888 2.475 . . . . 2.58 112.015 167.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.54 -3.29 10.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.861 2.374 . . . . 2.06 114.413 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -87.07 -8.62 56.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.008 1.276 . . . . 2.12 113.395 171.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.64 123.19 18.2 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.029 -1.669 . . . . 2.88 109.567 171.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.36 116.17 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.293 -1.002 . . . . 2.6 108.293 165.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.57 141.51 15.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.458 1.028 . . . . 1.12 111.271 -177.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.44 151.29 37.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.961 1.097 . . . . 2.77 113.961 -175.229 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 25.5 p -133.53 170.78 15.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.588 3.155 . . . . 3.07 108.908 -176.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.81 161.06 15.04 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.902 1.715 . . . . 2.03 109.455 -173.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.4 p -69.03 169.11 12.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.048 1.424 . . . . 3.01 112.266 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -40.7 -43.4 1.95 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.973 1.709 . . . . 5.57 112.732 170.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -67.53 -38.38 84.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.505 1.122 . . . . 3.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.51 -47.63 59.53 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.119 -0.988 . . . . 3.47 111.453 174.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.1 m -65.6 -24.77 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.851 0.686 . . . . 2.85 112.851 177.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.11 -33.43 29.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.194 0.906 . . . . 3.03 112.34 169.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -59.61 -51.48 69.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.42 1.464 . . . . 2.6 110.655 171.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.52 -20.64 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.31 0.485 . . . . 2.1 112.31 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -69.4 -54.37 14.77 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.947 0.794 . . . . 2.0 110.789 167.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.75 -45.09 82.22 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.258 1.423 . . . . 3.12 111.844 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -52.41 -56.45 14.96 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.335 1.054 . . . . 2.22 112.404 -175.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -91.53 10.72 26.73 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.122 -0.986 . . . . 3.31 113.576 176.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 61.24 33.45 19.13 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.343 1.457 . . . . 5.2 113.655 177.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.32 147.96 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.535 2.334 . . . . 2.99 110.447 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -119.83 153.16 36.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.421 1.105 . . . . 5.85 113.413 168.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -124.45 146.33 48.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 6.26 109.317 171.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 259' ' ' ASP . 26.2 m -123.51 72.29 49.56 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.721 1.208 . . . . 3.69 110.329 -179.269 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.66 125.03 10.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.603 2.202 . . . . 3.03 111.574 -171.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.96 136.33 14.15 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.454 -1.192 . . . . 2.43 111.377 178.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -80.98 58.1 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.17 3.246 . . . . 4.31 109.851 177.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt 72.24 164.22 0.28 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.967 2.507 . . . . 5.2 113.997 -157.489 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -149.39 149.59 31.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.079 1.752 . . . . 8.69 109.52 176.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 54.82 -63.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.468 2.307 . . . . 8.17 112.485 -149.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 169.85 -38.88 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 131.293 3.837 . . . . 6.85 108.792 -172.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.63 -28.51 12.46 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.658 1.725 . . . . 7.09 115.658 -173.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.49 154.77 32.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.006 1.276 . . . . 4.18 111.721 179.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.84 79.75 1.44 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.039 -1.038 . . . . 4.32 109.771 166.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.97 167.14 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.817 1.247 . . . . 2.95 112.744 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 166' ' ' PHE . 58.6 t -149.62 129.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 105.392 -2.077 . . . . 3.2 105.392 156.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 246' ' ' SER . 0.8 OUTLIER -87.16 158.34 19.17 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.267 0.94 . . . . 3.63 110.451 167.809 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.06 132.98 7.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.499 1.296 . . . . 2.44 114.499 -153.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -63.72 -12.8 37.71 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.713 2.116 . . . . 3.65 116.713 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . 0.31 5.8 tt 43.48 55.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 126.211 1.804 . . . . 3.37 115.441 169.26 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 22.3 mm -103.46 146.41 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.694 1.198 . . . . 2.92 111.005 174.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 77.3 mtp -108.3 117.11 33.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.789 1.636 . . . . 2.33 109.987 158.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.76 135.68 39.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.975 0.91 . . . . 2.59 112.694 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 56.6 tp -93.61 118.23 31.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.283 1.033 . . . . 2.17 110.998 178.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.4 148.88 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.43 1.092 . . . . 2.36 108.333 169.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -175.32 -142.17 4.02 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.481 -1.177 . . . . 2.79 112.43 -172.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -88.56 70.43 2.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.399 2.733 . . . . 3.02 110.069 -171.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -169.96 -67.93 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.113 1.365 . . . . 4.66 108.678 -163.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.82 -4.54 69.39 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 116.543 -2.254 . . . . 2.96 116.658 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.44 -47.84 6.39 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.497 2.148 . . . . 6.05 111.742 176.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 162.24 121.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.436 2.694 . . . . 4.31 111.051 171.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.83 -46.9 6.69 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.207 0.817 . . . . 4.27 113.207 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -169.74 164.18 9.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.526 1.93 . . . . 2.57 109.237 -170.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -158.39 135.02 9.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.838 1.255 . . . . 3.66 112.993 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -114.57 118.49 33.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.608 1.163 . . . . 2.35 108.711 -176.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.12 112.5 3.47 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 118.936 -0.924 . . . . 3.82 111.386 -174.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 52.62 60.72 3.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.47 1.129 . . . . 3.11 108.723 -155.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.7 p30 42.68 -147.58 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.401 2.28 . . . . 7.41 114.244 -172.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -147.31 -4.93 0.51 Allowed 'General case' 0 CA--C 1.549 0.91 0 O-C-N 120.297 -1.502 . . . . 4.56 114.018 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 72.61 136.39 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.03 2.932 . . . . 8.01 109.243 -163.498 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -47.53 63.81 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.375 1.621 . . . . 2.66 115.375 -155.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.82 -17.14 73.0 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 123.925 0.774 . . . . 1.62 114.518 -175.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.71 -29.02 61.05 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.327 1.063 . . . . 5.44 111.582 174.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.09 -40.72 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.585 -0.697 . . . . 1.52 109.477 174.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.99 88.09 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.951 -0.468 . . . . 1.49 111.599 171.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.06 79.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.185 0.809 . . . . 1.87 113.185 176.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 60.5 p -59.74 -60.2 4.22 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.514 0.726 . . . . 2.21 111.721 174.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 32.4 mm -58.92 -35.52 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 119.305 0.957 . . . . 2.81 111.95 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.28 73.69 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.483 -0.761 . . . . 1.8 112.932 175.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 90.8 m -76.09 -36.51 58.89 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.999 1.32 . . . . 2.01 110.806 173.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.038 0.835 . . . . 3.08 112.025 173.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 32.5 mmt -65.55 -10.2 33.04 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.667 -1.27 . . . . 5.4 114.043 168.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -57.07 2.88 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 116.39 -1.766 . . . . 7.47 112.081 172.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.55 -51.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.043 2.495 . . . . 2.4 112.738 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -72.08 169.66 15.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.839 0.856 . . . . 3.38 110.948 176.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 36.6 mmt-85 -113.91 144.33 43.23 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.604 -1.31 . . . . 8.75 112.521 -167.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -68.8 146.23 53.07 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.267 1.827 . . . . 7.23 111.562 176.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -128.83 54.36 1.79 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.529 1.059 . . . . 10.94 111.042 176.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 C--O 1.255 1.367 0 C-N-CA 129.966 3.306 . . . . 9.0 107.768 -147.097 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_